data_1hzk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hzk _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.485 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 47.7 Cg_endo . . . . . 0 C--O 1.215 -0.636 0 N-CA-C 110.226 -0.721 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -140.62 123.18 16.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 110.796 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -141.52 100.22 3.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.502 -0.749 . . . . 0.0 109.119 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.11 172.12 13.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 110.978 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 6' ' ' VAL . 5.2 p -137.02 128.44 42.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.642 -0.661 . . . . 0.0 109.612 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.635 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.1 m -46.62 -72.89 0.12 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.117 . . . . 0.0 110.221 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.635 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 53.0 Cg_endo -75.9 97.77 1.14 Allowed 'Trans proline' 0 N--CA 1.483 0.87 0 O-C-N 123.04 1.021 . . . . 0.0 110.031 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.32 4.4 41.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.13 -0.981 . . . . 0.0 110.25 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.6 p -155.57 167.7 29.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 110.245 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.39 42.22 97.37 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.541 ' O ' ' CE2' ' A' ' 109' ' ' PHE . 85.3 mt -90.43 136.83 32.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.303 -1.116 . . . . 0.0 110.137 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.462 ' HB2' ' OE1' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -110.75 156.53 20.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 110.459 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.22 119.28 6.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.04 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.42 -35.5 4.86 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.462 ' OE1' ' HB2' ' A' ' 13' ' ' SER . 33.4 tt0 -48.72 142.65 5.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -1.116 . . . . 0.0 110.044 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 58.9 p -95.3 161.6 14.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.351 -0.843 . . . . 0.0 110.597 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.497 ' CG1' HG13 ' A' ' 67' ' ' VAL . 16.5 m -132.29 151.07 34.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.412 -0.805 . . . . 0.0 109.636 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 1.5 m -99.35 122.02 41.9 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.063 -1.023 . . . . 0.0 109.804 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.483 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 7.4 t -110.95 146.47 15.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.38 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.0 p -140.68 128.64 21.97 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.389 -0.819 . . . . 0.0 110.397 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 39.9 t -121.66 100.78 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.4 OUTLIER -130.23 110.21 11.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.978 . . . . 0.0 110.251 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 169.32 -50.71 0.21 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.526 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -59.97 -138.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -1.131 . . . . 0.0 109.883 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.538 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -179.11 164.56 1.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.976 -1.078 . . . . 0.0 110.347 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 56' ' ' ASP . . . -54.26 128.89 33.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.398 -0.814 . . . . 0.0 110.479 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 119.69 18.92 4.24 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 9.5 mm-40 -154.9 127.31 7.87 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.235 -1.156 . . . . 0.0 110.457 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.471 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -93.56 170.1 9.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.344 -0.848 . . . . 0.0 109.952 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 79.5 m-85 -152.94 155.44 37.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.416 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 78.8 m-85 -122.81 111.25 16.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.663 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.48 ' CG2' HG22 ' A' ' 51' ' ' THR . 5.4 tt -95.98 120.91 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.102 -0.999 . . . . 0.0 110.433 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.66 160.37 43.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.112 -0.992 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.522 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 25.3 tt0 -114.15 133.56 55.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.64 -0.662 . . . . 0.0 109.219 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 66.0 m -139.49 156.24 47.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.985 -1.072 . . . . 0.0 111.146 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.63 144.0 16.92 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 41.6 Cg_endo -69.97 159.95 51.38 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.819 1.431 . . . . 0.0 110.68 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.516 ' CG1' HG23 ' A' ' 84' ' ' VAL . 6.6 m . . . . . 0 C--N 1.299 -1.618 0 O-C-N 121.517 -0.739 . . . . 0.0 110.02 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 7.1 m-20 . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 121.286 0.565 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -144.89 151.69 39.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.18 -0.95 . . . . 0.0 110.321 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 m -131.23 155.11 47.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.309 -0.869 . . . . 0.0 110.199 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.468 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 36.2 t-20 -87.9 124.08 67.78 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.07 -1.019 . . . . 0.0 110.195 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.402 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 53.0 Cg_endo -81.83 -41.06 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.898 1.473 . . . . 0.0 111.046 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.63 93.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.321 -0.862 . . . . 0.0 111.021 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 47.7 p -80.64 7.14 10.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.142 -0.974 . . . . 0.0 110.365 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 47' ' ' PRO . . . -75.78 104.98 6.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 110.223 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.48 HG22 ' CG2' ' A' ' 33' ' ' ILE . 9.8 t -136.9 163.16 31.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.884 . . . . 0.0 110.197 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -132.8 162.19 32.13 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 110.241 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 46.6 p90 -151.23 171.06 18.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.439 -0.788 . . . . 0.0 109.659 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.6 m -130.97 155.99 45.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.137 -0.977 . . . . 0.0 110.139 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.526 ' CG2' ' HB3' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -88.75 176.11 7.22 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.095 -1.003 . . . . 0.0 110.187 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.531 ' HA ' ' CB ' ' A' ' 27' ' ' ALA . 11.0 t70 -177.13 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.183 -0.948 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.43 86.92 0.07 Allowed 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.212 -0.93 . . . . 0.0 109.13 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.95 15.95 8.8 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.538 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 79.1 52.27 4.97 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.07 149.22 28.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -1.168 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.452 ' HB1' ' HB ' ' A' ' 22' ' ' VAL . . . -163.53 78.37 0.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 110.526 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.8 m -101.55 130.28 47.81 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.294 -0.879 . . . . 0.0 109.706 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.483 ' CE1' ' CG1' ' A' ' 20' ' ' VAL . 1.7 p90 -153.32 171.3 18.79 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.005 -1.059 . . . . 0.0 111.086 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.1 m -92.94 125.51 37.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.449 -0.782 . . . . 0.0 110.642 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.496 ' HB3' HG21 ' A' ' 18' ' ' VAL . 28.8 t80 -118.47 -173.07 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.597 -0.689 . . . . 0.0 109.375 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 3.9 t -147.76 167.78 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 120.756 -1.215 . . . . 0.0 110.371 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.497 HG13 ' CG1' ' A' ' 18' ' ' VAL . 13.1 m -139.37 161.78 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 0.0 110.243 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -143.35 122.79 13.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.262 -0.899 . . . . 0.0 110.097 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ARG . 2.7 ttpt -45.63 -48.19 14.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.044 -1.035 . . . . 0.0 109.365 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 85' ' ' ASP . 6.6 m -127.3 123.81 37.27 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.58 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 28.3 p90 -125.13 140.18 53.11 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.079 -1.013 . . . . 0.0 111.28 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 85.7 m -58.35 99.91 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.396 -0.815 . . . . 0.0 109.957 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.443 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -101.67 177.15 26.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.206 -1.173 . . . . 0.0 110.193 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 19.4 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.569 0.699 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.516 HG23 ' CG1' ' A' ' 39' ' ' VAL . 40.6 t -125.02 148.63 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 59.3 p30 -127.23 166.22 18.16 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.063 -1.023 . . . . 0.0 110.721 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -112.71 1.77 15.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.499 -0.751 . . . . 0.0 110.414 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.32 -58.26 4.66 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.69 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -81.64 -27.38 34.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.116 -0.99 . . . . 0.0 110.501 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.05 176.99 4.78 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.39 155.88 22.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.8 m -116.93 139.11 51.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 0.0 110.185 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -123.29 125.73 45.58 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 110.322 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -102.02 108.52 19.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.283 -0.886 . . . . 0.0 109.078 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.2 163.5 12.38 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.498 -1.334 . . . . 0.0 110.141 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 33' ' ' ILE . . . -155.16 118.27 4.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.449 -1.03 . . . . 0.0 109.872 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.61 -177.06 46.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -118.15 177.41 4.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -1.136 . . . . 0.0 110.265 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.0 t -70.64 -20.12 62.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.127 -0.983 . . . . 0.0 110.146 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.1 -44.05 5.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.497 HD11 ' N ' ' A' ' 101' ' ' ASP . 3.4 tm? -118.87 135.74 54.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.242 -1.152 . . . . 0.0 109.938 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.497 ' N ' HD11 ' A' ' 100' ' ' LEU . 41.0 m-20 -116.12 101.66 8.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.0 . . . . 0.0 110.322 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 19.8 mt -66.03 -61.16 2.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 110.003 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.12 -173.98 30.46 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -148.26 150.38 33.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.466 -1.02 . . . . 0.0 110.117 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.0 t -107.77 126.02 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.329 -0.857 . . . . 0.0 110.335 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.9 114.06 10.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.914 . . . . 0.0 109.841 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.522 ' CD1' ' OE1' ' A' ' 35' ' ' GLN . 58.1 mt -81.4 147.03 30.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.94 . . . . 0.0 110.573 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -127.74 158.16 38.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.853 . . . . 0.0 110.096 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 13.1 m-85 -128.74 92.26 3.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.275 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 N--CA 1.481 0.786 0 N-CA-C 110.423 -0.645 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -162.14 115.5 1.79 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.88 . . . . 0.0 110.405 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.577 ' CE2' HG23 ' A' ' 105' ' ' VAL . 51.5 t80 -126.96 114.85 18.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.2 m -143.76 170.35 16.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.06 -1.025 . . . . 0.0 110.593 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.52 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 4.0 p -134.5 138.4 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.386 -0.821 . . . . 0.0 110.239 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -54.84 -57.13 20.79 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.357 -0.839 . . . . 0.0 110.962 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 7' ' ' SER . 42.4 Cg_endo -69.09 -87.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.864 1.455 . . . . 0.0 110.797 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.52 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 71.53 14.19 6.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.283 -0.885 . . . . 0.0 109.836 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.2 t -178.13 149.13 0.53 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.88 45.92 62.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.433 HD23 ' HB2' ' A' ' 8' ' ' PRO . 17.2 mt -98.79 174.3 6.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.326 -1.102 . . . . 0.0 110.231 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.81 159.72 44.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 110.12 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.522 ' HB3' ' CB ' ' A' ' 69' ' ' LYS . 1.5 p30 -59.76 116.33 3.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.265 -0.897 . . . . 0.0 110.206 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.41 -33.6 6.07 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -45.68 154.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -1.108 . . . . 0.0 110.106 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.521 ' O ' ' NE2' ' A' ' 16' ' ' GLN . 5.5 t -98.53 172.03 7.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.54 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.441 ' CG1' HG11 ' A' ' 67' ' ' VAL . 8.4 m -149.09 154.68 9.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.385 -0.822 . . . . 0.0 109.9 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 0.4 OUTLIER -111.6 114.83 28.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.257 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.7 t -103.72 152.01 6.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.323 -0.861 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 18.8 t -149.36 132.56 16.39 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.492 -0.755 . . . . 0.0 109.998 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 6.6 t -124.09 153.24 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 110.338 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 1.0 OUTLIER -161.29 120.01 2.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.26 4.85 3.93 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.566 ' CB ' ' CG2' ' A' ' 55' ' ' THR . . . -103.61 -30.04 10.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.998 -1.295 . . . . 0.0 110.374 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.531 ' HA ' ' HA3' ' A' ' 59' ' ' GLY . . . 58.57 133.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.816 0.817 . . . . 0.0 111.43 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -39.08 141.63 0.29 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.538 0.685 . . . . 0.0 110.505 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.19 -10.11 13.44 Favored Glycine 0 C--N 1.288 -2.137 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 5.1 mm-40 -125.39 123.49 39.44 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.376 -1.073 . . . . 0.0 109.829 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.544 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 71.5 m -97.52 159.62 14.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.386 -0.821 . . . . 0.0 109.767 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 50.4 m-85 -147.38 153.16 39.3 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.192 -0.942 . . . . 0.0 110.344 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.502 ' CD1' ' HB2' ' A' ' 52' ' ' SER . 88.1 m-85 -115.54 108.82 16.95 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 109.372 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.455 ' CG2' HG22 ' A' ' 51' ' ' THR . 4.5 tt -98.39 128.35 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.124 -0.985 . . . . 0.0 110.73 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.57 152.0 32.31 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.306 -0.871 . . . . 0.0 110.458 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.4 135.06 33.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.845 . . . . 0.0 109.615 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.6 m -147.21 159.46 43.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 0.0 110.684 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.76 157.0 34.67 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.602 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.39 163.38 38.78 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.751 1.395 . . . . 0.0 110.764 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.699 0.762 . . . . 0.0 109.756 179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.211 0.529 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.5 158.68 15.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.913 . . . . 0.0 110.427 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.2 168.04 15.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.291 -0.881 . . . . 0.0 110.186 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.525 ' OD1' ' CG ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -104.25 102.74 34.66 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 109.923 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.15 -29.28 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.986 1.519 . . . . 0.0 110.437 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.82 -27.44 68.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.365 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 40.0 p -111.29 30.31 7.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.394 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.3 128.32 34.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 109.929 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.455 HG22 ' CG2' ' A' ' 33' ' ' ILE . 9.0 t -138.22 131.94 31.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.96 . . . . 0.0 110.543 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.502 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 28.8 t -111.91 142.55 44.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.408 -0.808 . . . . 0.0 109.952 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 45.9 p90 -144.24 -174.98 4.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.316 -0.865 . . . . 0.0 110.342 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 55' ' ' THR . 28.2 m -150.01 151.34 33.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.95 . . . . 0.0 109.796 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.566 ' CG2' ' CB ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -56.19 -160.67 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.024 -1.048 . . . . 0.0 110.529 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -153.92 -158.29 0.85 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.091 -1.006 . . . . 0.0 110.36 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.27 74.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.873 -1.142 . . . . 0.0 109.671 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.2 m -84.15 10.63 9.74 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.343 -0.848 . . . . 0.0 109.341 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.531 ' HA3' ' HA ' ' A' ' 26' ' ' ALA . . . 52.5 53.76 30.56 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.81 113.3 13.33 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.242 -1.152 . . . . 0.0 110.086 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -101.54 80.93 2.11 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.396 -0.815 . . . . 0.0 109.806 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 62.1 p -114.67 125.97 54.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 110.118 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.4 p90 -154.59 176.07 12.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.314 -0.866 . . . . 0.0 110.575 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 89.6 p -97.63 119.26 35.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.488 -0.757 . . . . 0.0 110.485 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 51.6 t80 -115.93 174.78 5.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.336 -0.852 . . . . 0.0 109.621 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.562 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 12.6 t -125.48 163.97 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.909 -1.119 . . . . 0.0 110.419 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.441 HG11 ' CG1' ' A' ' 18' ' ' VAL . 27.9 m -132.91 173.79 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.269 -0.894 . . . . 0.0 110.216 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -148.72 151.29 34.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.292 -0.88 . . . . 0.0 110.125 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.522 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 6.7 tttt -83.93 -39.86 19.25 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.235 -0.916 . . . . 0.0 109.884 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.8 p -132.85 147.29 52.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 109.753 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 12.6 p90 -165.92 148.33 7.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.961 -1.087 . . . . 0.0 111.028 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 13.0 m -64.08 123.3 18.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.311 -0.868 . . . . 0.0 109.638 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.04 175.29 15.88 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.373 -1.075 . . . . 0.0 109.854 179.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.8 p . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.454 0.645 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.0 t -131.69 102.32 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.47 -0.769 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.94 141.02 28.84 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.844 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.97 15.07 28.37 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.365 -0.835 . . . . 0.0 110.407 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.55 -59.74 2.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.511 HG23 ' N ' ' A' ' 89' ' ' ALA . 12.7 t -77.37 -20.08 55.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.511 ' N ' HG23 ' A' ' 88' ' ' THR . . . -103.64 -163.2 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.887 . . . . 0.0 110.126 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.84 144.45 45.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.317 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.57 133.69 53.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.198 -0.939 . . . . 0.0 109.895 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -142.53 132.98 25.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 110.594 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 33' ' ' ILE . 16.5 tp -93.45 118.03 30.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.883 . . . . 0.0 109.247 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.569 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -112.43 152.04 17.95 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.447 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -148.59 134.53 19.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.585 -0.95 . . . . 0.0 109.872 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.53 165.65 32.47 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.781 -1.2 . . . . 0.0 110.145 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -83.58 -157.14 0.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -1.102 . . . . 0.0 110.088 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.7 t -82.11 -31.11 30.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 110.26 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.08 -15.32 4.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.32 125.35 46.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -1.159 . . . . 0.0 110.143 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 101' ' ' ASP . 3.9 p30 -109.33 115.9 30.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.159 -0.963 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 81.7 mt -80.48 -62.08 1.78 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.151 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.55 -179.03 42.29 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.445 -1.36 . . . . 0.0 110.512 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.569 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 1.5 m-70 -137.41 121.35 17.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.744 -0.856 . . . . 0.0 109.673 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.577 HG23 ' CE2' ' A' ' 4' ' ' PHE . 93.2 t -94.07 123.7 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 0.0 110.145 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.82 105.05 5.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 110.305 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 39.0 mt -78.5 132.25 37.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 110.164 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.06 149.71 39.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -110.27 169.4 8.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 110.198 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.563 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.463 ' CG ' ' CD2' ' A' ' 102' ' ' LEU . 45.8 Cg_endo . . . . . 0 C--O 1.214 -0.72 0 N-CA-C 109.906 -0.844 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -111.2 129.77 55.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.32 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 5.5 t80 -148.73 112.16 5.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.233 -0.917 . . . . 0.0 109.589 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.19 148.96 28.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 111.0 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 p -107.01 174.55 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.45 -0.781 . . . . 0.0 109.525 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.657 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -81.97 -70.54 0.15 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.987 -1.071 . . . . 0.0 109.969 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.657 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 56.1 Cg_endo -83.15 91.12 0.94 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 O-C-N 122.972 0.985 . . . . 0.0 109.906 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.34 -1.52 55.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.891 -1.131 . . . . 0.0 110.687 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.0 m -138.28 118.88 13.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.196 -0.94 . . . . 0.0 109.979 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.46 72.88 1.13 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 109' ' ' PHE . 12.9 mt -95.3 167.41 11.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.327 -1.102 . . . . 0.0 110.41 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.54 ' HB2' ' CB ' ' A' ' 16' ' ' GLN . 51.7 m -115.42 140.75 48.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 110.358 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 14' ' ' ASP . 24.1 p30 -65.09 128.28 35.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.33 -0.856 . . . . 0.0 110.811 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.1 -26.77 6.53 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.54 ' CB ' ' HB2' ' A' ' 13' ' ' SER . 29.9 tt0 -62.2 149.08 42.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.126 . . . . 0.0 110.72 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -96.35 146.76 24.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.455 -0.778 . . . . 0.0 110.15 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.469 HG11 HG22 ' A' ' 67' ' ' VAL . 27.4 m -118.33 156.49 20.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.26 -0.9 . . . . 0.0 109.892 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.35 124.57 38.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.185 -0.947 . . . . 0.0 109.919 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.3 t -111.08 145.67 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.231 -0.918 . . . . 0.0 109.824 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.6 127.29 18.07 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.387 -0.821 . . . . 0.0 110.351 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 98.1 t -124.97 137.39 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.293 -0.88 . . . . 0.0 110.15 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 73.8 m -150.21 116.54 5.72 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.984 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 157.58 -64.78 0.3 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.481 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -52.82 -175.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -1.124 . . . . 0.0 110.018 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.525 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -150.88 150.01 30.37 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.014 -1.054 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -30.19 136.37 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.402 0.62 . . . . 0.0 111.237 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.415 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 108.12 11.22 24.55 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.476 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 69.4 mm-40 -142.25 118.59 10.84 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.266 -1.137 . . . . 0.0 110.695 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.416 HG21 ' O ' ' A' ' 53' ' ' PHE . 6.5 m -103.98 137.77 41.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.087 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 34.5 m-85 -123.36 166.11 15.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.969 -1.082 . . . . 0.0 111.171 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -121.65 110.13 15.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.537 -0.727 . . . . 0.0 109.597 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.541 ' CG2' HG21 ' A' ' 51' ' ' THR . 4.9 tt -87.88 113.09 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 110.327 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.81 166.17 28.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.716 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -127.92 140.84 51.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.472 -0.768 . . . . 0.0 110.021 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.6 m -138.21 165.85 25.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.937 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.97 153.93 33.69 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.641 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.71 167.45 25.65 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.796 1.419 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.882 . . . . 0.0 110.118 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 t0 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.289 0.566 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.405 ' HB3' ' HA3' ' A' ' 73' ' ' GLY . . . -142.78 127.19 17.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.362 -0.836 . . . . 0.0 109.881 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 11.9 t -110.67 168.11 9.71 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.092 -1.005 . . . . 0.0 110.709 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 41.7 p-10 -108.54 102.26 46.6 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.346 -0.847 . . . . 0.0 110.636 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.67 -21.32 12.95 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.001 1.527 . . . . 0.0 110.742 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.19 -41.91 85.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.234 -0.916 . . . . 0.0 110.589 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.37 10.09 42.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.259 -0.901 . . . . 0.0 110.002 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.0 131.45 35.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 110.256 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.541 HG21 ' CG2' ' A' ' 33' ' ' ILE . 4.5 t -138.38 165.21 27.34 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.307 -0.871 . . . . 0.0 109.887 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m -127.79 146.6 50.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 110.744 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 35.1 p90 -140.16 -177.6 5.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 109.858 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.5 m -141.29 156.64 45.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.963 . . . . 0.0 110.058 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.481 ' CG2' ' HB3' ' A' ' 25' ' ' ALA . 17.2 p -67.28 -156.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.0 110.38 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -154.78 -162.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.954 . . . . 0.0 110.235 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.65 -55.49 34.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.268 -0.895 . . . . 0.0 109.416 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 p -78.32 4.15 13.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.432 -0.793 . . . . 0.0 109.353 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 66.11 46.55 79.56 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.99 162.78 20.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.107 -1.231 . . . . 0.0 110.242 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -159.11 83.87 0.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.179 -0.951 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 m -111.04 121.9 46.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.283 -0.885 . . . . 0.0 109.362 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 20.6 p90 -155.54 179.98 8.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 110.782 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.1 m -92.25 151.81 20.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.473 -0.767 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.455 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 56.3 t80 -142.48 179.36 7.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.538 -0.726 . . . . 0.0 109.112 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.455 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.4 t -133.08 154.96 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.741 -1.224 . . . . 0.0 110.415 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.469 HG22 HG11 ' A' ' 18' ' ' VAL . 29.7 m -138.01 164.82 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.436 -0.79 . . . . 0.0 109.808 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 8.0 mtt85 -141.22 126.02 18.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.918 . . . . 0.0 110.334 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.549 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 14.3 tttt -55.08 -40.68 70.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.832 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.3 p -130.25 134.48 47.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.385 -0.822 . . . . 0.0 109.735 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 17.2 p90 -144.94 153.28 41.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.116 -0.99 . . . . 0.0 110.636 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.3 m -73.94 124.78 26.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.265 -0.897 . . . . 0.0 110.247 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.431 ' HA3' HG22 ' A' ' 84' ' ' VAL . . . -77.24 159.41 48.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.273 -1.133 . . . . 0.0 110.004 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.189 0.519 . . . . 0.0 110.014 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.431 HG22 ' HA3' ' A' ' 73' ' ' GLY . 82.6 t -134.45 146.05 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.234 -0.916 . . . . 0.0 110.163 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -134.66 125.49 27.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.006 . . . . 0.0 110.173 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 72.1 m -86.72 12.63 10.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.47 -58.28 8.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.816 . . . . 0.0 110.068 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -110.29 9.51 23.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.33 178.21 4.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.318 -0.864 . . . . 0.0 110.194 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.15 95.39 5.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 80.9 m -92.5 138.15 31.76 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.182 -0.949 . . . . 0.0 109.94 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -130.47 149.96 51.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.17 -0.956 . . . . 0.0 110.434 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 35' ' ' GLN . 0.3 OUTLIER -125.0 122.48 37.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 109.719 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.3 175.78 20.72 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.33 171.59 13.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -1.08 . . . . 0.0 110.12 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.81 165.06 10.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.69 -104.24 0.3 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -1.194 . . . . 0.0 110.622 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.42 -84.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.937 -1.102 . . . . 0.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.1 52.64 0.82 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.53 HD22 ' CE1' ' A' ' 31' ' ' TYR . 4.4 tt -115.21 -58.94 2.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.207 -1.172 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.5 t0 50.83 101.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.403 -0.811 . . . . 0.0 110.251 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.469 HD11 ' CD1' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -73.86 -67.72 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -161.68 179.28 37.17 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -148.04 117.17 6.84 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.357 -1.084 . . . . 0.0 110.03 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.1 136.09 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.69 118.62 23.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.233 -0.917 . . . . 0.0 110.183 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.469 ' CD2' HD12 ' A' ' 12' ' ' LEU . 48.6 mt -90.05 134.1 34.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -112.43 166.51 11.24 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.549 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 2.5 m-85 -152.72 71.44 0.93 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.496 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.5 Cg_endo . . . . . 0 N--CA 1.481 0.776 0 N-CA-C 110.493 -0.618 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.32 148.9 30.07 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.086 -1.009 . . . . 0.0 111.196 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.433 ' CB ' ' HB3' ' A' ' 102' ' ' LEU . 24.2 t80 -151.5 102.67 2.91 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 109.633 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.07 158.45 43.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.927 -1.108 . . . . 0.0 111.002 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 p -126.77 138.81 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 109.76 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.593 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -62.49 -66.17 1.71 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.127 -0.983 . . . . 0.0 110.499 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 53.1 Cg_endo -76.96 74.18 5.09 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 O-C-N 123.493 1.259 . . . . 0.0 110.48 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.41 -0.64 57.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.986 -1.071 . . . . 0.0 110.236 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.7 t -150.88 150.7 31.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 109.974 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.65 60.96 6.35 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 8' ' ' PRO . 5.1 mt -102.61 154.39 19.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.251 -1.147 . . . . 0.0 110.132 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 73.3 m -109.35 155.78 20.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.149 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 32.7 t0 -64.49 127.84 33.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.057 -1.027 . . . . 0.0 110.612 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.49 -30.4 5.3 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.488 ' HB3' ' O ' ' A' ' 13' ' ' SER . 5.1 tp60 -46.78 145.66 1.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -1.116 . . . . 0.0 110.162 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.38 133.42 42.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.383 -0.823 . . . . 0.0 109.523 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.545 ' CG2' ' HB3' ' A' ' 65' ' ' PHE . 18.0 m -98.0 172.94 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.093 -1.004 . . . . 0.0 110.027 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.4 m -124.09 114.14 19.3 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 t -102.19 151.5 5.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 O-C-N 121.482 -0.761 . . . . 0.0 109.732 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.0 135.29 27.3 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.334 -0.854 . . . . 0.0 110.435 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.504 ' HB ' ' CB ' ' A' ' 61' ' ' ALA . 58.6 t -126.14 137.81 56.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.513 -0.742 . . . . 0.0 109.472 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.3 m -140.6 127.7 20.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.075 -1.016 . . . . 0.0 110.637 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 129.92 -48.69 0.96 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.552 ' CB ' HG23 ' A' ' 55' ' ' THR . . . -57.45 -158.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -1.158 . . . . 0.0 109.345 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.583 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -170.95 149.99 3.05 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.596 -1.315 . . . . 0.0 111.818 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -40.12 141.98 0.42 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.438 0.637 . . . . 0.0 110.166 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.05 10.71 36.18 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.435 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 2.5 mm-40 -137.76 133.65 34.34 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.355 -1.085 . . . . 0.0 109.757 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 52.6 m -112.0 152.77 27.74 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.211 -0.93 . . . . 0.0 109.908 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.619 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 17.2 m-85 -135.26 159.46 41.47 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 109.809 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -119.39 105.91 11.75 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.24 -0.913 . . . . 0.0 110.044 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 33' ' ' ILE . 9.4 tt -95.12 125.42 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 109.86 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.458 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -137.85 148.02 45.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.888 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -116.76 126.63 53.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.441 -0.787 . . . . 0.0 109.571 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 72.7 m -145.21 173.08 12.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -0.99 . . . . 0.0 110.923 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.45 160.27 32.08 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.529 -0.732 . . . . 0.0 109.506 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.29 163.58 38.19 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.744 1.392 . . . . 0.0 111.208 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 2.4 p . . . . . 0 N--CA 1.496 1.871 0 O-C-N 121.524 -0.735 . . . . 0.0 110.288 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.604 0.716 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -130.29 159.2 37.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.238 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.59 154.55 48.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.953 -1.092 . . . . 0.0 111.186 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.568 ' OD1' ' CZ ' ' A' ' 71' ' ' TYR . 3.7 m120 -94.55 107.91 33.27 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.603 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.53 -33.3 8.77 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.902 1.475 . . . . 0.0 110.074 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.65 -6.63 27.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.362 -0.836 . . . . 0.0 110.175 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.407 ' OG1' ' CB ' ' A' ' 46' ' ' ASN . 53.0 p -120.29 -6.95 9.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.106 -0.996 . . . . 0.0 110.383 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.81 125.62 25.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.208 -0.933 . . . . 0.0 110.078 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.7 t -170.46 168.94 7.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.141 -0.975 . . . . 0.0 110.596 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.8 p -129.2 154.95 46.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 29.1 p90 -137.4 148.17 45.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.292 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.2 m -103.0 154.81 18.86 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.343 -0.848 . . . . 0.0 110.298 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.564 HG21 ' CE1' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -62.66 -156.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.27 -0.894 . . . . 0.0 110.544 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -142.84 -164.92 1.94 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.03 -1.044 . . . . 0.0 109.99 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.66 -52.51 64.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 108.975 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 p -84.17 12.77 5.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.515 -0.741 . . . . 0.0 109.073 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.583 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 67.93 12.79 63.05 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.38 108.95 19.93 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.272 -1.134 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.504 ' CB ' ' HB ' ' A' ' 22' ' ' VAL . . . -97.22 87.85 4.29 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.353 -0.842 . . . . 0.0 110.244 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.18 115.48 28.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.42 -0.8 . . . . 0.0 109.474 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.629 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 7.9 p90 -144.64 177.23 8.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.047 -1.033 . . . . 0.0 111.191 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -102.4 122.22 43.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.634 -0.666 . . . . 0.0 110.837 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.545 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 68.4 t80 -106.83 -177.18 3.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 109.043 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.2 t -135.2 155.31 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.745 -1.222 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 66' ' ' VAL . 33.1 m -141.3 174.56 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.493 -0.755 . . . . 0.0 109.486 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 5.0 mtt180 -155.9 126.51 6.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.993 -1.067 . . . . 0.0 110.805 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 8.5 ttpt -49.76 -46.13 50.28 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.205 -0.935 . . . . 0.0 109.449 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.0 m -128.62 156.45 43.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.587 -0.695 . . . . 0.0 109.165 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.568 ' CZ ' ' OD1' ' A' ' 46' ' ' ASN . 37.0 p90 -167.89 143.76 3.92 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.775 -1.203 . . . . 0.0 110.984 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 23.8 m -65.52 141.21 58.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.138 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.82 174.58 22.3 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.62 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 p . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.713 -0.875 . . . . 0.0 109.005 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.47 0.652 . . . . 0.0 110.524 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.441 HG23 ' CB ' ' A' ' 44' ' ' ALA . 97.8 t -116.93 152.5 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.403 -0.81 . . . . 0.0 109.997 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.25 127.49 39.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.084 -1.01 . . . . 0.0 110.029 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 4.2 t -84.07 -11.16 57.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.215 -0.928 . . . . 0.0 110.451 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.13 90.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 110.27 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.4 t -86.82 2.27 49.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.218 -0.926 . . . . 0.0 110.169 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.56 -140.13 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.21 159.02 44.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.303 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 55.7 m -119.94 141.06 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.95 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -133.36 135.4 44.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.466 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.458 HD11 ' O ' ' A' ' 34' ' ' ALA . 18.9 tp -109.76 120.13 41.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.848 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.487 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . -111.18 166.35 12.26 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -160.56 173.72 15.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -1.144 . . . . 0.0 110.024 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.13 -176.81 16.28 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -139.33 -150.69 0.34 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -1.072 . . . . 0.0 110.041 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.81 40.32 1.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 110.153 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -147.11 -43.48 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 69.7 mt -103.27 -153.74 0.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -1.166 . . . . 0.0 110.077 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -170.58 117.26 0.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 110.31 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.433 ' HB3' ' CB ' ' A' ' 4' ' ' PHE . 18.9 mt -118.56 -49.36 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.0 110.09 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.03 -150.71 17.82 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.574 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 3.6 p80 -146.89 136.93 23.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -1.11 . . . . 0.0 110.417 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.3 t -85.06 113.16 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.416 -0.803 . . . . 0.0 110.112 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.05 94.3 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -0.86 . . . . 0.0 110.112 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.88 162.02 14.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.315 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.54 152.41 46.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 3.3 m-85 -127.45 75.68 1.61 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.858 . . . . 0.0 110.005 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 CA-C-O 117.961 -1.466 . . . . 0.0 109.596 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.461 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.0 Cg_endo . . . . . 0 N--CA 1.482 0.796 0 N-CA-C 110.481 -0.623 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -148.63 127.43 12.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.974 . . . . 0.0 110.432 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -142.08 106.3 4.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.369 -0.832 . . . . 0.0 109.471 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.2 t -150.25 154.14 37.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.961 -1.087 . . . . 0.0 111.247 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.506 ' CG1' HG13 ' A' ' 105' ' ' VAL . 13.4 p -119.05 156.9 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.647 -0.658 . . . . 0.0 109.448 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.592 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -77.04 -65.89 0.36 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.926 -1.109 . . . . 0.0 110.217 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 52.7 Cg_endo -76.2 74.97 4.4 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.607 1.32 . . . . 0.0 110.221 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.53 -16.79 60.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.028 -1.045 . . . . 0.0 110.243 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.2 p -138.8 166.26 24.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.072 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.95 48.91 61.93 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 8' ' ' PRO . 20.7 mt -95.04 166.9 11.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -1.105 . . . . 0.0 110.242 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.05 152.43 45.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.286 -0.884 . . . . 0.0 110.346 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -63.67 117.23 6.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.83 -30.41 9.39 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -52.52 155.09 2.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.342 -1.093 . . . . 0.0 110.27 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.23 138.03 43.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 0.0 110.115 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 65' ' ' PHE . 17.1 m -103.81 153.56 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 109.859 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -95.61 111.34 23.29 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.491 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 t -104.87 151.61 7.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.46 -0.775 . . . . 0.0 110.049 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 34.2 t -149.82 133.11 16.45 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.445 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 53.2 t -123.75 146.59 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.527 -0.733 . . . . 0.0 109.992 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 2.3 p -162.56 120.22 2.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.118 -0.989 . . . . 0.0 110.282 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 149.39 -55.87 0.48 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.447 ' C ' ' HA3' ' A' ' 59' ' ' GLY . . . -63.92 -139.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.157 -1.202 . . . . 0.0 110.097 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.485 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.66 175.57 5.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.223 -0.923 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -65.2 131.74 47.31 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.493 -0.755 . . . . 0.0 110.666 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.6 6.85 7.76 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 2.6 mt-10 -132.0 106.09 7.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -1.199 . . . . 0.0 110.551 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 57.5 m -90.44 123.28 34.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.278 -0.889 . . . . 0.0 109.812 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 29' ' ' GLU . 59.6 m-85 -107.42 161.59 14.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 111.059 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -113.48 112.51 23.72 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.392 -0.817 . . . . 0.0 109.602 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.51 ' CG2' HG21 ' A' ' 51' ' ' THR . 4.5 tt -93.94 106.31 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.124 -0.985 . . . . 0.0 110.635 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 93' ' ' LEU . . . -142.23 168.53 19.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.381 -0.825 . . . . 0.0 109.772 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 9.8 pt20 -132.71 151.52 51.95 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 110.385 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.72 157.33 44.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 110.558 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -151.56 157.35 34.76 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.274 -0.891 . . . . 0.0 110.499 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 90' ' ' ALA . 43.3 Cg_endo -69.5 174.99 8.48 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.942 1.496 . . . . 0.0 110.22 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.072 -1.018 . . . . 0.0 110.845 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 11.7 p-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.33 0.586 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.484 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -136.12 155.35 50.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.426 -0.796 . . . . 0.0 109.7 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.454 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.1 m -126.28 151.47 47.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.211 -0.93 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.464 ' ND2' ' HB2' ' A' ' 71' ' ' TYR . 47.6 t-20 -97.16 108.5 44.5 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.15 -0.969 . . . . 0.0 110.243 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 49.9 Cg_endo -81.79 -33.96 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.919 1.484 . . . . 0.0 110.484 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.97 50.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 110.313 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 p -79.67 -3.05 45.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.262 -0.899 . . . . 0.0 110.064 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 47' ' ' PRO . . . -72.72 81.66 1.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.868 . . . . 0.0 110.5 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.51 HG21 ' CG2' ' A' ' 33' ' ' ILE . 4.2 t -100.26 174.49 6.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.291 -0.881 . . . . 0.0 109.883 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.65 122.34 15.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 110.304 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.494 ' C ' ' CD1' ' A' ' 53' ' ' PHE . 5.0 p90 -116.5 -175.01 2.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.912 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 7.2 m -134.69 143.35 47.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.961 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.513 HG21 ' CA ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -57.33 -155.94 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.136 -0.977 . . . . 0.0 110.299 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -145.49 -156.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.077 -1.015 . . . . 0.0 110.176 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.57 -61.89 2.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.028 -1.045 . . . . 0.0 109.909 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 52.7 p -87.94 28.5 1.03 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.242 -0.911 . . . . 0.0 109.325 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.513 ' CA ' HG21 ' A' ' 55' ' ' THR . . . 55.88 28.3 52.54 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -93.45 117.29 29.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.375 -1.074 . . . . 0.0 110.136 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.427 ' CB ' ' HB ' ' A' ' 22' ' ' VAL . . . -124.81 83.41 2.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 0.0 110.113 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -109.23 123.15 48.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.875 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 9.4 p90 -155.68 174.72 14.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.601 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.69 114.03 26.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.394 -0.816 . . . . 0.0 110.38 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.493 ' HB3' HG22 ' A' ' 18' ' ' VAL . 41.3 t80 -99.12 176.83 5.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.409 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.1 t -130.42 153.87 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.967 -1.083 . . . . 0.0 109.924 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.2 143.82 27.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.359 -0.838 . . . . 0.0 110.093 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -120.02 129.74 54.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 110.088 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -52.6 -35.91 55.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.905 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.3 p -131.35 143.37 50.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.936 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.464 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 22.7 p90 -145.16 153.0 40.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.17 -0.956 . . . . 0.0 110.511 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 9.2 m -72.18 124.43 25.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.305 -0.872 . . . . 0.0 109.847 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 74' ' ' SER . . . -99.19 171.87 24.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 5.6 p . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.347 -1.09 . . . . 0.0 109.869 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 5.0 p . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.287 0.565 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.484 HG21 ' CB ' ' A' ' 44' ' ' ALA . 45.7 t -150.87 133.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -109.21 141.59 41.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.937 . . . . 0.0 110.1 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.0 m -115.0 -3.8 12.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.199 -0.938 . . . . 0.0 110.143 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.19 -56.97 14.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 110.066 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 t -89.14 -16.41 31.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 110.05 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.46 -175.2 3.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 110.18 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.494 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -96.43 140.98 30.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -0.907 . . . . 0.0 110.325 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.43 ' C ' ' OD1' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -139.5 126.86 21.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.355 -0.841 . . . . 0.0 110.033 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.43 ' OD1' ' C ' ' A' ' 91' ' ' CYS . 31.9 m-20 -129.3 147.2 51.11 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 110.291 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.518 ' CD1' ' O ' ' A' ' 34' ' ' ALA . 14.3 tp -112.72 109.67 19.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.618 ' CA ' ' CD2' ' A' ' 104' ' ' HIS . . . -105.14 153.26 17.31 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.312 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.89 167.44 22.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.478 -1.013 . . . . 0.0 109.713 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.515 ' HA2' ' CD1' ' A' ' 31' ' ' TYR . . . 118.85 -175.7 15.81 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 100' ' ' LEU . 20.7 p-10 -137.8 -142.25 0.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -1.195 . . . . 0.0 110.433 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -102.78 -34.84 8.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.303 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.42 -30.69 64.23 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.464 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 6.0 tt -146.88 131.2 17.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -1.146 . . . . 0.0 110.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -96.88 138.48 34.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -0.993 . . . . 0.0 110.087 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.509 HD13 ' CG ' ' A' ' 31' ' ' TYR . 16.4 mt -97.56 -81.15 0.43 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.273 -0.892 . . . . 0.0 110.295 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 174.99 163.13 27.61 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.618 ' CD2' ' CA ' ' A' ' 94' ' ' GLY . 41.5 m170 -119.13 123.95 45.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.993 . . . . 0.0 110.069 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.506 HG13 ' CG1' ' A' ' 6' ' ' VAL . 31.5 t -102.68 115.51 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.111 -0.993 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.51 127.26 32.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.297 -0.877 . . . . 0.0 110.162 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.1 mt -98.42 169.52 9.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.335 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.3 m -155.26 160.36 40.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -132.66 105.33 7.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 0.0 110.135 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.431 179.949 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.461 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 45.8 Cg_endo . . . . . 0 N--CA 1.48 0.717 0 N-CA-C 110.407 -0.651 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.47 ' HB1' ' OG ' ' A' ' 23' ' ' SER . . . -147.0 151.2 36.58 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.172 -0.955 . . . . 0.0 110.747 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.493 ' CE1' ' CB ' ' A' ' 95' ' ' ALA . 76.9 t80 -149.98 116.72 5.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 110.022 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.64 149.72 31.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.073 -1.017 . . . . 0.0 110.611 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.523 HG11 ' CG1' ' A' ' 105' ' ' VAL . 4.3 p -130.87 139.0 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.923 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -69.76 -62.5 2.39 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.048 -1.032 . . . . 0.0 110.182 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 49.4 Cg_endo -74.32 77.51 2.85 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.837 1.441 . . . . 0.0 110.468 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.69 -5.63 57.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.114 -0.991 . . . . 0.0 110.13 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.0 p -151.62 166.45 31.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 110.241 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.8 52.46 48.24 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.477 ' CD2' HG12 ' A' ' 18' ' ' VAL . 1.4 mt -102.51 172.87 6.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.146 -1.208 . . . . 0.0 110.055 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -143.71 149.85 37.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 110.387 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 3.7 p30 -58.0 123.95 17.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.325 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.97 -34.81 4.56 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 0.9 OUTLIER -50.96 156.41 1.01 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -1.134 . . . . 0.0 109.815 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.95 137.83 47.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.634 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.477 HG12 ' CD2' ' A' ' 12' ' ' LEU . 16.5 m -107.66 175.41 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.424 -0.797 . . . . 0.0 110.131 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 6' ' ' VAL . 3.6 p -120.78 118.92 31.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 109.996 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.47 HG11 ' N ' ' A' ' 21' ' ' SER . 20.8 t -110.31 151.79 12.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.244 -0.91 . . . . 0.0 110.067 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.47 ' N ' HG11 ' A' ' 20' ' ' VAL . 15.7 m -143.12 128.16 18.51 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 110.31 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 61' ' ' ALA . 30.7 t -121.26 145.65 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 109.824 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.47 ' OG ' ' HB1' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -151.43 139.4 20.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 110.382 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 120.17 -75.34 0.32 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.535 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -49.54 126.7 14.0 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.179 -1.189 . . . . 0.0 109.563 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -97.08 165.65 11.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.111 -0.993 . . . . 0.0 111.092 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 56' ' ' ASP . . . -44.23 139.85 2.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.545 0.688 . . . . 0.0 110.568 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.92 9.22 8.34 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 50.4 mm-40 -147.65 121.84 9.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.119 -1.224 . . . . 0.0 110.406 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.459 ' OG1' ' OG1' ' A' ' 54' ' ' THR . 80.6 m -104.43 125.63 50.81 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.436 -0.79 . . . . 0.0 109.49 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 17.0 m-85 -110.01 176.94 4.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.09 -1.006 . . . . 0.0 110.434 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 12.5 m-85 -126.51 112.85 16.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.301 -0.874 . . . . 0.0 110.488 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.469 ' CG2' ' O ' ' A' ' 33' ' ' ILE . 13.0 tt -98.5 103.65 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 0.0 109.933 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . . . -138.56 169.33 17.98 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.294 -0.879 . . . . 0.0 110.651 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.529 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 34.1 mt-30 -106.07 155.47 19.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.423 -0.798 . . . . 0.0 110.334 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 98.1 m -150.69 148.52 28.68 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.219 -0.926 . . . . 0.0 110.471 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.548 ' CB ' ' HB3' ' A' ' 91' ' ' CYS . . . -151.76 165.83 16.57 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.02 175.51 11.15 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.99 1.521 . . . . 0.0 110.391 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.976 0 O-C-N 121.264 -0.898 . . . . 0.0 110.157 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p30 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.169 0.509 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.09 157.87 39.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 110.399 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 m -140.48 163.05 33.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.184 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.542 ' ND2' ' CD1' ' A' ' 71' ' ' TYR . 0.7 OUTLIER -81.54 123.91 80.5 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 110.358 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 48.8 Cg_endo -84.74 -72.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.931 1.49 . . . . 0.0 110.621 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.15 -62.89 1.52 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.206 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.509 ' OG1' ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -46.47 -22.54 0.28 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.444 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -62.83 105.38 0.66 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.031 . . . . 0.0 109.816 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 51' ' ' THR . 6.5 t -110.47 141.42 43.6 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.234 -0.916 . . . . 0.0 110.442 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.477 ' HB3' ' CD2' ' A' ' 32' ' ' TYR . 48.9 p -106.88 119.11 38.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 109.888 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 53.1 p90 -106.46 -178.06 3.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.034 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.459 ' OG1' ' OG1' ' A' ' 30' ' ' THR . 6.4 m -139.05 145.44 39.59 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.939 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.535 HG21 ' CB ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -57.17 -158.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.147 -0.97 . . . . 0.0 109.851 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -145.43 -161.78 1.37 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.881 -1.137 . . . . 0.0 110.448 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.81 -48.98 79.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.087 -1.008 . . . . 0.0 109.164 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p -87.03 13.82 8.56 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.515 -0.74 . . . . 0.0 109.099 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 57.27 30.31 61.08 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.02 118.91 37.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -1.094 . . . . 0.0 109.863 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.452 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . . . -118.81 81.2 1.66 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.511 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.9 m -110.61 122.65 48.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.304 -0.873 . . . . 0.0 109.293 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 12.3 p90 -157.31 179.1 9.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.024 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.09 138.04 31.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 110.726 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 73.9 t80 -123.14 178.62 5.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -0.795 . . . . 0.0 109.182 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.557 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 5.2 t -123.05 159.44 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.806 -1.184 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 67' ' ' VAL . 30.9 m -137.96 124.69 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.393 -0.817 . . . . 0.0 110.099 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 9.5 mmm-85 -115.85 123.85 49.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.53 -59.93 3.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -0.978 . . . . 0.0 109.204 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 p -108.41 126.44 52.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.306 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.542 ' CD1' ' ND2' ' A' ' 46' ' ' ASN . 50.0 p90 -140.31 163.91 31.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 110.485 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.09 123.87 21.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.637 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 74' ' ' SER . . . -98.21 166.42 22.13 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 89.5 p . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.39 -1.064 . . . . 0.0 109.599 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.257 0.551 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.435 HG21 ' HA3' ' A' ' 73' ' ' GLY . 49.1 t -144.15 154.63 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 110.13 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -134.58 131.57 38.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 110.064 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 32.7 m -92.97 33.23 1.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.878 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.15 -61.09 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 110.39 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.439 HG23 ' N ' ' A' ' 89' ' ' ALA . 5.0 t -87.67 -23.05 24.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.331 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.439 ' N ' HG23 ' A' ' 88' ' ' THR . . . -107.58 -178.32 3.59 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 110.096 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -123.82 148.81 46.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.181 -0.949 . . . . 0.0 110.12 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.548 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -126.85 133.78 50.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.026 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 5.7 m-20 -99.9 147.22 25.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 110.107 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.498 HD11 ' CG ' ' A' ' 35' ' ' GLN . 15.8 tp -106.7 110.96 23.28 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.1 -1.0 . . . . 0.0 109.52 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -112.65 153.43 17.48 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.493 ' CB ' ' CE1' ' A' ' 4' ' ' PHE . . . -133.29 104.87 6.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.428 -1.042 . . . . 0.0 110.122 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.58 174.17 46.41 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.452 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 5.5 p-10 -114.0 -156.84 0.61 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -1.156 . . . . 0.0 110.357 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -91.99 52.6 2.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 110.184 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 174.4 -32.03 0.1 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.452 ' HB2' ' OD1' ' A' ' 97' ' ' ASN . 0.6 OUTLIER -117.38 86.03 2.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -1.169 . . . . 0.0 110.297 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.53 116.31 22.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.941 . . . . 0.0 109.984 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.8 mt -81.94 -74.6 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.322 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.13 173.58 41.66 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.486 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 9.8 m-70 -136.69 122.62 20.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.584 -0.951 . . . . 0.0 110.111 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.523 ' CG1' HG11 ' A' ' 6' ' ' VAL . 17.2 t -112.23 107.45 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.072 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . . . -57.71 147.09 28.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 110.505 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.529 ' CD1' ' OE1' ' A' ' 35' ' ' GLN . 29.7 mt -116.18 141.56 47.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 109.984 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -110.82 165.55 11.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 110.34 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -139.95 97.51 3.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.24 -0.913 . . . . 0.0 110.321 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.448 ' HG2' HD22 ' A' ' 102' ' ' LEU . 43.9 Cg_endo . . . . . 0 N--CA 1.482 0.836 0 N-CA-C 110.361 -0.669 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -123.89 128.72 49.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.182 -0.949 . . . . 0.0 110.445 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.427 ' HB2' HD23 ' A' ' 102' ' ' LEU . 85.4 t80 -149.63 104.46 3.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.677 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.532 ' HA ' HG21 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -149.8 157.37 43.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.899 -1.126 . . . . 0.0 111.496 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.404 ' CG1' HG13 ' A' ' 105' ' ' VAL . 9.3 p -106.18 139.85 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.399 -0.813 . . . . 0.0 109.312 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.623 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 m -53.82 -72.4 0.19 Allowed Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 120.828 -1.17 . . . . 0.0 110.002 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.623 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 56.7 Cg_endo -80.13 79.37 3.36 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 O-C-N 122.956 0.977 . . . . 0.0 109.952 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.43 -20.97 61.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.846 -1.159 . . . . 0.0 109.999 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t -134.51 141.11 46.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.325 -0.86 . . . . 0.0 110.043 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.91 61.21 1.29 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 8' ' ' PRO . 3.5 mt -117.21 169.53 9.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.162 -1.199 . . . . 0.0 110.232 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 4.2 t -124.65 158.95 31.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 110.286 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.16 124.97 22.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.216 -0.927 . . . . 0.0 110.188 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 89.45 -29.45 6.17 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 13' ' ' SER . 28.9 tp60 -43.81 156.25 0.07 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.324 -1.104 . . . . 0.0 110.447 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.437 ' N ' ' HG3' ' A' ' 16' ' ' GLN . 1.8 m -107.16 134.92 49.56 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.448 -0.783 . . . . 0.0 109.315 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.466 HG21 HG12 ' A' ' 67' ' ' VAL . 32.7 m -110.97 153.93 12.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.801 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -105.97 121.37 43.97 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.973 -1.08 . . . . 0.0 110.237 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.6 t -97.1 151.82 4.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.581 -0.7 . . . . 0.0 109.223 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 t -142.46 121.25 12.69 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 121.281 -0.887 . . . . 0.0 109.857 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 61' ' ' ALA . 33.9 t -116.11 142.74 28.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 110.065 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.1 OUTLIER -160.38 105.17 1.47 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 110.254 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 157.3 -47.79 0.46 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.47 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . . . -59.41 -147.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.419 -1.047 . . . . 0.0 109.485 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -172.42 165.89 5.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.76 -1.213 . . . . 0.0 111.037 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -48.36 138.58 9.83 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.592 0.711 . . . . 0.0 110.782 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.07 25.49 12.74 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.535 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 2.3 mt-10 -141.07 105.95 4.94 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.203 -1.175 . . . . 0.0 110.375 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.7 m -103.73 151.31 23.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.822 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 46.6 m-85 -140.24 165.97 25.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.296 -0.877 . . . . 0.0 110.188 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 23.5 m-85 -112.66 109.77 19.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -0.901 . . . . 0.0 109.851 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.548 ' CG2' HG21 ' A' ' 51' ' ' THR . 3.2 tt -89.5 111.72 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.059 -1.026 . . . . 0.0 110.162 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 93' ' ' LEU . . . -144.05 159.45 42.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.468 -0.77 . . . . 0.0 110.247 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.455 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 14.6 tt0 -112.94 148.12 35.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.342 -0.849 . . . . 0.0 110.515 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 62.9 m -153.54 162.23 41.47 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.376 -0.827 . . . . 0.0 110.225 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.416 ' HB2' HG11 ' A' ' 84' ' ' VAL . . . -150.64 160.27 32.9 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.235 -0.915 . . . . 0.0 110.288 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.54 172.34 16.37 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.781 1.411 . . . . 0.0 110.343 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 39' ' ' VAL . 33.4 m . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.233 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p30 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.457 0.646 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.43 159.35 32.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.691 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.462 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.3 m -144.76 157.07 44.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.145 -0.972 . . . . 0.0 110.385 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.418 ' ND2' ' OG1' ' A' ' 49' ' ' THR . 3.2 t-20 -96.27 109.92 49.83 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.204 -0.935 . . . . 0.0 110.288 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 50.8 Cg_endo -86.92 -42.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.894 1.47 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.41 66.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.401 -0.812 . . . . 0.0 110.855 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.418 ' OG1' ' ND2' ' A' ' 46' ' ' ASN . 18.0 p -113.47 31.5 6.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.059 -1.025 . . . . 0.0 110.374 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.48 131.72 36.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.548 HG21 ' CG2' ' A' ' 33' ' ' ILE . 7.0 t -148.65 170.24 18.58 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.252 -0.905 . . . . 0.0 110.235 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 31' ' ' TYR . 43.7 t -135.6 166.99 21.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.068 -1.02 . . . . 0.0 110.983 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 16.3 p90 -148.91 -177.08 5.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.467 -0.771 . . . . 0.0 109.832 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.6 m -144.21 166.85 23.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.058 -1.026 . . . . 0.0 110.268 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.465 ' CG2' ' HB1' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -86.98 -156.94 0.35 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.239 -0.913 . . . . 0.0 110.416 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -144.36 -163.75 1.75 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.781 -1.199 . . . . 0.0 109.931 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.5 77.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.134 -0.979 . . . . 0.0 109.441 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.6 p -88.03 15.48 7.29 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.405 -0.81 . . . . 0.0 108.848 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.526 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 65.23 16.91 63.11 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.15 122.24 32.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.091 -1.241 . . . . 0.0 109.901 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . . . -132.96 85.22 2.2 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.179 -0.951 . . . . 0.0 110.386 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.62 129.02 49.07 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.525 -0.735 . . . . 0.0 109.196 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 6.0 p90 -161.02 179.9 8.07 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.14 -0.975 . . . . 0.0 110.571 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 m -108.29 144.62 35.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.297 -0.877 . . . . 0.0 111.548 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 36.5 t80 -135.71 166.09 24.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.58 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 3.6 t -106.85 154.95 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.607 -1.308 . . . . 0.0 110.963 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.466 HG12 HG21 ' A' ' 18' ' ' VAL . 25.4 m -140.73 158.66 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.531 -0.731 . . . . 0.0 109.958 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.18 148.48 41.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 110.578 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -72.89 -52.84 13.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -124.51 150.17 46.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.152 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 71' ' ' TYR . 45.6 p90 -161.1 132.1 5.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.03 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 99.6 m -57.37 119.63 6.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.484 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.41 -178.05 31.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.111 -1.229 . . . . 0.0 110.411 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 58.6 p . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.264 0.554 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 37' ' ' ALA . 20.9 t -106.68 164.2 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.291 -0.881 . . . . 0.0 110.425 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.531 ' OD2' ' CG2' ' A' ' 88' ' ' THR . 26.0 p-10 -153.52 149.36 27.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.343 -0.848 . . . . 0.0 110.184 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 34.8 m -104.11 -2.98 25.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.14 -65.8 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.968 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.531 ' CG2' ' OD2' ' A' ' 85' ' ' ASP . 7.1 t -82.39 -19.82 38.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.079 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.37 158.13 17.11 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.22 -0.925 . . . . 0.0 109.938 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.71 109.68 21.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.939 . . . . 0.0 110.234 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 24.2 p -108.7 164.36 12.44 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.205 -0.934 . . . . 0.0 109.824 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -149.03 159.64 44.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.1 -1.0 . . . . 0.0 110.626 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 34' ' ' ALA . 20.2 tp -107.27 113.53 26.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.365 -0.834 . . . . 0.0 109.174 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . -103.51 154.34 17.96 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.038 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -143.01 124.98 15.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.326 -1.102 . . . . 0.0 110.175 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.57 -171.0 36.64 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' SER . 11.9 p-10 -130.88 -50.57 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -1.222 . . . . 0.0 110.638 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 97' ' ' ASN . 0.5 OUTLIER 166.57 -39.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.219 -0.926 . . . . 0.0 110.474 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.61 -21.21 62.33 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.6 tt -120.75 -66.77 1.03 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -1.183 . . . . 0.0 110.137 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.58 87.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 110.476 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.448 HD22 ' HG2' ' A' ' 2' ' ' PRO . 0.3 OUTLIER -62.38 -39.04 91.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.048 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.25 -162.59 25.7 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.452 ' HB3' ' CA ' ' A' ' 94' ' ' GLY . 0.6 OUTLIER -146.51 129.4 16.32 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.284 -1.127 . . . . 0.0 110.014 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.532 HG21 ' HA ' ' A' ' 5' ' ' SER . 6.3 t -92.01 119.94 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.253 -0.904 . . . . 0.0 110.341 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.62 158.85 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 109.983 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.491 HD23 ' CD1' ' A' ' 12' ' ' LEU . 12.9 mt -134.83 150.25 50.47 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.086 -1.009 . . . . 0.0 110.697 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.7 m -140.96 159.61 41.84 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.35 -0.844 . . . . 0.0 110.046 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 32.6 m-85 -127.16 145.31 50.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.126 -0.984 . . . . 0.0 110.197 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.529 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 N--CA 1.485 0.972 0 N-CA-C 110.648 -0.559 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -155.3 138.45 15.61 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.264 -0.898 . . . . 0.0 110.898 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 1.6 t80 -152.36 102.96 2.8 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.345 -0.847 . . . . 0.0 109.793 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.9 t -146.2 151.9 38.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.097 -1.002 . . . . 0.0 110.734 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.494 HG11 ' CG1' ' A' ' 105' ' ' VAL . 8.0 p -115.63 122.62 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.799 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.1 m -47.1 -68.02 0.35 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.109 -0.994 . . . . 0.0 110.567 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 55.3 Cg_endo -76.06 79.14 2.98 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 O-C-N 123.311 1.164 . . . . 0.0 109.83 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.33 -6.73 57.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.974 -1.079 . . . . 0.0 110.689 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 p -146.96 146.43 30.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.212 -0.93 . . . . 0.0 109.71 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.41 ' C ' ' HG ' ' A' ' 12' ' ' LEU . . . 79.61 71.78 1.24 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.489 HD21 ' O ' ' A' ' 8' ' ' PRO . 4.0 mt -129.87 169.95 14.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -1.108 . . . . 0.0 109.751 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -136.23 169.49 17.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.49 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 30.5 p-10 -65.19 131.04 45.49 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.113 -0.992 . . . . 0.0 110.184 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.46 -29.86 5.53 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.476 ' HB3' ' O ' ' A' ' 13' ' ' SER . 9.4 tp60 -49.48 143.01 7.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -1.114 . . . . 0.0 110.308 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.32 133.62 42.48 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.487 ' CG2' ' HB3' ' A' ' 65' ' ' PHE . 16.6 m -101.85 163.26 3.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 109.785 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.1 121.57 44.94 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.983 -1.073 . . . . 0.0 110.28 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.91 151.41 14.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.68 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.5 m -146.34 121.68 10.27 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.323 -0.861 . . . . 0.0 109.992 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 86.2 t -120.54 139.38 48.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 109.831 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.9 p -157.66 136.44 11.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.054 -1.029 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.28 -46.47 1.09 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 26' ' ' ALA . . . -45.69 -52.11 11.38 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.155 -1.203 . . . . 0.0 110.237 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.558 ' HA ' ' HA3' ' A' ' 59' ' ' GLY . . . 72.07 137.92 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.435 -0.791 . . . . 0.0 110.888 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -33.37 130.66 0.23 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.391 0.615 . . . . 0.0 110.762 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.408 ' C ' ' HG3' ' A' ' 29' ' ' GLU . . . 122.37 9.59 6.49 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.438 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 60.1 mt-10 -147.99 130.15 15.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.0 110.185 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.475 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 3.4 m -111.57 146.63 37.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.402 -0.811 . . . . 0.0 109.898 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 30.6 m-85 -132.08 174.51 10.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.084 -1.01 . . . . 0.0 110.662 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.574 ' CD1' ' HB3' ' A' ' 52' ' ' SER . 73.7 m-85 -130.46 102.05 5.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.486 -0.759 . . . . 0.0 109.626 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.516 ' CG2' ' O ' ' A' ' 33' ' ' ILE . 1.3 tt -87.85 104.15 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.087 -1.008 . . . . 0.0 110.185 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.444 ' C ' HD11 ' A' ' 93' ' ' LEU . . . -138.97 157.21 46.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.845 . . . . 0.0 110.618 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.478 ' HB2' HD11 ' A' ' 93' ' ' LEU . 1.1 tt0 -122.92 147.06 47.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.53 -0.731 . . . . 0.0 110.08 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 67.3 m -150.24 171.21 17.31 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.194 -0.941 . . . . 0.0 110.668 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.43 152.15 28.53 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.532 -0.73 . . . . 0.0 109.71 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.03 166.5 29.41 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.835 1.439 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.516 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 30.6 t . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.415 -0.803 . . . . 0.0 109.921 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.429 ' C ' HG21 ' A' ' 39' ' ' VAL . 1.7 t70 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.236 0.541 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 39' ' ' VAL . . . -154.14 149.49 27.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.121 -0.987 . . . . 0.0 110.036 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.459 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -124.47 156.66 36.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.139 -0.975 . . . . 0.0 110.001 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.463 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 0.2 OUTLIER -100.12 101.91 16.08 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.044 -1.035 . . . . 0.0 110.516 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.8 Cg_endo -73.8 -30.78 9.03 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.976 1.514 . . . . 0.0 110.532 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.85 85.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.268 -0.895 . . . . 0.0 110.556 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 5.1 p -95.35 1.83 54.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.219 -0.925 . . . . 0.0 110.52 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.79 119.44 21.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.129 -0.982 . . . . 0.0 110.037 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 33' ' ' ILE . 11.3 t -146.33 145.24 30.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.985 . . . . 0.0 110.631 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.574 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 1.1 m -110.58 147.54 34.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.579 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 13.8 p90 -144.18 -176.4 5.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -0.876 . . . . 0.0 110.08 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.8 m -149.12 156.18 41.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.597 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.52 ' CG2' ' HB1' ' A' ' 25' ' ' ALA . 6.9 p -68.53 -161.64 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.045 -1.034 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -160.2 -155.5 0.44 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.963 -1.085 . . . . 0.0 110.943 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.69 64.56 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 109.346 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.5 t -71.03 -5.38 30.89 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.437 -0.79 . . . . 0.0 109.16 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 26' ' ' ALA . . . 53.72 53.98 33.11 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.78 126.63 8.95 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.161 -1.199 . . . . 0.0 110.7 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -113.38 85.77 2.26 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.321 -0.862 . . . . 0.0 110.002 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.17 136.45 49.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.658 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -171.03 173.26 5.13 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.203 -0.936 . . . . 0.0 110.782 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 m -94.37 117.26 29.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.376 -0.827 . . . . 0.0 110.342 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.487 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 36.1 t80 -98.63 -179.44 4.31 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.355 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 t -134.5 156.39 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.874 -1.141 . . . . 0.0 110.286 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.3 m -143.3 153.96 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.367 -0.833 . . . . 0.0 110.048 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -132.37 120.67 22.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 110.213 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HE2' ' CD2' ' A' ' 109' ' ' PHE . 4.3 tttt -49.41 -45.74 46.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.283 -0.886 . . . . 0.0 109.762 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.1 m -120.5 135.29 55.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.479 -0.763 . . . . 0.0 109.608 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -151.32 144.27 24.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.151 -0.968 . . . . 0.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 29.3 m -65.59 149.8 49.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 0.0 110.28 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.0 -167.17 13.64 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 O-C-N 121.298 -1.119 . . . . 0.0 110.0 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 3.9 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.278 0.561 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.439 HG23 ' CB ' ' A' ' 44' ' ' ALA . 62.7 t -116.95 123.84 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.02 111.1 23.75 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.163 -0.961 . . . . 0.0 110.094 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.15 9.02 29.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 110.084 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.36 -41.29 88.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.551 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 t -114.35 0.99 14.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.13 -0.981 . . . . 0.0 110.326 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.64 -139.16 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.24 142.16 31.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.4 m -128.9 133.82 48.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.1 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -129.27 148.26 51.18 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.189 -0.945 . . . . 0.0 110.091 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 35' ' ' GLN . 0.7 OUTLIER -125.61 118.97 26.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.072 -1.018 . . . . 0.0 109.153 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -122.74 159.59 17.34 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.275 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 33' ' ' ILE . . . -146.92 143.31 28.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.549 -0.971 . . . . 0.0 109.765 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 166.37 174.86 36.15 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.094 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 30' ' ' THR . 12.0 p-10 -119.35 -137.61 0.34 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.31 -1.112 . . . . 0.0 110.157 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.4 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -121.14 60.79 0.91 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.146 -0.971 . . . . 0.0 110.214 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.29 -24.26 0.12 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER -118.37 -60.84 1.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.235 . . . . 0.0 110.278 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.524 ' N ' HD12 ' A' ' 100' ' ' LEU . 38.9 t0 58.27 119.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 110.139 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.455 HD21 HD13 ' A' ' 100' ' ' LEU . 32.1 mt -84.81 -70.84 0.55 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.427 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 177.61 -175.6 47.64 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.577 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 1.6 m-70 -131.59 124.24 29.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.522 -0.987 . . . . 0.0 109.78 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.494 ' CG1' HG11 ' A' ' 6' ' ' VAL . 66.6 t -95.35 107.31 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.047 . . . . 0.0 110.515 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.01 112.37 2.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.442 ' HA ' HD21 ' A' ' 107' ' ' LEU . 79.7 mt -86.52 133.02 33.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.131 -0.981 . . . . 0.0 110.722 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.3 m -114.17 169.01 9.34 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.442 -0.786 . . . . 0.0 109.77 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.409 ' O ' ' O ' ' A' ' 110' ' ' GLY . 11.4 m-85 -134.14 163.4 29.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 110.075 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.269 0 CA-C-O 117.948 -1.474 . . . . 0.0 109.601 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.413 ' HB2' HD23 ' A' ' 102' ' ' LEU . 47.1 Cg_endo . . . . . 0 N--CA 1.483 0.883 0 N-CA-C 110.517 -0.609 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -142.43 133.9 26.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 110.498 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -146.31 111.01 5.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.233 -0.917 . . . . 0.0 109.955 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.07 149.98 34.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.129 -0.982 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.425 ' O ' HG11 ' A' ' 6' ' ' VAL . 9.2 p -117.04 154.51 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 109.532 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.615 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -72.83 -68.18 0.41 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.04 . . . . 0.0 110.014 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.615 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 54.6 Cg_endo -77.58 75.94 4.5 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.308 1.162 . . . . 0.0 109.978 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.52 -8.12 57.82 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.934 -1.104 . . . . 0.0 110.527 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.5 p -142.72 123.39 14.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.28 75.56 1.3 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.57 ' O ' ' CE1' ' A' ' 109' ' ' PHE . 2.3 mt -120.07 165.93 14.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -1.14 . . . . 0.0 110.085 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 9.4 m -124.16 161.2 26.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 109.876 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 8.7 p-10 -62.43 121.6 13.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 110.075 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.87 -27.56 8.83 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 13' ' ' SER . 2.7 tt0 -43.32 143.85 0.8 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.306 -1.114 . . . . 0.0 110.728 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.435 ' C ' HG13 ' A' ' 18' ' ' VAL . 80.0 p -96.75 150.72 20.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.659 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.505 HG12 ' CG1' ' A' ' 67' ' ' VAL . 27.0 m -130.76 154.33 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 110.084 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.4 m -101.92 132.91 47.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.007 . . . . 0.0 110.02 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.434 HG11 ' N ' ' A' ' 21' ' ' SER . 10.7 t -120.8 146.66 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.075 -1.016 . . . . 0.0 109.896 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.434 ' N ' HG11 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -138.71 126.2 21.84 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.424 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 84.8 t -117.67 141.61 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 109.919 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -152.96 145.53 24.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.135 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 121.35 -58.95 0.57 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.517 ' CB ' HG22 ' A' ' 55' ' ' THR . . . -52.54 -175.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.578 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.49 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -154.36 155.14 34.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.017 -1.052 . . . . 0.0 110.783 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -37.03 133.9 0.58 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.436 0.636 . . . . 0.0 110.864 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.36 16.25 16.83 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -143.61 120.29 11.15 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.168 -1.195 . . . . 0.0 110.382 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.438 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 8.8 m -103.44 148.22 26.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.983 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 33.2 m-85 -136.21 170.77 15.48 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 110.4 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 22.5 m-85 -117.68 167.23 11.54 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.427 -0.796 . . . . 0.0 109.967 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.602 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 4.4 tt -151.9 97.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.555 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -140.8 161.79 36.96 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.254 -0.903 . . . . 0.0 110.914 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 17.6 tt0 -116.78 139.98 49.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.52 -0.737 . . . . 0.0 109.81 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 96.0 m -136.76 162.58 32.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.52 159.12 33.85 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.428 -0.795 . . . . 0.0 110.01 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 46.2 Cg_endo -75.45 164.61 32.22 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.879 1.463 . . . . 0.0 110.678 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.434 ' CG1' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.357 -0.839 . . . . 0.0 109.941 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 1.4 t70 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.323 0.583 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.05 173.62 16.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 110.225 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 m -138.99 157.48 45.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.293 -0.879 . . . . 0.0 110.313 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.455 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 52.2 t-20 -95.69 114.77 64.69 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 110.007 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 47.0 Cg_endo -73.96 -30.72 8.8 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.967 1.509 . . . . 0.0 110.519 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.6 95.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.951 . . . . 0.0 110.143 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.2 p -87.29 7.23 29.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.375 -0.828 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 47' ' ' PRO . . . -77.96 119.26 21.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.312 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.602 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 9.7 t -156.17 170.71 21.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.859 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.428 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 14.6 p -141.91 148.11 38.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.072 -1.017 . . . . 0.0 110.565 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 48.8 p90 -135.46 -176.13 4.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.415 -0.803 . . . . 0.0 109.97 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.5 m -146.48 154.39 41.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.073 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.517 HG22 ' CB ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -72.6 -158.79 0.05 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -155.83 -157.09 0.7 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.783 -1.198 . . . . 0.0 110.498 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.62 -46.53 89.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.14 -0.975 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.8 t -83.6 9.91 10.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.278 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 51.14 49.98 41.4 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -133.0 138.63 46.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -1.091 . . . . 0.0 109.927 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.3 85.04 2.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 110.829 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 p -108.06 125.72 51.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.298 -0.876 . . . . 0.0 108.953 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -154.07 -179.19 7.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.026 -1.046 . . . . 0.0 111.405 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.49 135.3 39.54 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.465 0.65 . . . . 0.0 110.563 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 38.4 t80 -125.49 178.74 5.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 0.0 109.502 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 3.4 t -134.05 161.08 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.859 -1.151 . . . . 0.0 110.536 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.505 ' CG1' HG12 ' A' ' 18' ' ' VAL . 30.3 m -137.17 179.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.487 -0.758 . . . . 0.0 109.902 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 8.8 mtt85 -152.21 152.72 32.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.095 -1.003 . . . . 0.0 110.365 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 5.7 tttm -82.41 -25.46 33.68 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.263 -0.898 . . . . 0.0 109.314 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 85' ' ' ASP . 1.1 m -150.26 107.53 3.61 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.454 -0.778 . . . . 0.0 109.653 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.549 ' CE2' HG12 ' A' ' 84' ' ' VAL . 25.1 p90 -105.07 143.59 33.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 110.394 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.3 m -74.25 115.22 13.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 110.467 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.72 -174.5 44.33 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.156 -1.202 . . . . 0.0 110.482 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.358 0.599 . . . . 0.0 110.315 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.549 HG12 ' CE2' ' A' ' 71' ' ' TYR . 96.1 t -138.29 110.19 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.322 -0.861 . . . . 0.0 110.023 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 1.6 m-20 -92.71 161.24 14.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.246 -0.909 . . . . 0.0 110.551 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 94.7 m -109.88 -0.11 18.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.181 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.97 -60.88 2.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.173 -0.954 . . . . 0.0 110.333 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.409 HG22 ' N ' ' A' ' 89' ' ' ALA . 14.8 t -74.94 -30.48 61.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.174 -0.954 . . . . 0.0 110.279 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.409 ' N ' HG22 ' A' ' 88' ' ' THR . . . -108.09 155.72 20.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.892 . . . . 0.0 110.296 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.86 135.14 34.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.344 -0.847 . . . . 0.0 110.166 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.0 m -114.14 137.9 51.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 109.845 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -125.28 151.9 45.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.109 -0.995 . . . . 0.0 110.801 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.423 HD12 ' C ' ' A' ' 34' ' ' ALA . 5.6 tp -122.46 109.16 14.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 0.0 109.073 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -107.39 164.45 13.06 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.532 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -145.51 136.29 24.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.631 -0.923 . . . . 0.0 110.04 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.57 178.06 17.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -105.84 -160.07 0.73 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -1.197 . . . . 0.0 110.15 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.76 45.81 1.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 110.038 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.48 -51.77 0.05 OUTLIER Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.9 tt -103.05 91.33 4.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -1.193 . . . . 0.0 110.143 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -100.86 122.74 43.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.468 HD11 ' O ' ' A' ' 95' ' ' ALA . 2.1 mp -74.11 -29.36 61.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 110.174 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 140.53 -169.84 24.67 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.448 ' O ' ' ND1' ' A' ' 104' ' ' HIS . 31.0 p80 -144.23 126.71 15.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -1.11 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.403 HG12 HG12 ' A' ' 6' ' ' VAL . 85.8 t -92.58 128.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.189 -0.944 . . . . 0.0 110.228 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.57 136.04 42.09 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 88.7 mt -110.21 119.45 39.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.249 -0.907 . . . . 0.0 110.152 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -90.88 160.89 15.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.306 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.57 ' CE1' ' O ' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -146.79 78.67 1.5 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.822 . . . . 0.0 110.148 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 CA-C-O 117.948 -1.474 . . . . 0.0 109.591 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.481 0.769 0 N-CA-C 110.294 -0.695 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -141.55 136.21 30.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.087 -1.008 . . . . 0.0 110.772 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 95' ' ' ALA . 87.9 t80 -149.37 114.64 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.486 -0.759 . . . . 0.0 109.168 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.47 153.7 35.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.868 -1.145 . . . . 0.0 111.317 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.438 HG23 ' HD2' ' A' ' 8' ' ' PRO . 9.5 p -113.67 165.69 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.651 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -74.66 -61.87 1.04 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.663 -1.273 . . . . 0.0 110.432 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.651 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 55.9 Cg_endo -91.6 76.3 0.57 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 O-C-N 123.104 1.055 . . . . 0.0 110.143 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.89 -23.76 65.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.031 -1.043 . . . . 0.0 109.94 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.9 m -139.39 135.68 33.92 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.44 -0.787 . . . . 0.0 109.964 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.87 54.28 1.93 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.575 ' O ' ' CD1' ' A' ' 109' ' ' PHE . 2.2 mt -102.43 171.02 7.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.257 -1.143 . . . . 0.0 109.972 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -125.17 149.36 48.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 69' ' ' LYS . 4.4 p-10 -59.85 120.89 10.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.85 . . . . 0.0 109.978 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.8 -31.04 7.22 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 10.1 tt0 -55.52 147.93 16.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -1.127 . . . . 0.0 110.326 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 26.0 p -97.82 150.86 20.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 0.0 110.325 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.548 HG12 ' CD2' ' A' ' 12' ' ' LEU . 22.6 m -119.46 150.94 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.797 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 m -93.88 116.38 28.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.131 -0.981 . . . . 0.0 110.247 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 t -102.9 149.94 6.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.315 -0.865 . . . . 0.0 109.991 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 32.2 t -150.85 129.81 12.53 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 110.251 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 75.8 t -116.25 151.99 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.809 . . . . 0.0 109.901 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -164.7 113.07 1.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.208 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.65 -55.81 0.42 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -62.52 -142.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -1.148 . . . . 0.0 110.326 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -175.61 166.57 3.21 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.169 -0.957 . . . . 0.0 110.458 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -54.88 133.04 47.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.424 -0.798 . . . . 0.0 110.653 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.433 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 119.67 9.72 8.21 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 19.6 mm-40 -140.68 120.93 13.89 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.161 -1.2 . . . . 0.0 110.468 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.6 m -106.36 130.44 54.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.261 -0.899 . . . . 0.0 109.88 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 50.0 m-85 -115.65 -168.31 1.39 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.233 -0.917 . . . . 0.0 110.786 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 40.8 m-85 -138.68 112.11 8.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.432 -0.793 . . . . 0.0 109.987 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.514 ' CG2' ' O ' ' A' ' 33' ' ' ILE . 5.6 tt -94.42 112.69 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.187 -0.946 . . . . 0.0 109.735 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.71 155.3 42.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 111.307 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 22.6 tt0 -109.7 127.41 54.56 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 1.8 m -143.25 165.92 26.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.067 -1.021 . . . . 0.0 110.705 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 91' ' ' CYS . . . -150.77 164.17 21.28 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.613 -0.679 . . . . 0.0 109.441 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 37' ' ' ALA . 43.3 Cg_endo -71.79 162.83 40.82 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.748 1.394 . . . . 0.0 110.674 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.52 HG12 ' CB ' ' A' ' 44' ' ' ALA . 33.4 m . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.378 -0.827 . . . . 0.0 110.283 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.325 0.583 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.52 ' CB ' HG12 ' A' ' 39' ' ' VAL . . . -132.1 156.7 45.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.85 . . . . 0.0 109.671 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 12.2 t -147.55 160.7 42.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.106 -0.996 . . . . 0.0 110.511 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.463 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 41.2 t-20 -84.37 117.64 69.22 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.318 -0.864 . . . . 0.0 110.12 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.472 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 47.5 Cg_endo -74.63 -37.16 2.44 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.908 1.478 . . . . 0.0 110.554 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.07 -20.95 58.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.327 -0.858 . . . . 0.0 110.322 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 82.4 p -113.86 -10.96 12.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.925 . . . . 0.0 110.352 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB1' ' HA ' ' A' ' 47' ' ' PRO . . . -67.4 106.43 2.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.4 t -139.9 152.96 46.83 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.255 -0.903 . . . . 0.0 110.318 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 6.0 p -105.83 157.33 17.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.106 -0.996 . . . . 0.0 110.51 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 6.4 p90 -146.0 -177.4 5.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.047 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.3 m -138.6 161.29 37.48 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.216 -0.927 . . . . 0.0 110.013 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -158.09 0.09 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.205 -0.934 . . . . 0.0 109.934 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 27' ' ' ALA . 1.6 t0 -141.75 -151.31 0.35 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.967 -1.083 . . . . 0.0 110.406 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.6 -54.62 29.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.926 . . . . 0.0 109.533 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 60' ' ' ALA . 38.6 p -90.37 21.28 3.95 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 61.51 17.49 53.61 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.43 ' HB3' ' OG ' ' A' ' 58' ' ' SER . . . -89.68 137.83 31.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -1.164 . . . . 0.0 110.056 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -140.74 84.62 1.95 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 110.269 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.8 p -104.86 115.59 30.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.84 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -146.12 179.0 7.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.258 -0.901 . . . . 0.0 110.675 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.36 138.64 31.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.511 -0.743 . . . . 0.0 110.863 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.477 ' HB3' HG22 ' A' ' 18' ' ' VAL . 51.4 t80 -132.84 -175.55 3.81 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 21.7 t -144.66 163.03 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.726 -1.234 . . . . 0.0 110.798 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.431 ' C ' ' HG2' ' A' ' 68' ' ' ARG . 33.7 m -138.28 160.83 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 109.657 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.431 ' HG2' ' C ' ' A' ' 67' ' ' VAL . 0.9 OUTLIER -141.05 139.27 34.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.939 -1.1 . . . . 0.0 110.527 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 3.2 ttmt -61.14 -44.92 96.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.903 . . . . 0.0 109.746 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 95.5 p -138.75 149.46 45.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.767 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -155.03 153.65 31.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 110.337 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 7.0 m -70.42 128.4 36.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.892 . . . . 0.0 110.138 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 74' ' ' SER . . . -87.71 173.2 43.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 5.5 t . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.282 -1.128 . . . . 0.0 110.111 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.469 0.652 . . . . 0.0 110.526 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -127.62 155.87 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.411 -0.806 . . . . 0.0 109.676 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -143.97 140.71 29.79 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.033 -1.042 . . . . 0.0 110.499 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 89' ' ' ALA . 69.3 m -85.16 -9.78 57.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.817 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.77 -44.9 72.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 109.929 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 t -94.91 -8.78 36.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.958 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 86' ' ' CYS . . . -140.37 163.9 31.54 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.332 -0.855 . . . . 0.0 109.981 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.24 139.64 35.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.511 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.446 ' HB3' ' HB1' ' A' ' 37' ' ' ALA . 1.4 p -123.22 142.48 50.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.302 -0.874 . . . . 0.0 109.714 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -125.47 161.43 27.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.995 . . . . 0.0 110.604 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 13.7 tp -117.12 112.11 20.43 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.388 -0.82 . . . . 0.0 109.172 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.506 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -110.47 150.29 17.63 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.466 -1.35 . . . . 0.0 109.914 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -142.41 132.14 24.09 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.485 -1.009 . . . . 0.0 109.669 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.523 ' CA ' ' HB3' ' A' ' 31' ' ' TYR . . . 149.35 -159.37 28.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 100' ' ' LEU . 8.9 t-20 -121.18 159.08 26.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -1.083 . . . . 0.0 110.04 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -54.37 -30.57 52.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.1 -1.0 . . . . 0.0 110.107 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.74 -45.76 4.47 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 97' ' ' ASN . 8.8 tt -87.89 143.52 27.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.183 . . . . 0.0 110.204 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -117.25 92.68 3.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.129 -0.982 . . . . 0.0 110.354 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.4 OUTLIER -71.13 -54.87 9.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.897 . . . . 0.0 110.125 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 158.72 155.15 7.49 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.499 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.506 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 8.7 m-70 -125.82 119.52 28.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.675 -0.897 . . . . 0.0 109.264 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.9 t -103.46 107.35 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 110.632 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.91 48.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.264 -0.897 . . . . 0.0 109.717 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 41.1 mt -95.98 158.37 15.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 0.0 110.65 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.1 m -149.36 172.88 14.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.363 -0.835 . . . . 0.0 109.989 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 36.5 m-85 -135.09 118.24 16.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.199 -0.938 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.452 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 44.5 Cg_endo . . . . . 0 C--O 1.216 -0.617 0 N-CA-C 110.622 -0.569 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 23' ' ' SER . . . -151.22 151.2 31.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 95' ' ' ALA . 42.4 t80 -150.19 113.8 4.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.213 -0.929 . . . . 0.0 109.984 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.5 t -150.56 150.31 31.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.099 -1.001 . . . . 0.0 110.571 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.468 HG23 ' HD2' ' A' ' 8' ' ' PRO . 9.9 p -123.11 155.28 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.405 -0.809 . . . . 0.0 109.65 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -75.08 -66.4 0.43 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.036 -1.04 . . . . 0.0 110.382 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 46.3 Cg_endo -74.05 81.98 1.86 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.458 1.241 . . . . 0.0 110.259 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.06 -4.85 53.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.311 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.5 p -143.92 159.44 42.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.433 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.06 51.05 58.24 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.508 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 5.3 mt -88.5 154.79 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -1.154 . . . . 0.0 109.922 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 4.3 t -132.92 157.06 46.07 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.134 -0.979 . . . . 0.0 110.346 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -63.58 115.92 5.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.79 -32.63 7.36 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 26.5 tt0 -50.82 143.97 9.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -1.073 . . . . 0.0 110.116 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.4 t -98.85 152.61 19.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.499 ' HA ' ' HG3' ' A' ' 8' ' ' PRO . 28.7 m -128.11 150.47 33.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.288 -0.883 . . . . 0.0 109.927 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.454 ' O ' HG22 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -98.29 131.36 44.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 110.133 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.39 149.02 18.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -144.9 134.55 23.4 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.391 -0.818 . . . . 0.0 110.524 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.522 ' HB ' ' CB ' ' A' ' 61' ' ' ALA . 52.5 t -127.7 149.0 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.439 -0.788 . . . . 0.0 110.006 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.423 ' N ' HG11 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -153.12 -177.25 6.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.811 . . . . 0.0 109.596 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 71.52 17.3 76.24 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.498 -1.334 . . . . 0.0 109.819 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.459 ' HB1' HG22 ' A' ' 55' ' ' THR . . . -119.12 -159.47 0.77 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.155 -1.203 . . . . 0.0 110.269 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.567 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -170.98 161.06 6.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.443 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -53.6 131.17 38.3 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.572 -0.705 . . . . 0.0 110.272 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.59 21.58 5.72 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -144.36 116.44 8.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.235 -1.156 . . . . 0.0 110.621 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 53' ' ' PHE . 61.3 m -109.66 128.96 55.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 109.563 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 8.7 m-85 -114.31 175.5 5.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.004 -1.06 . . . . 0.0 110.715 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -124.93 124.5 42.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.473 -0.767 . . . . 0.0 109.46 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.479 ' CG2' HG23 ' A' ' 51' ' ' THR . 1.2 tt -105.06 124.38 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.089 -1.007 . . . . 0.0 110.482 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.99 155.87 38.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 111.201 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.517 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 36.6 tt0 -124.33 135.11 53.09 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.437 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 3.7 m -144.96 179.67 7.19 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.79 -1.194 . . . . 0.0 111.111 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . . . -152.07 175.71 2.77 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 37' ' ' ALA . 46.3 Cg_endo -83.23 163.28 15.2 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.751 1.395 . . . . 0.0 110.782 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 109.982 179.914 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.5 t0 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.354 0.597 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -131.79 173.3 11.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.789 . . . . 0.0 109.588 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.8 t -154.09 165.84 34.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.139 -0.976 . . . . 0.0 110.723 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.447 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 29.4 t-20 -80.03 124.58 82.91 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -86.01 -35.56 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.873 1.46 . . . . 0.0 111.389 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.24 3.61 4.45 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.139 -0.976 . . . . 0.0 111.506 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.447 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 71.7 p -124.07 7.29 8.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.863 -1.148 . . . . 0.0 110.677 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.32 120.3 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.026 -1.046 . . . . 0.0 110.193 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.479 HG23 ' CG2' ' A' ' 33' ' ' ILE . 10.0 t -160.57 165.63 30.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.226 -0.922 . . . . 0.0 110.315 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 31' ' ' TYR . 42.8 t -136.01 163.59 29.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.216 -0.928 . . . . 0.0 110.43 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 7.3 p90 -146.55 179.68 7.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.297 -0.877 . . . . 0.0 109.764 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 55' ' ' THR . 32.8 m -145.21 154.2 42.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.459 HG22 ' HB1' ' A' ' 25' ' ' ALA . 7.4 p -73.94 -156.15 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.355 -0.84 . . . . 0.0 110.068 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 27' ' ' ALA . 1.3 t0 -160.9 -151.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.924 -1.11 . . . . 0.0 110.799 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.21 -48.0 83.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 109.959 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.25 9.14 9.37 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.233 -0.917 . . . . 0.0 109.414 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.567 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 50.01 48.17 39.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.61 125.78 43.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.141 -1.211 . . . . 0.0 110.283 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.522 ' CB ' ' HB ' ' A' ' 22' ' ' VAL . . . -115.06 83.08 1.85 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 0.0 110.3 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.5 p -112.12 126.86 55.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.232 -0.918 . . . . 0.0 109.745 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 7.0 p90 -157.06 175.38 14.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 0.0 110.802 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 p -94.4 152.56 18.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.422 -0.799 . . . . 0.0 110.355 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.552 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 73.3 t80 -142.45 179.35 7.0 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 109.634 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.552 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.7 t -135.38 159.11 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.929 -1.107 . . . . 0.0 109.825 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.79 161.28 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.19 -0.944 . . . . 0.0 110.672 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -135.84 138.43 42.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.89 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' HD3' ' CB ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -76.9 -44.31 32.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.092 -1.005 . . . . 0.0 110.471 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.452 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 4.3 p -129.25 147.3 51.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.947 . . . . 0.0 110.413 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.508 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 11.0 p90 -161.82 156.03 22.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.223 -0.923 . . . . 0.0 110.347 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 73' ' ' GLY . 1.4 m -68.97 105.69 2.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.33 -0.856 . . . . 0.0 110.171 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 72' ' ' THR . . . -42.48 147.87 0.59 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 97.1 p . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.29 -1.123 . . . . 0.0 110.082 179.959 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.196 0.522 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.464 HG11 ' CZ ' ' A' ' 71' ' ' TYR . 85.4 t -144.88 111.24 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.153 -0.967 . . . . 0.0 110.701 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 70' ' ' SER . 1.7 m-20 -104.99 104.47 14.22 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 109.009 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.431 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -92.07 24.27 3.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.006 -1.059 . . . . 0.0 110.921 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.463 ' CB ' ' HD3' ' A' ' 69' ' ' LYS . . . -68.8 -37.83 79.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.178 -0.951 . . . . 0.0 109.204 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 t -116.0 -3.36 12.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.58 -0.7 . . . . 0.0 109.679 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -89.53 -139.98 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.354 -0.841 . . . . 0.0 110.294 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.78 102.88 8.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 110.415 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.92 126.15 44.52 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 15.6 p30 -130.5 139.23 50.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.093 -1.005 . . . . 0.0 110.798 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 35' ' ' GLN . 6.1 tp -119.19 110.39 16.97 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.59 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -113.16 162.51 12.34 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.805 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 4' ' ' PHE . . . -142.46 157.53 44.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.644 -0.915 . . . . 0.0 109.997 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.476 ' CA ' HD11 ' A' ' 102' ' ' LEU . . . 107.75 -177.67 21.29 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.465 ' OD1' HD23 ' A' ' 100' ' ' LEU . 4.5 p-10 -126.68 -155.75 0.7 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.194 -1.18 . . . . 0.0 109.996 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 94.3 p -92.62 69.33 4.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.307 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.57 -55.12 0.08 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.596 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 3.9 mm? -75.79 -32.66 59.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -1.135 . . . . 0.0 109.547 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 49.27 80.19 0.07 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.633 -0.667 . . . . 0.0 110.232 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.476 HD11 ' CA ' ' A' ' 96' ' ' GLY . 21.8 mt -76.16 -69.82 0.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 110.238 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.35 179.61 36.17 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.806 -1.187 . . . . 0.0 110.14 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.59 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 3.5 m-70 -134.59 123.37 23.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.585 -0.95 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.444 HG12 ' CG1' ' A' ' 6' ' ' VAL . 60.2 t -90.11 111.04 22.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.248 -0.908 . . . . 0.0 110.313 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.54 118.81 10.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.97 . . . . 0.0 109.29 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.517 ' CD1' ' OE1' ' A' ' 35' ' ' GLN . 49.7 mt -89.85 158.68 17.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 110.852 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -123.26 164.09 19.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.503 -0.748 . . . . 0.0 109.72 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.417 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 4.5 m-85 -149.28 174.57 12.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.199 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.509 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 49.3 Cg_endo . . . . . 0 C--O 1.214 -0.697 0 N-CA-C 110.103 -0.768 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -155.37 135.04 12.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.962 . . . . 0.0 110.306 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.487 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 1.2 t80 -147.78 99.3 3.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.399 -0.813 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.08 158.74 43.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 111.069 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.402 HG21 HG23 ' A' ' 20' ' ' VAL . 6.4 p -121.95 157.99 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.517 -0.739 . . . . 0.0 109.355 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.614 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.7 m -72.46 -70.19 0.29 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.883 -1.136 . . . . 0.0 110.137 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.614 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 53.9 Cg_endo -76.42 97.38 1.13 Allowed 'Trans proline' 0 N--CA 1.481 0.751 0 O-C-N 123.144 1.076 . . . . 0.0 110.031 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.5 -4.33 25.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.047 -1.033 . . . . 0.0 110.144 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.47 127.37 19.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 110.144 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.06 80.62 1.26 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.414 HD13 ' HB3' ' A' ' 107' ' ' LEU . 45.3 mt -126.44 162.09 26.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.311 -1.111 . . . . 0.0 110.248 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.78 158.03 44.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.117 -0.99 . . . . 0.0 110.813 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -61.51 121.53 12.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.19 -39.03 2.93 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -49.47 134.05 19.62 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.28 -1.129 . . . . 0.0 109.885 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.2 p -95.51 138.74 32.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.38 -0.825 . . . . 0.0 110.066 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 65' ' ' PHE . 15.9 m -108.58 170.18 2.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.375 -0.828 . . . . 0.0 109.665 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.503 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 27.0 p -116.65 121.59 42.11 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.18 -0.95 . . . . 0.0 109.262 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.402 HG23 HG21 ' A' ' 6' ' ' VAL . 17.3 t -112.16 150.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.118 -0.989 . . . . 0.0 110.41 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.65 132.55 22.74 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.492 -0.755 . . . . 0.0 110.114 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 18.3 t -120.71 139.43 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.483 ' OG ' ' HB3' ' A' ' 3' ' ' ALA . 2.4 p -151.35 143.56 24.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.252 -0.905 . . . . 0.0 110.108 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 120.39 -67.77 0.41 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 24' ' ' GLY . . . -54.18 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.086 -1.243 . . . . 0.0 109.363 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.513 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -165.55 162.65 19.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.943 -1.098 . . . . 0.0 110.976 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.5 130.91 1.3 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.459 0.647 . . . . 0.0 110.409 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.04 4.61 11.23 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.445 ' OE1' HD12 ' A' ' 100' ' ' LEU . 33.6 mt-10 -138.72 122.75 17.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.199 -1.177 . . . . 0.0 109.85 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 62.4 m -105.02 133.69 49.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 109.99 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.606 ' CE2' HD21 ' A' ' 100' ' ' LEU . 11.1 m-85 -120.05 171.8 8.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.533 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 14.0 m-85 -131.68 102.1 5.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 109.113 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.529 ' CG2' ' O ' ' A' ' 33' ' ' ILE . 3.0 tt -90.47 117.8 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.084 -1.01 . . . . 0.0 110.905 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.45 158.5 44.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.219 -0.926 . . . . 0.0 110.299 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.461 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 2.2 tt0 -116.85 144.47 44.47 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.226 -0.921 . . . . 0.0 110.19 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 77.2 m -150.23 161.43 42.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.283 -0.885 . . . . 0.0 110.776 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.51 ' CB ' ' SG ' ' A' ' 86' ' ' CYS . . . -138.17 156.04 74.0 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 121.371 -0.831 . . . . 0.0 109.816 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 44.4 Cg_endo -70.82 163.62 38.48 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.825 1.434 . . . . 0.0 111.836 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.471 HG11 ' HB1' ' A' ' 44' ' ' ALA . 5.8 m . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.689 . . . . 0.0 109.748 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 12.5 t70 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.722 0.773 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.532 ' CB ' HG23 ' A' ' 84' ' ' VAL . . . -149.72 162.88 39.37 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.68 162.15 27.22 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.916 -1.115 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.493 ' ND2' HG22 ' A' ' 49' ' ' THR . 57.4 t30 -103.91 113.35 65.47 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.553 -0.717 . . . . 0.0 110.171 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.26 -27.93 7.63 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.993 1.523 . . . . 0.0 110.242 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.26 -3.78 11.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.849 . . . . 0.0 110.285 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.493 HG22 ' ND2' ' A' ' 46' ' ' ASN . 3.5 p -131.24 -1.85 3.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.258 -0.901 . . . . 0.0 110.172 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.7 127.38 31.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.26 -0.9 . . . . 0.0 110.183 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 33' ' ' ILE . 4.4 t -159.47 150.51 19.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.979 . . . . 0.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 t -122.42 143.25 49.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.309 -0.869 . . . . 0.0 110.149 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -140.24 138.07 34.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.146 -0.971 . . . . 0.0 110.432 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.453 ' OG1' HG23 ' A' ' 30' ' ' THR . 15.6 m -105.48 151.56 24.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.194 -0.941 . . . . 0.0 109.525 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -61.71 -170.76 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.811 -1.18 . . . . 0.0 109.481 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 6.5 t0 -145.45 -158.72 0.92 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.914 -1.116 . . . . 0.0 110.818 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.39 -53.23 60.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 109.47 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 p -76.78 1.99 15.68 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 109.083 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 53.75 44.49 70.0 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.14 132.99 47.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.289 -1.124 . . . . 0.0 110.051 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.444 ' CB ' ' HB ' ' A' ' 22' ' ' VAL . . . -123.13 83.55 2.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.181 -0.95 . . . . 0.0 110.876 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.22 120.22 41.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.263 -0.898 . . . . 0.0 109.648 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -154.91 168.03 28.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.175 -0.953 . . . . 0.0 110.833 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 t -90.96 131.63 36.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.448 -0.783 . . . . 0.0 110.278 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 76.7 t80 -116.35 -179.73 3.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.557 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.1 t -133.37 158.1 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 120.858 -1.151 . . . . 0.0 110.01 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.458 ' O ' HG22 ' A' ' 67' ' ' VAL . 29.1 m -129.42 126.72 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.153 -0.967 . . . . 0.0 110.818 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 134.99 47.83 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.206 -0.934 . . . . 0.0 109.888 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -73.91 -45.86 47.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.218 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.4 m -135.12 152.11 51.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.939 . . . . 0.0 110.066 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.578 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 8.8 p90 -169.68 148.19 3.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.928 . . . . 0.0 110.317 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.61 124.77 17.32 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.146 -0.971 . . . . 0.0 109.395 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.539 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -110.14 167.6 12.77 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.505 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.658 -0.907 . . . . 0.0 108.909 179.923 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.3 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.211 0.529 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.539 ' CG2' ' HA3' ' A' ' 73' ' ' GLY . 88.0 t -125.82 156.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.183 -0.948 . . . . 0.0 110.297 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -156.19 130.92 9.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.19 -0.944 . . . . 0.0 110.381 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.51 ' SG ' ' CB ' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -90.52 7.89 36.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 109.978 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.53 -47.44 69.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.343 -0.848 . . . . 0.0 110.247 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.0 t -113.32 -0.04 14.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 110.174 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -103.46 -163.71 1.01 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.224 -0.923 . . . . 0.0 110.278 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.7 133.23 56.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 110.136 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.56 111.25 23.72 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.184 -0.948 . . . . 0.0 110.016 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -121.49 140.43 52.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.131 -0.981 . . . . 0.0 110.64 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.1 tp -112.84 141.42 46.67 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.435 -0.791 . . . . 0.0 109.244 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.24 167.73 32.41 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.08 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 33' ' ' ILE . . . -155.01 168.52 26.72 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.602 -0.94 . . . . 0.0 109.173 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.3 175.95 26.07 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.166 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 30' ' ' THR . 28.7 t30 -148.37 172.19 14.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -1.081 . . . . 0.0 109.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.99 -10.51 14.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 0.0 110.318 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.96 -43.58 7.1 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.606 HD21 ' CE2' ' A' ' 31' ' ' TYR . 2.3 pt? -154.12 -160.86 1.14 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -1.193 . . . . 0.0 110.436 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.516 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 3.4 m-20 -149.91 113.46 4.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.286 -0.884 . . . . 0.0 110.294 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.445 HD12 ' CD2' ' A' ' 31' ' ' TYR . 96.9 mt -71.58 -54.47 10.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 110.202 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.77 -160.34 27.71 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 7.5 p80 -158.35 140.62 14.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.267 -1.137 . . . . 0.0 109.999 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.9 t -103.04 124.1 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.112 -0.992 . . . . 0.0 110.587 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.61 103.21 3.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.256 -0.902 . . . . 0.0 109.956 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.414 ' HB3' HD13 ' A' ' 12' ' ' LEU . 12.8 mt -83.01 127.61 33.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.21 -0.931 . . . . 0.0 110.314 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.4 m -94.61 171.18 8.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.205 -0.935 . . . . 0.0 110.297 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -145.25 154.49 42.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.391 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.539 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . 44.3 Cg_endo . . . . . 0 N--CA 1.483 0.883 0 N-CA-C 109.873 -0.857 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 23' ' ' SER . . . -156.6 149.12 23.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.863 -1.148 . . . . 0.0 111.552 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -151.14 107.07 3.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.597 -0.689 . . . . 0.0 109.322 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.48 151.35 43.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.968 -1.083 . . . . 0.0 111.51 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.462 HG21 HG22 ' A' ' 20' ' ' VAL . 7.8 p -133.12 132.77 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.642 -0.661 . . . . 0.0 109.425 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.612 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -63.22 -66.74 1.36 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.038 -1.039 . . . . 0.0 110.839 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 50.9 Cg_endo -73.44 83.29 1.52 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.6 1.316 . . . . 0.0 110.667 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.7 4.62 53.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.112 -0.992 . . . . 0.0 110.005 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.8 p -151.75 170.38 19.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.95 55.92 28.19 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.466 HD12 ' HB3' ' A' ' 107' ' ' LEU . 58.0 mt -107.86 145.38 33.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -1.081 . . . . 0.0 109.953 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 0.4 OUTLIER -119.55 158.11 26.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 110.541 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 14' ' ' ASP . 41.0 t0 -59.34 124.04 18.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.894 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.01 -32.01 6.78 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 13' ' ' SER . 37.9 tt0 -56.9 146.38 26.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.305 -1.115 . . . . 0.0 109.985 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 11.3 m -102.37 153.22 20.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.57 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 65' ' ' PHE . 6.3 m -116.8 153.32 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.337 -0.852 . . . . 0.0 109.818 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -97.79 109.18 21.98 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.16 -0.962 . . . . 0.0 110.055 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.462 HG22 HG21 ' A' ' 6' ' ' VAL . 46.2 t -111.17 157.6 11.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 121.435 -0.791 . . . . 0.0 109.846 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 m -150.59 117.3 5.81 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.257 -0.902 . . . . 0.0 110.383 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 t -105.25 123.7 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 0.0 109.892 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 3' ' ' ALA . 0.1 OUTLIER -132.86 155.76 48.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.995 -1.066 . . . . 0.0 110.499 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 106.63 -35.74 4.85 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.483 ' HB3' HG23 ' A' ' 55' ' ' THR . . . -68.34 -150.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.306 -1.114 . . . . 0.0 109.747 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.54 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . 176.19 147.68 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.859 -1.151 . . . . 0.0 111.339 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -39.41 143.28 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.611 0.72 . . . . 0.0 110.415 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.45 18.47 14.49 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.478 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 4.5 tp10 -151.02 135.64 17.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.227 -1.161 . . . . 0.0 110.745 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 3.7 m -114.3 145.15 42.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 24.5 m-85 -128.34 179.58 5.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -0.95 . . . . 0.0 110.504 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -132.33 100.69 5.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.208 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.521 ' CG2' ' O ' ' A' ' 33' ' ' ILE . 7.6 tt -89.0 103.25 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -0.922 . . . . 0.0 110.134 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -138.7 163.24 32.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.139 -0.975 . . . . 0.0 110.555 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.458 ' HB3' HD13 ' A' ' 93' ' ' LEU . 18.0 pt20 -128.77 148.75 50.88 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.16 -0.962 . . . . 0.0 110.269 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 1.8 m -145.5 172.93 12.51 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.213 -0.929 . . . . 0.0 110.389 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.25 161.57 35.87 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.533 -0.729 . . . . 0.0 109.409 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.4 171.78 15.48 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.713 1.375 . . . . 0.0 110.329 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.1 -1.0 . . . . 0.0 110.402 -179.924 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 1.8 p30 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.266 0.555 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.492 ' CB ' HG23 ' A' ' 84' ' ' VAL . . . -108.49 147.12 32.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.37 -0.832 . . . . 0.0 109.163 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 12.2 t -124.14 170.41 10.73 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.793 -1.192 . . . . 0.0 111.007 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 8.4 t-20 -105.76 119.61 51.91 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 109.995 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.79 -35.04 3.62 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.871 1.459 . . . . 0.0 110.41 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.14 73.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.276 -0.89 . . . . 0.0 110.213 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.6 p -75.65 -16.71 60.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.317 -0.865 . . . . 0.0 109.983 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -76.26 87.93 3.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.837 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 33' ' ' ILE . 12.0 t -112.46 148.4 34.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.264 -0.898 . . . . 0.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 p -93.58 132.46 37.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.35 -0.844 . . . . 0.0 109.86 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.528 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 35.3 p90 -133.34 124.51 27.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.12 -0.988 . . . . 0.0 110.698 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.45 ' OG1' HG22 ' A' ' 30' ' ' THR . 47.3 m -89.22 153.87 20.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 110.345 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.483 HG23 ' HB3' ' A' ' 25' ' ' ALA . 1.8 p -61.67 -158.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.297 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 9.2 m-20 -149.18 -160.24 1.15 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.853 -1.154 . . . . 0.0 110.675 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.51 76.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.163 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.8 m -85.9 13.3 7.65 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.54 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 54.25 23.58 26.18 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.94 114.94 28.64 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.456 -1.026 . . . . 0.0 110.434 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.28 80.01 1.27 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.505 -0.747 . . . . 0.0 110.096 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -103.67 143.92 32.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.431 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -172.79 169.78 4.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.135 -0.978 . . . . 0.0 111.055 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.62 92.45 8.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.31 -0.869 . . . . 0.0 110.112 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.521 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 77.7 t80 -73.39 -174.97 1.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.438 -0.789 . . . . 0.0 109.505 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.521 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.1 t -138.66 155.42 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.883 -1.136 . . . . 0.0 109.561 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 18' ' ' VAL . 33.0 m -136.28 144.9 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.032 -1.043 . . . . 0.0 110.535 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.01 138.43 50.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -0.843 . . . . 0.0 110.228 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -64.16 -58.76 5.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.865 . . . . 0.0 110.234 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 p -130.04 155.23 46.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.269 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 11.0 p90 -168.35 158.3 9.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 109.796 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.58 127.59 32.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.157 -0.965 . . . . 0.0 110.191 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.496 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -96.05 168.1 25.7 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 13.2 t . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.182 -1.187 . . . . 0.0 110.308 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.321 0.581 . . . . 0.0 110.454 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.496 ' CG2' ' HA3' ' A' ' 73' ' ' GLY . 53.0 t -138.53 142.34 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.34 -0.85 . . . . 0.0 109.635 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.3 137.92 41.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.017 -1.052 . . . . 0.0 110.672 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 91' ' ' CYS . 65.1 m -93.19 27.48 2.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.44 -51.55 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.44 -0.787 . . . . 0.0 109.976 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.416 HG21 ' N ' ' A' ' 89' ' ' ALA . 4.4 t -97.64 -20.25 17.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.35 -0.843 . . . . 0.0 109.654 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.416 ' N ' HG21 ' A' ' 88' ' ' THR . . . -96.79 -161.85 0.91 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.361 -0.837 . . . . 0.0 109.77 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.49 130.88 56.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 110.59 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 86' ' ' CYS . 0.5 OUTLIER -107.3 116.39 31.85 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.342 -0.849 . . . . 0.0 109.551 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 91' ' ' CYS . 42.9 m-20 -130.77 136.35 48.63 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.966 -1.084 . . . . 0.0 111.268 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 35' ' ' GLN . 2.6 tp -107.12 118.27 36.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.491 -0.756 . . . . 0.0 109.671 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -111.21 161.3 12.84 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.28 170.82 17.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.337 -1.096 . . . . 0.0 110.195 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.32 167.96 12.65 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 100' ' ' LEU . 4.2 p-10 -118.4 -151.12 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 110.405 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.18 89.59 4.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.229 -0.919 . . . . 0.0 110.377 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.56 -21.53 3.59 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.531 ' CD1' ' HG ' ' A' ' 102' ' ' LEU . 2.9 tm? -103.81 -76.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.379 -1.071 . . . . 0.0 109.913 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 100' ' ' LEU . 4.3 t70 70.09 138.29 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.207 -0.933 . . . . 0.0 110.726 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.539 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 4.2 mt -133.0 -42.13 0.9 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.423 -0.798 . . . . 0.0 110.372 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.81 -149.01 20.39 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 14.2 p80 -158.74 134.39 8.78 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.253 -1.146 . . . . 0.0 110.312 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.16 161.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.387 -0.821 . . . . 0.0 109.593 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.98 124.93 48.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 0.0 110.242 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.466 ' HB3' HD12 ' A' ' 12' ' ' LEU . 79.3 mt -100.78 85.82 2.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.619 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.5 m -68.42 162.94 24.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.756 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.458 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 5.2 m-85 -136.52 75.76 1.56 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.144 -0.972 . . . . 0.0 110.382 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.358 0 CA-C-O 118.025 -1.43 . . . . 0.0 109.623 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.431 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 49.3 Cg_endo . . . . . 0 N--CA 1.48 0.685 0 N-CA-C 110.425 -0.644 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -162.21 79.49 0.52 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.126 -0.984 . . . . 0.0 110.527 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -91.37 114.9 27.55 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.056 -1.028 . . . . 0.0 109.718 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.6 p -150.81 152.44 33.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.044 -1.035 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.52 ' CG1' HG12 ' A' ' 105' ' ' VAL . 8.0 p -120.37 123.31 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.569 -0.707 . . . . 0.0 109.574 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.594 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.1 m -45.94 -67.95 0.34 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.999 . . . . 0.0 110.122 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 48.6 Cg_endo -76.15 78.98 3.04 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.342 1.18 . . . . 0.0 110.014 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.59 6.57 45.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 110.282 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -158.24 148.51 20.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.928 . . . . 0.0 110.338 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.63 67.61 1.92 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 8' ' ' PRO . 11.8 mt -122.22 173.62 7.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.387 -1.067 . . . . 0.0 110.162 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -137.83 157.3 46.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.158 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -60.82 109.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.135 -0.978 . . . . 0.0 110.26 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.85 -39.34 2.82 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -46.38 141.07 3.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.145 -1.209 . . . . 0.0 109.941 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.78 152.99 21.02 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.952 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.525 HG12 ' CG1' ' A' ' 67' ' ' VAL . 5.6 m -126.98 166.44 23.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.4 t -119.36 130.34 55.29 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.141 -0.974 . . . . 0.0 110.174 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.9 t -117.25 144.6 24.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 O-C-N 121.602 -0.686 . . . . 0.0 109.792 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 40.2 t -150.99 134.52 16.31 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.296 -0.878 . . . . 0.0 110.494 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 22.5 t -122.66 111.9 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.764 . . . . 0.0 110.092 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 58.8 m -125.47 113.34 17.36 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.083 -1.011 . . . . 0.0 111.068 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 154.16 -38.11 0.69 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.469 ' HB1' HG23 ' A' ' 55' ' ' THR . . . -69.49 -141.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -1.146 . . . . 0.0 109.807 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.558 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . 176.0 160.31 0.3 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.152 -0.968 . . . . 0.0 110.445 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.76 133.35 31.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.735 . . . . 0.0 110.417 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.437 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 127.35 12.17 3.19 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.524 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 73.5 mm-40 -152.18 144.61 24.09 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.949 -1.324 . . . . 0.0 110.545 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 53' ' ' PHE . 23.7 m -122.36 148.37 45.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.416 -0.803 . . . . 0.0 109.791 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.525 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 9.6 m-85 -140.02 -177.14 4.86 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.07 -1.018 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.578 ' CD1' ' HB3' ' A' ' 52' ' ' SER . 19.0 m-85 -132.81 124.83 28.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.463 ' O ' HG21 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -108.53 117.0 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.877 -1.14 . . . . 0.0 110.916 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.53 151.16 30.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 110.471 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -103.1 135.22 45.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.382 -0.824 . . . . 0.0 109.529 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 1.5 m -146.58 173.06 12.67 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.082 -1.011 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.433 ' HB3' ' OH ' ' A' ' 71' ' ' TYR . . . -151.02 152.35 31.3 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.524 -0.735 . . . . 0.0 109.466 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.41 156.41 61.71 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.689 1.363 . . . . 0.0 110.96 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.489 -0.757 . . . . 0.0 110.109 -179.945 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.244 0.545 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.414 ' CB ' ' HA3' ' A' ' 73' ' ' GLY . . . -126.85 152.22 47.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.863 . . . . 0.0 109.801 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 10.4 t -129.56 165.16 22.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 110.283 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -86.86 112.06 44.59 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.194 -0.941 . . . . 0.0 110.109 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.7 Cg_endo -74.49 -27.65 10.85 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.94 1.495 . . . . 0.0 110.661 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.46 -23.62 67.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.171 -0.956 . . . . 0.0 110.285 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.9 p -113.1 26.62 10.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.208 -0.932 . . . . 0.0 110.375 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.7 143.36 33.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.22 -0.925 . . . . 0.0 110.068 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.463 HG22 HG21 ' A' ' 33' ' ' ILE . 7.5 t -170.35 137.33 1.45 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.015 . . . . 0.0 110.627 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.578 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 5.4 p -107.6 155.79 19.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.305 -0.872 . . . . 0.0 110.548 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' A' ' 31' ' ' TYR . 12.3 p90 -151.93 -178.31 6.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.167 -0.958 . . . . 0.0 110.556 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.441 HG21 ' O ' ' A' ' 29' ' ' GLU . 31.2 m -141.16 168.67 19.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.458 -0.776 . . . . 0.0 109.64 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.469 HG23 ' HB1' ' A' ' 25' ' ' ALA . 1.0 OUTLIER -74.2 -164.7 0.26 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.956 -1.09 . . . . 0.0 110.462 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.35 -162.18 1.31 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.858 . . . . 0.0 109.779 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.04 -58.0 10.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -0.962 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 p -90.7 23.71 2.98 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.325 -0.859 . . . . 0.0 108.962 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.558 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 57.61 39.35 90.88 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -106.86 124.44 49.62 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.34 -1.094 . . . . 0.0 110.564 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.29 84.43 2.15 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.342 -0.849 . . . . 0.0 109.504 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 57.1 m -110.94 120.76 43.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 110.526 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.634 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 2.2 p90 -143.82 170.98 14.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 110.649 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 p -93.32 122.15 35.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.376 -0.828 . . . . 0.0 110.671 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -116.87 -169.62 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.489 -0.757 . . . . 0.0 109.206 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 t -145.51 165.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.8 -1.188 . . . . 0.0 109.623 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.525 ' CG1' HG12 ' A' ' 18' ' ' VAL . 34.2 m -130.43 152.95 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.069 -1.019 . . . . 0.0 110.789 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.434 ' HD3' ' C ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -133.42 150.46 51.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.339 -0.851 . . . . 0.0 109.96 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.555 ' CE ' ' CD1' ' A' ' 109' ' ' PHE . 3.2 ttmt -83.42 -36.99 23.81 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.097 -1.002 . . . . 0.0 110.553 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 p -136.04 150.01 49.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.197 -0.94 . . . . 0.0 110.092 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.505 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 16.4 p90 -161.34 166.11 27.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.254 -0.904 . . . . 0.0 110.328 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -88.53 117.53 27.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.218 -0.926 . . . . 0.0 110.061 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 74' ' ' SER . . . -101.37 154.78 19.02 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 2.5 p . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.312 -1.111 . . . . 0.0 110.017 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.369 0.604 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.426 ' CG1' ' CZ ' ' A' ' 71' ' ' TYR . 49.4 t -139.18 102.8 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.383 -0.823 . . . . 0.0 109.806 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -93.88 126.06 38.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.369 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 3.5 m -85.92 4.13 38.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.821 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.17 -63.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 109.991 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.3 t -72.85 -33.86 66.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.268 -0.895 . . . . 0.0 110.009 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.35 -177.77 4.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.326 -0.859 . . . . 0.0 109.919 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.48 139.17 38.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.373 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.34 130.47 54.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.64 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.422 ' ND2' ' N ' ' A' ' 92' ' ' ASN . 3.1 m-80 -133.93 163.69 28.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 110.796 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 35' ' ' GLN . 41.2 tp -127.58 111.12 13.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 0.0 109.214 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -101.27 165.49 18.36 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.056 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -157.38 101.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -1.072 . . . . 0.0 110.105 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 31' ' ' TYR . . . -178.83 174.88 46.96 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.489 ' CG ' ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -123.46 -155.01 0.63 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.068 -1.254 . . . . 0.0 109.88 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.489 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 11.3 p -99.97 78.14 2.08 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.31 -36.19 0.24 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.155 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.469 HD11 ' OH ' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -109.17 -47.52 3.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.908 -1.348 . . . . 0.0 110.744 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 100' ' ' LEU . 33.7 m-20 54.27 105.79 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.293 -0.88 . . . . 0.0 110.12 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 mt -94.43 -60.96 1.6 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 0.0 110.467 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 159.94 -162.5 33.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.431 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 15.7 p80 -151.29 132.39 14.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.295 -1.121 . . . . 0.0 110.261 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.52 HG12 ' CG1' ' A' ' 6' ' ' VAL . 16.1 t -87.2 130.1 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.188 -0.945 . . . . 0.0 110.011 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.56 123.2 28.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.0 110.16 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 39.4 mt -92.89 170.06 9.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 0.0 110.586 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 85.3 m -141.74 171.82 13.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.408 -0.807 . . . . 0.0 109.794 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.555 ' CD1' ' CE ' ' A' ' 69' ' ' LYS . 3.0 m-85 -146.08 115.76 7.24 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.861 . . . . 0.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 N--CA 1.48 0.72 0 N-CA-C 110.133 -0.756 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' SER . . . -140.49 129.57 23.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 110.52 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -148.96 99.23 2.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 0.0 109.538 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.5 p -148.01 148.27 30.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.468 ' CG1' HG13 ' A' ' 105' ' ' VAL . 10.1 p -106.15 159.52 6.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.609 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -74.15 -71.01 0.23 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.889 -1.132 . . . . 0.0 109.832 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 55.4 Cg_endo -77.8 84.68 1.94 Allowed 'Trans proline' 0 C--N 1.322 -0.853 0 O-C-N 123.209 1.11 . . . . 0.0 110.366 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.92 -14.2 61.02 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.89 -1.131 . . . . 0.0 109.667 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.8 t -139.58 162.29 35.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.627 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.24 47.49 10.83 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.474 HD22 HG13 ' A' ' 18' ' ' VAL . 14.0 mt -101.28 170.67 8.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.383 -1.069 . . . . 0.0 109.962 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 m -145.61 162.16 38.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.041 -1.037 . . . . 0.0 111.012 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.41 125.64 24.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.24 -26.8 7.43 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.467 ' OE1' ' N ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -51.22 138.62 20.28 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.345 -1.091 . . . . 0.0 110.29 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.467 ' N ' ' OE1' ' A' ' 16' ' ' GLN . 1.3 t -99.76 122.13 42.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.464 -0.773 . . . . 0.0 109.88 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.495 HG22 HG13 ' A' ' 67' ' ' VAL . 34.9 m -98.9 168.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.981 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.448 ' O ' HG21 ' A' ' 6' ' ' VAL . 3.7 m -116.44 120.48 38.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.975 . . . . 0.0 110.24 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.78 152.52 8.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.347 -0.845 . . . . 0.0 109.945 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.7 t -142.45 125.0 15.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 48.2 t -116.01 147.51 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.455 -0.778 . . . . 0.0 109.819 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 3' ' ' ALA . 11.8 t -160.24 153.55 22.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.082 -1.012 . . . . 0.0 110.189 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.34 -47.18 1.07 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.502 ' CB ' HG23 ' A' ' 55' ' ' THR . . . -60.22 -154.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.322 -1.105 . . . . 0.0 110.204 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.539 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -176.11 143.57 0.55 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 110.481 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -30.77 130.72 0.1 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.43 0.633 . . . . 0.0 111.236 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.442 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 112.61 6.37 23.38 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.468 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 1.6 mt-10 -131.81 121.37 24.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.12 -1.223 . . . . 0.0 110.278 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.576 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 57.6 m -104.22 147.15 27.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.986 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 30' ' ' THR . 16.2 m-85 -134.7 168.66 18.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.909 . . . . 0.0 110.4 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 17.7 m-85 -126.53 118.59 25.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.347 -0.846 . . . . 0.0 109.698 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.513 ' CG2' HG22 ' A' ' 51' ' ' THR . 7.8 tt -98.63 124.37 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 110.555 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.67 155.67 37.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.852 . . . . 0.0 110.235 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.415 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 26.6 tt0 -110.03 142.62 41.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 70.9 m -148.78 163.46 37.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.974 -1.079 . . . . 0.0 110.772 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.41 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . . . -146.13 166.16 18.01 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.519 -0.738 . . . . 0.0 109.42 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 37' ' ' ALA . 43.5 Cg_endo -71.54 163.49 38.83 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.736 1.387 . . . . 0.0 110.464 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.175 -0.953 . . . . 0.0 110.477 -179.909 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.242 0.544 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.04 173.4 9.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.54 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.0 m -140.76 154.98 46.51 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.027 -1.046 . . . . 0.0 111.061 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.573 ' OD1' ' CG ' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -89.51 116.41 66.27 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.35 -0.844 . . . . 0.0 110.082 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -85.2 -31.17 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.876 1.461 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.11 -10.53 54.71 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.311 -0.868 . . . . 0.0 110.663 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.439 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 63.6 p -124.95 25.5 7.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.094 -1.004 . . . . 0.0 110.399 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.79 108.54 18.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.068 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.513 HG22 ' CG2' ' A' ' 33' ' ' ILE . 10.1 t -130.95 157.15 43.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.892 . . . . 0.0 110.421 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.478 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 74.2 p -126.51 152.88 45.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.848 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 12.1 p90 -148.3 -179.6 7.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.422 -0.799 . . . . 0.0 109.549 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.6 m -143.33 161.23 38.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.937 -1.102 . . . . 0.0 110.306 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.502 HG23 ' CB ' ' A' ' 25' ' ' ALA . 21.8 p -65.11 -154.66 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.342 -0.849 . . . . 0.0 109.966 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.27 -158.8 0.65 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.142 -0.974 . . . . 0.0 110.422 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.7 -48.71 80.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.889 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.32 9.35 11.08 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.338 -0.852 . . . . 0.0 109.438 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 54.98 51.47 53.45 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.74 152.36 47.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.309 -1.112 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.22 81.79 1.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.577 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.3 m -104.0 118.79 37.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 20.1 p90 -155.16 177.54 11.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.135 -0.978 . . . . 0.0 111.073 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.31 131.3 41.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.644 -0.66 . . . . 0.0 110.445 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.473 ' O ' HG22 ' A' ' 18' ' ' VAL . 59.3 t80 -121.88 137.07 54.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.452 -0.78 . . . . 0.0 108.989 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.5 154.02 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.495 HG13 HG22 ' A' ' 18' ' ' VAL . 26.9 m -139.17 151.66 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.498 -0.751 . . . . 0.0 110.273 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.88 179.29 4.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.177 -0.952 . . . . 0.0 110.73 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.446 ' HG3' ' CE2' ' A' ' 109' ' ' PHE . 24.0 tttm -100.96 -30.43 11.65 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.777 0.799 . . . . 0.0 108.899 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.55 163.92 37.26 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.573 ' CG ' ' OD1' ' A' ' 46' ' ' ASN . 16.6 p90 -170.9 156.57 5.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.913 -1.117 . . . . 0.0 110.031 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 m -71.84 136.98 47.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.185 -0.947 . . . . 0.0 110.715 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -106.87 162.74 13.46 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.241 -1.152 . . . . 0.0 110.172 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.405 0.621 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG11 ' N ' ' A' ' 85' ' ' ASP . 95.5 t -98.78 160.52 3.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.359 -0.838 . . . . 0.0 109.643 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.412 ' N ' HG11 ' A' ' 84' ' ' VAL . 41.1 t0 -153.14 134.82 14.5 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 110.546 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 67.7 m -95.07 14.16 22.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.982 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.06 -45.16 9.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.258 -0.901 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.425 HG21 ' N ' ' A' ' 89' ' ' ALA . 15.2 t -98.84 -16.75 18.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.313 -0.867 . . . . 0.0 110.142 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.425 ' N ' HG21 ' A' ' 88' ' ' THR . . . -108.59 -143.59 0.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.861 . . . . 0.0 110.195 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.39 155.64 35.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 110.01 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.77 125.27 29.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.289 -0.882 . . . . 0.0 109.904 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 20.6 p30 -134.25 137.06 44.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 110.418 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 104' ' ' HIS . 1.4 tp -108.41 137.19 46.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.687 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.521 ' HA3' ' ND1' ' A' ' 104' ' ' HIS . . . -134.72 159.86 24.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -134.34 156.39 48.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.374 -1.074 . . . . 0.0 110.052 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 32' ' ' TYR . . . 142.42 162.99 9.48 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.428 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 14.1 p-10 -133.49 -151.01 0.43 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.203 -1.175 . . . . 0.0 110.455 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 p -91.7 95.1 9.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.307 -0.871 . . . . 0.0 110.274 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 132.91 -18.45 4.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.516 HD21 ' N ' ' A' ' 101' ' ' ASP . 8.0 tt -154.93 151.42 28.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.172 -1.193 . . . . 0.0 110.442 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.516 ' N ' HD21 ' A' ' 100' ' ' LEU . 1.8 p30 -135.6 162.58 32.31 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.375 -0.828 . . . . 0.0 109.796 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.6 mt -119.57 -85.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.102 -0.999 . . . . 0.0 110.397 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.539 ' C ' ' CD2' ' A' ' 104' ' ' HIS . . . -168.84 -169.24 32.0 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 103' ' ' GLY . 38.1 m-70 -142.74 120.49 11.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -1.134 . . . . 0.0 110.234 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.468 HG13 ' CG1' ' A' ' 6' ' ' VAL . 85.4 t -89.39 129.12 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -0.877 . . . . 0.0 109.853 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.3 112.12 11.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.044 -1.035 . . . . 0.0 110.434 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.428 HD23 HD12 ' A' ' 12' ' ' LEU . 72.0 mt -87.58 172.64 9.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 110.037 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.428 ' OG1' ' C ' ' A' ' 107' ' ' LEU . 1.4 m -162.8 159.64 24.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.286 -0.884 . . . . 0.0 110.117 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.446 ' CE2' ' HG3' ' A' ' 69' ' ' LYS . 15.1 m-85 -129.61 164.16 24.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 110.447 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 CA-C-O 117.948 -1.473 . . . . 0.0 109.5 179.991 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.474 ' HG2' ' HA ' ' A' ' 102' ' ' LEU . 45.2 Cg_endo . . . . . 0 N--CA 1.482 0.813 0 N-CA-C 110.283 -0.699 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.52 134.71 55.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.247 -0.908 . . . . 0.0 110.559 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -151.51 113.62 4.52 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.424 -0.797 . . . . 0.0 109.858 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.61 156.84 42.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.011 -1.056 . . . . 0.0 111.046 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.531 ' CG1' ' CB ' ' A' ' 9' ' ' ALA . 4.4 p -118.91 165.26 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.805 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -74.36 -65.25 0.59 Allowed Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.001 -1.062 . . . . 0.0 110.814 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 41.9 Cg_endo -71.08 -79.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.559 1.294 . . . . 0.0 110.827 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.531 ' CB ' ' CG1' ' A' ' 6' ' ' VAL . . . 70.85 19.33 5.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.205 -0.934 . . . . 0.0 110.0 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 t 178.3 148.78 0.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 110.167 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.49 59.71 9.79 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.46 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 1.2 mt -104.39 178.16 4.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.292 -1.123 . . . . 0.0 110.715 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -134.35 142.3 47.17 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.416 -0.803 . . . . 0.0 110.015 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 10.0 p-10 -56.93 106.03 0.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.946 . . . . 0.0 110.272 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.45 -45.1 1.32 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -47.1 157.62 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -1.107 . . . . 0.0 109.703 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -101.09 178.72 4.58 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.361 -0.837 . . . . 0.0 110.443 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.459 HG12 HG13 ' A' ' 67' ' ' VAL . 5.8 m -146.33 152.83 13.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.547 -0.721 . . . . 0.0 109.428 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.41 140.05 32.43 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 109.986 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.514 HG11 ' CZ ' ' A' ' 63' ' ' PHE . 14.7 t -129.1 149.07 33.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.142 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.89 129.07 17.68 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.492 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 23' ' ' SER . 52.1 t -119.92 143.58 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.601 -0.687 . . . . 0.0 109.755 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.43 ' N ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -155.65 177.55 11.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.048 -1.033 . . . . 0.0 110.307 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.74 -38.69 3.15 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.589 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -67.32 -151.43 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.16 -1.2 . . . . 0.0 110.673 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.581 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -172.84 159.15 4.08 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.224 -0.922 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 56' ' ' ASP . . . -50.45 125.38 12.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.541 -0.725 . . . . 0.0 110.463 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.413 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 124.79 13.18 3.79 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 6.5 mm-40 -144.14 120.79 11.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.037 -1.272 . . . . 0.0 110.874 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.4 m -105.06 132.75 50.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.529 -0.732 . . . . 0.0 109.255 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 31.4 m-85 -120.77 173.86 6.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.956 -1.09 . . . . 0.0 111.246 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -130.27 123.35 29.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.658 -0.651 . . . . 0.0 109.697 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.478 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 14.3 tt -100.44 125.2 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.131 -0.98 . . . . 0.0 110.651 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.62 146.53 25.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -0.906 . . . . 0.0 110.604 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -98.78 147.69 24.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.854 . . . . 0.0 109.239 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.6 m -144.35 155.9 44.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.028 -1.045 . . . . 0.0 111.512 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.42 ' HB3' ' OH ' ' A' ' 71' ' ' TYR . . . -154.0 141.33 13.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.38 166.19 24.43 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.63 1.332 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.524 HG12 ' CG2' ' A' ' 84' ' ' VAL . 4.2 m . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.312 -0.867 . . . . 0.0 110.591 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.253 0.549 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.434 ' HB3' HG13 ' A' ' 39' ' ' VAL . . . -147.82 145.01 28.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.487 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 18.4 m -128.23 178.21 6.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.015 . . . . 0.0 110.236 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.456 ' O ' ' CG ' ' A' ' 46' ' ' ASN . 15.3 p-10 -101.44 106.02 43.5 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 50.2 Cg_endo -88.12 -39.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.773 1.407 . . . . 0.0 110.65 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.98 -4.6 17.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 110.631 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -130.6 25.34 5.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.092 -1.005 . . . . 0.0 110.144 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.06 143.24 29.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.303 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.478 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 2.9 t -148.83 162.63 39.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 0.0 109.897 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.0 p -134.56 154.53 51.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.166 -0.959 . . . . 0.0 110.452 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 11.2 p90 -145.41 -177.6 5.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.758 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 29' ' ' GLU . 24.1 m -149.69 160.35 43.6 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 110.399 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.589 ' CG2' ' HB3' ' A' ' 25' ' ' ALA . 2.2 p -77.01 -160.94 0.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.35 -0.844 . . . . 0.0 110.487 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 16.3 p-10 -158.22 -147.38 0.17 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.953 -1.092 . . . . 0.0 111.115 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.569 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -84.72 71.36 10.83 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.056 0.932 . . . . 0.0 108.985 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER 154.67 -13.56 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.581 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.97 66.12 2.12 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.33 129.37 18.55 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.259 -1.142 . . . . 0.0 110.789 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.413 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . . . -130.17 83.9 2.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 110.007 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.4 m -100.35 123.76 44.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.544 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 6.9 p90 -158.77 176.04 12.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.24 -0.912 . . . . 0.0 110.556 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.2 t -101.66 158.7 15.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.721 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 85.7 t80 -147.02 -176.88 5.38 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.562 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.8 t -133.58 158.46 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.386 -1.446 . . . . 0.0 110.5 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.459 HG13 HG12 ' A' ' 18' ' ' VAL . 20.4 m -130.32 159.75 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.782 . . . . 0.0 109.471 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 13.4 mtm180 -143.63 112.01 6.36 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.373 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 68' ' ' ARG . 4.5 ttpm? -44.72 -50.33 10.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 108.875 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.08 111.02 17.77 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 36.1 p90 -121.26 131.84 54.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.213 -0.929 . . . . 0.0 110.816 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 26.1 m -61.64 124.38 20.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.451 -0.781 . . . . 0.0 110.303 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.69 -166.14 34.7 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 110.517 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.7 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.159 0.504 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.524 ' CG2' HG12 ' A' ' 39' ' ' VAL . 98.8 t -108.62 102.08 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.231 -0.918 . . . . 0.0 109.904 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.8 OUTLIER -98.82 120.32 39.06 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.417 -0.802 . . . . 0.0 109.575 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.82 37.26 0.58 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 110.717 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.59 -36.83 43.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.166 -0.958 . . . . 0.0 109.3 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.9 t -109.91 -11.5 14.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.433 -0.792 . . . . 0.0 109.48 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.06 -171.15 1.79 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.396 -0.815 . . . . 0.0 110.158 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.19 128.33 49.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.928 . . . . 0.0 110.14 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.1 m -93.78 151.79 19.37 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.102 -0.999 . . . . 0.0 109.861 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -142.88 123.89 14.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 110.694 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.4 tp -92.49 112.65 24.68 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.521 ' HA3' ' NE2' ' A' ' 104' ' ' HIS . . . -115.44 166.67 12.24 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.253 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.527 ' HB3' ' CD1' ' A' ' 102' ' ' LEU . . . -144.56 162.96 35.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.515 -0.991 . . . . 0.0 110.062 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 130.14 176.06 14.28 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 100' ' ' LEU . 8.3 p-10 -128.89 -156.16 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.249 . . . . 0.0 110.57 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.71 82.25 7.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.536 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 139.8 -35.87 1.88 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.461 ' HB3' ' OD1' ' A' ' 97' ' ' ASN . 4.7 tt -115.2 145.45 42.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -1.18 . . . . 0.0 110.336 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.8 121.61 32.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 110.061 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 95' ' ' ALA . 20.2 mt -77.18 -71.49 0.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.929 . . . . 0.0 110.12 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.36 -173.02 42.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.521 ' NE2' ' HA3' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -147.81 112.28 5.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -1.052 . . . . 0.0 109.895 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.5 t -96.12 121.74 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.174 -0.954 . . . . 0.0 110.339 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.46 132.76 43.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.102 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.9 mt -104.81 141.57 36.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.258 -0.901 . . . . 0.0 110.478 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.7 m -119.07 171.39 8.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.858 . . . . 0.0 109.859 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -147.73 85.98 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.231 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 CA-C-O 118.007 -1.44 . . . . 0.0 109.504 179.91 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.483 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.6 Cg_endo . . . . . 0 N--CA 1.485 1.004 0 N-CA-C 110.609 -0.574 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 23' ' ' SER . . . -155.85 141.9 18.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.202 -0.936 . . . . 0.0 110.718 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.602 ' CE2' ' CB ' ' A' ' 95' ' ' ALA . 25.2 t80 -150.24 116.92 5.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 t -150.41 164.92 34.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.9 -1.125 . . . . 0.0 111.355 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.477 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 4.8 p -122.2 176.16 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.602 -0.686 . . . . 0.0 109.662 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.6 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.3 m -78.19 -67.54 0.26 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.005 -1.059 . . . . 0.0 110.534 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 42.8 Cg_endo -72.81 -79.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.929 0 O-C-N 123.358 1.188 . . . . 0.0 110.629 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 8' ' ' PRO . . . 72.66 28.37 2.15 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.355 -0.841 . . . . 0.0 110.513 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER 171.05 119.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.19 -0.944 . . . . 0.0 110.231 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.56 66.63 2.02 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.463 HD22 ' HG2' ' A' ' 8' ' ' PRO . 1.5 mp -104.02 159.25 15.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -1.168 . . . . 0.0 110.537 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 29.0 t -107.76 151.3 25.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 110.028 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.4 127.87 33.27 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.225 -0.922 . . . . 0.0 111.164 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.66 -27.64 6.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 2.4 tt0 -52.35 141.89 18.48 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.291 -1.123 . . . . 0.0 110.596 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.54 148.98 22.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.358 -0.839 . . . . 0.0 109.869 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.419 HG21 ' CG1' ' A' ' 67' ' ' VAL . 24.4 m -129.76 179.76 3.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.794 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.19 134.72 55.22 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.382 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.408 HG13 ' CZ ' ' A' ' 63' ' ' PHE . 4.8 t -114.94 150.71 16.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -146.91 124.72 11.9 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.096 -1.003 . . . . 0.0 110.865 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.0 t -113.04 141.3 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.575 -0.703 . . . . 0.0 109.579 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -158.64 144.96 17.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.073 . . . . 0.0 110.666 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 118.85 -54.1 0.64 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.453 ' CB ' HG23 ' A' ' 55' ' ' THR . . . -59.07 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -1.134 . . . . 0.0 109.833 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.532 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.48 169.99 8.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.066 -1.021 . . . . 0.0 110.323 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -59.97 131.69 51.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.532 -0.73 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.15 16.25 4.0 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.489 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 65.5 mm-40 -149.24 132.72 16.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.166 -1.196 . . . . 0.0 110.385 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.434 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 3.6 m -104.28 162.96 12.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.354 -0.841 . . . . 0.0 110.13 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 74.8 m-85 -150.84 173.23 14.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.207 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 52.8 m-85 -133.97 102.88 5.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 109.324 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 33' ' ' ILE . 8.5 tt -89.56 107.95 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.941 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.95 157.22 43.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.158 -0.964 . . . . 0.0 110.803 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.509 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 2.0 tt0 -95.69 123.56 39.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.645 -0.659 . . . . 0.0 109.88 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.405 ' HA ' ' OH ' ' A' ' 71' ' ' TYR . 1.2 m -137.42 154.1 50.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.235 -0.916 . . . . 0.0 110.101 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.512 ' HB2' ' CB ' ' A' ' 91' ' ' CYS . . . -146.59 166.79 15.52 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 0.0 109.247 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 37' ' ' ALA . 41.4 Cg_endo -69.38 159.03 55.27 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.556 1.293 . . . . 0.0 110.633 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.468 -0.77 . . . . 0.0 110.026 179.996 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 4.8 p30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.358 0.599 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.74 157.81 15.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.902 . . . . 0.0 109.755 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.477 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 5.8 t -135.55 165.99 24.24 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.041 -1.037 . . . . 0.0 110.295 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.522 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -83.65 111.65 33.74 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.204 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 48.9 Cg_endo -77.87 -37.53 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.893 1.47 . . . . 0.0 110.32 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.63 98.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.886 . . . . 0.0 110.493 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.434 ' OG1' ' CG ' ' A' ' 46' ' ' ASN . 1.2 p -96.32 3.38 53.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.261 -0.899 . . . . 0.0 110.425 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.85 129.25 39.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.139 -0.975 . . . . 0.0 109.85 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.479 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.3 t -128.24 131.58 48.78 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.13 -0.982 . . . . 0.0 110.762 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.37 138.14 40.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.445 -0.784 . . . . 0.0 109.393 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 15.8 p90 -141.76 172.21 13.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.051 -1.03 . . . . 0.0 110.547 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.435 HG21 ' O ' ' A' ' 29' ' ' GLU . 88.5 m -133.87 162.41 32.11 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 109.375 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.468 ' HB ' ' HA2' ' A' ' 59' ' ' GLY . 0.7 OUTLIER -75.77 -164.74 0.38 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.914 -1.116 . . . . 0.0 110.384 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 27' ' ' ALA . 5.7 m-20 -145.34 -158.31 0.88 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.18 -0.95 . . . . 0.0 109.575 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.27 -50.04 75.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.902 -1.124 . . . . 0.0 109.53 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.4 t -90.36 21.06 4.05 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.349 -0.844 . . . . 0.0 108.813 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.532 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 49.81 32.0 17.39 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.33 140.73 41.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.371 -1.076 . . . . 0.0 110.483 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -145.59 84.96 1.69 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.411 -0.806 . . . . 0.0 109.704 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -99.99 120.95 40.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 109.983 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.2 p90 -150.63 178.39 9.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.223 -0.923 . . . . 0.0 110.831 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.8 p -96.62 139.12 33.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.46 -0.775 . . . . 0.0 111.016 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 50.2 t80 -131.15 176.17 8.49 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.561 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.8 t -124.61 157.09 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 120.727 -1.233 . . . . 0.0 110.299 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.419 ' CG1' HG21 ' A' ' 18' ' ' VAL . 13.8 m -134.9 128.35 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.397 -0.814 . . . . 0.0 109.904 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.498 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -115.82 144.38 44.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 110.343 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -56.94 -39.68 75.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.394 -0.816 . . . . 0.0 109.796 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.74 165.54 33.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.418 -0.801 . . . . 0.0 109.828 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.522 ' CB ' ' OD1' ' A' ' 46' ' ' ASN . 19.2 p90 -166.9 147.41 5.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 110.361 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.6 OUTLIER -66.18 118.58 10.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.038 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.48 179.81 25.7 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.287 -1.125 . . . . 0.0 110.055 -179.925 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 11.5 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.344 0.592 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.9 t -133.6 162.04 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.9 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 16.7 p-10 -160.43 161.97 33.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.963 . . . . 0.0 110.302 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 96.7 m -97.95 11.14 38.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.313 -0.867 . . . . 0.0 110.331 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.96 -42.03 14.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.19 -0.944 . . . . 0.0 110.34 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.4 t -113.49 -1.08 14.23 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.157 -0.965 . . . . 0.0 110.384 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.51 135.67 44.56 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.241 -0.912 . . . . 0.0 110.61 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.77 105.41 5.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.973 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.512 ' CB ' ' HB2' ' A' ' 37' ' ' ALA . 26.7 p -99.39 140.16 33.98 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.086 -1.009 . . . . 0.0 109.66 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 106' ' ' ALA . 19.1 m-20 -131.05 143.29 50.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.114 -0.991 . . . . 0.0 110.837 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.419 ' HA ' HD11 ' A' ' 93' ' ' LEU . 22.6 tp -88.41 99.41 12.25 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -93.07 165.45 27.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.602 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . . . -152.28 80.04 1.24 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.412 -1.051 . . . . 0.0 110.386 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -137.25 -167.59 11.12 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.477 ' O ' ' OG ' ' A' ' 98' ' ' SER . 2.2 p-10 -129.4 -63.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.246 . . . . 0.0 110.627 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 97' ' ' ASN . 19.6 m -170.83 -32.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.125 -0.984 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.77 -13.23 5.15 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.712 -1.233 . . . . 0.0 110.411 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 101' ' ' ASP . 0.9 OUTLIER -94.87 -52.39 4.27 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.972 -1.31 . . . . 0.0 110.532 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.0 p-10 40.61 98.29 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.701 0.762 . . . . 0.0 110.73 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.7 mt -84.45 -45.44 12.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.016 -1.052 . . . . 0.0 110.104 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.56 -161.82 30.0 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.437 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 21.4 p80 -155.06 142.35 19.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -1.153 . . . . 0.0 110.181 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.47 103.8 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.189 -0.944 . . . . 0.0 110.146 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.47 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . . . -50.62 103.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.893 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.509 ' CD1' ' OE1' ' A' ' 35' ' ' GLN . 54.0 mt -82.83 137.01 34.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 110.144 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.9 167.5 10.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.811 . . . . 0.0 110.092 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 12' ' ' LEU . 3.2 m-85 -142.04 166.83 23.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.927 . . . . 0.0 110.324 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.35 0 CA-C-O 118.008 -1.44 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.474 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 48.2 Cg_endo . . . . . 0 C--O 1.216 -0.589 0 N-CA-C 110.206 -0.728 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 23' ' ' SER . . . -145.71 145.75 31.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.078 -1.014 . . . . 0.0 110.302 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.475 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 39.0 t80 -151.29 113.04 4.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.226 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.47 151.53 36.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.683 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 19' ' ' SER . 9.2 p -128.48 149.19 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.776 . . . . 0.0 109.743 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -67.27 -66.59 1.14 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.052 -1.03 . . . . 0.0 110.191 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 50.4 Cg_endo -75.65 95.29 1.0 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.46 1.242 . . . . 0.0 110.233 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.83 10.56 32.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.097 -1.002 . . . . 0.0 110.311 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.1 t -168.64 154.54 6.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.899 . . . . 0.0 110.084 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.99 56.49 10.65 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 8' ' ' PRO . 2.7 mt -109.59 166.05 11.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -1.126 . . . . 0.0 110.15 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -128.53 164.34 23.01 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.237 -0.915 . . . . 0.0 110.28 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -62.26 125.45 23.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.316 -0.865 . . . . 0.0 109.94 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 89.61 -31.05 5.38 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.463 ' OE1' ' O ' ' A' ' 17' ' ' SER . 1.5 tm0? -42.4 143.9 0.58 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.417 -1.049 . . . . 0.0 110.014 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.463 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 2.1 p -95.55 167.61 11.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 110.287 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 65' ' ' PHE . 30.6 m -147.82 168.21 4.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.323 -0.861 . . . . 0.0 109.762 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.529 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 0.8 OUTLIER -117.04 137.68 52.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.161 -0.962 . . . . 0.0 110.242 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.483 HG23 HG22 ' A' ' 6' ' ' VAL . 11.5 t -126.32 152.57 33.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.444 -0.785 . . . . 0.0 109.81 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.11 127.55 14.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.381 -0.824 . . . . 0.0 110.169 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 t -119.28 147.63 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.322 -0.861 . . . . 0.0 110.077 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.474 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 6.2 p -155.52 131.99 10.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.132 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 131.21 -54.28 0.79 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.477 ' CB ' HG23 ' A' ' 55' ' ' THR . . . -58.73 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -1.123 . . . . 0.0 109.074 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.535 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.95 156.92 6.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.732 -1.23 . . . . 0.0 110.712 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -43.85 133.08 5.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.7 -0.625 . . . . 0.0 110.133 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 29' ' ' GLU . . . 115.28 11.95 10.26 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 1.8 mt-10 -141.94 116.59 9.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.335 -1.097 . . . . 0.0 110.191 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.2 m -104.21 134.01 48.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.757 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 29' ' ' GLU . 27.4 m-85 -117.88 -174.94 2.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.966 . . . . 0.0 110.81 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 34.5 m-85 -136.07 111.31 9.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.522 -0.736 . . . . 0.0 109.399 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.456 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 3.8 tt -86.86 112.96 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.888 . . . . 0.0 110.773 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.416 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -148.34 162.95 38.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.533 -0.729 . . . . 0.0 109.887 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 14.8 pt20 -116.29 146.07 42.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.925 . . . . 0.0 110.718 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.6 m -137.81 150.79 47.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.264 -0.897 . . . . 0.0 110.169 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.535 ' CB ' ' HB3' ' A' ' 91' ' ' CYS . . . -150.32 173.28 4.44 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.304 -0.873 . . . . 0.0 109.264 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 41.5 Cg_endo -67.71 165.02 29.03 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.736 1.387 . . . . 0.0 110.123 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 179.939 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.408 0.623 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.442 ' CB ' HG23 ' A' ' 84' ' ' VAL . . . -105.79 160.05 15.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.643 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -134.92 162.92 31.05 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.024 -1.047 . . . . 0.0 110.633 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.483 ' OD1' ' CD2' ' A' ' 71' ' ' TYR . 3.9 m120 -89.34 115.79 64.65 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.855 . . . . 0.0 110.134 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -90.08 -50.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.896 1.472 . . . . 0.0 111.254 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.98 79.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.389 -0.819 . . . . 0.0 111.52 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 22.4 p -82.7 19.25 1.35 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.09 -1.006 . . . . 0.0 111.108 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.1 67.63 9.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.973 -1.08 . . . . 0.0 109.94 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.456 HG23 HG23 ' A' ' 33' ' ' ILE . 2.6 t -79.82 164.34 23.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.359 -0.838 . . . . 0.0 110.432 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 94.2 p -118.44 143.39 46.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.289 -0.882 . . . . 0.0 110.769 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.472 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 31.0 p90 -140.55 128.88 22.49 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.274 -0.891 . . . . 0.0 109.962 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 9.3 m -92.15 168.57 11.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 110.829 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.477 HG23 ' CB ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -78.1 -158.89 0.14 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.465 -0.772 . . . . 0.0 110.339 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.37 -161.71 1.23 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.058 -1.026 . . . . 0.0 109.916 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.27 -53.81 54.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.023 -1.048 . . . . 0.0 109.158 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 60' ' ' ALA . 25.4 p -84.41 11.36 8.67 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.472 -0.767 . . . . 0.0 109.075 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.535 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 69.91 13.42 69.34 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.462 ' HB2' ' OG ' ' A' ' 58' ' ' SER . . . -86.21 121.28 28.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -1.123 . . . . 0.0 110.02 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -118.25 80.79 1.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.977 . . . . 0.0 110.499 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.82 129.63 48.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -0.972 . . . . 0.0 109.924 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 14.8 p90 -168.19 161.49 12.38 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.458 -0.776 . . . . 0.0 110.358 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 m -92.33 133.57 35.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.198 -0.939 . . . . 0.0 110.624 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.573 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 29.2 t80 -121.73 155.35 35.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 109.323 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.573 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 3.5 t -96.96 160.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.805 -1.184 . . . . 0.0 110.521 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 18' ' ' VAL . 29.7 m -131.77 177.24 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 0.0 109.989 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 2.3 mtt180 -150.35 135.69 17.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 0.0 110.501 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 87' ' ' ALA . 0.9 OUTLIER -67.67 -16.88 64.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -0.961 . . . . 0.0 109.234 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.8 p -150.34 156.39 41.43 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.56 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 16.7 p90 -163.72 144.1 8.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.981 -1.074 . . . . 0.0 110.54 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 28.5 m -65.89 132.93 49.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.892 . . . . 0.0 110.026 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -112.69 -177.59 19.74 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.9 p . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.192 -1.181 . . . . 0.0 110.188 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.8 m . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.404 0.621 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.442 HG23 ' CB ' ' A' ' 44' ' ' ALA . 54.6 t -128.97 162.27 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.455 -0.778 . . . . 0.0 110.044 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.419 ' N ' HG12 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -138.73 102.06 4.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.218 -0.926 . . . . 0.0 110.46 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 2.7 m -74.52 -2.63 26.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.298 -0.876 . . . . 0.0 110.232 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 69' ' ' LYS . . . -46.72 -45.25 19.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.192 -0.942 . . . . 0.0 109.906 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.1 t -116.69 -10.81 11.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.908 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 86' ' ' CYS . . . -94.09 -177.27 4.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.116 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.61 131.84 53.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.903 . . . . 0.0 110.068 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -127.29 139.49 52.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 106' ' ' ALA . 16.0 m-80 -103.85 125.81 50.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.973 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 35' ' ' GLN . 11.7 tp -88.7 101.96 14.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -108.12 171.57 16.17 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -156.67 120.98 4.43 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.437 -1.037 . . . . 0.0 110.297 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.37 176.36 47.95 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -115.8 -76.89 0.57 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -1.135 . . . . 0.0 109.849 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -168.19 -37.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.408 -0.808 . . . . 0.0 110.097 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.38 -12.14 57.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.436 ' C ' ' CD1' ' A' ' 100' ' ' LEU . 2.2 tm? -148.5 90.17 1.77 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -1.161 . . . . 0.0 110.053 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.18 134.86 34.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.478 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 4' ' ' PHE . 71.0 mt -82.69 -70.76 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 0.0 110.034 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.415 ' C ' ' CG ' ' A' ' 104' ' ' HIS . . . 168.38 -162.3 36.07 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.449 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -147.96 129.22 14.7 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.482 -1.011 . . . . 0.0 109.612 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.413 ' O ' ' HG ' ' A' ' 107' ' ' LEU . 93.5 t -98.3 108.48 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.092 -1.005 . . . . 0.0 110.6 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.448 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . . . -57.53 105.51 0.25 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.234 -0.916 . . . . 0.0 110.024 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.431 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 59.4 mt -82.64 164.51 20.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.24 -0.912 . . . . 0.0 110.374 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.5 m -133.15 168.13 19.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.267 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -153.33 167.35 29.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 CA-C-O 117.949 -1.473 . . . . 0.0 109.522 179.988 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.438 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 45.3 Cg_endo . . . . . 0 N--CA 1.48 0.698 0 N-CA-C 110.144 -0.752 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -134.4 134.98 42.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.047 -1.033 . . . . 0.0 110.581 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 8.1 t80 -141.24 115.45 9.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.468 -0.77 . . . . 0.0 109.531 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.463 ' HA ' HG23 ' A' ' 105' ' ' VAL . 4.0 t -153.1 172.54 16.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.077 -1.014 . . . . 0.0 110.811 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.599 ' CG1' ' CB ' ' A' ' 9' ' ' ALA . 12.0 p -120.8 144.97 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.662 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.583 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -54.66 -62.22 4.46 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.276 -0.89 . . . . 0.0 111.082 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 42.5 Cg_endo -71.85 -78.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.781 1.411 . . . . 0.0 110.629 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.599 ' CB ' ' CG1' ' A' ' 6' ' ' VAL . . . 69.13 14.68 8.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.015 . . . . 0.0 109.879 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.4 t -170.77 148.24 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.336 -0.852 . . . . 0.0 110.297 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.02 56.87 22.28 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.554 ' HB2' ' CE1' ' A' ' 109' ' ' PHE . 58.6 mt -98.28 166.47 11.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -1.129 . . . . 0.0 110.091 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -129.49 155.65 45.39 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.223 -0.923 . . . . 0.0 110.108 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.526 ' OD2' ' CD ' ' A' ' 68' ' ' ARG . 6.9 t70 -61.68 115.97 4.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 110.387 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 94.24 -28.45 10.79 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 0.2 OUTLIER -41.75 144.02 0.45 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.31 -1.112 . . . . 0.0 110.483 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 p -95.35 125.49 40.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.826 . . . . 0.0 110.193 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.49 ' CG2' HG13 ' A' ' 67' ' ' VAL . 35.7 m -104.38 -179.07 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.387 -0.82 . . . . 0.0 110.184 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -136.14 114.61 11.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.786 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.4 t -91.4 152.79 3.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.405 -0.81 . . . . 0.0 110.483 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 t -147.41 130.89 16.71 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.474 -0.766 . . . . 0.0 109.331 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.511 ' HB ' ' CB ' ' A' ' 61' ' ' ALA . 87.9 t -128.54 136.56 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.111 -0.993 . . . . 0.0 110.671 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.413 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 3.3 m -131.51 110.54 11.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.421 -0.799 . . . . 0.0 109.873 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 155.5 -58.14 0.39 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.516 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -57.9 -159.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -1.175 . . . . 0.0 109.664 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.548 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -166.21 159.45 15.14 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.899 -1.126 . . . . 0.0 111.014 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -42.06 136.98 1.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.717 -0.614 . . . . 0.0 110.576 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.41 -6.95 42.6 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 3.3 mm-40 -114.09 103.52 11.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -1.142 . . . . 0.0 110.26 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.442 ' HA ' ' CB ' ' A' ' 54' ' ' THR . 97.1 m -103.82 121.24 42.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.314 -0.866 . . . . 0.0 109.627 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.539 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 9.9 m-85 -107.0 -170.19 1.67 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 0.0 110.662 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 50.0 m-85 -131.58 111.54 11.83 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.491 -0.755 . . . . 0.0 109.505 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -89.63 137.06 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.074 -1.016 . . . . 0.0 111.215 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.83 155.06 35.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.497 -0.752 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -98.59 146.7 25.56 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.224 -0.923 . . . . 0.0 110.463 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 t -156.69 145.5 20.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.094 -1.004 . . . . 0.0 111.186 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.23 142.08 16.54 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.09 165.33 32.25 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 O-C-N 123.73 1.384 . . . . 0.0 110.79 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.435 -0.79 . . . . 0.0 109.719 179.958 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 t0 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.104 0.478 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.493 ' HB2' ' HA3' ' A' ' 73' ' ' GLY . . . -130.26 120.59 24.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.138 -0.976 . . . . 0.0 110.022 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.34 155.58 30.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.98 -1.075 . . . . 0.0 110.707 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -106.61 119.88 50.2 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.434 -0.791 . . . . 0.0 109.8 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -80.35 -22.81 6.65 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.882 1.464 . . . . 0.0 110.692 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.61 -37.82 85.68 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.192 -0.943 . . . . 0.0 110.593 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.9 p -91.99 23.08 3.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.24 -0.912 . . . . 0.0 110.489 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 82.37 4.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 110.567 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.0 t -106.7 170.37 7.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.893 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.514 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 52.8 p -118.46 147.68 43.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.027 -1.046 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.539 ' CE1' ' HB2' ' A' ' 31' ' ' TYR . 5.5 p90 -148.24 -179.19 6.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 109.006 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.442 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 3.1 t -157.33 170.93 21.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.875 -1.14 . . . . 0.0 110.928 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.516 HG21 ' CB ' ' A' ' 25' ' ' ALA . 1.5 p -81.03 -155.66 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.461 -0.774 . . . . 0.0 109.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -157.22 -153.62 0.42 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.728 -1.232 . . . . 0.0 110.803 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 -60.61 3.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.079 -1.013 . . . . 0.0 109.947 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -66.37 -6.76 15.43 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.89 7.23 69.69 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -91.55 119.28 31.34 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.137 -1.213 . . . . 0.0 110.176 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.511 ' CB ' ' HB ' ' A' ' 22' ' ' VAL . . . -92.61 82.27 4.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.893 . . . . 0.0 109.862 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.68 124.47 51.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.28 -0.888 . . . . 0.0 109.897 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -162.78 172.55 15.05 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.675 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.0 t -95.26 130.04 42.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.343 -0.848 . . . . 0.0 110.44 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 91.1 t80 -122.01 172.82 7.95 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.584 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -116.13 152.99 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.622 -1.298 . . . . 0.0 109.945 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.49 HG13 ' CG2' ' A' ' 18' ' ' VAL . 36.0 m -134.33 169.26 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.2 -0.938 . . . . 0.0 110.597 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.526 ' CD ' ' OD2' ' A' ' 14' ' ' ASP . 2.0 mmm-85 -139.59 164.64 29.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.823 . . . . 0.0 109.824 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -93.42 -54.04 3.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.177 -0.952 . . . . 0.0 110.04 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.01 129.27 47.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.288 -0.883 . . . . 0.0 109.88 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 10.0 p90 -138.23 139.88 39.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 0.0 110.492 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -65.72 114.84 5.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 110.032 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.493 ' HA3' ' HB2' ' A' ' 44' ' ' ALA . . . -85.07 170.65 45.49 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 95.7 p . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.218 -1.166 . . . . 0.0 110.574 179.958 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.164 0.507 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 71' ' ' TYR . 36.7 t -105.45 137.75 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.818 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.437 ' OD2' ' CB ' ' A' ' 87' ' ' ALA . 6.7 t70 -134.21 135.6 43.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.096 -1.002 . . . . 0.0 110.001 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -86.07 -4.75 59.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.437 ' CB ' ' OD2' ' A' ' 85' ' ' ASP . . . -65.27 -62.28 1.63 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.304 -0.872 . . . . 0.0 110.652 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.0 t -92.23 3.56 55.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.937 . . . . 0.0 110.46 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.36 -176.4 4.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.87 141.38 51.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 110.172 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 61.8 m -106.85 171.78 7.18 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.907 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -151.22 119.35 6.29 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.305 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.7 tp -94.12 101.65 13.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -108.27 167.24 13.18 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.375 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -147.61 160.26 42.86 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.653 -0.91 . . . . 0.0 109.715 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.57 173.99 44.41 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.957 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 31' ' ' TYR . 24.7 t30 -141.0 169.21 18.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.447 -1.031 . . . . 0.0 110.031 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.41 ' O ' ' OG ' ' A' ' 98' ' ' SER . 0.4 OUTLIER -68.91 84.42 0.32 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.243 -0.911 . . . . 0.0 110.426 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.37 -19.43 5.67 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -146.85 99.6 3.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.002 -1.293 . . . . 0.0 110.881 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.434 ' C ' ' HG ' ' A' ' 102' ' ' LEU . 6.6 m-20 -92.66 -173.21 3.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.273 -0.892 . . . . 0.0 109.814 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.434 ' HG ' ' C ' ' A' ' 101' ' ' ASP . 84.4 mt -142.54 -86.36 0.15 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.027 -1.045 . . . . 0.0 110.711 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.552 ' C ' ' CD2' ' A' ' 104' ' ' HIS . . . -178.74 -169.73 39.8 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.552 ' CD2' ' C ' ' A' ' 103' ' ' GLY . 9.0 m-70 -133.76 140.4 46.93 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.227 -1.161 . . . . 0.0 110.852 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 5' ' ' SER . 0.9 OUTLIER -97.75 121.3 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.66 103.79 2.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.812 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 68.4 mt -75.16 170.54 15.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.367 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.76 149.12 44.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 110.374 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.554 ' CE1' ' HB2' ' A' ' 12' ' ' LEU . 1.3 m-85 -139.17 91.05 2.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.116 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.478 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 44.8 Cg_endo . . . . . 0 C--O 1.214 -0.705 0 N-CA-C 110.131 -0.757 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -137.3 93.6 2.84 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.935 -1.103 . . . . 0.0 111.281 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 95' ' ' ALA . 34.1 t80 -112.62 106.04 14.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.071 -1.018 . . . . 0.0 109.614 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.9 m -151.08 155.82 39.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.944 -1.098 . . . . 0.0 111.112 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 19' ' ' SER . 7.5 p -109.41 160.55 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.467 -0.771 . . . . 0.0 109.708 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.565 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -80.16 -59.55 0.53 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.052 . . . . 0.0 110.206 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 54.0 Cg_endo -80.22 74.43 5.55 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.629 1.331 . . . . 0.0 110.38 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.98 -14.42 60.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.019 -1.05 . . . . 0.0 110.065 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.0 m -138.98 178.86 6.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 110.057 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.58 45.64 76.74 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 8' ' ' PRO . 21.5 mt -89.34 159.81 17.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -1.085 . . . . 0.0 110.192 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.432 ' HB2' ' OE1' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -129.63 145.91 51.46 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.318 -0.864 . . . . 0.0 110.212 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 69' ' ' LYS . 13.1 p-10 -57.21 111.18 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.44 -32.92 6.99 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.432 ' OE1' ' HB2' ' A' ' 13' ' ' SER . 55.5 tt0 -49.0 155.49 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -1.163 . . . . 0.0 110.383 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.485 ' O ' ' CG1' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -97.04 -178.16 4.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.371 -0.831 . . . . 0.0 110.568 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 65' ' ' PHE . 25.1 m -156.57 170.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.511 -0.743 . . . . 0.0 109.508 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 6' ' ' VAL . 2.8 m -120.06 123.85 44.42 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.945 -1.097 . . . . 0.0 110.688 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.6 143.01 22.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.441 -0.787 . . . . 0.0 109.657 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.47 133.8 33.19 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.795 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 56.7 t -123.35 111.9 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.464 -0.773 . . . . 0.0 109.913 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.45 ' OG ' ' HB1' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -130.22 116.09 17.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.105 -0.997 . . . . 0.0 110.487 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 150.04 -29.57 1.11 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.541 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -79.95 -147.27 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -1.136 . . . . 0.0 110.195 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.554 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -175.19 142.17 0.6 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.027 -1.046 . . . . 0.0 111.145 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -38.05 132.1 1.03 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.414 0.626 . . . . 0.0 110.699 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.443 ' O ' ' OE2' ' A' ' 29' ' ' GLU . . . 118.35 6.1 12.28 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' OE2' ' O ' ' A' ' 28' ' ' GLY . 53.1 mm-40 -140.11 119.28 12.8 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.217 -1.166 . . . . 0.0 110.521 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.457 HG21 ' O ' ' A' ' 53' ' ' PHE . 5.2 m -101.32 133.84 45.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.43 -0.794 . . . . 0.0 109.491 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 39.0 m-85 -121.15 -172.52 2.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.085 -1.009 . . . . 0.0 111.032 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.517 ' CD1' ' HB2' ' A' ' 52' ' ' SER . 68.0 m-85 -130.25 160.63 33.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.607 -0.683 . . . . 0.0 109.633 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 tt -145.66 116.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.067 -1.021 . . . . 0.0 110.391 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.441 ' O ' ' CD1' ' A' ' 93' ' ' LEU . . . -151.35 169.95 20.72 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.151 -0.968 . . . . 0.0 111.052 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.466 ' CG ' HD13 ' A' ' 107' ' ' LEU . 1.9 tt0 -104.15 160.08 15.15 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.515 -0.741 . . . . 0.0 109.386 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -160.98 141.53 11.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.021 -1.05 . . . . 0.0 111.385 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.486 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -140.51 154.53 69.45 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.98 164.59 34.2 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.622 1.327 . . . . 0.0 111.121 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 44' ' ' ALA . 11.6 m . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.661 0.743 . . . . 0.0 109.919 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.357 0.599 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.536 ' CB ' ' HA3' ' A' ' 73' ' ' GLY . . . -129.99 130.2 44.71 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -117.8 159.57 22.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 110.276 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.466 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 6.0 t-20 -90.77 117.51 67.99 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 0.0 110.363 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 48.8 Cg_endo -81.19 -34.11 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.855 1.45 . . . . 0.0 110.636 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.71 95.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.255 -0.903 . . . . 0.0 110.342 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 6.4 p -88.31 20.71 3.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.364 -0.835 . . . . 0.0 110.063 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 47' ' ' PRO . . . -78.23 132.25 37.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.0 110.086 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.8 t -161.96 159.05 26.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.297 -0.877 . . . . 0.0 109.983 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.517 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 33.5 t -127.99 161.23 29.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.188 -0.945 . . . . 0.0 110.431 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.593 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 33.8 p90 -146.99 -176.41 5.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.294 -0.879 . . . . 0.0 110.381 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.433 ' OG1' HG21 ' A' ' 30' ' ' THR . 29.3 m -141.48 154.08 45.32 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.541 ' CG2' ' HB3' ' A' ' 25' ' ' ALA . 43.1 p -63.24 -150.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.067 -1.02 . . . . 0.0 110.429 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.5 -161.03 1.22 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.187 -0.946 . . . . 0.0 110.292 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.63 -53.38 58.15 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 109.176 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 p -87.95 15.9 6.65 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.554 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 62.41 39.05 97.28 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.09 106.17 13.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -1.087 . . . . 0.0 110.231 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.06 89.73 3.09 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.505 -0.747 . . . . 0.0 110.094 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.6 p -112.01 128.42 56.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.819 . . . . 0.0 109.554 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -153.08 176.38 11.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.126 -0.984 . . . . 0.0 110.824 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 p -94.59 141.43 28.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.33 -0.856 . . . . 0.0 110.521 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.522 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 75.0 t80 -133.36 162.35 32.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.458 -0.777 . . . . 0.0 109.575 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.476 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 21.6 t -112.13 168.19 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 120.731 -1.231 . . . . 0.0 110.801 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.505 HG13 ' CG1' ' A' ' 18' ' ' VAL . 25.1 m -138.08 174.99 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.401 -0.812 . . . . 0.0 110.382 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -148.88 145.81 27.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.31 -0.868 . . . . 0.0 110.121 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 3.2 ttpt -65.8 -51.49 58.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.995 . . . . 0.0 109.464 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.404 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 96.0 p -135.45 165.86 24.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 109.617 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.46 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 37.7 p90 -170.26 150.96 3.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.086 -1.009 . . . . 0.0 110.223 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -68.52 113.39 6.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.225 -0.922 . . . . 0.0 110.094 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 44' ' ' ALA . . . -59.24 -175.79 0.82 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.312 -1.11 . . . . 0.0 110.62 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.3 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.15 0.5 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.486 ' CG1' ' HB3' ' A' ' 37' ' ' ALA . 5.9 t -141.39 156.99 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.333 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.465 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 23.8 m-20 -146.68 149.43 33.46 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.433 -0.792 . . . . 0.0 109.789 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 68.8 m -114.35 -13.8 12.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.85 -56.59 16.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.233 -0.917 . . . . 0.0 110.816 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.3 t -100.74 -13.02 18.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.065 -1.022 . . . . 0.0 110.784 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 85' ' ' ASP . . . -91.32 -141.98 0.18 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.254 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.38 82.98 0.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.906 . . . . 0.0 109.781 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.421 ' C ' ' OD1' ' A' ' 92' ' ' ASN . 28.1 p -97.34 164.82 12.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.109 -0.994 . . . . 0.0 110.436 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 92' ' ' ASN . 2.2 m120 -141.47 166.52 24.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 110.031 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' A' ' 34' ' ' ALA . 5.7 tp -116.01 127.25 54.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 109.603 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.58 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -118.31 157.71 15.08 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -141.73 140.79 33.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -1.107 . . . . 0.0 110.086 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 139.42 163.69 9.6 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -124.29 -156.99 0.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.23 -1.159 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.8 t -90.14 36.81 0.88 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.905 . . . . 0.0 110.404 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.4 -50.19 0.05 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.477 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -135.13 89.38 2.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.196 -1.179 . . . . 0.0 110.409 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.02 158.34 11.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.158 -0.963 . . . . 0.0 109.814 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 91.8 mt -121.52 -84.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 110.432 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.98 -177.37 38.67 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.005 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.58 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 27.5 m-70 -139.92 113.56 8.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.571 -0.958 . . . . 0.0 109.887 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.461 HG11 HG12 ' A' ' 6' ' ' VAL . 18.0 t -88.25 161.55 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 109.836 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.81 134.21 49.3 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.157 -0.964 . . . . 0.0 110.122 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.466 HD13 ' CG ' ' A' ' 35' ' ' GLN . 58.1 mt -105.48 147.45 28.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.236 -0.915 . . . . 0.0 110.432 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.97 159.68 42.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.408 -0.808 . . . . 0.0 109.824 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 42.3 m-85 -128.17 156.18 43.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.562 179.986 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.469 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 47.4 Cg_endo . . . . . 0 N--CA 1.479 0.669 0 N-CA-C 110.353 -0.672 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -151.53 109.45 3.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.085 -1.01 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -108.36 115.83 30.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.6 m -146.13 151.84 38.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.894 -1.129 . . . . 0.0 111.159 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.477 ' CG1' HG11 ' A' ' 105' ' ' VAL . 9.8 p -115.97 151.8 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.467 -0.771 . . . . 0.0 109.473 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.599 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -77.22 -57.87 1.05 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.923 -1.111 . . . . 0.0 110.411 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.599 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 54.9 Cg_endo -86.55 68.81 4.48 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.538 1.283 . . . . 0.0 110.334 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.38 -20.35 65.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 109.811 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.5 p -142.76 130.04 21.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.434 -0.791 . . . . 0.0 110.239 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.19 47.56 0.99 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 108' ' ' THR . 1.0 OUTLIER -108.15 172.03 7.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -1.097 . . . . 0.0 110.221 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -148.08 164.28 34.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.94 . . . . 0.0 110.343 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 23.9 t70 -64.85 123.39 19.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 110.137 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.78 -30.42 7.96 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -58.75 146.83 35.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -1.119 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.3 p -90.35 179.51 5.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 110.539 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' A' ' 65' ' ' PHE . 5.3 m -149.41 160.66 5.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.504 -0.747 . . . . 0.0 109.83 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 14.0 m -112.04 118.49 35.57 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.949 -1.094 . . . . 0.0 110.107 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 t -109.06 147.95 13.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 110.073 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.7 t -142.28 129.06 20.51 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.482 -0.761 . . . . 0.0 110.159 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 12.2 t -118.55 107.67 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.368 -0.832 . . . . 0.0 110.024 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.4 OUTLIER -111.92 141.42 45.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.271 -0.893 . . . . 0.0 110.567 179.989 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 122.0 -74.11 0.36 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.484 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -54.79 145.14 20.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -1.178 . . . . 0.0 109.707 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.562 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -118.47 157.8 26.54 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.102 -0.999 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -34.07 136.24 0.13 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.506 0.669 . . . . 0.0 110.819 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.39 1.93 12.2 Favored Glycine 0 C--N 1.295 -1.74 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 1.0 OUTLIER -137.52 129.01 28.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.324 -1.104 . . . . 0.0 110.189 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.518 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 89.0 m -107.22 146.68 31.1 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.525 -0.734 . . . . 0.0 109.815 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 30' ' ' THR . 13.2 m-85 -133.09 169.09 17.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.129 -0.982 . . . . 0.0 110.728 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.482 ' CD2' ' HB3' ' A' ' 52' ' ' SER . 19.4 m-85 -128.64 106.87 9.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 109.539 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.526 ' CG2' HG21 ' A' ' 51' ' ' THR . 18.1 tt -89.54 136.61 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.255 -0.903 . . . . 0.0 110.845 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.65 177.84 9.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.334 -0.854 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.432 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 55.5 tt0 -134.73 150.72 50.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.307 -0.871 . . . . 0.0 109.964 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 69.5 m -150.95 163.44 38.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.102 -0.999 . . . . 0.0 111.224 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.1 152.49 28.07 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.791 -0.568 . . . . 0.0 109.709 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.57 172.15 16.31 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.802 1.422 . . . . 0.0 110.339 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.421 HG11 ' CB ' ' A' ' 44' ' ' ALA . 16.0 m . . . . . 0 N--CA 1.493 1.698 0 O-C-N 120.929 -1.107 . . . . 0.0 110.589 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 p30 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.627 0.727 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.421 ' CB ' HG11 ' A' ' 39' ' ' VAL . . . -150.21 118.75 6.5 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 109.094 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.1 m -108.9 162.03 14.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.971 -1.08 . . . . 0.0 111.089 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 48' ' ' ALA . 50.3 t-20 -111.52 92.98 17.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.432 -0.792 . . . . 0.0 109.746 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.98 -12.52 32.63 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.047 1.551 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . . . -68.31 -31.83 71.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.133 -0.98 . . . . 0.0 110.178 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 p -97.15 8.63 44.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 110.149 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.14 110.53 5.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.409 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.526 HG21 ' CG2' ' A' ' 33' ' ' ILE . 1.1 t -129.03 140.38 51.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 110.054 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.482 ' HB3' ' CD2' ' A' ' 32' ' ' TYR . 6.9 p -109.21 148.51 30.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.173 -0.955 . . . . 0.0 110.227 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 22.7 p90 -148.06 -177.13 5.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.0 110.177 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 55' ' ' THR . 25.4 m -137.62 153.05 49.94 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 110.091 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 3.3 p -56.85 -159.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.179 -0.951 . . . . 0.0 110.142 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -146.89 -161.81 1.41 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.936 -1.103 . . . . 0.0 110.599 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.31 -51.02 70.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.28 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.93 12.35 7.66 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 60.25 20.09 53.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.75 110.16 22.26 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -1.114 . . . . 0.0 110.22 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -101.36 90.95 4.27 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.541 -0.724 . . . . 0.0 109.417 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 p -103.48 115.08 29.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 109.548 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.546 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 15.1 p90 -147.74 171.06 16.26 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.395 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.9 155.3 17.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 0.0 110.84 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.578 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 90.0 t80 -140.32 176.78 8.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.483 -0.76 . . . . 0.0 108.971 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.578 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -128.35 154.56 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.576 -1.328 . . . . 0.0 110.442 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.87 125.8 61.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.526 -0.734 . . . . 0.0 109.85 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -111.73 116.55 30.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 110.407 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 14' ' ' ASP . 29.6 ttpt -56.76 -55.95 27.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.615 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.4 m -99.57 130.03 45.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.828 . . . . 0.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.457 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 33.9 p90 -155.3 131.08 9.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -0.878 . . . . 0.0 109.982 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.4 m -54.58 134.41 46.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.118 -0.989 . . . . 0.0 110.394 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.47 167.32 12.35 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.028 -1.278 . . . . 0.0 110.564 -179.94 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.5 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.121 0.486 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.4 t -121.44 157.83 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.129 -0.982 . . . . 0.0 110.424 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 39.6 p-10 -152.06 118.28 5.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 110.052 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.3 m -90.58 32.31 0.98 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.165 -0.959 . . . . 0.0 110.306 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.1 87.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.213 -0.93 . . . . 0.0 109.983 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -130.67 6.16 4.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.51 -159.17 0.59 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.846 . . . . 0.0 109.811 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -115.49 120.38 39.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.51 141.0 44.24 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.77 144.1 29.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.062 -1.023 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.58 135.39 53.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.646 -0.659 . . . . 0.0 109.254 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.95 177.02 21.7 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.223 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -151.68 170.82 18.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.452 -1.028 . . . . 0.0 109.986 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.76 159.3 8.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 99' ' ' GLY . 21.0 t30 -119.2 158.18 26.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -1.177 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.78 92.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.067 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 97' ' ' ASN . . . 124.02 -45.33 1.19 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.492 HD13 ' N ' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -91.47 132.11 36.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -1.129 . . . . 0.0 110.202 179.914 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 5.8 m-20 -105.8 144.65 32.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 110.191 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 21.1 mt -122.36 -75.14 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.162 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 159.38 -179.72 34.78 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.591 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 0.0 OUTLIER -145.72 128.74 16.52 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.491 -1.005 . . . . 0.0 109.56 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.477 HG11 ' CG1' ' A' ' 6' ' ' VAL . 58.2 t -105.11 155.12 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.409 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -92.18 147.07 23.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.818 . . . . 0.0 109.833 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.48 105.66 9.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 110.353 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.438 ' O ' HD12 ' A' ' 12' ' ' LEU . 3.6 m -79.58 173.96 12.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.882 . . . . 0.0 110.167 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.77 88.68 2.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.224 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 CA-C-O 118.005 -1.442 . . . . 0.0 109.569 179.96 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.46 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 48.6 Cg_endo . . . . . 0 N--CA 1.481 0.742 0 N-CA-C 110.537 -0.601 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -129.18 144.82 51.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.873 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 23.5 t80 -150.36 104.75 3.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.926 . . . . 0.0 109.888 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p -150.58 152.55 34.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 110.68 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.523 ' CG1' ' CB ' ' A' ' 9' ' ' ALA . 14.8 p -106.52 158.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -0.838 . . . . 0.0 109.55 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.594 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -60.46 -63.76 3.9 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.113 -0.992 . . . . 0.0 110.787 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 44.7 Cg_endo -72.33 -86.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.772 1.406 . . . . 0.0 111.189 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.523 ' CB ' ' CG1' ' A' ' 6' ' ' VAL . . . 71.81 18.35 5.15 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.407 -0.808 . . . . 0.0 109.918 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.434 ' HA ' ' HB ' ' A' ' 108' ' ' THR . 3.9 m -171.4 108.48 0.27 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.362 -0.836 . . . . 0.0 110.076 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.09 76.09 1.32 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.467 HD21 ' HB2' ' A' ' 8' ' ' PRO . 9.7 mt -128.05 172.74 10.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -1.101 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -138.29 162.82 33.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 110.082 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -57.93 123.99 17.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.067 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 94.99 -32.32 6.23 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 17' ' ' SER . 9.0 tm0? -42.01 138.26 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.39 -1.065 . . . . 0.0 110.149 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.46 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -94.07 150.39 20.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.983 -179.99 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.475 HG23 ' HB3' ' A' ' 65' ' ' PHE . 33.3 m -128.79 176.95 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.926 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.464 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 0.3 OUTLIER -133.48 121.78 22.7 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.939 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 68.0 t -98.31 158.86 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.254 -0.903 . . . . 0.0 110.053 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.08 122.26 7.75 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.388 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 53.1 t -121.24 144.27 30.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.339 -0.85 . . . . 0.0 109.758 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m -156.61 127.55 6.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 110.298 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 142.61 -63.58 0.5 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 24' ' ' GLY . . . -56.67 -159.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 109.816 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.556 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -165.8 162.7 18.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.928 -1.107 . . . . 0.0 111.054 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 56' ' ' ASP . . . -41.24 134.5 2.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.551 -0.718 . . . . 0.0 110.241 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 114.6 7.41 18.13 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 5.6 mt-10 -139.86 128.64 23.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.243 -1.151 . . . . 0.0 109.906 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.502 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 20.6 m -108.87 157.8 18.28 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.866 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.568 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 15.8 m-85 -137.34 173.2 11.94 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 110.019 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 14.7 m-85 -131.08 103.52 6.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 110.021 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.505 ' CG2' HG22 ' A' ' 51' ' ' THR . 1.2 tt -87.23 124.29 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.179 -0.951 . . . . 0.0 110.272 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 93' ' ' LEU . . . -150.56 160.46 43.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 110.207 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.465 ' OE1' ' HB3' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -126.59 138.2 53.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 110.544 179.978 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.2 m -146.94 169.22 19.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.25 -0.906 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.61 152.35 28.61 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.17 -0.956 . . . . 0.0 110.119 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.22 174.73 10.98 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.006 1.529 . . . . 0.0 110.178 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.434 HG21 ' CA ' ' A' ' 43' ' ' ASP . 4.7 t . . . . . 0 C--N 1.304 -1.384 0 O-C-N 121.218 -0.926 . . . . 0.0 109.582 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.434 ' CA ' HG21 ' A' ' 39' ' ' VAL . 37.1 m-20 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.384 0.611 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.33 165.39 13.91 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.423 -0.798 . . . . 0.0 108.902 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -147.05 158.18 43.85 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.721 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.577 ' OD1' ' CD2' ' A' ' 71' ' ' TYR . 3.4 m120 -100.11 116.11 64.87 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.489 -0.757 . . . . 0.0 109.694 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.62 -28.59 4.19 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.818 1.431 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.11 -35.42 74.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.245 -0.91 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.6 p -86.94 14.08 7.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.214 -0.929 . . . . 0.0 110.684 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.38 95.62 10.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.952 . . . . 0.0 110.271 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.505 HG22 ' CG2' ' A' ' 33' ' ' ILE . 5.0 t -137.03 167.62 21.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.7 p -126.2 149.54 48.96 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.196 -0.94 . . . . 0.0 110.34 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 20.7 p90 -143.41 141.93 31.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.142 -0.974 . . . . 0.0 110.135 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.6 m -104.21 155.55 18.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -0.933 . . . . 0.0 110.494 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.415 HG21 ' HB2' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -63.04 -156.08 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.319 -0.863 . . . . 0.0 109.806 179.946 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.445 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -140.83 -166.88 2.24 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.927 -1.108 . . . . 0.0 110.436 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.93 -57.24 13.93 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -1.85 23.63 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.254 -0.904 . . . . 0.0 108.999 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.556 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.83 69.06 1.46 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.58 125.69 13.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -1.084 . . . . 0.0 109.618 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.442 ' CB ' ' HB ' ' A' ' 22' ' ' VAL . . . -118.6 80.6 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 110.781 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.29 140.21 46.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -0.831 . . . . 0.0 109.078 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -171.1 -179.65 2.78 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.114 -0.991 . . . . 0.0 111.38 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t -96.43 140.78 30.58 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.608 0.718 . . . . 0.0 110.551 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.475 ' HB3' HG23 ' A' ' 18' ' ' VAL . 20.3 t80 -134.32 -172.19 2.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -0.79 . . . . 0.0 108.888 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 t -143.69 165.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.645 -1.285 . . . . 0.0 110.325 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 16' ' ' GLN . 33.2 m -137.88 142.51 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.312 -0.868 . . . . 0.0 110.305 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -121.22 134.52 55.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.072 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 23.3 ttmt -73.26 -59.81 2.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.137 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t -109.58 141.84 41.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 110.196 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.577 ' CD2' ' OD1' ' A' ' 46' ' ' ASN . 33.4 p90 -153.56 122.5 6.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.825 . . . . 0.0 109.986 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 92.2 m -43.89 124.74 3.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.307 -0.871 . . . . 0.0 110.738 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.66 148.88 19.08 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 120.787 -1.419 . . . . 0.0 111.168 -179.979 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 20.0 p . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.282 0.563 . . . . 0.0 109.918 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 85' ' ' ASP . 74.6 t -102.34 153.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 109.993 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.46 ' N ' HG11 ' A' ' 84' ' ' VAL . 6.0 t0 -132.8 148.7 52.32 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 110.203 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 1.8 t -104.94 15.01 28.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 110.17 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.23 -56.16 4.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 110.334 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -87.7 -28.12 21.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.23 -0.919 . . . . 0.0 110.238 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.7 -158.26 0.64 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.218 -0.926 . . . . 0.0 110.01 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.45 147.95 42.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.9 . . . . 0.0 110.225 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.465 ' HB3' ' OE1' ' A' ' 35' ' ' GLN . 94.4 m -106.61 130.35 54.38 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.911 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -112.77 125.23 54.1 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 110.557 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 34' ' ' ALA . 50.1 tp -107.62 112.34 25.02 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -120.89 160.2 15.3 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.487 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -144.07 124.48 13.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.506 -0.996 . . . . 0.0 109.802 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.35 167.37 39.39 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.414 ' CG ' ' N ' ' A' ' 98' ' ' SER . 4.0 t30 -104.43 -86.08 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -1.094 . . . . 0.0 110.416 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.414 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 46.8 t -159.89 71.07 0.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.255 -0.903 . . . . 0.0 110.007 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.01 -17.3 6.74 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.489 HD23 ' CE2' ' A' ' 31' ' ' TYR . 38.3 tp -94.86 -66.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.462 -1.022 . . . . 0.0 109.655 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.9 t0 61.89 128.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.76 . . . . 0.0 110.632 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.536 ' CD1' ' CD2' ' A' ' 31' ' ' TYR . 35.3 mt -96.85 -39.51 9.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.468 -0.77 . . . . 0.0 109.571 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.18 177.58 26.01 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.587 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 2.0 m-70 -133.7 120.05 20.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.656 -0.908 . . . . 0.0 109.601 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.6 t -92.25 132.59 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.207 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.18 106.71 18.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 110.325 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.2 mt -74.83 126.81 31.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.24 -0.913 . . . . 0.0 110.13 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.434 ' HB ' ' HA ' ' A' ' 10' ' ' SER . 2.2 m -90.37 162.49 15.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.926 . . . . 0.0 110.092 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 108' ' ' THR . 3.9 m-85 -148.4 171.81 15.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.548 179.979 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.543 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 54.9 Cg_endo . . . . . 0 CA--C 1.543 0.956 0 N-CA-C 109.447 -1.02 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . 179.73 133.58 0.1 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.887 -1.133 . . . . 0.0 110.461 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -150.85 97.98 2.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.401 -0.812 . . . . 0.0 109.543 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.1 p -139.26 168.83 18.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.059 -1.026 . . . . 0.0 111.148 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.98 148.64 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.555 -0.716 . . . . 0.0 109.09 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.648 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.0 m -62.21 -76.87 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.868 -1.145 . . . . 0.0 110.463 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 55.6 Cg_endo -77.81 75.3 4.84 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 O-C-N 122.788 0.888 . . . . 0.0 109.847 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.09 -22.89 63.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.148 -0.97 . . . . 0.0 110.301 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.5 t -131.69 135.18 46.66 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.174 -0.954 . . . . 0.0 110.12 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.98 65.71 1.28 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 8' ' ' PRO . 7.4 mt -110.21 165.05 12.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -1.139 . . . . 0.0 109.887 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.5 157.22 28.74 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.21 -0.931 . . . . 0.0 110.169 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -68.5 127.2 32.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.84 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.8 -25.54 11.4 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -54.47 149.55 10.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.337 -1.096 . . . . 0.0 110.437 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 m -101.99 129.19 48.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.229 -0.92 . . . . 0.0 109.957 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.4 m -95.91 175.29 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 23.3 p -129.37 113.57 15.12 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.376 -0.828 . . . . 0.0 109.734 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t -97.57 151.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.275 -0.891 . . . . 0.0 110.05 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 t -141.82 118.49 11.03 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.323 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 35.3 t -113.83 138.14 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.558 -0.714 . . . . 0.0 109.778 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 19.3 p -150.9 116.25 5.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.983 -1.073 . . . . 0.0 110.754 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.543 ' HA3' ' CB ' ' A' ' 2' ' ' PRO . . . 156.31 -52.44 0.42 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.473 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -58.15 -157.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.358 -1.083 . . . . 0.0 109.711 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.49 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -161.26 160.59 30.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.966 -1.084 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.91 130.6 9.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.604 -0.685 . . . . 0.0 110.25 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 29' ' ' GLU . . . 117.92 12.33 7.84 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.541 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 70.6 mt-10 -139.18 113.26 8.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.283 . . . . 0.0 110.444 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.444 HG21 ' N ' ' A' ' 31' ' ' TYR . 31.1 m -90.83 166.46 13.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.471 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.541 ' CE2' ' O ' ' A' ' 29' ' ' GLU . 93.9 m-85 -150.61 167.11 28.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.992 -1.068 . . . . 0.0 110.827 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' A' ' 31' ' ' TYR . 12.3 m-85 -131.68 106.92 8.46 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.467 HG23 HG23 ' A' ' 51' ' ' THR . 4.7 tt -98.25 137.8 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.994 . . . . 0.0 111.452 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.04 161.02 43.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.669 -0.645 . . . . 0.0 109.458 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 35' ' ' GLN . 5.3 pt20 -119.23 134.04 55.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 110.523 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.419 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 3.5 m -144.23 -178.5 5.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.43 -0.794 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.61 156.95 33.57 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.301 -0.875 . . . . 0.0 109.467 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 41.3 Cg_endo -71.96 151.4 56.29 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 O-C-N 123.748 1.394 . . . . 0.0 110.686 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.477 HG11 ' N ' ' A' ' 43' ' ' ASP . 10.8 p . . . . . 0 C--N 1.298 -1.674 0 O-C-N 121.502 -0.749 . . . . 0.0 109.476 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.477 ' N ' HG11 ' A' ' 39' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.291 0.567 . . . . 0.0 111.007 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.508 ' HB3' HG23 ' A' ' 84' ' ' VAL . . . -95.24 133.08 39.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.283 -0.886 . . . . 0.0 108.942 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 15.7 t -113.91 168.0 10.17 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.779 -1.201 . . . . 0.0 111.604 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -108.88 112.09 60.41 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.71 . . . . 0.0 110.037 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.62 -24.78 15.57 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.0 1.526 . . . . 0.0 110.646 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -8.86 10.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.206 -0.934 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.02 35.69 4.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.977 -1.077 . . . . 0.0 110.541 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.79 133.66 34.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.163 -0.961 . . . . 0.0 110.541 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.467 HG23 HG23 ' A' ' 33' ' ' ILE . 9.9 t -159.95 156.84 27.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.35 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t -130.03 161.6 30.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.162 -0.961 . . . . 0.0 110.755 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 7.9 p90 -149.28 179.73 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.401 -0.812 . . . . 0.0 109.763 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.455 HG21 ' N ' ' A' ' 55' ' ' THR . 38.4 m -146.88 158.11 43.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.051 -1.031 . . . . 0.0 110.332 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.455 ' N ' HG21 ' A' ' 54' ' ' THR . 2.8 p -73.3 -161.23 0.09 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.07 -152.16 0.26 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.1 -1.0 . . . . 0.0 110.885 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.35 -46.51 89.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.889 . . . . 0.0 109.488 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.4 t -85.16 12.96 6.88 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.569 -0.707 . . . . 0.0 109.209 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 45.3 40.66 7.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.81 126.16 41.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 110.374 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.1 90.08 3.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 110.539 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.78 117.01 32.99 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.329 -0.857 . . . . 0.0 109.562 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.634 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.4 p90 -149.91 171.15 17.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.249 -0.907 . . . . 0.0 110.877 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.04 128.11 47.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 110.647 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.51 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 50.0 t80 -113.64 -179.96 3.79 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.51 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.7 t -128.27 156.89 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.704 -1.248 . . . . 0.0 109.907 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.7 m -146.82 157.09 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 110.308 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.23 150.51 50.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.428 -0.795 . . . . 0.0 110.187 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 29.7 tttt -76.5 -59.4 2.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 110.566 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.0 m -117.57 137.62 52.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.143 -0.973 . . . . 0.0 110.169 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -162.2 151.53 15.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.12 -0.987 . . . . 0.0 110.304 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.1 m -68.47 134.29 49.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.0 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 44' ' ' ALA . . . -118.82 -176.48 16.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.237 -1.154 . . . . 0.0 109.915 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.331 0.586 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 44' ' ' ALA . 78.3 t -133.05 116.43 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.393 -0.817 . . . . 0.0 109.882 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.427 ' OD2' HG22 ' A' ' 88' ' ' THR . 4.9 p-10 -101.26 142.0 33.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 0.0 110.392 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 4.4 t -98.2 17.28 18.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.25 -0.907 . . . . 0.0 110.031 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.1 -59.92 2.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 110.214 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.477 HG21 ' N ' ' A' ' 89' ' ' ALA . 5.9 t -79.78 -24.85 41.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.289 -0.882 . . . . 0.0 110.081 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.477 ' N ' HG21 ' A' ' 88' ' ' THR . . . -101.01 -154.96 0.49 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.382 -0.824 . . . . 0.0 109.909 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.21 146.47 33.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.401 -0.812 . . . . 0.0 110.086 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.28 126.85 43.94 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.261 -0.9 . . . . 0.0 109.67 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -110.8 121.2 44.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 111.005 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 65' ' ' PHE . 1.1 tp -107.05 118.41 36.63 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.418 -0.801 . . . . 0.0 108.912 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -137.47 176.73 20.38 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.279 -1.439 . . . . 0.0 110.529 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.89 175.75 11.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.615 -0.932 . . . . 0.0 110.054 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 136.63 167.06 11.05 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -131.46 -153.15 0.54 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.187 -1.184 . . . . 0.0 109.933 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 t -104.04 80.15 1.7 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.176 -0.953 . . . . 0.0 110.089 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.55 -18.31 0.36 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 101' ' ' ASP . 7.9 tp -140.79 -67.95 0.41 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.282 . . . . 0.0 110.561 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 100' ' ' LEU . 0.7 OUTLIER 69.42 153.06 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.306 -0.871 . . . . 0.0 110.091 179.983 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.7 mt -121.79 -86.31 0.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 110.38 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -167.91 -160.66 15.94 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -159.09 138.45 11.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -1.09 . . . . 0.0 110.335 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.5 t -104.9 127.96 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.255 -0.903 . . . . 0.0 110.207 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.87 93.74 5.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 65.9 mt -60.19 170.13 1.38 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.4 m -141.19 169.84 16.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 0.0 110.096 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -142.65 96.57 2.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.913 . . . . 0.0 110.138 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.61 179.978 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 N--CA 1.483 0.885 0 N-CA-C 110.428 -0.643 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -140.38 135.8 32.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.025 -1.047 . . . . 0.0 111.004 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -150.84 108.53 3.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.557 -0.715 . . . . 0.0 109.096 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.0 p -146.56 161.59 40.18 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.82 -1.175 . . . . 0.0 111.484 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.438 HG22 ' HD2' ' A' ' 8' ' ' PRO . 7.7 p -129.94 143.32 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.594 -0.691 . . . . 0.0 109.719 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.612 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.2 m -56.86 -68.84 0.53 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.976 -1.077 . . . . 0.0 110.224 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 50.7 Cg_endo -75.88 95.1 1.01 Allowed 'Trans proline' 0 C--N 1.321 -0.89 0 O-C-N 123.354 1.186 . . . . 0.0 110.228 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.96 -1.94 28.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.0 -1.063 . . . . 0.0 110.364 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 t -157.21 109.51 2.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.955 . . . . 0.0 110.057 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.45 60.99 0.54 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.506 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 1.1 mp -108.25 165.84 11.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -1.166 . . . . 0.0 110.068 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 11.4 t -117.27 147.97 42.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.319 -0.863 . . . . 0.0 110.072 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.23 119.21 7.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 110.326 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.11 -35.15 4.97 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 34.2 tt0 -49.21 153.81 0.92 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.326 -1.102 . . . . 0.0 110.381 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 m -105.46 132.75 51.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.959 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.506 ' CG1' ' CD2' ' A' ' 12' ' ' LEU . 24.4 m -100.6 178.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.255 -0.903 . . . . 0.0 110.282 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.9 m -121.1 117.28 26.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 109.807 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.8 t -102.54 150.2 6.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.393 -0.817 . . . . 0.0 110.154 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.91 127.94 18.49 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.309 -0.869 . . . . 0.0 110.4 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.468 ' HB ' ' HB1' ' A' ' 61' ' ' ALA . 58.7 t -117.37 147.59 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.632 -0.667 . . . . 0.0 109.917 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 3.6 p -168.05 119.76 0.84 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.127 -0.983 . . . . 0.0 110.393 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.78 3.4 5.48 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 26' ' ' ALA . . . -105.64 -39.67 6.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.056 -1.261 . . . . 0.0 110.266 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.561 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . 72.62 147.84 0.09 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.327 -0.858 . . . . 0.0 110.837 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -46.79 134.22 10.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.713 -0.617 . . . . 0.0 110.768 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 131.82 1.51 4.56 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 39.6 mm-40 -146.45 130.61 17.44 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.87 -1.371 . . . . 0.0 110.896 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.547 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -96.72 171.67 8.38 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.879 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.547 ' CD1' ' O ' ' A' ' 30' ' ' THR . 61.3 m-85 -151.61 172.54 15.9 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.871 -1.143 . . . . 0.0 111.028 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 52' ' ' SER . 61.4 m-85 -144.31 109.46 5.07 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.443 -0.785 . . . . 0.0 109.752 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.603 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 5.6 tt -88.41 132.68 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.213 -0.929 . . . . 0.0 110.451 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.58 167.63 25.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.203 -0.936 . . . . 0.0 110.426 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.455 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 10.5 pt20 -126.56 141.81 51.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.315 -0.865 . . . . 0.0 109.991 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -143.38 157.71 44.24 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.979 -1.076 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.19 157.05 57.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.37 159.13 54.91 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 123.741 1.39 . . . . 0.0 110.792 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.466 HG13 HG22 ' A' ' 84' ' ' VAL . 32.5 m . . . . . 0 C--N 1.299 -1.615 0 O-C-N 121.478 -0.763 . . . . 0.0 109.483 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.0 t0 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.151 0.501 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.29 139.29 46.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 8.7 t -123.49 144.51 49.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.176 -0.953 . . . . 0.0 110.506 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.46 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 32.0 t-20 -71.67 122.97 88.67 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.26 -0.9 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -83.47 -39.11 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.932 1.491 . . . . 0.0 110.953 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.88 -56.92 15.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.426 -0.796 . . . . 0.0 110.766 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.8 p -56.87 -14.53 3.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.642 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.98 137.28 55.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 110.768 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.603 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 13.0 t -147.03 165.9 28.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.582 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -130.95 152.91 49.75 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.874 -1.142 . . . . 0.0 111.82 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 31' ' ' TYR . 32.3 p90 -149.12 146.25 27.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.502 -0.749 . . . . 0.0 109.779 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.443 ' OG1' HG22 ' A' ' 30' ' ' THR . 76.2 m -108.75 155.27 20.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.975 -1.078 . . . . 0.0 110.771 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -65.42 -157.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.305 -0.872 . . . . 0.0 109.606 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -150.94 -159.78 1.08 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.818 -1.176 . . . . 0.0 110.478 -179.967 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.06 62.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.156 -0.965 . . . . 0.0 109.743 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 t -85.46 13.69 6.45 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.424 -0.797 . . . . 0.0 108.854 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 60.58 27.35 65.98 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -110.83 114.16 27.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.345 -1.091 . . . . 0.0 110.35 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.468 ' HB1' ' HB ' ' A' ' 22' ' ' VAL . . . -117.56 88.63 2.95 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.2 p -102.29 125.99 49.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.487 -0.758 . . . . 0.0 109.395 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -154.01 176.19 12.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.957 . . . . 0.0 111.079 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 t -100.22 129.89 46.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.468 -0.77 . . . . 0.0 110.362 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 55.1 t80 -118.45 177.91 4.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 109.307 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.555 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -125.77 154.99 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.811 -1.181 . . . . 0.0 110.389 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.467 HG13 HG22 ' A' ' 18' ' ' VAL . 5.6 m -132.7 171.69 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.822 . . . . 0.0 109.704 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.89 139.21 23.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.984 . . . . 0.0 110.282 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.574 ' HA ' ' CE2' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -77.39 -47.71 19.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.339 -0.851 . . . . 0.0 110.204 179.991 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -122.95 136.1 54.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.847 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -163.36 157.05 19.56 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 3.2 m -69.48 111.14 5.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.425 -0.797 . . . . 0.0 109.992 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.29 162.75 54.3 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.111 -1.229 . . . . 0.0 110.75 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.4 p . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.171 0.51 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.466 HG22 HG13 ' A' ' 39' ' ' VAL . 55.2 t -141.4 155.84 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -0.903 . . . . 0.0 110.318 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -144.36 139.83 28.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.863 . . . . 0.0 110.126 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -100.73 2.44 41.35 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 110.178 -179.97 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.34 -60.5 2.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.881 . . . . 0.0 110.622 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.8 t -91.94 -20.89 20.92 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.207 -0.933 . . . . 0.0 110.731 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.63 -176.16 3.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.578 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.26 147.13 45.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.345 -0.847 . . . . 0.0 110.1 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.7 m -120.61 156.3 31.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.175 -0.953 . . . . 0.0 110.436 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 18.5 p30 -136.69 143.44 43.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 109.947 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.489 ' HB2' ' CD1' ' A' ' 107' ' ' LEU . 1.5 tp -105.62 135.79 46.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.249 -0.907 . . . . 0.0 109.998 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.473 ' HA3' ' ND1' ' A' ' 104' ' ' HIS . . . -131.69 149.46 19.32 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -137.15 155.77 49.18 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.502 -0.999 . . . . 0.0 109.899 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.27 164.61 13.25 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.458 ' CG ' ' N ' ' A' ' 98' ' ' SER . 1.4 t30 -113.42 173.45 6.4 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.248 -1.148 . . . . 0.0 109.857 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.458 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 88.9 p -66.09 89.32 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.152 -0.968 . . . . 0.0 109.943 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 131.69 -20.4 4.61 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 tt -111.37 161.21 16.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.395 -1.062 . . . . 0.0 110.055 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.57 98.25 2.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.214 -0.929 . . . . 0.0 110.368 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.2 mt -78.73 -70.14 0.52 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.294 -0.879 . . . . 0.0 110.131 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.535 ' C ' ' CD2' ' A' ' 104' ' ' HIS . . . 164.1 -177.12 39.97 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.588 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 4.9 m-70 -131.8 129.5 40.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -1.091 . . . . 0.0 110.03 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.0 t -93.39 116.8 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 110.473 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.56 128.95 39.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.39 -0.819 . . . . 0.0 110.086 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.489 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 74.8 mt -114.44 119.09 35.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 110.508 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 m -98.57 169.37 9.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 109.932 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 10.7 m-85 -132.3 136.11 46.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.995 . . . . 0.0 110.326 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.995 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.48 0.728 0 N-CA-C 110.479 -0.623 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -105.47 135.03 47.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.895 . . . . 0.0 110.162 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -150.56 107.44 3.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.789 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -146.13 153.07 40.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.096 -1.003 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.431 HG21 ' HD2' ' A' ' 8' ' ' PRO . 9.0 p -115.24 135.82 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.344 -0.847 . . . . 0.0 109.776 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -57.01 -67.63 0.8 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.056 -1.028 . . . . 0.0 110.262 -179.987 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 52.7 Cg_endo -75.69 87.94 1.34 Allowed 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.338 1.178 . . . . 0.0 109.956 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.61 -3.1 56.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.143 -0.973 . . . . 0.0 110.67 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.0 m -149.75 166.58 29.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.202 -0.936 . . . . 0.0 110.336 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.95 37.56 94.43 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 8' ' ' PRO . 40.5 mt -92.9 173.71 7.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.254 -1.144 . . . . 0.0 110.138 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.3 152.07 35.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 110.393 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 1.6 t70 -60.01 126.76 28.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 109.99 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.83 -33.27 5.65 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -56.61 149.47 17.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.345 -1.091 . . . . 0.0 109.893 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.01 134.07 47.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 110.663 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.479 ' HB ' ' HG2' ' A' ' 8' ' ' PRO . 31.5 m -113.28 173.13 3.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.483 -0.76 . . . . 0.0 109.704 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.76 133.5 55.87 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.097 -1.002 . . . . 0.0 110.314 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.9 t -119.7 151.21 22.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.746 -0.596 . . . . 0.0 109.513 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.6 p -143.6 133.33 23.8 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.2 t -122.44 138.51 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.507 -0.746 . . . . 0.0 110.171 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 10.8 m -150.02 80.1 1.37 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.861 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . -161.85 -71.55 0.02 OUTLIER Glycine 0 C--N 1.283 -2.386 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.461 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -56.09 -164.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -1.198 . . . . 0.0 109.902 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -160.39 157.77 28.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.143 -0.973 . . . . 0.0 110.387 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 56' ' ' ASP . . . -36.14 118.55 0.53 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.602 -0.686 . . . . 0.0 110.633 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.56 -0.34 2.46 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -146.85 130.63 17.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.086 -1.244 . . . . 0.0 110.661 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.472 HG23 ' OG1' ' A' ' 54' ' ' THR . 37.9 m -107.27 121.8 45.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.701 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.571 ' CE1' HD21 ' A' ' 100' ' ' LEU . 52.2 m-85 -103.62 177.77 4.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.052 -1.03 . . . . 0.0 110.603 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.638 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 10.0 m-85 -132.81 116.69 16.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -0.892 . . . . 0.0 110.096 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.489 HG13 HD12 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -94.33 123.72 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.893 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.88 156.31 39.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.117 -0.99 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.464 ' HG2' ' HB2' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -100.17 152.91 19.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.316 -0.865 . . . . 0.0 109.532 179.944 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 99.1 m -151.6 152.25 32.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.062 -1.024 . . . . 0.0 110.934 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.464 ' CB ' ' HB3' ' A' ' 91' ' ' CYS . . . -150.41 145.79 19.01 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.476 -0.765 . . . . 0.0 109.292 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.74 161.03 42.66 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.79 1.416 . . . . 0.0 110.989 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.443 HG13 HG23 ' A' ' 84' ' ' VAL . 33.8 m . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.471 -0.768 . . . . 0.0 110.17 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.316 0.579 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.94 164.94 24.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.133 -0.979 . . . . 0.0 110.028 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.482 ' O ' ' CD ' ' A' ' 47' ' ' PRO . 1.3 m -143.74 -178.74 6.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.27 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 5.6 m120 -105.59 76.14 0.34 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 0.0 110.319 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.482 ' CD ' ' O ' ' A' ' 45' ' ' CYS . 43.2 Cg_endo -69.32 -41.3 4.97 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.987 1.519 . . . . 0.0 110.324 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.98 -34.95 74.0 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.38 -0.825 . . . . 0.0 110.005 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.9 34.2 5.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.856 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -86.33 103.67 15.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.014 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.42 HG23 ' CG2' ' A' ' 33' ' ' ILE . 10.0 t -102.37 167.65 9.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 0.0 110.502 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 2.4 m -143.99 162.94 34.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.955 . . . . 0.0 110.673 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 51.5 p90 -143.27 -177.13 5.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.472 ' OG1' HG23 ' A' ' 30' ' ' THR . 50.0 m -146.19 149.9 34.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.348 -0.845 . . . . 0.0 109.746 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.404 HG23 ' C ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -64.22 -174.77 0.13 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.04 -1.038 . . . . 0.0 109.707 -179.978 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -146.8 -147.77 0.23 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.96 -1.088 . . . . 0.0 110.806 -179.903 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.585 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -83.02 71.24 10.12 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.15 0.976 . . . . 0.0 109.255 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER 152.7 -14.58 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.569 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 75.57 28.68 60.95 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.42 129.66 56.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.226 -1.161 . . . . 0.0 110.015 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.99 86.24 2.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.317 -0.864 . . . . 0.0 110.641 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.39 111.85 24.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.848 . . . . 0.0 109.412 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 19.2 p90 -143.58 178.56 7.7 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.084 -1.01 . . . . 0.0 110.967 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.1 p -98.98 125.54 44.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.469 -0.769 . . . . 0.0 110.247 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.441 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 8.3 t80 -120.65 139.92 52.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.37 156.43 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.891 -1.131 . . . . 0.0 110.473 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.465 HG12 ' CG1' ' A' ' 18' ' ' VAL . 26.8 m -124.97 151.82 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.539 -0.726 . . . . 0.0 110.077 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.01 107.04 10.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 110.408 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.575 ' HB2' ' CE1' ' A' ' 109' ' ' PHE . 4.4 ttpt -55.39 -49.61 71.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.643 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.0 m -114.15 132.43 56.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -0.8 . . . . 0.0 109.905 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 71' ' ' TYR . 23.4 p90 -150.36 146.7 26.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.2 m -68.62 129.75 40.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 110.036 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.25 148.52 18.43 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.7 p . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.293 -1.122 . . . . 0.0 110.345 -179.96 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.3 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.297 0.57 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.46 HG11 ' HB1' ' A' ' 37' ' ' ALA . 84.0 t -119.06 147.08 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 110.167 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.446 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 5.1 m-20 -137.04 137.23 39.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.176 -0.952 . . . . 0.0 110.697 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 62.6 m -92.1 7.8 40.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.725 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.01 -62.0 1.74 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 110.5 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.9 t -104.65 14.31 30.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.192 -0.943 . . . . 0.0 110.432 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 85' ' ' ASP . . . -118.17 -167.94 1.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.234 -0.916 . . . . 0.0 110.055 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.06 98.97 4.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 110.325 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 12.0 p -108.03 151.44 25.83 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.928 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -127.47 158.7 36.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.489 HD12 HG13 ' A' ' 33' ' ' ILE . 10.0 tp -109.03 121.61 45.5 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.536 ' HA3' ' ND1' ' A' ' 104' ' ' HIS . . . -126.87 157.91 20.7 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.592 -1.29 . . . . 0.0 110.341 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -132.37 161.44 33.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -1.062 . . . . 0.0 110.082 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.501 ' HA2' ' CD1' ' A' ' 102' ' ' LEU . . . 138.73 -171.35 23.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 98' ' ' SER . 6.1 p-10 -109.25 -46.09 3.63 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.021 -1.282 . . . . 0.0 110.362 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER 174.19 -27.66 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.207 -0.933 . . . . 0.0 110.446 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.86 3.95 4.23 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.305 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.571 HD21 ' CE1' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -84.87 -42.08 15.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.945 -1.326 . . . . 0.0 110.174 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 100' ' ' LEU . 17.4 t0 65.44 81.07 0.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.326 -0.859 . . . . 0.0 110.261 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.501 ' CD1' ' HA2' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -79.77 -63.88 1.31 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 110.146 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.11 162.48 29.4 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.536 ' ND1' ' HA3' ' A' ' 94' ' ' GLY . 93.3 m-70 -138.57 113.24 9.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.518 -0.989 . . . . 0.0 109.686 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.1 t -101.59 113.97 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.226 -0.921 . . . . 0.0 110.795 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.17 139.1 55.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.107 -0.996 . . . . 0.0 109.321 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.45 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 80.7 mt -115.34 167.91 10.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.957 -1.089 . . . . 0.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.2 m -149.1 175.35 11.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 109.975 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 69' ' ' LYS . 43.3 m-85 -147.45 102.37 3.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.375 -0.828 . . . . 0.0 110.2 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.966 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.512 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 46.2 Cg_endo . . . . . 0 C--O 1.214 -0.687 0 N-CA-C 110.315 -0.687 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -135.98 138.15 41.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.073 -1.017 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -152.0 108.82 3.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.307 -0.871 . . . . 0.0 109.675 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 t -148.69 161.22 42.19 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.972 -1.08 . . . . 0.0 111.161 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.485 HG11 HG11 ' A' ' 105' ' ' VAL . 8.1 p -121.67 147.54 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.534 -0.729 . . . . 0.0 109.859 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.611 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -55.91 -67.56 0.73 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 120.84 -1.163 . . . . 0.0 109.064 179.975 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.611 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 52.9 Cg_endo -76.94 129.71 10.83 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 O-C-N 123.473 1.249 . . . . 0.0 109.552 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.1 26.74 2.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.936 -1.102 . . . . 0.0 110.263 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.07 145.79 0.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.032 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.01 58.88 10.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.512 ' CD2' ' HB2' ' A' ' 8' ' ' PRO . 20.5 mt -105.81 175.11 5.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.255 -1.144 . . . . 0.0 110.41 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.6 t -133.09 148.15 52.17 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.251 -0.906 . . . . 0.0 110.403 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 69' ' ' LYS . 29.9 p30 -57.33 119.89 7.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 110.459 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.14 -35.34 5.11 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -47.62 148.65 1.41 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.028 -1.278 . . . . 0.0 110.428 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.502 ' O ' ' CG1' ' A' ' 18' ' ' VAL . 2.6 p -97.36 177.24 5.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 110.155 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 17' ' ' SER . 29.3 m -156.47 169.66 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.277 -0.889 . . . . 0.0 110.077 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 m -114.8 121.23 42.66 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.2 -0.938 . . . . 0.0 109.76 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.458 HG11 ' CZ ' ' A' ' 63' ' ' PHE . 6.0 t -105.86 142.04 19.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.419 -0.8 . . . . 0.0 109.969 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.1 m -138.56 126.3 22.23 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.492 -0.755 . . . . 0.0 110.004 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.465 ' HB ' ' HB1' ' A' ' 61' ' ' ALA . 55.7 t -117.97 127.46 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.649 -0.657 . . . . 0.0 110.39 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.8 108.84 8.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.173 -0.955 . . . . 0.0 109.957 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 150.47 -82.38 0.18 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.501 ' O ' ' CA ' ' A' ' 59' ' ' GLY . . . -42.41 131.08 3.8 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.265 -1.138 . . . . 0.0 109.836 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -103.74 158.93 16.04 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.093 -1.005 . . . . 0.0 111.972 -179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 56' ' ' ASP . . . -38.34 141.95 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.554 0.692 . . . . 0.0 111.07 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.11 7.28 4.11 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.577 ' CG ' ' CZ ' ' A' ' 31' ' ' TYR . 14.8 tp10 -161.92 136.58 7.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.923 -1.339 . . . . 0.0 111.223 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.457 HG22 ' OG1' ' A' ' 54' ' ' THR . 68.8 m -104.47 124.43 49.25 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.632 ' CD1' ' CD1' ' A' ' 102' ' ' LEU . 76.2 m-85 -103.13 172.96 6.52 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 111.55 -179.826 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.569 ' CE1' ' OG ' ' A' ' 52' ' ' SER . 96.3 m-85 -124.13 100.25 6.63 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.582 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 5.7 tt -86.59 104.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.12 -0.988 . . . . 0.0 109.863 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.419 ' C ' HD11 ' A' ' 93' ' ' LEU . . . -148.83 166.24 29.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.446 -0.784 . . . . 0.0 110.478 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.509 ' CG ' ' HB2' ' A' ' 93' ' ' LEU . 8.1 mt-30 -97.82 144.33 27.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 109.782 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.8 m -145.27 151.22 38.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.01 . . . . 0.0 110.952 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . . . -148.78 164.6 20.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.585 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 37' ' ' ALA . 41.6 Cg_endo -69.15 162.35 42.11 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.788 1.415 . . . . 0.0 110.605 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.468 -0.77 . . . . 0.0 110.17 -179.978 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 5.8 p30 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.313 0.578 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.67 165.4 33.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.975 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.8 m -141.77 168.12 20.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.179 -0.951 . . . . 0.0 110.236 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.51 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 0.3 OUTLIER -100.86 100.35 12.54 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.172 -179.976 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.0 Cg_endo -72.78 -34.61 6.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.013 1.533 . . . . 0.0 110.416 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.09 92.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 110.3 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.3 p -98.57 25.41 6.44 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.333 -0.854 . . . . 0.0 109.994 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -86.49 110.75 19.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.915 . . . . 0.0 110.302 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.582 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 7.5 t -116.32 133.45 56.01 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.319 -0.863 . . . . 0.0 110.018 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.569 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 12.2 t -108.77 137.79 46.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.279 -0.888 . . . . 0.0 110.58 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 30.3 p90 -135.38 -177.98 4.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 110.016 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.457 ' OG1' HG22 ' A' ' 30' ' ' THR . 40.3 m -138.29 152.88 48.94 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.317 -0.865 . . . . 0.0 109.761 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.476 HG23 ' HB2' ' A' ' 25' ' ' ALA . 2.5 p -61.58 -162.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.942 -1.099 . . . . 0.0 109.963 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.446 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 3.0 t70 -143.43 -164.26 1.83 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.06 -1.025 . . . . 0.0 110.675 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.81 82.82 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.097 -1.002 . . . . 0.0 108.831 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -90.25 16.27 8.92 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 55.45 30.48 55.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.81 133.88 52.98 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.459 -1.024 . . . . 0.0 110.341 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.465 ' HB1' ' HB ' ' A' ' 22' ' ' VAL . . . -137.57 84.97 2.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.268 -0.895 . . . . 0.0 110.683 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.66 112.71 25.6 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.268 -0.895 . . . . 0.0 109.149 179.809 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.458 ' CZ ' HG11 ' A' ' 20' ' ' VAL . 18.6 p90 -145.91 179.53 7.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.106 -0.996 . . . . 0.0 111.024 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -93.9 145.44 24.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.572 -0.705 . . . . 0.0 110.565 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.542 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 52.6 t80 -139.64 177.18 8.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.435 -0.791 . . . . 0.0 109.593 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.542 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 21.6 t -132.08 165.23 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.825 -1.172 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 67' ' ' VAL . 13.5 m -141.33 129.22 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.452 -0.78 . . . . 0.0 110.098 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 68' ' ' ARG . 6.2 tpt180 -108.58 144.79 35.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 110.259 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 20.6 ttpt -68.95 -39.7 79.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.077 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 p -132.8 155.12 49.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.548 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 13.4 p90 -162.17 147.58 12.9 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.149 -0.97 . . . . 0.0 110.661 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 m -60.17 113.6 2.44 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.354 -0.841 . . . . 0.0 110.367 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.511 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -99.14 150.31 19.22 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.151 -1.206 . . . . 0.0 110.215 -179.988 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.45 0.643 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.511 ' CG2' ' HA3' ' A' ' 73' ' ' GLY . 58.9 t -92.49 133.6 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.81 . . . . 0.0 109.665 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -113.38 135.72 53.55 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.99 -1.069 . . . . 0.0 110.117 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 1.3 t -85.26 1.07 49.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.69 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.54 -61.66 1.72 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.085 -1.009 . . . . 0.0 110.547 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.3 t -84.56 -16.74 41.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.215 -0.928 . . . . 0.0 110.384 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.04 158.7 22.74 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.142 -0.974 . . . . 0.0 110.265 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.84 144.7 27.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.083 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 3.7 m -125.01 129.52 50.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.24 -0.913 . . . . 0.0 110.098 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 92' ' ' ASN . 1.8 m120 -111.62 127.68 55.82 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 110.014 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.509 ' HB2' ' CG ' ' A' ' 35' ' ' GLN . 15.1 tp -93.23 108.9 20.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.92 . . . . 0.0 109.216 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -128.88 170.87 19.93 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.25 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -140.13 123.42 16.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -1.022 . . . . 0.0 109.866 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.93 166.59 36.29 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.469 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 5.1 p-10 -100.54 -43.39 6.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -1.113 . . . . 0.0 110.288 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 43.0 t -179.41 -43.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.18 -0.95 . . . . 0.0 110.627 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.67 27.45 3.21 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.469 ' HB2' ' OD1' ' A' ' 97' ' ' ASN . 3.4 tt -111.84 -44.57 3.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -1.187 . . . . 0.0 110.061 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.8 96.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.342 -0.848 . . . . 0.0 110.249 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.632 ' CD1' ' CD1' ' A' ' 31' ' ' TYR . 43.6 mt -83.68 -41.1 18.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -0.906 . . . . 0.0 110.258 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.99 162.24 12.97 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 5.3 p80 -145.5 122.06 11.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.519 -0.989 . . . . 0.0 109.751 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.485 HG11 HG11 ' A' ' 6' ' ' VAL . 91.5 t -96.86 113.92 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.541 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.4 117.84 6.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 109.812 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.495 ' CD1' ' CD ' ' A' ' 35' ' ' GLN . 83.5 mt -93.52 144.43 25.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.249 -0.907 . . . . 0.0 110.516 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 m -127.18 162.14 26.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 110.288 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.474 ' CD2' ' HG3' ' A' ' 69' ' ' LYS . 6.6 m-85 -135.72 126.62 27.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.202 -0.937 . . . . 0.0 110.058 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 118.036 -1.424 . . . . 0.0 109.611 179.897 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.448 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 47.3 Cg_endo . . . . . 0 N--CA 1.48 0.687 0 N-CA-C 110.495 -0.617 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -148.31 148.7 30.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.899 . . . . 0.0 110.411 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.458 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 17.1 t80 -148.24 115.45 6.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.305 -0.872 . . . . 0.0 109.76 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 t -143.55 153.45 42.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.991 -1.068 . . . . 0.0 111.092 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 19' ' ' SER . 4.8 p -131.27 168.81 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.516 -0.74 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.625 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -93.22 -63.1 0.16 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.864 -1.147 . . . . 0.0 110.329 179.965 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.625 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 55.2 Cg_endo -84.66 99.9 0.74 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 O-C-N 123.159 1.084 . . . . 0.0 110.08 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.03 -0.8 50.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.997 -1.065 . . . . 0.0 110.352 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.1 p -151.49 165.64 33.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.903 . . . . 0.0 109.95 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.09 64.27 3.91 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 8' ' ' PRO . 4.7 mt -117.03 139.63 50.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.412 -1.052 . . . . 0.0 110.337 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 15.0 t -100.96 158.72 15.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 110.241 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 4.4 p-10 -68.84 112.4 5.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 0.0 110.14 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.1 -24.92 21.9 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 37.6 tt0 -59.36 155.29 14.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.29 -1.123 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.405 ' O ' ' CG1' ' A' ' 18' ' ' VAL . 20.7 t -99.32 -179.17 4.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.478 -0.763 . . . . 0.0 110.245 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.555 ' CG2' ' HB3' ' A' ' 65' ' ' PHE . 14.0 m -154.55 176.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 0.0 110.045 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 6' ' ' VAL . 38.5 m -118.25 123.73 46.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 110.094 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.27 151.3 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.155 -0.966 . . . . 0.0 110.299 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.9 m -140.62 123.35 16.25 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.406 -0.809 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.7 t -113.88 132.69 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 75.5 m -145.12 128.28 16.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.041 . . . . 0.0 110.59 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 140.02 -57.39 0.6 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.493 ' HB1' HG22 ' A' ' 55' ' ' THR . . . -54.63 -167.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -1.163 . . . . 0.0 109.741 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.548 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -159.35 156.14 28.03 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.032 -1.043 . . . . 0.0 110.669 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -38.7 121.87 1.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.644 -0.66 . . . . 0.0 110.968 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.76 10.56 3.91 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 4.4 mm-40 -146.36 119.07 8.59 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.071 -1.252 . . . . 0.0 110.843 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.486 HG23 ' OG1' ' A' ' 54' ' ' THR . 88.0 m -105.92 114.11 28.06 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 29' ' ' GLU . 32.2 m-85 -96.85 -178.16 4.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.1 -1.0 . . . . 0.0 111.769 -179.804 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.571 ' CD1' ' HB2' ' A' ' 52' ' ' SER . 22.4 m-85 -134.54 124.43 25.48 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.564 HG22 ' CG2' ' A' ' 51' ' ' THR . 3.3 tt -105.41 119.66 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.904 -1.123 . . . . 0.0 110.991 -179.823 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.465 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -152.96 171.85 17.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.331 -0.856 . . . . 0.0 110.01 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 6.1 pt20 -127.52 156.27 42.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.24 -0.913 . . . . 0.0 110.006 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 9.6 m -140.73 169.51 17.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.12 -0.988 . . . . 0.0 110.383 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.07 163.13 25.69 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.331 -0.856 . . . . 0.0 110.028 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -79.05 170.29 18.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.951 1.501 . . . . 0.0 110.635 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.502 2.149 0 O-C-N 121.335 -0.853 . . . . 0.0 110.305 -179.978 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 121.344 0.592 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -159.3 175.24 13.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.358 -0.839 . . . . 0.0 110.072 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 38.9 t -158.95 165.92 33.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.346 -0.846 . . . . 0.0 110.242 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.453 ' ND2' HG22 ' A' ' 49' ' ' THR . 57.1 t-20 -97.29 121.29 59.12 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.295 -0.878 . . . . 0.0 110.629 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -81.75 -33.41 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.936 1.493 . . . . 0.0 110.822 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.81 96.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.192 -0.943 . . . . 0.0 110.595 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.453 HG22 ' ND2' ' A' ' 46' ' ' ASN . 54.1 p -78.05 5.72 9.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 0.0 110.443 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.12 88.76 7.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 110.565 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.564 ' CG2' HG22 ' A' ' 33' ' ' ILE . 12.8 t -99.53 174.49 6.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.571 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 2.8 t -131.78 148.42 52.56 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.988 -1.07 . . . . 0.0 111.063 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.533 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 24.9 p90 -150.3 151.62 33.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.508 -0.745 . . . . 0.0 109.343 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.486 ' OG1' HG23 ' A' ' 30' ' ' THR . 10.4 m -119.84 155.54 32.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.028 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.493 HG22 ' HB1' ' A' ' 25' ' ' ALA . 3.8 p -67.13 -158.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.298 -0.876 . . . . 0.0 110.297 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 55' ' ' THR . 8.8 m-20 -143.75 -162.93 1.55 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.06 -1.025 . . . . 0.0 109.985 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.77 -40.21 96.13 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.096 -1.002 . . . . 0.0 109.188 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 t -90.27 10.77 23.43 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.516 -0.74 . . . . 0.0 109.507 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 59.35 61.06 7.71 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.59 135.18 23.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.282 -1.128 . . . . 0.0 110.088 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.13 84.92 2.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 110.92 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.11 118.31 36.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.115 -0.991 . . . . 0.0 108.619 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -151.98 179.55 8.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.952 -1.092 . . . . 0.0 110.908 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.6 p -89.6 157.16 18.15 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.544 -0.722 . . . . 0.0 110.156 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.555 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 34.4 t80 -138.41 177.43 7.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.423 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.435 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.5 t -135.87 155.18 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.817 -1.177 . . . . 0.0 110.108 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.7 m -133.25 169.76 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.432 -0.792 . . . . 0.0 109.814 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 1.3 ttt85 -149.1 141.9 24.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.202 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -74.16 -48.07 31.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 110.22 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 95.4 p -119.9 144.75 47.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.933 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.543 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 21.5 p90 -162.01 142.79 10.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.112 -0.992 . . . . 0.0 110.693 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 54.1 m -55.66 122.29 11.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.304 -0.872 . . . . 0.0 109.877 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.1 168.78 13.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.389 -1.065 . . . . 0.0 109.979 -180.0 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 90.7 p . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.372 0.606 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 85' ' ' ASP . 78.0 t -112.19 153.79 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.279 -0.888 . . . . 0.0 110.134 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.518 ' N ' HG13 ' A' ' 84' ' ' VAL . 2.5 t0 -140.11 126.05 19.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 110.147 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 43.3 t -85.03 43.51 1.01 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.196 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.35 -52.13 5.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 110.193 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.6 t -101.28 1.08 38.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.124 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.36 -162.84 0.91 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.17 -0.956 . . . . 0.0 110.288 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.26 136.03 51.42 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.868 . . . . 0.0 110.151 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.3 p -125.05 127.79 47.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 110.071 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -107.89 165.75 11.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.377 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 34' ' ' ALA . 7.8 tp -128.54 110.71 12.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 109.544 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.57 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -116.28 162.58 12.59 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.298 -179.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.425 ' HB2' HD12 ' A' ' 102' ' ' LEU . . . -124.39 167.87 13.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.978 . . . . 0.0 109.869 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 31' ' ' TYR . . . 115.8 -166.05 12.24 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.403 ' CG ' ' N ' ' A' ' 98' ' ' SER . 7.9 t30 -147.59 168.71 21.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -1.177 . . . . 0.0 110.222 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.403 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 1.6 m -49.71 107.12 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 121.9 -46.69 1.09 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.523 HD23 ' CE1' ' A' ' 31' ' ' TYR . 0.4 OUTLIER -103.05 163.14 12.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -1.142 . . . . 0.0 110.135 179.987 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -146.68 131.25 17.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.333 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 4' ' ' PHE . 97.8 mt -106.96 -45.55 4.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.087 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.17 173.11 29.38 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.57 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 3.1 m-70 -140.85 108.32 5.57 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.343 -1.092 . . . . 0.0 109.94 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 t -90.21 113.67 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.32 -0.863 . . . . 0.0 110.445 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.69 130.87 47.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.169 -0.957 . . . . 0.0 109.88 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 31.5 mt -100.29 166.61 10.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.1 -1.0 . . . . 0.0 110.175 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -137.03 161.52 35.85 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.282 -0.886 . . . . 0.0 110.013 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 7.2 m-85 -139.65 148.16 42.03 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.349 -0.844 . . . . 0.0 110.05 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.04 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.964 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.447 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 46.1 Cg_endo . . . . . 0 N--CA 1.48 0.725 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -147.06 124.81 11.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.103 -0.998 . . . . 0.0 110.427 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.555 ' CE2' HD12 ' A' ' 33' ' ' ILE . 14.1 t80 -138.76 114.6 10.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.408 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.2 t -150.43 172.24 15.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.987 -1.071 . . . . 0.0 110.943 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.41 HG23 HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -130.02 145.55 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.854 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.597 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -66.17 -66.99 1.07 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.974 -1.079 . . . . 0.0 109.906 179.993 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.597 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 56.0 Cg_endo -79.27 69.47 7.91 Favored 'Trans proline' 0 N--CA 1.483 0.873 0 O-C-N 123.465 1.245 . . . . 0.0 110.081 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.41 -11.92 59.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.951 -1.093 . . . . 0.0 110.481 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.8 126.23 31.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 110.164 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.9 71.69 1.25 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.476 HD22 ' HB2' ' A' ' 8' ' ' PRO . 91.5 mt -112.57 165.67 12.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -1.144 . . . . 0.0 110.077 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -133.22 148.56 52.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.152 -0.967 . . . . 0.0 110.487 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -60.43 129.5 41.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.887 . . . . 0.0 110.141 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.01 -30.56 5.79 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -57.26 151.96 14.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.362 -1.081 . . . . 0.0 110.411 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -101.97 135.03 44.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.389 -0.819 . . . . 0.0 110.088 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.529 ' CG1' HG11 ' A' ' 67' ' ' VAL . 18.2 m -100.95 171.25 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.981 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.96 114.09 24.16 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.028 -1.045 . . . . 0.0 109.968 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 21' ' ' SER . 17.6 t -101.6 149.27 6.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.264 -0.897 . . . . 0.0 110.297 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.466 ' N ' HG13 ' A' ' 20' ' ' VAL . 42.0 t -150.02 128.18 12.0 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.483 -0.76 . . . . 0.0 110.183 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.4 t -120.71 137.69 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 109.887 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 2.3 p -150.52 111.0 4.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.957 -1.089 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 160.95 -52.14 0.34 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.502 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -60.27 -151.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -1.131 . . . . 0.0 110.096 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.52 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -167.83 163.51 14.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.137 -0.977 . . . . 0.0 110.545 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 56' ' ' ASP . . . -50.24 128.75 20.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.557 -0.714 . . . . 0.0 111.059 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.434 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 122.36 7.94 7.34 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.526 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 5.7 mm-40 -141.3 129.72 22.49 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.093 -1.239 . . . . 0.0 110.687 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.568 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.7 m -115.02 151.94 33.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 109.324 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 30' ' ' THR . 7.9 m-85 -139.7 -178.16 5.29 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.902 -1.124 . . . . 0.0 111.298 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.476 ' CE1' ' HB3' ' A' ' 52' ' ' SER . 55.4 m-85 -132.99 108.35 8.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.592 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 4.1 tt -87.56 125.44 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.154 -0.966 . . . . 0.0 110.851 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.1 165.21 35.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.24 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -118.05 150.85 38.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.204 -0.935 . . . . 0.0 110.029 179.986 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 72.2 m -150.8 164.65 35.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.897 . . . . 0.0 111.001 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.42 149.41 22.73 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.706 . . . . 0.0 109.495 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.52 164.42 32.93 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.839 1.442 . . . . 0.0 110.536 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 44' ' ' ALA . 17.4 m . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.333 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.255 0.55 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -110.52 150.71 28.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.155 -0.966 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.3 m -136.65 160.38 39.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.261 -0.899 . . . . 0.0 110.267 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.84 95.37 16.84 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.242 -0.911 . . . . 0.0 110.369 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -76.55 -30.45 5.05 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.966 1.508 . . . . 0.0 110.452 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.84 -38.95 70.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.309 -0.869 . . . . 0.0 110.295 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.49 36.82 1.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.817 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.3 144.11 28.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.489 -0.757 . . . . 0.0 110.788 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.592 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 11.0 t -151.22 143.51 24.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.833 . . . . 0.0 109.736 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.476 ' HB3' ' CE1' ' A' ' 32' ' ' TYR . 12.2 p -109.76 151.61 26.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.083 -1.011 . . . . 0.0 110.532 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -151.14 136.22 17.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 29' ' ' GLU . 26.3 m -102.15 171.95 7.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.256 -0.902 . . . . 0.0 110.571 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -84.89 -160.89 0.52 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.301 -0.874 . . . . 0.0 110.222 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 1.6 m-20 -149.1 -157.88 0.86 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.205 -0.935 . . . . 0.0 109.827 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.7 -53.66 55.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.91 -1.119 . . . . 0.0 109.997 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 t -87.12 16.17 5.38 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.265 -0.897 . . . . 0.0 109.215 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 56.84 48.79 75.63 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.0 129.98 56.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.282 -1.128 . . . . 0.0 110.426 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.18 85.1 2.21 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.331 -0.856 . . . . 0.0 110.077 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 23.7 p -110.63 134.3 52.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 109.901 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 25.8 p90 -163.85 173.64 12.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.233 -0.917 . . . . 0.0 110.504 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 t -94.08 137.9 32.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.797 . . . . 0.0 110.446 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.485 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 55.8 t80 -127.39 -179.46 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.532 -0.73 . . . . 0.0 109.374 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.485 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.2 t -128.02 154.92 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.853 -1.154 . . . . 0.0 110.209 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.529 HG11 ' CG1' ' A' ' 18' ' ' VAL . 22.2 m -129.0 178.67 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.373 -0.83 . . . . 0.0 110.111 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 3.0 mtp180 -150.31 118.66 6.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.849 . . . . 0.0 110.313 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 11.2 ttmt -49.81 -36.71 27.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.197 -0.939 . . . . 0.0 109.773 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.419 ' OG ' ' OD1' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -142.64 141.81 31.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.902 179.967 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.462 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 24.2 p90 -151.67 141.76 22.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -66.51 136.93 56.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.173 -179.933 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.74 170.38 49.06 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.208 -1.172 . . . . 0.0 110.231 -179.976 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.401 0.619 . . . . 0.0 110.841 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 71' ' ' TYR . 56.0 t -112.01 108.71 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 109.546 179.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 87' ' ' ALA . 18.8 t70 -88.24 135.78 33.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 0.0 110.246 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 91' ' ' CYS . 7.5 m -110.79 41.82 1.72 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.467 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . . . -97.88 -52.01 3.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 109.964 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -99.17 -9.24 24.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.861 . . . . 0.0 110.063 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.87 -133.41 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 109.935 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -151.05 97.26 2.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.082 -1.011 . . . . 0.0 110.807 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -88.51 113.41 24.07 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.184 -0.948 . . . . 0.0 109.048 179.914 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 16.6 p30 -113.48 129.73 56.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.972 -1.08 . . . . 0.0 111.293 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 35' ' ' GLN . 13.1 tp -99.43 111.13 23.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.366 -0.834 . . . . 0.0 109.373 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -125.43 171.92 17.39 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.84 178.98 6.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -1.078 . . . . 0.0 110.021 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 138.48 157.56 7.45 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' A' ' 98' ' ' SER . 8.2 p30 -107.55 -29.19 9.33 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.28 -1.129 . . . . 0.0 110.328 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.419 ' HB2' ' OD1' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -172.18 -72.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.7 -10.7 32.37 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.54 ' CD2' ' CE1' ' A' ' 31' ' ' TYR . 21.5 tp -73.78 -64.59 0.97 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.02 -1.282 . . . . 0.0 110.196 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 92.3 m-20 55.29 103.33 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.01 -6.11 55.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 110.374 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.4 ' O ' ' HA2' ' A' ' 94' ' ' GLY . . . 106.97 -175.39 20.62 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.476 ' O ' ' ND1' ' A' ' 104' ' ' HIS . 34.2 p80 -148.7 132.22 16.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.251 -1.146 . . . . 0.0 110.132 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -93.83 130.46 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.147 -180.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.47 114.29 8.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 110.408 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.2 136.5 33.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.848 . . . . 0.0 110.354 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 109' ' ' PHE . 98.3 m -107.25 173.2 6.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.291 -0.88 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.48 ' N ' HG22 ' A' ' 108' ' ' THR . 7.6 m-85 -142.8 122.69 13.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.889 . . . . 0.0 110.292 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.973 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.42 ' HG2' ' HA ' ' A' ' 102' ' ' LEU . 47.1 Cg_endo . . . . . 0 N--CA 1.483 0.854 0 N-CA-C 110.551 -0.596 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -132.13 146.7 52.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.222 -0.924 . . . . 0.0 110.596 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 12.4 t80 -149.5 113.17 5.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.462 -0.774 . . . . 0.0 109.592 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.537 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 0.2 OUTLIER -151.15 167.02 29.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.032 -1.042 . . . . 0.0 110.959 -179.9 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.453 HG21 ' HD2' ' A' ' 8' ' ' PRO . 7.5 p -128.25 141.05 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.725 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -55.88 -67.38 0.77 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.08 -1.012 . . . . 0.0 110.289 -179.965 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 49.5 Cg_endo -74.4 82.81 1.8 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.386 1.203 . . . . 0.0 109.807 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.65 1.99 52.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.975 . . . . 0.0 110.501 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.8 p -150.27 148.89 29.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.252 -0.905 . . . . 0.0 110.165 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.3 58.71 3.55 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mt -105.44 170.63 7.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.303 -1.116 . . . . 0.0 110.45 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.47 149.4 43.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 110.183 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.8 96.94 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.83 -34.06 3.23 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -54.22 142.89 24.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 110.143 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 66.3 m -91.68 134.09 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 110.069 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.493 HG21 HG13 ' A' ' 67' ' ' VAL . 23.2 m -100.88 148.86 6.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 110.168 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.21 106.1 18.11 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.34 -0.85 . . . . 0.0 109.309 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.513 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 36.9 t -93.37 149.74 4.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.499 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.75 119.27 5.63 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.857 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 23.8 t -107.08 132.51 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.771 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.513 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 30.3 m -127.77 120.36 27.72 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 148.75 -77.69 0.23 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.505 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -47.12 172.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.216 -1.167 . . . . 0.0 110.029 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.525 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -139.6 161.63 37.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 110.464 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -39.04 122.79 1.25 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.674 -0.641 . . . . 0.0 110.653 -179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.57 0.76 7.84 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.472 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 30.9 mm-40 -132.93 130.51 39.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -1.184 . . . . 0.0 110.597 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 53' ' ' PHE . 57.5 m -106.34 161.25 14.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.503 -0.748 . . . . 0.0 109.659 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 80.1 m-85 -149.96 176.47 10.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.041 -1.037 . . . . 0.0 110.552 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 17.7 m-85 -122.78 147.62 46.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.456 -0.778 . . . . 0.0 109.093 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.585 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 5.2 tt -128.35 116.53 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.955 -1.091 . . . . 0.0 110.15 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.46 158.58 44.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.428 ' OE1' ' HB3' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -93.62 136.12 34.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.608 -0.682 . . . . 0.0 109.958 179.912 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.2 m -142.98 143.39 31.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.89 174.72 3.24 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.454 -0.778 . . . . 0.0 109.496 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.86 165.67 31.86 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.733 1.386 . . . . 0.0 110.351 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.297 -0.877 . . . . 0.0 110.366 -179.958 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.363 0.601 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.534 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . . . -117.37 151.9 36.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.35 -0.844 . . . . 0.0 109.895 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.466 ' O ' ' HA2' ' A' ' 73' ' ' GLY . 2.4 m -116.05 164.34 14.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.153 -0.967 . . . . 0.0 110.368 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.478 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 59.3 t-20 -96.0 123.2 56.17 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.275 -0.891 . . . . 0.0 110.174 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.76 -33.74 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.861 1.453 . . . . 0.0 110.681 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.45 -19.77 65.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.346 -0.846 . . . . 0.0 110.815 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.16 32.93 5.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.045 -1.035 . . . . 0.0 110.476 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.52 106.29 18.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.224 -0.922 . . . . 0.0 110.511 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.585 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 14.9 t -131.42 -178.57 4.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.0 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.4 ' CB ' ' CD1' ' A' ' 32' ' ' TYR . 55.6 p -144.12 147.19 33.4 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.115 -0.991 . . . . 0.0 110.839 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 20.6 p90 -136.09 -176.99 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.763 . . . . 0.0 109.539 179.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.5 m -145.47 154.32 42.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.796 -1.19 . . . . 0.0 110.256 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.505 HG21 ' CB ' ' A' ' 25' ' ' ALA . 2.0 p -69.99 -158.02 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.209 -0.932 . . . . 0.0 109.915 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -160.03 -155.67 0.45 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.902 -1.124 . . . . 0.0 110.148 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.14 78.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.918 -1.114 . . . . 0.0 109.527 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 t -79.29 4.99 13.51 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.379 -0.825 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 56.05 38.03 74.05 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -124.91 127.19 46.71 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.268 -1.136 . . . . 0.0 110.104 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.418 ' CB ' ' HB ' ' A' ' 22' ' ' VAL . . . -101.14 80.35 2.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 110.365 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.9 m -101.08 120.18 39.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.676 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.513 ' CE1' ' HB ' ' A' ' 20' ' ' VAL . 7.0 p90 -155.73 174.79 14.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.192 -0.942 . . . . 0.0 110.833 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.5 m -98.32 132.6 43.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 40.5 t80 -130.35 179.63 5.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.443 -0.786 . . . . 0.0 109.238 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.467 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.8 t -129.38 155.9 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.81 -1.181 . . . . 0.0 110.352 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.493 HG13 HG21 ' A' ' 18' ' ' VAL . 31.8 m -125.21 159.02 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.404 -0.81 . . . . 0.0 110.357 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -133.21 132.9 42.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.263 -0.898 . . . . 0.0 110.034 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -72.8 -10.83 60.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.137 -0.977 . . . . 0.0 110.362 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.2 p -150.29 139.37 21.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.131 -0.981 . . . . 0.0 110.536 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 9.6 p90 -168.09 138.76 2.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.299 -0.876 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.2 OUTLIER -68.68 137.34 54.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.258 -0.901 . . . . 0.0 110.091 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 45' ' ' CYS . . . -121.7 -166.48 12.88 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 p . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.305 -1.115 . . . . 0.0 110.138 -179.997 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.307 0.575 . . . . 0.0 110.283 . . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.534 ' CG2' ' HB3' ' A' ' 44' ' ' ALA . 74.0 t -125.21 159.1 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.383 -0.823 . . . . 0.0 110.21 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -154.75 146.61 23.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.882 . . . . 0.0 110.056 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.81 17.73 22.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 110.105 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.62 -42.78 61.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 110.674 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -117.74 -16.42 10.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.148 -0.97 . . . . 0.0 110.361 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.43 147.09 34.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.953 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.17 154.51 27.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 0.0 110.178 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.428 ' HB3' ' OE1' ' A' ' 35' ' ' GLN . 82.7 m -120.93 162.74 19.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 0.0 110.329 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -146.09 121.3 10.18 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.31 -0.868 . . . . 0.0 110.237 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 45.2 tp -86.95 112.1 21.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.046 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.562 ' HA3' ' CD2' ' A' ' 104' ' ' HIS . . . -121.14 163.37 14.61 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.501 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -132.42 159.07 40.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.551 -0.97 . . . . 0.0 110.507 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 101' ' ' ASP . . . 169.31 159.2 14.45 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 31' ' ' TYR . 1.5 p30 -143.34 -41.14 0.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.991 -1.299 . . . . 0.0 111.246 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.43 78.01 1.2 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.951 -1.093 . . . . 0.0 111.294 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.45 9.24 29.97 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 101' ' ' ASP . 1.6 tt -99.35 -51.33 3.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.285 . . . . 0.0 109.827 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.523 ' HA ' ' CA ' ' A' ' 96' ' ' GLY . 1.1 m-20 54.21 164.54 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.485 -0.759 . . . . 0.0 110.123 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.501 HD11 ' CB ' ' A' ' 31' ' ' TYR . 31.7 mt -126.36 -47.68 1.59 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.904 -179.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 167.35 174.35 36.36 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.562 ' CD2' ' HA3' ' A' ' 94' ' ' GLY . 1.9 m170 -129.56 126.77 39.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.851 -0.793 . . . . 0.0 109.652 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 5' ' ' SER . 20.0 t -108.23 120.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.048 -1.032 . . . . 0.0 110.439 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.06 107.55 10.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.932 . . . . 0.0 109.382 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 12.6 mt -88.61 171.86 9.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.308 -0.87 . . . . 0.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -147.77 158.68 44.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.449 -0.782 . . . . 0.0 109.838 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -122.16 119.85 32.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.058 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.59 179.997 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.457 ' HB2' HD22 ' A' ' 102' ' ' LEU . 43.8 Cg_endo . . . . . 0 N--CA 1.482 0.838 0 N-CA-C 110.49 -0.619 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -154.04 121.77 5.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.897 . . . . 0.0 110.334 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.426 ' HB2' HD23 ' A' ' 102' ' ' LEU . 87.8 t80 -141.47 110.79 6.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.211 -0.931 . . . . 0.0 109.562 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.8 t -150.69 161.13 43.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.078 -1.014 . . . . 0.0 110.999 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.558 ' CG1' ' CB ' ' A' ' 9' ' ' ALA . 6.2 p -114.93 160.42 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.494 -0.754 . . . . 0.0 109.674 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -62.96 -66.52 1.5 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.048 -1.032 . . . . 0.0 110.561 -179.993 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 43.1 Cg_endo -73.54 -73.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.424 1.223 . . . . 0.0 110.591 -179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.558 ' CB ' ' CG1' ' A' ' 6' ' ' VAL . . . 75.26 -1.04 3.15 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.443 -0.786 . . . . 0.0 110.203 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.446 ' OG ' ' C ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER -164.21 145.42 8.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 110.248 -179.951 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.96 41.22 61.83 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' A' ' 18' ' ' VAL . 1.3 mp -90.78 174.79 7.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -1.164 . . . . 0.0 110.091 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 1.5 t -128.56 150.34 50.24 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.361 -0.837 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -56.94 108.04 0.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.189 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.92 -35.19 5.09 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.4 tt0 -45.95 152.94 0.33 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.303 -1.116 . . . . 0.0 110.357 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 p -103.53 154.4 19.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.403 -0.811 . . . . 0.0 110.378 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.527 HG12 ' CD2' ' A' ' 12' ' ' LEU . 21.1 m -129.13 150.23 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.302 -0.874 . . . . 0.0 110.026 -179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 m -94.91 115.15 27.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.136 -0.978 . . . . 0.0 109.842 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.588 HG12 ' CZ ' ' A' ' 63' ' ' PHE . 42.7 t -100.8 147.65 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.529 ' N ' HG11 ' A' ' 20' ' ' VAL . 2.8 t -146.06 139.3 25.95 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.47 -0.769 . . . . 0.0 110.469 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.48 ' O ' ' OG ' ' A' ' 23' ' ' SER . 47.6 t -128.29 153.59 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.526 -0.734 . . . . 0.0 110.007 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 7.3 m -165.89 120.89 1.23 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.946 -1.096 . . . . 0.0 110.672 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 25' ' ' ALA . . . 139.29 -59.98 0.58 Allowed Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.354 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.551 ' HB2' ' CG2' ' A' ' 55' ' ' THR . . . -39.53 -47.9 1.95 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.199 -1.177 . . . . 0.0 110.985 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.568 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . 73.99 141.79 0.07 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.398 -0.814 . . . . 0.0 110.595 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -39.13 136.33 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.527 0.68 . . . . 0.0 110.866 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.01 12.55 4.36 Favored Glycine 0 N--CA 1.481 1.643 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -156.3 126.73 6.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.056 -1.261 . . . . 0.0 110.62 179.975 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 53' ' ' PHE . 1.6 m -94.1 143.11 26.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.463 -0.773 . . . . 0.0 109.858 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 29' ' ' GLU . 25.7 m-85 -134.34 146.14 49.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.08 -1.012 . . . . 0.0 111.154 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 97.5 m-85 -113.86 124.48 52.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.389 -0.82 . . . . 0.0 109.05 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.564 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 12.4 tt -96.3 120.44 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.83 -1.169 . . . . 0.0 110.652 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.468 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -152.07 153.29 33.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 110.142 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.451 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 14.3 pt20 -121.41 150.39 41.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.111 -0.993 . . . . 0.0 110.288 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 96.6 m -152.02 164.28 37.53 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.202 -0.936 . . . . 0.0 111.095 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -153.06 158.47 32.86 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.662 -0.649 . . . . 0.0 109.978 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.01 173.11 8.83 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.792 1.417 . . . . 0.0 110.668 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 39' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.242 -0.912 . . . . 0.0 111.043 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.461 ' C ' HG12 ' A' ' 39' ' ' VAL . 10.0 t70 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.4 0.619 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.17 151.17 45.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.455 -0.778 . . . . 0.0 109.741 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 0.8 OUTLIER -139.77 161.62 37.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 0.0 110.444 179.97 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -107.9 89.81 5.82 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.344 -0.848 . . . . 0.0 110.179 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 48.6 Cg_endo -76.27 -31.79 4.44 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.974 1.513 . . . . 0.0 110.681 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.3 -27.16 63.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.304 -0.873 . . . . 0.0 110.438 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 p -108.55 39.18 2.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 110.149 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.31 138.9 31.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 110.414 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.564 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 3.7 t -153.1 134.96 14.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.892 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.574 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 87.9 p -108.04 145.09 34.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.727 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 14.7 p90 -150.97 -175.75 5.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 109.586 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.0 m -145.5 160.53 41.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.178 -0.951 . . . . 0.0 109.627 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.551 ' CG2' ' HB2' ' A' ' 25' ' ' ALA . 3.0 p -60.72 -162.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.94 -1.1 . . . . 0.0 109.966 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.19 -164.24 1.81 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.044 -1.035 . . . . 0.0 109.879 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.11 67.02 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.036 -1.04 . . . . 0.0 109.414 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.479 ' OG ' ' HB2' ' A' ' 60' ' ' ALA . 77.2 p -89.73 18.28 5.71 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.568 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 59.13 29.38 65.44 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.479 ' HB2' ' OG ' ' A' ' 58' ' ' SER . . . -105.99 123.82 48.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.293 -1.122 . . . . 0.0 110.499 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.42 ' HB1' ' HB ' ' A' ' 22' ' ' VAL . . . -126.5 85.12 2.34 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.6 p -106.15 124.94 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.235 -0.916 . . . . 0.0 109.699 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.639 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 4.8 p90 -153.89 177.03 11.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.076 -1.015 . . . . 0.0 110.645 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.39 141.31 28.87 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.5 -0.75 . . . . 0.0 110.625 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.432 ' C ' ' CG2' ' A' ' 66' ' ' VAL . 45.8 t80 -138.78 -174.75 3.92 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.432 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 3.2 t -147.22 161.54 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.824 -1.173 . . . . 0.0 110.242 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 26.7 m -133.64 -177.04 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.397 -0.814 . . . . 0.0 110.012 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 26.4 mtt180 -158.45 123.29 4.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.038 -1.039 . . . . 0.0 110.629 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.582 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 10.9 tttm -62.42 -43.59 98.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.867 . . . . 0.0 109.556 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m -127.97 118.88 24.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -131.24 143.63 50.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.953 . . . . 0.0 110.461 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.5 m -60.91 141.91 56.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.96 . . . . 0.0 109.885 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -127.76 154.76 19.84 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.394 -1.062 . . . . 0.0 110.274 179.986 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 69.8 m . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.277 0.561 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.9 t -122.41 149.58 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.213 -0.929 . . . . 0.0 109.999 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -127.58 162.35 26.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.168 -0.957 . . . . 0.0 110.553 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 89' ' ' ALA . 19.1 m -106.36 -9.76 16.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 0.0 110.095 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.16 -52.55 9.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.345 -0.847 . . . . 0.0 110.334 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.5 HG22 ' N ' ' A' ' 89' ' ' ALA . 14.6 t -71.36 -19.6 62.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.15 -0.969 . . . . 0.0 109.866 -179.926 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.5 ' N ' HG22 ' A' ' 88' ' ' THR . . . -133.12 -160.17 1.03 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.391 -0.818 . . . . 0.0 109.873 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.88 135.11 45.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.173 -0.955 . . . . 0.0 109.857 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 1.9 p -121.27 146.7 46.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.133 -0.979 . . . . 0.0 109.774 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -127.6 147.84 50.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.09 -1.006 . . . . 0.0 111.146 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.468 HD11 ' O ' ' A' ' 34' ' ' ALA . 8.0 tp -119.05 114.75 22.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.455 -0.778 . . . . 0.0 109.053 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -129.13 178.77 17.11 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.578 -1.296 . . . . 0.0 110.26 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -140.73 172.33 12.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.394 -1.062 . . . . 0.0 110.163 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 144.74 169.4 13.28 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' CG ' ' N ' ' A' ' 98' ' ' SER . 5.2 p30 -89.47 -45.19 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -1.187 . . . . 0.0 110.276 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.473 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER 171.54 -41.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.429 -0.795 . . . . 0.0 109.955 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.84 -12.41 22.52 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.571 HD22 ' CE1' ' A' ' 31' ' ' TYR . 1.1 tt -87.21 -65.83 0.97 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.196 -1.179 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 100' ' ' LEU . 13.9 t0 68.17 75.13 0.28 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.348 -0.845 . . . . 0.0 110.012 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.457 HD22 ' HB2' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -49.99 -36.53 28.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.335 -0.853 . . . . 0.0 110.45 -179.942 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.44 170.37 13.13 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.424 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -135.31 125.74 26.66 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.216 -1.167 . . . . 0.0 109.91 179.983 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.48 124.54 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.985 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.07 125.52 25.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.246 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 76.6 mt -95.84 164.99 12.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.291 -179.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.524 ' C ' ' CD1' ' A' ' 109' ' ' PHE . 6.2 m -158.5 175.99 12.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.311 -0.868 . . . . 0.0 110.054 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.582 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 69.0 m-85 -142.64 152.0 42.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.308 -0.87 . . . . 0.0 110.277 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.039 -1.423 . . . . 0.0 109.598 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.513 ' N ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 1' ' ' ALA . 47.7 Cg_endo -74.74 -171.0 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.797 1.42 . . . . 0.0 110.226 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -140.62 123.18 16.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 110.796 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -141.52 100.22 3.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.502 -0.749 . . . . 0.0 109.119 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.11 172.12 13.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 110.978 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 6' ' ' VAL . 5.2 p -137.02 128.44 42.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.642 -0.661 . . . . 0.0 109.612 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.635 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.1 m -46.62 -72.89 0.12 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.117 . . . . 0.0 110.221 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.635 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 53.0 Cg_endo -75.9 97.77 1.14 Allowed 'Trans proline' 0 N--CA 1.483 0.87 0 O-C-N 123.04 1.021 . . . . 0.0 110.031 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.32 4.4 41.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.13 -0.981 . . . . 0.0 110.25 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.6 p -155.57 167.7 29.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 110.245 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.39 42.22 97.37 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.541 ' O ' ' CE2' ' A' ' 109' ' ' PHE . 85.3 mt -90.43 136.83 32.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.303 -1.116 . . . . 0.0 110.137 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.462 ' HB2' ' OE1' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -110.75 156.53 20.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 110.459 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.22 119.28 6.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.04 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.42 -35.5 4.86 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.462 ' OE1' ' HB2' ' A' ' 13' ' ' SER . 33.4 tt0 -48.72 142.65 5.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -1.116 . . . . 0.0 110.044 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 58.9 p -95.3 161.6 14.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.351 -0.843 . . . . 0.0 110.597 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.497 ' CG1' HG13 ' A' ' 67' ' ' VAL . 16.5 m -132.29 151.07 34.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.412 -0.805 . . . . 0.0 109.636 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 1.5 m -99.35 122.02 41.9 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.063 -1.023 . . . . 0.0 109.804 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.483 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 7.4 t -110.95 146.47 15.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.38 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.0 p -140.68 128.64 21.97 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.389 -0.819 . . . . 0.0 110.397 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 39.9 t -121.66 100.78 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.4 OUTLIER -130.23 110.21 11.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.978 . . . . 0.0 110.251 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 169.32 -50.71 0.21 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.526 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -59.97 -138.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -1.131 . . . . 0.0 109.883 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.538 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -179.11 164.56 1.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.976 -1.078 . . . . 0.0 110.347 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 56' ' ' ASP . . . -54.26 128.89 33.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.398 -0.814 . . . . 0.0 110.479 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 119.69 18.92 4.24 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 9.5 mm-40 -154.9 127.31 7.87 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.235 -1.156 . . . . 0.0 110.457 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.471 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -93.56 170.1 9.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.344 -0.848 . . . . 0.0 109.952 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 79.5 m-85 -152.94 155.44 37.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.416 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 78.8 m-85 -122.81 111.25 16.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.663 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.48 ' CG2' HG22 ' A' ' 51' ' ' THR . 5.4 tt -95.98 120.91 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.102 -0.999 . . . . 0.0 110.433 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.66 160.37 43.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.112 -0.992 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.522 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 25.3 tt0 -114.15 133.56 55.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.64 -0.662 . . . . 0.0 109.219 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 66.0 m -139.49 156.24 47.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.985 -1.072 . . . . 0.0 111.146 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.63 144.0 16.92 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 41.6 Cg_endo -69.97 159.95 51.38 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.819 1.431 . . . . 0.0 110.68 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.516 ' CG1' HG23 ' A' ' 84' ' ' VAL . 6.6 m -127.91 162.77 33.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.517 -0.739 . . . . 0.0 110.02 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -50.94 -22.62 6.31 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.26 -70.17 1.3 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.452 ' HG3' ' OD1' ' A' ' 43' ' ' ASP . 2.9 tp-100 -147.79 -86.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -1.0 . . . . 0.0 110.407 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 7.1 m-20 -150.99 153.46 35.22 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.146 -0.971 . . . . 0.0 110.36 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -144.89 151.69 39.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.18 -0.95 . . . . 0.0 110.321 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 m -131.23 155.11 47.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.309 -0.869 . . . . 0.0 110.199 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.468 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 36.2 t-20 -87.9 124.08 67.78 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.07 -1.019 . . . . 0.0 110.195 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.402 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 53.0 Cg_endo -81.83 -41.06 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.898 1.473 . . . . 0.0 111.046 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.63 93.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.321 -0.862 . . . . 0.0 111.021 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 47.7 p -80.64 7.14 10.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.142 -0.974 . . . . 0.0 110.365 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 47' ' ' PRO . . . -75.78 104.98 6.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 110.223 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.48 HG22 ' CG2' ' A' ' 33' ' ' ILE . 9.8 t -136.9 163.16 31.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.884 . . . . 0.0 110.197 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -132.8 162.19 32.13 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 110.241 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 46.6 p90 -151.23 171.06 18.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.439 -0.788 . . . . 0.0 109.659 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.6 m -130.97 155.99 45.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.137 -0.977 . . . . 0.0 110.139 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.526 ' CG2' ' HB3' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -88.75 176.11 7.22 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.095 -1.003 . . . . 0.0 110.187 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.531 ' HA ' ' CB ' ' A' ' 27' ' ' ALA . 11.0 t70 -177.13 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.183 -0.948 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.43 86.92 0.07 Allowed 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.212 -0.93 . . . . 0.0 109.13 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.95 15.95 8.8 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 79.1 52.27 4.97 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.07 149.22 28.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -1.168 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.452 ' HB1' ' HB ' ' A' ' 22' ' ' VAL . . . -163.53 78.37 0.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 110.526 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.8 m -101.55 130.28 47.81 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.294 -0.879 . . . . 0.0 109.706 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.483 ' CE1' ' CG1' ' A' ' 20' ' ' VAL . 1.7 p90 -153.32 171.3 18.79 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.005 -1.059 . . . . 0.0 111.086 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.1 m -92.94 125.51 37.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.449 -0.782 . . . . 0.0 110.642 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.496 ' HB3' HG21 ' A' ' 18' ' ' VAL . 28.8 t80 -118.47 -173.07 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.597 -0.689 . . . . 0.0 109.375 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 3.9 t -147.76 167.78 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 120.756 -1.215 . . . . 0.0 110.371 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.497 HG13 ' CG1' ' A' ' 18' ' ' VAL . 13.1 m -139.37 161.78 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 0.0 110.243 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -143.35 122.79 13.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.262 -0.899 . . . . 0.0 110.097 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ARG . 2.7 ttpt -45.63 -48.19 14.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.044 -1.035 . . . . 0.0 109.365 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 85' ' ' ASP . 6.6 m -127.3 123.81 37.27 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.58 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 28.3 p90 -125.13 140.18 53.11 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.079 -1.013 . . . . 0.0 111.28 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 85.7 m -58.35 99.91 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.396 -0.815 . . . . 0.0 109.957 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.443 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -101.67 177.15 26.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.0 t -158.04 143.63 16.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -1.173 . . . . 0.0 110.193 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.547 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 3.9 m -69.8 149.64 96.62 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.855 . . . . 0.0 110.231 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 75' ' ' THR . 47.6 Cg_endo -82.88 14.68 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.009 1.531 . . . . 0.0 110.404 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -118.31 41.52 2.93 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.193 -0.942 . . . . 0.0 110.171 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.61 23.39 54.9 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.48 ' O ' ' OG1' ' A' ' 75' ' ' THR . 5.6 m -124.62 87.76 54.23 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.194 -1.18 . . . . 0.0 110.284 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.45 86.06 0.85 Allowed 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.89 1.468 . . . . 0.0 110.187 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.437 HG11 ' N ' ' A' ' 82' ' ' GLY . 5.6 p -51.48 -45.2 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.339 -0.851 . . . . 0.0 110.544 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.437 ' N ' HG11 ' A' ' 81' ' ' VAL . . . 142.58 -144.24 13.75 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 19.4 m -81.27 160.01 24.34 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.337 -1.096 . . . . 0.0 110.762 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.516 HG23 ' CG1' ' A' ' 39' ' ' VAL . 40.6 t -125.02 148.63 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 59.3 p30 -127.23 166.22 18.16 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.063 -1.023 . . . . 0.0 110.721 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -112.71 1.77 15.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.499 -0.751 . . . . 0.0 110.414 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.32 -58.26 4.66 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.69 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -81.64 -27.38 34.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.116 -0.99 . . . . 0.0 110.501 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.05 176.99 4.78 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.39 155.88 22.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.8 m -116.93 139.11 51.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 0.0 110.185 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -123.29 125.73 45.58 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 110.322 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -102.02 108.52 19.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.283 -0.886 . . . . 0.0 109.078 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.2 163.5 12.38 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.498 -1.334 . . . . 0.0 110.141 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 33' ' ' ILE . . . -155.16 118.27 4.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.449 -1.03 . . . . 0.0 109.872 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.61 -177.06 46.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -118.15 177.41 4.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -1.136 . . . . 0.0 110.265 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.0 t -70.64 -20.12 62.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.127 -0.983 . . . . 0.0 110.146 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.1 -44.05 5.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.497 HD11 ' N ' ' A' ' 101' ' ' ASP . 3.4 tm? -118.87 135.74 54.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.242 -1.152 . . . . 0.0 109.938 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.497 ' N ' HD11 ' A' ' 100' ' ' LEU . 41.0 m-20 -116.12 101.66 8.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.0 . . . . 0.0 110.322 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 19.8 mt -66.03 -61.16 2.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 110.003 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.12 -173.98 30.46 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -148.26 150.38 33.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.466 -1.02 . . . . 0.0 110.117 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.0 t -107.77 126.02 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.329 -0.857 . . . . 0.0 110.335 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.9 114.06 10.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.914 . . . . 0.0 109.841 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.522 ' CD1' ' OE1' ' A' ' 35' ' ' GLN . 58.1 mt -81.4 147.03 30.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.94 . . . . 0.0 110.573 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -127.74 158.16 38.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.853 . . . . 0.0 110.096 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 13.1 m-85 -128.74 92.26 3.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.275 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.19 -162.73 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.86 1.453 . . . . 0.0 110.423 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -162.14 115.5 1.79 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.88 . . . . 0.0 110.405 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.577 ' CE2' HG23 ' A' ' 105' ' ' VAL . 51.5 t80 -126.96 114.85 18.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.2 m -143.76 170.35 16.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.06 -1.025 . . . . 0.0 110.593 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.52 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 4.0 p -134.5 138.4 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.386 -0.821 . . . . 0.0 110.239 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -54.84 -57.13 20.79 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.357 -0.839 . . . . 0.0 110.962 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 7' ' ' SER . 42.4 Cg_endo -69.09 -87.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.864 1.455 . . . . 0.0 110.797 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.52 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 71.53 14.19 6.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.283 -0.885 . . . . 0.0 109.836 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.2 t -178.13 149.13 0.53 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.88 45.92 62.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.433 HD23 ' HB2' ' A' ' 8' ' ' PRO . 17.2 mt -98.79 174.3 6.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.326 -1.102 . . . . 0.0 110.231 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.81 159.72 44.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 110.12 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.522 ' HB3' ' CB ' ' A' ' 69' ' ' LYS . 1.5 p30 -59.76 116.33 3.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.265 -0.897 . . . . 0.0 110.206 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.41 -33.6 6.07 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -45.68 154.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -1.108 . . . . 0.0 110.106 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.521 ' O ' ' NE2' ' A' ' 16' ' ' GLN . 5.5 t -98.53 172.03 7.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.54 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.441 ' CG1' HG11 ' A' ' 67' ' ' VAL . 8.4 m -149.09 154.68 9.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.385 -0.822 . . . . 0.0 109.9 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 0.4 OUTLIER -111.6 114.83 28.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.257 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.7 t -103.72 152.01 6.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.323 -0.861 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 18.8 t -149.36 132.56 16.39 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.492 -0.755 . . . . 0.0 109.998 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 6.6 t -124.09 153.24 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 110.338 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 1.0 OUTLIER -161.29 120.01 2.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.26 4.85 3.93 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.566 ' CB ' ' CG2' ' A' ' 55' ' ' THR . . . -103.61 -30.04 10.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.998 -1.295 . . . . 0.0 110.374 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.531 ' HA ' ' HA3' ' A' ' 59' ' ' GLY . . . 58.57 133.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.816 0.817 . . . . 0.0 111.43 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -39.08 141.63 0.29 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.538 0.685 . . . . 0.0 110.505 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.19 -10.11 13.44 Favored Glycine 0 C--N 1.288 -2.137 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 5.1 mm-40 -125.39 123.49 39.44 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.376 -1.073 . . . . 0.0 109.829 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.544 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 71.5 m -97.52 159.62 14.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.386 -0.821 . . . . 0.0 109.767 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 50.4 m-85 -147.38 153.16 39.3 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.192 -0.942 . . . . 0.0 110.344 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.502 ' CD1' ' HB2' ' A' ' 52' ' ' SER . 88.1 m-85 -115.54 108.82 16.95 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 109.372 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.455 ' CG2' HG22 ' A' ' 51' ' ' THR . 4.5 tt -98.39 128.35 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.124 -0.985 . . . . 0.0 110.73 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.57 152.0 32.31 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.306 -0.871 . . . . 0.0 110.458 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.4 135.06 33.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.845 . . . . 0.0 109.615 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.6 m -147.21 159.46 43.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 0.0 110.684 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.76 157.0 34.67 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.602 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.39 163.38 38.78 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.751 1.395 . . . . 0.0 110.764 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.7 m -133.2 54.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.699 0.762 . . . . 0.0 109.756 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.34 47.8 55.47 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.49 -67.59 0.25 Allowed Glycine 0 N--CA 1.491 2.359 0 O-C-N 121.0 -1.294 . . . . 0.0 110.05 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.43 ' OE1' HG23 ' A' ' 75' ' ' THR . 1.7 mt-30 -116.41 -161.45 0.8 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.351 -1.088 . . . . 0.0 110.365 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -127.35 119.97 27.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.317 -0.864 . . . . 0.0 109.831 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.5 158.68 15.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.913 . . . . 0.0 110.427 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.2 168.04 15.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.291 -0.881 . . . . 0.0 110.186 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.525 ' OD1' ' CG ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -104.25 102.74 34.66 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 109.923 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.15 -29.28 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.986 1.519 . . . . 0.0 110.437 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.82 -27.44 68.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.365 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 40.0 p -111.29 30.31 7.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.394 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.3 128.32 34.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 109.929 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.455 HG22 ' CG2' ' A' ' 33' ' ' ILE . 9.0 t -138.22 131.94 31.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.96 . . . . 0.0 110.543 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.502 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 28.8 t -111.91 142.55 44.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.408 -0.808 . . . . 0.0 109.952 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 45.9 p90 -144.24 -174.98 4.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.316 -0.865 . . . . 0.0 110.342 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 55' ' ' THR . 28.2 m -150.01 151.34 33.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.95 . . . . 0.0 109.796 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.566 ' CG2' ' CB ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -56.19 -160.67 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.024 -1.048 . . . . 0.0 110.529 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -153.92 -158.29 0.85 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.091 -1.006 . . . . 0.0 110.36 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.27 74.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.873 -1.142 . . . . 0.0 109.671 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.2 m -84.15 10.63 9.74 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.343 -0.848 . . . . 0.0 109.341 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.531 ' HA3' ' HA ' ' A' ' 26' ' ' ALA . . . 52.5 53.76 30.56 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.81 113.3 13.33 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.242 -1.152 . . . . 0.0 110.086 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -101.54 80.93 2.11 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.396 -0.815 . . . . 0.0 109.806 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 62.1 p -114.67 125.97 54.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 110.118 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.4 p90 -154.59 176.07 12.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.314 -0.866 . . . . 0.0 110.575 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 89.6 p -97.63 119.26 35.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.488 -0.757 . . . . 0.0 110.485 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 51.6 t80 -115.93 174.78 5.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.336 -0.852 . . . . 0.0 109.621 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.562 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 12.6 t -125.48 163.97 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.909 -1.119 . . . . 0.0 110.419 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.441 HG11 ' CG1' ' A' ' 18' ' ' VAL . 27.9 m -132.91 173.79 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.269 -0.894 . . . . 0.0 110.216 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -148.72 151.29 34.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.292 -0.88 . . . . 0.0 110.125 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.522 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 6.7 tttt -83.93 -39.86 19.25 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.235 -0.916 . . . . 0.0 109.884 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.8 p -132.85 147.29 52.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 109.753 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 12.6 p90 -165.92 148.33 7.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.961 -1.087 . . . . 0.0 111.028 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 13.0 m -64.08 123.3 18.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.311 -0.868 . . . . 0.0 109.638 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.04 175.29 15.88 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 t -165.16 123.7 1.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -1.075 . . . . 0.0 109.854 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 79' ' ' THR . 32.1 p -59.94 144.21 86.6 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.922 . . . . 0.0 110.577 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.82 0.95 9.42 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 124.255 1.661 . . . . 0.0 110.467 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -90.41 -44.35 9.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.938 . . . . 0.0 110.431 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.37 60.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.469 ' O ' ' OG1' ' A' ' 75' ' ' THR . 15.0 m -166.11 99.7 0.72 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.184 -1.186 . . . . 0.0 110.275 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.77 119.35 6.26 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.988 1.52 . . . . 0.0 110.113 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 p -94.6 -26.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.262 -0.899 . . . . 0.0 110.358 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.82 -147.15 16.39 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.8 p -65.79 153.82 40.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.45 -1.03 . . . . 0.0 110.669 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.0 t -131.69 102.32 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.47 -0.769 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.94 141.02 28.84 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.844 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.97 15.07 28.37 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.365 -0.835 . . . . 0.0 110.407 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.55 -59.74 2.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.511 HG23 ' N ' ' A' ' 89' ' ' ALA . 12.7 t -77.37 -20.08 55.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.511 ' N ' HG23 ' A' ' 88' ' ' THR . . . -103.64 -163.2 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.887 . . . . 0.0 110.126 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.84 144.45 45.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.317 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.57 133.69 53.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.198 -0.939 . . . . 0.0 109.895 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -142.53 132.98 25.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 110.594 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 33' ' ' ILE . 16.5 tp -93.45 118.03 30.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.883 . . . . 0.0 109.247 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.569 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -112.43 152.04 17.95 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.447 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -148.59 134.53 19.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.585 -0.95 . . . . 0.0 109.872 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.53 165.65 32.47 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.781 -1.2 . . . . 0.0 110.145 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -83.58 -157.14 0.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -1.102 . . . . 0.0 110.088 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.7 t -82.11 -31.11 30.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 110.26 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.08 -15.32 4.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.32 125.35 46.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -1.159 . . . . 0.0 110.143 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 101' ' ' ASP . 3.9 p30 -109.33 115.9 30.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.159 -0.963 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 81.7 mt -80.48 -62.08 1.78 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.151 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.55 -179.03 42.29 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.445 -1.36 . . . . 0.0 110.512 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.569 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 1.5 m-70 -137.41 121.35 17.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.744 -0.856 . . . . 0.0 109.673 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.577 HG23 ' CE2' ' A' ' 4' ' ' PHE . 93.2 t -94.07 123.7 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 0.0 110.145 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.82 105.05 5.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 110.305 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 39.0 mt -78.5 132.25 37.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 110.164 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.06 149.71 39.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -110.27 169.4 8.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 110.198 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.563 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 1' ' ' ALA . 45.8 Cg_endo -72.64 -162.2 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.959 1.505 . . . . 0.0 109.906 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -111.2 129.77 55.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.32 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 5.5 t80 -148.73 112.16 5.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.233 -0.917 . . . . 0.0 109.589 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.19 148.96 28.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 111.0 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 p -107.01 174.55 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.45 -0.781 . . . . 0.0 109.525 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.657 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -81.97 -70.54 0.15 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.987 -1.071 . . . . 0.0 109.969 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.657 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 56.1 Cg_endo -83.15 91.12 0.94 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 O-C-N 122.972 0.985 . . . . 0.0 109.906 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.34 -1.52 55.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.891 -1.131 . . . . 0.0 110.687 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.0 m -138.28 118.88 13.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.196 -0.94 . . . . 0.0 109.979 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.46 72.88 1.13 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 109' ' ' PHE . 12.9 mt -95.3 167.41 11.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.327 -1.102 . . . . 0.0 110.41 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.54 ' HB2' ' CB ' ' A' ' 16' ' ' GLN . 51.7 m -115.42 140.75 48.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 110.358 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 14' ' ' ASP . 24.1 p30 -65.09 128.28 35.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.33 -0.856 . . . . 0.0 110.811 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.1 -26.77 6.53 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.54 ' CB ' ' HB2' ' A' ' 13' ' ' SER . 29.9 tt0 -62.2 149.08 42.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.126 . . . . 0.0 110.72 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -96.35 146.76 24.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.455 -0.778 . . . . 0.0 110.15 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.469 HG11 HG22 ' A' ' 67' ' ' VAL . 27.4 m -118.33 156.49 20.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.26 -0.9 . . . . 0.0 109.892 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.35 124.57 38.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.185 -0.947 . . . . 0.0 109.919 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.3 t -111.08 145.67 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.231 -0.918 . . . . 0.0 109.824 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.6 127.29 18.07 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.387 -0.821 . . . . 0.0 110.351 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 98.1 t -124.97 137.39 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.293 -0.88 . . . . 0.0 110.15 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 73.8 m -150.21 116.54 5.72 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.984 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 157.58 -64.78 0.3 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.481 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -52.82 -175.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -1.124 . . . . 0.0 110.018 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.525 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -150.88 150.01 30.37 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.014 -1.054 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -30.19 136.37 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.402 0.62 . . . . 0.0 111.237 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.415 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 108.12 11.22 24.55 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.476 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 69.4 mm-40 -142.25 118.59 10.84 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.266 -1.137 . . . . 0.0 110.695 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.416 HG21 ' O ' ' A' ' 53' ' ' PHE . 6.5 m -103.98 137.77 41.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.087 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 34.5 m-85 -123.36 166.11 15.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.969 -1.082 . . . . 0.0 111.171 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -121.65 110.13 15.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.537 -0.727 . . . . 0.0 109.597 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.541 ' CG2' HG21 ' A' ' 51' ' ' THR . 4.9 tt -87.88 113.09 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 110.327 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.81 166.17 28.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.716 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -127.92 140.84 51.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.472 -0.768 . . . . 0.0 110.021 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.6 m -138.21 165.85 25.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.937 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.97 153.93 33.69 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.641 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.71 167.45 25.65 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.796 1.419 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 42' ' ' GLN . 17.2 m -131.51 62.16 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.882 . . . . 0.0 110.118 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.67 5.09 49.57 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 163.75 -58.06 0.27 Allowed Glycine 0 N--CA 1.493 2.493 0 O-C-N 121.058 -1.26 . . . . 0.0 110.274 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.527 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 49.6 mt-30 -78.77 -163.25 0.45 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.19 -1.182 . . . . 0.0 110.456 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -133.16 139.34 47.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.853 . . . . 0.0 110.308 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.405 ' HB3' ' HA3' ' A' ' 73' ' ' GLY . . . -142.78 127.19 17.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.362 -0.836 . . . . 0.0 109.881 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 11.9 t -110.67 168.11 9.71 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.092 -1.005 . . . . 0.0 110.709 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 41.7 p-10 -108.54 102.26 46.6 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.346 -0.847 . . . . 0.0 110.636 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.67 -21.32 12.95 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.001 1.527 . . . . 0.0 110.742 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.19 -41.91 85.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.234 -0.916 . . . . 0.0 110.589 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.37 10.09 42.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.259 -0.901 . . . . 0.0 110.002 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.0 131.45 35.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 110.256 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.541 HG21 ' CG2' ' A' ' 33' ' ' ILE . 4.5 t -138.38 165.21 27.34 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.307 -0.871 . . . . 0.0 109.887 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m -127.79 146.6 50.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 110.744 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 35.1 p90 -140.16 -177.6 5.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 109.858 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.5 m -141.29 156.64 45.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.963 . . . . 0.0 110.058 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.481 ' CG2' ' HB3' ' A' ' 25' ' ' ALA . 17.2 p -67.28 -156.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.0 110.38 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -154.78 -162.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.954 . . . . 0.0 110.235 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.65 -55.49 34.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.268 -0.895 . . . . 0.0 109.416 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 p -78.32 4.15 13.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.432 -0.793 . . . . 0.0 109.353 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 66.11 46.55 79.56 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.99 162.78 20.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.107 -1.231 . . . . 0.0 110.242 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -159.11 83.87 0.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.179 -0.951 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 m -111.04 121.9 46.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.283 -0.885 . . . . 0.0 109.362 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 20.6 p90 -155.54 179.98 8.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 110.782 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.1 m -92.25 151.81 20.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.473 -0.767 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.455 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 56.3 t80 -142.48 179.36 7.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.538 -0.726 . . . . 0.0 109.112 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.455 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.4 t -133.08 154.96 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.741 -1.224 . . . . 0.0 110.415 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.469 HG22 HG11 ' A' ' 18' ' ' VAL . 29.7 m -138.01 164.82 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.436 -0.79 . . . . 0.0 109.808 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 8.0 mtt85 -141.22 126.02 18.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.918 . . . . 0.0 110.334 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.549 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 14.3 tttt -55.08 -40.68 70.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.832 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.3 p -130.25 134.48 47.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.385 -0.822 . . . . 0.0 109.735 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 17.2 p90 -144.94 153.28 41.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.116 -0.99 . . . . 0.0 110.636 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.3 m -73.94 124.78 26.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.265 -0.897 . . . . 0.0 110.247 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.431 ' HA3' HG22 ' A' ' 84' ' ' VAL . . . -77.24 159.41 48.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t -168.78 127.81 1.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -1.133 . . . . 0.0 110.004 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 74.9 p -63.09 160.47 38.97 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.979 . . . . 0.0 110.471 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.11 13.89 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.084 1.571 . . . . 0.0 110.806 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -111.28 -21.4 11.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.938 . . . . 0.0 110.304 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.31 18.43 5.83 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 53.4 m -112.48 121.1 39.77 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.214 -1.168 . . . . 0.0 110.244 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.25 -170.6 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.896 1.472 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 82' ' ' GLY . 7.7 p -173.83 -37.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.163 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.455 ' N ' HG13 ' A' ' 81' ' ' VAL . . . 158.85 -179.82 34.22 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.87 172.76 9.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -1.136 . . . . 0.0 110.014 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.431 HG22 ' HA3' ' A' ' 73' ' ' GLY . 82.6 t -134.45 146.05 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.234 -0.916 . . . . 0.0 110.163 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -134.66 125.49 27.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.006 . . . . 0.0 110.173 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 72.1 m -86.72 12.63 10.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.47 -58.28 8.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.816 . . . . 0.0 110.068 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -110.29 9.51 23.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.33 178.21 4.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.318 -0.864 . . . . 0.0 110.194 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.15 95.39 5.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 80.9 m -92.5 138.15 31.76 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.182 -0.949 . . . . 0.0 109.94 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -130.47 149.96 51.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.17 -0.956 . . . . 0.0 110.434 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 35' ' ' GLN . 0.3 OUTLIER -125.0 122.48 37.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 109.719 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.3 175.78 20.72 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.33 171.59 13.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -1.08 . . . . 0.0 110.12 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.81 165.06 10.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.69 -104.24 0.3 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -1.194 . . . . 0.0 110.622 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.42 -84.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.937 -1.102 . . . . 0.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.1 52.64 0.82 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.53 HD22 ' CE1' ' A' ' 31' ' ' TYR . 4.4 tt -115.21 -58.94 2.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.207 -1.172 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.5 t0 50.83 101.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.403 -0.811 . . . . 0.0 110.251 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.469 HD11 ' CD1' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -73.86 -67.72 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -161.68 179.28 37.17 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -148.04 117.17 6.84 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.357 -1.084 . . . . 0.0 110.03 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.1 136.09 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.69 118.62 23.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.233 -0.917 . . . . 0.0 110.183 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.469 ' CD2' HD12 ' A' ' 12' ' ' LEU . 48.6 mt -90.05 134.1 34.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -112.43 166.51 11.24 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.549 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 2.5 m-85 -152.72 71.44 0.93 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.496 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.5 Cg_endo -70.46 -160.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.83 1.437 . . . . 0.0 110.493 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.32 148.9 30.07 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.086 -1.009 . . . . 0.0 111.196 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.433 ' CB ' ' HB3' ' A' ' 102' ' ' LEU . 24.2 t80 -151.5 102.67 2.91 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 109.633 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.07 158.45 43.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.927 -1.108 . . . . 0.0 111.002 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 p -126.77 138.81 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 109.76 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.593 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -62.49 -66.17 1.71 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.127 -0.983 . . . . 0.0 110.499 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 53.1 Cg_endo -76.96 74.18 5.09 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 O-C-N 123.493 1.259 . . . . 0.0 110.48 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.41 -0.64 57.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.986 -1.071 . . . . 0.0 110.236 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.7 t -150.88 150.7 31.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 109.974 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.65 60.96 6.35 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 8' ' ' PRO . 5.1 mt -102.61 154.39 19.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.251 -1.147 . . . . 0.0 110.132 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 73.3 m -109.35 155.78 20.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.149 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 32.7 t0 -64.49 127.84 33.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.057 -1.027 . . . . 0.0 110.612 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.49 -30.4 5.3 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.488 ' HB3' ' O ' ' A' ' 13' ' ' SER . 5.1 tp60 -46.78 145.66 1.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -1.116 . . . . 0.0 110.162 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.38 133.42 42.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.383 -0.823 . . . . 0.0 109.523 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.545 ' CG2' ' HB3' ' A' ' 65' ' ' PHE . 18.0 m -98.0 172.94 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.093 -1.004 . . . . 0.0 110.027 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.4 m -124.09 114.14 19.3 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 t -102.19 151.5 5.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 O-C-N 121.482 -0.761 . . . . 0.0 109.732 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.0 135.29 27.3 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.334 -0.854 . . . . 0.0 110.435 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.504 ' HB ' ' CB ' ' A' ' 61' ' ' ALA . 58.6 t -126.14 137.81 56.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.513 -0.742 . . . . 0.0 109.472 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.3 m -140.6 127.7 20.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.075 -1.016 . . . . 0.0 110.637 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 129.92 -48.69 0.96 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.552 ' CB ' HG23 ' A' ' 55' ' ' THR . . . -57.45 -158.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -1.158 . . . . 0.0 109.345 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.583 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -170.95 149.99 3.05 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.596 -1.315 . . . . 0.0 111.818 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -40.12 141.98 0.42 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.438 0.637 . . . . 0.0 110.166 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.05 10.71 36.18 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.435 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 2.5 mm-40 -137.76 133.65 34.34 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.355 -1.085 . . . . 0.0 109.757 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 52.6 m -112.0 152.77 27.74 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.211 -0.93 . . . . 0.0 109.908 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.619 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 17.2 m-85 -135.26 159.46 41.47 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 109.809 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -119.39 105.91 11.75 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.24 -0.913 . . . . 0.0 110.044 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 33' ' ' ILE . 9.4 tt -95.12 125.42 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 109.86 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.458 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -137.85 148.02 45.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.888 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -116.76 126.63 53.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.441 -0.787 . . . . 0.0 109.571 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 72.7 m -145.21 173.08 12.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -0.99 . . . . 0.0 110.923 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.45 160.27 32.08 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.529 -0.732 . . . . 0.0 109.506 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.29 163.58 38.19 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.744 1.392 . . . . 0.0 111.208 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 2.4 p -141.63 68.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.524 -0.735 . . . . 0.0 110.288 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.62 48.58 12.74 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.6 -33.37 4.62 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.462 ' HB2' ' CG1' ' A' ' 39' ' ' VAL . 4.3 mt-30 -80.55 -160.29 0.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.452 -1.028 . . . . 0.0 109.522 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.404 ' HB2' ' HG3' ' A' ' 76' ' ' PRO . 3.2 m-20 -141.55 140.77 33.49 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.045 -1.034 . . . . 0.0 110.694 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -130.29 159.2 37.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.238 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.59 154.55 48.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.953 -1.092 . . . . 0.0 111.186 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.568 ' OD1' ' CZ ' ' A' ' 71' ' ' TYR . 3.7 m120 -94.55 107.91 33.27 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.603 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.53 -33.3 8.77 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.902 1.475 . . . . 0.0 110.074 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.65 -6.63 27.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.362 -0.836 . . . . 0.0 110.175 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.407 ' OG1' ' CB ' ' A' ' 46' ' ' ASN . 53.0 p -120.29 -6.95 9.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.106 -0.996 . . . . 0.0 110.383 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.81 125.62 25.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.208 -0.933 . . . . 0.0 110.078 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.7 t -170.46 168.94 7.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.141 -0.975 . . . . 0.0 110.596 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.8 p -129.2 154.95 46.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 29.1 p90 -137.4 148.17 45.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.292 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.2 m -103.0 154.81 18.86 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.343 -0.848 . . . . 0.0 110.298 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.564 HG21 ' CE1' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -62.66 -156.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.27 -0.894 . . . . 0.0 110.544 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -142.84 -164.92 1.94 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.03 -1.044 . . . . 0.0 109.99 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.66 -52.51 64.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 108.975 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 p -84.17 12.77 5.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.515 -0.741 . . . . 0.0 109.073 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.583 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 67.93 12.79 63.05 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.38 108.95 19.93 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.272 -1.134 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.504 ' CB ' ' HB ' ' A' ' 22' ' ' VAL . . . -97.22 87.85 4.29 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.353 -0.842 . . . . 0.0 110.244 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.18 115.48 28.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.42 -0.8 . . . . 0.0 109.474 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.629 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 7.9 p90 -144.64 177.23 8.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.047 -1.033 . . . . 0.0 111.191 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -102.4 122.22 43.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.634 -0.666 . . . . 0.0 110.837 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.545 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 68.4 t80 -106.83 -177.18 3.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 109.043 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.2 t -135.2 155.31 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.745 -1.222 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 66' ' ' VAL . 33.1 m -141.3 174.56 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.493 -0.755 . . . . 0.0 109.486 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 5.0 mtt180 -155.9 126.51 6.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.993 -1.067 . . . . 0.0 110.805 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 8.5 ttpt -49.76 -46.13 50.28 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.205 -0.935 . . . . 0.0 109.449 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.0 m -128.62 156.45 43.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.587 -0.695 . . . . 0.0 109.165 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.568 ' CZ ' ' OD1' ' A' ' 46' ' ' ASN . 37.0 p90 -167.89 143.76 3.92 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.775 -1.203 . . . . 0.0 110.984 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 23.8 m -65.52 141.21 58.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.138 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.82 174.58 22.3 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.62 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 p -134.73 -149.8 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.713 -0.875 . . . . 0.0 109.005 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 79' ' ' THR . 46.1 p -112.03 161.4 26.02 Favored Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 121.069 -1.019 . . . . 0.0 110.255 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.458 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 51.7 Cg_endo -86.57 25.84 0.66 Allowed 'Trans proline' 0 C--N 1.3 -2.022 0 O-C-N 124.165 1.613 . . . . 0.0 110.661 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -155.14 16.69 0.42 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.996 -1.065 . . . . 0.0 111.504 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.486 ' O ' ' OG1' ' A' ' 79' ' ' THR . . . 88.48 74.22 1.28 Allowed Glycine 0 N--CA 1.498 2.825 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.286 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.526 ' O ' ' CG2' ' A' ' 75' ' ' THR . 4.0 m -172.53 127.6 0.55 Allowed Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.41 -1.053 . . . . 0.0 109.481 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -80.38 146.72 17.61 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.739 1.389 . . . . 0.0 110.592 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.3 m -132.64 -33.91 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.358 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.14 -152.61 20.63 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER -94.11 157.89 15.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -1.165 . . . . 0.0 110.524 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.441 HG23 ' CB ' ' A' ' 44' ' ' ALA . 97.8 t -116.93 152.5 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.403 -0.81 . . . . 0.0 109.997 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.25 127.49 39.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.084 -1.01 . . . . 0.0 110.029 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 4.2 t -84.07 -11.16 57.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.215 -0.928 . . . . 0.0 110.451 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.13 90.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 110.27 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.4 t -86.82 2.27 49.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.218 -0.926 . . . . 0.0 110.169 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.56 -140.13 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.21 159.02 44.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.303 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 55.7 m -119.94 141.06 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.95 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -133.36 135.4 44.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.466 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.458 HD11 ' O ' ' A' ' 34' ' ' ALA . 18.9 tp -109.76 120.13 41.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.848 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.487 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . -111.18 166.35 12.26 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -160.56 173.72 15.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -1.144 . . . . 0.0 110.024 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.13 -176.81 16.28 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -139.33 -150.69 0.34 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -1.072 . . . . 0.0 110.041 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.81 40.32 1.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 110.153 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -147.11 -43.48 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 69.7 mt -103.27 -153.74 0.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -1.166 . . . . 0.0 110.077 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -170.58 117.26 0.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 110.31 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.433 ' HB3' ' CB ' ' A' ' 4' ' ' PHE . 18.9 mt -118.56 -49.36 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.0 110.09 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.03 -150.71 17.82 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.574 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 3.6 p80 -146.89 136.93 23.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -1.11 . . . . 0.0 110.417 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.3 t -85.06 113.16 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.416 -0.803 . . . . 0.0 110.112 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.05 94.3 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -0.86 . . . . 0.0 110.112 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.88 162.02 14.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.315 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.54 152.41 46.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 3.3 m-85 -127.45 75.68 1.61 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.858 . . . . 0.0 110.005 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 CA-C-O 117.961 -1.466 . . . . 0.0 109.596 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.461 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.0 Cg_endo -71.24 -159.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.117 1.588 . . . . 0.0 110.481 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -148.63 127.43 12.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.974 . . . . 0.0 110.432 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -142.08 106.3 4.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.369 -0.832 . . . . 0.0 109.471 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.2 t -150.25 154.14 37.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.961 -1.087 . . . . 0.0 111.247 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.506 ' CG1' HG13 ' A' ' 105' ' ' VAL . 13.4 p -119.05 156.9 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.647 -0.658 . . . . 0.0 109.448 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.592 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -77.04 -65.89 0.36 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.926 -1.109 . . . . 0.0 110.217 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 52.7 Cg_endo -76.2 74.97 4.4 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.607 1.32 . . . . 0.0 110.221 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.53 -16.79 60.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.028 -1.045 . . . . 0.0 110.243 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.2 p -138.8 166.26 24.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.072 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.95 48.91 61.93 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 8' ' ' PRO . 20.7 mt -95.04 166.9 11.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -1.105 . . . . 0.0 110.242 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.05 152.43 45.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.286 -0.884 . . . . 0.0 110.346 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -63.67 117.23 6.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.83 -30.41 9.39 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -52.52 155.09 2.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.342 -1.093 . . . . 0.0 110.27 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.23 138.03 43.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 0.0 110.115 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 65' ' ' PHE . 17.1 m -103.81 153.56 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 109.859 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -95.61 111.34 23.29 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.491 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 t -104.87 151.61 7.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.46 -0.775 . . . . 0.0 110.049 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 34.2 t -149.82 133.11 16.45 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.445 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 53.2 t -123.75 146.59 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.527 -0.733 . . . . 0.0 109.992 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 2.3 p -162.56 120.22 2.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.118 -0.989 . . . . 0.0 110.282 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 149.39 -55.87 0.48 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.447 ' C ' ' HA3' ' A' ' 59' ' ' GLY . . . -63.92 -139.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.157 -1.202 . . . . 0.0 110.097 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.485 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.66 175.57 5.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.223 -0.923 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -65.2 131.74 47.31 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.493 -0.755 . . . . 0.0 110.666 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.6 6.85 7.76 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 2.6 mt-10 -132.0 106.09 7.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -1.199 . . . . 0.0 110.551 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 57.5 m -90.44 123.28 34.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.278 -0.889 . . . . 0.0 109.812 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 29' ' ' GLU . 59.6 m-85 -107.42 161.59 14.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 111.059 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -113.48 112.51 23.72 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.392 -0.817 . . . . 0.0 109.602 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.51 ' CG2' HG21 ' A' ' 51' ' ' THR . 4.5 tt -93.94 106.31 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.124 -0.985 . . . . 0.0 110.635 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 93' ' ' LEU . . . -142.23 168.53 19.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.381 -0.825 . . . . 0.0 109.772 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 9.8 pt20 -132.71 151.52 51.95 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 110.385 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.72 157.33 44.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 110.558 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -151.56 157.35 34.76 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.274 -0.891 . . . . 0.0 110.499 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 90' ' ' ALA . 43.3 Cg_endo -69.5 174.99 8.48 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.942 1.496 . . . . 0.0 110.22 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -141.15 58.37 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.072 -1.018 . . . . 0.0 110.845 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.16 -23.86 5.82 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.77 -49.36 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -88.18 -150.98 0.19 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -1.104 . . . . 0.0 110.043 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 11.7 p-10 -149.07 149.14 30.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.944 . . . . 0.0 110.39 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.484 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -136.12 155.35 50.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.426 -0.796 . . . . 0.0 109.7 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.454 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.1 m -126.28 151.47 47.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.211 -0.93 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.464 ' ND2' ' HB2' ' A' ' 71' ' ' TYR . 47.6 t-20 -97.16 108.5 44.5 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.15 -0.969 . . . . 0.0 110.243 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 49.9 Cg_endo -81.79 -33.96 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.919 1.484 . . . . 0.0 110.484 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.97 50.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 110.313 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 p -79.67 -3.05 45.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.262 -0.899 . . . . 0.0 110.064 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 47' ' ' PRO . . . -72.72 81.66 1.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.868 . . . . 0.0 110.5 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.51 HG21 ' CG2' ' A' ' 33' ' ' ILE . 4.2 t -100.26 174.49 6.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.291 -0.881 . . . . 0.0 109.883 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.65 122.34 15.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 110.304 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.494 ' C ' ' CD1' ' A' ' 53' ' ' PHE . 5.0 p90 -116.5 -175.01 2.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.912 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 7.2 m -134.69 143.35 47.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.961 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.513 HG21 ' CA ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -57.33 -155.94 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.136 -0.977 . . . . 0.0 110.299 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -145.49 -156.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.077 -1.015 . . . . 0.0 110.176 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.57 -61.89 2.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.028 -1.045 . . . . 0.0 109.909 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 52.7 p -87.94 28.5 1.03 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.242 -0.911 . . . . 0.0 109.325 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.513 ' CA ' HG21 ' A' ' 55' ' ' THR . . . 55.88 28.3 52.54 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -93.45 117.29 29.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.375 -1.074 . . . . 0.0 110.136 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.427 ' CB ' ' HB ' ' A' ' 22' ' ' VAL . . . -124.81 83.41 2.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 0.0 110.113 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -109.23 123.15 48.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.875 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 9.4 p90 -155.68 174.72 14.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.601 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.69 114.03 26.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.394 -0.816 . . . . 0.0 110.38 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.493 ' HB3' HG22 ' A' ' 18' ' ' VAL . 41.3 t80 -99.12 176.83 5.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.409 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.1 t -130.42 153.87 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.967 -1.083 . . . . 0.0 109.924 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.2 143.82 27.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.359 -0.838 . . . . 0.0 110.093 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -120.02 129.74 54.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 110.088 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -52.6 -35.91 55.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.905 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.3 p -131.35 143.37 50.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.936 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.464 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 22.7 p90 -145.16 153.0 40.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.17 -0.956 . . . . 0.0 110.511 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 9.2 m -72.18 124.43 25.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.305 -0.872 . . . . 0.0 109.847 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 74' ' ' SER . . . -99.19 171.87 24.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 5.6 p 175.26 130.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -1.09 . . . . 0.0 109.869 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 79' ' ' THR . 32.5 p -84.04 149.22 55.55 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.164 -0.96 . . . . 0.0 110.604 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.6 -21.28 5.2 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.284 1.676 . . . . 0.0 110.333 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.17 -66.23 0.62 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.345 -0.847 . . . . 0.0 110.365 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.452 ' O ' ' OG1' ' A' ' 79' ' ' THR . . . 172.0 67.3 0.04 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.474 ' O ' ' OG1' ' A' ' 75' ' ' THR . 57.1 m -166.3 92.07 0.8 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.396 -1.061 . . . . 0.0 109.853 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.58 79.46 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.06 1.558 . . . . 0.0 110.475 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.8 m -49.22 -44.11 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.365 -0.835 . . . . 0.0 110.056 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.85 -159.07 13.89 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 5.0 p -58.25 169.77 0.8 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -1.13 . . . . 0.0 110.139 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.484 HG21 ' CB ' ' A' ' 44' ' ' ALA . 45.7 t -150.87 133.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -109.21 141.59 41.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.937 . . . . 0.0 110.1 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.0 m -115.0 -3.8 12.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.199 -0.938 . . . . 0.0 110.143 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.19 -56.97 14.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 110.066 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 t -89.14 -16.41 31.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 110.05 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.46 -175.2 3.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 110.18 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.494 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -96.43 140.98 30.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -0.907 . . . . 0.0 110.325 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.43 ' C ' ' OD1' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -139.5 126.86 21.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.355 -0.841 . . . . 0.0 110.033 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.43 ' OD1' ' C ' ' A' ' 91' ' ' CYS . 31.9 m-20 -129.3 147.2 51.11 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 110.291 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.518 ' CD1' ' O ' ' A' ' 34' ' ' ALA . 14.3 tp -112.72 109.67 19.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.618 ' CA ' ' CD2' ' A' ' 104' ' ' HIS . . . -105.14 153.26 17.31 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.312 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.89 167.44 22.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.478 -1.013 . . . . 0.0 109.713 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.515 ' HA2' ' CD1' ' A' ' 31' ' ' TYR . . . 118.85 -175.7 15.81 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 100' ' ' LEU . 20.7 p-10 -137.8 -142.25 0.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -1.195 . . . . 0.0 110.433 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -102.78 -34.84 8.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.303 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.42 -30.69 64.23 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.464 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 6.0 tt -146.88 131.2 17.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -1.146 . . . . 0.0 110.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -96.88 138.48 34.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -0.993 . . . . 0.0 110.087 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.509 HD13 ' CG ' ' A' ' 31' ' ' TYR . 16.4 mt -97.56 -81.15 0.43 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.273 -0.892 . . . . 0.0 110.295 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 174.99 163.13 27.61 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.618 ' CD2' ' CA ' ' A' ' 94' ' ' GLY . 41.5 m170 -119.13 123.95 45.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.993 . . . . 0.0 110.069 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.506 HG13 ' CG1' ' A' ' 6' ' ' VAL . 31.5 t -102.68 115.51 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.111 -0.993 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.51 127.26 32.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.297 -0.877 . . . . 0.0 110.162 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.1 mt -98.42 169.52 9.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.335 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.3 m -155.26 160.36 40.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -132.66 105.33 7.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 0.0 110.135 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.431 179.949 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 120.748 0.309 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.461 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 45.8 Cg_endo -73.8 176.51 9.31 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.043 1.549 . . . . 0.0 110.407 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.47 ' HB1' ' OG ' ' A' ' 23' ' ' SER . . . -147.0 151.2 36.58 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.172 -0.955 . . . . 0.0 110.747 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.493 ' CE1' ' CB ' ' A' ' 95' ' ' ALA . 76.9 t80 -149.98 116.72 5.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 110.022 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.64 149.72 31.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.073 -1.017 . . . . 0.0 110.611 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.523 HG11 ' CG1' ' A' ' 105' ' ' VAL . 4.3 p -130.87 139.0 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.923 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -69.76 -62.5 2.39 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.048 -1.032 . . . . 0.0 110.182 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 49.4 Cg_endo -74.32 77.51 2.85 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.837 1.441 . . . . 0.0 110.468 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.69 -5.63 57.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.114 -0.991 . . . . 0.0 110.13 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.0 p -151.62 166.45 31.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 110.241 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.8 52.46 48.24 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.477 ' CD2' HG12 ' A' ' 18' ' ' VAL . 1.4 mt -102.51 172.87 6.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.146 -1.208 . . . . 0.0 110.055 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -143.71 149.85 37.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 110.387 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 3.7 p30 -58.0 123.95 17.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.325 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.97 -34.81 4.56 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 0.9 OUTLIER -50.96 156.41 1.01 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -1.134 . . . . 0.0 109.815 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.95 137.83 47.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.634 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.477 HG12 ' CD2' ' A' ' 12' ' ' LEU . 16.5 m -107.66 175.41 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.424 -0.797 . . . . 0.0 110.131 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 6' ' ' VAL . 3.6 p -120.78 118.92 31.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 109.996 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.47 HG11 ' N ' ' A' ' 21' ' ' SER . 20.8 t -110.31 151.79 12.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.244 -0.91 . . . . 0.0 110.067 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.47 ' N ' HG11 ' A' ' 20' ' ' VAL . 15.7 m -143.12 128.16 18.51 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 110.31 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 61' ' ' ALA . 30.7 t -121.26 145.65 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 109.824 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.47 ' OG ' ' HB1' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -151.43 139.4 20.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 110.382 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 120.17 -75.34 0.32 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.535 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -49.54 126.7 14.0 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.179 -1.189 . . . . 0.0 109.563 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -97.08 165.65 11.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.111 -0.993 . . . . 0.0 111.092 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 56' ' ' ASP . . . -44.23 139.85 2.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.545 0.688 . . . . 0.0 110.568 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.92 9.22 8.34 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 50.4 mm-40 -147.65 121.84 9.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.119 -1.224 . . . . 0.0 110.406 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.459 ' OG1' ' OG1' ' A' ' 54' ' ' THR . 80.6 m -104.43 125.63 50.81 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.436 -0.79 . . . . 0.0 109.49 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 17.0 m-85 -110.01 176.94 4.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.09 -1.006 . . . . 0.0 110.434 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 12.5 m-85 -126.51 112.85 16.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.301 -0.874 . . . . 0.0 110.488 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.469 ' CG2' ' O ' ' A' ' 33' ' ' ILE . 13.0 tt -98.5 103.65 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 0.0 109.933 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . . . -138.56 169.33 17.98 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.294 -0.879 . . . . 0.0 110.651 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.529 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 34.1 mt-30 -106.07 155.47 19.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.423 -0.798 . . . . 0.0 110.334 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 98.1 m -150.69 148.52 28.68 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.219 -0.926 . . . . 0.0 110.471 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.548 ' CB ' ' HB3' ' A' ' 91' ' ' CYS . . . -151.76 165.83 16.57 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.02 175.51 11.15 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.99 1.521 . . . . 0.0 110.391 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.68 58.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.264 -0.898 . . . . 0.0 110.157 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.14 -6.64 34.35 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 179.66 -56.28 0.08 OUTLIER Glycine 0 N--CA 1.493 2.451 0 O-C-N 120.823 -1.398 . . . . 0.0 109.921 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -85.21 -167.24 1.76 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -1.168 . . . . 0.0 110.44 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -118.72 166.72 12.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.373 -0.829 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.09 157.87 39.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 110.399 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 m -140.48 163.05 33.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.184 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.542 ' ND2' ' CD1' ' A' ' 71' ' ' TYR . 0.7 OUTLIER -81.54 123.91 80.5 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 110.358 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 48.8 Cg_endo -84.74 -72.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.931 1.49 . . . . 0.0 110.621 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.15 -62.89 1.52 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.206 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.509 ' OG1' ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -46.47 -22.54 0.28 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.444 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -62.83 105.38 0.66 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.031 . . . . 0.0 109.816 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 51' ' ' THR . 6.5 t -110.47 141.42 43.6 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.234 -0.916 . . . . 0.0 110.442 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.477 ' HB3' ' CD2' ' A' ' 32' ' ' TYR . 48.9 p -106.88 119.11 38.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 109.888 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 53.1 p90 -106.46 -178.06 3.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.034 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.459 ' OG1' ' OG1' ' A' ' 30' ' ' THR . 6.4 m -139.05 145.44 39.59 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.939 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.535 HG21 ' CB ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -57.17 -158.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.147 -0.97 . . . . 0.0 109.851 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -145.43 -161.78 1.37 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.881 -1.137 . . . . 0.0 110.448 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.81 -48.98 79.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.087 -1.008 . . . . 0.0 109.164 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p -87.03 13.82 8.56 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.515 -0.74 . . . . 0.0 109.099 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 57.27 30.31 61.08 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.02 118.91 37.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -1.094 . . . . 0.0 109.863 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.452 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . . . -118.81 81.2 1.66 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.511 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.9 m -110.61 122.65 48.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.304 -0.873 . . . . 0.0 109.293 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 12.3 p90 -157.31 179.1 9.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.024 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.09 138.04 31.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 110.726 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 73.9 t80 -123.14 178.62 5.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -0.795 . . . . 0.0 109.182 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.557 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 5.2 t -123.05 159.44 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.806 -1.184 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 67' ' ' VAL . 30.9 m -137.96 124.69 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.393 -0.817 . . . . 0.0 110.099 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 9.5 mmm-85 -115.85 123.85 49.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.53 -59.93 3.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -0.978 . . . . 0.0 109.204 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 p -108.41 126.44 52.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.306 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.542 ' CD1' ' ND2' ' A' ' 46' ' ' ASN . 50.0 p90 -140.31 163.91 31.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 110.485 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.09 123.87 21.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.637 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 74' ' ' SER . . . -98.21 166.42 22.13 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 89.5 p -178.56 130.02 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.39 -1.064 . . . . 0.0 109.599 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 79' ' ' THR . 55.0 p -43.0 153.41 0.34 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.214 -0.929 . . . . 0.0 110.388 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.97 0.07 9.34 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 124.112 1.585 . . . . 0.0 110.309 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -93.58 -52.66 4.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.326 -0.859 . . . . 0.0 110.186 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.13 -24.27 0.19 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.458 ' O ' ' OG1' ' A' ' 75' ' ' THR . 4.1 m -70.44 132.71 87.46 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.098 -1.236 . . . . 0.0 110.292 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.7 141.06 27.11 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.892 1.469 . . . . 0.0 109.755 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.6 p -117.73 -4.96 11.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 120.987 -1.071 . . . . 0.0 110.168 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.1 -155.13 16.22 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.06 174.85 6.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -1.128 . . . . 0.0 110.389 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.435 HG21 ' HA3' ' A' ' 73' ' ' GLY . 49.1 t -144.15 154.63 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 110.13 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -134.58 131.57 38.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 110.064 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 32.7 m -92.97 33.23 1.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.878 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.15 -61.09 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 110.39 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.439 HG23 ' N ' ' A' ' 89' ' ' ALA . 5.0 t -87.67 -23.05 24.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.331 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.439 ' N ' HG23 ' A' ' 88' ' ' THR . . . -107.58 -178.32 3.59 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 110.096 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -123.82 148.81 46.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.181 -0.949 . . . . 0.0 110.12 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.548 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -126.85 133.78 50.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.026 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 5.7 m-20 -99.9 147.22 25.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 110.107 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.498 HD11 ' CG ' ' A' ' 35' ' ' GLN . 15.8 tp -106.7 110.96 23.28 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.1 -1.0 . . . . 0.0 109.52 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -112.65 153.43 17.48 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.493 ' CB ' ' CE1' ' A' ' 4' ' ' PHE . . . -133.29 104.87 6.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.428 -1.042 . . . . 0.0 110.122 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.58 174.17 46.41 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.452 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 5.5 p-10 -114.0 -156.84 0.61 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -1.156 . . . . 0.0 110.357 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -91.99 52.6 2.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 110.184 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 174.4 -32.03 0.1 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.452 ' HB2' ' OD1' ' A' ' 97' ' ' ASN . 0.6 OUTLIER -117.38 86.03 2.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -1.169 . . . . 0.0 110.297 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.53 116.31 22.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.941 . . . . 0.0 109.984 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.8 mt -81.94 -74.6 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.322 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.13 173.58 41.66 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.486 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 9.8 m-70 -136.69 122.62 20.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.584 -0.951 . . . . 0.0 110.111 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.523 ' CG1' HG11 ' A' ' 6' ' ' VAL . 17.2 t -112.23 107.45 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.072 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . . . -57.71 147.09 28.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 110.505 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.529 ' CD1' ' OE1' ' A' ' 35' ' ' GLN . 29.7 mt -116.18 141.56 47.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 109.984 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -110.82 165.55 11.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 110.34 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -139.95 97.51 3.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.24 -0.913 . . . . 0.0 110.321 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.526 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.526 ' CD ' ' CB ' ' A' ' 1' ' ' ALA . 43.9 Cg_endo -72.43 -159.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 124.002 1.527 . . . . 0.0 110.361 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -123.89 128.72 49.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.182 -0.949 . . . . 0.0 110.445 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.427 ' HB2' HD23 ' A' ' 102' ' ' LEU . 85.4 t80 -149.63 104.46 3.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.677 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.532 ' HA ' HG21 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -149.8 157.37 43.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.899 -1.126 . . . . 0.0 111.496 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.404 ' CG1' HG13 ' A' ' 105' ' ' VAL . 9.3 p -106.18 139.85 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.399 -0.813 . . . . 0.0 109.312 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.623 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 m -53.82 -72.4 0.19 Allowed Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 120.828 -1.17 . . . . 0.0 110.002 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.623 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 56.7 Cg_endo -80.13 79.37 3.36 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 O-C-N 122.956 0.977 . . . . 0.0 109.952 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.43 -20.97 61.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.846 -1.159 . . . . 0.0 109.999 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t -134.51 141.11 46.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.325 -0.86 . . . . 0.0 110.043 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.91 61.21 1.29 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 8' ' ' PRO . 3.5 mt -117.21 169.53 9.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.162 -1.199 . . . . 0.0 110.232 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 4.2 t -124.65 158.95 31.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 110.286 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.16 124.97 22.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.216 -0.927 . . . . 0.0 110.188 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 89.45 -29.45 6.17 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 13' ' ' SER . 28.9 tp60 -43.81 156.25 0.07 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.324 -1.104 . . . . 0.0 110.447 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.437 ' N ' ' HG3' ' A' ' 16' ' ' GLN . 1.8 m -107.16 134.92 49.56 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.448 -0.783 . . . . 0.0 109.315 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.466 HG21 HG12 ' A' ' 67' ' ' VAL . 32.7 m -110.97 153.93 12.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.801 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -105.97 121.37 43.97 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.973 -1.08 . . . . 0.0 110.237 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.6 t -97.1 151.82 4.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.581 -0.7 . . . . 0.0 109.223 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 t -142.46 121.25 12.69 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 121.281 -0.887 . . . . 0.0 109.857 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 61' ' ' ALA . 33.9 t -116.11 142.74 28.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 110.065 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.1 OUTLIER -160.38 105.17 1.47 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 110.254 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 157.3 -47.79 0.46 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.47 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . . . -59.41 -147.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.419 -1.047 . . . . 0.0 109.485 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -172.42 165.89 5.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.76 -1.213 . . . . 0.0 111.037 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -48.36 138.58 9.83 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.592 0.711 . . . . 0.0 110.782 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.07 25.49 12.74 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.535 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 2.3 mt-10 -141.07 105.95 4.94 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.203 -1.175 . . . . 0.0 110.375 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.7 m -103.73 151.31 23.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.822 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 46.6 m-85 -140.24 165.97 25.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.296 -0.877 . . . . 0.0 110.188 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 23.5 m-85 -112.66 109.77 19.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -0.901 . . . . 0.0 109.851 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.548 ' CG2' HG21 ' A' ' 51' ' ' THR . 3.2 tt -89.5 111.72 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.059 -1.026 . . . . 0.0 110.162 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 93' ' ' LEU . . . -144.05 159.45 42.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.468 -0.77 . . . . 0.0 110.247 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.455 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 14.6 tt0 -112.94 148.12 35.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.342 -0.849 . . . . 0.0 110.515 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 62.9 m -153.54 162.23 41.47 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.376 -0.827 . . . . 0.0 110.225 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.416 ' HB2' HG11 ' A' ' 84' ' ' VAL . . . -150.64 160.27 32.9 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.235 -0.915 . . . . 0.0 110.288 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.54 172.34 16.37 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.781 1.411 . . . . 0.0 110.343 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.59 ' CG2' ' CB ' ' A' ' 42' ' ' GLN . 33.4 m -149.94 65.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.233 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.59 41.26 90.12 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.04 -38.13 3.46 Favored Glycine 0 N--CA 1.487 2.061 0 O-C-N 121.025 -1.279 . . . . 0.0 110.001 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.59 ' CB ' ' CG2' ' A' ' 39' ' ' VAL . 1.1 mt-30 -80.41 -172.42 3.53 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.26 -1.141 . . . . 0.0 109.62 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -136.15 135.54 39.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.046 -1.034 . . . . 0.0 110.348 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.43 159.35 32.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.691 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.462 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.3 m -144.76 157.07 44.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.145 -0.972 . . . . 0.0 110.385 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.418 ' ND2' ' OG1' ' A' ' 49' ' ' THR . 3.2 t-20 -96.27 109.92 49.83 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.204 -0.935 . . . . 0.0 110.288 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 50.8 Cg_endo -86.92 -42.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.894 1.47 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.41 66.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.401 -0.812 . . . . 0.0 110.855 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.418 ' OG1' ' ND2' ' A' ' 46' ' ' ASN . 18.0 p -113.47 31.5 6.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.059 -1.025 . . . . 0.0 110.374 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.48 131.72 36.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.548 HG21 ' CG2' ' A' ' 33' ' ' ILE . 7.0 t -148.65 170.24 18.58 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.252 -0.905 . . . . 0.0 110.235 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 31' ' ' TYR . 43.7 t -135.6 166.99 21.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.068 -1.02 . . . . 0.0 110.983 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 16.3 p90 -148.91 -177.08 5.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.467 -0.771 . . . . 0.0 109.832 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.6 m -144.21 166.85 23.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.058 -1.026 . . . . 0.0 110.268 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.465 ' CG2' ' HB1' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -86.98 -156.94 0.35 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.239 -0.913 . . . . 0.0 110.416 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -144.36 -163.75 1.75 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.781 -1.199 . . . . 0.0 109.931 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.5 77.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.134 -0.979 . . . . 0.0 109.441 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.6 p -88.03 15.48 7.29 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.405 -0.81 . . . . 0.0 108.848 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.526 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 65.23 16.91 63.11 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.15 122.24 32.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.091 -1.241 . . . . 0.0 109.901 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . . . -132.96 85.22 2.2 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.179 -0.951 . . . . 0.0 110.386 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.62 129.02 49.07 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.525 -0.735 . . . . 0.0 109.196 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 6.0 p90 -161.02 179.9 8.07 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.14 -0.975 . . . . 0.0 110.571 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 m -108.29 144.62 35.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.297 -0.877 . . . . 0.0 111.548 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 36.5 t80 -135.71 166.09 24.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.58 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 3.6 t -106.85 154.95 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.607 -1.308 . . . . 0.0 110.963 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.466 HG12 HG21 ' A' ' 18' ' ' VAL . 25.4 m -140.73 158.66 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.531 -0.731 . . . . 0.0 109.958 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.18 148.48 41.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 110.578 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -72.89 -52.84 13.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -124.51 150.17 46.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.152 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 71' ' ' TYR . 45.6 p90 -161.1 132.1 5.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.03 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 99.6 m -57.37 119.63 6.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.484 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.41 -178.05 31.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.33 140.41 12.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.111 -1.229 . . . . 0.0 110.411 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 25.6 p -48.08 167.19 0.19 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.432 -0.792 . . . . 0.0 110.279 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 41.5 Cg_endo -67.1 -12.78 37.35 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.785 1.413 . . . . 0.0 110.644 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -86.36 -15.71 39.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 109.946 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.62 26.86 8.33 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.428 HG22 ' HD2' ' A' ' 80' ' ' PRO . 29.2 m -113.16 132.25 22.49 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.336 -1.097 . . . . 0.0 110.389 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' A' ' 79' ' ' THR . 47.3 Cg_endo -74.61 127.96 11.4 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.936 1.493 . . . . 0.0 110.395 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.431 HG11 ' N ' ' A' ' 82' ' ' GLY . 14.5 p -122.59 -35.94 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 109.98 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.431 ' N ' HG11 ' A' ' 81' ' ' VAL . . . -175.08 157.77 24.94 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 58.6 p -78.13 157.63 29.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -1.167 . . . . 0.0 110.231 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 37' ' ' ALA . 20.9 t -106.68 164.2 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.291 -0.881 . . . . 0.0 110.425 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.531 ' OD2' ' CG2' ' A' ' 88' ' ' THR . 26.0 p-10 -153.52 149.36 27.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.343 -0.848 . . . . 0.0 110.184 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 34.8 m -104.11 -2.98 25.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.14 -65.8 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.968 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.531 ' CG2' ' OD2' ' A' ' 85' ' ' ASP . 7.1 t -82.39 -19.82 38.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.079 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.37 158.13 17.11 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.22 -0.925 . . . . 0.0 109.938 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.71 109.68 21.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.939 . . . . 0.0 110.234 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 24.2 p -108.7 164.36 12.44 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.205 -0.934 . . . . 0.0 109.824 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -149.03 159.64 44.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.1 -1.0 . . . . 0.0 110.626 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 34' ' ' ALA . 20.2 tp -107.27 113.53 26.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.365 -0.834 . . . . 0.0 109.174 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . -103.51 154.34 17.96 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.038 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -143.01 124.98 15.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.326 -1.102 . . . . 0.0 110.175 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.57 -171.0 36.64 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' SER . 11.9 p-10 -130.88 -50.57 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -1.222 . . . . 0.0 110.638 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 97' ' ' ASN . 0.5 OUTLIER 166.57 -39.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.219 -0.926 . . . . 0.0 110.474 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.61 -21.21 62.33 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.6 tt -120.75 -66.77 1.03 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -1.183 . . . . 0.0 110.137 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.58 87.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 110.476 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.448 HD22 ' HG2' ' A' ' 2' ' ' PRO . 0.3 OUTLIER -62.38 -39.04 91.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.048 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.25 -162.59 25.7 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.452 ' HB3' ' CA ' ' A' ' 94' ' ' GLY . 0.6 OUTLIER -146.51 129.4 16.32 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.284 -1.127 . . . . 0.0 110.014 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.532 HG21 ' HA ' ' A' ' 5' ' ' SER . 6.3 t -92.01 119.94 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.253 -0.904 . . . . 0.0 110.341 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.62 158.85 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 109.983 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.491 HD23 ' CD1' ' A' ' 12' ' ' LEU . 12.9 mt -134.83 150.25 50.47 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.086 -1.009 . . . . 0.0 110.697 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.7 m -140.96 159.61 41.84 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.35 -0.844 . . . . 0.0 110.046 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 32.6 m-85 -127.16 145.31 50.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.126 -0.984 . . . . 0.0 110.197 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.529 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.475 ' O ' ' HA3' ' A' ' 24' ' ' GLY . . . . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 120.794 0.33 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.09 167.49 25.98 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.085 1.571 . . . . 0.0 110.648 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -155.3 138.45 15.61 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.264 -0.898 . . . . 0.0 110.898 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 1.6 t80 -152.36 102.96 2.8 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.345 -0.847 . . . . 0.0 109.793 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.9 t -146.2 151.9 38.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.097 -1.002 . . . . 0.0 110.734 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.494 HG11 ' CG1' ' A' ' 105' ' ' VAL . 8.0 p -115.63 122.62 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.799 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.1 m -47.1 -68.02 0.35 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.109 -0.994 . . . . 0.0 110.567 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 55.3 Cg_endo -76.06 79.14 2.98 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 O-C-N 123.311 1.164 . . . . 0.0 109.83 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.33 -6.73 57.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.974 -1.079 . . . . 0.0 110.689 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 p -146.96 146.43 30.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.212 -0.93 . . . . 0.0 109.71 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.41 ' C ' ' HG ' ' A' ' 12' ' ' LEU . . . 79.61 71.78 1.24 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.489 HD21 ' O ' ' A' ' 8' ' ' PRO . 4.0 mt -129.87 169.95 14.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -1.108 . . . . 0.0 109.751 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -136.23 169.49 17.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.49 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 30.5 p-10 -65.19 131.04 45.49 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.113 -0.992 . . . . 0.0 110.184 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.46 -29.86 5.53 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.476 ' HB3' ' O ' ' A' ' 13' ' ' SER . 9.4 tp60 -49.48 143.01 7.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -1.114 . . . . 0.0 110.308 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.32 133.62 42.48 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.487 ' CG2' ' HB3' ' A' ' 65' ' ' PHE . 16.6 m -101.85 163.26 3.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 109.785 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.1 121.57 44.94 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.983 -1.073 . . . . 0.0 110.28 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.91 151.41 14.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.68 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.5 m -146.34 121.68 10.27 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.323 -0.861 . . . . 0.0 109.992 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 86.2 t -120.54 139.38 48.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 109.831 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.9 p -157.66 136.44 11.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.054 -1.029 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 1' ' ' ALA . . . 124.28 -46.47 1.09 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 26' ' ' ALA . . . -45.69 -52.11 11.38 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.155 -1.203 . . . . 0.0 110.237 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.558 ' HA ' ' HA3' ' A' ' 59' ' ' GLY . . . 72.07 137.92 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.435 -0.791 . . . . 0.0 110.888 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -33.37 130.66 0.23 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.391 0.615 . . . . 0.0 110.762 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.408 ' C ' ' HG3' ' A' ' 29' ' ' GLU . . . 122.37 9.59 6.49 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.438 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 60.1 mt-10 -147.99 130.15 15.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.0 110.185 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.475 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 3.4 m -111.57 146.63 37.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.402 -0.811 . . . . 0.0 109.898 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 30.6 m-85 -132.08 174.51 10.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.084 -1.01 . . . . 0.0 110.662 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.574 ' CD1' ' HB3' ' A' ' 52' ' ' SER . 73.7 m-85 -130.46 102.05 5.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.486 -0.759 . . . . 0.0 109.626 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.516 ' CG2' ' O ' ' A' ' 33' ' ' ILE . 1.3 tt -87.85 104.15 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.087 -1.008 . . . . 0.0 110.185 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.444 ' C ' HD11 ' A' ' 93' ' ' LEU . . . -138.97 157.21 46.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.845 . . . . 0.0 110.618 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.478 ' HB2' HD11 ' A' ' 93' ' ' LEU . 1.1 tt0 -122.92 147.06 47.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.53 -0.731 . . . . 0.0 110.08 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 67.3 m -150.24 171.21 17.31 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.194 -0.941 . . . . 0.0 110.668 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.43 152.15 28.53 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.532 -0.73 . . . . 0.0 109.71 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.03 166.5 29.41 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.835 1.439 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.516 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 30.6 t -134.35 146.78 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.415 -0.803 . . . . 0.0 109.921 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -48.49 -35.89 16.54 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -76.64 -42.07 22.64 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -170.18 -79.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.176 -1.191 . . . . 0.0 110.211 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.429 ' C ' HG21 ' A' ' 39' ' ' VAL . 1.7 t70 -165.44 166.79 18.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.116 -0.99 . . . . 0.0 110.162 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 39' ' ' VAL . . . -154.14 149.49 27.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.121 -0.987 . . . . 0.0 110.036 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.459 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -124.47 156.66 36.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.139 -0.975 . . . . 0.0 110.001 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.463 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 0.2 OUTLIER -100.12 101.91 16.08 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.044 -1.035 . . . . 0.0 110.516 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.8 Cg_endo -73.8 -30.78 9.03 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.976 1.514 . . . . 0.0 110.532 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.85 85.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.268 -0.895 . . . . 0.0 110.556 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 5.1 p -95.35 1.83 54.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.219 -0.925 . . . . 0.0 110.52 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.79 119.44 21.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.129 -0.982 . . . . 0.0 110.037 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 33' ' ' ILE . 11.3 t -146.33 145.24 30.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.985 . . . . 0.0 110.631 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.574 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 1.1 m -110.58 147.54 34.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.579 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 13.8 p90 -144.18 -176.4 5.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -0.876 . . . . 0.0 110.08 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.8 m -149.12 156.18 41.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.597 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.52 ' CG2' ' HB1' ' A' ' 25' ' ' ALA . 6.9 p -68.53 -161.64 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.045 -1.034 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -160.2 -155.5 0.44 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.963 -1.085 . . . . 0.0 110.943 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.69 64.56 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 109.346 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.5 t -71.03 -5.38 30.89 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.437 -0.79 . . . . 0.0 109.16 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 26' ' ' ALA . . . 53.72 53.98 33.11 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.78 126.63 8.95 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.161 -1.199 . . . . 0.0 110.7 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -113.38 85.77 2.26 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.321 -0.862 . . . . 0.0 110.002 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.17 136.45 49.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.658 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -171.03 173.26 5.13 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.203 -0.936 . . . . 0.0 110.782 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 m -94.37 117.26 29.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.376 -0.827 . . . . 0.0 110.342 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.487 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 36.1 t80 -98.63 -179.44 4.31 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.355 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 t -134.5 156.39 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.874 -1.141 . . . . 0.0 110.286 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.3 m -143.3 153.96 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.367 -0.833 . . . . 0.0 110.048 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -132.37 120.67 22.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 110.213 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HE2' ' CD2' ' A' ' 109' ' ' PHE . 4.3 tttt -49.41 -45.74 46.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.283 -0.886 . . . . 0.0 109.762 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.1 m -120.5 135.29 55.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.479 -0.763 . . . . 0.0 109.608 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -151.32 144.27 24.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.151 -0.968 . . . . 0.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 29.3 m -65.59 149.8 49.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 0.0 110.28 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.0 -167.17 13.64 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.97 -165.63 2.09 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.298 -1.119 . . . . 0.0 110.0 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 79' ' ' THR . 7.6 p -111.18 165.3 13.0 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.16 -0.962 . . . . 0.0 110.338 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -77.75 -8.43 16.89 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.105 1.582 . . . . 0.0 109.963 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.87 8.24 40.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.43 -0.794 . . . . 0.0 110.065 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.8 55.14 5.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.464 ' O ' ' OG1' ' A' ' 75' ' ' THR . 22.7 m -149.72 133.4 8.7 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.225 -1.162 . . . . 0.0 110.547 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.04 110.07 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.917 1.483 . . . . 0.0 110.211 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.459 ' HB ' HG21 ' A' ' 75' ' ' THR . 8.4 p -90.5 -18.44 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.404 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.29 -152.59 19.54 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 3.9 m -97.83 161.73 13.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -1.183 . . . . 0.0 110.284 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.439 HG23 ' CB ' ' A' ' 44' ' ' ALA . 62.7 t -116.95 123.84 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.02 111.1 23.75 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.163 -0.961 . . . . 0.0 110.094 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.15 9.02 29.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 110.084 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.36 -41.29 88.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.551 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 t -114.35 0.99 14.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.13 -0.981 . . . . 0.0 110.326 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.64 -139.16 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.24 142.16 31.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.4 m -128.9 133.82 48.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.1 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -129.27 148.26 51.18 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.189 -0.945 . . . . 0.0 110.091 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 35' ' ' GLN . 0.7 OUTLIER -125.61 118.97 26.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.072 -1.018 . . . . 0.0 109.153 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -122.74 159.59 17.34 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.275 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 33' ' ' ILE . . . -146.92 143.31 28.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.549 -0.971 . . . . 0.0 109.765 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 166.37 174.86 36.15 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.094 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 30' ' ' THR . 12.0 p-10 -119.35 -137.61 0.34 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.31 -1.112 . . . . 0.0 110.157 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.4 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -121.14 60.79 0.91 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.146 -0.971 . . . . 0.0 110.214 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.29 -24.26 0.12 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER -118.37 -60.84 1.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.235 . . . . 0.0 110.278 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.524 ' N ' HD12 ' A' ' 100' ' ' LEU . 38.9 t0 58.27 119.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 110.139 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.455 HD21 HD13 ' A' ' 100' ' ' LEU . 32.1 mt -84.81 -70.84 0.55 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.427 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 177.61 -175.6 47.64 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.577 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 1.6 m-70 -131.59 124.24 29.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.522 -0.987 . . . . 0.0 109.78 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.494 ' CG1' HG11 ' A' ' 6' ' ' VAL . 66.6 t -95.35 107.31 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.047 . . . . 0.0 110.515 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.01 112.37 2.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.442 ' HA ' HD21 ' A' ' 107' ' ' LEU . 79.7 mt -86.52 133.02 33.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.131 -0.981 . . . . 0.0 110.722 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.3 m -114.17 169.01 9.34 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.442 -0.786 . . . . 0.0 109.77 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.409 ' O ' ' O ' ' A' ' 110' ' ' GLY . 11.4 m-85 -134.14 163.4 29.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 110.075 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.269 0 CA-C-O 117.948 -1.474 . . . . 0.0 109.601 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.413 ' HB2' HD23 ' A' ' 102' ' ' LEU . 47.1 Cg_endo -72.51 -161.67 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.935 1.492 . . . . 0.0 110.517 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -142.43 133.9 26.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 110.498 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -146.31 111.01 5.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.233 -0.917 . . . . 0.0 109.955 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.07 149.98 34.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.129 -0.982 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.425 ' O ' HG11 ' A' ' 6' ' ' VAL . 9.2 p -117.04 154.51 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 109.532 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.615 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -72.83 -68.18 0.41 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.04 . . . . 0.0 110.014 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.615 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 54.6 Cg_endo -77.58 75.94 4.5 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.308 1.162 . . . . 0.0 109.978 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.52 -8.12 57.82 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.934 -1.104 . . . . 0.0 110.527 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.5 p -142.72 123.39 14.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.28 75.56 1.3 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.57 ' O ' ' CE1' ' A' ' 109' ' ' PHE . 2.3 mt -120.07 165.93 14.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -1.14 . . . . 0.0 110.085 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 9.4 m -124.16 161.2 26.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 109.876 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 8.7 p-10 -62.43 121.6 13.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 110.075 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.87 -27.56 8.83 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 13' ' ' SER . 2.7 tt0 -43.32 143.85 0.8 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.306 -1.114 . . . . 0.0 110.728 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.435 ' C ' HG13 ' A' ' 18' ' ' VAL . 80.0 p -96.75 150.72 20.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.659 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.505 HG12 ' CG1' ' A' ' 67' ' ' VAL . 27.0 m -130.76 154.33 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 110.084 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.4 m -101.92 132.91 47.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.007 . . . . 0.0 110.02 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.434 HG11 ' N ' ' A' ' 21' ' ' SER . 10.7 t -120.8 146.66 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.075 -1.016 . . . . 0.0 109.896 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.434 ' N ' HG11 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -138.71 126.2 21.84 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.424 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 84.8 t -117.67 141.61 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 109.919 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -152.96 145.53 24.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.135 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 121.35 -58.95 0.57 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.517 ' CB ' HG22 ' A' ' 55' ' ' THR . . . -52.54 -175.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.578 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.49 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -154.36 155.14 34.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.017 -1.052 . . . . 0.0 110.783 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -37.03 133.9 0.58 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.436 0.636 . . . . 0.0 110.864 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.36 16.25 16.83 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -143.61 120.29 11.15 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.168 -1.195 . . . . 0.0 110.382 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.438 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 8.8 m -103.44 148.22 26.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.983 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 33.2 m-85 -136.21 170.77 15.48 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 110.4 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 22.5 m-85 -117.68 167.23 11.54 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.427 -0.796 . . . . 0.0 109.967 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.602 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 4.4 tt -151.9 97.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.555 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -140.8 161.79 36.96 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.254 -0.903 . . . . 0.0 110.914 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 17.6 tt0 -116.78 139.98 49.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.52 -0.737 . . . . 0.0 109.81 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 96.0 m -136.76 162.58 32.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.52 159.12 33.85 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.428 -0.795 . . . . 0.0 110.01 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 46.2 Cg_endo -75.45 164.61 32.22 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.879 1.463 . . . . 0.0 110.678 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.434 ' CG1' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -142.3 170.25 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.357 -0.839 . . . . 0.0 109.941 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.28 -40.78 61.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 42' ' ' GLN . . . -67.5 -60.56 5.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 41' ' ' GLY . 2.6 mt-30 -166.81 -68.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.441 -1.035 . . . . 0.0 110.132 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 1.4 t70 -161.1 166.65 27.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 110.297 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.05 173.62 16.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 110.225 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 m -138.99 157.48 45.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.293 -0.879 . . . . 0.0 110.313 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.455 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 52.2 t-20 -95.69 114.77 64.69 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 110.007 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 47.0 Cg_endo -73.96 -30.72 8.8 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.967 1.509 . . . . 0.0 110.519 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.6 95.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.951 . . . . 0.0 110.143 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.2 p -87.29 7.23 29.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.375 -0.828 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 47' ' ' PRO . . . -77.96 119.26 21.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.312 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.602 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 9.7 t -156.17 170.71 21.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.859 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.428 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 14.6 p -141.91 148.11 38.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.072 -1.017 . . . . 0.0 110.565 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 48.8 p90 -135.46 -176.13 4.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.415 -0.803 . . . . 0.0 109.97 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.5 m -146.48 154.39 41.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.073 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.517 HG22 ' CB ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -72.6 -158.79 0.05 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -155.83 -157.09 0.7 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.783 -1.198 . . . . 0.0 110.498 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.62 -46.53 89.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.14 -0.975 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.8 t -83.6 9.91 10.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.278 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 51.14 49.98 41.4 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -133.0 138.63 46.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -1.091 . . . . 0.0 109.927 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.3 85.04 2.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 110.829 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 p -108.06 125.72 51.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.298 -0.876 . . . . 0.0 108.953 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -154.07 -179.19 7.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.026 -1.046 . . . . 0.0 111.405 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.49 135.3 39.54 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.465 0.65 . . . . 0.0 110.563 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 38.4 t80 -125.49 178.74 5.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 0.0 109.502 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 3.4 t -134.05 161.08 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.859 -1.151 . . . . 0.0 110.536 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.505 ' CG1' HG12 ' A' ' 18' ' ' VAL . 30.3 m -137.17 179.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.487 -0.758 . . . . 0.0 109.902 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 8.8 mtt85 -152.21 152.72 32.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.095 -1.003 . . . . 0.0 110.365 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 5.7 tttm -82.41 -25.46 33.68 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.263 -0.898 . . . . 0.0 109.314 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 85' ' ' ASP . 1.1 m -150.26 107.53 3.61 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.454 -0.778 . . . . 0.0 109.653 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.549 ' CE2' HG12 ' A' ' 84' ' ' VAL . 25.1 p90 -105.07 143.59 33.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 110.394 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.3 m -74.25 115.22 13.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 110.467 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.72 -174.5 44.33 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.86 152.89 0.79 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -1.202 . . . . 0.0 110.482 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.0 p -90.02 160.56 40.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.344 -0.848 . . . . 0.0 110.348 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -83.07 -20.47 5.15 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.01 1.532 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.54 -74.33 0.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.104 -0.998 . . . . 0.0 110.472 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.19 58.36 0.06 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 m -154.91 106.89 2.31 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.278 -1.131 . . . . 0.0 109.975 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.11 105.51 1.98 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.968 1.509 . . . . 0.0 110.29 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.5 t -63.78 -34.42 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 110.245 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.95 -150.74 18.04 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -85.31 167.06 15.95 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.287 -1.125 . . . . 0.0 110.315 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.549 HG12 ' CE2' ' A' ' 71' ' ' TYR . 96.1 t -138.29 110.19 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.322 -0.861 . . . . 0.0 110.023 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 1.6 m-20 -92.71 161.24 14.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.246 -0.909 . . . . 0.0 110.551 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 94.7 m -109.88 -0.11 18.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.181 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.97 -60.88 2.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.173 -0.954 . . . . 0.0 110.333 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.409 HG22 ' N ' ' A' ' 89' ' ' ALA . 14.8 t -74.94 -30.48 61.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.174 -0.954 . . . . 0.0 110.279 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.409 ' N ' HG22 ' A' ' 88' ' ' THR . . . -108.09 155.72 20.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.892 . . . . 0.0 110.296 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.86 135.14 34.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.344 -0.847 . . . . 0.0 110.166 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.0 m -114.14 137.9 51.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 109.845 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -125.28 151.9 45.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.109 -0.995 . . . . 0.0 110.801 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.423 HD12 ' C ' ' A' ' 34' ' ' ALA . 5.6 tp -122.46 109.16 14.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 0.0 109.073 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -107.39 164.45 13.06 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.532 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -145.51 136.29 24.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.631 -0.923 . . . . 0.0 110.04 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.57 178.06 17.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -105.84 -160.07 0.73 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -1.197 . . . . 0.0 110.15 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.76 45.81 1.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 110.038 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.48 -51.77 0.05 OUTLIER Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.9 tt -103.05 91.33 4.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -1.193 . . . . 0.0 110.143 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -100.86 122.74 43.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.468 HD11 ' O ' ' A' ' 95' ' ' ALA . 2.1 mp -74.11 -29.36 61.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 110.174 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 140.53 -169.84 24.67 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.448 ' O ' ' ND1' ' A' ' 104' ' ' HIS . 31.0 p80 -144.23 126.71 15.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -1.11 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.403 HG12 HG12 ' A' ' 6' ' ' VAL . 85.8 t -92.58 128.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.189 -0.944 . . . . 0.0 110.228 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.57 136.04 42.09 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 88.7 mt -110.21 119.45 39.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.249 -0.907 . . . . 0.0 110.152 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -90.88 160.89 15.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.306 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.57 ' CE1' ' O ' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -146.79 78.67 1.5 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.822 . . . . 0.0 110.148 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 CA-C-O 117.948 -1.474 . . . . 0.0 109.591 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 120.744 0.307 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.85 -159.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.025 1.539 . . . . 0.0 110.294 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -141.55 136.21 30.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.087 -1.008 . . . . 0.0 110.772 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 95' ' ' ALA . 87.9 t80 -149.37 114.64 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.486 -0.759 . . . . 0.0 109.168 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.47 153.7 35.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.868 -1.145 . . . . 0.0 111.317 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.438 HG23 ' HD2' ' A' ' 8' ' ' PRO . 9.5 p -113.67 165.69 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.651 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -74.66 -61.87 1.04 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.663 -1.273 . . . . 0.0 110.432 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.651 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 55.9 Cg_endo -91.6 76.3 0.57 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 O-C-N 123.104 1.055 . . . . 0.0 110.143 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.89 -23.76 65.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.031 -1.043 . . . . 0.0 109.94 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.9 m -139.39 135.68 33.92 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.44 -0.787 . . . . 0.0 109.964 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.87 54.28 1.93 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.575 ' O ' ' CD1' ' A' ' 109' ' ' PHE . 2.2 mt -102.43 171.02 7.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.257 -1.143 . . . . 0.0 109.972 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -125.17 149.36 48.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 69' ' ' LYS . 4.4 p-10 -59.85 120.89 10.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.85 . . . . 0.0 109.978 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.8 -31.04 7.22 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 10.1 tt0 -55.52 147.93 16.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -1.127 . . . . 0.0 110.326 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 26.0 p -97.82 150.86 20.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 0.0 110.325 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.548 HG12 ' CD2' ' A' ' 12' ' ' LEU . 22.6 m -119.46 150.94 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.797 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 m -93.88 116.38 28.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.131 -0.981 . . . . 0.0 110.247 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 t -102.9 149.94 6.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.315 -0.865 . . . . 0.0 109.991 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 32.2 t -150.85 129.81 12.53 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 110.251 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 75.8 t -116.25 151.99 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.809 . . . . 0.0 109.901 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -164.7 113.07 1.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.208 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.65 -55.81 0.42 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -62.52 -142.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -1.148 . . . . 0.0 110.326 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -175.61 166.57 3.21 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.169 -0.957 . . . . 0.0 110.458 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -54.88 133.04 47.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.424 -0.798 . . . . 0.0 110.653 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.433 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 119.67 9.72 8.21 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 19.6 mm-40 -140.68 120.93 13.89 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.161 -1.2 . . . . 0.0 110.468 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.6 m -106.36 130.44 54.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.261 -0.899 . . . . 0.0 109.88 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 50.0 m-85 -115.65 -168.31 1.39 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.233 -0.917 . . . . 0.0 110.786 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 40.8 m-85 -138.68 112.11 8.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.432 -0.793 . . . . 0.0 109.987 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.514 ' CG2' ' O ' ' A' ' 33' ' ' ILE . 5.6 tt -94.42 112.69 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.187 -0.946 . . . . 0.0 109.735 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.71 155.3 42.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 111.307 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 22.6 tt0 -109.7 127.41 54.56 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 1.8 m -143.25 165.92 26.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.067 -1.021 . . . . 0.0 110.705 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 91' ' ' CYS . . . -150.77 164.17 21.28 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.613 -0.679 . . . . 0.0 109.441 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 37' ' ' ALA . 43.3 Cg_endo -71.79 162.83 40.82 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.748 1.394 . . . . 0.0 110.674 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.52 HG12 ' CB ' ' A' ' 44' ' ' ALA . 33.4 m -140.81 66.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.378 -0.827 . . . . 0.0 110.283 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.53 -28.99 7.03 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.19 -35.46 0.13 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -84.37 -170.35 3.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -1.163 . . . . 0.0 110.096 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -122.37 134.12 54.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.55 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.52 ' CB ' HG12 ' A' ' 39' ' ' VAL . . . -132.1 156.7 45.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.85 . . . . 0.0 109.671 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 12.2 t -147.55 160.7 42.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.106 -0.996 . . . . 0.0 110.511 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.463 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 41.2 t-20 -84.37 117.64 69.22 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.318 -0.864 . . . . 0.0 110.12 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.472 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 47.5 Cg_endo -74.63 -37.16 2.44 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.908 1.478 . . . . 0.0 110.554 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.07 -20.95 58.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.327 -0.858 . . . . 0.0 110.322 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 82.4 p -113.86 -10.96 12.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.925 . . . . 0.0 110.352 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB1' ' HA ' ' A' ' 47' ' ' PRO . . . -67.4 106.43 2.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.4 t -139.9 152.96 46.83 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.255 -0.903 . . . . 0.0 110.318 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 6.0 p -105.83 157.33 17.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.106 -0.996 . . . . 0.0 110.51 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 6.4 p90 -146.0 -177.4 5.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.047 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.3 m -138.6 161.29 37.48 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.216 -0.927 . . . . 0.0 110.013 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -158.09 0.09 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.205 -0.934 . . . . 0.0 109.934 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 27' ' ' ALA . 1.6 t0 -141.75 -151.31 0.35 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.967 -1.083 . . . . 0.0 110.406 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.6 -54.62 29.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.926 . . . . 0.0 109.533 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 60' ' ' ALA . 38.6 p -90.37 21.28 3.95 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 61.51 17.49 53.61 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.43 ' HB3' ' OG ' ' A' ' 58' ' ' SER . . . -89.68 137.83 31.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -1.164 . . . . 0.0 110.056 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -140.74 84.62 1.95 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 110.269 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.8 p -104.86 115.59 30.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.84 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -146.12 179.0 7.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.258 -0.901 . . . . 0.0 110.675 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.36 138.64 31.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.511 -0.743 . . . . 0.0 110.863 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.477 ' HB3' HG22 ' A' ' 18' ' ' VAL . 51.4 t80 -132.84 -175.55 3.81 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 21.7 t -144.66 163.03 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.726 -1.234 . . . . 0.0 110.798 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.431 ' C ' ' HG2' ' A' ' 68' ' ' ARG . 33.7 m -138.28 160.83 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 109.657 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.431 ' HG2' ' C ' ' A' ' 67' ' ' VAL . 0.9 OUTLIER -141.05 139.27 34.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.939 -1.1 . . . . 0.0 110.527 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 3.2 ttmt -61.14 -44.92 96.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.903 . . . . 0.0 109.746 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 95.5 p -138.75 149.46 45.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.767 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -155.03 153.65 31.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 110.337 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 7.0 m -70.42 128.4 36.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.892 . . . . 0.0 110.138 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 74' ' ' SER . . . -87.71 173.2 43.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 5.5 t -177.18 145.53 0.46 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.282 -1.128 . . . . 0.0 110.111 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.471 ' OG1' ' HB ' ' A' ' 79' ' ' THR . 48.2 p -74.95 153.41 86.77 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.236 -0.915 . . . . 0.0 110.639 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.19 9.47 3.96 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.272 1.67 . . . . 0.0 110.396 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -114.61 -22.04 9.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.112 -0.993 . . . . 0.0 110.719 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.525 ' N ' ' HG3' ' A' ' 77' ' ' GLU . . . 123.84 62.9 0.19 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.471 ' HB ' ' OG1' ' A' ' 75' ' ' THR . 7.7 m -156.1 97.83 2.23 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.264 -1.139 . . . . 0.0 109.933 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.03 105.13 1.63 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.003 1.528 . . . . 0.0 110.433 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.79 -71.66 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.331 -0.856 . . . . 0.0 110.318 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.88 -151.67 7.52 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.2 OUTLIER -103.43 160.5 14.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.377 -1.072 . . . . 0.0 110.526 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -127.62 155.87 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.411 -0.806 . . . . 0.0 109.676 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -143.97 140.71 29.79 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.033 -1.042 . . . . 0.0 110.499 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 89' ' ' ALA . 69.3 m -85.16 -9.78 57.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.817 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.77 -44.9 72.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 109.929 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 t -94.91 -8.78 36.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.958 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 86' ' ' CYS . . . -140.37 163.9 31.54 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.332 -0.855 . . . . 0.0 109.981 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.24 139.64 35.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.511 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.446 ' HB3' ' HB1' ' A' ' 37' ' ' ALA . 1.4 p -123.22 142.48 50.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.302 -0.874 . . . . 0.0 109.714 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -125.47 161.43 27.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.995 . . . . 0.0 110.604 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 13.7 tp -117.12 112.11 20.43 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.388 -0.82 . . . . 0.0 109.172 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.506 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -110.47 150.29 17.63 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.466 -1.35 . . . . 0.0 109.914 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -142.41 132.14 24.09 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.485 -1.009 . . . . 0.0 109.669 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.523 ' CA ' ' HB3' ' A' ' 31' ' ' TYR . . . 149.35 -159.37 28.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 100' ' ' LEU . 8.9 t-20 -121.18 159.08 26.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -1.083 . . . . 0.0 110.04 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -54.37 -30.57 52.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.1 -1.0 . . . . 0.0 110.107 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.74 -45.76 4.47 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 97' ' ' ASN . 8.8 tt -87.89 143.52 27.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.183 . . . . 0.0 110.204 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -117.25 92.68 3.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.129 -0.982 . . . . 0.0 110.354 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.4 OUTLIER -71.13 -54.87 9.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.897 . . . . 0.0 110.125 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 158.72 155.15 7.49 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.499 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.506 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 8.7 m-70 -125.82 119.52 28.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.675 -0.897 . . . . 0.0 109.264 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.9 t -103.46 107.35 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 110.632 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.91 48.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.264 -0.897 . . . . 0.0 109.717 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 41.1 mt -95.98 158.37 15.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 0.0 110.65 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.1 m -149.36 172.88 14.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.363 -0.835 . . . . 0.0 109.989 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 36.5 m-85 -135.09 118.24 16.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.199 -0.938 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.528 ' N ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 120.556 0.217 . . . . 0.0 110.444 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 1' ' ' ALA . 44.5 Cg_endo -74.65 -172.29 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.933 1.491 . . . . 0.0 110.622 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 23' ' ' SER . . . -151.22 151.2 31.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 95' ' ' ALA . 42.4 t80 -150.19 113.8 4.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.213 -0.929 . . . . 0.0 109.984 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.5 t -150.56 150.31 31.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.099 -1.001 . . . . 0.0 110.571 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.468 HG23 ' HD2' ' A' ' 8' ' ' PRO . 9.9 p -123.11 155.28 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.405 -0.809 . . . . 0.0 109.65 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -75.08 -66.4 0.43 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.036 -1.04 . . . . 0.0 110.382 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 46.3 Cg_endo -74.05 81.98 1.86 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.458 1.241 . . . . 0.0 110.259 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.06 -4.85 53.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.311 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.5 p -143.92 159.44 42.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.433 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.06 51.05 58.24 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.508 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 5.3 mt -88.5 154.79 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -1.154 . . . . 0.0 109.922 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 4.3 t -132.92 157.06 46.07 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.134 -0.979 . . . . 0.0 110.346 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -63.58 115.92 5.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.79 -32.63 7.36 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 26.5 tt0 -50.82 143.97 9.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -1.073 . . . . 0.0 110.116 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.4 t -98.85 152.61 19.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.499 ' HA ' ' HG3' ' A' ' 8' ' ' PRO . 28.7 m -128.11 150.47 33.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.288 -0.883 . . . . 0.0 109.927 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.454 ' O ' HG22 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -98.29 131.36 44.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 110.133 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.39 149.02 18.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -144.9 134.55 23.4 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.391 -0.818 . . . . 0.0 110.524 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.522 ' HB ' ' CB ' ' A' ' 61' ' ' ALA . 52.5 t -127.7 149.0 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.439 -0.788 . . . . 0.0 110.006 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.423 ' N ' HG11 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -153.12 -177.25 6.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.811 . . . . 0.0 109.596 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 1' ' ' ALA . . . 71.52 17.3 76.24 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.498 -1.334 . . . . 0.0 109.819 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.459 ' HB1' HG22 ' A' ' 55' ' ' THR . . . -119.12 -159.47 0.77 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.155 -1.203 . . . . 0.0 110.269 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.567 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -170.98 161.06 6.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.443 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -53.6 131.17 38.3 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.572 -0.705 . . . . 0.0 110.272 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.59 21.58 5.72 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -144.36 116.44 8.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.235 -1.156 . . . . 0.0 110.621 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 53' ' ' PHE . 61.3 m -109.66 128.96 55.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 109.563 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 8.7 m-85 -114.31 175.5 5.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.004 -1.06 . . . . 0.0 110.715 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -124.93 124.5 42.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.473 -0.767 . . . . 0.0 109.46 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.479 ' CG2' HG23 ' A' ' 51' ' ' THR . 1.2 tt -105.06 124.38 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.089 -1.007 . . . . 0.0 110.482 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.99 155.87 38.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 111.201 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.517 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 36.6 tt0 -124.33 135.11 53.09 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.437 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 3.7 m -144.96 179.67 7.19 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.79 -1.194 . . . . 0.0 111.111 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . . . -152.07 175.71 2.77 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 37' ' ' ALA . 46.3 Cg_endo -83.23 163.28 15.2 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.751 1.395 . . . . 0.0 110.782 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.42 HG11 ' C ' ' A' ' 42' ' ' GLN . 14.9 p -150.28 158.66 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 109.982 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -50.72 -43.51 47.05 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 42' ' ' GLN . . . -62.49 -43.5 98.94 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.6 OUTLIER 171.01 -75.28 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.513 -0.993 . . . . 0.0 109.602 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -149.76 137.5 20.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 110.417 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -131.79 173.3 11.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.789 . . . . 0.0 109.588 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.8 t -154.09 165.84 34.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.139 -0.976 . . . . 0.0 110.723 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.447 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 29.4 t-20 -80.03 124.58 82.91 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -86.01 -35.56 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.873 1.46 . . . . 0.0 111.389 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.24 3.61 4.45 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.139 -0.976 . . . . 0.0 111.506 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.447 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 71.7 p -124.07 7.29 8.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.863 -1.148 . . . . 0.0 110.677 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.32 120.3 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.026 -1.046 . . . . 0.0 110.193 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.479 HG23 ' CG2' ' A' ' 33' ' ' ILE . 10.0 t -160.57 165.63 30.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.226 -0.922 . . . . 0.0 110.315 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 31' ' ' TYR . 42.8 t -136.01 163.59 29.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.216 -0.928 . . . . 0.0 110.43 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 7.3 p90 -146.55 179.68 7.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.297 -0.877 . . . . 0.0 109.764 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 55' ' ' THR . 32.8 m -145.21 154.2 42.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.459 HG22 ' HB1' ' A' ' 25' ' ' ALA . 7.4 p -73.94 -156.15 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.355 -0.84 . . . . 0.0 110.068 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 27' ' ' ALA . 1.3 t0 -160.9 -151.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.924 -1.11 . . . . 0.0 110.799 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.21 -48.0 83.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 109.959 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.25 9.14 9.37 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.233 -0.917 . . . . 0.0 109.414 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.567 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 50.01 48.17 39.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.61 125.78 43.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.141 -1.211 . . . . 0.0 110.283 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.522 ' CB ' ' HB ' ' A' ' 22' ' ' VAL . . . -115.06 83.08 1.85 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 0.0 110.3 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.5 p -112.12 126.86 55.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.232 -0.918 . . . . 0.0 109.745 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 7.0 p90 -157.06 175.38 14.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 0.0 110.802 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 p -94.4 152.56 18.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.422 -0.799 . . . . 0.0 110.355 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.552 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 73.3 t80 -142.45 179.35 7.0 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 109.634 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.552 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.7 t -135.38 159.11 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.929 -1.107 . . . . 0.0 109.825 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.79 161.28 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.19 -0.944 . . . . 0.0 110.672 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -135.84 138.43 42.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.89 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' HD3' ' CB ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -76.9 -44.31 32.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.092 -1.005 . . . . 0.0 110.471 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.452 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 4.3 p -129.25 147.3 51.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.947 . . . . 0.0 110.413 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.508 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 11.0 p90 -161.82 156.03 22.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.223 -0.923 . . . . 0.0 110.347 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 73' ' ' GLY . 1.4 m -68.97 105.69 2.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.33 -0.856 . . . . 0.0 110.171 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 72' ' ' THR . . . -42.48 147.87 0.59 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 97.1 p -170.16 117.42 0.55 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.29 -1.123 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.469 ' OG1' ' HB ' ' A' ' 79' ' ' THR . 79.5 p -58.36 161.18 8.05 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.893 . . . . 0.0 110.502 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.62 1.41 8.85 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 124.183 1.622 . . . . 0.0 110.303 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -100.74 -26.56 13.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.546 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.64 65.89 0.2 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.469 ' HB ' ' OG1' ' A' ' 75' ' ' THR . 88.3 m -155.78 96.77 2.35 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.197 -1.178 . . . . 0.0 110.036 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.5 110.95 3.17 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.963 1.507 . . . . 0.0 110.366 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.5 t -83.25 -67.85 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.239 -0.913 . . . . 0.0 110.283 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.02 -150.54 6.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 m -88.16 157.27 18.87 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.377 -1.072 . . . . 0.0 110.252 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.464 HG11 ' CZ ' ' A' ' 71' ' ' TYR . 85.4 t -144.88 111.24 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.153 -0.967 . . . . 0.0 110.701 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 70' ' ' SER . 1.7 m-20 -104.99 104.47 14.22 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 109.009 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.431 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -92.07 24.27 3.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.006 -1.059 . . . . 0.0 110.921 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.463 ' CB ' ' HD3' ' A' ' 69' ' ' LYS . . . -68.8 -37.83 79.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.178 -0.951 . . . . 0.0 109.204 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 t -116.0 -3.36 12.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.58 -0.7 . . . . 0.0 109.679 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -89.53 -139.98 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.354 -0.841 . . . . 0.0 110.294 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.78 102.88 8.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 110.415 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.92 126.15 44.52 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 15.6 p30 -130.5 139.23 50.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.093 -1.005 . . . . 0.0 110.798 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 35' ' ' GLN . 6.1 tp -119.19 110.39 16.97 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.59 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -113.16 162.51 12.34 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.805 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 4' ' ' PHE . . . -142.46 157.53 44.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.644 -0.915 . . . . 0.0 109.997 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.476 ' CA ' HD11 ' A' ' 102' ' ' LEU . . . 107.75 -177.67 21.29 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.465 ' OD1' HD23 ' A' ' 100' ' ' LEU . 4.5 p-10 -126.68 -155.75 0.7 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.194 -1.18 . . . . 0.0 109.996 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 94.3 p -92.62 69.33 4.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.307 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.57 -55.12 0.08 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.596 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 3.9 mm? -75.79 -32.66 59.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -1.135 . . . . 0.0 109.547 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 49.27 80.19 0.07 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.633 -0.667 . . . . 0.0 110.232 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.476 HD11 ' CA ' ' A' ' 96' ' ' GLY . 21.8 mt -76.16 -69.82 0.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 110.238 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.35 179.61 36.17 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.806 -1.187 . . . . 0.0 110.14 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.59 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 3.5 m-70 -134.59 123.37 23.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.585 -0.95 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.444 HG12 ' CG1' ' A' ' 6' ' ' VAL . 60.2 t -90.11 111.04 22.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.248 -0.908 . . . . 0.0 110.313 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.54 118.81 10.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.97 . . . . 0.0 109.29 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.517 ' CD1' ' OE1' ' A' ' 35' ' ' GLN . 49.7 mt -89.85 158.68 17.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 110.852 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -123.26 164.09 19.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.503 -0.748 . . . . 0.0 109.72 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.417 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 4.5 m-85 -149.28 174.57 12.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.199 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.507 ' N ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.509 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 49.3 Cg_endo -74.31 175.11 11.41 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.976 1.514 . . . . 0.0 110.103 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -155.37 135.04 12.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.962 . . . . 0.0 110.306 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 1.2 t80 -147.78 99.3 3.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.399 -0.813 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.08 158.74 43.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 111.069 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.402 HG21 HG23 ' A' ' 20' ' ' VAL . 6.4 p -121.95 157.99 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.517 -0.739 . . . . 0.0 109.355 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.614 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.7 m -72.46 -70.19 0.29 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.883 -1.136 . . . . 0.0 110.137 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.614 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 53.9 Cg_endo -76.42 97.38 1.13 Allowed 'Trans proline' 0 N--CA 1.481 0.751 0 O-C-N 123.144 1.076 . . . . 0.0 110.031 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.5 -4.33 25.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.047 -1.033 . . . . 0.0 110.144 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.47 127.37 19.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 110.144 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.06 80.62 1.26 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.414 HD13 ' HB3' ' A' ' 107' ' ' LEU . 45.3 mt -126.44 162.09 26.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.311 -1.111 . . . . 0.0 110.248 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.78 158.03 44.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.117 -0.99 . . . . 0.0 110.813 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -61.51 121.53 12.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.19 -39.03 2.93 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -49.47 134.05 19.62 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.28 -1.129 . . . . 0.0 109.885 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.2 p -95.51 138.74 32.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.38 -0.825 . . . . 0.0 110.066 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 65' ' ' PHE . 15.9 m -108.58 170.18 2.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.375 -0.828 . . . . 0.0 109.665 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.503 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 27.0 p -116.65 121.59 42.11 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.18 -0.95 . . . . 0.0 109.262 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.402 HG23 HG21 ' A' ' 6' ' ' VAL . 17.3 t -112.16 150.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.118 -0.989 . . . . 0.0 110.41 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.65 132.55 22.74 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.492 -0.755 . . . . 0.0 110.114 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 18.3 t -120.71 139.43 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.483 ' OG ' ' HB3' ' A' ' 3' ' ' ALA . 2.4 p -151.35 143.56 24.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.252 -0.905 . . . . 0.0 110.108 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 120.39 -67.77 0.41 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 24' ' ' GLY . . . -54.18 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.086 -1.243 . . . . 0.0 109.363 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.513 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -165.55 162.65 19.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.943 -1.098 . . . . 0.0 110.976 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.5 130.91 1.3 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.459 0.647 . . . . 0.0 110.409 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.04 4.61 11.23 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.445 ' OE1' HD12 ' A' ' 100' ' ' LEU . 33.6 mt-10 -138.72 122.75 17.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.199 -1.177 . . . . 0.0 109.85 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 62.4 m -105.02 133.69 49.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 109.99 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.606 ' CE2' HD21 ' A' ' 100' ' ' LEU . 11.1 m-85 -120.05 171.8 8.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.533 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 14.0 m-85 -131.68 102.1 5.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 109.113 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.529 ' CG2' ' O ' ' A' ' 33' ' ' ILE . 3.0 tt -90.47 117.8 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.084 -1.01 . . . . 0.0 110.905 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.45 158.5 44.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.219 -0.926 . . . . 0.0 110.299 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.461 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 2.2 tt0 -116.85 144.47 44.47 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.226 -0.921 . . . . 0.0 110.19 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 77.2 m -150.23 161.43 42.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.283 -0.885 . . . . 0.0 110.776 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.51 ' CB ' ' SG ' ' A' ' 86' ' ' CYS . . . -138.17 156.04 74.0 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 121.371 -0.831 . . . . 0.0 109.816 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 44.4 Cg_endo -70.82 163.62 38.48 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.825 1.434 . . . . 0.0 111.836 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.471 HG11 ' HB1' ' A' ' 44' ' ' ALA . 5.8 m -137.66 167.03 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.689 . . . . 0.0 109.748 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -50.24 -30.36 17.63 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.14 -69.63 1.38 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.98 -75.76 0.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -1.111 . . . . 0.0 109.966 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 12.5 t70 -155.79 167.58 29.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.253 -0.905 . . . . 0.0 110.911 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.532 ' CB ' HG23 ' A' ' 84' ' ' VAL . . . -149.72 162.88 39.37 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.68 162.15 27.22 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.916 -1.115 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.493 ' ND2' HG22 ' A' ' 49' ' ' THR . 57.4 t30 -103.91 113.35 65.47 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.553 -0.717 . . . . 0.0 110.171 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.26 -27.93 7.63 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.993 1.523 . . . . 0.0 110.242 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.26 -3.78 11.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.849 . . . . 0.0 110.285 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.493 HG22 ' ND2' ' A' ' 46' ' ' ASN . 3.5 p -131.24 -1.85 3.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.258 -0.901 . . . . 0.0 110.172 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.7 127.38 31.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.26 -0.9 . . . . 0.0 110.183 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 33' ' ' ILE . 4.4 t -159.47 150.51 19.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.979 . . . . 0.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 t -122.42 143.25 49.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.309 -0.869 . . . . 0.0 110.149 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -140.24 138.07 34.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.146 -0.971 . . . . 0.0 110.432 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.453 ' OG1' HG23 ' A' ' 30' ' ' THR . 15.6 m -105.48 151.56 24.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.194 -0.941 . . . . 0.0 109.525 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -61.71 -170.76 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.811 -1.18 . . . . 0.0 109.481 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 6.5 t0 -145.45 -158.72 0.92 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.914 -1.116 . . . . 0.0 110.818 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.39 -53.23 60.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 109.47 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 p -76.78 1.99 15.68 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 109.083 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 53.75 44.49 70.0 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.14 132.99 47.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.289 -1.124 . . . . 0.0 110.051 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.444 ' CB ' ' HB ' ' A' ' 22' ' ' VAL . . . -123.13 83.55 2.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.181 -0.95 . . . . 0.0 110.876 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.22 120.22 41.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.263 -0.898 . . . . 0.0 109.648 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -154.91 168.03 28.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.175 -0.953 . . . . 0.0 110.833 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 t -90.96 131.63 36.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.448 -0.783 . . . . 0.0 110.278 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 76.7 t80 -116.35 -179.73 3.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.557 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.1 t -133.37 158.1 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 120.858 -1.151 . . . . 0.0 110.01 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.458 ' O ' HG22 ' A' ' 67' ' ' VAL . 29.1 m -129.42 126.72 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.153 -0.967 . . . . 0.0 110.818 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 134.99 47.83 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.206 -0.934 . . . . 0.0 109.888 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -73.91 -45.86 47.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.218 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.4 m -135.12 152.11 51.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.939 . . . . 0.0 110.066 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.578 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 8.8 p90 -169.68 148.19 3.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.928 . . . . 0.0 110.317 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.61 124.77 17.32 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.146 -0.971 . . . . 0.0 109.395 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.539 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -110.14 167.6 12.77 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.505 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 12.6 t -173.52 154.35 2.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.658 -0.907 . . . . 0.0 108.909 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.492 ' O ' ' CA ' ' A' ' 79' ' ' THR . 1.0 OUTLIER -126.44 158.03 68.58 Favored Pre-proline 0 N--CA 1.486 1.369 0 O-C-N 120.554 -1.341 . . . . 0.0 112.42 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -81.99 -48.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.513 1.796 . . . . 0.0 108.659 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -87.59 -27.16 22.7 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' ' 79' ' ' THR . . . -99.8 -9.86 48.2 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.492 ' CA ' ' O ' ' A' ' 75' ' ' THR . 0.5 OUTLIER 67.28 162.55 0.13 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.361 -1.081 . . . . 0.0 110.919 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 37.5 Cg_endo -63.21 114.17 2.36 Favored 'Trans proline' 0 C--N 1.301 -1.951 0 O-C-N 124.364 1.718 . . . . 0.0 111.088 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.5 t -87.59 -62.24 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.489 -0.757 . . . . 0.0 110.019 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.23 -153.37 11.22 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.3 m -74.31 159.77 31.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -1.166 . . . . 0.0 110.033 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.539 ' CG2' ' HA3' ' A' ' 73' ' ' GLY . 88.0 t -125.82 156.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.183 -0.948 . . . . 0.0 110.297 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -156.19 130.92 9.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.19 -0.944 . . . . 0.0 110.381 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.51 ' SG ' ' CB ' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -90.52 7.89 36.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 109.978 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.53 -47.44 69.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.343 -0.848 . . . . 0.0 110.247 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.0 t -113.32 -0.04 14.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 110.174 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -103.46 -163.71 1.01 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.224 -0.923 . . . . 0.0 110.278 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.7 133.23 56.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 110.136 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.56 111.25 23.72 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.184 -0.948 . . . . 0.0 110.016 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -121.49 140.43 52.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.131 -0.981 . . . . 0.0 110.64 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.1 tp -112.84 141.42 46.67 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.435 -0.791 . . . . 0.0 109.244 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.24 167.73 32.41 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.08 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 33' ' ' ILE . . . -155.01 168.52 26.72 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.602 -0.94 . . . . 0.0 109.173 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.3 175.95 26.07 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.166 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 30' ' ' THR . 28.7 t30 -148.37 172.19 14.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -1.081 . . . . 0.0 109.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.99 -10.51 14.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 0.0 110.318 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.96 -43.58 7.1 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.606 HD21 ' CE2' ' A' ' 31' ' ' TYR . 2.3 pt? -154.12 -160.86 1.14 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -1.193 . . . . 0.0 110.436 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.516 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 3.4 m-20 -149.91 113.46 4.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.286 -0.884 . . . . 0.0 110.294 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.445 HD12 ' CD2' ' A' ' 31' ' ' TYR . 96.9 mt -71.58 -54.47 10.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 110.202 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.77 -160.34 27.71 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 7.5 p80 -158.35 140.62 14.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.267 -1.137 . . . . 0.0 109.999 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.9 t -103.04 124.1 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.112 -0.992 . . . . 0.0 110.587 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.61 103.21 3.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.256 -0.902 . . . . 0.0 109.956 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.414 ' HB3' HD13 ' A' ' 12' ' ' LEU . 12.8 mt -83.01 127.61 33.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.21 -0.931 . . . . 0.0 110.314 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.4 m -94.61 171.18 8.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.205 -0.935 . . . . 0.0 110.297 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -145.25 154.49 42.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.391 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 120.723 0.297 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.539 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . 44.3 Cg_endo -69.36 -178.92 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.99 1.521 . . . . 0.0 109.873 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 23' ' ' SER . . . -156.6 149.12 23.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.863 -1.148 . . . . 0.0 111.552 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -151.14 107.07 3.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.597 -0.689 . . . . 0.0 109.322 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.48 151.35 43.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.968 -1.083 . . . . 0.0 111.51 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.462 HG21 HG22 ' A' ' 20' ' ' VAL . 7.8 p -133.12 132.77 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.642 -0.661 . . . . 0.0 109.425 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.612 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -63.22 -66.74 1.36 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.038 -1.039 . . . . 0.0 110.839 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 50.9 Cg_endo -73.44 83.29 1.52 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.6 1.316 . . . . 0.0 110.667 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.7 4.62 53.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.112 -0.992 . . . . 0.0 110.005 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.8 p -151.75 170.38 19.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.95 55.92 28.19 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.466 HD12 ' HB3' ' A' ' 107' ' ' LEU . 58.0 mt -107.86 145.38 33.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -1.081 . . . . 0.0 109.953 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 0.4 OUTLIER -119.55 158.11 26.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 110.541 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 14' ' ' ASP . 41.0 t0 -59.34 124.04 18.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.894 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.01 -32.01 6.78 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 13' ' ' SER . 37.9 tt0 -56.9 146.38 26.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.305 -1.115 . . . . 0.0 109.985 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 11.3 m -102.37 153.22 20.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.57 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 65' ' ' PHE . 6.3 m -116.8 153.32 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.337 -0.852 . . . . 0.0 109.818 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -97.79 109.18 21.98 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.16 -0.962 . . . . 0.0 110.055 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.462 HG22 HG21 ' A' ' 6' ' ' VAL . 46.2 t -111.17 157.6 11.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 121.435 -0.791 . . . . 0.0 109.846 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 m -150.59 117.3 5.81 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.257 -0.902 . . . . 0.0 110.383 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 t -105.25 123.7 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 0.0 109.892 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 3' ' ' ALA . 0.1 OUTLIER -132.86 155.76 48.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.995 -1.066 . . . . 0.0 110.499 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 106.63 -35.74 4.85 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.483 ' HB3' HG23 ' A' ' 55' ' ' THR . . . -68.34 -150.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.306 -1.114 . . . . 0.0 109.747 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.54 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . 176.19 147.68 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.859 -1.151 . . . . 0.0 111.339 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -39.41 143.28 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.611 0.72 . . . . 0.0 110.415 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.45 18.47 14.49 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.478 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 4.5 tp10 -151.02 135.64 17.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.227 -1.161 . . . . 0.0 110.745 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 3.7 m -114.3 145.15 42.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 24.5 m-85 -128.34 179.58 5.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -0.95 . . . . 0.0 110.504 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -132.33 100.69 5.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.208 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.521 ' CG2' ' O ' ' A' ' 33' ' ' ILE . 7.6 tt -89.0 103.25 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -0.922 . . . . 0.0 110.134 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -138.7 163.24 32.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.139 -0.975 . . . . 0.0 110.555 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.458 ' HB3' HD13 ' A' ' 93' ' ' LEU . 18.0 pt20 -128.77 148.75 50.88 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.16 -0.962 . . . . 0.0 110.269 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 1.8 m -145.5 172.93 12.51 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.213 -0.929 . . . . 0.0 110.389 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.25 161.57 35.87 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.533 -0.729 . . . . 0.0 109.409 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.4 171.78 15.48 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.713 1.375 . . . . 0.0 110.329 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 40' ' ' GLY . 2.8 t -144.08 60.58 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.1 -1.0 . . . . 0.0 110.402 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' VAL . . . 43.37 40.19 4.6 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.07 -68.36 0.23 Allowed Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.006 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.59 -151.45 0.48 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.443 -1.034 . . . . 0.0 109.588 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 1.8 p30 -138.89 124.81 19.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.833 -1.167 . . . . 0.0 110.363 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.492 ' CB ' HG23 ' A' ' 84' ' ' VAL . . . -108.49 147.12 32.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.37 -0.832 . . . . 0.0 109.163 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 12.2 t -124.14 170.41 10.73 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.793 -1.192 . . . . 0.0 111.007 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 8.4 t-20 -105.76 119.61 51.91 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 109.995 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.79 -35.04 3.62 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.871 1.459 . . . . 0.0 110.41 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.14 73.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.276 -0.89 . . . . 0.0 110.213 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.6 p -75.65 -16.71 60.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.317 -0.865 . . . . 0.0 109.983 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -76.26 87.93 3.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.837 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 33' ' ' ILE . 12.0 t -112.46 148.4 34.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.264 -0.898 . . . . 0.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 p -93.58 132.46 37.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.35 -0.844 . . . . 0.0 109.86 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.528 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 35.3 p90 -133.34 124.51 27.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.12 -0.988 . . . . 0.0 110.698 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.45 ' OG1' HG22 ' A' ' 30' ' ' THR . 47.3 m -89.22 153.87 20.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 110.345 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.483 HG23 ' HB3' ' A' ' 25' ' ' ALA . 1.8 p -61.67 -158.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.297 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 9.2 m-20 -149.18 -160.24 1.15 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.853 -1.154 . . . . 0.0 110.675 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.51 76.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.163 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.8 m -85.9 13.3 7.65 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.54 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 54.25 23.58 26.18 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.94 114.94 28.64 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.456 -1.026 . . . . 0.0 110.434 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.28 80.01 1.27 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.505 -0.747 . . . . 0.0 110.096 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -103.67 143.92 32.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.431 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -172.79 169.78 4.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.135 -0.978 . . . . 0.0 111.055 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.62 92.45 8.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.31 -0.869 . . . . 0.0 110.112 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.521 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 77.7 t80 -73.39 -174.97 1.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.438 -0.789 . . . . 0.0 109.505 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.521 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.1 t -138.66 155.42 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.883 -1.136 . . . . 0.0 109.561 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 18' ' ' VAL . 33.0 m -136.28 144.9 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.032 -1.043 . . . . 0.0 110.535 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.01 138.43 50.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -0.843 . . . . 0.0 110.228 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -64.16 -58.76 5.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.865 . . . . 0.0 110.234 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 p -130.04 155.23 46.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.269 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 11.0 p90 -168.35 158.3 9.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 109.796 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.58 127.59 32.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.157 -0.965 . . . . 0.0 110.191 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.496 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -96.05 168.1 25.7 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 13.2 t 177.74 146.4 0.13 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.182 -1.187 . . . . 0.0 110.308 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.8 p -66.59 154.79 90.53 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.245 -0.909 . . . . 0.0 110.173 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -80.44 12.07 2.68 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.012 1.532 . . . . 0.0 110.74 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.421 ' OE1' ' C ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -114.54 -72.14 0.71 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.132 -0.98 . . . . 0.0 110.296 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.91 56.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 53.3 m -156.04 92.9 2.56 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.291 -1.123 . . . . 0.0 110.168 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.56 138.49 29.64 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.992 1.522 . . . . 0.0 110.027 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.0 t -108.37 -33.64 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.936 . . . . 0.0 110.58 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.95 -171.65 29.93 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.9 p -68.98 166.51 17.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.401 -1.058 . . . . 0.0 110.454 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.496 ' CG2' ' HA3' ' A' ' 73' ' ' GLY . 53.0 t -138.53 142.34 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.34 -0.85 . . . . 0.0 109.635 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.3 137.92 41.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.017 -1.052 . . . . 0.0 110.672 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 91' ' ' CYS . 65.1 m -93.19 27.48 2.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.44 -51.55 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.44 -0.787 . . . . 0.0 109.976 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.416 HG21 ' N ' ' A' ' 89' ' ' ALA . 4.4 t -97.64 -20.25 17.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.35 -0.843 . . . . 0.0 109.654 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.416 ' N ' HG21 ' A' ' 88' ' ' THR . . . -96.79 -161.85 0.91 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.361 -0.837 . . . . 0.0 109.77 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.49 130.88 56.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 110.59 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 86' ' ' CYS . 0.5 OUTLIER -107.3 116.39 31.85 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.342 -0.849 . . . . 0.0 109.551 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 91' ' ' CYS . 42.9 m-20 -130.77 136.35 48.63 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.966 -1.084 . . . . 0.0 111.268 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 35' ' ' GLN . 2.6 tp -107.12 118.27 36.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.491 -0.756 . . . . 0.0 109.671 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -111.21 161.3 12.84 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.28 170.82 17.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.337 -1.096 . . . . 0.0 110.195 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.32 167.96 12.65 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 100' ' ' LEU . 4.2 p-10 -118.4 -151.12 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 110.405 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.18 89.59 4.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.229 -0.919 . . . . 0.0 110.377 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.56 -21.53 3.59 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.531 ' CD1' ' HG ' ' A' ' 102' ' ' LEU . 2.9 tm? -103.81 -76.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.379 -1.071 . . . . 0.0 109.913 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 100' ' ' LEU . 4.3 t70 70.09 138.29 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.207 -0.933 . . . . 0.0 110.726 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.539 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 4.2 mt -133.0 -42.13 0.9 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.423 -0.798 . . . . 0.0 110.372 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.81 -149.01 20.39 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 14.2 p80 -158.74 134.39 8.78 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.253 -1.146 . . . . 0.0 110.312 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.16 161.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.387 -0.821 . . . . 0.0 109.593 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.98 124.93 48.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 0.0 110.242 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.466 ' HB3' HD12 ' A' ' 12' ' ' LEU . 79.3 mt -100.78 85.82 2.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.619 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.5 m -68.42 162.94 24.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.756 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.458 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 5.2 m-85 -136.52 75.76 1.56 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.144 -0.972 . . . . 0.0 110.382 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.358 0 CA-C-O 118.025 -1.43 . . . . 0.0 109.623 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.763 0.316 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 49.3 Cg_endo -75.24 -176.85 3.12 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.914 1.481 . . . . 0.0 110.425 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -162.21 79.49 0.52 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.126 -0.984 . . . . 0.0 110.527 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -91.37 114.9 27.55 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.056 -1.028 . . . . 0.0 109.718 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.6 p -150.81 152.44 33.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.044 -1.035 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.52 ' CG1' HG12 ' A' ' 105' ' ' VAL . 8.0 p -120.37 123.31 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.569 -0.707 . . . . 0.0 109.574 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.594 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.1 m -45.94 -67.95 0.34 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.999 . . . . 0.0 110.122 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 48.6 Cg_endo -76.15 78.98 3.04 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.342 1.18 . . . . 0.0 110.014 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.59 6.57 45.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 110.282 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -158.24 148.51 20.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.928 . . . . 0.0 110.338 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.63 67.61 1.92 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 8' ' ' PRO . 11.8 mt -122.22 173.62 7.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.387 -1.067 . . . . 0.0 110.162 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -137.83 157.3 46.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.158 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -60.82 109.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.135 -0.978 . . . . 0.0 110.26 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.85 -39.34 2.82 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -46.38 141.07 3.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.145 -1.209 . . . . 0.0 109.941 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.78 152.99 21.02 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.952 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.525 HG12 ' CG1' ' A' ' 67' ' ' VAL . 5.6 m -126.98 166.44 23.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.4 t -119.36 130.34 55.29 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.141 -0.974 . . . . 0.0 110.174 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.9 t -117.25 144.6 24.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 O-C-N 121.602 -0.686 . . . . 0.0 109.792 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 40.2 t -150.99 134.52 16.31 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.296 -0.878 . . . . 0.0 110.494 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 22.5 t -122.66 111.9 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.764 . . . . 0.0 110.092 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 58.8 m -125.47 113.34 17.36 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.083 -1.011 . . . . 0.0 111.068 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 154.16 -38.11 0.69 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.469 ' HB1' HG23 ' A' ' 55' ' ' THR . . . -69.49 -141.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -1.146 . . . . 0.0 109.807 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.558 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . 176.0 160.31 0.3 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.152 -0.968 . . . . 0.0 110.445 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.76 133.35 31.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.735 . . . . 0.0 110.417 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.437 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 127.35 12.17 3.19 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.524 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 73.5 mm-40 -152.18 144.61 24.09 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.949 -1.324 . . . . 0.0 110.545 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 53' ' ' PHE . 23.7 m -122.36 148.37 45.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.416 -0.803 . . . . 0.0 109.791 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.525 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 9.6 m-85 -140.02 -177.14 4.86 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.07 -1.018 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.578 ' CD1' ' HB3' ' A' ' 52' ' ' SER . 19.0 m-85 -132.81 124.83 28.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.463 ' O ' HG21 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -108.53 117.0 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.877 -1.14 . . . . 0.0 110.916 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.53 151.16 30.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 110.471 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -103.1 135.22 45.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.382 -0.824 . . . . 0.0 109.529 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 1.5 m -146.58 173.06 12.67 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.082 -1.011 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.433 ' HB3' ' OH ' ' A' ' 71' ' ' TYR . . . -151.02 152.35 31.3 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.524 -0.735 . . . . 0.0 109.466 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.41 156.41 61.71 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.689 1.363 . . . . 0.0 110.96 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.51 ' CG1' HG13 ' A' ' 81' ' ' VAL . 4.8 m -124.36 -167.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.489 -0.757 . . . . 0.0 110.109 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.99 18.97 10.81 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 42' ' ' GLN . . . -146.36 -57.36 0.02 OUTLIER Glycine 0 N--CA 1.489 2.226 0 O-C-N 120.929 -1.336 . . . . 0.0 110.171 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 41' ' ' GLY . 8.3 mp0 -143.58 -108.36 0.12 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.149 -1.206 . . . . 0.0 110.215 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -149.47 134.33 17.88 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.997 -1.064 . . . . 0.0 110.229 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.414 ' CB ' ' HA3' ' A' ' 73' ' ' GLY . . . -126.85 152.22 47.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.863 . . . . 0.0 109.801 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 10.4 t -129.56 165.16 22.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 110.283 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -86.86 112.06 44.59 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.194 -0.941 . . . . 0.0 110.109 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.7 Cg_endo -74.49 -27.65 10.85 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.94 1.495 . . . . 0.0 110.661 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.46 -23.62 67.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.171 -0.956 . . . . 0.0 110.285 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.9 p -113.1 26.62 10.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.208 -0.932 . . . . 0.0 110.375 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.7 143.36 33.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.22 -0.925 . . . . 0.0 110.068 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.463 HG22 HG21 ' A' ' 33' ' ' ILE . 7.5 t -170.35 137.33 1.45 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.015 . . . . 0.0 110.627 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.578 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 5.4 p -107.6 155.79 19.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.305 -0.872 . . . . 0.0 110.548 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' A' ' 31' ' ' TYR . 12.3 p90 -151.93 -178.31 6.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.167 -0.958 . . . . 0.0 110.556 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.441 HG21 ' O ' ' A' ' 29' ' ' GLU . 31.2 m -141.16 168.67 19.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.458 -0.776 . . . . 0.0 109.64 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.469 HG23 ' HB1' ' A' ' 25' ' ' ALA . 1.0 OUTLIER -74.2 -164.7 0.26 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.956 -1.09 . . . . 0.0 110.462 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.35 -162.18 1.31 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.858 . . . . 0.0 109.779 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.04 -58.0 10.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -0.962 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 p -90.7 23.71 2.98 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.325 -0.859 . . . . 0.0 108.962 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.558 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 57.61 39.35 90.88 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -106.86 124.44 49.62 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.34 -1.094 . . . . 0.0 110.564 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.29 84.43 2.15 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.342 -0.849 . . . . 0.0 109.504 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 57.1 m -110.94 120.76 43.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 110.526 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.634 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 2.2 p90 -143.82 170.98 14.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 110.649 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 p -93.32 122.15 35.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.376 -0.828 . . . . 0.0 110.671 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -116.87 -169.62 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.489 -0.757 . . . . 0.0 109.206 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 t -145.51 165.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.8 -1.188 . . . . 0.0 109.623 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.525 ' CG1' HG12 ' A' ' 18' ' ' VAL . 34.2 m -130.43 152.95 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.069 -1.019 . . . . 0.0 110.789 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.434 ' HD3' ' C ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -133.42 150.46 51.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.339 -0.851 . . . . 0.0 109.96 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.555 ' CE ' ' CD1' ' A' ' 109' ' ' PHE . 3.2 ttmt -83.42 -36.99 23.81 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.097 -1.002 . . . . 0.0 110.553 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 p -136.04 150.01 49.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.197 -0.94 . . . . 0.0 110.092 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.505 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 16.4 p90 -161.34 166.11 27.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.254 -0.904 . . . . 0.0 110.328 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -88.53 117.53 27.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.218 -0.926 . . . . 0.0 110.061 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 74' ' ' SER . . . -101.37 154.78 19.02 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 2.5 p 171.22 130.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.312 -1.111 . . . . 0.0 110.017 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 79' ' ' THR . 22.9 p -84.45 143.68 41.96 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 110.48 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 75' ' ' THR . 49.9 Cg_endo -88.93 21.29 0.99 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.067 1.562 . . . . 0.0 110.713 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -108.03 -11.42 15.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.064 -1.023 . . . . 0.0 110.547 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.02 23.46 1.61 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.469 ' O ' ' OG1' ' A' ' 75' ' ' THR . 19.9 m -140.49 63.65 22.12 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.123 -1.222 . . . . 0.0 110.258 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.04 145.82 50.73 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.946 1.498 . . . . 0.0 110.199 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.51 HG13 ' CG1' ' A' ' 39' ' ' VAL . 56.2 t -112.02 -44.69 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.95 . . . . 0.0 110.619 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.21 -150.75 18.54 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m -57.53 148.92 22.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.443 -1.033 . . . . 0.0 110.593 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.426 ' CG1' ' CZ ' ' A' ' 71' ' ' TYR . 49.4 t -139.18 102.8 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.383 -0.823 . . . . 0.0 109.806 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -93.88 126.06 38.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.369 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 3.5 m -85.92 4.13 38.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.821 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.17 -63.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 109.991 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.3 t -72.85 -33.86 66.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.268 -0.895 . . . . 0.0 110.009 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.35 -177.77 4.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.326 -0.859 . . . . 0.0 109.919 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.48 139.17 38.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.373 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.34 130.47 54.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.64 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.422 ' ND2' ' N ' ' A' ' 92' ' ' ASN . 3.1 m-80 -133.93 163.69 28.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 110.796 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 35' ' ' GLN . 41.2 tp -127.58 111.12 13.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 0.0 109.214 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -101.27 165.49 18.36 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.056 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -157.38 101.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -1.072 . . . . 0.0 110.105 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 31' ' ' TYR . . . -178.83 174.88 46.96 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.489 ' CG ' ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -123.46 -155.01 0.63 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.068 -1.254 . . . . 0.0 109.88 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.489 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 11.3 p -99.97 78.14 2.08 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.31 -36.19 0.24 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.155 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.469 HD11 ' OH ' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -109.17 -47.52 3.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.908 -1.348 . . . . 0.0 110.744 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 100' ' ' LEU . 33.7 m-20 54.27 105.79 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.293 -0.88 . . . . 0.0 110.12 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 mt -94.43 -60.96 1.6 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 0.0 110.467 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 159.94 -162.5 33.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.431 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 15.7 p80 -151.29 132.39 14.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.295 -1.121 . . . . 0.0 110.261 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.52 HG12 ' CG1' ' A' ' 6' ' ' VAL . 16.1 t -87.2 130.1 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.188 -0.945 . . . . 0.0 110.011 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.56 123.2 28.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.0 110.16 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 39.4 mt -92.89 170.06 9.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 0.0 110.586 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 85.3 m -141.74 171.82 13.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.408 -0.807 . . . . 0.0 109.794 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.555 ' CD1' ' CE ' ' A' ' 69' ' ' LYS . 3.0 m-85 -146.08 115.76 7.24 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.861 . . . . 0.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 120.735 0.303 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.02 -157.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.051 1.553 . . . . 0.0 110.133 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' SER . . . -140.49 129.57 23.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 110.52 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -148.96 99.23 2.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 0.0 109.538 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.5 p -148.01 148.27 30.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.468 ' CG1' HG13 ' A' ' 105' ' ' VAL . 10.1 p -106.15 159.52 6.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.609 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -74.15 -71.01 0.23 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.889 -1.132 . . . . 0.0 109.832 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 55.4 Cg_endo -77.8 84.68 1.94 Allowed 'Trans proline' 0 C--N 1.322 -0.853 0 O-C-N 123.209 1.11 . . . . 0.0 110.366 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.92 -14.2 61.02 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.89 -1.131 . . . . 0.0 109.667 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.8 t -139.58 162.29 35.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.627 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.24 47.49 10.83 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.474 HD22 HG13 ' A' ' 18' ' ' VAL . 14.0 mt -101.28 170.67 8.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.383 -1.069 . . . . 0.0 109.962 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 m -145.61 162.16 38.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.041 -1.037 . . . . 0.0 111.012 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.41 125.64 24.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.24 -26.8 7.43 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.467 ' OE1' ' N ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -51.22 138.62 20.28 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.345 -1.091 . . . . 0.0 110.29 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.467 ' N ' ' OE1' ' A' ' 16' ' ' GLN . 1.3 t -99.76 122.13 42.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.464 -0.773 . . . . 0.0 109.88 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.495 HG22 HG13 ' A' ' 67' ' ' VAL . 34.9 m -98.9 168.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.981 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.448 ' O ' HG21 ' A' ' 6' ' ' VAL . 3.7 m -116.44 120.48 38.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.975 . . . . 0.0 110.24 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.78 152.52 8.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.347 -0.845 . . . . 0.0 109.945 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.7 t -142.45 125.0 15.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 48.2 t -116.01 147.51 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.455 -0.778 . . . . 0.0 109.819 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 3' ' ' ALA . 11.8 t -160.24 153.55 22.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.082 -1.012 . . . . 0.0 110.189 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.34 -47.18 1.07 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.502 ' CB ' HG23 ' A' ' 55' ' ' THR . . . -60.22 -154.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.322 -1.105 . . . . 0.0 110.204 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.539 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -176.11 143.57 0.55 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 110.481 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -30.77 130.72 0.1 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.43 0.633 . . . . 0.0 111.236 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.442 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 112.61 6.37 23.38 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.468 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 1.6 mt-10 -131.81 121.37 24.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.12 -1.223 . . . . 0.0 110.278 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.576 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 57.6 m -104.22 147.15 27.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.986 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 30' ' ' THR . 16.2 m-85 -134.7 168.66 18.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.909 . . . . 0.0 110.4 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 17.7 m-85 -126.53 118.59 25.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.347 -0.846 . . . . 0.0 109.698 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.513 ' CG2' HG22 ' A' ' 51' ' ' THR . 7.8 tt -98.63 124.37 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 110.555 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.67 155.67 37.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.852 . . . . 0.0 110.235 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.415 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 26.6 tt0 -110.03 142.62 41.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 70.9 m -148.78 163.46 37.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.974 -1.079 . . . . 0.0 110.772 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.41 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . . . -146.13 166.16 18.01 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.519 -0.738 . . . . 0.0 109.42 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 37' ' ' ALA . 43.5 Cg_endo -71.54 163.49 38.83 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.736 1.387 . . . . 0.0 110.464 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.36 69.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.175 -0.953 . . . . 0.0 110.477 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.38 9.15 87.24 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.2 -57.81 0.52 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.34 -150.89 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.335 -1.097 . . . . 0.0 109.898 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -150.41 116.69 5.69 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.147 -0.971 . . . . 0.0 110.418 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.04 173.4 9.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.54 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.0 m -140.76 154.98 46.51 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.027 -1.046 . . . . 0.0 111.061 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.573 ' OD1' ' CG ' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -89.51 116.41 66.27 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.35 -0.844 . . . . 0.0 110.082 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -85.2 -31.17 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.876 1.461 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.11 -10.53 54.71 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.311 -0.868 . . . . 0.0 110.663 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.439 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 63.6 p -124.95 25.5 7.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.094 -1.004 . . . . 0.0 110.399 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.79 108.54 18.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.068 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.513 HG22 ' CG2' ' A' ' 33' ' ' ILE . 10.1 t -130.95 157.15 43.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.892 . . . . 0.0 110.421 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.478 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 74.2 p -126.51 152.88 45.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.848 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 12.1 p90 -148.3 -179.6 7.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.422 -0.799 . . . . 0.0 109.549 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.6 m -143.33 161.23 38.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.937 -1.102 . . . . 0.0 110.306 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.502 HG23 ' CB ' ' A' ' 25' ' ' ALA . 21.8 p -65.11 -154.66 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.342 -0.849 . . . . 0.0 109.966 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.27 -158.8 0.65 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.142 -0.974 . . . . 0.0 110.422 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.7 -48.71 80.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.889 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.32 9.35 11.08 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.338 -0.852 . . . . 0.0 109.438 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 54.98 51.47 53.45 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.74 152.36 47.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.309 -1.112 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.22 81.79 1.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.577 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.3 m -104.0 118.79 37.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 20.1 p90 -155.16 177.54 11.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.135 -0.978 . . . . 0.0 111.073 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.31 131.3 41.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.644 -0.66 . . . . 0.0 110.445 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.473 ' O ' HG22 ' A' ' 18' ' ' VAL . 59.3 t80 -121.88 137.07 54.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.452 -0.78 . . . . 0.0 108.989 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.5 154.02 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.495 HG13 HG22 ' A' ' 18' ' ' VAL . 26.9 m -139.17 151.66 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.498 -0.751 . . . . 0.0 110.273 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.88 179.29 4.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.177 -0.952 . . . . 0.0 110.73 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.446 ' HG3' ' CE2' ' A' ' 109' ' ' PHE . 24.0 tttm -100.96 -30.43 11.65 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.777 0.799 . . . . 0.0 108.899 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.55 163.92 37.26 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.573 ' CG ' ' OD1' ' A' ' 46' ' ' ASN . 16.6 p90 -170.9 156.57 5.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.913 -1.117 . . . . 0.0 110.031 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 m -71.84 136.98 47.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.185 -0.947 . . . . 0.0 110.715 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -106.87 162.74 13.46 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.0 t -149.61 168.12 24.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.241 -1.152 . . . . 0.0 110.172 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.464 HG21 ' CG2' ' A' ' 81' ' ' VAL . 17.5 p -97.02 161.28 26.83 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.965 . . . . 0.0 110.41 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.93 -17.5 17.52 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.104 1.581 . . . . 0.0 110.746 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -78.89 -37.03 41.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.183 -0.948 . . . . 0.0 110.564 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.26 50.29 0.18 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.452 ' O ' ' OG1' ' A' ' 75' ' ' THR . 1.6 m -148.55 135.97 10.81 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.357 -1.084 . . . . 0.0 109.856 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.97 158.07 46.44 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.037 1.546 . . . . 0.0 110.269 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.464 ' CG2' HG21 ' A' ' 75' ' ' THR . 21.2 t -130.37 -46.79 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 110.249 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.3 -156.17 27.93 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 p -105.59 136.71 44.68 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.185 -1.185 . . . . 0.0 110.35 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG11 ' N ' ' A' ' 85' ' ' ASP . 95.5 t -98.78 160.52 3.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.359 -0.838 . . . . 0.0 109.643 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.412 ' N ' HG11 ' A' ' 84' ' ' VAL . 41.1 t0 -153.14 134.82 14.5 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 110.546 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 67.7 m -95.07 14.16 22.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.982 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.06 -45.16 9.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.258 -0.901 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.425 HG21 ' N ' ' A' ' 89' ' ' ALA . 15.2 t -98.84 -16.75 18.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.313 -0.867 . . . . 0.0 110.142 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.425 ' N ' HG21 ' A' ' 88' ' ' THR . . . -108.59 -143.59 0.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.861 . . . . 0.0 110.195 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.39 155.64 35.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 110.01 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.77 125.27 29.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.289 -0.882 . . . . 0.0 109.904 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 20.6 p30 -134.25 137.06 44.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 110.418 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 104' ' ' HIS . 1.4 tp -108.41 137.19 46.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.687 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.521 ' HA3' ' ND1' ' A' ' 104' ' ' HIS . . . -134.72 159.86 24.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -134.34 156.39 48.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.374 -1.074 . . . . 0.0 110.052 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 32' ' ' TYR . . . 142.42 162.99 9.48 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.428 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 14.1 p-10 -133.49 -151.01 0.43 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.203 -1.175 . . . . 0.0 110.455 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 p -91.7 95.1 9.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.307 -0.871 . . . . 0.0 110.274 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 132.91 -18.45 4.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.516 HD21 ' N ' ' A' ' 101' ' ' ASP . 8.0 tt -154.93 151.42 28.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.172 -1.193 . . . . 0.0 110.442 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.516 ' N ' HD21 ' A' ' 100' ' ' LEU . 1.8 p30 -135.6 162.58 32.31 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.375 -0.828 . . . . 0.0 109.796 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.6 mt -119.57 -85.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.102 -0.999 . . . . 0.0 110.397 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.539 ' C ' ' CD2' ' A' ' 104' ' ' HIS . . . -168.84 -169.24 32.0 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 103' ' ' GLY . 38.1 m-70 -142.74 120.49 11.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -1.134 . . . . 0.0 110.234 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.468 HG13 ' CG1' ' A' ' 6' ' ' VAL . 85.4 t -89.39 129.12 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -0.877 . . . . 0.0 109.853 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.3 112.12 11.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.044 -1.035 . . . . 0.0 110.434 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.428 HD23 HD12 ' A' ' 12' ' ' LEU . 72.0 mt -87.58 172.64 9.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 110.037 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.428 ' OG1' ' C ' ' A' ' 107' ' ' LEU . 1.4 m -162.8 159.64 24.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.286 -0.884 . . . . 0.0 110.117 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.446 ' CE2' ' HG3' ' A' ' 69' ' ' LYS . 15.1 m-85 -129.61 164.16 24.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 110.447 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 CA-C-O 117.948 -1.473 . . . . 0.0 109.5 179.991 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 120.879 0.371 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.474 ' HG2' ' HA ' ' A' ' 102' ' ' LEU . 45.2 Cg_endo -73.02 -157.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.978 1.515 . . . . 0.0 110.283 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.52 134.71 55.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.247 -0.908 . . . . 0.0 110.559 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -151.51 113.62 4.52 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.424 -0.797 . . . . 0.0 109.858 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.61 156.84 42.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.011 -1.056 . . . . 0.0 111.046 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.531 ' CG1' ' CB ' ' A' ' 9' ' ' ALA . 4.4 p -118.91 165.26 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.805 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -74.36 -65.25 0.59 Allowed Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.001 -1.062 . . . . 0.0 110.814 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 41.9 Cg_endo -71.08 -79.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.559 1.294 . . . . 0.0 110.827 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.531 ' CB ' ' CG1' ' A' ' 6' ' ' VAL . . . 70.85 19.33 5.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.205 -0.934 . . . . 0.0 110.0 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 t 178.3 148.78 0.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 110.167 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.49 59.71 9.79 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.46 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 1.2 mt -104.39 178.16 4.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.292 -1.123 . . . . 0.0 110.715 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -134.35 142.3 47.17 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.416 -0.803 . . . . 0.0 110.015 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 10.0 p-10 -56.93 106.03 0.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.946 . . . . 0.0 110.272 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.45 -45.1 1.32 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -47.1 157.62 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -1.107 . . . . 0.0 109.703 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -101.09 178.72 4.58 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.361 -0.837 . . . . 0.0 110.443 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.459 HG12 HG13 ' A' ' 67' ' ' VAL . 5.8 m -146.33 152.83 13.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.547 -0.721 . . . . 0.0 109.428 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.41 140.05 32.43 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 109.986 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.514 HG11 ' CZ ' ' A' ' 63' ' ' PHE . 14.7 t -129.1 149.07 33.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.142 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.89 129.07 17.68 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.492 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 23' ' ' SER . 52.1 t -119.92 143.58 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.601 -0.687 . . . . 0.0 109.755 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.43 ' N ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -155.65 177.55 11.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.048 -1.033 . . . . 0.0 110.307 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.74 -38.69 3.15 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.589 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -67.32 -151.43 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.16 -1.2 . . . . 0.0 110.673 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.581 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -172.84 159.15 4.08 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.224 -0.922 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 56' ' ' ASP . . . -50.45 125.38 12.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.541 -0.725 . . . . 0.0 110.463 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.413 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 124.79 13.18 3.79 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 6.5 mm-40 -144.14 120.79 11.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.037 -1.272 . . . . 0.0 110.874 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.4 m -105.06 132.75 50.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.529 -0.732 . . . . 0.0 109.255 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 31.4 m-85 -120.77 173.86 6.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.956 -1.09 . . . . 0.0 111.246 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -130.27 123.35 29.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.658 -0.651 . . . . 0.0 109.697 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.478 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 14.3 tt -100.44 125.2 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.131 -0.98 . . . . 0.0 110.651 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.62 146.53 25.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -0.906 . . . . 0.0 110.604 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -98.78 147.69 24.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.854 . . . . 0.0 109.239 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.6 m -144.35 155.9 44.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.028 -1.045 . . . . 0.0 111.512 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.42 ' HB3' ' OH ' ' A' ' 71' ' ' TYR . . . -154.0 141.33 13.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.38 166.19 24.43 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.63 1.332 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.524 HG12 ' CG2' ' A' ' 84' ' ' VAL . 4.2 m -147.5 172.98 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.312 -0.867 . . . . 0.0 110.591 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -52.77 -46.89 59.56 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.62 -59.23 10.94 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -174.48 -75.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.405 -1.056 . . . . 0.0 110.118 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -143.49 150.16 38.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.182 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.434 ' HB3' HG13 ' A' ' 39' ' ' VAL . . . -147.82 145.01 28.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.487 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 18.4 m -128.23 178.21 6.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.015 . . . . 0.0 110.236 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.456 ' O ' ' CG ' ' A' ' 46' ' ' ASN . 15.3 p-10 -101.44 106.02 43.5 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 50.2 Cg_endo -88.12 -39.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.773 1.407 . . . . 0.0 110.65 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.98 -4.6 17.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 110.631 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -130.6 25.34 5.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.092 -1.005 . . . . 0.0 110.144 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.06 143.24 29.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.303 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.478 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 2.9 t -148.83 162.63 39.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 0.0 109.897 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.0 p -134.56 154.53 51.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.166 -0.959 . . . . 0.0 110.452 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 11.2 p90 -145.41 -177.6 5.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.758 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 29' ' ' GLU . 24.1 m -149.69 160.35 43.6 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 110.399 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.589 ' CG2' ' HB3' ' A' ' 25' ' ' ALA . 2.2 p -77.01 -160.94 0.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.35 -0.844 . . . . 0.0 110.487 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 16.3 p-10 -158.22 -147.38 0.17 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.953 -1.092 . . . . 0.0 111.115 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.569 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -84.72 71.36 10.83 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.056 0.932 . . . . 0.0 108.985 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER 154.67 -13.56 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.581 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.97 66.12 2.12 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.33 129.37 18.55 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.259 -1.142 . . . . 0.0 110.789 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.413 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . . . -130.17 83.9 2.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 110.007 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.4 m -100.35 123.76 44.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.544 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 6.9 p90 -158.77 176.04 12.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.24 -0.912 . . . . 0.0 110.556 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.2 t -101.66 158.7 15.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.721 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 85.7 t80 -147.02 -176.88 5.38 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.562 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.8 t -133.58 158.46 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.386 -1.446 . . . . 0.0 110.5 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.459 HG13 HG12 ' A' ' 18' ' ' VAL . 20.4 m -130.32 159.75 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.782 . . . . 0.0 109.471 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 13.4 mtm180 -143.63 112.01 6.36 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.373 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 68' ' ' ARG . 4.5 ttpm? -44.72 -50.33 10.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 108.875 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.08 111.02 17.77 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 36.1 p90 -121.26 131.84 54.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.213 -0.929 . . . . 0.0 110.816 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 26.1 m -61.64 124.38 20.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.451 -0.781 . . . . 0.0 110.303 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.69 -166.14 34.7 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -173.66 146.84 1.34 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 110.517 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 79' ' ' THR . 77.2 p -96.83 164.17 18.6 Favored Pre-proline 0 C--N 1.304 -1.389 0 O-C-N 121.37 -0.831 . . . . 0.0 110.233 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -81.68 -0.46 10.41 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 124.033 1.544 . . . . 0.0 110.237 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -101.27 29.26 4.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 110.612 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.74 55.59 28.11 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.462 ' O ' ' OG1' ' A' ' 75' ' ' THR . 19.0 m -153.37 113.55 2.64 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.247 -1.149 . . . . 0.0 110.248 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.67 105.39 1.77 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.959 1.505 . . . . 0.0 110.37 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.53 -11.24 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.179 -0.951 . . . . 0.0 110.028 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.21 -157.67 15.08 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.7 m -96.95 148.35 23.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -1.164 . . . . 0.0 110.069 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.524 ' CG2' HG12 ' A' ' 39' ' ' VAL . 98.8 t -108.62 102.08 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.231 -0.918 . . . . 0.0 109.904 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.8 OUTLIER -98.82 120.32 39.06 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.417 -0.802 . . . . 0.0 109.575 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.82 37.26 0.58 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 110.717 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.59 -36.83 43.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.166 -0.958 . . . . 0.0 109.3 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.9 t -109.91 -11.5 14.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.433 -0.792 . . . . 0.0 109.48 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.06 -171.15 1.79 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.396 -0.815 . . . . 0.0 110.158 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.19 128.33 49.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.928 . . . . 0.0 110.14 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.1 m -93.78 151.79 19.37 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.102 -0.999 . . . . 0.0 109.861 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -142.88 123.89 14.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 110.694 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.4 tp -92.49 112.65 24.68 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.521 ' HA3' ' NE2' ' A' ' 104' ' ' HIS . . . -115.44 166.67 12.24 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.253 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.527 ' HB3' ' CD1' ' A' ' 102' ' ' LEU . . . -144.56 162.96 35.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.515 -0.991 . . . . 0.0 110.062 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 130.14 176.06 14.28 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 100' ' ' LEU . 8.3 p-10 -128.89 -156.16 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.249 . . . . 0.0 110.57 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.71 82.25 7.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.536 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 139.8 -35.87 1.88 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.461 ' HB3' ' OD1' ' A' ' 97' ' ' ASN . 4.7 tt -115.2 145.45 42.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -1.18 . . . . 0.0 110.336 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.8 121.61 32.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 110.061 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 95' ' ' ALA . 20.2 mt -77.18 -71.49 0.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.929 . . . . 0.0 110.12 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.36 -173.02 42.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.521 ' NE2' ' HA3' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -147.81 112.28 5.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -1.052 . . . . 0.0 109.895 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.5 t -96.12 121.74 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.174 -0.954 . . . . 0.0 110.339 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.46 132.76 43.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.102 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.9 mt -104.81 141.57 36.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.258 -0.901 . . . . 0.0 110.478 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.7 m -119.07 171.39 8.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.858 . . . . 0.0 109.859 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -147.73 85.98 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.231 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 CA-C-O 118.007 -1.44 . . . . 0.0 109.504 179.91 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.487 ' O ' ' HA3' ' A' ' 24' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.483 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.6 Cg_endo -69.22 165.37 30.59 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.105 1.581 . . . . 0.0 110.609 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 23' ' ' SER . . . -155.85 141.9 18.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.202 -0.936 . . . . 0.0 110.718 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.602 ' CE2' ' CB ' ' A' ' 95' ' ' ALA . 25.2 t80 -150.24 116.92 5.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 t -150.41 164.92 34.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.9 -1.125 . . . . 0.0 111.355 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.477 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 4.8 p -122.2 176.16 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.602 -0.686 . . . . 0.0 109.662 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.6 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.3 m -78.19 -67.54 0.26 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.005 -1.059 . . . . 0.0 110.534 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 42.8 Cg_endo -72.81 -79.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.929 0 O-C-N 123.358 1.188 . . . . 0.0 110.629 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 8' ' ' PRO . . . 72.66 28.37 2.15 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.355 -0.841 . . . . 0.0 110.513 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER 171.05 119.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.19 -0.944 . . . . 0.0 110.231 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.56 66.63 2.02 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.463 HD22 ' HG2' ' A' ' 8' ' ' PRO . 1.5 mp -104.02 159.25 15.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -1.168 . . . . 0.0 110.537 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 29.0 t -107.76 151.3 25.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 110.028 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.4 127.87 33.27 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.225 -0.922 . . . . 0.0 111.164 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.66 -27.64 6.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 2.4 tt0 -52.35 141.89 18.48 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.291 -1.123 . . . . 0.0 110.596 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.54 148.98 22.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.358 -0.839 . . . . 0.0 109.869 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.419 HG21 ' CG1' ' A' ' 67' ' ' VAL . 24.4 m -129.76 179.76 3.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.794 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.19 134.72 55.22 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.382 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.408 HG13 ' CZ ' ' A' ' 63' ' ' PHE . 4.8 t -114.94 150.71 16.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -146.91 124.72 11.9 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.096 -1.003 . . . . 0.0 110.865 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.0 t -113.04 141.3 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.575 -0.703 . . . . 0.0 109.579 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -158.64 144.96 17.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.073 . . . . 0.0 110.666 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 1' ' ' ALA . . . 118.85 -54.1 0.64 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.453 ' CB ' HG23 ' A' ' 55' ' ' THR . . . -59.07 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -1.134 . . . . 0.0 109.833 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.532 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.48 169.99 8.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.066 -1.021 . . . . 0.0 110.323 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -59.97 131.69 51.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.532 -0.73 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.15 16.25 4.0 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.489 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 65.5 mm-40 -149.24 132.72 16.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.166 -1.196 . . . . 0.0 110.385 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.434 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 3.6 m -104.28 162.96 12.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.354 -0.841 . . . . 0.0 110.13 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 74.8 m-85 -150.84 173.23 14.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.207 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 52.8 m-85 -133.97 102.88 5.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 109.324 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 33' ' ' ILE . 8.5 tt -89.56 107.95 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.941 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.95 157.22 43.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.158 -0.964 . . . . 0.0 110.803 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.509 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 2.0 tt0 -95.69 123.56 39.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.645 -0.659 . . . . 0.0 109.88 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.405 ' HA ' ' OH ' ' A' ' 71' ' ' TYR . 1.2 m -137.42 154.1 50.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.235 -0.916 . . . . 0.0 110.101 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.512 ' HB2' ' CB ' ' A' ' 91' ' ' CYS . . . -146.59 166.79 15.52 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 0.0 109.247 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 37' ' ' ALA . 41.4 Cg_endo -69.38 159.03 55.27 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.556 1.293 . . . . 0.0 110.633 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m -144.12 63.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.468 -0.77 . . . . 0.0 110.026 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.88 -29.84 9.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -175.41 -46.77 0.06 OUTLIER Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 5.1 mt-30 -89.24 -166.76 1.68 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.388 -1.066 . . . . 0.0 110.219 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 4.8 p30 -130.7 110.97 11.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 110.34 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.74 157.81 15.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.902 . . . . 0.0 109.755 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.477 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 5.8 t -135.55 165.99 24.24 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.041 -1.037 . . . . 0.0 110.295 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.522 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -83.65 111.65 33.74 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.204 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 48.9 Cg_endo -77.87 -37.53 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.893 1.47 . . . . 0.0 110.32 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.63 98.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.886 . . . . 0.0 110.493 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.434 ' OG1' ' CG ' ' A' ' 46' ' ' ASN . 1.2 p -96.32 3.38 53.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.261 -0.899 . . . . 0.0 110.425 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.85 129.25 39.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.139 -0.975 . . . . 0.0 109.85 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.479 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.3 t -128.24 131.58 48.78 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.13 -0.982 . . . . 0.0 110.762 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.37 138.14 40.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.445 -0.784 . . . . 0.0 109.393 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 15.8 p90 -141.76 172.21 13.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.051 -1.03 . . . . 0.0 110.547 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.435 HG21 ' O ' ' A' ' 29' ' ' GLU . 88.5 m -133.87 162.41 32.11 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 109.375 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.468 ' HB ' ' HA2' ' A' ' 59' ' ' GLY . 0.7 OUTLIER -75.77 -164.74 0.38 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.914 -1.116 . . . . 0.0 110.384 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 27' ' ' ALA . 5.7 m-20 -145.34 -158.31 0.88 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.18 -0.95 . . . . 0.0 109.575 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.27 -50.04 75.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.902 -1.124 . . . . 0.0 109.53 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.4 t -90.36 21.06 4.05 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.349 -0.844 . . . . 0.0 108.813 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.532 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 49.81 32.0 17.39 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.33 140.73 41.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.371 -1.076 . . . . 0.0 110.483 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -145.59 84.96 1.69 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.411 -0.806 . . . . 0.0 109.704 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -99.99 120.95 40.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 109.983 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.2 p90 -150.63 178.39 9.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.223 -0.923 . . . . 0.0 110.831 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.8 p -96.62 139.12 33.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.46 -0.775 . . . . 0.0 111.016 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 50.2 t80 -131.15 176.17 8.49 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.561 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.8 t -124.61 157.09 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 120.727 -1.233 . . . . 0.0 110.299 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.419 ' CG1' HG21 ' A' ' 18' ' ' VAL . 13.8 m -134.9 128.35 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.397 -0.814 . . . . 0.0 109.904 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.498 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -115.82 144.38 44.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 110.343 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -56.94 -39.68 75.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.394 -0.816 . . . . 0.0 109.796 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.74 165.54 33.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.418 -0.801 . . . . 0.0 109.828 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.522 ' CB ' ' OD1' ' A' ' 46' ' ' ASN . 19.2 p90 -166.9 147.41 5.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 110.361 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.6 OUTLIER -66.18 118.58 10.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.038 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.48 179.81 25.7 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -160.44 150.14 17.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.287 -1.125 . . . . 0.0 110.055 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 70.6 p -45.34 164.37 0.19 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 44.9 Cg_endo -72.54 -12.39 26.98 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.094 1.576 . . . . 0.0 110.481 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -86.96 -69.75 0.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 110.199 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.62 51.18 0.03 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 m -141.22 126.66 11.01 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.26 -1.141 . . . . 0.0 110.193 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.31 121.63 6.96 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.814 1.428 . . . . 0.0 110.403 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.39 -17.45 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.295 -0.878 . . . . 0.0 110.068 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.34 -159.65 28.5 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 11.5 p -104.44 169.57 8.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.199 -1.177 . . . . 0.0 110.367 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.9 t -133.6 162.04 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.9 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 16.7 p-10 -160.43 161.97 33.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.963 . . . . 0.0 110.302 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 96.7 m -97.95 11.14 38.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.313 -0.867 . . . . 0.0 110.331 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.96 -42.03 14.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.19 -0.944 . . . . 0.0 110.34 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.4 t -113.49 -1.08 14.23 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.157 -0.965 . . . . 0.0 110.384 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.51 135.67 44.56 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.241 -0.912 . . . . 0.0 110.61 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.77 105.41 5.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.973 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.512 ' CB ' ' HB2' ' A' ' 37' ' ' ALA . 26.7 p -99.39 140.16 33.98 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.086 -1.009 . . . . 0.0 109.66 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 106' ' ' ALA . 19.1 m-20 -131.05 143.29 50.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.114 -0.991 . . . . 0.0 110.837 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.419 ' HA ' HD11 ' A' ' 93' ' ' LEU . 22.6 tp -88.41 99.41 12.25 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -93.07 165.45 27.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.602 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . . . -152.28 80.04 1.24 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.412 -1.051 . . . . 0.0 110.386 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -137.25 -167.59 11.12 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.477 ' O ' ' OG ' ' A' ' 98' ' ' SER . 2.2 p-10 -129.4 -63.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.246 . . . . 0.0 110.627 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 97' ' ' ASN . 19.6 m -170.83 -32.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.125 -0.984 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.77 -13.23 5.15 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.712 -1.233 . . . . 0.0 110.411 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 101' ' ' ASP . 0.9 OUTLIER -94.87 -52.39 4.27 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.972 -1.31 . . . . 0.0 110.532 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.0 p-10 40.61 98.29 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.701 0.762 . . . . 0.0 110.73 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.7 mt -84.45 -45.44 12.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.016 -1.052 . . . . 0.0 110.104 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.56 -161.82 30.0 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.437 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 21.4 p80 -155.06 142.35 19.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -1.153 . . . . 0.0 110.181 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.47 103.8 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.189 -0.944 . . . . 0.0 110.146 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.47 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . . . -50.62 103.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.893 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.509 ' CD1' ' OE1' ' A' ' 35' ' ' GLN . 54.0 mt -82.83 137.01 34.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 110.144 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.9 167.5 10.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.811 . . . . 0.0 110.092 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 12' ' ' LEU . 3.2 m-85 -142.04 166.83 23.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.927 . . . . 0.0 110.324 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.35 0 CA-C-O 118.008 -1.44 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.497 1.921 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 1' ' ' ALA . 48.2 Cg_endo -74.81 -170.78 0.81 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.867 1.456 . . . . 0.0 110.206 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 23' ' ' SER . . . -145.71 145.75 31.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.078 -1.014 . . . . 0.0 110.302 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.475 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 39.0 t80 -151.29 113.04 4.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.226 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.47 151.53 36.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.683 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 19' ' ' SER . 9.2 p -128.48 149.19 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.776 . . . . 0.0 109.743 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -67.27 -66.59 1.14 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.052 -1.03 . . . . 0.0 110.191 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 50.4 Cg_endo -75.65 95.29 1.0 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.46 1.242 . . . . 0.0 110.233 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.83 10.56 32.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.097 -1.002 . . . . 0.0 110.311 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.1 t -168.64 154.54 6.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.899 . . . . 0.0 110.084 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.99 56.49 10.65 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 8' ' ' PRO . 2.7 mt -109.59 166.05 11.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -1.126 . . . . 0.0 110.15 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -128.53 164.34 23.01 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.237 -0.915 . . . . 0.0 110.28 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -62.26 125.45 23.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.316 -0.865 . . . . 0.0 109.94 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 89.61 -31.05 5.38 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.463 ' OE1' ' O ' ' A' ' 17' ' ' SER . 1.5 tm0? -42.4 143.9 0.58 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.417 -1.049 . . . . 0.0 110.014 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.463 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 2.1 p -95.55 167.61 11.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 110.287 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 65' ' ' PHE . 30.6 m -147.82 168.21 4.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.323 -0.861 . . . . 0.0 109.762 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.529 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 0.8 OUTLIER -117.04 137.68 52.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.161 -0.962 . . . . 0.0 110.242 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.483 HG23 HG22 ' A' ' 6' ' ' VAL . 11.5 t -126.32 152.57 33.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.444 -0.785 . . . . 0.0 109.81 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.11 127.55 14.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.381 -0.824 . . . . 0.0 110.169 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 t -119.28 147.63 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.322 -0.861 . . . . 0.0 110.077 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.474 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 6.2 p -155.52 131.99 10.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.132 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 131.21 -54.28 0.79 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.477 ' CB ' HG23 ' A' ' 55' ' ' THR . . . -58.73 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -1.123 . . . . 0.0 109.074 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.535 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.95 156.92 6.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.732 -1.23 . . . . 0.0 110.712 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -43.85 133.08 5.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.7 -0.625 . . . . 0.0 110.133 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 29' ' ' GLU . . . 115.28 11.95 10.26 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 1.8 mt-10 -141.94 116.59 9.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.335 -1.097 . . . . 0.0 110.191 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.2 m -104.21 134.01 48.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.757 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 29' ' ' GLU . 27.4 m-85 -117.88 -174.94 2.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.966 . . . . 0.0 110.81 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 34.5 m-85 -136.07 111.31 9.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.522 -0.736 . . . . 0.0 109.399 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.456 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 3.8 tt -86.86 112.96 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.888 . . . . 0.0 110.773 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.416 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -148.34 162.95 38.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.533 -0.729 . . . . 0.0 109.887 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 14.8 pt20 -116.29 146.07 42.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.925 . . . . 0.0 110.718 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.6 m -137.81 150.79 47.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.264 -0.897 . . . . 0.0 110.169 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.535 ' CB ' ' HB3' ' A' ' 91' ' ' CYS . . . -150.32 173.28 4.44 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.304 -0.873 . . . . 0.0 109.264 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 41.5 Cg_endo -67.71 165.02 29.03 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.736 1.387 . . . . 0.0 110.123 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 p -134.66 56.13 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.26 21.31 56.53 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.21 -63.18 0.22 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.09 -1.528 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -102.69 -160.23 0.77 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.293 -1.122 . . . . 0.0 110.94 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -115.24 122.66 46.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.184 -0.948 . . . . 0.0 110.727 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.442 ' CB ' HG23 ' A' ' 84' ' ' VAL . . . -105.79 160.05 15.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.643 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -134.92 162.92 31.05 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.024 -1.047 . . . . 0.0 110.633 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.483 ' OD1' ' CD2' ' A' ' 71' ' ' TYR . 3.9 m120 -89.34 115.79 64.65 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.855 . . . . 0.0 110.134 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -90.08 -50.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.896 1.472 . . . . 0.0 111.254 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.98 79.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.389 -0.819 . . . . 0.0 111.52 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 22.4 p -82.7 19.25 1.35 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.09 -1.006 . . . . 0.0 111.108 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.1 67.63 9.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.973 -1.08 . . . . 0.0 109.94 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.456 HG23 HG23 ' A' ' 33' ' ' ILE . 2.6 t -79.82 164.34 23.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.359 -0.838 . . . . 0.0 110.432 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 94.2 p -118.44 143.39 46.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.289 -0.882 . . . . 0.0 110.769 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.472 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 31.0 p90 -140.55 128.88 22.49 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.274 -0.891 . . . . 0.0 109.962 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 9.3 m -92.15 168.57 11.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 110.829 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.477 HG23 ' CB ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -78.1 -158.89 0.14 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.465 -0.772 . . . . 0.0 110.339 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.37 -161.71 1.23 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.058 -1.026 . . . . 0.0 109.916 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.27 -53.81 54.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.023 -1.048 . . . . 0.0 109.158 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 60' ' ' ALA . 25.4 p -84.41 11.36 8.67 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.472 -0.767 . . . . 0.0 109.075 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.535 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 69.91 13.42 69.34 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.462 ' HB2' ' OG ' ' A' ' 58' ' ' SER . . . -86.21 121.28 28.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -1.123 . . . . 0.0 110.02 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -118.25 80.79 1.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.977 . . . . 0.0 110.499 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.82 129.63 48.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -0.972 . . . . 0.0 109.924 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 14.8 p90 -168.19 161.49 12.38 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.458 -0.776 . . . . 0.0 110.358 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 m -92.33 133.57 35.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.198 -0.939 . . . . 0.0 110.624 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.573 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 29.2 t80 -121.73 155.35 35.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 109.323 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.573 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 3.5 t -96.96 160.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.805 -1.184 . . . . 0.0 110.521 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 18' ' ' VAL . 29.7 m -131.77 177.24 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 0.0 109.989 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 2.3 mtt180 -150.35 135.69 17.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 0.0 110.501 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 87' ' ' ALA . 0.9 OUTLIER -67.67 -16.88 64.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -0.961 . . . . 0.0 109.234 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.8 p -150.34 156.39 41.43 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.56 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 16.7 p90 -163.72 144.1 8.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.981 -1.074 . . . . 0.0 110.54 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 28.5 m -65.89 132.93 49.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.892 . . . . 0.0 110.026 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -112.69 -177.59 19.74 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.9 p -172.72 160.15 4.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -1.181 . . . . 0.0 110.188 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 79' ' ' THR . 82.6 p -87.69 158.92 50.39 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.277 -0.889 . . . . 0.0 110.361 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -79.14 4.62 6.4 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 124.186 1.624 . . . . 0.0 110.143 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -99.49 27.98 4.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.297 -0.877 . . . . 0.0 110.343 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.63 49.67 76.08 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.465 ' O ' ' OG1' ' A' ' 75' ' ' THR . 22.7 m -155.18 110.73 2.27 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.221 -1.164 . . . . 0.0 110.311 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.46 124.69 10.57 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.987 1.52 . . . . 0.0 110.131 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.409 HG11 ' N ' ' A' ' 82' ' ' GLY . 13.5 p -95.48 -13.43 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.424 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.409 ' N ' HG11 ' A' ' 81' ' ' VAL . . . 140.39 -155.43 24.65 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.8 m -113.54 176.06 5.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.301 -1.117 . . . . 0.0 110.46 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.442 HG23 ' CB ' ' A' ' 44' ' ' ALA . 54.6 t -128.97 162.27 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.455 -0.778 . . . . 0.0 110.044 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.419 ' N ' HG12 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -138.73 102.06 4.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.218 -0.926 . . . . 0.0 110.46 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 2.7 m -74.52 -2.63 26.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.298 -0.876 . . . . 0.0 110.232 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 69' ' ' LYS . . . -46.72 -45.25 19.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.192 -0.942 . . . . 0.0 109.906 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.1 t -116.69 -10.81 11.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.908 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 86' ' ' CYS . . . -94.09 -177.27 4.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.116 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.61 131.84 53.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.903 . . . . 0.0 110.068 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -127.29 139.49 52.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 106' ' ' ALA . 16.0 m-80 -103.85 125.81 50.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.973 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 35' ' ' GLN . 11.7 tp -88.7 101.96 14.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -108.12 171.57 16.17 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -156.67 120.98 4.43 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.437 -1.037 . . . . 0.0 110.297 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.37 176.36 47.95 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -115.8 -76.89 0.57 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -1.135 . . . . 0.0 109.849 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -168.19 -37.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.408 -0.808 . . . . 0.0 110.097 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.38 -12.14 57.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.436 ' C ' ' CD1' ' A' ' 100' ' ' LEU . 2.2 tm? -148.5 90.17 1.77 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -1.161 . . . . 0.0 110.053 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.18 134.86 34.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.478 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 4' ' ' PHE . 71.0 mt -82.69 -70.76 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 0.0 110.034 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.415 ' C ' ' CG ' ' A' ' 104' ' ' HIS . . . 168.38 -162.3 36.07 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.449 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -147.96 129.22 14.7 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.482 -1.011 . . . . 0.0 109.612 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.413 ' O ' ' HG ' ' A' ' 107' ' ' LEU . 93.5 t -98.3 108.48 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.092 -1.005 . . . . 0.0 110.6 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.448 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . . . -57.53 105.51 0.25 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.234 -0.916 . . . . 0.0 110.024 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.431 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 59.4 mt -82.64 164.51 20.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.24 -0.912 . . . . 0.0 110.374 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.5 m -133.15 168.13 19.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.267 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -153.33 167.35 29.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 CA-C-O 117.949 -1.473 . . . . 0.0 109.522 179.988 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.431 ' CB ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.765 0.316 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.438 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 45.3 Cg_endo -73.42 -175.9 2.24 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.892 1.469 . . . . 0.0 110.144 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -134.4 134.98 42.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.047 -1.033 . . . . 0.0 110.581 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 8.1 t80 -141.24 115.45 9.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.468 -0.77 . . . . 0.0 109.531 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.463 ' HA ' HG23 ' A' ' 105' ' ' VAL . 4.0 t -153.1 172.54 16.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.077 -1.014 . . . . 0.0 110.811 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.599 ' CG1' ' CB ' ' A' ' 9' ' ' ALA . 12.0 p -120.8 144.97 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.662 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.583 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -54.66 -62.22 4.46 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.276 -0.89 . . . . 0.0 111.082 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 42.5 Cg_endo -71.85 -78.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.781 1.411 . . . . 0.0 110.629 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.599 ' CB ' ' CG1' ' A' ' 6' ' ' VAL . . . 69.13 14.68 8.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.015 . . . . 0.0 109.879 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.4 t -170.77 148.24 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.336 -0.852 . . . . 0.0 110.297 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.02 56.87 22.28 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.554 ' HB2' ' CE1' ' A' ' 109' ' ' PHE . 58.6 mt -98.28 166.47 11.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -1.129 . . . . 0.0 110.091 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -129.49 155.65 45.39 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.223 -0.923 . . . . 0.0 110.108 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.526 ' OD2' ' CD ' ' A' ' 68' ' ' ARG . 6.9 t70 -61.68 115.97 4.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 110.387 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 94.24 -28.45 10.79 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 0.2 OUTLIER -41.75 144.02 0.45 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.31 -1.112 . . . . 0.0 110.483 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 p -95.35 125.49 40.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.826 . . . . 0.0 110.193 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.49 ' CG2' HG13 ' A' ' 67' ' ' VAL . 35.7 m -104.38 -179.07 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.387 -0.82 . . . . 0.0 110.184 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -136.14 114.61 11.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.786 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.4 t -91.4 152.79 3.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.405 -0.81 . . . . 0.0 110.483 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 t -147.41 130.89 16.71 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.474 -0.766 . . . . 0.0 109.331 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.511 ' HB ' ' CB ' ' A' ' 61' ' ' ALA . 87.9 t -128.54 136.56 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.111 -0.993 . . . . 0.0 110.671 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.413 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 3.3 m -131.51 110.54 11.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.421 -0.799 . . . . 0.0 109.873 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 155.5 -58.14 0.39 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.516 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -57.9 -159.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -1.175 . . . . 0.0 109.664 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.548 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -166.21 159.45 15.14 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.899 -1.126 . . . . 0.0 111.014 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -42.06 136.98 1.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.717 -0.614 . . . . 0.0 110.576 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.41 -6.95 42.6 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 3.3 mm-40 -114.09 103.52 11.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -1.142 . . . . 0.0 110.26 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.442 ' HA ' ' CB ' ' A' ' 54' ' ' THR . 97.1 m -103.82 121.24 42.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.314 -0.866 . . . . 0.0 109.627 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.539 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 9.9 m-85 -107.0 -170.19 1.67 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 0.0 110.662 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 50.0 m-85 -131.58 111.54 11.83 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.491 -0.755 . . . . 0.0 109.505 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -89.63 137.06 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.074 -1.016 . . . . 0.0 111.215 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.83 155.06 35.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.497 -0.752 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -98.59 146.7 25.56 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.224 -0.923 . . . . 0.0 110.463 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 t -156.69 145.5 20.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.094 -1.004 . . . . 0.0 111.186 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.23 142.08 16.54 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.09 165.33 32.25 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 O-C-N 123.73 1.384 . . . . 0.0 110.79 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.68 54.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.435 -0.79 . . . . 0.0 109.719 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 45.06 41.35 7.66 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 167.72 -69.29 0.17 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.646 -1.264 . . . . 0.0 109.984 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -104.89 -164.54 1.05 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.323 -1.104 . . . . 0.0 110.59 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -116.32 143.02 46.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.402 -0.811 . . . . 0.0 110.073 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.493 ' HB2' ' HA3' ' A' ' 73' ' ' GLY . . . -130.26 120.59 24.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.138 -0.976 . . . . 0.0 110.022 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.34 155.58 30.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.98 -1.075 . . . . 0.0 110.707 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -106.61 119.88 50.2 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.434 -0.791 . . . . 0.0 109.8 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -80.35 -22.81 6.65 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.882 1.464 . . . . 0.0 110.692 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.61 -37.82 85.68 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.192 -0.943 . . . . 0.0 110.593 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.9 p -91.99 23.08 3.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.24 -0.912 . . . . 0.0 110.489 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 82.37 4.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 110.567 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.0 t -106.7 170.37 7.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.893 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.514 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 52.8 p -118.46 147.68 43.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.027 -1.046 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.539 ' CE1' ' HB2' ' A' ' 31' ' ' TYR . 5.5 p90 -148.24 -179.19 6.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 109.006 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.442 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 3.1 t -157.33 170.93 21.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.875 -1.14 . . . . 0.0 110.928 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.516 HG21 ' CB ' ' A' ' 25' ' ' ALA . 1.5 p -81.03 -155.66 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.461 -0.774 . . . . 0.0 109.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -157.22 -153.62 0.42 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.728 -1.232 . . . . 0.0 110.803 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 -60.61 3.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.079 -1.013 . . . . 0.0 109.947 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -66.37 -6.76 15.43 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.89 7.23 69.69 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -91.55 119.28 31.34 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.137 -1.213 . . . . 0.0 110.176 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.511 ' CB ' ' HB ' ' A' ' 22' ' ' VAL . . . -92.61 82.27 4.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.893 . . . . 0.0 109.862 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.68 124.47 51.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.28 -0.888 . . . . 0.0 109.897 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -162.78 172.55 15.05 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.675 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.0 t -95.26 130.04 42.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.343 -0.848 . . . . 0.0 110.44 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 91.1 t80 -122.01 172.82 7.95 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.584 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -116.13 152.99 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.622 -1.298 . . . . 0.0 109.945 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.49 HG13 ' CG2' ' A' ' 18' ' ' VAL . 36.0 m -134.33 169.26 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.2 -0.938 . . . . 0.0 110.597 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.526 ' CD ' ' OD2' ' A' ' 14' ' ' ASP . 2.0 mmm-85 -139.59 164.64 29.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.823 . . . . 0.0 109.824 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -93.42 -54.04 3.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.177 -0.952 . . . . 0.0 110.04 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.01 129.27 47.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.288 -0.883 . . . . 0.0 109.88 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 10.0 p90 -138.23 139.88 39.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 0.0 110.492 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -65.72 114.84 5.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 110.032 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.493 ' HA3' ' HB2' ' A' ' 44' ' ' ALA . . . -85.07 170.65 45.49 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 95.7 p -162.47 177.1 9.79 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -1.166 . . . . 0.0 110.574 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.522 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 2.0 p -86.09 172.93 7.57 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.443 -0.786 . . . . 0.0 109.913 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 46.6 Cg_endo -75.36 11.69 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.727 1.383 . . . . 0.0 111.204 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.12 -27.37 3.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.85 63.9 0.11 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.14 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.487 ' HB ' ' OG1' ' A' ' 75' ' ' THR . 29.9 m -159.6 107.95 1.48 Allowed Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.165 -1.197 . . . . 0.0 110.087 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 44.6 Cg_endo -71.46 110.43 2.86 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.053 1.554 . . . . 0.0 110.855 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.3 t -74.58 -30.0 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.909 . . . . 0.0 109.53 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.1 153.11 9.53 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -63.25 142.63 58.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.17 -1.194 . . . . 0.0 110.185 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 71' ' ' TYR . 36.7 t -105.45 137.75 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.818 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.437 ' OD2' ' CB ' ' A' ' 87' ' ' ALA . 6.7 t70 -134.21 135.6 43.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.096 -1.002 . . . . 0.0 110.001 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -86.07 -4.75 59.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.437 ' CB ' ' OD2' ' A' ' 85' ' ' ASP . . . -65.27 -62.28 1.63 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.304 -0.872 . . . . 0.0 110.652 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.0 t -92.23 3.56 55.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.937 . . . . 0.0 110.46 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.36 -176.4 4.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.87 141.38 51.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 110.172 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 61.8 m -106.85 171.78 7.18 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.907 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -151.22 119.35 6.29 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.305 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.7 tp -94.12 101.65 13.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -108.27 167.24 13.18 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.375 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -147.61 160.26 42.86 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.653 -0.91 . . . . 0.0 109.715 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.57 173.99 44.41 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.957 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 31' ' ' TYR . 24.7 t30 -141.0 169.21 18.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.447 -1.031 . . . . 0.0 110.031 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.41 ' O ' ' OG ' ' A' ' 98' ' ' SER . 0.4 OUTLIER -68.91 84.42 0.32 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.243 -0.911 . . . . 0.0 110.426 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.37 -19.43 5.67 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -146.85 99.6 3.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.002 -1.293 . . . . 0.0 110.881 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.434 ' C ' ' HG ' ' A' ' 102' ' ' LEU . 6.6 m-20 -92.66 -173.21 3.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.273 -0.892 . . . . 0.0 109.814 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.434 ' HG ' ' C ' ' A' ' 101' ' ' ASP . 84.4 mt -142.54 -86.36 0.15 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.027 -1.045 . . . . 0.0 110.711 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.552 ' C ' ' CD2' ' A' ' 104' ' ' HIS . . . -178.74 -169.73 39.8 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.552 ' CD2' ' C ' ' A' ' 103' ' ' GLY . 9.0 m-70 -133.76 140.4 46.93 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.227 -1.161 . . . . 0.0 110.852 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 5' ' ' SER . 0.9 OUTLIER -97.75 121.3 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.66 103.79 2.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.812 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 68.4 mt -75.16 170.54 15.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.367 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.76 149.12 44.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 110.374 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.554 ' CE1' ' HB2' ' A' ' 12' ' ' LEU . 1.3 m-85 -139.17 91.05 2.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.116 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 120.745 0.307 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.478 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 44.8 Cg_endo -74.29 -157.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.954 1.502 . . . . 0.0 110.131 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -137.3 93.6 2.84 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.935 -1.103 . . . . 0.0 111.281 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 95' ' ' ALA . 34.1 t80 -112.62 106.04 14.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.071 -1.018 . . . . 0.0 109.614 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.9 m -151.08 155.82 39.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.944 -1.098 . . . . 0.0 111.112 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 19' ' ' SER . 7.5 p -109.41 160.55 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.467 -0.771 . . . . 0.0 109.708 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.565 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -80.16 -59.55 0.53 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.052 . . . . 0.0 110.206 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 54.0 Cg_endo -80.22 74.43 5.55 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.629 1.331 . . . . 0.0 110.38 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.98 -14.42 60.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.019 -1.05 . . . . 0.0 110.065 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.0 m -138.98 178.86 6.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 110.057 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.58 45.64 76.74 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 8' ' ' PRO . 21.5 mt -89.34 159.81 17.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -1.085 . . . . 0.0 110.192 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.432 ' HB2' ' OE1' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -129.63 145.91 51.46 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.318 -0.864 . . . . 0.0 110.212 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 69' ' ' LYS . 13.1 p-10 -57.21 111.18 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.44 -32.92 6.99 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.432 ' OE1' ' HB2' ' A' ' 13' ' ' SER . 55.5 tt0 -49.0 155.49 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -1.163 . . . . 0.0 110.383 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.485 ' O ' ' CG1' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -97.04 -178.16 4.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.371 -0.831 . . . . 0.0 110.568 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 65' ' ' PHE . 25.1 m -156.57 170.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.511 -0.743 . . . . 0.0 109.508 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 6' ' ' VAL . 2.8 m -120.06 123.85 44.42 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.945 -1.097 . . . . 0.0 110.688 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.6 143.01 22.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.441 -0.787 . . . . 0.0 109.657 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.47 133.8 33.19 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.795 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 56.7 t -123.35 111.9 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.464 -0.773 . . . . 0.0 109.913 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.45 ' OG ' ' HB1' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -130.22 116.09 17.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.105 -0.997 . . . . 0.0 110.487 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 150.04 -29.57 1.11 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.541 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -79.95 -147.27 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -1.136 . . . . 0.0 110.195 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.554 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -175.19 142.17 0.6 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.027 -1.046 . . . . 0.0 111.145 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -38.05 132.1 1.03 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.414 0.626 . . . . 0.0 110.699 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.443 ' O ' ' OE2' ' A' ' 29' ' ' GLU . . . 118.35 6.1 12.28 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' OE2' ' O ' ' A' ' 28' ' ' GLY . 53.1 mm-40 -140.11 119.28 12.8 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.217 -1.166 . . . . 0.0 110.521 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.457 HG21 ' O ' ' A' ' 53' ' ' PHE . 5.2 m -101.32 133.84 45.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.43 -0.794 . . . . 0.0 109.491 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 39.0 m-85 -121.15 -172.52 2.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.085 -1.009 . . . . 0.0 111.032 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.517 ' CD1' ' HB2' ' A' ' 52' ' ' SER . 68.0 m-85 -130.25 160.63 33.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.607 -0.683 . . . . 0.0 109.633 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 tt -145.66 116.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.067 -1.021 . . . . 0.0 110.391 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.441 ' O ' ' CD1' ' A' ' 93' ' ' LEU . . . -151.35 169.95 20.72 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.151 -0.968 . . . . 0.0 111.052 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.466 ' CG ' HD13 ' A' ' 107' ' ' LEU . 1.9 tt0 -104.15 160.08 15.15 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.515 -0.741 . . . . 0.0 109.386 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -160.98 141.53 11.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.021 -1.05 . . . . 0.0 111.385 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.486 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -140.51 154.53 69.45 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.98 164.59 34.2 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.622 1.327 . . . . 0.0 111.121 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 44' ' ' ALA . 11.6 m -136.62 55.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.661 0.743 . . . . 0.0 109.919 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.89 -22.64 8.96 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -179.76 -39.47 0.07 OUTLIER Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.674 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.526 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 2.4 mm-40 -91.68 168.1 11.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.957 -1.319 . . . . 0.0 110.419 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.39 139.14 32.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.094 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.536 ' CB ' ' HA3' ' A' ' 73' ' ' GLY . . . -129.99 130.2 44.71 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -117.8 159.57 22.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 110.276 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.466 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 6.0 t-20 -90.77 117.51 67.99 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 0.0 110.363 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 48.8 Cg_endo -81.19 -34.11 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.855 1.45 . . . . 0.0 110.636 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.71 95.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.255 -0.903 . . . . 0.0 110.342 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 6.4 p -88.31 20.71 3.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.364 -0.835 . . . . 0.0 110.063 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 47' ' ' PRO . . . -78.23 132.25 37.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.0 110.086 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.8 t -161.96 159.05 26.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.297 -0.877 . . . . 0.0 109.983 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.517 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 33.5 t -127.99 161.23 29.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.188 -0.945 . . . . 0.0 110.431 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.593 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 33.8 p90 -146.99 -176.41 5.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.294 -0.879 . . . . 0.0 110.381 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.433 ' OG1' HG21 ' A' ' 30' ' ' THR . 29.3 m -141.48 154.08 45.32 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.541 ' CG2' ' HB3' ' A' ' 25' ' ' ALA . 43.1 p -63.24 -150.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.067 -1.02 . . . . 0.0 110.429 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.5 -161.03 1.22 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.187 -0.946 . . . . 0.0 110.292 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.63 -53.38 58.15 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 109.176 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 p -87.95 15.9 6.65 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.554 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 62.41 39.05 97.28 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.09 106.17 13.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -1.087 . . . . 0.0 110.231 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.06 89.73 3.09 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.505 -0.747 . . . . 0.0 110.094 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.6 p -112.01 128.42 56.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.819 . . . . 0.0 109.554 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -153.08 176.38 11.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.126 -0.984 . . . . 0.0 110.824 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 p -94.59 141.43 28.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.33 -0.856 . . . . 0.0 110.521 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.522 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 75.0 t80 -133.36 162.35 32.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.458 -0.777 . . . . 0.0 109.575 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.476 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 21.6 t -112.13 168.19 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 120.731 -1.231 . . . . 0.0 110.801 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.505 HG13 ' CG1' ' A' ' 18' ' ' VAL . 25.1 m -138.08 174.99 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.401 -0.812 . . . . 0.0 110.382 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -148.88 145.81 27.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.31 -0.868 . . . . 0.0 110.121 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 3.2 ttpt -65.8 -51.49 58.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.995 . . . . 0.0 109.464 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.404 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 96.0 p -135.45 165.86 24.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 109.617 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.46 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 37.7 p90 -170.26 150.96 3.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.086 -1.009 . . . . 0.0 110.223 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -68.52 113.39 6.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.225 -0.922 . . . . 0.0 110.094 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 44' ' ' ALA . . . -59.24 -175.79 0.82 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 12.1 m -140.69 -173.67 3.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -1.11 . . . . 0.0 110.62 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.508 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 3.0 p -106.68 170.17 6.01 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.565 -0.709 . . . . 0.0 110.028 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.508 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 39.2 Cg_endo -64.83 -11.19 28.18 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.775 1.408 . . . . 0.0 109.843 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -88.31 -33.61 17.96 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.484 -0.76 . . . . 0.0 109.543 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 120.7 41.44 0.53 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.0 m -136.25 126.53 16.37 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.262 -1.14 . . . . 0.0 110.685 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 44.2 Cg_endo -72.89 120.52 6.69 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.971 1.511 . . . . 0.0 110.245 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 82' ' ' GLY . 7.3 p -141.84 -43.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.216 -0.928 . . . . 0.0 110.42 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.49 ' N ' HG13 ' A' ' 81' ' ' VAL . . . -90.78 155.44 23.87 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.3 p -93.13 153.23 18.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.379 -1.071 . . . . 0.0 110.209 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.486 ' CG1' ' HB3' ' A' ' 37' ' ' ALA . 5.9 t -141.39 156.99 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.333 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.465 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 23.8 m-20 -146.68 149.43 33.46 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.433 -0.792 . . . . 0.0 109.789 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 68.8 m -114.35 -13.8 12.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.85 -56.59 16.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.233 -0.917 . . . . 0.0 110.816 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.3 t -100.74 -13.02 18.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.065 -1.022 . . . . 0.0 110.784 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 85' ' ' ASP . . . -91.32 -141.98 0.18 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.254 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.38 82.98 0.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.906 . . . . 0.0 109.781 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.421 ' C ' ' OD1' ' A' ' 92' ' ' ASN . 28.1 p -97.34 164.82 12.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.109 -0.994 . . . . 0.0 110.436 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 92' ' ' ASN . 2.2 m120 -141.47 166.52 24.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 110.031 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' A' ' 34' ' ' ALA . 5.7 tp -116.01 127.25 54.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 109.603 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.58 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -118.31 157.71 15.08 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -141.73 140.79 33.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -1.107 . . . . 0.0 110.086 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 139.42 163.69 9.6 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -124.29 -156.99 0.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.23 -1.159 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.8 t -90.14 36.81 0.88 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.905 . . . . 0.0 110.404 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.4 -50.19 0.05 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.477 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -135.13 89.38 2.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.196 -1.179 . . . . 0.0 110.409 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.02 158.34 11.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.158 -0.963 . . . . 0.0 109.814 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 91.8 mt -121.52 -84.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 110.432 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.98 -177.37 38.67 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.005 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.58 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 27.5 m-70 -139.92 113.56 8.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.571 -0.958 . . . . 0.0 109.887 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.461 HG11 HG12 ' A' ' 6' ' ' VAL . 18.0 t -88.25 161.55 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 109.836 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.81 134.21 49.3 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.157 -0.964 . . . . 0.0 110.122 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.466 HD13 ' CG ' ' A' ' 35' ' ' GLN . 58.1 mt -105.48 147.45 28.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.236 -0.915 . . . . 0.0 110.432 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.97 159.68 42.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.408 -0.808 . . . . 0.0 109.824 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 42.3 m-85 -128.17 156.18 43.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.562 179.986 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 120.729 0.299 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.469 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 47.4 Cg_endo -73.68 -165.9 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.011 1.532 . . . . 0.0 110.353 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -151.53 109.45 3.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.085 -1.01 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -108.36 115.83 30.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.6 m -146.13 151.84 38.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.894 -1.129 . . . . 0.0 111.159 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.477 ' CG1' HG11 ' A' ' 105' ' ' VAL . 9.8 p -115.97 151.8 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.467 -0.771 . . . . 0.0 109.473 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.599 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -77.22 -57.87 1.05 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.923 -1.111 . . . . 0.0 110.411 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.599 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 54.9 Cg_endo -86.55 68.81 4.48 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.538 1.283 . . . . 0.0 110.334 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.38 -20.35 65.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 109.811 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.5 p -142.76 130.04 21.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.434 -0.791 . . . . 0.0 110.239 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.19 47.56 0.99 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 108' ' ' THR . 1.0 OUTLIER -108.15 172.03 7.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -1.097 . . . . 0.0 110.221 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -148.08 164.28 34.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.94 . . . . 0.0 110.343 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 23.9 t70 -64.85 123.39 19.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 110.137 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.78 -30.42 7.96 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -58.75 146.83 35.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -1.119 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.3 p -90.35 179.51 5.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 110.539 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' A' ' 65' ' ' PHE . 5.3 m -149.41 160.66 5.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.504 -0.747 . . . . 0.0 109.83 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 14.0 m -112.04 118.49 35.57 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.949 -1.094 . . . . 0.0 110.107 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 t -109.06 147.95 13.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 110.073 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.7 t -142.28 129.06 20.51 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.482 -0.761 . . . . 0.0 110.159 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 12.2 t -118.55 107.67 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.368 -0.832 . . . . 0.0 110.024 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.4 OUTLIER -111.92 141.42 45.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.271 -0.893 . . . . 0.0 110.567 179.989 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 122.0 -74.11 0.36 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.484 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -54.79 145.14 20.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -1.178 . . . . 0.0 109.707 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.562 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -118.47 157.8 26.54 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.102 -0.999 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -34.07 136.24 0.13 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.506 0.669 . . . . 0.0 110.819 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.39 1.93 12.2 Favored Glycine 0 C--N 1.295 -1.74 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 1.0 OUTLIER -137.52 129.01 28.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.324 -1.104 . . . . 0.0 110.189 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.518 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 89.0 m -107.22 146.68 31.1 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.525 -0.734 . . . . 0.0 109.815 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 30' ' ' THR . 13.2 m-85 -133.09 169.09 17.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.129 -0.982 . . . . 0.0 110.728 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.482 ' CD2' ' HB3' ' A' ' 52' ' ' SER . 19.4 m-85 -128.64 106.87 9.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 109.539 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.526 ' CG2' HG21 ' A' ' 51' ' ' THR . 18.1 tt -89.54 136.61 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.255 -0.903 . . . . 0.0 110.845 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.65 177.84 9.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.334 -0.854 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.432 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 55.5 tt0 -134.73 150.72 50.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.307 -0.871 . . . . 0.0 109.964 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 69.5 m -150.95 163.44 38.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.102 -0.999 . . . . 0.0 111.224 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.1 152.49 28.07 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.791 -0.568 . . . . 0.0 109.709 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.57 172.15 16.31 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.802 1.422 . . . . 0.0 110.339 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.421 HG11 ' CB ' ' A' ' 44' ' ' ALA . 16.0 m -138.15 55.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.929 -1.107 . . . . 0.0 110.589 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.94 24.9 74.42 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.91 -57.45 0.47 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.045 -1.55 . . . . 0.0 111.142 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.405 ' O ' HG21 ' A' ' 39' ' ' VAL . 3.6 mm-40 -88.56 -164.47 1.13 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.118 -1.225 . . . . 0.0 110.667 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -122.32 155.63 35.57 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.473 -0.767 . . . . 0.0 110.496 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.421 ' CB ' HG11 ' A' ' 39' ' ' VAL . . . -150.21 118.75 6.5 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 109.094 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.1 m -108.9 162.03 14.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.971 -1.08 . . . . 0.0 111.089 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 48' ' ' ALA . 50.3 t-20 -111.52 92.98 17.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.432 -0.792 . . . . 0.0 109.746 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.98 -12.52 32.63 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.047 1.551 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . . . -68.31 -31.83 71.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.133 -0.98 . . . . 0.0 110.178 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 p -97.15 8.63 44.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 110.149 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.14 110.53 5.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.409 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.526 HG21 ' CG2' ' A' ' 33' ' ' ILE . 1.1 t -129.03 140.38 51.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 110.054 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.482 ' HB3' ' CD2' ' A' ' 32' ' ' TYR . 6.9 p -109.21 148.51 30.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.173 -0.955 . . . . 0.0 110.227 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 22.7 p90 -148.06 -177.13 5.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.0 110.177 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 55' ' ' THR . 25.4 m -137.62 153.05 49.94 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 110.091 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 3.3 p -56.85 -159.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.179 -0.951 . . . . 0.0 110.142 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -146.89 -161.81 1.41 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.936 -1.103 . . . . 0.0 110.599 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.31 -51.02 70.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.28 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.93 12.35 7.66 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 60.25 20.09 53.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.75 110.16 22.26 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -1.114 . . . . 0.0 110.22 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -101.36 90.95 4.27 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.541 -0.724 . . . . 0.0 109.417 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 p -103.48 115.08 29.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 109.548 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.546 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 15.1 p90 -147.74 171.06 16.26 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.395 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.9 155.3 17.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 0.0 110.84 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.578 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 90.0 t80 -140.32 176.78 8.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.483 -0.76 . . . . 0.0 108.971 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.578 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -128.35 154.56 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.576 -1.328 . . . . 0.0 110.442 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.87 125.8 61.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.526 -0.734 . . . . 0.0 109.85 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -111.73 116.55 30.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 110.407 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 14' ' ' ASP . 29.6 ttpt -56.76 -55.95 27.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.615 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.4 m -99.57 130.03 45.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.828 . . . . 0.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.457 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 33.9 p90 -155.3 131.08 9.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -0.878 . . . . 0.0 109.982 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.4 m -54.58 134.41 46.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.118 -0.989 . . . . 0.0 110.394 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.47 167.32 12.35 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.541 ' CB ' ' HA ' ' A' ' 80' ' ' PRO . 59.6 p -173.83 83.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.028 -1.278 . . . . 0.0 110.564 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.615 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 25.0 p 37.63 -147.8 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.414 0 O-C-N 121.613 -0.679 . . . . 0.0 109.454 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.615 ' CD ' ' CB ' ' A' ' 75' ' ' THR . 43.9 Cg_endo -72.2 -51.8 0.2 Allowed 'Trans proline' 0 C--O 1.214 -0.712 0 CA-C-N 119.224 0.758 . . . . 0.0 110.571 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 6.7 tt0 179.66 77.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.213 -0.93 . . . . 0.0 110.182 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.8 -15.01 0.07 OUTLIER Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.342 -1.409 . . . . 0.0 111.197 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.457 ' HB ' HG21 ' A' ' 75' ' ' THR . 97.9 m -135.87 107.63 9.79 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.552 -1.558 . . . . 0.0 111.213 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 74' ' ' SER . 48.9 Cg_endo -76.94 119.85 5.24 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.066 1.561 . . . . 0.0 109.976 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 m -103.52 -12.52 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.083 -1.01 . . . . 0.0 110.565 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.92 -174.04 27.77 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.5 p -90.98 160.97 15.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -1.165 . . . . 0.0 110.156 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.4 t -121.44 157.83 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.129 -0.982 . . . . 0.0 110.424 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 39.6 p-10 -152.06 118.28 5.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 110.052 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.3 m -90.58 32.31 0.98 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.165 -0.959 . . . . 0.0 110.306 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.1 87.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.213 -0.93 . . . . 0.0 109.983 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -130.67 6.16 4.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.51 -159.17 0.59 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.846 . . . . 0.0 109.811 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -115.49 120.38 39.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.51 141.0 44.24 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.77 144.1 29.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.062 -1.023 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.58 135.39 53.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.646 -0.659 . . . . 0.0 109.254 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.95 177.02 21.7 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.223 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -151.68 170.82 18.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.452 -1.028 . . . . 0.0 109.986 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.76 159.3 8.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 99' ' ' GLY . 21.0 t30 -119.2 158.18 26.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -1.177 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.78 92.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.067 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 97' ' ' ASN . . . 124.02 -45.33 1.19 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.492 HD13 ' N ' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -91.47 132.11 36.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -1.129 . . . . 0.0 110.202 179.914 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 5.8 m-20 -105.8 144.65 32.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 110.191 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 21.1 mt -122.36 -75.14 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.162 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 159.38 -179.72 34.78 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.591 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 0.0 OUTLIER -145.72 128.74 16.52 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.491 -1.005 . . . . 0.0 109.56 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.477 HG11 ' CG1' ' A' ' 6' ' ' VAL . 58.2 t -105.11 155.12 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.409 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -92.18 147.07 23.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.818 . . . . 0.0 109.833 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.48 105.66 9.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 110.353 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.438 ' O ' HD12 ' A' ' 12' ' ' LEU . 3.6 m -79.58 173.96 12.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.882 . . . . 0.0 110.167 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.77 88.68 2.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.224 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 CA-C-O 118.005 -1.442 . . . . 0.0 109.569 179.96 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.529 ' N ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 120.663 0.268 . . . . 0.0 110.409 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 1' ' ' ALA . 48.6 Cg_endo -73.52 179.72 5.29 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.931 1.49 . . . . 0.0 110.537 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -129.18 144.82 51.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.873 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 23.5 t80 -150.36 104.75 3.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.926 . . . . 0.0 109.888 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p -150.58 152.55 34.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 110.68 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.523 ' CG1' ' CB ' ' A' ' 9' ' ' ALA . 14.8 p -106.52 158.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -0.838 . . . . 0.0 109.55 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.594 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -60.46 -63.76 3.9 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.113 -0.992 . . . . 0.0 110.787 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 44.7 Cg_endo -72.33 -86.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.772 1.406 . . . . 0.0 111.189 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.523 ' CB ' ' CG1' ' A' ' 6' ' ' VAL . . . 71.81 18.35 5.15 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.407 -0.808 . . . . 0.0 109.918 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.434 ' HA ' ' HB ' ' A' ' 108' ' ' THR . 3.9 m -171.4 108.48 0.27 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.362 -0.836 . . . . 0.0 110.076 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.09 76.09 1.32 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.467 HD21 ' HB2' ' A' ' 8' ' ' PRO . 9.7 mt -128.05 172.74 10.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -1.101 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -138.29 162.82 33.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 110.082 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -57.93 123.99 17.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.067 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 94.99 -32.32 6.23 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 17' ' ' SER . 9.0 tm0? -42.01 138.26 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.39 -1.065 . . . . 0.0 110.149 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.46 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -94.07 150.39 20.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.983 -179.99 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.475 HG23 ' HB3' ' A' ' 65' ' ' PHE . 33.3 m -128.79 176.95 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.926 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.464 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 0.3 OUTLIER -133.48 121.78 22.7 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.939 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 68.0 t -98.31 158.86 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.254 -0.903 . . . . 0.0 110.053 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.08 122.26 7.75 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.388 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 53.1 t -121.24 144.27 30.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.339 -0.85 . . . . 0.0 109.758 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m -156.61 127.55 6.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 110.298 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 142.61 -63.58 0.5 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 24' ' ' GLY . . . -56.67 -159.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 109.816 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.556 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -165.8 162.7 18.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.928 -1.107 . . . . 0.0 111.054 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 56' ' ' ASP . . . -41.24 134.5 2.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.551 -0.718 . . . . 0.0 110.241 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 114.6 7.41 18.13 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 5.6 mt-10 -139.86 128.64 23.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.243 -1.151 . . . . 0.0 109.906 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.502 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 20.6 m -108.87 157.8 18.28 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.866 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.568 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 15.8 m-85 -137.34 173.2 11.94 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 110.019 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 14.7 m-85 -131.08 103.52 6.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 110.021 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.505 ' CG2' HG22 ' A' ' 51' ' ' THR . 1.2 tt -87.23 124.29 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.179 -0.951 . . . . 0.0 110.272 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 93' ' ' LEU . . . -150.56 160.46 43.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 110.207 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.465 ' OE1' ' HB3' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -126.59 138.2 53.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 110.544 179.978 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.2 m -146.94 169.22 19.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.25 -0.906 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.61 152.35 28.61 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.17 -0.956 . . . . 0.0 110.119 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.22 174.73 10.98 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.006 1.529 . . . . 0.0 110.178 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 4.7 t -134.58 177.38 6.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.218 -0.926 . . . . 0.0 109.582 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.53 -0.47 31.44 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.431 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -154.35 -29.52 0.03 OUTLIER Glycine 0 N--CA 1.494 2.519 0 O-C-N 120.806 -1.408 . . . . 0.0 110.963 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.464 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 2.0 mm-40 -143.13 -159.42 0.98 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.023 -1.281 . . . . 0.0 109.745 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.434 ' CA ' HG21 ' A' ' 39' ' ' VAL . 37.1 m-20 -119.6 142.04 48.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.935 -1.103 . . . . 0.0 110.79 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.33 165.39 13.91 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.423 -0.798 . . . . 0.0 108.902 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -147.05 158.18 43.85 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.721 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.577 ' OD1' ' CD2' ' A' ' 71' ' ' TYR . 3.4 m120 -100.11 116.11 64.87 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.489 -0.757 . . . . 0.0 109.694 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.62 -28.59 4.19 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.818 1.431 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.11 -35.42 74.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.245 -0.91 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.6 p -86.94 14.08 7.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.214 -0.929 . . . . 0.0 110.684 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.38 95.62 10.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.952 . . . . 0.0 110.271 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.505 HG22 ' CG2' ' A' ' 33' ' ' ILE . 5.0 t -137.03 167.62 21.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.7 p -126.2 149.54 48.96 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.196 -0.94 . . . . 0.0 110.34 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 20.7 p90 -143.41 141.93 31.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.142 -0.974 . . . . 0.0 110.135 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.6 m -104.21 155.55 18.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -0.933 . . . . 0.0 110.494 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.415 HG21 ' HB2' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -63.04 -156.08 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.319 -0.863 . . . . 0.0 109.806 179.946 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.445 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -140.83 -166.88 2.24 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.927 -1.108 . . . . 0.0 110.436 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.93 -57.24 13.93 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -1.85 23.63 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.254 -0.904 . . . . 0.0 108.999 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.556 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.83 69.06 1.46 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.58 125.69 13.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -1.084 . . . . 0.0 109.618 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.442 ' CB ' ' HB ' ' A' ' 22' ' ' VAL . . . -118.6 80.6 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 110.781 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.29 140.21 46.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -0.831 . . . . 0.0 109.078 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -171.1 -179.65 2.78 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.114 -0.991 . . . . 0.0 111.38 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t -96.43 140.78 30.58 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.608 0.718 . . . . 0.0 110.551 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.475 ' HB3' HG23 ' A' ' 18' ' ' VAL . 20.3 t80 -134.32 -172.19 2.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -0.79 . . . . 0.0 108.888 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 t -143.69 165.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.645 -1.285 . . . . 0.0 110.325 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 16' ' ' GLN . 33.2 m -137.88 142.51 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.312 -0.868 . . . . 0.0 110.305 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -121.22 134.52 55.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.072 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 23.3 ttmt -73.26 -59.81 2.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.137 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t -109.58 141.84 41.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 110.196 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.577 ' CD2' ' OD1' ' A' ' 46' ' ' ASN . 33.4 p90 -153.56 122.5 6.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.825 . . . . 0.0 109.986 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 92.2 m -43.89 124.74 3.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.307 -0.871 . . . . 0.0 110.738 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.66 148.88 19.08 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.2 t -151.29 148.19 27.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.787 -1.419 . . . . 0.0 111.168 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 75.5 p -84.61 175.63 4.46 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.484 -0.76 . . . . 0.0 109.902 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 50.0 Cg_endo -87.95 21.96 0.95 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.748 1.394 . . . . 0.0 110.631 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -128.97 12.27 6.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.127 -0.983 . . . . 0.0 110.565 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' A' ' 80' ' ' PRO . . . 78.86 11.89 84.75 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.2 m -96.68 105.44 23.25 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.066 -1.256 . . . . 0.0 110.099 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 78' ' ' GLY . 45.4 Cg_endo -72.75 137.2 26.82 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.043 1.549 . . . . 0.0 110.143 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 81' ' ' VAL . 9.2 p -119.76 16.02 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.215 -0.928 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.87 -169.66 18.17 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 20.0 p -104.5 153.42 21.17 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.088 -1.243 . . . . 0.0 109.918 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 85' ' ' ASP . 74.6 t -102.34 153.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 109.993 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.46 ' N ' HG11 ' A' ' 84' ' ' VAL . 6.0 t0 -132.8 148.7 52.32 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 110.203 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 1.8 t -104.94 15.01 28.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 110.17 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.23 -56.16 4.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 110.334 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -87.7 -28.12 21.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.23 -0.919 . . . . 0.0 110.238 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.7 -158.26 0.64 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.218 -0.926 . . . . 0.0 110.01 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.45 147.95 42.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.9 . . . . 0.0 110.225 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.465 ' HB3' ' OE1' ' A' ' 35' ' ' GLN . 94.4 m -106.61 130.35 54.38 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.911 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -112.77 125.23 54.1 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 110.557 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 34' ' ' ALA . 50.1 tp -107.62 112.34 25.02 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -120.89 160.2 15.3 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.487 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -144.07 124.48 13.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.506 -0.996 . . . . 0.0 109.802 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.35 167.37 39.39 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.414 ' CG ' ' N ' ' A' ' 98' ' ' SER . 4.0 t30 -104.43 -86.08 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -1.094 . . . . 0.0 110.416 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.414 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 46.8 t -159.89 71.07 0.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.255 -0.903 . . . . 0.0 110.007 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.01 -17.3 6.74 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.489 HD23 ' CE2' ' A' ' 31' ' ' TYR . 38.3 tp -94.86 -66.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.462 -1.022 . . . . 0.0 109.655 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.9 t0 61.89 128.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.76 . . . . 0.0 110.632 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.536 ' CD1' ' CD2' ' A' ' 31' ' ' TYR . 35.3 mt -96.85 -39.51 9.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.468 -0.77 . . . . 0.0 109.571 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.18 177.58 26.01 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.587 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 2.0 m-70 -133.7 120.05 20.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.656 -0.908 . . . . 0.0 109.601 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.6 t -92.25 132.59 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.207 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.18 106.71 18.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 110.325 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.2 mt -74.83 126.81 31.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.24 -0.913 . . . . 0.0 110.13 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.434 ' HB ' ' HA ' ' A' ' 10' ' ' SER . 2.2 m -90.37 162.49 15.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.926 . . . . 0.0 110.092 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 108' ' ' THR . 3.9 m-85 -148.4 171.81 15.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.548 179.979 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.543 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 54.9 Cg_endo -74.6 -102.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.9 1.474 . . . . 0.0 109.447 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . 179.73 133.58 0.1 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.887 -1.133 . . . . 0.0 110.461 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -150.85 97.98 2.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.401 -0.812 . . . . 0.0 109.543 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.1 p -139.26 168.83 18.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.059 -1.026 . . . . 0.0 111.148 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.98 148.64 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.555 -0.716 . . . . 0.0 109.09 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.648 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.0 m -62.21 -76.87 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.868 -1.145 . . . . 0.0 110.463 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 55.6 Cg_endo -77.81 75.3 4.84 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 O-C-N 122.788 0.888 . . . . 0.0 109.847 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.09 -22.89 63.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.148 -0.97 . . . . 0.0 110.301 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.5 t -131.69 135.18 46.66 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.174 -0.954 . . . . 0.0 110.12 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.98 65.71 1.28 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 8' ' ' PRO . 7.4 mt -110.21 165.05 12.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -1.139 . . . . 0.0 109.887 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.5 157.22 28.74 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.21 -0.931 . . . . 0.0 110.169 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -68.5 127.2 32.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.84 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.8 -25.54 11.4 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -54.47 149.55 10.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.337 -1.096 . . . . 0.0 110.437 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 m -101.99 129.19 48.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.229 -0.92 . . . . 0.0 109.957 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.4 m -95.91 175.29 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 23.3 p -129.37 113.57 15.12 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.376 -0.828 . . . . 0.0 109.734 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t -97.57 151.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.275 -0.891 . . . . 0.0 110.05 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 t -141.82 118.49 11.03 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.323 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 35.3 t -113.83 138.14 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.558 -0.714 . . . . 0.0 109.778 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 19.3 p -150.9 116.25 5.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.983 -1.073 . . . . 0.0 110.754 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.543 ' HA3' ' CB ' ' A' ' 2' ' ' PRO . . . 156.31 -52.44 0.42 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.473 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -58.15 -157.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.358 -1.083 . . . . 0.0 109.711 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.49 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -161.26 160.59 30.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.966 -1.084 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.91 130.6 9.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.604 -0.685 . . . . 0.0 110.25 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 29' ' ' GLU . . . 117.92 12.33 7.84 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.541 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 70.6 mt-10 -139.18 113.26 8.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.283 . . . . 0.0 110.444 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.444 HG21 ' N ' ' A' ' 31' ' ' TYR . 31.1 m -90.83 166.46 13.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.471 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.541 ' CE2' ' O ' ' A' ' 29' ' ' GLU . 93.9 m-85 -150.61 167.11 28.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.992 -1.068 . . . . 0.0 110.827 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' A' ' 31' ' ' TYR . 12.3 m-85 -131.68 106.92 8.46 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.467 HG23 HG23 ' A' ' 51' ' ' THR . 4.7 tt -98.25 137.8 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.994 . . . . 0.0 111.452 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.04 161.02 43.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.669 -0.645 . . . . 0.0 109.458 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 35' ' ' GLN . 5.3 pt20 -119.23 134.04 55.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 110.523 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.419 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 3.5 m -144.23 -178.5 5.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.43 -0.794 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.61 156.95 33.57 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.301 -0.875 . . . . 0.0 109.467 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 41.3 Cg_endo -71.96 151.4 56.29 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 O-C-N 123.748 1.394 . . . . 0.0 110.686 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.477 HG11 ' N ' ' A' ' 43' ' ' ASP . 10.8 p -132.79 175.28 11.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 121.502 -0.749 . . . . 0.0 109.476 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -54.28 -22.39 22.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.27 -74.14 1.17 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.447 ' O ' ' OD2' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -138.4 -74.03 0.4 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -1.118 . . . . 0.0 110.094 -179.965 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.477 ' N ' HG11 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -164.93 118.12 1.25 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.186 -0.946 . . . . 0.0 111.007 -179.943 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.508 ' HB3' HG23 ' A' ' 84' ' ' VAL . . . -95.24 133.08 39.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.283 -0.886 . . . . 0.0 108.942 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 15.7 t -113.91 168.0 10.17 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.779 -1.201 . . . . 0.0 111.604 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -108.88 112.09 60.41 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.71 . . . . 0.0 110.037 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.62 -24.78 15.57 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.0 1.526 . . . . 0.0 110.646 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -8.86 10.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.206 -0.934 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.02 35.69 4.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.977 -1.077 . . . . 0.0 110.541 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.79 133.66 34.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.163 -0.961 . . . . 0.0 110.541 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.467 HG23 HG23 ' A' ' 33' ' ' ILE . 9.9 t -159.95 156.84 27.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.35 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t -130.03 161.6 30.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.162 -0.961 . . . . 0.0 110.755 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 7.9 p90 -149.28 179.73 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.401 -0.812 . . . . 0.0 109.763 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.455 HG21 ' N ' ' A' ' 55' ' ' THR . 38.4 m -146.88 158.11 43.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.051 -1.031 . . . . 0.0 110.332 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.455 ' N ' HG21 ' A' ' 54' ' ' THR . 2.8 p -73.3 -161.23 0.09 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.07 -152.16 0.26 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.1 -1.0 . . . . 0.0 110.885 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.35 -46.51 89.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.889 . . . . 0.0 109.488 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.4 t -85.16 12.96 6.88 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.569 -0.707 . . . . 0.0 109.209 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 45.3 40.66 7.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.81 126.16 41.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 110.374 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.1 90.08 3.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 110.539 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.78 117.01 32.99 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.329 -0.857 . . . . 0.0 109.562 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.634 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.4 p90 -149.91 171.15 17.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.249 -0.907 . . . . 0.0 110.877 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.04 128.11 47.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 110.647 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.51 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 50.0 t80 -113.64 -179.96 3.79 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.51 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.7 t -128.27 156.89 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.704 -1.248 . . . . 0.0 109.907 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.7 m -146.82 157.09 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 110.308 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.23 150.51 50.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.428 -0.795 . . . . 0.0 110.187 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 29.7 tttt -76.5 -59.4 2.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 110.566 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.0 m -117.57 137.62 52.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.143 -0.973 . . . . 0.0 110.169 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -162.2 151.53 15.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.12 -0.987 . . . . 0.0 110.304 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.1 m -68.47 134.29 49.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.0 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 44' ' ' ALA . . . -118.82 -176.48 16.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER 179.45 138.82 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -1.154 . . . . 0.0 109.915 -179.98 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 79' ' ' THR . 73.7 p -73.55 144.46 83.61 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 110.396 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.58 -16.51 10.46 Favored 'Trans proline' 0 C--N 1.297 -2.135 0 O-C-N 124.2 1.632 . . . . 0.0 110.069 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -73.16 -13.38 61.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.368 -0.833 . . . . 0.0 110.275 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 79' ' ' THR . . . 106.3 62.86 0.6 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.482 ' O ' ' OG1' ' A' ' 75' ' ' THR . 70.7 m -165.54 95.65 0.82 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.255 -1.144 . . . . 0.0 110.348 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.05 142.19 46.0 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 O-C-N 123.823 1.433 . . . . 0.0 109.944 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 82' ' ' GLY . 3.5 p -120.79 -34.18 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.148 -0.97 . . . . 0.0 110.676 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.433 ' N ' HG11 ' A' ' 81' ' ' VAL . . . 141.89 -147.81 19.4 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 82.5 p -90.3 168.83 11.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.354 -1.086 . . . . 0.0 110.45 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 44' ' ' ALA . 78.3 t -133.05 116.43 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.393 -0.817 . . . . 0.0 109.882 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.427 ' OD2' HG22 ' A' ' 88' ' ' THR . 4.9 p-10 -101.26 142.0 33.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 0.0 110.392 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 4.4 t -98.2 17.28 18.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.25 -0.907 . . . . 0.0 110.031 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.1 -59.92 2.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 110.214 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.477 HG21 ' N ' ' A' ' 89' ' ' ALA . 5.9 t -79.78 -24.85 41.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.289 -0.882 . . . . 0.0 110.081 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.477 ' N ' HG21 ' A' ' 88' ' ' THR . . . -101.01 -154.96 0.49 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.382 -0.824 . . . . 0.0 109.909 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.21 146.47 33.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.401 -0.812 . . . . 0.0 110.086 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.28 126.85 43.94 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.261 -0.9 . . . . 0.0 109.67 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -110.8 121.2 44.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 111.005 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 65' ' ' PHE . 1.1 tp -107.05 118.41 36.63 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.418 -0.801 . . . . 0.0 108.912 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -137.47 176.73 20.38 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.279 -1.439 . . . . 0.0 110.529 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.89 175.75 11.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.615 -0.932 . . . . 0.0 110.054 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 136.63 167.06 11.05 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -131.46 -153.15 0.54 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.187 -1.184 . . . . 0.0 109.933 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 t -104.04 80.15 1.7 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.176 -0.953 . . . . 0.0 110.089 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.55 -18.31 0.36 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 101' ' ' ASP . 7.9 tp -140.79 -67.95 0.41 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.282 . . . . 0.0 110.561 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 100' ' ' LEU . 0.7 OUTLIER 69.42 153.06 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.306 -0.871 . . . . 0.0 110.091 179.983 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.7 mt -121.79 -86.31 0.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 110.38 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -167.91 -160.66 15.94 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -159.09 138.45 11.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -1.09 . . . . 0.0 110.335 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.5 t -104.9 127.96 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.255 -0.903 . . . . 0.0 110.207 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.87 93.74 5.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 65.9 mt -60.19 170.13 1.38 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.4 m -141.19 169.84 16.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 0.0 110.096 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -142.65 96.57 2.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.913 . . . . 0.0 110.138 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.61 179.978 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.404 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.404 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 42.8 Cg_endo -69.82 -159.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.897 1.472 . . . . 0.0 110.428 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -140.38 135.8 32.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.025 -1.047 . . . . 0.0 111.004 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -150.84 108.53 3.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.557 -0.715 . . . . 0.0 109.096 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.0 p -146.56 161.59 40.18 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.82 -1.175 . . . . 0.0 111.484 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.438 HG22 ' HD2' ' A' ' 8' ' ' PRO . 7.7 p -129.94 143.32 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.594 -0.691 . . . . 0.0 109.719 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.612 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.2 m -56.86 -68.84 0.53 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.976 -1.077 . . . . 0.0 110.224 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 50.7 Cg_endo -75.88 95.1 1.01 Allowed 'Trans proline' 0 C--N 1.321 -0.89 0 O-C-N 123.354 1.186 . . . . 0.0 110.228 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.96 -1.94 28.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.0 -1.063 . . . . 0.0 110.364 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 t -157.21 109.51 2.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.955 . . . . 0.0 110.057 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.45 60.99 0.54 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.506 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 1.1 mp -108.25 165.84 11.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -1.166 . . . . 0.0 110.068 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 11.4 t -117.27 147.97 42.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.319 -0.863 . . . . 0.0 110.072 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.23 119.21 7.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 110.326 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.11 -35.15 4.97 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 34.2 tt0 -49.21 153.81 0.92 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.326 -1.102 . . . . 0.0 110.381 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 m -105.46 132.75 51.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.959 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.506 ' CG1' ' CD2' ' A' ' 12' ' ' LEU . 24.4 m -100.6 178.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.255 -0.903 . . . . 0.0 110.282 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.9 m -121.1 117.28 26.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 109.807 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.8 t -102.54 150.2 6.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.393 -0.817 . . . . 0.0 110.154 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.91 127.94 18.49 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.309 -0.869 . . . . 0.0 110.4 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.468 ' HB ' ' HB1' ' A' ' 61' ' ' ALA . 58.7 t -117.37 147.59 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.632 -0.667 . . . . 0.0 109.917 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 3.6 p -168.05 119.76 0.84 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.127 -0.983 . . . . 0.0 110.393 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.78 3.4 5.48 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 26' ' ' ALA . . . -105.64 -39.67 6.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.056 -1.261 . . . . 0.0 110.266 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.561 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . 72.62 147.84 0.09 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.327 -0.858 . . . . 0.0 110.837 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -46.79 134.22 10.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.713 -0.617 . . . . 0.0 110.768 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 131.82 1.51 4.56 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 39.6 mm-40 -146.45 130.61 17.44 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.87 -1.371 . . . . 0.0 110.896 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.547 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -96.72 171.67 8.38 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.879 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.547 ' CD1' ' O ' ' A' ' 30' ' ' THR . 61.3 m-85 -151.61 172.54 15.9 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.871 -1.143 . . . . 0.0 111.028 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 52' ' ' SER . 61.4 m-85 -144.31 109.46 5.07 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.443 -0.785 . . . . 0.0 109.752 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.603 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 5.6 tt -88.41 132.68 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.213 -0.929 . . . . 0.0 110.451 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.58 167.63 25.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.203 -0.936 . . . . 0.0 110.426 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.455 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 10.5 pt20 -126.56 141.81 51.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.315 -0.865 . . . . 0.0 109.991 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -143.38 157.71 44.24 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.979 -1.076 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.19 157.05 57.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.37 159.13 54.91 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 123.741 1.39 . . . . 0.0 110.792 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 42' ' ' GLN . 32.5 m -130.38 -158.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.478 -0.763 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.52 32.23 4.27 Favored Glycine 0 C--N 1.279 -2.617 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -173.94 -52.38 0.05 OUTLIER Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.365 -1.398 . . . . 0.0 111.058 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.539 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 5.3 mm100 -141.24 -157.45 0.77 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.121 -1.223 . . . . 0.0 110.76 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -106.04 122.24 45.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.177 -0.952 . . . . 0.0 110.059 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.471 ' HB2' HG11 ' A' ' 81' ' ' VAL . . . -111.29 139.29 46.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 8.7 t -123.49 144.51 49.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.176 -0.953 . . . . 0.0 110.506 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.46 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 32.0 t-20 -71.67 122.97 88.67 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.26 -0.9 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -83.47 -39.11 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.932 1.491 . . . . 0.0 110.953 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.88 -56.92 15.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.426 -0.796 . . . . 0.0 110.766 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.8 p -56.87 -14.53 3.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.642 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.98 137.28 55.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 110.768 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.603 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 13.0 t -147.03 165.9 28.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.582 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -130.95 152.91 49.75 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.874 -1.142 . . . . 0.0 111.82 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 31' ' ' TYR . 32.3 p90 -149.12 146.25 27.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.502 -0.749 . . . . 0.0 109.779 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.443 ' OG1' HG22 ' A' ' 30' ' ' THR . 76.2 m -108.75 155.27 20.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.975 -1.078 . . . . 0.0 110.771 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -65.42 -157.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.305 -0.872 . . . . 0.0 109.606 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -150.94 -159.78 1.08 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.818 -1.176 . . . . 0.0 110.478 -179.967 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.06 62.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.156 -0.965 . . . . 0.0 109.743 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 t -85.46 13.69 6.45 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.424 -0.797 . . . . 0.0 108.854 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 60.58 27.35 65.98 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -110.83 114.16 27.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.345 -1.091 . . . . 0.0 110.35 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.468 ' HB1' ' HB ' ' A' ' 22' ' ' VAL . . . -117.56 88.63 2.95 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.2 p -102.29 125.99 49.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.487 -0.758 . . . . 0.0 109.395 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -154.01 176.19 12.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.957 . . . . 0.0 111.079 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 t -100.22 129.89 46.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.468 -0.77 . . . . 0.0 110.362 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 55.1 t80 -118.45 177.91 4.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 109.307 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.555 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -125.77 154.99 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.811 -1.181 . . . . 0.0 110.389 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.467 HG13 HG22 ' A' ' 18' ' ' VAL . 5.6 m -132.7 171.69 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.822 . . . . 0.0 109.704 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.89 139.21 23.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.984 . . . . 0.0 110.282 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.574 ' HA ' ' CE2' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -77.39 -47.71 19.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.339 -0.851 . . . . 0.0 110.204 179.991 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -122.95 136.1 54.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.847 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -163.36 157.05 19.56 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 3.2 m -69.48 111.14 5.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.425 -0.797 . . . . 0.0 109.992 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.29 162.75 54.3 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -176.54 158.25 1.74 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.111 -1.229 . . . . 0.0 110.75 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.534 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 43.8 p -70.85 171.26 8.68 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.451 -0.78 . . . . 0.0 109.514 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 46.4 Cg_endo -74.73 -7.89 19.82 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.473 1.249 . . . . 0.0 110.931 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -96.78 -59.36 1.82 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.061 -1.025 . . . . 0.0 110.14 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.86 55.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -129.72 108.6 17.12 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.226 -1.161 . . . . 0.0 110.154 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.422 ' HA ' ' OG ' ' A' ' 74' ' ' SER . 46.4 Cg_endo -72.74 78.94 2.0 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.931 1.49 . . . . 0.0 110.574 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 44' ' ' ALA . 10.7 p -57.89 -22.37 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 110.104 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.52 152.02 5.55 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.4 p -58.76 172.87 0.47 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.256 -1.144 . . . . 0.0 110.034 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.466 HG22 HG13 ' A' ' 39' ' ' VAL . 55.2 t -141.4 155.84 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -0.903 . . . . 0.0 110.318 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -144.36 139.83 28.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.863 . . . . 0.0 110.126 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -100.73 2.44 41.35 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 110.178 -179.97 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.34 -60.5 2.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.881 . . . . 0.0 110.622 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.8 t -91.94 -20.89 20.92 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.207 -0.933 . . . . 0.0 110.731 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.63 -176.16 3.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.578 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.26 147.13 45.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.345 -0.847 . . . . 0.0 110.1 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.7 m -120.61 156.3 31.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.175 -0.953 . . . . 0.0 110.436 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 18.5 p30 -136.69 143.44 43.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 109.947 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.489 ' HB2' ' CD1' ' A' ' 107' ' ' LEU . 1.5 tp -105.62 135.79 46.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.249 -0.907 . . . . 0.0 109.998 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.473 ' HA3' ' ND1' ' A' ' 104' ' ' HIS . . . -131.69 149.46 19.32 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -137.15 155.77 49.18 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.502 -0.999 . . . . 0.0 109.899 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.27 164.61 13.25 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.458 ' CG ' ' N ' ' A' ' 98' ' ' SER . 1.4 t30 -113.42 173.45 6.4 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.248 -1.148 . . . . 0.0 109.857 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.458 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 88.9 p -66.09 89.32 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.152 -0.968 . . . . 0.0 109.943 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 131.69 -20.4 4.61 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 tt -111.37 161.21 16.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.395 -1.062 . . . . 0.0 110.055 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.57 98.25 2.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.214 -0.929 . . . . 0.0 110.368 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.2 mt -78.73 -70.14 0.52 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.294 -0.879 . . . . 0.0 110.131 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.535 ' C ' ' CD2' ' A' ' 104' ' ' HIS . . . 164.1 -177.12 39.97 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.588 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 4.9 m-70 -131.8 129.5 40.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -1.091 . . . . 0.0 110.03 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.0 t -93.39 116.8 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 110.473 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.56 128.95 39.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.39 -0.819 . . . . 0.0 110.086 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.489 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 74.8 mt -114.44 119.09 35.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 110.508 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 m -98.57 169.37 9.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 109.932 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 10.7 m-85 -132.3 136.11 46.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.995 . . . . 0.0 110.326 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.995 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.435 ' CB ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 120.771 0.32 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 1' ' ' ALA . 47.5 Cg_endo -73.81 -172.62 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.013 1.533 . . . . 0.0 110.479 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -105.47 135.03 47.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.895 . . . . 0.0 110.162 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -150.56 107.44 3.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.789 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -146.13 153.07 40.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.096 -1.003 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.431 HG21 ' HD2' ' A' ' 8' ' ' PRO . 9.0 p -115.24 135.82 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.344 -0.847 . . . . 0.0 109.776 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -57.01 -67.63 0.8 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.056 -1.028 . . . . 0.0 110.262 -179.987 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 52.7 Cg_endo -75.69 87.94 1.34 Allowed 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.338 1.178 . . . . 0.0 109.956 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.61 -3.1 56.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.143 -0.973 . . . . 0.0 110.67 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.0 m -149.75 166.58 29.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.202 -0.936 . . . . 0.0 110.336 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.95 37.56 94.43 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 8' ' ' PRO . 40.5 mt -92.9 173.71 7.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.254 -1.144 . . . . 0.0 110.138 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.3 152.07 35.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 110.393 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 1.6 t70 -60.01 126.76 28.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 109.99 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.83 -33.27 5.65 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -56.61 149.47 17.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.345 -1.091 . . . . 0.0 109.893 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.01 134.07 47.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 110.663 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.479 ' HB ' ' HG2' ' A' ' 8' ' ' PRO . 31.5 m -113.28 173.13 3.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.483 -0.76 . . . . 0.0 109.704 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.76 133.5 55.87 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.097 -1.002 . . . . 0.0 110.314 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.9 t -119.7 151.21 22.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.746 -0.596 . . . . 0.0 109.513 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.6 p -143.6 133.33 23.8 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.2 t -122.44 138.51 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.507 -0.746 . . . . 0.0 110.171 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 10.8 m -150.02 80.1 1.37 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.861 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . -161.85 -71.55 0.02 OUTLIER Glycine 0 C--N 1.283 -2.386 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.461 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -56.09 -164.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -1.198 . . . . 0.0 109.902 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -160.39 157.77 28.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.143 -0.973 . . . . 0.0 110.387 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 56' ' ' ASP . . . -36.14 118.55 0.53 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.602 -0.686 . . . . 0.0 110.633 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.56 -0.34 2.46 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -146.85 130.63 17.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.086 -1.244 . . . . 0.0 110.661 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.472 HG23 ' OG1' ' A' ' 54' ' ' THR . 37.9 m -107.27 121.8 45.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.701 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.571 ' CE1' HD21 ' A' ' 100' ' ' LEU . 52.2 m-85 -103.62 177.77 4.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.052 -1.03 . . . . 0.0 110.603 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.638 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 10.0 m-85 -132.81 116.69 16.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -0.892 . . . . 0.0 110.096 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.489 HG13 HD12 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -94.33 123.72 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.893 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.88 156.31 39.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.117 -0.99 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.464 ' HG2' ' HB2' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -100.17 152.91 19.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.316 -0.865 . . . . 0.0 109.532 179.944 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 99.1 m -151.6 152.25 32.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.062 -1.024 . . . . 0.0 110.934 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.464 ' CB ' ' HB3' ' A' ' 91' ' ' CYS . . . -150.41 145.79 19.01 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.476 -0.765 . . . . 0.0 109.292 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.74 161.03 42.66 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.79 1.416 . . . . 0.0 110.989 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.443 HG13 HG23 ' A' ' 84' ' ' VAL . 33.8 m -127.09 -166.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.471 -0.768 . . . . 0.0 110.17 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.13 28.26 5.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' C ' ' HG2' ' A' ' 42' ' ' GLN . . . -149.88 -58.95 0.01 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.454 ' HG2' ' C ' ' A' ' 41' ' ' GLY . 20.7 mm100 -145.62 -121.8 0.07 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.207 -1.172 . . . . 0.0 110.02 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -129.0 147.51 50.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.994 -1.066 . . . . 0.0 110.067 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.94 164.94 24.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.133 -0.979 . . . . 0.0 110.028 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.482 ' O ' ' CD ' ' A' ' 47' ' ' PRO . 1.3 m -143.74 -178.74 6.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.27 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 5.6 m120 -105.59 76.14 0.34 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 0.0 110.319 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.482 ' CD ' ' O ' ' A' ' 45' ' ' CYS . 43.2 Cg_endo -69.32 -41.3 4.97 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.987 1.519 . . . . 0.0 110.324 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.98 -34.95 74.0 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.38 -0.825 . . . . 0.0 110.005 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.9 34.2 5.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.856 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -86.33 103.67 15.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.014 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.42 HG23 ' CG2' ' A' ' 33' ' ' ILE . 10.0 t -102.37 167.65 9.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 0.0 110.502 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 2.4 m -143.99 162.94 34.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.955 . . . . 0.0 110.673 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 51.5 p90 -143.27 -177.13 5.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.472 ' OG1' HG23 ' A' ' 30' ' ' THR . 50.0 m -146.19 149.9 34.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.348 -0.845 . . . . 0.0 109.746 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.404 HG23 ' C ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -64.22 -174.77 0.13 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.04 -1.038 . . . . 0.0 109.707 -179.978 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -146.8 -147.77 0.23 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.96 -1.088 . . . . 0.0 110.806 -179.903 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.585 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -83.02 71.24 10.12 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.15 0.976 . . . . 0.0 109.255 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER 152.7 -14.58 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.569 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 75.57 28.68 60.95 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.42 129.66 56.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.226 -1.161 . . . . 0.0 110.015 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.99 86.24 2.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.317 -0.864 . . . . 0.0 110.641 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.39 111.85 24.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.848 . . . . 0.0 109.412 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 19.2 p90 -143.58 178.56 7.7 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.084 -1.01 . . . . 0.0 110.967 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.1 p -98.98 125.54 44.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.469 -0.769 . . . . 0.0 110.247 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.441 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 8.3 t80 -120.65 139.92 52.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.37 156.43 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.891 -1.131 . . . . 0.0 110.473 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.465 HG12 ' CG1' ' A' ' 18' ' ' VAL . 26.8 m -124.97 151.82 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.539 -0.726 . . . . 0.0 110.077 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.01 107.04 10.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 110.408 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.575 ' HB2' ' CE1' ' A' ' 109' ' ' PHE . 4.4 ttpt -55.39 -49.61 71.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.643 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.0 m -114.15 132.43 56.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -0.8 . . . . 0.0 109.905 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 71' ' ' TYR . 23.4 p90 -150.36 146.7 26.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.2 m -68.62 129.75 40.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 110.036 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.25 148.52 18.43 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.7 p -171.75 178.65 3.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.293 -1.122 . . . . 0.0 110.345 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.2 p -101.61 163.11 18.49 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.208 -0.932 . . . . 0.0 110.263 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.04 -4.78 15.26 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.076 1.566 . . . . 0.0 110.668 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.43 -58.17 2.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.216 -0.927 . . . . 0.0 110.334 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.08 56.92 0.02 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.6 m -139.57 95.71 8.87 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.345 -1.091 . . . . 0.0 110.128 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.12 100.81 1.33 Allowed 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.059 1.558 . . . . 0.0 110.495 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.482 HG21 ' N ' ' A' ' 82' ' ' GLY . 32.0 m -71.6 -26.69 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.195 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.482 ' N ' HG21 ' A' ' 81' ' ' VAL . . . 137.33 -172.05 22.89 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.3 p -88.62 149.35 23.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -1.204 . . . . 0.0 110.095 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.46 HG11 ' HB1' ' A' ' 37' ' ' ALA . 84.0 t -119.06 147.08 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 110.167 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.446 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 5.1 m-20 -137.04 137.23 39.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.176 -0.952 . . . . 0.0 110.697 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 62.6 m -92.1 7.8 40.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.725 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.01 -62.0 1.74 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 110.5 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.9 t -104.65 14.31 30.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.192 -0.943 . . . . 0.0 110.432 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 85' ' ' ASP . . . -118.17 -167.94 1.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.234 -0.916 . . . . 0.0 110.055 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.06 98.97 4.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 110.325 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 12.0 p -108.03 151.44 25.83 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.928 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -127.47 158.7 36.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.489 HD12 HG13 ' A' ' 33' ' ' ILE . 10.0 tp -109.03 121.61 45.5 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.536 ' HA3' ' ND1' ' A' ' 104' ' ' HIS . . . -126.87 157.91 20.7 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.592 -1.29 . . . . 0.0 110.341 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -132.37 161.44 33.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -1.062 . . . . 0.0 110.082 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.501 ' HA2' ' CD1' ' A' ' 102' ' ' LEU . . . 138.73 -171.35 23.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 98' ' ' SER . 6.1 p-10 -109.25 -46.09 3.63 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.021 -1.282 . . . . 0.0 110.362 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER 174.19 -27.66 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.207 -0.933 . . . . 0.0 110.446 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.86 3.95 4.23 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.305 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.571 HD21 ' CE1' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -84.87 -42.08 15.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.945 -1.326 . . . . 0.0 110.174 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 100' ' ' LEU . 17.4 t0 65.44 81.07 0.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.326 -0.859 . . . . 0.0 110.261 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.501 ' CD1' ' HA2' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -79.77 -63.88 1.31 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 110.146 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.11 162.48 29.4 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.536 ' ND1' ' HA3' ' A' ' 94' ' ' GLY . 93.3 m-70 -138.57 113.24 9.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.518 -0.989 . . . . 0.0 109.686 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.1 t -101.59 113.97 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.226 -0.921 . . . . 0.0 110.795 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.17 139.1 55.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.107 -0.996 . . . . 0.0 109.321 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.45 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 80.7 mt -115.34 167.91 10.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.957 -1.089 . . . . 0.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.2 m -149.1 175.35 11.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 109.975 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 69' ' ' LYS . 43.3 m-85 -147.45 102.37 3.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.375 -0.828 . . . . 0.0 110.2 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.966 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.415 ' CB ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.512 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 46.2 Cg_endo -73.07 -176.25 2.32 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.947 1.498 . . . . 0.0 110.315 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -135.98 138.15 41.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.073 -1.017 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -152.0 108.82 3.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.307 -0.871 . . . . 0.0 109.675 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 t -148.69 161.22 42.19 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.972 -1.08 . . . . 0.0 111.161 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.485 HG11 HG11 ' A' ' 105' ' ' VAL . 8.1 p -121.67 147.54 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.534 -0.729 . . . . 0.0 109.859 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.611 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -55.91 -67.56 0.73 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 120.84 -1.163 . . . . 0.0 109.064 179.975 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.611 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 52.9 Cg_endo -76.94 129.71 10.83 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 O-C-N 123.473 1.249 . . . . 0.0 109.552 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.1 26.74 2.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.936 -1.102 . . . . 0.0 110.263 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.07 145.79 0.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.032 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.01 58.88 10.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.512 ' CD2' ' HB2' ' A' ' 8' ' ' PRO . 20.5 mt -105.81 175.11 5.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.255 -1.144 . . . . 0.0 110.41 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.6 t -133.09 148.15 52.17 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.251 -0.906 . . . . 0.0 110.403 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 69' ' ' LYS . 29.9 p30 -57.33 119.89 7.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 110.459 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.14 -35.34 5.11 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -47.62 148.65 1.41 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.028 -1.278 . . . . 0.0 110.428 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.502 ' O ' ' CG1' ' A' ' 18' ' ' VAL . 2.6 p -97.36 177.24 5.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 110.155 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 17' ' ' SER . 29.3 m -156.47 169.66 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.277 -0.889 . . . . 0.0 110.077 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 m -114.8 121.23 42.66 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.2 -0.938 . . . . 0.0 109.76 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.458 HG11 ' CZ ' ' A' ' 63' ' ' PHE . 6.0 t -105.86 142.04 19.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.419 -0.8 . . . . 0.0 109.969 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.1 m -138.56 126.3 22.23 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.492 -0.755 . . . . 0.0 110.004 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.465 ' HB ' ' HB1' ' A' ' 61' ' ' ALA . 55.7 t -117.97 127.46 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.649 -0.657 . . . . 0.0 110.39 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.8 108.84 8.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.173 -0.955 . . . . 0.0 109.957 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 150.47 -82.38 0.18 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.501 ' O ' ' CA ' ' A' ' 59' ' ' GLY . . . -42.41 131.08 3.8 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.265 -1.138 . . . . 0.0 109.836 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -103.74 158.93 16.04 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.093 -1.005 . . . . 0.0 111.972 -179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 56' ' ' ASP . . . -38.34 141.95 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.554 0.692 . . . . 0.0 111.07 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.11 7.28 4.11 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.577 ' CG ' ' CZ ' ' A' ' 31' ' ' TYR . 14.8 tp10 -161.92 136.58 7.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.923 -1.339 . . . . 0.0 111.223 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.457 HG22 ' OG1' ' A' ' 54' ' ' THR . 68.8 m -104.47 124.43 49.25 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.632 ' CD1' ' CD1' ' A' ' 102' ' ' LEU . 76.2 m-85 -103.13 172.96 6.52 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 111.55 -179.826 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.569 ' CE1' ' OG ' ' A' ' 52' ' ' SER . 96.3 m-85 -124.13 100.25 6.63 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.582 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 5.7 tt -86.59 104.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.12 -0.988 . . . . 0.0 109.863 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' C ' HD11 ' A' ' 93' ' ' LEU . . . -148.83 166.24 29.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.446 -0.784 . . . . 0.0 110.478 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.509 ' CG ' ' HB2' ' A' ' 93' ' ' LEU . 8.1 mt-30 -97.82 144.33 27.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 109.782 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.8 m -145.27 151.22 38.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.01 . . . . 0.0 110.952 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . . . -148.78 164.6 20.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.585 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 37' ' ' ALA . 41.6 Cg_endo -69.15 162.35 42.11 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.788 1.415 . . . . 0.0 110.605 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -141.73 174.72 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.468 -0.77 . . . . 0.0 110.17 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -49.21 -46.03 34.57 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.35 -67.58 1.96 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -163.49 -72.58 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.307 -1.114 . . . . 0.0 110.029 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 5.8 p30 -132.33 158.57 41.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 110.208 179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.67 165.4 33.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.975 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.8 m -141.77 168.12 20.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.179 -0.951 . . . . 0.0 110.236 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.51 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 0.3 OUTLIER -100.86 100.35 12.54 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.172 -179.976 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.0 Cg_endo -72.78 -34.61 6.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.013 1.533 . . . . 0.0 110.416 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.09 92.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 110.3 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.3 p -98.57 25.41 6.44 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.333 -0.854 . . . . 0.0 109.994 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -86.49 110.75 19.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.915 . . . . 0.0 110.302 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.582 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 7.5 t -116.32 133.45 56.01 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.319 -0.863 . . . . 0.0 110.018 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.569 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 12.2 t -108.77 137.79 46.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.279 -0.888 . . . . 0.0 110.58 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 30.3 p90 -135.38 -177.98 4.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 110.016 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.457 ' OG1' HG22 ' A' ' 30' ' ' THR . 40.3 m -138.29 152.88 48.94 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.317 -0.865 . . . . 0.0 109.761 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.476 HG23 ' HB2' ' A' ' 25' ' ' ALA . 2.5 p -61.58 -162.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.942 -1.099 . . . . 0.0 109.963 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.446 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 3.0 t70 -143.43 -164.26 1.83 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.06 -1.025 . . . . 0.0 110.675 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.81 82.82 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.097 -1.002 . . . . 0.0 108.831 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -90.25 16.27 8.92 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 55.45 30.48 55.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.81 133.88 52.98 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.459 -1.024 . . . . 0.0 110.341 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.465 ' HB1' ' HB ' ' A' ' 22' ' ' VAL . . . -137.57 84.97 2.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.268 -0.895 . . . . 0.0 110.683 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.66 112.71 25.6 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.268 -0.895 . . . . 0.0 109.149 179.809 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.458 ' CZ ' HG11 ' A' ' 20' ' ' VAL . 18.6 p90 -145.91 179.53 7.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.106 -0.996 . . . . 0.0 111.024 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -93.9 145.44 24.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.572 -0.705 . . . . 0.0 110.565 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.542 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 52.6 t80 -139.64 177.18 8.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.435 -0.791 . . . . 0.0 109.593 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.542 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 21.6 t -132.08 165.23 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.825 -1.172 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 67' ' ' VAL . 13.5 m -141.33 129.22 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.452 -0.78 . . . . 0.0 110.098 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 68' ' ' ARG . 6.2 tpt180 -108.58 144.79 35.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 110.259 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 20.6 ttpt -68.95 -39.7 79.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.077 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 p -132.8 155.12 49.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.548 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 13.4 p90 -162.17 147.58 12.9 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.149 -0.97 . . . . 0.0 110.661 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 m -60.17 113.6 2.44 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.354 -0.841 . . . . 0.0 110.367 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.511 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -99.14 150.31 19.22 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.9 m -138.26 152.25 48.39 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.151 -1.206 . . . . 0.0 110.215 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 68.8 p -69.48 165.58 38.87 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.335 -0.853 . . . . 0.0 110.209 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.458 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 47.0 Cg_endo -74.14 -22.64 16.64 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.916 1.482 . . . . 0.0 110.583 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -15.88 63.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.21 -0.931 . . . . 0.0 110.226 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.65 37.71 3.64 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.0 m -135.59 122.29 14.47 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.227 -1.161 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.01 127.1 9.77 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.912 1.48 . . . . 0.0 110.188 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.419 ' CG2' HG22 ' A' ' 75' ' ' THR . 5.9 t -102.18 -35.97 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 110.176 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 173.11 -150.95 12.83 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 m -108.69 138.83 44.38 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.303 -1.116 . . . . 0.0 110.31 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.511 ' CG2' ' HA3' ' A' ' 73' ' ' GLY . 58.9 t -92.49 133.6 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.81 . . . . 0.0 109.665 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -113.38 135.72 53.55 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.99 -1.069 . . . . 0.0 110.117 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 1.3 t -85.26 1.07 49.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.69 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.54 -61.66 1.72 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.085 -1.009 . . . . 0.0 110.547 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.3 t -84.56 -16.74 41.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.215 -0.928 . . . . 0.0 110.384 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.04 158.7 22.74 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.142 -0.974 . . . . 0.0 110.265 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.84 144.7 27.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.083 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 3.7 m -125.01 129.52 50.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.24 -0.913 . . . . 0.0 110.098 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 92' ' ' ASN . 1.8 m120 -111.62 127.68 55.82 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 110.014 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.509 ' HB2' ' CG ' ' A' ' 35' ' ' GLN . 15.1 tp -93.23 108.9 20.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.92 . . . . 0.0 109.216 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -128.88 170.87 19.93 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.25 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -140.13 123.42 16.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -1.022 . . . . 0.0 109.866 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.93 166.59 36.29 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.469 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 5.1 p-10 -100.54 -43.39 6.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -1.113 . . . . 0.0 110.288 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 43.0 t -179.41 -43.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.18 -0.95 . . . . 0.0 110.627 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.67 27.45 3.21 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.469 ' HB2' ' OD1' ' A' ' 97' ' ' ASN . 3.4 tt -111.84 -44.57 3.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -1.187 . . . . 0.0 110.061 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.8 96.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.342 -0.848 . . . . 0.0 110.249 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.632 ' CD1' ' CD1' ' A' ' 31' ' ' TYR . 43.6 mt -83.68 -41.1 18.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -0.906 . . . . 0.0 110.258 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.99 162.24 12.97 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 5.3 p80 -145.5 122.06 11.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.519 -0.989 . . . . 0.0 109.751 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.485 HG11 HG11 ' A' ' 6' ' ' VAL . 91.5 t -96.86 113.92 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.541 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.4 117.84 6.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 109.812 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.495 ' CD1' ' CD ' ' A' ' 35' ' ' GLN . 83.5 mt -93.52 144.43 25.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.249 -0.907 . . . . 0.0 110.516 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 m -127.18 162.14 26.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 110.288 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.474 ' CD2' ' HG3' ' A' ' 69' ' ' LYS . 6.6 m-85 -135.72 126.62 27.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.202 -0.937 . . . . 0.0 110.058 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 118.036 -1.424 . . . . 0.0 109.611 179.897 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.755 0.312 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.448 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 47.3 Cg_endo -72.74 -163.66 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.909 1.478 . . . . 0.0 110.495 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -148.31 148.7 30.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.899 . . . . 0.0 110.411 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.458 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 17.1 t80 -148.24 115.45 6.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.305 -0.872 . . . . 0.0 109.76 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 t -143.55 153.45 42.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.991 -1.068 . . . . 0.0 111.092 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 19' ' ' SER . 4.8 p -131.27 168.81 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.516 -0.74 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.625 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -93.22 -63.1 0.16 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.864 -1.147 . . . . 0.0 110.329 179.965 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.625 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 55.2 Cg_endo -84.66 99.9 0.74 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 O-C-N 123.159 1.084 . . . . 0.0 110.08 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.03 -0.8 50.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.997 -1.065 . . . . 0.0 110.352 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.1 p -151.49 165.64 33.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.903 . . . . 0.0 109.95 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.09 64.27 3.91 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 8' ' ' PRO . 4.7 mt -117.03 139.63 50.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.412 -1.052 . . . . 0.0 110.337 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 15.0 t -100.96 158.72 15.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 110.241 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 4.4 p-10 -68.84 112.4 5.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 0.0 110.14 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.1 -24.92 21.9 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 37.6 tt0 -59.36 155.29 14.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.29 -1.123 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.405 ' O ' ' CG1' ' A' ' 18' ' ' VAL . 20.7 t -99.32 -179.17 4.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.478 -0.763 . . . . 0.0 110.245 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.555 ' CG2' ' HB3' ' A' ' 65' ' ' PHE . 14.0 m -154.55 176.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 0.0 110.045 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 6' ' ' VAL . 38.5 m -118.25 123.73 46.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 110.094 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.27 151.3 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.155 -0.966 . . . . 0.0 110.299 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.9 m -140.62 123.35 16.25 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.406 -0.809 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.7 t -113.88 132.69 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 75.5 m -145.12 128.28 16.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.041 . . . . 0.0 110.59 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 140.02 -57.39 0.6 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.493 ' HB1' HG22 ' A' ' 55' ' ' THR . . . -54.63 -167.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -1.163 . . . . 0.0 109.741 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.548 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -159.35 156.14 28.03 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.032 -1.043 . . . . 0.0 110.669 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -38.7 121.87 1.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.644 -0.66 . . . . 0.0 110.968 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.76 10.56 3.91 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 4.4 mm-40 -146.36 119.07 8.59 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.071 -1.252 . . . . 0.0 110.843 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.486 HG23 ' OG1' ' A' ' 54' ' ' THR . 88.0 m -105.92 114.11 28.06 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 29' ' ' GLU . 32.2 m-85 -96.85 -178.16 4.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.1 -1.0 . . . . 0.0 111.769 -179.804 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.571 ' CD1' ' HB2' ' A' ' 52' ' ' SER . 22.4 m-85 -134.54 124.43 25.48 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.564 HG22 ' CG2' ' A' ' 51' ' ' THR . 3.3 tt -105.41 119.66 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.904 -1.123 . . . . 0.0 110.991 -179.823 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.465 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -152.96 171.85 17.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.331 -0.856 . . . . 0.0 110.01 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 6.1 pt20 -127.52 156.27 42.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.24 -0.913 . . . . 0.0 110.006 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 9.6 m -140.73 169.51 17.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.12 -0.988 . . . . 0.0 110.383 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.07 163.13 25.69 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.331 -0.856 . . . . 0.0 110.028 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -79.05 170.29 18.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.951 1.501 . . . . 0.0 110.635 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.463 HG22 ' HG2' ' A' ' 42' ' ' GLN . 1.5 m -133.22 -169.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.335 -0.853 . . . . 0.0 110.305 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.79 34.03 4.21 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.46 -39.99 0.02 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.463 ' HG2' HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -157.19 -116.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -1.166 . . . . 0.0 110.301 -179.978 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -133.0 167.0 21.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.765 -1.209 . . . . 0.0 110.425 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -159.3 175.24 13.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.358 -0.839 . . . . 0.0 110.072 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 38.9 t -158.95 165.92 33.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.346 -0.846 . . . . 0.0 110.242 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.453 ' ND2' HG22 ' A' ' 49' ' ' THR . 57.1 t-20 -97.29 121.29 59.12 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.295 -0.878 . . . . 0.0 110.629 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -81.75 -33.41 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.936 1.493 . . . . 0.0 110.822 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.81 96.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.192 -0.943 . . . . 0.0 110.595 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.453 HG22 ' ND2' ' A' ' 46' ' ' ASN . 54.1 p -78.05 5.72 9.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 0.0 110.443 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.12 88.76 7.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 110.565 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.564 ' CG2' HG22 ' A' ' 33' ' ' ILE . 12.8 t -99.53 174.49 6.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.571 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 2.8 t -131.78 148.42 52.56 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.988 -1.07 . . . . 0.0 111.063 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.533 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 24.9 p90 -150.3 151.62 33.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.508 -0.745 . . . . 0.0 109.343 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.486 ' OG1' HG23 ' A' ' 30' ' ' THR . 10.4 m -119.84 155.54 32.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.028 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.493 HG22 ' HB1' ' A' ' 25' ' ' ALA . 3.8 p -67.13 -158.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.298 -0.876 . . . . 0.0 110.297 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 55' ' ' THR . 8.8 m-20 -143.75 -162.93 1.55 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.06 -1.025 . . . . 0.0 109.985 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.77 -40.21 96.13 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.096 -1.002 . . . . 0.0 109.188 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 t -90.27 10.77 23.43 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.516 -0.74 . . . . 0.0 109.507 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 59.35 61.06 7.71 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.59 135.18 23.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.282 -1.128 . . . . 0.0 110.088 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.13 84.92 2.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 110.92 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.11 118.31 36.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.115 -0.991 . . . . 0.0 108.619 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -151.98 179.55 8.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.952 -1.092 . . . . 0.0 110.908 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.6 p -89.6 157.16 18.15 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.544 -0.722 . . . . 0.0 110.156 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.555 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 34.4 t80 -138.41 177.43 7.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.423 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.435 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.5 t -135.87 155.18 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.817 -1.177 . . . . 0.0 110.108 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.7 m -133.25 169.76 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.432 -0.792 . . . . 0.0 109.814 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 1.3 ttt85 -149.1 141.9 24.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.202 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -74.16 -48.07 31.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 110.22 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 95.4 p -119.9 144.75 47.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.933 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.543 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 21.5 p90 -162.01 142.79 10.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.112 -0.992 . . . . 0.0 110.693 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 54.1 m -55.66 122.29 11.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.304 -0.872 . . . . 0.0 109.877 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.1 168.78 13.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.9 t -157.95 153.01 25.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -1.065 . . . . 0.0 109.979 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.467 ' OG1' ' HB ' ' A' ' 79' ' ' THR . 57.0 p -56.55 162.21 3.58 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.095 -1.003 . . . . 0.0 110.199 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.22 -31.39 5.98 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.147 1.604 . . . . 0.0 110.383 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -68.8 -34.42 75.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.334 -0.854 . . . . 0.0 110.187 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.8 67.49 0.14 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.467 ' HB ' ' OG1' ' A' ' 75' ' ' THR . 11.4 m -150.77 106.33 3.05 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.183 -1.187 . . . . 0.0 110.019 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.35 136.87 27.24 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.075 1.566 . . . . 0.0 110.539 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.6 t -123.18 -76.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.333 -0.855 . . . . 0.0 110.271 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.12 -155.91 6.74 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 90.7 p -97.4 150.69 20.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.31 -1.112 . . . . 0.0 110.427 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 85' ' ' ASP . 78.0 t -112.19 153.79 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.279 -0.888 . . . . 0.0 110.134 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.518 ' N ' HG13 ' A' ' 84' ' ' VAL . 2.5 t0 -140.11 126.05 19.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 110.147 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 43.3 t -85.03 43.51 1.01 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.196 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.35 -52.13 5.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 110.193 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.6 t -101.28 1.08 38.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.124 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.36 -162.84 0.91 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.17 -0.956 . . . . 0.0 110.288 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.26 136.03 51.42 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.868 . . . . 0.0 110.151 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.3 p -125.05 127.79 47.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 110.071 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -107.89 165.75 11.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.377 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 34' ' ' ALA . 7.8 tp -128.54 110.71 12.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 109.544 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.57 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -116.28 162.58 12.59 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.298 -179.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.425 ' HB2' HD12 ' A' ' 102' ' ' LEU . . . -124.39 167.87 13.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.978 . . . . 0.0 109.869 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 31' ' ' TYR . . . 115.8 -166.05 12.24 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.403 ' CG ' ' N ' ' A' ' 98' ' ' SER . 7.9 t30 -147.59 168.71 21.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -1.177 . . . . 0.0 110.222 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.403 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 1.6 m -49.71 107.12 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 121.9 -46.69 1.09 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.523 HD23 ' CE1' ' A' ' 31' ' ' TYR . 0.4 OUTLIER -103.05 163.14 12.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -1.142 . . . . 0.0 110.135 179.987 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -146.68 131.25 17.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.333 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 4' ' ' PHE . 97.8 mt -106.96 -45.55 4.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.087 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.17 173.11 29.38 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.57 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 3.1 m-70 -140.85 108.32 5.57 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.343 -1.092 . . . . 0.0 109.94 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 t -90.21 113.67 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.32 -0.863 . . . . 0.0 110.445 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.69 130.87 47.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.169 -0.957 . . . . 0.0 109.88 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 31.5 mt -100.29 166.61 10.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.1 -1.0 . . . . 0.0 110.175 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -137.03 161.52 35.85 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.282 -0.886 . . . . 0.0 110.013 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 7.2 m-85 -139.65 148.16 42.03 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.349 -0.844 . . . . 0.0 110.05 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.04 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.964 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.749 0.309 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.447 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 46.1 Cg_endo -71.28 -158.34 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.999 1.526 . . . . 0.0 110.145 179.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -147.06 124.81 11.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.103 -0.998 . . . . 0.0 110.427 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.555 ' CE2' HD12 ' A' ' 33' ' ' ILE . 14.1 t80 -138.76 114.6 10.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.408 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.2 t -150.43 172.24 15.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.987 -1.071 . . . . 0.0 110.943 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.41 HG23 HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -130.02 145.55 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.854 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.597 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -66.17 -66.99 1.07 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.974 -1.079 . . . . 0.0 109.906 179.993 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.597 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 56.0 Cg_endo -79.27 69.47 7.91 Favored 'Trans proline' 0 N--CA 1.483 0.873 0 O-C-N 123.465 1.245 . . . . 0.0 110.081 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.41 -11.92 59.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.951 -1.093 . . . . 0.0 110.481 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.8 126.23 31.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 110.164 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.9 71.69 1.25 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.476 HD22 ' HB2' ' A' ' 8' ' ' PRO . 91.5 mt -112.57 165.67 12.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -1.144 . . . . 0.0 110.077 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -133.22 148.56 52.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.152 -0.967 . . . . 0.0 110.487 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -60.43 129.5 41.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.887 . . . . 0.0 110.141 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.01 -30.56 5.79 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -57.26 151.96 14.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.362 -1.081 . . . . 0.0 110.411 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -101.97 135.03 44.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.389 -0.819 . . . . 0.0 110.088 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.529 ' CG1' HG11 ' A' ' 67' ' ' VAL . 18.2 m -100.95 171.25 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.981 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.96 114.09 24.16 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.028 -1.045 . . . . 0.0 109.968 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 21' ' ' SER . 17.6 t -101.6 149.27 6.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.264 -0.897 . . . . 0.0 110.297 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.466 ' N ' HG13 ' A' ' 20' ' ' VAL . 42.0 t -150.02 128.18 12.0 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.483 -0.76 . . . . 0.0 110.183 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.4 t -120.71 137.69 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 109.887 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 2.3 p -150.52 111.0 4.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.957 -1.089 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 160.95 -52.14 0.34 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.502 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -60.27 -151.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -1.131 . . . . 0.0 110.096 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.52 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -167.83 163.51 14.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.137 -0.977 . . . . 0.0 110.545 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 56' ' ' ASP . . . -50.24 128.75 20.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.557 -0.714 . . . . 0.0 111.059 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.434 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 122.36 7.94 7.34 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.526 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 5.7 mm-40 -141.3 129.72 22.49 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.093 -1.239 . . . . 0.0 110.687 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.568 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.7 m -115.02 151.94 33.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 109.324 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 30' ' ' THR . 7.9 m-85 -139.7 -178.16 5.29 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.902 -1.124 . . . . 0.0 111.298 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.476 ' CE1' ' HB3' ' A' ' 52' ' ' SER . 55.4 m-85 -132.99 108.35 8.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.592 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 4.1 tt -87.56 125.44 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.154 -0.966 . . . . 0.0 110.851 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.1 165.21 35.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.24 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -118.05 150.85 38.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.204 -0.935 . . . . 0.0 110.029 179.986 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 72.2 m -150.8 164.65 35.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.897 . . . . 0.0 111.001 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.42 149.41 22.73 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.706 . . . . 0.0 109.495 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.52 164.42 32.93 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.839 1.442 . . . . 0.0 110.536 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 44' ' ' ALA . 17.4 m -134.32 57.22 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.333 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.57 -14.81 15.83 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -178.2 -48.22 0.07 OUTLIER Glycine 0 N--CA 1.492 2.433 0 O-C-N 120.688 -1.478 . . . . 0.0 110.671 179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 39' ' ' VAL . 1.8 tp60 -88.92 165.4 14.63 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.07 -1.253 . . . . 0.0 110.693 -179.875 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -98.95 127.44 44.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 110.039 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -110.52 150.71 28.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.155 -0.966 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.3 m -136.65 160.38 39.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.261 -0.899 . . . . 0.0 110.267 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.84 95.37 16.84 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.242 -0.911 . . . . 0.0 110.369 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -76.55 -30.45 5.05 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.966 1.508 . . . . 0.0 110.452 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.84 -38.95 70.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.309 -0.869 . . . . 0.0 110.295 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.49 36.82 1.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.817 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.3 144.11 28.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.489 -0.757 . . . . 0.0 110.788 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.592 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 11.0 t -151.22 143.51 24.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.833 . . . . 0.0 109.736 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.476 ' HB3' ' CE1' ' A' ' 32' ' ' TYR . 12.2 p -109.76 151.61 26.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.083 -1.011 . . . . 0.0 110.532 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -151.14 136.22 17.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 29' ' ' GLU . 26.3 m -102.15 171.95 7.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.256 -0.902 . . . . 0.0 110.571 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -84.89 -160.89 0.52 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.301 -0.874 . . . . 0.0 110.222 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 1.6 m-20 -149.1 -157.88 0.86 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.205 -0.935 . . . . 0.0 109.827 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.7 -53.66 55.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.91 -1.119 . . . . 0.0 109.997 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 t -87.12 16.17 5.38 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.265 -0.897 . . . . 0.0 109.215 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 56.84 48.79 75.63 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.0 129.98 56.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.282 -1.128 . . . . 0.0 110.426 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.18 85.1 2.21 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.331 -0.856 . . . . 0.0 110.077 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 23.7 p -110.63 134.3 52.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 109.901 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 25.8 p90 -163.85 173.64 12.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.233 -0.917 . . . . 0.0 110.504 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 t -94.08 137.9 32.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.797 . . . . 0.0 110.446 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.485 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 55.8 t80 -127.39 -179.46 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.532 -0.73 . . . . 0.0 109.374 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.485 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.2 t -128.02 154.92 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.853 -1.154 . . . . 0.0 110.209 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.529 HG11 ' CG1' ' A' ' 18' ' ' VAL . 22.2 m -129.0 178.67 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.373 -0.83 . . . . 0.0 110.111 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 3.0 mtp180 -150.31 118.66 6.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.849 . . . . 0.0 110.313 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 11.2 ttmt -49.81 -36.71 27.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.197 -0.939 . . . . 0.0 109.773 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.419 ' OG ' ' OD1' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -142.64 141.81 31.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.902 179.967 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.462 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 24.2 p90 -151.67 141.76 22.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -66.51 136.93 56.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.173 -179.933 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.74 170.38 49.06 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 79' ' ' THR . 8.4 t -152.97 132.89 13.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -1.172 . . . . 0.0 110.231 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.523 ' OG1' ' CB ' ' A' ' 79' ' ' THR . 8.5 p -89.72 167.91 16.2 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.181 -0.949 . . . . 0.0 110.065 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 49.4 Cg_endo -77.74 8.12 3.56 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.019 1.536 . . . . 0.0 110.74 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.486 ' OE2' ' OG1' ' A' ' 79' ' ' THR . 0.4 OUTLIER -127.76 -28.35 2.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.092 -1.005 . . . . 0.0 110.403 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.413 ' C ' ' OG1' ' A' ' 79' ' ' THR . . . 137.47 81.65 0.1 Allowed Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.536 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.523 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 2.8 m -163.76 118.35 1.09 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.216 -1.167 . . . . 0.0 109.793 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.51 -14.27 36.62 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.863 1.454 . . . . 0.0 110.573 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.442 ' O ' ' CG1' ' A' ' 81' ' ' VAL . 93.6 t 49.33 21.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.231 -0.918 . . . . 0.0 110.344 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.64 -153.88 43.01 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.7 OUTLIER -102.16 139.1 38.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.498 -1.001 . . . . 0.0 110.841 -179.859 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 71' ' ' TYR . 56.0 t -112.01 108.71 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 109.546 179.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 87' ' ' ALA . 18.8 t70 -88.24 135.78 33.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 0.0 110.246 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 91' ' ' CYS . 7.5 m -110.79 41.82 1.72 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.467 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . . . -97.88 -52.01 3.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 109.964 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -99.17 -9.24 24.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.861 . . . . 0.0 110.063 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.87 -133.41 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 109.935 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -151.05 97.26 2.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.082 -1.011 . . . . 0.0 110.807 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -88.51 113.41 24.07 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.184 -0.948 . . . . 0.0 109.048 179.914 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 16.6 p30 -113.48 129.73 56.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.972 -1.08 . . . . 0.0 111.293 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 35' ' ' GLN . 13.1 tp -99.43 111.13 23.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.366 -0.834 . . . . 0.0 109.373 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -125.43 171.92 17.39 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.84 178.98 6.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -1.078 . . . . 0.0 110.021 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 138.48 157.56 7.45 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' A' ' 98' ' ' SER . 8.2 p30 -107.55 -29.19 9.33 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.28 -1.129 . . . . 0.0 110.328 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.419 ' HB2' ' OD1' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -172.18 -72.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.7 -10.7 32.37 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.54 ' CD2' ' CE1' ' A' ' 31' ' ' TYR . 21.5 tp -73.78 -64.59 0.97 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.02 -1.282 . . . . 0.0 110.196 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 92.3 m-20 55.29 103.33 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.01 -6.11 55.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 110.374 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.4 ' O ' ' HA2' ' A' ' 94' ' ' GLY . . . 106.97 -175.39 20.62 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.476 ' O ' ' ND1' ' A' ' 104' ' ' HIS . 34.2 p80 -148.7 132.22 16.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.251 -1.146 . . . . 0.0 110.132 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -93.83 130.46 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.147 -180.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.47 114.29 8.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 110.408 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.2 136.5 33.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.848 . . . . 0.0 110.354 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 109' ' ' PHE . 98.3 m -107.25 173.2 6.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.291 -0.88 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.48 ' N ' HG22 ' A' ' 108' ' ' THR . 7.6 m-85 -142.8 122.69 13.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.889 . . . . 0.0 110.292 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.973 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.429 ' HB3' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 120.747 0.308 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 1' ' ' ALA . 47.1 Cg_endo -72.77 -162.58 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.115 1.587 . . . . 0.0 110.551 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -132.13 146.7 52.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.222 -0.924 . . . . 0.0 110.596 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 12.4 t80 -149.5 113.17 5.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.462 -0.774 . . . . 0.0 109.592 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.537 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 0.2 OUTLIER -151.15 167.02 29.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.032 -1.042 . . . . 0.0 110.959 -179.9 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.453 HG21 ' HD2' ' A' ' 8' ' ' PRO . 7.5 p -128.25 141.05 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.725 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -55.88 -67.38 0.77 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.08 -1.012 . . . . 0.0 110.289 -179.965 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 49.5 Cg_endo -74.4 82.81 1.8 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.386 1.203 . . . . 0.0 109.807 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.65 1.99 52.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.975 . . . . 0.0 110.501 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.8 p -150.27 148.89 29.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.252 -0.905 . . . . 0.0 110.165 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.3 58.71 3.55 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mt -105.44 170.63 7.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.303 -1.116 . . . . 0.0 110.45 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.47 149.4 43.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 110.183 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.8 96.94 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.83 -34.06 3.23 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -54.22 142.89 24.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 110.143 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 66.3 m -91.68 134.09 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 110.069 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.493 HG21 HG13 ' A' ' 67' ' ' VAL . 23.2 m -100.88 148.86 6.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 110.168 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.21 106.1 18.11 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.34 -0.85 . . . . 0.0 109.309 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.513 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 36.9 t -93.37 149.74 4.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.499 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.75 119.27 5.63 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.857 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 23.8 t -107.08 132.51 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.771 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.513 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 30.3 m -127.77 120.36 27.72 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 148.75 -77.69 0.23 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.505 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -47.12 172.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.216 -1.167 . . . . 0.0 110.029 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.525 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -139.6 161.63 37.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 110.464 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -39.04 122.79 1.25 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.674 -0.641 . . . . 0.0 110.653 -179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.57 0.76 7.84 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.472 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 30.9 mm-40 -132.93 130.51 39.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -1.184 . . . . 0.0 110.597 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 53' ' ' PHE . 57.5 m -106.34 161.25 14.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.503 -0.748 . . . . 0.0 109.659 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 80.1 m-85 -149.96 176.47 10.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.041 -1.037 . . . . 0.0 110.552 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 17.7 m-85 -122.78 147.62 46.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.456 -0.778 . . . . 0.0 109.093 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.585 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 5.2 tt -128.35 116.53 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.955 -1.091 . . . . 0.0 110.15 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.46 158.58 44.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.428 ' OE1' ' HB3' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -93.62 136.12 34.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.608 -0.682 . . . . 0.0 109.958 179.912 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.2 m -142.98 143.39 31.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.89 174.72 3.24 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.454 -0.778 . . . . 0.0 109.496 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.86 165.67 31.86 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.733 1.386 . . . . 0.0 110.351 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -146.41 84.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.297 -0.877 . . . . 0.0 110.366 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.28 3.8 54.23 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 143.11 -51.7 0.66 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.58 -141.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.367 -1.078 . . . . 0.0 110.006 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.36 127.76 7.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.106 -0.996 . . . . 0.0 110.405 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.534 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . . . -117.37 151.9 36.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.35 -0.844 . . . . 0.0 109.895 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.466 ' O ' ' HA2' ' A' ' 73' ' ' GLY . 2.4 m -116.05 164.34 14.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.153 -0.967 . . . . 0.0 110.368 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.478 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 59.3 t-20 -96.0 123.2 56.17 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.275 -0.891 . . . . 0.0 110.174 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.76 -33.74 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.861 1.453 . . . . 0.0 110.681 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.45 -19.77 65.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.346 -0.846 . . . . 0.0 110.815 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.16 32.93 5.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.045 -1.035 . . . . 0.0 110.476 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.52 106.29 18.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.224 -0.922 . . . . 0.0 110.511 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.585 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 14.9 t -131.42 -178.57 4.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.0 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.4 ' CB ' ' CD1' ' A' ' 32' ' ' TYR . 55.6 p -144.12 147.19 33.4 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.115 -0.991 . . . . 0.0 110.839 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 20.6 p90 -136.09 -176.99 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.763 . . . . 0.0 109.539 179.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.5 m -145.47 154.32 42.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.796 -1.19 . . . . 0.0 110.256 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.505 HG21 ' CB ' ' A' ' 25' ' ' ALA . 2.0 p -69.99 -158.02 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.209 -0.932 . . . . 0.0 109.915 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -160.03 -155.67 0.45 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.902 -1.124 . . . . 0.0 110.148 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.14 78.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.918 -1.114 . . . . 0.0 109.527 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 t -79.29 4.99 13.51 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.379 -0.825 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 56.05 38.03 74.05 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -124.91 127.19 46.71 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.268 -1.136 . . . . 0.0 110.104 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.418 ' CB ' ' HB ' ' A' ' 22' ' ' VAL . . . -101.14 80.35 2.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 110.365 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.9 m -101.08 120.18 39.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.676 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.513 ' CE1' ' HB ' ' A' ' 20' ' ' VAL . 7.0 p90 -155.73 174.79 14.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.192 -0.942 . . . . 0.0 110.833 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.5 m -98.32 132.6 43.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 40.5 t80 -130.35 179.63 5.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.443 -0.786 . . . . 0.0 109.238 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.467 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.8 t -129.38 155.9 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.81 -1.181 . . . . 0.0 110.352 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.493 HG13 HG21 ' A' ' 18' ' ' VAL . 31.8 m -125.21 159.02 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.404 -0.81 . . . . 0.0 110.357 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -133.21 132.9 42.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.263 -0.898 . . . . 0.0 110.034 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -72.8 -10.83 60.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.137 -0.977 . . . . 0.0 110.362 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.2 p -150.29 139.37 21.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.131 -0.981 . . . . 0.0 110.536 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 9.6 p90 -168.09 138.76 2.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.299 -0.876 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.2 OUTLIER -68.68 137.34 54.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.258 -0.901 . . . . 0.0 110.091 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 45' ' ' CYS . . . -121.7 -166.48 12.88 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 p -158.88 -176.01 5.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -1.115 . . . . 0.0 110.138 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 79' ' ' THR . 1.2 p -75.69 168.49 27.28 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.36 -0.838 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -80.2 14.57 1.91 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.058 1.557 . . . . 0.0 111.106 -179.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 78' ' ' GLY . 12.8 pt-20 -123.2 -41.09 2.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.947 -1.096 . . . . 0.0 110.358 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.505 ' N ' ' HG3' ' A' ' 77' ' ' GLU . . . 142.09 52.14 0.04 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.45 ' O ' ' OG1' ' A' ' 75' ' ' THR . 28.1 m -151.35 113.51 3.04 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.289 -1.124 . . . . 0.0 110.119 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.31 145.19 42.81 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.913 1.48 . . . . 0.0 110.693 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 82' ' ' GLY . 6.2 p -138.86 -36.94 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 110.319 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.486 ' N ' HG12 ' A' ' 81' ' ' VAL . . . -162.98 -171.79 29.65 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.7 OUTLIER -105.79 176.1 5.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -1.147 . . . . 0.0 110.283 179.947 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.534 ' CG2' ' HB3' ' A' ' 44' ' ' ALA . 74.0 t -125.21 159.1 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.383 -0.823 . . . . 0.0 110.21 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -154.75 146.61 23.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.882 . . . . 0.0 110.056 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.81 17.73 22.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 110.105 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.62 -42.78 61.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 110.674 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -117.74 -16.42 10.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.148 -0.97 . . . . 0.0 110.361 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.43 147.09 34.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.953 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.17 154.51 27.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 0.0 110.178 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.428 ' HB3' ' OE1' ' A' ' 35' ' ' GLN . 82.7 m -120.93 162.74 19.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 0.0 110.329 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -146.09 121.3 10.18 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.31 -0.868 . . . . 0.0 110.237 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 45.2 tp -86.95 112.1 21.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.046 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.562 ' HA3' ' CD2' ' A' ' 104' ' ' HIS . . . -121.14 163.37 14.61 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.501 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -132.42 159.07 40.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.551 -0.97 . . . . 0.0 110.507 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 101' ' ' ASP . . . 169.31 159.2 14.45 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 31' ' ' TYR . 1.5 p30 -143.34 -41.14 0.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.991 -1.299 . . . . 0.0 111.246 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.43 78.01 1.2 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.951 -1.093 . . . . 0.0 111.294 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.45 9.24 29.97 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 101' ' ' ASP . 1.6 tt -99.35 -51.33 3.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.285 . . . . 0.0 109.827 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.523 ' HA ' ' CA ' ' A' ' 96' ' ' GLY . 1.1 m-20 54.21 164.54 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.485 -0.759 . . . . 0.0 110.123 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.501 HD11 ' CB ' ' A' ' 31' ' ' TYR . 31.7 mt -126.36 -47.68 1.59 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.904 -179.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 167.35 174.35 36.36 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.562 ' CD2' ' HA3' ' A' ' 94' ' ' GLY . 1.9 m170 -129.56 126.77 39.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.851 -0.793 . . . . 0.0 109.652 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 5' ' ' SER . 20.0 t -108.23 120.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.048 -1.032 . . . . 0.0 110.439 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.06 107.55 10.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.932 . . . . 0.0 109.382 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 12.6 mt -88.61 171.86 9.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.308 -0.87 . . . . 0.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -147.77 158.68 44.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.449 -0.782 . . . . 0.0 109.838 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -122.16 119.85 32.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.058 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.59 179.997 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.809 0.338 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.457 ' HB2' HD22 ' A' ' 102' ' ' LEU . 43.8 Cg_endo -69.3 -174.01 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.999 1.526 . . . . 0.0 110.49 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 23' ' ' SER . . . -154.04 121.77 5.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.897 . . . . 0.0 110.334 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.426 ' HB2' HD23 ' A' ' 102' ' ' LEU . 87.8 t80 -141.47 110.79 6.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.211 -0.931 . . . . 0.0 109.562 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.8 t -150.69 161.13 43.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.078 -1.014 . . . . 0.0 110.999 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.558 ' CG1' ' CB ' ' A' ' 9' ' ' ALA . 6.2 p -114.93 160.42 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.494 -0.754 . . . . 0.0 109.674 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -62.96 -66.52 1.5 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.048 -1.032 . . . . 0.0 110.561 -179.993 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 43.1 Cg_endo -73.54 -73.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.424 1.223 . . . . 0.0 110.591 -179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.558 ' CB ' ' CG1' ' A' ' 6' ' ' VAL . . . 75.26 -1.04 3.15 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.443 -0.786 . . . . 0.0 110.203 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.446 ' OG ' ' C ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER -164.21 145.42 8.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 110.248 -179.951 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.96 41.22 61.83 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' A' ' 18' ' ' VAL . 1.3 mp -90.78 174.79 7.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -1.164 . . . . 0.0 110.091 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 1.5 t -128.56 150.34 50.24 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.361 -0.837 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -56.94 108.04 0.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.189 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.92 -35.19 5.09 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.4 tt0 -45.95 152.94 0.33 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.303 -1.116 . . . . 0.0 110.357 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 p -103.53 154.4 19.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.403 -0.811 . . . . 0.0 110.378 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.527 HG12 ' CD2' ' A' ' 12' ' ' LEU . 21.1 m -129.13 150.23 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.302 -0.874 . . . . 0.0 110.026 -179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 m -94.91 115.15 27.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.136 -0.978 . . . . 0.0 109.842 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.588 HG12 ' CZ ' ' A' ' 63' ' ' PHE . 42.7 t -100.8 147.65 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.529 ' N ' HG11 ' A' ' 20' ' ' VAL . 2.8 t -146.06 139.3 25.95 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.47 -0.769 . . . . 0.0 110.469 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.48 ' O ' ' OG ' ' A' ' 23' ' ' SER . 47.6 t -128.29 153.59 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.526 -0.734 . . . . 0.0 110.007 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 7.3 m -165.89 120.89 1.23 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.946 -1.096 . . . . 0.0 110.672 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 25' ' ' ALA . . . 139.29 -59.98 0.58 Allowed Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.354 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.551 ' HB2' ' CG2' ' A' ' 55' ' ' THR . . . -39.53 -47.9 1.95 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.199 -1.177 . . . . 0.0 110.985 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.568 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . 73.99 141.79 0.07 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.398 -0.814 . . . . 0.0 110.595 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -39.13 136.33 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.527 0.68 . . . . 0.0 110.866 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.01 12.55 4.36 Favored Glycine 0 N--CA 1.481 1.643 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -156.3 126.73 6.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.056 -1.261 . . . . 0.0 110.62 179.975 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 53' ' ' PHE . 1.6 m -94.1 143.11 26.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.463 -0.773 . . . . 0.0 109.858 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 29' ' ' GLU . 25.7 m-85 -134.34 146.14 49.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.08 -1.012 . . . . 0.0 111.154 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 97.5 m-85 -113.86 124.48 52.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.389 -0.82 . . . . 0.0 109.05 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.564 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 12.4 tt -96.3 120.44 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.83 -1.169 . . . . 0.0 110.652 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.468 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -152.07 153.29 33.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 110.142 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.451 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 14.3 pt20 -121.41 150.39 41.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.111 -0.993 . . . . 0.0 110.288 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 96.6 m -152.02 164.28 37.53 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.202 -0.936 . . . . 0.0 111.095 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -153.06 158.47 32.86 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.662 -0.649 . . . . 0.0 109.978 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.01 173.11 8.83 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.792 1.417 . . . . 0.0 110.668 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 42' ' ' GLN . 2.1 p -146.91 70.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.242 -0.912 . . . . 0.0 111.043 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.56 33.24 67.41 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.63 -44.24 1.55 Allowed Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.53 ' HB2' ' CG1' ' A' ' 39' ' ' VAL . 4.6 mm-40 -76.01 -154.94 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.421 -1.047 . . . . 0.0 109.845 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.461 ' C ' HG12 ' A' ' 39' ' ' VAL . 10.0 t70 -136.44 153.03 51.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.027 -1.046 . . . . 0.0 110.637 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.17 151.17 45.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.455 -0.778 . . . . 0.0 109.741 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 0.8 OUTLIER -139.77 161.62 37.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 0.0 110.444 179.97 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -107.9 89.81 5.82 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.344 -0.848 . . . . 0.0 110.179 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 48.6 Cg_endo -76.27 -31.79 4.44 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.974 1.513 . . . . 0.0 110.681 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.3 -27.16 63.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.304 -0.873 . . . . 0.0 110.438 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 p -108.55 39.18 2.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 110.149 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.31 138.9 31.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 110.414 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.564 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 3.7 t -153.1 134.96 14.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.892 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.574 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 87.9 p -108.04 145.09 34.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.727 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 14.7 p90 -150.97 -175.75 5.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 109.586 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.0 m -145.5 160.53 41.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.178 -0.951 . . . . 0.0 109.627 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.551 ' CG2' ' HB2' ' A' ' 25' ' ' ALA . 3.0 p -60.72 -162.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.94 -1.1 . . . . 0.0 109.966 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.19 -164.24 1.81 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.044 -1.035 . . . . 0.0 109.879 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.11 67.02 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.036 -1.04 . . . . 0.0 109.414 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.479 ' OG ' ' HB2' ' A' ' 60' ' ' ALA . 77.2 p -89.73 18.28 5.71 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.568 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 59.13 29.38 65.44 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.479 ' HB2' ' OG ' ' A' ' 58' ' ' SER . . . -105.99 123.82 48.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.293 -1.122 . . . . 0.0 110.499 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.42 ' HB1' ' HB ' ' A' ' 22' ' ' VAL . . . -126.5 85.12 2.34 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.6 p -106.15 124.94 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.235 -0.916 . . . . 0.0 109.699 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.639 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 4.8 p90 -153.89 177.03 11.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.076 -1.015 . . . . 0.0 110.645 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.39 141.31 28.87 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.5 -0.75 . . . . 0.0 110.625 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.432 ' C ' ' CG2' ' A' ' 66' ' ' VAL . 45.8 t80 -138.78 -174.75 3.92 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.432 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 3.2 t -147.22 161.54 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.824 -1.173 . . . . 0.0 110.242 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 26.7 m -133.64 -177.04 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.397 -0.814 . . . . 0.0 110.012 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 26.4 mtt180 -158.45 123.29 4.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.038 -1.039 . . . . 0.0 110.629 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.582 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 10.9 tttm -62.42 -43.59 98.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.867 . . . . 0.0 109.556 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m -127.97 118.88 24.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -131.24 143.63 50.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.953 . . . . 0.0 110.461 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.5 m -60.91 141.91 56.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.96 . . . . 0.0 109.885 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -127.76 154.76 19.84 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 p -141.21 162.17 36.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -1.062 . . . . 0.0 110.274 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.578 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 3.8 p -80.25 176.62 3.61 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.847 . . . . 0.0 109.561 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 46.3 Cg_endo -74.51 -25.21 13.16 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.751 1.395 . . . . 0.0 110.545 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -13.22 60.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 109.939 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.32 57.09 1.22 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 83.4 m -135.75 117.61 12.04 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.226 -1.161 . . . . 0.0 110.195 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.43 80.89 1.87 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.894 1.471 . . . . 0.0 110.372 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.2 t -57.65 -37.78 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.915 . . . . 0.0 110.233 179.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.36 -154.55 25.35 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 69.8 m -100.43 161.03 13.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.235 -1.156 . . . . 0.0 110.458 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.9 t -122.41 149.58 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.213 -0.929 . . . . 0.0 109.999 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -127.58 162.35 26.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.168 -0.957 . . . . 0.0 110.553 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 89' ' ' ALA . 19.1 m -106.36 -9.76 16.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 0.0 110.095 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.16 -52.55 9.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.345 -0.847 . . . . 0.0 110.334 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.5 HG22 ' N ' ' A' ' 89' ' ' ALA . 14.6 t -71.36 -19.6 62.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.15 -0.969 . . . . 0.0 109.866 -179.926 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.5 ' N ' HG22 ' A' ' 88' ' ' THR . . . -133.12 -160.17 1.03 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.391 -0.818 . . . . 0.0 109.873 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.88 135.11 45.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.173 -0.955 . . . . 0.0 109.857 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 1.9 p -121.27 146.7 46.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.133 -0.979 . . . . 0.0 109.774 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -127.6 147.84 50.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.09 -1.006 . . . . 0.0 111.146 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.468 HD11 ' O ' ' A' ' 34' ' ' ALA . 8.0 tp -119.05 114.75 22.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.455 -0.778 . . . . 0.0 109.053 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -129.13 178.77 17.11 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.578 -1.296 . . . . 0.0 110.26 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -140.73 172.33 12.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.394 -1.062 . . . . 0.0 110.163 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 144.74 169.4 13.28 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' CG ' ' N ' ' A' ' 98' ' ' SER . 5.2 p30 -89.47 -45.19 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -1.187 . . . . 0.0 110.276 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.473 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER 171.54 -41.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.429 -0.795 . . . . 0.0 109.955 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.84 -12.41 22.52 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.571 HD22 ' CE1' ' A' ' 31' ' ' TYR . 1.1 tt -87.21 -65.83 0.97 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.196 -1.179 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 100' ' ' LEU . 13.9 t0 68.17 75.13 0.28 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.348 -0.845 . . . . 0.0 110.012 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.457 HD22 ' HB2' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -49.99 -36.53 28.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.335 -0.853 . . . . 0.0 110.45 -179.942 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.44 170.37 13.13 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.424 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -135.31 125.74 26.66 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.216 -1.167 . . . . 0.0 109.91 179.983 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.48 124.54 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.985 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.07 125.52 25.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.246 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 76.6 mt -95.84 164.99 12.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.291 -179.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.524 ' C ' ' CD1' ' A' ' 109' ' ' PHE . 6.2 m -158.5 175.99 12.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.311 -0.868 . . . . 0.0 110.054 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.582 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 69.0 m-85 -142.64 152.0 42.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.308 -0.87 . . . . 0.0 110.277 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.039 -1.423 . . . . 0.0 109.598 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.557 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 47.7 Cg_endo . . . . . 0 C--O 1.215 -0.636 0 N-CA-C 110.226 -0.721 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.77 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -140.62 123.18 16.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 110.796 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.452 ' HD1' HG22 ' A' ' 22' ' ' VAL . 81.9 t80 -141.52 100.22 3.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.502 -0.749 . . . . 0.0 109.119 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.11 172.12 13.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 110.978 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 6' ' ' VAL . 5.2 p -137.02 128.44 42.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.642 -0.661 . . . . 0.0 109.612 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.635 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.1 m -46.62 -72.89 0.12 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.117 . . . . 0.0 110.221 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.635 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 53.0 Cg_endo -75.9 97.77 1.14 Allowed 'Trans proline' 0 N--CA 1.483 0.87 0 O-C-N 123.04 1.021 . . . . 0.0 110.031 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.32 4.4 41.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.13 -0.981 . . . . 0.0 110.25 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.6 p -155.57 167.7 29.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 110.245 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.39 42.22 97.37 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.541 ' O ' ' CE2' ' A' ' 109' ' ' PHE . 85.3 mt -90.43 136.83 32.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.303 -1.116 . . . . 0.0 110.137 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.487 ' HB2' ' OE1' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -110.75 156.53 20.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 110.459 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 8.1 p-10 -57.22 119.28 6.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.04 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.42 -35.5 4.86 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.487 ' OE1' ' HB2' ' A' ' 13' ' ' SER . 33.4 tt0 -48.72 142.65 5.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -1.116 . . . . 0.0 110.044 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 58.9 p -95.3 161.6 14.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.351 -0.843 . . . . 0.0 110.597 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.542 HG23 ' HB3' ' A' ' 65' ' ' PHE . 16.5 m -132.29 151.07 34.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.412 -0.805 . . . . 0.0 109.636 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 1.5 m -99.35 122.02 41.9 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.063 -1.023 . . . . 0.0 109.804 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.483 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 7.4 t -110.95 146.47 15.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.38 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.0 p -140.68 128.64 21.97 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.389 -0.819 . . . . 0.0 110.397 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.792 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 39.9 t -121.66 100.78 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.77 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.4 OUTLIER -130.23 110.21 11.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.978 . . . . 0.0 110.251 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 169.32 -50.71 0.21 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.922 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -59.97 -138.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -1.131 . . . . 0.0 109.883 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -179.11 164.56 1.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.976 -1.078 . . . . 0.0 110.347 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.804 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . . . -54.26 128.89 33.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.398 -0.814 . . . . 0.0 110.479 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 119.69 18.92 4.24 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 9.5 mm-40 -154.9 127.31 7.87 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.235 -1.156 . . . . 0.0 110.457 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.471 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -93.56 170.1 9.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.344 -0.848 . . . . 0.0 109.952 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 79.5 m-85 -152.94 155.44 37.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.416 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 78.8 m-85 -122.81 111.25 16.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.663 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.752 HG23 HG23 ' A' ' 51' ' ' THR . 5.4 tt -95.98 120.91 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.102 -0.999 . . . . 0.0 110.433 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.66 160.37 43.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.112 -0.992 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.522 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 25.3 tt0 -114.15 133.56 55.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.64 -0.662 . . . . 0.0 109.219 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 66.0 m -139.49 156.24 47.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.985 -1.072 . . . . 0.0 111.146 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.63 144.0 16.92 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 41.6 Cg_endo -69.97 159.95 51.38 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.819 1.431 . . . . 0.0 110.68 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 C--N 1.299 -1.618 0 O-C-N 121.517 -0.739 . . . . 0.0 110.02 -179.916 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 7.1 m-20 . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 121.286 0.565 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.442 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -144.89 151.69 39.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.18 -0.95 . . . . 0.0 110.321 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 m -131.23 155.11 47.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.309 -0.869 . . . . 0.0 110.199 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.465 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 36.2 t-20 -87.9 124.08 67.78 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.07 -1.019 . . . . 0.0 110.195 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -81.83 -41.06 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.898 1.473 . . . . 0.0 111.046 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.63 93.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.321 -0.862 . . . . 0.0 111.021 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 47.7 p -80.64 7.14 10.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.142 -0.974 . . . . 0.0 110.365 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.78 104.98 6.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 110.223 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.752 HG23 HG23 ' A' ' 33' ' ' ILE . 9.8 t -136.9 163.16 31.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.884 . . . . 0.0 110.197 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -132.8 162.19 32.13 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 110.241 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 46.6 p90 -151.23 171.06 18.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.439 -0.788 . . . . 0.0 109.659 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.6 m -130.97 155.99 45.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.137 -0.977 . . . . 0.0 110.139 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.922 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -88.75 176.11 7.22 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.095 -1.003 . . . . 0.0 110.187 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.804 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 11.0 t70 -177.13 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.183 -0.948 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.43 86.92 0.07 Allowed 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.212 -0.93 . . . . 0.0 109.13 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.95 15.95 8.8 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 79.1 52.27 4.97 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.07 149.22 28.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -1.168 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.792 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -163.53 78.37 0.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 110.526 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.8 m -101.55 130.28 47.81 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.294 -0.879 . . . . 0.0 109.706 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.483 ' CE1' ' CG1' ' A' ' 20' ' ' VAL . 1.7 p90 -153.32 171.3 18.79 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.005 -1.059 . . . . 0.0 111.086 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.1 m -92.94 125.51 37.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.449 -0.782 . . . . 0.0 110.642 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.542 ' HB3' HG23 ' A' ' 18' ' ' VAL . 28.8 t80 -118.47 -173.07 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.597 -0.689 . . . . 0.0 109.375 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 3.9 t -147.76 167.78 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 120.756 -1.215 . . . . 0.0 110.371 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 13.1 m -139.37 161.78 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 0.0 110.243 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -143.35 122.79 13.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.262 -0.899 . . . . 0.0 110.097 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ARG . 2.7 ttpt -45.63 -48.19 14.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.044 -1.035 . . . . 0.0 109.365 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 6.6 m -127.3 123.81 37.27 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.58 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 28.3 p90 -125.13 140.18 53.11 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.079 -1.013 . . . . 0.0 111.28 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 85.7 m -58.35 99.91 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.396 -0.815 . . . . 0.0 109.957 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.67 177.15 26.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.206 -1.173 . . . . 0.0 110.193 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 19.4 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.569 0.699 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 70' ' ' SER . 40.6 t -125.02 148.63 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 59.3 p30 -127.23 166.22 18.16 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.063 -1.023 . . . . 0.0 110.721 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -112.71 1.77 15.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.499 -0.751 . . . . 0.0 110.414 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.32 -58.26 4.66 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.69 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -81.64 -27.38 34.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.116 -0.99 . . . . 0.0 110.501 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.05 176.99 4.78 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.39 155.88 22.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.8 m -116.93 139.11 51.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 0.0 110.185 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -123.29 125.73 45.58 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 110.322 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -102.02 108.52 19.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.283 -0.886 . . . . 0.0 109.078 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.2 163.5 12.38 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.498 -1.334 . . . . 0.0 110.141 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.602 ' O ' HD12 ' A' ' 102' ' ' LEU . . . -155.16 118.27 4.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.449 -1.03 . . . . 0.0 109.872 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.61 -177.06 46.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -118.15 177.41 4.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -1.136 . . . . 0.0 110.265 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.0 t -70.64 -20.12 62.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.127 -0.983 . . . . 0.0 110.146 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.1 -44.05 5.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.755 HD13 ' C ' ' A' ' 100' ' ' LEU . 3.4 tm? -118.87 135.74 54.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.242 -1.152 . . . . 0.0 109.938 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.745 ' N ' HD13 ' A' ' 100' ' ' LEU . 41.0 m-20 -116.12 101.66 8.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.0 . . . . 0.0 110.322 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 95' ' ' ALA . 19.8 mt -66.03 -61.16 2.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 110.003 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.12 -173.98 30.46 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -148.26 150.38 33.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.466 -1.02 . . . . 0.0 110.117 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.504 HG11 HG12 ' A' ' 6' ' ' VAL . 12.0 t -107.77 126.02 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.329 -0.857 . . . . 0.0 110.335 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.9 114.06 10.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.914 . . . . 0.0 109.841 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.522 ' CD1' ' OE1' ' A' ' 35' ' ' GLN . 58.1 mt -81.4 147.03 30.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.94 . . . . 0.0 110.573 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -127.74 158.16 38.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.853 . . . . 0.0 110.096 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 13.1 m-85 -128.74 92.26 3.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.275 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.976 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.433 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 46.8 Cg_endo . . . . . 0 N--CA 1.481 0.786 0 N-CA-C 110.423 -0.645 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -162.14 115.5 1.79 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.88 . . . . 0.0 110.405 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -126.96 114.85 18.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.2 m -143.76 170.35 16.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.06 -1.025 . . . . 0.0 110.593 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.917 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 4.0 p -134.5 138.4 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.386 -0.821 . . . . 0.0 110.239 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.543 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -54.84 -57.13 20.79 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.357 -0.839 . . . . 0.0 110.962 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.762 ' HD2' HG22 ' A' ' 6' ' ' VAL . 42.4 Cg_endo -69.09 -87.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.864 1.455 . . . . 0.0 110.797 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.917 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 71.53 14.19 6.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.283 -0.885 . . . . 0.0 109.836 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.2 t -178.13 149.13 0.53 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.88 45.92 62.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' A' ' 8' ' ' PRO . 17.2 mt -98.79 174.3 6.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.326 -1.102 . . . . 0.0 110.231 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.81 159.72 44.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 110.12 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.53 ' HB3' ' CB ' ' A' ' 69' ' ' LYS . 1.5 p30 -59.76 116.33 3.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.265 -0.897 . . . . 0.0 110.206 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.41 -33.6 6.07 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -45.68 154.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -1.108 . . . . 0.0 110.106 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -98.53 172.03 7.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.54 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.4 m -149.09 154.68 9.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.385 -0.822 . . . . 0.0 109.9 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.488 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 0.4 OUTLIER -111.6 114.83 28.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.257 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.7 t -103.72 152.01 6.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.323 -0.861 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 18.8 t -149.36 132.56 16.39 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.492 -0.755 . . . . 0.0 109.998 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.829 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 6.6 t -124.09 153.24 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 110.338 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.661 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 1.0 OUTLIER -161.29 120.01 2.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 131.26 4.85 3.93 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 1.001 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -103.61 -30.04 10.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.998 -1.295 . . . . 0.0 110.374 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.539 ' HA ' ' HA3' ' A' ' 59' ' ' GLY . . . 58.57 133.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.816 0.817 . . . . 0.0 111.43 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -39.08 141.63 0.29 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.538 0.685 . . . . 0.0 110.505 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.19 -10.11 13.44 Favored Glycine 0 C--N 1.288 -2.137 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.485 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 5.1 mm-40 -125.39 123.49 39.44 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.376 -1.073 . . . . 0.0 109.829 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.544 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 71.5 m -97.52 159.62 14.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.386 -0.821 . . . . 0.0 109.767 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 50.4 m-85 -147.38 153.16 39.3 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.192 -0.942 . . . . 0.0 110.344 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 52' ' ' SER . 88.1 m-85 -115.54 108.82 16.95 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 109.372 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.706 HD11 HD21 ' A' ' 93' ' ' LEU . 4.5 tt -98.39 128.35 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.124 -0.985 . . . . 0.0 110.73 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.57 152.0 32.31 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.306 -0.871 . . . . 0.0 110.458 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.4 135.06 33.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.845 . . . . 0.0 109.615 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.6 m -147.21 159.46 43.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 0.0 110.684 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.76 157.0 34.67 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.602 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 44.3 Cg_endo -72.39 163.38 38.78 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.751 1.395 . . . . 0.0 110.764 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 39' ' ' VAL . 16.7 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.699 0.762 . . . . 0.0 109.756 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 10.0 t70 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.211 0.529 . . . . 0.0 109.831 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.5 158.68 15.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.913 . . . . 0.0 110.427 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.2 168.04 15.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.291 -0.881 . . . . 0.0 110.186 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.525 ' OD1' ' CG ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -104.25 102.74 34.66 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 109.923 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.15 -29.28 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.986 1.519 . . . . 0.0 110.437 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.82 -27.44 68.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.365 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 40.0 p -111.29 30.31 7.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.394 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.3 128.32 34.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 109.929 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.655 ' CG2' HG23 ' A' ' 33' ' ' ILE . 9.0 t -138.22 131.94 31.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.96 . . . . 0.0 110.543 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.491 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 28.8 t -111.91 142.55 44.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.408 -0.808 . . . . 0.0 109.952 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 45.9 p90 -144.24 -174.98 4.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.316 -0.865 . . . . 0.0 110.342 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 55' ' ' THR . 28.2 m -150.01 151.34 33.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.95 . . . . 0.0 109.796 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 1.001 ' CG2' ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -56.19 -160.67 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.024 -1.048 . . . . 0.0 110.529 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.653 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 2.3 m-20 -153.92 -158.29 0.85 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.091 -1.006 . . . . 0.0 110.36 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.27 74.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.873 -1.142 . . . . 0.0 109.671 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.2 m -84.15 10.63 9.74 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.343 -0.848 . . . . 0.0 109.341 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 26' ' ' ALA . . . 52.5 53.76 30.56 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.81 113.3 13.33 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.242 -1.152 . . . . 0.0 110.086 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.829 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -101.54 80.93 2.11 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.396 -0.815 . . . . 0.0 109.806 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 62.1 p -114.67 125.97 54.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 110.118 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.4 p90 -154.59 176.07 12.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.314 -0.866 . . . . 0.0 110.575 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 89.6 p -97.63 119.26 35.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.488 -0.757 . . . . 0.0 110.485 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 51.6 t80 -115.93 174.78 5.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.336 -0.852 . . . . 0.0 109.621 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.562 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 12.6 t -125.48 163.97 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.909 -1.119 . . . . 0.0 110.419 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.91 173.79 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.269 -0.894 . . . . 0.0 110.216 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -148.72 151.29 34.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.292 -0.88 . . . . 0.0 110.125 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.53 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 6.7 tttt -83.93 -39.86 19.25 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.235 -0.916 . . . . 0.0 109.884 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.422 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 28.8 p -132.85 147.29 52.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 109.753 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 12.6 p90 -165.92 148.33 7.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.961 -1.087 . . . . 0.0 111.028 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 13.0 m -64.08 123.3 18.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.311 -0.868 . . . . 0.0 109.638 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.04 175.29 15.88 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.373 -1.075 . . . . 0.0 109.854 179.966 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.8 p . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.454 0.645 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.0 t -131.69 102.32 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.47 -0.769 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.422 ' OD1' ' HB2' ' A' ' 70' ' ' SER . 1.1 m-20 -88.94 141.02 28.84 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.844 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.97 15.07 28.37 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.365 -0.835 . . . . 0.0 110.407 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.55 -59.74 2.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 t -77.37 -20.08 55.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -103.64 -163.2 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.887 . . . . 0.0 110.126 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.84 144.45 45.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.317 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.57 133.69 53.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.198 -0.939 . . . . 0.0 109.895 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -142.53 132.98 25.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 110.594 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.706 HD21 HD11 ' A' ' 33' ' ' ILE . 16.5 tp -93.45 118.03 30.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.883 . . . . 0.0 109.247 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.592 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -112.43 152.04 17.95 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.447 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -148.59 134.53 19.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.585 -0.95 . . . . 0.0 109.872 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.53 165.65 32.47 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.781 -1.2 . . . . 0.0 110.145 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -83.58 -157.14 0.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -1.102 . . . . 0.0 110.088 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.7 t -82.11 -31.11 30.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 110.26 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.08 -15.32 4.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.526 HD13 ' N ' ' A' ' 101' ' ' ASP . 0.8 OUTLIER -100.32 125.35 46.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -1.159 . . . . 0.0 110.143 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.526 ' N ' HD13 ' A' ' 100' ' ' LEU . 3.9 p30 -109.33 115.9 30.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.159 -0.963 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 81.7 mt -80.48 -62.08 1.78 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.151 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.55 -179.03 42.29 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.445 -1.36 . . . . 0.0 110.512 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.592 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 1.5 m-70 -137.41 121.35 17.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.744 -0.856 . . . . 0.0 109.673 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -94.07 123.7 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 0.0 110.145 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.82 105.05 5.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 110.305 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.698 HD11 ' HB2' ' A' ' 93' ' ' LEU . 39.0 mt -78.5 132.25 37.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 110.164 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.06 149.71 39.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -110.27 169.4 8.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 110.198 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.563 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.889 ' CG ' HD23 ' A' ' 102' ' ' LEU . 45.8 Cg_endo . . . . . 0 C--O 1.214 -0.72 0 N-CA-C 109.906 -0.844 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -111.2 129.77 55.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.32 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 5.5 t80 -148.73 112.16 5.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.233 -0.917 . . . . 0.0 109.589 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.19 148.96 28.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 111.0 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 7' ' ' SER . 5.4 p -107.01 174.55 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.45 -0.781 . . . . 0.0 109.525 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.687 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -81.97 -70.54 0.15 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.987 -1.071 . . . . 0.0 109.969 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.687 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 56.1 Cg_endo -83.15 91.12 0.94 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 O-C-N 122.972 0.985 . . . . 0.0 109.906 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.34 -1.52 55.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.891 -1.131 . . . . 0.0 110.687 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.0 m -138.28 118.88 13.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.196 -0.94 . . . . 0.0 109.979 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.46 72.88 1.13 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.796 ' CD1' HD22 ' A' ' 107' ' ' LEU . 12.9 mt -95.3 167.41 11.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.327 -1.102 . . . . 0.0 110.41 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.568 ' HB2' ' CB ' ' A' ' 16' ' ' GLN . 51.7 m -115.42 140.75 48.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 110.358 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 24.1 p30 -65.09 128.28 35.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.33 -0.856 . . . . 0.0 110.811 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.1 -26.77 6.53 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.568 ' CB ' ' HB2' ' A' ' 13' ' ' SER . 29.9 tt0 -62.2 149.08 42.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.126 . . . . 0.0 110.72 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -96.35 146.76 24.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.455 -0.778 . . . . 0.0 110.15 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.421 HG12 ' HG2' ' A' ' 8' ' ' PRO . 27.4 m -118.33 156.49 20.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.26 -0.9 . . . . 0.0 109.892 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.35 124.57 38.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.185 -0.947 . . . . 0.0 109.919 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.3 t -111.08 145.67 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.231 -0.918 . . . . 0.0 109.824 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.6 127.29 18.07 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.387 -0.821 . . . . 0.0 110.351 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 98.1 t -124.97 137.39 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.293 -0.88 . . . . 0.0 110.15 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 73.8 m -150.21 116.54 5.72 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.984 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 157.58 -64.78 0.3 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -52.82 -175.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -1.124 . . . . 0.0 110.018 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.542 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -150.88 150.01 30.37 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.014 -1.054 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -30.19 136.37 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.402 0.62 . . . . 0.0 111.237 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.401 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 108.12 11.22 24.55 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.492 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 69.4 mm-40 -142.25 118.59 10.84 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.266 -1.137 . . . . 0.0 110.695 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.496 ' O ' ' ND2' ' A' ' 97' ' ' ASN . 6.5 m -103.98 137.77 41.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.087 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.612 ' CG ' HD11 ' A' ' 102' ' ' LEU . 34.5 m-85 -123.36 166.11 15.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.969 -1.082 . . . . 0.0 111.171 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -121.65 110.13 15.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.537 -0.727 . . . . 0.0 109.597 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.718 HG23 ' O ' ' A' ' 33' ' ' ILE . 4.9 tt -87.88 113.09 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 110.327 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.81 166.17 28.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.716 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.602 ' HG3' HD12 ' A' ' 107' ' ' LEU . 0.5 OUTLIER -127.92 140.84 51.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.472 -0.768 . . . . 0.0 110.021 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.6 m -138.21 165.85 25.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.937 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.437 ' HB2' ' SG ' ' A' ' 91' ' ' CYS . . . -150.97 153.93 33.69 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.641 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.71 167.45 25.65 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.796 1.419 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.882 . . . . 0.0 110.118 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 t0 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.289 0.566 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.405 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -142.78 127.19 17.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.362 -0.836 . . . . 0.0 109.881 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 11.9 t -110.67 168.11 9.71 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.092 -1.005 . . . . 0.0 110.709 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 41.7 p-10 -108.54 102.26 46.6 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.346 -0.847 . . . . 0.0 110.636 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.67 -21.32 12.95 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.001 1.527 . . . . 0.0 110.742 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.19 -41.91 85.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.234 -0.916 . . . . 0.0 110.589 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.37 10.09 42.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.259 -0.901 . . . . 0.0 110.002 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.0 131.45 35.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 110.256 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.663 HG23 ' CG2' ' A' ' 33' ' ' ILE . 4.5 t -138.38 165.21 27.34 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.307 -0.871 . . . . 0.0 109.887 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m -127.79 146.6 50.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 110.744 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 35.1 p90 -140.16 -177.6 5.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 109.858 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.5 m -141.29 156.64 45.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.963 . . . . 0.0 110.058 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.416 HG23 ' HE2' ' A' ' 31' ' ' TYR . 17.2 p -67.28 -156.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.0 110.38 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 11.8 t0 -154.78 -162.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.954 . . . . 0.0 110.235 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.65 -55.49 34.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.268 -0.895 . . . . 0.0 109.416 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 p -78.32 4.15 13.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.432 -0.793 . . . . 0.0 109.353 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 66.11 46.55 79.56 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.99 162.78 20.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.107 -1.231 . . . . 0.0 110.242 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -159.11 83.87 0.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.179 -0.951 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 m -111.04 121.9 46.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.283 -0.885 . . . . 0.0 109.362 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 20.6 p90 -155.54 179.98 8.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 110.782 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.1 m -92.25 151.81 20.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.473 -0.767 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.455 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 56.3 t80 -142.48 179.36 7.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.538 -0.726 . . . . 0.0 109.112 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.455 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.4 t -133.08 154.96 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.741 -1.224 . . . . 0.0 110.415 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.468 HG21 HD22 ' A' ' 12' ' ' LEU . 29.7 m -138.01 164.82 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.436 -0.79 . . . . 0.0 109.808 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 8.0 mtt85 -141.22 126.02 18.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.918 . . . . 0.0 110.334 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 14.3 tttt -55.08 -40.68 70.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.832 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.3 p -130.25 134.48 47.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.385 -0.822 . . . . 0.0 109.735 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 17.2 p90 -144.94 153.28 41.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.116 -0.99 . . . . 0.0 110.636 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 21.3 m -73.94 124.78 26.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.265 -0.897 . . . . 0.0 110.247 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.405 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -77.24 159.41 48.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.273 -1.133 . . . . 0.0 110.004 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.189 0.519 . . . . 0.0 110.014 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.427 HG11 ' OH ' ' A' ' 71' ' ' TYR . 82.6 t -134.45 146.05 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.234 -0.916 . . . . 0.0 110.163 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -134.66 125.49 27.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.006 . . . . 0.0 110.173 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 72.1 m -86.72 12.63 10.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.47 -58.28 8.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.816 . . . . 0.0 110.068 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -110.29 9.51 23.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.33 178.21 4.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.318 -0.864 . . . . 0.0 110.194 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.15 95.39 5.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 37' ' ' ALA . 80.9 m -92.5 138.15 31.76 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.182 -0.949 . . . . 0.0 109.94 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -130.47 149.96 51.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.17 -0.956 . . . . 0.0 110.434 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 35' ' ' GLN . 0.3 OUTLIER -125.0 122.48 37.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 109.719 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.3 175.78 20.72 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.33 171.59 13.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -1.08 . . . . 0.0 110.12 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.81 165.06 10.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 30' ' ' THR . 1.1 p30 -129.69 -104.24 0.3 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -1.194 . . . . 0.0 110.622 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.42 -84.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.937 -1.102 . . . . 0.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.1 52.64 0.82 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.604 HD13 ' HE1' ' A' ' 31' ' ' TYR . 4.4 tt -115.21 -58.94 2.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.207 -1.172 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.5 t0 50.83 101.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.403 -0.811 . . . . 0.0 110.251 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.889 HD23 ' CG ' ' A' ' 2' ' ' PRO . 0.5 OUTLIER -73.86 -67.72 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -161.68 179.28 37.17 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -148.04 117.17 6.84 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.357 -1.084 . . . . 0.0 110.03 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.1 136.09 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.69 118.62 23.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.233 -0.917 . . . . 0.0 110.183 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.796 HD22 ' CD1' ' A' ' 12' ' ' LEU . 48.6 mt -90.05 134.1 34.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -112.43 166.51 11.24 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.507 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 2.5 m-85 -152.72 71.44 0.93 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.528 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.5 Cg_endo . . . . . 0 N--CA 1.481 0.776 0 N-CA-C 110.493 -0.618 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.406 ' HB3' ' H ' ' A' ' 23' ' ' SER . . . -149.32 148.9 30.07 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.086 -1.009 . . . . 0.0 111.196 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.443 ' CB ' ' HB3' ' A' ' 102' ' ' LEU . 24.2 t80 -151.5 102.67 2.91 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 109.633 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.07 158.45 43.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.927 -1.108 . . . . 0.0 111.002 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.484 HG12 HG11 ' A' ' 105' ' ' VAL . 5.1 p -126.77 138.81 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 109.76 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.606 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -62.49 -66.17 1.71 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.127 -0.983 . . . . 0.0 110.499 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.606 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 53.1 Cg_endo -76.96 74.18 5.09 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 O-C-N 123.493 1.259 . . . . 0.0 110.48 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.41 -0.64 57.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.986 -1.071 . . . . 0.0 110.236 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.7 t -150.88 150.7 31.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 109.974 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.65 60.96 6.35 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.6 HD21 ' O ' ' A' ' 8' ' ' PRO . 5.1 mt -102.61 154.39 19.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.251 -1.147 . . . . 0.0 110.132 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 73.3 m -109.35 155.78 20.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.149 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 32.7 t0 -64.49 127.84 33.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.057 -1.027 . . . . 0.0 110.612 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.49 -30.4 5.3 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 13' ' ' SER . 5.1 tp60 -46.78 145.66 1.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -1.116 . . . . 0.0 110.162 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.38 133.42 42.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.383 -0.823 . . . . 0.0 109.523 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.745 HG23 ' HB3' ' A' ' 65' ' ' PHE . 18.0 m -98.0 172.94 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.093 -1.004 . . . . 0.0 110.027 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.4 m -124.09 114.14 19.3 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 t -102.19 151.5 5.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 O-C-N 121.482 -0.761 . . . . 0.0 109.732 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.0 135.29 27.3 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.334 -0.854 . . . . 0.0 110.435 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.948 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 58.6 t -126.14 137.81 56.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.513 -0.742 . . . . 0.0 109.472 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' ' 3' ' ' ALA . 42.3 m -140.6 127.7 20.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.075 -1.016 . . . . 0.0 110.637 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 129.92 -48.69 0.96 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.522 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -57.45 -158.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -1.158 . . . . 0.0 109.345 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.599 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -170.95 149.99 3.05 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.596 -1.315 . . . . 0.0 111.818 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -40.12 141.98 0.42 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.438 0.637 . . . . 0.0 110.166 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.05 10.71 36.18 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 2.5 mm-40 -137.76 133.65 34.34 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.355 -1.085 . . . . 0.0 109.757 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 52.6 m -112.0 152.77 27.74 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.211 -0.93 . . . . 0.0 109.908 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.641 ' HE2' HD12 ' A' ' 100' ' ' LEU . 17.2 m-85 -135.26 159.46 41.47 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 109.809 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -119.39 105.91 11.75 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.24 -0.913 . . . . 0.0 110.044 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.599 ' CG1' HD11 ' A' ' 93' ' ' LEU . 9.4 tt -95.12 125.42 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 109.86 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.609 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -137.85 148.02 45.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.888 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.76 126.63 53.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.441 -0.787 . . . . 0.0 109.571 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 72.7 m -145.21 173.08 12.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -0.99 . . . . 0.0 110.923 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.45 160.27 32.08 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.529 -0.732 . . . . 0.0 109.506 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.29 163.58 38.19 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.744 1.392 . . . . 0.0 111.208 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.743 ' O ' HG22 ' A' ' 39' ' ' VAL . 2.4 p . . . . . 0 N--CA 1.496 1.871 0 O-C-N 121.524 -0.735 . . . . 0.0 110.288 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.604 0.716 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -130.29 159.2 37.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.238 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.59 154.55 48.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.953 -1.092 . . . . 0.0 111.186 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.568 ' OD1' ' CZ ' ' A' ' 71' ' ' TYR . 3.7 m120 -94.55 107.91 33.27 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.603 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.53 -33.3 8.77 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.902 1.475 . . . . 0.0 110.074 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.65 -6.63 27.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.362 -0.836 . . . . 0.0 110.175 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.407 ' OG1' ' CB ' ' A' ' 46' ' ' ASN . 53.0 p -120.29 -6.95 9.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.106 -0.996 . . . . 0.0 110.383 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.81 125.62 25.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.208 -0.933 . . . . 0.0 110.078 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.7 t -170.46 168.94 7.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.141 -0.975 . . . . 0.0 110.596 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.8 p -129.2 154.95 46.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 29.1 p90 -137.4 148.17 45.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.292 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.2 m -103.0 154.81 18.86 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.343 -0.848 . . . . 0.0 110.298 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.522 HG21 ' HB1' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -62.66 -156.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.27 -0.894 . . . . 0.0 110.544 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -142.84 -164.92 1.94 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.03 -1.044 . . . . 0.0 109.99 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.66 -52.51 64.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 108.975 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 p -84.17 12.77 5.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.515 -0.741 . . . . 0.0 109.073 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.599 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 67.93 12.79 63.05 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -89.38 108.95 19.93 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.272 -1.134 . . . . 0.0 109.542 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.948 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -97.22 87.85 4.29 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.353 -0.842 . . . . 0.0 110.244 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.18 115.48 28.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.42 -0.8 . . . . 0.0 109.474 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.629 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 7.9 p90 -144.64 177.23 8.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.047 -1.033 . . . . 0.0 111.191 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -102.4 122.22 43.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.634 -0.666 . . . . 0.0 110.837 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.745 ' HB3' HG23 ' A' ' 18' ' ' VAL . 68.4 t80 -106.83 -177.18 3.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 109.043 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.425 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.2 t -135.2 155.31 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.745 -1.222 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.1 m -141.3 174.56 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.493 -0.755 . . . . 0.0 109.486 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 5.0 mtt180 -155.9 126.51 6.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.993 -1.067 . . . . 0.0 110.805 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 8.5 ttpt -49.76 -46.13 50.28 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.205 -0.935 . . . . 0.0 109.449 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.0 m -128.62 156.45 43.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.587 -0.695 . . . . 0.0 109.165 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.568 ' CZ ' ' OD1' ' A' ' 46' ' ' ASN . 37.0 p90 -167.89 143.76 3.92 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.775 -1.203 . . . . 0.0 110.984 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 23.8 m -65.52 141.21 58.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.138 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.82 174.58 22.3 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.62 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 p . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.713 -0.875 . . . . 0.0 109.005 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.47 0.652 . . . . 0.0 110.524 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.402 HG21 ' CB ' ' A' ' 44' ' ' ALA . 97.8 t -116.93 152.5 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.403 -0.81 . . . . 0.0 109.997 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.25 127.49 39.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.084 -1.01 . . . . 0.0 110.029 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 4.2 t -84.07 -11.16 57.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.215 -0.928 . . . . 0.0 110.451 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.13 90.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 110.27 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.4 t -86.82 2.27 49.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.218 -0.926 . . . . 0.0 110.169 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.56 -140.13 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.21 159.02 44.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.303 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 55.7 m -119.94 141.06 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.95 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -133.36 135.4 44.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.466 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 34' ' ' ALA . 18.9 tp -109.76 120.13 41.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.848 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.503 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . -111.18 166.35 12.26 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -160.56 173.72 15.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -1.144 . . . . 0.0 110.024 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.13 -176.81 16.28 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -139.33 -150.69 0.34 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -1.072 . . . . 0.0 110.041 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.81 40.32 1.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 110.153 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -147.11 -43.48 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.641 HD12 ' HE2' ' A' ' 31' ' ' TYR . 69.7 mt -103.27 -153.74 0.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -1.166 . . . . 0.0 110.077 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -170.58 117.26 0.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 110.31 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.443 ' HB3' ' CB ' ' A' ' 4' ' ' PHE . 18.9 mt -118.56 -49.36 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.0 110.09 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.03 -150.71 17.82 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.503 ' HB3' ' CA ' ' A' ' 94' ' ' GLY . 8.5 p-80 -146.89 136.93 23.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -1.11 . . . . 0.0 110.417 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.484 HG11 HG12 ' A' ' 6' ' ' VAL . 18.3 t -85.06 113.16 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.416 -0.803 . . . . 0.0 110.112 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.05 94.3 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -0.86 . . . . 0.0 110.112 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.88 162.02 14.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.315 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.54 152.41 46.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.414 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 3.3 m-85 -127.45 75.68 1.61 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.858 . . . . 0.0 110.005 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 CA-C-O 117.961 -1.466 . . . . 0.0 109.596 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.512 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.0 Cg_endo . . . . . 0 N--CA 1.482 0.796 0 N-CA-C 110.481 -0.623 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -148.63 127.43 12.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.974 . . . . 0.0 110.432 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -142.08 106.3 4.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.369 -0.832 . . . . 0.0 109.471 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.2 t -150.25 154.14 37.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.961 -1.087 . . . . 0.0 111.247 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.6 HG12 HG11 ' A' ' 105' ' ' VAL . 13.4 p -119.05 156.9 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.647 -0.658 . . . . 0.0 109.448 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.592 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -77.04 -65.89 0.36 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.926 -1.109 . . . . 0.0 110.217 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.683 ' O ' HD21 ' A' ' 12' ' ' LEU . 52.7 Cg_endo -76.2 74.97 4.4 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.607 1.32 . . . . 0.0 110.221 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.53 -16.79 60.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.028 -1.045 . . . . 0.0 110.243 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.2 p -138.8 166.26 24.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.072 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.95 48.91 61.93 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.683 HD21 ' O ' ' A' ' 8' ' ' PRO . 20.7 mt -95.04 166.9 11.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -1.105 . . . . 0.0 110.242 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -126.05 152.43 45.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.286 -0.884 . . . . 0.0 110.346 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -63.67 117.23 6.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.83 -30.41 9.39 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 13' ' ' SER . 8.1 tt0 -52.52 155.09 2.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.342 -1.093 . . . . 0.0 110.27 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.23 138.03 43.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 0.0 110.115 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.567 ' CG1' HD22 ' A' ' 12' ' ' LEU . 17.1 m -103.81 153.56 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 109.859 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 0.7 OUTLIER -95.61 111.34 23.29 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.491 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 t -104.87 151.61 7.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.46 -0.775 . . . . 0.0 110.049 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 34.2 t -149.82 133.11 16.45 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.445 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.814 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 53.2 t -123.75 146.59 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.527 -0.733 . . . . 0.0 109.992 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 2.3 p -162.56 120.22 2.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.118 -0.989 . . . . 0.0 110.282 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 149.39 -55.87 0.48 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.652 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -63.92 -139.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.157 -1.202 . . . . 0.0 110.097 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.489 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.66 175.57 5.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.223 -0.923 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -65.2 131.74 47.31 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.493 -0.755 . . . . 0.0 110.666 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.6 6.85 7.76 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 2.6 mt-10 -132.0 106.09 7.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -1.199 . . . . 0.0 110.551 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 57.5 m -90.44 123.28 34.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.278 -0.889 . . . . 0.0 109.812 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.658 ' OH ' HD22 ' A' ' 100' ' ' LEU . 59.6 m-85 -107.42 161.59 14.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 111.059 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -113.48 112.51 23.72 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.392 -0.817 . . . . 0.0 109.602 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 33' ' ' ILE . 4.5 tt -93.94 106.31 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.124 -0.985 . . . . 0.0 110.635 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 1.022 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -142.23 168.53 19.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.381 -0.825 . . . . 0.0 109.772 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 9.8 pt20 -132.71 151.52 51.95 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 110.385 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.72 157.33 44.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 110.558 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 90' ' ' ALA . . . -151.56 157.35 34.76 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.274 -0.891 . . . . 0.0 110.499 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 43.3 Cg_endo -69.5 174.99 8.48 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.942 1.496 . . . . 0.0 110.22 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.072 -1.018 . . . . 0.0 110.845 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 11.7 p-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.33 0.586 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.568 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -136.12 155.35 50.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.426 -0.796 . . . . 0.0 109.7 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.1 m -126.28 151.47 47.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.211 -0.93 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.482 ' ND2' ' HB2' ' A' ' 71' ' ' TYR . 47.6 t-20 -97.16 108.5 44.5 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.15 -0.969 . . . . 0.0 110.243 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 49.9 Cg_endo -81.79 -33.96 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.919 1.484 . . . . 0.0 110.484 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.97 50.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 110.313 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 p -79.67 -3.05 45.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.262 -0.899 . . . . 0.0 110.064 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 47' ' ' PRO . . . -72.72 81.66 1.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.868 . . . . 0.0 110.5 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.535 HG23 ' CG2' ' A' ' 33' ' ' ILE . 4.2 t -100.26 174.49 6.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.291 -0.881 . . . . 0.0 109.883 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.65 122.34 15.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 110.304 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.494 ' C ' ' CD1' ' A' ' 53' ' ' PHE . 5.0 p90 -116.5 -175.01 2.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.912 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 55' ' ' THR . 7.2 m -134.69 143.35 47.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.961 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -57.33 -155.94 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.136 -0.977 . . . . 0.0 110.299 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -145.49 -156.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.077 -1.015 . . . . 0.0 110.176 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.57 -61.89 2.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.028 -1.045 . . . . 0.0 109.909 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 52.7 p -87.94 28.5 1.03 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.242 -0.911 . . . . 0.0 109.325 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.489 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 55.88 28.3 52.54 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -93.45 117.29 29.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.375 -1.074 . . . . 0.0 110.136 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.814 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -124.81 83.41 2.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 0.0 110.113 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -109.23 123.15 48.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.875 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 9.4 p90 -155.68 174.72 14.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.601 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.69 114.03 26.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.394 -0.816 . . . . 0.0 110.38 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.505 ' HB3' HG23 ' A' ' 18' ' ' VAL . 41.3 t80 -99.12 176.83 5.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.409 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.1 t -130.42 153.87 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.967 -1.083 . . . . 0.0 109.924 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.2 143.82 27.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.359 -0.838 . . . . 0.0 110.093 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -120.02 129.74 54.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 110.088 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -52.6 -35.91 55.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.905 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.3 p -131.35 143.37 50.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.936 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.482 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 22.7 p90 -145.16 153.0 40.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.17 -0.956 . . . . 0.0 110.511 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 9.2 m -72.18 124.43 25.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.305 -0.872 . . . . 0.0 109.847 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.568 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -99.19 171.87 24.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 5.6 p . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.347 -1.09 . . . . 0.0 109.869 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 5.0 p . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.287 0.565 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.52 HG21 ' CB ' ' A' ' 44' ' ' ALA . 45.7 t -150.87 133.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -109.21 141.59 41.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.937 . . . . 0.0 110.1 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.0 m -115.0 -3.8 12.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.199 -0.938 . . . . 0.0 110.143 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.19 -56.97 14.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 110.066 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 88' ' ' THR . 5.4 t -89.14 -16.41 31.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 110.05 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.46 -175.2 3.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 110.18 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.634 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -96.43 140.98 30.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -0.907 . . . . 0.0 110.325 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.43 ' C ' ' OD1' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -139.5 126.86 21.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.355 -0.841 . . . . 0.0 110.033 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.43 ' OD1' ' C ' ' A' ' 91' ' ' CYS . 31.9 m-20 -129.3 147.2 51.11 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 110.291 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.022 HD12 ' O ' ' A' ' 34' ' ' ALA . 14.3 tp -112.72 109.67 19.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -105.14 153.26 17.31 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.312 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.89 167.44 22.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.478 -1.013 . . . . 0.0 109.713 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.516 ' HA2' ' CD1' ' A' ' 31' ' ' TYR . . . 118.85 -175.7 15.81 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 100' ' ' LEU . 20.7 p-10 -137.8 -142.25 0.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -1.195 . . . . 0.0 110.433 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -102.78 -34.84 8.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.303 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.42 -30.69 64.23 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.658 HD22 ' OH ' ' A' ' 31' ' ' TYR . 6.0 tt -146.88 131.2 17.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -1.146 . . . . 0.0 110.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -96.88 138.48 34.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -0.993 . . . . 0.0 110.087 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 102' ' ' LEU . 16.4 mt -97.56 -81.15 0.43 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.273 -0.892 . . . . 0.0 110.295 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 174.99 163.13 27.61 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.46 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 2.0 m-70 -119.13 123.95 45.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.993 . . . . 0.0 110.069 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.6 HG11 HG12 ' A' ' 6' ' ' VAL . 31.5 t -102.68 115.51 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.111 -0.993 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.51 127.26 32.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.297 -0.877 . . . . 0.0 110.162 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.1 mt -98.42 169.52 9.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.335 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.3 m -155.26 160.36 40.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -132.66 105.33 7.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 0.0 110.135 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.431 179.949 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 45.8 Cg_endo . . . . . 0 N--CA 1.48 0.717 0 N-CA-C 110.407 -0.651 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.451 ' HB3' ' OG ' ' A' ' 23' ' ' SER . . . -147.0 151.2 36.58 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.172 -0.955 . . . . 0.0 110.747 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.547 ' CE1' ' HB3' ' A' ' 95' ' ' ALA . 76.9 t80 -149.98 116.72 5.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 110.022 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.64 149.72 31.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.073 -1.017 . . . . 0.0 110.611 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.005 HG12 HG11 ' A' ' 105' ' ' VAL . 4.3 p -130.87 139.0 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.923 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -69.76 -62.5 2.39 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.048 -1.032 . . . . 0.0 110.182 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 49.4 Cg_endo -74.32 77.51 2.85 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.837 1.441 . . . . 0.0 110.468 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.69 -5.63 57.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.114 -0.991 . . . . 0.0 110.13 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.0 p -151.62 166.45 31.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 110.241 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.8 52.46 48.24 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.492 HD13 ' HB3' ' A' ' 107' ' ' LEU . 1.4 mt -102.51 172.87 6.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.146 -1.208 . . . . 0.0 110.055 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.488 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -143.71 149.85 37.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 110.387 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 3.7 p30 -58.0 123.95 17.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.325 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.97 -34.81 4.56 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 13.2 tt0 -50.96 156.41 1.01 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -1.134 . . . . 0.0 109.815 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.95 137.83 47.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.634 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 67' ' ' VAL . 16.5 m -107.66 175.41 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.424 -0.797 . . . . 0.0 110.131 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.468 ' OG ' ' HD3' ' A' ' 8' ' ' PRO . 3.6 p -120.78 118.92 31.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 109.996 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.493 HG21 HD11 ' A' ' 33' ' ' ILE . 20.8 t -110.31 151.79 12.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.244 -0.91 . . . . 0.0 110.067 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -143.12 128.16 18.51 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 110.31 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.771 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 30.7 t -121.26 145.65 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 109.824 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -151.43 139.4 20.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 110.382 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 120.17 -75.34 0.32 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.561 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -49.54 126.7 14.0 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.179 -1.189 . . . . 0.0 109.563 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.571 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -97.08 165.65 11.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.111 -0.993 . . . . 0.0 111.092 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -44.23 139.85 2.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.545 0.688 . . . . 0.0 110.568 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.92 9.22 8.34 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 50.4 mm-40 -147.65 121.84 9.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.119 -1.224 . . . . 0.0 110.406 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 53' ' ' PHE . 80.6 m -104.43 125.63 50.81 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.436 -0.79 . . . . 0.0 109.49 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.737 ' CE1' HD13 ' A' ' 100' ' ' LEU . 17.0 m-85 -110.01 176.94 4.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.09 -1.006 . . . . 0.0 110.434 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 12.5 m-85 -126.51 112.85 16.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.301 -0.874 . . . . 0.0 110.488 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 33' ' ' ILE . 13.0 tt -98.5 103.65 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 0.0 109.933 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.61 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -138.56 169.33 17.98 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.294 -0.879 . . . . 0.0 110.651 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.788 ' OE1' HD12 ' A' ' 107' ' ' LEU . 34.1 mt-30 -106.07 155.47 19.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.423 -0.798 . . . . 0.0 110.334 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 98.1 m -150.69 148.52 28.68 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.219 -0.926 . . . . 0.0 110.471 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 1.052 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -151.76 165.83 16.57 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 49.9 Cg_endo -75.02 175.51 11.15 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.99 1.521 . . . . 0.0 110.391 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.444 ' CG1' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.976 0 O-C-N 121.264 -0.898 . . . . 0.0 110.157 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 1.6 p30 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.169 0.509 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.09 157.87 39.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 110.399 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 m -140.48 163.05 33.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.184 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.788 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 3.7 m-20 -81.54 123.91 80.5 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 110.358 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.583 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 48.8 Cg_endo -84.74 -72.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.931 1.49 . . . . 0.0 110.621 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.15 -62.89 1.52 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.206 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.47 -22.54 0.28 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.444 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.788 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -62.83 105.38 0.66 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.031 . . . . 0.0 109.816 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -110.47 141.42 43.6 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.234 -0.916 . . . . 0.0 110.442 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.49 ' HB3' ' CD2' ' A' ' 32' ' ' TYR . 48.9 p -106.88 119.11 38.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 109.888 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.629 ' O ' HG23 ' A' ' 30' ' ' THR . 53.1 p90 -106.46 -178.06 3.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.034 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 55' ' ' THR . 6.4 m -139.05 145.44 39.59 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.939 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.561 HG21 ' CB ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -57.17 -158.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.147 -0.97 . . . . 0.0 109.851 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -145.43 -161.78 1.37 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.881 -1.137 . . . . 0.0 110.448 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.81 -48.98 79.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.087 -1.008 . . . . 0.0 109.164 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p -87.03 13.82 8.56 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.515 -0.74 . . . . 0.0 109.099 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 57.27 30.31 61.08 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.02 118.91 37.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -1.094 . . . . 0.0 109.863 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.771 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -118.81 81.2 1.66 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.511 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.9 m -110.61 122.65 48.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.304 -0.873 . . . . 0.0 109.293 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 12.3 p90 -157.31 179.1 9.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.024 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.09 138.04 31.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 110.726 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 73.9 t80 -123.14 178.62 5.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -0.795 . . . . 0.0 109.182 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.557 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 5.2 t -123.05 159.44 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.806 -1.184 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 18' ' ' VAL . 30.9 m -137.96 124.69 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.393 -0.817 . . . . 0.0 110.099 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 9.5 mmm-85 -115.85 123.85 49.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.53 -59.93 3.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -0.978 . . . . 0.0 109.204 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 p -108.41 126.44 52.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.306 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -140.31 163.91 31.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 110.485 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.09 123.87 21.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.637 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.439 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -98.21 166.42 22.13 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 89.5 p . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.39 -1.064 . . . . 0.0 109.599 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.257 0.551 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.444 HG22 ' CG1' ' A' ' 39' ' ' VAL . 49.1 t -144.15 154.63 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 110.13 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -134.58 131.57 38.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 110.064 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 32.7 m -92.97 33.23 1.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.878 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.15 -61.09 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 110.39 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.475 ' H ' HG22 ' A' ' 88' ' ' THR . 5.0 t -87.67 -23.05 24.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.331 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.58 -178.32 3.59 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 110.096 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -123.82 148.81 46.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.181 -0.949 . . . . 0.0 110.12 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 1.052 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -126.85 133.78 50.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.026 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 5.7 m-20 -99.9 147.22 25.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 110.107 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.864 ' HB2' HD11 ' A' ' 107' ' ' LEU . 15.8 tp -106.7 110.96 23.28 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.1 -1.0 . . . . 0.0 109.52 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.65 153.43 17.48 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.547 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . . . -133.29 104.87 6.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.428 -1.042 . . . . 0.0 110.122 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.58 174.17 46.41 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 5.5 p-10 -114.0 -156.84 0.61 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -1.156 . . . . 0.0 110.357 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -91.99 52.6 2.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 110.184 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 174.4 -32.03 0.1 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.737 HD13 ' CE1' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -117.38 86.03 2.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -1.169 . . . . 0.0 110.297 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.53 116.31 22.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.941 . . . . 0.0 109.984 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 95' ' ' ALA . 87.8 mt -81.94 -74.6 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.322 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.13 173.58 41.66 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -136.69 122.62 20.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.584 -0.951 . . . . 0.0 110.111 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.005 HG11 HG12 ' A' ' 6' ' ' VAL . 17.2 t -112.23 107.45 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.072 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . . . -57.71 147.09 28.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 110.505 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.864 HD11 ' HB2' ' A' ' 93' ' ' LEU . 29.7 mt -116.18 141.56 47.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 109.984 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -110.82 165.55 11.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 110.34 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -139.95 97.51 3.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.24 -0.913 . . . . 0.0 110.321 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.519 ' HG2' HD23 ' A' ' 102' ' ' LEU . 43.9 Cg_endo . . . . . 0 N--CA 1.482 0.836 0 N-CA-C 110.361 -0.669 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -123.89 128.72 49.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.182 -0.949 . . . . 0.0 110.445 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.493 ' HB2' HD22 ' A' ' 102' ' ' LEU . 85.4 t80 -149.63 104.46 3.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.677 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.613 ' HA ' HG21 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -149.8 157.37 43.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.899 -1.126 . . . . 0.0 111.496 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.634 HG12 HG11 ' A' ' 105' ' ' VAL . 9.3 p -106.18 139.85 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.399 -0.813 . . . . 0.0 109.312 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.651 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 m -53.82 -72.4 0.19 Allowed Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 120.828 -1.17 . . . . 0.0 110.002 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.668 ' O ' HD21 ' A' ' 12' ' ' LEU . 56.7 Cg_endo -80.13 79.37 3.36 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 O-C-N 122.956 0.977 . . . . 0.0 109.952 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.43 -20.97 61.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.846 -1.159 . . . . 0.0 109.999 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t -134.51 141.11 46.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.325 -0.86 . . . . 0.0 110.043 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.91 61.21 1.29 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.668 HD21 ' O ' ' A' ' 8' ' ' PRO . 3.5 mt -117.21 169.53 9.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.162 -1.199 . . . . 0.0 110.232 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 4.2 t -124.65 158.95 31.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 110.286 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.16 124.97 22.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.216 -0.927 . . . . 0.0 110.188 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 89.45 -29.45 6.17 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.492 ' HB3' ' O ' ' A' ' 13' ' ' SER . 28.9 tp60 -43.81 156.25 0.07 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.324 -1.104 . . . . 0.0 110.447 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.424 ' N ' ' HG3' ' A' ' 16' ' ' GLN . 1.8 m -107.16 134.92 49.56 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.448 -0.783 . . . . 0.0 109.315 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.448 ' CG1' HD22 ' A' ' 12' ' ' LEU . 32.7 m -110.97 153.93 12.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.801 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -105.97 121.37 43.97 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.973 -1.08 . . . . 0.0 110.237 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.6 t -97.1 151.82 4.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.581 -0.7 . . . . 0.0 109.223 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 t -142.46 121.25 12.69 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 121.281 -0.887 . . . . 0.0 109.857 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 33.9 t -116.11 142.74 28.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 110.065 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.685 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.1 OUTLIER -160.38 105.17 1.47 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 110.254 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 157.3 -47.79 0.46 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.792 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -59.41 -147.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.419 -1.047 . . . . 0.0 109.485 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.529 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -172.42 165.89 5.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.76 -1.213 . . . . 0.0 111.037 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -48.36 138.58 9.83 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.592 0.711 . . . . 0.0 110.782 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.07 25.49 12.74 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.537 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 2.3 mt-10 -141.07 105.95 4.94 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.203 -1.175 . . . . 0.0 110.375 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.7 m -103.73 151.31 23.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.822 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 46.6 m-85 -140.24 165.97 25.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.296 -0.877 . . . . 0.0 110.188 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 23.5 m-85 -112.66 109.77 19.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -0.901 . . . . 0.0 109.851 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 33' ' ' ILE . 3.2 tt -89.5 111.72 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.059 -1.026 . . . . 0.0 110.162 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 1.032 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -144.05 159.45 42.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.468 -0.77 . . . . 0.0 110.247 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.455 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 2.4 tt0 -112.94 148.12 35.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.342 -0.849 . . . . 0.0 110.515 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 62.9 m -153.54 162.23 41.47 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.376 -0.827 . . . . 0.0 110.225 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.515 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.64 160.27 32.9 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.235 -0.915 . . . . 0.0 110.288 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.472 ' C ' HG13 ' A' ' 39' ' ' VAL . 49.4 Cg_endo -74.54 172.34 16.37 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.781 1.411 . . . . 0.0 110.343 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.596 HG11 ' HB2' ' A' ' 44' ' ' ALA . 33.4 m . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.233 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p30 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.457 0.646 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.596 ' HB2' HG11 ' A' ' 39' ' ' VAL . . . -125.43 159.35 32.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.691 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.466 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.3 m -144.76 157.07 44.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.145 -0.972 . . . . 0.0 110.385 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.479 HD21 ' HA ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -96.27 109.92 49.83 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.204 -0.935 . . . . 0.0 110.288 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 50.8 Cg_endo -86.92 -42.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.894 1.47 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.41 66.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.401 -0.812 . . . . 0.0 110.855 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.0 p -113.47 31.5 6.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.059 -1.025 . . . . 0.0 110.374 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.48 131.72 36.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.557 HG23 ' CG2' ' A' ' 33' ' ' ILE . 7.0 t -148.65 170.24 18.58 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.252 -0.905 . . . . 0.0 110.235 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.7 t -135.6 166.99 21.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.068 -1.02 . . . . 0.0 110.983 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 16.3 p90 -148.91 -177.08 5.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.467 -0.771 . . . . 0.0 109.832 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.6 m -144.21 166.85 23.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.058 -1.026 . . . . 0.0 110.268 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.792 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -86.98 -156.94 0.35 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.239 -0.913 . . . . 0.0 110.416 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -144.36 -163.75 1.75 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.781 -1.199 . . . . 0.0 109.931 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.5 77.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.134 -0.979 . . . . 0.0 109.441 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.6 p -88.03 15.48 7.29 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.405 -0.81 . . . . 0.0 108.848 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 65.23 16.91 63.11 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.15 122.24 32.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.091 -1.241 . . . . 0.0 109.901 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 55' ' ' THR . . . -132.96 85.22 2.2 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.179 -0.951 . . . . 0.0 110.386 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.62 129.02 49.07 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.525 -0.735 . . . . 0.0 109.196 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 6.0 p90 -161.02 179.9 8.07 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.14 -0.975 . . . . 0.0 110.571 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 m -108.29 144.62 35.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.297 -0.877 . . . . 0.0 111.548 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 36.5 t80 -135.71 166.09 24.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.58 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 3.6 t -106.85 154.95 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.607 -1.308 . . . . 0.0 110.963 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.4 m -140.73 158.66 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.531 -0.731 . . . . 0.0 109.958 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.18 148.48 41.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 110.578 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -52.84 13.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -124.51 150.17 46.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.152 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 71' ' ' TYR . 45.6 p90 -161.1 132.1 5.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.03 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 99.6 m -57.37 119.63 6.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.484 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.417 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -99.41 -178.05 31.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.111 -1.229 . . . . 0.0 110.411 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 58.6 p . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.264 0.554 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 37' ' ' ALA . 20.9 t -106.68 164.2 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.291 -0.881 . . . . 0.0 110.425 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.917 ' OD2' HG22 ' A' ' 88' ' ' THR . 26.0 p-10 -153.52 149.36 27.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.343 -0.848 . . . . 0.0 110.184 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 34.8 m -104.11 -2.98 25.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.14 -65.8 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.968 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.917 HG22 ' OD2' ' A' ' 85' ' ' ASP . 7.1 t -82.39 -19.82 38.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.079 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 85' ' ' ASP . . . -106.37 158.13 17.11 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.22 -0.925 . . . . 0.0 109.938 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.71 109.68 21.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.939 . . . . 0.0 110.234 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 24.2 p -108.7 164.36 12.44 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.205 -0.934 . . . . 0.0 109.824 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -149.03 159.64 44.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.1 -1.0 . . . . 0.0 110.626 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.032 HD12 ' O ' ' A' ' 34' ' ' ALA . 20.2 tp -107.27 113.53 26.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.365 -0.834 . . . . 0.0 109.174 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.46 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . -103.51 154.34 17.96 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.038 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -143.01 124.98 15.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.326 -1.102 . . . . 0.0 110.175 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.57 -171.0 36.64 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' SER . 11.9 p-10 -130.88 -50.57 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -1.222 . . . . 0.0 110.638 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 97' ' ' ASN . 0.5 OUTLIER 166.57 -39.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.219 -0.926 . . . . 0.0 110.474 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.61 -21.21 62.33 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.576 HD13 ' OH ' ' A' ' 31' ' ' TYR . 6.6 tt -120.75 -66.77 1.03 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -1.183 . . . . 0.0 110.137 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.58 87.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 110.476 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.519 HD23 ' HG2' ' A' ' 2' ' ' PRO . 0.3 OUTLIER -62.38 -39.04 91.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.048 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.25 -162.59 25.7 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.46 ' HB3' ' CA ' ' A' ' 94' ' ' GLY . 0.6 OUTLIER -146.51 129.4 16.32 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.284 -1.127 . . . . 0.0 110.014 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.634 HG11 HG12 ' A' ' 6' ' ' VAL . 6.3 t -92.01 119.94 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.253 -0.904 . . . . 0.0 110.341 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.62 158.85 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 109.983 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.443 HD22 HD13 ' A' ' 12' ' ' LEU . 12.9 mt -134.83 150.25 50.47 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.086 -1.009 . . . . 0.0 110.697 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.7 m -140.96 159.61 41.84 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.35 -0.844 . . . . 0.0 110.046 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -127.16 145.31 50.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.126 -0.984 . . . . 0.0 110.197 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.529 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.4 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 45.5 Cg_endo . . . . . 0 N--CA 1.485 0.972 0 N-CA-C 110.648 -0.559 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -155.3 138.45 15.61 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.264 -0.898 . . . . 0.0 110.898 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 1.6 t80 -152.36 102.96 2.8 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.345 -0.847 . . . . 0.0 109.793 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.9 t -146.2 151.9 38.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.097 -1.002 . . . . 0.0 110.734 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.878 ' CG1' HG11 ' A' ' 105' ' ' VAL . 8.0 p -115.63 122.62 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.799 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 m -47.1 -68.02 0.35 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.109 -0.994 . . . . 0.0 110.567 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 55.3 Cg_endo -76.06 79.14 2.98 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 O-C-N 123.311 1.164 . . . . 0.0 109.83 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.33 -6.73 57.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.974 -1.079 . . . . 0.0 110.689 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 p -146.96 146.43 30.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.212 -0.93 . . . . 0.0 109.71 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.425 ' C ' ' HG ' ' A' ' 12' ' ' LEU . . . 79.61 71.78 1.24 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' A' ' 8' ' ' PRO . 4.0 mt -129.87 169.95 14.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -1.108 . . . . 0.0 109.751 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -136.23 169.49 17.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.49 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 30.5 p-10 -65.19 131.04 45.49 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.113 -0.992 . . . . 0.0 110.184 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.46 -29.86 5.53 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.5 ' HB3' ' O ' ' A' ' 13' ' ' SER . 9.4 tp60 -49.48 143.01 7.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -1.114 . . . . 0.0 110.308 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.32 133.62 42.48 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.742 HG23 ' HB3' ' A' ' 65' ' ' PHE . 16.6 m -101.85 163.26 3.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 109.785 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.431 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -113.1 121.57 44.94 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.983 -1.073 . . . . 0.0 110.28 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.91 151.41 14.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.68 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.5 m -146.34 121.68 10.27 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.323 -0.861 . . . . 0.0 109.992 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 86.2 t -120.54 139.38 48.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 109.831 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.9 p -157.66 136.44 11.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.054 -1.029 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 124.28 -46.47 1.09 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 1.042 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -45.69 -52.11 11.38 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.155 -1.203 . . . . 0.0 110.237 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 25' ' ' ALA . . . 72.07 137.92 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.435 -0.791 . . . . 0.0 110.888 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -33.37 130.66 0.23 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.391 0.615 . . . . 0.0 110.762 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 29' ' ' GLU . . . 122.37 9.59 6.49 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 60.1 mt-10 -147.99 130.15 15.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.0 110.185 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.497 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 3.4 m -111.57 146.63 37.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.402 -0.811 . . . . 0.0 109.898 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.729 ' OH ' ' HB1' ' A' ' 25' ' ' ALA . 30.6 m-85 -132.08 174.51 10.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.084 -1.01 . . . . 0.0 110.662 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' ' 52' ' ' SER . 73.7 m-85 -130.46 102.05 5.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.486 -0.759 . . . . 0.0 109.626 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 33' ' ' ILE . 1.3 tt -87.85 104.15 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.087 -1.008 . . . . 0.0 110.185 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -138.97 157.21 46.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.845 . . . . 0.0 110.618 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.407 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 1.1 tt0 -122.92 147.06 47.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.53 -0.731 . . . . 0.0 110.08 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 67.3 m -150.24 171.21 17.31 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.194 -0.941 . . . . 0.0 110.668 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.43 152.15 28.53 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.532 -0.73 . . . . 0.0 109.71 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.03 166.5 29.41 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.835 1.439 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.843 HG21 ' HB2' ' A' ' 44' ' ' ALA . 30.6 t . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.415 -0.803 . . . . 0.0 109.921 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t70 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.236 0.541 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.843 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -154.14 149.49 27.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.121 -0.987 . . . . 0.0 110.036 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.483 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -124.47 156.66 36.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.139 -0.975 . . . . 0.0 110.001 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.458 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 9.2 t-20 -100.12 101.91 16.08 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.044 -1.035 . . . . 0.0 110.516 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.8 Cg_endo -73.8 -30.78 9.03 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.976 1.514 . . . . 0.0 110.532 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.85 85.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.268 -0.895 . . . . 0.0 110.556 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 5.1 p -95.35 1.83 54.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.219 -0.925 . . . . 0.0 110.52 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.79 119.44 21.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.129 -0.982 . . . . 0.0 110.037 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.412 HG23 ' CG2' ' A' ' 33' ' ' ILE . 11.3 t -146.33 145.24 30.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.985 . . . . 0.0 110.631 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.567 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 1.1 m -110.58 147.54 34.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 13.8 p90 -144.18 -176.4 5.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -0.876 . . . . 0.0 110.08 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.8 m -149.12 156.18 41.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.597 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 1.042 HG21 ' HB3' ' A' ' 25' ' ' ALA . 6.9 p -68.53 -161.64 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.045 -1.034 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -160.2 -155.5 0.44 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.963 -1.085 . . . . 0.0 110.943 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.69 64.56 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 109.346 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.5 t -71.03 -5.38 30.89 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.437 -0.79 . . . . 0.0 109.16 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 26' ' ' ALA . . . 53.72 53.98 33.11 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.78 126.63 8.95 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.161 -1.199 . . . . 0.0 110.7 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.514 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -113.38 85.77 2.26 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.321 -0.862 . . . . 0.0 110.002 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.17 136.45 49.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.658 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -171.03 173.26 5.13 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.203 -0.936 . . . . 0.0 110.782 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 m -94.37 117.26 29.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.376 -0.827 . . . . 0.0 110.342 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.742 ' HB3' HG23 ' A' ' 18' ' ' VAL . 36.1 t80 -98.63 -179.44 4.31 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.355 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 t -134.5 156.39 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.874 -1.141 . . . . 0.0 110.286 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.3 m -143.3 153.96 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.367 -0.833 . . . . 0.0 110.048 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -132.37 120.67 22.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 110.213 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HE2' ' CD2' ' A' ' 109' ' ' PHE . 4.3 tttt -49.41 -45.74 46.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.283 -0.886 . . . . 0.0 109.762 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.1 m -120.5 135.29 55.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.479 -0.763 . . . . 0.0 109.608 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -151.32 144.27 24.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.151 -0.968 . . . . 0.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 29.3 m -65.59 149.8 49.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 0.0 110.28 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.0 -167.17 13.64 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 O-C-N 121.298 -1.119 . . . . 0.0 110.0 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 3.9 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.278 0.561 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.65 HG21 ' CB ' ' A' ' 44' ' ' ALA . 62.7 t -116.95 123.84 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.02 111.1 23.75 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.163 -0.961 . . . . 0.0 110.094 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -90.15 9.02 29.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 110.084 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.36 -41.29 88.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.551 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 t -114.35 0.99 14.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.13 -0.981 . . . . 0.0 110.326 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -100.64 -139.16 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.24 142.16 31.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.4 m -128.9 133.82 48.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.1 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -129.27 148.26 51.18 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.189 -0.945 . . . . 0.0 110.091 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.537 HD12 ' C ' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -125.61 118.97 26.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.072 -1.018 . . . . 0.0 109.153 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -122.74 159.59 17.34 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.275 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -146.92 143.31 28.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.549 -0.971 . . . . 0.0 109.765 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 166.37 174.86 36.15 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.094 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 30' ' ' THR . 12.0 p-10 -119.35 -137.61 0.34 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.31 -1.112 . . . . 0.0 110.157 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.4 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -121.14 60.79 0.91 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.146 -0.971 . . . . 0.0 110.214 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.29 -24.26 0.12 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.833 HD13 ' N ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER -118.37 -60.84 1.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.235 . . . . 0.0 110.278 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.833 ' N ' HD13 ' A' ' 100' ' ' LEU . 38.9 t0 58.27 119.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 110.139 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.1 mt -84.81 -70.84 0.55 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.427 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 177.61 -175.6 47.64 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.403 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 1.1 m80 -131.59 124.24 29.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.522 -0.987 . . . . 0.0 109.78 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.878 HG11 ' CG1' ' A' ' 6' ' ' VAL . 66.6 t -95.35 107.31 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.047 . . . . 0.0 110.515 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.01 112.37 2.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.7 mt -86.52 133.02 33.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.131 -0.981 . . . . 0.0 110.722 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.3 m -114.17 169.01 9.34 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.442 -0.786 . . . . 0.0 109.77 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.43 ' CD2' ' HE2' ' A' ' 69' ' ' LYS . 11.4 m-85 -134.14 163.4 29.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 110.075 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.269 0 CA-C-O 117.948 -1.474 . . . . 0.0 109.601 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.515 ' HB2' HD23 ' A' ' 102' ' ' LEU . 47.1 Cg_endo . . . . . 0 N--CA 1.483 0.883 0 N-CA-C 110.517 -0.609 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -142.43 133.9 26.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 110.498 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -146.31 111.01 5.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.233 -0.917 . . . . 0.0 109.955 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.07 149.98 34.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.129 -0.982 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.68 HG12 HG11 ' A' ' 105' ' ' VAL . 9.2 p -117.04 154.51 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 109.532 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.622 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -72.83 -68.18 0.41 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.04 . . . . 0.0 110.014 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.622 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 54.6 Cg_endo -77.58 75.94 4.5 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.308 1.162 . . . . 0.0 109.978 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.52 -8.12 57.82 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.934 -1.104 . . . . 0.0 110.527 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.5 p -142.72 123.39 14.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.28 75.56 1.3 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.57 ' O ' ' CE1' ' A' ' 109' ' ' PHE . 2.3 mt -120.07 165.93 14.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -1.14 . . . . 0.0 110.085 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.444 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 9.4 m -124.16 161.2 26.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 109.876 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 8.7 p-10 -62.43 121.6 13.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 110.075 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.87 -27.56 8.83 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.508 ' O ' HG22 ' A' ' 67' ' ' VAL . 2.7 tt0 -43.32 143.85 0.8 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.306 -1.114 . . . . 0.0 110.728 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.0 p -96.75 150.72 20.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.659 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.76 154.33 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 110.084 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.4 m -101.92 132.91 47.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.007 . . . . 0.0 110.02 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 t -120.8 146.66 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.075 -1.016 . . . . 0.0 109.896 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.71 126.2 21.84 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.424 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 84.8 t -117.67 141.61 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 109.919 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.585 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -152.96 145.53 24.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.135 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 121.35 -58.95 0.57 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.824 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -52.54 -175.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.578 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.499 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -154.36 155.14 34.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.017 -1.052 . . . . 0.0 110.783 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -37.03 133.9 0.58 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.436 0.636 . . . . 0.0 110.864 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.36 16.25 16.83 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -143.61 120.29 11.15 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.168 -1.195 . . . . 0.0 110.382 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.438 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 8.8 m -103.44 148.22 26.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.983 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.717 ' CE1' HD22 ' A' ' 100' ' ' LEU . 33.2 m-85 -136.21 170.77 15.48 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 110.4 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 22.5 m-85 -117.68 167.23 11.54 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.427 -0.796 . . . . 0.0 109.967 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.809 ' CG2' HG23 ' A' ' 51' ' ' THR . 4.4 tt -151.9 97.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.555 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.504 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -140.8 161.79 36.96 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.254 -0.903 . . . . 0.0 110.914 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -116.78 139.98 49.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.52 -0.737 . . . . 0.0 109.81 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 96.0 m -136.76 162.58 32.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.519 ' HB2' ' SG ' ' A' ' 91' ' ' CYS . . . -151.52 159.12 33.85 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.428 -0.795 . . . . 0.0 110.01 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 46.2 Cg_endo -75.45 164.61 32.22 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.879 1.463 . . . . 0.0 110.678 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.651 ' CG1' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.357 -0.839 . . . . 0.0 109.941 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 1.4 t70 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.323 0.583 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.494 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -159.05 173.62 16.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 110.225 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 m -138.99 157.48 45.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.293 -0.879 . . . . 0.0 110.313 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 52.2 t-20 -95.69 114.77 64.69 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 110.007 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.96 -30.72 8.8 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.967 1.509 . . . . 0.0 110.519 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.6 95.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.951 . . . . 0.0 110.143 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.2 p -87.29 7.23 29.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.375 -0.828 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.96 119.26 21.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.312 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.809 HG23 ' CG2' ' A' ' 33' ' ' ILE . 9.7 t -156.17 170.71 21.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.859 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.458 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 14.6 p -141.91 148.11 38.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.072 -1.017 . . . . 0.0 110.565 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 48.8 p90 -135.46 -176.13 4.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.415 -0.803 . . . . 0.0 109.97 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.5 m -146.48 154.39 41.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.073 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.824 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -72.6 -158.79 0.05 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 14.5 t0 -155.83 -157.09 0.7 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.783 -1.198 . . . . 0.0 110.498 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.62 -46.53 89.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.14 -0.975 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.8 t -83.6 9.91 10.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.278 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.499 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 51.14 49.98 41.4 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -133.0 138.63 46.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -1.091 . . . . 0.0 109.927 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -135.3 85.04 2.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 110.829 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 p -108.06 125.72 51.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.298 -0.876 . . . . 0.0 108.953 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -154.07 -179.19 7.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.026 -1.046 . . . . 0.0 111.405 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.49 135.3 39.54 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.465 0.65 . . . . 0.0 110.563 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 38.4 t80 -125.49 178.74 5.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 0.0 109.502 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 3.4 t -134.05 161.08 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.859 -1.151 . . . . 0.0 110.536 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 16' ' ' GLN . 30.3 m -137.17 179.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.487 -0.758 . . . . 0.0 109.902 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 8.8 mtt85 -152.21 152.72 32.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.095 -1.003 . . . . 0.0 110.365 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 5.7 tttm -82.41 -25.46 33.68 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.263 -0.898 . . . . 0.0 109.314 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 85' ' ' ASP . 1.1 m -150.26 107.53 3.61 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.454 -0.778 . . . . 0.0 109.653 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.636 ' CZ ' HG11 ' A' ' 84' ' ' VAL . 25.1 p90 -105.07 143.59 33.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 110.394 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.3 m -74.25 115.22 13.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 110.467 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.494 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -90.72 -174.5 44.33 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.156 -1.202 . . . . 0.0 110.482 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.358 0.599 . . . . 0.0 110.315 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.651 HG22 ' CG1' ' A' ' 39' ' ' VAL . 96.1 t -138.29 110.19 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.322 -0.861 . . . . 0.0 110.023 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 1.6 m-20 -92.71 161.24 14.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.246 -0.909 . . . . 0.0 110.551 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 94.7 m -109.88 -0.11 18.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.181 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.97 -60.88 2.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.173 -0.954 . . . . 0.0 110.333 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -74.94 -30.48 61.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.174 -0.954 . . . . 0.0 110.279 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.09 155.72 20.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.892 . . . . 0.0 110.296 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.86 135.14 34.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.344 -0.847 . . . . 0.0 110.166 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 37' ' ' ALA . 2.0 m -114.14 137.9 51.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 109.845 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -125.28 151.9 45.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.109 -0.995 . . . . 0.0 110.801 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 34' ' ' ALA . 5.6 tp -122.46 109.16 14.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 0.0 109.073 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -107.39 164.45 13.06 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.532 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.643 ' O ' HD12 ' A' ' 102' ' ' LEU . . . -145.51 136.29 24.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.631 -0.923 . . . . 0.0 110.04 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.57 178.06 17.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -105.84 -160.07 0.73 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -1.197 . . . . 0.0 110.15 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.76 45.81 1.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 110.038 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.48 -51.77 0.05 OUTLIER Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.717 HD22 ' CE1' ' A' ' 31' ' ' TYR . 7.9 tt -103.05 91.33 4.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -1.193 . . . . 0.0 110.143 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -100.86 122.74 43.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 95' ' ' ALA . 2.1 mp -74.11 -29.36 61.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 110.174 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 140.53 -169.84 24.67 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.448 ' O ' ' ND1' ' A' ' 104' ' ' HIS . 31.0 p80 -144.23 126.71 15.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -1.11 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.68 HG11 HG12 ' A' ' 6' ' ' VAL . 85.8 t -92.58 128.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.189 -0.944 . . . . 0.0 110.228 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.57 136.04 42.09 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 88.7 mt -110.21 119.45 39.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.249 -0.907 . . . . 0.0 110.152 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -90.88 160.89 15.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.306 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.57 ' CE1' ' O ' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -146.79 78.67 1.5 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.822 . . . . 0.0 110.148 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 CA-C-O 117.948 -1.474 . . . . 0.0 109.591 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.481 0.769 0 N-CA-C 110.294 -0.695 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -141.55 136.21 30.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.087 -1.008 . . . . 0.0 110.772 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.458 ' HD1' HG22 ' A' ' 22' ' ' VAL . 87.9 t80 -149.37 114.64 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.486 -0.759 . . . . 0.0 109.168 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.47 153.7 35.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.868 -1.145 . . . . 0.0 111.317 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.757 HG22 ' HD2' ' A' ' 8' ' ' PRO . 9.5 p -113.67 165.69 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.67 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -74.66 -61.87 1.04 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.663 -1.273 . . . . 0.0 110.432 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.757 ' HD2' HG22 ' A' ' 6' ' ' VAL . 55.9 Cg_endo -91.6 76.3 0.57 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 O-C-N 123.104 1.055 . . . . 0.0 110.143 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.89 -23.76 65.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.031 -1.043 . . . . 0.0 109.94 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.9 m -139.39 135.68 33.92 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.44 -0.787 . . . . 0.0 109.964 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.87 54.28 1.93 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.701 HD21 ' O ' ' A' ' 8' ' ' PRO . 2.2 mt -102.43 171.02 7.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.257 -1.143 . . . . 0.0 109.972 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -125.17 149.36 48.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 69' ' ' LYS . 4.4 p-10 -59.85 120.89 10.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.85 . . . . 0.0 109.978 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.8 -31.04 7.22 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.498 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 14.3 tt0 -55.52 147.93 16.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -1.127 . . . . 0.0 110.326 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 26.0 p -97.82 150.86 20.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 0.0 110.325 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.722 HG12 ' HG2' ' A' ' 8' ' ' PRO . 22.6 m -119.46 150.94 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.797 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 m -93.88 116.38 28.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.131 -0.981 . . . . 0.0 110.247 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 t -102.9 149.94 6.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.315 -0.865 . . . . 0.0 109.991 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 32.2 t -150.85 129.81 12.53 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 110.251 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.707 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 75.8 t -116.25 151.99 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.809 . . . . 0.0 109.901 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.755 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -164.7 113.07 1.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.208 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.65 -55.81 0.42 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.75 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -62.52 -142.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -1.148 . . . . 0.0 110.326 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.557 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -175.61 166.57 3.21 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.169 -0.957 . . . . 0.0 110.458 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -54.88 133.04 47.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.424 -0.798 . . . . 0.0 110.653 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.423 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 119.67 9.72 8.21 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 19.6 mm-40 -140.68 120.93 13.89 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.161 -1.2 . . . . 0.0 110.468 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 53' ' ' PHE . 63.6 m -106.36 130.44 54.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.261 -0.899 . . . . 0.0 109.88 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 50.0 m-85 -115.65 -168.31 1.39 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.233 -0.917 . . . . 0.0 110.786 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 40.8 m-85 -138.68 112.11 8.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.432 -0.793 . . . . 0.0 109.987 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 33' ' ' ILE . 5.6 tt -94.42 112.69 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.187 -0.946 . . . . 0.0 109.735 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.46 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -146.71 155.3 42.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 111.307 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 22.6 tt0 -109.7 127.41 54.56 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 1.8 m -143.25 165.92 26.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.067 -1.021 . . . . 0.0 110.705 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.493 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.77 164.17 21.28 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.613 -0.679 . . . . 0.0 109.441 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 43.3 Cg_endo -71.79 162.83 40.82 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.748 1.394 . . . . 0.0 110.674 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 39' ' ' VAL . 33.4 m . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.378 -0.827 . . . . 0.0 110.283 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.325 0.583 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.521 ' CB ' HG11 ' A' ' 39' ' ' VAL . . . -132.1 156.7 45.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.85 . . . . 0.0 109.671 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 12.2 t -147.55 160.7 42.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.106 -0.996 . . . . 0.0 110.511 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.464 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 41.2 t-20 -84.37 117.64 69.22 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.318 -0.864 . . . . 0.0 110.12 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.63 -37.16 2.44 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.908 1.478 . . . . 0.0 110.554 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.07 -20.95 58.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.327 -0.858 . . . . 0.0 110.322 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 82.4 p -113.86 -10.96 12.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.925 . . . . 0.0 110.352 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.4 106.43 2.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.4 t -139.9 152.96 46.83 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.255 -0.903 . . . . 0.0 110.318 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 6.0 p -105.83 157.33 17.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.106 -0.996 . . . . 0.0 110.51 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 6.4 p90 -146.0 -177.4 5.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.047 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.3 m -138.6 161.29 37.48 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.216 -0.927 . . . . 0.0 110.013 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.75 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -76.22 -158.09 0.09 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.205 -0.934 . . . . 0.0 109.934 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 1.6 t0 -141.75 -151.31 0.35 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.967 -1.083 . . . . 0.0 110.406 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.6 -54.62 29.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.926 . . . . 0.0 109.533 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.6 p -90.37 21.28 3.95 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.557 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 61.51 17.49 53.61 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -89.68 137.83 31.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -1.164 . . . . 0.0 110.056 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.707 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -140.74 84.62 1.95 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 110.269 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.8 p -104.86 115.59 30.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.84 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -146.12 179.0 7.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.258 -0.901 . . . . 0.0 110.675 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.36 138.64 31.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.511 -0.743 . . . . 0.0 110.863 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.484 ' HB3' HG23 ' A' ' 18' ' ' VAL . 51.4 t80 -132.84 -175.55 3.81 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 21.7 t -144.66 163.03 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.726 -1.234 . . . . 0.0 110.798 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.427 ' C ' ' HG2' ' A' ' 68' ' ' ARG . 33.7 m -138.28 160.83 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 109.657 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.427 ' HG2' ' C ' ' A' ' 67' ' ' VAL . 0.9 OUTLIER -141.05 139.27 34.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.939 -1.1 . . . . 0.0 110.527 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 3.2 ttmt -61.14 -44.92 96.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.903 . . . . 0.0 109.746 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 95.5 p -138.75 149.46 45.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.767 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -155.03 153.65 31.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 110.337 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 7.0 m -70.42 128.4 36.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.892 . . . . 0.0 110.138 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 74' ' ' SER . . . -87.71 173.2 43.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 5.5 t . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.282 -1.128 . . . . 0.0 110.111 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.469 0.652 . . . . 0.0 110.526 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -127.62 155.87 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.411 -0.806 . . . . 0.0 109.676 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -143.97 140.71 29.79 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.033 -1.042 . . . . 0.0 110.499 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 89' ' ' ALA . 69.3 m -85.16 -9.78 57.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.817 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.77 -44.9 72.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 109.929 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 t -94.91 -8.78 36.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.958 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 86' ' ' CYS . . . -140.37 163.9 31.54 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.332 -0.855 . . . . 0.0 109.981 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.24 139.64 35.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.511 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 1.4 p -123.22 142.48 50.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.302 -0.874 . . . . 0.0 109.714 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -125.47 161.43 27.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.995 . . . . 0.0 110.604 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.46 HD12 ' C ' ' A' ' 34' ' ' ALA . 13.7 tp -117.12 112.11 20.43 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.388 -0.82 . . . . 0.0 109.172 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.45 ' HA3' ' CD2' ' A' ' 104' ' ' HIS . . . -110.47 150.29 17.63 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.466 -1.35 . . . . 0.0 109.914 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -142.41 132.14 24.09 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.485 -1.009 . . . . 0.0 109.669 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.528 ' CA ' ' HB3' ' A' ' 31' ' ' TYR . . . 149.35 -159.37 28.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 100' ' ' LEU . 8.9 t-20 -121.18 159.08 26.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -1.083 . . . . 0.0 110.04 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -54.37 -30.57 52.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.1 -1.0 . . . . 0.0 110.107 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.74 -45.76 4.47 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.594 HD22 ' CE1' ' A' ' 31' ' ' TYR . 8.8 tt -87.89 143.52 27.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.183 . . . . 0.0 110.204 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -117.25 92.68 3.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.129 -0.982 . . . . 0.0 110.354 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.4 OUTLIER -71.13 -54.87 9.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.897 . . . . 0.0 110.125 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 158.72 155.15 7.49 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.499 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.45 ' CD2' ' HA3' ' A' ' 94' ' ' GLY . 17.6 m80 -125.82 119.52 28.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.675 -0.897 . . . . 0.0 109.264 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.9 t -103.46 107.35 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 110.632 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.91 48.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.264 -0.897 . . . . 0.0 109.717 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 41.1 mt -95.98 158.37 15.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 0.0 110.65 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.554 HG22 ' N ' ' A' ' 109' ' ' PHE . 75.1 m -149.36 172.88 14.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.363 -0.835 . . . . 0.0 109.989 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 36.5 m-85 -135.09 118.24 16.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.199 -0.938 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.464 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 44.5 Cg_endo . . . . . 0 C--O 1.216 -0.617 0 N-CA-C 110.622 -0.569 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.536 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -151.22 151.2 31.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -150.19 113.8 4.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.213 -0.929 . . . . 0.0 109.984 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.5 t -150.56 150.31 31.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.099 -1.001 . . . . 0.0 110.571 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.584 HG12 HG11 ' A' ' 105' ' ' VAL . 9.9 p -123.11 155.28 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.405 -0.809 . . . . 0.0 109.65 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -75.08 -66.4 0.43 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.036 -1.04 . . . . 0.0 110.382 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 46.3 Cg_endo -74.05 81.98 1.86 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.458 1.241 . . . . 0.0 110.259 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.06 -4.85 53.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.311 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.5 p -143.92 159.44 42.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.433 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.06 51.05 58.24 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.509 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 5.3 mt -88.5 154.79 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -1.154 . . . . 0.0 109.922 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 4.3 t -132.92 157.06 46.07 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.134 -0.979 . . . . 0.0 110.346 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -63.58 115.92 5.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.79 -32.63 7.36 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 26.5 tt0 -50.82 143.97 9.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -1.073 . . . . 0.0 110.116 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.4 t -98.85 152.61 19.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.54 ' HA ' ' HG3' ' A' ' 8' ' ' PRO . 28.7 m -128.11 150.47 33.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.288 -0.883 . . . . 0.0 109.927 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -98.29 131.36 44.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 110.133 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.39 149.02 18.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -144.9 134.55 23.4 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.391 -0.818 . . . . 0.0 110.524 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.934 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 52.5 t -127.7 149.0 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.439 -0.788 . . . . 0.0 110.006 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 2' ' ' PRO . 0.7 OUTLIER -153.12 -177.25 6.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.811 . . . . 0.0 109.596 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 71.52 17.3 76.24 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.498 -1.334 . . . . 0.0 109.819 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.803 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -119.12 -159.47 0.77 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.155 -1.203 . . . . 0.0 110.269 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.573 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -170.98 161.06 6.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.443 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -53.6 131.17 38.3 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.572 -0.705 . . . . 0.0 110.272 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.59 21.58 5.72 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -144.36 116.44 8.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.235 -1.156 . . . . 0.0 110.621 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.405 HG23 ' OG1' ' A' ' 54' ' ' THR . 61.3 m -109.66 128.96 55.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 109.563 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 8.7 m-85 -114.31 175.5 5.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.004 -1.06 . . . . 0.0 110.715 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -124.93 124.5 42.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.473 -0.767 . . . . 0.0 109.46 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 33' ' ' ILE . 1.2 tt -105.06 124.38 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.089 -1.007 . . . . 0.0 110.482 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.99 155.87 38.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 111.201 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.517 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 36.6 tt0 -124.33 135.11 53.09 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.437 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 3.7 m -144.96 179.67 7.19 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.79 -1.194 . . . . 0.0 111.111 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.608 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -152.07 175.71 2.77 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.608 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 46.3 Cg_endo -83.23 163.28 15.2 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.751 1.395 . . . . 0.0 110.782 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.436 HG12 ' CA ' ' A' ' 43' ' ' ASP . 14.9 p . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 109.982 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.436 ' CA ' HG12 ' A' ' 39' ' ' VAL . 19.5 t0 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.354 0.597 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -131.79 173.3 11.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.789 . . . . 0.0 109.588 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.8 t -154.09 165.84 34.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.139 -0.976 . . . . 0.0 110.723 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 29.4 t-20 -80.03 124.58 82.91 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 46' ' ' ASN . 50.5 Cg_endo -86.01 -35.56 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.873 1.46 . . . . 0.0 111.389 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.24 3.61 4.45 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.139 -0.976 . . . . 0.0 111.506 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 71.7 p -124.07 7.29 8.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.863 -1.148 . . . . 0.0 110.677 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.32 120.3 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.026 -1.046 . . . . 0.0 110.193 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.462 HG23 ' CG2' ' A' ' 33' ' ' ILE . 10.0 t -160.57 165.63 30.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.226 -0.922 . . . . 0.0 110.315 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.8 t -136.01 163.59 29.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.216 -0.928 . . . . 0.0 110.43 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 7.3 p90 -146.55 179.68 7.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.297 -0.877 . . . . 0.0 109.764 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.405 ' OG1' HG23 ' A' ' 30' ' ' THR . 32.8 m -145.21 154.2 42.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.803 HG21 ' HB1' ' A' ' 25' ' ' ALA . 7.4 p -73.94 -156.15 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.355 -0.84 . . . . 0.0 110.068 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 27' ' ' ALA . 1.3 t0 -160.9 -151.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.924 -1.11 . . . . 0.0 110.799 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.21 -48.0 83.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 109.959 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.25 9.14 9.37 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.233 -0.917 . . . . 0.0 109.414 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.573 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 50.01 48.17 39.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.61 125.78 43.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.141 -1.211 . . . . 0.0 110.283 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.934 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -115.06 83.08 1.85 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 0.0 110.3 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.5 p -112.12 126.86 55.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.232 -0.918 . . . . 0.0 109.745 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 7.0 p90 -157.06 175.38 14.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 0.0 110.802 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 p -94.4 152.56 18.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.422 -0.799 . . . . 0.0 110.355 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.552 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 73.3 t80 -142.45 179.35 7.0 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 109.634 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.552 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.7 t -135.38 159.11 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.929 -1.107 . . . . 0.0 109.825 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 16' ' ' GLN . 33.7 m -132.79 161.28 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.19 -0.944 . . . . 0.0 110.672 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -135.84 138.43 42.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.89 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.818 ' HD3' ' HB2' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -76.9 -44.31 32.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.092 -1.005 . . . . 0.0 110.471 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.48 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 4.3 p -129.25 147.3 51.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.947 . . . . 0.0 110.413 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.508 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 11.0 p90 -161.82 156.03 22.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.223 -0.923 . . . . 0.0 110.347 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 73' ' ' GLY . 1.4 m -68.97 105.69 2.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.33 -0.856 . . . . 0.0 110.171 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 72' ' ' THR . . . -42.48 147.87 0.59 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 97.1 p . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.29 -1.123 . . . . 0.0 110.082 179.959 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.196 0.522 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.4 t -144.88 111.24 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.153 -0.967 . . . . 0.0 110.701 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.48 ' OD1' ' HB2' ' A' ' 70' ' ' SER . 1.7 m-20 -104.99 104.47 14.22 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 109.009 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.673 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -92.07 24.27 3.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.006 -1.059 . . . . 0.0 110.921 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.818 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . . . -68.8 -37.83 79.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.178 -0.951 . . . . 0.0 109.204 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 t -116.0 -3.36 12.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.58 -0.7 . . . . 0.0 109.679 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.673 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -89.53 -139.98 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.354 -0.841 . . . . 0.0 110.294 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.78 102.88 8.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 110.415 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.92 126.15 44.52 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 15.6 p30 -130.5 139.23 50.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.093 -1.005 . . . . 0.0 110.798 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.745 ' HB2' HD11 ' A' ' 107' ' ' LEU . 6.1 tp -119.19 110.39 16.97 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.674 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -113.16 162.51 12.34 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.805 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.46 157.53 44.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.644 -0.915 . . . . 0.0 109.997 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 31' ' ' TYR . . . 107.75 -177.67 21.29 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.518 ' OD1' HD23 ' A' ' 100' ' ' LEU . 4.5 p-10 -126.68 -155.75 0.7 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.194 -1.18 . . . . 0.0 109.996 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 94.3 p -92.62 69.33 4.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.307 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.57 -55.12 0.08 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.753 HD22 ' N ' ' A' ' 100' ' ' LEU . 3.9 mm? -75.79 -32.66 59.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -1.135 . . . . 0.0 109.547 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 49.27 80.19 0.07 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.633 -0.667 . . . . 0.0 110.232 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.463 ' HG ' ' HA3' ' A' ' 96' ' ' GLY . 21.8 mt -76.16 -69.82 0.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 110.238 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.35 179.61 36.17 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.806 -1.187 . . . . 0.0 110.14 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.674 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 5.6 m80 -134.59 123.37 23.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.585 -0.95 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.584 HG11 HG12 ' A' ' 6' ' ' VAL . 60.2 t -90.11 111.04 22.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.248 -0.908 . . . . 0.0 110.313 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.54 118.81 10.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.97 . . . . 0.0 109.29 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 93' ' ' LEU . 49.7 mt -89.85 158.68 17.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 110.852 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -123.26 164.09 19.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.503 -0.748 . . . . 0.0 109.72 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.442 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 4.5 m-85 -149.28 174.57 12.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.199 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.548 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 49.3 Cg_endo . . . . . 0 C--O 1.214 -0.697 0 N-CA-C 110.103 -0.768 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -155.37 135.04 12.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.962 . . . . 0.0 110.306 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.487 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 1.2 t80 -147.78 99.3 3.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.399 -0.813 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.08 158.74 43.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 111.069 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.694 HG12 HG11 ' A' ' 105' ' ' VAL . 6.4 p -121.95 157.99 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.517 -0.739 . . . . 0.0 109.355 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.614 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.7 m -72.46 -70.19 0.29 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.883 -1.136 . . . . 0.0 110.137 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.614 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 53.9 Cg_endo -76.42 97.38 1.13 Allowed 'Trans proline' 0 N--CA 1.481 0.751 0 O-C-N 123.144 1.076 . . . . 0.0 110.031 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.5 -4.33 25.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.047 -1.033 . . . . 0.0 110.144 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.47 127.37 19.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 110.144 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' O ' HD23 ' A' ' 12' ' ' LEU . . . 88.06 80.62 1.26 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.498 HD12 ' HB3' ' A' ' 107' ' ' LEU . 45.3 mt -126.44 162.09 26.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.311 -1.111 . . . . 0.0 110.248 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.78 158.03 44.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.117 -0.99 . . . . 0.0 110.813 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -61.51 121.53 12.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.19 -39.03 2.93 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.551 ' O ' HG22 ' A' ' 67' ' ' VAL . 37.6 tt0 -49.47 134.05 19.62 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.28 -1.129 . . . . 0.0 109.885 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.2 p -95.51 138.74 32.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.38 -0.825 . . . . 0.0 110.066 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 65' ' ' PHE . 15.9 m -108.58 170.18 2.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.375 -0.828 . . . . 0.0 109.665 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.511 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 27.0 p -116.65 121.59 42.11 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.18 -0.95 . . . . 0.0 109.262 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t -112.16 150.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.118 -0.989 . . . . 0.0 110.41 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.65 132.55 22.74 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.492 -0.755 . . . . 0.0 110.114 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.81 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 18.3 t -120.71 139.43 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 3' ' ' ALA . 2.4 p -151.35 143.56 24.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.252 -0.905 . . . . 0.0 110.108 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 120.39 -67.77 0.41 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 24' ' ' GLY . . . -54.18 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.086 -1.243 . . . . 0.0 109.363 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.52 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -165.55 162.65 19.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.943 -1.098 . . . . 0.0 110.976 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.5 130.91 1.3 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.459 0.647 . . . . 0.0 110.409 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.417 ' C ' ' HG3' ' A' ' 29' ' ' GLU . . . 120.04 4.61 11.23 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 33.6 mt-10 -138.72 122.75 17.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.199 -1.177 . . . . 0.0 109.85 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.56 HG23 ' OG1' ' A' ' 54' ' ' THR . 62.4 m -105.02 133.69 49.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 109.99 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.924 ' CE2' HD21 ' A' ' 100' ' ' LEU . 11.1 m-85 -120.05 171.8 8.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.533 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 14.0 m-85 -131.68 102.1 5.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 109.113 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.659 ' CG2' HG23 ' A' ' 51' ' ' THR . 3.0 tt -90.47 117.8 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.084 -1.01 . . . . 0.0 110.905 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.45 158.5 44.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.219 -0.926 . . . . 0.0 110.299 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.462 ' HG2' ' N ' ' A' ' 36' ' ' CYS . 2.2 tt0 -116.85 144.47 44.47 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.226 -0.921 . . . . 0.0 110.19 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 77.2 m -150.23 161.43 42.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.283 -0.885 . . . . 0.0 110.776 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . . . -138.17 156.04 74.0 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 121.371 -0.831 . . . . 0.0 109.816 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 44.4 Cg_endo -70.82 163.62 38.48 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.825 1.434 . . . . 0.0 111.836 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.568 HG22 ' CA ' ' A' ' 43' ' ' ASP . 5.8 m . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.689 . . . . 0.0 109.748 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.568 ' CA ' HG22 ' A' ' 39' ' ' VAL . 12.5 t70 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.722 0.773 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -149.72 162.88 39.37 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.68 162.15 27.22 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.916 -1.115 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . 1.7 t-20 -103.91 113.35 65.47 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.553 -0.717 . . . . 0.0 110.171 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.442 ' HD2' HD21 ' A' ' 46' ' ' ASN . 47.6 Cg_endo -76.26 -27.93 7.63 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.993 1.523 . . . . 0.0 110.242 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.26 -3.78 11.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.849 . . . . 0.0 110.285 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.5 p -131.24 -1.85 3.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.258 -0.901 . . . . 0.0 110.172 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.7 127.38 31.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.26 -0.9 . . . . 0.0 110.183 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.659 HG23 ' CG2' ' A' ' 33' ' ' ILE . 4.4 t -159.47 150.51 19.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.979 . . . . 0.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 t -122.42 143.25 49.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.309 -0.869 . . . . 0.0 110.149 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -140.24 138.07 34.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.146 -0.971 . . . . 0.0 110.432 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.56 ' OG1' HG23 ' A' ' 30' ' ' THR . 15.6 m -105.48 151.56 24.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.194 -0.941 . . . . 0.0 109.525 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -61.71 -170.76 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.811 -1.18 . . . . 0.0 109.481 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 6.5 t0 -145.45 -158.72 0.92 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.914 -1.116 . . . . 0.0 110.818 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.39 -53.23 60.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 109.47 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 p -76.78 1.99 15.68 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 109.083 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 53.75 44.49 70.0 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.14 132.99 47.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.289 -1.124 . . . . 0.0 110.051 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.81 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -123.13 83.55 2.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.181 -0.95 . . . . 0.0 110.876 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.22 120.22 41.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.263 -0.898 . . . . 0.0 109.648 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -154.91 168.03 28.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.175 -0.953 . . . . 0.0 110.833 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 t -90.96 131.63 36.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.448 -0.783 . . . . 0.0 110.278 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 76.7 t80 -116.35 -179.73 3.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.557 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.1 t -133.37 158.1 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 120.858 -1.151 . . . . 0.0 110.01 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 16' ' ' GLN . 29.1 m -129.42 126.72 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.153 -0.967 . . . . 0.0 110.818 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 134.99 47.83 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.206 -0.934 . . . . 0.0 109.888 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -73.91 -45.86 47.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.218 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.4 m -135.12 152.11 51.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.939 . . . . 0.0 110.066 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.578 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 8.8 p90 -169.68 148.19 3.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.928 . . . . 0.0 110.317 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.3 OUTLIER -54.61 124.77 17.32 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.146 -0.971 . . . . 0.0 109.395 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.669 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -110.14 167.6 12.77 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.505 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.658 -0.907 . . . . 0.0 108.909 179.923 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 5.3 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.211 0.529 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.669 HG21 ' HA3' ' A' ' 73' ' ' GLY . 88.0 t -125.82 156.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.183 -0.948 . . . . 0.0 110.297 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -156.19 130.92 9.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.19 -0.944 . . . . 0.0 110.381 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -90.52 7.89 36.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 109.978 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.53 -47.44 69.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.343 -0.848 . . . . 0.0 110.247 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.0 t -113.32 -0.04 14.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 110.174 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -103.46 -163.71 1.01 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.224 -0.923 . . . . 0.0 110.278 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.7 133.23 56.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 110.136 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.56 111.25 23.72 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.184 -0.948 . . . . 0.0 110.016 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -121.49 140.43 52.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.131 -0.981 . . . . 0.0 110.64 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.1 tp -112.84 141.42 46.67 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.435 -0.791 . . . . 0.0 109.244 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.24 167.73 32.41 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.08 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 33' ' ' ILE . . . -155.01 168.52 26.72 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.602 -0.94 . . . . 0.0 109.173 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.3 175.95 26.07 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.166 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 30' ' ' THR . 28.7 t30 -148.37 172.19 14.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -1.081 . . . . 0.0 109.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.99 -10.51 14.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 0.0 110.318 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.96 -43.58 7.1 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.924 HD21 ' CE2' ' A' ' 31' ' ' TYR . 2.3 pt? -154.12 -160.86 1.14 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -1.193 . . . . 0.0 110.436 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.518 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 3.4 m-20 -149.91 113.46 4.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.286 -0.884 . . . . 0.0 110.294 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.588 HD11 ' CD2' ' A' ' 31' ' ' TYR . 96.9 mt -71.58 -54.47 10.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 110.202 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.77 -160.34 27.71 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -158.35 140.62 14.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.267 -1.137 . . . . 0.0 109.999 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.694 HG11 HG12 ' A' ' 6' ' ' VAL . 15.9 t -103.04 124.1 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.112 -0.992 . . . . 0.0 110.587 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.61 103.21 3.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.256 -0.902 . . . . 0.0 109.956 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.498 ' HB3' HD12 ' A' ' 12' ' ' LEU . 12.8 mt -83.01 127.61 33.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.21 -0.931 . . . . 0.0 110.314 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 109' ' ' PHE . 37.4 m -94.61 171.18 8.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.205 -0.935 . . . . 0.0 110.297 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.505 ' N ' HG22 ' A' ' 108' ' ' THR . 1.2 m-85 -145.25 154.49 42.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.391 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.867 ' HB2' HD21 ' A' ' 102' ' ' LEU . 44.3 Cg_endo . . . . . 0 N--CA 1.483 0.883 0 N-CA-C 109.873 -0.857 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -156.6 149.12 23.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.863 -1.148 . . . . 0.0 111.552 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.446 ' CE2' HG23 ' A' ' 105' ' ' VAL . 44.5 t80 -151.14 107.07 3.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.597 -0.689 . . . . 0.0 109.322 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.48 151.35 43.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.968 -1.083 . . . . 0.0 111.51 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.75 ' CG1' HG11 ' A' ' 105' ' ' VAL . 7.8 p -133.12 132.77 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.642 -0.661 . . . . 0.0 109.425 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.612 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -63.22 -66.74 1.36 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.038 -1.039 . . . . 0.0 110.839 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 50.9 Cg_endo -73.44 83.29 1.52 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.6 1.316 . . . . 0.0 110.667 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.7 4.62 53.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.112 -0.992 . . . . 0.0 110.005 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.8 p -151.75 170.38 19.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.95 55.92 28.19 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.519 ' CD1' HD22 ' A' ' 107' ' ' LEU . 58.0 mt -107.86 145.38 33.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -1.081 . . . . 0.0 109.953 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 0.4 OUTLIER -119.55 158.11 26.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 110.541 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 14' ' ' ASP . 41.0 t0 -59.34 124.04 18.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.894 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.01 -32.01 6.78 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.453 ' HB3' ' O ' ' A' ' 13' ' ' SER . 37.9 tt0 -56.9 146.38 26.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.305 -1.115 . . . . 0.0 109.985 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 11.3 m -102.37 153.22 20.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.57 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.655 HG23 ' HB3' ' A' ' 65' ' ' PHE . 6.3 m -116.8 153.32 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.337 -0.852 . . . . 0.0 109.818 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -97.79 109.18 21.98 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.16 -0.962 . . . . 0.0 110.055 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.45 ' CG2' HG23 ' A' ' 6' ' ' VAL . 46.2 t -111.17 157.6 11.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 121.435 -0.791 . . . . 0.0 109.846 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 m -150.59 117.3 5.81 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.257 -0.902 . . . . 0.0 110.383 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 4.2 t -105.25 123.7 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 0.0 109.892 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.555 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.1 OUTLIER -132.86 155.76 48.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.995 -1.066 . . . . 0.0 110.499 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 106.63 -35.74 4.85 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.693 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -68.34 -150.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.306 -1.114 . . . . 0.0 109.747 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 25' ' ' ALA . . . 176.19 147.68 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.859 -1.151 . . . . 0.0 111.339 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -39.41 143.28 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.611 0.72 . . . . 0.0 110.415 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.45 18.47 14.49 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.623 ' O ' HG23 ' A' ' 54' ' ' THR . 4.5 tp10 -151.02 135.64 17.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.227 -1.161 . . . . 0.0 110.745 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.54 HG23 ' OG1' ' A' ' 54' ' ' THR . 3.7 m -114.3 145.15 42.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.751 ' CE1' HG23 ' A' ' 55' ' ' THR . 24.5 m-85 -128.34 179.58 5.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -0.95 . . . . 0.0 110.504 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -132.33 100.69 5.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.208 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.76 HG23 ' O ' ' A' ' 33' ' ' ILE . 7.6 tt -89.0 103.25 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -0.922 . . . . 0.0 110.134 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.497 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -138.7 163.24 32.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.139 -0.975 . . . . 0.0 110.555 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.434 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 18.0 pt20 -128.77 148.75 50.88 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.16 -0.962 . . . . 0.0 110.269 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 1.8 m -145.5 172.93 12.51 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.213 -0.929 . . . . 0.0 110.389 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.25 161.57 35.87 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.533 -0.729 . . . . 0.0 109.409 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.665 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 43.7 Cg_endo -71.4 171.78 15.48 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.713 1.375 . . . . 0.0 110.329 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.1 -1.0 . . . . 0.0 110.402 -179.924 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 1.8 p30 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.266 0.555 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.687 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -108.49 147.12 32.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.37 -0.832 . . . . 0.0 109.163 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 12.2 t -124.14 170.41 10.73 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.793 -1.192 . . . . 0.0 111.007 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.438 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 8.4 t-20 -105.76 119.61 51.91 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 109.995 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.79 -35.04 3.62 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.871 1.459 . . . . 0.0 110.41 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.14 73.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.276 -0.89 . . . . 0.0 110.213 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.6 p -75.65 -16.71 60.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.317 -0.865 . . . . 0.0 109.983 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -76.26 87.93 3.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.837 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 33' ' ' ILE . 12.0 t -112.46 148.4 34.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.264 -0.898 . . . . 0.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 p -93.58 132.46 37.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.35 -0.844 . . . . 0.0 109.86 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 35.3 p90 -133.34 124.51 27.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.12 -0.988 . . . . 0.0 110.698 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 29' ' ' GLU . 47.3 m -89.22 153.87 20.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 110.345 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.751 HG23 ' CE1' ' A' ' 31' ' ' TYR . 1.8 p -61.67 -158.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.297 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 9.2 m-20 -149.18 -160.24 1.15 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.853 -1.154 . . . . 0.0 110.675 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.51 76.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.163 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.8 m -85.9 13.3 7.65 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.564 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 54.25 23.58 26.18 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -110.94 114.94 28.64 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.456 -1.026 . . . . 0.0 110.434 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.28 80.01 1.27 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.505 -0.747 . . . . 0.0 110.096 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -103.67 143.92 32.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.431 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -172.79 169.78 4.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.135 -0.978 . . . . 0.0 111.055 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.62 92.45 8.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.31 -0.869 . . . . 0.0 110.112 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.655 ' HB3' HG23 ' A' ' 18' ' ' VAL . 77.7 t80 -73.39 -174.97 1.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.438 -0.789 . . . . 0.0 109.505 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.521 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.1 t -138.66 155.42 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.883 -1.136 . . . . 0.0 109.561 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 12' ' ' LEU . 33.0 m -136.28 144.9 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.032 -1.043 . . . . 0.0 110.535 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.01 138.43 50.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -0.843 . . . . 0.0 110.228 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -64.16 -58.76 5.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.865 . . . . 0.0 110.234 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 p -130.04 155.23 46.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.269 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 11.0 p90 -168.35 158.3 9.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 109.796 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.7 OUTLIER -62.58 127.59 32.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.157 -0.965 . . . . 0.0 110.191 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.505 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -96.05 168.1 25.7 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 13.2 t . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.182 -1.187 . . . . 0.0 110.308 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 15.9 p . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.321 0.581 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.687 HG21 ' HB3' ' A' ' 44' ' ' ALA . 53.0 t -138.53 142.34 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.34 -0.85 . . . . 0.0 109.635 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.3 137.92 41.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.017 -1.052 . . . . 0.0 110.672 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 91' ' ' CYS . 65.1 m -93.19 27.48 2.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.44 -51.55 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.44 -0.787 . . . . 0.0 109.976 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.446 ' H ' HG22 ' A' ' 88' ' ' THR . 4.4 t -97.64 -20.25 17.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.35 -0.843 . . . . 0.0 109.654 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.665 ' HB1' ' HG2' ' A' ' 38' ' ' PRO . . . -96.79 -161.85 0.91 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.361 -0.837 . . . . 0.0 109.77 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.49 130.88 56.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 110.59 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 86' ' ' CYS . 0.5 OUTLIER -107.3 116.39 31.85 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.342 -0.849 . . . . 0.0 109.551 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 91' ' ' CYS . 42.9 m-20 -130.77 136.35 48.63 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.966 -1.084 . . . . 0.0 111.268 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 34' ' ' ALA . 2.6 tp -107.12 118.27 36.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.491 -0.756 . . . . 0.0 109.671 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -111.21 161.3 12.84 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.28 170.82 17.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.337 -1.096 . . . . 0.0 110.195 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.32 167.96 12.65 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.494 ' HB3' ' O ' ' A' ' 30' ' ' THR . 4.2 p-10 -118.4 -151.12 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 110.405 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.18 89.59 4.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.229 -0.919 . . . . 0.0 110.377 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.56 -21.53 3.59 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.845 HD21 ' HG3' ' A' ' 2' ' ' PRO . 2.9 tm? -103.81 -76.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.379 -1.071 . . . . 0.0 109.913 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.713 ' N ' HD13 ' A' ' 100' ' ' LEU . 4.3 t70 70.09 138.29 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.207 -0.933 . . . . 0.0 110.726 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.867 HD21 ' HB2' ' A' ' 2' ' ' PRO . 4.2 mt -133.0 -42.13 0.9 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.423 -0.798 . . . . 0.0 110.372 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.81 -149.01 20.39 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.43 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 14.2 p80 -158.74 134.39 8.78 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.253 -1.146 . . . . 0.0 110.312 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.75 HG11 ' CG1' ' A' ' 6' ' ' VAL . 2.5 t -86.16 161.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.387 -0.821 . . . . 0.0 109.593 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.98 124.93 48.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 0.0 110.242 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.519 HD22 ' CD1' ' A' ' 12' ' ' LEU . 79.3 mt -100.78 85.82 2.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.619 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.5 m -68.42 162.94 24.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.756 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.458 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 5.2 m-85 -136.52 75.76 1.56 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.144 -0.972 . . . . 0.0 110.382 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.358 0 CA-C-O 118.025 -1.43 . . . . 0.0 109.623 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.476 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 49.3 Cg_endo . . . . . 0 N--CA 1.48 0.685 0 N-CA-C 110.425 -0.644 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -162.21 79.49 0.52 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.126 -0.984 . . . . 0.0 110.527 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.529 ' HD1' HG22 ' A' ' 22' ' ' VAL . 25.0 t80 -91.37 114.9 27.55 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.056 -1.028 . . . . 0.0 109.718 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.6 p -150.81 152.44 33.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.044 -1.035 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.745 HG12 HG11 ' A' ' 105' ' ' VAL . 8.0 p -120.37 123.31 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.569 -0.707 . . . . 0.0 109.574 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.614 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 m -45.94 -67.95 0.34 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.999 . . . . 0.0 110.122 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.614 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 48.6 Cg_endo -76.15 78.98 3.04 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.342 1.18 . . . . 0.0 110.014 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.481 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -99.59 6.57 45.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 110.282 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -158.24 148.51 20.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.928 . . . . 0.0 110.338 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.63 67.61 1.92 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.55 ' CD1' HD22 ' A' ' 107' ' ' LEU . 11.8 mt -122.22 173.62 7.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.387 -1.067 . . . . 0.0 110.162 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -137.83 157.3 46.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.158 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -60.82 109.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.135 -0.978 . . . . 0.0 110.26 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.85 -39.34 2.82 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.43 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.2 tm0? -46.38 141.07 3.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.145 -1.209 . . . . 0.0 109.941 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.78 152.99 21.02 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.952 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.637 HG11 HG11 ' A' ' 67' ' ' VAL . 5.6 m -126.98 166.44 23.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.4 t -119.36 130.34 55.29 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.141 -0.974 . . . . 0.0 110.174 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.9 t -117.25 144.6 24.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 O-C-N 121.602 -0.686 . . . . 0.0 109.792 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 40.2 t -150.99 134.52 16.31 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.296 -0.878 . . . . 0.0 110.494 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.529 HG22 ' HD1' ' A' ' 4' ' ' PHE . 22.5 t -122.66 111.9 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.764 . . . . 0.0 110.092 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.64 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 58.8 m -125.47 113.34 17.36 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.083 -1.011 . . . . 0.0 111.068 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 154.16 -38.11 0.69 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -69.49 -141.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -1.146 . . . . 0.0 109.807 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 25' ' ' ALA . . . 176.0 160.31 0.3 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.152 -0.968 . . . . 0.0 110.445 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.76 133.35 31.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.735 . . . . 0.0 110.417 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.424 ' O ' ' CD ' ' A' ' 29' ' ' GLU . . . 127.35 12.17 3.19 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.524 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 73.5 mm-40 -152.18 144.61 24.09 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.949 -1.324 . . . . 0.0 110.545 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.403 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 23.7 m -122.36 148.37 45.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.416 -0.803 . . . . 0.0 109.791 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.721 ' HE2' HD22 ' A' ' 100' ' ' LEU . 9.6 m-85 -140.02 -177.14 4.86 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.07 -1.018 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.589 ' CD1' ' HB3' ' A' ' 52' ' ' SER . 19.0 m-85 -132.81 124.83 28.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -108.53 117.0 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.877 -1.14 . . . . 0.0 110.916 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.612 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -152.53 151.16 30.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 110.471 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.534 ' HB2' HD13 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -103.1 135.22 45.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.382 -0.824 . . . . 0.0 109.529 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 1.5 m -146.58 173.06 12.67 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.082 -1.011 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.02 152.35 31.3 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.524 -0.735 . . . . 0.0 109.466 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.41 156.41 61.71 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.689 1.363 . . . . 0.0 110.96 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.489 -0.757 . . . . 0.0 110.109 -179.945 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.244 0.545 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.744 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -126.85 152.22 47.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.863 . . . . 0.0 109.801 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 10.4 t -129.56 165.16 22.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 110.283 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -86.86 112.06 44.59 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.194 -0.941 . . . . 0.0 110.109 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.7 Cg_endo -74.49 -27.65 10.85 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.94 1.495 . . . . 0.0 110.661 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.46 -23.62 67.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.171 -0.956 . . . . 0.0 110.285 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.526 HG21 ' HE ' ' A' ' 68' ' ' ARG . 4.9 p -113.1 26.62 10.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.208 -0.932 . . . . 0.0 110.375 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.7 143.36 33.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.22 -0.925 . . . . 0.0 110.068 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.482 HG23 HG23 ' A' ' 33' ' ' ILE . 7.5 t -170.35 137.33 1.45 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.015 . . . . 0.0 110.627 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.589 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 5.4 p -107.6 155.79 19.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.305 -0.872 . . . . 0.0 110.548 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 31' ' ' TYR . 12.3 p90 -151.93 -178.31 6.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.167 -0.958 . . . . 0.0 110.556 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 29' ' ' GLU . 31.2 m -141.16 168.67 19.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.458 -0.776 . . . . 0.0 109.64 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.425 ' N ' HG22 ' A' ' 54' ' ' THR . 1.0 OUTLIER -74.2 -164.7 0.26 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.956 -1.09 . . . . 0.0 110.462 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.35 -162.18 1.31 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.858 . . . . 0.0 109.779 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.04 -58.0 10.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -0.962 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 p -90.7 23.71 2.98 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.325 -0.859 . . . . 0.0 108.962 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 57.61 39.35 90.88 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -106.86 124.44 49.62 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.34 -1.094 . . . . 0.0 110.564 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -132.29 84.43 2.15 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.342 -0.849 . . . . 0.0 109.504 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 57.1 m -110.94 120.76 43.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 110.526 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.634 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 2.2 p90 -143.82 170.98 14.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 110.649 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 p -93.32 122.15 35.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.376 -0.828 . . . . 0.0 110.671 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.426 ' HB3' HG23 ' A' ' 18' ' ' VAL . 9.1 t80 -116.87 -169.62 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.489 -0.757 . . . . 0.0 109.206 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.412 HG23 ' C ' ' A' ' 65' ' ' PHE . 11.2 t -145.51 165.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.8 -1.188 . . . . 0.0 109.623 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.637 HG11 HG11 ' A' ' 18' ' ' VAL . 34.2 m -130.43 152.95 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.069 -1.019 . . . . 0.0 110.789 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.526 ' HE ' HG21 ' A' ' 49' ' ' THR . 0.0 OUTLIER -133.42 150.46 51.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.339 -0.851 . . . . 0.0 109.96 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.573 ' HE2' ' CG ' ' A' ' 109' ' ' PHE . 3.2 ttmt -83.42 -36.99 23.81 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.097 -1.002 . . . . 0.0 110.553 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 p -136.04 150.01 49.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.197 -0.94 . . . . 0.0 110.092 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.561 ' CZ ' HG11 ' A' ' 84' ' ' VAL . 16.4 p90 -161.34 166.11 27.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.254 -0.904 . . . . 0.0 110.328 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -88.53 117.53 27.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.218 -0.926 . . . . 0.0 110.061 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.744 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -101.37 154.78 19.02 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 2.5 p . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.312 -1.111 . . . . 0.0 110.017 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.369 0.604 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.561 HG11 ' CZ ' ' A' ' 71' ' ' TYR . 49.4 t -139.18 102.8 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.383 -0.823 . . . . 0.0 109.806 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -93.88 126.06 38.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.369 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 3.5 m -85.92 4.13 38.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.821 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.17 -63.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 109.991 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.429 HG23 ' N ' ' A' ' 89' ' ' ALA . 13.3 t -72.85 -33.86 66.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.268 -0.895 . . . . 0.0 110.009 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.429 ' N ' HG23 ' A' ' 88' ' ' THR . . . -93.35 -177.77 4.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.326 -0.859 . . . . 0.0 109.919 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.48 139.17 38.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.373 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.34 130.47 54.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.64 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -133.93 163.69 28.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 110.796 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.612 HD12 ' O ' ' A' ' 34' ' ' ALA . 41.2 tp -127.58 111.12 13.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 0.0 109.214 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.27 165.49 18.36 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.056 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -157.38 101.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -1.072 . . . . 0.0 110.105 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.83 174.88 46.96 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.489 ' CG ' ' N ' ' A' ' 98' ' ' SER . 0.8 OUTLIER -123.46 -155.01 0.63 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.068 -1.254 . . . . 0.0 109.88 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.489 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 11.3 p -99.97 78.14 2.08 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.31 -36.19 0.24 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.155 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.721 HD22 ' HE2' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -109.17 -47.52 3.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.908 -1.348 . . . . 0.0 110.744 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 100' ' ' LEU . 33.7 m-20 54.27 105.79 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.293 -0.88 . . . . 0.0 110.12 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 2' ' ' PRO . 5.4 mt -94.43 -60.96 1.6 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 0.0 110.467 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 159.94 -162.5 33.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 15.7 p80 -151.29 132.39 14.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.295 -1.121 . . . . 0.0 110.261 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.745 HG11 HG12 ' A' ' 6' ' ' VAL . 16.1 t -87.2 130.1 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.188 -0.945 . . . . 0.0 110.011 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.56 123.2 28.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.0 110.16 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.55 HD22 ' CD1' ' A' ' 12' ' ' LEU . 39.4 mt -92.89 170.06 9.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 0.0 110.586 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.552 HG22 ' N ' ' A' ' 109' ' ' PHE . 85.3 m -141.74 171.82 13.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.408 -0.807 . . . . 0.0 109.794 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.573 ' CG ' ' HE2' ' A' ' 69' ' ' LYS . 3.0 m-85 -146.08 115.76 7.24 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.861 . . . . 0.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 N--CA 1.48 0.72 0 N-CA-C 110.133 -0.756 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -140.49 129.57 23.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 110.52 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -148.96 99.23 2.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 0.0 109.538 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.5 p -148.01 148.27 30.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.757 HG12 HG11 ' A' ' 105' ' ' VAL . 10.1 p -106.15 159.52 6.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.622 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -74.15 -71.01 0.23 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.889 -1.132 . . . . 0.0 109.832 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.622 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 55.4 Cg_endo -77.8 84.68 1.94 Allowed 'Trans proline' 0 C--N 1.322 -0.853 0 O-C-N 123.209 1.11 . . . . 0.0 110.366 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 107' ' ' LEU . . . -73.92 -14.2 61.02 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.89 -1.131 . . . . 0.0 109.667 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.8 t -139.58 162.29 35.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.627 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.24 47.49 10.83 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.63 ' CD1' HD22 ' A' ' 107' ' ' LEU . 14.0 mt -101.28 170.67 8.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.383 -1.069 . . . . 0.0 109.962 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 m -145.61 162.16 38.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.041 -1.037 . . . . 0.0 111.012 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.41 125.64 24.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.24 -26.8 7.43 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.467 ' OE1' ' N ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -51.22 138.62 20.28 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.345 -1.091 . . . . 0.0 110.29 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.467 ' N ' ' OE1' ' A' ' 16' ' ' GLN . 1.3 t -99.76 122.13 42.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.464 -0.773 . . . . 0.0 109.88 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 65' ' ' PHE . 34.9 m -98.9 168.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.981 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.7 m -116.44 120.48 38.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.975 . . . . 0.0 110.24 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.78 152.52 8.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.347 -0.845 . . . . 0.0 109.945 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.7 t -142.45 125.0 15.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.758 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 48.2 t -116.01 147.51 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.455 -0.778 . . . . 0.0 109.819 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 3' ' ' ALA . 11.8 t -160.24 153.55 22.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.082 -1.012 . . . . 0.0 110.189 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.34 -47.18 1.07 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -60.22 -154.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.322 -1.105 . . . . 0.0 110.204 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.536 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -176.11 143.57 0.55 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 110.481 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -30.77 130.72 0.1 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.43 0.633 . . . . 0.0 111.236 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.455 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 112.61 6.37 23.38 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.475 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 1.6 mt-10 -131.81 121.37 24.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.12 -1.223 . . . . 0.0 110.278 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.576 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 57.6 m -104.22 147.15 27.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.986 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.672 ' CE1' HD22 ' A' ' 100' ' ' LEU . 16.2 m-85 -134.7 168.66 18.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.909 . . . . 0.0 110.4 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 17.7 m-85 -126.53 118.59 25.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.347 -0.846 . . . . 0.0 109.698 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.66 ' CG2' HG23 ' A' ' 51' ' ' THR . 7.8 tt -98.63 124.37 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 110.555 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.67 155.67 37.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.852 . . . . 0.0 110.235 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.415 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 26.6 tt0 -110.03 142.62 41.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 70.9 m -148.78 163.46 37.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.974 -1.079 . . . . 0.0 110.772 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -146.13 166.16 18.01 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.519 -0.738 . . . . 0.0 109.42 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 43.5 Cg_endo -71.54 163.49 38.83 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.736 1.387 . . . . 0.0 110.464 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 39' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.175 -0.953 . . . . 0.0 110.477 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.242 0.544 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -86.04 173.4 9.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.54 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.0 m -140.76 154.98 46.51 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.027 -1.046 . . . . 0.0 111.061 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.573 ' OD1' ' CG ' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -89.51 116.41 66.27 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.35 -0.844 . . . . 0.0 110.082 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -85.2 -31.17 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.876 1.461 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.11 -10.53 54.71 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.311 -0.868 . . . . 0.0 110.663 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 63.6 p -124.95 25.5 7.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.094 -1.004 . . . . 0.0 110.399 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.79 108.54 18.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.068 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.66 HG23 ' CG2' ' A' ' 33' ' ' ILE . 10.1 t -130.95 157.15 43.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.892 . . . . 0.0 110.421 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.508 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 74.2 p -126.51 152.88 45.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.848 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 12.1 p90 -148.3 -179.6 7.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.422 -0.799 . . . . 0.0 109.549 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.6 m -143.33 161.23 38.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.937 -1.102 . . . . 0.0 110.306 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.621 HG21 ' HB1' ' A' ' 25' ' ' ALA . 21.8 p -65.11 -154.66 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.342 -0.849 . . . . 0.0 109.966 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -160.27 -158.8 0.65 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.142 -0.974 . . . . 0.0 110.422 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.7 -48.71 80.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.889 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.32 9.35 11.08 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.338 -0.852 . . . . 0.0 109.438 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 54.98 51.47 53.45 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.74 152.36 47.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.309 -1.112 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.758 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -141.22 81.79 1.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.577 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.3 m -104.0 118.79 37.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 20.1 p90 -155.16 177.54 11.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.135 -0.978 . . . . 0.0 111.073 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.31 131.3 41.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.644 -0.66 . . . . 0.0 110.445 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.743 ' O ' HG22 ' A' ' 18' ' ' VAL . 59.3 t80 -121.88 137.07 54.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.452 -0.78 . . . . 0.0 108.989 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.5 154.02 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.17 151.66 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.498 -0.751 . . . . 0.0 110.273 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.88 179.29 4.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.177 -0.952 . . . . 0.0 110.73 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.46 ' HG3' ' CE2' ' A' ' 109' ' ' PHE . 24.0 tttm -100.96 -30.43 11.65 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.777 0.799 . . . . 0.0 108.899 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.55 163.92 37.26 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.573 ' CG ' ' OD1' ' A' ' 46' ' ' ASN . 16.6 p90 -170.9 156.57 5.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.913 -1.117 . . . . 0.0 110.031 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 m -71.84 136.98 47.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.185 -0.947 . . . . 0.0 110.715 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.46 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -106.87 162.74 13.46 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.241 -1.152 . . . . 0.0 110.172 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.405 0.621 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' A' ' 44' ' ' ALA . 95.5 t -98.78 160.52 3.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.359 -0.838 . . . . 0.0 109.643 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -153.14 134.82 14.5 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 110.546 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 67.7 m -95.07 14.16 22.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.982 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.06 -45.16 9.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.258 -0.901 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.2 t -98.84 -16.75 18.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.313 -0.867 . . . . 0.0 110.142 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.59 -143.59 0.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.861 . . . . 0.0 110.195 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.39 155.64 35.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 110.01 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.77 125.27 29.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.289 -0.882 . . . . 0.0 109.904 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 20.6 p30 -134.25 137.06 44.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 110.418 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 104' ' ' HIS . 1.4 tp -108.41 137.19 46.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.687 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.545 ' HA3' ' ND1' ' A' ' 104' ' ' HIS . . . -134.72 159.86 24.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -134.34 156.39 48.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.374 -1.074 . . . . 0.0 110.052 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 32' ' ' TYR . . . 142.42 162.99 9.48 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.449 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 14.1 p-10 -133.49 -151.01 0.43 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.203 -1.175 . . . . 0.0 110.455 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 p -91.7 95.1 9.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.307 -0.871 . . . . 0.0 110.274 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 132.91 -18.45 4.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.872 HD23 ' N ' ' A' ' 101' ' ' ASP . 8.0 tt -154.93 151.42 28.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.172 -1.193 . . . . 0.0 110.442 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.872 ' N ' HD23 ' A' ' 100' ' ' LEU . 1.8 p30 -135.6 162.58 32.31 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.375 -0.828 . . . . 0.0 109.796 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.6 mt -119.57 -85.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.102 -0.999 . . . . 0.0 110.397 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.539 ' C ' ' CD2' ' A' ' 104' ' ' HIS . . . -168.84 -169.24 32.0 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.545 ' ND1' ' HA3' ' A' ' 94' ' ' GLY . 38.1 m-70 -142.74 120.49 11.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -1.134 . . . . 0.0 110.234 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.757 HG11 HG12 ' A' ' 6' ' ' VAL . 85.4 t -89.39 129.12 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -0.877 . . . . 0.0 109.853 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.3 112.12 11.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.044 -1.035 . . . . 0.0 110.434 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.63 HD22 ' CD1' ' A' ' 12' ' ' LEU . 72.0 mt -87.58 172.64 9.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 110.037 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.428 ' OG1' ' C ' ' A' ' 107' ' ' LEU . 1.4 m -162.8 159.64 24.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.286 -0.884 . . . . 0.0 110.117 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.46 ' CE2' ' HG3' ' A' ' 69' ' ' LYS . 15.1 m-85 -129.61 164.16 24.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 110.447 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 CA-C-O 117.948 -1.473 . . . . 0.0 109.5 179.991 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.532 ' HG2' ' HA ' ' A' ' 102' ' ' LEU . 45.2 Cg_endo . . . . . 0 N--CA 1.482 0.813 0 N-CA-C 110.283 -0.699 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -119.52 134.71 55.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.247 -0.908 . . . . 0.0 110.559 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.481 ' HD1' HG22 ' A' ' 22' ' ' VAL . 72.7 t80 -151.51 113.62 4.52 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.424 -0.797 . . . . 0.0 109.858 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.61 156.84 42.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.011 -1.056 . . . . 0.0 111.046 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.007 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 4.4 p -118.91 165.26 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.805 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -74.36 -65.25 0.59 Allowed Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.001 -1.062 . . . . 0.0 110.814 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.726 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 41.9 Cg_endo -71.08 -79.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.559 1.294 . . . . 0.0 110.827 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 1.007 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 70.85 19.33 5.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.205 -0.934 . . . . 0.0 110.0 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 t 178.3 148.78 0.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 110.167 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.49 59.71 9.79 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.505 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 1.2 mt -104.39 178.16 4.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.292 -1.123 . . . . 0.0 110.715 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 16' ' ' GLN . 3.2 m -134.35 142.3 47.17 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.416 -0.803 . . . . 0.0 110.015 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 10.0 p-10 -56.93 106.03 0.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.946 . . . . 0.0 110.272 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.45 -45.1 1.32 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.505 ' OE1' ' HA ' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -47.1 157.62 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -1.107 . . . . 0.0 109.703 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -101.09 178.72 4.58 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.361 -0.837 . . . . 0.0 110.443 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.575 HG11 HG11 ' A' ' 67' ' ' VAL . 5.8 m -146.33 152.83 13.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.547 -0.721 . . . . 0.0 109.428 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.506 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -97.41 140.05 32.43 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 109.986 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.413 HG11 ' CZ ' ' A' ' 63' ' ' PHE . 14.7 t -129.1 149.07 33.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.142 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.89 129.07 17.68 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.492 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.794 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 52.1 t -119.92 143.58 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.601 -0.687 . . . . 0.0 109.755 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -155.65 177.55 11.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.048 -1.033 . . . . 0.0 110.307 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.74 -38.69 3.15 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.575 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -67.32 -151.43 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.16 -1.2 . . . . 0.0 110.673 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.599 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -172.84 159.15 4.08 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.224 -0.922 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.885 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -50.45 125.38 12.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.541 -0.725 . . . . 0.0 110.463 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.412 ' O ' ' OE1' ' A' ' 29' ' ' GLU . . . 124.79 13.18 3.79 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 6.5 mm-40 -144.14 120.79 11.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.037 -1.272 . . . . 0.0 110.874 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.421 HG23 ' OG1' ' A' ' 54' ' ' THR . 60.4 m -105.06 132.75 50.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.529 -0.732 . . . . 0.0 109.255 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.852 ' CE1' HD22 ' A' ' 100' ' ' LEU . 31.4 m-85 -120.77 173.86 6.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.956 -1.09 . . . . 0.0 111.246 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -130.27 123.35 29.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.658 -0.651 . . . . 0.0 109.697 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.839 ' CG2' HG23 ' A' ' 51' ' ' THR . 14.3 tt -100.44 125.2 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.131 -0.98 . . . . 0.0 110.651 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.62 146.53 25.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -0.906 . . . . 0.0 110.604 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -98.78 147.69 24.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.854 . . . . 0.0 109.239 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.6 m -144.35 155.9 44.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.028 -1.045 . . . . 0.0 111.512 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.425 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -154.0 141.33 13.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.38 166.19 24.43 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.63 1.332 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.852 HG11 HG22 ' A' ' 84' ' ' VAL . 4.2 m . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.312 -0.867 . . . . 0.0 110.591 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.253 0.549 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.451 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -147.82 145.01 28.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.502 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 18.4 m -128.23 178.21 6.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.015 . . . . 0.0 110.236 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.456 ' O ' ' CG ' ' A' ' 46' ' ' ASN . 15.3 p-10 -101.44 106.02 43.5 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 50.2 Cg_endo -88.12 -39.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.773 1.407 . . . . 0.0 110.65 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.98 -4.6 17.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 110.631 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.404 ' OG1' ' HB2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -130.6 25.34 5.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.092 -1.005 . . . . 0.0 110.144 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.06 143.24 29.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.303 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.839 HG23 ' CG2' ' A' ' 33' ' ' ILE . 2.9 t -148.83 162.63 39.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 0.0 109.897 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.0 p -134.56 154.53 51.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.166 -0.959 . . . . 0.0 110.452 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 11.2 p90 -145.41 -177.6 5.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.758 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.421 ' OG1' HG23 ' A' ' 30' ' ' THR . 24.1 m -149.69 160.35 43.6 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 110.399 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.575 HG21 ' CB ' ' A' ' 25' ' ' ALA . 2.2 p -77.01 -160.94 0.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.35 -0.844 . . . . 0.0 110.487 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.885 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 16.3 p-10 -158.22 -147.38 0.17 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.953 -1.092 . . . . 0.0 111.115 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.569 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -84.72 71.36 10.83 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.056 0.932 . . . . 0.0 108.985 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER 154.67 -13.56 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.793 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.599 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.97 66.12 2.12 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.33 129.37 18.55 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.259 -1.142 . . . . 0.0 110.789 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.794 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -130.17 83.9 2.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 110.007 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.4 m -100.35 123.76 44.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.544 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 6.9 p90 -158.77 176.04 12.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.24 -0.912 . . . . 0.0 110.556 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.2 t -101.66 158.7 15.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.721 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 85.7 t80 -147.02 -176.88 5.38 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.562 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.8 t -133.58 158.46 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.386 -1.446 . . . . 0.0 110.5 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.575 HG11 HG11 ' A' ' 18' ' ' VAL . 20.4 m -130.32 159.75 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.782 . . . . 0.0 109.471 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 13.4 mtm180 -143.63 112.01 6.36 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.373 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 68' ' ' ARG . 4.5 ttpm? -44.72 -50.33 10.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 108.875 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.08 111.02 17.77 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 36.1 p90 -121.26 131.84 54.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.213 -0.929 . . . . 0.0 110.816 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 26.1 m -61.64 124.38 20.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.451 -0.781 . . . . 0.0 110.303 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.4 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -95.69 -166.14 34.7 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 110.517 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.7 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.159 0.504 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.852 HG22 HG11 ' A' ' 39' ' ' VAL . 98.8 t -108.62 102.08 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.231 -0.918 . . . . 0.0 109.904 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.8 OUTLIER -98.82 120.32 39.06 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.417 -0.802 . . . . 0.0 109.575 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.82 37.26 0.58 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 110.717 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.59 -36.83 43.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.166 -0.958 . . . . 0.0 109.3 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.9 t -109.91 -11.5 14.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.433 -0.792 . . . . 0.0 109.48 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.06 -171.15 1.79 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.396 -0.815 . . . . 0.0 110.158 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.19 128.33 49.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.928 . . . . 0.0 110.14 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.1 m -93.78 151.79 19.37 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.102 -0.999 . . . . 0.0 109.861 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -142.88 123.89 14.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 110.694 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.552 HD11 HG12 ' A' ' 33' ' ' ILE . 16.4 tp -92.49 112.65 24.68 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.542 ' HA3' ' NE2' ' A' ' 104' ' ' HIS . . . -115.44 166.67 12.24 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.253 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.709 ' HB1' HD12 ' A' ' 102' ' ' LEU . . . -144.56 162.96 35.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.515 -0.991 . . . . 0.0 110.062 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 130.14 176.06 14.28 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.484 ' OD1' ' HB3' ' A' ' 100' ' ' LEU . 8.3 p-10 -128.89 -156.16 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.249 . . . . 0.0 110.57 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.71 82.25 7.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.536 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 139.8 -35.87 1.88 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.852 HD22 ' CE1' ' A' ' 31' ' ' TYR . 4.7 tt -115.2 145.45 42.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -1.18 . . . . 0.0 110.336 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.8 121.61 32.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 110.061 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.709 HD12 ' HB1' ' A' ' 95' ' ' ALA . 20.2 mt -77.18 -71.49 0.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.929 . . . . 0.0 110.12 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.36 -173.02 42.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.542 ' NE2' ' HA3' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -147.81 112.28 5.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -1.052 . . . . 0.0 109.895 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.427 HG11 ' CG1' ' A' ' 6' ' ' VAL . 17.5 t -96.12 121.74 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.174 -0.954 . . . . 0.0 110.339 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.46 132.76 43.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.102 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.9 mt -104.81 141.57 36.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.258 -0.901 . . . . 0.0 110.478 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 109' ' ' PHE . 8.7 m -119.07 171.39 8.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.858 . . . . 0.0 109.859 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.401 ' N ' HG22 ' A' ' 108' ' ' THR . 8.8 m-85 -147.73 85.98 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.231 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 CA-C-O 118.007 -1.44 . . . . 0.0 109.504 179.91 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.511 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.6 Cg_endo . . . . . 0 N--CA 1.485 1.004 0 N-CA-C 110.609 -0.574 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -155.85 141.9 18.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.202 -0.936 . . . . 0.0 110.718 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.602 ' CE2' ' CB ' ' A' ' 95' ' ' ALA . 25.2 t80 -150.24 116.92 5.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 t -150.41 164.92 34.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.9 -1.125 . . . . 0.0 111.355 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.961 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 4.8 p -122.2 176.16 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.602 -0.686 . . . . 0.0 109.662 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.6 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.3 m -78.19 -67.54 0.26 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.005 -1.059 . . . . 0.0 110.534 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.738 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 42.8 Cg_endo -72.81 -79.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.929 0 O-C-N 123.358 1.188 . . . . 0.0 110.629 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.961 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 72.66 28.37 2.15 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.355 -0.841 . . . . 0.0 110.513 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER 171.05 119.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.19 -0.944 . . . . 0.0 110.231 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.56 66.63 2.02 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 109' ' ' PHE . 1.5 mp -104.02 159.25 15.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -1.168 . . . . 0.0 110.537 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.502 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 29.0 t -107.76 151.3 25.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 110.028 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.4 127.87 33.27 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.225 -0.922 . . . . 0.0 111.164 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.66 -27.64 6.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 2.4 tt0 -52.35 141.89 18.48 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.291 -1.123 . . . . 0.0 110.596 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.54 148.98 22.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.358 -0.839 . . . . 0.0 109.869 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.528 HG12 ' HG3' ' A' ' 8' ' ' PRO . 24.4 m -129.76 179.76 3.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.794 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.19 134.72 55.22 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.382 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.486 HG11 ' CD1' ' A' ' 33' ' ' ILE . 4.8 t -114.94 150.71 16.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -146.91 124.72 11.9 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.096 -1.003 . . . . 0.0 110.865 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 87.0 t -113.04 141.3 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.575 -0.703 . . . . 0.0 109.579 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.712 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -158.64 144.96 17.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.073 . . . . 0.0 110.666 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 118.85 -54.1 0.64 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.513 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -59.07 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -1.134 . . . . 0.0 109.833 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.544 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.48 169.99 8.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.066 -1.021 . . . . 0.0 110.323 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -59.97 131.69 51.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.532 -0.73 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.15 16.25 4.0 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.516 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 65.5 mm-40 -149.24 132.72 16.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.166 -1.196 . . . . 0.0 110.385 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.434 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 3.6 m -104.28 162.96 12.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.354 -0.841 . . . . 0.0 110.13 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.771 ' CE1' HD13 ' A' ' 100' ' ' LEU . 74.8 m-85 -150.84 173.23 14.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.207 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 52.8 m-85 -133.97 102.88 5.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 109.324 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.839 ' CG2' HG23 ' A' ' 51' ' ' THR . 8.5 tt -89.56 107.95 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.941 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.424 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -147.95 157.22 43.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.158 -0.964 . . . . 0.0 110.803 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.509 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 2.0 tt0 -95.69 123.56 39.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.645 -0.659 . . . . 0.0 109.88 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.429 ' HA ' ' OH ' ' A' ' 71' ' ' TYR . 1.2 m -137.42 154.1 50.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.235 -0.916 . . . . 0.0 110.101 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.522 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -146.59 166.79 15.52 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 0.0 109.247 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 41.4 Cg_endo -69.38 159.03 55.27 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.556 1.293 . . . . 0.0 110.633 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.673 HG12 HG22 ' A' ' 84' ' ' VAL . 16.1 m . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.468 -0.77 . . . . 0.0 110.026 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 4.8 p30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.358 0.599 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.74 157.81 15.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.902 . . . . 0.0 109.755 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.488 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 5.8 t -135.55 165.99 24.24 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.041 -1.037 . . . . 0.0 110.295 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.546 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -83.65 111.65 33.74 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.204 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 48.9 Cg_endo -77.87 -37.53 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.893 1.47 . . . . 0.0 110.32 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.63 98.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.886 . . . . 0.0 110.493 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.48 HG21 ' NE ' ' A' ' 68' ' ' ARG . 1.2 p -96.32 3.38 53.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.261 -0.899 . . . . 0.0 110.425 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -65.85 129.25 39.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.139 -0.975 . . . . 0.0 109.85 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.839 HG23 ' CG2' ' A' ' 33' ' ' ILE . 1.3 t -128.24 131.58 48.78 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.13 -0.982 . . . . 0.0 110.762 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.37 138.14 40.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.445 -0.784 . . . . 0.0 109.393 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 15.8 p90 -141.76 172.21 13.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.051 -1.03 . . . . 0.0 110.547 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.5 m -133.87 162.41 32.11 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 109.375 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.513 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -75.77 -164.74 0.38 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.914 -1.116 . . . . 0.0 110.384 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 27' ' ' ALA . 5.7 m-20 -145.34 -158.31 0.88 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.18 -0.95 . . . . 0.0 109.575 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.27 -50.04 75.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.902 -1.124 . . . . 0.0 109.53 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.4 t -90.36 21.06 4.05 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.349 -0.844 . . . . 0.0 108.813 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.544 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 49.81 32.0 17.39 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.33 140.73 41.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.371 -1.076 . . . . 0.0 110.483 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -145.59 84.96 1.69 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.411 -0.806 . . . . 0.0 109.704 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -99.99 120.95 40.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 109.983 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.2 p90 -150.63 178.39 9.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.223 -0.923 . . . . 0.0 110.831 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.8 p -96.62 139.12 33.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.46 -0.775 . . . . 0.0 111.016 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 50.2 t80 -131.15 176.17 8.49 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.561 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.8 t -124.61 157.09 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 120.727 -1.233 . . . . 0.0 110.299 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 67' ' ' VAL . 13.8 m -134.9 128.35 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.397 -0.814 . . . . 0.0 109.904 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.48 ' NE ' HG21 ' A' ' 49' ' ' THR . 0.0 OUTLIER -115.82 144.38 44.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 110.343 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -56.94 -39.68 75.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.394 -0.816 . . . . 0.0 109.796 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.74 165.54 33.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.418 -0.801 . . . . 0.0 109.828 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.522 ' CB ' ' OD1' ' A' ' 46' ' ' ASN . 19.2 p90 -166.9 147.41 5.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 110.361 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.6 OUTLIER -66.18 118.58 10.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.038 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.48 179.81 25.7 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.287 -1.125 . . . . 0.0 110.055 -179.925 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 11.5 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.344 0.592 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.673 HG22 HG12 ' A' ' 39' ' ' VAL . 72.9 t -133.6 162.04 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.9 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 16.7 p-10 -160.43 161.97 33.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.963 . . . . 0.0 110.302 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 96.7 m -97.95 11.14 38.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.313 -0.867 . . . . 0.0 110.331 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.96 -42.03 14.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.19 -0.944 . . . . 0.0 110.34 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.418 HG22 ' OD2' ' A' ' 85' ' ' ASP . 13.4 t -113.49 -1.08 14.23 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.157 -0.965 . . . . 0.0 110.384 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.51 135.67 44.56 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.241 -0.912 . . . . 0.0 110.61 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.77 105.41 5.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.973 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.487 ' CB ' ' HB2' ' A' ' 37' ' ' ALA . 26.7 p -99.39 140.16 33.98 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.086 -1.009 . . . . 0.0 109.66 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.484 ' OD1' ' HA ' ' A' ' 106' ' ' ALA . 19.1 m-20 -131.05 143.29 50.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.114 -0.991 . . . . 0.0 110.837 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.495 ' HB2' HD11 ' A' ' 107' ' ' LEU . 22.6 tp -88.41 99.41 12.25 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.07 165.45 27.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.731 ' O ' HD12 ' A' ' 102' ' ' LEU . . . -152.28 80.04 1.24 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.412 -1.051 . . . . 0.0 110.386 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -137.25 -167.59 11.12 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.477 ' O ' ' OG ' ' A' ' 98' ' ' SER . 2.2 p-10 -129.4 -63.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.246 . . . . 0.0 110.627 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 97' ' ' ASN . 19.6 m -170.83 -32.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.125 -0.984 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.77 -13.23 5.15 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.712 -1.233 . . . . 0.0 110.411 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.771 HD13 ' CE1' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -94.87 -52.39 4.27 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.972 -1.31 . . . . 0.0 110.532 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.0 p-10 40.61 98.29 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.701 0.762 . . . . 0.0 110.73 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 95' ' ' ALA . 6.7 mt -84.45 -45.44 12.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.016 -1.052 . . . . 0.0 110.104 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.56 -161.82 30.0 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -155.06 142.35 19.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -1.153 . . . . 0.0 110.181 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.47 103.8 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.189 -0.944 . . . . 0.0 110.146 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.484 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . . . -50.62 103.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.893 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.509 ' CD1' ' OE1' ' A' ' 35' ' ' GLN . 54.0 mt -82.83 137.01 34.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 110.144 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.9 167.5 10.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.811 . . . . 0.0 110.092 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 12' ' ' LEU . 3.2 m-85 -142.04 166.83 23.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.927 . . . . 0.0 110.324 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.35 0 CA-C-O 118.008 -1.44 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.515 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 48.2 Cg_endo . . . . . 0 C--O 1.216 -0.589 0 N-CA-C 110.206 -0.728 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.498 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -145.71 145.75 31.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.078 -1.014 . . . . 0.0 110.302 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 39.0 t80 -151.29 113.04 4.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.226 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.47 151.53 36.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.683 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 19' ' ' SER . 9.2 p -128.48 149.19 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.776 . . . . 0.0 109.743 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -67.27 -66.59 1.14 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.052 -1.03 . . . . 0.0 110.191 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.711 ' HB2' HD21 ' A' ' 12' ' ' LEU . 50.4 Cg_endo -75.65 95.29 1.0 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.46 1.242 . . . . 0.0 110.233 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.83 10.56 32.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.097 -1.002 . . . . 0.0 110.311 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.1 t -168.64 154.54 6.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.899 . . . . 0.0 110.084 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.99 56.49 10.65 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.711 HD21 ' HB2' ' A' ' 8' ' ' PRO . 2.7 mt -109.59 166.05 11.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -1.126 . . . . 0.0 110.15 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -128.53 164.34 23.01 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.237 -0.915 . . . . 0.0 110.28 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -62.26 125.45 23.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.316 -0.865 . . . . 0.0 109.94 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 89.61 -31.05 5.38 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.69 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.5 tm0? -42.4 143.9 0.58 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.417 -1.049 . . . . 0.0 110.014 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.463 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 2.1 p -95.55 167.61 11.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 110.287 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 65' ' ' PHE . 30.6 m -147.82 168.21 4.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.323 -0.861 . . . . 0.0 109.762 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.825 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -117.04 137.68 52.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.161 -0.962 . . . . 0.0 110.242 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 t -126.32 152.57 33.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.444 -0.785 . . . . 0.0 109.81 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.11 127.55 14.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.381 -0.824 . . . . 0.0 110.169 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.795 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 10.9 t -119.28 147.63 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.322 -0.861 . . . . 0.0 110.077 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 3' ' ' ALA . 6.2 p -155.52 131.99 10.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.132 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 131.21 -54.28 0.79 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.803 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -58.73 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -1.123 . . . . 0.0 109.074 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.95 156.92 6.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.732 -1.23 . . . . 0.0 110.712 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -43.85 133.08 5.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.7 -0.625 . . . . 0.0 110.133 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 29' ' ' GLU . . . 115.28 11.95 10.26 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 1.8 mt-10 -141.94 116.59 9.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.335 -1.097 . . . . 0.0 110.191 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.2 m -104.21 134.01 48.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.757 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 29' ' ' GLU . 27.4 m-85 -117.88 -174.94 2.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.966 . . . . 0.0 110.81 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 34.5 m-85 -136.07 111.31 9.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.522 -0.736 . . . . 0.0 109.399 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.705 ' CG2' HG23 ' A' ' 51' ' ' THR . 3.8 tt -86.86 112.96 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.888 . . . . 0.0 110.773 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.411 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -148.34 162.95 38.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.533 -0.729 . . . . 0.0 109.887 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 14.8 pt20 -116.29 146.07 42.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.925 . . . . 0.0 110.718 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.6 m -137.81 150.79 47.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.264 -0.897 . . . . 0.0 110.169 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.992 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.32 173.28 4.44 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.304 -0.873 . . . . 0.0 109.264 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.763 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 41.5 Cg_endo -67.71 165.02 29.03 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.736 1.387 . . . . 0.0 110.123 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 39' ' ' VAL . 15.0 p . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.408 0.623 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.473 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -105.79 160.05 15.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.643 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -134.92 162.92 31.05 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.024 -1.047 . . . . 0.0 110.633 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.484 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 3.9 m120 -89.34 115.79 64.65 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.855 . . . . 0.0 110.134 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -90.08 -50.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.896 1.472 . . . . 0.0 111.254 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.98 79.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.389 -0.819 . . . . 0.0 111.52 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 22.4 p -82.7 19.25 1.35 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.09 -1.006 . . . . 0.0 111.108 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -87.1 67.63 9.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.973 -1.08 . . . . 0.0 109.94 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.705 HG23 ' CG2' ' A' ' 33' ' ' ILE . 2.6 t -79.82 164.34 23.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.359 -0.838 . . . . 0.0 110.432 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 94.2 p -118.44 143.39 46.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.289 -0.882 . . . . 0.0 110.769 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.472 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 31.0 p90 -140.55 128.88 22.49 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.274 -0.891 . . . . 0.0 109.962 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 9.3 m -92.15 168.57 11.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 110.829 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.803 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -78.1 -158.89 0.14 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.465 -0.772 . . . . 0.0 110.339 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.37 -161.71 1.23 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.058 -1.026 . . . . 0.0 109.916 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.27 -53.81 54.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.023 -1.048 . . . . 0.0 109.158 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.4 p -84.41 11.36 8.67 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.472 -0.767 . . . . 0.0 109.075 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.533 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 69.91 13.42 69.34 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.21 121.28 28.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -1.123 . . . . 0.0 110.02 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.795 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -118.25 80.79 1.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.977 . . . . 0.0 110.499 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.82 129.63 48.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -0.972 . . . . 0.0 109.924 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 14.8 p90 -168.19 161.49 12.38 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.458 -0.776 . . . . 0.0 110.358 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 m -92.33 133.57 35.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.198 -0.939 . . . . 0.0 110.624 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.81 ' O ' HG22 ' A' ' 18' ' ' VAL . 29.2 t80 -121.73 155.35 35.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 109.323 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.573 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 3.5 t -96.96 160.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.805 -1.184 . . . . 0.0 110.521 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 16' ' ' GLN . 29.7 m -131.77 177.24 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 0.0 109.989 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 2.3 mtt180 -150.35 135.69 17.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 0.0 110.501 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 87' ' ' ALA . 0.9 OUTLIER -67.67 -16.88 64.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -0.961 . . . . 0.0 109.234 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.8 p -150.34 156.39 41.43 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.56 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 16.7 p90 -163.72 144.1 8.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.981 -1.074 . . . . 0.0 110.54 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 28.5 m -65.89 132.93 49.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.892 . . . . 0.0 110.026 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.403 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -112.69 -177.59 19.74 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.9 p . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.192 -1.181 . . . . 0.0 110.188 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.8 m . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.404 0.621 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.473 HG21 ' CB ' ' A' ' 44' ' ' ALA . 54.6 t -128.97 162.27 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.455 -0.778 . . . . 0.0 110.044 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.431 ' N ' HG12 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -138.73 102.06 4.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.218 -0.926 . . . . 0.0 110.46 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 2.7 m -74.52 -2.63 26.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.298 -0.876 . . . . 0.0 110.232 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 69' ' ' LYS . . . -46.72 -45.25 19.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.192 -0.942 . . . . 0.0 109.906 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.1 t -116.69 -10.81 11.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.908 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -94.09 -177.27 4.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.116 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.61 131.84 53.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.903 . . . . 0.0 110.068 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.992 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -127.29 139.49 52.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' A' ' 106' ' ' ALA . 16.0 m-80 -103.85 125.81 50.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.973 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.849 ' HB2' HD11 ' A' ' 107' ' ' LEU . 11.7 tp -88.7 101.96 14.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -108.12 171.57 16.17 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -156.67 120.98 4.43 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.437 -1.037 . . . . 0.0 110.297 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.37 176.36 47.95 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -115.8 -76.89 0.57 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -1.135 . . . . 0.0 109.849 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -168.19 -37.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.408 -0.808 . . . . 0.0 110.097 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.38 -12.14 57.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.637 HD13 ' C ' ' A' ' 100' ' ' LEU . 2.2 tm? -148.5 90.17 1.77 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -1.161 . . . . 0.0 110.053 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.18 134.86 34.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.478 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 4' ' ' PHE . 71.0 mt -82.69 -70.76 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 0.0 110.034 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.415 ' C ' ' CG ' ' A' ' 104' ' ' HIS . . . 168.38 -162.3 36.07 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.459 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -147.96 129.22 14.7 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.482 -1.011 . . . . 0.0 109.612 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.76 HG11 HG12 ' A' ' 6' ' ' VAL . 93.5 t -98.3 108.48 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.092 -1.005 . . . . 0.0 110.6 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.4 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . . . -57.53 105.51 0.25 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.234 -0.916 . . . . 0.0 110.024 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.849 HD11 ' HB2' ' A' ' 93' ' ' LEU . 59.4 mt -82.64 164.51 20.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.24 -0.912 . . . . 0.0 110.374 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.5 m -133.15 168.13 19.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.267 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -153.33 167.35 29.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 CA-C-O 117.949 -1.473 . . . . 0.0 109.522 179.988 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.478 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 45.3 Cg_endo . . . . . 0 N--CA 1.48 0.698 0 N-CA-C 110.144 -0.752 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.893 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -134.4 134.98 42.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.047 -1.033 . . . . 0.0 110.581 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 8.1 t80 -141.24 115.45 9.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.468 -0.77 . . . . 0.0 109.531 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.589 ' HA ' HG21 ' A' ' 105' ' ' VAL . 4.0 t -153.1 172.54 16.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.077 -1.014 . . . . 0.0 110.811 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.999 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 12.0 p -120.8 144.97 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.662 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.583 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -54.66 -62.22 4.46 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.276 -0.89 . . . . 0.0 111.082 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.864 ' HD2' HG22 ' A' ' 6' ' ' VAL . 42.5 Cg_endo -71.85 -78.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.781 1.411 . . . . 0.0 110.629 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.999 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 69.13 14.68 8.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.015 . . . . 0.0 109.879 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.4 t -170.77 148.24 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.336 -0.852 . . . . 0.0 110.297 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.02 56.87 22.28 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.573 ' HB2' ' CE1' ' A' ' 109' ' ' PHE . 58.6 mt -98.28 166.47 11.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -1.129 . . . . 0.0 110.091 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.468 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -129.49 155.65 45.39 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.223 -0.923 . . . . 0.0 110.108 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.526 ' OD2' ' CD ' ' A' ' 68' ' ' ARG . 6.9 t70 -61.68 115.97 4.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 110.387 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 94.24 -28.45 10.79 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 0.2 OUTLIER -41.75 144.02 0.45 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.31 -1.112 . . . . 0.0 110.483 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 p -95.35 125.49 40.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.826 . . . . 0.0 110.193 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.667 HG11 HG11 ' A' ' 67' ' ' VAL . 35.7 m -104.38 -179.07 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.387 -0.82 . . . . 0.0 110.184 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -136.14 114.61 11.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.786 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.4 t -91.4 152.79 3.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.405 -0.81 . . . . 0.0 110.483 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 t -147.41 130.89 16.71 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.474 -0.766 . . . . 0.0 109.331 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.986 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 87.9 t -128.54 136.56 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.111 -0.993 . . . . 0.0 110.671 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.548 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 3.3 m -131.51 110.54 11.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.421 -0.799 . . . . 0.0 109.873 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 155.5 -58.14 0.39 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.868 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -57.9 -159.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -1.175 . . . . 0.0 109.664 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.562 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -166.21 159.45 15.14 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.899 -1.126 . . . . 0.0 111.014 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -42.06 136.98 1.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.717 -0.614 . . . . 0.0 110.576 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.41 -6.95 42.6 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.489 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 3.3 mm-40 -114.09 103.52 11.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -1.142 . . . . 0.0 110.26 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 53' ' ' PHE . 97.1 m -103.82 121.24 42.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.314 -0.866 . . . . 0.0 109.627 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.683 ' OH ' ' HB1' ' A' ' 25' ' ' ALA . 9.9 m-85 -107.0 -170.19 1.67 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 0.0 110.662 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 50.0 m-85 -131.58 111.54 11.83 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.491 -0.755 . . . . 0.0 109.505 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.479 HG22 HG23 ' A' ' 51' ' ' THR . 1.1 tt -89.63 137.06 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.074 -1.016 . . . . 0.0 111.215 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.402 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -153.83 155.06 35.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.497 -0.752 . . . . 0.0 110.267 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -98.59 146.7 25.56 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.224 -0.923 . . . . 0.0 110.463 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 t -156.69 145.5 20.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.094 -1.004 . . . . 0.0 111.186 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.408 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -147.23 142.08 16.54 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.09 165.33 32.25 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 O-C-N 123.73 1.384 . . . . 0.0 110.79 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 39' ' ' VAL . 18.7 m . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.435 -0.79 . . . . 0.0 109.719 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 t0 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.104 0.478 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -130.26 120.59 24.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.138 -0.976 . . . . 0.0 110.022 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.34 155.58 30.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.98 -1.075 . . . . 0.0 110.707 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -106.61 119.88 50.2 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.434 -0.791 . . . . 0.0 109.8 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -80.35 -22.81 6.65 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.882 1.464 . . . . 0.0 110.692 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.61 -37.82 85.68 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.192 -0.943 . . . . 0.0 110.593 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.9 p -91.99 23.08 3.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.24 -0.912 . . . . 0.0 110.489 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 82.37 4.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 110.567 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.479 HG23 HG22 ' A' ' 33' ' ' ILE . 4.0 t -106.7 170.37 7.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.893 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.545 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 52.8 p -118.46 147.68 43.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.027 -1.046 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.546 ' CE1' ' HB2' ' A' ' 31' ' ' TYR . 5.5 p90 -148.24 -179.19 6.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 109.006 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.405 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 3.1 t -157.33 170.93 21.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.875 -1.14 . . . . 0.0 110.928 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.868 HG21 ' HB3' ' A' ' 25' ' ' ALA . 1.5 p -81.03 -155.66 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.461 -0.774 . . . . 0.0 109.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.638 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 4.1 p-10 -157.22 -153.62 0.42 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.728 -1.232 . . . . 0.0 110.803 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 -60.61 3.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.079 -1.013 . . . . 0.0 109.947 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -66.37 -6.76 15.43 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.89 7.23 69.69 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -91.55 119.28 31.34 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.137 -1.213 . . . . 0.0 110.176 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.986 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -92.61 82.27 4.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.893 . . . . 0.0 109.862 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.68 124.47 51.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.28 -0.888 . . . . 0.0 109.897 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -162.78 172.55 15.05 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.675 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.0 t -95.26 130.04 42.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.343 -0.848 . . . . 0.0 110.44 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 91.1 t80 -122.01 172.82 7.95 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.584 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -116.13 152.99 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.622 -1.298 . . . . 0.0 109.945 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.667 HG11 HG11 ' A' ' 18' ' ' VAL . 36.0 m -134.33 169.26 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.2 -0.938 . . . . 0.0 110.597 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.526 ' CD ' ' OD2' ' A' ' 14' ' ' ASP . 2.0 mmm-85 -139.59 164.64 29.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.823 . . . . 0.0 109.824 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -93.42 -54.04 3.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.177 -0.952 . . . . 0.0 110.04 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.01 129.27 47.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.288 -0.883 . . . . 0.0 109.88 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 10.0 p90 -138.23 139.88 39.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 0.0 110.492 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -65.72 114.84 5.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 110.032 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.527 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -85.07 170.65 45.49 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 95.7 p . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.218 -1.166 . . . . 0.0 110.574 179.958 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.164 0.507 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.532 HG11 ' CZ ' ' A' ' 71' ' ' TYR . 36.7 t -105.45 137.75 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.818 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.895 ' OD2' ' HB3' ' A' ' 87' ' ' ALA . 6.7 t70 -134.21 135.6 43.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.096 -1.002 . . . . 0.0 110.001 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -86.07 -4.75 59.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.895 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . . . -65.27 -62.28 1.63 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.304 -0.872 . . . . 0.0 110.652 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.0 t -92.23 3.56 55.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.937 . . . . 0.0 110.46 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 85' ' ' ASP . . . -132.36 -176.4 4.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 110.094 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.87 141.38 51.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 110.172 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 61.8 m -106.85 171.78 7.18 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.907 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -151.22 119.35 6.29 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.305 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.534 ' HB2' HD11 ' A' ' 107' ' ' LEU . 21.7 tp -94.12 101.65 13.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.685 ' HA3' ' CD2' ' A' ' 104' ' ' HIS . . . -108.27 167.24 13.18 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.375 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -147.61 160.26 42.86 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.653 -0.91 . . . . 0.0 109.715 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.57 173.99 44.41 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.957 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 31' ' ' TYR . 24.7 t30 -141.0 169.21 18.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.447 -1.031 . . . . 0.0 110.031 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.91 84.42 0.32 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.243 -0.911 . . . . 0.0 110.426 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.37 -19.43 5.67 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.448 ' HA ' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -146.85 99.6 3.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.002 -1.293 . . . . 0.0 110.881 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.468 ' O ' HD23 ' A' ' 102' ' ' LEU . 6.6 m-20 -92.66 -173.21 3.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.273 -0.892 . . . . 0.0 109.814 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 101' ' ' ASP . 84.4 mt -142.54 -86.36 0.15 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.027 -1.045 . . . . 0.0 110.711 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.74 -169.73 39.8 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.685 ' CD2' ' HA3' ' A' ' 94' ' ' GLY . 7.1 m80 -133.76 140.4 46.93 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.227 -1.161 . . . . 0.0 110.852 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' A' ' 5' ' ' SER . 0.9 OUTLIER -97.75 121.3 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.66 103.79 2.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.812 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 93' ' ' LEU . 68.4 mt -75.16 170.54 15.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.367 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.76 149.12 44.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 110.374 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 12' ' ' LEU . 1.3 m-85 -139.17 91.05 2.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.116 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.51 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 44.8 Cg_endo . . . . . 0 C--O 1.214 -0.705 0 N-CA-C 110.131 -0.757 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -137.3 93.6 2.84 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.935 -1.103 . . . . 0.0 111.281 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -112.62 106.04 14.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.071 -1.018 . . . . 0.0 109.614 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.9 m -151.08 155.82 39.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.944 -1.098 . . . . 0.0 111.112 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.847 HG22 ' HD2' ' A' ' 8' ' ' PRO . 7.5 p -109.41 160.55 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.467 -0.771 . . . . 0.0 109.708 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.582 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -80.16 -59.55 0.53 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.052 . . . . 0.0 110.206 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.847 ' HD2' HG22 ' A' ' 6' ' ' VAL . 54.0 Cg_endo -80.22 74.43 5.55 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.629 1.331 . . . . 0.0 110.38 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.98 -14.42 60.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.019 -1.05 . . . . 0.0 110.065 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.0 m -138.98 178.86 6.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 110.057 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.58 45.64 76.74 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.507 HD21 ' O ' ' A' ' 8' ' ' PRO . 21.5 mt -89.34 159.81 17.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -1.085 . . . . 0.0 110.192 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -129.63 145.91 51.46 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.318 -0.864 . . . . 0.0 110.212 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 69' ' ' LYS . 13.1 p-10 -57.21 111.18 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.44 -32.92 6.99 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 55.5 tt0 -49.0 155.49 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -1.163 . . . . 0.0 110.383 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.54 ' O ' HG13 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -97.04 -178.16 4.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.371 -0.831 . . . . 0.0 110.568 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.843 HG22 ' O ' ' A' ' 65' ' ' PHE . 25.1 m -156.57 170.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.511 -0.743 . . . . 0.0 109.508 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 m -120.06 123.85 44.42 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.945 -1.097 . . . . 0.0 110.688 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.6 143.01 22.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.441 -0.787 . . . . 0.0 109.657 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.47 133.8 33.19 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.795 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 56.7 t -123.35 111.9 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.464 -0.773 . . . . 0.0 109.913 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -130.22 116.09 17.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.105 -0.997 . . . . 0.0 110.487 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 150.04 -29.57 1.11 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.425 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -79.95 -147.27 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -1.136 . . . . 0.0 110.195 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.565 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -175.19 142.17 0.6 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.027 -1.046 . . . . 0.0 111.145 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.05 132.1 1.03 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.414 0.626 . . . . 0.0 110.699 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.443 ' O ' ' OE2' ' A' ' 29' ' ' GLU . . . 118.35 6.1 12.28 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' OE2' ' O ' ' A' ' 28' ' ' GLY . 53.1 mm-40 -140.11 119.28 12.8 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.217 -1.166 . . . . 0.0 110.521 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.51 HG23 ' OG1' ' A' ' 54' ' ' THR . 5.2 m -101.32 133.84 45.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.43 -0.794 . . . . 0.0 109.491 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.614 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 39.0 m-85 -121.15 -172.52 2.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.085 -1.009 . . . . 0.0 111.032 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.506 ' CD1' ' HB2' ' A' ' 52' ' ' SER . 68.0 m-85 -130.25 160.63 33.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.607 -0.683 . . . . 0.0 109.633 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 33' ' ' ILE . 4.5 tt -145.66 116.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.067 -1.021 . . . . 0.0 110.391 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.825 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -151.35 169.95 20.72 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.151 -0.968 . . . . 0.0 111.052 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -104.15 160.08 15.15 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.515 -0.741 . . . . 0.0 109.386 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -160.98 141.53 11.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.021 -1.05 . . . . 0.0 111.385 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -140.51 154.53 69.45 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.98 164.59 34.2 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.622 1.327 . . . . 0.0 111.121 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.49 HG11 ' HB2' ' A' ' 44' ' ' ALA . 11.6 m . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.661 0.743 . . . . 0.0 109.919 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.357 0.599 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.877 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -129.99 130.2 44.71 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -117.8 159.57 22.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 110.276 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.47 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 6.0 t-20 -90.77 117.51 67.99 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 0.0 110.363 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -81.19 -34.11 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.855 1.45 . . . . 0.0 110.636 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.71 95.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.255 -0.903 . . . . 0.0 110.342 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.47 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 6.4 p -88.31 20.71 3.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.364 -0.835 . . . . 0.0 110.063 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.23 132.25 37.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.0 110.086 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.58 HG23 ' CG2' ' A' ' 33' ' ' ILE . 9.8 t -161.96 159.05 26.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.297 -0.877 . . . . 0.0 109.983 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.506 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 33.5 t -127.99 161.23 29.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.188 -0.945 . . . . 0.0 110.431 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.614 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 33.8 p90 -146.99 -176.41 5.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.294 -0.879 . . . . 0.0 110.381 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.51 ' OG1' HG23 ' A' ' 30' ' ' THR . 29.3 m -141.48 154.08 45.32 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.502 ' HB ' ' HA2' ' A' ' 59' ' ' GLY . 43.1 p -63.24 -150.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.067 -1.02 . . . . 0.0 110.429 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.783 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -152.5 -161.03 1.22 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.187 -0.946 . . . . 0.0 110.292 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.63 -53.38 58.15 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 109.176 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 p -87.95 15.9 6.65 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 62.41 39.05 97.28 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -117.09 106.17 13.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -1.087 . . . . 0.0 110.231 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.506 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -107.06 89.73 3.09 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.505 -0.747 . . . . 0.0 110.094 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.6 p -112.01 128.42 56.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.819 . . . . 0.0 109.554 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -153.08 176.38 11.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.126 -0.984 . . . . 0.0 110.824 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 p -94.59 141.43 28.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.33 -0.856 . . . . 0.0 110.521 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.843 ' O ' HG22 ' A' ' 18' ' ' VAL . 75.0 t80 -133.36 162.35 32.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.458 -0.777 . . . . 0.0 109.575 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.476 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 21.6 t -112.13 168.19 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 120.731 -1.231 . . . . 0.0 110.801 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.633 HG11 HG11 ' A' ' 18' ' ' VAL . 25.1 m -138.08 174.99 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.401 -0.812 . . . . 0.0 110.382 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -148.88 145.81 27.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.31 -0.868 . . . . 0.0 110.121 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 3.2 ttpt -65.8 -51.49 58.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.995 . . . . 0.0 109.464 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.433 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 96.0 p -135.45 165.86 24.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 109.617 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.732 ' CZ ' HG11 ' A' ' 84' ' ' VAL . 37.7 p90 -170.26 150.96 3.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.086 -1.009 . . . . 0.0 110.223 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -68.52 113.39 6.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.225 -0.922 . . . . 0.0 110.094 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.877 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -59.24 -175.79 0.82 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.433 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 12.1 m . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.312 -1.11 . . . . 0.0 110.62 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.3 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.15 0.5 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.732 HG11 ' CZ ' ' A' ' 71' ' ' TYR . 5.9 t -141.39 156.99 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.333 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.794 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 23.8 m-20 -146.68 149.43 33.46 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.433 -0.792 . . . . 0.0 109.789 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 68.8 m -114.35 -13.8 12.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.85 -56.59 16.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.233 -0.917 . . . . 0.0 110.816 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.471 ' H ' HG22 ' A' ' 88' ' ' THR . 3.3 t -100.74 -13.02 18.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.065 -1.022 . . . . 0.0 110.784 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' A' ' 85' ' ' ASP . . . -91.32 -141.98 0.18 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.254 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.38 82.98 0.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.906 . . . . 0.0 109.781 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.683 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 28.1 p -97.34 164.82 12.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.109 -0.994 . . . . 0.0 110.436 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 92' ' ' ASN . 2.2 m120 -141.47 166.52 24.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 110.031 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.825 HD12 ' O ' ' A' ' 34' ' ' ALA . 5.7 tp -116.01 127.25 54.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 109.603 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.568 ' HA3' ' CD2' ' A' ' 104' ' ' HIS . . . -118.31 157.71 15.08 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -141.73 140.79 33.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -1.107 . . . . 0.0 110.086 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 139.42 163.69 9.6 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -124.29 -156.99 0.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.23 -1.159 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.8 t -90.14 36.81 0.88 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.905 . . . . 0.0 110.404 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.4 -50.19 0.05 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.6 HD13 ' OH ' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -135.13 89.38 2.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.196 -1.179 . . . . 0.0 110.409 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.02 158.34 11.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.158 -0.963 . . . . 0.0 109.814 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.495 HD23 ' HG3' ' A' ' 2' ' ' PRO . 91.8 mt -121.52 -84.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 110.432 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.98 -177.37 38.67 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.005 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.568 ' CD2' ' HA3' ' A' ' 94' ' ' GLY . 43.8 m80 -139.92 113.56 8.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.571 -0.958 . . . . 0.0 109.887 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.59 HG11 HG12 ' A' ' 6' ' ' VAL . 18.0 t -88.25 161.55 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 109.836 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.81 134.21 49.3 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.157 -0.964 . . . . 0.0 110.122 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.609 HD11 ' HB2' ' A' ' 93' ' ' LEU . 58.1 mt -105.48 147.45 28.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.236 -0.915 . . . . 0.0 110.432 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.97 159.68 42.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.408 -0.808 . . . . 0.0 109.824 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.491 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 42.3 m-85 -128.17 156.18 43.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.562 179.986 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.51 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 47.4 Cg_endo . . . . . 0 N--CA 1.479 0.669 0 N-CA-C 110.353 -0.672 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -151.53 109.45 3.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.085 -1.01 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -108.36 115.83 30.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.6 m -146.13 151.84 38.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.894 -1.129 . . . . 0.0 111.159 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.831 HG22 ' HD2' ' A' ' 8' ' ' PRO . 9.8 p -115.97 151.8 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.467 -0.771 . . . . 0.0 109.473 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.614 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -77.22 -57.87 1.05 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.923 -1.111 . . . . 0.0 110.411 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.831 ' HD2' HG22 ' A' ' 6' ' ' VAL . 54.9 Cg_endo -86.55 68.81 4.48 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.538 1.283 . . . . 0.0 110.334 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.38 -20.35 65.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 109.811 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.5 p -142.76 130.04 21.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.434 -0.791 . . . . 0.0 110.239 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.19 47.56 0.99 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -108.15 172.03 7.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -1.097 . . . . 0.0 110.221 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -148.08 164.28 34.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.94 . . . . 0.0 110.343 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.462 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 23.9 t70 -64.85 123.39 19.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 110.137 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.78 -30.42 7.96 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 12' ' ' LEU . 47.1 tt0 -58.75 146.83 35.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -1.119 . . . . 0.0 110.207 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.3 p -90.35 179.51 5.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 110.539 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.66 HG23 ' HB3' ' A' ' 65' ' ' PHE . 5.3 m -149.41 160.66 5.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.504 -0.747 . . . . 0.0 109.83 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 14.0 m -112.04 118.49 35.57 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.949 -1.094 . . . . 0.0 110.107 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 t -109.06 147.95 13.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 110.073 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.7 t -142.28 129.06 20.51 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.482 -0.761 . . . . 0.0 110.159 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 12.2 t -118.55 107.67 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.368 -0.832 . . . . 0.0 110.024 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.4 OUTLIER -111.92 141.42 45.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.271 -0.893 . . . . 0.0 110.567 179.989 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 122.0 -74.11 0.36 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.503 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -54.79 145.14 20.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -1.178 . . . . 0.0 109.707 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.574 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -118.47 157.8 26.54 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.102 -0.999 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -34.07 136.24 0.13 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.506 0.669 . . . . 0.0 110.819 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.39 1.93 12.2 Favored Glycine 0 C--N 1.295 -1.74 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 1.0 OUTLIER -137.52 129.01 28.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.324 -1.104 . . . . 0.0 110.189 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.518 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 89.0 m -107.22 146.68 31.1 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.525 -0.734 . . . . 0.0 109.815 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 29' ' ' GLU . 13.2 m-85 -133.09 169.09 17.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.129 -0.982 . . . . 0.0 110.728 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CD2' ' HB3' ' A' ' 52' ' ' SER . 19.4 m-85 -128.64 106.87 9.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 109.539 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.612 ' CG2' HG23 ' A' ' 51' ' ' THR . 18.1 tt -89.54 136.61 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.255 -0.903 . . . . 0.0 110.845 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.65 177.84 9.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.334 -0.854 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.553 ' HB2' HD12 ' A' ' 93' ' ' LEU . 55.5 tt0 -134.73 150.72 50.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.307 -0.871 . . . . 0.0 109.964 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 69.5 m -150.95 163.44 38.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.102 -0.999 . . . . 0.0 111.224 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.564 ' HB3' ' OH ' ' A' ' 71' ' ' TYR . . . -153.1 152.49 28.07 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.791 -0.568 . . . . 0.0 109.709 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.57 172.15 16.31 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.802 1.422 . . . . 0.0 110.339 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 44' ' ' ALA . 16.0 m . . . . . 0 N--CA 1.493 1.698 0 O-C-N 120.929 -1.107 . . . . 0.0 110.589 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 p30 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.627 0.727 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.717 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -150.21 118.75 6.5 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 109.094 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.1 m -108.9 162.03 14.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.971 -1.08 . . . . 0.0 111.089 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -111.52 92.98 17.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.432 -0.792 . . . . 0.0 109.746 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.98 -12.52 32.63 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.047 1.551 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.31 -31.83 71.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.133 -0.98 . . . . 0.0 110.178 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 p -97.15 8.63 44.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 110.149 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.14 110.53 5.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.409 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.612 HG23 ' CG2' ' A' ' 33' ' ' ILE . 1.1 t -129.03 140.38 51.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 110.054 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.496 ' HB3' ' CD2' ' A' ' 32' ' ' TYR . 6.9 p -109.21 148.51 30.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.173 -0.955 . . . . 0.0 110.227 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 22.7 p90 -148.06 -177.13 5.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.0 110.177 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 55' ' ' THR . 25.4 m -137.62 153.05 49.94 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 110.091 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 3.3 p -56.85 -159.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.179 -0.951 . . . . 0.0 110.142 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 45.3 m-20 -146.89 -161.81 1.41 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.936 -1.103 . . . . 0.0 110.599 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.31 -51.02 70.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.28 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.93 12.35 7.66 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.574 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 60.25 20.09 53.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.75 110.16 22.26 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -1.114 . . . . 0.0 110.22 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.678 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -101.36 90.95 4.27 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.541 -0.724 . . . . 0.0 109.417 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 p -103.48 115.08 29.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 109.548 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.546 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 15.1 p90 -147.74 171.06 16.26 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.395 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.9 155.3 17.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 0.0 110.84 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.66 ' HB3' HG23 ' A' ' 18' ' ' VAL . 90.0 t80 -140.32 176.78 8.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.483 -0.76 . . . . 0.0 108.971 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.578 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -128.35 154.56 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.576 -1.328 . . . . 0.0 110.442 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 67' ' ' VAL . 29.4 m -129.87 125.8 61.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.526 -0.734 . . . . 0.0 109.85 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -111.73 116.55 30.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 110.407 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 14' ' ' ASP . 29.6 ttpt -56.76 -55.95 27.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.615 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.4 m -99.57 130.03 45.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.828 . . . . 0.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.564 ' OH ' ' HB3' ' A' ' 37' ' ' ALA . 33.9 p90 -155.3 131.08 9.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -0.878 . . . . 0.0 109.982 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.4 m -54.58 134.41 46.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.118 -0.989 . . . . 0.0 110.394 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.717 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -115.47 167.32 12.35 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.028 -1.278 . . . . 0.0 110.564 -179.94 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.5 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.121 0.486 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.437 HG21 ' HB1' ' A' ' 44' ' ' ALA . 34.4 t -121.44 157.83 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.129 -0.982 . . . . 0.0 110.424 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 39.6 p-10 -152.06 118.28 5.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 110.052 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.3 m -90.58 32.31 0.98 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.165 -0.959 . . . . 0.0 110.306 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.1 87.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.213 -0.93 . . . . 0.0 109.983 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -130.67 6.16 4.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.51 -159.17 0.59 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.846 . . . . 0.0 109.811 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -115.49 120.38 39.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.51 141.0 44.24 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.77 144.1 29.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.062 -1.023 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.553 HD12 ' HB2' ' A' ' 35' ' ' GLN . 0.4 OUTLIER -123.58 135.39 53.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.646 -0.659 . . . . 0.0 109.254 179.956 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.95 177.02 21.7 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.223 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -151.68 170.82 18.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.452 -1.028 . . . . 0.0 109.986 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.413 ' HA2' ' HG ' ' A' ' 102' ' ' LEU . . . 150.76 159.3 8.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 99' ' ' GLY . 21.0 t30 -119.2 158.18 26.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -1.177 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.78 92.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.067 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 97' ' ' ASN . . . 124.02 -45.33 1.19 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -91.47 132.11 36.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -1.129 . . . . 0.0 110.202 179.914 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.679 ' N ' HD13 ' A' ' 100' ' ' LEU . 5.8 m-20 -105.8 144.65 32.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 110.191 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 101' ' ' ASP . 21.1 mt -122.36 -75.14 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.162 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 159.38 -179.72 34.78 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.72 128.74 16.52 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.491 -1.005 . . . . 0.0 109.56 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.642 HG11 HG12 ' A' ' 6' ' ' VAL . 58.2 t -105.11 155.12 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.409 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -92.18 147.07 23.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.818 . . . . 0.0 109.833 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.48 105.66 9.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 110.353 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 109' ' ' PHE . 3.6 m -79.58 173.96 12.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.882 . . . . 0.0 110.167 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.445 ' H ' HG22 ' A' ' 108' ' ' THR . 2.1 m-85 -136.77 88.68 2.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 CA-C-O 118.005 -1.442 . . . . 0.0 109.569 179.96 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.473 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 48.6 Cg_endo . . . . . 0 N--CA 1.481 0.742 0 N-CA-C 110.537 -0.601 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -129.18 144.82 51.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.873 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.492 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 23.5 t80 -150.36 104.75 3.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.926 . . . . 0.0 109.888 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p -150.58 152.55 34.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 110.68 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.03 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 14.8 p -106.52 158.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -0.838 . . . . 0.0 109.55 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.594 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -60.46 -63.76 3.9 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.113 -0.992 . . . . 0.0 110.787 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.99 ' HD2' HG22 ' A' ' 6' ' ' VAL . 44.7 Cg_endo -72.33 -86.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.772 1.406 . . . . 0.0 111.189 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 1.03 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 71.81 18.35 5.15 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.407 -0.808 . . . . 0.0 109.918 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.484 ' HA ' ' HB ' ' A' ' 108' ' ' THR . 3.9 m -171.4 108.48 0.27 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.362 -0.836 . . . . 0.0 110.076 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.09 76.09 1.32 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.522 HD21 ' HB2' ' A' ' 8' ' ' PRO . 9.7 mt -128.05 172.74 10.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -1.101 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -138.29 162.82 33.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 110.082 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -57.93 123.99 17.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.067 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 94.99 -32.32 6.23 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 17' ' ' SER . 9.0 tm0? -42.01 138.26 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.39 -1.065 . . . . 0.0 110.149 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.46 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -94.07 150.39 20.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.983 -179.99 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 65' ' ' PHE . 33.3 m -128.79 176.95 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.926 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 0.3 OUTLIER -133.48 121.78 22.7 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.939 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 21' ' ' SER . 68.0 t -98.31 158.86 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.254 -0.903 . . . . 0.0 110.053 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.41 ' N ' HG12 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -151.08 122.26 7.75 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.388 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.844 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 53.1 t -121.24 144.27 30.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.339 -0.85 . . . . 0.0 109.758 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.456 ' H ' ' HB3' ' A' ' 3' ' ' ALA . 1.1 m -156.61 127.55 6.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 142.61 -63.58 0.5 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.562 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -56.67 -159.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 109.816 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.57 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -165.8 162.7 18.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.928 -1.107 . . . . 0.0 111.054 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -41.24 134.5 2.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.551 -0.718 . . . . 0.0 110.241 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 114.6 7.41 18.13 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 54' ' ' THR . 5.6 mt-10 -139.86 128.64 23.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.243 -1.151 . . . . 0.0 109.906 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.502 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 20.6 m -108.87 157.8 18.28 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.866 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.963 ' CD2' HD11 ' A' ' 102' ' ' LEU . 15.8 m-85 -137.34 173.2 11.94 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 110.019 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 14.7 m-85 -131.08 103.52 6.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 110.021 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.684 ' CG2' HG23 ' A' ' 51' ' ' THR . 1.2 tt -87.23 124.29 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.179 -0.951 . . . . 0.0 110.272 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 1.026 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -150.56 160.46 43.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 110.207 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.486 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -126.59 138.2 53.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 110.544 179.978 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.2 m -146.94 169.22 19.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.25 -0.906 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.61 152.35 28.61 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.17 -0.956 . . . . 0.0 110.119 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.22 174.73 10.98 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.006 1.529 . . . . 0.0 110.178 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 43' ' ' ASP . 4.7 t . . . . . 0 C--N 1.304 -1.384 0 O-C-N 121.218 -0.926 . . . . 0.0 109.582 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.465 ' HA ' HG23 ' A' ' 39' ' ' VAL . 37.1 m-20 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.384 0.611 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.726 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -118.33 165.39 13.91 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.423 -0.798 . . . . 0.0 108.902 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -147.05 158.18 43.85 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.721 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.577 ' OD1' ' CD2' ' A' ' 71' ' ' TYR . 3.4 m120 -100.11 116.11 64.87 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.489 -0.757 . . . . 0.0 109.694 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.62 -28.59 4.19 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.818 1.431 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.11 -35.42 74.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.245 -0.91 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.6 p -86.94 14.08 7.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.214 -0.929 . . . . 0.0 110.684 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.38 95.62 10.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.952 . . . . 0.0 110.271 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.684 HG23 ' CG2' ' A' ' 33' ' ' ILE . 5.0 t -137.03 167.62 21.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.7 p -126.2 149.54 48.96 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.196 -0.94 . . . . 0.0 110.34 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 20.7 p90 -143.41 141.93 31.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.142 -0.974 . . . . 0.0 110.135 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 29' ' ' GLU . 18.6 m -104.21 155.55 18.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -0.933 . . . . 0.0 110.494 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.562 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -63.04 -156.08 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.319 -0.863 . . . . 0.0 109.806 179.946 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -140.83 -166.88 2.24 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.927 -1.108 . . . . 0.0 110.436 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.93 -57.24 13.93 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -1.85 23.63 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.254 -0.904 . . . . 0.0 108.999 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.83 69.06 1.46 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.58 125.69 13.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -1.084 . . . . 0.0 109.618 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.844 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -118.6 80.6 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 110.781 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.29 140.21 46.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -0.831 . . . . 0.0 109.078 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.4 ' HZ ' HD13 ' A' ' 33' ' ' ILE . 32.7 p90 -171.1 -179.65 2.78 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.114 -0.991 . . . . 0.0 111.38 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t -96.43 140.78 30.58 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.608 0.718 . . . . 0.0 110.551 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.587 ' HB3' HG23 ' A' ' 18' ' ' VAL . 20.3 t80 -134.32 -172.19 2.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -0.79 . . . . 0.0 108.888 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 t -143.69 165.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.645 -1.285 . . . . 0.0 110.325 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.572 HG11 HG11 ' A' ' 18' ' ' VAL . 33.2 m -137.88 142.51 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.312 -0.868 . . . . 0.0 110.305 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -121.22 134.52 55.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.072 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 23.3 ttmt -73.26 -59.81 2.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.137 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t -109.58 141.84 41.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 110.196 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.577 ' CD2' ' OD1' ' A' ' 46' ' ' ASN . 33.4 p90 -153.56 122.5 6.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.825 . . . . 0.0 109.986 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 92.2 m -43.89 124.74 3.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.307 -0.871 . . . . 0.0 110.738 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.66 148.88 19.08 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 120.787 -1.419 . . . . 0.0 111.168 -179.979 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 20.0 p . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.282 0.563 . . . . 0.0 109.918 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.726 HG21 ' CB ' ' A' ' 44' ' ' ALA . 74.6 t -102.34 153.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 109.993 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -132.8 148.7 52.32 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 110.203 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 1.8 t -104.94 15.01 28.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 110.17 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.23 -56.16 4.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 110.334 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -87.7 -28.12 21.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.23 -0.919 . . . . 0.0 110.238 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.7 -158.26 0.64 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.218 -0.926 . . . . 0.0 110.01 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.45 147.95 42.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.9 . . . . 0.0 110.225 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.469 ' HB3' ' OE1' ' A' ' 35' ' ' GLN . 94.4 m -106.61 130.35 54.38 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.911 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -112.77 125.23 54.1 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 110.557 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.026 HD12 ' O ' ' A' ' 34' ' ' ALA . 50.1 tp -107.62 112.34 25.02 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.599 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -120.89 160.2 15.3 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.487 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -144.07 124.48 13.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.506 -0.996 . . . . 0.0 109.802 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.35 167.37 39.39 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.414 ' CG ' ' N ' ' A' ' 98' ' ' SER . 4.3 t-20 -104.43 -86.08 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -1.094 . . . . 0.0 110.416 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.414 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 46.8 t -159.89 71.07 0.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.255 -0.903 . . . . 0.0 110.007 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.01 -17.3 6.74 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 31' ' ' TYR . 38.3 tp -94.86 -66.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.462 -1.022 . . . . 0.0 109.655 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.9 t0 61.89 128.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.76 . . . . 0.0 110.632 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.963 HD11 ' CD2' ' A' ' 31' ' ' TYR . 35.3 mt -96.85 -39.51 9.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.468 -0.77 . . . . 0.0 109.571 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.18 177.58 26.01 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.599 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 2.0 m-70 -133.7 120.05 20.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.656 -0.908 . . . . 0.0 109.601 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.6 t -92.25 132.59 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.207 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.18 106.71 18.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 110.325 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.2 mt -74.83 126.81 31.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.24 -0.913 . . . . 0.0 110.13 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.484 ' HB ' ' HA ' ' A' ' 10' ' ' SER . 2.2 m -90.37 162.49 15.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.926 . . . . 0.0 110.092 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 108' ' ' THR . 3.9 m-85 -148.4 171.81 15.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.548 179.979 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.541 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 54.9 Cg_endo . . . . . 0 CA--C 1.543 0.956 0 N-CA-C 109.447 -1.02 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . 179.73 133.58 0.1 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.887 -1.133 . . . . 0.0 110.461 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -150.85 97.98 2.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.401 -0.812 . . . . 0.0 109.543 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.1 p -139.26 168.83 18.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.059 -1.026 . . . . 0.0 111.148 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG12 HG11 ' A' ' 105' ' ' VAL . 8.0 p -124.98 148.64 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.555 -0.716 . . . . 0.0 109.09 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.648 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.0 m -62.21 -76.87 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.868 -1.145 . . . . 0.0 110.463 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 55.6 Cg_endo -77.81 75.3 4.84 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 O-C-N 122.788 0.888 . . . . 0.0 109.847 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.09 -22.89 63.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.148 -0.97 . . . . 0.0 110.301 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.5 t -131.69 135.18 46.66 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.174 -0.954 . . . . 0.0 110.12 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.98 65.71 1.28 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.626 HD21 ' O ' ' A' ' 8' ' ' PRO . 7.4 mt -110.21 165.05 12.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -1.139 . . . . 0.0 109.887 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.5 157.22 28.74 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.21 -0.931 . . . . 0.0 110.169 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -68.5 127.2 32.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.84 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.8 -25.54 11.4 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -54.47 149.55 10.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.337 -1.096 . . . . 0.0 110.437 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 m -101.99 129.19 48.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.229 -0.92 . . . . 0.0 109.957 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 18' ' ' VAL . 16.4 m -95.91 175.29 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 23.3 p -129.37 113.57 15.12 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.376 -0.828 . . . . 0.0 109.734 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t -97.57 151.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.275 -0.891 . . . . 0.0 110.05 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 t -141.82 118.49 11.03 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.323 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 35.3 t -113.83 138.14 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.558 -0.714 . . . . 0.0 109.778 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.459 ' H ' ' HB3' ' A' ' 3' ' ' ALA . 19.3 p -150.9 116.25 5.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.983 -1.073 . . . . 0.0 110.754 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.541 ' HA3' ' CB ' ' A' ' 2' ' ' PRO . . . 156.31 -52.44 0.42 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.528 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -58.15 -157.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.358 -1.083 . . . . 0.0 109.711 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.506 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -161.26 160.59 30.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.966 -1.084 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -45.91 130.6 9.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.604 -0.685 . . . . 0.0 110.25 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.432 ' C ' ' HG3' ' A' ' 29' ' ' GLU . . . 117.92 12.33 7.84 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.541 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 70.6 mt-10 -139.18 113.26 8.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.283 . . . . 0.0 110.444 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.408 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 31.1 m -90.83 166.46 13.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.471 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.681 ' HE1' HD23 ' A' ' 100' ' ' LEU . 93.9 m-85 -150.61 167.11 28.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.992 -1.068 . . . . 0.0 110.827 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' A' ' 31' ' ' TYR . 12.3 m-85 -131.68 106.92 8.46 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.413 ' CG2' HG23 ' A' ' 51' ' ' THR . 4.7 tt -98.25 137.8 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.994 . . . . 0.0 111.452 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.04 161.02 43.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.669 -0.645 . . . . 0.0 109.458 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 35' ' ' GLN . 5.3 pt20 -119.23 134.04 55.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 110.523 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.419 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 3.5 m -144.23 -178.5 5.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.43 -0.794 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.61 156.95 33.57 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.301 -0.875 . . . . 0.0 109.467 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 41.3 Cg_endo -71.96 151.4 56.29 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 O-C-N 123.748 1.394 . . . . 0.0 110.686 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 43' ' ' ASP . 10.8 p . . . . . 0 C--N 1.298 -1.674 0 O-C-N 121.502 -0.749 . . . . 0.0 109.476 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.503 ' N ' HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.291 0.567 . . . . 0.0 111.007 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.8 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -95.24 133.08 39.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.283 -0.886 . . . . 0.0 108.942 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 15.7 t -113.91 168.0 10.17 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.779 -1.201 . . . . 0.0 111.604 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -108.88 112.09 60.41 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.71 . . . . 0.0 110.037 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.62 -24.78 15.57 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.0 1.526 . . . . 0.0 110.646 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -8.86 10.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.206 -0.934 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.02 35.69 4.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.977 -1.077 . . . . 0.0 110.541 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.79 133.66 34.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.163 -0.961 . . . . 0.0 110.541 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.413 HG23 ' CG2' ' A' ' 33' ' ' ILE . 9.9 t -159.95 156.84 27.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.35 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t -130.03 161.6 30.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.162 -0.961 . . . . 0.0 110.755 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 7.9 p90 -149.28 179.73 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.401 -0.812 . . . . 0.0 109.763 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.4 m -146.88 158.11 43.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.051 -1.031 . . . . 0.0 110.332 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.528 HG21 ' HB3' ' A' ' 25' ' ' ALA . 2.8 p -73.3 -161.23 0.09 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -161.07 -152.16 0.26 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.1 -1.0 . . . . 0.0 110.885 -179.947 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.35 -46.51 89.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.889 . . . . 0.0 109.488 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.4 t -85.16 12.96 6.88 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.569 -0.707 . . . . 0.0 109.209 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.506 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 45.3 40.66 7.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.81 126.16 41.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 110.374 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 53' ' ' PHE . . . -112.1 90.08 3.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 110.539 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.78 117.01 32.99 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.329 -0.857 . . . . 0.0 109.562 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.634 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.4 p90 -149.91 171.15 17.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.249 -0.907 . . . . 0.0 110.877 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.04 128.11 47.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 110.647 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.51 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 50.0 t80 -113.64 -179.96 3.79 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.51 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.7 t -128.27 156.89 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.704 -1.248 . . . . 0.0 109.907 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG13 ' C ' ' A' ' 66' ' ' VAL . 30.7 m -146.82 157.09 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 110.308 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.23 150.51 50.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.428 -0.795 . . . . 0.0 110.187 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 29.7 tttt -76.5 -59.4 2.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 110.566 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.0 m -117.57 137.62 52.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.143 -0.973 . . . . 0.0 110.169 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -162.2 151.53 15.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.12 -0.987 . . . . 0.0 110.304 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 38.1 m -68.47 134.29 49.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.0 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.636 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -118.82 -176.48 16.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.237 -1.154 . . . . 0.0 109.915 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 82.5 p . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.331 0.586 . . . . 0.0 110.45 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.8 HG21 ' HB3' ' A' ' 44' ' ' ALA . 78.3 t -133.05 116.43 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.393 -0.817 . . . . 0.0 109.882 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.767 ' OD2' HG22 ' A' ' 88' ' ' THR . 4.9 p-10 -101.26 142.0 33.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 0.0 110.392 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 4.4 t -98.2 17.28 18.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.25 -0.907 . . . . 0.0 110.031 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.1 -59.92 2.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 110.214 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.767 HG22 ' OD2' ' A' ' 85' ' ' ASP . 5.9 t -79.78 -24.85 41.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.289 -0.882 . . . . 0.0 110.081 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -101.01 -154.96 0.49 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.382 -0.824 . . . . 0.0 109.909 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.21 146.47 33.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.401 -0.812 . . . . 0.0 110.086 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.28 126.85 43.94 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.261 -0.9 . . . . 0.0 109.67 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -110.8 121.2 44.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 111.005 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 65' ' ' PHE . 1.1 tp -107.05 118.41 36.63 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.418 -0.801 . . . . 0.0 108.912 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -137.47 176.73 20.38 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.279 -1.439 . . . . 0.0 110.529 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.89 175.75 11.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.615 -0.932 . . . . 0.0 110.054 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 136.63 167.06 11.05 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -131.46 -153.15 0.54 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.187 -1.184 . . . . 0.0 109.933 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 t -104.04 80.15 1.7 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.176 -0.953 . . . . 0.0 110.089 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.55 -18.31 0.36 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.681 HD23 ' HE1' ' A' ' 31' ' ' TYR . 7.9 tp -140.79 -67.95 0.41 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.282 . . . . 0.0 110.561 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.5 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.7 OUTLIER 69.42 153.06 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.306 -0.871 . . . . 0.0 110.091 179.983 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.7 mt -121.79 -86.31 0.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 110.38 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -167.91 -160.66 15.94 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -159.09 138.45 11.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -1.09 . . . . 0.0 110.335 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.497 HG11 HG12 ' A' ' 6' ' ' VAL . 81.5 t -104.9 127.96 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.255 -0.903 . . . . 0.0 110.207 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.87 93.74 5.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.511 HD22 HD11 ' A' ' 12' ' ' LEU . 65.9 mt -60.19 170.13 1.38 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 109' ' ' PHE . 17.4 m -141.19 169.84 16.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 0.0 110.096 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.412 ' N ' HG22 ' A' ' 108' ' ' THR . 5.9 m-85 -142.65 96.57 2.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.913 . . . . 0.0 110.138 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.61 179.978 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 N--CA 1.483 0.885 0 N-CA-C 110.428 -0.643 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -140.38 135.8 32.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.025 -1.047 . . . . 0.0 111.004 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.404 ' CE2' HG23 ' A' ' 105' ' ' VAL . 65.9 t80 -150.84 108.53 3.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.557 -0.715 . . . . 0.0 109.096 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.0 p -146.56 161.59 40.18 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.82 -1.175 . . . . 0.0 111.484 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.889 HG12 HG11 ' A' ' 105' ' ' VAL . 7.7 p -129.94 143.32 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.594 -0.691 . . . . 0.0 109.719 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.612 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.2 m -56.86 -68.84 0.53 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.976 -1.077 . . . . 0.0 110.224 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 50.7 Cg_endo -75.88 95.1 1.01 Allowed 'Trans proline' 0 C--N 1.321 -0.89 0 O-C-N 123.354 1.186 . . . . 0.0 110.228 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.96 -1.94 28.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.0 -1.063 . . . . 0.0 110.364 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 t -157.21 109.51 2.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.955 . . . . 0.0 110.057 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.45 60.99 0.54 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.506 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 1.1 mp -108.25 165.84 11.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -1.166 . . . . 0.0 110.068 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 11.4 t -117.27 147.97 42.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.319 -0.863 . . . . 0.0 110.072 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.23 119.21 7.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 110.326 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.11 -35.15 4.97 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 34.2 tt0 -49.21 153.81 0.92 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.326 -1.102 . . . . 0.0 110.381 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 m -105.46 132.75 51.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.959 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.506 ' CG1' ' CD2' ' A' ' 12' ' ' LEU . 24.4 m -100.6 178.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.255 -0.903 . . . . 0.0 110.282 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.9 m -121.1 117.28 26.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 109.807 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.484 HG21 HD13 ' A' ' 33' ' ' ILE . 20.8 t -102.54 150.2 6.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.393 -0.817 . . . . 0.0 110.154 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.91 127.94 18.49 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.309 -0.869 . . . . 0.0 110.4 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 58.7 t -117.37 147.59 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.632 -0.667 . . . . 0.0 109.917 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.732 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 3.6 p -168.05 119.76 0.84 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.127 -0.983 . . . . 0.0 110.393 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.78 3.4 5.48 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.884 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -105.64 -39.67 6.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.056 -1.261 . . . . 0.0 110.266 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 25' ' ' ALA . . . 72.62 147.84 0.09 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.327 -0.858 . . . . 0.0 110.837 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.79 134.22 10.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.713 -0.617 . . . . 0.0 110.768 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 131.82 1.51 4.56 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 39.6 mm-40 -146.45 130.61 17.44 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.87 -1.371 . . . . 0.0 110.896 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.687 HG23 ' OG1' ' A' ' 54' ' ' THR . 0.2 OUTLIER -96.72 171.67 8.38 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.879 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.547 ' CD1' ' O ' ' A' ' 30' ' ' THR . 61.3 m-85 -151.61 172.54 15.9 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.871 -1.143 . . . . 0.0 111.028 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 52' ' ' SER . 61.4 m-85 -144.31 109.46 5.07 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.443 -0.785 . . . . 0.0 109.752 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.699 HD11 HD21 ' A' ' 93' ' ' LEU . 5.6 tt -88.41 132.68 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.213 -0.929 . . . . 0.0 110.451 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.58 167.63 25.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.203 -0.936 . . . . 0.0 110.426 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.455 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 10.5 pt20 -126.56 141.81 51.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.315 -0.865 . . . . 0.0 109.991 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -143.38 157.71 44.24 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.979 -1.076 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.748 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -144.19 157.05 57.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.37 159.13 54.91 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 123.741 1.39 . . . . 0.0 110.792 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.602 HG12 HG22 ' A' ' 84' ' ' VAL . 32.5 m . . . . . 0 C--N 1.299 -1.615 0 O-C-N 121.478 -0.763 . . . . 0.0 109.483 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.0 t0 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.151 0.501 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.433 ' HB1' ' N ' ' A' ' 74' ' ' SER . . . -111.29 139.29 46.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 8.7 t -123.49 144.51 49.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.176 -0.953 . . . . 0.0 110.506 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.453 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 32.0 t-20 -71.67 122.97 88.67 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.26 -0.9 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.539 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 52.4 Cg_endo -83.47 -39.11 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.932 1.491 . . . . 0.0 110.953 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.88 -56.92 15.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.426 -0.796 . . . . 0.0 110.766 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.8 p -56.87 -14.53 3.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.642 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 47' ' ' PRO . . . -56.98 137.28 55.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 110.768 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.628 HG23 HG22 ' A' ' 33' ' ' ILE . 13.0 t -147.03 165.9 28.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.589 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -130.95 152.91 49.75 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.874 -1.142 . . . . 0.0 111.82 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 31' ' ' TYR . 32.3 p90 -149.12 146.25 27.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.502 -0.749 . . . . 0.0 109.779 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.687 ' OG1' HG23 ' A' ' 30' ' ' THR . 76.2 m -108.75 155.27 20.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.975 -1.078 . . . . 0.0 110.771 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.884 HG21 ' HB3' ' A' ' 25' ' ' ALA . 1.2 p -65.42 -157.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.305 -0.872 . . . . 0.0 109.606 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.94 -159.78 1.08 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.818 -1.176 . . . . 0.0 110.478 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.06 62.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.156 -0.965 . . . . 0.0 109.743 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 t -85.46 13.69 6.45 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.424 -0.797 . . . . 0.0 108.854 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 60.58 27.35 65.98 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -110.83 114.16 27.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.345 -1.091 . . . . 0.0 110.35 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.502 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -117.56 88.63 2.95 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.2 p -102.29 125.99 49.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.487 -0.758 . . . . 0.0 109.395 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -154.01 176.19 12.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.957 . . . . 0.0 111.079 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 t -100.22 129.89 46.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.468 -0.77 . . . . 0.0 110.362 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 55.1 t80 -118.45 177.91 4.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 109.307 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.555 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -125.77 154.99 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.811 -1.181 . . . . 0.0 110.389 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.416 HG11 HG11 ' A' ' 18' ' ' VAL . 5.6 m -132.7 171.69 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.822 . . . . 0.0 109.704 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.89 139.21 23.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.984 . . . . 0.0 110.282 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.529 ' HA ' ' CE2' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -77.39 -47.71 19.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.339 -0.851 . . . . 0.0 110.204 179.991 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -122.95 136.1 54.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.847 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -163.36 157.05 19.56 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 3.2 m -69.48 111.14 5.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.425 -0.797 . . . . 0.0 109.992 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.29 162.75 54.3 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.433 ' N ' ' HB1' ' A' ' 44' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.111 -1.229 . . . . 0.0 110.75 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.4 p . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.171 0.51 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 37' ' ' ALA . 55.2 t -141.4 155.84 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -0.903 . . . . 0.0 110.318 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -144.36 139.83 28.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.863 . . . . 0.0 110.126 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -100.73 2.44 41.35 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 110.178 -179.97 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.34 -60.5 2.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.881 . . . . 0.0 110.622 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.8 t -91.94 -20.89 20.92 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.207 -0.933 . . . . 0.0 110.731 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.63 -176.16 3.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.578 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.26 147.13 45.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.345 -0.847 . . . . 0.0 110.1 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.7 m -120.61 156.3 31.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.175 -0.953 . . . . 0.0 110.436 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 18.5 p30 -136.69 143.44 43.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 109.947 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.699 HD21 HD11 ' A' ' 33' ' ' ILE . 1.5 tp -105.62 135.79 46.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.249 -0.907 . . . . 0.0 109.998 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.701 ' HA3' ' CD2' ' A' ' 104' ' ' HIS . . . -131.69 149.46 19.32 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -137.15 155.77 49.18 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.502 -0.999 . . . . 0.0 109.899 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.27 164.61 13.25 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.458 ' CG ' ' N ' ' A' ' 98' ' ' SER . 4.6 t-20 -113.42 173.45 6.4 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.248 -1.148 . . . . 0.0 109.857 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.458 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 88.9 p -66.09 89.32 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.152 -0.968 . . . . 0.0 109.943 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 131.69 -20.4 4.61 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 101' ' ' ASP . 1.2 tt -111.37 161.21 16.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.395 -1.062 . . . . 0.0 110.055 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.591 ' N ' HD23 ' A' ' 100' ' ' LEU . 4.6 p-10 -148.57 98.25 2.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.214 -0.929 . . . . 0.0 110.368 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.2 mt -78.73 -70.14 0.52 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.294 -0.879 . . . . 0.0 110.131 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 164.1 -177.12 39.97 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.701 ' CD2' ' HA3' ' A' ' 94' ' ' GLY . 3.0 m80 -131.8 129.5 40.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -1.091 . . . . 0.0 110.03 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.889 HG11 HG12 ' A' ' 6' ' ' VAL . 46.0 t -93.39 116.8 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 110.473 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.56 128.95 39.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.39 -0.819 . . . . 0.0 110.086 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.509 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 74.8 mt -114.44 119.09 35.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 110.508 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.424 HG22 ' N ' ' A' ' 109' ' ' PHE . 23.6 m -98.57 169.37 9.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 109.932 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.529 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 10.7 m-85 -132.3 136.11 46.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.995 . . . . 0.0 110.326 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.995 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.412 ' HG2' HD23 ' A' ' 102' ' ' LEU . 47.5 Cg_endo . . . . . 0 N--CA 1.48 0.728 0 N-CA-C 110.479 -0.623 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.47 135.03 47.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.895 . . . . 0.0 110.162 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -150.56 107.44 3.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.789 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -146.13 153.07 40.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.096 -1.003 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.918 HG12 HG11 ' A' ' 105' ' ' VAL . 9.0 p -115.24 135.82 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.344 -0.847 . . . . 0.0 109.776 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -57.01 -67.63 0.8 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.056 -1.028 . . . . 0.0 110.262 -179.987 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 52.7 Cg_endo -75.69 87.94 1.34 Allowed 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.338 1.178 . . . . 0.0 109.956 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.61 -3.1 56.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.143 -0.973 . . . . 0.0 110.67 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.0 m -149.75 166.58 29.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.202 -0.936 . . . . 0.0 110.336 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.95 37.56 94.43 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 8' ' ' PRO . 40.5 mt -92.9 173.71 7.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.254 -1.144 . . . . 0.0 110.138 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.3 152.07 35.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 110.393 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 1.6 t70 -60.01 126.76 28.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 109.99 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.83 -33.27 5.65 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -56.61 149.47 17.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.345 -1.091 . . . . 0.0 109.893 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.01 134.07 47.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 110.663 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 65' ' ' PHE . 31.5 m -113.28 173.13 3.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.483 -0.76 . . . . 0.0 109.704 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -117.76 133.5 55.87 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.097 -1.002 . . . . 0.0 110.314 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.9 t -119.7 151.21 22.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.746 -0.596 . . . . 0.0 109.513 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.6 p -143.6 133.33 23.8 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 85.2 t -122.44 138.51 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.507 -0.746 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.8 m -150.02 80.1 1.37 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.861 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . -161.85 -71.55 0.02 OUTLIER Glycine 0 C--N 1.283 -2.386 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.477 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -56.09 -164.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -1.198 . . . . 0.0 109.902 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.577 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -160.39 157.77 28.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.143 -0.973 . . . . 0.0 110.387 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -36.14 118.55 0.53 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.602 -0.686 . . . . 0.0 110.633 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.56 -0.34 2.46 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -146.85 130.63 17.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.086 -1.244 . . . . 0.0 110.661 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.4 HG23 ' OG1' ' A' ' 54' ' ' THR . 37.9 m -107.27 121.8 45.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.701 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.651 ' HE1' HD13 ' A' ' 100' ' ' LEU . 52.2 m-85 -103.62 177.77 4.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.052 -1.03 . . . . 0.0 110.603 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.638 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 10.0 m-85 -132.81 116.69 16.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -0.892 . . . . 0.0 110.096 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.598 ' CG2' HG23 ' A' ' 51' ' ' THR . 0.5 OUTLIER -94.33 123.72 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.893 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.88 156.31 39.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.117 -0.99 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.694 ' OE1' HD12 ' A' ' 107' ' ' LEU . 0.3 OUTLIER -100.17 152.91 19.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.316 -0.865 . . . . 0.0 109.532 179.944 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 99.1 m -151.6 152.25 32.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.062 -1.024 . . . . 0.0 110.934 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.793 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.41 145.79 19.01 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.476 -0.765 . . . . 0.0 109.292 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.74 161.03 42.66 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.79 1.416 . . . . 0.0 110.989 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.685 HG12 HG22 ' A' ' 84' ' ' VAL . 33.8 m . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.471 -0.768 . . . . 0.0 110.17 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.316 0.579 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.94 164.94 24.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.133 -0.979 . . . . 0.0 110.028 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.3 m -143.74 -178.74 6.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.27 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 7.4 m-80 -105.59 76.14 0.34 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 0.0 110.319 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 43.2 Cg_endo -69.32 -41.3 4.97 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.987 1.519 . . . . 0.0 110.324 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.98 -34.95 74.0 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.38 -0.825 . . . . 0.0 110.005 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.9 34.2 5.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.856 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -86.33 103.67 15.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.014 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.598 HG23 ' CG2' ' A' ' 33' ' ' ILE . 10.0 t -102.37 167.65 9.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 0.0 110.502 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 2.4 m -143.99 162.94 34.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.955 . . . . 0.0 110.673 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 51.5 p90 -143.27 -177.13 5.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.4 ' OG1' HG23 ' A' ' 30' ' ' THR . 50.0 m -146.19 149.9 34.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.348 -0.845 . . . . 0.0 109.746 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.494 HG21 ' N ' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -64.22 -174.77 0.13 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.04 -1.038 . . . . 0.0 109.707 -179.978 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.736 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -146.8 -147.77 0.23 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.96 -1.088 . . . . 0.0 110.806 -179.903 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.585 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -83.02 71.24 10.12 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.15 0.976 . . . . 0.0 109.255 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER 152.7 -14.58 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.577 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 75.57 28.68 60.95 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.42 129.66 56.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.226 -1.161 . . . . 0.0 110.015 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -131.99 86.24 2.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.317 -0.864 . . . . 0.0 110.641 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.39 111.85 24.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.848 . . . . 0.0 109.412 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 19.2 p90 -143.58 178.56 7.7 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.084 -1.01 . . . . 0.0 110.967 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.1 p -98.98 125.54 44.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.469 -0.769 . . . . 0.0 110.247 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.671 ' O ' HG22 ' A' ' 18' ' ' VAL . 8.3 t80 -120.65 139.92 52.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.37 156.43 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.891 -1.131 . . . . 0.0 110.473 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.416 HG13 HG22 ' A' ' 18' ' ' VAL . 26.8 m -124.97 151.82 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.539 -0.726 . . . . 0.0 110.077 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.01 107.04 10.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 110.408 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.566 ' HB2' ' CE1' ' A' ' 109' ' ' PHE . 4.4 ttpt -55.39 -49.61 71.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.643 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.0 m -114.15 132.43 56.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -0.8 . . . . 0.0 109.905 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 71' ' ' TYR . 23.4 p90 -150.36 146.7 26.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.2 m -68.62 129.75 40.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 110.036 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.25 148.52 18.43 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.7 p . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.293 -1.122 . . . . 0.0 110.345 -179.96 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.3 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.297 0.57 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.685 HG22 HG12 ' A' ' 39' ' ' VAL . 84.0 t -119.06 147.08 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 110.167 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -137.04 137.23 39.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.176 -0.952 . . . . 0.0 110.697 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 62.6 m -92.1 7.8 40.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.725 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.01 -62.0 1.74 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 110.5 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.9 t -104.65 14.31 30.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.192 -0.943 . . . . 0.0 110.432 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.17 -167.94 1.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.234 -0.916 . . . . 0.0 110.055 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.06 98.97 4.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 110.325 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.793 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 12.0 p -108.03 151.44 25.83 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.928 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -127.47 158.7 36.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.732 ' HB2' HD11 ' A' ' 107' ' ' LEU . 10.0 tp -109.03 121.61 45.5 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.565 ' HA3' ' ND1' ' A' ' 104' ' ' HIS . . . -126.87 157.91 20.7 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.592 -1.29 . . . . 0.0 110.341 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -132.37 161.44 33.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -1.062 . . . . 0.0 110.082 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.848 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 138.73 -171.35 23.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 98' ' ' SER . 6.1 p-10 -109.25 -46.09 3.63 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.021 -1.282 . . . . 0.0 110.362 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER 174.19 -27.66 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.207 -0.933 . . . . 0.0 110.446 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.86 3.95 4.23 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.305 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.651 HD13 ' HE1' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -84.87 -42.08 15.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.945 -1.326 . . . . 0.0 110.174 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 100' ' ' LEU . 17.4 t0 65.44 81.07 0.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.326 -0.859 . . . . 0.0 110.261 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.848 HD12 ' HA2' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -79.77 -63.88 1.31 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 110.146 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.11 162.48 29.4 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.565 ' ND1' ' HA3' ' A' ' 94' ' ' GLY . 93.3 m-70 -138.57 113.24 9.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.518 -0.989 . . . . 0.0 109.686 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.918 HG11 HG12 ' A' ' 6' ' ' VAL . 94.1 t -101.59 113.97 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.226 -0.921 . . . . 0.0 110.795 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.17 139.1 55.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.107 -0.996 . . . . 0.0 109.321 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.732 HD11 ' HB2' ' A' ' 93' ' ' LEU . 80.7 mt -115.34 167.91 10.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.957 -1.089 . . . . 0.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 109' ' ' PHE . 19.2 m -149.1 175.35 11.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 109.975 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 69' ' ' LYS . 43.3 m-85 -147.45 102.37 3.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.375 -0.828 . . . . 0.0 110.2 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.966 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.543 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 46.2 Cg_endo . . . . . 0 C--O 1.214 -0.687 0 N-CA-C 110.315 -0.687 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -135.98 138.15 41.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.073 -1.017 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -152.0 108.82 3.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.307 -0.871 . . . . 0.0 109.675 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 t -148.69 161.22 42.19 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.972 -1.08 . . . . 0.0 111.161 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.669 HG22 ' HD2' ' A' ' 8' ' ' PRO . 8.1 p -121.67 147.54 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.534 -0.729 . . . . 0.0 109.859 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.611 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -55.91 -67.56 0.73 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 120.84 -1.163 . . . . 0.0 109.064 179.975 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.669 ' HD2' HG22 ' A' ' 6' ' ' VAL . 52.9 Cg_endo -76.94 129.71 10.83 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 O-C-N 123.473 1.249 . . . . 0.0 109.552 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.1 26.74 2.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.936 -1.102 . . . . 0.0 110.263 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.07 145.79 0.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.032 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.01 58.88 10.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 8' ' ' PRO . 20.5 mt -105.81 175.11 5.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.255 -1.144 . . . . 0.0 110.41 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.6 t -133.09 148.15 52.17 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.251 -0.906 . . . . 0.0 110.403 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.541 ' HB3' ' CB ' ' A' ' 69' ' ' LYS . 29.9 p30 -57.33 119.89 7.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 110.459 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.14 -35.34 5.11 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -47.62 148.65 1.41 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.028 -1.278 . . . . 0.0 110.428 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.586 ' C ' HG13 ' A' ' 18' ' ' VAL . 2.6 p -97.36 177.24 5.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 110.155 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.606 HG12 ' CG ' ' A' ' 8' ' ' PRO . 29.3 m -156.47 169.66 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.277 -0.889 . . . . 0.0 110.077 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 m -114.8 121.23 42.66 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.2 -0.938 . . . . 0.0 109.76 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 t -105.86 142.04 19.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.419 -0.8 . . . . 0.0 109.969 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.1 m -138.56 126.3 22.23 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.492 -0.755 . . . . 0.0 110.004 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 55.7 t -117.97 127.46 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.649 -0.657 . . . . 0.0 110.39 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.8 108.84 8.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.173 -0.955 . . . . 0.0 109.957 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 150.47 -82.38 0.18 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.501 ' O ' ' CA ' ' A' ' 59' ' ' GLY . . . -42.41 131.08 3.8 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.265 -1.138 . . . . 0.0 109.836 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.562 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -103.74 158.93 16.04 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.093 -1.005 . . . . 0.0 111.972 -179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.34 141.95 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.554 0.692 . . . . 0.0 111.07 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.11 7.28 4.11 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.577 ' CG ' ' CZ ' ' A' ' 31' ' ' TYR . 14.8 tp10 -161.92 136.58 7.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.923 -1.339 . . . . 0.0 111.223 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 53' ' ' PHE . 68.8 m -104.47 124.43 49.25 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.764 ' CD1' HD11 ' A' ' 102' ' ' LEU . 76.2 m-85 -103.13 172.96 6.52 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 111.55 -179.826 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.531 ' CE1' ' OG ' ' A' ' 52' ' ' SER . 96.3 m-85 -124.13 100.25 6.63 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.768 HG23 ' O ' ' A' ' 33' ' ' ILE . 5.7 tt -86.59 104.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.12 -0.988 . . . . 0.0 109.863 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.624 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -148.83 166.24 29.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.446 -0.784 . . . . 0.0 110.478 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.604 ' CD ' HD12 ' A' ' 107' ' ' LEU . 8.1 mt-30 -97.82 144.33 27.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 109.782 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.8 m -145.27 151.22 38.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.01 . . . . 0.0 110.952 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -148.78 164.6 20.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.585 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 41.6 Cg_endo -69.15 162.35 42.11 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.788 1.415 . . . . 0.0 110.605 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.468 -0.77 . . . . 0.0 110.17 -179.978 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 5.8 p30 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.313 0.578 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.67 165.4 33.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.975 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.498 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.8 m -141.77 168.12 20.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.179 -0.951 . . . . 0.0 110.236 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.51 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 0.3 OUTLIER -100.86 100.35 12.54 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.172 -179.976 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.0 Cg_endo -72.78 -34.61 6.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.013 1.533 . . . . 0.0 110.416 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.09 92.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 110.3 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.3 p -98.57 25.41 6.44 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.333 -0.854 . . . . 0.0 109.994 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -86.49 110.75 19.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.915 . . . . 0.0 110.302 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.582 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 7.5 t -116.32 133.45 56.01 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.319 -0.863 . . . . 0.0 110.018 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.531 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 12.2 t -108.77 137.79 46.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.279 -0.888 . . . . 0.0 110.58 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 30.3 p90 -135.38 -177.98 4.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 110.016 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 40.3 m -138.29 152.88 48.94 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.317 -0.865 . . . . 0.0 109.761 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.632 HG23 ' HE2' ' A' ' 31' ' ' TYR . 2.5 p -61.58 -162.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.942 -1.099 . . . . 0.0 109.963 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.612 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 3.0 t70 -143.43 -164.26 1.83 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.06 -1.025 . . . . 0.0 110.675 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.81 82.82 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.097 -1.002 . . . . 0.0 108.831 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -90.25 16.27 8.92 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 55.45 30.48 55.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.81 133.88 52.98 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.459 -1.024 . . . . 0.0 110.341 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.52 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -137.57 84.97 2.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.268 -0.895 . . . . 0.0 110.683 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.66 112.71 25.6 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.268 -0.895 . . . . 0.0 109.149 179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -145.91 179.53 7.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.106 -0.996 . . . . 0.0 111.024 -179.771 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -93.9 145.44 24.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.572 -0.705 . . . . 0.0 110.565 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.542 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 52.6 t80 -139.64 177.18 8.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.435 -0.791 . . . . 0.0 109.593 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.542 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 21.6 t -132.08 165.23 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.825 -1.172 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 66' ' ' VAL . 13.5 m -141.33 129.22 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.452 -0.78 . . . . 0.0 110.098 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -108.58 144.79 35.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 110.259 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.541 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 20.6 ttpt -68.95 -39.7 79.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.077 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 p -132.8 155.12 49.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.548 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 13.4 p90 -162.17 147.58 12.9 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.149 -0.97 . . . . 0.0 110.661 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 m -60.17 113.6 2.44 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.354 -0.841 . . . . 0.0 110.367 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.513 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -99.14 150.31 19.22 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.151 -1.206 . . . . 0.0 110.215 -179.988 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.45 0.643 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.513 ' CG2' ' HA3' ' A' ' 73' ' ' GLY . 58.9 t -92.49 133.6 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.81 . . . . 0.0 109.665 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -113.38 135.72 53.55 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.99 -1.069 . . . . 0.0 110.117 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 1.3 t -85.26 1.07 49.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.69 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.54 -61.66 1.72 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.085 -1.009 . . . . 0.0 110.547 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.3 t -84.56 -16.74 41.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.215 -0.928 . . . . 0.0 110.384 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.04 158.7 22.74 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.142 -0.974 . . . . 0.0 110.265 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.84 144.7 27.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.083 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 3.7 m -125.01 129.52 50.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.24 -0.913 . . . . 0.0 110.098 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 92' ' ' ASN . 1.8 m120 -111.62 127.68 55.82 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 110.014 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.624 HD12 ' O ' ' A' ' 34' ' ' ALA . 15.1 tp -93.23 108.9 20.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.92 . . . . 0.0 109.216 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -128.88 170.87 19.93 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.25 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -140.13 123.42 16.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -1.022 . . . . 0.0 109.866 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.93 166.59 36.29 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.492 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 5.1 p-10 -100.54 -43.39 6.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -1.113 . . . . 0.0 110.288 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 43.0 t -179.41 -43.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.18 -0.95 . . . . 0.0 110.627 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.67 27.45 3.21 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.512 HD22 ' HE1' ' A' ' 31' ' ' TYR . 3.4 tt -111.84 -44.57 3.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -1.187 . . . . 0.0 110.061 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.8 96.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.342 -0.848 . . . . 0.0 110.249 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.764 HD11 ' CD1' ' A' ' 31' ' ' TYR . 43.6 mt -83.68 -41.1 18.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -0.906 . . . . 0.0 110.258 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.99 162.24 12.97 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -145.5 122.06 11.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.519 -0.989 . . . . 0.0 109.751 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.502 HG11 HG12 ' A' ' 6' ' ' VAL . 91.5 t -96.86 113.92 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.541 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.4 117.84 6.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 109.812 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.604 HD12 ' CD ' ' A' ' 35' ' ' GLN . 83.5 mt -93.52 144.43 25.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.249 -0.907 . . . . 0.0 110.516 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 m -127.18 162.14 26.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 110.288 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.472 ' CD2' ' HG3' ' A' ' 69' ' ' LYS . 6.6 m-85 -135.72 126.62 27.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.202 -0.937 . . . . 0.0 110.058 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 118.036 -1.424 . . . . 0.0 109.611 179.897 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.506 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 47.3 Cg_endo . . . . . 0 N--CA 1.48 0.687 0 N-CA-C 110.495 -0.617 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -148.31 148.7 30.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.899 . . . . 0.0 110.411 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 17.1 t80 -148.24 115.45 6.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.305 -0.872 . . . . 0.0 109.76 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 t -143.55 153.45 42.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.991 -1.068 . . . . 0.0 111.092 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.532 HG22 ' HD2' ' A' ' 8' ' ' PRO . 4.8 p -131.27 168.81 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.516 -0.74 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.645 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -93.22 -63.1 0.16 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.864 -1.147 . . . . 0.0 110.329 179.965 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.645 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 55.2 Cg_endo -84.66 99.9 0.74 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 O-C-N 123.159 1.084 . . . . 0.0 110.08 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.03 -0.8 50.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.997 -1.065 . . . . 0.0 110.352 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.1 p -151.49 165.64 33.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.903 . . . . 0.0 109.95 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.09 64.27 3.91 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.44 ' O ' ' CE2' ' A' ' 109' ' ' PHE . 4.7 mt -117.03 139.63 50.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.412 -1.052 . . . . 0.0 110.337 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 15.0 t -100.96 158.72 15.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 110.241 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 4.4 p-10 -68.84 112.4 5.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 0.0 110.14 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.1 -24.92 21.9 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 37.6 tt0 -59.36 155.29 14.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.29 -1.123 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 18' ' ' VAL . 20.7 t -99.32 -179.17 4.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.478 -0.763 . . . . 0.0 110.245 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.794 HG23 ' HB3' ' A' ' 65' ' ' PHE . 14.0 m -154.55 176.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 0.0 110.045 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.5 m -118.25 123.73 46.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 110.094 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.27 151.3 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.155 -0.966 . . . . 0.0 110.299 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.9 m -140.62 123.35 16.25 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.406 -0.809 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 84.7 t -113.88 132.69 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 75.5 m -145.12 128.28 16.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.041 . . . . 0.0 110.59 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 140.02 -57.39 0.6 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.76 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -54.63 -167.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -1.163 . . . . 0.0 109.741 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.551 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -159.35 156.14 28.03 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.032 -1.043 . . . . 0.0 110.669 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.7 121.87 1.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.644 -0.66 . . . . 0.0 110.968 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.76 10.56 3.91 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 4.4 mm-40 -146.36 119.07 8.59 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.071 -1.252 . . . . 0.0 110.843 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.417 HG23 ' OG1' ' A' ' 54' ' ' THR . 88.0 m -105.92 114.11 28.06 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.973 ' CE1' HD22 ' A' ' 100' ' ' LEU . 32.2 m-85 -96.85 -178.16 4.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.1 -1.0 . . . . 0.0 111.769 -179.804 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 31' ' ' TYR . 22.4 m-85 -134.54 124.43 25.48 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 33' ' ' ILE . 3.3 tt -105.41 119.66 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.904 -1.123 . . . . 0.0 110.991 -179.823 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . . . -152.96 171.85 17.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.331 -0.856 . . . . 0.0 110.01 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 6.1 pt20 -127.52 156.27 42.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.24 -0.913 . . . . 0.0 110.006 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 9.6 m -140.73 169.51 17.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.12 -0.988 . . . . 0.0 110.383 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.07 163.13 25.69 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.331 -0.856 . . . . 0.0 110.028 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -79.05 170.29 18.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.951 1.501 . . . . 0.0 110.635 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.466 HG12 HG22 ' A' ' 84' ' ' VAL . 1.5 m . . . . . 0 N--CA 1.502 2.149 0 O-C-N 121.335 -0.853 . . . . 0.0 110.305 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 121.344 0.592 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -159.3 175.24 13.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.358 -0.839 . . . . 0.0 110.072 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 38.9 t -158.95 165.92 33.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.346 -0.846 . . . . 0.0 110.242 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.504 ' ND2' HG23 ' A' ' 49' ' ' THR . 57.1 t-20 -97.29 121.29 59.12 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.295 -0.878 . . . . 0.0 110.629 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -81.75 -33.41 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.936 1.493 . . . . 0.0 110.822 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.81 96.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.192 -0.943 . . . . 0.0 110.595 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.504 HG23 ' ND2' ' A' ' 46' ' ' ASN . 54.1 p -78.05 5.72 9.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 0.0 110.443 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.568 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -84.12 88.76 7.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 110.565 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.549 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 12.8 t -99.53 174.49 6.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.556 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 2.8 t -131.78 148.42 52.56 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.988 -1.07 . . . . 0.0 111.063 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 24.9 p90 -150.3 151.62 33.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.508 -0.745 . . . . 0.0 109.343 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.417 ' OG1' HG23 ' A' ' 30' ' ' THR . 10.4 m -119.84 155.54 32.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.028 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.76 HG21 ' CB ' ' A' ' 25' ' ' ALA . 3.8 p -67.13 -158.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.298 -0.876 . . . . 0.0 110.297 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 8.8 m-20 -143.75 -162.93 1.55 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.06 -1.025 . . . . 0.0 109.985 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.77 -40.21 96.13 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.096 -1.002 . . . . 0.0 109.188 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 t -90.27 10.77 23.43 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.516 -0.74 . . . . 0.0 109.507 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.551 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 59.35 61.06 7.71 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.59 135.18 23.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.282 -1.128 . . . . 0.0 110.088 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -137.13 84.92 2.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 110.92 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.11 118.31 36.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.115 -0.991 . . . . 0.0 108.619 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -151.98 179.55 8.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.952 -1.092 . . . . 0.0 110.908 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.6 p -89.6 157.16 18.15 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.544 -0.722 . . . . 0.0 110.156 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.794 ' HB3' HG23 ' A' ' 18' ' ' VAL . 34.4 t80 -138.41 177.43 7.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.423 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.435 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.5 t -135.87 155.18 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.817 -1.177 . . . . 0.0 110.108 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 12' ' ' LEU . 25.7 m -133.25 169.76 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.432 -0.792 . . . . 0.0 109.814 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 1.3 ttt85 -149.1 141.9 24.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.202 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -74.16 -48.07 31.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 110.22 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 95.4 p -119.9 144.75 47.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.933 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.543 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 21.5 p90 -162.01 142.79 10.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.112 -0.992 . . . . 0.0 110.693 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 54.1 m -55.66 122.29 11.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.304 -0.872 . . . . 0.0 109.877 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.1 168.78 13.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.389 -1.065 . . . . 0.0 109.979 -180.0 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 90.7 p . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.372 0.606 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.466 HG22 HG12 ' A' ' 39' ' ' VAL . 78.0 t -112.19 153.79 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.279 -0.888 . . . . 0.0 110.134 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -140.11 126.05 19.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 110.147 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 43.3 t -85.03 43.51 1.01 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.196 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.35 -52.13 5.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 110.193 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.6 t -101.28 1.08 38.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.124 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.36 -162.84 0.91 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.17 -0.956 . . . . 0.0 110.288 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.26 136.03 51.42 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.868 . . . . 0.0 110.151 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 2.3 p -125.05 127.79 47.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 110.071 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -107.89 165.75 11.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.377 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 107' ' ' LEU . 7.8 tp -128.54 110.71 12.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 109.544 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.642 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -116.28 162.58 12.59 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.298 -179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.39 167.87 13.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.978 . . . . 0.0 109.869 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 115.8 -166.05 12.24 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.403 ' CG ' ' N ' ' A' ' 98' ' ' SER . 7.9 t30 -147.59 168.71 21.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -1.177 . . . . 0.0 110.222 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.403 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 1.6 m -49.71 107.12 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 121.9 -46.69 1.09 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.973 HD22 ' CE1' ' A' ' 31' ' ' TYR . 0.4 OUTLIER -103.05 163.14 12.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -1.142 . . . . 0.0 110.135 179.987 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -146.68 131.25 17.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.333 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 4' ' ' PHE . 97.8 mt -106.96 -45.55 4.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.087 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.17 173.11 29.38 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.642 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 9.4 m80 -140.85 108.32 5.57 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.343 -1.092 . . . . 0.0 109.94 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.525 HG11 HG12 ' A' ' 6' ' ' VAL . 1.9 t -90.21 113.67 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.32 -0.863 . . . . 0.0 110.445 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.69 130.87 47.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.169 -0.957 . . . . 0.0 109.88 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.876 HD11 ' HB2' ' A' ' 93' ' ' LEU . 31.5 mt -100.29 166.61 10.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.1 -1.0 . . . . 0.0 110.175 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -137.03 161.52 35.85 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.282 -0.886 . . . . 0.0 110.013 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 7.2 m-85 -139.65 148.16 42.03 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.349 -0.844 . . . . 0.0 110.05 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.04 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.964 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.502 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 46.1 Cg_endo . . . . . 0 N--CA 1.48 0.725 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -147.06 124.81 11.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.103 -0.998 . . . . 0.0 110.427 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.514 ' HE2' HD12 ' A' ' 33' ' ' ILE . 14.1 t80 -138.76 114.6 10.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.408 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.455 ' HA ' HG21 ' A' ' 105' ' ' VAL . 34.2 t -150.43 172.24 15.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.987 -1.071 . . . . 0.0 110.943 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.546 HG23 HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -130.02 145.55 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.854 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.622 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -66.17 -66.99 1.07 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.974 -1.079 . . . . 0.0 109.906 179.993 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.799 ' O ' HD21 ' A' ' 12' ' ' LEU . 56.0 Cg_endo -79.27 69.47 7.91 Favored 'Trans proline' 0 N--CA 1.483 0.873 0 O-C-N 123.465 1.245 . . . . 0.0 110.081 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.41 -11.92 59.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.951 -1.093 . . . . 0.0 110.481 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.8 126.23 31.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 110.164 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.9 71.69 1.25 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.799 HD21 ' O ' ' A' ' 8' ' ' PRO . 91.5 mt -112.57 165.67 12.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -1.144 . . . . 0.0 110.077 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -133.22 148.56 52.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.152 -0.967 . . . . 0.0 110.487 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -60.43 129.5 41.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.887 . . . . 0.0 110.141 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.01 -30.56 5.79 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -57.26 151.96 14.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.362 -1.081 . . . . 0.0 110.411 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -101.97 135.03 44.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.389 -0.819 . . . . 0.0 110.088 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.525 HG11 HG11 ' A' ' 67' ' ' VAL . 18.2 m -100.95 171.25 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.981 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.96 114.09 24.16 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.028 -1.045 . . . . 0.0 109.968 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.546 HG22 HG23 ' A' ' 6' ' ' VAL . 17.6 t -101.6 149.27 6.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.264 -0.897 . . . . 0.0 110.297 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.0 t -150.02 128.18 12.0 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.483 -0.76 . . . . 0.0 110.183 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 52.4 t -120.71 137.69 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 109.887 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.719 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 2.3 p -150.52 111.0 4.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.957 -1.089 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 160.95 -52.14 0.34 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.583 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -60.27 -151.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -1.131 . . . . 0.0 110.096 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.531 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -167.83 163.51 14.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.137 -0.977 . . . . 0.0 110.545 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -50.24 128.75 20.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.557 -0.714 . . . . 0.0 111.059 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.432 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 122.36 7.94 7.34 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.526 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 5.7 mm-40 -141.3 129.72 22.49 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.093 -1.239 . . . . 0.0 110.687 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.568 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.7 m -115.02 151.94 33.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 109.324 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 30' ' ' THR . 7.9 m-85 -139.7 -178.16 5.29 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.902 -1.124 . . . . 0.0 111.298 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 52' ' ' SER . 55.4 m-85 -132.99 108.35 8.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.744 HG22 HG23 ' A' ' 51' ' ' THR . 4.1 tt -87.56 125.44 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.154 -0.966 . . . . 0.0 110.851 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.729 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -152.1 165.21 35.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.24 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.457 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 1.0 OUTLIER -118.05 150.85 38.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.204 -0.935 . . . . 0.0 110.029 179.986 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 72.2 m -150.8 164.65 35.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.897 . . . . 0.0 111.001 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.42 149.41 22.73 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.706 . . . . 0.0 109.495 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.52 164.42 32.93 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.839 1.442 . . . . 0.0 110.536 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.538 HG12 HG22 ' A' ' 84' ' ' VAL . 17.4 m . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.333 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.255 0.55 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -110.52 150.71 28.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.155 -0.966 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.422 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.3 m -136.65 160.38 39.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.261 -0.899 . . . . 0.0 110.267 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -108.84 95.37 16.84 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.242 -0.911 . . . . 0.0 110.369 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 48.8 Cg_endo -76.55 -30.45 5.05 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.966 1.508 . . . . 0.0 110.452 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.84 -38.95 70.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.309 -0.869 . . . . 0.0 110.295 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.49 36.82 1.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.817 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.3 144.11 28.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.489 -0.757 . . . . 0.0 110.788 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.744 HG23 HG22 ' A' ' 33' ' ' ILE . 11.0 t -151.22 143.51 24.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.833 . . . . 0.0 109.736 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.496 ' HB3' ' CE1' ' A' ' 32' ' ' TYR . 12.2 p -109.76 151.61 26.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.083 -1.011 . . . . 0.0 110.532 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -151.14 136.22 17.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.52 ' OG1' HG23 ' A' ' 30' ' ' THR . 26.3 m -102.15 171.95 7.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.256 -0.902 . . . . 0.0 110.571 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.583 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -84.89 -160.89 0.52 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.301 -0.874 . . . . 0.0 110.222 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 1.6 m-20 -149.1 -157.88 0.86 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.205 -0.935 . . . . 0.0 109.827 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.7 -53.66 55.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.91 -1.119 . . . . 0.0 109.997 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 t -87.12 16.17 5.38 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.265 -0.897 . . . . 0.0 109.215 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 56.84 48.79 75.63 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.0 129.98 56.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.282 -1.128 . . . . 0.0 110.426 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.572 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -132.18 85.1 2.21 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.331 -0.856 . . . . 0.0 110.077 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.7 p -110.63 134.3 52.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 109.901 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 25.8 p90 -163.85 173.64 12.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.233 -0.917 . . . . 0.0 110.504 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 t -94.08 137.9 32.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.797 . . . . 0.0 110.446 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.485 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 55.8 t80 -127.39 -179.46 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.532 -0.73 . . . . 0.0 109.374 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.485 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.2 t -128.02 154.92 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.853 -1.154 . . . . 0.0 110.209 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 22.2 m -129.0 178.67 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.373 -0.83 . . . . 0.0 110.111 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 3.0 mtp180 -150.31 118.66 6.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.849 . . . . 0.0 110.313 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 11.2 ttmt -49.81 -36.71 27.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.197 -0.939 . . . . 0.0 109.773 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.64 141.81 31.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.902 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.469 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 24.2 p90 -151.67 141.76 22.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -66.51 136.93 56.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.173 -179.933 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.74 170.38 49.06 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.208 -1.172 . . . . 0.0 110.231 -179.976 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.401 0.619 . . . . 0.0 110.841 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.538 HG22 HG12 ' A' ' 39' ' ' VAL . 56.0 t -112.01 108.71 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 109.546 179.844 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -88.24 135.78 33.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 0.0 110.246 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 91' ' ' CYS . 7.5 m -110.79 41.82 1.72 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.88 -52.01 3.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 109.964 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -99.17 -9.24 24.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.861 . . . . 0.0 110.063 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.87 -133.41 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 109.935 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -151.05 97.26 2.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.082 -1.011 . . . . 0.0 110.807 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -88.51 113.41 24.07 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.184 -0.948 . . . . 0.0 109.048 179.914 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 16.6 p30 -113.48 129.73 56.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.972 -1.08 . . . . 0.0 111.293 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 34' ' ' ALA . 13.1 tp -99.43 111.13 23.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.366 -0.834 . . . . 0.0 109.373 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -125.43 171.92 17.39 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 102' ' ' LEU . . . -134.84 178.98 6.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -1.078 . . . . 0.0 110.021 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 138.48 157.56 7.45 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.42 ' OD1' ' HB2' ' A' ' 98' ' ' SER . 8.2 p30 -107.55 -29.19 9.33 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.28 -1.129 . . . . 0.0 110.328 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.42 ' HB2' ' OD1' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -172.18 -72.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.7 -10.7 32.37 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.54 ' CD2' ' CE1' ' A' ' 31' ' ' TYR . 21.5 tp -73.78 -64.59 0.97 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.02 -1.282 . . . . 0.0 110.196 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 92.3 m-20 55.29 103.33 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -79.01 -6.11 55.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 110.374 179.966 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 94' ' ' GLY . . . 106.97 -175.39 20.62 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.476 ' O ' ' ND1' ' A' ' 104' ' ' HIS . 34.2 p80 -148.7 132.22 16.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.251 -1.146 . . . . 0.0 110.132 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.455 HG21 ' HA ' ' A' ' 5' ' ' SER . 54.4 t -93.83 130.46 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.147 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.47 114.29 8.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 110.408 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HB3' HD12 ' A' ' 12' ' ' LEU . 34.7 mt -93.2 136.5 33.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.848 . . . . 0.0 110.354 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.594 HG22 ' N ' ' A' ' 109' ' ' PHE . 98.3 m -107.25 173.2 6.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.291 -0.88 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.594 ' N ' HG22 ' A' ' 108' ' ' THR . 7.6 m-85 -142.8 122.69 13.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.889 . . . . 0.0 110.292 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.973 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.476 ' HG2' ' HA ' ' A' ' 102' ' ' LEU . 47.1 Cg_endo . . . . . 0 N--CA 1.483 0.854 0 N-CA-C 110.551 -0.596 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -132.13 146.7 52.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.222 -0.924 . . . . 0.0 110.596 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 12.4 t80 -149.5 113.17 5.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.462 -0.774 . . . . 0.0 109.592 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.62 ' HA ' HG21 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -151.15 167.02 29.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.032 -1.042 . . . . 0.0 110.959 -179.9 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.646 HG12 HG11 ' A' ' 105' ' ' VAL . 7.5 p -128.25 141.05 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.725 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -55.88 -67.38 0.77 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.08 -1.012 . . . . 0.0 110.289 -179.965 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 49.5 Cg_endo -74.4 82.81 1.8 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.386 1.203 . . . . 0.0 109.807 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.65 1.99 52.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.975 . . . . 0.0 110.501 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.8 p -150.27 148.89 29.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.252 -0.905 . . . . 0.0 110.165 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.3 58.71 3.55 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mt -105.44 170.63 7.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.303 -1.116 . . . . 0.0 110.45 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.47 149.4 43.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 110.183 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.8 96.94 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.83 -34.06 3.23 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -54.22 142.89 24.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 110.143 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 66.3 m -91.68 134.09 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 110.069 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.614 HG11 HG11 ' A' ' 67' ' ' VAL . 23.2 m -100.88 148.86 6.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 110.168 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.21 106.1 18.11 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.34 -0.85 . . . . 0.0 109.309 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.525 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 36.9 t -93.37 149.74 4.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.499 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.75 119.27 5.63 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.857 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.85 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 23.8 t -107.08 132.51 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.771 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.673 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 30.3 m -127.77 120.36 27.72 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 148.75 -77.69 0.23 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.609 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -47.12 172.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.216 -1.167 . . . . 0.0 110.029 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.542 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -139.6 161.63 37.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 110.464 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -39.04 122.79 1.25 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.674 -0.641 . . . . 0.0 110.653 -179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.57 0.76 7.84 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.497 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 30.9 mm-40 -132.93 130.51 39.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -1.184 . . . . 0.0 110.597 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.427 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 57.5 m -106.34 161.25 14.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.503 -0.748 . . . . 0.0 109.659 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.72 ' HE1' HD22 ' A' ' 100' ' ' LEU . 80.1 m-85 -149.96 176.47 10.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.041 -1.037 . . . . 0.0 110.552 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 17.7 m-85 -122.78 147.62 46.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.456 -0.778 . . . . 0.0 109.093 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.585 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 5.2 tt -128.35 116.53 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.955 -1.091 . . . . 0.0 110.15 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.615 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -148.46 158.58 44.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.917 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.45 ' OE1' ' HB3' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -93.62 136.12 34.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.608 -0.682 . . . . 0.0 109.958 179.912 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.2 m -142.98 143.39 31.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.783 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -144.89 174.72 3.24 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.454 -0.778 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.783 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 43.1 Cg_endo -71.86 165.67 31.86 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.733 1.386 . . . . 0.0 110.351 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.4 p . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.297 -0.877 . . . . 0.0 110.366 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.363 0.601 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.473 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -117.37 151.9 36.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.35 -0.844 . . . . 0.0 109.895 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.49 ' O ' ' HA2' ' A' ' 73' ' ' GLY . 2.4 m -116.05 164.34 14.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.153 -0.967 . . . . 0.0 110.368 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.47 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 59.3 t-20 -96.0 123.2 56.17 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.275 -0.891 . . . . 0.0 110.174 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.76 -33.74 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.861 1.453 . . . . 0.0 110.681 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.45 -19.77 65.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.346 -0.846 . . . . 0.0 110.815 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.16 32.93 5.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.045 -1.035 . . . . 0.0 110.476 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.52 106.29 18.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.224 -0.922 . . . . 0.0 110.511 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.585 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 14.9 t -131.42 -178.57 4.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.0 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.4 ' CB ' ' CD1' ' A' ' 32' ' ' TYR . 55.6 p -144.12 147.19 33.4 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.115 -0.991 . . . . 0.0 110.839 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 20.6 p90 -136.09 -176.99 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.763 . . . . 0.0 109.539 179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.5 m -145.47 154.32 42.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.796 -1.19 . . . . 0.0 110.256 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.609 HG21 ' HB3' ' A' ' 25' ' ' ALA . 2.0 p -69.99 -158.02 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.209 -0.932 . . . . 0.0 109.915 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 3.3 m-20 -160.03 -155.67 0.45 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.902 -1.124 . . . . 0.0 110.148 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.14 78.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.918 -1.114 . . . . 0.0 109.527 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 t -79.29 4.99 13.51 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.379 -0.825 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 56.05 38.03 74.05 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -124.91 127.19 46.71 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.268 -1.136 . . . . 0.0 110.104 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.85 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -101.14 80.35 2.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 110.365 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.9 m -101.08 120.18 39.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.676 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.525 ' CE1' ' HB ' ' A' ' 20' ' ' VAL . 7.0 p90 -155.73 174.79 14.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.192 -0.942 . . . . 0.0 110.833 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.5 m -98.32 132.6 43.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 40.5 t80 -130.35 179.63 5.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.443 -0.786 . . . . 0.0 109.238 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.467 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.8 t -129.38 155.9 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.81 -1.181 . . . . 0.0 110.352 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.614 HG11 HG11 ' A' ' 18' ' ' VAL . 31.8 m -125.21 159.02 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.404 -0.81 . . . . 0.0 110.357 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -133.21 132.9 42.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.263 -0.898 . . . . 0.0 110.034 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -72.8 -10.83 60.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.137 -0.977 . . . . 0.0 110.362 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.2 p -150.29 139.37 21.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.131 -0.981 . . . . 0.0 110.536 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 9.6 p90 -168.09 138.76 2.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.299 -0.876 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.2 OUTLIER -68.68 137.34 54.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.258 -0.901 . . . . 0.0 110.091 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 45' ' ' CYS . . . -121.7 -166.48 12.88 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 p . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.305 -1.115 . . . . 0.0 110.138 -179.997 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.307 0.575 . . . . 0.0 110.283 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 44' ' ' ALA . 74.0 t -125.21 159.1 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.383 -0.823 . . . . 0.0 110.21 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -154.75 146.61 23.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.882 . . . . 0.0 110.056 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.81 17.73 22.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 110.105 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.62 -42.78 61.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 110.674 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -117.74 -16.42 10.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.148 -0.97 . . . . 0.0 110.361 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.43 147.09 34.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.953 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.17 154.51 27.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 0.0 110.178 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.45 ' HB3' ' OE1' ' A' ' 35' ' ' GLN . 82.7 m -120.93 162.74 19.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 0.0 110.329 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -146.09 121.3 10.18 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.31 -0.868 . . . . 0.0 110.237 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 34' ' ' ALA . 45.2 tp -86.95 112.1 21.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.046 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -121.14 163.37 14.61 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.501 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 102' ' ' LEU . . . -132.42 159.07 40.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.551 -0.97 . . . . 0.0 110.507 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 101' ' ' ASP . . . 169.31 159.2 14.45 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 31' ' ' TYR . 11.9 p-10 -143.34 -41.14 0.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.991 -1.299 . . . . 0.0 111.246 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.43 78.01 1.2 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.951 -1.093 . . . . 0.0 111.294 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.45 9.24 29.97 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.72 HD22 ' HE1' ' A' ' 31' ' ' TYR . 1.6 tt -99.35 -51.33 3.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.285 . . . . 0.0 109.827 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.523 ' HA ' ' CA ' ' A' ' 96' ' ' GLY . 1.1 m-20 54.21 164.54 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.485 -0.759 . . . . 0.0 110.123 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 31.7 mt -126.36 -47.68 1.59 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.904 -179.984 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 167.35 174.35 36.36 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.416 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -129.56 126.77 39.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.851 -0.793 . . . . 0.0 109.652 -179.985 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.646 HG11 HG12 ' A' ' 6' ' ' VAL . 20.0 t -108.23 120.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.048 -1.032 . . . . 0.0 110.439 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.06 107.55 10.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.932 . . . . 0.0 109.382 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 12.6 mt -88.61 171.86 9.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.308 -0.87 . . . . 0.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -147.77 158.68 44.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.449 -0.782 . . . . 0.0 109.838 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -122.16 119.85 32.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.058 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.59 179.997 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 N--CA 1.482 0.838 0 N-CA-C 110.49 -0.619 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -154.04 121.77 5.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.897 . . . . 0.0 110.334 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -141.47 110.79 6.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.211 -0.931 . . . . 0.0 109.562 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.8 t -150.69 161.13 43.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.078 -1.014 . . . . 0.0 110.999 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.91 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 6.2 p -114.93 160.42 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.494 -0.754 . . . . 0.0 109.674 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -62.96 -66.52 1.5 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.048 -1.032 . . . . 0.0 110.561 -179.993 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.758 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 43.1 Cg_endo -73.54 -73.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.424 1.223 . . . . 0.0 110.591 -179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.91 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 75.26 -1.04 3.15 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.443 -0.786 . . . . 0.0 110.203 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.446 ' OG ' ' C ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER -164.21 145.42 8.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 110.248 -179.951 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.96 41.22 61.83 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 108' ' ' THR . 1.3 mp -90.78 174.79 7.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -1.164 . . . . 0.0 110.091 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 1.5 t -128.56 150.34 50.24 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.361 -0.837 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 6.2 p-10 -56.94 108.04 0.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.189 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.92 -35.19 5.09 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.4 tt0 -45.95 152.94 0.33 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.303 -1.116 . . . . 0.0 110.357 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 3.6 p -103.53 154.4 19.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.403 -0.811 . . . . 0.0 110.378 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.1 m -129.13 150.23 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.302 -0.874 . . . . 0.0 110.026 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 m -94.91 115.15 27.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.136 -0.978 . . . . 0.0 109.842 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t -100.8 147.65 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 2.8 t -146.06 139.3 25.95 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.47 -0.769 . . . . 0.0 110.469 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 47.6 t -128.29 153.59 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.526 -0.734 . . . . 0.0 110.007 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.56 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 7.3 m -165.89 120.89 1.23 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.946 -1.096 . . . . 0.0 110.672 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 25' ' ' ALA . . . 139.29 -59.98 0.58 Allowed Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.354 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.75 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -39.53 -47.9 1.95 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.199 -1.177 . . . . 0.0 110.985 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 25' ' ' ALA . . . 73.99 141.79 0.07 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.398 -0.814 . . . . 0.0 110.595 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -39.13 136.33 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.527 0.68 . . . . 0.0 110.866 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.01 12.55 4.36 Favored Glycine 0 N--CA 1.481 1.643 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -156.3 126.73 6.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.056 -1.261 . . . . 0.0 110.62 179.975 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.809 HG23 ' OG1' ' A' ' 54' ' ' THR . 1.6 m -94.1 143.11 26.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.463 -0.773 . . . . 0.0 109.858 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.618 ' CE1' HD22 ' A' ' 100' ' ' LEU . 25.7 m-85 -134.34 146.14 49.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.08 -1.012 . . . . 0.0 111.154 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.609 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 97.5 m-85 -113.86 124.48 52.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.389 -0.82 . . . . 0.0 109.05 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.763 ' CG2' HG23 ' A' ' 51' ' ' THR . 12.4 tt -96.3 120.44 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.83 -1.169 . . . . 0.0 110.652 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.477 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -152.07 153.29 33.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 110.142 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . 14.3 pt20 -121.41 150.39 41.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.111 -0.993 . . . . 0.0 110.288 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 96.6 m -152.02 164.28 37.53 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.202 -0.936 . . . . 0.0 111.095 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -153.06 158.47 32.86 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.662 -0.649 . . . . 0.0 109.978 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.01 173.11 8.83 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.792 1.417 . . . . 0.0 110.668 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.78 ' O ' HG22 ' A' ' 39' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.242 -0.912 . . . . 0.0 111.043 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.4 0.619 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.48 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -140.17 151.17 45.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.455 -0.778 . . . . 0.0 109.741 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.505 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 0.8 OUTLIER -139.77 161.62 37.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 0.0 110.444 179.97 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -107.9 89.81 5.82 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.344 -0.848 . . . . 0.0 110.179 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 48.6 Cg_endo -76.27 -31.79 4.44 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.974 1.513 . . . . 0.0 110.681 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.3 -27.16 63.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.304 -0.873 . . . . 0.0 110.438 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 p -108.55 39.18 2.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 110.149 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.31 138.9 31.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 110.414 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.763 HG23 ' CG2' ' A' ' 33' ' ' ILE . 3.7 t -153.1 134.96 14.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.892 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.609 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 87.9 p -108.04 145.09 34.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.727 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 14.7 p90 -150.97 -175.75 5.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 109.586 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.809 ' OG1' HG23 ' A' ' 30' ' ' THR . 7.0 m -145.5 160.53 41.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.178 -0.951 . . . . 0.0 109.627 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.71 HG21 ' HB3' ' A' ' 25' ' ' ALA . 3.0 p -60.72 -162.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.94 -1.1 . . . . 0.0 109.966 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -143.19 -164.24 1.81 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.044 -1.035 . . . . 0.0 109.879 -179.981 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.11 67.02 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.036 -1.04 . . . . 0.0 109.414 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.2 p -89.73 18.28 5.71 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 59.13 29.38 65.44 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -105.99 123.82 48.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.293 -1.122 . . . . 0.0 110.499 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.761 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -126.5 85.12 2.34 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.6 p -106.15 124.94 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.235 -0.916 . . . . 0.0 109.699 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.639 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 4.8 p90 -153.89 177.03 11.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.076 -1.015 . . . . 0.0 110.645 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.39 141.31 28.87 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.5 -0.75 . . . . 0.0 110.625 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.432 ' C ' ' CG2' ' A' ' 66' ' ' VAL . 45.8 t80 -138.78 -174.75 3.92 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.432 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 3.2 t -147.22 161.54 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.824 -1.173 . . . . 0.0 110.242 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 26.7 m -133.64 -177.04 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.397 -0.814 . . . . 0.0 110.012 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 26.4 mtt180 -158.45 123.29 4.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.038 -1.039 . . . . 0.0 110.629 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.54 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 10.9 tttm -62.42 -43.59 98.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.867 . . . . 0.0 109.556 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m -127.97 118.88 24.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -131.24 143.63 50.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.953 . . . . 0.0 110.461 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.5 m -60.91 141.91 56.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.96 . . . . 0.0 109.885 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.48 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -127.76 154.76 19.84 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.394 -1.062 . . . . 0.0 110.274 179.986 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 69.8 m . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.277 0.561 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.442 HG21 ' CB ' ' A' ' 44' ' ' ALA . 70.9 t -122.41 149.58 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.213 -0.929 . . . . 0.0 109.999 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -127.58 162.35 26.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.168 -0.957 . . . . 0.0 110.553 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 89' ' ' ALA . 19.1 m -106.36 -9.76 16.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 0.0 110.095 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.16 -52.55 9.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.345 -0.847 . . . . 0.0 110.334 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.6 t -71.36 -19.6 62.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.15 -0.969 . . . . 0.0 109.866 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 86' ' ' CYS . . . -133.12 -160.17 1.03 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.391 -0.818 . . . . 0.0 109.873 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.88 135.11 45.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.173 -0.955 . . . . 0.0 109.857 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 1.9 p -121.27 146.7 46.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.133 -0.979 . . . . 0.0 109.774 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -127.6 147.84 50.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.09 -1.006 . . . . 0.0 111.146 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 34' ' ' ALA . 8.0 tp -119.05 114.75 22.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.455 -0.778 . . . . 0.0 109.053 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -129.13 178.77 17.11 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.578 -1.296 . . . . 0.0 110.26 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -140.73 172.33 12.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.394 -1.062 . . . . 0.0 110.163 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 144.74 169.4 13.28 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' CG ' ' N ' ' A' ' 98' ' ' SER . 5.2 p30 -89.47 -45.19 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -1.187 . . . . 0.0 110.276 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.473 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER 171.54 -41.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.429 -0.795 . . . . 0.0 109.955 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.84 -12.41 22.52 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.618 HD22 ' CE1' ' A' ' 31' ' ' TYR . 1.1 tt -87.21 -65.83 0.97 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.196 -1.179 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 100' ' ' LEU . 13.9 t0 68.17 75.13 0.28 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.348 -0.845 . . . . 0.0 110.012 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.99 -36.53 28.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.335 -0.853 . . . . 0.0 110.45 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.44 170.37 13.13 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.439 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -135.31 125.74 26.66 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.216 -1.167 . . . . 0.0 109.91 179.983 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.48 124.54 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.985 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.07 125.52 25.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.246 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 107' ' ' LEU . 76.6 mt -95.84 164.99 12.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.291 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.566 ' O ' HD12 ' A' ' 12' ' ' LEU . 6.2 m -158.5 175.99 12.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.311 -0.868 . . . . 0.0 110.054 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.54 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 69.0 m-85 -142.64 152.0 42.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.308 -0.87 . . . . 0.0 110.277 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.039 -1.423 . . . . 0.0 109.598 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.903 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.903 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 47.7 Cg_endo -74.74 -171.0 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.797 1.42 . . . . 0.0 110.226 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.77 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -140.62 123.18 16.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 110.796 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.452 ' HD1' HG22 ' A' ' 22' ' ' VAL . 81.9 t80 -141.52 100.22 3.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.502 -0.749 . . . . 0.0 109.119 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.11 172.12 13.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 110.978 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 6' ' ' VAL . 5.2 p -137.02 128.44 42.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.642 -0.661 . . . . 0.0 109.612 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.635 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.1 m -46.62 -72.89 0.12 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.117 . . . . 0.0 110.221 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.635 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 53.0 Cg_endo -75.9 97.77 1.14 Allowed 'Trans proline' 0 N--CA 1.483 0.87 0 O-C-N 123.04 1.021 . . . . 0.0 110.031 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.32 4.4 41.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.13 -0.981 . . . . 0.0 110.25 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.6 p -155.57 167.7 29.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 110.245 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.39 42.22 97.37 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.541 ' O ' ' CE2' ' A' ' 109' ' ' PHE . 85.3 mt -90.43 136.83 32.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.303 -1.116 . . . . 0.0 110.137 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.487 ' HB2' ' OE1' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -110.75 156.53 20.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 110.459 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 8.1 p-10 -57.22 119.28 6.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.04 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.42 -35.5 4.86 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.487 ' OE1' ' HB2' ' A' ' 13' ' ' SER . 33.4 tt0 -48.72 142.65 5.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -1.116 . . . . 0.0 110.044 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 58.9 p -95.3 161.6 14.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.351 -0.843 . . . . 0.0 110.597 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.542 HG23 ' HB3' ' A' ' 65' ' ' PHE . 16.5 m -132.29 151.07 34.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.412 -0.805 . . . . 0.0 109.636 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 1.5 m -99.35 122.02 41.9 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.063 -1.023 . . . . 0.0 109.804 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.483 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 7.4 t -110.95 146.47 15.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.38 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.0 p -140.68 128.64 21.97 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.389 -0.819 . . . . 0.0 110.397 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.792 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 39.9 t -121.66 100.78 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.77 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.4 OUTLIER -130.23 110.21 11.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.978 . . . . 0.0 110.251 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 169.32 -50.71 0.21 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.922 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -59.97 -138.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -1.131 . . . . 0.0 109.883 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -179.11 164.56 1.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.976 -1.078 . . . . 0.0 110.347 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.804 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . . . -54.26 128.89 33.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.398 -0.814 . . . . 0.0 110.479 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 119.69 18.92 4.24 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 9.5 mm-40 -154.9 127.31 7.87 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.235 -1.156 . . . . 0.0 110.457 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.471 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -93.56 170.1 9.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.344 -0.848 . . . . 0.0 109.952 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 79.5 m-85 -152.94 155.44 37.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.416 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 78.8 m-85 -122.81 111.25 16.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.663 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.752 HG23 HG23 ' A' ' 51' ' ' THR . 5.4 tt -95.98 120.91 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.102 -0.999 . . . . 0.0 110.433 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.66 160.37 43.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.112 -0.992 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.522 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 25.3 tt0 -114.15 133.56 55.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.64 -0.662 . . . . 0.0 109.219 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 66.0 m -139.49 156.24 47.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.985 -1.072 . . . . 0.0 111.146 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.63 144.0 16.92 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 41.6 Cg_endo -69.97 159.95 51.38 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.819 1.431 . . . . 0.0 110.68 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 42' ' ' GLN . 6.6 m -127.91 162.77 33.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.517 -0.739 . . . . 0.0 110.02 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -50.94 -22.62 6.31 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.26 -70.17 1.3 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.772 ' H ' HG23 ' A' ' 39' ' ' VAL . 2.9 tp-100 -147.79 -86.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -1.0 . . . . 0.0 110.407 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 7.1 m-20 -150.99 153.46 35.22 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.146 -0.971 . . . . 0.0 110.36 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.442 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -144.89 151.69 39.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.18 -0.95 . . . . 0.0 110.321 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 m -131.23 155.11 47.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.309 -0.869 . . . . 0.0 110.199 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.465 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 36.2 t-20 -87.9 124.08 67.78 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.07 -1.019 . . . . 0.0 110.195 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -81.83 -41.06 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.898 1.473 . . . . 0.0 111.046 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.63 93.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.321 -0.862 . . . . 0.0 111.021 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 47.7 p -80.64 7.14 10.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.142 -0.974 . . . . 0.0 110.365 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.78 104.98 6.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 110.223 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.752 HG23 HG23 ' A' ' 33' ' ' ILE . 9.8 t -136.9 163.16 31.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.884 . . . . 0.0 110.197 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -132.8 162.19 32.13 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 110.241 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 46.6 p90 -151.23 171.06 18.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.439 -0.788 . . . . 0.0 109.659 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.6 m -130.97 155.99 45.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.137 -0.977 . . . . 0.0 110.139 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.922 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -88.75 176.11 7.22 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.095 -1.003 . . . . 0.0 110.187 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.804 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 11.0 t70 -177.13 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.183 -0.948 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.43 86.92 0.07 Allowed 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.212 -0.93 . . . . 0.0 109.13 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.95 15.95 8.8 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 79.1 52.27 4.97 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.07 149.22 28.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -1.168 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.792 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -163.53 78.37 0.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 110.526 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.8 m -101.55 130.28 47.81 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.294 -0.879 . . . . 0.0 109.706 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.483 ' CE1' ' CG1' ' A' ' 20' ' ' VAL . 1.7 p90 -153.32 171.3 18.79 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.005 -1.059 . . . . 0.0 111.086 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.1 m -92.94 125.51 37.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.449 -0.782 . . . . 0.0 110.642 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.542 ' HB3' HG23 ' A' ' 18' ' ' VAL . 28.8 t80 -118.47 -173.07 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.597 -0.689 . . . . 0.0 109.375 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 3.9 t -147.76 167.78 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 120.756 -1.215 . . . . 0.0 110.371 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 13.1 m -139.37 161.78 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 0.0 110.243 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -143.35 122.79 13.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.262 -0.899 . . . . 0.0 110.097 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ARG . 2.7 ttpt -45.63 -48.19 14.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.044 -1.035 . . . . 0.0 109.365 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 6.6 m -127.3 123.81 37.27 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.58 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 28.3 p90 -125.13 140.18 53.11 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.079 -1.013 . . . . 0.0 111.28 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 85.7 m -58.35 99.91 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.396 -0.815 . . . . 0.0 109.957 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.67 177.15 26.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.0 t -158.04 143.63 16.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -1.173 . . . . 0.0 110.193 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.654 HG22 ' HD2' ' A' ' 76' ' ' PRO . 3.9 m -69.8 149.64 96.62 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.855 . . . . 0.0 110.231 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.654 ' HD2' HG22 ' A' ' 75' ' ' THR . 47.6 Cg_endo -82.88 14.68 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.009 1.531 . . . . 0.0 110.404 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -118.31 41.52 2.93 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.193 -0.942 . . . . 0.0 110.171 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.61 23.39 54.9 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 79' ' ' THR . 5.6 m -124.62 87.76 54.23 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.194 -1.18 . . . . 0.0 110.284 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.45 86.06 0.85 Allowed 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.89 1.468 . . . . 0.0 110.187 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.572 HG13 ' N ' ' A' ' 82' ' ' GLY . 5.6 p -51.48 -45.2 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.339 -0.851 . . . . 0.0 110.544 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.572 ' N ' HG13 ' A' ' 81' ' ' VAL . . . 142.58 -144.24 13.75 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 19.4 m -81.27 160.01 24.34 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.337 -1.096 . . . . 0.0 110.762 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 70' ' ' SER . 40.6 t -125.02 148.63 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 59.3 p30 -127.23 166.22 18.16 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.063 -1.023 . . . . 0.0 110.721 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -112.71 1.77 15.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.499 -0.751 . . . . 0.0 110.414 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.32 -58.26 4.66 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.69 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -81.64 -27.38 34.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.116 -0.99 . . . . 0.0 110.501 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.05 176.99 4.78 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.39 155.88 22.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.8 m -116.93 139.11 51.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 0.0 110.185 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -123.29 125.73 45.58 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 110.322 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -102.02 108.52 19.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.283 -0.886 . . . . 0.0 109.078 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.2 163.5 12.38 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.498 -1.334 . . . . 0.0 110.141 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.602 ' O ' HD12 ' A' ' 102' ' ' LEU . . . -155.16 118.27 4.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.449 -1.03 . . . . 0.0 109.872 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.61 -177.06 46.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -118.15 177.41 4.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -1.136 . . . . 0.0 110.265 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.0 t -70.64 -20.12 62.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.127 -0.983 . . . . 0.0 110.146 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.1 -44.05 5.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.755 HD13 ' C ' ' A' ' 100' ' ' LEU . 3.4 tm? -118.87 135.74 54.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.242 -1.152 . . . . 0.0 109.938 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.745 ' N ' HD13 ' A' ' 100' ' ' LEU . 41.0 m-20 -116.12 101.66 8.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.0 . . . . 0.0 110.322 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 95' ' ' ALA . 19.8 mt -66.03 -61.16 2.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 110.003 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.12 -173.98 30.46 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -148.26 150.38 33.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.466 -1.02 . . . . 0.0 110.117 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.504 HG11 HG12 ' A' ' 6' ' ' VAL . 12.0 t -107.77 126.02 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.329 -0.857 . . . . 0.0 110.335 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.9 114.06 10.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.914 . . . . 0.0 109.841 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.522 ' CD1' ' OE1' ' A' ' 35' ' ' GLN . 58.1 mt -81.4 147.03 30.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.94 . . . . 0.0 110.573 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -127.74 158.16 38.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.853 . . . . 0.0 110.096 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 13.1 m-85 -128.74 92.26 3.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.275 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.976 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.433 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -73.19 -162.73 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.86 1.453 . . . . 0.0 110.423 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -162.14 115.5 1.79 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.88 . . . . 0.0 110.405 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -126.96 114.85 18.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.2 m -143.76 170.35 16.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.06 -1.025 . . . . 0.0 110.593 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.917 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 4.0 p -134.5 138.4 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.386 -0.821 . . . . 0.0 110.239 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.543 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -54.84 -57.13 20.79 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.357 -0.839 . . . . 0.0 110.962 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.762 ' HD2' HG22 ' A' ' 6' ' ' VAL . 42.4 Cg_endo -69.09 -87.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.864 1.455 . . . . 0.0 110.797 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.917 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 71.53 14.19 6.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.283 -0.885 . . . . 0.0 109.836 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.2 t -178.13 149.13 0.53 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.88 45.92 62.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' A' ' 8' ' ' PRO . 17.2 mt -98.79 174.3 6.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.326 -1.102 . . . . 0.0 110.231 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.81 159.72 44.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 110.12 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.53 ' HB3' ' CB ' ' A' ' 69' ' ' LYS . 1.5 p30 -59.76 116.33 3.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.265 -0.897 . . . . 0.0 110.206 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.41 -33.6 6.07 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -45.68 154.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -1.108 . . . . 0.0 110.106 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -98.53 172.03 7.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.54 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.4 m -149.09 154.68 9.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.385 -0.822 . . . . 0.0 109.9 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.488 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 0.4 OUTLIER -111.6 114.83 28.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.257 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.7 t -103.72 152.01 6.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.323 -0.861 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 18.8 t -149.36 132.56 16.39 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.492 -0.755 . . . . 0.0 109.998 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.829 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 6.6 t -124.09 153.24 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 110.338 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.661 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 1.0 OUTLIER -161.29 120.01 2.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 131.26 4.85 3.93 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 1.001 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -103.61 -30.04 10.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.998 -1.295 . . . . 0.0 110.374 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.539 ' HA ' ' HA3' ' A' ' 59' ' ' GLY . . . 58.57 133.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.816 0.817 . . . . 0.0 111.43 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -39.08 141.63 0.29 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.538 0.685 . . . . 0.0 110.505 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.19 -10.11 13.44 Favored Glycine 0 C--N 1.288 -2.137 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.485 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 5.1 mm-40 -125.39 123.49 39.44 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.376 -1.073 . . . . 0.0 109.829 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.544 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 71.5 m -97.52 159.62 14.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.386 -0.821 . . . . 0.0 109.767 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 50.4 m-85 -147.38 153.16 39.3 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.192 -0.942 . . . . 0.0 110.344 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 52' ' ' SER . 88.1 m-85 -115.54 108.82 16.95 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 109.372 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.706 HD11 HD21 ' A' ' 93' ' ' LEU . 4.5 tt -98.39 128.35 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.124 -0.985 . . . . 0.0 110.73 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.57 152.0 32.31 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.306 -0.871 . . . . 0.0 110.458 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.4 135.06 33.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.845 . . . . 0.0 109.615 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.6 m -147.21 159.46 43.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 0.0 110.684 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.76 157.0 34.67 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.602 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 44.3 Cg_endo -72.39 163.38 38.78 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.751 1.395 . . . . 0.0 110.764 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 39' ' ' VAL . 16.7 m -133.2 54.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.699 0.762 . . . . 0.0 109.756 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.34 47.8 55.47 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.49 -67.59 0.25 Allowed Glycine 0 N--CA 1.491 2.359 0 O-C-N 121.0 -1.294 . . . . 0.0 110.05 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.446 ' OE1' HG21 ' A' ' 75' ' ' THR . 1.7 mt-30 -116.41 -161.45 0.8 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.351 -1.088 . . . . 0.0 110.365 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 10.0 t70 -127.35 119.97 27.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.317 -0.864 . . . . 0.0 109.831 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.5 158.68 15.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.913 . . . . 0.0 110.427 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.2 168.04 15.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.291 -0.881 . . . . 0.0 110.186 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.525 ' OD1' ' CG ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -104.25 102.74 34.66 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 109.923 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.15 -29.28 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.986 1.519 . . . . 0.0 110.437 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.82 -27.44 68.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.365 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 40.0 p -111.29 30.31 7.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.394 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.3 128.32 34.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 109.929 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.655 ' CG2' HG23 ' A' ' 33' ' ' ILE . 9.0 t -138.22 131.94 31.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.96 . . . . 0.0 110.543 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.491 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 28.8 t -111.91 142.55 44.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.408 -0.808 . . . . 0.0 109.952 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 45.9 p90 -144.24 -174.98 4.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.316 -0.865 . . . . 0.0 110.342 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 55' ' ' THR . 28.2 m -150.01 151.34 33.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.95 . . . . 0.0 109.796 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 1.001 ' CG2' ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -56.19 -160.67 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.024 -1.048 . . . . 0.0 110.529 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.653 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 2.3 m-20 -153.92 -158.29 0.85 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.091 -1.006 . . . . 0.0 110.36 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.27 74.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.873 -1.142 . . . . 0.0 109.671 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.2 m -84.15 10.63 9.74 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.343 -0.848 . . . . 0.0 109.341 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 26' ' ' ALA . . . 52.5 53.76 30.56 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.81 113.3 13.33 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.242 -1.152 . . . . 0.0 110.086 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.829 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -101.54 80.93 2.11 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.396 -0.815 . . . . 0.0 109.806 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 62.1 p -114.67 125.97 54.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 110.118 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.4 p90 -154.59 176.07 12.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.314 -0.866 . . . . 0.0 110.575 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 89.6 p -97.63 119.26 35.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.488 -0.757 . . . . 0.0 110.485 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 51.6 t80 -115.93 174.78 5.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.336 -0.852 . . . . 0.0 109.621 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.562 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 12.6 t -125.48 163.97 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.909 -1.119 . . . . 0.0 110.419 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.91 173.79 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.269 -0.894 . . . . 0.0 110.216 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -148.72 151.29 34.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.292 -0.88 . . . . 0.0 110.125 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.53 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 6.7 tttt -83.93 -39.86 19.25 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.235 -0.916 . . . . 0.0 109.884 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.422 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 28.8 p -132.85 147.29 52.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 109.753 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 12.6 p90 -165.92 148.33 7.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.961 -1.087 . . . . 0.0 111.028 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 13.0 m -64.08 123.3 18.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.311 -0.868 . . . . 0.0 109.638 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.04 175.29 15.88 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 t -165.16 123.7 1.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -1.075 . . . . 0.0 109.854 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.446 HG21 ' OE1' ' A' ' 42' ' ' GLN . 32.1 p -59.94 144.21 86.6 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.922 . . . . 0.0 110.577 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.82 0.95 9.42 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 124.255 1.661 . . . . 0.0 110.467 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -90.41 -44.35 9.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.938 . . . . 0.0 110.431 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.37 60.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.428 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 15.0 m -166.11 99.7 0.72 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.184 -1.186 . . . . 0.0 110.275 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 79' ' ' THR . 43.5 Cg_endo -70.77 119.35 6.26 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.988 1.52 . . . . 0.0 110.113 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.459 ' H ' HG12 ' A' ' 81' ' ' VAL . 2.7 p -94.6 -26.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.262 -0.899 . . . . 0.0 110.358 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.82 -147.15 16.39 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.8 p -65.79 153.82 40.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.45 -1.03 . . . . 0.0 110.669 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.0 t -131.69 102.32 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.47 -0.769 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.422 ' OD1' ' HB2' ' A' ' 70' ' ' SER . 1.1 m-20 -88.94 141.02 28.84 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.844 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.97 15.07 28.37 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.365 -0.835 . . . . 0.0 110.407 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.55 -59.74 2.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 t -77.37 -20.08 55.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -103.64 -163.2 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.887 . . . . 0.0 110.126 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.84 144.45 45.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.317 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.57 133.69 53.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.198 -0.939 . . . . 0.0 109.895 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -142.53 132.98 25.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 110.594 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.706 HD21 HD11 ' A' ' 33' ' ' ILE . 16.5 tp -93.45 118.03 30.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.883 . . . . 0.0 109.247 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.592 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -112.43 152.04 17.95 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.447 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -148.59 134.53 19.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.585 -0.95 . . . . 0.0 109.872 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.53 165.65 32.47 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.781 -1.2 . . . . 0.0 110.145 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -83.58 -157.14 0.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -1.102 . . . . 0.0 110.088 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.7 t -82.11 -31.11 30.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 110.26 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.08 -15.32 4.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.526 HD13 ' N ' ' A' ' 101' ' ' ASP . 0.8 OUTLIER -100.32 125.35 46.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -1.159 . . . . 0.0 110.143 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.526 ' N ' HD13 ' A' ' 100' ' ' LEU . 3.9 p30 -109.33 115.9 30.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.159 -0.963 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 81.7 mt -80.48 -62.08 1.78 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.151 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.55 -179.03 42.29 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.445 -1.36 . . . . 0.0 110.512 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.592 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 1.5 m-70 -137.41 121.35 17.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.744 -0.856 . . . . 0.0 109.673 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -94.07 123.7 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 0.0 110.145 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.82 105.05 5.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 110.305 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.698 HD11 ' HB2' ' A' ' 93' ' ' LEU . 39.0 mt -78.5 132.25 37.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 110.164 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.06 149.71 39.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -110.27 169.4 8.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 110.198 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.563 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.91 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.91 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 45.8 Cg_endo -72.64 -162.2 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.959 1.505 . . . . 0.0 109.906 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -111.2 129.77 55.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.32 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 5.5 t80 -148.73 112.16 5.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.233 -0.917 . . . . 0.0 109.589 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.19 148.96 28.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 111.0 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 7' ' ' SER . 5.4 p -107.01 174.55 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.45 -0.781 . . . . 0.0 109.525 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.687 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -81.97 -70.54 0.15 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.987 -1.071 . . . . 0.0 109.969 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.687 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 56.1 Cg_endo -83.15 91.12 0.94 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 O-C-N 122.972 0.985 . . . . 0.0 109.906 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.34 -1.52 55.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.891 -1.131 . . . . 0.0 110.687 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.0 m -138.28 118.88 13.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.196 -0.94 . . . . 0.0 109.979 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.46 72.88 1.13 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.796 ' CD1' HD22 ' A' ' 107' ' ' LEU . 12.9 mt -95.3 167.41 11.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.327 -1.102 . . . . 0.0 110.41 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.568 ' HB2' ' CB ' ' A' ' 16' ' ' GLN . 51.7 m -115.42 140.75 48.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 110.358 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 24.1 p30 -65.09 128.28 35.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.33 -0.856 . . . . 0.0 110.811 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.1 -26.77 6.53 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.568 ' CB ' ' HB2' ' A' ' 13' ' ' SER . 29.9 tt0 -62.2 149.08 42.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.126 . . . . 0.0 110.72 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -96.35 146.76 24.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.455 -0.778 . . . . 0.0 110.15 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.421 HG12 ' HG2' ' A' ' 8' ' ' PRO . 27.4 m -118.33 156.49 20.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.26 -0.9 . . . . 0.0 109.892 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.35 124.57 38.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.185 -0.947 . . . . 0.0 109.919 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.3 t -111.08 145.67 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.231 -0.918 . . . . 0.0 109.824 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.6 127.29 18.07 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.387 -0.821 . . . . 0.0 110.351 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 98.1 t -124.97 137.39 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.293 -0.88 . . . . 0.0 110.15 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 73.8 m -150.21 116.54 5.72 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.984 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 157.58 -64.78 0.3 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -52.82 -175.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -1.124 . . . . 0.0 110.018 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.542 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -150.88 150.01 30.37 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.014 -1.054 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -30.19 136.37 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.402 0.62 . . . . 0.0 111.237 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.401 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 108.12 11.22 24.55 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.492 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 69.4 mm-40 -142.25 118.59 10.84 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.266 -1.137 . . . . 0.0 110.695 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.496 ' O ' ' ND2' ' A' ' 97' ' ' ASN . 6.5 m -103.98 137.77 41.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.087 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.612 ' CG ' HD11 ' A' ' 102' ' ' LEU . 34.5 m-85 -123.36 166.11 15.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.969 -1.082 . . . . 0.0 111.171 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -121.65 110.13 15.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.537 -0.727 . . . . 0.0 109.597 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.718 HG23 ' O ' ' A' ' 33' ' ' ILE . 4.9 tt -87.88 113.09 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 110.327 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.81 166.17 28.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.716 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.602 ' HG3' HD12 ' A' ' 107' ' ' LEU . 0.5 OUTLIER -127.92 140.84 51.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.472 -0.768 . . . . 0.0 110.021 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.6 m -138.21 165.85 25.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.937 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.437 ' HB2' ' SG ' ' A' ' 91' ' ' CYS . . . -150.97 153.93 33.69 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.641 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.71 167.45 25.65 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.796 1.419 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 42' ' ' GLN . 17.2 m -131.51 62.16 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.882 . . . . 0.0 110.118 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.67 5.09 49.57 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 163.75 -58.06 0.27 Allowed Glycine 0 N--CA 1.493 2.493 0 O-C-N 121.058 -1.26 . . . . 0.0 110.274 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.536 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 49.6 mt-30 -78.77 -163.25 0.45 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.19 -1.182 . . . . 0.0 110.456 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -133.16 139.34 47.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.853 . . . . 0.0 110.308 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.405 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -142.78 127.19 17.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.362 -0.836 . . . . 0.0 109.881 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 11.9 t -110.67 168.11 9.71 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.092 -1.005 . . . . 0.0 110.709 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 41.7 p-10 -108.54 102.26 46.6 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.346 -0.847 . . . . 0.0 110.636 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.67 -21.32 12.95 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.001 1.527 . . . . 0.0 110.742 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.19 -41.91 85.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.234 -0.916 . . . . 0.0 110.589 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.37 10.09 42.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.259 -0.901 . . . . 0.0 110.002 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.0 131.45 35.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 110.256 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.663 HG23 ' CG2' ' A' ' 33' ' ' ILE . 4.5 t -138.38 165.21 27.34 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.307 -0.871 . . . . 0.0 109.887 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m -127.79 146.6 50.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 110.744 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 35.1 p90 -140.16 -177.6 5.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 109.858 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.5 m -141.29 156.64 45.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.963 . . . . 0.0 110.058 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.416 HG23 ' HE2' ' A' ' 31' ' ' TYR . 17.2 p -67.28 -156.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.0 110.38 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 11.8 t0 -154.78 -162.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.954 . . . . 0.0 110.235 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.65 -55.49 34.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.268 -0.895 . . . . 0.0 109.416 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 p -78.32 4.15 13.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.432 -0.793 . . . . 0.0 109.353 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 66.11 46.55 79.56 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.99 162.78 20.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.107 -1.231 . . . . 0.0 110.242 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -159.11 83.87 0.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.179 -0.951 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 m -111.04 121.9 46.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.283 -0.885 . . . . 0.0 109.362 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 20.6 p90 -155.54 179.98 8.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 110.782 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.1 m -92.25 151.81 20.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.473 -0.767 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.455 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 56.3 t80 -142.48 179.36 7.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.538 -0.726 . . . . 0.0 109.112 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.455 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.4 t -133.08 154.96 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.741 -1.224 . . . . 0.0 110.415 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.468 HG21 HD22 ' A' ' 12' ' ' LEU . 29.7 m -138.01 164.82 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.436 -0.79 . . . . 0.0 109.808 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 8.0 mtt85 -141.22 126.02 18.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.918 . . . . 0.0 110.334 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 14.3 tttt -55.08 -40.68 70.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.832 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.3 p -130.25 134.48 47.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.385 -0.822 . . . . 0.0 109.735 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 17.2 p90 -144.94 153.28 41.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.116 -0.99 . . . . 0.0 110.636 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 21.3 m -73.94 124.78 26.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.265 -0.897 . . . . 0.0 110.247 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.405 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -77.24 159.41 48.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t -168.78 127.81 1.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -1.133 . . . . 0.0 110.004 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 74.9 p -63.09 160.47 38.97 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.979 . . . . 0.0 110.471 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.11 13.89 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.084 1.571 . . . . 0.0 110.806 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -111.28 -21.4 11.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.938 . . . . 0.0 110.304 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.31 18.43 5.83 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 53.4 m -112.48 121.1 39.77 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.214 -1.168 . . . . 0.0 110.244 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.25 -170.6 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.896 1.472 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 82' ' ' GLY . 7.7 p -173.83 -37.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.163 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.454 ' N ' HG13 ' A' ' 81' ' ' VAL . . . 158.85 -179.82 34.22 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER -86.87 172.76 9.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -1.136 . . . . 0.0 110.014 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.427 HG11 ' OH ' ' A' ' 71' ' ' TYR . 82.6 t -134.45 146.05 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.234 -0.916 . . . . 0.0 110.163 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -134.66 125.49 27.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.006 . . . . 0.0 110.173 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 72.1 m -86.72 12.63 10.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.47 -58.28 8.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.816 . . . . 0.0 110.068 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -110.29 9.51 23.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.33 178.21 4.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.318 -0.864 . . . . 0.0 110.194 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.15 95.39 5.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 37' ' ' ALA . 80.9 m -92.5 138.15 31.76 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.182 -0.949 . . . . 0.0 109.94 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -130.47 149.96 51.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.17 -0.956 . . . . 0.0 110.434 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 35' ' ' GLN . 0.3 OUTLIER -125.0 122.48 37.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 109.719 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.3 175.78 20.72 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.33 171.59 13.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -1.08 . . . . 0.0 110.12 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.81 165.06 10.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 30' ' ' THR . 1.1 p30 -129.69 -104.24 0.3 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -1.194 . . . . 0.0 110.622 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.42 -84.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.937 -1.102 . . . . 0.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.1 52.64 0.82 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.604 HD13 ' HE1' ' A' ' 31' ' ' TYR . 4.4 tt -115.21 -58.94 2.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.207 -1.172 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.5 t0 50.83 101.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.403 -0.811 . . . . 0.0 110.251 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.889 HD23 ' CG ' ' A' ' 2' ' ' PRO . 0.5 OUTLIER -73.86 -67.72 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -161.68 179.28 37.17 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -148.04 117.17 6.84 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.357 -1.084 . . . . 0.0 110.03 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.1 136.09 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.69 118.62 23.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.233 -0.917 . . . . 0.0 110.183 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.796 HD22 ' CD1' ' A' ' 12' ' ' LEU . 48.6 mt -90.05 134.1 34.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -112.43 166.51 11.24 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.507 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 2.5 m-85 -152.72 71.44 0.93 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.528 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.5 Cg_endo -70.46 -160.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.83 1.437 . . . . 0.0 110.493 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.406 ' HB3' ' H ' ' A' ' 23' ' ' SER . . . -149.32 148.9 30.07 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.086 -1.009 . . . . 0.0 111.196 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.443 ' CB ' ' HB3' ' A' ' 102' ' ' LEU . 24.2 t80 -151.5 102.67 2.91 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 109.633 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.07 158.45 43.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.927 -1.108 . . . . 0.0 111.002 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.484 HG12 HG11 ' A' ' 105' ' ' VAL . 5.1 p -126.77 138.81 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 109.76 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.606 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -62.49 -66.17 1.71 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.127 -0.983 . . . . 0.0 110.499 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.606 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 53.1 Cg_endo -76.96 74.18 5.09 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 O-C-N 123.493 1.259 . . . . 0.0 110.48 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.41 -0.64 57.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.986 -1.071 . . . . 0.0 110.236 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.7 t -150.88 150.7 31.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 109.974 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.65 60.96 6.35 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.6 HD21 ' O ' ' A' ' 8' ' ' PRO . 5.1 mt -102.61 154.39 19.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.251 -1.147 . . . . 0.0 110.132 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 73.3 m -109.35 155.78 20.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.149 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 32.7 t0 -64.49 127.84 33.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.057 -1.027 . . . . 0.0 110.612 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.49 -30.4 5.3 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 13' ' ' SER . 5.1 tp60 -46.78 145.66 1.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -1.116 . . . . 0.0 110.162 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.38 133.42 42.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.383 -0.823 . . . . 0.0 109.523 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.745 HG23 ' HB3' ' A' ' 65' ' ' PHE . 18.0 m -98.0 172.94 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.093 -1.004 . . . . 0.0 110.027 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.4 m -124.09 114.14 19.3 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 t -102.19 151.5 5.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 O-C-N 121.482 -0.761 . . . . 0.0 109.732 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.0 135.29 27.3 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.334 -0.854 . . . . 0.0 110.435 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.948 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 58.6 t -126.14 137.81 56.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.513 -0.742 . . . . 0.0 109.472 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' ' 3' ' ' ALA . 42.3 m -140.6 127.7 20.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.075 -1.016 . . . . 0.0 110.637 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 129.92 -48.69 0.96 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.522 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -57.45 -158.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -1.158 . . . . 0.0 109.345 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.599 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -170.95 149.99 3.05 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.596 -1.315 . . . . 0.0 111.818 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -40.12 141.98 0.42 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.438 0.637 . . . . 0.0 110.166 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.05 10.71 36.18 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 2.5 mm-40 -137.76 133.65 34.34 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.355 -1.085 . . . . 0.0 109.757 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 52.6 m -112.0 152.77 27.74 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.211 -0.93 . . . . 0.0 109.908 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.641 ' HE2' HD12 ' A' ' 100' ' ' LEU . 17.2 m-85 -135.26 159.46 41.47 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 109.809 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -119.39 105.91 11.75 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.24 -0.913 . . . . 0.0 110.044 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.599 ' CG1' HD11 ' A' ' 93' ' ' LEU . 9.4 tt -95.12 125.42 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 109.86 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.609 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -137.85 148.02 45.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.888 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.76 126.63 53.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.441 -0.787 . . . . 0.0 109.571 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 72.7 m -145.21 173.08 12.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -0.99 . . . . 0.0 110.923 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.45 160.27 32.08 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.529 -0.732 . . . . 0.0 109.506 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.29 163.58 38.19 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.744 1.392 . . . . 0.0 111.208 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.953 HG13 ' HB2' ' A' ' 42' ' ' GLN . 2.4 p -141.63 68.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.524 -0.735 . . . . 0.0 110.288 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.62 48.58 12.74 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.6 -33.37 4.62 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.953 ' HB2' HG13 ' A' ' 39' ' ' VAL . 4.3 mt-30 -80.55 -160.29 0.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.452 -1.028 . . . . 0.0 109.522 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.422 ' HB2' ' HG3' ' A' ' 76' ' ' PRO . 3.2 m-20 -141.55 140.77 33.49 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.045 -1.034 . . . . 0.0 110.694 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -130.29 159.2 37.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.238 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.59 154.55 48.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.953 -1.092 . . . . 0.0 111.186 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.568 ' OD1' ' CZ ' ' A' ' 71' ' ' TYR . 3.7 m120 -94.55 107.91 33.27 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.603 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.53 -33.3 8.77 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.902 1.475 . . . . 0.0 110.074 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.65 -6.63 27.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.362 -0.836 . . . . 0.0 110.175 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.407 ' OG1' ' CB ' ' A' ' 46' ' ' ASN . 53.0 p -120.29 -6.95 9.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.106 -0.996 . . . . 0.0 110.383 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.81 125.62 25.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.208 -0.933 . . . . 0.0 110.078 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.7 t -170.46 168.94 7.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.141 -0.975 . . . . 0.0 110.596 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.8 p -129.2 154.95 46.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 29.1 p90 -137.4 148.17 45.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.292 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.2 m -103.0 154.81 18.86 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.343 -0.848 . . . . 0.0 110.298 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.522 HG21 ' HB1' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -62.66 -156.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.27 -0.894 . . . . 0.0 110.544 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -142.84 -164.92 1.94 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.03 -1.044 . . . . 0.0 109.99 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.66 -52.51 64.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 108.975 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 p -84.17 12.77 5.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.515 -0.741 . . . . 0.0 109.073 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.599 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 67.93 12.79 63.05 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -89.38 108.95 19.93 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.272 -1.134 . . . . 0.0 109.542 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.948 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -97.22 87.85 4.29 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.353 -0.842 . . . . 0.0 110.244 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.18 115.48 28.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.42 -0.8 . . . . 0.0 109.474 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.629 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 7.9 p90 -144.64 177.23 8.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.047 -1.033 . . . . 0.0 111.191 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -102.4 122.22 43.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.634 -0.666 . . . . 0.0 110.837 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.745 ' HB3' HG23 ' A' ' 18' ' ' VAL . 68.4 t80 -106.83 -177.18 3.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 109.043 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.425 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.2 t -135.2 155.31 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.745 -1.222 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.1 m -141.3 174.56 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.493 -0.755 . . . . 0.0 109.486 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 5.0 mtt180 -155.9 126.51 6.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.993 -1.067 . . . . 0.0 110.805 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 8.5 ttpt -49.76 -46.13 50.28 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.205 -0.935 . . . . 0.0 109.449 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.0 m -128.62 156.45 43.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.587 -0.695 . . . . 0.0 109.165 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.568 ' CZ ' ' OD1' ' A' ' 46' ' ' ASN . 37.0 p90 -167.89 143.76 3.92 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.775 -1.203 . . . . 0.0 110.984 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 23.8 m -65.52 141.21 58.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.138 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.82 174.58 22.3 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.62 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.406 ' HA ' HG22 ' A' ' 81' ' ' VAL . 34.6 p -134.73 -149.8 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.713 -0.875 . . . . 0.0 109.005 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 79' ' ' THR . 46.1 p -112.03 161.4 26.02 Favored Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 121.069 -1.019 . . . . 0.0 110.255 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.469 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 51.7 Cg_endo -86.57 25.84 0.66 Allowed 'Trans proline' 0 C--N 1.3 -2.022 0 O-C-N 124.165 1.613 . . . . 0.0 110.661 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -155.14 16.69 0.42 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.996 -1.065 . . . . 0.0 111.504 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.435 ' O ' ' OG1' ' A' ' 79' ' ' THR . . . 88.48 74.22 1.28 Allowed Glycine 0 N--CA 1.498 2.825 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.286 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.675 ' O ' HG23 ' A' ' 75' ' ' THR . 4.0 m -172.53 127.6 0.55 Allowed Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.41 -1.053 . . . . 0.0 109.481 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -80.38 146.72 17.61 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.739 1.389 . . . . 0.0 110.592 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 74' ' ' SER . 1.3 m -132.64 -33.91 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.358 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.14 -152.61 20.63 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER -94.11 157.89 15.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -1.165 . . . . 0.0 110.524 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.402 HG21 ' CB ' ' A' ' 44' ' ' ALA . 97.8 t -116.93 152.5 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.403 -0.81 . . . . 0.0 109.997 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.25 127.49 39.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.084 -1.01 . . . . 0.0 110.029 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 4.2 t -84.07 -11.16 57.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.215 -0.928 . . . . 0.0 110.451 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.13 90.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 110.27 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.4 t -86.82 2.27 49.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.218 -0.926 . . . . 0.0 110.169 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.56 -140.13 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.21 159.02 44.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.303 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 55.7 m -119.94 141.06 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.95 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -133.36 135.4 44.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.466 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 34' ' ' ALA . 18.9 tp -109.76 120.13 41.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.848 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.503 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . -111.18 166.35 12.26 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -160.56 173.72 15.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -1.144 . . . . 0.0 110.024 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.13 -176.81 16.28 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -139.33 -150.69 0.34 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -1.072 . . . . 0.0 110.041 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.81 40.32 1.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 110.153 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -147.11 -43.48 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.641 HD12 ' HE2' ' A' ' 31' ' ' TYR . 69.7 mt -103.27 -153.74 0.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -1.166 . . . . 0.0 110.077 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -170.58 117.26 0.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 110.31 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.443 ' HB3' ' CB ' ' A' ' 4' ' ' PHE . 18.9 mt -118.56 -49.36 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.0 110.09 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.03 -150.71 17.82 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.503 ' HB3' ' CA ' ' A' ' 94' ' ' GLY . 8.5 p-80 -146.89 136.93 23.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -1.11 . . . . 0.0 110.417 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.484 HG11 HG12 ' A' ' 6' ' ' VAL . 18.3 t -85.06 113.16 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.416 -0.803 . . . . 0.0 110.112 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.05 94.3 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -0.86 . . . . 0.0 110.112 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.88 162.02 14.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.315 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.54 152.41 46.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.414 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 3.3 m-85 -127.45 75.68 1.61 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.858 . . . . 0.0 110.005 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 CA-C-O 117.961 -1.466 . . . . 0.0 109.596 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.512 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.0 Cg_endo -71.24 -159.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.117 1.588 . . . . 0.0 110.481 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -148.63 127.43 12.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.974 . . . . 0.0 110.432 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -142.08 106.3 4.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.369 -0.832 . . . . 0.0 109.471 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.2 t -150.25 154.14 37.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.961 -1.087 . . . . 0.0 111.247 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.6 HG12 HG11 ' A' ' 105' ' ' VAL . 13.4 p -119.05 156.9 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.647 -0.658 . . . . 0.0 109.448 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.592 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -77.04 -65.89 0.36 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.926 -1.109 . . . . 0.0 110.217 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.683 ' O ' HD21 ' A' ' 12' ' ' LEU . 52.7 Cg_endo -76.2 74.97 4.4 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.607 1.32 . . . . 0.0 110.221 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.53 -16.79 60.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.028 -1.045 . . . . 0.0 110.243 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.2 p -138.8 166.26 24.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.072 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.95 48.91 61.93 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.683 HD21 ' O ' ' A' ' 8' ' ' PRO . 20.7 mt -95.04 166.9 11.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -1.105 . . . . 0.0 110.242 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -126.05 152.43 45.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.286 -0.884 . . . . 0.0 110.346 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -63.67 117.23 6.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.83 -30.41 9.39 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 13' ' ' SER . 8.1 tt0 -52.52 155.09 2.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.342 -1.093 . . . . 0.0 110.27 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.23 138.03 43.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 0.0 110.115 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.567 ' CG1' HD22 ' A' ' 12' ' ' LEU . 17.1 m -103.81 153.56 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 109.859 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 0.7 OUTLIER -95.61 111.34 23.29 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.491 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 t -104.87 151.61 7.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.46 -0.775 . . . . 0.0 110.049 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 34.2 t -149.82 133.11 16.45 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.445 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.814 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 53.2 t -123.75 146.59 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.527 -0.733 . . . . 0.0 109.992 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 2.3 p -162.56 120.22 2.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.118 -0.989 . . . . 0.0 110.282 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 149.39 -55.87 0.48 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.652 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -63.92 -139.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.157 -1.202 . . . . 0.0 110.097 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.489 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.66 175.57 5.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.223 -0.923 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -65.2 131.74 47.31 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.493 -0.755 . . . . 0.0 110.666 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.6 6.85 7.76 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 2.6 mt-10 -132.0 106.09 7.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -1.199 . . . . 0.0 110.551 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 57.5 m -90.44 123.28 34.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.278 -0.889 . . . . 0.0 109.812 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.658 ' OH ' HD22 ' A' ' 100' ' ' LEU . 59.6 m-85 -107.42 161.59 14.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 111.059 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -113.48 112.51 23.72 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.392 -0.817 . . . . 0.0 109.602 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 33' ' ' ILE . 4.5 tt -93.94 106.31 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.124 -0.985 . . . . 0.0 110.635 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 1.022 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -142.23 168.53 19.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.381 -0.825 . . . . 0.0 109.772 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 9.8 pt20 -132.71 151.52 51.95 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 110.385 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.72 157.33 44.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 110.558 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 90' ' ' ALA . . . -151.56 157.35 34.76 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.274 -0.891 . . . . 0.0 110.499 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 43.3 Cg_endo -69.5 174.99 8.48 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.942 1.496 . . . . 0.0 110.22 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -141.15 58.37 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.072 -1.018 . . . . 0.0 110.845 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.16 -23.86 5.82 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.77 -49.36 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -88.18 -150.98 0.19 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -1.104 . . . . 0.0 110.043 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 11.7 p-10 -149.07 149.14 30.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.944 . . . . 0.0 110.39 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.568 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -136.12 155.35 50.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.426 -0.796 . . . . 0.0 109.7 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.1 m -126.28 151.47 47.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.211 -0.93 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.482 ' ND2' ' HB2' ' A' ' 71' ' ' TYR . 47.6 t-20 -97.16 108.5 44.5 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.15 -0.969 . . . . 0.0 110.243 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 49.9 Cg_endo -81.79 -33.96 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.919 1.484 . . . . 0.0 110.484 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.97 50.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 110.313 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 p -79.67 -3.05 45.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.262 -0.899 . . . . 0.0 110.064 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 47' ' ' PRO . . . -72.72 81.66 1.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.868 . . . . 0.0 110.5 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.535 HG23 ' CG2' ' A' ' 33' ' ' ILE . 4.2 t -100.26 174.49 6.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.291 -0.881 . . . . 0.0 109.883 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.65 122.34 15.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 110.304 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.494 ' C ' ' CD1' ' A' ' 53' ' ' PHE . 5.0 p90 -116.5 -175.01 2.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.912 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 55' ' ' THR . 7.2 m -134.69 143.35 47.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.961 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -57.33 -155.94 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.136 -0.977 . . . . 0.0 110.299 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -145.49 -156.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.077 -1.015 . . . . 0.0 110.176 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.57 -61.89 2.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.028 -1.045 . . . . 0.0 109.909 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 52.7 p -87.94 28.5 1.03 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.242 -0.911 . . . . 0.0 109.325 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.489 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 55.88 28.3 52.54 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -93.45 117.29 29.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.375 -1.074 . . . . 0.0 110.136 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.814 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -124.81 83.41 2.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 0.0 110.113 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -109.23 123.15 48.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.875 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 9.4 p90 -155.68 174.72 14.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.601 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.69 114.03 26.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.394 -0.816 . . . . 0.0 110.38 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.505 ' HB3' HG23 ' A' ' 18' ' ' VAL . 41.3 t80 -99.12 176.83 5.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.409 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.1 t -130.42 153.87 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.967 -1.083 . . . . 0.0 109.924 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.2 143.82 27.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.359 -0.838 . . . . 0.0 110.093 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -120.02 129.74 54.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 110.088 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -52.6 -35.91 55.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.905 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.3 p -131.35 143.37 50.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.936 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.482 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 22.7 p90 -145.16 153.0 40.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.17 -0.956 . . . . 0.0 110.511 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 9.2 m -72.18 124.43 25.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.305 -0.872 . . . . 0.0 109.847 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.568 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -99.19 171.87 24.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 5.6 p 175.26 130.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -1.09 . . . . 0.0 109.869 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.408 ' OG1' ' HB ' ' A' ' 79' ' ' THR . 32.5 p -84.04 149.22 55.55 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.164 -0.96 . . . . 0.0 110.604 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.6 -21.28 5.2 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.284 1.676 . . . . 0.0 110.333 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.17 -66.23 0.62 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.345 -0.847 . . . . 0.0 110.365 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.452 ' O ' ' OG1' ' A' ' 79' ' ' THR . . . 172.0 67.3 0.04 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 78' ' ' GLY . 57.1 m -166.3 92.07 0.8 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.396 -1.061 . . . . 0.0 109.853 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.58 79.46 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.06 1.558 . . . . 0.0 110.475 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.566 HG23 ' N ' ' A' ' 82' ' ' GLY . 27.8 m -49.22 -44.11 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.365 -0.835 . . . . 0.0 110.056 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.566 ' N ' HG23 ' A' ' 81' ' ' VAL . . . 113.85 -159.07 13.89 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 5.0 p -58.25 169.77 0.8 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -1.13 . . . . 0.0 110.139 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.52 HG21 ' CB ' ' A' ' 44' ' ' ALA . 45.7 t -150.87 133.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -109.21 141.59 41.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.937 . . . . 0.0 110.1 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.0 m -115.0 -3.8 12.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.199 -0.938 . . . . 0.0 110.143 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.19 -56.97 14.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 110.066 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 88' ' ' THR . 5.4 t -89.14 -16.41 31.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 110.05 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.46 -175.2 3.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 110.18 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.634 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -96.43 140.98 30.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -0.907 . . . . 0.0 110.325 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.43 ' C ' ' OD1' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -139.5 126.86 21.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.355 -0.841 . . . . 0.0 110.033 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.43 ' OD1' ' C ' ' A' ' 91' ' ' CYS . 31.9 m-20 -129.3 147.2 51.11 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 110.291 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.022 HD12 ' O ' ' A' ' 34' ' ' ALA . 14.3 tp -112.72 109.67 19.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -105.14 153.26 17.31 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.312 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.89 167.44 22.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.478 -1.013 . . . . 0.0 109.713 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.516 ' HA2' ' CD1' ' A' ' 31' ' ' TYR . . . 118.85 -175.7 15.81 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 100' ' ' LEU . 20.7 p-10 -137.8 -142.25 0.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -1.195 . . . . 0.0 110.433 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -102.78 -34.84 8.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.303 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.42 -30.69 64.23 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.658 HD22 ' OH ' ' A' ' 31' ' ' TYR . 6.0 tt -146.88 131.2 17.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -1.146 . . . . 0.0 110.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -96.88 138.48 34.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -0.993 . . . . 0.0 110.087 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 102' ' ' LEU . 16.4 mt -97.56 -81.15 0.43 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.273 -0.892 . . . . 0.0 110.295 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 174.99 163.13 27.61 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.46 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 2.0 m-70 -119.13 123.95 45.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.993 . . . . 0.0 110.069 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.6 HG11 HG12 ' A' ' 6' ' ' VAL . 31.5 t -102.68 115.51 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.111 -0.993 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.51 127.26 32.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.297 -0.877 . . . . 0.0 110.162 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.1 mt -98.42 169.52 9.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.335 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.3 m -155.26 160.36 40.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -132.66 105.33 7.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 0.0 110.135 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.431 179.949 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 120.748 0.309 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 45.8 Cg_endo -73.8 176.51 9.31 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.043 1.549 . . . . 0.0 110.407 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.451 ' HB3' ' OG ' ' A' ' 23' ' ' SER . . . -147.0 151.2 36.58 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.172 -0.955 . . . . 0.0 110.747 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.547 ' CE1' ' HB3' ' A' ' 95' ' ' ALA . 76.9 t80 -149.98 116.72 5.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 110.022 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.64 149.72 31.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.073 -1.017 . . . . 0.0 110.611 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.005 HG12 HG11 ' A' ' 105' ' ' VAL . 4.3 p -130.87 139.0 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.923 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -69.76 -62.5 2.39 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.048 -1.032 . . . . 0.0 110.182 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 49.4 Cg_endo -74.32 77.51 2.85 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.837 1.441 . . . . 0.0 110.468 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.69 -5.63 57.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.114 -0.991 . . . . 0.0 110.13 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.0 p -151.62 166.45 31.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 110.241 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.8 52.46 48.24 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.492 HD13 ' HB3' ' A' ' 107' ' ' LEU . 1.4 mt -102.51 172.87 6.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.146 -1.208 . . . . 0.0 110.055 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.488 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -143.71 149.85 37.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 110.387 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 3.7 p30 -58.0 123.95 17.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.325 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.97 -34.81 4.56 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 13.2 tt0 -50.96 156.41 1.01 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -1.134 . . . . 0.0 109.815 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.95 137.83 47.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.634 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 67' ' ' VAL . 16.5 m -107.66 175.41 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.424 -0.797 . . . . 0.0 110.131 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.468 ' OG ' ' HD3' ' A' ' 8' ' ' PRO . 3.6 p -120.78 118.92 31.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 109.996 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.493 HG21 HD11 ' A' ' 33' ' ' ILE . 20.8 t -110.31 151.79 12.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.244 -0.91 . . . . 0.0 110.067 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -143.12 128.16 18.51 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 110.31 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.771 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 30.7 t -121.26 145.65 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 109.824 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -151.43 139.4 20.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 110.382 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 120.17 -75.34 0.32 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.561 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -49.54 126.7 14.0 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.179 -1.189 . . . . 0.0 109.563 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.571 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -97.08 165.65 11.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.111 -0.993 . . . . 0.0 111.092 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -44.23 139.85 2.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.545 0.688 . . . . 0.0 110.568 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.92 9.22 8.34 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 50.4 mm-40 -147.65 121.84 9.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.119 -1.224 . . . . 0.0 110.406 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 53' ' ' PHE . 80.6 m -104.43 125.63 50.81 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.436 -0.79 . . . . 0.0 109.49 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.737 ' CE1' HD13 ' A' ' 100' ' ' LEU . 17.0 m-85 -110.01 176.94 4.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.09 -1.006 . . . . 0.0 110.434 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 12.5 m-85 -126.51 112.85 16.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.301 -0.874 . . . . 0.0 110.488 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 33' ' ' ILE . 13.0 tt -98.5 103.65 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 0.0 109.933 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.61 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -138.56 169.33 17.98 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.294 -0.879 . . . . 0.0 110.651 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.788 ' OE1' HD12 ' A' ' 107' ' ' LEU . 34.1 mt-30 -106.07 155.47 19.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.423 -0.798 . . . . 0.0 110.334 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 98.1 m -150.69 148.52 28.68 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.219 -0.926 . . . . 0.0 110.471 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 1.052 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -151.76 165.83 16.57 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 49.9 Cg_endo -75.02 175.51 11.15 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.99 1.521 . . . . 0.0 110.391 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.444 ' CG1' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.68 58.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.264 -0.898 . . . . 0.0 110.157 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.14 -6.64 34.35 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 179.66 -56.28 0.08 OUTLIER Glycine 0 N--CA 1.493 2.451 0 O-C-N 120.823 -1.398 . . . . 0.0 109.921 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -85.21 -167.24 1.76 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -1.168 . . . . 0.0 110.44 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 1.6 p30 -118.72 166.72 12.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.373 -0.829 . . . . 0.0 110.036 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.09 157.87 39.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 110.399 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 m -140.48 163.05 33.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.184 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.788 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 3.7 m-20 -81.54 123.91 80.5 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 110.358 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.583 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 48.8 Cg_endo -84.74 -72.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.931 1.49 . . . . 0.0 110.621 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.15 -62.89 1.52 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.206 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.47 -22.54 0.28 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.444 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.788 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -62.83 105.38 0.66 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.031 . . . . 0.0 109.816 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -110.47 141.42 43.6 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.234 -0.916 . . . . 0.0 110.442 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.49 ' HB3' ' CD2' ' A' ' 32' ' ' TYR . 48.9 p -106.88 119.11 38.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 109.888 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.629 ' O ' HG23 ' A' ' 30' ' ' THR . 53.1 p90 -106.46 -178.06 3.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.034 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 55' ' ' THR . 6.4 m -139.05 145.44 39.59 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.939 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.561 HG21 ' CB ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -57.17 -158.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.147 -0.97 . . . . 0.0 109.851 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -145.43 -161.78 1.37 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.881 -1.137 . . . . 0.0 110.448 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.81 -48.98 79.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.087 -1.008 . . . . 0.0 109.164 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p -87.03 13.82 8.56 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.515 -0.74 . . . . 0.0 109.099 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 57.27 30.31 61.08 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.02 118.91 37.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -1.094 . . . . 0.0 109.863 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.771 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -118.81 81.2 1.66 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.511 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.9 m -110.61 122.65 48.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.304 -0.873 . . . . 0.0 109.293 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 12.3 p90 -157.31 179.1 9.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.024 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.09 138.04 31.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 110.726 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 73.9 t80 -123.14 178.62 5.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -0.795 . . . . 0.0 109.182 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.557 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 5.2 t -123.05 159.44 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.806 -1.184 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 18' ' ' VAL . 30.9 m -137.96 124.69 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.393 -0.817 . . . . 0.0 110.099 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 9.5 mmm-85 -115.85 123.85 49.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.53 -59.93 3.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -0.978 . . . . 0.0 109.204 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 p -108.41 126.44 52.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.306 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -140.31 163.91 31.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 110.485 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.09 123.87 21.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.637 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.439 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -98.21 166.42 22.13 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 89.5 p -178.56 130.02 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.39 -1.064 . . . . 0.0 109.599 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 79' ' ' THR . 55.0 p -43.0 153.41 0.34 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.214 -0.929 . . . . 0.0 110.388 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.97 0.07 9.34 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 124.112 1.585 . . . . 0.0 110.309 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -93.58 -52.66 4.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.326 -0.859 . . . . 0.0 110.186 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.13 -24.27 0.19 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.441 ' O ' ' OG1' ' A' ' 75' ' ' THR . 4.1 m -70.44 132.71 87.46 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.098 -1.236 . . . . 0.0 110.292 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.7 141.06 27.11 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.892 1.469 . . . . 0.0 109.755 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.6 p -117.73 -4.96 11.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 120.987 -1.071 . . . . 0.0 110.168 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.1 -155.13 16.22 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.06 174.85 6.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -1.128 . . . . 0.0 110.389 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.444 HG22 ' CG1' ' A' ' 39' ' ' VAL . 49.1 t -144.15 154.63 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 110.13 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -134.58 131.57 38.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 110.064 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 32.7 m -92.97 33.23 1.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.878 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.15 -61.09 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 110.39 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.475 ' H ' HG22 ' A' ' 88' ' ' THR . 5.0 t -87.67 -23.05 24.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.331 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.58 -178.32 3.59 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 110.096 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -123.82 148.81 46.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.181 -0.949 . . . . 0.0 110.12 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 1.052 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -126.85 133.78 50.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.026 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 5.7 m-20 -99.9 147.22 25.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 110.107 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.864 ' HB2' HD11 ' A' ' 107' ' ' LEU . 15.8 tp -106.7 110.96 23.28 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.1 -1.0 . . . . 0.0 109.52 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.65 153.43 17.48 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.547 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . . . -133.29 104.87 6.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.428 -1.042 . . . . 0.0 110.122 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.58 174.17 46.41 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 5.5 p-10 -114.0 -156.84 0.61 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -1.156 . . . . 0.0 110.357 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -91.99 52.6 2.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 110.184 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 174.4 -32.03 0.1 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.737 HD13 ' CE1' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -117.38 86.03 2.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -1.169 . . . . 0.0 110.297 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.53 116.31 22.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.941 . . . . 0.0 109.984 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 95' ' ' ALA . 87.8 mt -81.94 -74.6 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.322 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.13 173.58 41.66 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -136.69 122.62 20.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.584 -0.951 . . . . 0.0 110.111 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.005 HG11 HG12 ' A' ' 6' ' ' VAL . 17.2 t -112.23 107.45 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.072 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . . . -57.71 147.09 28.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 110.505 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.864 HD11 ' HB2' ' A' ' 93' ' ' LEU . 29.7 mt -116.18 141.56 47.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 109.984 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -110.82 165.55 11.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 110.34 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -139.95 97.51 3.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.24 -0.913 . . . . 0.0 110.321 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.958 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.958 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 43.9 Cg_endo -72.43 -159.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 124.002 1.527 . . . . 0.0 110.361 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -123.89 128.72 49.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.182 -0.949 . . . . 0.0 110.445 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.493 ' HB2' HD22 ' A' ' 102' ' ' LEU . 85.4 t80 -149.63 104.46 3.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.677 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.613 ' HA ' HG21 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -149.8 157.37 43.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.899 -1.126 . . . . 0.0 111.496 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.634 HG12 HG11 ' A' ' 105' ' ' VAL . 9.3 p -106.18 139.85 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.399 -0.813 . . . . 0.0 109.312 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.651 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 m -53.82 -72.4 0.19 Allowed Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 120.828 -1.17 . . . . 0.0 110.002 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.668 ' O ' HD21 ' A' ' 12' ' ' LEU . 56.7 Cg_endo -80.13 79.37 3.36 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 O-C-N 122.956 0.977 . . . . 0.0 109.952 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.43 -20.97 61.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.846 -1.159 . . . . 0.0 109.999 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t -134.51 141.11 46.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.325 -0.86 . . . . 0.0 110.043 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.91 61.21 1.29 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.668 HD21 ' O ' ' A' ' 8' ' ' PRO . 3.5 mt -117.21 169.53 9.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.162 -1.199 . . . . 0.0 110.232 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 4.2 t -124.65 158.95 31.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 110.286 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.16 124.97 22.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.216 -0.927 . . . . 0.0 110.188 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 89.45 -29.45 6.17 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.492 ' HB3' ' O ' ' A' ' 13' ' ' SER . 28.9 tp60 -43.81 156.25 0.07 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.324 -1.104 . . . . 0.0 110.447 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.424 ' N ' ' HG3' ' A' ' 16' ' ' GLN . 1.8 m -107.16 134.92 49.56 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.448 -0.783 . . . . 0.0 109.315 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.448 ' CG1' HD22 ' A' ' 12' ' ' LEU . 32.7 m -110.97 153.93 12.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.801 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -105.97 121.37 43.97 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.973 -1.08 . . . . 0.0 110.237 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.6 t -97.1 151.82 4.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.581 -0.7 . . . . 0.0 109.223 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 t -142.46 121.25 12.69 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 121.281 -0.887 . . . . 0.0 109.857 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 33.9 t -116.11 142.74 28.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 110.065 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.685 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.1 OUTLIER -160.38 105.17 1.47 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 110.254 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 157.3 -47.79 0.46 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.792 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -59.41 -147.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.419 -1.047 . . . . 0.0 109.485 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.529 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -172.42 165.89 5.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.76 -1.213 . . . . 0.0 111.037 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -48.36 138.58 9.83 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.592 0.711 . . . . 0.0 110.782 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.07 25.49 12.74 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 2.3 mt-10 -141.07 105.95 4.94 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.203 -1.175 . . . . 0.0 110.375 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.7 m -103.73 151.31 23.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.822 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 46.6 m-85 -140.24 165.97 25.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.296 -0.877 . . . . 0.0 110.188 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 23.5 m-85 -112.66 109.77 19.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -0.901 . . . . 0.0 109.851 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 33' ' ' ILE . 3.2 tt -89.5 111.72 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.059 -1.026 . . . . 0.0 110.162 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 1.032 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -144.05 159.45 42.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.468 -0.77 . . . . 0.0 110.247 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.455 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 2.4 tt0 -112.94 148.12 35.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.342 -0.849 . . . . 0.0 110.515 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 62.9 m -153.54 162.23 41.47 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.376 -0.827 . . . . 0.0 110.225 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.515 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.64 160.27 32.9 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.235 -0.915 . . . . 0.0 110.288 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.472 ' C ' HG13 ' A' ' 39' ' ' VAL . 49.4 Cg_endo -74.54 172.34 16.37 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.781 1.411 . . . . 0.0 110.343 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.665 HG23 ' CB ' ' A' ' 42' ' ' GLN . 33.4 m -149.94 65.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.233 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.59 41.26 90.12 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.04 -38.13 3.46 Favored Glycine 0 N--CA 1.487 2.061 0 O-C-N 121.025 -1.279 . . . . 0.0 110.001 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.665 ' CB ' HG23 ' A' ' 39' ' ' VAL . 1.1 mt-30 -80.41 -172.42 3.53 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.26 -1.141 . . . . 0.0 109.62 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -136.15 135.54 39.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.046 -1.034 . . . . 0.0 110.348 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.596 ' HB2' HG11 ' A' ' 39' ' ' VAL . . . -125.43 159.35 32.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.691 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.466 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.3 m -144.76 157.07 44.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.145 -0.972 . . . . 0.0 110.385 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.479 HD21 ' HA ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -96.27 109.92 49.83 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.204 -0.935 . . . . 0.0 110.288 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 50.8 Cg_endo -86.92 -42.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.894 1.47 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.41 66.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.401 -0.812 . . . . 0.0 110.855 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.0 p -113.47 31.5 6.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.059 -1.025 . . . . 0.0 110.374 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.48 131.72 36.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.557 HG23 ' CG2' ' A' ' 33' ' ' ILE . 7.0 t -148.65 170.24 18.58 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.252 -0.905 . . . . 0.0 110.235 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.7 t -135.6 166.99 21.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.068 -1.02 . . . . 0.0 110.983 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 16.3 p90 -148.91 -177.08 5.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.467 -0.771 . . . . 0.0 109.832 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.6 m -144.21 166.85 23.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.058 -1.026 . . . . 0.0 110.268 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.792 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -86.98 -156.94 0.35 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.239 -0.913 . . . . 0.0 110.416 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -144.36 -163.75 1.75 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.781 -1.199 . . . . 0.0 109.931 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.5 77.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.134 -0.979 . . . . 0.0 109.441 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.6 p -88.03 15.48 7.29 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.405 -0.81 . . . . 0.0 108.848 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 65.23 16.91 63.11 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.15 122.24 32.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.091 -1.241 . . . . 0.0 109.901 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 55' ' ' THR . . . -132.96 85.22 2.2 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.179 -0.951 . . . . 0.0 110.386 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.62 129.02 49.07 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.525 -0.735 . . . . 0.0 109.196 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 6.0 p90 -161.02 179.9 8.07 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.14 -0.975 . . . . 0.0 110.571 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 m -108.29 144.62 35.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.297 -0.877 . . . . 0.0 111.548 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 36.5 t80 -135.71 166.09 24.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.58 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 3.6 t -106.85 154.95 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.607 -1.308 . . . . 0.0 110.963 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.4 m -140.73 158.66 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.531 -0.731 . . . . 0.0 109.958 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.18 148.48 41.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 110.578 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -52.84 13.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -124.51 150.17 46.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.152 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 71' ' ' TYR . 45.6 p90 -161.1 132.1 5.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.03 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 99.6 m -57.37 119.63 6.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.484 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.417 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -99.41 -178.05 31.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.33 140.41 12.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.111 -1.229 . . . . 0.0 110.411 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.505 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 25.6 p -48.08 167.19 0.19 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.432 -0.792 . . . . 0.0 110.279 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 41.5 Cg_endo -67.1 -12.78 37.35 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.785 1.413 . . . . 0.0 110.644 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -86.36 -15.71 39.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 109.946 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.62 26.86 8.33 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.2 m -113.16 132.25 22.49 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.336 -1.097 . . . . 0.0 110.389 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.61 127.96 11.4 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.936 1.493 . . . . 0.0 110.395 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 82' ' ' GLY . 14.5 p -122.59 -35.94 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 109.98 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.485 ' N ' HG13 ' A' ' 81' ' ' VAL . . . -175.08 157.77 24.94 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 58.6 p -78.13 157.63 29.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -1.167 . . . . 0.0 110.231 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 37' ' ' ALA . 20.9 t -106.68 164.2 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.291 -0.881 . . . . 0.0 110.425 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.917 ' OD2' HG22 ' A' ' 88' ' ' THR . 26.0 p-10 -153.52 149.36 27.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.343 -0.848 . . . . 0.0 110.184 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 34.8 m -104.11 -2.98 25.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.14 -65.8 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.968 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.917 HG22 ' OD2' ' A' ' 85' ' ' ASP . 7.1 t -82.39 -19.82 38.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.079 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 85' ' ' ASP . . . -106.37 158.13 17.11 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.22 -0.925 . . . . 0.0 109.938 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.71 109.68 21.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.939 . . . . 0.0 110.234 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 24.2 p -108.7 164.36 12.44 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.205 -0.934 . . . . 0.0 109.824 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -149.03 159.64 44.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.1 -1.0 . . . . 0.0 110.626 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.032 HD12 ' O ' ' A' ' 34' ' ' ALA . 20.2 tp -107.27 113.53 26.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.365 -0.834 . . . . 0.0 109.174 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.46 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . -103.51 154.34 17.96 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.038 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -143.01 124.98 15.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.326 -1.102 . . . . 0.0 110.175 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.57 -171.0 36.64 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' SER . 11.9 p-10 -130.88 -50.57 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -1.222 . . . . 0.0 110.638 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 97' ' ' ASN . 0.5 OUTLIER 166.57 -39.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.219 -0.926 . . . . 0.0 110.474 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.61 -21.21 62.33 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.576 HD13 ' OH ' ' A' ' 31' ' ' TYR . 6.6 tt -120.75 -66.77 1.03 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -1.183 . . . . 0.0 110.137 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.58 87.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 110.476 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.519 HD23 ' HG2' ' A' ' 2' ' ' PRO . 0.3 OUTLIER -62.38 -39.04 91.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.048 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.25 -162.59 25.7 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.46 ' HB3' ' CA ' ' A' ' 94' ' ' GLY . 0.6 OUTLIER -146.51 129.4 16.32 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.284 -1.127 . . . . 0.0 110.014 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.634 HG11 HG12 ' A' ' 6' ' ' VAL . 6.3 t -92.01 119.94 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.253 -0.904 . . . . 0.0 110.341 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.62 158.85 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 109.983 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.443 HD22 HD13 ' A' ' 12' ' ' LEU . 12.9 mt -134.83 150.25 50.47 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.086 -1.009 . . . . 0.0 110.697 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.7 m -140.96 159.61 41.84 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.35 -0.844 . . . . 0.0 110.046 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -127.16 145.31 50.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.126 -0.984 . . . . 0.0 110.197 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.529 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.5 ' O ' ' HA3' ' A' ' 24' ' ' GLY . . . . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 120.794 0.33 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 1' ' ' ALA . 45.5 Cg_endo -71.09 167.49 25.98 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.085 1.571 . . . . 0.0 110.648 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -155.3 138.45 15.61 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.264 -0.898 . . . . 0.0 110.898 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 1.6 t80 -152.36 102.96 2.8 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.345 -0.847 . . . . 0.0 109.793 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.9 t -146.2 151.9 38.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.097 -1.002 . . . . 0.0 110.734 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.878 ' CG1' HG11 ' A' ' 105' ' ' VAL . 8.0 p -115.63 122.62 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.799 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 m -47.1 -68.02 0.35 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.109 -0.994 . . . . 0.0 110.567 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 55.3 Cg_endo -76.06 79.14 2.98 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 O-C-N 123.311 1.164 . . . . 0.0 109.83 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.33 -6.73 57.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.974 -1.079 . . . . 0.0 110.689 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 p -146.96 146.43 30.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.212 -0.93 . . . . 0.0 109.71 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.425 ' C ' ' HG ' ' A' ' 12' ' ' LEU . . . 79.61 71.78 1.24 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' A' ' 8' ' ' PRO . 4.0 mt -129.87 169.95 14.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -1.108 . . . . 0.0 109.751 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -136.23 169.49 17.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.49 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 30.5 p-10 -65.19 131.04 45.49 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.113 -0.992 . . . . 0.0 110.184 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.46 -29.86 5.53 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.5 ' HB3' ' O ' ' A' ' 13' ' ' SER . 9.4 tp60 -49.48 143.01 7.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -1.114 . . . . 0.0 110.308 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.32 133.62 42.48 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.742 HG23 ' HB3' ' A' ' 65' ' ' PHE . 16.6 m -101.85 163.26 3.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 109.785 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.431 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -113.1 121.57 44.94 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.983 -1.073 . . . . 0.0 110.28 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.91 151.41 14.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.68 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.5 m -146.34 121.68 10.27 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.323 -0.861 . . . . 0.0 109.992 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 86.2 t -120.54 139.38 48.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 109.831 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.9 p -157.66 136.44 11.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.054 -1.029 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 1' ' ' ALA . . . 124.28 -46.47 1.09 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 1.042 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -45.69 -52.11 11.38 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.155 -1.203 . . . . 0.0 110.237 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 25' ' ' ALA . . . 72.07 137.92 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.435 -0.791 . . . . 0.0 110.888 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -33.37 130.66 0.23 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.391 0.615 . . . . 0.0 110.762 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 29' ' ' GLU . . . 122.37 9.59 6.49 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 60.1 mt-10 -147.99 130.15 15.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.0 110.185 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.497 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 3.4 m -111.57 146.63 37.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.402 -0.811 . . . . 0.0 109.898 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.729 ' OH ' ' HB1' ' A' ' 25' ' ' ALA . 30.6 m-85 -132.08 174.51 10.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.084 -1.01 . . . . 0.0 110.662 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' ' 52' ' ' SER . 73.7 m-85 -130.46 102.05 5.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.486 -0.759 . . . . 0.0 109.626 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 33' ' ' ILE . 1.3 tt -87.85 104.15 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.087 -1.008 . . . . 0.0 110.185 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -138.97 157.21 46.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.845 . . . . 0.0 110.618 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.407 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 1.1 tt0 -122.92 147.06 47.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.53 -0.731 . . . . 0.0 110.08 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 67.3 m -150.24 171.21 17.31 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.194 -0.941 . . . . 0.0 110.668 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.43 152.15 28.53 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.532 -0.73 . . . . 0.0 109.71 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.03 166.5 29.41 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.835 1.439 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.843 HG21 ' HB2' ' A' ' 44' ' ' ALA . 30.6 t -134.35 146.78 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.415 -0.803 . . . . 0.0 109.921 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -48.49 -35.89 16.54 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -76.64 -42.07 22.64 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -170.18 -79.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.176 -1.191 . . . . 0.0 110.211 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.44 166.79 18.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.116 -0.99 . . . . 0.0 110.162 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.843 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -154.14 149.49 27.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.121 -0.987 . . . . 0.0 110.036 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.483 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -124.47 156.66 36.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.139 -0.975 . . . . 0.0 110.001 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.458 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 9.2 t-20 -100.12 101.91 16.08 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.044 -1.035 . . . . 0.0 110.516 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.8 Cg_endo -73.8 -30.78 9.03 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.976 1.514 . . . . 0.0 110.532 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.85 85.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.268 -0.895 . . . . 0.0 110.556 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 5.1 p -95.35 1.83 54.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.219 -0.925 . . . . 0.0 110.52 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.79 119.44 21.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.129 -0.982 . . . . 0.0 110.037 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.412 HG23 ' CG2' ' A' ' 33' ' ' ILE . 11.3 t -146.33 145.24 30.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.985 . . . . 0.0 110.631 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.567 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 1.1 m -110.58 147.54 34.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 13.8 p90 -144.18 -176.4 5.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -0.876 . . . . 0.0 110.08 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.8 m -149.12 156.18 41.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.597 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 1.042 HG21 ' HB3' ' A' ' 25' ' ' ALA . 6.9 p -68.53 -161.64 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.045 -1.034 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -160.2 -155.5 0.44 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.963 -1.085 . . . . 0.0 110.943 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.69 64.56 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 109.346 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.5 t -71.03 -5.38 30.89 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.437 -0.79 . . . . 0.0 109.16 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 26' ' ' ALA . . . 53.72 53.98 33.11 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.78 126.63 8.95 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.161 -1.199 . . . . 0.0 110.7 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.514 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -113.38 85.77 2.26 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.321 -0.862 . . . . 0.0 110.002 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.17 136.45 49.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.658 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -171.03 173.26 5.13 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.203 -0.936 . . . . 0.0 110.782 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 m -94.37 117.26 29.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.376 -0.827 . . . . 0.0 110.342 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.742 ' HB3' HG23 ' A' ' 18' ' ' VAL . 36.1 t80 -98.63 -179.44 4.31 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.355 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 t -134.5 156.39 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.874 -1.141 . . . . 0.0 110.286 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.3 m -143.3 153.96 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.367 -0.833 . . . . 0.0 110.048 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -132.37 120.67 22.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 110.213 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HE2' ' CD2' ' A' ' 109' ' ' PHE . 4.3 tttt -49.41 -45.74 46.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.283 -0.886 . . . . 0.0 109.762 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.1 m -120.5 135.29 55.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.479 -0.763 . . . . 0.0 109.608 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -151.32 144.27 24.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.151 -0.968 . . . . 0.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 29.3 m -65.59 149.8 49.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 0.0 110.28 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.0 -167.17 13.64 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.97 -165.63 2.09 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.298 -1.119 . . . . 0.0 110.0 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 7.6 p -111.18 165.3 13.0 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.16 -0.962 . . . . 0.0 110.338 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 48.0 Cg_endo -77.75 -8.43 16.89 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.105 1.582 . . . . 0.0 109.963 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.87 8.24 40.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.43 -0.794 . . . . 0.0 110.065 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.8 55.14 5.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.7 m -149.72 133.4 8.7 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.225 -1.162 . . . . 0.0 110.547 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.04 110.07 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.917 1.483 . . . . 0.0 110.211 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.4 p -90.5 -18.44 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.404 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.29 -152.59 19.54 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 3.9 m -97.83 161.73 13.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -1.183 . . . . 0.0 110.284 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.65 HG21 ' CB ' ' A' ' 44' ' ' ALA . 62.7 t -116.95 123.84 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.02 111.1 23.75 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.163 -0.961 . . . . 0.0 110.094 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -90.15 9.02 29.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 110.084 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.36 -41.29 88.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.551 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 t -114.35 0.99 14.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.13 -0.981 . . . . 0.0 110.326 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -100.64 -139.16 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.24 142.16 31.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.4 m -128.9 133.82 48.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.1 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -129.27 148.26 51.18 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.189 -0.945 . . . . 0.0 110.091 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.537 HD12 ' C ' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -125.61 118.97 26.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.072 -1.018 . . . . 0.0 109.153 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -122.74 159.59 17.34 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.275 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -146.92 143.31 28.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.549 -0.971 . . . . 0.0 109.765 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 166.37 174.86 36.15 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.094 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 30' ' ' THR . 12.0 p-10 -119.35 -137.61 0.34 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.31 -1.112 . . . . 0.0 110.157 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.4 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -121.14 60.79 0.91 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.146 -0.971 . . . . 0.0 110.214 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.29 -24.26 0.12 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.833 HD13 ' N ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER -118.37 -60.84 1.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.235 . . . . 0.0 110.278 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.833 ' N ' HD13 ' A' ' 100' ' ' LEU . 38.9 t0 58.27 119.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 110.139 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.1 mt -84.81 -70.84 0.55 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.427 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 177.61 -175.6 47.64 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.403 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 1.1 m80 -131.59 124.24 29.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.522 -0.987 . . . . 0.0 109.78 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.878 HG11 ' CG1' ' A' ' 6' ' ' VAL . 66.6 t -95.35 107.31 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.047 . . . . 0.0 110.515 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.01 112.37 2.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.7 mt -86.52 133.02 33.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.131 -0.981 . . . . 0.0 110.722 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.3 m -114.17 169.01 9.34 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.442 -0.786 . . . . 0.0 109.77 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.43 ' CD2' ' HE2' ' A' ' 69' ' ' LYS . 11.4 m-85 -134.14 163.4 29.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 110.075 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.269 0 CA-C-O 117.948 -1.474 . . . . 0.0 109.601 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.515 ' HB2' HD23 ' A' ' 102' ' ' LEU . 47.1 Cg_endo -72.51 -161.67 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.935 1.492 . . . . 0.0 110.517 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -142.43 133.9 26.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 110.498 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -146.31 111.01 5.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.233 -0.917 . . . . 0.0 109.955 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.07 149.98 34.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.129 -0.982 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.68 HG12 HG11 ' A' ' 105' ' ' VAL . 9.2 p -117.04 154.51 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 109.532 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.622 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -72.83 -68.18 0.41 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.04 . . . . 0.0 110.014 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.622 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 54.6 Cg_endo -77.58 75.94 4.5 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.308 1.162 . . . . 0.0 109.978 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.52 -8.12 57.82 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.934 -1.104 . . . . 0.0 110.527 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.5 p -142.72 123.39 14.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.28 75.56 1.3 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.57 ' O ' ' CE1' ' A' ' 109' ' ' PHE . 2.3 mt -120.07 165.93 14.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -1.14 . . . . 0.0 110.085 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.444 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 9.4 m -124.16 161.2 26.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 109.876 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 8.7 p-10 -62.43 121.6 13.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 110.075 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.87 -27.56 8.83 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.508 ' O ' HG22 ' A' ' 67' ' ' VAL . 2.7 tt0 -43.32 143.85 0.8 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.306 -1.114 . . . . 0.0 110.728 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.0 p -96.75 150.72 20.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.659 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.76 154.33 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 110.084 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.4 m -101.92 132.91 47.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.007 . . . . 0.0 110.02 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 t -120.8 146.66 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.075 -1.016 . . . . 0.0 109.896 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.71 126.2 21.84 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.424 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 84.8 t -117.67 141.61 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 109.919 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.585 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -152.96 145.53 24.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.135 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 121.35 -58.95 0.57 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.824 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -52.54 -175.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.578 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.499 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -154.36 155.14 34.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.017 -1.052 . . . . 0.0 110.783 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -37.03 133.9 0.58 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.436 0.636 . . . . 0.0 110.864 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.36 16.25 16.83 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -143.61 120.29 11.15 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.168 -1.195 . . . . 0.0 110.382 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.438 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 8.8 m -103.44 148.22 26.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.983 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.717 ' CE1' HD22 ' A' ' 100' ' ' LEU . 33.2 m-85 -136.21 170.77 15.48 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 110.4 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 22.5 m-85 -117.68 167.23 11.54 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.427 -0.796 . . . . 0.0 109.967 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.809 ' CG2' HG23 ' A' ' 51' ' ' THR . 4.4 tt -151.9 97.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.555 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.504 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -140.8 161.79 36.96 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.254 -0.903 . . . . 0.0 110.914 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -116.78 139.98 49.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.52 -0.737 . . . . 0.0 109.81 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 96.0 m -136.76 162.58 32.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.519 ' HB2' ' SG ' ' A' ' 91' ' ' CYS . . . -151.52 159.12 33.85 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.428 -0.795 . . . . 0.0 110.01 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 46.2 Cg_endo -75.45 164.61 32.22 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.879 1.463 . . . . 0.0 110.678 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.651 ' CG1' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -142.3 170.25 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.357 -0.839 . . . . 0.0 109.941 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.28 -40.78 61.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 42' ' ' GLN . . . -67.5 -60.56 5.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.563 ' H ' HG23 ' A' ' 39' ' ' VAL . 2.6 mt-30 -166.81 -68.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.441 -1.035 . . . . 0.0 110.132 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 1.4 t70 -161.1 166.65 27.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 110.297 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.494 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -159.05 173.62 16.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 110.225 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 m -138.99 157.48 45.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.293 -0.879 . . . . 0.0 110.313 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 52.2 t-20 -95.69 114.77 64.69 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 110.007 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.96 -30.72 8.8 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.967 1.509 . . . . 0.0 110.519 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.6 95.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.951 . . . . 0.0 110.143 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.2 p -87.29 7.23 29.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.375 -0.828 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.96 119.26 21.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.312 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.809 HG23 ' CG2' ' A' ' 33' ' ' ILE . 9.7 t -156.17 170.71 21.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.859 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.458 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 14.6 p -141.91 148.11 38.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.072 -1.017 . . . . 0.0 110.565 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 48.8 p90 -135.46 -176.13 4.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.415 -0.803 . . . . 0.0 109.97 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.5 m -146.48 154.39 41.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.073 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.824 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -72.6 -158.79 0.05 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 14.5 t0 -155.83 -157.09 0.7 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.783 -1.198 . . . . 0.0 110.498 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.62 -46.53 89.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.14 -0.975 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.8 t -83.6 9.91 10.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.278 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.499 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 51.14 49.98 41.4 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -133.0 138.63 46.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -1.091 . . . . 0.0 109.927 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -135.3 85.04 2.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 110.829 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 p -108.06 125.72 51.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.298 -0.876 . . . . 0.0 108.953 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -154.07 -179.19 7.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.026 -1.046 . . . . 0.0 111.405 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.49 135.3 39.54 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.465 0.65 . . . . 0.0 110.563 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 38.4 t80 -125.49 178.74 5.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 0.0 109.502 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 3.4 t -134.05 161.08 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.859 -1.151 . . . . 0.0 110.536 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 16' ' ' GLN . 30.3 m -137.17 179.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.487 -0.758 . . . . 0.0 109.902 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 8.8 mtt85 -152.21 152.72 32.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.095 -1.003 . . . . 0.0 110.365 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 5.7 tttm -82.41 -25.46 33.68 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.263 -0.898 . . . . 0.0 109.314 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 85' ' ' ASP . 1.1 m -150.26 107.53 3.61 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.454 -0.778 . . . . 0.0 109.653 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.636 ' CZ ' HG11 ' A' ' 84' ' ' VAL . 25.1 p90 -105.07 143.59 33.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 110.394 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.3 m -74.25 115.22 13.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 110.467 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.494 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -90.72 -174.5 44.33 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.86 152.89 0.79 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -1.202 . . . . 0.0 110.482 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.412 HG23 HG23 ' A' ' 81' ' ' VAL . 46.0 p -90.02 160.56 40.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.344 -0.848 . . . . 0.0 110.348 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -83.07 -20.47 5.15 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.01 1.532 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.54 -74.33 0.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.104 -0.998 . . . . 0.0 110.472 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.19 58.36 0.06 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 m -154.91 106.89 2.31 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.278 -1.131 . . . . 0.0 109.975 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.11 105.51 1.98 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.968 1.509 . . . . 0.0 110.29 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.455 HG11 ' HB ' ' A' ' 39' ' ' VAL . 45.5 t -63.78 -34.42 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 110.245 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.95 -150.74 18.04 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -85.31 167.06 15.95 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.287 -1.125 . . . . 0.0 110.315 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.651 HG22 ' CG1' ' A' ' 39' ' ' VAL . 96.1 t -138.29 110.19 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.322 -0.861 . . . . 0.0 110.023 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 1.6 m-20 -92.71 161.24 14.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.246 -0.909 . . . . 0.0 110.551 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 94.7 m -109.88 -0.11 18.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.181 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.97 -60.88 2.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.173 -0.954 . . . . 0.0 110.333 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -74.94 -30.48 61.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.174 -0.954 . . . . 0.0 110.279 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.09 155.72 20.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.892 . . . . 0.0 110.296 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.86 135.14 34.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.344 -0.847 . . . . 0.0 110.166 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 37' ' ' ALA . 2.0 m -114.14 137.9 51.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 109.845 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -125.28 151.9 45.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.109 -0.995 . . . . 0.0 110.801 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 34' ' ' ALA . 5.6 tp -122.46 109.16 14.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 0.0 109.073 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -107.39 164.45 13.06 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.532 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.643 ' O ' HD12 ' A' ' 102' ' ' LEU . . . -145.51 136.29 24.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.631 -0.923 . . . . 0.0 110.04 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.57 178.06 17.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -105.84 -160.07 0.73 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -1.197 . . . . 0.0 110.15 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.76 45.81 1.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 110.038 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.48 -51.77 0.05 OUTLIER Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.717 HD22 ' CE1' ' A' ' 31' ' ' TYR . 7.9 tt -103.05 91.33 4.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -1.193 . . . . 0.0 110.143 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -100.86 122.74 43.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 95' ' ' ALA . 2.1 mp -74.11 -29.36 61.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 110.174 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 140.53 -169.84 24.67 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.448 ' O ' ' ND1' ' A' ' 104' ' ' HIS . 31.0 p80 -144.23 126.71 15.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -1.11 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.68 HG11 HG12 ' A' ' 6' ' ' VAL . 85.8 t -92.58 128.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.189 -0.944 . . . . 0.0 110.228 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.57 136.04 42.09 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 88.7 mt -110.21 119.45 39.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.249 -0.907 . . . . 0.0 110.152 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -90.88 160.89 15.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.306 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.57 ' CE1' ' O ' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -146.79 78.67 1.5 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.822 . . . . 0.0 110.148 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 CA-C-O 117.948 -1.474 . . . . 0.0 109.591 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 120.744 0.307 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.492 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 46.3 Cg_endo -72.85 -159.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.025 1.539 . . . . 0.0 110.294 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -141.55 136.21 30.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.087 -1.008 . . . . 0.0 110.772 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.458 ' HD1' HG22 ' A' ' 22' ' ' VAL . 87.9 t80 -149.37 114.64 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.486 -0.759 . . . . 0.0 109.168 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.47 153.7 35.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.868 -1.145 . . . . 0.0 111.317 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.757 HG22 ' HD2' ' A' ' 8' ' ' PRO . 9.5 p -113.67 165.69 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.67 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -74.66 -61.87 1.04 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.663 -1.273 . . . . 0.0 110.432 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.757 ' HD2' HG22 ' A' ' 6' ' ' VAL . 55.9 Cg_endo -91.6 76.3 0.57 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 O-C-N 123.104 1.055 . . . . 0.0 110.143 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.89 -23.76 65.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.031 -1.043 . . . . 0.0 109.94 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.9 m -139.39 135.68 33.92 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.44 -0.787 . . . . 0.0 109.964 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.87 54.28 1.93 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.701 HD21 ' O ' ' A' ' 8' ' ' PRO . 2.2 mt -102.43 171.02 7.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.257 -1.143 . . . . 0.0 109.972 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -125.17 149.36 48.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 69' ' ' LYS . 4.4 p-10 -59.85 120.89 10.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.85 . . . . 0.0 109.978 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.8 -31.04 7.22 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.498 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 14.3 tt0 -55.52 147.93 16.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -1.127 . . . . 0.0 110.326 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 26.0 p -97.82 150.86 20.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 0.0 110.325 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.722 HG12 ' HG2' ' A' ' 8' ' ' PRO . 22.6 m -119.46 150.94 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.797 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 m -93.88 116.38 28.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.131 -0.981 . . . . 0.0 110.247 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 t -102.9 149.94 6.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.315 -0.865 . . . . 0.0 109.991 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 32.2 t -150.85 129.81 12.53 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 110.251 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.707 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 75.8 t -116.25 151.99 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.809 . . . . 0.0 109.901 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.755 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -164.7 113.07 1.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.208 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.65 -55.81 0.42 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.75 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -62.52 -142.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -1.148 . . . . 0.0 110.326 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.557 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -175.61 166.57 3.21 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.169 -0.957 . . . . 0.0 110.458 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -54.88 133.04 47.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.424 -0.798 . . . . 0.0 110.653 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.423 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 119.67 9.72 8.21 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 19.6 mm-40 -140.68 120.93 13.89 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.161 -1.2 . . . . 0.0 110.468 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 53' ' ' PHE . 63.6 m -106.36 130.44 54.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.261 -0.899 . . . . 0.0 109.88 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 50.0 m-85 -115.65 -168.31 1.39 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.233 -0.917 . . . . 0.0 110.786 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 40.8 m-85 -138.68 112.11 8.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.432 -0.793 . . . . 0.0 109.987 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 33' ' ' ILE . 5.6 tt -94.42 112.69 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.187 -0.946 . . . . 0.0 109.735 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.46 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -146.71 155.3 42.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 111.307 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 22.6 tt0 -109.7 127.41 54.56 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 1.8 m -143.25 165.92 26.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.067 -1.021 . . . . 0.0 110.705 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.493 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.77 164.17 21.28 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.613 -0.679 . . . . 0.0 109.441 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 43.3 Cg_endo -71.79 162.83 40.82 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.748 1.394 . . . . 0.0 110.674 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 39' ' ' VAL . 33.4 m -140.81 66.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.378 -0.827 . . . . 0.0 110.283 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.53 -28.99 7.03 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.19 -35.46 0.13 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -84.37 -170.35 3.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -1.163 . . . . 0.0 110.096 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -122.37 134.12 54.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.55 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.521 ' CB ' HG11 ' A' ' 39' ' ' VAL . . . -132.1 156.7 45.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.85 . . . . 0.0 109.671 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 12.2 t -147.55 160.7 42.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.106 -0.996 . . . . 0.0 110.511 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.464 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 41.2 t-20 -84.37 117.64 69.22 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.318 -0.864 . . . . 0.0 110.12 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.63 -37.16 2.44 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.908 1.478 . . . . 0.0 110.554 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.07 -20.95 58.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.327 -0.858 . . . . 0.0 110.322 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 82.4 p -113.86 -10.96 12.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.925 . . . . 0.0 110.352 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.4 106.43 2.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.4 t -139.9 152.96 46.83 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.255 -0.903 . . . . 0.0 110.318 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 6.0 p -105.83 157.33 17.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.106 -0.996 . . . . 0.0 110.51 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 6.4 p90 -146.0 -177.4 5.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.047 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.3 m -138.6 161.29 37.48 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.216 -0.927 . . . . 0.0 110.013 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.75 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -76.22 -158.09 0.09 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.205 -0.934 . . . . 0.0 109.934 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 1.6 t0 -141.75 -151.31 0.35 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.967 -1.083 . . . . 0.0 110.406 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.6 -54.62 29.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.926 . . . . 0.0 109.533 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.6 p -90.37 21.28 3.95 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.557 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 61.51 17.49 53.61 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -89.68 137.83 31.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -1.164 . . . . 0.0 110.056 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.707 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -140.74 84.62 1.95 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 110.269 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.8 p -104.86 115.59 30.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.84 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -146.12 179.0 7.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.258 -0.901 . . . . 0.0 110.675 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.36 138.64 31.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.511 -0.743 . . . . 0.0 110.863 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.484 ' HB3' HG23 ' A' ' 18' ' ' VAL . 51.4 t80 -132.84 -175.55 3.81 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 21.7 t -144.66 163.03 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.726 -1.234 . . . . 0.0 110.798 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.427 ' C ' ' HG2' ' A' ' 68' ' ' ARG . 33.7 m -138.28 160.83 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 109.657 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.427 ' HG2' ' C ' ' A' ' 67' ' ' VAL . 0.9 OUTLIER -141.05 139.27 34.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.939 -1.1 . . . . 0.0 110.527 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 3.2 ttmt -61.14 -44.92 96.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.903 . . . . 0.0 109.746 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 95.5 p -138.75 149.46 45.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.767 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -155.03 153.65 31.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 110.337 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 7.0 m -70.42 128.4 36.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.892 . . . . 0.0 110.138 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 74' ' ' SER . . . -87.71 173.2 43.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 5.5 t -177.18 145.53 0.46 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.282 -1.128 . . . . 0.0 110.111 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.479 ' OG1' ' HB ' ' A' ' 79' ' ' THR . 48.2 p -74.95 153.41 86.77 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.236 -0.915 . . . . 0.0 110.639 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 75' ' ' THR . 53.0 Cg_endo -82.19 9.47 3.96 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.272 1.67 . . . . 0.0 110.396 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -114.61 -22.04 9.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.112 -0.993 . . . . 0.0 110.719 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.519 ' N ' ' HG3' ' A' ' 77' ' ' GLU . . . 123.84 62.9 0.19 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.479 ' HB ' ' OG1' ' A' ' 75' ' ' THR . 7.7 m -156.1 97.83 2.23 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.264 -1.139 . . . . 0.0 109.933 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 79' ' ' THR . 44.0 Cg_endo -71.03 105.13 1.63 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.003 1.528 . . . . 0.0 110.433 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 82' ' ' GLY . 24.1 t -79.79 -71.66 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.331 -0.856 . . . . 0.0 110.318 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.435 ' N ' HG12 ' A' ' 81' ' ' VAL . . . -169.88 -151.67 7.52 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.2 OUTLIER -103.43 160.5 14.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.377 -1.072 . . . . 0.0 110.526 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -127.62 155.87 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.411 -0.806 . . . . 0.0 109.676 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -143.97 140.71 29.79 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.033 -1.042 . . . . 0.0 110.499 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 89' ' ' ALA . 69.3 m -85.16 -9.78 57.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.817 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.77 -44.9 72.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 109.929 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 t -94.91 -8.78 36.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.958 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 86' ' ' CYS . . . -140.37 163.9 31.54 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.332 -0.855 . . . . 0.0 109.981 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.24 139.64 35.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.511 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 1.4 p -123.22 142.48 50.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.302 -0.874 . . . . 0.0 109.714 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -125.47 161.43 27.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.995 . . . . 0.0 110.604 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.46 HD12 ' C ' ' A' ' 34' ' ' ALA . 13.7 tp -117.12 112.11 20.43 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.388 -0.82 . . . . 0.0 109.172 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.45 ' HA3' ' CD2' ' A' ' 104' ' ' HIS . . . -110.47 150.29 17.63 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.466 -1.35 . . . . 0.0 109.914 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -142.41 132.14 24.09 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.485 -1.009 . . . . 0.0 109.669 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.528 ' CA ' ' HB3' ' A' ' 31' ' ' TYR . . . 149.35 -159.37 28.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 100' ' ' LEU . 8.9 t-20 -121.18 159.08 26.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -1.083 . . . . 0.0 110.04 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -54.37 -30.57 52.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.1 -1.0 . . . . 0.0 110.107 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.74 -45.76 4.47 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.594 HD22 ' CE1' ' A' ' 31' ' ' TYR . 8.8 tt -87.89 143.52 27.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.183 . . . . 0.0 110.204 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -117.25 92.68 3.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.129 -0.982 . . . . 0.0 110.354 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.4 OUTLIER -71.13 -54.87 9.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.897 . . . . 0.0 110.125 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 158.72 155.15 7.49 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.499 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.45 ' CD2' ' HA3' ' A' ' 94' ' ' GLY . 17.6 m80 -125.82 119.52 28.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.675 -0.897 . . . . 0.0 109.264 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.9 t -103.46 107.35 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 110.632 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.91 48.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.264 -0.897 . . . . 0.0 109.717 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 41.1 mt -95.98 158.37 15.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 0.0 110.65 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.554 HG22 ' N ' ' A' ' 109' ' ' PHE . 75.1 m -149.36 172.88 14.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.363 -0.835 . . . . 0.0 109.989 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 36.5 m-85 -135.09 118.24 16.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.199 -0.938 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.875 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 120.556 0.217 . . . . 0.0 110.444 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.875 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 44.5 Cg_endo -74.65 -172.29 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.933 1.491 . . . . 0.0 110.622 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.536 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -151.22 151.2 31.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -150.19 113.8 4.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.213 -0.929 . . . . 0.0 109.984 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.5 t -150.56 150.31 31.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.099 -1.001 . . . . 0.0 110.571 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.584 HG12 HG11 ' A' ' 105' ' ' VAL . 9.9 p -123.11 155.28 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.405 -0.809 . . . . 0.0 109.65 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -75.08 -66.4 0.43 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.036 -1.04 . . . . 0.0 110.382 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 46.3 Cg_endo -74.05 81.98 1.86 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.458 1.241 . . . . 0.0 110.259 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.06 -4.85 53.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.311 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.5 p -143.92 159.44 42.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.433 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.06 51.05 58.24 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.509 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 5.3 mt -88.5 154.79 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -1.154 . . . . 0.0 109.922 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 4.3 t -132.92 157.06 46.07 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.134 -0.979 . . . . 0.0 110.346 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -63.58 115.92 5.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.79 -32.63 7.36 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 26.5 tt0 -50.82 143.97 9.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -1.073 . . . . 0.0 110.116 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.4 t -98.85 152.61 19.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.54 ' HA ' ' HG3' ' A' ' 8' ' ' PRO . 28.7 m -128.11 150.47 33.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.288 -0.883 . . . . 0.0 109.927 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -98.29 131.36 44.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 110.133 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.39 149.02 18.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -144.9 134.55 23.4 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.391 -0.818 . . . . 0.0 110.524 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.934 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 52.5 t -127.7 149.0 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.439 -0.788 . . . . 0.0 110.006 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 2' ' ' PRO . 0.7 OUTLIER -153.12 -177.25 6.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.811 . . . . 0.0 109.596 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 1' ' ' ALA . . . 71.52 17.3 76.24 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.498 -1.334 . . . . 0.0 109.819 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.803 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -119.12 -159.47 0.77 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.155 -1.203 . . . . 0.0 110.269 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.573 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -170.98 161.06 6.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.443 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -53.6 131.17 38.3 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.572 -0.705 . . . . 0.0 110.272 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.59 21.58 5.72 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -144.36 116.44 8.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.235 -1.156 . . . . 0.0 110.621 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.405 HG23 ' OG1' ' A' ' 54' ' ' THR . 61.3 m -109.66 128.96 55.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 109.563 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 8.7 m-85 -114.31 175.5 5.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.004 -1.06 . . . . 0.0 110.715 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -124.93 124.5 42.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.473 -0.767 . . . . 0.0 109.46 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 33' ' ' ILE . 1.2 tt -105.06 124.38 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.089 -1.007 . . . . 0.0 110.482 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.99 155.87 38.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 111.201 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.517 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 36.6 tt0 -124.33 135.11 53.09 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.437 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 3.7 m -144.96 179.67 7.19 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.79 -1.194 . . . . 0.0 111.111 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.608 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -152.07 175.71 2.77 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.608 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 46.3 Cg_endo -83.23 163.28 15.2 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.751 1.395 . . . . 0.0 110.782 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.808 HG13 ' H ' ' A' ' 42' ' ' GLN . 14.9 p -150.28 158.66 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 109.982 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -50.72 -43.51 47.05 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 42' ' ' GLN . . . -62.49 -43.5 98.94 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.808 ' H ' HG13 ' A' ' 39' ' ' VAL . 0.6 OUTLIER 171.01 -75.28 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.513 -0.993 . . . . 0.0 109.602 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.436 ' CA ' HG12 ' A' ' 39' ' ' VAL . 19.5 t0 -149.76 137.5 20.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 110.417 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -131.79 173.3 11.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.789 . . . . 0.0 109.588 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.8 t -154.09 165.84 34.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.139 -0.976 . . . . 0.0 110.723 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 29.4 t-20 -80.03 124.58 82.91 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 46' ' ' ASN . 50.5 Cg_endo -86.01 -35.56 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.873 1.46 . . . . 0.0 111.389 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.24 3.61 4.45 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.139 -0.976 . . . . 0.0 111.506 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 71.7 p -124.07 7.29 8.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.863 -1.148 . . . . 0.0 110.677 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.32 120.3 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.026 -1.046 . . . . 0.0 110.193 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.462 HG23 ' CG2' ' A' ' 33' ' ' ILE . 10.0 t -160.57 165.63 30.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.226 -0.922 . . . . 0.0 110.315 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.8 t -136.01 163.59 29.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.216 -0.928 . . . . 0.0 110.43 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 7.3 p90 -146.55 179.68 7.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.297 -0.877 . . . . 0.0 109.764 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.405 ' OG1' HG23 ' A' ' 30' ' ' THR . 32.8 m -145.21 154.2 42.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.803 HG21 ' HB1' ' A' ' 25' ' ' ALA . 7.4 p -73.94 -156.15 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.355 -0.84 . . . . 0.0 110.068 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 27' ' ' ALA . 1.3 t0 -160.9 -151.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.924 -1.11 . . . . 0.0 110.799 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.21 -48.0 83.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 109.959 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.25 9.14 9.37 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.233 -0.917 . . . . 0.0 109.414 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.573 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 50.01 48.17 39.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.61 125.78 43.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.141 -1.211 . . . . 0.0 110.283 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.934 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -115.06 83.08 1.85 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 0.0 110.3 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.5 p -112.12 126.86 55.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.232 -0.918 . . . . 0.0 109.745 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 7.0 p90 -157.06 175.38 14.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 0.0 110.802 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 p -94.4 152.56 18.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.422 -0.799 . . . . 0.0 110.355 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.552 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 73.3 t80 -142.45 179.35 7.0 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 109.634 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.552 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.7 t -135.38 159.11 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.929 -1.107 . . . . 0.0 109.825 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 16' ' ' GLN . 33.7 m -132.79 161.28 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.19 -0.944 . . . . 0.0 110.672 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -135.84 138.43 42.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.89 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.818 ' HD3' ' HB2' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -76.9 -44.31 32.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.092 -1.005 . . . . 0.0 110.471 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.48 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 4.3 p -129.25 147.3 51.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.947 . . . . 0.0 110.413 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.508 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 11.0 p90 -161.82 156.03 22.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.223 -0.923 . . . . 0.0 110.347 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 73' ' ' GLY . 1.4 m -68.97 105.69 2.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.33 -0.856 . . . . 0.0 110.171 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 72' ' ' THR . . . -42.48 147.87 0.59 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 97.1 p -170.16 117.42 0.55 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.29 -1.123 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.48 ' OG1' ' HB ' ' A' ' 79' ' ' THR . 79.5 p -58.36 161.18 8.05 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.893 . . . . 0.0 110.502 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.62 1.41 8.85 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 124.183 1.622 . . . . 0.0 110.303 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -100.74 -26.56 13.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.546 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.64 65.89 0.2 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.48 ' HB ' ' OG1' ' A' ' 75' ' ' THR . 88.3 m -155.78 96.77 2.35 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.197 -1.178 . . . . 0.0 110.036 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.5 110.95 3.17 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.963 1.507 . . . . 0.0 110.366 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.5 t -83.25 -67.85 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.239 -0.913 . . . . 0.0 110.283 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.02 -150.54 6.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 m -88.16 157.27 18.87 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.377 -1.072 . . . . 0.0 110.252 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.4 t -144.88 111.24 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.153 -0.967 . . . . 0.0 110.701 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.48 ' OD1' ' HB2' ' A' ' 70' ' ' SER . 1.7 m-20 -104.99 104.47 14.22 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 109.009 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.673 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -92.07 24.27 3.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.006 -1.059 . . . . 0.0 110.921 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.818 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . . . -68.8 -37.83 79.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.178 -0.951 . . . . 0.0 109.204 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 t -116.0 -3.36 12.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.58 -0.7 . . . . 0.0 109.679 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.673 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -89.53 -139.98 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.354 -0.841 . . . . 0.0 110.294 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.78 102.88 8.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 110.415 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.92 126.15 44.52 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 15.6 p30 -130.5 139.23 50.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.093 -1.005 . . . . 0.0 110.798 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.745 ' HB2' HD11 ' A' ' 107' ' ' LEU . 6.1 tp -119.19 110.39 16.97 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.674 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -113.16 162.51 12.34 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.805 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.46 157.53 44.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.644 -0.915 . . . . 0.0 109.997 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 31' ' ' TYR . . . 107.75 -177.67 21.29 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.518 ' OD1' HD23 ' A' ' 100' ' ' LEU . 4.5 p-10 -126.68 -155.75 0.7 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.194 -1.18 . . . . 0.0 109.996 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 94.3 p -92.62 69.33 4.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.307 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.57 -55.12 0.08 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.753 HD22 ' N ' ' A' ' 100' ' ' LEU . 3.9 mm? -75.79 -32.66 59.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -1.135 . . . . 0.0 109.547 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 49.27 80.19 0.07 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.633 -0.667 . . . . 0.0 110.232 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.463 ' HG ' ' HA3' ' A' ' 96' ' ' GLY . 21.8 mt -76.16 -69.82 0.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 110.238 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.35 179.61 36.17 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.806 -1.187 . . . . 0.0 110.14 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.674 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 5.6 m80 -134.59 123.37 23.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.585 -0.95 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.584 HG11 HG12 ' A' ' 6' ' ' VAL . 60.2 t -90.11 111.04 22.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.248 -0.908 . . . . 0.0 110.313 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.54 118.81 10.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.97 . . . . 0.0 109.29 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 93' ' ' LEU . 49.7 mt -89.85 158.68 17.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 110.852 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -123.26 164.09 19.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.503 -0.748 . . . . 0.0 109.72 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.442 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 4.5 m-85 -149.28 174.57 12.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.199 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.916 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.916 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 49.3 Cg_endo -74.31 175.11 11.41 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.976 1.514 . . . . 0.0 110.103 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -155.37 135.04 12.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.962 . . . . 0.0 110.306 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 1.2 t80 -147.78 99.3 3.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.399 -0.813 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.08 158.74 43.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 111.069 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.694 HG12 HG11 ' A' ' 105' ' ' VAL . 6.4 p -121.95 157.99 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.517 -0.739 . . . . 0.0 109.355 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.614 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.7 m -72.46 -70.19 0.29 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.883 -1.136 . . . . 0.0 110.137 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.614 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 53.9 Cg_endo -76.42 97.38 1.13 Allowed 'Trans proline' 0 N--CA 1.481 0.751 0 O-C-N 123.144 1.076 . . . . 0.0 110.031 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.5 -4.33 25.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.047 -1.033 . . . . 0.0 110.144 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.47 127.37 19.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 110.144 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' O ' HD23 ' A' ' 12' ' ' LEU . . . 88.06 80.62 1.26 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.498 HD12 ' HB3' ' A' ' 107' ' ' LEU . 45.3 mt -126.44 162.09 26.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.311 -1.111 . . . . 0.0 110.248 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.78 158.03 44.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.117 -0.99 . . . . 0.0 110.813 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -61.51 121.53 12.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.19 -39.03 2.93 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.551 ' O ' HG22 ' A' ' 67' ' ' VAL . 37.6 tt0 -49.47 134.05 19.62 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.28 -1.129 . . . . 0.0 109.885 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.2 p -95.51 138.74 32.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.38 -0.825 . . . . 0.0 110.066 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 65' ' ' PHE . 15.9 m -108.58 170.18 2.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.375 -0.828 . . . . 0.0 109.665 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.511 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 27.0 p -116.65 121.59 42.11 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.18 -0.95 . . . . 0.0 109.262 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t -112.16 150.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.118 -0.989 . . . . 0.0 110.41 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.65 132.55 22.74 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.492 -0.755 . . . . 0.0 110.114 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.81 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 18.3 t -120.71 139.43 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 3' ' ' ALA . 2.4 p -151.35 143.56 24.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.252 -0.905 . . . . 0.0 110.108 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 120.39 -67.77 0.41 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 24' ' ' GLY . . . -54.18 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.086 -1.243 . . . . 0.0 109.363 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.52 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -165.55 162.65 19.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.943 -1.098 . . . . 0.0 110.976 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.5 130.91 1.3 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.459 0.647 . . . . 0.0 110.409 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.417 ' C ' ' HG3' ' A' ' 29' ' ' GLU . . . 120.04 4.61 11.23 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 33.6 mt-10 -138.72 122.75 17.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.199 -1.177 . . . . 0.0 109.85 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.56 HG23 ' OG1' ' A' ' 54' ' ' THR . 62.4 m -105.02 133.69 49.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 109.99 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.924 ' CE2' HD21 ' A' ' 100' ' ' LEU . 11.1 m-85 -120.05 171.8 8.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.533 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 14.0 m-85 -131.68 102.1 5.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 109.113 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.659 ' CG2' HG23 ' A' ' 51' ' ' THR . 3.0 tt -90.47 117.8 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.084 -1.01 . . . . 0.0 110.905 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.45 158.5 44.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.219 -0.926 . . . . 0.0 110.299 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.462 ' HG2' ' N ' ' A' ' 36' ' ' CYS . 2.2 tt0 -116.85 144.47 44.47 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.226 -0.921 . . . . 0.0 110.19 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 77.2 m -150.23 161.43 42.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.283 -0.885 . . . . 0.0 110.776 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . . . -138.17 156.04 74.0 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 121.371 -0.831 . . . . 0.0 109.816 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 44.4 Cg_endo -70.82 163.62 38.48 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.825 1.434 . . . . 0.0 111.836 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.775 HG23 ' H ' ' A' ' 42' ' ' GLN . 5.8 m -137.66 167.03 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.689 . . . . 0.0 109.748 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -50.24 -30.36 17.63 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.14 -69.63 1.38 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.775 ' H ' HG23 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -149.98 -75.76 0.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -1.111 . . . . 0.0 109.966 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.568 ' CA ' HG22 ' A' ' 39' ' ' VAL . 12.5 t70 -155.79 167.58 29.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.253 -0.905 . . . . 0.0 110.911 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -149.72 162.88 39.37 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.68 162.15 27.22 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.916 -1.115 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . 1.7 t-20 -103.91 113.35 65.47 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.553 -0.717 . . . . 0.0 110.171 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.442 ' HD2' HD21 ' A' ' 46' ' ' ASN . 47.6 Cg_endo -76.26 -27.93 7.63 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.993 1.523 . . . . 0.0 110.242 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.26 -3.78 11.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.849 . . . . 0.0 110.285 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.5 p -131.24 -1.85 3.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.258 -0.901 . . . . 0.0 110.172 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.7 127.38 31.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.26 -0.9 . . . . 0.0 110.183 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.659 HG23 ' CG2' ' A' ' 33' ' ' ILE . 4.4 t -159.47 150.51 19.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.979 . . . . 0.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 t -122.42 143.25 49.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.309 -0.869 . . . . 0.0 110.149 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -140.24 138.07 34.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.146 -0.971 . . . . 0.0 110.432 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.56 ' OG1' HG23 ' A' ' 30' ' ' THR . 15.6 m -105.48 151.56 24.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.194 -0.941 . . . . 0.0 109.525 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -61.71 -170.76 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.811 -1.18 . . . . 0.0 109.481 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 6.5 t0 -145.45 -158.72 0.92 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.914 -1.116 . . . . 0.0 110.818 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.39 -53.23 60.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 109.47 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 p -76.78 1.99 15.68 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 109.083 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 53.75 44.49 70.0 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.14 132.99 47.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.289 -1.124 . . . . 0.0 110.051 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.81 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -123.13 83.55 2.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.181 -0.95 . . . . 0.0 110.876 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.22 120.22 41.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.263 -0.898 . . . . 0.0 109.648 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -154.91 168.03 28.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.175 -0.953 . . . . 0.0 110.833 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 t -90.96 131.63 36.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.448 -0.783 . . . . 0.0 110.278 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 76.7 t80 -116.35 -179.73 3.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.557 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.1 t -133.37 158.1 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 120.858 -1.151 . . . . 0.0 110.01 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 16' ' ' GLN . 29.1 m -129.42 126.72 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.153 -0.967 . . . . 0.0 110.818 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 134.99 47.83 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.206 -0.934 . . . . 0.0 109.888 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -73.91 -45.86 47.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.218 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.4 m -135.12 152.11 51.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.939 . . . . 0.0 110.066 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.578 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 8.8 p90 -169.68 148.19 3.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.928 . . . . 0.0 110.317 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.3 OUTLIER -54.61 124.77 17.32 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.146 -0.971 . . . . 0.0 109.395 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.669 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -110.14 167.6 12.77 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.505 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 12.6 t -173.52 154.35 2.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.658 -0.907 . . . . 0.0 108.909 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 79' ' ' THR . 1.0 OUTLIER -126.44 158.03 68.58 Favored Pre-proline 0 N--CA 1.486 1.369 0 O-C-N 120.554 -1.341 . . . . 0.0 112.42 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 75' ' ' THR . 49.3 Cg_endo -81.99 -48.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.513 1.796 . . . . 0.0 108.659 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -87.59 -27.16 22.7 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.448 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . -99.8 -9.86 48.2 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 75' ' ' THR . 0.5 OUTLIER 67.28 162.55 0.13 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.361 -1.081 . . . . 0.0 110.919 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.629 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 37.5 Cg_endo -63.21 114.17 2.36 Favored 'Trans proline' 0 C--N 1.301 -1.951 0 O-C-N 124.364 1.718 . . . . 0.0 111.088 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.5 t -87.59 -62.24 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.489 -0.757 . . . . 0.0 110.019 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.23 -153.37 11.22 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 5.3 m -74.31 159.77 31.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -1.166 . . . . 0.0 110.033 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.669 HG21 ' HA3' ' A' ' 73' ' ' GLY . 88.0 t -125.82 156.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.183 -0.948 . . . . 0.0 110.297 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -156.19 130.92 9.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.19 -0.944 . . . . 0.0 110.381 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -90.52 7.89 36.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 109.978 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.53 -47.44 69.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.343 -0.848 . . . . 0.0 110.247 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.0 t -113.32 -0.04 14.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 110.174 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -103.46 -163.71 1.01 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.224 -0.923 . . . . 0.0 110.278 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.7 133.23 56.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 110.136 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.56 111.25 23.72 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.184 -0.948 . . . . 0.0 110.016 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -121.49 140.43 52.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.131 -0.981 . . . . 0.0 110.64 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.1 tp -112.84 141.42 46.67 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.435 -0.791 . . . . 0.0 109.244 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.24 167.73 32.41 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.08 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 33' ' ' ILE . . . -155.01 168.52 26.72 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.602 -0.94 . . . . 0.0 109.173 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.3 175.95 26.07 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.166 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 30' ' ' THR . 28.7 t30 -148.37 172.19 14.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -1.081 . . . . 0.0 109.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.99 -10.51 14.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 0.0 110.318 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.96 -43.58 7.1 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.924 HD21 ' CE2' ' A' ' 31' ' ' TYR . 2.3 pt? -154.12 -160.86 1.14 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -1.193 . . . . 0.0 110.436 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.518 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 3.4 m-20 -149.91 113.46 4.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.286 -0.884 . . . . 0.0 110.294 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.588 HD11 ' CD2' ' A' ' 31' ' ' TYR . 96.9 mt -71.58 -54.47 10.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 110.202 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.77 -160.34 27.71 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -158.35 140.62 14.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.267 -1.137 . . . . 0.0 109.999 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.694 HG11 HG12 ' A' ' 6' ' ' VAL . 15.9 t -103.04 124.1 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.112 -0.992 . . . . 0.0 110.587 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.61 103.21 3.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.256 -0.902 . . . . 0.0 109.956 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.498 ' HB3' HD12 ' A' ' 12' ' ' LEU . 12.8 mt -83.01 127.61 33.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.21 -0.931 . . . . 0.0 110.314 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 109' ' ' PHE . 37.4 m -94.61 171.18 8.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.205 -0.935 . . . . 0.0 110.297 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.505 ' N ' HG22 ' A' ' 108' ' ' THR . 1.2 m-85 -145.25 154.49 42.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.391 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 120.723 0.297 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.867 ' HB2' HD21 ' A' ' 102' ' ' LEU . 44.3 Cg_endo -69.36 -178.92 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.99 1.521 . . . . 0.0 109.873 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -156.6 149.12 23.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.863 -1.148 . . . . 0.0 111.552 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.446 ' CE2' HG23 ' A' ' 105' ' ' VAL . 44.5 t80 -151.14 107.07 3.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.597 -0.689 . . . . 0.0 109.322 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.48 151.35 43.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.968 -1.083 . . . . 0.0 111.51 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.75 ' CG1' HG11 ' A' ' 105' ' ' VAL . 7.8 p -133.12 132.77 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.642 -0.661 . . . . 0.0 109.425 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.612 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -63.22 -66.74 1.36 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.038 -1.039 . . . . 0.0 110.839 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 50.9 Cg_endo -73.44 83.29 1.52 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.6 1.316 . . . . 0.0 110.667 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.7 4.62 53.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.112 -0.992 . . . . 0.0 110.005 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.8 p -151.75 170.38 19.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.95 55.92 28.19 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.519 ' CD1' HD22 ' A' ' 107' ' ' LEU . 58.0 mt -107.86 145.38 33.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -1.081 . . . . 0.0 109.953 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 0.4 OUTLIER -119.55 158.11 26.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 110.541 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 14' ' ' ASP . 41.0 t0 -59.34 124.04 18.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.894 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.01 -32.01 6.78 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.453 ' HB3' ' O ' ' A' ' 13' ' ' SER . 37.9 tt0 -56.9 146.38 26.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.305 -1.115 . . . . 0.0 109.985 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 11.3 m -102.37 153.22 20.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.57 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.655 HG23 ' HB3' ' A' ' 65' ' ' PHE . 6.3 m -116.8 153.32 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.337 -0.852 . . . . 0.0 109.818 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -97.79 109.18 21.98 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.16 -0.962 . . . . 0.0 110.055 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.45 ' CG2' HG23 ' A' ' 6' ' ' VAL . 46.2 t -111.17 157.6 11.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 121.435 -0.791 . . . . 0.0 109.846 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 m -150.59 117.3 5.81 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.257 -0.902 . . . . 0.0 110.383 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 4.2 t -105.25 123.7 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 0.0 109.892 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.555 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.1 OUTLIER -132.86 155.76 48.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.995 -1.066 . . . . 0.0 110.499 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 106.63 -35.74 4.85 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.693 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -68.34 -150.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.306 -1.114 . . . . 0.0 109.747 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 25' ' ' ALA . . . 176.19 147.68 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.859 -1.151 . . . . 0.0 111.339 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -39.41 143.28 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.611 0.72 . . . . 0.0 110.415 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.45 18.47 14.49 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.623 ' O ' HG23 ' A' ' 54' ' ' THR . 4.5 tp10 -151.02 135.64 17.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.227 -1.161 . . . . 0.0 110.745 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.54 HG23 ' OG1' ' A' ' 54' ' ' THR . 3.7 m -114.3 145.15 42.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.751 ' CE1' HG23 ' A' ' 55' ' ' THR . 24.5 m-85 -128.34 179.58 5.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -0.95 . . . . 0.0 110.504 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -132.33 100.69 5.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.208 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.76 HG23 ' O ' ' A' ' 33' ' ' ILE . 7.6 tt -89.0 103.25 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -0.922 . . . . 0.0 110.134 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.497 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -138.7 163.24 32.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.139 -0.975 . . . . 0.0 110.555 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.434 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 18.0 pt20 -128.77 148.75 50.88 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.16 -0.962 . . . . 0.0 110.269 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 1.8 m -145.5 172.93 12.51 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.213 -0.929 . . . . 0.0 110.389 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.25 161.57 35.87 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.533 -0.729 . . . . 0.0 109.409 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.665 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 43.7 Cg_endo -71.4 171.78 15.48 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.713 1.375 . . . . 0.0 110.329 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 40' ' ' GLY . 2.8 t -144.08 60.58 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.1 -1.0 . . . . 0.0 110.402 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' VAL . . . 43.37 40.19 4.6 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.07 -68.36 0.23 Allowed Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.006 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.59 -151.45 0.48 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.443 -1.034 . . . . 0.0 109.588 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 1.8 p30 -138.89 124.81 19.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.833 -1.167 . . . . 0.0 110.363 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.687 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -108.49 147.12 32.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.37 -0.832 . . . . 0.0 109.163 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 12.2 t -124.14 170.41 10.73 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.793 -1.192 . . . . 0.0 111.007 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.438 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 8.4 t-20 -105.76 119.61 51.91 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 109.995 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.79 -35.04 3.62 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.871 1.459 . . . . 0.0 110.41 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.14 73.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.276 -0.89 . . . . 0.0 110.213 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.6 p -75.65 -16.71 60.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.317 -0.865 . . . . 0.0 109.983 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -76.26 87.93 3.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.837 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 33' ' ' ILE . 12.0 t -112.46 148.4 34.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.264 -0.898 . . . . 0.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 p -93.58 132.46 37.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.35 -0.844 . . . . 0.0 109.86 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 35.3 p90 -133.34 124.51 27.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.12 -0.988 . . . . 0.0 110.698 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 29' ' ' GLU . 47.3 m -89.22 153.87 20.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 110.345 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.751 HG23 ' CE1' ' A' ' 31' ' ' TYR . 1.8 p -61.67 -158.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.297 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 9.2 m-20 -149.18 -160.24 1.15 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.853 -1.154 . . . . 0.0 110.675 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.51 76.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.163 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.8 m -85.9 13.3 7.65 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.564 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 54.25 23.58 26.18 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -110.94 114.94 28.64 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.456 -1.026 . . . . 0.0 110.434 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.28 80.01 1.27 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.505 -0.747 . . . . 0.0 110.096 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -103.67 143.92 32.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.431 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -172.79 169.78 4.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.135 -0.978 . . . . 0.0 111.055 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.62 92.45 8.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.31 -0.869 . . . . 0.0 110.112 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.655 ' HB3' HG23 ' A' ' 18' ' ' VAL . 77.7 t80 -73.39 -174.97 1.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.438 -0.789 . . . . 0.0 109.505 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.521 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.1 t -138.66 155.42 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.883 -1.136 . . . . 0.0 109.561 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 12' ' ' LEU . 33.0 m -136.28 144.9 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.032 -1.043 . . . . 0.0 110.535 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.01 138.43 50.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -0.843 . . . . 0.0 110.228 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -64.16 -58.76 5.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.865 . . . . 0.0 110.234 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 p -130.04 155.23 46.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.269 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 11.0 p90 -168.35 158.3 9.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 109.796 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.7 OUTLIER -62.58 127.59 32.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.157 -0.965 . . . . 0.0 110.191 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.505 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -96.05 168.1 25.7 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 13.2 t 177.74 146.4 0.13 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.182 -1.187 . . . . 0.0 110.308 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.8 p -66.59 154.79 90.53 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.245 -0.909 . . . . 0.0 110.173 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -80.44 12.07 2.68 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.012 1.532 . . . . 0.0 110.74 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.421 ' OE1' ' C ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -114.54 -72.14 0.71 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.132 -0.98 . . . . 0.0 110.296 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.91 56.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 53.3 m -156.04 92.9 2.56 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.291 -1.123 . . . . 0.0 110.168 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.56 138.49 29.64 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.992 1.522 . . . . 0.0 110.027 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.0 t -108.37 -33.64 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.936 . . . . 0.0 110.58 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.95 -171.65 29.93 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 15.9 p -68.98 166.51 17.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.401 -1.058 . . . . 0.0 110.454 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.687 HG21 ' HB3' ' A' ' 44' ' ' ALA . 53.0 t -138.53 142.34 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.34 -0.85 . . . . 0.0 109.635 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.3 137.92 41.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.017 -1.052 . . . . 0.0 110.672 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 91' ' ' CYS . 65.1 m -93.19 27.48 2.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.44 -51.55 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.44 -0.787 . . . . 0.0 109.976 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.446 ' H ' HG22 ' A' ' 88' ' ' THR . 4.4 t -97.64 -20.25 17.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.35 -0.843 . . . . 0.0 109.654 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.665 ' HB1' ' HG2' ' A' ' 38' ' ' PRO . . . -96.79 -161.85 0.91 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.361 -0.837 . . . . 0.0 109.77 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.49 130.88 56.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 110.59 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 86' ' ' CYS . 0.5 OUTLIER -107.3 116.39 31.85 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.342 -0.849 . . . . 0.0 109.551 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 91' ' ' CYS . 42.9 m-20 -130.77 136.35 48.63 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.966 -1.084 . . . . 0.0 111.268 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 34' ' ' ALA . 2.6 tp -107.12 118.27 36.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.491 -0.756 . . . . 0.0 109.671 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -111.21 161.3 12.84 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.28 170.82 17.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.337 -1.096 . . . . 0.0 110.195 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.32 167.96 12.65 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.494 ' HB3' ' O ' ' A' ' 30' ' ' THR . 4.2 p-10 -118.4 -151.12 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 110.405 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.18 89.59 4.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.229 -0.919 . . . . 0.0 110.377 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.56 -21.53 3.59 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.845 HD21 ' HG3' ' A' ' 2' ' ' PRO . 2.9 tm? -103.81 -76.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.379 -1.071 . . . . 0.0 109.913 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.713 ' N ' HD13 ' A' ' 100' ' ' LEU . 4.3 t70 70.09 138.29 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.207 -0.933 . . . . 0.0 110.726 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.867 HD21 ' HB2' ' A' ' 2' ' ' PRO . 4.2 mt -133.0 -42.13 0.9 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.423 -0.798 . . . . 0.0 110.372 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.81 -149.01 20.39 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.43 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 14.2 p80 -158.74 134.39 8.78 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.253 -1.146 . . . . 0.0 110.312 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.75 HG11 ' CG1' ' A' ' 6' ' ' VAL . 2.5 t -86.16 161.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.387 -0.821 . . . . 0.0 109.593 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.98 124.93 48.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 0.0 110.242 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.519 HD22 ' CD1' ' A' ' 12' ' ' LEU . 79.3 mt -100.78 85.82 2.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.619 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.5 m -68.42 162.94 24.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.756 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.458 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 5.2 m-85 -136.52 75.76 1.56 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.144 -0.972 . . . . 0.0 110.382 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.358 0 CA-C-O 118.025 -1.43 . . . . 0.0 109.623 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' A' ' 24' ' ' GLY . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.763 0.316 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.476 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 49.3 Cg_endo -75.24 -176.85 3.12 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.914 1.481 . . . . 0.0 110.425 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -162.21 79.49 0.52 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.126 -0.984 . . . . 0.0 110.527 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.529 ' HD1' HG22 ' A' ' 22' ' ' VAL . 25.0 t80 -91.37 114.9 27.55 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.056 -1.028 . . . . 0.0 109.718 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.6 p -150.81 152.44 33.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.044 -1.035 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.745 HG12 HG11 ' A' ' 105' ' ' VAL . 8.0 p -120.37 123.31 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.569 -0.707 . . . . 0.0 109.574 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.614 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 m -45.94 -67.95 0.34 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.999 . . . . 0.0 110.122 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.614 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 48.6 Cg_endo -76.15 78.98 3.04 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.342 1.18 . . . . 0.0 110.014 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.481 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -99.59 6.57 45.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 110.282 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -158.24 148.51 20.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.928 . . . . 0.0 110.338 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.63 67.61 1.92 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.55 ' CD1' HD22 ' A' ' 107' ' ' LEU . 11.8 mt -122.22 173.62 7.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.387 -1.067 . . . . 0.0 110.162 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -137.83 157.3 46.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.158 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -60.82 109.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.135 -0.978 . . . . 0.0 110.26 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.85 -39.34 2.82 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.43 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.2 tm0? -46.38 141.07 3.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.145 -1.209 . . . . 0.0 109.941 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.78 152.99 21.02 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.952 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.637 HG11 HG11 ' A' ' 67' ' ' VAL . 5.6 m -126.98 166.44 23.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.4 t -119.36 130.34 55.29 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.141 -0.974 . . . . 0.0 110.174 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.9 t -117.25 144.6 24.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 O-C-N 121.602 -0.686 . . . . 0.0 109.792 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 40.2 t -150.99 134.52 16.31 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.296 -0.878 . . . . 0.0 110.494 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.529 HG22 ' HD1' ' A' ' 4' ' ' PHE . 22.5 t -122.66 111.9 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.764 . . . . 0.0 110.092 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.64 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 58.8 m -125.47 113.34 17.36 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.083 -1.011 . . . . 0.0 111.068 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 154.16 -38.11 0.69 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -69.49 -141.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -1.146 . . . . 0.0 109.807 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 25' ' ' ALA . . . 176.0 160.31 0.3 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.152 -0.968 . . . . 0.0 110.445 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.76 133.35 31.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.735 . . . . 0.0 110.417 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.424 ' O ' ' CD ' ' A' ' 29' ' ' GLU . . . 127.35 12.17 3.19 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.524 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 73.5 mm-40 -152.18 144.61 24.09 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.949 -1.324 . . . . 0.0 110.545 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.403 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 23.7 m -122.36 148.37 45.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.416 -0.803 . . . . 0.0 109.791 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.721 ' HE2' HD22 ' A' ' 100' ' ' LEU . 9.6 m-85 -140.02 -177.14 4.86 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.07 -1.018 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.589 ' CD1' ' HB3' ' A' ' 52' ' ' SER . 19.0 m-85 -132.81 124.83 28.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -108.53 117.0 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.877 -1.14 . . . . 0.0 110.916 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.612 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -152.53 151.16 30.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 110.471 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.534 ' HB2' HD13 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -103.1 135.22 45.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.382 -0.824 . . . . 0.0 109.529 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 1.5 m -146.58 173.06 12.67 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.082 -1.011 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.02 152.35 31.3 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.524 -0.735 . . . . 0.0 109.466 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.41 156.41 61.71 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.689 1.363 . . . . 0.0 110.96 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.846 HG11 HG11 ' A' ' 81' ' ' VAL . 4.8 m -124.36 -167.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.489 -0.757 . . . . 0.0 110.109 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.99 18.97 10.81 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 42' ' ' GLN . . . -146.36 -57.36 0.02 OUTLIER Glycine 0 N--CA 1.489 2.226 0 O-C-N 120.929 -1.336 . . . . 0.0 110.171 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.629 ' H ' HG23 ' A' ' 39' ' ' VAL . 8.3 mp0 -143.58 -108.36 0.12 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.149 -1.206 . . . . 0.0 110.215 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -149.47 134.33 17.88 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.997 -1.064 . . . . 0.0 110.229 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.744 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -126.85 152.22 47.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.863 . . . . 0.0 109.801 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 10.4 t -129.56 165.16 22.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 110.283 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -86.86 112.06 44.59 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.194 -0.941 . . . . 0.0 110.109 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.7 Cg_endo -74.49 -27.65 10.85 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.94 1.495 . . . . 0.0 110.661 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.46 -23.62 67.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.171 -0.956 . . . . 0.0 110.285 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.526 HG21 ' HE ' ' A' ' 68' ' ' ARG . 4.9 p -113.1 26.62 10.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.208 -0.932 . . . . 0.0 110.375 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.7 143.36 33.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.22 -0.925 . . . . 0.0 110.068 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.482 HG23 HG23 ' A' ' 33' ' ' ILE . 7.5 t -170.35 137.33 1.45 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.015 . . . . 0.0 110.627 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.589 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 5.4 p -107.6 155.79 19.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.305 -0.872 . . . . 0.0 110.548 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 31' ' ' TYR . 12.3 p90 -151.93 -178.31 6.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.167 -0.958 . . . . 0.0 110.556 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 29' ' ' GLU . 31.2 m -141.16 168.67 19.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.458 -0.776 . . . . 0.0 109.64 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.425 ' N ' HG22 ' A' ' 54' ' ' THR . 1.0 OUTLIER -74.2 -164.7 0.26 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.956 -1.09 . . . . 0.0 110.462 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.35 -162.18 1.31 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.858 . . . . 0.0 109.779 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.04 -58.0 10.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -0.962 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 p -90.7 23.71 2.98 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.325 -0.859 . . . . 0.0 108.962 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 57.61 39.35 90.88 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -106.86 124.44 49.62 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.34 -1.094 . . . . 0.0 110.564 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -132.29 84.43 2.15 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.342 -0.849 . . . . 0.0 109.504 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 57.1 m -110.94 120.76 43.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 110.526 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.634 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 2.2 p90 -143.82 170.98 14.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 110.649 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 p -93.32 122.15 35.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.376 -0.828 . . . . 0.0 110.671 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.426 ' HB3' HG23 ' A' ' 18' ' ' VAL . 9.1 t80 -116.87 -169.62 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.489 -0.757 . . . . 0.0 109.206 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.412 HG23 ' C ' ' A' ' 65' ' ' PHE . 11.2 t -145.51 165.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.8 -1.188 . . . . 0.0 109.623 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.637 HG11 HG11 ' A' ' 18' ' ' VAL . 34.2 m -130.43 152.95 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.069 -1.019 . . . . 0.0 110.789 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.526 ' HE ' HG21 ' A' ' 49' ' ' THR . 0.0 OUTLIER -133.42 150.46 51.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.339 -0.851 . . . . 0.0 109.96 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.573 ' HE2' ' CG ' ' A' ' 109' ' ' PHE . 3.2 ttmt -83.42 -36.99 23.81 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.097 -1.002 . . . . 0.0 110.553 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 p -136.04 150.01 49.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.197 -0.94 . . . . 0.0 110.092 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.561 ' CZ ' HG11 ' A' ' 84' ' ' VAL . 16.4 p90 -161.34 166.11 27.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.254 -0.904 . . . . 0.0 110.328 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -88.53 117.53 27.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.218 -0.926 . . . . 0.0 110.061 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.744 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -101.37 154.78 19.02 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 2.5 p 171.22 130.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.312 -1.111 . . . . 0.0 110.017 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.469 ' OG1' ' HB ' ' A' ' 79' ' ' THR . 22.9 p -84.45 143.68 41.96 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 110.48 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 75' ' ' THR . 49.9 Cg_endo -88.93 21.29 0.99 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.067 1.562 . . . . 0.0 110.713 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -108.03 -11.42 15.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.064 -1.023 . . . . 0.0 110.547 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.02 23.46 1.61 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.469 ' HB ' ' OG1' ' A' ' 75' ' ' THR . 19.9 m -140.49 63.65 22.12 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.123 -1.222 . . . . 0.0 110.258 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.04 145.82 50.73 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.946 1.498 . . . . 0.0 110.199 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.846 HG11 HG11 ' A' ' 39' ' ' VAL . 56.2 t -112.02 -44.69 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.95 . . . . 0.0 110.619 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.21 -150.75 18.54 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m -57.53 148.92 22.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.443 -1.033 . . . . 0.0 110.593 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.561 HG11 ' CZ ' ' A' ' 71' ' ' TYR . 49.4 t -139.18 102.8 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.383 -0.823 . . . . 0.0 109.806 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -93.88 126.06 38.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.369 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 3.5 m -85.92 4.13 38.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.821 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.17 -63.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 109.991 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.429 HG23 ' N ' ' A' ' 89' ' ' ALA . 13.3 t -72.85 -33.86 66.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.268 -0.895 . . . . 0.0 110.009 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.429 ' N ' HG23 ' A' ' 88' ' ' THR . . . -93.35 -177.77 4.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.326 -0.859 . . . . 0.0 109.919 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.48 139.17 38.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.373 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.34 130.47 54.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.64 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -133.93 163.69 28.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 110.796 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.612 HD12 ' O ' ' A' ' 34' ' ' ALA . 41.2 tp -127.58 111.12 13.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 0.0 109.214 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.27 165.49 18.36 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.056 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -157.38 101.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -1.072 . . . . 0.0 110.105 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.83 174.88 46.96 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.489 ' CG ' ' N ' ' A' ' 98' ' ' SER . 0.8 OUTLIER -123.46 -155.01 0.63 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.068 -1.254 . . . . 0.0 109.88 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.489 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 11.3 p -99.97 78.14 2.08 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.31 -36.19 0.24 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.155 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.721 HD22 ' HE2' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -109.17 -47.52 3.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.908 -1.348 . . . . 0.0 110.744 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 100' ' ' LEU . 33.7 m-20 54.27 105.79 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.293 -0.88 . . . . 0.0 110.12 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 2' ' ' PRO . 5.4 mt -94.43 -60.96 1.6 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 0.0 110.467 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 159.94 -162.5 33.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 15.7 p80 -151.29 132.39 14.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.295 -1.121 . . . . 0.0 110.261 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.745 HG11 HG12 ' A' ' 6' ' ' VAL . 16.1 t -87.2 130.1 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.188 -0.945 . . . . 0.0 110.011 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.56 123.2 28.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.0 110.16 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.55 HD22 ' CD1' ' A' ' 12' ' ' LEU . 39.4 mt -92.89 170.06 9.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 0.0 110.586 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.552 HG22 ' N ' ' A' ' 109' ' ' PHE . 85.3 m -141.74 171.82 13.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.408 -0.807 . . . . 0.0 109.794 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.573 ' CG ' ' HE2' ' A' ' 69' ' ' LYS . 3.0 m-85 -146.08 115.76 7.24 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.861 . . . . 0.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.406 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 120.735 0.303 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.406 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 45.1 Cg_endo -73.02 -157.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.051 1.553 . . . . 0.0 110.133 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -140.49 129.57 23.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 110.52 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -148.96 99.23 2.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 0.0 109.538 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.5 p -148.01 148.27 30.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.757 HG12 HG11 ' A' ' 105' ' ' VAL . 10.1 p -106.15 159.52 6.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.622 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -74.15 -71.01 0.23 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.889 -1.132 . . . . 0.0 109.832 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.622 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 55.4 Cg_endo -77.8 84.68 1.94 Allowed 'Trans proline' 0 C--N 1.322 -0.853 0 O-C-N 123.209 1.11 . . . . 0.0 110.366 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 107' ' ' LEU . . . -73.92 -14.2 61.02 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.89 -1.131 . . . . 0.0 109.667 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.8 t -139.58 162.29 35.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.627 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.24 47.49 10.83 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.63 ' CD1' HD22 ' A' ' 107' ' ' LEU . 14.0 mt -101.28 170.67 8.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.383 -1.069 . . . . 0.0 109.962 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 m -145.61 162.16 38.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.041 -1.037 . . . . 0.0 111.012 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.41 125.64 24.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.24 -26.8 7.43 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.467 ' OE1' ' N ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -51.22 138.62 20.28 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.345 -1.091 . . . . 0.0 110.29 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.467 ' N ' ' OE1' ' A' ' 16' ' ' GLN . 1.3 t -99.76 122.13 42.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.464 -0.773 . . . . 0.0 109.88 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 65' ' ' PHE . 34.9 m -98.9 168.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.981 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.7 m -116.44 120.48 38.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.975 . . . . 0.0 110.24 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.78 152.52 8.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.347 -0.845 . . . . 0.0 109.945 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.7 t -142.45 125.0 15.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.758 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 48.2 t -116.01 147.51 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.455 -0.778 . . . . 0.0 109.819 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 3' ' ' ALA . 11.8 t -160.24 153.55 22.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.082 -1.012 . . . . 0.0 110.189 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.34 -47.18 1.07 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -60.22 -154.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.322 -1.105 . . . . 0.0 110.204 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.536 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -176.11 143.57 0.55 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 110.481 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -30.77 130.72 0.1 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.43 0.633 . . . . 0.0 111.236 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.455 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 112.61 6.37 23.38 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.475 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 1.6 mt-10 -131.81 121.37 24.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.12 -1.223 . . . . 0.0 110.278 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.576 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 57.6 m -104.22 147.15 27.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.986 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.672 ' CE1' HD22 ' A' ' 100' ' ' LEU . 16.2 m-85 -134.7 168.66 18.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.909 . . . . 0.0 110.4 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 17.7 m-85 -126.53 118.59 25.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.347 -0.846 . . . . 0.0 109.698 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.66 ' CG2' HG23 ' A' ' 51' ' ' THR . 7.8 tt -98.63 124.37 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 110.555 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.67 155.67 37.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.852 . . . . 0.0 110.235 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.415 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 26.6 tt0 -110.03 142.62 41.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 70.9 m -148.78 163.46 37.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.974 -1.079 . . . . 0.0 110.772 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -146.13 166.16 18.01 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.519 -0.738 . . . . 0.0 109.42 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 43.5 Cg_endo -71.54 163.49 38.83 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.736 1.387 . . . . 0.0 110.464 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 39' ' ' VAL . 7.2 p -148.36 69.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.175 -0.953 . . . . 0.0 110.477 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.38 9.15 87.24 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.2 -57.81 0.52 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.34 -150.89 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.335 -1.097 . . . . 0.0 109.898 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -150.41 116.69 5.69 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.147 -0.971 . . . . 0.0 110.418 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -86.04 173.4 9.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.54 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.0 m -140.76 154.98 46.51 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.027 -1.046 . . . . 0.0 111.061 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.573 ' OD1' ' CG ' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -89.51 116.41 66.27 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.35 -0.844 . . . . 0.0 110.082 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -85.2 -31.17 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.876 1.461 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.11 -10.53 54.71 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.311 -0.868 . . . . 0.0 110.663 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 63.6 p -124.95 25.5 7.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.094 -1.004 . . . . 0.0 110.399 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.79 108.54 18.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.068 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.66 HG23 ' CG2' ' A' ' 33' ' ' ILE . 10.1 t -130.95 157.15 43.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.892 . . . . 0.0 110.421 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.508 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 74.2 p -126.51 152.88 45.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.848 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 12.1 p90 -148.3 -179.6 7.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.422 -0.799 . . . . 0.0 109.549 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.6 m -143.33 161.23 38.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.937 -1.102 . . . . 0.0 110.306 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.621 HG21 ' HB1' ' A' ' 25' ' ' ALA . 21.8 p -65.11 -154.66 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.342 -0.849 . . . . 0.0 109.966 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -160.27 -158.8 0.65 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.142 -0.974 . . . . 0.0 110.422 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.7 -48.71 80.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.889 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.32 9.35 11.08 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.338 -0.852 . . . . 0.0 109.438 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 54.98 51.47 53.45 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.74 152.36 47.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.309 -1.112 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.758 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -141.22 81.79 1.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.577 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.3 m -104.0 118.79 37.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 20.1 p90 -155.16 177.54 11.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.135 -0.978 . . . . 0.0 111.073 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.31 131.3 41.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.644 -0.66 . . . . 0.0 110.445 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.743 ' O ' HG22 ' A' ' 18' ' ' VAL . 59.3 t80 -121.88 137.07 54.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.452 -0.78 . . . . 0.0 108.989 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.5 154.02 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.17 151.66 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.498 -0.751 . . . . 0.0 110.273 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.88 179.29 4.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.177 -0.952 . . . . 0.0 110.73 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.46 ' HG3' ' CE2' ' A' ' 109' ' ' PHE . 24.0 tttm -100.96 -30.43 11.65 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.777 0.799 . . . . 0.0 108.899 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.55 163.92 37.26 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.573 ' CG ' ' OD1' ' A' ' 46' ' ' ASN . 16.6 p90 -170.9 156.57 5.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.913 -1.117 . . . . 0.0 110.031 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 m -71.84 136.98 47.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.185 -0.947 . . . . 0.0 110.715 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.46 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -106.87 162.74 13.46 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.0 t -149.61 168.12 24.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.241 -1.152 . . . . 0.0 110.172 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.437 HG23 ' CG2' ' A' ' 81' ' ' VAL . 17.5 p -97.02 161.28 26.83 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.965 . . . . 0.0 110.41 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.93 -17.5 17.52 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.104 1.581 . . . . 0.0 110.746 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -78.89 -37.03 41.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.183 -0.948 . . . . 0.0 110.564 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.26 50.29 0.18 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 m -148.55 135.97 10.81 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.357 -1.084 . . . . 0.0 109.856 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.97 158.07 46.44 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.037 1.546 . . . . 0.0 110.269 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.437 ' CG2' HG23 ' A' ' 75' ' ' THR . 21.2 t -130.37 -46.79 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 110.249 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.3 -156.17 27.93 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 p -105.59 136.71 44.68 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.185 -1.185 . . . . 0.0 110.35 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' A' ' 44' ' ' ALA . 95.5 t -98.78 160.52 3.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.359 -0.838 . . . . 0.0 109.643 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -153.14 134.82 14.5 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 110.546 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 67.7 m -95.07 14.16 22.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.982 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.06 -45.16 9.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.258 -0.901 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.2 t -98.84 -16.75 18.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.313 -0.867 . . . . 0.0 110.142 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.59 -143.59 0.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.861 . . . . 0.0 110.195 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.39 155.64 35.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 110.01 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.77 125.27 29.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.289 -0.882 . . . . 0.0 109.904 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 20.6 p30 -134.25 137.06 44.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 110.418 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 104' ' ' HIS . 1.4 tp -108.41 137.19 46.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.687 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.545 ' HA3' ' ND1' ' A' ' 104' ' ' HIS . . . -134.72 159.86 24.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -134.34 156.39 48.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.374 -1.074 . . . . 0.0 110.052 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 32' ' ' TYR . . . 142.42 162.99 9.48 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.449 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 14.1 p-10 -133.49 -151.01 0.43 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.203 -1.175 . . . . 0.0 110.455 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 p -91.7 95.1 9.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.307 -0.871 . . . . 0.0 110.274 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 132.91 -18.45 4.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.872 HD23 ' N ' ' A' ' 101' ' ' ASP . 8.0 tt -154.93 151.42 28.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.172 -1.193 . . . . 0.0 110.442 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.872 ' N ' HD23 ' A' ' 100' ' ' LEU . 1.8 p30 -135.6 162.58 32.31 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.375 -0.828 . . . . 0.0 109.796 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.6 mt -119.57 -85.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.102 -0.999 . . . . 0.0 110.397 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.539 ' C ' ' CD2' ' A' ' 104' ' ' HIS . . . -168.84 -169.24 32.0 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.545 ' ND1' ' HA3' ' A' ' 94' ' ' GLY . 38.1 m-70 -142.74 120.49 11.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -1.134 . . . . 0.0 110.234 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.757 HG11 HG12 ' A' ' 6' ' ' VAL . 85.4 t -89.39 129.12 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -0.877 . . . . 0.0 109.853 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.3 112.12 11.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.044 -1.035 . . . . 0.0 110.434 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.63 HD22 ' CD1' ' A' ' 12' ' ' LEU . 72.0 mt -87.58 172.64 9.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 110.037 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.428 ' OG1' ' C ' ' A' ' 107' ' ' LEU . 1.4 m -162.8 159.64 24.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.286 -0.884 . . . . 0.0 110.117 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.46 ' CE2' ' HG3' ' A' ' 69' ' ' LYS . 15.1 m-85 -129.61 164.16 24.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 110.447 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 CA-C-O 117.948 -1.473 . . . . 0.0 109.5 179.991 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 120.879 0.371 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.532 ' HG2' ' HA ' ' A' ' 102' ' ' LEU . 45.2 Cg_endo -73.02 -157.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.978 1.515 . . . . 0.0 110.283 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -119.52 134.71 55.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.247 -0.908 . . . . 0.0 110.559 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.481 ' HD1' HG22 ' A' ' 22' ' ' VAL . 72.7 t80 -151.51 113.62 4.52 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.424 -0.797 . . . . 0.0 109.858 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.61 156.84 42.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.011 -1.056 . . . . 0.0 111.046 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.007 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 4.4 p -118.91 165.26 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.805 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -74.36 -65.25 0.59 Allowed Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.001 -1.062 . . . . 0.0 110.814 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.726 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 41.9 Cg_endo -71.08 -79.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.559 1.294 . . . . 0.0 110.827 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 1.007 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 70.85 19.33 5.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.205 -0.934 . . . . 0.0 110.0 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 t 178.3 148.78 0.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 110.167 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.49 59.71 9.79 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.505 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 1.2 mt -104.39 178.16 4.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.292 -1.123 . . . . 0.0 110.715 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 16' ' ' GLN . 3.2 m -134.35 142.3 47.17 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.416 -0.803 . . . . 0.0 110.015 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 10.0 p-10 -56.93 106.03 0.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.946 . . . . 0.0 110.272 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.45 -45.1 1.32 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.505 ' OE1' ' HA ' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -47.1 157.62 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -1.107 . . . . 0.0 109.703 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -101.09 178.72 4.58 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.361 -0.837 . . . . 0.0 110.443 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.575 HG11 HG11 ' A' ' 67' ' ' VAL . 5.8 m -146.33 152.83 13.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.547 -0.721 . . . . 0.0 109.428 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.506 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -97.41 140.05 32.43 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 109.986 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.413 HG11 ' CZ ' ' A' ' 63' ' ' PHE . 14.7 t -129.1 149.07 33.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.142 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.89 129.07 17.68 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.492 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.794 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 52.1 t -119.92 143.58 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.601 -0.687 . . . . 0.0 109.755 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -155.65 177.55 11.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.048 -1.033 . . . . 0.0 110.307 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.74 -38.69 3.15 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.575 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -67.32 -151.43 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.16 -1.2 . . . . 0.0 110.673 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.599 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -172.84 159.15 4.08 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.224 -0.922 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.885 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -50.45 125.38 12.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.541 -0.725 . . . . 0.0 110.463 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' O ' ' OE1' ' A' ' 29' ' ' GLU . . . 124.79 13.18 3.79 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 6.5 mm-40 -144.14 120.79 11.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.037 -1.272 . . . . 0.0 110.874 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.421 HG23 ' OG1' ' A' ' 54' ' ' THR . 60.4 m -105.06 132.75 50.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.529 -0.732 . . . . 0.0 109.255 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.852 ' CE1' HD22 ' A' ' 100' ' ' LEU . 31.4 m-85 -120.77 173.86 6.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.956 -1.09 . . . . 0.0 111.246 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -130.27 123.35 29.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.658 -0.651 . . . . 0.0 109.697 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.839 ' CG2' HG23 ' A' ' 51' ' ' THR . 14.3 tt -100.44 125.2 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.131 -0.98 . . . . 0.0 110.651 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.62 146.53 25.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -0.906 . . . . 0.0 110.604 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -98.78 147.69 24.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.854 . . . . 0.0 109.239 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.6 m -144.35 155.9 44.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.028 -1.045 . . . . 0.0 111.512 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.425 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -154.0 141.33 13.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.38 166.19 24.43 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.63 1.332 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.852 HG11 HG22 ' A' ' 84' ' ' VAL . 4.2 m -147.5 172.98 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.312 -0.867 . . . . 0.0 110.591 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -52.77 -46.89 59.56 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.62 -59.23 10.94 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.612 ' H ' HG23 ' A' ' 39' ' ' VAL . 1.4 tt0 -174.48 -75.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.405 -1.056 . . . . 0.0 110.118 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -143.49 150.16 38.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.182 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.451 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -147.82 145.01 28.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.502 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 18.4 m -128.23 178.21 6.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.015 . . . . 0.0 110.236 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.456 ' O ' ' CG ' ' A' ' 46' ' ' ASN . 15.3 p-10 -101.44 106.02 43.5 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 50.2 Cg_endo -88.12 -39.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.773 1.407 . . . . 0.0 110.65 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.98 -4.6 17.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 110.631 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.404 ' OG1' ' HB2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -130.6 25.34 5.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.092 -1.005 . . . . 0.0 110.144 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.06 143.24 29.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.303 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.839 HG23 ' CG2' ' A' ' 33' ' ' ILE . 2.9 t -148.83 162.63 39.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 0.0 109.897 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.0 p -134.56 154.53 51.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.166 -0.959 . . . . 0.0 110.452 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 11.2 p90 -145.41 -177.6 5.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.758 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.421 ' OG1' HG23 ' A' ' 30' ' ' THR . 24.1 m -149.69 160.35 43.6 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 110.399 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.575 HG21 ' CB ' ' A' ' 25' ' ' ALA . 2.2 p -77.01 -160.94 0.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.35 -0.844 . . . . 0.0 110.487 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.885 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 16.3 p-10 -158.22 -147.38 0.17 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.953 -1.092 . . . . 0.0 111.115 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.569 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -84.72 71.36 10.83 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.056 0.932 . . . . 0.0 108.985 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER 154.67 -13.56 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.793 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.599 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.97 66.12 2.12 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.33 129.37 18.55 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.259 -1.142 . . . . 0.0 110.789 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.794 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -130.17 83.9 2.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 110.007 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.4 m -100.35 123.76 44.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.544 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 6.9 p90 -158.77 176.04 12.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.24 -0.912 . . . . 0.0 110.556 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.2 t -101.66 158.7 15.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.721 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 85.7 t80 -147.02 -176.88 5.38 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.562 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.8 t -133.58 158.46 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.386 -1.446 . . . . 0.0 110.5 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.575 HG11 HG11 ' A' ' 18' ' ' VAL . 20.4 m -130.32 159.75 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.782 . . . . 0.0 109.471 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 13.4 mtm180 -143.63 112.01 6.36 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.373 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 68' ' ' ARG . 4.5 ttpm? -44.72 -50.33 10.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 108.875 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.08 111.02 17.77 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 36.1 p90 -121.26 131.84 54.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.213 -0.929 . . . . 0.0 110.816 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 26.1 m -61.64 124.38 20.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.451 -0.781 . . . . 0.0 110.303 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.4 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -95.69 -166.14 34.7 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -173.66 146.84 1.34 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 110.517 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 77.2 p -96.83 164.17 18.6 Favored Pre-proline 0 C--N 1.304 -1.389 0 O-C-N 121.37 -0.831 . . . . 0.0 110.233 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -81.68 -0.46 10.41 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 124.033 1.544 . . . . 0.0 110.237 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -101.27 29.26 4.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 110.612 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.74 55.59 28.11 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.0 m -153.37 113.55 2.64 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.247 -1.149 . . . . 0.0 110.248 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.67 105.39 1.77 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.959 1.505 . . . . 0.0 110.37 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.53 -11.24 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.179 -0.951 . . . . 0.0 110.028 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.21 -157.67 15.08 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.7 m -96.95 148.35 23.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -1.164 . . . . 0.0 110.069 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.852 HG22 HG11 ' A' ' 39' ' ' VAL . 98.8 t -108.62 102.08 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.231 -0.918 . . . . 0.0 109.904 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.8 OUTLIER -98.82 120.32 39.06 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.417 -0.802 . . . . 0.0 109.575 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.82 37.26 0.58 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 110.717 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.59 -36.83 43.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.166 -0.958 . . . . 0.0 109.3 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.9 t -109.91 -11.5 14.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.433 -0.792 . . . . 0.0 109.48 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.06 -171.15 1.79 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.396 -0.815 . . . . 0.0 110.158 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.19 128.33 49.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.928 . . . . 0.0 110.14 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.1 m -93.78 151.79 19.37 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.102 -0.999 . . . . 0.0 109.861 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -142.88 123.89 14.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 110.694 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.552 HD11 HG12 ' A' ' 33' ' ' ILE . 16.4 tp -92.49 112.65 24.68 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.542 ' HA3' ' NE2' ' A' ' 104' ' ' HIS . . . -115.44 166.67 12.24 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.253 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.709 ' HB1' HD12 ' A' ' 102' ' ' LEU . . . -144.56 162.96 35.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.515 -0.991 . . . . 0.0 110.062 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 130.14 176.06 14.28 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.484 ' OD1' ' HB3' ' A' ' 100' ' ' LEU . 8.3 p-10 -128.89 -156.16 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.249 . . . . 0.0 110.57 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.71 82.25 7.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.536 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 139.8 -35.87 1.88 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.852 HD22 ' CE1' ' A' ' 31' ' ' TYR . 4.7 tt -115.2 145.45 42.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -1.18 . . . . 0.0 110.336 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.8 121.61 32.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 110.061 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.709 HD12 ' HB1' ' A' ' 95' ' ' ALA . 20.2 mt -77.18 -71.49 0.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.929 . . . . 0.0 110.12 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.36 -173.02 42.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.542 ' NE2' ' HA3' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -147.81 112.28 5.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -1.052 . . . . 0.0 109.895 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.427 HG11 ' CG1' ' A' ' 6' ' ' VAL . 17.5 t -96.12 121.74 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.174 -0.954 . . . . 0.0 110.339 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.46 132.76 43.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.102 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.9 mt -104.81 141.57 36.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.258 -0.901 . . . . 0.0 110.478 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 109' ' ' PHE . 8.7 m -119.07 171.39 8.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.858 . . . . 0.0 109.859 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.401 ' N ' HG22 ' A' ' 108' ' ' THR . 8.8 m-85 -147.73 85.98 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.231 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 CA-C-O 118.007 -1.44 . . . . 0.0 109.504 179.91 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.517 ' O ' ' HA3' ' A' ' 24' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.511 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.6 Cg_endo -69.22 165.37 30.59 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.105 1.581 . . . . 0.0 110.609 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -155.85 141.9 18.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.202 -0.936 . . . . 0.0 110.718 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.602 ' CE2' ' CB ' ' A' ' 95' ' ' ALA . 25.2 t80 -150.24 116.92 5.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 t -150.41 164.92 34.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.9 -1.125 . . . . 0.0 111.355 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.961 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 4.8 p -122.2 176.16 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.602 -0.686 . . . . 0.0 109.662 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.6 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.3 m -78.19 -67.54 0.26 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.005 -1.059 . . . . 0.0 110.534 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.738 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 42.8 Cg_endo -72.81 -79.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.929 0 O-C-N 123.358 1.188 . . . . 0.0 110.629 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.961 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 72.66 28.37 2.15 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.355 -0.841 . . . . 0.0 110.513 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER 171.05 119.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.19 -0.944 . . . . 0.0 110.231 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.56 66.63 2.02 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 109' ' ' PHE . 1.5 mp -104.02 159.25 15.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -1.168 . . . . 0.0 110.537 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.502 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 29.0 t -107.76 151.3 25.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 110.028 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.4 127.87 33.27 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.225 -0.922 . . . . 0.0 111.164 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.66 -27.64 6.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 2.4 tt0 -52.35 141.89 18.48 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.291 -1.123 . . . . 0.0 110.596 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.54 148.98 22.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.358 -0.839 . . . . 0.0 109.869 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.528 HG12 ' HG3' ' A' ' 8' ' ' PRO . 24.4 m -129.76 179.76 3.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.794 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.19 134.72 55.22 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.382 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.486 HG11 ' CD1' ' A' ' 33' ' ' ILE . 4.8 t -114.94 150.71 16.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -146.91 124.72 11.9 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.096 -1.003 . . . . 0.0 110.865 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 87.0 t -113.04 141.3 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.575 -0.703 . . . . 0.0 109.579 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.712 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -158.64 144.96 17.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.073 . . . . 0.0 110.666 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 1' ' ' ALA . . . 118.85 -54.1 0.64 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.513 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -59.07 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -1.134 . . . . 0.0 109.833 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.544 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.48 169.99 8.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.066 -1.021 . . . . 0.0 110.323 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -59.97 131.69 51.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.532 -0.73 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.15 16.25 4.0 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.516 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 65.5 mm-40 -149.24 132.72 16.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.166 -1.196 . . . . 0.0 110.385 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.434 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 3.6 m -104.28 162.96 12.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.354 -0.841 . . . . 0.0 110.13 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.771 ' CE1' HD13 ' A' ' 100' ' ' LEU . 74.8 m-85 -150.84 173.23 14.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.207 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 52.8 m-85 -133.97 102.88 5.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 109.324 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.839 ' CG2' HG23 ' A' ' 51' ' ' THR . 8.5 tt -89.56 107.95 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.941 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.424 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -147.95 157.22 43.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.158 -0.964 . . . . 0.0 110.803 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.509 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 2.0 tt0 -95.69 123.56 39.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.645 -0.659 . . . . 0.0 109.88 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.429 ' HA ' ' OH ' ' A' ' 71' ' ' TYR . 1.2 m -137.42 154.1 50.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.235 -0.916 . . . . 0.0 110.101 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.522 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -146.59 166.79 15.52 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 0.0 109.247 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 41.4 Cg_endo -69.38 159.03 55.27 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.556 1.293 . . . . 0.0 110.633 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.673 HG12 HG22 ' A' ' 84' ' ' VAL . 16.1 m -144.12 63.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.468 -0.77 . . . . 0.0 110.026 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.88 -29.84 9.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -175.41 -46.77 0.06 OUTLIER Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 5.1 mt-30 -89.24 -166.76 1.68 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.388 -1.066 . . . . 0.0 110.219 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 4.8 p30 -130.7 110.97 11.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 110.34 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.74 157.81 15.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.902 . . . . 0.0 109.755 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.488 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 5.8 t -135.55 165.99 24.24 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.041 -1.037 . . . . 0.0 110.295 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.546 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -83.65 111.65 33.74 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.204 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 48.9 Cg_endo -77.87 -37.53 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.893 1.47 . . . . 0.0 110.32 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.63 98.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.886 . . . . 0.0 110.493 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.48 HG21 ' NE ' ' A' ' 68' ' ' ARG . 1.2 p -96.32 3.38 53.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.261 -0.899 . . . . 0.0 110.425 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -65.85 129.25 39.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.139 -0.975 . . . . 0.0 109.85 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.839 HG23 ' CG2' ' A' ' 33' ' ' ILE . 1.3 t -128.24 131.58 48.78 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.13 -0.982 . . . . 0.0 110.762 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.37 138.14 40.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.445 -0.784 . . . . 0.0 109.393 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 15.8 p90 -141.76 172.21 13.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.051 -1.03 . . . . 0.0 110.547 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.5 m -133.87 162.41 32.11 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 109.375 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.513 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -75.77 -164.74 0.38 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.914 -1.116 . . . . 0.0 110.384 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 27' ' ' ALA . 5.7 m-20 -145.34 -158.31 0.88 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.18 -0.95 . . . . 0.0 109.575 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.27 -50.04 75.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.902 -1.124 . . . . 0.0 109.53 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.4 t -90.36 21.06 4.05 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.349 -0.844 . . . . 0.0 108.813 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.544 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 49.81 32.0 17.39 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.33 140.73 41.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.371 -1.076 . . . . 0.0 110.483 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -145.59 84.96 1.69 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.411 -0.806 . . . . 0.0 109.704 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -99.99 120.95 40.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 109.983 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.2 p90 -150.63 178.39 9.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.223 -0.923 . . . . 0.0 110.831 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.8 p -96.62 139.12 33.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.46 -0.775 . . . . 0.0 111.016 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 50.2 t80 -131.15 176.17 8.49 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.561 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.8 t -124.61 157.09 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 120.727 -1.233 . . . . 0.0 110.299 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 67' ' ' VAL . 13.8 m -134.9 128.35 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.397 -0.814 . . . . 0.0 109.904 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.48 ' NE ' HG21 ' A' ' 49' ' ' THR . 0.0 OUTLIER -115.82 144.38 44.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 110.343 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -56.94 -39.68 75.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.394 -0.816 . . . . 0.0 109.796 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.74 165.54 33.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.418 -0.801 . . . . 0.0 109.828 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.522 ' CB ' ' OD1' ' A' ' 46' ' ' ASN . 19.2 p90 -166.9 147.41 5.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 110.361 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.6 OUTLIER -66.18 118.58 10.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.038 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.48 179.81 25.7 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -160.44 150.14 17.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.287 -1.125 . . . . 0.0 110.055 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 70.6 p -45.34 164.37 0.19 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 44.9 Cg_endo -72.54 -12.39 26.98 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.094 1.576 . . . . 0.0 110.481 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -86.96 -69.75 0.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 110.199 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.62 51.18 0.03 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 m -141.22 126.66 11.01 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.26 -1.141 . . . . 0.0 110.193 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.31 121.63 6.96 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.814 1.428 . . . . 0.0 110.403 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.39 -17.45 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.295 -0.878 . . . . 0.0 110.068 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.34 -159.65 28.5 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 11.5 p -104.44 169.57 8.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.199 -1.177 . . . . 0.0 110.367 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.673 HG22 HG12 ' A' ' 39' ' ' VAL . 72.9 t -133.6 162.04 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.9 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 16.7 p-10 -160.43 161.97 33.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.963 . . . . 0.0 110.302 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 96.7 m -97.95 11.14 38.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.313 -0.867 . . . . 0.0 110.331 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.96 -42.03 14.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.19 -0.944 . . . . 0.0 110.34 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.418 HG22 ' OD2' ' A' ' 85' ' ' ASP . 13.4 t -113.49 -1.08 14.23 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.157 -0.965 . . . . 0.0 110.384 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.51 135.67 44.56 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.241 -0.912 . . . . 0.0 110.61 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.77 105.41 5.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.973 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.487 ' CB ' ' HB2' ' A' ' 37' ' ' ALA . 26.7 p -99.39 140.16 33.98 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.086 -1.009 . . . . 0.0 109.66 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.484 ' OD1' ' HA ' ' A' ' 106' ' ' ALA . 19.1 m-20 -131.05 143.29 50.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.114 -0.991 . . . . 0.0 110.837 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.495 ' HB2' HD11 ' A' ' 107' ' ' LEU . 22.6 tp -88.41 99.41 12.25 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.07 165.45 27.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.731 ' O ' HD12 ' A' ' 102' ' ' LEU . . . -152.28 80.04 1.24 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.412 -1.051 . . . . 0.0 110.386 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -137.25 -167.59 11.12 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.477 ' O ' ' OG ' ' A' ' 98' ' ' SER . 2.2 p-10 -129.4 -63.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.246 . . . . 0.0 110.627 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 97' ' ' ASN . 19.6 m -170.83 -32.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.125 -0.984 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.77 -13.23 5.15 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.712 -1.233 . . . . 0.0 110.411 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.771 HD13 ' CE1' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -94.87 -52.39 4.27 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.972 -1.31 . . . . 0.0 110.532 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.0 p-10 40.61 98.29 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.701 0.762 . . . . 0.0 110.73 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 95' ' ' ALA . 6.7 mt -84.45 -45.44 12.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.016 -1.052 . . . . 0.0 110.104 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.56 -161.82 30.0 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -155.06 142.35 19.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -1.153 . . . . 0.0 110.181 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.47 103.8 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.189 -0.944 . . . . 0.0 110.146 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.484 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . . . -50.62 103.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.893 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.509 ' CD1' ' OE1' ' A' ' 35' ' ' GLN . 54.0 mt -82.83 137.01 34.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 110.144 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.9 167.5 10.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.811 . . . . 0.0 110.092 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 12' ' ' LEU . 3.2 m-85 -142.04 166.83 23.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.927 . . . . 0.0 110.324 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.35 0 CA-C-O 118.008 -1.44 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.907 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.497 1.921 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.907 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 48.2 Cg_endo -74.81 -170.78 0.81 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.867 1.456 . . . . 0.0 110.206 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.498 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -145.71 145.75 31.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.078 -1.014 . . . . 0.0 110.302 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 39.0 t80 -151.29 113.04 4.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.226 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.47 151.53 36.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.683 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 19' ' ' SER . 9.2 p -128.48 149.19 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.776 . . . . 0.0 109.743 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -67.27 -66.59 1.14 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.052 -1.03 . . . . 0.0 110.191 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.711 ' HB2' HD21 ' A' ' 12' ' ' LEU . 50.4 Cg_endo -75.65 95.29 1.0 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.46 1.242 . . . . 0.0 110.233 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.83 10.56 32.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.097 -1.002 . . . . 0.0 110.311 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.1 t -168.64 154.54 6.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.899 . . . . 0.0 110.084 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.99 56.49 10.65 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.711 HD21 ' HB2' ' A' ' 8' ' ' PRO . 2.7 mt -109.59 166.05 11.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -1.126 . . . . 0.0 110.15 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -128.53 164.34 23.01 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.237 -0.915 . . . . 0.0 110.28 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -62.26 125.45 23.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.316 -0.865 . . . . 0.0 109.94 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 89.61 -31.05 5.38 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.69 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.5 tm0? -42.4 143.9 0.58 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.417 -1.049 . . . . 0.0 110.014 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.463 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 2.1 p -95.55 167.61 11.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 110.287 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 65' ' ' PHE . 30.6 m -147.82 168.21 4.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.323 -0.861 . . . . 0.0 109.762 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.825 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -117.04 137.68 52.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.161 -0.962 . . . . 0.0 110.242 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 t -126.32 152.57 33.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.444 -0.785 . . . . 0.0 109.81 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.11 127.55 14.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.381 -0.824 . . . . 0.0 110.169 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.795 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 10.9 t -119.28 147.63 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.322 -0.861 . . . . 0.0 110.077 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 3' ' ' ALA . 6.2 p -155.52 131.99 10.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.132 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 131.21 -54.28 0.79 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.803 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -58.73 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -1.123 . . . . 0.0 109.074 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.95 156.92 6.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.732 -1.23 . . . . 0.0 110.712 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -43.85 133.08 5.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.7 -0.625 . . . . 0.0 110.133 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 29' ' ' GLU . . . 115.28 11.95 10.26 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 1.8 mt-10 -141.94 116.59 9.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.335 -1.097 . . . . 0.0 110.191 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.2 m -104.21 134.01 48.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.757 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 29' ' ' GLU . 27.4 m-85 -117.88 -174.94 2.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.966 . . . . 0.0 110.81 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 34.5 m-85 -136.07 111.31 9.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.522 -0.736 . . . . 0.0 109.399 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.705 ' CG2' HG23 ' A' ' 51' ' ' THR . 3.8 tt -86.86 112.96 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.888 . . . . 0.0 110.773 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.411 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -148.34 162.95 38.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.533 -0.729 . . . . 0.0 109.887 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 14.8 pt20 -116.29 146.07 42.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.925 . . . . 0.0 110.718 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.6 m -137.81 150.79 47.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.264 -0.897 . . . . 0.0 110.169 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.992 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.32 173.28 4.44 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.304 -0.873 . . . . 0.0 109.264 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.763 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 41.5 Cg_endo -67.71 165.02 29.03 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.736 1.387 . . . . 0.0 110.123 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 42' ' ' GLN . 15.0 p -134.66 56.13 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.26 21.31 56.53 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.21 -63.18 0.22 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.09 -1.528 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.631 ' O ' HG12 ' A' ' 39' ' ' VAL . 5.4 mm100 -102.69 -160.23 0.77 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.293 -1.122 . . . . 0.0 110.94 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -115.24 122.66 46.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.184 -0.948 . . . . 0.0 110.727 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.473 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -105.79 160.05 15.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.643 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -134.92 162.92 31.05 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.024 -1.047 . . . . 0.0 110.633 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.484 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 3.9 m120 -89.34 115.79 64.65 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.855 . . . . 0.0 110.134 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -90.08 -50.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.896 1.472 . . . . 0.0 111.254 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.98 79.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.389 -0.819 . . . . 0.0 111.52 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 22.4 p -82.7 19.25 1.35 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.09 -1.006 . . . . 0.0 111.108 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -87.1 67.63 9.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.973 -1.08 . . . . 0.0 109.94 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.705 HG23 ' CG2' ' A' ' 33' ' ' ILE . 2.6 t -79.82 164.34 23.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.359 -0.838 . . . . 0.0 110.432 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 94.2 p -118.44 143.39 46.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.289 -0.882 . . . . 0.0 110.769 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.472 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 31.0 p90 -140.55 128.88 22.49 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.274 -0.891 . . . . 0.0 109.962 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 9.3 m -92.15 168.57 11.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 110.829 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.803 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -78.1 -158.89 0.14 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.465 -0.772 . . . . 0.0 110.339 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.37 -161.71 1.23 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.058 -1.026 . . . . 0.0 109.916 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.27 -53.81 54.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.023 -1.048 . . . . 0.0 109.158 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.4 p -84.41 11.36 8.67 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.472 -0.767 . . . . 0.0 109.075 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.533 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 69.91 13.42 69.34 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.21 121.28 28.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -1.123 . . . . 0.0 110.02 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.795 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -118.25 80.79 1.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.977 . . . . 0.0 110.499 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.82 129.63 48.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -0.972 . . . . 0.0 109.924 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 14.8 p90 -168.19 161.49 12.38 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.458 -0.776 . . . . 0.0 110.358 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 m -92.33 133.57 35.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.198 -0.939 . . . . 0.0 110.624 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.81 ' O ' HG22 ' A' ' 18' ' ' VAL . 29.2 t80 -121.73 155.35 35.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 109.323 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.573 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 3.5 t -96.96 160.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.805 -1.184 . . . . 0.0 110.521 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 16' ' ' GLN . 29.7 m -131.77 177.24 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 0.0 109.989 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 2.3 mtt180 -150.35 135.69 17.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 0.0 110.501 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 87' ' ' ALA . 0.9 OUTLIER -67.67 -16.88 64.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -0.961 . . . . 0.0 109.234 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.8 p -150.34 156.39 41.43 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.56 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 16.7 p90 -163.72 144.1 8.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.981 -1.074 . . . . 0.0 110.54 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 28.5 m -65.89 132.93 49.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.892 . . . . 0.0 110.026 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.403 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -112.69 -177.59 19.74 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.9 p -172.72 160.15 4.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -1.181 . . . . 0.0 110.188 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 79' ' ' THR . 82.6 p -87.69 158.92 50.39 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.277 -0.889 . . . . 0.0 110.361 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -79.14 4.62 6.4 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 124.186 1.624 . . . . 0.0 110.143 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -99.49 27.98 4.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.297 -0.877 . . . . 0.0 110.343 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.63 49.67 76.08 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.402 ' O ' ' OG1' ' A' ' 75' ' ' THR . 22.7 m -155.18 110.73 2.27 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.221 -1.164 . . . . 0.0 110.311 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.46 124.69 10.57 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.987 1.52 . . . . 0.0 110.131 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 p -95.48 -13.43 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.424 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.39 -155.43 24.65 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.8 m -113.54 176.06 5.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.301 -1.117 . . . . 0.0 110.46 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.473 HG21 ' CB ' ' A' ' 44' ' ' ALA . 54.6 t -128.97 162.27 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.455 -0.778 . . . . 0.0 110.044 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.431 ' N ' HG12 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -138.73 102.06 4.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.218 -0.926 . . . . 0.0 110.46 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 2.7 m -74.52 -2.63 26.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.298 -0.876 . . . . 0.0 110.232 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 69' ' ' LYS . . . -46.72 -45.25 19.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.192 -0.942 . . . . 0.0 109.906 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.1 t -116.69 -10.81 11.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.908 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -94.09 -177.27 4.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.116 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.61 131.84 53.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.903 . . . . 0.0 110.068 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.992 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -127.29 139.49 52.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' A' ' 106' ' ' ALA . 16.0 m-80 -103.85 125.81 50.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.973 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.849 ' HB2' HD11 ' A' ' 107' ' ' LEU . 11.7 tp -88.7 101.96 14.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -108.12 171.57 16.17 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -156.67 120.98 4.43 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.437 -1.037 . . . . 0.0 110.297 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.37 176.36 47.95 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -115.8 -76.89 0.57 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -1.135 . . . . 0.0 109.849 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -168.19 -37.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.408 -0.808 . . . . 0.0 110.097 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.38 -12.14 57.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.637 HD13 ' C ' ' A' ' 100' ' ' LEU . 2.2 tm? -148.5 90.17 1.77 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -1.161 . . . . 0.0 110.053 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.18 134.86 34.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.478 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 4' ' ' PHE . 71.0 mt -82.69 -70.76 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 0.0 110.034 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.415 ' C ' ' CG ' ' A' ' 104' ' ' HIS . . . 168.38 -162.3 36.07 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.459 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -147.96 129.22 14.7 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.482 -1.011 . . . . 0.0 109.612 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.76 HG11 HG12 ' A' ' 6' ' ' VAL . 93.5 t -98.3 108.48 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.092 -1.005 . . . . 0.0 110.6 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.4 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . . . -57.53 105.51 0.25 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.234 -0.916 . . . . 0.0 110.024 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.849 HD11 ' HB2' ' A' ' 93' ' ' LEU . 59.4 mt -82.64 164.51 20.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.24 -0.912 . . . . 0.0 110.374 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.5 m -133.15 168.13 19.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.267 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -153.33 167.35 29.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 CA-C-O 117.949 -1.473 . . . . 0.0 109.522 179.988 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.816 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.765 0.316 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 45.3 Cg_endo -73.42 -175.9 2.24 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.892 1.469 . . . . 0.0 110.144 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.893 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -134.4 134.98 42.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.047 -1.033 . . . . 0.0 110.581 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 8.1 t80 -141.24 115.45 9.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.468 -0.77 . . . . 0.0 109.531 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.589 ' HA ' HG21 ' A' ' 105' ' ' VAL . 4.0 t -153.1 172.54 16.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.077 -1.014 . . . . 0.0 110.811 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.999 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 12.0 p -120.8 144.97 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.662 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.583 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -54.66 -62.22 4.46 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.276 -0.89 . . . . 0.0 111.082 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.864 ' HD2' HG22 ' A' ' 6' ' ' VAL . 42.5 Cg_endo -71.85 -78.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.781 1.411 . . . . 0.0 110.629 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.999 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 69.13 14.68 8.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.015 . . . . 0.0 109.879 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.4 t -170.77 148.24 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.336 -0.852 . . . . 0.0 110.297 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.02 56.87 22.28 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.573 ' HB2' ' CE1' ' A' ' 109' ' ' PHE . 58.6 mt -98.28 166.47 11.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -1.129 . . . . 0.0 110.091 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.468 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -129.49 155.65 45.39 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.223 -0.923 . . . . 0.0 110.108 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.526 ' OD2' ' CD ' ' A' ' 68' ' ' ARG . 6.9 t70 -61.68 115.97 4.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 110.387 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 94.24 -28.45 10.79 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 0.2 OUTLIER -41.75 144.02 0.45 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.31 -1.112 . . . . 0.0 110.483 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 p -95.35 125.49 40.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.826 . . . . 0.0 110.193 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.667 HG11 HG11 ' A' ' 67' ' ' VAL . 35.7 m -104.38 -179.07 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.387 -0.82 . . . . 0.0 110.184 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -136.14 114.61 11.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.786 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.4 t -91.4 152.79 3.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.405 -0.81 . . . . 0.0 110.483 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 t -147.41 130.89 16.71 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.474 -0.766 . . . . 0.0 109.331 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.986 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 87.9 t -128.54 136.56 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.111 -0.993 . . . . 0.0 110.671 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.548 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 3.3 m -131.51 110.54 11.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.421 -0.799 . . . . 0.0 109.873 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 155.5 -58.14 0.39 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.868 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -57.9 -159.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -1.175 . . . . 0.0 109.664 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.562 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -166.21 159.45 15.14 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.899 -1.126 . . . . 0.0 111.014 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -42.06 136.98 1.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.717 -0.614 . . . . 0.0 110.576 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.41 -6.95 42.6 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.489 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 3.3 mm-40 -114.09 103.52 11.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -1.142 . . . . 0.0 110.26 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 53' ' ' PHE . 97.1 m -103.82 121.24 42.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.314 -0.866 . . . . 0.0 109.627 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.683 ' OH ' ' HB1' ' A' ' 25' ' ' ALA . 9.9 m-85 -107.0 -170.19 1.67 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 0.0 110.662 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 50.0 m-85 -131.58 111.54 11.83 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.491 -0.755 . . . . 0.0 109.505 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.479 HG22 HG23 ' A' ' 51' ' ' THR . 1.1 tt -89.63 137.06 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.074 -1.016 . . . . 0.0 111.215 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.402 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -153.83 155.06 35.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.497 -0.752 . . . . 0.0 110.267 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -98.59 146.7 25.56 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.224 -0.923 . . . . 0.0 110.463 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 t -156.69 145.5 20.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.094 -1.004 . . . . 0.0 111.186 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -147.23 142.08 16.54 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.09 165.33 32.25 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 O-C-N 123.73 1.384 . . . . 0.0 110.79 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 39' ' ' VAL . 18.7 m -122.68 54.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.435 -0.79 . . . . 0.0 109.719 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 45.06 41.35 7.66 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 167.72 -69.29 0.17 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.646 -1.264 . . . . 0.0 109.984 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -104.89 -164.54 1.05 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.323 -1.104 . . . . 0.0 110.59 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -116.32 143.02 46.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.402 -0.811 . . . . 0.0 110.073 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -130.26 120.59 24.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.138 -0.976 . . . . 0.0 110.022 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.34 155.58 30.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.98 -1.075 . . . . 0.0 110.707 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -106.61 119.88 50.2 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.434 -0.791 . . . . 0.0 109.8 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -80.35 -22.81 6.65 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.882 1.464 . . . . 0.0 110.692 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.61 -37.82 85.68 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.192 -0.943 . . . . 0.0 110.593 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.9 p -91.99 23.08 3.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.24 -0.912 . . . . 0.0 110.489 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 82.37 4.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 110.567 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.479 HG23 HG22 ' A' ' 33' ' ' ILE . 4.0 t -106.7 170.37 7.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.893 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.545 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 52.8 p -118.46 147.68 43.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.027 -1.046 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.546 ' CE1' ' HB2' ' A' ' 31' ' ' TYR . 5.5 p90 -148.24 -179.19 6.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 109.006 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.405 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 3.1 t -157.33 170.93 21.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.875 -1.14 . . . . 0.0 110.928 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.868 HG21 ' HB3' ' A' ' 25' ' ' ALA . 1.5 p -81.03 -155.66 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.461 -0.774 . . . . 0.0 109.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.638 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 4.1 p-10 -157.22 -153.62 0.42 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.728 -1.232 . . . . 0.0 110.803 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 -60.61 3.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.079 -1.013 . . . . 0.0 109.947 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -66.37 -6.76 15.43 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.89 7.23 69.69 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -91.55 119.28 31.34 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.137 -1.213 . . . . 0.0 110.176 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.986 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -92.61 82.27 4.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.893 . . . . 0.0 109.862 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.68 124.47 51.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.28 -0.888 . . . . 0.0 109.897 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -162.78 172.55 15.05 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.675 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.0 t -95.26 130.04 42.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.343 -0.848 . . . . 0.0 110.44 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 91.1 t80 -122.01 172.82 7.95 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.584 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -116.13 152.99 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.622 -1.298 . . . . 0.0 109.945 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.667 HG11 HG11 ' A' ' 18' ' ' VAL . 36.0 m -134.33 169.26 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.2 -0.938 . . . . 0.0 110.597 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.526 ' CD ' ' OD2' ' A' ' 14' ' ' ASP . 2.0 mmm-85 -139.59 164.64 29.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.823 . . . . 0.0 109.824 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -93.42 -54.04 3.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.177 -0.952 . . . . 0.0 110.04 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.01 129.27 47.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.288 -0.883 . . . . 0.0 109.88 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 10.0 p90 -138.23 139.88 39.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 0.0 110.492 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -65.72 114.84 5.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 110.032 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.527 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -85.07 170.65 45.49 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 95.7 p -162.47 177.1 9.79 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -1.166 . . . . 0.0 110.574 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.538 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 2.0 p -86.09 172.93 7.57 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.443 -0.786 . . . . 0.0 109.913 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.538 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 46.6 Cg_endo -75.36 11.69 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.727 1.383 . . . . 0.0 111.204 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.12 -27.37 3.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.85 63.9 0.11 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.14 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.501 ' HB ' ' OG1' ' A' ' 75' ' ' THR . 29.9 m -159.6 107.95 1.48 Allowed Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.165 -1.197 . . . . 0.0 110.087 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 44.6 Cg_endo -71.46 110.43 2.86 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.053 1.554 . . . . 0.0 110.855 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.3 t -74.58 -30.0 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.909 . . . . 0.0 109.53 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.1 153.11 9.53 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -63.25 142.63 58.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.17 -1.194 . . . . 0.0 110.185 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.532 HG11 ' CZ ' ' A' ' 71' ' ' TYR . 36.7 t -105.45 137.75 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.818 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.895 ' OD2' ' HB3' ' A' ' 87' ' ' ALA . 6.7 t70 -134.21 135.6 43.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.096 -1.002 . . . . 0.0 110.001 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -86.07 -4.75 59.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.895 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . . . -65.27 -62.28 1.63 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.304 -0.872 . . . . 0.0 110.652 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.0 t -92.23 3.56 55.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.937 . . . . 0.0 110.46 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 85' ' ' ASP . . . -132.36 -176.4 4.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 110.094 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.87 141.38 51.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 110.172 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 61.8 m -106.85 171.78 7.18 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.907 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -151.22 119.35 6.29 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.305 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.534 ' HB2' HD11 ' A' ' 107' ' ' LEU . 21.7 tp -94.12 101.65 13.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.685 ' HA3' ' CD2' ' A' ' 104' ' ' HIS . . . -108.27 167.24 13.18 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.375 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -147.61 160.26 42.86 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.653 -0.91 . . . . 0.0 109.715 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.57 173.99 44.41 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.957 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 31' ' ' TYR . 24.7 t30 -141.0 169.21 18.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.447 -1.031 . . . . 0.0 110.031 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.91 84.42 0.32 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.243 -0.911 . . . . 0.0 110.426 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.37 -19.43 5.67 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.448 ' HA ' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -146.85 99.6 3.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.002 -1.293 . . . . 0.0 110.881 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.468 ' O ' HD23 ' A' ' 102' ' ' LEU . 6.6 m-20 -92.66 -173.21 3.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.273 -0.892 . . . . 0.0 109.814 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 101' ' ' ASP . 84.4 mt -142.54 -86.36 0.15 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.027 -1.045 . . . . 0.0 110.711 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.74 -169.73 39.8 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.685 ' CD2' ' HA3' ' A' ' 94' ' ' GLY . 7.1 m80 -133.76 140.4 46.93 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.227 -1.161 . . . . 0.0 110.852 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' A' ' 5' ' ' SER . 0.9 OUTLIER -97.75 121.3 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.66 103.79 2.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.812 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 93' ' ' LEU . 68.4 mt -75.16 170.54 15.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.367 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.76 149.12 44.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 110.374 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 12' ' ' LEU . 1.3 m-85 -139.17 91.05 2.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.116 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 120.745 0.307 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.51 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 44.8 Cg_endo -74.29 -157.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.954 1.502 . . . . 0.0 110.131 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -137.3 93.6 2.84 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.935 -1.103 . . . . 0.0 111.281 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -112.62 106.04 14.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.071 -1.018 . . . . 0.0 109.614 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.9 m -151.08 155.82 39.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.944 -1.098 . . . . 0.0 111.112 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.847 HG22 ' HD2' ' A' ' 8' ' ' PRO . 7.5 p -109.41 160.55 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.467 -0.771 . . . . 0.0 109.708 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.582 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -80.16 -59.55 0.53 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.052 . . . . 0.0 110.206 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.847 ' HD2' HG22 ' A' ' 6' ' ' VAL . 54.0 Cg_endo -80.22 74.43 5.55 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.629 1.331 . . . . 0.0 110.38 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.98 -14.42 60.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.019 -1.05 . . . . 0.0 110.065 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.0 m -138.98 178.86 6.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 110.057 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.58 45.64 76.74 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.507 HD21 ' O ' ' A' ' 8' ' ' PRO . 21.5 mt -89.34 159.81 17.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -1.085 . . . . 0.0 110.192 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -129.63 145.91 51.46 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.318 -0.864 . . . . 0.0 110.212 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 69' ' ' LYS . 13.1 p-10 -57.21 111.18 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.44 -32.92 6.99 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 55.5 tt0 -49.0 155.49 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -1.163 . . . . 0.0 110.383 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.54 ' O ' HG13 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -97.04 -178.16 4.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.371 -0.831 . . . . 0.0 110.568 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.843 HG22 ' O ' ' A' ' 65' ' ' PHE . 25.1 m -156.57 170.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.511 -0.743 . . . . 0.0 109.508 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 m -120.06 123.85 44.42 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.945 -1.097 . . . . 0.0 110.688 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.6 143.01 22.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.441 -0.787 . . . . 0.0 109.657 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.47 133.8 33.19 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.795 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 56.7 t -123.35 111.9 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.464 -0.773 . . . . 0.0 109.913 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -130.22 116.09 17.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.105 -0.997 . . . . 0.0 110.487 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 150.04 -29.57 1.11 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.425 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -79.95 -147.27 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -1.136 . . . . 0.0 110.195 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.565 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -175.19 142.17 0.6 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.027 -1.046 . . . . 0.0 111.145 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.05 132.1 1.03 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.414 0.626 . . . . 0.0 110.699 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.443 ' O ' ' OE2' ' A' ' 29' ' ' GLU . . . 118.35 6.1 12.28 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' OE2' ' O ' ' A' ' 28' ' ' GLY . 53.1 mm-40 -140.11 119.28 12.8 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.217 -1.166 . . . . 0.0 110.521 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.51 HG23 ' OG1' ' A' ' 54' ' ' THR . 5.2 m -101.32 133.84 45.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.43 -0.794 . . . . 0.0 109.491 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.614 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 39.0 m-85 -121.15 -172.52 2.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.085 -1.009 . . . . 0.0 111.032 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.506 ' CD1' ' HB2' ' A' ' 52' ' ' SER . 68.0 m-85 -130.25 160.63 33.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.607 -0.683 . . . . 0.0 109.633 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 33' ' ' ILE . 4.5 tt -145.66 116.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.067 -1.021 . . . . 0.0 110.391 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.825 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -151.35 169.95 20.72 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.151 -0.968 . . . . 0.0 111.052 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -104.15 160.08 15.15 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.515 -0.741 . . . . 0.0 109.386 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -160.98 141.53 11.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.021 -1.05 . . . . 0.0 111.385 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -140.51 154.53 69.45 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.98 164.59 34.2 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.622 1.327 . . . . 0.0 111.121 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 42' ' ' GLN . 11.6 m -136.62 55.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.661 0.743 . . . . 0.0 109.919 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.89 -22.64 8.96 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -179.76 -39.47 0.07 OUTLIER Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.674 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.868 ' O ' HG22 ' A' ' 39' ' ' VAL . 2.4 mm-40 -91.68 168.1 11.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.957 -1.319 . . . . 0.0 110.419 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.39 139.14 32.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.094 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.877 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -129.99 130.2 44.71 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -117.8 159.57 22.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 110.276 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.47 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 6.0 t-20 -90.77 117.51 67.99 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 0.0 110.363 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -81.19 -34.11 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.855 1.45 . . . . 0.0 110.636 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.71 95.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.255 -0.903 . . . . 0.0 110.342 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.47 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 6.4 p -88.31 20.71 3.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.364 -0.835 . . . . 0.0 110.063 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.23 132.25 37.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.0 110.086 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.58 HG23 ' CG2' ' A' ' 33' ' ' ILE . 9.8 t -161.96 159.05 26.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.297 -0.877 . . . . 0.0 109.983 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.506 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 33.5 t -127.99 161.23 29.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.188 -0.945 . . . . 0.0 110.431 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.614 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 33.8 p90 -146.99 -176.41 5.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.294 -0.879 . . . . 0.0 110.381 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.51 ' OG1' HG23 ' A' ' 30' ' ' THR . 29.3 m -141.48 154.08 45.32 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.502 ' HB ' ' HA2' ' A' ' 59' ' ' GLY . 43.1 p -63.24 -150.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.067 -1.02 . . . . 0.0 110.429 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.783 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -152.5 -161.03 1.22 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.187 -0.946 . . . . 0.0 110.292 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.63 -53.38 58.15 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 109.176 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 p -87.95 15.9 6.65 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 62.41 39.05 97.28 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -117.09 106.17 13.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -1.087 . . . . 0.0 110.231 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.506 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -107.06 89.73 3.09 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.505 -0.747 . . . . 0.0 110.094 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.6 p -112.01 128.42 56.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.819 . . . . 0.0 109.554 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -153.08 176.38 11.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.126 -0.984 . . . . 0.0 110.824 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 p -94.59 141.43 28.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.33 -0.856 . . . . 0.0 110.521 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.843 ' O ' HG22 ' A' ' 18' ' ' VAL . 75.0 t80 -133.36 162.35 32.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.458 -0.777 . . . . 0.0 109.575 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.476 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 21.6 t -112.13 168.19 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 120.731 -1.231 . . . . 0.0 110.801 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.633 HG11 HG11 ' A' ' 18' ' ' VAL . 25.1 m -138.08 174.99 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.401 -0.812 . . . . 0.0 110.382 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -148.88 145.81 27.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.31 -0.868 . . . . 0.0 110.121 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 3.2 ttpt -65.8 -51.49 58.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.995 . . . . 0.0 109.464 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.433 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 96.0 p -135.45 165.86 24.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 109.617 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.732 ' CZ ' HG11 ' A' ' 84' ' ' VAL . 37.7 p90 -170.26 150.96 3.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.086 -1.009 . . . . 0.0 110.223 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -68.52 113.39 6.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.225 -0.922 . . . . 0.0 110.094 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.877 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -59.24 -175.79 0.82 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 12.1 m -140.69 -173.67 3.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -1.11 . . . . 0.0 110.62 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.519 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 3.0 p -106.68 170.17 6.01 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.565 -0.709 . . . . 0.0 110.028 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 39.2 Cg_endo -64.83 -11.19 28.18 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.775 1.408 . . . . 0.0 109.843 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -88.31 -33.61 17.96 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.484 -0.76 . . . . 0.0 109.543 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 120.7 41.44 0.53 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.0 m -136.25 126.53 16.37 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.262 -1.14 . . . . 0.0 110.685 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 44.2 Cg_endo -72.89 120.52 6.69 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.971 1.511 . . . . 0.0 110.245 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.554 HG13 ' N ' ' A' ' 82' ' ' GLY . 7.3 p -141.84 -43.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.216 -0.928 . . . . 0.0 110.42 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.554 ' N ' HG13 ' A' ' 81' ' ' VAL . . . -90.78 155.44 23.87 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.3 p -93.13 153.23 18.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.379 -1.071 . . . . 0.0 110.209 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.732 HG11 ' CZ ' ' A' ' 71' ' ' TYR . 5.9 t -141.39 156.99 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.333 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.794 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 23.8 m-20 -146.68 149.43 33.46 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.433 -0.792 . . . . 0.0 109.789 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 68.8 m -114.35 -13.8 12.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.85 -56.59 16.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.233 -0.917 . . . . 0.0 110.816 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.471 ' H ' HG22 ' A' ' 88' ' ' THR . 3.3 t -100.74 -13.02 18.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.065 -1.022 . . . . 0.0 110.784 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' A' ' 85' ' ' ASP . . . -91.32 -141.98 0.18 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.254 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.38 82.98 0.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.906 . . . . 0.0 109.781 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.683 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 28.1 p -97.34 164.82 12.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.109 -0.994 . . . . 0.0 110.436 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 92' ' ' ASN . 2.2 m120 -141.47 166.52 24.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 110.031 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.825 HD12 ' O ' ' A' ' 34' ' ' ALA . 5.7 tp -116.01 127.25 54.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 109.603 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.568 ' HA3' ' CD2' ' A' ' 104' ' ' HIS . . . -118.31 157.71 15.08 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -141.73 140.79 33.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -1.107 . . . . 0.0 110.086 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 139.42 163.69 9.6 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -124.29 -156.99 0.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.23 -1.159 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.8 t -90.14 36.81 0.88 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.905 . . . . 0.0 110.404 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.4 -50.19 0.05 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.6 HD13 ' OH ' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -135.13 89.38 2.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.196 -1.179 . . . . 0.0 110.409 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.02 158.34 11.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.158 -0.963 . . . . 0.0 109.814 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.495 HD23 ' HG3' ' A' ' 2' ' ' PRO . 91.8 mt -121.52 -84.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 110.432 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.98 -177.37 38.67 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.005 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.568 ' CD2' ' HA3' ' A' ' 94' ' ' GLY . 43.8 m80 -139.92 113.56 8.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.571 -0.958 . . . . 0.0 109.887 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.59 HG11 HG12 ' A' ' 6' ' ' VAL . 18.0 t -88.25 161.55 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 109.836 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.81 134.21 49.3 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.157 -0.964 . . . . 0.0 110.122 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.609 HD11 ' HB2' ' A' ' 93' ' ' LEU . 58.1 mt -105.48 147.45 28.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.236 -0.915 . . . . 0.0 110.432 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.97 159.68 42.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.408 -0.808 . . . . 0.0 109.824 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.491 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 42.3 m-85 -128.17 156.18 43.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.562 179.986 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 120.729 0.299 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.51 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 47.4 Cg_endo -73.68 -165.9 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.011 1.532 . . . . 0.0 110.353 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -151.53 109.45 3.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.085 -1.01 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -108.36 115.83 30.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.6 m -146.13 151.84 38.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.894 -1.129 . . . . 0.0 111.159 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.831 HG22 ' HD2' ' A' ' 8' ' ' PRO . 9.8 p -115.97 151.8 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.467 -0.771 . . . . 0.0 109.473 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.614 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -77.22 -57.87 1.05 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.923 -1.111 . . . . 0.0 110.411 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.831 ' HD2' HG22 ' A' ' 6' ' ' VAL . 54.9 Cg_endo -86.55 68.81 4.48 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.538 1.283 . . . . 0.0 110.334 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.38 -20.35 65.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 109.811 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.5 p -142.76 130.04 21.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.434 -0.791 . . . . 0.0 110.239 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.19 47.56 0.99 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -108.15 172.03 7.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -1.097 . . . . 0.0 110.221 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -148.08 164.28 34.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.94 . . . . 0.0 110.343 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.462 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 23.9 t70 -64.85 123.39 19.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 110.137 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.78 -30.42 7.96 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 12' ' ' LEU . 47.1 tt0 -58.75 146.83 35.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -1.119 . . . . 0.0 110.207 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.3 p -90.35 179.51 5.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 110.539 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.66 HG23 ' HB3' ' A' ' 65' ' ' PHE . 5.3 m -149.41 160.66 5.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.504 -0.747 . . . . 0.0 109.83 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 14.0 m -112.04 118.49 35.57 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.949 -1.094 . . . . 0.0 110.107 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 t -109.06 147.95 13.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 110.073 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.7 t -142.28 129.06 20.51 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.482 -0.761 . . . . 0.0 110.159 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 12.2 t -118.55 107.67 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.368 -0.832 . . . . 0.0 110.024 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.4 OUTLIER -111.92 141.42 45.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.271 -0.893 . . . . 0.0 110.567 179.989 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 122.0 -74.11 0.36 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.503 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -54.79 145.14 20.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -1.178 . . . . 0.0 109.707 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.574 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -118.47 157.8 26.54 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.102 -0.999 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -34.07 136.24 0.13 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.506 0.669 . . . . 0.0 110.819 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.39 1.93 12.2 Favored Glycine 0 C--N 1.295 -1.74 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 1.0 OUTLIER -137.52 129.01 28.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.324 -1.104 . . . . 0.0 110.189 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.518 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 89.0 m -107.22 146.68 31.1 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.525 -0.734 . . . . 0.0 109.815 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 29' ' ' GLU . 13.2 m-85 -133.09 169.09 17.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.129 -0.982 . . . . 0.0 110.728 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CD2' ' HB3' ' A' ' 52' ' ' SER . 19.4 m-85 -128.64 106.87 9.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 109.539 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.612 ' CG2' HG23 ' A' ' 51' ' ' THR . 18.1 tt -89.54 136.61 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.255 -0.903 . . . . 0.0 110.845 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.65 177.84 9.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.334 -0.854 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.553 ' HB2' HD12 ' A' ' 93' ' ' LEU . 55.5 tt0 -134.73 150.72 50.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.307 -0.871 . . . . 0.0 109.964 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 69.5 m -150.95 163.44 38.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.102 -0.999 . . . . 0.0 111.224 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.564 ' HB3' ' OH ' ' A' ' 71' ' ' TYR . . . -153.1 152.49 28.07 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.791 -0.568 . . . . 0.0 109.709 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.57 172.15 16.31 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.802 1.422 . . . . 0.0 110.339 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 44' ' ' ALA . 16.0 m -138.15 55.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.929 -1.107 . . . . 0.0 110.589 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.94 24.9 74.42 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.91 -57.45 0.47 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.045 -1.55 . . . . 0.0 111.142 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -88.56 -164.47 1.13 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.118 -1.225 . . . . 0.0 110.667 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -122.32 155.63 35.57 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.473 -0.767 . . . . 0.0 110.496 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.717 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -150.21 118.75 6.5 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 109.094 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.1 m -108.9 162.03 14.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.971 -1.08 . . . . 0.0 111.089 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -111.52 92.98 17.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.432 -0.792 . . . . 0.0 109.746 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.98 -12.52 32.63 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.047 1.551 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.31 -31.83 71.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.133 -0.98 . . . . 0.0 110.178 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 p -97.15 8.63 44.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 110.149 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.14 110.53 5.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.409 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.612 HG23 ' CG2' ' A' ' 33' ' ' ILE . 1.1 t -129.03 140.38 51.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 110.054 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.496 ' HB3' ' CD2' ' A' ' 32' ' ' TYR . 6.9 p -109.21 148.51 30.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.173 -0.955 . . . . 0.0 110.227 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 22.7 p90 -148.06 -177.13 5.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.0 110.177 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 55' ' ' THR . 25.4 m -137.62 153.05 49.94 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 110.091 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 3.3 p -56.85 -159.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.179 -0.951 . . . . 0.0 110.142 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 45.3 m-20 -146.89 -161.81 1.41 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.936 -1.103 . . . . 0.0 110.599 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.31 -51.02 70.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.28 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.93 12.35 7.66 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.574 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 60.25 20.09 53.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.75 110.16 22.26 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -1.114 . . . . 0.0 110.22 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.678 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -101.36 90.95 4.27 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.541 -0.724 . . . . 0.0 109.417 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 p -103.48 115.08 29.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 109.548 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.546 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 15.1 p90 -147.74 171.06 16.26 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.395 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.9 155.3 17.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 0.0 110.84 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.66 ' HB3' HG23 ' A' ' 18' ' ' VAL . 90.0 t80 -140.32 176.78 8.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.483 -0.76 . . . . 0.0 108.971 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.578 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -128.35 154.56 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.576 -1.328 . . . . 0.0 110.442 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 67' ' ' VAL . 29.4 m -129.87 125.8 61.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.526 -0.734 . . . . 0.0 109.85 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -111.73 116.55 30.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 110.407 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 14' ' ' ASP . 29.6 ttpt -56.76 -55.95 27.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.615 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.4 m -99.57 130.03 45.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.828 . . . . 0.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.564 ' OH ' ' HB3' ' A' ' 37' ' ' ALA . 33.9 p90 -155.3 131.08 9.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -0.878 . . . . 0.0 109.982 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.4 m -54.58 134.41 46.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.118 -0.989 . . . . 0.0 110.394 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.717 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -115.47 167.32 12.35 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.52 ' CB ' ' HA ' ' A' ' 80' ' ' PRO . 59.6 p -173.83 83.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.028 -1.278 . . . . 0.0 110.564 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.633 ' HB ' ' CD ' ' A' ' 76' ' ' PRO . 25.0 p 37.63 -147.8 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.414 0 O-C-N 121.613 -0.679 . . . . 0.0 109.454 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.633 ' CD ' ' HB ' ' A' ' 75' ' ' THR . 43.9 Cg_endo -72.2 -51.8 0.2 Allowed 'Trans proline' 0 C--O 1.214 -0.712 0 CA-C-N 119.224 0.758 . . . . 0.0 110.571 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 6.7 tt0 179.66 77.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.213 -0.93 . . . . 0.0 110.182 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.8 -15.01 0.07 OUTLIER Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.342 -1.409 . . . . 0.0 111.197 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.402 ' HB ' HG21 ' A' ' 75' ' ' THR . 97.9 m -135.87 107.63 9.79 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.552 -1.558 . . . . 0.0 111.213 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.52 ' HA ' ' CB ' ' A' ' 74' ' ' SER . 48.9 Cg_endo -76.94 119.85 5.24 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.066 1.561 . . . . 0.0 109.976 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 m -103.52 -12.52 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.083 -1.01 . . . . 0.0 110.565 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.92 -174.04 27.77 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.5 p -90.98 160.97 15.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -1.165 . . . . 0.0 110.156 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.437 HG21 ' HB1' ' A' ' 44' ' ' ALA . 34.4 t -121.44 157.83 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.129 -0.982 . . . . 0.0 110.424 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 39.6 p-10 -152.06 118.28 5.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 110.052 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.3 m -90.58 32.31 0.98 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.165 -0.959 . . . . 0.0 110.306 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.1 87.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.213 -0.93 . . . . 0.0 109.983 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -130.67 6.16 4.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.51 -159.17 0.59 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.846 . . . . 0.0 109.811 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -115.49 120.38 39.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.51 141.0 44.24 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.77 144.1 29.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.062 -1.023 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.553 HD12 ' HB2' ' A' ' 35' ' ' GLN . 0.4 OUTLIER -123.58 135.39 53.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.646 -0.659 . . . . 0.0 109.254 179.956 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.95 177.02 21.7 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.223 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -151.68 170.82 18.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.452 -1.028 . . . . 0.0 109.986 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.413 ' HA2' ' HG ' ' A' ' 102' ' ' LEU . . . 150.76 159.3 8.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 99' ' ' GLY . 21.0 t30 -119.2 158.18 26.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -1.177 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.78 92.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.067 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 97' ' ' ASN . . . 124.02 -45.33 1.19 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -91.47 132.11 36.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -1.129 . . . . 0.0 110.202 179.914 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.679 ' N ' HD13 ' A' ' 100' ' ' LEU . 5.8 m-20 -105.8 144.65 32.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 110.191 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 101' ' ' ASP . 21.1 mt -122.36 -75.14 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.162 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 159.38 -179.72 34.78 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.72 128.74 16.52 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.491 -1.005 . . . . 0.0 109.56 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.642 HG11 HG12 ' A' ' 6' ' ' VAL . 58.2 t -105.11 155.12 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.409 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -92.18 147.07 23.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.818 . . . . 0.0 109.833 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.48 105.66 9.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 110.353 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 109' ' ' PHE . 3.6 m -79.58 173.96 12.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.882 . . . . 0.0 110.167 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.445 ' H ' HG22 ' A' ' 108' ' ' THR . 2.1 m-85 -136.77 88.68 2.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 CA-C-O 118.005 -1.442 . . . . 0.0 109.569 179.96 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.922 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 120.663 0.268 . . . . 0.0 110.409 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.922 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 48.6 Cg_endo -73.52 179.72 5.29 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.931 1.49 . . . . 0.0 110.537 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -129.18 144.82 51.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.873 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.492 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 23.5 t80 -150.36 104.75 3.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.926 . . . . 0.0 109.888 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p -150.58 152.55 34.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 110.68 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.03 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 14.8 p -106.52 158.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -0.838 . . . . 0.0 109.55 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.594 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -60.46 -63.76 3.9 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.113 -0.992 . . . . 0.0 110.787 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.99 ' HD2' HG22 ' A' ' 6' ' ' VAL . 44.7 Cg_endo -72.33 -86.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.772 1.406 . . . . 0.0 111.189 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 1.03 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 71.81 18.35 5.15 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.407 -0.808 . . . . 0.0 109.918 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.484 ' HA ' ' HB ' ' A' ' 108' ' ' THR . 3.9 m -171.4 108.48 0.27 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.362 -0.836 . . . . 0.0 110.076 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.09 76.09 1.32 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.522 HD21 ' HB2' ' A' ' 8' ' ' PRO . 9.7 mt -128.05 172.74 10.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -1.101 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -138.29 162.82 33.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 110.082 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -57.93 123.99 17.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.067 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 94.99 -32.32 6.23 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 17' ' ' SER . 9.0 tm0? -42.01 138.26 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.39 -1.065 . . . . 0.0 110.149 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.46 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -94.07 150.39 20.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.983 -179.99 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 65' ' ' PHE . 33.3 m -128.79 176.95 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.926 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 0.3 OUTLIER -133.48 121.78 22.7 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.939 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 21' ' ' SER . 68.0 t -98.31 158.86 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.254 -0.903 . . . . 0.0 110.053 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.41 ' N ' HG12 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -151.08 122.26 7.75 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.388 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.844 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 53.1 t -121.24 144.27 30.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.339 -0.85 . . . . 0.0 109.758 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.456 ' H ' ' HB3' ' A' ' 3' ' ' ALA . 1.1 m -156.61 127.55 6.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 142.61 -63.58 0.5 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.562 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -56.67 -159.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 109.816 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.57 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -165.8 162.7 18.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.928 -1.107 . . . . 0.0 111.054 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -41.24 134.5 2.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.551 -0.718 . . . . 0.0 110.241 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 114.6 7.41 18.13 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 54' ' ' THR . 5.6 mt-10 -139.86 128.64 23.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.243 -1.151 . . . . 0.0 109.906 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.502 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 20.6 m -108.87 157.8 18.28 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.866 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.963 ' CD2' HD11 ' A' ' 102' ' ' LEU . 15.8 m-85 -137.34 173.2 11.94 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 110.019 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 14.7 m-85 -131.08 103.52 6.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 110.021 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.684 ' CG2' HG23 ' A' ' 51' ' ' THR . 1.2 tt -87.23 124.29 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.179 -0.951 . . . . 0.0 110.272 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 1.026 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -150.56 160.46 43.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 110.207 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.486 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -126.59 138.2 53.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 110.544 179.978 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.2 m -146.94 169.22 19.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.25 -0.906 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.61 152.35 28.61 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.17 -0.956 . . . . 0.0 110.119 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.22 174.73 10.98 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.006 1.529 . . . . 0.0 110.178 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.526 HG12 ' H ' ' A' ' 40' ' ' GLY . 4.7 t -134.58 177.38 6.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.218 -0.926 . . . . 0.0 109.582 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.526 ' H ' HG12 ' A' ' 39' ' ' VAL . . . -70.53 -0.47 31.44 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.431 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.472 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -154.35 -29.52 0.03 OUTLIER Glycine 0 N--CA 1.494 2.519 0 O-C-N 120.806 -1.408 . . . . 0.0 110.963 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.472 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 2.0 mm-40 -143.13 -159.42 0.98 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.023 -1.281 . . . . 0.0 109.745 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.465 ' HA ' HG23 ' A' ' 39' ' ' VAL . 37.1 m-20 -119.6 142.04 48.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.935 -1.103 . . . . 0.0 110.79 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.726 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -118.33 165.39 13.91 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.423 -0.798 . . . . 0.0 108.902 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -147.05 158.18 43.85 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.721 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.577 ' OD1' ' CD2' ' A' ' 71' ' ' TYR . 3.4 m120 -100.11 116.11 64.87 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.489 -0.757 . . . . 0.0 109.694 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.62 -28.59 4.19 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.818 1.431 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.11 -35.42 74.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.245 -0.91 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.6 p -86.94 14.08 7.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.214 -0.929 . . . . 0.0 110.684 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.38 95.62 10.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.952 . . . . 0.0 110.271 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.684 HG23 ' CG2' ' A' ' 33' ' ' ILE . 5.0 t -137.03 167.62 21.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.7 p -126.2 149.54 48.96 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.196 -0.94 . . . . 0.0 110.34 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 20.7 p90 -143.41 141.93 31.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.142 -0.974 . . . . 0.0 110.135 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 29' ' ' GLU . 18.6 m -104.21 155.55 18.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -0.933 . . . . 0.0 110.494 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.562 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -63.04 -156.08 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.319 -0.863 . . . . 0.0 109.806 179.946 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -140.83 -166.88 2.24 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.927 -1.108 . . . . 0.0 110.436 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.93 -57.24 13.93 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -1.85 23.63 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.254 -0.904 . . . . 0.0 108.999 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.83 69.06 1.46 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.58 125.69 13.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -1.084 . . . . 0.0 109.618 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.844 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -118.6 80.6 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 110.781 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.29 140.21 46.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -0.831 . . . . 0.0 109.078 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.4 ' HZ ' HD13 ' A' ' 33' ' ' ILE . 32.7 p90 -171.1 -179.65 2.78 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.114 -0.991 . . . . 0.0 111.38 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t -96.43 140.78 30.58 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.608 0.718 . . . . 0.0 110.551 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.587 ' HB3' HG23 ' A' ' 18' ' ' VAL . 20.3 t80 -134.32 -172.19 2.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -0.79 . . . . 0.0 108.888 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 t -143.69 165.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.645 -1.285 . . . . 0.0 110.325 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.572 HG11 HG11 ' A' ' 18' ' ' VAL . 33.2 m -137.88 142.51 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.312 -0.868 . . . . 0.0 110.305 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -121.22 134.52 55.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.072 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 23.3 ttmt -73.26 -59.81 2.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.137 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t -109.58 141.84 41.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 110.196 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.577 ' CD2' ' OD1' ' A' ' 46' ' ' ASN . 33.4 p90 -153.56 122.5 6.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.825 . . . . 0.0 109.986 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 92.2 m -43.89 124.74 3.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.307 -0.871 . . . . 0.0 110.738 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.66 148.88 19.08 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.2 t -151.29 148.19 27.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.787 -1.419 . . . . 0.0 111.168 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.53 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 75.5 p -84.61 175.63 4.46 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.484 -0.76 . . . . 0.0 109.902 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.53 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 50.0 Cg_endo -87.95 21.96 0.95 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.748 1.394 . . . . 0.0 110.631 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -128.97 12.27 6.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.127 -0.983 . . . . 0.0 110.565 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 80' ' ' PRO . . . 78.86 11.89 84.75 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.2 m -96.68 105.44 23.25 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.066 -1.256 . . . . 0.0 110.099 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 78' ' ' GLY . 45.4 Cg_endo -72.75 137.2 26.82 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.043 1.549 . . . . 0.0 110.143 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 81' ' ' VAL . 9.2 p -119.76 16.02 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.215 -0.928 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.87 -169.66 18.17 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 20.0 p -104.5 153.42 21.17 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.088 -1.243 . . . . 0.0 109.918 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.726 HG21 ' CB ' ' A' ' 44' ' ' ALA . 74.6 t -102.34 153.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 109.993 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -132.8 148.7 52.32 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 110.203 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 1.8 t -104.94 15.01 28.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 110.17 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.23 -56.16 4.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 110.334 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -87.7 -28.12 21.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.23 -0.919 . . . . 0.0 110.238 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.7 -158.26 0.64 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.218 -0.926 . . . . 0.0 110.01 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.45 147.95 42.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.9 . . . . 0.0 110.225 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.469 ' HB3' ' OE1' ' A' ' 35' ' ' GLN . 94.4 m -106.61 130.35 54.38 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.911 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -112.77 125.23 54.1 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 110.557 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.026 HD12 ' O ' ' A' ' 34' ' ' ALA . 50.1 tp -107.62 112.34 25.02 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.599 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -120.89 160.2 15.3 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.487 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -144.07 124.48 13.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.506 -0.996 . . . . 0.0 109.802 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.35 167.37 39.39 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.414 ' CG ' ' N ' ' A' ' 98' ' ' SER . 4.3 t-20 -104.43 -86.08 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -1.094 . . . . 0.0 110.416 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.414 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 46.8 t -159.89 71.07 0.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.255 -0.903 . . . . 0.0 110.007 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.01 -17.3 6.74 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 31' ' ' TYR . 38.3 tp -94.86 -66.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.462 -1.022 . . . . 0.0 109.655 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.9 t0 61.89 128.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.76 . . . . 0.0 110.632 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.963 HD11 ' CD2' ' A' ' 31' ' ' TYR . 35.3 mt -96.85 -39.51 9.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.468 -0.77 . . . . 0.0 109.571 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.18 177.58 26.01 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.599 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 2.0 m-70 -133.7 120.05 20.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.656 -0.908 . . . . 0.0 109.601 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.6 t -92.25 132.59 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.207 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.18 106.71 18.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 110.325 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.2 mt -74.83 126.81 31.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.24 -0.913 . . . . 0.0 110.13 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.484 ' HB ' ' HA ' ' A' ' 10' ' ' SER . 2.2 m -90.37 162.49 15.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.926 . . . . 0.0 110.092 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 108' ' ' THR . 3.9 m-85 -148.4 171.81 15.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.548 179.979 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.541 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 54.9 Cg_endo -74.6 -102.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.9 1.474 . . . . 0.0 109.447 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . 179.73 133.58 0.1 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.887 -1.133 . . . . 0.0 110.461 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -150.85 97.98 2.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.401 -0.812 . . . . 0.0 109.543 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.1 p -139.26 168.83 18.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.059 -1.026 . . . . 0.0 111.148 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG12 HG11 ' A' ' 105' ' ' VAL . 8.0 p -124.98 148.64 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.555 -0.716 . . . . 0.0 109.09 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.648 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.0 m -62.21 -76.87 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.868 -1.145 . . . . 0.0 110.463 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 55.6 Cg_endo -77.81 75.3 4.84 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 O-C-N 122.788 0.888 . . . . 0.0 109.847 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.09 -22.89 63.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.148 -0.97 . . . . 0.0 110.301 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.5 t -131.69 135.18 46.66 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.174 -0.954 . . . . 0.0 110.12 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.98 65.71 1.28 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.626 HD21 ' O ' ' A' ' 8' ' ' PRO . 7.4 mt -110.21 165.05 12.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -1.139 . . . . 0.0 109.887 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.5 157.22 28.74 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.21 -0.931 . . . . 0.0 110.169 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -68.5 127.2 32.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.84 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.8 -25.54 11.4 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -54.47 149.55 10.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.337 -1.096 . . . . 0.0 110.437 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 m -101.99 129.19 48.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.229 -0.92 . . . . 0.0 109.957 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 18' ' ' VAL . 16.4 m -95.91 175.29 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 23.3 p -129.37 113.57 15.12 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.376 -0.828 . . . . 0.0 109.734 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t -97.57 151.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.275 -0.891 . . . . 0.0 110.05 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 t -141.82 118.49 11.03 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.323 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 35.3 t -113.83 138.14 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.558 -0.714 . . . . 0.0 109.778 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.459 ' H ' ' HB3' ' A' ' 3' ' ' ALA . 19.3 p -150.9 116.25 5.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.983 -1.073 . . . . 0.0 110.754 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.541 ' HA3' ' CB ' ' A' ' 2' ' ' PRO . . . 156.31 -52.44 0.42 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.528 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -58.15 -157.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.358 -1.083 . . . . 0.0 109.711 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.506 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -161.26 160.59 30.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.966 -1.084 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -45.91 130.6 9.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.604 -0.685 . . . . 0.0 110.25 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.432 ' C ' ' HG3' ' A' ' 29' ' ' GLU . . . 117.92 12.33 7.84 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.541 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 70.6 mt-10 -139.18 113.26 8.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.283 . . . . 0.0 110.444 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.408 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 31.1 m -90.83 166.46 13.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.471 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.681 ' HE1' HD23 ' A' ' 100' ' ' LEU . 93.9 m-85 -150.61 167.11 28.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.992 -1.068 . . . . 0.0 110.827 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' A' ' 31' ' ' TYR . 12.3 m-85 -131.68 106.92 8.46 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.413 ' CG2' HG23 ' A' ' 51' ' ' THR . 4.7 tt -98.25 137.8 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.994 . . . . 0.0 111.452 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.04 161.02 43.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.669 -0.645 . . . . 0.0 109.458 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 35' ' ' GLN . 5.3 pt20 -119.23 134.04 55.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 110.523 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.419 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 3.5 m -144.23 -178.5 5.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.43 -0.794 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.61 156.95 33.57 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.301 -0.875 . . . . 0.0 109.467 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 41.3 Cg_endo -71.96 151.4 56.29 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 O-C-N 123.748 1.394 . . . . 0.0 110.686 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.6 HG13 ' H ' ' A' ' 41' ' ' GLY . 10.8 p -132.79 175.28 11.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 121.502 -0.749 . . . . 0.0 109.476 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.571 ' N ' HG22 ' A' ' 39' ' ' VAL . . . -54.28 -22.39 22.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.6 ' H ' HG13 ' A' ' 39' ' ' VAL . . . -97.27 -74.14 1.17 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.447 ' O ' ' OD2' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -138.4 -74.03 0.4 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -1.118 . . . . 0.0 110.094 -179.965 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.503 ' N ' HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -164.93 118.12 1.25 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.186 -0.946 . . . . 0.0 111.007 -179.943 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.8 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -95.24 133.08 39.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.283 -0.886 . . . . 0.0 108.942 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 15.7 t -113.91 168.0 10.17 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.779 -1.201 . . . . 0.0 111.604 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -108.88 112.09 60.41 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.71 . . . . 0.0 110.037 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.62 -24.78 15.57 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.0 1.526 . . . . 0.0 110.646 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -8.86 10.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.206 -0.934 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.02 35.69 4.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.977 -1.077 . . . . 0.0 110.541 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.79 133.66 34.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.163 -0.961 . . . . 0.0 110.541 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.413 HG23 ' CG2' ' A' ' 33' ' ' ILE . 9.9 t -159.95 156.84 27.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.35 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t -130.03 161.6 30.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.162 -0.961 . . . . 0.0 110.755 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 7.9 p90 -149.28 179.73 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.401 -0.812 . . . . 0.0 109.763 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.4 m -146.88 158.11 43.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.051 -1.031 . . . . 0.0 110.332 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.528 HG21 ' HB3' ' A' ' 25' ' ' ALA . 2.8 p -73.3 -161.23 0.09 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -161.07 -152.16 0.26 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.1 -1.0 . . . . 0.0 110.885 -179.947 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.35 -46.51 89.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.889 . . . . 0.0 109.488 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.4 t -85.16 12.96 6.88 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.569 -0.707 . . . . 0.0 109.209 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.506 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 45.3 40.66 7.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.81 126.16 41.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 110.374 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 53' ' ' PHE . . . -112.1 90.08 3.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 110.539 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.78 117.01 32.99 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.329 -0.857 . . . . 0.0 109.562 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.634 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.4 p90 -149.91 171.15 17.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.249 -0.907 . . . . 0.0 110.877 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.04 128.11 47.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 110.647 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.51 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 50.0 t80 -113.64 -179.96 3.79 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.51 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.7 t -128.27 156.89 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.704 -1.248 . . . . 0.0 109.907 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG13 ' C ' ' A' ' 66' ' ' VAL . 30.7 m -146.82 157.09 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 110.308 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.23 150.51 50.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.428 -0.795 . . . . 0.0 110.187 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 29.7 tttt -76.5 -59.4 2.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 110.566 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.0 m -117.57 137.62 52.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.143 -0.973 . . . . 0.0 110.169 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -162.2 151.53 15.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.12 -0.987 . . . . 0.0 110.304 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 38.1 m -68.47 134.29 49.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.0 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.636 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -118.82 -176.48 16.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER 179.45 138.82 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -1.154 . . . . 0.0 109.915 -179.98 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.7 p -73.55 144.46 83.61 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 110.396 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.58 -16.51 10.46 Favored 'Trans proline' 0 C--N 1.297 -2.135 0 O-C-N 124.2 1.632 . . . . 0.0 110.069 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -73.16 -13.38 61.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.368 -0.833 . . . . 0.0 110.275 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.455 ' O ' ' OG1' ' A' ' 79' ' ' THR . . . 106.3 62.86 0.6 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 78' ' ' GLY . 70.7 m -165.54 95.65 0.82 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.255 -1.144 . . . . 0.0 110.348 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.05 142.19 46.0 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 O-C-N 123.823 1.433 . . . . 0.0 109.944 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.506 HG11 HG21 ' A' ' 39' ' ' VAL . 3.5 p -120.79 -34.18 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.148 -0.97 . . . . 0.0 110.676 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.89 -147.81 19.4 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 82.5 p -90.3 168.83 11.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.354 -1.086 . . . . 0.0 110.45 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.8 HG21 ' HB3' ' A' ' 44' ' ' ALA . 78.3 t -133.05 116.43 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.393 -0.817 . . . . 0.0 109.882 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.767 ' OD2' HG22 ' A' ' 88' ' ' THR . 4.9 p-10 -101.26 142.0 33.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 0.0 110.392 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 4.4 t -98.2 17.28 18.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.25 -0.907 . . . . 0.0 110.031 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.1 -59.92 2.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 110.214 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.767 HG22 ' OD2' ' A' ' 85' ' ' ASP . 5.9 t -79.78 -24.85 41.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.289 -0.882 . . . . 0.0 110.081 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -101.01 -154.96 0.49 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.382 -0.824 . . . . 0.0 109.909 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.21 146.47 33.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.401 -0.812 . . . . 0.0 110.086 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.28 126.85 43.94 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.261 -0.9 . . . . 0.0 109.67 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -110.8 121.2 44.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 111.005 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 65' ' ' PHE . 1.1 tp -107.05 118.41 36.63 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.418 -0.801 . . . . 0.0 108.912 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -137.47 176.73 20.38 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.279 -1.439 . . . . 0.0 110.529 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.89 175.75 11.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.615 -0.932 . . . . 0.0 110.054 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 136.63 167.06 11.05 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -131.46 -153.15 0.54 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.187 -1.184 . . . . 0.0 109.933 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 t -104.04 80.15 1.7 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.176 -0.953 . . . . 0.0 110.089 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.55 -18.31 0.36 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.681 HD23 ' HE1' ' A' ' 31' ' ' TYR . 7.9 tp -140.79 -67.95 0.41 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.282 . . . . 0.0 110.561 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.5 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.7 OUTLIER 69.42 153.06 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.306 -0.871 . . . . 0.0 110.091 179.983 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.7 mt -121.79 -86.31 0.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 110.38 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -167.91 -160.66 15.94 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -159.09 138.45 11.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -1.09 . . . . 0.0 110.335 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.497 HG11 HG12 ' A' ' 6' ' ' VAL . 81.5 t -104.9 127.96 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.255 -0.903 . . . . 0.0 110.207 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.87 93.74 5.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.511 HD22 HD11 ' A' ' 12' ' ' LEU . 65.9 mt -60.19 170.13 1.38 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 109' ' ' PHE . 17.4 m -141.19 169.84 16.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 0.0 110.096 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.412 ' N ' HG22 ' A' ' 108' ' ' THR . 5.9 m-85 -142.65 96.57 2.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.913 . . . . 0.0 110.138 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.61 179.978 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.631 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.631 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 42.8 Cg_endo -69.82 -159.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.897 1.472 . . . . 0.0 110.428 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -140.38 135.8 32.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.025 -1.047 . . . . 0.0 111.004 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.404 ' CE2' HG23 ' A' ' 105' ' ' VAL . 65.9 t80 -150.84 108.53 3.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.557 -0.715 . . . . 0.0 109.096 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.0 p -146.56 161.59 40.18 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.82 -1.175 . . . . 0.0 111.484 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.889 HG12 HG11 ' A' ' 105' ' ' VAL . 7.7 p -129.94 143.32 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.594 -0.691 . . . . 0.0 109.719 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.612 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.2 m -56.86 -68.84 0.53 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.976 -1.077 . . . . 0.0 110.224 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 50.7 Cg_endo -75.88 95.1 1.01 Allowed 'Trans proline' 0 C--N 1.321 -0.89 0 O-C-N 123.354 1.186 . . . . 0.0 110.228 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.96 -1.94 28.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.0 -1.063 . . . . 0.0 110.364 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 t -157.21 109.51 2.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.955 . . . . 0.0 110.057 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.45 60.99 0.54 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.506 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 1.1 mp -108.25 165.84 11.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -1.166 . . . . 0.0 110.068 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 11.4 t -117.27 147.97 42.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.319 -0.863 . . . . 0.0 110.072 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.23 119.21 7.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 110.326 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.11 -35.15 4.97 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 34.2 tt0 -49.21 153.81 0.92 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.326 -1.102 . . . . 0.0 110.381 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 m -105.46 132.75 51.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.959 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.506 ' CG1' ' CD2' ' A' ' 12' ' ' LEU . 24.4 m -100.6 178.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.255 -0.903 . . . . 0.0 110.282 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.9 m -121.1 117.28 26.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 109.807 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.484 HG21 HD13 ' A' ' 33' ' ' ILE . 20.8 t -102.54 150.2 6.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.393 -0.817 . . . . 0.0 110.154 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.91 127.94 18.49 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.309 -0.869 . . . . 0.0 110.4 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 58.7 t -117.37 147.59 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.632 -0.667 . . . . 0.0 109.917 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.732 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 3.6 p -168.05 119.76 0.84 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.127 -0.983 . . . . 0.0 110.393 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.78 3.4 5.48 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.884 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -105.64 -39.67 6.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.056 -1.261 . . . . 0.0 110.266 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 25' ' ' ALA . . . 72.62 147.84 0.09 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.327 -0.858 . . . . 0.0 110.837 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.79 134.22 10.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.713 -0.617 . . . . 0.0 110.768 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 131.82 1.51 4.56 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 39.6 mm-40 -146.45 130.61 17.44 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.87 -1.371 . . . . 0.0 110.896 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.687 HG23 ' OG1' ' A' ' 54' ' ' THR . 0.2 OUTLIER -96.72 171.67 8.38 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.879 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.547 ' CD1' ' O ' ' A' ' 30' ' ' THR . 61.3 m-85 -151.61 172.54 15.9 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.871 -1.143 . . . . 0.0 111.028 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 52' ' ' SER . 61.4 m-85 -144.31 109.46 5.07 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.443 -0.785 . . . . 0.0 109.752 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.699 HD11 HD21 ' A' ' 93' ' ' LEU . 5.6 tt -88.41 132.68 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.213 -0.929 . . . . 0.0 110.451 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.58 167.63 25.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.203 -0.936 . . . . 0.0 110.426 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.455 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 10.5 pt20 -126.56 141.81 51.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.315 -0.865 . . . . 0.0 109.991 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -143.38 157.71 44.24 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.979 -1.076 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.748 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -144.19 157.05 57.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.37 159.13 54.91 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 123.741 1.39 . . . . 0.0 110.792 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.01 HG22 ' O ' ' A' ' 42' ' ' GLN . 32.5 m -130.38 -158.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.478 -0.763 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.52 32.23 4.27 Favored Glycine 0 C--N 1.279 -2.617 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -173.94 -52.38 0.05 OUTLIER Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.365 -1.398 . . . . 0.0 111.058 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 1.01 ' O ' HG22 ' A' ' 39' ' ' VAL . 5.3 mm100 -141.24 -157.45 0.77 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.121 -1.223 . . . . 0.0 110.76 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -106.04 122.24 45.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.177 -0.952 . . . . 0.0 110.059 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.869 ' HB2' HG11 ' A' ' 81' ' ' VAL . . . -111.29 139.29 46.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 8.7 t -123.49 144.51 49.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.176 -0.953 . . . . 0.0 110.506 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.453 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 32.0 t-20 -71.67 122.97 88.67 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.26 -0.9 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.539 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 52.4 Cg_endo -83.47 -39.11 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.932 1.491 . . . . 0.0 110.953 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.88 -56.92 15.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.426 -0.796 . . . . 0.0 110.766 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.8 p -56.87 -14.53 3.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.642 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 47' ' ' PRO . . . -56.98 137.28 55.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 110.768 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.628 HG23 HG22 ' A' ' 33' ' ' ILE . 13.0 t -147.03 165.9 28.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.589 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -130.95 152.91 49.75 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.874 -1.142 . . . . 0.0 111.82 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 31' ' ' TYR . 32.3 p90 -149.12 146.25 27.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.502 -0.749 . . . . 0.0 109.779 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.687 ' OG1' HG23 ' A' ' 30' ' ' THR . 76.2 m -108.75 155.27 20.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.975 -1.078 . . . . 0.0 110.771 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.884 HG21 ' HB3' ' A' ' 25' ' ' ALA . 1.2 p -65.42 -157.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.305 -0.872 . . . . 0.0 109.606 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.94 -159.78 1.08 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.818 -1.176 . . . . 0.0 110.478 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.06 62.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.156 -0.965 . . . . 0.0 109.743 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 t -85.46 13.69 6.45 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.424 -0.797 . . . . 0.0 108.854 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 60.58 27.35 65.98 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -110.83 114.16 27.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.345 -1.091 . . . . 0.0 110.35 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.502 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -117.56 88.63 2.95 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.2 p -102.29 125.99 49.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.487 -0.758 . . . . 0.0 109.395 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -154.01 176.19 12.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.957 . . . . 0.0 111.079 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 t -100.22 129.89 46.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.468 -0.77 . . . . 0.0 110.362 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 55.1 t80 -118.45 177.91 4.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 109.307 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.555 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -125.77 154.99 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.811 -1.181 . . . . 0.0 110.389 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.416 HG11 HG11 ' A' ' 18' ' ' VAL . 5.6 m -132.7 171.69 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.822 . . . . 0.0 109.704 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.89 139.21 23.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.984 . . . . 0.0 110.282 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.529 ' HA ' ' CE2' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -77.39 -47.71 19.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.339 -0.851 . . . . 0.0 110.204 179.991 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -122.95 136.1 54.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.847 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -163.36 157.05 19.56 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 3.2 m -69.48 111.14 5.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.425 -0.797 . . . . 0.0 109.992 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.29 162.75 54.3 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.433 ' N ' ' HB1' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -176.54 158.25 1.74 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.111 -1.229 . . . . 0.0 110.75 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.566 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 43.8 p -70.85 171.26 8.68 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.451 -0.78 . . . . 0.0 109.514 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 46.4 Cg_endo -74.73 -7.89 19.82 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.473 1.249 . . . . 0.0 110.931 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -96.78 -59.36 1.82 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.061 -1.025 . . . . 0.0 110.14 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.86 55.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -129.72 108.6 17.12 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.226 -1.161 . . . . 0.0 110.154 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.74 78.94 2.0 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.931 1.49 . . . . 0.0 110.574 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.869 HG11 ' HB2' ' A' ' 44' ' ' ALA . 10.7 p -57.89 -22.37 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 110.104 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.52 152.02 5.55 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.4 p -58.76 172.87 0.47 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.256 -1.144 . . . . 0.0 110.034 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 37' ' ' ALA . 55.2 t -141.4 155.84 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -0.903 . . . . 0.0 110.318 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -144.36 139.83 28.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.863 . . . . 0.0 110.126 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -100.73 2.44 41.35 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 110.178 -179.97 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.34 -60.5 2.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.881 . . . . 0.0 110.622 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.8 t -91.94 -20.89 20.92 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.207 -0.933 . . . . 0.0 110.731 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.63 -176.16 3.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.578 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.26 147.13 45.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.345 -0.847 . . . . 0.0 110.1 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.7 m -120.61 156.3 31.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.175 -0.953 . . . . 0.0 110.436 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 18.5 p30 -136.69 143.44 43.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 109.947 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.699 HD21 HD11 ' A' ' 33' ' ' ILE . 1.5 tp -105.62 135.79 46.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.249 -0.907 . . . . 0.0 109.998 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.701 ' HA3' ' CD2' ' A' ' 104' ' ' HIS . . . -131.69 149.46 19.32 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -137.15 155.77 49.18 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.502 -0.999 . . . . 0.0 109.899 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.27 164.61 13.25 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.458 ' CG ' ' N ' ' A' ' 98' ' ' SER . 4.6 t-20 -113.42 173.45 6.4 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.248 -1.148 . . . . 0.0 109.857 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.458 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 88.9 p -66.09 89.32 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.152 -0.968 . . . . 0.0 109.943 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 131.69 -20.4 4.61 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 101' ' ' ASP . 1.2 tt -111.37 161.21 16.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.395 -1.062 . . . . 0.0 110.055 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.591 ' N ' HD23 ' A' ' 100' ' ' LEU . 4.6 p-10 -148.57 98.25 2.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.214 -0.929 . . . . 0.0 110.368 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.2 mt -78.73 -70.14 0.52 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.294 -0.879 . . . . 0.0 110.131 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 164.1 -177.12 39.97 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.701 ' CD2' ' HA3' ' A' ' 94' ' ' GLY . 3.0 m80 -131.8 129.5 40.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -1.091 . . . . 0.0 110.03 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.889 HG11 HG12 ' A' ' 6' ' ' VAL . 46.0 t -93.39 116.8 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 110.473 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.56 128.95 39.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.39 -0.819 . . . . 0.0 110.086 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.509 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 74.8 mt -114.44 119.09 35.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 110.508 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.424 HG22 ' N ' ' A' ' 109' ' ' PHE . 23.6 m -98.57 169.37 9.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 109.932 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.529 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 10.7 m-85 -132.3 136.11 46.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.995 . . . . 0.0 110.326 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.995 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.829 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 120.771 0.32 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.829 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 47.5 Cg_endo -73.81 -172.62 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.013 1.533 . . . . 0.0 110.479 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.47 135.03 47.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.895 . . . . 0.0 110.162 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -150.56 107.44 3.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.789 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -146.13 153.07 40.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.096 -1.003 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.918 HG12 HG11 ' A' ' 105' ' ' VAL . 9.0 p -115.24 135.82 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.344 -0.847 . . . . 0.0 109.776 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -57.01 -67.63 0.8 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.056 -1.028 . . . . 0.0 110.262 -179.987 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 52.7 Cg_endo -75.69 87.94 1.34 Allowed 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.338 1.178 . . . . 0.0 109.956 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.61 -3.1 56.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.143 -0.973 . . . . 0.0 110.67 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.0 m -149.75 166.58 29.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.202 -0.936 . . . . 0.0 110.336 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.95 37.56 94.43 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 8' ' ' PRO . 40.5 mt -92.9 173.71 7.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.254 -1.144 . . . . 0.0 110.138 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.3 152.07 35.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 110.393 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 1.6 t70 -60.01 126.76 28.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 109.99 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.83 -33.27 5.65 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -56.61 149.47 17.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.345 -1.091 . . . . 0.0 109.893 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.01 134.07 47.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 110.663 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 65' ' ' PHE . 31.5 m -113.28 173.13 3.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.483 -0.76 . . . . 0.0 109.704 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -117.76 133.5 55.87 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.097 -1.002 . . . . 0.0 110.314 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.9 t -119.7 151.21 22.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.746 -0.596 . . . . 0.0 109.513 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.6 p -143.6 133.33 23.8 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 85.2 t -122.44 138.51 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.507 -0.746 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.8 m -150.02 80.1 1.37 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.861 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . -161.85 -71.55 0.02 OUTLIER Glycine 0 C--N 1.283 -2.386 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.477 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -56.09 -164.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -1.198 . . . . 0.0 109.902 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.577 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -160.39 157.77 28.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.143 -0.973 . . . . 0.0 110.387 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -36.14 118.55 0.53 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.602 -0.686 . . . . 0.0 110.633 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.56 -0.34 2.46 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -146.85 130.63 17.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.086 -1.244 . . . . 0.0 110.661 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.4 HG23 ' OG1' ' A' ' 54' ' ' THR . 37.9 m -107.27 121.8 45.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.701 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.651 ' HE1' HD13 ' A' ' 100' ' ' LEU . 52.2 m-85 -103.62 177.77 4.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.052 -1.03 . . . . 0.0 110.603 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.638 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 10.0 m-85 -132.81 116.69 16.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -0.892 . . . . 0.0 110.096 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.598 ' CG2' HG23 ' A' ' 51' ' ' THR . 0.5 OUTLIER -94.33 123.72 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.893 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.88 156.31 39.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.117 -0.99 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.694 ' OE1' HD12 ' A' ' 107' ' ' LEU . 0.3 OUTLIER -100.17 152.91 19.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.316 -0.865 . . . . 0.0 109.532 179.944 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 99.1 m -151.6 152.25 32.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.062 -1.024 . . . . 0.0 110.934 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.793 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.41 145.79 19.01 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.476 -0.765 . . . . 0.0 109.292 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.74 161.03 42.66 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.79 1.416 . . . . 0.0 110.989 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.685 HG12 HG22 ' A' ' 84' ' ' VAL . 33.8 m -127.09 -166.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.471 -0.768 . . . . 0.0 110.17 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.13 28.26 5.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.595 ' H ' HG23 ' A' ' 39' ' ' VAL . . . -149.88 -58.95 0.01 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.448 ' HG2' ' C ' ' A' ' 41' ' ' GLY . 20.7 mm100 -145.62 -121.8 0.07 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.207 -1.172 . . . . 0.0 110.02 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -129.0 147.51 50.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.994 -1.066 . . . . 0.0 110.067 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.94 164.94 24.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.133 -0.979 . . . . 0.0 110.028 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.3 m -143.74 -178.74 6.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.27 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 7.4 m-80 -105.59 76.14 0.34 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 0.0 110.319 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 43.2 Cg_endo -69.32 -41.3 4.97 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.987 1.519 . . . . 0.0 110.324 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.98 -34.95 74.0 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.38 -0.825 . . . . 0.0 110.005 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.9 34.2 5.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.856 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -86.33 103.67 15.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.014 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.598 HG23 ' CG2' ' A' ' 33' ' ' ILE . 10.0 t -102.37 167.65 9.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 0.0 110.502 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 2.4 m -143.99 162.94 34.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.955 . . . . 0.0 110.673 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 51.5 p90 -143.27 -177.13 5.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.4 ' OG1' HG23 ' A' ' 30' ' ' THR . 50.0 m -146.19 149.9 34.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.348 -0.845 . . . . 0.0 109.746 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.494 HG21 ' N ' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -64.22 -174.77 0.13 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.04 -1.038 . . . . 0.0 109.707 -179.978 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.736 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -146.8 -147.77 0.23 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.96 -1.088 . . . . 0.0 110.806 -179.903 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.585 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -83.02 71.24 10.12 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.15 0.976 . . . . 0.0 109.255 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER 152.7 -14.58 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.577 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 75.57 28.68 60.95 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.42 129.66 56.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.226 -1.161 . . . . 0.0 110.015 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -131.99 86.24 2.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.317 -0.864 . . . . 0.0 110.641 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.39 111.85 24.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.848 . . . . 0.0 109.412 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 19.2 p90 -143.58 178.56 7.7 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.084 -1.01 . . . . 0.0 110.967 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.1 p -98.98 125.54 44.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.469 -0.769 . . . . 0.0 110.247 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.671 ' O ' HG22 ' A' ' 18' ' ' VAL . 8.3 t80 -120.65 139.92 52.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.37 156.43 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.891 -1.131 . . . . 0.0 110.473 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.416 HG13 HG22 ' A' ' 18' ' ' VAL . 26.8 m -124.97 151.82 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.539 -0.726 . . . . 0.0 110.077 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.01 107.04 10.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 110.408 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.566 ' HB2' ' CE1' ' A' ' 109' ' ' PHE . 4.4 ttpt -55.39 -49.61 71.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.643 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.0 m -114.15 132.43 56.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -0.8 . . . . 0.0 109.905 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 71' ' ' TYR . 23.4 p90 -150.36 146.7 26.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.2 m -68.62 129.75 40.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 110.036 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.25 148.52 18.43 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.7 p -171.75 178.65 3.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.293 -1.122 . . . . 0.0 110.345 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.2 p -101.61 163.11 18.49 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.208 -0.932 . . . . 0.0 110.263 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.04 -4.78 15.26 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.076 1.566 . . . . 0.0 110.668 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.43 -58.17 2.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.216 -0.927 . . . . 0.0 110.334 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.08 56.92 0.02 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.6 m -139.57 95.71 8.87 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.345 -1.091 . . . . 0.0 110.128 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.12 100.81 1.33 Allowed 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.059 1.558 . . . . 0.0 110.495 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.0 m -71.6 -26.69 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.195 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.33 -172.05 22.89 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.3 p -88.62 149.35 23.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -1.204 . . . . 0.0 110.095 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.685 HG22 HG12 ' A' ' 39' ' ' VAL . 84.0 t -119.06 147.08 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 110.167 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -137.04 137.23 39.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.176 -0.952 . . . . 0.0 110.697 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 62.6 m -92.1 7.8 40.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.725 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.01 -62.0 1.74 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 110.5 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.9 t -104.65 14.31 30.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.192 -0.943 . . . . 0.0 110.432 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.17 -167.94 1.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.234 -0.916 . . . . 0.0 110.055 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.06 98.97 4.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 110.325 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.793 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 12.0 p -108.03 151.44 25.83 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.928 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -127.47 158.7 36.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.732 ' HB2' HD11 ' A' ' 107' ' ' LEU . 10.0 tp -109.03 121.61 45.5 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.565 ' HA3' ' ND1' ' A' ' 104' ' ' HIS . . . -126.87 157.91 20.7 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.592 -1.29 . . . . 0.0 110.341 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -132.37 161.44 33.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -1.062 . . . . 0.0 110.082 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.848 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 138.73 -171.35 23.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 98' ' ' SER . 6.1 p-10 -109.25 -46.09 3.63 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.021 -1.282 . . . . 0.0 110.362 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER 174.19 -27.66 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.207 -0.933 . . . . 0.0 110.446 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.86 3.95 4.23 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.305 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.651 HD13 ' HE1' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -84.87 -42.08 15.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.945 -1.326 . . . . 0.0 110.174 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 100' ' ' LEU . 17.4 t0 65.44 81.07 0.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.326 -0.859 . . . . 0.0 110.261 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.848 HD12 ' HA2' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -79.77 -63.88 1.31 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 110.146 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.11 162.48 29.4 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.565 ' ND1' ' HA3' ' A' ' 94' ' ' GLY . 93.3 m-70 -138.57 113.24 9.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.518 -0.989 . . . . 0.0 109.686 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.918 HG11 HG12 ' A' ' 6' ' ' VAL . 94.1 t -101.59 113.97 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.226 -0.921 . . . . 0.0 110.795 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.17 139.1 55.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.107 -0.996 . . . . 0.0 109.321 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.732 HD11 ' HB2' ' A' ' 93' ' ' LEU . 80.7 mt -115.34 167.91 10.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.957 -1.089 . . . . 0.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 109' ' ' PHE . 19.2 m -149.1 175.35 11.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 109.975 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 69' ' ' LYS . 43.3 m-85 -147.45 102.37 3.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.375 -0.828 . . . . 0.0 110.2 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.966 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.806 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.806 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 46.2 Cg_endo -73.07 -176.25 2.32 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.947 1.498 . . . . 0.0 110.315 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -135.98 138.15 41.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.073 -1.017 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -152.0 108.82 3.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.307 -0.871 . . . . 0.0 109.675 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 t -148.69 161.22 42.19 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.972 -1.08 . . . . 0.0 111.161 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.669 HG22 ' HD2' ' A' ' 8' ' ' PRO . 8.1 p -121.67 147.54 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.534 -0.729 . . . . 0.0 109.859 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.611 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -55.91 -67.56 0.73 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 120.84 -1.163 . . . . 0.0 109.064 179.975 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.669 ' HD2' HG22 ' A' ' 6' ' ' VAL . 52.9 Cg_endo -76.94 129.71 10.83 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 O-C-N 123.473 1.249 . . . . 0.0 109.552 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.1 26.74 2.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.936 -1.102 . . . . 0.0 110.263 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.07 145.79 0.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.032 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.01 58.88 10.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 8' ' ' PRO . 20.5 mt -105.81 175.11 5.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.255 -1.144 . . . . 0.0 110.41 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.6 t -133.09 148.15 52.17 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.251 -0.906 . . . . 0.0 110.403 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.541 ' HB3' ' CB ' ' A' ' 69' ' ' LYS . 29.9 p30 -57.33 119.89 7.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 110.459 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.14 -35.34 5.11 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -47.62 148.65 1.41 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.028 -1.278 . . . . 0.0 110.428 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.586 ' C ' HG13 ' A' ' 18' ' ' VAL . 2.6 p -97.36 177.24 5.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 110.155 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.606 HG12 ' CG ' ' A' ' 8' ' ' PRO . 29.3 m -156.47 169.66 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.277 -0.889 . . . . 0.0 110.077 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 m -114.8 121.23 42.66 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.2 -0.938 . . . . 0.0 109.76 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 t -105.86 142.04 19.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.419 -0.8 . . . . 0.0 109.969 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.1 m -138.56 126.3 22.23 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.492 -0.755 . . . . 0.0 110.004 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 55.7 t -117.97 127.46 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.649 -0.657 . . . . 0.0 110.39 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.8 108.84 8.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.173 -0.955 . . . . 0.0 109.957 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 150.47 -82.38 0.18 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.501 ' O ' ' CA ' ' A' ' 59' ' ' GLY . . . -42.41 131.08 3.8 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.265 -1.138 . . . . 0.0 109.836 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.562 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -103.74 158.93 16.04 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.093 -1.005 . . . . 0.0 111.972 -179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.34 141.95 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.554 0.692 . . . . 0.0 111.07 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.11 7.28 4.11 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.577 ' CG ' ' CZ ' ' A' ' 31' ' ' TYR . 14.8 tp10 -161.92 136.58 7.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.923 -1.339 . . . . 0.0 111.223 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 53' ' ' PHE . 68.8 m -104.47 124.43 49.25 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.764 ' CD1' HD11 ' A' ' 102' ' ' LEU . 76.2 m-85 -103.13 172.96 6.52 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 111.55 -179.826 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.531 ' CE1' ' OG ' ' A' ' 52' ' ' SER . 96.3 m-85 -124.13 100.25 6.63 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.768 HG23 ' O ' ' A' ' 33' ' ' ILE . 5.7 tt -86.59 104.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.12 -0.988 . . . . 0.0 109.863 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.624 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -148.83 166.24 29.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.446 -0.784 . . . . 0.0 110.478 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.604 ' CD ' HD12 ' A' ' 107' ' ' LEU . 8.1 mt-30 -97.82 144.33 27.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 109.782 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.8 m -145.27 151.22 38.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.01 . . . . 0.0 110.952 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -148.78 164.6 20.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.585 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 41.6 Cg_endo -69.15 162.35 42.11 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.788 1.415 . . . . 0.0 110.605 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 40' ' ' GLY . 8.2 p -141.73 174.72 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.468 -0.77 . . . . 0.0 110.17 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.526 ' N ' HG22 ' A' ' 39' ' ' VAL . . . -49.21 -46.03 34.57 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.35 -67.58 1.96 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -163.49 -72.58 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.307 -1.114 . . . . 0.0 110.029 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 5.8 p30 -132.33 158.57 41.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 110.208 179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.67 165.4 33.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.975 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.498 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.8 m -141.77 168.12 20.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.179 -0.951 . . . . 0.0 110.236 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.51 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 0.3 OUTLIER -100.86 100.35 12.54 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.172 -179.976 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.0 Cg_endo -72.78 -34.61 6.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.013 1.533 . . . . 0.0 110.416 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.09 92.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 110.3 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.3 p -98.57 25.41 6.44 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.333 -0.854 . . . . 0.0 109.994 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -86.49 110.75 19.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.915 . . . . 0.0 110.302 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.582 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 7.5 t -116.32 133.45 56.01 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.319 -0.863 . . . . 0.0 110.018 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.531 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 12.2 t -108.77 137.79 46.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.279 -0.888 . . . . 0.0 110.58 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 30.3 p90 -135.38 -177.98 4.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 110.016 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 40.3 m -138.29 152.88 48.94 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.317 -0.865 . . . . 0.0 109.761 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.632 HG23 ' HE2' ' A' ' 31' ' ' TYR . 2.5 p -61.58 -162.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.942 -1.099 . . . . 0.0 109.963 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.612 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 3.0 t70 -143.43 -164.26 1.83 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.06 -1.025 . . . . 0.0 110.675 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.81 82.82 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.097 -1.002 . . . . 0.0 108.831 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -90.25 16.27 8.92 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 55.45 30.48 55.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.81 133.88 52.98 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.459 -1.024 . . . . 0.0 110.341 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.52 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -137.57 84.97 2.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.268 -0.895 . . . . 0.0 110.683 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.66 112.71 25.6 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.268 -0.895 . . . . 0.0 109.149 179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -145.91 179.53 7.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.106 -0.996 . . . . 0.0 111.024 -179.771 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -93.9 145.44 24.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.572 -0.705 . . . . 0.0 110.565 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.542 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 52.6 t80 -139.64 177.18 8.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.435 -0.791 . . . . 0.0 109.593 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.542 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 21.6 t -132.08 165.23 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.825 -1.172 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 66' ' ' VAL . 13.5 m -141.33 129.22 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.452 -0.78 . . . . 0.0 110.098 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -108.58 144.79 35.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 110.259 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.541 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 20.6 ttpt -68.95 -39.7 79.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.077 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 p -132.8 155.12 49.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.548 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 13.4 p90 -162.17 147.58 12.9 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.149 -0.97 . . . . 0.0 110.661 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 m -60.17 113.6 2.44 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.354 -0.841 . . . . 0.0 110.367 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.513 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -99.14 150.31 19.22 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.9 m -138.26 152.25 48.39 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.151 -1.206 . . . . 0.0 110.215 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.484 HG23 ' CG2' ' A' ' 81' ' ' VAL . 68.8 p -69.48 165.58 38.87 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.335 -0.853 . . . . 0.0 110.209 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 47.0 Cg_endo -74.14 -22.64 16.64 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.916 1.482 . . . . 0.0 110.583 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -15.88 63.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.21 -0.931 . . . . 0.0 110.226 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.65 37.71 3.64 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.0 m -135.59 122.29 14.47 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.227 -1.161 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.01 127.1 9.77 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.912 1.48 . . . . 0.0 110.188 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.484 ' CG2' HG23 ' A' ' 75' ' ' THR . 5.9 t -102.18 -35.97 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 110.176 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 173.11 -150.95 12.83 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 m -108.69 138.83 44.38 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.303 -1.116 . . . . 0.0 110.31 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.513 ' CG2' ' HA3' ' A' ' 73' ' ' GLY . 58.9 t -92.49 133.6 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.81 . . . . 0.0 109.665 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -113.38 135.72 53.55 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.99 -1.069 . . . . 0.0 110.117 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 1.3 t -85.26 1.07 49.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.69 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.54 -61.66 1.72 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.085 -1.009 . . . . 0.0 110.547 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.3 t -84.56 -16.74 41.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.215 -0.928 . . . . 0.0 110.384 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.04 158.7 22.74 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.142 -0.974 . . . . 0.0 110.265 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.84 144.7 27.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.083 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 3.7 m -125.01 129.52 50.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.24 -0.913 . . . . 0.0 110.098 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 92' ' ' ASN . 1.8 m120 -111.62 127.68 55.82 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 110.014 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.624 HD12 ' O ' ' A' ' 34' ' ' ALA . 15.1 tp -93.23 108.9 20.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.92 . . . . 0.0 109.216 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -128.88 170.87 19.93 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.25 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -140.13 123.42 16.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -1.022 . . . . 0.0 109.866 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.93 166.59 36.29 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.492 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 5.1 p-10 -100.54 -43.39 6.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -1.113 . . . . 0.0 110.288 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 43.0 t -179.41 -43.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.18 -0.95 . . . . 0.0 110.627 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.67 27.45 3.21 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.512 HD22 ' HE1' ' A' ' 31' ' ' TYR . 3.4 tt -111.84 -44.57 3.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -1.187 . . . . 0.0 110.061 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.8 96.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.342 -0.848 . . . . 0.0 110.249 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.764 HD11 ' CD1' ' A' ' 31' ' ' TYR . 43.6 mt -83.68 -41.1 18.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -0.906 . . . . 0.0 110.258 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.99 162.24 12.97 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -145.5 122.06 11.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.519 -0.989 . . . . 0.0 109.751 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.502 HG11 HG12 ' A' ' 6' ' ' VAL . 91.5 t -96.86 113.92 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.541 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.4 117.84 6.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 109.812 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.604 HD12 ' CD ' ' A' ' 35' ' ' GLN . 83.5 mt -93.52 144.43 25.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.249 -0.907 . . . . 0.0 110.516 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 m -127.18 162.14 26.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 110.288 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.472 ' CD2' ' HG3' ' A' ' 69' ' ' LYS . 6.6 m-85 -135.72 126.62 27.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.202 -0.937 . . . . 0.0 110.058 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 118.036 -1.424 . . . . 0.0 109.611 179.897 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.4 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.755 0.312 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.506 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 47.3 Cg_endo -72.74 -163.66 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.909 1.478 . . . . 0.0 110.495 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -148.31 148.7 30.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.899 . . . . 0.0 110.411 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 17.1 t80 -148.24 115.45 6.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.305 -0.872 . . . . 0.0 109.76 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 t -143.55 153.45 42.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.991 -1.068 . . . . 0.0 111.092 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.532 HG22 ' HD2' ' A' ' 8' ' ' PRO . 4.8 p -131.27 168.81 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.516 -0.74 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.645 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -93.22 -63.1 0.16 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.864 -1.147 . . . . 0.0 110.329 179.965 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.645 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 55.2 Cg_endo -84.66 99.9 0.74 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 O-C-N 123.159 1.084 . . . . 0.0 110.08 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.03 -0.8 50.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.997 -1.065 . . . . 0.0 110.352 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.1 p -151.49 165.64 33.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.903 . . . . 0.0 109.95 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.09 64.27 3.91 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.44 ' O ' ' CE2' ' A' ' 109' ' ' PHE . 4.7 mt -117.03 139.63 50.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.412 -1.052 . . . . 0.0 110.337 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 15.0 t -100.96 158.72 15.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 110.241 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 4.4 p-10 -68.84 112.4 5.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 0.0 110.14 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.1 -24.92 21.9 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 37.6 tt0 -59.36 155.29 14.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.29 -1.123 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 18' ' ' VAL . 20.7 t -99.32 -179.17 4.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.478 -0.763 . . . . 0.0 110.245 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.794 HG23 ' HB3' ' A' ' 65' ' ' PHE . 14.0 m -154.55 176.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 0.0 110.045 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.5 m -118.25 123.73 46.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 110.094 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.27 151.3 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.155 -0.966 . . . . 0.0 110.299 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.9 m -140.62 123.35 16.25 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.406 -0.809 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 84.7 t -113.88 132.69 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 75.5 m -145.12 128.28 16.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.041 . . . . 0.0 110.59 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 140.02 -57.39 0.6 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.76 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -54.63 -167.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -1.163 . . . . 0.0 109.741 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.551 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -159.35 156.14 28.03 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.032 -1.043 . . . . 0.0 110.669 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.7 121.87 1.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.644 -0.66 . . . . 0.0 110.968 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.76 10.56 3.91 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 4.4 mm-40 -146.36 119.07 8.59 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.071 -1.252 . . . . 0.0 110.843 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.417 HG23 ' OG1' ' A' ' 54' ' ' THR . 88.0 m -105.92 114.11 28.06 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.973 ' CE1' HD22 ' A' ' 100' ' ' LEU . 32.2 m-85 -96.85 -178.16 4.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.1 -1.0 . . . . 0.0 111.769 -179.804 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 31' ' ' TYR . 22.4 m-85 -134.54 124.43 25.48 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 33' ' ' ILE . 3.3 tt -105.41 119.66 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.904 -1.123 . . . . 0.0 110.991 -179.823 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . . . -152.96 171.85 17.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.331 -0.856 . . . . 0.0 110.01 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 6.1 pt20 -127.52 156.27 42.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.24 -0.913 . . . . 0.0 110.006 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 9.6 m -140.73 169.51 17.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.12 -0.988 . . . . 0.0 110.383 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.07 163.13 25.69 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.331 -0.856 . . . . 0.0 110.028 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -79.05 170.29 18.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.951 1.501 . . . . 0.0 110.635 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.874 HG23 ' H ' ' A' ' 42' ' ' GLN . 1.5 m -133.22 -169.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.335 -0.853 . . . . 0.0 110.305 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.79 34.03 4.21 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.46 -39.99 0.02 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.874 ' H ' HG23 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -157.19 -116.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -1.166 . . . . 0.0 110.301 -179.978 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -133.0 167.0 21.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.765 -1.209 . . . . 0.0 110.425 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -159.3 175.24 13.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.358 -0.839 . . . . 0.0 110.072 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 38.9 t -158.95 165.92 33.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.346 -0.846 . . . . 0.0 110.242 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.504 ' ND2' HG23 ' A' ' 49' ' ' THR . 57.1 t-20 -97.29 121.29 59.12 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.295 -0.878 . . . . 0.0 110.629 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -81.75 -33.41 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.936 1.493 . . . . 0.0 110.822 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.81 96.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.192 -0.943 . . . . 0.0 110.595 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.504 HG23 ' ND2' ' A' ' 46' ' ' ASN . 54.1 p -78.05 5.72 9.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 0.0 110.443 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.568 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -84.12 88.76 7.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 110.565 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.549 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 12.8 t -99.53 174.49 6.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.556 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 2.8 t -131.78 148.42 52.56 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.988 -1.07 . . . . 0.0 111.063 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 24.9 p90 -150.3 151.62 33.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.508 -0.745 . . . . 0.0 109.343 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.417 ' OG1' HG23 ' A' ' 30' ' ' THR . 10.4 m -119.84 155.54 32.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.028 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.76 HG21 ' CB ' ' A' ' 25' ' ' ALA . 3.8 p -67.13 -158.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.298 -0.876 . . . . 0.0 110.297 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 8.8 m-20 -143.75 -162.93 1.55 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.06 -1.025 . . . . 0.0 109.985 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.77 -40.21 96.13 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.096 -1.002 . . . . 0.0 109.188 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 t -90.27 10.77 23.43 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.516 -0.74 . . . . 0.0 109.507 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.551 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 59.35 61.06 7.71 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.59 135.18 23.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.282 -1.128 . . . . 0.0 110.088 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -137.13 84.92 2.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 110.92 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.11 118.31 36.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.115 -0.991 . . . . 0.0 108.619 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -151.98 179.55 8.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.952 -1.092 . . . . 0.0 110.908 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.6 p -89.6 157.16 18.15 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.544 -0.722 . . . . 0.0 110.156 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.794 ' HB3' HG23 ' A' ' 18' ' ' VAL . 34.4 t80 -138.41 177.43 7.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.423 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.435 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.5 t -135.87 155.18 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.817 -1.177 . . . . 0.0 110.108 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 12' ' ' LEU . 25.7 m -133.25 169.76 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.432 -0.792 . . . . 0.0 109.814 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 1.3 ttt85 -149.1 141.9 24.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.202 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -74.16 -48.07 31.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 110.22 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 95.4 p -119.9 144.75 47.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.933 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.543 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 21.5 p90 -162.01 142.79 10.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.112 -0.992 . . . . 0.0 110.693 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 54.1 m -55.66 122.29 11.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.304 -0.872 . . . . 0.0 109.877 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.1 168.78 13.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.9 t -157.95 153.01 25.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -1.065 . . . . 0.0 109.979 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.475 ' OG1' ' HB ' ' A' ' 79' ' ' THR . 57.0 p -56.55 162.21 3.58 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.095 -1.003 . . . . 0.0 110.199 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.22 -31.39 5.98 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.147 1.604 . . . . 0.0 110.383 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -68.8 -34.42 75.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.334 -0.854 . . . . 0.0 110.187 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.8 67.49 0.14 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.475 ' HB ' ' OG1' ' A' ' 75' ' ' THR . 11.4 m -150.77 106.33 3.05 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.183 -1.187 . . . . 0.0 110.019 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.35 136.87 27.24 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.075 1.566 . . . . 0.0 110.539 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.6 t -123.18 -76.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.333 -0.855 . . . . 0.0 110.271 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.12 -155.91 6.74 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 90.7 p -97.4 150.69 20.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.31 -1.112 . . . . 0.0 110.427 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.466 HG22 HG12 ' A' ' 39' ' ' VAL . 78.0 t -112.19 153.79 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.279 -0.888 . . . . 0.0 110.134 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -140.11 126.05 19.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 110.147 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 43.3 t -85.03 43.51 1.01 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.196 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.35 -52.13 5.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 110.193 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.6 t -101.28 1.08 38.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.124 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.36 -162.84 0.91 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.17 -0.956 . . . . 0.0 110.288 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.26 136.03 51.42 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.868 . . . . 0.0 110.151 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 2.3 p -125.05 127.79 47.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 110.071 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -107.89 165.75 11.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.377 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 107' ' ' LEU . 7.8 tp -128.54 110.71 12.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 109.544 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.642 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -116.28 162.58 12.59 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.298 -179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.39 167.87 13.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.978 . . . . 0.0 109.869 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 115.8 -166.05 12.24 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.403 ' CG ' ' N ' ' A' ' 98' ' ' SER . 7.9 t30 -147.59 168.71 21.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -1.177 . . . . 0.0 110.222 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.403 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 1.6 m -49.71 107.12 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 121.9 -46.69 1.09 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.973 HD22 ' CE1' ' A' ' 31' ' ' TYR . 0.4 OUTLIER -103.05 163.14 12.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -1.142 . . . . 0.0 110.135 179.987 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -146.68 131.25 17.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.333 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 4' ' ' PHE . 97.8 mt -106.96 -45.55 4.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.087 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.17 173.11 29.38 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.642 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 9.4 m80 -140.85 108.32 5.57 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.343 -1.092 . . . . 0.0 109.94 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.525 HG11 HG12 ' A' ' 6' ' ' VAL . 1.9 t -90.21 113.67 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.32 -0.863 . . . . 0.0 110.445 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.69 130.87 47.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.169 -0.957 . . . . 0.0 109.88 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.876 HD11 ' HB2' ' A' ' 93' ' ' LEU . 31.5 mt -100.29 166.61 10.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.1 -1.0 . . . . 0.0 110.175 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -137.03 161.52 35.85 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.282 -0.886 . . . . 0.0 110.013 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 7.2 m-85 -139.65 148.16 42.03 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.349 -0.844 . . . . 0.0 110.05 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.04 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.964 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.402 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.749 0.309 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.502 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 46.1 Cg_endo -71.28 -158.34 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.999 1.526 . . . . 0.0 110.145 179.962 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -147.06 124.81 11.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.103 -0.998 . . . . 0.0 110.427 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.514 ' HE2' HD12 ' A' ' 33' ' ' ILE . 14.1 t80 -138.76 114.6 10.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.408 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.455 ' HA ' HG21 ' A' ' 105' ' ' VAL . 34.2 t -150.43 172.24 15.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.987 -1.071 . . . . 0.0 110.943 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.546 HG23 HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -130.02 145.55 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.854 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.622 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -66.17 -66.99 1.07 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.974 -1.079 . . . . 0.0 109.906 179.993 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.799 ' O ' HD21 ' A' ' 12' ' ' LEU . 56.0 Cg_endo -79.27 69.47 7.91 Favored 'Trans proline' 0 N--CA 1.483 0.873 0 O-C-N 123.465 1.245 . . . . 0.0 110.081 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.41 -11.92 59.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.951 -1.093 . . . . 0.0 110.481 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.8 126.23 31.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 110.164 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.9 71.69 1.25 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.799 HD21 ' O ' ' A' ' 8' ' ' PRO . 91.5 mt -112.57 165.67 12.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -1.144 . . . . 0.0 110.077 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -133.22 148.56 52.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.152 -0.967 . . . . 0.0 110.487 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -60.43 129.5 41.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.887 . . . . 0.0 110.141 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.01 -30.56 5.79 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -57.26 151.96 14.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.362 -1.081 . . . . 0.0 110.411 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -101.97 135.03 44.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.389 -0.819 . . . . 0.0 110.088 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.525 HG11 HG11 ' A' ' 67' ' ' VAL . 18.2 m -100.95 171.25 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.981 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.96 114.09 24.16 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.028 -1.045 . . . . 0.0 109.968 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.546 HG22 HG23 ' A' ' 6' ' ' VAL . 17.6 t -101.6 149.27 6.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.264 -0.897 . . . . 0.0 110.297 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.0 t -150.02 128.18 12.0 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.483 -0.76 . . . . 0.0 110.183 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 52.4 t -120.71 137.69 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 109.887 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.719 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 2.3 p -150.52 111.0 4.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.957 -1.089 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 160.95 -52.14 0.34 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.583 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -60.27 -151.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -1.131 . . . . 0.0 110.096 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.531 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -167.83 163.51 14.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.137 -0.977 . . . . 0.0 110.545 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -50.24 128.75 20.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.557 -0.714 . . . . 0.0 111.059 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.432 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 122.36 7.94 7.34 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.526 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 5.7 mm-40 -141.3 129.72 22.49 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.093 -1.239 . . . . 0.0 110.687 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.568 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.7 m -115.02 151.94 33.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 109.324 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 30' ' ' THR . 7.9 m-85 -139.7 -178.16 5.29 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.902 -1.124 . . . . 0.0 111.298 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 52' ' ' SER . 55.4 m-85 -132.99 108.35 8.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.744 HG22 HG23 ' A' ' 51' ' ' THR . 4.1 tt -87.56 125.44 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.154 -0.966 . . . . 0.0 110.851 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.729 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -152.1 165.21 35.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.24 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.457 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 1.0 OUTLIER -118.05 150.85 38.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.204 -0.935 . . . . 0.0 110.029 179.986 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 72.2 m -150.8 164.65 35.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.897 . . . . 0.0 111.001 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.42 149.41 22.73 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.706 . . . . 0.0 109.495 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.52 164.42 32.93 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.839 1.442 . . . . 0.0 110.536 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 42' ' ' GLN . 17.4 m -134.32 57.22 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.333 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.57 -14.81 15.83 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -178.2 -48.22 0.07 OUTLIER Glycine 0 N--CA 1.492 2.433 0 O-C-N 120.688 -1.478 . . . . 0.0 110.671 179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.822 ' O ' HG22 ' A' ' 39' ' ' VAL . 1.8 tp60 -88.92 165.4 14.63 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.07 -1.253 . . . . 0.0 110.693 -179.875 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -98.95 127.44 44.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 110.039 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -110.52 150.71 28.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.155 -0.966 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.422 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.3 m -136.65 160.38 39.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.261 -0.899 . . . . 0.0 110.267 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -108.84 95.37 16.84 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.242 -0.911 . . . . 0.0 110.369 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 48.8 Cg_endo -76.55 -30.45 5.05 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.966 1.508 . . . . 0.0 110.452 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.84 -38.95 70.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.309 -0.869 . . . . 0.0 110.295 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.49 36.82 1.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.817 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.3 144.11 28.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.489 -0.757 . . . . 0.0 110.788 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.744 HG23 HG22 ' A' ' 33' ' ' ILE . 11.0 t -151.22 143.51 24.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.833 . . . . 0.0 109.736 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.496 ' HB3' ' CE1' ' A' ' 32' ' ' TYR . 12.2 p -109.76 151.61 26.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.083 -1.011 . . . . 0.0 110.532 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -151.14 136.22 17.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.52 ' OG1' HG23 ' A' ' 30' ' ' THR . 26.3 m -102.15 171.95 7.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.256 -0.902 . . . . 0.0 110.571 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.583 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -84.89 -160.89 0.52 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.301 -0.874 . . . . 0.0 110.222 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 1.6 m-20 -149.1 -157.88 0.86 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.205 -0.935 . . . . 0.0 109.827 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.7 -53.66 55.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.91 -1.119 . . . . 0.0 109.997 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 t -87.12 16.17 5.38 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.265 -0.897 . . . . 0.0 109.215 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 56.84 48.79 75.63 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.0 129.98 56.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.282 -1.128 . . . . 0.0 110.426 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.572 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -132.18 85.1 2.21 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.331 -0.856 . . . . 0.0 110.077 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.7 p -110.63 134.3 52.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 109.901 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 25.8 p90 -163.85 173.64 12.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.233 -0.917 . . . . 0.0 110.504 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 t -94.08 137.9 32.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.797 . . . . 0.0 110.446 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.485 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 55.8 t80 -127.39 -179.46 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.532 -0.73 . . . . 0.0 109.374 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.485 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.2 t -128.02 154.92 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.853 -1.154 . . . . 0.0 110.209 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 22.2 m -129.0 178.67 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.373 -0.83 . . . . 0.0 110.111 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 3.0 mtp180 -150.31 118.66 6.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.849 . . . . 0.0 110.313 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 11.2 ttmt -49.81 -36.71 27.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.197 -0.939 . . . . 0.0 109.773 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.64 141.81 31.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.902 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.469 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 24.2 p90 -151.67 141.76 22.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -66.51 136.93 56.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.173 -179.933 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.74 170.38 49.06 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 79' ' ' THR . 8.4 t -152.97 132.89 13.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -1.172 . . . . 0.0 110.231 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.523 ' OG1' ' CB ' ' A' ' 79' ' ' THR . 8.5 p -89.72 167.91 16.2 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.181 -0.949 . . . . 0.0 110.065 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 49.4 Cg_endo -77.74 8.12 3.56 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.019 1.536 . . . . 0.0 110.74 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.486 ' OE2' ' OG1' ' A' ' 79' ' ' THR . 0.4 OUTLIER -127.76 -28.35 2.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.092 -1.005 . . . . 0.0 110.403 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.413 ' C ' ' OG1' ' A' ' 79' ' ' THR . . . 137.47 81.65 0.1 Allowed Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.536 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.523 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 2.8 m -163.76 118.35 1.09 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.216 -1.167 . . . . 0.0 109.793 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.51 -14.27 36.62 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.863 1.454 . . . . 0.0 110.573 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.693 ' O ' HG12 ' A' ' 81' ' ' VAL . 93.6 t 49.33 21.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.231 -0.918 . . . . 0.0 110.344 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.64 -153.88 43.01 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.7 OUTLIER -102.16 139.1 38.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.498 -1.001 . . . . 0.0 110.841 -179.859 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.538 HG22 HG12 ' A' ' 39' ' ' VAL . 56.0 t -112.01 108.71 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 109.546 179.844 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -88.24 135.78 33.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 0.0 110.246 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 91' ' ' CYS . 7.5 m -110.79 41.82 1.72 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.88 -52.01 3.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 109.964 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -99.17 -9.24 24.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.861 . . . . 0.0 110.063 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.87 -133.41 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 109.935 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -151.05 97.26 2.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.082 -1.011 . . . . 0.0 110.807 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -88.51 113.41 24.07 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.184 -0.948 . . . . 0.0 109.048 179.914 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 16.6 p30 -113.48 129.73 56.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.972 -1.08 . . . . 0.0 111.293 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 34' ' ' ALA . 13.1 tp -99.43 111.13 23.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.366 -0.834 . . . . 0.0 109.373 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -125.43 171.92 17.39 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 102' ' ' LEU . . . -134.84 178.98 6.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -1.078 . . . . 0.0 110.021 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 138.48 157.56 7.45 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.42 ' OD1' ' HB2' ' A' ' 98' ' ' SER . 8.2 p30 -107.55 -29.19 9.33 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.28 -1.129 . . . . 0.0 110.328 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.42 ' HB2' ' OD1' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -172.18 -72.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.7 -10.7 32.37 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.54 ' CD2' ' CE1' ' A' ' 31' ' ' TYR . 21.5 tp -73.78 -64.59 0.97 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.02 -1.282 . . . . 0.0 110.196 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 92.3 m-20 55.29 103.33 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -79.01 -6.11 55.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 110.374 179.966 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 94' ' ' GLY . . . 106.97 -175.39 20.62 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.476 ' O ' ' ND1' ' A' ' 104' ' ' HIS . 34.2 p80 -148.7 132.22 16.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.251 -1.146 . . . . 0.0 110.132 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.455 HG21 ' HA ' ' A' ' 5' ' ' SER . 54.4 t -93.83 130.46 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.147 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.47 114.29 8.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 110.408 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HB3' HD12 ' A' ' 12' ' ' LEU . 34.7 mt -93.2 136.5 33.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.848 . . . . 0.0 110.354 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.594 HG22 ' N ' ' A' ' 109' ' ' PHE . 98.3 m -107.25 173.2 6.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.291 -0.88 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.594 ' N ' HG22 ' A' ' 108' ' ' THR . 7.6 m-85 -142.8 122.69 13.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.889 . . . . 0.0 110.292 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.973 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 120.747 0.308 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 47.1 Cg_endo -72.77 -162.58 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.115 1.587 . . . . 0.0 110.551 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -132.13 146.7 52.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.222 -0.924 . . . . 0.0 110.596 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 12.4 t80 -149.5 113.17 5.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.462 -0.774 . . . . 0.0 109.592 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.62 ' HA ' HG21 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -151.15 167.02 29.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.032 -1.042 . . . . 0.0 110.959 -179.9 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.646 HG12 HG11 ' A' ' 105' ' ' VAL . 7.5 p -128.25 141.05 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.725 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -55.88 -67.38 0.77 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.08 -1.012 . . . . 0.0 110.289 -179.965 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 49.5 Cg_endo -74.4 82.81 1.8 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.386 1.203 . . . . 0.0 109.807 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.65 1.99 52.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.975 . . . . 0.0 110.501 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.8 p -150.27 148.89 29.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.252 -0.905 . . . . 0.0 110.165 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.3 58.71 3.55 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mt -105.44 170.63 7.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.303 -1.116 . . . . 0.0 110.45 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.47 149.4 43.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 110.183 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.8 96.94 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.83 -34.06 3.23 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -54.22 142.89 24.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 110.143 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 66.3 m -91.68 134.09 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 110.069 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.614 HG11 HG11 ' A' ' 67' ' ' VAL . 23.2 m -100.88 148.86 6.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 110.168 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.21 106.1 18.11 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.34 -0.85 . . . . 0.0 109.309 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.525 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 36.9 t -93.37 149.74 4.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.499 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.75 119.27 5.63 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.857 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.85 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 23.8 t -107.08 132.51 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.771 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.673 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 30.3 m -127.77 120.36 27.72 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 148.75 -77.69 0.23 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.609 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -47.12 172.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.216 -1.167 . . . . 0.0 110.029 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.542 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -139.6 161.63 37.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 110.464 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -39.04 122.79 1.25 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.674 -0.641 . . . . 0.0 110.653 -179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.57 0.76 7.84 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.497 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 30.9 mm-40 -132.93 130.51 39.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -1.184 . . . . 0.0 110.597 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.427 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 57.5 m -106.34 161.25 14.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.503 -0.748 . . . . 0.0 109.659 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.72 ' HE1' HD22 ' A' ' 100' ' ' LEU . 80.1 m-85 -149.96 176.47 10.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.041 -1.037 . . . . 0.0 110.552 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 17.7 m-85 -122.78 147.62 46.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.456 -0.778 . . . . 0.0 109.093 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.585 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 5.2 tt -128.35 116.53 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.955 -1.091 . . . . 0.0 110.15 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.615 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -148.46 158.58 44.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.917 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.45 ' OE1' ' HB3' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -93.62 136.12 34.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.608 -0.682 . . . . 0.0 109.958 179.912 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.2 m -142.98 143.39 31.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.783 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -144.89 174.72 3.24 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.454 -0.778 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.783 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 43.1 Cg_endo -71.86 165.67 31.86 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.733 1.386 . . . . 0.0 110.351 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.4 p -146.41 84.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.297 -0.877 . . . . 0.0 110.366 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.28 3.8 54.23 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 143.11 -51.7 0.66 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.58 -141.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.367 -1.078 . . . . 0.0 110.006 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.36 127.76 7.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.106 -0.996 . . . . 0.0 110.405 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.473 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -117.37 151.9 36.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.35 -0.844 . . . . 0.0 109.895 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.49 ' O ' ' HA2' ' A' ' 73' ' ' GLY . 2.4 m -116.05 164.34 14.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.153 -0.967 . . . . 0.0 110.368 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.47 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 59.3 t-20 -96.0 123.2 56.17 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.275 -0.891 . . . . 0.0 110.174 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.76 -33.74 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.861 1.453 . . . . 0.0 110.681 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.45 -19.77 65.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.346 -0.846 . . . . 0.0 110.815 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.16 32.93 5.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.045 -1.035 . . . . 0.0 110.476 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.52 106.29 18.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.224 -0.922 . . . . 0.0 110.511 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.585 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 14.9 t -131.42 -178.57 4.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.0 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.4 ' CB ' ' CD1' ' A' ' 32' ' ' TYR . 55.6 p -144.12 147.19 33.4 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.115 -0.991 . . . . 0.0 110.839 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 20.6 p90 -136.09 -176.99 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.763 . . . . 0.0 109.539 179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.5 m -145.47 154.32 42.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.796 -1.19 . . . . 0.0 110.256 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.609 HG21 ' HB3' ' A' ' 25' ' ' ALA . 2.0 p -69.99 -158.02 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.209 -0.932 . . . . 0.0 109.915 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 3.3 m-20 -160.03 -155.67 0.45 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.902 -1.124 . . . . 0.0 110.148 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.14 78.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.918 -1.114 . . . . 0.0 109.527 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 t -79.29 4.99 13.51 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.379 -0.825 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 56.05 38.03 74.05 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -124.91 127.19 46.71 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.268 -1.136 . . . . 0.0 110.104 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.85 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -101.14 80.35 2.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 110.365 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.9 m -101.08 120.18 39.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.676 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.525 ' CE1' ' HB ' ' A' ' 20' ' ' VAL . 7.0 p90 -155.73 174.79 14.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.192 -0.942 . . . . 0.0 110.833 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.5 m -98.32 132.6 43.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 40.5 t80 -130.35 179.63 5.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.443 -0.786 . . . . 0.0 109.238 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.467 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.8 t -129.38 155.9 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.81 -1.181 . . . . 0.0 110.352 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.614 HG11 HG11 ' A' ' 18' ' ' VAL . 31.8 m -125.21 159.02 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.404 -0.81 . . . . 0.0 110.357 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -133.21 132.9 42.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.263 -0.898 . . . . 0.0 110.034 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -72.8 -10.83 60.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.137 -0.977 . . . . 0.0 110.362 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.2 p -150.29 139.37 21.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.131 -0.981 . . . . 0.0 110.536 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 9.6 p90 -168.09 138.76 2.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.299 -0.876 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.2 OUTLIER -68.68 137.34 54.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.258 -0.901 . . . . 0.0 110.091 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 45' ' ' CYS . . . -121.7 -166.48 12.88 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 p -158.88 -176.01 5.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -1.115 . . . . 0.0 110.138 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.4 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 1.2 p -75.69 168.49 27.28 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.36 -0.838 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 49.5 Cg_endo -80.2 14.57 1.91 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.058 1.557 . . . . 0.0 111.106 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' A' ' 78' ' ' GLY . 12.8 pt-20 -123.2 -41.09 2.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.947 -1.096 . . . . 0.0 110.358 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.522 ' N ' ' HG3' ' A' ' 77' ' ' GLU . . . 142.09 52.14 0.04 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.1 m -151.35 113.51 3.04 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.289 -1.124 . . . . 0.0 110.119 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.31 145.19 42.81 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.913 1.48 . . . . 0.0 110.693 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.452 HG13 ' N ' ' A' ' 82' ' ' GLY . 6.2 p -138.86 -36.94 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 110.319 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.452 ' N ' HG13 ' A' ' 81' ' ' VAL . . . -162.98 -171.79 29.65 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.7 OUTLIER -105.79 176.1 5.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -1.147 . . . . 0.0 110.283 179.947 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 44' ' ' ALA . 74.0 t -125.21 159.1 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.383 -0.823 . . . . 0.0 110.21 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -154.75 146.61 23.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.882 . . . . 0.0 110.056 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.81 17.73 22.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 110.105 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.62 -42.78 61.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 110.674 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -117.74 -16.42 10.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.148 -0.97 . . . . 0.0 110.361 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.43 147.09 34.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.953 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.17 154.51 27.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 0.0 110.178 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.45 ' HB3' ' OE1' ' A' ' 35' ' ' GLN . 82.7 m -120.93 162.74 19.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 0.0 110.329 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -146.09 121.3 10.18 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.31 -0.868 . . . . 0.0 110.237 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 34' ' ' ALA . 45.2 tp -86.95 112.1 21.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.046 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -121.14 163.37 14.61 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.501 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 102' ' ' LEU . . . -132.42 159.07 40.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.551 -0.97 . . . . 0.0 110.507 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 101' ' ' ASP . . . 169.31 159.2 14.45 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 31' ' ' TYR . 11.9 p-10 -143.34 -41.14 0.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.991 -1.299 . . . . 0.0 111.246 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.43 78.01 1.2 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.951 -1.093 . . . . 0.0 111.294 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.45 9.24 29.97 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.72 HD22 ' HE1' ' A' ' 31' ' ' TYR . 1.6 tt -99.35 -51.33 3.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.285 . . . . 0.0 109.827 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.523 ' HA ' ' CA ' ' A' ' 96' ' ' GLY . 1.1 m-20 54.21 164.54 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.485 -0.759 . . . . 0.0 110.123 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 31.7 mt -126.36 -47.68 1.59 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.904 -179.984 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 167.35 174.35 36.36 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.416 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -129.56 126.77 39.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.851 -0.793 . . . . 0.0 109.652 -179.985 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.646 HG11 HG12 ' A' ' 6' ' ' VAL . 20.0 t -108.23 120.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.048 -1.032 . . . . 0.0 110.439 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.06 107.55 10.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.932 . . . . 0.0 109.382 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 12.6 mt -88.61 171.86 9.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.308 -0.87 . . . . 0.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -147.77 158.68 44.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.449 -0.782 . . . . 0.0 109.838 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -122.16 119.85 32.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.058 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.59 179.997 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.437 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.809 0.338 . . . . 0.0 110.138 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 1' ' ' ALA . 43.8 Cg_endo -69.3 -174.01 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.999 1.526 . . . . 0.0 110.49 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -154.04 121.77 5.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.897 . . . . 0.0 110.334 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -141.47 110.79 6.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.211 -0.931 . . . . 0.0 109.562 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.8 t -150.69 161.13 43.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.078 -1.014 . . . . 0.0 110.999 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.91 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 6.2 p -114.93 160.42 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.494 -0.754 . . . . 0.0 109.674 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -62.96 -66.52 1.5 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.048 -1.032 . . . . 0.0 110.561 -179.993 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.758 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 43.1 Cg_endo -73.54 -73.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.424 1.223 . . . . 0.0 110.591 -179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.91 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 75.26 -1.04 3.15 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.443 -0.786 . . . . 0.0 110.203 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.446 ' OG ' ' C ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER -164.21 145.42 8.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 110.248 -179.951 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.96 41.22 61.83 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 108' ' ' THR . 1.3 mp -90.78 174.79 7.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -1.164 . . . . 0.0 110.091 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 1.5 t -128.56 150.34 50.24 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.361 -0.837 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 6.2 p-10 -56.94 108.04 0.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.189 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.92 -35.19 5.09 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.4 tt0 -45.95 152.94 0.33 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.303 -1.116 . . . . 0.0 110.357 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 3.6 p -103.53 154.4 19.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.403 -0.811 . . . . 0.0 110.378 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.1 m -129.13 150.23 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.302 -0.874 . . . . 0.0 110.026 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 m -94.91 115.15 27.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.136 -0.978 . . . . 0.0 109.842 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t -100.8 147.65 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 2.8 t -146.06 139.3 25.95 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.47 -0.769 . . . . 0.0 110.469 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 47.6 t -128.29 153.59 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.526 -0.734 . . . . 0.0 110.007 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.56 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 7.3 m -165.89 120.89 1.23 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.946 -1.096 . . . . 0.0 110.672 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 25' ' ' ALA . . . 139.29 -59.98 0.58 Allowed Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.354 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.75 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -39.53 -47.9 1.95 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.199 -1.177 . . . . 0.0 110.985 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 25' ' ' ALA . . . 73.99 141.79 0.07 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.398 -0.814 . . . . 0.0 110.595 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -39.13 136.33 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.527 0.68 . . . . 0.0 110.866 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.01 12.55 4.36 Favored Glycine 0 N--CA 1.481 1.643 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -156.3 126.73 6.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.056 -1.261 . . . . 0.0 110.62 179.975 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.809 HG23 ' OG1' ' A' ' 54' ' ' THR . 1.6 m -94.1 143.11 26.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.463 -0.773 . . . . 0.0 109.858 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.618 ' CE1' HD22 ' A' ' 100' ' ' LEU . 25.7 m-85 -134.34 146.14 49.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.08 -1.012 . . . . 0.0 111.154 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.609 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 97.5 m-85 -113.86 124.48 52.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.389 -0.82 . . . . 0.0 109.05 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.763 ' CG2' HG23 ' A' ' 51' ' ' THR . 12.4 tt -96.3 120.44 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.83 -1.169 . . . . 0.0 110.652 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.477 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -152.07 153.29 33.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 110.142 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . 14.3 pt20 -121.41 150.39 41.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.111 -0.993 . . . . 0.0 110.288 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 96.6 m -152.02 164.28 37.53 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.202 -0.936 . . . . 0.0 111.095 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -153.06 158.47 32.86 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.662 -0.649 . . . . 0.0 109.978 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.01 173.11 8.83 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.792 1.417 . . . . 0.0 110.668 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.915 HG13 ' HB2' ' A' ' 42' ' ' GLN . 2.1 p -146.91 70.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.242 -0.912 . . . . 0.0 111.043 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.56 33.24 67.41 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.63 -44.24 1.55 Allowed Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.915 ' HB2' HG13 ' A' ' 39' ' ' VAL . 4.6 mm-40 -76.01 -154.94 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.421 -1.047 . . . . 0.0 109.845 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -136.44 153.03 51.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.027 -1.046 . . . . 0.0 110.637 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.48 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -140.17 151.17 45.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.455 -0.778 . . . . 0.0 109.741 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.505 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 0.8 OUTLIER -139.77 161.62 37.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 0.0 110.444 179.97 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -107.9 89.81 5.82 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.344 -0.848 . . . . 0.0 110.179 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 48.6 Cg_endo -76.27 -31.79 4.44 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.974 1.513 . . . . 0.0 110.681 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.3 -27.16 63.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.304 -0.873 . . . . 0.0 110.438 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 p -108.55 39.18 2.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 110.149 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.31 138.9 31.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 110.414 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.763 HG23 ' CG2' ' A' ' 33' ' ' ILE . 3.7 t -153.1 134.96 14.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.892 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.609 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 87.9 p -108.04 145.09 34.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.727 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 14.7 p90 -150.97 -175.75 5.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 109.586 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.809 ' OG1' HG23 ' A' ' 30' ' ' THR . 7.0 m -145.5 160.53 41.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.178 -0.951 . . . . 0.0 109.627 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.71 HG21 ' HB3' ' A' ' 25' ' ' ALA . 3.0 p -60.72 -162.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.94 -1.1 . . . . 0.0 109.966 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -143.19 -164.24 1.81 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.044 -1.035 . . . . 0.0 109.879 -179.981 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.11 67.02 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.036 -1.04 . . . . 0.0 109.414 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.2 p -89.73 18.28 5.71 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 59.13 29.38 65.44 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -105.99 123.82 48.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.293 -1.122 . . . . 0.0 110.499 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.761 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -126.5 85.12 2.34 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.6 p -106.15 124.94 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.235 -0.916 . . . . 0.0 109.699 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.639 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 4.8 p90 -153.89 177.03 11.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.076 -1.015 . . . . 0.0 110.645 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.39 141.31 28.87 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.5 -0.75 . . . . 0.0 110.625 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.432 ' C ' ' CG2' ' A' ' 66' ' ' VAL . 45.8 t80 -138.78 -174.75 3.92 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.432 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 3.2 t -147.22 161.54 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.824 -1.173 . . . . 0.0 110.242 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 26.7 m -133.64 -177.04 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.397 -0.814 . . . . 0.0 110.012 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 26.4 mtt180 -158.45 123.29 4.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.038 -1.039 . . . . 0.0 110.629 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.54 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 10.9 tttm -62.42 -43.59 98.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.867 . . . . 0.0 109.556 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m -127.97 118.88 24.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -131.24 143.63 50.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.953 . . . . 0.0 110.461 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.5 m -60.91 141.91 56.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.96 . . . . 0.0 109.885 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.48 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -127.76 154.76 19.84 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 p -141.21 162.17 36.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -1.062 . . . . 0.0 110.274 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.623 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 3.8 p -80.25 176.62 3.61 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.847 . . . . 0.0 109.561 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.623 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 46.3 Cg_endo -74.51 -25.21 13.16 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.751 1.395 . . . . 0.0 110.545 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -13.22 60.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 109.939 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.32 57.09 1.22 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 83.4 m -135.75 117.61 12.04 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.226 -1.161 . . . . 0.0 110.195 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.43 80.89 1.87 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.894 1.471 . . . . 0.0 110.372 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.2 t -57.65 -37.78 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.915 . . . . 0.0 110.233 179.879 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.36 -154.55 25.35 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 69.8 m -100.43 161.03 13.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.235 -1.156 . . . . 0.0 110.458 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.442 HG21 ' CB ' ' A' ' 44' ' ' ALA . 70.9 t -122.41 149.58 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.213 -0.929 . . . . 0.0 109.999 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -127.58 162.35 26.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.168 -0.957 . . . . 0.0 110.553 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 89' ' ' ALA . 19.1 m -106.36 -9.76 16.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 0.0 110.095 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.16 -52.55 9.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.345 -0.847 . . . . 0.0 110.334 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.6 t -71.36 -19.6 62.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.15 -0.969 . . . . 0.0 109.866 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 86' ' ' CYS . . . -133.12 -160.17 1.03 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.391 -0.818 . . . . 0.0 109.873 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.88 135.11 45.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.173 -0.955 . . . . 0.0 109.857 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 1.9 p -121.27 146.7 46.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.133 -0.979 . . . . 0.0 109.774 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -127.6 147.84 50.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.09 -1.006 . . . . 0.0 111.146 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 34' ' ' ALA . 8.0 tp -119.05 114.75 22.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.455 -0.778 . . . . 0.0 109.053 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -129.13 178.77 17.11 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.578 -1.296 . . . . 0.0 110.26 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -140.73 172.33 12.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.394 -1.062 . . . . 0.0 110.163 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 144.74 169.4 13.28 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' CG ' ' N ' ' A' ' 98' ' ' SER . 5.2 p30 -89.47 -45.19 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -1.187 . . . . 0.0 110.276 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.473 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER 171.54 -41.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.429 -0.795 . . . . 0.0 109.955 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.84 -12.41 22.52 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.618 HD22 ' CE1' ' A' ' 31' ' ' TYR . 1.1 tt -87.21 -65.83 0.97 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.196 -1.179 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 100' ' ' LEU . 13.9 t0 68.17 75.13 0.28 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.348 -0.845 . . . . 0.0 110.012 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.99 -36.53 28.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.335 -0.853 . . . . 0.0 110.45 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.44 170.37 13.13 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.439 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -135.31 125.74 26.66 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.216 -1.167 . . . . 0.0 109.91 179.983 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.48 124.54 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.985 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.07 125.52 25.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.246 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 107' ' ' LEU . 76.6 mt -95.84 164.99 12.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.291 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.566 ' O ' HD12 ' A' ' 12' ' ' LEU . 6.2 m -158.5 175.99 12.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.311 -0.868 . . . . 0.0 110.054 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.54 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 69.0 m-85 -142.64 152.0 42.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.308 -0.87 . . . . 0.0 110.277 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.039 -1.423 . . . . 0.0 109.598 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.557 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 47.7 Cg_endo . . . . . 0 C--O 1.215 -0.636 0 N-CA-C 110.226 -0.721 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.77 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -140.62 123.18 16.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 110.796 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.452 ' HD1' HG22 ' A' ' 22' ' ' VAL . 81.9 t80 -141.52 100.22 3.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.502 -0.749 . . . . 0.0 109.119 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.11 172.12 13.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 110.978 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 6' ' ' VAL . 5.2 p -137.02 128.44 42.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.642 -0.661 . . . . 0.0 109.612 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.635 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.1 m -46.62 -72.89 0.12 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.117 . . . . 0.0 110.221 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.635 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 53.0 Cg_endo -75.9 97.77 1.14 Allowed 'Trans proline' 0 N--CA 1.483 0.87 0 O-C-N 123.04 1.021 . . . . 0.0 110.031 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.32 4.4 41.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.13 -0.981 . . . . 0.0 110.25 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.6 p -155.57 167.7 29.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 110.245 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.39 42.22 97.37 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.541 ' O ' ' CE2' ' A' ' 109' ' ' PHE . 85.3 mt -90.43 136.83 32.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.303 -1.116 . . . . 0.0 110.137 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.487 ' HB2' ' OE1' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -110.75 156.53 20.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 110.459 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 8.1 p-10 -57.22 119.28 6.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.04 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.42 -35.5 4.86 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.487 ' OE1' ' HB2' ' A' ' 13' ' ' SER . 33.4 tt0 -48.72 142.65 5.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -1.116 . . . . 0.0 110.044 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 58.9 p -95.3 161.6 14.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.351 -0.843 . . . . 0.0 110.597 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.542 HG23 ' HB3' ' A' ' 65' ' ' PHE . 16.5 m -132.29 151.07 34.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.412 -0.805 . . . . 0.0 109.636 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 1.5 m -99.35 122.02 41.9 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.063 -1.023 . . . . 0.0 109.804 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.483 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 7.4 t -110.95 146.47 15.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.38 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.0 p -140.68 128.64 21.97 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.389 -0.819 . . . . 0.0 110.397 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.792 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 39.9 t -121.66 100.78 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.77 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.4 OUTLIER -130.23 110.21 11.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.978 . . . . 0.0 110.251 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 169.32 -50.71 0.21 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.922 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -59.97 -138.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -1.131 . . . . 0.0 109.883 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -179.11 164.56 1.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.976 -1.078 . . . . 0.0 110.347 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.804 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . . . -54.26 128.89 33.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.398 -0.814 . . . . 0.0 110.479 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 119.69 18.92 4.24 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 9.5 mm-40 -154.9 127.31 7.87 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.235 -1.156 . . . . 0.0 110.457 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.471 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -93.56 170.1 9.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.344 -0.848 . . . . 0.0 109.952 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 79.5 m-85 -152.94 155.44 37.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.416 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 78.8 m-85 -122.81 111.25 16.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.663 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.752 HG23 HG23 ' A' ' 51' ' ' THR . 5.4 tt -95.98 120.91 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.102 -0.999 . . . . 0.0 110.433 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.66 160.37 43.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.112 -0.992 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.522 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 25.3 tt0 -114.15 133.56 55.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.64 -0.662 . . . . 0.0 109.219 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 66.0 m -139.49 156.24 47.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.985 -1.072 . . . . 0.0 111.146 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.63 144.0 16.92 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 41.6 Cg_endo -69.97 159.95 51.38 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.819 1.431 . . . . 0.0 110.68 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 C--N 1.299 -1.618 0 O-C-N 121.517 -0.739 . . . . 0.0 110.02 -179.916 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 7.1 m-20 . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 121.286 0.565 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.442 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -144.89 151.69 39.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.18 -0.95 . . . . 0.0 110.321 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 m -131.23 155.11 47.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.309 -0.869 . . . . 0.0 110.199 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.465 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 36.2 t-20 -87.9 124.08 67.78 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.07 -1.019 . . . . 0.0 110.195 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -81.83 -41.06 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.898 1.473 . . . . 0.0 111.046 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.63 93.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.321 -0.862 . . . . 0.0 111.021 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 47.7 p -80.64 7.14 10.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.142 -0.974 . . . . 0.0 110.365 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.78 104.98 6.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 110.223 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.752 HG23 HG23 ' A' ' 33' ' ' ILE . 9.8 t -136.9 163.16 31.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.884 . . . . 0.0 110.197 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -132.8 162.19 32.13 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 110.241 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 46.6 p90 -151.23 171.06 18.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.439 -0.788 . . . . 0.0 109.659 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.6 m -130.97 155.99 45.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.137 -0.977 . . . . 0.0 110.139 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.922 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -88.75 176.11 7.22 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.095 -1.003 . . . . 0.0 110.187 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.804 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 11.0 t70 -177.13 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.183 -0.948 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.43 86.92 0.07 Allowed 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.212 -0.93 . . . . 0.0 109.13 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.95 15.95 8.8 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 79.1 52.27 4.97 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.07 149.22 28.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -1.168 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.792 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -163.53 78.37 0.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 110.526 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.8 m -101.55 130.28 47.81 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.294 -0.879 . . . . 0.0 109.706 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.483 ' CE1' ' CG1' ' A' ' 20' ' ' VAL . 1.7 p90 -153.32 171.3 18.79 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.005 -1.059 . . . . 0.0 111.086 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.1 m -92.94 125.51 37.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.449 -0.782 . . . . 0.0 110.642 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.542 ' HB3' HG23 ' A' ' 18' ' ' VAL . 28.8 t80 -118.47 -173.07 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.597 -0.689 . . . . 0.0 109.375 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 3.9 t -147.76 167.78 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 120.756 -1.215 . . . . 0.0 110.371 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 13.1 m -139.37 161.78 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 0.0 110.243 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -143.35 122.79 13.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.262 -0.899 . . . . 0.0 110.097 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ARG . 2.7 ttpt -45.63 -48.19 14.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.044 -1.035 . . . . 0.0 109.365 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 6.6 m -127.3 123.81 37.27 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.58 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 28.3 p90 -125.13 140.18 53.11 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.079 -1.013 . . . . 0.0 111.28 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 85.7 m -58.35 99.91 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.396 -0.815 . . . . 0.0 109.957 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.67 177.15 26.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.206 -1.173 . . . . 0.0 110.193 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 19.4 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.569 0.699 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 70' ' ' SER . 40.6 t -125.02 148.63 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 59.3 p30 -127.23 166.22 18.16 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.063 -1.023 . . . . 0.0 110.721 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -112.71 1.77 15.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.499 -0.751 . . . . 0.0 110.414 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.32 -58.26 4.66 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.69 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -81.64 -27.38 34.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.116 -0.99 . . . . 0.0 110.501 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.05 176.99 4.78 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.39 155.88 22.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.8 m -116.93 139.11 51.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 0.0 110.185 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -123.29 125.73 45.58 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 110.322 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -102.02 108.52 19.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.283 -0.886 . . . . 0.0 109.078 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.2 163.5 12.38 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.498 -1.334 . . . . 0.0 110.141 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.602 ' O ' HD12 ' A' ' 102' ' ' LEU . . . -155.16 118.27 4.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.449 -1.03 . . . . 0.0 109.872 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.61 -177.06 46.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -118.15 177.41 4.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -1.136 . . . . 0.0 110.265 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.0 t -70.64 -20.12 62.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.127 -0.983 . . . . 0.0 110.146 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.1 -44.05 5.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.755 HD13 ' C ' ' A' ' 100' ' ' LEU . 3.4 tm? -118.87 135.74 54.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.242 -1.152 . . . . 0.0 109.938 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.745 ' N ' HD13 ' A' ' 100' ' ' LEU . 41.0 m-20 -116.12 101.66 8.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.0 . . . . 0.0 110.322 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 95' ' ' ALA . 19.8 mt -66.03 -61.16 2.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 110.003 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.12 -173.98 30.46 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -148.26 150.38 33.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.466 -1.02 . . . . 0.0 110.117 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.504 HG11 HG12 ' A' ' 6' ' ' VAL . 12.0 t -107.77 126.02 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.329 -0.857 . . . . 0.0 110.335 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.9 114.06 10.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.914 . . . . 0.0 109.841 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.522 ' CD1' ' OE1' ' A' ' 35' ' ' GLN . 58.1 mt -81.4 147.03 30.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.94 . . . . 0.0 110.573 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -127.74 158.16 38.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.853 . . . . 0.0 110.096 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 13.1 m-85 -128.74 92.26 3.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.275 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.433 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 46.8 Cg_endo . . . . . 0 N--CA 1.481 0.786 0 N-CA-C 110.423 -0.645 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -162.14 115.5 1.79 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.88 . . . . 0.0 110.405 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -126.96 114.85 18.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.2 m -143.76 170.35 16.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.06 -1.025 . . . . 0.0 110.593 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.917 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 4.0 p -134.5 138.4 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.386 -0.821 . . . . 0.0 110.239 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.543 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -54.84 -57.13 20.79 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.357 -0.839 . . . . 0.0 110.962 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.762 ' HD2' HG22 ' A' ' 6' ' ' VAL . 42.4 Cg_endo -69.09 -87.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.864 1.455 . . . . 0.0 110.797 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.917 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 71.53 14.19 6.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.283 -0.885 . . . . 0.0 109.836 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.2 t -178.13 149.13 0.53 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.88 45.92 62.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' A' ' 8' ' ' PRO . 17.2 mt -98.79 174.3 6.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.326 -1.102 . . . . 0.0 110.231 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.81 159.72 44.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 110.12 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.53 ' HB3' ' CB ' ' A' ' 69' ' ' LYS . 1.5 p30 -59.76 116.33 3.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.265 -0.897 . . . . 0.0 110.206 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.41 -33.6 6.07 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -45.68 154.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -1.108 . . . . 0.0 110.106 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.521 ' O ' ' NE2' ' A' ' 16' ' ' GLN . 5.5 t -98.53 172.03 7.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.54 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.4 m -149.09 154.68 9.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.385 -0.822 . . . . 0.0 109.9 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.488 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 0.4 OUTLIER -111.6 114.83 28.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.257 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.7 t -103.72 152.01 6.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.323 -0.861 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 18.8 t -149.36 132.56 16.39 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.492 -0.755 . . . . 0.0 109.998 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.829 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 6.6 t -124.09 153.24 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 110.338 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.661 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 1.0 OUTLIER -161.29 120.01 2.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 131.26 4.85 3.93 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 1.001 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -103.61 -30.04 10.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.998 -1.295 . . . . 0.0 110.374 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.539 ' HA ' ' HA3' ' A' ' 59' ' ' GLY . . . 58.57 133.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.816 0.817 . . . . 0.0 111.43 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -39.08 141.63 0.29 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.538 0.685 . . . . 0.0 110.505 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.19 -10.11 13.44 Favored Glycine 0 C--N 1.288 -2.137 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.485 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 5.1 mm-40 -125.39 123.49 39.44 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.376 -1.073 . . . . 0.0 109.829 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.544 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 71.5 m -97.52 159.62 14.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.386 -0.821 . . . . 0.0 109.767 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 50.4 m-85 -147.38 153.16 39.3 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.192 -0.942 . . . . 0.0 110.344 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 52' ' ' SER . 88.1 m-85 -115.54 108.82 16.95 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 109.372 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.706 HD11 HD21 ' A' ' 93' ' ' LEU . 4.5 tt -98.39 128.35 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.124 -0.985 . . . . 0.0 110.73 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.57 152.0 32.31 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.306 -0.871 . . . . 0.0 110.458 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.4 135.06 33.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.845 . . . . 0.0 109.615 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.6 m -147.21 159.46 43.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 0.0 110.684 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.76 157.0 34.67 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.602 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 44.3 Cg_endo -72.39 163.38 38.78 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.751 1.395 . . . . 0.0 110.764 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 39' ' ' VAL . 16.7 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.699 0.762 . . . . 0.0 109.756 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 10.0 t70 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.211 0.529 . . . . 0.0 109.831 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.5 158.68 15.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.913 . . . . 0.0 110.427 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.2 168.04 15.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.291 -0.881 . . . . 0.0 110.186 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.525 ' OD1' ' CG ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -104.25 102.74 34.66 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 109.923 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.15 -29.28 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.986 1.519 . . . . 0.0 110.437 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.82 -27.44 68.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.365 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 40.0 p -111.29 30.31 7.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.394 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.3 128.32 34.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 109.929 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.655 ' CG2' HG23 ' A' ' 33' ' ' ILE . 9.0 t -138.22 131.94 31.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.96 . . . . 0.0 110.543 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.491 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 28.8 t -111.91 142.55 44.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.408 -0.808 . . . . 0.0 109.952 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 45.9 p90 -144.24 -174.98 4.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.316 -0.865 . . . . 0.0 110.342 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 55' ' ' THR . 28.2 m -150.01 151.34 33.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.95 . . . . 0.0 109.796 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 1.001 ' CG2' ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -56.19 -160.67 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.024 -1.048 . . . . 0.0 110.529 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.653 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 2.3 m-20 -153.92 -158.29 0.85 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.091 -1.006 . . . . 0.0 110.36 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.27 74.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.873 -1.142 . . . . 0.0 109.671 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.2 m -84.15 10.63 9.74 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.343 -0.848 . . . . 0.0 109.341 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 26' ' ' ALA . . . 52.5 53.76 30.56 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.81 113.3 13.33 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.242 -1.152 . . . . 0.0 110.086 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.829 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -101.54 80.93 2.11 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.396 -0.815 . . . . 0.0 109.806 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 62.1 p -114.67 125.97 54.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 110.118 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.4 p90 -154.59 176.07 12.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.314 -0.866 . . . . 0.0 110.575 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 89.6 p -97.63 119.26 35.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.488 -0.757 . . . . 0.0 110.485 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 51.6 t80 -115.93 174.78 5.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.336 -0.852 . . . . 0.0 109.621 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.562 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 12.6 t -125.48 163.97 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.909 -1.119 . . . . 0.0 110.419 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.91 173.79 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.269 -0.894 . . . . 0.0 110.216 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -148.72 151.29 34.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.292 -0.88 . . . . 0.0 110.125 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.53 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 6.7 tttt -83.93 -39.86 19.25 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.235 -0.916 . . . . 0.0 109.884 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.422 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 28.8 p -132.85 147.29 52.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 109.753 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 12.6 p90 -165.92 148.33 7.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.961 -1.087 . . . . 0.0 111.028 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 13.0 m -64.08 123.3 18.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.311 -0.868 . . . . 0.0 109.638 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.04 175.29 15.88 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.373 -1.075 . . . . 0.0 109.854 179.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.8 p . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.454 0.645 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.0 t -131.69 102.32 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.47 -0.769 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.422 ' OD1' ' HB2' ' A' ' 70' ' ' SER . 1.1 m-20 -88.94 141.02 28.84 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.844 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.97 15.07 28.37 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.365 -0.835 . . . . 0.0 110.407 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.55 -59.74 2.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 t -77.37 -20.08 55.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -103.64 -163.2 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.887 . . . . 0.0 110.126 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.84 144.45 45.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.317 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.57 133.69 53.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.198 -0.939 . . . . 0.0 109.895 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -142.53 132.98 25.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 110.594 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.706 HD21 HD11 ' A' ' 33' ' ' ILE . 16.5 tp -93.45 118.03 30.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.883 . . . . 0.0 109.247 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.592 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -112.43 152.04 17.95 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.447 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -148.59 134.53 19.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.585 -0.95 . . . . 0.0 109.872 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.53 165.65 32.47 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.781 -1.2 . . . . 0.0 110.145 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -83.58 -157.14 0.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -1.102 . . . . 0.0 110.088 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.7 t -82.11 -31.11 30.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 110.26 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.08 -15.32 4.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.526 HD13 ' N ' ' A' ' 101' ' ' ASP . 0.8 OUTLIER -100.32 125.35 46.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -1.159 . . . . 0.0 110.143 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.526 ' N ' HD13 ' A' ' 100' ' ' LEU . 3.9 p30 -109.33 115.9 30.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.159 -0.963 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 81.7 mt -80.48 -62.08 1.78 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.151 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.55 -179.03 42.29 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.445 -1.36 . . . . 0.0 110.512 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.592 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 1.5 m-70 -137.41 121.35 17.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.744 -0.856 . . . . 0.0 109.673 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -94.07 123.7 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 0.0 110.145 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.82 105.05 5.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 110.305 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.698 HD11 ' HB2' ' A' ' 93' ' ' LEU . 39.0 mt -78.5 132.25 37.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 110.164 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.06 149.71 39.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -110.27 169.4 8.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 110.198 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.563 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.889 ' CG ' HD23 ' A' ' 102' ' ' LEU . 45.8 Cg_endo . . . . . 0 C--O 1.214 -0.72 0 N-CA-C 109.906 -0.844 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -111.2 129.77 55.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.32 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 5.5 t80 -148.73 112.16 5.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.233 -0.917 . . . . 0.0 109.589 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.19 148.96 28.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 111.0 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 7' ' ' SER . 5.4 p -107.01 174.55 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.45 -0.781 . . . . 0.0 109.525 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.687 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -81.97 -70.54 0.15 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.987 -1.071 . . . . 0.0 109.969 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.687 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 56.1 Cg_endo -83.15 91.12 0.94 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 O-C-N 122.972 0.985 . . . . 0.0 109.906 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.34 -1.52 55.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.891 -1.131 . . . . 0.0 110.687 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.0 m -138.28 118.88 13.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.196 -0.94 . . . . 0.0 109.979 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.46 72.88 1.13 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.796 ' CD1' HD22 ' A' ' 107' ' ' LEU . 12.9 mt -95.3 167.41 11.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.327 -1.102 . . . . 0.0 110.41 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.568 ' HB2' ' CB ' ' A' ' 16' ' ' GLN . 51.7 m -115.42 140.75 48.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 110.358 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 24.1 p30 -65.09 128.28 35.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.33 -0.856 . . . . 0.0 110.811 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.1 -26.77 6.53 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.568 ' CB ' ' HB2' ' A' ' 13' ' ' SER . 29.9 tt0 -62.2 149.08 42.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.126 . . . . 0.0 110.72 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -96.35 146.76 24.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.455 -0.778 . . . . 0.0 110.15 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.421 HG12 ' HG2' ' A' ' 8' ' ' PRO . 27.4 m -118.33 156.49 20.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.26 -0.9 . . . . 0.0 109.892 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.35 124.57 38.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.185 -0.947 . . . . 0.0 109.919 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.3 t -111.08 145.67 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.231 -0.918 . . . . 0.0 109.824 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.6 127.29 18.07 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.387 -0.821 . . . . 0.0 110.351 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 98.1 t -124.97 137.39 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.293 -0.88 . . . . 0.0 110.15 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 73.8 m -150.21 116.54 5.72 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.984 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 157.58 -64.78 0.3 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -52.82 -175.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -1.124 . . . . 0.0 110.018 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.542 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -150.88 150.01 30.37 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.014 -1.054 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -30.19 136.37 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.402 0.62 . . . . 0.0 111.237 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.401 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 108.12 11.22 24.55 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.492 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 69.4 mm-40 -142.25 118.59 10.84 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.266 -1.137 . . . . 0.0 110.695 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 m -103.98 137.77 41.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.087 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.612 ' CG ' HD11 ' A' ' 102' ' ' LEU . 34.5 m-85 -123.36 166.11 15.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.969 -1.082 . . . . 0.0 111.171 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -121.65 110.13 15.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.537 -0.727 . . . . 0.0 109.597 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.718 HG23 ' O ' ' A' ' 33' ' ' ILE . 4.9 tt -87.88 113.09 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 110.327 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.81 166.17 28.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.716 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.602 ' HG3' HD12 ' A' ' 107' ' ' LEU . 0.5 OUTLIER -127.92 140.84 51.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.472 -0.768 . . . . 0.0 110.021 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.6 m -138.21 165.85 25.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.937 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.437 ' HB2' ' SG ' ' A' ' 91' ' ' CYS . . . -150.97 153.93 33.69 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.641 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.71 167.45 25.65 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.796 1.419 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.882 . . . . 0.0 110.118 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 t0 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.289 0.566 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.405 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -142.78 127.19 17.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.362 -0.836 . . . . 0.0 109.881 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 11.9 t -110.67 168.11 9.71 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.092 -1.005 . . . . 0.0 110.709 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 41.7 p-10 -108.54 102.26 46.6 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.346 -0.847 . . . . 0.0 110.636 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.67 -21.32 12.95 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.001 1.527 . . . . 0.0 110.742 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.19 -41.91 85.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.234 -0.916 . . . . 0.0 110.589 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.37 10.09 42.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.259 -0.901 . . . . 0.0 110.002 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.0 131.45 35.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 110.256 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.663 HG23 ' CG2' ' A' ' 33' ' ' ILE . 4.5 t -138.38 165.21 27.34 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.307 -0.871 . . . . 0.0 109.887 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m -127.79 146.6 50.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 110.744 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 35.1 p90 -140.16 -177.6 5.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 109.858 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.5 m -141.29 156.64 45.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.963 . . . . 0.0 110.058 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.416 HG23 ' HE2' ' A' ' 31' ' ' TYR . 17.2 p -67.28 -156.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.0 110.38 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 11.8 t0 -154.78 -162.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.954 . . . . 0.0 110.235 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.65 -55.49 34.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.268 -0.895 . . . . 0.0 109.416 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 p -78.32 4.15 13.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.432 -0.793 . . . . 0.0 109.353 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 66.11 46.55 79.56 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.99 162.78 20.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.107 -1.231 . . . . 0.0 110.242 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -159.11 83.87 0.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.179 -0.951 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 m -111.04 121.9 46.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.283 -0.885 . . . . 0.0 109.362 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 20.6 p90 -155.54 179.98 8.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 110.782 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.1 m -92.25 151.81 20.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.473 -0.767 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.455 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 56.3 t80 -142.48 179.36 7.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.538 -0.726 . . . . 0.0 109.112 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.455 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.4 t -133.08 154.96 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.741 -1.224 . . . . 0.0 110.415 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.468 HG21 HD22 ' A' ' 12' ' ' LEU . 29.7 m -138.01 164.82 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.436 -0.79 . . . . 0.0 109.808 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 8.0 mtt85 -141.22 126.02 18.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.918 . . . . 0.0 110.334 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 14.3 tttt -55.08 -40.68 70.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.832 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.3 p -130.25 134.48 47.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.385 -0.822 . . . . 0.0 109.735 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 17.2 p90 -144.94 153.28 41.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.116 -0.99 . . . . 0.0 110.636 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 21.3 m -73.94 124.78 26.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.265 -0.897 . . . . 0.0 110.247 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.405 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -77.24 159.41 48.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.273 -1.133 . . . . 0.0 110.004 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.189 0.519 . . . . 0.0 110.014 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.427 HG11 ' OH ' ' A' ' 71' ' ' TYR . 82.6 t -134.45 146.05 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.234 -0.916 . . . . 0.0 110.163 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -134.66 125.49 27.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.006 . . . . 0.0 110.173 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 72.1 m -86.72 12.63 10.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.47 -58.28 8.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.816 . . . . 0.0 110.068 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -110.29 9.51 23.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.33 178.21 4.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.318 -0.864 . . . . 0.0 110.194 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.15 95.39 5.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 37' ' ' ALA . 80.9 m -92.5 138.15 31.76 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.182 -0.949 . . . . 0.0 109.94 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -130.47 149.96 51.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.17 -0.956 . . . . 0.0 110.434 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 35' ' ' GLN . 0.3 OUTLIER -125.0 122.48 37.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 109.719 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.3 175.78 20.72 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.33 171.59 13.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -1.08 . . . . 0.0 110.12 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.81 165.06 10.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.468 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -129.69 -104.24 0.3 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -1.194 . . . . 0.0 110.622 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.423 ' N ' HD22 ' A' ' 97' ' ' ASN . 0.6 OUTLIER -65.42 -84.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.937 -1.102 . . . . 0.0 110.575 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.1 52.64 0.82 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.604 HD13 ' HE1' ' A' ' 31' ' ' TYR . 4.4 tt -115.21 -58.94 2.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.207 -1.172 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.5 t0 50.83 101.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.403 -0.811 . . . . 0.0 110.251 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.889 HD23 ' CG ' ' A' ' 2' ' ' PRO . 0.5 OUTLIER -73.86 -67.72 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -161.68 179.28 37.17 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -148.04 117.17 6.84 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.357 -1.084 . . . . 0.0 110.03 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.1 136.09 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.69 118.62 23.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.233 -0.917 . . . . 0.0 110.183 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.796 HD22 ' CD1' ' A' ' 12' ' ' LEU . 48.6 mt -90.05 134.1 34.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -112.43 166.51 11.24 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.507 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 2.5 m-85 -152.72 71.44 0.93 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.528 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.5 Cg_endo . . . . . 0 N--CA 1.481 0.776 0 N-CA-C 110.493 -0.618 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.406 ' HB3' ' H ' ' A' ' 23' ' ' SER . . . -149.32 148.9 30.07 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.086 -1.009 . . . . 0.0 111.196 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.443 ' CB ' ' HB3' ' A' ' 102' ' ' LEU . 24.2 t80 -151.5 102.67 2.91 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 109.633 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.07 158.45 43.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.927 -1.108 . . . . 0.0 111.002 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.484 HG12 HG11 ' A' ' 105' ' ' VAL . 5.1 p -126.77 138.81 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 109.76 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.606 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -62.49 -66.17 1.71 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.127 -0.983 . . . . 0.0 110.499 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.606 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 53.1 Cg_endo -76.96 74.18 5.09 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 O-C-N 123.493 1.259 . . . . 0.0 110.48 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.41 -0.64 57.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.986 -1.071 . . . . 0.0 110.236 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.7 t -150.88 150.7 31.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 109.974 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.65 60.96 6.35 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.6 HD21 ' O ' ' A' ' 8' ' ' PRO . 5.1 mt -102.61 154.39 19.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.251 -1.147 . . . . 0.0 110.132 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 73.3 m -109.35 155.78 20.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.149 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 32.7 t0 -64.49 127.84 33.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.057 -1.027 . . . . 0.0 110.612 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.49 -30.4 5.3 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 13' ' ' SER . 5.1 tp60 -46.78 145.66 1.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -1.116 . . . . 0.0 110.162 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.38 133.42 42.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.383 -0.823 . . . . 0.0 109.523 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.745 HG23 ' HB3' ' A' ' 65' ' ' PHE . 18.0 m -98.0 172.94 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.093 -1.004 . . . . 0.0 110.027 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.4 m -124.09 114.14 19.3 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 t -102.19 151.5 5.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 O-C-N 121.482 -0.761 . . . . 0.0 109.732 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.0 135.29 27.3 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.334 -0.854 . . . . 0.0 110.435 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.948 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 58.6 t -126.14 137.81 56.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.513 -0.742 . . . . 0.0 109.472 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' ' 3' ' ' ALA . 42.3 m -140.6 127.7 20.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.075 -1.016 . . . . 0.0 110.637 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 129.92 -48.69 0.96 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.522 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -57.45 -158.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -1.158 . . . . 0.0 109.345 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.599 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -170.95 149.99 3.05 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.596 -1.315 . . . . 0.0 111.818 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -40.12 141.98 0.42 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.438 0.637 . . . . 0.0 110.166 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.05 10.71 36.18 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 2.5 mm-40 -137.76 133.65 34.34 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.355 -1.085 . . . . 0.0 109.757 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 52.6 m -112.0 152.77 27.74 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.211 -0.93 . . . . 0.0 109.908 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.641 ' HE2' HD12 ' A' ' 100' ' ' LEU . 17.2 m-85 -135.26 159.46 41.47 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 109.809 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -119.39 105.91 11.75 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.24 -0.913 . . . . 0.0 110.044 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.599 ' CG1' HD11 ' A' ' 93' ' ' LEU . 9.4 tt -95.12 125.42 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 109.86 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.609 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -137.85 148.02 45.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.888 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -116.76 126.63 53.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.441 -0.787 . . . . 0.0 109.571 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 72.7 m -145.21 173.08 12.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -0.99 . . . . 0.0 110.923 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.45 160.27 32.08 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.529 -0.732 . . . . 0.0 109.506 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.29 163.58 38.19 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.744 1.392 . . . . 0.0 111.208 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.743 ' O ' HG22 ' A' ' 39' ' ' VAL . 2.4 p . . . . . 0 N--CA 1.496 1.871 0 O-C-N 121.524 -0.735 . . . . 0.0 110.288 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.604 0.716 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -130.29 159.2 37.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.238 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.59 154.55 48.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.953 -1.092 . . . . 0.0 111.186 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.568 ' OD1' ' CZ ' ' A' ' 71' ' ' TYR . 3.7 m120 -94.55 107.91 33.27 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.603 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.53 -33.3 8.77 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.902 1.475 . . . . 0.0 110.074 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.65 -6.63 27.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.362 -0.836 . . . . 0.0 110.175 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.407 ' OG1' ' CB ' ' A' ' 46' ' ' ASN . 53.0 p -120.29 -6.95 9.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.106 -0.996 . . . . 0.0 110.383 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.81 125.62 25.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.208 -0.933 . . . . 0.0 110.078 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.7 t -170.46 168.94 7.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.141 -0.975 . . . . 0.0 110.596 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.8 p -129.2 154.95 46.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 29.1 p90 -137.4 148.17 45.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.292 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.2 m -103.0 154.81 18.86 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.343 -0.848 . . . . 0.0 110.298 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.522 HG21 ' HB1' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -62.66 -156.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.27 -0.894 . . . . 0.0 110.544 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -142.84 -164.92 1.94 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.03 -1.044 . . . . 0.0 109.99 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.66 -52.51 64.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 108.975 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 p -84.17 12.77 5.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.515 -0.741 . . . . 0.0 109.073 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.599 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 67.93 12.79 63.05 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -89.38 108.95 19.93 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.272 -1.134 . . . . 0.0 109.542 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.948 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -97.22 87.85 4.29 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.353 -0.842 . . . . 0.0 110.244 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.18 115.48 28.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.42 -0.8 . . . . 0.0 109.474 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.629 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 7.9 p90 -144.64 177.23 8.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.047 -1.033 . . . . 0.0 111.191 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -102.4 122.22 43.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.634 -0.666 . . . . 0.0 110.837 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.745 ' HB3' HG23 ' A' ' 18' ' ' VAL . 68.4 t80 -106.83 -177.18 3.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 109.043 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.425 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.2 t -135.2 155.31 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.745 -1.222 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.1 m -141.3 174.56 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.493 -0.755 . . . . 0.0 109.486 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 5.0 mtt180 -155.9 126.51 6.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.993 -1.067 . . . . 0.0 110.805 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 8.5 ttpt -49.76 -46.13 50.28 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.205 -0.935 . . . . 0.0 109.449 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.0 m -128.62 156.45 43.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.587 -0.695 . . . . 0.0 109.165 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.568 ' CZ ' ' OD1' ' A' ' 46' ' ' ASN . 37.0 p90 -167.89 143.76 3.92 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.775 -1.203 . . . . 0.0 110.984 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 23.8 m -65.52 141.21 58.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.138 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.82 174.58 22.3 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.62 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 p . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.713 -0.875 . . . . 0.0 109.005 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.47 0.652 . . . . 0.0 110.524 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.402 HG21 ' CB ' ' A' ' 44' ' ' ALA . 97.8 t -116.93 152.5 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.403 -0.81 . . . . 0.0 109.997 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.25 127.49 39.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.084 -1.01 . . . . 0.0 110.029 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 4.2 t -84.07 -11.16 57.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.215 -0.928 . . . . 0.0 110.451 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.13 90.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 110.27 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.4 t -86.82 2.27 49.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.218 -0.926 . . . . 0.0 110.169 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.56 -140.13 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.21 159.02 44.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.303 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 55.7 m -119.94 141.06 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.95 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -133.36 135.4 44.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.466 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 34' ' ' ALA . 18.9 tp -109.76 120.13 41.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.848 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.503 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . -111.18 166.35 12.26 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -160.56 173.72 15.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -1.144 . . . . 0.0 110.024 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.13 -176.81 16.28 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -139.33 -150.69 0.34 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -1.072 . . . . 0.0 110.041 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.81 40.32 1.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 110.153 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -147.11 -43.48 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.641 HD12 ' HE2' ' A' ' 31' ' ' TYR . 69.7 mt -103.27 -153.74 0.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -1.166 . . . . 0.0 110.077 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -170.58 117.26 0.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 110.31 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.443 ' HB3' ' CB ' ' A' ' 4' ' ' PHE . 18.9 mt -118.56 -49.36 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.0 110.09 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.03 -150.71 17.82 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.574 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 3.6 p80 -146.89 136.93 23.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -1.11 . . . . 0.0 110.417 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.484 HG11 HG12 ' A' ' 6' ' ' VAL . 18.3 t -85.06 113.16 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.416 -0.803 . . . . 0.0 110.112 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.05 94.3 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -0.86 . . . . 0.0 110.112 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.88 162.02 14.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.315 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.54 152.41 46.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.414 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 3.3 m-85 -127.45 75.68 1.61 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.858 . . . . 0.0 110.005 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 CA-C-O 117.961 -1.466 . . . . 0.0 109.596 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.512 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.0 Cg_endo . . . . . 0 N--CA 1.482 0.796 0 N-CA-C 110.481 -0.623 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -148.63 127.43 12.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.974 . . . . 0.0 110.432 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -142.08 106.3 4.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.369 -0.832 . . . . 0.0 109.471 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.2 t -150.25 154.14 37.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.961 -1.087 . . . . 0.0 111.247 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.6 HG12 HG11 ' A' ' 105' ' ' VAL . 13.4 p -119.05 156.9 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.647 -0.658 . . . . 0.0 109.448 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.592 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -77.04 -65.89 0.36 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.926 -1.109 . . . . 0.0 110.217 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.683 ' O ' HD21 ' A' ' 12' ' ' LEU . 52.7 Cg_endo -76.2 74.97 4.4 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.607 1.32 . . . . 0.0 110.221 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.53 -16.79 60.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.028 -1.045 . . . . 0.0 110.243 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.2 p -138.8 166.26 24.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.072 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.95 48.91 61.93 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.683 HD21 ' O ' ' A' ' 8' ' ' PRO . 20.7 mt -95.04 166.9 11.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -1.105 . . . . 0.0 110.242 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -126.05 152.43 45.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.286 -0.884 . . . . 0.0 110.346 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -63.67 117.23 6.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.83 -30.41 9.39 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 13' ' ' SER . 8.1 tt0 -52.52 155.09 2.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.342 -1.093 . . . . 0.0 110.27 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.23 138.03 43.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 0.0 110.115 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.567 ' CG1' HD22 ' A' ' 12' ' ' LEU . 17.1 m -103.81 153.56 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 109.859 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 0.7 OUTLIER -95.61 111.34 23.29 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.491 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 t -104.87 151.61 7.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.46 -0.775 . . . . 0.0 110.049 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 34.2 t -149.82 133.11 16.45 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.445 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.814 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 53.2 t -123.75 146.59 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.527 -0.733 . . . . 0.0 109.992 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 2.3 p -162.56 120.22 2.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.118 -0.989 . . . . 0.0 110.282 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 149.39 -55.87 0.48 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.652 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -63.92 -139.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.157 -1.202 . . . . 0.0 110.097 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.489 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.66 175.57 5.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.223 -0.923 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -65.2 131.74 47.31 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.493 -0.755 . . . . 0.0 110.666 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.6 6.85 7.76 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 2.6 mt-10 -132.0 106.09 7.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -1.199 . . . . 0.0 110.551 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 57.5 m -90.44 123.28 34.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.278 -0.889 . . . . 0.0 109.812 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.658 ' OH ' HD22 ' A' ' 100' ' ' LEU . 59.6 m-85 -107.42 161.59 14.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 111.059 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -113.48 112.51 23.72 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.392 -0.817 . . . . 0.0 109.602 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 33' ' ' ILE . 4.5 tt -93.94 106.31 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.124 -0.985 . . . . 0.0 110.635 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 1.022 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -142.23 168.53 19.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.381 -0.825 . . . . 0.0 109.772 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 9.8 pt20 -132.71 151.52 51.95 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 110.385 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.72 157.33 44.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 110.558 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 90' ' ' ALA . . . -151.56 157.35 34.76 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.274 -0.891 . . . . 0.0 110.499 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 43.3 Cg_endo -69.5 174.99 8.48 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.942 1.496 . . . . 0.0 110.22 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.072 -1.018 . . . . 0.0 110.845 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 11.7 p-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.33 0.586 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.568 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -136.12 155.35 50.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.426 -0.796 . . . . 0.0 109.7 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.1 m -126.28 151.47 47.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.211 -0.93 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.482 ' ND2' ' HB2' ' A' ' 71' ' ' TYR . 47.6 t-20 -97.16 108.5 44.5 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.15 -0.969 . . . . 0.0 110.243 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 49.9 Cg_endo -81.79 -33.96 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.919 1.484 . . . . 0.0 110.484 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.97 50.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 110.313 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 p -79.67 -3.05 45.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.262 -0.899 . . . . 0.0 110.064 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 47' ' ' PRO . . . -72.72 81.66 1.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.868 . . . . 0.0 110.5 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.535 HG23 ' CG2' ' A' ' 33' ' ' ILE . 4.2 t -100.26 174.49 6.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.291 -0.881 . . . . 0.0 109.883 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.65 122.34 15.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 110.304 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.494 ' C ' ' CD1' ' A' ' 53' ' ' PHE . 5.0 p90 -116.5 -175.01 2.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.912 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 55' ' ' THR . 7.2 m -134.69 143.35 47.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.961 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -57.33 -155.94 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.136 -0.977 . . . . 0.0 110.299 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -145.49 -156.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.077 -1.015 . . . . 0.0 110.176 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.57 -61.89 2.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.028 -1.045 . . . . 0.0 109.909 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 52.7 p -87.94 28.5 1.03 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.242 -0.911 . . . . 0.0 109.325 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.489 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 55.88 28.3 52.54 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -93.45 117.29 29.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.375 -1.074 . . . . 0.0 110.136 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.814 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -124.81 83.41 2.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 0.0 110.113 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -109.23 123.15 48.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.875 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 9.4 p90 -155.68 174.72 14.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.601 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.69 114.03 26.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.394 -0.816 . . . . 0.0 110.38 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.505 ' HB3' HG23 ' A' ' 18' ' ' VAL . 41.3 t80 -99.12 176.83 5.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.409 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.1 t -130.42 153.87 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.967 -1.083 . . . . 0.0 109.924 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.2 143.82 27.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.359 -0.838 . . . . 0.0 110.093 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -120.02 129.74 54.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 110.088 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -52.6 -35.91 55.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.905 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.3 p -131.35 143.37 50.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.936 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.482 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 22.7 p90 -145.16 153.0 40.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.17 -0.956 . . . . 0.0 110.511 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 9.2 m -72.18 124.43 25.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.305 -0.872 . . . . 0.0 109.847 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.568 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -99.19 171.87 24.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 5.6 p . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.347 -1.09 . . . . 0.0 109.869 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 5.0 p . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.287 0.565 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.52 HG21 ' CB ' ' A' ' 44' ' ' ALA . 45.7 t -150.87 133.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -109.21 141.59 41.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.937 . . . . 0.0 110.1 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.0 m -115.0 -3.8 12.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.199 -0.938 . . . . 0.0 110.143 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.19 -56.97 14.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 110.066 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 88' ' ' THR . 5.4 t -89.14 -16.41 31.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 110.05 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.46 -175.2 3.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 110.18 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.634 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -96.43 140.98 30.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -0.907 . . . . 0.0 110.325 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.43 ' C ' ' OD1' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -139.5 126.86 21.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.355 -0.841 . . . . 0.0 110.033 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.43 ' OD1' ' C ' ' A' ' 91' ' ' CYS . 31.9 m-20 -129.3 147.2 51.11 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 110.291 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.022 HD12 ' O ' ' A' ' 34' ' ' ALA . 14.3 tp -112.72 109.67 19.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.618 ' CA ' ' CD2' ' A' ' 104' ' ' HIS . . . -105.14 153.26 17.31 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.312 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.89 167.44 22.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.478 -1.013 . . . . 0.0 109.713 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.516 ' HA2' ' CD1' ' A' ' 31' ' ' TYR . . . 118.85 -175.7 15.81 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 100' ' ' LEU . 20.7 p-10 -137.8 -142.25 0.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -1.195 . . . . 0.0 110.433 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -102.78 -34.84 8.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.303 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.42 -30.69 64.23 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.658 HD22 ' OH ' ' A' ' 31' ' ' TYR . 6.0 tt -146.88 131.2 17.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -1.146 . . . . 0.0 110.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -96.88 138.48 34.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -0.993 . . . . 0.0 110.087 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 102' ' ' LEU . 16.4 mt -97.56 -81.15 0.43 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.273 -0.892 . . . . 0.0 110.295 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 174.99 163.13 27.61 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.618 ' CD2' ' CA ' ' A' ' 94' ' ' GLY . 41.5 m170 -119.13 123.95 45.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.993 . . . . 0.0 110.069 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.6 HG11 HG12 ' A' ' 6' ' ' VAL . 31.5 t -102.68 115.51 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.111 -0.993 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.51 127.26 32.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.297 -0.877 . . . . 0.0 110.162 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.1 mt -98.42 169.52 9.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.335 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.3 m -155.26 160.36 40.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -132.66 105.33 7.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 0.0 110.135 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.431 179.949 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 45.8 Cg_endo . . . . . 0 N--CA 1.48 0.717 0 N-CA-C 110.407 -0.651 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.451 ' HB3' ' OG ' ' A' ' 23' ' ' SER . . . -147.0 151.2 36.58 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.172 -0.955 . . . . 0.0 110.747 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.547 ' CE1' ' HB3' ' A' ' 95' ' ' ALA . 76.9 t80 -149.98 116.72 5.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 110.022 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.64 149.72 31.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.073 -1.017 . . . . 0.0 110.611 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.005 HG12 HG11 ' A' ' 105' ' ' VAL . 4.3 p -130.87 139.0 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.923 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -69.76 -62.5 2.39 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.048 -1.032 . . . . 0.0 110.182 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 49.4 Cg_endo -74.32 77.51 2.85 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.837 1.441 . . . . 0.0 110.468 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.69 -5.63 57.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.114 -0.991 . . . . 0.0 110.13 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.0 p -151.62 166.45 31.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 110.241 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.8 52.46 48.24 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.492 HD13 ' HB3' ' A' ' 107' ' ' LEU . 1.4 mt -102.51 172.87 6.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.146 -1.208 . . . . 0.0 110.055 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.488 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -143.71 149.85 37.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 110.387 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 3.7 p30 -58.0 123.95 17.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.325 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.97 -34.81 4.56 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 0.9 OUTLIER -50.96 156.41 1.01 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -1.134 . . . . 0.0 109.815 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.95 137.83 47.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.634 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 67' ' ' VAL . 16.5 m -107.66 175.41 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.424 -0.797 . . . . 0.0 110.131 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.468 ' OG ' ' HD3' ' A' ' 8' ' ' PRO . 3.6 p -120.78 118.92 31.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 109.996 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.493 HG21 HD11 ' A' ' 33' ' ' ILE . 20.8 t -110.31 151.79 12.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.244 -0.91 . . . . 0.0 110.067 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -143.12 128.16 18.51 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 110.31 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.771 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 30.7 t -121.26 145.65 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 109.824 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -151.43 139.4 20.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 110.382 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 120.17 -75.34 0.32 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.561 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -49.54 126.7 14.0 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.179 -1.189 . . . . 0.0 109.563 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.571 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -97.08 165.65 11.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.111 -0.993 . . . . 0.0 111.092 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -44.23 139.85 2.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.545 0.688 . . . . 0.0 110.568 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.92 9.22 8.34 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 50.4 mm-40 -147.65 121.84 9.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.119 -1.224 . . . . 0.0 110.406 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 53' ' ' PHE . 80.6 m -104.43 125.63 50.81 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.436 -0.79 . . . . 0.0 109.49 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.737 ' CE1' HD13 ' A' ' 100' ' ' LEU . 17.0 m-85 -110.01 176.94 4.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.09 -1.006 . . . . 0.0 110.434 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 12.5 m-85 -126.51 112.85 16.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.301 -0.874 . . . . 0.0 110.488 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 33' ' ' ILE . 13.0 tt -98.5 103.65 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 0.0 109.933 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.61 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -138.56 169.33 17.98 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.294 -0.879 . . . . 0.0 110.651 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.788 ' OE1' HD12 ' A' ' 107' ' ' LEU . 34.1 mt-30 -106.07 155.47 19.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.423 -0.798 . . . . 0.0 110.334 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 98.1 m -150.69 148.52 28.68 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.219 -0.926 . . . . 0.0 110.471 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 1.052 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -151.76 165.83 16.57 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 49.9 Cg_endo -75.02 175.51 11.15 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.99 1.521 . . . . 0.0 110.391 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.444 ' CG1' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.976 0 O-C-N 121.264 -0.898 . . . . 0.0 110.157 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 1.6 p30 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.169 0.509 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.09 157.87 39.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 110.399 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 m -140.48 163.05 33.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.184 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.788 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -81.54 123.91 80.5 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 110.358 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.583 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 48.8 Cg_endo -84.74 -72.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.931 1.49 . . . . 0.0 110.621 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.15 -62.89 1.52 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.206 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.509 ' OG1' ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -46.47 -22.54 0.28 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.444 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.788 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -62.83 105.38 0.66 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.031 . . . . 0.0 109.816 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -110.47 141.42 43.6 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.234 -0.916 . . . . 0.0 110.442 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.49 ' HB3' ' CD2' ' A' ' 32' ' ' TYR . 48.9 p -106.88 119.11 38.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 109.888 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.629 ' O ' HG23 ' A' ' 30' ' ' THR . 53.1 p90 -106.46 -178.06 3.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.034 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 55' ' ' THR . 6.4 m -139.05 145.44 39.59 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.939 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.561 HG21 ' CB ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -57.17 -158.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.147 -0.97 . . . . 0.0 109.851 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -145.43 -161.78 1.37 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.881 -1.137 . . . . 0.0 110.448 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.81 -48.98 79.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.087 -1.008 . . . . 0.0 109.164 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p -87.03 13.82 8.56 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.515 -0.74 . . . . 0.0 109.099 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 57.27 30.31 61.08 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.02 118.91 37.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -1.094 . . . . 0.0 109.863 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.771 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -118.81 81.2 1.66 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.511 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.9 m -110.61 122.65 48.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.304 -0.873 . . . . 0.0 109.293 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 12.3 p90 -157.31 179.1 9.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.024 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.09 138.04 31.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 110.726 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 73.9 t80 -123.14 178.62 5.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -0.795 . . . . 0.0 109.182 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.557 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 5.2 t -123.05 159.44 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.806 -1.184 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 18' ' ' VAL . 30.9 m -137.96 124.69 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.393 -0.817 . . . . 0.0 110.099 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 9.5 mmm-85 -115.85 123.85 49.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.53 -59.93 3.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -0.978 . . . . 0.0 109.204 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 p -108.41 126.44 52.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.306 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.542 ' CD1' ' ND2' ' A' ' 46' ' ' ASN . 50.0 p90 -140.31 163.91 31.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 110.485 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.09 123.87 21.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.637 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.439 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -98.21 166.42 22.13 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 89.5 p . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.39 -1.064 . . . . 0.0 109.599 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.257 0.551 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.444 HG22 ' CG1' ' A' ' 39' ' ' VAL . 49.1 t -144.15 154.63 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 110.13 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -134.58 131.57 38.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 110.064 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 32.7 m -92.97 33.23 1.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.878 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.15 -61.09 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 110.39 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.475 ' H ' HG22 ' A' ' 88' ' ' THR . 5.0 t -87.67 -23.05 24.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.331 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.58 -178.32 3.59 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 110.096 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -123.82 148.81 46.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.181 -0.949 . . . . 0.0 110.12 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 1.052 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -126.85 133.78 50.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.026 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 5.7 m-20 -99.9 147.22 25.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 110.107 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.864 ' HB2' HD11 ' A' ' 107' ' ' LEU . 15.8 tp -106.7 110.96 23.28 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.1 -1.0 . . . . 0.0 109.52 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.502 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -112.65 153.43 17.48 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.547 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . . . -133.29 104.87 6.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.428 -1.042 . . . . 0.0 110.122 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.58 174.17 46.41 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 5.5 p-10 -114.0 -156.84 0.61 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -1.156 . . . . 0.0 110.357 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -91.99 52.6 2.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 110.184 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 174.4 -32.03 0.1 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.737 HD13 ' CE1' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -117.38 86.03 2.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -1.169 . . . . 0.0 110.297 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.53 116.31 22.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.941 . . . . 0.0 109.984 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 95' ' ' ALA . 87.8 mt -81.94 -74.6 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.322 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.13 173.58 41.66 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.502 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 9.8 m-70 -136.69 122.62 20.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.584 -0.951 . . . . 0.0 110.111 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.005 HG11 HG12 ' A' ' 6' ' ' VAL . 17.2 t -112.23 107.45 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.072 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . . . -57.71 147.09 28.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 110.505 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.864 HD11 ' HB2' ' A' ' 93' ' ' LEU . 29.7 mt -116.18 141.56 47.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 109.984 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -110.82 165.55 11.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 110.34 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -139.95 97.51 3.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.24 -0.913 . . . . 0.0 110.321 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.519 ' HG2' HD23 ' A' ' 102' ' ' LEU . 43.9 Cg_endo . . . . . 0 N--CA 1.482 0.836 0 N-CA-C 110.361 -0.669 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -123.89 128.72 49.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.182 -0.949 . . . . 0.0 110.445 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.493 ' HB2' HD22 ' A' ' 102' ' ' LEU . 85.4 t80 -149.63 104.46 3.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.677 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.613 ' HA ' HG21 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -149.8 157.37 43.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.899 -1.126 . . . . 0.0 111.496 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.634 HG12 HG11 ' A' ' 105' ' ' VAL . 9.3 p -106.18 139.85 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.399 -0.813 . . . . 0.0 109.312 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.651 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 m -53.82 -72.4 0.19 Allowed Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 120.828 -1.17 . . . . 0.0 110.002 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.668 ' O ' HD21 ' A' ' 12' ' ' LEU . 56.7 Cg_endo -80.13 79.37 3.36 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 O-C-N 122.956 0.977 . . . . 0.0 109.952 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.43 -20.97 61.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.846 -1.159 . . . . 0.0 109.999 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t -134.51 141.11 46.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.325 -0.86 . . . . 0.0 110.043 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.91 61.21 1.29 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.668 HD21 ' O ' ' A' ' 8' ' ' PRO . 3.5 mt -117.21 169.53 9.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.162 -1.199 . . . . 0.0 110.232 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 4.2 t -124.65 158.95 31.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 110.286 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.16 124.97 22.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.216 -0.927 . . . . 0.0 110.188 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 89.45 -29.45 6.17 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.492 ' HB3' ' O ' ' A' ' 13' ' ' SER . 28.9 tp60 -43.81 156.25 0.07 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.324 -1.104 . . . . 0.0 110.447 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.424 ' N ' ' HG3' ' A' ' 16' ' ' GLN . 1.8 m -107.16 134.92 49.56 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.448 -0.783 . . . . 0.0 109.315 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.448 ' CG1' HD22 ' A' ' 12' ' ' LEU . 32.7 m -110.97 153.93 12.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.801 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -105.97 121.37 43.97 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.973 -1.08 . . . . 0.0 110.237 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.6 t -97.1 151.82 4.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.581 -0.7 . . . . 0.0 109.223 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 t -142.46 121.25 12.69 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 121.281 -0.887 . . . . 0.0 109.857 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 33.9 t -116.11 142.74 28.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 110.065 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.685 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.1 OUTLIER -160.38 105.17 1.47 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 110.254 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 157.3 -47.79 0.46 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.792 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -59.41 -147.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.419 -1.047 . . . . 0.0 109.485 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.529 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -172.42 165.89 5.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.76 -1.213 . . . . 0.0 111.037 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -48.36 138.58 9.83 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.592 0.711 . . . . 0.0 110.782 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.07 25.49 12.74 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.537 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 2.3 mt-10 -141.07 105.95 4.94 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.203 -1.175 . . . . 0.0 110.375 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.7 m -103.73 151.31 23.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.822 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 46.6 m-85 -140.24 165.97 25.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.296 -0.877 . . . . 0.0 110.188 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 23.5 m-85 -112.66 109.77 19.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -0.901 . . . . 0.0 109.851 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 33' ' ' ILE . 3.2 tt -89.5 111.72 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.059 -1.026 . . . . 0.0 110.162 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 1.032 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -144.05 159.45 42.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.468 -0.77 . . . . 0.0 110.247 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.745 HE21 HD13 ' A' ' 107' ' ' LEU . 14.6 tt0 -112.94 148.12 35.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.342 -0.849 . . . . 0.0 110.515 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 62.9 m -153.54 162.23 41.47 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.376 -0.827 . . . . 0.0 110.225 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.515 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.64 160.27 32.9 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.235 -0.915 . . . . 0.0 110.288 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.472 ' C ' HG13 ' A' ' 39' ' ' VAL . 49.4 Cg_endo -74.54 172.34 16.37 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.781 1.411 . . . . 0.0 110.343 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.596 HG11 ' HB2' ' A' ' 44' ' ' ALA . 33.4 m . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.233 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p30 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.457 0.646 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.596 ' HB2' HG11 ' A' ' 39' ' ' VAL . . . -125.43 159.35 32.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.691 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.466 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.3 m -144.76 157.07 44.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.145 -0.972 . . . . 0.0 110.385 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.418 ' ND2' ' OG1' ' A' ' 49' ' ' THR . 3.2 t-20 -96.27 109.92 49.83 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.204 -0.935 . . . . 0.0 110.288 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 50.8 Cg_endo -86.92 -42.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.894 1.47 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.41 66.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.401 -0.812 . . . . 0.0 110.855 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.418 ' OG1' ' ND2' ' A' ' 46' ' ' ASN . 18.0 p -113.47 31.5 6.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.059 -1.025 . . . . 0.0 110.374 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.48 131.72 36.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.557 HG23 ' CG2' ' A' ' 33' ' ' ILE . 7.0 t -148.65 170.24 18.58 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.252 -0.905 . . . . 0.0 110.235 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.7 t -135.6 166.99 21.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.068 -1.02 . . . . 0.0 110.983 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 16.3 p90 -148.91 -177.08 5.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.467 -0.771 . . . . 0.0 109.832 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.6 m -144.21 166.85 23.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.058 -1.026 . . . . 0.0 110.268 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.792 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -86.98 -156.94 0.35 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.239 -0.913 . . . . 0.0 110.416 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -144.36 -163.75 1.75 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.781 -1.199 . . . . 0.0 109.931 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.5 77.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.134 -0.979 . . . . 0.0 109.441 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.6 p -88.03 15.48 7.29 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.405 -0.81 . . . . 0.0 108.848 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 65.23 16.91 63.11 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.15 122.24 32.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.091 -1.241 . . . . 0.0 109.901 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 55' ' ' THR . . . -132.96 85.22 2.2 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.179 -0.951 . . . . 0.0 110.386 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.62 129.02 49.07 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.525 -0.735 . . . . 0.0 109.196 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 6.0 p90 -161.02 179.9 8.07 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.14 -0.975 . . . . 0.0 110.571 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 m -108.29 144.62 35.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.297 -0.877 . . . . 0.0 111.548 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 36.5 t80 -135.71 166.09 24.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.58 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 3.6 t -106.85 154.95 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.607 -1.308 . . . . 0.0 110.963 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.4 m -140.73 158.66 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.531 -0.731 . . . . 0.0 109.958 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.18 148.48 41.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 110.578 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -52.84 13.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -124.51 150.17 46.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.152 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 71' ' ' TYR . 45.6 p90 -161.1 132.1 5.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.03 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 99.6 m -57.37 119.63 6.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.484 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.417 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -99.41 -178.05 31.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.111 -1.229 . . . . 0.0 110.411 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 58.6 p . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.264 0.554 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 37' ' ' ALA . 20.9 t -106.68 164.2 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.291 -0.881 . . . . 0.0 110.425 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.917 ' OD2' HG22 ' A' ' 88' ' ' THR . 26.0 p-10 -153.52 149.36 27.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.343 -0.848 . . . . 0.0 110.184 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 34.8 m -104.11 -2.98 25.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.14 -65.8 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.968 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.917 HG22 ' OD2' ' A' ' 85' ' ' ASP . 7.1 t -82.39 -19.82 38.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.079 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 85' ' ' ASP . . . -106.37 158.13 17.11 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.22 -0.925 . . . . 0.0 109.938 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.71 109.68 21.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.939 . . . . 0.0 110.234 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 24.2 p -108.7 164.36 12.44 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.205 -0.934 . . . . 0.0 109.824 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -149.03 159.64 44.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.1 -1.0 . . . . 0.0 110.626 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.032 HD12 ' O ' ' A' ' 34' ' ' ALA . 20.2 tp -107.27 113.53 26.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.365 -0.834 . . . . 0.0 109.174 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.46 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . -103.51 154.34 17.96 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.038 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -143.01 124.98 15.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.326 -1.102 . . . . 0.0 110.175 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.57 -171.0 36.64 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' SER . 11.9 p-10 -130.88 -50.57 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -1.222 . . . . 0.0 110.638 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 97' ' ' ASN . 0.5 OUTLIER 166.57 -39.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.219 -0.926 . . . . 0.0 110.474 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.61 -21.21 62.33 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.576 HD13 ' OH ' ' A' ' 31' ' ' TYR . 6.6 tt -120.75 -66.77 1.03 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -1.183 . . . . 0.0 110.137 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.58 87.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 110.476 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.519 HD23 ' HG2' ' A' ' 2' ' ' PRO . 0.3 OUTLIER -62.38 -39.04 91.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.048 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.25 -162.59 25.7 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.46 ' HB3' ' CA ' ' A' ' 94' ' ' GLY . 0.6 OUTLIER -146.51 129.4 16.32 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.284 -1.127 . . . . 0.0 110.014 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.634 HG11 HG12 ' A' ' 6' ' ' VAL . 6.3 t -92.01 119.94 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.253 -0.904 . . . . 0.0 110.341 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.62 158.85 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 109.983 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.745 HD13 HE21 ' A' ' 35' ' ' GLN . 12.9 mt -134.83 150.25 50.47 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.086 -1.009 . . . . 0.0 110.697 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.7 m -140.96 159.61 41.84 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.35 -0.844 . . . . 0.0 110.046 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -127.16 145.31 50.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.126 -0.984 . . . . 0.0 110.197 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.529 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.4 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 45.5 Cg_endo . . . . . 0 N--CA 1.485 0.972 0 N-CA-C 110.648 -0.559 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -155.3 138.45 15.61 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.264 -0.898 . . . . 0.0 110.898 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 1.6 t80 -152.36 102.96 2.8 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.345 -0.847 . . . . 0.0 109.793 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.9 t -146.2 151.9 38.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.097 -1.002 . . . . 0.0 110.734 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.878 ' CG1' HG11 ' A' ' 105' ' ' VAL . 8.0 p -115.63 122.62 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.799 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 m -47.1 -68.02 0.35 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.109 -0.994 . . . . 0.0 110.567 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 55.3 Cg_endo -76.06 79.14 2.98 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 O-C-N 123.311 1.164 . . . . 0.0 109.83 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.33 -6.73 57.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.974 -1.079 . . . . 0.0 110.689 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 p -146.96 146.43 30.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.212 -0.93 . . . . 0.0 109.71 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.425 ' C ' ' HG ' ' A' ' 12' ' ' LEU . . . 79.61 71.78 1.24 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' A' ' 8' ' ' PRO . 4.0 mt -129.87 169.95 14.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -1.108 . . . . 0.0 109.751 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -136.23 169.49 17.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.49 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 30.5 p-10 -65.19 131.04 45.49 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.113 -0.992 . . . . 0.0 110.184 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.46 -29.86 5.53 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.5 ' HB3' ' O ' ' A' ' 13' ' ' SER . 9.4 tp60 -49.48 143.01 7.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -1.114 . . . . 0.0 110.308 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.32 133.62 42.48 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.742 HG23 ' HB3' ' A' ' 65' ' ' PHE . 16.6 m -101.85 163.26 3.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 109.785 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.431 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -113.1 121.57 44.94 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.983 -1.073 . . . . 0.0 110.28 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.91 151.41 14.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.68 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.5 m -146.34 121.68 10.27 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.323 -0.861 . . . . 0.0 109.992 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 86.2 t -120.54 139.38 48.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 109.831 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.9 p -157.66 136.44 11.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.054 -1.029 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 124.28 -46.47 1.09 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 1.042 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -45.69 -52.11 11.38 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.155 -1.203 . . . . 0.0 110.237 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 25' ' ' ALA . . . 72.07 137.92 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.435 -0.791 . . . . 0.0 110.888 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -33.37 130.66 0.23 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.391 0.615 . . . . 0.0 110.762 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 29' ' ' GLU . . . 122.37 9.59 6.49 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 60.1 mt-10 -147.99 130.15 15.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.0 110.185 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.497 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 3.4 m -111.57 146.63 37.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.402 -0.811 . . . . 0.0 109.898 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.729 ' OH ' ' HB1' ' A' ' 25' ' ' ALA . 30.6 m-85 -132.08 174.51 10.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.084 -1.01 . . . . 0.0 110.662 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' ' 52' ' ' SER . 73.7 m-85 -130.46 102.05 5.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.486 -0.759 . . . . 0.0 109.626 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 33' ' ' ILE . 1.3 tt -87.85 104.15 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.087 -1.008 . . . . 0.0 110.185 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -138.97 157.21 46.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.845 . . . . 0.0 110.618 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.407 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 1.1 tt0 -122.92 147.06 47.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.53 -0.731 . . . . 0.0 110.08 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 67.3 m -150.24 171.21 17.31 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.194 -0.941 . . . . 0.0 110.668 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.43 152.15 28.53 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.532 -0.73 . . . . 0.0 109.71 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.03 166.5 29.41 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.835 1.439 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.843 HG21 ' HB2' ' A' ' 44' ' ' ALA . 30.6 t . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.415 -0.803 . . . . 0.0 109.921 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t70 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.236 0.541 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.843 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -154.14 149.49 27.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.121 -0.987 . . . . 0.0 110.036 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.483 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -124.47 156.66 36.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.139 -0.975 . . . . 0.0 110.001 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.458 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 0.2 OUTLIER -100.12 101.91 16.08 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.044 -1.035 . . . . 0.0 110.516 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.8 Cg_endo -73.8 -30.78 9.03 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.976 1.514 . . . . 0.0 110.532 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.85 85.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.268 -0.895 . . . . 0.0 110.556 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 5.1 p -95.35 1.83 54.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.219 -0.925 . . . . 0.0 110.52 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.79 119.44 21.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.129 -0.982 . . . . 0.0 110.037 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.412 HG23 ' CG2' ' A' ' 33' ' ' ILE . 11.3 t -146.33 145.24 30.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.985 . . . . 0.0 110.631 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.567 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 1.1 m -110.58 147.54 34.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 13.8 p90 -144.18 -176.4 5.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -0.876 . . . . 0.0 110.08 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.8 m -149.12 156.18 41.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.597 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 1.042 HG21 ' HB3' ' A' ' 25' ' ' ALA . 6.9 p -68.53 -161.64 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.045 -1.034 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -160.2 -155.5 0.44 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.963 -1.085 . . . . 0.0 110.943 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.69 64.56 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 109.346 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.5 t -71.03 -5.38 30.89 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.437 -0.79 . . . . 0.0 109.16 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 26' ' ' ALA . . . 53.72 53.98 33.11 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.78 126.63 8.95 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.161 -1.199 . . . . 0.0 110.7 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.514 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -113.38 85.77 2.26 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.321 -0.862 . . . . 0.0 110.002 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.17 136.45 49.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.658 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -171.03 173.26 5.13 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.203 -0.936 . . . . 0.0 110.782 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 m -94.37 117.26 29.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.376 -0.827 . . . . 0.0 110.342 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.742 ' HB3' HG23 ' A' ' 18' ' ' VAL . 36.1 t80 -98.63 -179.44 4.31 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.355 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 t -134.5 156.39 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.874 -1.141 . . . . 0.0 110.286 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.3 m -143.3 153.96 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.367 -0.833 . . . . 0.0 110.048 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -132.37 120.67 22.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 110.213 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HE2' ' CD2' ' A' ' 109' ' ' PHE . 4.3 tttt -49.41 -45.74 46.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.283 -0.886 . . . . 0.0 109.762 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.1 m -120.5 135.29 55.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.479 -0.763 . . . . 0.0 109.608 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -151.32 144.27 24.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.151 -0.968 . . . . 0.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 29.3 m -65.59 149.8 49.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 0.0 110.28 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.0 -167.17 13.64 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 O-C-N 121.298 -1.119 . . . . 0.0 110.0 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 3.9 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.278 0.561 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.65 HG21 ' CB ' ' A' ' 44' ' ' ALA . 62.7 t -116.95 123.84 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.02 111.1 23.75 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.163 -0.961 . . . . 0.0 110.094 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -90.15 9.02 29.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 110.084 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.36 -41.29 88.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.551 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 t -114.35 0.99 14.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.13 -0.981 . . . . 0.0 110.326 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -100.64 -139.16 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.24 142.16 31.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.4 m -128.9 133.82 48.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.1 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -129.27 148.26 51.18 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.189 -0.945 . . . . 0.0 110.091 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.537 HD12 ' C ' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -125.61 118.97 26.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.072 -1.018 . . . . 0.0 109.153 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -122.74 159.59 17.34 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.275 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -146.92 143.31 28.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.549 -0.971 . . . . 0.0 109.765 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 166.37 174.86 36.15 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.094 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 30' ' ' THR . 12.0 p-10 -119.35 -137.61 0.34 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.31 -1.112 . . . . 0.0 110.157 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.4 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -121.14 60.79 0.91 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.146 -0.971 . . . . 0.0 110.214 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.29 -24.26 0.12 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.833 HD13 ' N ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER -118.37 -60.84 1.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.235 . . . . 0.0 110.278 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.833 ' N ' HD13 ' A' ' 100' ' ' LEU . 38.9 t0 58.27 119.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 110.139 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.1 mt -84.81 -70.84 0.55 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.427 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 177.61 -175.6 47.64 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.577 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 1.6 m-70 -131.59 124.24 29.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.522 -0.987 . . . . 0.0 109.78 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.878 HG11 ' CG1' ' A' ' 6' ' ' VAL . 66.6 t -95.35 107.31 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.047 . . . . 0.0 110.515 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.01 112.37 2.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.7 mt -86.52 133.02 33.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.131 -0.981 . . . . 0.0 110.722 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.3 m -114.17 169.01 9.34 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.442 -0.786 . . . . 0.0 109.77 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.43 ' CD2' ' HE2' ' A' ' 69' ' ' LYS . 11.4 m-85 -134.14 163.4 29.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 110.075 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.269 0 CA-C-O 117.948 -1.474 . . . . 0.0 109.601 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.515 ' HB2' HD23 ' A' ' 102' ' ' LEU . 47.1 Cg_endo . . . . . 0 N--CA 1.483 0.883 0 N-CA-C 110.517 -0.609 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -142.43 133.9 26.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 110.498 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -146.31 111.01 5.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.233 -0.917 . . . . 0.0 109.955 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.07 149.98 34.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.129 -0.982 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.68 HG12 HG11 ' A' ' 105' ' ' VAL . 9.2 p -117.04 154.51 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 109.532 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.622 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -72.83 -68.18 0.41 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.04 . . . . 0.0 110.014 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.622 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 54.6 Cg_endo -77.58 75.94 4.5 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.308 1.162 . . . . 0.0 109.978 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.52 -8.12 57.82 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.934 -1.104 . . . . 0.0 110.527 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.5 p -142.72 123.39 14.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.28 75.56 1.3 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.57 ' O ' ' CE1' ' A' ' 109' ' ' PHE . 2.3 mt -120.07 165.93 14.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -1.14 . . . . 0.0 110.085 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.444 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 9.4 m -124.16 161.2 26.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 109.876 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 8.7 p-10 -62.43 121.6 13.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 110.075 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.87 -27.56 8.83 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.508 ' O ' HG22 ' A' ' 67' ' ' VAL . 2.7 tt0 -43.32 143.85 0.8 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.306 -1.114 . . . . 0.0 110.728 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.0 p -96.75 150.72 20.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.659 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.76 154.33 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 110.084 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.4 m -101.92 132.91 47.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.007 . . . . 0.0 110.02 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 t -120.8 146.66 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.075 -1.016 . . . . 0.0 109.896 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.71 126.2 21.84 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.424 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 84.8 t -117.67 141.61 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 109.919 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.585 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -152.96 145.53 24.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.135 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 121.35 -58.95 0.57 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.824 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -52.54 -175.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.578 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.499 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -154.36 155.14 34.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.017 -1.052 . . . . 0.0 110.783 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -37.03 133.9 0.58 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.436 0.636 . . . . 0.0 110.864 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.36 16.25 16.83 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -143.61 120.29 11.15 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.168 -1.195 . . . . 0.0 110.382 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.438 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 8.8 m -103.44 148.22 26.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.983 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.717 ' CE1' HD22 ' A' ' 100' ' ' LEU . 33.2 m-85 -136.21 170.77 15.48 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 110.4 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 22.5 m-85 -117.68 167.23 11.54 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.427 -0.796 . . . . 0.0 109.967 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.809 ' CG2' HG23 ' A' ' 51' ' ' THR . 4.4 tt -151.9 97.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.555 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.504 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -140.8 161.79 36.96 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.254 -0.903 . . . . 0.0 110.914 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.668 HE21 HD12 ' A' ' 107' ' ' LEU . 17.6 tt0 -116.78 139.98 49.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.52 -0.737 . . . . 0.0 109.81 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 96.0 m -136.76 162.58 32.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.519 ' HB2' ' SG ' ' A' ' 91' ' ' CYS . . . -151.52 159.12 33.85 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.428 -0.795 . . . . 0.0 110.01 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 46.2 Cg_endo -75.45 164.61 32.22 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.879 1.463 . . . . 0.0 110.678 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.651 ' CG1' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.357 -0.839 . . . . 0.0 109.941 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 1.4 t70 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.323 0.583 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.494 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -159.05 173.62 16.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 110.225 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 m -138.99 157.48 45.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.293 -0.879 . . . . 0.0 110.313 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 52.2 t-20 -95.69 114.77 64.69 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 110.007 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.96 -30.72 8.8 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.967 1.509 . . . . 0.0 110.519 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.6 95.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.951 . . . . 0.0 110.143 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.2 p -87.29 7.23 29.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.375 -0.828 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.96 119.26 21.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.312 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.809 HG23 ' CG2' ' A' ' 33' ' ' ILE . 9.7 t -156.17 170.71 21.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.859 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.458 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 14.6 p -141.91 148.11 38.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.072 -1.017 . . . . 0.0 110.565 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 48.8 p90 -135.46 -176.13 4.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.415 -0.803 . . . . 0.0 109.97 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.5 m -146.48 154.39 41.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.073 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.824 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -72.6 -158.79 0.05 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 14.5 t0 -155.83 -157.09 0.7 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.783 -1.198 . . . . 0.0 110.498 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.62 -46.53 89.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.14 -0.975 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.8 t -83.6 9.91 10.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.278 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.499 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 51.14 49.98 41.4 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -133.0 138.63 46.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -1.091 . . . . 0.0 109.927 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -135.3 85.04 2.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 110.829 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 p -108.06 125.72 51.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.298 -0.876 . . . . 0.0 108.953 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -154.07 -179.19 7.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.026 -1.046 . . . . 0.0 111.405 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.49 135.3 39.54 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.465 0.65 . . . . 0.0 110.563 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 38.4 t80 -125.49 178.74 5.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 0.0 109.502 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 3.4 t -134.05 161.08 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.859 -1.151 . . . . 0.0 110.536 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 16' ' ' GLN . 30.3 m -137.17 179.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.487 -0.758 . . . . 0.0 109.902 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 8.8 mtt85 -152.21 152.72 32.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.095 -1.003 . . . . 0.0 110.365 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 5.7 tttm -82.41 -25.46 33.68 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.263 -0.898 . . . . 0.0 109.314 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 85' ' ' ASP . 1.1 m -150.26 107.53 3.61 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.454 -0.778 . . . . 0.0 109.653 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.636 ' CZ ' HG11 ' A' ' 84' ' ' VAL . 25.1 p90 -105.07 143.59 33.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 110.394 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.3 m -74.25 115.22 13.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 110.467 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.494 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -90.72 -174.5 44.33 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.156 -1.202 . . . . 0.0 110.482 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.358 0.599 . . . . 0.0 110.315 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.651 HG22 ' CG1' ' A' ' 39' ' ' VAL . 96.1 t -138.29 110.19 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.322 -0.861 . . . . 0.0 110.023 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 1.6 m-20 -92.71 161.24 14.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.246 -0.909 . . . . 0.0 110.551 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 94.7 m -109.88 -0.11 18.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.181 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.97 -60.88 2.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.173 -0.954 . . . . 0.0 110.333 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -74.94 -30.48 61.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.174 -0.954 . . . . 0.0 110.279 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.09 155.72 20.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.892 . . . . 0.0 110.296 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.86 135.14 34.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.344 -0.847 . . . . 0.0 110.166 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 37' ' ' ALA . 2.0 m -114.14 137.9 51.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 109.845 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -125.28 151.9 45.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.109 -0.995 . . . . 0.0 110.801 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 34' ' ' ALA . 5.6 tp -122.46 109.16 14.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 0.0 109.073 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -107.39 164.45 13.06 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.532 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.643 ' O ' HD12 ' A' ' 102' ' ' LEU . . . -145.51 136.29 24.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.631 -0.923 . . . . 0.0 110.04 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.57 178.06 17.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -105.84 -160.07 0.73 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -1.197 . . . . 0.0 110.15 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.76 45.81 1.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 110.038 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.48 -51.77 0.05 OUTLIER Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.717 HD22 ' CE1' ' A' ' 31' ' ' TYR . 7.9 tt -103.05 91.33 4.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -1.193 . . . . 0.0 110.143 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -100.86 122.74 43.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 95' ' ' ALA . 2.1 mp -74.11 -29.36 61.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 110.174 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 140.53 -169.84 24.67 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.448 ' O ' ' ND1' ' A' ' 104' ' ' HIS . 31.0 p80 -144.23 126.71 15.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -1.11 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.68 HG11 HG12 ' A' ' 6' ' ' VAL . 85.8 t -92.58 128.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.189 -0.944 . . . . 0.0 110.228 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.57 136.04 42.09 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.668 HD12 HE21 ' A' ' 35' ' ' GLN . 88.7 mt -110.21 119.45 39.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.249 -0.907 . . . . 0.0 110.152 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -90.88 160.89 15.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.306 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.57 ' CE1' ' O ' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -146.79 78.67 1.5 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.822 . . . . 0.0 110.148 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 CA-C-O 117.948 -1.474 . . . . 0.0 109.591 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.481 0.769 0 N-CA-C 110.294 -0.695 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -141.55 136.21 30.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.087 -1.008 . . . . 0.0 110.772 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.458 ' HD1' HG22 ' A' ' 22' ' ' VAL . 87.9 t80 -149.37 114.64 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.486 -0.759 . . . . 0.0 109.168 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.47 153.7 35.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.868 -1.145 . . . . 0.0 111.317 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.757 HG22 ' HD2' ' A' ' 8' ' ' PRO . 9.5 p -113.67 165.69 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.67 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -74.66 -61.87 1.04 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.663 -1.273 . . . . 0.0 110.432 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.757 ' HD2' HG22 ' A' ' 6' ' ' VAL . 55.9 Cg_endo -91.6 76.3 0.57 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 O-C-N 123.104 1.055 . . . . 0.0 110.143 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.89 -23.76 65.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.031 -1.043 . . . . 0.0 109.94 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.9 m -139.39 135.68 33.92 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.44 -0.787 . . . . 0.0 109.964 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.87 54.28 1.93 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.701 HD21 ' O ' ' A' ' 8' ' ' PRO . 2.2 mt -102.43 171.02 7.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.257 -1.143 . . . . 0.0 109.972 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -125.17 149.36 48.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 69' ' ' LYS . 4.4 p-10 -59.85 120.89 10.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.85 . . . . 0.0 109.978 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.8 -31.04 7.22 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.498 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 10.1 tt0 -55.52 147.93 16.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -1.127 . . . . 0.0 110.326 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 26.0 p -97.82 150.86 20.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 0.0 110.325 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.722 HG12 ' HG2' ' A' ' 8' ' ' PRO . 22.6 m -119.46 150.94 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.797 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 m -93.88 116.38 28.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.131 -0.981 . . . . 0.0 110.247 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 t -102.9 149.94 6.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.315 -0.865 . . . . 0.0 109.991 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 32.2 t -150.85 129.81 12.53 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 110.251 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.707 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 75.8 t -116.25 151.99 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.809 . . . . 0.0 109.901 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.755 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -164.7 113.07 1.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.208 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.65 -55.81 0.42 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.75 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -62.52 -142.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -1.148 . . . . 0.0 110.326 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.557 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -175.61 166.57 3.21 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.169 -0.957 . . . . 0.0 110.458 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -54.88 133.04 47.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.424 -0.798 . . . . 0.0 110.653 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.423 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 119.67 9.72 8.21 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 19.6 mm-40 -140.68 120.93 13.89 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.161 -1.2 . . . . 0.0 110.468 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 53' ' ' PHE . 63.6 m -106.36 130.44 54.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.261 -0.899 . . . . 0.0 109.88 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 50.0 m-85 -115.65 -168.31 1.39 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.233 -0.917 . . . . 0.0 110.786 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 40.8 m-85 -138.68 112.11 8.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.432 -0.793 . . . . 0.0 109.987 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 33' ' ' ILE . 5.6 tt -94.42 112.69 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.187 -0.946 . . . . 0.0 109.735 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.46 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -146.71 155.3 42.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 111.307 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 22.6 tt0 -109.7 127.41 54.56 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 1.8 m -143.25 165.92 26.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.067 -1.021 . . . . 0.0 110.705 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.493 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.77 164.17 21.28 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.613 -0.679 . . . . 0.0 109.441 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 43.3 Cg_endo -71.79 162.83 40.82 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.748 1.394 . . . . 0.0 110.674 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 39' ' ' VAL . 33.4 m . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.378 -0.827 . . . . 0.0 110.283 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.325 0.583 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.521 ' CB ' HG11 ' A' ' 39' ' ' VAL . . . -132.1 156.7 45.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.85 . . . . 0.0 109.671 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 12.2 t -147.55 160.7 42.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.106 -0.996 . . . . 0.0 110.511 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.464 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 41.2 t-20 -84.37 117.64 69.22 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.318 -0.864 . . . . 0.0 110.12 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.63 -37.16 2.44 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.908 1.478 . . . . 0.0 110.554 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.07 -20.95 58.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.327 -0.858 . . . . 0.0 110.322 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 82.4 p -113.86 -10.96 12.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.925 . . . . 0.0 110.352 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.4 106.43 2.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.4 t -139.9 152.96 46.83 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.255 -0.903 . . . . 0.0 110.318 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 6.0 p -105.83 157.33 17.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.106 -0.996 . . . . 0.0 110.51 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 6.4 p90 -146.0 -177.4 5.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.047 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.3 m -138.6 161.29 37.48 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.216 -0.927 . . . . 0.0 110.013 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.75 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -76.22 -158.09 0.09 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.205 -0.934 . . . . 0.0 109.934 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 1.6 t0 -141.75 -151.31 0.35 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.967 -1.083 . . . . 0.0 110.406 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.6 -54.62 29.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.926 . . . . 0.0 109.533 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.6 p -90.37 21.28 3.95 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.557 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 61.51 17.49 53.61 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -89.68 137.83 31.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -1.164 . . . . 0.0 110.056 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.707 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -140.74 84.62 1.95 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 110.269 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.8 p -104.86 115.59 30.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.84 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -146.12 179.0 7.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.258 -0.901 . . . . 0.0 110.675 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.36 138.64 31.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.511 -0.743 . . . . 0.0 110.863 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.484 ' HB3' HG23 ' A' ' 18' ' ' VAL . 51.4 t80 -132.84 -175.55 3.81 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 21.7 t -144.66 163.03 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.726 -1.234 . . . . 0.0 110.798 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.427 ' C ' ' HG2' ' A' ' 68' ' ' ARG . 33.7 m -138.28 160.83 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 109.657 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.427 ' HG2' ' C ' ' A' ' 67' ' ' VAL . 0.9 OUTLIER -141.05 139.27 34.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.939 -1.1 . . . . 0.0 110.527 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 3.2 ttmt -61.14 -44.92 96.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.903 . . . . 0.0 109.746 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 95.5 p -138.75 149.46 45.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.767 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -155.03 153.65 31.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 110.337 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 7.0 m -70.42 128.4 36.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.892 . . . . 0.0 110.138 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 74' ' ' SER . . . -87.71 173.2 43.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 5.5 t . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.282 -1.128 . . . . 0.0 110.111 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.469 0.652 . . . . 0.0 110.526 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -127.62 155.87 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.411 -0.806 . . . . 0.0 109.676 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -143.97 140.71 29.79 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.033 -1.042 . . . . 0.0 110.499 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 89' ' ' ALA . 69.3 m -85.16 -9.78 57.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.817 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.77 -44.9 72.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 109.929 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 t -94.91 -8.78 36.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.958 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 86' ' ' CYS . . . -140.37 163.9 31.54 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.332 -0.855 . . . . 0.0 109.981 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.24 139.64 35.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.511 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 1.4 p -123.22 142.48 50.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.302 -0.874 . . . . 0.0 109.714 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -125.47 161.43 27.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.995 . . . . 0.0 110.604 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.46 HD12 ' C ' ' A' ' 34' ' ' ALA . 13.7 tp -117.12 112.11 20.43 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.388 -0.82 . . . . 0.0 109.172 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -110.47 150.29 17.63 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.466 -1.35 . . . . 0.0 109.914 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -142.41 132.14 24.09 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.485 -1.009 . . . . 0.0 109.669 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.528 ' CA ' ' HB3' ' A' ' 31' ' ' TYR . . . 149.35 -159.37 28.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 100' ' ' LEU . 8.9 t-20 -121.18 159.08 26.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -1.083 . . . . 0.0 110.04 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -54.37 -30.57 52.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.1 -1.0 . . . . 0.0 110.107 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.74 -45.76 4.47 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.594 HD22 ' CE1' ' A' ' 31' ' ' TYR . 8.8 tt -87.89 143.52 27.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.183 . . . . 0.0 110.204 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -117.25 92.68 3.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.129 -0.982 . . . . 0.0 110.354 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.4 OUTLIER -71.13 -54.87 9.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.897 . . . . 0.0 110.125 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 158.72 155.15 7.49 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.499 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.525 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 8.7 m-70 -125.82 119.52 28.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.675 -0.897 . . . . 0.0 109.264 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.9 t -103.46 107.35 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 110.632 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.91 48.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.264 -0.897 . . . . 0.0 109.717 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 41.1 mt -95.98 158.37 15.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 0.0 110.65 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.554 HG22 ' N ' ' A' ' 109' ' ' PHE . 75.1 m -149.36 172.88 14.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.363 -0.835 . . . . 0.0 109.989 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 36.5 m-85 -135.09 118.24 16.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.199 -0.938 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.464 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 44.5 Cg_endo . . . . . 0 C--O 1.216 -0.617 0 N-CA-C 110.622 -0.569 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.536 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -151.22 151.2 31.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -150.19 113.8 4.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.213 -0.929 . . . . 0.0 109.984 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.5 t -150.56 150.31 31.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.099 -1.001 . . . . 0.0 110.571 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.584 HG12 HG11 ' A' ' 105' ' ' VAL . 9.9 p -123.11 155.28 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.405 -0.809 . . . . 0.0 109.65 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -75.08 -66.4 0.43 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.036 -1.04 . . . . 0.0 110.382 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 46.3 Cg_endo -74.05 81.98 1.86 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.458 1.241 . . . . 0.0 110.259 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.06 -4.85 53.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.311 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.5 p -143.92 159.44 42.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.433 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.06 51.05 58.24 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.509 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 5.3 mt -88.5 154.79 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -1.154 . . . . 0.0 109.922 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 4.3 t -132.92 157.06 46.07 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.134 -0.979 . . . . 0.0 110.346 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -63.58 115.92 5.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.79 -32.63 7.36 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 26.5 tt0 -50.82 143.97 9.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -1.073 . . . . 0.0 110.116 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.4 t -98.85 152.61 19.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.54 ' HA ' ' HG3' ' A' ' 8' ' ' PRO . 28.7 m -128.11 150.47 33.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.288 -0.883 . . . . 0.0 109.927 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -98.29 131.36 44.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 110.133 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.39 149.02 18.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -144.9 134.55 23.4 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.391 -0.818 . . . . 0.0 110.524 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.934 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 52.5 t -127.7 149.0 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.439 -0.788 . . . . 0.0 110.006 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 2' ' ' PRO . 0.7 OUTLIER -153.12 -177.25 6.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.811 . . . . 0.0 109.596 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 71.52 17.3 76.24 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.498 -1.334 . . . . 0.0 109.819 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.803 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -119.12 -159.47 0.77 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.155 -1.203 . . . . 0.0 110.269 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.573 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -170.98 161.06 6.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.443 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -53.6 131.17 38.3 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.572 -0.705 . . . . 0.0 110.272 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.59 21.58 5.72 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -144.36 116.44 8.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.235 -1.156 . . . . 0.0 110.621 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.405 HG23 ' OG1' ' A' ' 54' ' ' THR . 61.3 m -109.66 128.96 55.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 109.563 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 8.7 m-85 -114.31 175.5 5.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.004 -1.06 . . . . 0.0 110.715 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -124.93 124.5 42.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.473 -0.767 . . . . 0.0 109.46 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 33' ' ' ILE . 1.2 tt -105.06 124.38 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.089 -1.007 . . . . 0.0 110.482 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.99 155.87 38.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 111.201 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.517 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 36.6 tt0 -124.33 135.11 53.09 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.437 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 3.7 m -144.96 179.67 7.19 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.79 -1.194 . . . . 0.0 111.111 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.608 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -152.07 175.71 2.77 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.608 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 46.3 Cg_endo -83.23 163.28 15.2 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.751 1.395 . . . . 0.0 110.782 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.436 HG12 ' CA ' ' A' ' 43' ' ' ASP . 14.9 p . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 109.982 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.436 ' CA ' HG12 ' A' ' 39' ' ' VAL . 19.5 t0 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.354 0.597 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -131.79 173.3 11.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.789 . . . . 0.0 109.588 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.8 t -154.09 165.84 34.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.139 -0.976 . . . . 0.0 110.723 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 29.4 t-20 -80.03 124.58 82.91 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 46' ' ' ASN . 50.5 Cg_endo -86.01 -35.56 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.873 1.46 . . . . 0.0 111.389 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.24 3.61 4.45 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.139 -0.976 . . . . 0.0 111.506 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 71.7 p -124.07 7.29 8.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.863 -1.148 . . . . 0.0 110.677 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.32 120.3 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.026 -1.046 . . . . 0.0 110.193 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.462 HG23 ' CG2' ' A' ' 33' ' ' ILE . 10.0 t -160.57 165.63 30.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.226 -0.922 . . . . 0.0 110.315 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.8 t -136.01 163.59 29.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.216 -0.928 . . . . 0.0 110.43 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 7.3 p90 -146.55 179.68 7.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.297 -0.877 . . . . 0.0 109.764 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.405 ' OG1' HG23 ' A' ' 30' ' ' THR . 32.8 m -145.21 154.2 42.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.803 HG21 ' HB1' ' A' ' 25' ' ' ALA . 7.4 p -73.94 -156.15 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.355 -0.84 . . . . 0.0 110.068 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 27' ' ' ALA . 1.3 t0 -160.9 -151.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.924 -1.11 . . . . 0.0 110.799 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.21 -48.0 83.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 109.959 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.25 9.14 9.37 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.233 -0.917 . . . . 0.0 109.414 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.573 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 50.01 48.17 39.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.61 125.78 43.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.141 -1.211 . . . . 0.0 110.283 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.934 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -115.06 83.08 1.85 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 0.0 110.3 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.5 p -112.12 126.86 55.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.232 -0.918 . . . . 0.0 109.745 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 7.0 p90 -157.06 175.38 14.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 0.0 110.802 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 p -94.4 152.56 18.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.422 -0.799 . . . . 0.0 110.355 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.552 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 73.3 t80 -142.45 179.35 7.0 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 109.634 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.552 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.7 t -135.38 159.11 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.929 -1.107 . . . . 0.0 109.825 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 16' ' ' GLN . 33.7 m -132.79 161.28 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.19 -0.944 . . . . 0.0 110.672 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -135.84 138.43 42.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.89 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.818 ' HD3' ' HB2' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -76.9 -44.31 32.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.092 -1.005 . . . . 0.0 110.471 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.48 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 4.3 p -129.25 147.3 51.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.947 . . . . 0.0 110.413 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.508 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 11.0 p90 -161.82 156.03 22.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.223 -0.923 . . . . 0.0 110.347 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 73' ' ' GLY . 1.4 m -68.97 105.69 2.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.33 -0.856 . . . . 0.0 110.171 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 72' ' ' THR . . . -42.48 147.87 0.59 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 97.1 p . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.29 -1.123 . . . . 0.0 110.082 179.959 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.196 0.522 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.4 t -144.88 111.24 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.153 -0.967 . . . . 0.0 110.701 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.48 ' OD1' ' HB2' ' A' ' 70' ' ' SER . 1.7 m-20 -104.99 104.47 14.22 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 109.009 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.673 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -92.07 24.27 3.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.006 -1.059 . . . . 0.0 110.921 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.818 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . . . -68.8 -37.83 79.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.178 -0.951 . . . . 0.0 109.204 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 t -116.0 -3.36 12.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.58 -0.7 . . . . 0.0 109.679 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.673 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -89.53 -139.98 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.354 -0.841 . . . . 0.0 110.294 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.78 102.88 8.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 110.415 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.92 126.15 44.52 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 15.6 p30 -130.5 139.23 50.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.093 -1.005 . . . . 0.0 110.798 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.745 ' HB2' HD11 ' A' ' 107' ' ' LEU . 6.1 tp -119.19 110.39 16.97 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.604 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -113.16 162.51 12.34 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.805 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.46 157.53 44.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.644 -0.915 . . . . 0.0 109.997 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 31' ' ' TYR . . . 107.75 -177.67 21.29 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.518 ' OD1' HD23 ' A' ' 100' ' ' LEU . 4.5 p-10 -126.68 -155.75 0.7 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.194 -1.18 . . . . 0.0 109.996 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 94.3 p -92.62 69.33 4.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.307 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.57 -55.12 0.08 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.753 HD22 ' N ' ' A' ' 100' ' ' LEU . 3.9 mm? -75.79 -32.66 59.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -1.135 . . . . 0.0 109.547 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 49.27 80.19 0.07 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.633 -0.667 . . . . 0.0 110.232 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.463 ' HG ' ' HA3' ' A' ' 96' ' ' GLY . 21.8 mt -76.16 -69.82 0.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 110.238 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.35 179.61 36.17 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.806 -1.187 . . . . 0.0 110.14 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.604 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 3.5 m-70 -134.59 123.37 23.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.585 -0.95 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.584 HG11 HG12 ' A' ' 6' ' ' VAL . 60.2 t -90.11 111.04 22.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.248 -0.908 . . . . 0.0 110.313 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.54 118.81 10.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.97 . . . . 0.0 109.29 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 93' ' ' LEU . 49.7 mt -89.85 158.68 17.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 110.852 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -123.26 164.09 19.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.503 -0.748 . . . . 0.0 109.72 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.442 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 4.5 m-85 -149.28 174.57 12.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.199 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.548 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 49.3 Cg_endo . . . . . 0 C--O 1.214 -0.697 0 N-CA-C 110.103 -0.768 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -155.37 135.04 12.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.962 . . . . 0.0 110.306 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.487 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 1.2 t80 -147.78 99.3 3.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.399 -0.813 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.08 158.74 43.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 111.069 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.694 HG12 HG11 ' A' ' 105' ' ' VAL . 6.4 p -121.95 157.99 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.517 -0.739 . . . . 0.0 109.355 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.614 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.7 m -72.46 -70.19 0.29 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.883 -1.136 . . . . 0.0 110.137 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.614 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 53.9 Cg_endo -76.42 97.38 1.13 Allowed 'Trans proline' 0 N--CA 1.481 0.751 0 O-C-N 123.144 1.076 . . . . 0.0 110.031 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.5 -4.33 25.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.047 -1.033 . . . . 0.0 110.144 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.47 127.37 19.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 110.144 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' O ' HD23 ' A' ' 12' ' ' LEU . . . 88.06 80.62 1.26 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.498 HD12 ' HB3' ' A' ' 107' ' ' LEU . 45.3 mt -126.44 162.09 26.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.311 -1.111 . . . . 0.0 110.248 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.78 158.03 44.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.117 -0.99 . . . . 0.0 110.813 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -61.51 121.53 12.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.19 -39.03 2.93 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.551 ' O ' HG22 ' A' ' 67' ' ' VAL . 37.6 tt0 -49.47 134.05 19.62 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.28 -1.129 . . . . 0.0 109.885 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.2 p -95.51 138.74 32.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.38 -0.825 . . . . 0.0 110.066 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 65' ' ' PHE . 15.9 m -108.58 170.18 2.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.375 -0.828 . . . . 0.0 109.665 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.511 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 27.0 p -116.65 121.59 42.11 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.18 -0.95 . . . . 0.0 109.262 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t -112.16 150.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.118 -0.989 . . . . 0.0 110.41 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.65 132.55 22.74 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.492 -0.755 . . . . 0.0 110.114 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.81 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 18.3 t -120.71 139.43 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 3' ' ' ALA . 2.4 p -151.35 143.56 24.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.252 -0.905 . . . . 0.0 110.108 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 120.39 -67.77 0.41 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 24' ' ' GLY . . . -54.18 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.086 -1.243 . . . . 0.0 109.363 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.52 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -165.55 162.65 19.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.943 -1.098 . . . . 0.0 110.976 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.5 130.91 1.3 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.459 0.647 . . . . 0.0 110.409 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.417 ' C ' ' HG3' ' A' ' 29' ' ' GLU . . . 120.04 4.61 11.23 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 33.6 mt-10 -138.72 122.75 17.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.199 -1.177 . . . . 0.0 109.85 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.56 HG23 ' OG1' ' A' ' 54' ' ' THR . 62.4 m -105.02 133.69 49.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 109.99 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.924 ' CE2' HD21 ' A' ' 100' ' ' LEU . 11.1 m-85 -120.05 171.8 8.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.533 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 14.0 m-85 -131.68 102.1 5.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 109.113 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.659 ' CG2' HG23 ' A' ' 51' ' ' THR . 3.0 tt -90.47 117.8 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.084 -1.01 . . . . 0.0 110.905 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.45 158.5 44.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.219 -0.926 . . . . 0.0 110.299 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.462 ' HG2' ' N ' ' A' ' 36' ' ' CYS . 2.2 tt0 -116.85 144.47 44.47 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.226 -0.921 . . . . 0.0 110.19 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 77.2 m -150.23 161.43 42.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.283 -0.885 . . . . 0.0 110.776 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . . . -138.17 156.04 74.0 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 121.371 -0.831 . . . . 0.0 109.816 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 44.4 Cg_endo -70.82 163.62 38.48 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.825 1.434 . . . . 0.0 111.836 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.568 HG22 ' CA ' ' A' ' 43' ' ' ASP . 5.8 m . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.689 . . . . 0.0 109.748 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.568 ' CA ' HG22 ' A' ' 39' ' ' VAL . 12.5 t70 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.722 0.773 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -149.72 162.88 39.37 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.68 162.15 27.22 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.916 -1.115 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . 57.4 t30 -103.91 113.35 65.47 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.553 -0.717 . . . . 0.0 110.171 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.26 -27.93 7.63 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.993 1.523 . . . . 0.0 110.242 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.26 -3.78 11.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.849 . . . . 0.0 110.285 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.435 ' OG1' ' ND2' ' A' ' 46' ' ' ASN . 3.5 p -131.24 -1.85 3.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.258 -0.901 . . . . 0.0 110.172 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.7 127.38 31.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.26 -0.9 . . . . 0.0 110.183 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.659 HG23 ' CG2' ' A' ' 33' ' ' ILE . 4.4 t -159.47 150.51 19.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.979 . . . . 0.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 t -122.42 143.25 49.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.309 -0.869 . . . . 0.0 110.149 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -140.24 138.07 34.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.146 -0.971 . . . . 0.0 110.432 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.56 ' OG1' HG23 ' A' ' 30' ' ' THR . 15.6 m -105.48 151.56 24.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.194 -0.941 . . . . 0.0 109.525 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -61.71 -170.76 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.811 -1.18 . . . . 0.0 109.481 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 6.5 t0 -145.45 -158.72 0.92 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.914 -1.116 . . . . 0.0 110.818 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.39 -53.23 60.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 109.47 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 p -76.78 1.99 15.68 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 109.083 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 53.75 44.49 70.0 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.14 132.99 47.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.289 -1.124 . . . . 0.0 110.051 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.81 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -123.13 83.55 2.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.181 -0.95 . . . . 0.0 110.876 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.22 120.22 41.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.263 -0.898 . . . . 0.0 109.648 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -154.91 168.03 28.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.175 -0.953 . . . . 0.0 110.833 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 t -90.96 131.63 36.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.448 -0.783 . . . . 0.0 110.278 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 76.7 t80 -116.35 -179.73 3.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.557 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.1 t -133.37 158.1 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 120.858 -1.151 . . . . 0.0 110.01 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 16' ' ' GLN . 29.1 m -129.42 126.72 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.153 -0.967 . . . . 0.0 110.818 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 134.99 47.83 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.206 -0.934 . . . . 0.0 109.888 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -73.91 -45.86 47.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.218 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.4 m -135.12 152.11 51.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.939 . . . . 0.0 110.066 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.578 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 8.8 p90 -169.68 148.19 3.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.928 . . . . 0.0 110.317 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.3 OUTLIER -54.61 124.77 17.32 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.146 -0.971 . . . . 0.0 109.395 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.669 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -110.14 167.6 12.77 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.505 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.658 -0.907 . . . . 0.0 108.909 179.923 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 5.3 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.211 0.529 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.669 HG21 ' HA3' ' A' ' 73' ' ' GLY . 88.0 t -125.82 156.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.183 -0.948 . . . . 0.0 110.297 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -156.19 130.92 9.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.19 -0.944 . . . . 0.0 110.381 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -90.52 7.89 36.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 109.978 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.53 -47.44 69.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.343 -0.848 . . . . 0.0 110.247 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.0 t -113.32 -0.04 14.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 110.174 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -103.46 -163.71 1.01 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.224 -0.923 . . . . 0.0 110.278 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.7 133.23 56.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 110.136 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.56 111.25 23.72 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.184 -0.948 . . . . 0.0 110.016 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -121.49 140.43 52.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.131 -0.981 . . . . 0.0 110.64 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.1 tp -112.84 141.42 46.67 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.435 -0.791 . . . . 0.0 109.244 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.24 167.73 32.41 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.08 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 33' ' ' ILE . . . -155.01 168.52 26.72 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.602 -0.94 . . . . 0.0 109.173 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.3 175.95 26.07 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.166 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 30' ' ' THR . 28.7 t30 -148.37 172.19 14.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -1.081 . . . . 0.0 109.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.99 -10.51 14.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 0.0 110.318 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.96 -43.58 7.1 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.924 HD21 ' CE2' ' A' ' 31' ' ' TYR . 2.3 pt? -154.12 -160.86 1.14 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -1.193 . . . . 0.0 110.436 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.518 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 3.4 m-20 -149.91 113.46 4.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.286 -0.884 . . . . 0.0 110.294 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.588 HD11 ' CD2' ' A' ' 31' ' ' TYR . 96.9 mt -71.58 -54.47 10.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 110.202 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.77 -160.34 27.71 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 7.5 p80 -158.35 140.62 14.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.267 -1.137 . . . . 0.0 109.999 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.694 HG11 HG12 ' A' ' 6' ' ' VAL . 15.9 t -103.04 124.1 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.112 -0.992 . . . . 0.0 110.587 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.61 103.21 3.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.256 -0.902 . . . . 0.0 109.956 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.498 ' HB3' HD12 ' A' ' 12' ' ' LEU . 12.8 mt -83.01 127.61 33.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.21 -0.931 . . . . 0.0 110.314 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 109' ' ' PHE . 37.4 m -94.61 171.18 8.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.205 -0.935 . . . . 0.0 110.297 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.505 ' N ' HG22 ' A' ' 108' ' ' THR . 1.2 m-85 -145.25 154.49 42.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.391 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.867 ' HB2' HD21 ' A' ' 102' ' ' LEU . 44.3 Cg_endo . . . . . 0 N--CA 1.483 0.883 0 N-CA-C 109.873 -0.857 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -156.6 149.12 23.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.863 -1.148 . . . . 0.0 111.552 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.446 ' CE2' HG23 ' A' ' 105' ' ' VAL . 44.5 t80 -151.14 107.07 3.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.597 -0.689 . . . . 0.0 109.322 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.48 151.35 43.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.968 -1.083 . . . . 0.0 111.51 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.75 ' CG1' HG11 ' A' ' 105' ' ' VAL . 7.8 p -133.12 132.77 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.642 -0.661 . . . . 0.0 109.425 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.612 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -63.22 -66.74 1.36 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.038 -1.039 . . . . 0.0 110.839 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 50.9 Cg_endo -73.44 83.29 1.52 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.6 1.316 . . . . 0.0 110.667 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.7 4.62 53.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.112 -0.992 . . . . 0.0 110.005 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.8 p -151.75 170.38 19.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.95 55.92 28.19 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.519 ' CD1' HD22 ' A' ' 107' ' ' LEU . 58.0 mt -107.86 145.38 33.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -1.081 . . . . 0.0 109.953 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 0.4 OUTLIER -119.55 158.11 26.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 110.541 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 14' ' ' ASP . 41.0 t0 -59.34 124.04 18.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.894 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.01 -32.01 6.78 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.453 ' HB3' ' O ' ' A' ' 13' ' ' SER . 37.9 tt0 -56.9 146.38 26.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.305 -1.115 . . . . 0.0 109.985 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 11.3 m -102.37 153.22 20.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.57 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.655 HG23 ' HB3' ' A' ' 65' ' ' PHE . 6.3 m -116.8 153.32 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.337 -0.852 . . . . 0.0 109.818 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -97.79 109.18 21.98 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.16 -0.962 . . . . 0.0 110.055 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.45 ' CG2' HG23 ' A' ' 6' ' ' VAL . 46.2 t -111.17 157.6 11.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 121.435 -0.791 . . . . 0.0 109.846 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 m -150.59 117.3 5.81 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.257 -0.902 . . . . 0.0 110.383 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 4.2 t -105.25 123.7 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 0.0 109.892 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.555 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.1 OUTLIER -132.86 155.76 48.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.995 -1.066 . . . . 0.0 110.499 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 106.63 -35.74 4.85 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.693 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -68.34 -150.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.306 -1.114 . . . . 0.0 109.747 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 25' ' ' ALA . . . 176.19 147.68 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.859 -1.151 . . . . 0.0 111.339 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -39.41 143.28 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.611 0.72 . . . . 0.0 110.415 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.45 18.47 14.49 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.623 ' O ' HG23 ' A' ' 54' ' ' THR . 4.5 tp10 -151.02 135.64 17.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.227 -1.161 . . . . 0.0 110.745 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.54 HG23 ' OG1' ' A' ' 54' ' ' THR . 3.7 m -114.3 145.15 42.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.751 ' CE1' HG23 ' A' ' 55' ' ' THR . 24.5 m-85 -128.34 179.58 5.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -0.95 . . . . 0.0 110.504 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -132.33 100.69 5.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.208 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.76 HG23 ' O ' ' A' ' 33' ' ' ILE . 7.6 tt -89.0 103.25 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -0.922 . . . . 0.0 110.134 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.497 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -138.7 163.24 32.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.139 -0.975 . . . . 0.0 110.555 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.434 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 18.0 pt20 -128.77 148.75 50.88 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.16 -0.962 . . . . 0.0 110.269 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 1.8 m -145.5 172.93 12.51 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.213 -0.929 . . . . 0.0 110.389 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.25 161.57 35.87 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.533 -0.729 . . . . 0.0 109.409 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.665 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 43.7 Cg_endo -71.4 171.78 15.48 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.713 1.375 . . . . 0.0 110.329 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.1 -1.0 . . . . 0.0 110.402 -179.924 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 1.8 p30 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.266 0.555 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.687 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -108.49 147.12 32.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.37 -0.832 . . . . 0.0 109.163 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 12.2 t -124.14 170.41 10.73 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.793 -1.192 . . . . 0.0 111.007 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.438 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 8.4 t-20 -105.76 119.61 51.91 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 109.995 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.79 -35.04 3.62 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.871 1.459 . . . . 0.0 110.41 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.14 73.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.276 -0.89 . . . . 0.0 110.213 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.6 p -75.65 -16.71 60.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.317 -0.865 . . . . 0.0 109.983 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -76.26 87.93 3.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.837 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 33' ' ' ILE . 12.0 t -112.46 148.4 34.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.264 -0.898 . . . . 0.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 p -93.58 132.46 37.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.35 -0.844 . . . . 0.0 109.86 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 35.3 p90 -133.34 124.51 27.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.12 -0.988 . . . . 0.0 110.698 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 29' ' ' GLU . 47.3 m -89.22 153.87 20.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 110.345 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.751 HG23 ' CE1' ' A' ' 31' ' ' TYR . 1.8 p -61.67 -158.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.297 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 9.2 m-20 -149.18 -160.24 1.15 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.853 -1.154 . . . . 0.0 110.675 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.51 76.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.163 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.8 m -85.9 13.3 7.65 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.564 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 54.25 23.58 26.18 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -110.94 114.94 28.64 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.456 -1.026 . . . . 0.0 110.434 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.28 80.01 1.27 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.505 -0.747 . . . . 0.0 110.096 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -103.67 143.92 32.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.431 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -172.79 169.78 4.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.135 -0.978 . . . . 0.0 111.055 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.62 92.45 8.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.31 -0.869 . . . . 0.0 110.112 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.655 ' HB3' HG23 ' A' ' 18' ' ' VAL . 77.7 t80 -73.39 -174.97 1.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.438 -0.789 . . . . 0.0 109.505 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.521 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.1 t -138.66 155.42 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.883 -1.136 . . . . 0.0 109.561 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 12' ' ' LEU . 33.0 m -136.28 144.9 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.032 -1.043 . . . . 0.0 110.535 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.01 138.43 50.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -0.843 . . . . 0.0 110.228 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -64.16 -58.76 5.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.865 . . . . 0.0 110.234 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 p -130.04 155.23 46.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.269 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 11.0 p90 -168.35 158.3 9.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 109.796 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.7 OUTLIER -62.58 127.59 32.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.157 -0.965 . . . . 0.0 110.191 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.505 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -96.05 168.1 25.7 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 13.2 t . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.182 -1.187 . . . . 0.0 110.308 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 15.9 p . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.321 0.581 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.687 HG21 ' HB3' ' A' ' 44' ' ' ALA . 53.0 t -138.53 142.34 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.34 -0.85 . . . . 0.0 109.635 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.3 137.92 41.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.017 -1.052 . . . . 0.0 110.672 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 91' ' ' CYS . 65.1 m -93.19 27.48 2.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.44 -51.55 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.44 -0.787 . . . . 0.0 109.976 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.446 ' H ' HG22 ' A' ' 88' ' ' THR . 4.4 t -97.64 -20.25 17.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.35 -0.843 . . . . 0.0 109.654 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.665 ' HB1' ' HG2' ' A' ' 38' ' ' PRO . . . -96.79 -161.85 0.91 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.361 -0.837 . . . . 0.0 109.77 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.49 130.88 56.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 110.59 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 86' ' ' CYS . 0.5 OUTLIER -107.3 116.39 31.85 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.342 -0.849 . . . . 0.0 109.551 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 91' ' ' CYS . 42.9 m-20 -130.77 136.35 48.63 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.966 -1.084 . . . . 0.0 111.268 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 34' ' ' ALA . 2.6 tp -107.12 118.27 36.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.491 -0.756 . . . . 0.0 109.671 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -111.21 161.3 12.84 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.28 170.82 17.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.337 -1.096 . . . . 0.0 110.195 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.32 167.96 12.65 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.494 ' HB3' ' O ' ' A' ' 30' ' ' THR . 4.2 p-10 -118.4 -151.12 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 110.405 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.18 89.59 4.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.229 -0.919 . . . . 0.0 110.377 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.56 -21.53 3.59 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.845 HD21 ' HG3' ' A' ' 2' ' ' PRO . 2.9 tm? -103.81 -76.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.379 -1.071 . . . . 0.0 109.913 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.713 ' N ' HD13 ' A' ' 100' ' ' LEU . 4.3 t70 70.09 138.29 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.207 -0.933 . . . . 0.0 110.726 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.867 HD21 ' HB2' ' A' ' 2' ' ' PRO . 4.2 mt -133.0 -42.13 0.9 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.423 -0.798 . . . . 0.0 110.372 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.81 -149.01 20.39 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.43 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 14.2 p80 -158.74 134.39 8.78 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.253 -1.146 . . . . 0.0 110.312 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.75 HG11 ' CG1' ' A' ' 6' ' ' VAL . 2.5 t -86.16 161.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.387 -0.821 . . . . 0.0 109.593 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.98 124.93 48.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 0.0 110.242 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.519 HD22 ' CD1' ' A' ' 12' ' ' LEU . 79.3 mt -100.78 85.82 2.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.619 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.5 m -68.42 162.94 24.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.756 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.458 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 5.2 m-85 -136.52 75.76 1.56 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.144 -0.972 . . . . 0.0 110.382 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.358 0 CA-C-O 118.025 -1.43 . . . . 0.0 109.623 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.476 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 49.3 Cg_endo . . . . . 0 N--CA 1.48 0.685 0 N-CA-C 110.425 -0.644 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -162.21 79.49 0.52 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.126 -0.984 . . . . 0.0 110.527 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.529 ' HD1' HG22 ' A' ' 22' ' ' VAL . 25.0 t80 -91.37 114.9 27.55 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.056 -1.028 . . . . 0.0 109.718 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.6 p -150.81 152.44 33.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.044 -1.035 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.745 HG12 HG11 ' A' ' 105' ' ' VAL . 8.0 p -120.37 123.31 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.569 -0.707 . . . . 0.0 109.574 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.614 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 m -45.94 -67.95 0.34 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.999 . . . . 0.0 110.122 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.614 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 48.6 Cg_endo -76.15 78.98 3.04 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.342 1.18 . . . . 0.0 110.014 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.481 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -99.59 6.57 45.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 110.282 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -158.24 148.51 20.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.928 . . . . 0.0 110.338 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.63 67.61 1.92 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.55 ' CD1' HD22 ' A' ' 107' ' ' LEU . 11.8 mt -122.22 173.62 7.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.387 -1.067 . . . . 0.0 110.162 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -137.83 157.3 46.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.158 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -60.82 109.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.135 -0.978 . . . . 0.0 110.26 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.85 -39.34 2.82 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.43 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.2 tm0? -46.38 141.07 3.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.145 -1.209 . . . . 0.0 109.941 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.78 152.99 21.02 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.952 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.637 HG11 HG11 ' A' ' 67' ' ' VAL . 5.6 m -126.98 166.44 23.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.4 t -119.36 130.34 55.29 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.141 -0.974 . . . . 0.0 110.174 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.9 t -117.25 144.6 24.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 O-C-N 121.602 -0.686 . . . . 0.0 109.792 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 40.2 t -150.99 134.52 16.31 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.296 -0.878 . . . . 0.0 110.494 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.529 HG22 ' HD1' ' A' ' 4' ' ' PHE . 22.5 t -122.66 111.9 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.764 . . . . 0.0 110.092 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.64 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 58.8 m -125.47 113.34 17.36 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.083 -1.011 . . . . 0.0 111.068 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 154.16 -38.11 0.69 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -69.49 -141.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -1.146 . . . . 0.0 109.807 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 25' ' ' ALA . . . 176.0 160.31 0.3 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.152 -0.968 . . . . 0.0 110.445 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.76 133.35 31.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.735 . . . . 0.0 110.417 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.424 ' O ' ' CD ' ' A' ' 29' ' ' GLU . . . 127.35 12.17 3.19 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.524 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 73.5 mm-40 -152.18 144.61 24.09 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.949 -1.324 . . . . 0.0 110.545 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.403 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 23.7 m -122.36 148.37 45.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.416 -0.803 . . . . 0.0 109.791 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.721 ' HE2' HD22 ' A' ' 100' ' ' LEU . 9.6 m-85 -140.02 -177.14 4.86 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.07 -1.018 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.589 ' CD1' ' HB3' ' A' ' 52' ' ' SER . 19.0 m-85 -132.81 124.83 28.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -108.53 117.0 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.877 -1.14 . . . . 0.0 110.916 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.612 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -152.53 151.16 30.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 110.471 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.534 ' HB2' HD13 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -103.1 135.22 45.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.382 -0.824 . . . . 0.0 109.529 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 1.5 m -146.58 173.06 12.67 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.082 -1.011 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.02 152.35 31.3 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.524 -0.735 . . . . 0.0 109.466 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.41 156.41 61.71 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.689 1.363 . . . . 0.0 110.96 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.489 -0.757 . . . . 0.0 110.109 -179.945 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.244 0.545 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.744 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -126.85 152.22 47.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.863 . . . . 0.0 109.801 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 10.4 t -129.56 165.16 22.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 110.283 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -86.86 112.06 44.59 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.194 -0.941 . . . . 0.0 110.109 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.7 Cg_endo -74.49 -27.65 10.85 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.94 1.495 . . . . 0.0 110.661 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.46 -23.62 67.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.171 -0.956 . . . . 0.0 110.285 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.526 HG21 ' HE ' ' A' ' 68' ' ' ARG . 4.9 p -113.1 26.62 10.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.208 -0.932 . . . . 0.0 110.375 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.7 143.36 33.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.22 -0.925 . . . . 0.0 110.068 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.482 HG23 HG23 ' A' ' 33' ' ' ILE . 7.5 t -170.35 137.33 1.45 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.015 . . . . 0.0 110.627 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.589 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 5.4 p -107.6 155.79 19.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.305 -0.872 . . . . 0.0 110.548 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 31' ' ' TYR . 12.3 p90 -151.93 -178.31 6.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.167 -0.958 . . . . 0.0 110.556 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 29' ' ' GLU . 31.2 m -141.16 168.67 19.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.458 -0.776 . . . . 0.0 109.64 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.425 ' N ' HG22 ' A' ' 54' ' ' THR . 1.0 OUTLIER -74.2 -164.7 0.26 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.956 -1.09 . . . . 0.0 110.462 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.35 -162.18 1.31 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.858 . . . . 0.0 109.779 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.04 -58.0 10.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -0.962 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 p -90.7 23.71 2.98 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.325 -0.859 . . . . 0.0 108.962 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 57.61 39.35 90.88 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -106.86 124.44 49.62 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.34 -1.094 . . . . 0.0 110.564 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -132.29 84.43 2.15 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.342 -0.849 . . . . 0.0 109.504 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 57.1 m -110.94 120.76 43.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 110.526 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.634 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 2.2 p90 -143.82 170.98 14.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 110.649 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 p -93.32 122.15 35.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.376 -0.828 . . . . 0.0 110.671 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.426 ' HB3' HG23 ' A' ' 18' ' ' VAL . 9.1 t80 -116.87 -169.62 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.489 -0.757 . . . . 0.0 109.206 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.412 HG23 ' C ' ' A' ' 65' ' ' PHE . 11.2 t -145.51 165.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.8 -1.188 . . . . 0.0 109.623 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.637 HG11 HG11 ' A' ' 18' ' ' VAL . 34.2 m -130.43 152.95 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.069 -1.019 . . . . 0.0 110.789 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.526 ' HE ' HG21 ' A' ' 49' ' ' THR . 0.0 OUTLIER -133.42 150.46 51.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.339 -0.851 . . . . 0.0 109.96 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.573 ' HE2' ' CG ' ' A' ' 109' ' ' PHE . 3.2 ttmt -83.42 -36.99 23.81 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.097 -1.002 . . . . 0.0 110.553 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 p -136.04 150.01 49.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.197 -0.94 . . . . 0.0 110.092 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.561 ' CZ ' HG11 ' A' ' 84' ' ' VAL . 16.4 p90 -161.34 166.11 27.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.254 -0.904 . . . . 0.0 110.328 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -88.53 117.53 27.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.218 -0.926 . . . . 0.0 110.061 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.744 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -101.37 154.78 19.02 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 2.5 p . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.312 -1.111 . . . . 0.0 110.017 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.369 0.604 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.561 HG11 ' CZ ' ' A' ' 71' ' ' TYR . 49.4 t -139.18 102.8 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.383 -0.823 . . . . 0.0 109.806 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -93.88 126.06 38.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.369 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 3.5 m -85.92 4.13 38.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.821 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.17 -63.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 109.991 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.429 HG23 ' N ' ' A' ' 89' ' ' ALA . 13.3 t -72.85 -33.86 66.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.268 -0.895 . . . . 0.0 110.009 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.429 ' N ' HG23 ' A' ' 88' ' ' THR . . . -93.35 -177.77 4.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.326 -0.859 . . . . 0.0 109.919 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.48 139.17 38.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.373 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.34 130.47 54.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.64 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.422 ' ND2' ' N ' ' A' ' 92' ' ' ASN . 3.1 m-80 -133.93 163.69 28.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 110.796 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.612 HD12 ' O ' ' A' ' 34' ' ' ALA . 41.2 tp -127.58 111.12 13.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 0.0 109.214 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.27 165.49 18.36 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.056 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -157.38 101.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -1.072 . . . . 0.0 110.105 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.83 174.88 46.96 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.489 ' CG ' ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -123.46 -155.01 0.63 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.068 -1.254 . . . . 0.0 109.88 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.489 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 11.3 p -99.97 78.14 2.08 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.31 -36.19 0.24 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.155 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.721 HD22 ' HE2' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -109.17 -47.52 3.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.908 -1.348 . . . . 0.0 110.744 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 100' ' ' LEU . 33.7 m-20 54.27 105.79 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.293 -0.88 . . . . 0.0 110.12 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 2' ' ' PRO . 5.4 mt -94.43 -60.96 1.6 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 0.0 110.467 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 159.94 -162.5 33.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 15.7 p80 -151.29 132.39 14.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.295 -1.121 . . . . 0.0 110.261 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.745 HG11 HG12 ' A' ' 6' ' ' VAL . 16.1 t -87.2 130.1 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.188 -0.945 . . . . 0.0 110.011 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.56 123.2 28.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.0 110.16 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.55 HD22 ' CD1' ' A' ' 12' ' ' LEU . 39.4 mt -92.89 170.06 9.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 0.0 110.586 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.552 HG22 ' N ' ' A' ' 109' ' ' PHE . 85.3 m -141.74 171.82 13.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.408 -0.807 . . . . 0.0 109.794 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.573 ' CG ' ' HE2' ' A' ' 69' ' ' LYS . 3.0 m-85 -146.08 115.76 7.24 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.861 . . . . 0.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 N--CA 1.48 0.72 0 N-CA-C 110.133 -0.756 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -140.49 129.57 23.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 110.52 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -148.96 99.23 2.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 0.0 109.538 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.5 p -148.01 148.27 30.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.757 HG12 HG11 ' A' ' 105' ' ' VAL . 10.1 p -106.15 159.52 6.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.622 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -74.15 -71.01 0.23 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.889 -1.132 . . . . 0.0 109.832 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.622 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 55.4 Cg_endo -77.8 84.68 1.94 Allowed 'Trans proline' 0 C--N 1.322 -0.853 0 O-C-N 123.209 1.11 . . . . 0.0 110.366 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 107' ' ' LEU . . . -73.92 -14.2 61.02 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.89 -1.131 . . . . 0.0 109.667 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.8 t -139.58 162.29 35.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.627 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.24 47.49 10.83 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.63 ' CD1' HD22 ' A' ' 107' ' ' LEU . 14.0 mt -101.28 170.67 8.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.383 -1.069 . . . . 0.0 109.962 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 m -145.61 162.16 38.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.041 -1.037 . . . . 0.0 111.012 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.41 125.64 24.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.24 -26.8 7.43 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.467 ' OE1' ' N ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -51.22 138.62 20.28 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.345 -1.091 . . . . 0.0 110.29 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.467 ' N ' ' OE1' ' A' ' 16' ' ' GLN . 1.3 t -99.76 122.13 42.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.464 -0.773 . . . . 0.0 109.88 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 65' ' ' PHE . 34.9 m -98.9 168.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.981 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.7 m -116.44 120.48 38.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.975 . . . . 0.0 110.24 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.78 152.52 8.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.347 -0.845 . . . . 0.0 109.945 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.7 t -142.45 125.0 15.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.758 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 48.2 t -116.01 147.51 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.455 -0.778 . . . . 0.0 109.819 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 3' ' ' ALA . 11.8 t -160.24 153.55 22.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.082 -1.012 . . . . 0.0 110.189 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.34 -47.18 1.07 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -60.22 -154.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.322 -1.105 . . . . 0.0 110.204 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.536 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -176.11 143.57 0.55 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 110.481 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -30.77 130.72 0.1 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.43 0.633 . . . . 0.0 111.236 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.455 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 112.61 6.37 23.38 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.475 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 1.6 mt-10 -131.81 121.37 24.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.12 -1.223 . . . . 0.0 110.278 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.576 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 57.6 m -104.22 147.15 27.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.986 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.672 ' CE1' HD22 ' A' ' 100' ' ' LEU . 16.2 m-85 -134.7 168.66 18.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.909 . . . . 0.0 110.4 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 17.7 m-85 -126.53 118.59 25.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.347 -0.846 . . . . 0.0 109.698 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.66 ' CG2' HG23 ' A' ' 51' ' ' THR . 7.8 tt -98.63 124.37 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 110.555 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.67 155.67 37.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.852 . . . . 0.0 110.235 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.415 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 26.6 tt0 -110.03 142.62 41.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 70.9 m -148.78 163.46 37.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.974 -1.079 . . . . 0.0 110.772 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -146.13 166.16 18.01 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.519 -0.738 . . . . 0.0 109.42 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 43.5 Cg_endo -71.54 163.49 38.83 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.736 1.387 . . . . 0.0 110.464 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 39' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.175 -0.953 . . . . 0.0 110.477 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.242 0.544 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -86.04 173.4 9.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.54 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.0 m -140.76 154.98 46.51 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.027 -1.046 . . . . 0.0 111.061 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.573 ' OD1' ' CG ' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -89.51 116.41 66.27 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.35 -0.844 . . . . 0.0 110.082 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -85.2 -31.17 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.876 1.461 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.11 -10.53 54.71 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.311 -0.868 . . . . 0.0 110.663 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 63.6 p -124.95 25.5 7.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.094 -1.004 . . . . 0.0 110.399 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.79 108.54 18.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.068 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.66 HG23 ' CG2' ' A' ' 33' ' ' ILE . 10.1 t -130.95 157.15 43.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.892 . . . . 0.0 110.421 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.508 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 74.2 p -126.51 152.88 45.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.848 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 12.1 p90 -148.3 -179.6 7.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.422 -0.799 . . . . 0.0 109.549 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.6 m -143.33 161.23 38.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.937 -1.102 . . . . 0.0 110.306 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.621 HG21 ' HB1' ' A' ' 25' ' ' ALA . 21.8 p -65.11 -154.66 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.342 -0.849 . . . . 0.0 109.966 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -160.27 -158.8 0.65 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.142 -0.974 . . . . 0.0 110.422 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.7 -48.71 80.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.889 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.32 9.35 11.08 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.338 -0.852 . . . . 0.0 109.438 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 54.98 51.47 53.45 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.74 152.36 47.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.309 -1.112 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.758 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -141.22 81.79 1.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.577 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.3 m -104.0 118.79 37.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 20.1 p90 -155.16 177.54 11.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.135 -0.978 . . . . 0.0 111.073 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.31 131.3 41.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.644 -0.66 . . . . 0.0 110.445 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.743 ' O ' HG22 ' A' ' 18' ' ' VAL . 59.3 t80 -121.88 137.07 54.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.452 -0.78 . . . . 0.0 108.989 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.5 154.02 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.17 151.66 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.498 -0.751 . . . . 0.0 110.273 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.88 179.29 4.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.177 -0.952 . . . . 0.0 110.73 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.46 ' HG3' ' CE2' ' A' ' 109' ' ' PHE . 24.0 tttm -100.96 -30.43 11.65 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.777 0.799 . . . . 0.0 108.899 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.55 163.92 37.26 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.573 ' CG ' ' OD1' ' A' ' 46' ' ' ASN . 16.6 p90 -170.9 156.57 5.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.913 -1.117 . . . . 0.0 110.031 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 m -71.84 136.98 47.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.185 -0.947 . . . . 0.0 110.715 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.46 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -106.87 162.74 13.46 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.241 -1.152 . . . . 0.0 110.172 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.405 0.621 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' A' ' 44' ' ' ALA . 95.5 t -98.78 160.52 3.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.359 -0.838 . . . . 0.0 109.643 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -153.14 134.82 14.5 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 110.546 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 67.7 m -95.07 14.16 22.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.982 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.06 -45.16 9.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.258 -0.901 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.2 t -98.84 -16.75 18.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.313 -0.867 . . . . 0.0 110.142 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.59 -143.59 0.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.861 . . . . 0.0 110.195 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.39 155.64 35.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 110.01 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.77 125.27 29.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.289 -0.882 . . . . 0.0 109.904 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 20.6 p30 -134.25 137.06 44.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 110.418 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 104' ' ' HIS . 1.4 tp -108.41 137.19 46.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.687 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.545 ' HA3' ' ND1' ' A' ' 104' ' ' HIS . . . -134.72 159.86 24.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -134.34 156.39 48.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.374 -1.074 . . . . 0.0 110.052 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 32' ' ' TYR . . . 142.42 162.99 9.48 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.449 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 14.1 p-10 -133.49 -151.01 0.43 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.203 -1.175 . . . . 0.0 110.455 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 p -91.7 95.1 9.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.307 -0.871 . . . . 0.0 110.274 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 132.91 -18.45 4.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.872 HD23 ' N ' ' A' ' 101' ' ' ASP . 8.0 tt -154.93 151.42 28.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.172 -1.193 . . . . 0.0 110.442 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.872 ' N ' HD23 ' A' ' 100' ' ' LEU . 1.8 p30 -135.6 162.58 32.31 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.375 -0.828 . . . . 0.0 109.796 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.6 mt -119.57 -85.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.102 -0.999 . . . . 0.0 110.397 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.539 ' C ' ' CD2' ' A' ' 104' ' ' HIS . . . -168.84 -169.24 32.0 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.545 ' ND1' ' HA3' ' A' ' 94' ' ' GLY . 38.1 m-70 -142.74 120.49 11.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -1.134 . . . . 0.0 110.234 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.757 HG11 HG12 ' A' ' 6' ' ' VAL . 85.4 t -89.39 129.12 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -0.877 . . . . 0.0 109.853 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.3 112.12 11.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.044 -1.035 . . . . 0.0 110.434 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.63 HD22 ' CD1' ' A' ' 12' ' ' LEU . 72.0 mt -87.58 172.64 9.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 110.037 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.428 ' OG1' ' C ' ' A' ' 107' ' ' LEU . 1.4 m -162.8 159.64 24.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.286 -0.884 . . . . 0.0 110.117 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.46 ' CE2' ' HG3' ' A' ' 69' ' ' LYS . 15.1 m-85 -129.61 164.16 24.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 110.447 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 CA-C-O 117.948 -1.473 . . . . 0.0 109.5 179.991 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.532 ' HG2' ' HA ' ' A' ' 102' ' ' LEU . 45.2 Cg_endo . . . . . 0 N--CA 1.482 0.813 0 N-CA-C 110.283 -0.699 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -119.52 134.71 55.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.247 -0.908 . . . . 0.0 110.559 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.481 ' HD1' HG22 ' A' ' 22' ' ' VAL . 72.7 t80 -151.51 113.62 4.52 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.424 -0.797 . . . . 0.0 109.858 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.61 156.84 42.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.011 -1.056 . . . . 0.0 111.046 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.007 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 4.4 p -118.91 165.26 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.805 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -74.36 -65.25 0.59 Allowed Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.001 -1.062 . . . . 0.0 110.814 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.726 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 41.9 Cg_endo -71.08 -79.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.559 1.294 . . . . 0.0 110.827 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 1.007 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 70.85 19.33 5.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.205 -0.934 . . . . 0.0 110.0 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 t 178.3 148.78 0.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 110.167 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.49 59.71 9.79 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.505 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 1.2 mt -104.39 178.16 4.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.292 -1.123 . . . . 0.0 110.715 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 16' ' ' GLN . 3.2 m -134.35 142.3 47.17 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.416 -0.803 . . . . 0.0 110.015 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 10.0 p-10 -56.93 106.03 0.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.946 . . . . 0.0 110.272 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.45 -45.1 1.32 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.505 ' OE1' ' HA ' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -47.1 157.62 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -1.107 . . . . 0.0 109.703 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -101.09 178.72 4.58 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.361 -0.837 . . . . 0.0 110.443 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.575 HG11 HG11 ' A' ' 67' ' ' VAL . 5.8 m -146.33 152.83 13.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.547 -0.721 . . . . 0.0 109.428 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.506 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -97.41 140.05 32.43 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 109.986 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.413 HG11 ' CZ ' ' A' ' 63' ' ' PHE . 14.7 t -129.1 149.07 33.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.142 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.89 129.07 17.68 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.492 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.794 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 52.1 t -119.92 143.58 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.601 -0.687 . . . . 0.0 109.755 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -155.65 177.55 11.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.048 -1.033 . . . . 0.0 110.307 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.74 -38.69 3.15 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.575 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -67.32 -151.43 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.16 -1.2 . . . . 0.0 110.673 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.599 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -172.84 159.15 4.08 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.224 -0.922 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.885 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -50.45 125.38 12.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.541 -0.725 . . . . 0.0 110.463 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.412 ' O ' ' OE1' ' A' ' 29' ' ' GLU . . . 124.79 13.18 3.79 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 6.5 mm-40 -144.14 120.79 11.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.037 -1.272 . . . . 0.0 110.874 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.421 HG23 ' OG1' ' A' ' 54' ' ' THR . 60.4 m -105.06 132.75 50.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.529 -0.732 . . . . 0.0 109.255 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.852 ' CE1' HD22 ' A' ' 100' ' ' LEU . 31.4 m-85 -120.77 173.86 6.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.956 -1.09 . . . . 0.0 111.246 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -130.27 123.35 29.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.658 -0.651 . . . . 0.0 109.697 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.839 ' CG2' HG23 ' A' ' 51' ' ' THR . 14.3 tt -100.44 125.2 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.131 -0.98 . . . . 0.0 110.651 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.62 146.53 25.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -0.906 . . . . 0.0 110.604 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -98.78 147.69 24.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.854 . . . . 0.0 109.239 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.6 m -144.35 155.9 44.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.028 -1.045 . . . . 0.0 111.512 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.425 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -154.0 141.33 13.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.38 166.19 24.43 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.63 1.332 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.852 HG11 HG22 ' A' ' 84' ' ' VAL . 4.2 m . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.312 -0.867 . . . . 0.0 110.591 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.253 0.549 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.451 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -147.82 145.01 28.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.502 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 18.4 m -128.23 178.21 6.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.015 . . . . 0.0 110.236 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.456 ' O ' ' CG ' ' A' ' 46' ' ' ASN . 15.3 p-10 -101.44 106.02 43.5 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 50.2 Cg_endo -88.12 -39.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.773 1.407 . . . . 0.0 110.65 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.98 -4.6 17.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 110.631 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.404 ' OG1' ' HB2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -130.6 25.34 5.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.092 -1.005 . . . . 0.0 110.144 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.06 143.24 29.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.303 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.839 HG23 ' CG2' ' A' ' 33' ' ' ILE . 2.9 t -148.83 162.63 39.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 0.0 109.897 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.0 p -134.56 154.53 51.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.166 -0.959 . . . . 0.0 110.452 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 11.2 p90 -145.41 -177.6 5.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.758 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.421 ' OG1' HG23 ' A' ' 30' ' ' THR . 24.1 m -149.69 160.35 43.6 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 110.399 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.575 HG21 ' CB ' ' A' ' 25' ' ' ALA . 2.2 p -77.01 -160.94 0.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.35 -0.844 . . . . 0.0 110.487 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.885 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 16.3 p-10 -158.22 -147.38 0.17 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.953 -1.092 . . . . 0.0 111.115 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.569 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -84.72 71.36 10.83 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.056 0.932 . . . . 0.0 108.985 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER 154.67 -13.56 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.599 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.97 66.12 2.12 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.33 129.37 18.55 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.259 -1.142 . . . . 0.0 110.789 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.794 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -130.17 83.9 2.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 110.007 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.4 m -100.35 123.76 44.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.544 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 6.9 p90 -158.77 176.04 12.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.24 -0.912 . . . . 0.0 110.556 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.2 t -101.66 158.7 15.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.721 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 85.7 t80 -147.02 -176.88 5.38 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.562 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.8 t -133.58 158.46 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.386 -1.446 . . . . 0.0 110.5 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.575 HG11 HG11 ' A' ' 18' ' ' VAL . 20.4 m -130.32 159.75 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.782 . . . . 0.0 109.471 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 13.4 mtm180 -143.63 112.01 6.36 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.373 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 68' ' ' ARG . 4.5 ttpm? -44.72 -50.33 10.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 108.875 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.08 111.02 17.77 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 36.1 p90 -121.26 131.84 54.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.213 -0.929 . . . . 0.0 110.816 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 26.1 m -61.64 124.38 20.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.451 -0.781 . . . . 0.0 110.303 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.4 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -95.69 -166.14 34.7 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 110.517 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.7 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.159 0.504 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.852 HG22 HG11 ' A' ' 39' ' ' VAL . 98.8 t -108.62 102.08 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.231 -0.918 . . . . 0.0 109.904 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.8 OUTLIER -98.82 120.32 39.06 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.417 -0.802 . . . . 0.0 109.575 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.82 37.26 0.58 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 110.717 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.59 -36.83 43.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.166 -0.958 . . . . 0.0 109.3 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.9 t -109.91 -11.5 14.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.433 -0.792 . . . . 0.0 109.48 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.06 -171.15 1.79 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.396 -0.815 . . . . 0.0 110.158 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.19 128.33 49.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.928 . . . . 0.0 110.14 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.1 m -93.78 151.79 19.37 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.102 -0.999 . . . . 0.0 109.861 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -142.88 123.89 14.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 110.694 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.552 HD11 HG12 ' A' ' 33' ' ' ILE . 16.4 tp -92.49 112.65 24.68 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.542 ' HA3' ' NE2' ' A' ' 104' ' ' HIS . . . -115.44 166.67 12.24 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.253 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.709 ' HB1' HD12 ' A' ' 102' ' ' LEU . . . -144.56 162.96 35.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.515 -0.991 . . . . 0.0 110.062 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 130.14 176.06 14.28 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.484 ' OD1' ' HB3' ' A' ' 100' ' ' LEU . 8.3 p-10 -128.89 -156.16 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.249 . . . . 0.0 110.57 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.71 82.25 7.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.536 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 139.8 -35.87 1.88 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.852 HD22 ' CE1' ' A' ' 31' ' ' TYR . 4.7 tt -115.2 145.45 42.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -1.18 . . . . 0.0 110.336 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.8 121.61 32.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 110.061 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.709 HD12 ' HB1' ' A' ' 95' ' ' ALA . 20.2 mt -77.18 -71.49 0.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.929 . . . . 0.0 110.12 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.36 -173.02 42.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.542 ' NE2' ' HA3' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -147.81 112.28 5.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -1.052 . . . . 0.0 109.895 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.427 HG11 ' CG1' ' A' ' 6' ' ' VAL . 17.5 t -96.12 121.74 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.174 -0.954 . . . . 0.0 110.339 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.46 132.76 43.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.102 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.9 mt -104.81 141.57 36.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.258 -0.901 . . . . 0.0 110.478 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 109' ' ' PHE . 8.7 m -119.07 171.39 8.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.858 . . . . 0.0 109.859 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.401 ' N ' HG22 ' A' ' 108' ' ' THR . 8.8 m-85 -147.73 85.98 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.231 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 CA-C-O 118.007 -1.44 . . . . 0.0 109.504 179.91 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.511 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.6 Cg_endo . . . . . 0 N--CA 1.485 1.004 0 N-CA-C 110.609 -0.574 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -155.85 141.9 18.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.202 -0.936 . . . . 0.0 110.718 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.602 ' CE2' ' CB ' ' A' ' 95' ' ' ALA . 25.2 t80 -150.24 116.92 5.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 t -150.41 164.92 34.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.9 -1.125 . . . . 0.0 111.355 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.961 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 4.8 p -122.2 176.16 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.602 -0.686 . . . . 0.0 109.662 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.6 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.3 m -78.19 -67.54 0.26 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.005 -1.059 . . . . 0.0 110.534 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.738 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 42.8 Cg_endo -72.81 -79.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.929 0 O-C-N 123.358 1.188 . . . . 0.0 110.629 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.961 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 72.66 28.37 2.15 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.355 -0.841 . . . . 0.0 110.513 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER 171.05 119.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.19 -0.944 . . . . 0.0 110.231 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.56 66.63 2.02 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 109' ' ' PHE . 1.5 mp -104.02 159.25 15.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -1.168 . . . . 0.0 110.537 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.502 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 29.0 t -107.76 151.3 25.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 110.028 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.4 127.87 33.27 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.225 -0.922 . . . . 0.0 111.164 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.66 -27.64 6.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 2.4 tt0 -52.35 141.89 18.48 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.291 -1.123 . . . . 0.0 110.596 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.54 148.98 22.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.358 -0.839 . . . . 0.0 109.869 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.528 HG12 ' HG3' ' A' ' 8' ' ' PRO . 24.4 m -129.76 179.76 3.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.794 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.19 134.72 55.22 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.382 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.486 HG11 ' CD1' ' A' ' 33' ' ' ILE . 4.8 t -114.94 150.71 16.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -146.91 124.72 11.9 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.096 -1.003 . . . . 0.0 110.865 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 87.0 t -113.04 141.3 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.575 -0.703 . . . . 0.0 109.579 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.712 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -158.64 144.96 17.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.073 . . . . 0.0 110.666 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 118.85 -54.1 0.64 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.513 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -59.07 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -1.134 . . . . 0.0 109.833 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.544 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.48 169.99 8.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.066 -1.021 . . . . 0.0 110.323 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -59.97 131.69 51.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.532 -0.73 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.15 16.25 4.0 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.516 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 65.5 mm-40 -149.24 132.72 16.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.166 -1.196 . . . . 0.0 110.385 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.434 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 3.6 m -104.28 162.96 12.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.354 -0.841 . . . . 0.0 110.13 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.771 ' CE1' HD13 ' A' ' 100' ' ' LEU . 74.8 m-85 -150.84 173.23 14.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.207 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 52.8 m-85 -133.97 102.88 5.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 109.324 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.839 ' CG2' HG23 ' A' ' 51' ' ' THR . 8.5 tt -89.56 107.95 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.941 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.424 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -147.95 157.22 43.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.158 -0.964 . . . . 0.0 110.803 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.509 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 2.0 tt0 -95.69 123.56 39.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.645 -0.659 . . . . 0.0 109.88 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.429 ' HA ' ' OH ' ' A' ' 71' ' ' TYR . 1.2 m -137.42 154.1 50.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.235 -0.916 . . . . 0.0 110.101 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.522 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -146.59 166.79 15.52 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 0.0 109.247 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 41.4 Cg_endo -69.38 159.03 55.27 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.556 1.293 . . . . 0.0 110.633 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.673 HG12 HG22 ' A' ' 84' ' ' VAL . 16.1 m . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.468 -0.77 . . . . 0.0 110.026 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 4.8 p30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.358 0.599 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.74 157.81 15.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.902 . . . . 0.0 109.755 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.488 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 5.8 t -135.55 165.99 24.24 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.041 -1.037 . . . . 0.0 110.295 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.546 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -83.65 111.65 33.74 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.204 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 48.9 Cg_endo -77.87 -37.53 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.893 1.47 . . . . 0.0 110.32 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.63 98.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.886 . . . . 0.0 110.493 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.48 HG21 ' NE ' ' A' ' 68' ' ' ARG . 1.2 p -96.32 3.38 53.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.261 -0.899 . . . . 0.0 110.425 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -65.85 129.25 39.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.139 -0.975 . . . . 0.0 109.85 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.839 HG23 ' CG2' ' A' ' 33' ' ' ILE . 1.3 t -128.24 131.58 48.78 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.13 -0.982 . . . . 0.0 110.762 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.37 138.14 40.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.445 -0.784 . . . . 0.0 109.393 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 15.8 p90 -141.76 172.21 13.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.051 -1.03 . . . . 0.0 110.547 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.5 m -133.87 162.41 32.11 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 109.375 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.513 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -75.77 -164.74 0.38 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.914 -1.116 . . . . 0.0 110.384 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 27' ' ' ALA . 5.7 m-20 -145.34 -158.31 0.88 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.18 -0.95 . . . . 0.0 109.575 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.27 -50.04 75.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.902 -1.124 . . . . 0.0 109.53 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.4 t -90.36 21.06 4.05 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.349 -0.844 . . . . 0.0 108.813 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.544 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 49.81 32.0 17.39 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.33 140.73 41.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.371 -1.076 . . . . 0.0 110.483 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -145.59 84.96 1.69 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.411 -0.806 . . . . 0.0 109.704 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -99.99 120.95 40.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 109.983 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.2 p90 -150.63 178.39 9.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.223 -0.923 . . . . 0.0 110.831 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.8 p -96.62 139.12 33.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.46 -0.775 . . . . 0.0 111.016 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 50.2 t80 -131.15 176.17 8.49 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.561 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.8 t -124.61 157.09 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 120.727 -1.233 . . . . 0.0 110.299 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 67' ' ' VAL . 13.8 m -134.9 128.35 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.397 -0.814 . . . . 0.0 109.904 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.48 ' NE ' HG21 ' A' ' 49' ' ' THR . 0.0 OUTLIER -115.82 144.38 44.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 110.343 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -56.94 -39.68 75.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.394 -0.816 . . . . 0.0 109.796 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.74 165.54 33.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.418 -0.801 . . . . 0.0 109.828 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.522 ' CB ' ' OD1' ' A' ' 46' ' ' ASN . 19.2 p90 -166.9 147.41 5.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 110.361 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.6 OUTLIER -66.18 118.58 10.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.038 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.48 179.81 25.7 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.287 -1.125 . . . . 0.0 110.055 -179.925 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 11.5 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.344 0.592 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.673 HG22 HG12 ' A' ' 39' ' ' VAL . 72.9 t -133.6 162.04 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.9 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 16.7 p-10 -160.43 161.97 33.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.963 . . . . 0.0 110.302 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 96.7 m -97.95 11.14 38.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.313 -0.867 . . . . 0.0 110.331 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.96 -42.03 14.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.19 -0.944 . . . . 0.0 110.34 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.418 HG22 ' OD2' ' A' ' 85' ' ' ASP . 13.4 t -113.49 -1.08 14.23 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.157 -0.965 . . . . 0.0 110.384 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.51 135.67 44.56 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.241 -0.912 . . . . 0.0 110.61 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.77 105.41 5.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.973 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.487 ' CB ' ' HB2' ' A' ' 37' ' ' ALA . 26.7 p -99.39 140.16 33.98 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.086 -1.009 . . . . 0.0 109.66 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.484 ' OD1' ' HA ' ' A' ' 106' ' ' ALA . 19.1 m-20 -131.05 143.29 50.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.114 -0.991 . . . . 0.0 110.837 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.495 ' HB2' HD11 ' A' ' 107' ' ' LEU . 22.6 tp -88.41 99.41 12.25 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.07 165.45 27.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.731 ' O ' HD12 ' A' ' 102' ' ' LEU . . . -152.28 80.04 1.24 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.412 -1.051 . . . . 0.0 110.386 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -137.25 -167.59 11.12 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.477 ' O ' ' OG ' ' A' ' 98' ' ' SER . 2.2 p-10 -129.4 -63.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.246 . . . . 0.0 110.627 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 97' ' ' ASN . 19.6 m -170.83 -32.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.125 -0.984 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.77 -13.23 5.15 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.712 -1.233 . . . . 0.0 110.411 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.771 HD13 ' CE1' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -94.87 -52.39 4.27 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.972 -1.31 . . . . 0.0 110.532 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.0 p-10 40.61 98.29 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.701 0.762 . . . . 0.0 110.73 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 95' ' ' ALA . 6.7 mt -84.45 -45.44 12.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.016 -1.052 . . . . 0.0 110.104 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.56 -161.82 30.0 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -155.06 142.35 19.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -1.153 . . . . 0.0 110.181 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.47 103.8 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.189 -0.944 . . . . 0.0 110.146 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.484 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . . . -50.62 103.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.893 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.509 ' CD1' ' OE1' ' A' ' 35' ' ' GLN . 54.0 mt -82.83 137.01 34.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 110.144 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.9 167.5 10.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.811 . . . . 0.0 110.092 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 12' ' ' LEU . 3.2 m-85 -142.04 166.83 23.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.927 . . . . 0.0 110.324 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.35 0 CA-C-O 118.008 -1.44 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.515 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 48.2 Cg_endo . . . . . 0 C--O 1.216 -0.589 0 N-CA-C 110.206 -0.728 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.498 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -145.71 145.75 31.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.078 -1.014 . . . . 0.0 110.302 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 39.0 t80 -151.29 113.04 4.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.226 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.47 151.53 36.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.683 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 19' ' ' SER . 9.2 p -128.48 149.19 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.776 . . . . 0.0 109.743 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -67.27 -66.59 1.14 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.052 -1.03 . . . . 0.0 110.191 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.711 ' HB2' HD21 ' A' ' 12' ' ' LEU . 50.4 Cg_endo -75.65 95.29 1.0 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.46 1.242 . . . . 0.0 110.233 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.83 10.56 32.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.097 -1.002 . . . . 0.0 110.311 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.1 t -168.64 154.54 6.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.899 . . . . 0.0 110.084 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.99 56.49 10.65 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.711 HD21 ' HB2' ' A' ' 8' ' ' PRO . 2.7 mt -109.59 166.05 11.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -1.126 . . . . 0.0 110.15 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -128.53 164.34 23.01 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.237 -0.915 . . . . 0.0 110.28 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -62.26 125.45 23.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.316 -0.865 . . . . 0.0 109.94 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 89.61 -31.05 5.38 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.69 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.5 tm0? -42.4 143.9 0.58 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.417 -1.049 . . . . 0.0 110.014 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.463 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 2.1 p -95.55 167.61 11.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 110.287 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 65' ' ' PHE . 30.6 m -147.82 168.21 4.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.323 -0.861 . . . . 0.0 109.762 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.825 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -117.04 137.68 52.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.161 -0.962 . . . . 0.0 110.242 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 t -126.32 152.57 33.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.444 -0.785 . . . . 0.0 109.81 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.11 127.55 14.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.381 -0.824 . . . . 0.0 110.169 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.795 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 10.9 t -119.28 147.63 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.322 -0.861 . . . . 0.0 110.077 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 3' ' ' ALA . 6.2 p -155.52 131.99 10.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.132 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 131.21 -54.28 0.79 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.803 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -58.73 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -1.123 . . . . 0.0 109.074 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.95 156.92 6.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.732 -1.23 . . . . 0.0 110.712 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -43.85 133.08 5.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.7 -0.625 . . . . 0.0 110.133 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 29' ' ' GLU . . . 115.28 11.95 10.26 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 1.8 mt-10 -141.94 116.59 9.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.335 -1.097 . . . . 0.0 110.191 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.2 m -104.21 134.01 48.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.757 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 29' ' ' GLU . 27.4 m-85 -117.88 -174.94 2.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.966 . . . . 0.0 110.81 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 34.5 m-85 -136.07 111.31 9.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.522 -0.736 . . . . 0.0 109.399 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.705 ' CG2' HG23 ' A' ' 51' ' ' THR . 3.8 tt -86.86 112.96 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.888 . . . . 0.0 110.773 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.411 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -148.34 162.95 38.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.533 -0.729 . . . . 0.0 109.887 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 14.8 pt20 -116.29 146.07 42.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.925 . . . . 0.0 110.718 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.6 m -137.81 150.79 47.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.264 -0.897 . . . . 0.0 110.169 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.992 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.32 173.28 4.44 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.304 -0.873 . . . . 0.0 109.264 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.763 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 41.5 Cg_endo -67.71 165.02 29.03 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.736 1.387 . . . . 0.0 110.123 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 39' ' ' VAL . 15.0 p . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.408 0.623 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.473 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -105.79 160.05 15.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.643 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -134.92 162.92 31.05 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.024 -1.047 . . . . 0.0 110.633 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.484 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 3.9 m120 -89.34 115.79 64.65 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.855 . . . . 0.0 110.134 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -90.08 -50.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.896 1.472 . . . . 0.0 111.254 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.98 79.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.389 -0.819 . . . . 0.0 111.52 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 22.4 p -82.7 19.25 1.35 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.09 -1.006 . . . . 0.0 111.108 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -87.1 67.63 9.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.973 -1.08 . . . . 0.0 109.94 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.705 HG23 ' CG2' ' A' ' 33' ' ' ILE . 2.6 t -79.82 164.34 23.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.359 -0.838 . . . . 0.0 110.432 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 94.2 p -118.44 143.39 46.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.289 -0.882 . . . . 0.0 110.769 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.472 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 31.0 p90 -140.55 128.88 22.49 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.274 -0.891 . . . . 0.0 109.962 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 9.3 m -92.15 168.57 11.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 110.829 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.803 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -78.1 -158.89 0.14 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.465 -0.772 . . . . 0.0 110.339 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.37 -161.71 1.23 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.058 -1.026 . . . . 0.0 109.916 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.27 -53.81 54.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.023 -1.048 . . . . 0.0 109.158 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.4 p -84.41 11.36 8.67 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.472 -0.767 . . . . 0.0 109.075 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.533 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 69.91 13.42 69.34 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.21 121.28 28.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -1.123 . . . . 0.0 110.02 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.795 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -118.25 80.79 1.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.977 . . . . 0.0 110.499 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.82 129.63 48.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -0.972 . . . . 0.0 109.924 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 14.8 p90 -168.19 161.49 12.38 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.458 -0.776 . . . . 0.0 110.358 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 m -92.33 133.57 35.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.198 -0.939 . . . . 0.0 110.624 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.81 ' O ' HG22 ' A' ' 18' ' ' VAL . 29.2 t80 -121.73 155.35 35.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 109.323 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.573 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 3.5 t -96.96 160.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.805 -1.184 . . . . 0.0 110.521 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 16' ' ' GLN . 29.7 m -131.77 177.24 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 0.0 109.989 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 2.3 mtt180 -150.35 135.69 17.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 0.0 110.501 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 87' ' ' ALA . 0.9 OUTLIER -67.67 -16.88 64.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -0.961 . . . . 0.0 109.234 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.8 p -150.34 156.39 41.43 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.56 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 16.7 p90 -163.72 144.1 8.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.981 -1.074 . . . . 0.0 110.54 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 28.5 m -65.89 132.93 49.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.892 . . . . 0.0 110.026 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.403 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -112.69 -177.59 19.74 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.9 p . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.192 -1.181 . . . . 0.0 110.188 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.8 m . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.404 0.621 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.473 HG21 ' CB ' ' A' ' 44' ' ' ALA . 54.6 t -128.97 162.27 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.455 -0.778 . . . . 0.0 110.044 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.431 ' N ' HG12 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -138.73 102.06 4.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.218 -0.926 . . . . 0.0 110.46 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 2.7 m -74.52 -2.63 26.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.298 -0.876 . . . . 0.0 110.232 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 69' ' ' LYS . . . -46.72 -45.25 19.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.192 -0.942 . . . . 0.0 109.906 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.1 t -116.69 -10.81 11.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.908 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -94.09 -177.27 4.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.116 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.61 131.84 53.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.903 . . . . 0.0 110.068 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.992 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -127.29 139.49 52.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' A' ' 106' ' ' ALA . 16.0 m-80 -103.85 125.81 50.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.973 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.849 ' HB2' HD11 ' A' ' 107' ' ' LEU . 11.7 tp -88.7 101.96 14.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -108.12 171.57 16.17 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -156.67 120.98 4.43 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.437 -1.037 . . . . 0.0 110.297 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.37 176.36 47.95 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -115.8 -76.89 0.57 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -1.135 . . . . 0.0 109.849 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -168.19 -37.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.408 -0.808 . . . . 0.0 110.097 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.38 -12.14 57.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.637 HD13 ' C ' ' A' ' 100' ' ' LEU . 2.2 tm? -148.5 90.17 1.77 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -1.161 . . . . 0.0 110.053 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.18 134.86 34.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.478 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 4' ' ' PHE . 71.0 mt -82.69 -70.76 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 0.0 110.034 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.415 ' C ' ' CG ' ' A' ' 104' ' ' HIS . . . 168.38 -162.3 36.07 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.459 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -147.96 129.22 14.7 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.482 -1.011 . . . . 0.0 109.612 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.76 HG11 HG12 ' A' ' 6' ' ' VAL . 93.5 t -98.3 108.48 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.092 -1.005 . . . . 0.0 110.6 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.4 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . . . -57.53 105.51 0.25 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.234 -0.916 . . . . 0.0 110.024 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.849 HD11 ' HB2' ' A' ' 93' ' ' LEU . 59.4 mt -82.64 164.51 20.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.24 -0.912 . . . . 0.0 110.374 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.5 m -133.15 168.13 19.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.267 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -153.33 167.35 29.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 CA-C-O 117.949 -1.473 . . . . 0.0 109.522 179.988 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.478 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 45.3 Cg_endo . . . . . 0 N--CA 1.48 0.698 0 N-CA-C 110.144 -0.752 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.893 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -134.4 134.98 42.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.047 -1.033 . . . . 0.0 110.581 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 8.1 t80 -141.24 115.45 9.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.468 -0.77 . . . . 0.0 109.531 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.589 ' HA ' HG21 ' A' ' 105' ' ' VAL . 4.0 t -153.1 172.54 16.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.077 -1.014 . . . . 0.0 110.811 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.999 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 12.0 p -120.8 144.97 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.662 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.583 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -54.66 -62.22 4.46 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.276 -0.89 . . . . 0.0 111.082 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.864 ' HD2' HG22 ' A' ' 6' ' ' VAL . 42.5 Cg_endo -71.85 -78.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.781 1.411 . . . . 0.0 110.629 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.999 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 69.13 14.68 8.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.015 . . . . 0.0 109.879 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.4 t -170.77 148.24 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.336 -0.852 . . . . 0.0 110.297 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.02 56.87 22.28 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.573 ' HB2' ' CE1' ' A' ' 109' ' ' PHE . 58.6 mt -98.28 166.47 11.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -1.129 . . . . 0.0 110.091 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.468 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -129.49 155.65 45.39 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.223 -0.923 . . . . 0.0 110.108 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.526 ' OD2' ' CD ' ' A' ' 68' ' ' ARG . 6.9 t70 -61.68 115.97 4.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 110.387 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 94.24 -28.45 10.79 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 0.2 OUTLIER -41.75 144.02 0.45 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.31 -1.112 . . . . 0.0 110.483 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 p -95.35 125.49 40.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.826 . . . . 0.0 110.193 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.667 HG11 HG11 ' A' ' 67' ' ' VAL . 35.7 m -104.38 -179.07 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.387 -0.82 . . . . 0.0 110.184 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -136.14 114.61 11.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.786 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.4 t -91.4 152.79 3.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.405 -0.81 . . . . 0.0 110.483 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 t -147.41 130.89 16.71 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.474 -0.766 . . . . 0.0 109.331 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.986 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 87.9 t -128.54 136.56 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.111 -0.993 . . . . 0.0 110.671 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.548 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 3.3 m -131.51 110.54 11.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.421 -0.799 . . . . 0.0 109.873 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 155.5 -58.14 0.39 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.868 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -57.9 -159.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -1.175 . . . . 0.0 109.664 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.562 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -166.21 159.45 15.14 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.899 -1.126 . . . . 0.0 111.014 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -42.06 136.98 1.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.717 -0.614 . . . . 0.0 110.576 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.41 -6.95 42.6 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.489 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 3.3 mm-40 -114.09 103.52 11.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -1.142 . . . . 0.0 110.26 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 53' ' ' PHE . 97.1 m -103.82 121.24 42.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.314 -0.866 . . . . 0.0 109.627 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.683 ' OH ' ' HB1' ' A' ' 25' ' ' ALA . 9.9 m-85 -107.0 -170.19 1.67 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 0.0 110.662 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 50.0 m-85 -131.58 111.54 11.83 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.491 -0.755 . . . . 0.0 109.505 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.479 HG22 HG23 ' A' ' 51' ' ' THR . 1.1 tt -89.63 137.06 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.074 -1.016 . . . . 0.0 111.215 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.402 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -153.83 155.06 35.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.497 -0.752 . . . . 0.0 110.267 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -98.59 146.7 25.56 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.224 -0.923 . . . . 0.0 110.463 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 t -156.69 145.5 20.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.094 -1.004 . . . . 0.0 111.186 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.408 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -147.23 142.08 16.54 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.09 165.33 32.25 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 O-C-N 123.73 1.384 . . . . 0.0 110.79 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 39' ' ' VAL . 18.7 m . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.435 -0.79 . . . . 0.0 109.719 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 t0 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.104 0.478 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -130.26 120.59 24.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.138 -0.976 . . . . 0.0 110.022 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.34 155.58 30.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.98 -1.075 . . . . 0.0 110.707 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -106.61 119.88 50.2 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.434 -0.791 . . . . 0.0 109.8 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -80.35 -22.81 6.65 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.882 1.464 . . . . 0.0 110.692 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.61 -37.82 85.68 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.192 -0.943 . . . . 0.0 110.593 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.9 p -91.99 23.08 3.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.24 -0.912 . . . . 0.0 110.489 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 82.37 4.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 110.567 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.479 HG23 HG22 ' A' ' 33' ' ' ILE . 4.0 t -106.7 170.37 7.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.893 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.545 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 52.8 p -118.46 147.68 43.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.027 -1.046 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.546 ' CE1' ' HB2' ' A' ' 31' ' ' TYR . 5.5 p90 -148.24 -179.19 6.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 109.006 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.405 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 3.1 t -157.33 170.93 21.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.875 -1.14 . . . . 0.0 110.928 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.868 HG21 ' HB3' ' A' ' 25' ' ' ALA . 1.5 p -81.03 -155.66 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.461 -0.774 . . . . 0.0 109.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.638 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 4.1 p-10 -157.22 -153.62 0.42 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.728 -1.232 . . . . 0.0 110.803 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 -60.61 3.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.079 -1.013 . . . . 0.0 109.947 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -66.37 -6.76 15.43 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.89 7.23 69.69 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -91.55 119.28 31.34 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.137 -1.213 . . . . 0.0 110.176 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.986 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -92.61 82.27 4.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.893 . . . . 0.0 109.862 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.68 124.47 51.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.28 -0.888 . . . . 0.0 109.897 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -162.78 172.55 15.05 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.675 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.0 t -95.26 130.04 42.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.343 -0.848 . . . . 0.0 110.44 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 91.1 t80 -122.01 172.82 7.95 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.584 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -116.13 152.99 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.622 -1.298 . . . . 0.0 109.945 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.667 HG11 HG11 ' A' ' 18' ' ' VAL . 36.0 m -134.33 169.26 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.2 -0.938 . . . . 0.0 110.597 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.526 ' CD ' ' OD2' ' A' ' 14' ' ' ASP . 2.0 mmm-85 -139.59 164.64 29.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.823 . . . . 0.0 109.824 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -93.42 -54.04 3.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.177 -0.952 . . . . 0.0 110.04 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.01 129.27 47.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.288 -0.883 . . . . 0.0 109.88 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 10.0 p90 -138.23 139.88 39.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 0.0 110.492 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -65.72 114.84 5.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 110.032 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.527 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -85.07 170.65 45.49 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 95.7 p . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.218 -1.166 . . . . 0.0 110.574 179.958 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.164 0.507 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.532 HG11 ' CZ ' ' A' ' 71' ' ' TYR . 36.7 t -105.45 137.75 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.818 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.895 ' OD2' ' HB3' ' A' ' 87' ' ' ALA . 6.7 t70 -134.21 135.6 43.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.096 -1.002 . . . . 0.0 110.001 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -86.07 -4.75 59.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.895 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . . . -65.27 -62.28 1.63 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.304 -0.872 . . . . 0.0 110.652 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.0 t -92.23 3.56 55.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.937 . . . . 0.0 110.46 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 85' ' ' ASP . . . -132.36 -176.4 4.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 110.094 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.87 141.38 51.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 110.172 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 61.8 m -106.85 171.78 7.18 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.907 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -151.22 119.35 6.29 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.305 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.534 ' HB2' HD11 ' A' ' 107' ' ' LEU . 21.7 tp -94.12 101.65 13.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -108.27 167.24 13.18 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.375 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -147.61 160.26 42.86 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.653 -0.91 . . . . 0.0 109.715 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.57 173.99 44.41 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.957 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 31' ' ' TYR . 24.7 t30 -141.0 169.21 18.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.447 -1.031 . . . . 0.0 110.031 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.91 84.42 0.32 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.243 -0.911 . . . . 0.0 110.426 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.37 -19.43 5.67 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.448 ' HA ' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -146.85 99.6 3.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.002 -1.293 . . . . 0.0 110.881 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.468 ' O ' HD23 ' A' ' 102' ' ' LEU . 6.6 m-20 -92.66 -173.21 3.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.273 -0.892 . . . . 0.0 109.814 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 101' ' ' ASP . 84.4 mt -142.54 -86.36 0.15 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.027 -1.045 . . . . 0.0 110.711 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.552 ' C ' ' CD2' ' A' ' 104' ' ' HIS . . . -178.74 -169.73 39.8 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.552 ' CD2' ' C ' ' A' ' 103' ' ' GLY . 9.0 m-70 -133.76 140.4 46.93 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.227 -1.161 . . . . 0.0 110.852 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' A' ' 5' ' ' SER . 0.9 OUTLIER -97.75 121.3 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.66 103.79 2.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.812 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 93' ' ' LEU . 68.4 mt -75.16 170.54 15.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.367 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.76 149.12 44.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 110.374 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 12' ' ' LEU . 1.3 m-85 -139.17 91.05 2.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.116 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.51 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 44.8 Cg_endo . . . . . 0 C--O 1.214 -0.705 0 N-CA-C 110.131 -0.757 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -137.3 93.6 2.84 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.935 -1.103 . . . . 0.0 111.281 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -112.62 106.04 14.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.071 -1.018 . . . . 0.0 109.614 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.9 m -151.08 155.82 39.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.944 -1.098 . . . . 0.0 111.112 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.847 HG22 ' HD2' ' A' ' 8' ' ' PRO . 7.5 p -109.41 160.55 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.467 -0.771 . . . . 0.0 109.708 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.582 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -80.16 -59.55 0.53 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.052 . . . . 0.0 110.206 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.847 ' HD2' HG22 ' A' ' 6' ' ' VAL . 54.0 Cg_endo -80.22 74.43 5.55 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.629 1.331 . . . . 0.0 110.38 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.98 -14.42 60.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.019 -1.05 . . . . 0.0 110.065 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.0 m -138.98 178.86 6.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 110.057 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.58 45.64 76.74 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.507 HD21 ' O ' ' A' ' 8' ' ' PRO . 21.5 mt -89.34 159.81 17.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -1.085 . . . . 0.0 110.192 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -129.63 145.91 51.46 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.318 -0.864 . . . . 0.0 110.212 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 69' ' ' LYS . 13.1 p-10 -57.21 111.18 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.44 -32.92 6.99 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 55.5 tt0 -49.0 155.49 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -1.163 . . . . 0.0 110.383 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.54 ' O ' HG13 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -97.04 -178.16 4.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.371 -0.831 . . . . 0.0 110.568 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.843 HG22 ' O ' ' A' ' 65' ' ' PHE . 25.1 m -156.57 170.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.511 -0.743 . . . . 0.0 109.508 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 m -120.06 123.85 44.42 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.945 -1.097 . . . . 0.0 110.688 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.6 143.01 22.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.441 -0.787 . . . . 0.0 109.657 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.47 133.8 33.19 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.795 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 56.7 t -123.35 111.9 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.464 -0.773 . . . . 0.0 109.913 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -130.22 116.09 17.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.105 -0.997 . . . . 0.0 110.487 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 150.04 -29.57 1.11 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.425 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -79.95 -147.27 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -1.136 . . . . 0.0 110.195 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.565 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -175.19 142.17 0.6 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.027 -1.046 . . . . 0.0 111.145 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.05 132.1 1.03 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.414 0.626 . . . . 0.0 110.699 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.443 ' O ' ' OE2' ' A' ' 29' ' ' GLU . . . 118.35 6.1 12.28 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' OE2' ' O ' ' A' ' 28' ' ' GLY . 53.1 mm-40 -140.11 119.28 12.8 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.217 -1.166 . . . . 0.0 110.521 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.51 HG23 ' OG1' ' A' ' 54' ' ' THR . 5.2 m -101.32 133.84 45.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.43 -0.794 . . . . 0.0 109.491 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.614 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 39.0 m-85 -121.15 -172.52 2.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.085 -1.009 . . . . 0.0 111.032 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.506 ' CD1' ' HB2' ' A' ' 52' ' ' SER . 68.0 m-85 -130.25 160.63 33.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.607 -0.683 . . . . 0.0 109.633 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 33' ' ' ILE . 4.5 tt -145.66 116.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.067 -1.021 . . . . 0.0 110.391 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.825 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -151.35 169.95 20.72 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.151 -0.968 . . . . 0.0 111.052 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -104.15 160.08 15.15 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.515 -0.741 . . . . 0.0 109.386 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -160.98 141.53 11.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.021 -1.05 . . . . 0.0 111.385 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -140.51 154.53 69.45 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.98 164.59 34.2 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.622 1.327 . . . . 0.0 111.121 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.49 HG11 ' HB2' ' A' ' 44' ' ' ALA . 11.6 m . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.661 0.743 . . . . 0.0 109.919 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.357 0.599 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.877 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -129.99 130.2 44.71 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -117.8 159.57 22.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 110.276 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.47 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 6.0 t-20 -90.77 117.51 67.99 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 0.0 110.363 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -81.19 -34.11 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.855 1.45 . . . . 0.0 110.636 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.71 95.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.255 -0.903 . . . . 0.0 110.342 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.47 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 6.4 p -88.31 20.71 3.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.364 -0.835 . . . . 0.0 110.063 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.23 132.25 37.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.0 110.086 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.58 HG23 ' CG2' ' A' ' 33' ' ' ILE . 9.8 t -161.96 159.05 26.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.297 -0.877 . . . . 0.0 109.983 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.506 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 33.5 t -127.99 161.23 29.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.188 -0.945 . . . . 0.0 110.431 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.614 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 33.8 p90 -146.99 -176.41 5.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.294 -0.879 . . . . 0.0 110.381 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.51 ' OG1' HG23 ' A' ' 30' ' ' THR . 29.3 m -141.48 154.08 45.32 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.502 ' HB ' ' HA2' ' A' ' 59' ' ' GLY . 43.1 p -63.24 -150.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.067 -1.02 . . . . 0.0 110.429 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.783 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -152.5 -161.03 1.22 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.187 -0.946 . . . . 0.0 110.292 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.63 -53.38 58.15 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 109.176 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 p -87.95 15.9 6.65 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 62.41 39.05 97.28 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -117.09 106.17 13.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -1.087 . . . . 0.0 110.231 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.506 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -107.06 89.73 3.09 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.505 -0.747 . . . . 0.0 110.094 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.6 p -112.01 128.42 56.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.819 . . . . 0.0 109.554 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -153.08 176.38 11.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.126 -0.984 . . . . 0.0 110.824 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 p -94.59 141.43 28.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.33 -0.856 . . . . 0.0 110.521 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.843 ' O ' HG22 ' A' ' 18' ' ' VAL . 75.0 t80 -133.36 162.35 32.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.458 -0.777 . . . . 0.0 109.575 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.476 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 21.6 t -112.13 168.19 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 120.731 -1.231 . . . . 0.0 110.801 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.633 HG11 HG11 ' A' ' 18' ' ' VAL . 25.1 m -138.08 174.99 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.401 -0.812 . . . . 0.0 110.382 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -148.88 145.81 27.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.31 -0.868 . . . . 0.0 110.121 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 3.2 ttpt -65.8 -51.49 58.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.995 . . . . 0.0 109.464 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.433 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 96.0 p -135.45 165.86 24.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 109.617 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.732 ' CZ ' HG11 ' A' ' 84' ' ' VAL . 37.7 p90 -170.26 150.96 3.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.086 -1.009 . . . . 0.0 110.223 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -68.52 113.39 6.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.225 -0.922 . . . . 0.0 110.094 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.877 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -59.24 -175.79 0.82 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.433 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 12.1 m . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.312 -1.11 . . . . 0.0 110.62 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.3 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.15 0.5 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.732 HG11 ' CZ ' ' A' ' 71' ' ' TYR . 5.9 t -141.39 156.99 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.333 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.794 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 23.8 m-20 -146.68 149.43 33.46 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.433 -0.792 . . . . 0.0 109.789 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 68.8 m -114.35 -13.8 12.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.85 -56.59 16.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.233 -0.917 . . . . 0.0 110.816 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.471 ' H ' HG22 ' A' ' 88' ' ' THR . 3.3 t -100.74 -13.02 18.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.065 -1.022 . . . . 0.0 110.784 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' A' ' 85' ' ' ASP . . . -91.32 -141.98 0.18 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.254 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.38 82.98 0.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.906 . . . . 0.0 109.781 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.683 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 28.1 p -97.34 164.82 12.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.109 -0.994 . . . . 0.0 110.436 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 92' ' ' ASN . 2.2 m120 -141.47 166.52 24.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 110.031 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.825 HD12 ' O ' ' A' ' 34' ' ' ALA . 5.7 tp -116.01 127.25 54.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 109.603 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.602 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -118.31 157.71 15.08 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -141.73 140.79 33.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -1.107 . . . . 0.0 110.086 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 139.42 163.69 9.6 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -124.29 -156.99 0.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.23 -1.159 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.8 t -90.14 36.81 0.88 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.905 . . . . 0.0 110.404 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.4 -50.19 0.05 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.6 HD13 ' OH ' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -135.13 89.38 2.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.196 -1.179 . . . . 0.0 110.409 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.02 158.34 11.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.158 -0.963 . . . . 0.0 109.814 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.495 HD23 ' HG3' ' A' ' 2' ' ' PRO . 91.8 mt -121.52 -84.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 110.432 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.98 -177.37 38.67 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.005 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.602 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 27.5 m-70 -139.92 113.56 8.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.571 -0.958 . . . . 0.0 109.887 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.59 HG11 HG12 ' A' ' 6' ' ' VAL . 18.0 t -88.25 161.55 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 109.836 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.81 134.21 49.3 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.157 -0.964 . . . . 0.0 110.122 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.609 HD11 ' HB2' ' A' ' 93' ' ' LEU . 58.1 mt -105.48 147.45 28.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.236 -0.915 . . . . 0.0 110.432 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.97 159.68 42.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.408 -0.808 . . . . 0.0 109.824 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.491 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 42.3 m-85 -128.17 156.18 43.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.562 179.986 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.51 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 47.4 Cg_endo . . . . . 0 N--CA 1.479 0.669 0 N-CA-C 110.353 -0.672 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -151.53 109.45 3.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.085 -1.01 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -108.36 115.83 30.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.6 m -146.13 151.84 38.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.894 -1.129 . . . . 0.0 111.159 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.831 HG22 ' HD2' ' A' ' 8' ' ' PRO . 9.8 p -115.97 151.8 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.467 -0.771 . . . . 0.0 109.473 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.614 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -77.22 -57.87 1.05 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.923 -1.111 . . . . 0.0 110.411 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.831 ' HD2' HG22 ' A' ' 6' ' ' VAL . 54.9 Cg_endo -86.55 68.81 4.48 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.538 1.283 . . . . 0.0 110.334 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.38 -20.35 65.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 109.811 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.5 p -142.76 130.04 21.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.434 -0.791 . . . . 0.0 110.239 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.19 47.56 0.99 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -108.15 172.03 7.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -1.097 . . . . 0.0 110.221 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -148.08 164.28 34.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.94 . . . . 0.0 110.343 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.462 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 23.9 t70 -64.85 123.39 19.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 110.137 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.78 -30.42 7.96 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 12' ' ' LEU . 47.1 tt0 -58.75 146.83 35.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -1.119 . . . . 0.0 110.207 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.3 p -90.35 179.51 5.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 110.539 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.66 HG23 ' HB3' ' A' ' 65' ' ' PHE . 5.3 m -149.41 160.66 5.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.504 -0.747 . . . . 0.0 109.83 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 14.0 m -112.04 118.49 35.57 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.949 -1.094 . . . . 0.0 110.107 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 t -109.06 147.95 13.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 110.073 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.7 t -142.28 129.06 20.51 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.482 -0.761 . . . . 0.0 110.159 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 12.2 t -118.55 107.67 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.368 -0.832 . . . . 0.0 110.024 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.4 OUTLIER -111.92 141.42 45.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.271 -0.893 . . . . 0.0 110.567 179.989 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 122.0 -74.11 0.36 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.503 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -54.79 145.14 20.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -1.178 . . . . 0.0 109.707 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.574 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -118.47 157.8 26.54 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.102 -0.999 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -34.07 136.24 0.13 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.506 0.669 . . . . 0.0 110.819 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.39 1.93 12.2 Favored Glycine 0 C--N 1.295 -1.74 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 1.0 OUTLIER -137.52 129.01 28.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.324 -1.104 . . . . 0.0 110.189 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.518 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 89.0 m -107.22 146.68 31.1 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.525 -0.734 . . . . 0.0 109.815 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 29' ' ' GLU . 13.2 m-85 -133.09 169.09 17.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.129 -0.982 . . . . 0.0 110.728 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CD2' ' HB3' ' A' ' 52' ' ' SER . 19.4 m-85 -128.64 106.87 9.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 109.539 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.612 ' CG2' HG23 ' A' ' 51' ' ' THR . 18.1 tt -89.54 136.61 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.255 -0.903 . . . . 0.0 110.845 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.65 177.84 9.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.334 -0.854 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.553 ' HB2' HD12 ' A' ' 93' ' ' LEU . 55.5 tt0 -134.73 150.72 50.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.307 -0.871 . . . . 0.0 109.964 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 69.5 m -150.95 163.44 38.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.102 -0.999 . . . . 0.0 111.224 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.564 ' HB3' ' OH ' ' A' ' 71' ' ' TYR . . . -153.1 152.49 28.07 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.791 -0.568 . . . . 0.0 109.709 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.57 172.15 16.31 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.802 1.422 . . . . 0.0 110.339 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 44' ' ' ALA . 16.0 m . . . . . 0 N--CA 1.493 1.698 0 O-C-N 120.929 -1.107 . . . . 0.0 110.589 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 p30 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.627 0.727 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.717 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -150.21 118.75 6.5 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 109.094 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.1 m -108.9 162.03 14.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.971 -1.08 . . . . 0.0 111.089 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -111.52 92.98 17.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.432 -0.792 . . . . 0.0 109.746 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.98 -12.52 32.63 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.047 1.551 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.31 -31.83 71.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.133 -0.98 . . . . 0.0 110.178 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 p -97.15 8.63 44.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 110.149 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.14 110.53 5.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.409 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.612 HG23 ' CG2' ' A' ' 33' ' ' ILE . 1.1 t -129.03 140.38 51.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 110.054 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.496 ' HB3' ' CD2' ' A' ' 32' ' ' TYR . 6.9 p -109.21 148.51 30.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.173 -0.955 . . . . 0.0 110.227 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 22.7 p90 -148.06 -177.13 5.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.0 110.177 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 55' ' ' THR . 25.4 m -137.62 153.05 49.94 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 110.091 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 3.3 p -56.85 -159.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.179 -0.951 . . . . 0.0 110.142 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 45.3 m-20 -146.89 -161.81 1.41 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.936 -1.103 . . . . 0.0 110.599 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.31 -51.02 70.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.28 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.93 12.35 7.66 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.574 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 60.25 20.09 53.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.75 110.16 22.26 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -1.114 . . . . 0.0 110.22 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.678 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -101.36 90.95 4.27 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.541 -0.724 . . . . 0.0 109.417 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 p -103.48 115.08 29.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 109.548 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.546 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 15.1 p90 -147.74 171.06 16.26 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.395 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.9 155.3 17.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 0.0 110.84 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.66 ' HB3' HG23 ' A' ' 18' ' ' VAL . 90.0 t80 -140.32 176.78 8.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.483 -0.76 . . . . 0.0 108.971 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.578 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -128.35 154.56 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.576 -1.328 . . . . 0.0 110.442 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 67' ' ' VAL . 29.4 m -129.87 125.8 61.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.526 -0.734 . . . . 0.0 109.85 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -111.73 116.55 30.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 110.407 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 14' ' ' ASP . 29.6 ttpt -56.76 -55.95 27.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.615 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.4 m -99.57 130.03 45.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.828 . . . . 0.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.564 ' OH ' ' HB3' ' A' ' 37' ' ' ALA . 33.9 p90 -155.3 131.08 9.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -0.878 . . . . 0.0 109.982 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.4 m -54.58 134.41 46.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.118 -0.989 . . . . 0.0 110.394 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.717 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -115.47 167.32 12.35 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.028 -1.278 . . . . 0.0 110.564 -179.94 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.5 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.121 0.486 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.437 HG21 ' HB1' ' A' ' 44' ' ' ALA . 34.4 t -121.44 157.83 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.129 -0.982 . . . . 0.0 110.424 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 39.6 p-10 -152.06 118.28 5.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 110.052 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.3 m -90.58 32.31 0.98 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.165 -0.959 . . . . 0.0 110.306 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.1 87.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.213 -0.93 . . . . 0.0 109.983 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -130.67 6.16 4.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.51 -159.17 0.59 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.846 . . . . 0.0 109.811 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -115.49 120.38 39.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.51 141.0 44.24 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.77 144.1 29.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.062 -1.023 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.553 HD12 ' HB2' ' A' ' 35' ' ' GLN . 0.4 OUTLIER -123.58 135.39 53.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.646 -0.659 . . . . 0.0 109.254 179.956 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.95 177.02 21.7 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.223 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -151.68 170.82 18.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.452 -1.028 . . . . 0.0 109.986 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.413 ' HA2' ' HG ' ' A' ' 102' ' ' LEU . . . 150.76 159.3 8.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 99' ' ' GLY . 21.0 t30 -119.2 158.18 26.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -1.177 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.78 92.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.067 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 97' ' ' ASN . . . 124.02 -45.33 1.19 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -91.47 132.11 36.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -1.129 . . . . 0.0 110.202 179.914 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.679 ' N ' HD13 ' A' ' 100' ' ' LEU . 5.8 m-20 -105.8 144.65 32.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 110.191 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 101' ' ' ASP . 21.1 mt -122.36 -75.14 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.162 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 159.38 -179.72 34.78 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.591 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 0.0 OUTLIER -145.72 128.74 16.52 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.491 -1.005 . . . . 0.0 109.56 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.642 HG11 HG12 ' A' ' 6' ' ' VAL . 58.2 t -105.11 155.12 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.409 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -92.18 147.07 23.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.818 . . . . 0.0 109.833 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.48 105.66 9.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 110.353 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 109' ' ' PHE . 3.6 m -79.58 173.96 12.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.882 . . . . 0.0 110.167 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.445 ' H ' HG22 ' A' ' 108' ' ' THR . 2.1 m-85 -136.77 88.68 2.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 CA-C-O 118.005 -1.442 . . . . 0.0 109.569 179.96 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.473 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 48.6 Cg_endo . . . . . 0 N--CA 1.481 0.742 0 N-CA-C 110.537 -0.601 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -129.18 144.82 51.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.873 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.492 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 23.5 t80 -150.36 104.75 3.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.926 . . . . 0.0 109.888 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p -150.58 152.55 34.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 110.68 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.03 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 14.8 p -106.52 158.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -0.838 . . . . 0.0 109.55 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.594 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -60.46 -63.76 3.9 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.113 -0.992 . . . . 0.0 110.787 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.99 ' HD2' HG22 ' A' ' 6' ' ' VAL . 44.7 Cg_endo -72.33 -86.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.772 1.406 . . . . 0.0 111.189 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 1.03 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 71.81 18.35 5.15 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.407 -0.808 . . . . 0.0 109.918 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.484 ' HA ' ' HB ' ' A' ' 108' ' ' THR . 3.9 m -171.4 108.48 0.27 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.362 -0.836 . . . . 0.0 110.076 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.09 76.09 1.32 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.522 HD21 ' HB2' ' A' ' 8' ' ' PRO . 9.7 mt -128.05 172.74 10.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -1.101 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -138.29 162.82 33.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 110.082 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -57.93 123.99 17.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.067 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 94.99 -32.32 6.23 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 17' ' ' SER . 9.0 tm0? -42.01 138.26 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.39 -1.065 . . . . 0.0 110.149 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.46 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -94.07 150.39 20.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.983 -179.99 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 65' ' ' PHE . 33.3 m -128.79 176.95 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.926 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 0.3 OUTLIER -133.48 121.78 22.7 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.939 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 21' ' ' SER . 68.0 t -98.31 158.86 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.254 -0.903 . . . . 0.0 110.053 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.41 ' N ' HG12 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -151.08 122.26 7.75 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.388 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.844 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 53.1 t -121.24 144.27 30.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.339 -0.85 . . . . 0.0 109.758 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.456 ' H ' ' HB3' ' A' ' 3' ' ' ALA . 1.1 m -156.61 127.55 6.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 142.61 -63.58 0.5 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.562 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -56.67 -159.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 109.816 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.57 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -165.8 162.7 18.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.928 -1.107 . . . . 0.0 111.054 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -41.24 134.5 2.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.551 -0.718 . . . . 0.0 110.241 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 114.6 7.41 18.13 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 54' ' ' THR . 5.6 mt-10 -139.86 128.64 23.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.243 -1.151 . . . . 0.0 109.906 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.502 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 20.6 m -108.87 157.8 18.28 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.866 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.963 ' CD2' HD11 ' A' ' 102' ' ' LEU . 15.8 m-85 -137.34 173.2 11.94 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 110.019 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 14.7 m-85 -131.08 103.52 6.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 110.021 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.684 ' CG2' HG23 ' A' ' 51' ' ' THR . 1.2 tt -87.23 124.29 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.179 -0.951 . . . . 0.0 110.272 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 1.026 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -150.56 160.46 43.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 110.207 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.486 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -126.59 138.2 53.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 110.544 179.978 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.2 m -146.94 169.22 19.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.25 -0.906 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.61 152.35 28.61 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.17 -0.956 . . . . 0.0 110.119 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.22 174.73 10.98 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.006 1.529 . . . . 0.0 110.178 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 43' ' ' ASP . 4.7 t . . . . . 0 C--N 1.304 -1.384 0 O-C-N 121.218 -0.926 . . . . 0.0 109.582 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.465 ' HA ' HG23 ' A' ' 39' ' ' VAL . 37.1 m-20 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.384 0.611 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.726 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -118.33 165.39 13.91 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.423 -0.798 . . . . 0.0 108.902 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -147.05 158.18 43.85 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.721 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.577 ' OD1' ' CD2' ' A' ' 71' ' ' TYR . 3.4 m120 -100.11 116.11 64.87 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.489 -0.757 . . . . 0.0 109.694 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.62 -28.59 4.19 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.818 1.431 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.11 -35.42 74.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.245 -0.91 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.6 p -86.94 14.08 7.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.214 -0.929 . . . . 0.0 110.684 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.38 95.62 10.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.952 . . . . 0.0 110.271 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.684 HG23 ' CG2' ' A' ' 33' ' ' ILE . 5.0 t -137.03 167.62 21.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.7 p -126.2 149.54 48.96 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.196 -0.94 . . . . 0.0 110.34 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 20.7 p90 -143.41 141.93 31.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.142 -0.974 . . . . 0.0 110.135 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 29' ' ' GLU . 18.6 m -104.21 155.55 18.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -0.933 . . . . 0.0 110.494 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.562 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -63.04 -156.08 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.319 -0.863 . . . . 0.0 109.806 179.946 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -140.83 -166.88 2.24 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.927 -1.108 . . . . 0.0 110.436 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.93 -57.24 13.93 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -1.85 23.63 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.254 -0.904 . . . . 0.0 108.999 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.83 69.06 1.46 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.58 125.69 13.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -1.084 . . . . 0.0 109.618 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.844 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -118.6 80.6 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 110.781 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.29 140.21 46.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -0.831 . . . . 0.0 109.078 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.4 ' HZ ' HD13 ' A' ' 33' ' ' ILE . 32.7 p90 -171.1 -179.65 2.78 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.114 -0.991 . . . . 0.0 111.38 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t -96.43 140.78 30.58 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.608 0.718 . . . . 0.0 110.551 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.587 ' HB3' HG23 ' A' ' 18' ' ' VAL . 20.3 t80 -134.32 -172.19 2.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -0.79 . . . . 0.0 108.888 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 t -143.69 165.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.645 -1.285 . . . . 0.0 110.325 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.572 HG11 HG11 ' A' ' 18' ' ' VAL . 33.2 m -137.88 142.51 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.312 -0.868 . . . . 0.0 110.305 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -121.22 134.52 55.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.072 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 23.3 ttmt -73.26 -59.81 2.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.137 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t -109.58 141.84 41.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 110.196 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.577 ' CD2' ' OD1' ' A' ' 46' ' ' ASN . 33.4 p90 -153.56 122.5 6.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.825 . . . . 0.0 109.986 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 92.2 m -43.89 124.74 3.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.307 -0.871 . . . . 0.0 110.738 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.66 148.88 19.08 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.498 1.928 0 O-C-N 120.787 -1.419 . . . . 0.0 111.168 -179.979 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 20.0 p . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.282 0.563 . . . . 0.0 109.918 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.726 HG21 ' CB ' ' A' ' 44' ' ' ALA . 74.6 t -102.34 153.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 109.993 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -132.8 148.7 52.32 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 110.203 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 1.8 t -104.94 15.01 28.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 110.17 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.23 -56.16 4.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 110.334 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -87.7 -28.12 21.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.23 -0.919 . . . . 0.0 110.238 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.7 -158.26 0.64 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.218 -0.926 . . . . 0.0 110.01 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.45 147.95 42.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.9 . . . . 0.0 110.225 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.469 ' HB3' ' OE1' ' A' ' 35' ' ' GLN . 94.4 m -106.61 130.35 54.38 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.911 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -112.77 125.23 54.1 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 110.557 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.026 HD12 ' O ' ' A' ' 34' ' ' ALA . 50.1 tp -107.62 112.34 25.02 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.599 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -120.89 160.2 15.3 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.487 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -144.07 124.48 13.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.506 -0.996 . . . . 0.0 109.802 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.35 167.37 39.39 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.414 ' CG ' ' N ' ' A' ' 98' ' ' SER . 4.0 t30 -104.43 -86.08 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -1.094 . . . . 0.0 110.416 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.414 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 46.8 t -159.89 71.07 0.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.255 -0.903 . . . . 0.0 110.007 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.01 -17.3 6.74 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 31' ' ' TYR . 38.3 tp -94.86 -66.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.462 -1.022 . . . . 0.0 109.655 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.9 t0 61.89 128.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.76 . . . . 0.0 110.632 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.963 HD11 ' CD2' ' A' ' 31' ' ' TYR . 35.3 mt -96.85 -39.51 9.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.468 -0.77 . . . . 0.0 109.571 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.18 177.58 26.01 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.599 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 2.0 m-70 -133.7 120.05 20.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.656 -0.908 . . . . 0.0 109.601 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.6 t -92.25 132.59 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.207 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.18 106.71 18.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 110.325 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.2 mt -74.83 126.81 31.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.24 -0.913 . . . . 0.0 110.13 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.484 ' HB ' ' HA ' ' A' ' 10' ' ' SER . 2.2 m -90.37 162.49 15.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.926 . . . . 0.0 110.092 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 108' ' ' THR . 3.9 m-85 -148.4 171.81 15.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.548 179.979 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.541 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 54.9 Cg_endo . . . . . 0 CA--C 1.543 0.956 0 N-CA-C 109.447 -1.02 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . 179.73 133.58 0.1 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.887 -1.133 . . . . 0.0 110.461 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -150.85 97.98 2.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.401 -0.812 . . . . 0.0 109.543 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.1 p -139.26 168.83 18.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.059 -1.026 . . . . 0.0 111.148 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG12 HG11 ' A' ' 105' ' ' VAL . 8.0 p -124.98 148.64 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.555 -0.716 . . . . 0.0 109.09 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.648 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.0 m -62.21 -76.87 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.868 -1.145 . . . . 0.0 110.463 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 55.6 Cg_endo -77.81 75.3 4.84 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 O-C-N 122.788 0.888 . . . . 0.0 109.847 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.09 -22.89 63.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.148 -0.97 . . . . 0.0 110.301 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.5 t -131.69 135.18 46.66 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.174 -0.954 . . . . 0.0 110.12 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.98 65.71 1.28 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.626 HD21 ' O ' ' A' ' 8' ' ' PRO . 7.4 mt -110.21 165.05 12.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -1.139 . . . . 0.0 109.887 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.5 157.22 28.74 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.21 -0.931 . . . . 0.0 110.169 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -68.5 127.2 32.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.84 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.8 -25.54 11.4 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -54.47 149.55 10.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.337 -1.096 . . . . 0.0 110.437 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 m -101.99 129.19 48.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.229 -0.92 . . . . 0.0 109.957 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 18' ' ' VAL . 16.4 m -95.91 175.29 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 23.3 p -129.37 113.57 15.12 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.376 -0.828 . . . . 0.0 109.734 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t -97.57 151.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.275 -0.891 . . . . 0.0 110.05 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 t -141.82 118.49 11.03 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.323 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 35.3 t -113.83 138.14 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.558 -0.714 . . . . 0.0 109.778 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.459 ' H ' ' HB3' ' A' ' 3' ' ' ALA . 19.3 p -150.9 116.25 5.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.983 -1.073 . . . . 0.0 110.754 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.541 ' HA3' ' CB ' ' A' ' 2' ' ' PRO . . . 156.31 -52.44 0.42 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.528 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -58.15 -157.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.358 -1.083 . . . . 0.0 109.711 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.506 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -161.26 160.59 30.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.966 -1.084 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -45.91 130.6 9.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.604 -0.685 . . . . 0.0 110.25 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.432 ' C ' ' HG3' ' A' ' 29' ' ' GLU . . . 117.92 12.33 7.84 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.541 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 70.6 mt-10 -139.18 113.26 8.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.283 . . . . 0.0 110.444 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.408 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 31.1 m -90.83 166.46 13.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.471 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.681 ' HE1' HD23 ' A' ' 100' ' ' LEU . 93.9 m-85 -150.61 167.11 28.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.992 -1.068 . . . . 0.0 110.827 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' A' ' 31' ' ' TYR . 12.3 m-85 -131.68 106.92 8.46 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.413 ' CG2' HG23 ' A' ' 51' ' ' THR . 4.7 tt -98.25 137.8 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.994 . . . . 0.0 111.452 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.04 161.02 43.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.669 -0.645 . . . . 0.0 109.458 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 35' ' ' GLN . 5.3 pt20 -119.23 134.04 55.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 110.523 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.419 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 3.5 m -144.23 -178.5 5.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.43 -0.794 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.61 156.95 33.57 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.301 -0.875 . . . . 0.0 109.467 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 41.3 Cg_endo -71.96 151.4 56.29 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 O-C-N 123.748 1.394 . . . . 0.0 110.686 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 43' ' ' ASP . 10.8 p . . . . . 0 C--N 1.298 -1.674 0 O-C-N 121.502 -0.749 . . . . 0.0 109.476 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.503 ' N ' HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.291 0.567 . . . . 0.0 111.007 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.8 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -95.24 133.08 39.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.283 -0.886 . . . . 0.0 108.942 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 15.7 t -113.91 168.0 10.17 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.779 -1.201 . . . . 0.0 111.604 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -108.88 112.09 60.41 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.71 . . . . 0.0 110.037 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.62 -24.78 15.57 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.0 1.526 . . . . 0.0 110.646 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -8.86 10.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.206 -0.934 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.02 35.69 4.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.977 -1.077 . . . . 0.0 110.541 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.79 133.66 34.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.163 -0.961 . . . . 0.0 110.541 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.413 HG23 ' CG2' ' A' ' 33' ' ' ILE . 9.9 t -159.95 156.84 27.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.35 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t -130.03 161.6 30.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.162 -0.961 . . . . 0.0 110.755 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 7.9 p90 -149.28 179.73 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.401 -0.812 . . . . 0.0 109.763 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.4 m -146.88 158.11 43.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.051 -1.031 . . . . 0.0 110.332 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.528 HG21 ' HB3' ' A' ' 25' ' ' ALA . 2.8 p -73.3 -161.23 0.09 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -161.07 -152.16 0.26 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.1 -1.0 . . . . 0.0 110.885 -179.947 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.35 -46.51 89.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.889 . . . . 0.0 109.488 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.4 t -85.16 12.96 6.88 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.569 -0.707 . . . . 0.0 109.209 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.506 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 45.3 40.66 7.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.81 126.16 41.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 110.374 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 53' ' ' PHE . . . -112.1 90.08 3.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 110.539 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.78 117.01 32.99 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.329 -0.857 . . . . 0.0 109.562 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.634 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.4 p90 -149.91 171.15 17.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.249 -0.907 . . . . 0.0 110.877 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.04 128.11 47.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 110.647 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.51 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 50.0 t80 -113.64 -179.96 3.79 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.51 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.7 t -128.27 156.89 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.704 -1.248 . . . . 0.0 109.907 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG13 ' C ' ' A' ' 66' ' ' VAL . 30.7 m -146.82 157.09 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 110.308 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.23 150.51 50.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.428 -0.795 . . . . 0.0 110.187 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 29.7 tttt -76.5 -59.4 2.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 110.566 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.0 m -117.57 137.62 52.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.143 -0.973 . . . . 0.0 110.169 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -162.2 151.53 15.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.12 -0.987 . . . . 0.0 110.304 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 38.1 m -68.47 134.29 49.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.0 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.636 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -118.82 -176.48 16.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.237 -1.154 . . . . 0.0 109.915 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 82.5 p . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.331 0.586 . . . . 0.0 110.45 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.8 HG21 ' HB3' ' A' ' 44' ' ' ALA . 78.3 t -133.05 116.43 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.393 -0.817 . . . . 0.0 109.882 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.767 ' OD2' HG22 ' A' ' 88' ' ' THR . 4.9 p-10 -101.26 142.0 33.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 0.0 110.392 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 4.4 t -98.2 17.28 18.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.25 -0.907 . . . . 0.0 110.031 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.1 -59.92 2.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 110.214 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.767 HG22 ' OD2' ' A' ' 85' ' ' ASP . 5.9 t -79.78 -24.85 41.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.289 -0.882 . . . . 0.0 110.081 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -101.01 -154.96 0.49 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.382 -0.824 . . . . 0.0 109.909 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.21 146.47 33.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.401 -0.812 . . . . 0.0 110.086 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.28 126.85 43.94 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.261 -0.9 . . . . 0.0 109.67 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -110.8 121.2 44.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 111.005 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 65' ' ' PHE . 1.1 tp -107.05 118.41 36.63 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.418 -0.801 . . . . 0.0 108.912 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -137.47 176.73 20.38 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.279 -1.439 . . . . 0.0 110.529 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.89 175.75 11.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.615 -0.932 . . . . 0.0 110.054 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 136.63 167.06 11.05 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -131.46 -153.15 0.54 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.187 -1.184 . . . . 0.0 109.933 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 t -104.04 80.15 1.7 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.176 -0.953 . . . . 0.0 110.089 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.55 -18.31 0.36 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.681 HD23 ' HE1' ' A' ' 31' ' ' TYR . 7.9 tp -140.79 -67.95 0.41 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.282 . . . . 0.0 110.561 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.5 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.7 OUTLIER 69.42 153.06 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.306 -0.871 . . . . 0.0 110.091 179.983 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.7 mt -121.79 -86.31 0.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 110.38 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -167.91 -160.66 15.94 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -159.09 138.45 11.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -1.09 . . . . 0.0 110.335 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.497 HG11 HG12 ' A' ' 6' ' ' VAL . 81.5 t -104.9 127.96 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.255 -0.903 . . . . 0.0 110.207 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.87 93.74 5.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.511 HD22 HD11 ' A' ' 12' ' ' LEU . 65.9 mt -60.19 170.13 1.38 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 109' ' ' PHE . 17.4 m -141.19 169.84 16.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 0.0 110.096 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.412 ' N ' HG22 ' A' ' 108' ' ' THR . 5.9 m-85 -142.65 96.57 2.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.913 . . . . 0.0 110.138 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.61 179.978 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 N--CA 1.483 0.885 0 N-CA-C 110.428 -0.643 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -140.38 135.8 32.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.025 -1.047 . . . . 0.0 111.004 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.404 ' CE2' HG23 ' A' ' 105' ' ' VAL . 65.9 t80 -150.84 108.53 3.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.557 -0.715 . . . . 0.0 109.096 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.0 p -146.56 161.59 40.18 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.82 -1.175 . . . . 0.0 111.484 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.889 HG12 HG11 ' A' ' 105' ' ' VAL . 7.7 p -129.94 143.32 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.594 -0.691 . . . . 0.0 109.719 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.612 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.2 m -56.86 -68.84 0.53 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.976 -1.077 . . . . 0.0 110.224 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 50.7 Cg_endo -75.88 95.1 1.01 Allowed 'Trans proline' 0 C--N 1.321 -0.89 0 O-C-N 123.354 1.186 . . . . 0.0 110.228 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.96 -1.94 28.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.0 -1.063 . . . . 0.0 110.364 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 t -157.21 109.51 2.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.955 . . . . 0.0 110.057 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.45 60.99 0.54 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.506 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 1.1 mp -108.25 165.84 11.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -1.166 . . . . 0.0 110.068 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 11.4 t -117.27 147.97 42.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.319 -0.863 . . . . 0.0 110.072 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.23 119.21 7.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 110.326 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.11 -35.15 4.97 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 34.2 tt0 -49.21 153.81 0.92 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.326 -1.102 . . . . 0.0 110.381 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 m -105.46 132.75 51.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.959 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.506 ' CG1' ' CD2' ' A' ' 12' ' ' LEU . 24.4 m -100.6 178.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.255 -0.903 . . . . 0.0 110.282 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.9 m -121.1 117.28 26.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 109.807 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.484 HG21 HD13 ' A' ' 33' ' ' ILE . 20.8 t -102.54 150.2 6.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.393 -0.817 . . . . 0.0 110.154 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.91 127.94 18.49 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.309 -0.869 . . . . 0.0 110.4 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 58.7 t -117.37 147.59 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.632 -0.667 . . . . 0.0 109.917 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.732 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 3.6 p -168.05 119.76 0.84 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.127 -0.983 . . . . 0.0 110.393 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.78 3.4 5.48 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.884 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -105.64 -39.67 6.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.056 -1.261 . . . . 0.0 110.266 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 25' ' ' ALA . . . 72.62 147.84 0.09 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.327 -0.858 . . . . 0.0 110.837 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.79 134.22 10.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.713 -0.617 . . . . 0.0 110.768 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 131.82 1.51 4.56 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 39.6 mm-40 -146.45 130.61 17.44 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.87 -1.371 . . . . 0.0 110.896 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.687 HG23 ' OG1' ' A' ' 54' ' ' THR . 0.2 OUTLIER -96.72 171.67 8.38 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.879 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.547 ' CD1' ' O ' ' A' ' 30' ' ' THR . 61.3 m-85 -151.61 172.54 15.9 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.871 -1.143 . . . . 0.0 111.028 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 52' ' ' SER . 61.4 m-85 -144.31 109.46 5.07 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.443 -0.785 . . . . 0.0 109.752 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.699 HD11 HD21 ' A' ' 93' ' ' LEU . 5.6 tt -88.41 132.68 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.213 -0.929 . . . . 0.0 110.451 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.58 167.63 25.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.203 -0.936 . . . . 0.0 110.426 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.455 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 10.5 pt20 -126.56 141.81 51.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.315 -0.865 . . . . 0.0 109.991 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -143.38 157.71 44.24 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.979 -1.076 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.748 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -144.19 157.05 57.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.37 159.13 54.91 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 123.741 1.39 . . . . 0.0 110.792 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.602 HG12 HG22 ' A' ' 84' ' ' VAL . 32.5 m . . . . . 0 C--N 1.299 -1.615 0 O-C-N 121.478 -0.763 . . . . 0.0 109.483 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.0 t0 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.151 0.501 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.433 ' HB1' ' N ' ' A' ' 74' ' ' SER . . . -111.29 139.29 46.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 8.7 t -123.49 144.51 49.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.176 -0.953 . . . . 0.0 110.506 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.453 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 32.0 t-20 -71.67 122.97 88.67 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.26 -0.9 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.539 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 52.4 Cg_endo -83.47 -39.11 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.932 1.491 . . . . 0.0 110.953 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.88 -56.92 15.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.426 -0.796 . . . . 0.0 110.766 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.8 p -56.87 -14.53 3.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.642 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 47' ' ' PRO . . . -56.98 137.28 55.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 110.768 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.628 HG23 HG22 ' A' ' 33' ' ' ILE . 13.0 t -147.03 165.9 28.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.589 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -130.95 152.91 49.75 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.874 -1.142 . . . . 0.0 111.82 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 31' ' ' TYR . 32.3 p90 -149.12 146.25 27.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.502 -0.749 . . . . 0.0 109.779 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.687 ' OG1' HG23 ' A' ' 30' ' ' THR . 76.2 m -108.75 155.27 20.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.975 -1.078 . . . . 0.0 110.771 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.884 HG21 ' HB3' ' A' ' 25' ' ' ALA . 1.2 p -65.42 -157.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.305 -0.872 . . . . 0.0 109.606 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.94 -159.78 1.08 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.818 -1.176 . . . . 0.0 110.478 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.06 62.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.156 -0.965 . . . . 0.0 109.743 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 t -85.46 13.69 6.45 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.424 -0.797 . . . . 0.0 108.854 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 60.58 27.35 65.98 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -110.83 114.16 27.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.345 -1.091 . . . . 0.0 110.35 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.502 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -117.56 88.63 2.95 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.2 p -102.29 125.99 49.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.487 -0.758 . . . . 0.0 109.395 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -154.01 176.19 12.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.957 . . . . 0.0 111.079 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 t -100.22 129.89 46.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.468 -0.77 . . . . 0.0 110.362 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 55.1 t80 -118.45 177.91 4.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 109.307 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.555 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -125.77 154.99 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.811 -1.181 . . . . 0.0 110.389 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.416 HG11 HG11 ' A' ' 18' ' ' VAL . 5.6 m -132.7 171.69 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.822 . . . . 0.0 109.704 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.89 139.21 23.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.984 . . . . 0.0 110.282 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.529 ' HA ' ' CE2' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -77.39 -47.71 19.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.339 -0.851 . . . . 0.0 110.204 179.991 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -122.95 136.1 54.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.847 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -163.36 157.05 19.56 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 3.2 m -69.48 111.14 5.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.425 -0.797 . . . . 0.0 109.992 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.29 162.75 54.3 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.433 ' N ' ' HB1' ' A' ' 44' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.111 -1.229 . . . . 0.0 110.75 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.4 p . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.171 0.51 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 37' ' ' ALA . 55.2 t -141.4 155.84 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -0.903 . . . . 0.0 110.318 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -144.36 139.83 28.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.863 . . . . 0.0 110.126 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -100.73 2.44 41.35 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 110.178 -179.97 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.34 -60.5 2.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.881 . . . . 0.0 110.622 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.8 t -91.94 -20.89 20.92 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.207 -0.933 . . . . 0.0 110.731 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.63 -176.16 3.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.578 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.26 147.13 45.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.345 -0.847 . . . . 0.0 110.1 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.7 m -120.61 156.3 31.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.175 -0.953 . . . . 0.0 110.436 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 18.5 p30 -136.69 143.44 43.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 109.947 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.699 HD21 HD11 ' A' ' 33' ' ' ILE . 1.5 tp -105.62 135.79 46.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.249 -0.907 . . . . 0.0 109.998 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.501 ' HA3' ' ND1' ' A' ' 104' ' ' HIS . . . -131.69 149.46 19.32 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -137.15 155.77 49.18 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.502 -0.999 . . . . 0.0 109.899 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.27 164.61 13.25 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.458 ' CG ' ' N ' ' A' ' 98' ' ' SER . 1.4 t30 -113.42 173.45 6.4 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.248 -1.148 . . . . 0.0 109.857 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.458 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 88.9 p -66.09 89.32 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.152 -0.968 . . . . 0.0 109.943 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 131.69 -20.4 4.61 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 101' ' ' ASP . 1.2 tt -111.37 161.21 16.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.395 -1.062 . . . . 0.0 110.055 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.591 ' N ' HD23 ' A' ' 100' ' ' LEU . 4.6 p-10 -148.57 98.25 2.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.214 -0.929 . . . . 0.0 110.368 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.2 mt -78.73 -70.14 0.52 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.294 -0.879 . . . . 0.0 110.131 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.535 ' C ' ' CD2' ' A' ' 104' ' ' HIS . . . 164.1 -177.12 39.97 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.588 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 4.9 m-70 -131.8 129.5 40.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -1.091 . . . . 0.0 110.03 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.889 HG11 HG12 ' A' ' 6' ' ' VAL . 46.0 t -93.39 116.8 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 110.473 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.56 128.95 39.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.39 -0.819 . . . . 0.0 110.086 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.509 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 74.8 mt -114.44 119.09 35.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 110.508 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.424 HG22 ' N ' ' A' ' 109' ' ' PHE . 23.6 m -98.57 169.37 9.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 109.932 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.529 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 10.7 m-85 -132.3 136.11 46.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.995 . . . . 0.0 110.326 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.995 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.412 ' HG2' HD23 ' A' ' 102' ' ' LEU . 47.5 Cg_endo . . . . . 0 N--CA 1.48 0.728 0 N-CA-C 110.479 -0.623 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.47 135.03 47.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.895 . . . . 0.0 110.162 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -150.56 107.44 3.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.789 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -146.13 153.07 40.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.096 -1.003 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.918 HG12 HG11 ' A' ' 105' ' ' VAL . 9.0 p -115.24 135.82 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.344 -0.847 . . . . 0.0 109.776 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -57.01 -67.63 0.8 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.056 -1.028 . . . . 0.0 110.262 -179.987 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 52.7 Cg_endo -75.69 87.94 1.34 Allowed 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.338 1.178 . . . . 0.0 109.956 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.61 -3.1 56.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.143 -0.973 . . . . 0.0 110.67 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.0 m -149.75 166.58 29.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.202 -0.936 . . . . 0.0 110.336 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.95 37.56 94.43 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 8' ' ' PRO . 40.5 mt -92.9 173.71 7.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.254 -1.144 . . . . 0.0 110.138 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.3 152.07 35.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 110.393 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 1.6 t70 -60.01 126.76 28.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 109.99 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.83 -33.27 5.65 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -56.61 149.47 17.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.345 -1.091 . . . . 0.0 109.893 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.01 134.07 47.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 110.663 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 65' ' ' PHE . 31.5 m -113.28 173.13 3.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.483 -0.76 . . . . 0.0 109.704 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -117.76 133.5 55.87 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.097 -1.002 . . . . 0.0 110.314 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.9 t -119.7 151.21 22.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.746 -0.596 . . . . 0.0 109.513 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.6 p -143.6 133.33 23.8 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 85.2 t -122.44 138.51 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.507 -0.746 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.8 m -150.02 80.1 1.37 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.861 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . -161.85 -71.55 0.02 OUTLIER Glycine 0 C--N 1.283 -2.386 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.477 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -56.09 -164.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -1.198 . . . . 0.0 109.902 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.577 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -160.39 157.77 28.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.143 -0.973 . . . . 0.0 110.387 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -36.14 118.55 0.53 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.602 -0.686 . . . . 0.0 110.633 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.56 -0.34 2.46 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -146.85 130.63 17.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.086 -1.244 . . . . 0.0 110.661 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.4 HG23 ' OG1' ' A' ' 54' ' ' THR . 37.9 m -107.27 121.8 45.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.701 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.651 ' HE1' HD13 ' A' ' 100' ' ' LEU . 52.2 m-85 -103.62 177.77 4.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.052 -1.03 . . . . 0.0 110.603 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.638 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 10.0 m-85 -132.81 116.69 16.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -0.892 . . . . 0.0 110.096 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.598 ' CG2' HG23 ' A' ' 51' ' ' THR . 0.5 OUTLIER -94.33 123.72 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.893 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.88 156.31 39.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.117 -0.99 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.694 ' OE1' HD12 ' A' ' 107' ' ' LEU . 0.3 OUTLIER -100.17 152.91 19.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.316 -0.865 . . . . 0.0 109.532 179.944 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 99.1 m -151.6 152.25 32.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.062 -1.024 . . . . 0.0 110.934 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.793 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.41 145.79 19.01 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.476 -0.765 . . . . 0.0 109.292 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.74 161.03 42.66 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.79 1.416 . . . . 0.0 110.989 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.685 HG12 HG22 ' A' ' 84' ' ' VAL . 33.8 m . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.471 -0.768 . . . . 0.0 110.17 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.316 0.579 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.94 164.94 24.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.133 -0.979 . . . . 0.0 110.028 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.3 m -143.74 -178.74 6.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.27 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 5.6 m120 -105.59 76.14 0.34 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 0.0 110.319 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 43.2 Cg_endo -69.32 -41.3 4.97 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.987 1.519 . . . . 0.0 110.324 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.98 -34.95 74.0 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.38 -0.825 . . . . 0.0 110.005 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.9 34.2 5.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.856 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -86.33 103.67 15.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.014 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.598 HG23 ' CG2' ' A' ' 33' ' ' ILE . 10.0 t -102.37 167.65 9.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 0.0 110.502 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 2.4 m -143.99 162.94 34.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.955 . . . . 0.0 110.673 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 51.5 p90 -143.27 -177.13 5.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.4 ' OG1' HG23 ' A' ' 30' ' ' THR . 50.0 m -146.19 149.9 34.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.348 -0.845 . . . . 0.0 109.746 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.494 HG21 ' N ' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -64.22 -174.77 0.13 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.04 -1.038 . . . . 0.0 109.707 -179.978 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.736 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -146.8 -147.77 0.23 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.96 -1.088 . . . . 0.0 110.806 -179.903 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.585 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -83.02 71.24 10.12 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.15 0.976 . . . . 0.0 109.255 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER 152.7 -14.58 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.577 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 75.57 28.68 60.95 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.42 129.66 56.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.226 -1.161 . . . . 0.0 110.015 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -131.99 86.24 2.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.317 -0.864 . . . . 0.0 110.641 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.39 111.85 24.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.848 . . . . 0.0 109.412 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 19.2 p90 -143.58 178.56 7.7 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.084 -1.01 . . . . 0.0 110.967 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.1 p -98.98 125.54 44.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.469 -0.769 . . . . 0.0 110.247 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.671 ' O ' HG22 ' A' ' 18' ' ' VAL . 8.3 t80 -120.65 139.92 52.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.37 156.43 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.891 -1.131 . . . . 0.0 110.473 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.416 HG13 HG22 ' A' ' 18' ' ' VAL . 26.8 m -124.97 151.82 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.539 -0.726 . . . . 0.0 110.077 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.01 107.04 10.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 110.408 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.566 ' HB2' ' CE1' ' A' ' 109' ' ' PHE . 4.4 ttpt -55.39 -49.61 71.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.643 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.0 m -114.15 132.43 56.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -0.8 . . . . 0.0 109.905 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 71' ' ' TYR . 23.4 p90 -150.36 146.7 26.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.2 m -68.62 129.75 40.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 110.036 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.25 148.52 18.43 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.7 p . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.293 -1.122 . . . . 0.0 110.345 -179.96 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.3 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.297 0.57 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.685 HG22 HG12 ' A' ' 39' ' ' VAL . 84.0 t -119.06 147.08 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 110.167 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -137.04 137.23 39.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.176 -0.952 . . . . 0.0 110.697 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 62.6 m -92.1 7.8 40.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.725 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.01 -62.0 1.74 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 110.5 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.9 t -104.65 14.31 30.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.192 -0.943 . . . . 0.0 110.432 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.17 -167.94 1.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.234 -0.916 . . . . 0.0 110.055 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.06 98.97 4.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 110.325 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.793 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 12.0 p -108.03 151.44 25.83 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.928 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -127.47 158.7 36.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.732 ' HB2' HD11 ' A' ' 107' ' ' LEU . 10.0 tp -109.03 121.61 45.5 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.565 ' HA3' ' ND1' ' A' ' 104' ' ' HIS . . . -126.87 157.91 20.7 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.592 -1.29 . . . . 0.0 110.341 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -132.37 161.44 33.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -1.062 . . . . 0.0 110.082 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.848 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 138.73 -171.35 23.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 98' ' ' SER . 6.1 p-10 -109.25 -46.09 3.63 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.021 -1.282 . . . . 0.0 110.362 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER 174.19 -27.66 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.207 -0.933 . . . . 0.0 110.446 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.86 3.95 4.23 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.305 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.651 HD13 ' HE1' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -84.87 -42.08 15.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.945 -1.326 . . . . 0.0 110.174 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 100' ' ' LEU . 17.4 t0 65.44 81.07 0.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.326 -0.859 . . . . 0.0 110.261 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.848 HD12 ' HA2' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -79.77 -63.88 1.31 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 110.146 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.11 162.48 29.4 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.565 ' ND1' ' HA3' ' A' ' 94' ' ' GLY . 93.3 m-70 -138.57 113.24 9.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.518 -0.989 . . . . 0.0 109.686 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.918 HG11 HG12 ' A' ' 6' ' ' VAL . 94.1 t -101.59 113.97 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.226 -0.921 . . . . 0.0 110.795 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.17 139.1 55.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.107 -0.996 . . . . 0.0 109.321 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.732 HD11 ' HB2' ' A' ' 93' ' ' LEU . 80.7 mt -115.34 167.91 10.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.957 -1.089 . . . . 0.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 109' ' ' PHE . 19.2 m -149.1 175.35 11.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 109.975 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 69' ' ' LYS . 43.3 m-85 -147.45 102.37 3.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.375 -0.828 . . . . 0.0 110.2 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.966 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.543 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 46.2 Cg_endo . . . . . 0 C--O 1.214 -0.687 0 N-CA-C 110.315 -0.687 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -135.98 138.15 41.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.073 -1.017 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -152.0 108.82 3.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.307 -0.871 . . . . 0.0 109.675 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 t -148.69 161.22 42.19 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.972 -1.08 . . . . 0.0 111.161 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.669 HG22 ' HD2' ' A' ' 8' ' ' PRO . 8.1 p -121.67 147.54 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.534 -0.729 . . . . 0.0 109.859 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.611 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -55.91 -67.56 0.73 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 120.84 -1.163 . . . . 0.0 109.064 179.975 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.669 ' HD2' HG22 ' A' ' 6' ' ' VAL . 52.9 Cg_endo -76.94 129.71 10.83 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 O-C-N 123.473 1.249 . . . . 0.0 109.552 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.1 26.74 2.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.936 -1.102 . . . . 0.0 110.263 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.07 145.79 0.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.032 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.01 58.88 10.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 8' ' ' PRO . 20.5 mt -105.81 175.11 5.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.255 -1.144 . . . . 0.0 110.41 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.6 t -133.09 148.15 52.17 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.251 -0.906 . . . . 0.0 110.403 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.541 ' HB3' ' CB ' ' A' ' 69' ' ' LYS . 29.9 p30 -57.33 119.89 7.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 110.459 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.14 -35.34 5.11 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -47.62 148.65 1.41 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.028 -1.278 . . . . 0.0 110.428 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.586 ' C ' HG13 ' A' ' 18' ' ' VAL . 2.6 p -97.36 177.24 5.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 110.155 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.606 HG12 ' CG ' ' A' ' 8' ' ' PRO . 29.3 m -156.47 169.66 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.277 -0.889 . . . . 0.0 110.077 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 m -114.8 121.23 42.66 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.2 -0.938 . . . . 0.0 109.76 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 t -105.86 142.04 19.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.419 -0.8 . . . . 0.0 109.969 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.1 m -138.56 126.3 22.23 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.492 -0.755 . . . . 0.0 110.004 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 55.7 t -117.97 127.46 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.649 -0.657 . . . . 0.0 110.39 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.8 108.84 8.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.173 -0.955 . . . . 0.0 109.957 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 150.47 -82.38 0.18 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.501 ' O ' ' CA ' ' A' ' 59' ' ' GLY . . . -42.41 131.08 3.8 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.265 -1.138 . . . . 0.0 109.836 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.562 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -103.74 158.93 16.04 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.093 -1.005 . . . . 0.0 111.972 -179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.34 141.95 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.554 0.692 . . . . 0.0 111.07 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.11 7.28 4.11 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.577 ' CG ' ' CZ ' ' A' ' 31' ' ' TYR . 14.8 tp10 -161.92 136.58 7.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.923 -1.339 . . . . 0.0 111.223 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 53' ' ' PHE . 68.8 m -104.47 124.43 49.25 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.764 ' CD1' HD11 ' A' ' 102' ' ' LEU . 76.2 m-85 -103.13 172.96 6.52 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 111.55 -179.826 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.531 ' CE1' ' OG ' ' A' ' 52' ' ' SER . 96.3 m-85 -124.13 100.25 6.63 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.768 HG23 ' O ' ' A' ' 33' ' ' ILE . 5.7 tt -86.59 104.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.12 -0.988 . . . . 0.0 109.863 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.624 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -148.83 166.24 29.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.446 -0.784 . . . . 0.0 110.478 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.604 ' CD ' HD12 ' A' ' 107' ' ' LEU . 8.1 mt-30 -97.82 144.33 27.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 109.782 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.8 m -145.27 151.22 38.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.01 . . . . 0.0 110.952 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -148.78 164.6 20.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.585 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 41.6 Cg_endo -69.15 162.35 42.11 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.788 1.415 . . . . 0.0 110.605 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.468 -0.77 . . . . 0.0 110.17 -179.978 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 5.8 p30 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.313 0.578 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.67 165.4 33.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.975 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.498 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.8 m -141.77 168.12 20.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.179 -0.951 . . . . 0.0 110.236 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.51 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 0.3 OUTLIER -100.86 100.35 12.54 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.172 -179.976 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.0 Cg_endo -72.78 -34.61 6.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.013 1.533 . . . . 0.0 110.416 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.09 92.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 110.3 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.3 p -98.57 25.41 6.44 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.333 -0.854 . . . . 0.0 109.994 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -86.49 110.75 19.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.915 . . . . 0.0 110.302 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.582 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 7.5 t -116.32 133.45 56.01 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.319 -0.863 . . . . 0.0 110.018 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.531 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 12.2 t -108.77 137.79 46.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.279 -0.888 . . . . 0.0 110.58 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 30.3 p90 -135.38 -177.98 4.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 110.016 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 40.3 m -138.29 152.88 48.94 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.317 -0.865 . . . . 0.0 109.761 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.632 HG23 ' HE2' ' A' ' 31' ' ' TYR . 2.5 p -61.58 -162.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.942 -1.099 . . . . 0.0 109.963 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.612 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 3.0 t70 -143.43 -164.26 1.83 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.06 -1.025 . . . . 0.0 110.675 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.81 82.82 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.097 -1.002 . . . . 0.0 108.831 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -90.25 16.27 8.92 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 55.45 30.48 55.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.81 133.88 52.98 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.459 -1.024 . . . . 0.0 110.341 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.52 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -137.57 84.97 2.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.268 -0.895 . . . . 0.0 110.683 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.66 112.71 25.6 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.268 -0.895 . . . . 0.0 109.149 179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -145.91 179.53 7.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.106 -0.996 . . . . 0.0 111.024 -179.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -93.9 145.44 24.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.572 -0.705 . . . . 0.0 110.565 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.542 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 52.6 t80 -139.64 177.18 8.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.435 -0.791 . . . . 0.0 109.593 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.542 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 21.6 t -132.08 165.23 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.825 -1.172 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 66' ' ' VAL . 13.5 m -141.33 129.22 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.452 -0.78 . . . . 0.0 110.098 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -108.58 144.79 35.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 110.259 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.541 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 20.6 ttpt -68.95 -39.7 79.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.077 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 p -132.8 155.12 49.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.548 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 13.4 p90 -162.17 147.58 12.9 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.149 -0.97 . . . . 0.0 110.661 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 m -60.17 113.6 2.44 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.354 -0.841 . . . . 0.0 110.367 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.513 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -99.14 150.31 19.22 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.151 -1.206 . . . . 0.0 110.215 -179.988 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.45 0.643 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.513 ' CG2' ' HA3' ' A' ' 73' ' ' GLY . 58.9 t -92.49 133.6 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.81 . . . . 0.0 109.665 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -113.38 135.72 53.55 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.99 -1.069 . . . . 0.0 110.117 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 1.3 t -85.26 1.07 49.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.69 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.54 -61.66 1.72 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.085 -1.009 . . . . 0.0 110.547 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.3 t -84.56 -16.74 41.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.215 -0.928 . . . . 0.0 110.384 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.04 158.7 22.74 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.142 -0.974 . . . . 0.0 110.265 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.84 144.7 27.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.083 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 3.7 m -125.01 129.52 50.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.24 -0.913 . . . . 0.0 110.098 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 92' ' ' ASN . 1.8 m120 -111.62 127.68 55.82 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 110.014 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.624 HD12 ' O ' ' A' ' 34' ' ' ALA . 15.1 tp -93.23 108.9 20.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.92 . . . . 0.0 109.216 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -128.88 170.87 19.93 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.25 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -140.13 123.42 16.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -1.022 . . . . 0.0 109.866 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.93 166.59 36.29 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.492 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 5.1 p-10 -100.54 -43.39 6.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -1.113 . . . . 0.0 110.288 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 43.0 t -179.41 -43.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.18 -0.95 . . . . 0.0 110.627 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.67 27.45 3.21 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.512 HD22 ' HE1' ' A' ' 31' ' ' TYR . 3.4 tt -111.84 -44.57 3.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -1.187 . . . . 0.0 110.061 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.8 96.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.342 -0.848 . . . . 0.0 110.249 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.764 HD11 ' CD1' ' A' ' 31' ' ' TYR . 43.6 mt -83.68 -41.1 18.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -0.906 . . . . 0.0 110.258 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.99 162.24 12.97 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 5.3 p80 -145.5 122.06 11.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.519 -0.989 . . . . 0.0 109.751 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.502 HG11 HG12 ' A' ' 6' ' ' VAL . 91.5 t -96.86 113.92 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.541 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.4 117.84 6.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 109.812 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.604 HD12 ' CD ' ' A' ' 35' ' ' GLN . 83.5 mt -93.52 144.43 25.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.249 -0.907 . . . . 0.0 110.516 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 m -127.18 162.14 26.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 110.288 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.472 ' CD2' ' HG3' ' A' ' 69' ' ' LYS . 6.6 m-85 -135.72 126.62 27.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.202 -0.937 . . . . 0.0 110.058 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 118.036 -1.424 . . . . 0.0 109.611 179.897 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.506 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 47.3 Cg_endo . . . . . 0 N--CA 1.48 0.687 0 N-CA-C 110.495 -0.617 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -148.31 148.7 30.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.899 . . . . 0.0 110.411 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 17.1 t80 -148.24 115.45 6.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.305 -0.872 . . . . 0.0 109.76 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 t -143.55 153.45 42.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.991 -1.068 . . . . 0.0 111.092 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.532 HG22 ' HD2' ' A' ' 8' ' ' PRO . 4.8 p -131.27 168.81 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.516 -0.74 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.645 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -93.22 -63.1 0.16 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.864 -1.147 . . . . 0.0 110.329 179.965 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.645 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 55.2 Cg_endo -84.66 99.9 0.74 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 O-C-N 123.159 1.084 . . . . 0.0 110.08 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.03 -0.8 50.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.997 -1.065 . . . . 0.0 110.352 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.1 p -151.49 165.64 33.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.903 . . . . 0.0 109.95 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.09 64.27 3.91 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.44 ' O ' ' CE2' ' A' ' 109' ' ' PHE . 4.7 mt -117.03 139.63 50.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.412 -1.052 . . . . 0.0 110.337 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 15.0 t -100.96 158.72 15.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 110.241 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 4.4 p-10 -68.84 112.4 5.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 0.0 110.14 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.1 -24.92 21.9 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 37.6 tt0 -59.36 155.29 14.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.29 -1.123 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 18' ' ' VAL . 20.7 t -99.32 -179.17 4.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.478 -0.763 . . . . 0.0 110.245 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.794 HG23 ' HB3' ' A' ' 65' ' ' PHE . 14.0 m -154.55 176.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 0.0 110.045 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.5 m -118.25 123.73 46.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 110.094 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.27 151.3 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.155 -0.966 . . . . 0.0 110.299 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.9 m -140.62 123.35 16.25 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.406 -0.809 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 84.7 t -113.88 132.69 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 75.5 m -145.12 128.28 16.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.041 . . . . 0.0 110.59 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 140.02 -57.39 0.6 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.76 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -54.63 -167.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -1.163 . . . . 0.0 109.741 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.551 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -159.35 156.14 28.03 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.032 -1.043 . . . . 0.0 110.669 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.7 121.87 1.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.644 -0.66 . . . . 0.0 110.968 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.76 10.56 3.91 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 4.4 mm-40 -146.36 119.07 8.59 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.071 -1.252 . . . . 0.0 110.843 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.417 HG23 ' OG1' ' A' ' 54' ' ' THR . 88.0 m -105.92 114.11 28.06 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.973 ' CE1' HD22 ' A' ' 100' ' ' LEU . 32.2 m-85 -96.85 -178.16 4.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.1 -1.0 . . . . 0.0 111.769 -179.804 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 31' ' ' TYR . 22.4 m-85 -134.54 124.43 25.48 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 33' ' ' ILE . 3.3 tt -105.41 119.66 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.904 -1.123 . . . . 0.0 110.991 -179.823 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . . . -152.96 171.85 17.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.331 -0.856 . . . . 0.0 110.01 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 6.1 pt20 -127.52 156.27 42.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.24 -0.913 . . . . 0.0 110.006 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 9.6 m -140.73 169.51 17.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.12 -0.988 . . . . 0.0 110.383 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.07 163.13 25.69 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.331 -0.856 . . . . 0.0 110.028 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -79.05 170.29 18.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.951 1.501 . . . . 0.0 110.635 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.466 HG12 HG22 ' A' ' 84' ' ' VAL . 1.5 m . . . . . 0 N--CA 1.502 2.149 0 O-C-N 121.335 -0.853 . . . . 0.0 110.305 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 121.344 0.592 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -159.3 175.24 13.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.358 -0.839 . . . . 0.0 110.072 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 38.9 t -158.95 165.92 33.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.346 -0.846 . . . . 0.0 110.242 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.504 ' ND2' HG23 ' A' ' 49' ' ' THR . 57.1 t-20 -97.29 121.29 59.12 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.295 -0.878 . . . . 0.0 110.629 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -81.75 -33.41 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.936 1.493 . . . . 0.0 110.822 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.81 96.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.192 -0.943 . . . . 0.0 110.595 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.504 HG23 ' ND2' ' A' ' 46' ' ' ASN . 54.1 p -78.05 5.72 9.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 0.0 110.443 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.568 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -84.12 88.76 7.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 110.565 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.549 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 12.8 t -99.53 174.49 6.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.556 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 2.8 t -131.78 148.42 52.56 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.988 -1.07 . . . . 0.0 111.063 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 24.9 p90 -150.3 151.62 33.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.508 -0.745 . . . . 0.0 109.343 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.417 ' OG1' HG23 ' A' ' 30' ' ' THR . 10.4 m -119.84 155.54 32.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.028 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.76 HG21 ' CB ' ' A' ' 25' ' ' ALA . 3.8 p -67.13 -158.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.298 -0.876 . . . . 0.0 110.297 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 8.8 m-20 -143.75 -162.93 1.55 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.06 -1.025 . . . . 0.0 109.985 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.77 -40.21 96.13 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.096 -1.002 . . . . 0.0 109.188 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 t -90.27 10.77 23.43 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.516 -0.74 . . . . 0.0 109.507 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.551 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 59.35 61.06 7.71 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.59 135.18 23.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.282 -1.128 . . . . 0.0 110.088 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -137.13 84.92 2.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 110.92 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.11 118.31 36.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.115 -0.991 . . . . 0.0 108.619 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -151.98 179.55 8.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.952 -1.092 . . . . 0.0 110.908 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.6 p -89.6 157.16 18.15 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.544 -0.722 . . . . 0.0 110.156 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.794 ' HB3' HG23 ' A' ' 18' ' ' VAL . 34.4 t80 -138.41 177.43 7.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.423 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.435 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.5 t -135.87 155.18 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.817 -1.177 . . . . 0.0 110.108 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 12' ' ' LEU . 25.7 m -133.25 169.76 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.432 -0.792 . . . . 0.0 109.814 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 1.3 ttt85 -149.1 141.9 24.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.202 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -74.16 -48.07 31.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 110.22 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 95.4 p -119.9 144.75 47.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.933 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.543 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 21.5 p90 -162.01 142.79 10.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.112 -0.992 . . . . 0.0 110.693 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 54.1 m -55.66 122.29 11.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.304 -0.872 . . . . 0.0 109.877 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.1 168.78 13.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.389 -1.065 . . . . 0.0 109.979 -180.0 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 90.7 p . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.372 0.606 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.466 HG22 HG12 ' A' ' 39' ' ' VAL . 78.0 t -112.19 153.79 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.279 -0.888 . . . . 0.0 110.134 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -140.11 126.05 19.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 110.147 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 43.3 t -85.03 43.51 1.01 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.196 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.35 -52.13 5.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 110.193 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.6 t -101.28 1.08 38.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.124 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.36 -162.84 0.91 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.17 -0.956 . . . . 0.0 110.288 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.26 136.03 51.42 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.868 . . . . 0.0 110.151 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 2.3 p -125.05 127.79 47.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 110.071 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -107.89 165.75 11.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.377 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 107' ' ' LEU . 7.8 tp -128.54 110.71 12.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 109.544 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.579 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -116.28 162.58 12.59 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.298 -179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.39 167.87 13.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.978 . . . . 0.0 109.869 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 115.8 -166.05 12.24 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.403 ' CG ' ' N ' ' A' ' 98' ' ' SER . 7.9 t30 -147.59 168.71 21.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -1.177 . . . . 0.0 110.222 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.403 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 1.6 m -49.71 107.12 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 121.9 -46.69 1.09 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.973 HD22 ' CE1' ' A' ' 31' ' ' TYR . 0.4 OUTLIER -103.05 163.14 12.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -1.142 . . . . 0.0 110.135 179.987 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -146.68 131.25 17.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.333 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 4' ' ' PHE . 97.8 mt -106.96 -45.55 4.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.087 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.17 173.11 29.38 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.579 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 3.1 m-70 -140.85 108.32 5.57 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.343 -1.092 . . . . 0.0 109.94 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.525 HG11 HG12 ' A' ' 6' ' ' VAL . 1.9 t -90.21 113.67 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.32 -0.863 . . . . 0.0 110.445 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.69 130.87 47.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.169 -0.957 . . . . 0.0 109.88 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.876 HD11 ' HB2' ' A' ' 93' ' ' LEU . 31.5 mt -100.29 166.61 10.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.1 -1.0 . . . . 0.0 110.175 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -137.03 161.52 35.85 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.282 -0.886 . . . . 0.0 110.013 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 7.2 m-85 -139.65 148.16 42.03 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.349 -0.844 . . . . 0.0 110.05 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.04 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.964 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.502 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 46.1 Cg_endo . . . . . 0 N--CA 1.48 0.725 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -147.06 124.81 11.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.103 -0.998 . . . . 0.0 110.427 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.514 ' HE2' HD12 ' A' ' 33' ' ' ILE . 14.1 t80 -138.76 114.6 10.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.408 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.455 ' HA ' HG21 ' A' ' 105' ' ' VAL . 34.2 t -150.43 172.24 15.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.987 -1.071 . . . . 0.0 110.943 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.546 HG23 HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -130.02 145.55 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.854 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.622 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -66.17 -66.99 1.07 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.974 -1.079 . . . . 0.0 109.906 179.993 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.799 ' O ' HD21 ' A' ' 12' ' ' LEU . 56.0 Cg_endo -79.27 69.47 7.91 Favored 'Trans proline' 0 N--CA 1.483 0.873 0 O-C-N 123.465 1.245 . . . . 0.0 110.081 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.41 -11.92 59.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.951 -1.093 . . . . 0.0 110.481 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.8 126.23 31.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 110.164 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.9 71.69 1.25 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.799 HD21 ' O ' ' A' ' 8' ' ' PRO . 91.5 mt -112.57 165.67 12.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -1.144 . . . . 0.0 110.077 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -133.22 148.56 52.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.152 -0.967 . . . . 0.0 110.487 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -60.43 129.5 41.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.887 . . . . 0.0 110.141 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.01 -30.56 5.79 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -57.26 151.96 14.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.362 -1.081 . . . . 0.0 110.411 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -101.97 135.03 44.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.389 -0.819 . . . . 0.0 110.088 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.525 HG11 HG11 ' A' ' 67' ' ' VAL . 18.2 m -100.95 171.25 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.981 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.96 114.09 24.16 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.028 -1.045 . . . . 0.0 109.968 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.546 HG22 HG23 ' A' ' 6' ' ' VAL . 17.6 t -101.6 149.27 6.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.264 -0.897 . . . . 0.0 110.297 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.0 t -150.02 128.18 12.0 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.483 -0.76 . . . . 0.0 110.183 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 52.4 t -120.71 137.69 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 109.887 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.719 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 2.3 p -150.52 111.0 4.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.957 -1.089 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 160.95 -52.14 0.34 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.583 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -60.27 -151.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -1.131 . . . . 0.0 110.096 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.531 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -167.83 163.51 14.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.137 -0.977 . . . . 0.0 110.545 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -50.24 128.75 20.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.557 -0.714 . . . . 0.0 111.059 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.432 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 122.36 7.94 7.34 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.526 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 5.7 mm-40 -141.3 129.72 22.49 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.093 -1.239 . . . . 0.0 110.687 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.568 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.7 m -115.02 151.94 33.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 109.324 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 30' ' ' THR . 7.9 m-85 -139.7 -178.16 5.29 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.902 -1.124 . . . . 0.0 111.298 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 52' ' ' SER . 55.4 m-85 -132.99 108.35 8.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.744 HG22 HG23 ' A' ' 51' ' ' THR . 4.1 tt -87.56 125.44 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.154 -0.966 . . . . 0.0 110.851 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.729 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -152.1 165.21 35.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.24 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.457 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 1.0 OUTLIER -118.05 150.85 38.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.204 -0.935 . . . . 0.0 110.029 179.986 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 72.2 m -150.8 164.65 35.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.897 . . . . 0.0 111.001 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.42 149.41 22.73 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.706 . . . . 0.0 109.495 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.52 164.42 32.93 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.839 1.442 . . . . 0.0 110.536 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.538 HG12 HG22 ' A' ' 84' ' ' VAL . 17.4 m . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.333 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.255 0.55 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -110.52 150.71 28.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.155 -0.966 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.422 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.3 m -136.65 160.38 39.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.261 -0.899 . . . . 0.0 110.267 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.84 95.37 16.84 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.242 -0.911 . . . . 0.0 110.369 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 48.8 Cg_endo -76.55 -30.45 5.05 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.966 1.508 . . . . 0.0 110.452 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.84 -38.95 70.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.309 -0.869 . . . . 0.0 110.295 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.49 36.82 1.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.817 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.3 144.11 28.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.489 -0.757 . . . . 0.0 110.788 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.744 HG23 HG22 ' A' ' 33' ' ' ILE . 11.0 t -151.22 143.51 24.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.833 . . . . 0.0 109.736 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.496 ' HB3' ' CE1' ' A' ' 32' ' ' TYR . 12.2 p -109.76 151.61 26.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.083 -1.011 . . . . 0.0 110.532 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -151.14 136.22 17.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.52 ' OG1' HG23 ' A' ' 30' ' ' THR . 26.3 m -102.15 171.95 7.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.256 -0.902 . . . . 0.0 110.571 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.583 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -84.89 -160.89 0.52 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.301 -0.874 . . . . 0.0 110.222 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 1.6 m-20 -149.1 -157.88 0.86 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.205 -0.935 . . . . 0.0 109.827 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.7 -53.66 55.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.91 -1.119 . . . . 0.0 109.997 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 t -87.12 16.17 5.38 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.265 -0.897 . . . . 0.0 109.215 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 56.84 48.79 75.63 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.0 129.98 56.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.282 -1.128 . . . . 0.0 110.426 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.572 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -132.18 85.1 2.21 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.331 -0.856 . . . . 0.0 110.077 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.7 p -110.63 134.3 52.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 109.901 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 25.8 p90 -163.85 173.64 12.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.233 -0.917 . . . . 0.0 110.504 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 t -94.08 137.9 32.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.797 . . . . 0.0 110.446 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.485 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 55.8 t80 -127.39 -179.46 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.532 -0.73 . . . . 0.0 109.374 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.485 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.2 t -128.02 154.92 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.853 -1.154 . . . . 0.0 110.209 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 22.2 m -129.0 178.67 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.373 -0.83 . . . . 0.0 110.111 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 3.0 mtp180 -150.31 118.66 6.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.849 . . . . 0.0 110.313 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 11.2 ttmt -49.81 -36.71 27.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.197 -0.939 . . . . 0.0 109.773 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.64 141.81 31.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.902 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.469 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 24.2 p90 -151.67 141.76 22.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -66.51 136.93 56.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.173 -179.933 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.74 170.38 49.06 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.208 -1.172 . . . . 0.0 110.231 -179.976 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.401 0.619 . . . . 0.0 110.841 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.538 HG22 HG12 ' A' ' 39' ' ' VAL . 56.0 t -112.01 108.71 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 109.546 179.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -88.24 135.78 33.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 0.0 110.246 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 91' ' ' CYS . 7.5 m -110.79 41.82 1.72 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.88 -52.01 3.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 109.964 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -99.17 -9.24 24.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.861 . . . . 0.0 110.063 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.87 -133.41 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 109.935 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -151.05 97.26 2.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.082 -1.011 . . . . 0.0 110.807 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -88.51 113.41 24.07 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.184 -0.948 . . . . 0.0 109.048 179.914 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 16.6 p30 -113.48 129.73 56.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.972 -1.08 . . . . 0.0 111.293 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 34' ' ' ALA . 13.1 tp -99.43 111.13 23.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.366 -0.834 . . . . 0.0 109.373 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -125.43 171.92 17.39 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 102' ' ' LEU . . . -134.84 178.98 6.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -1.078 . . . . 0.0 110.021 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 138.48 157.56 7.45 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.42 ' OD1' ' HB2' ' A' ' 98' ' ' SER . 8.2 p30 -107.55 -29.19 9.33 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.28 -1.129 . . . . 0.0 110.328 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.42 ' HB2' ' OD1' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -172.18 -72.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.7 -10.7 32.37 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.54 ' CD2' ' CE1' ' A' ' 31' ' ' TYR . 21.5 tp -73.78 -64.59 0.97 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.02 -1.282 . . . . 0.0 110.196 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 92.3 m-20 55.29 103.33 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -79.01 -6.11 55.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 110.374 179.966 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 94' ' ' GLY . . . 106.97 -175.39 20.62 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.476 ' O ' ' ND1' ' A' ' 104' ' ' HIS . 34.2 p80 -148.7 132.22 16.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.251 -1.146 . . . . 0.0 110.132 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.455 HG21 ' HA ' ' A' ' 5' ' ' SER . 54.4 t -93.83 130.46 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.147 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.47 114.29 8.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 110.408 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HB3' HD12 ' A' ' 12' ' ' LEU . 34.7 mt -93.2 136.5 33.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.848 . . . . 0.0 110.354 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.594 HG22 ' N ' ' A' ' 109' ' ' PHE . 98.3 m -107.25 173.2 6.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.291 -0.88 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.594 ' N ' HG22 ' A' ' 108' ' ' THR . 7.6 m-85 -142.8 122.69 13.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.889 . . . . 0.0 110.292 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.973 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.476 ' HG2' ' HA ' ' A' ' 102' ' ' LEU . 47.1 Cg_endo . . . . . 0 N--CA 1.483 0.854 0 N-CA-C 110.551 -0.596 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -132.13 146.7 52.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.222 -0.924 . . . . 0.0 110.596 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 12.4 t80 -149.5 113.17 5.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.462 -0.774 . . . . 0.0 109.592 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.62 ' HA ' HG21 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -151.15 167.02 29.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.032 -1.042 . . . . 0.0 110.959 -179.9 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.646 HG12 HG11 ' A' ' 105' ' ' VAL . 7.5 p -128.25 141.05 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.725 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -55.88 -67.38 0.77 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.08 -1.012 . . . . 0.0 110.289 -179.965 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 49.5 Cg_endo -74.4 82.81 1.8 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.386 1.203 . . . . 0.0 109.807 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.65 1.99 52.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.975 . . . . 0.0 110.501 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.8 p -150.27 148.89 29.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.252 -0.905 . . . . 0.0 110.165 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.3 58.71 3.55 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mt -105.44 170.63 7.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.303 -1.116 . . . . 0.0 110.45 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.47 149.4 43.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 110.183 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.8 96.94 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.83 -34.06 3.23 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -54.22 142.89 24.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 110.143 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 66.3 m -91.68 134.09 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 110.069 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.614 HG11 HG11 ' A' ' 67' ' ' VAL . 23.2 m -100.88 148.86 6.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 110.168 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.21 106.1 18.11 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.34 -0.85 . . . . 0.0 109.309 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.525 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 36.9 t -93.37 149.74 4.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.499 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.75 119.27 5.63 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.857 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.85 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 23.8 t -107.08 132.51 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.771 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.673 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 30.3 m -127.77 120.36 27.72 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 148.75 -77.69 0.23 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.609 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -47.12 172.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.216 -1.167 . . . . 0.0 110.029 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.542 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -139.6 161.63 37.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 110.464 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -39.04 122.79 1.25 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.674 -0.641 . . . . 0.0 110.653 -179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.57 0.76 7.84 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.497 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 30.9 mm-40 -132.93 130.51 39.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -1.184 . . . . 0.0 110.597 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.427 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 57.5 m -106.34 161.25 14.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.503 -0.748 . . . . 0.0 109.659 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.72 ' HE1' HD22 ' A' ' 100' ' ' LEU . 80.1 m-85 -149.96 176.47 10.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.041 -1.037 . . . . 0.0 110.552 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 17.7 m-85 -122.78 147.62 46.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.456 -0.778 . . . . 0.0 109.093 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.585 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 5.2 tt -128.35 116.53 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.955 -1.091 . . . . 0.0 110.15 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.615 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -148.46 158.58 44.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.917 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.45 ' OE1' ' HB3' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -93.62 136.12 34.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.608 -0.682 . . . . 0.0 109.958 179.912 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.2 m -142.98 143.39 31.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.783 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -144.89 174.72 3.24 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.454 -0.778 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.783 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 43.1 Cg_endo -71.86 165.67 31.86 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.733 1.386 . . . . 0.0 110.351 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.4 p . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.297 -0.877 . . . . 0.0 110.366 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.363 0.601 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.473 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -117.37 151.9 36.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.35 -0.844 . . . . 0.0 109.895 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.49 ' O ' ' HA2' ' A' ' 73' ' ' GLY . 2.4 m -116.05 164.34 14.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.153 -0.967 . . . . 0.0 110.368 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.47 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 59.3 t-20 -96.0 123.2 56.17 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.275 -0.891 . . . . 0.0 110.174 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.76 -33.74 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.861 1.453 . . . . 0.0 110.681 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.45 -19.77 65.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.346 -0.846 . . . . 0.0 110.815 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.16 32.93 5.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.045 -1.035 . . . . 0.0 110.476 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.52 106.29 18.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.224 -0.922 . . . . 0.0 110.511 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.585 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 14.9 t -131.42 -178.57 4.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.0 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.4 ' CB ' ' CD1' ' A' ' 32' ' ' TYR . 55.6 p -144.12 147.19 33.4 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.115 -0.991 . . . . 0.0 110.839 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 20.6 p90 -136.09 -176.99 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.763 . . . . 0.0 109.539 179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.5 m -145.47 154.32 42.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.796 -1.19 . . . . 0.0 110.256 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.609 HG21 ' HB3' ' A' ' 25' ' ' ALA . 2.0 p -69.99 -158.02 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.209 -0.932 . . . . 0.0 109.915 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 3.3 m-20 -160.03 -155.67 0.45 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.902 -1.124 . . . . 0.0 110.148 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.14 78.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.918 -1.114 . . . . 0.0 109.527 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 t -79.29 4.99 13.51 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.379 -0.825 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 56.05 38.03 74.05 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -124.91 127.19 46.71 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.268 -1.136 . . . . 0.0 110.104 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.85 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -101.14 80.35 2.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 110.365 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.9 m -101.08 120.18 39.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.676 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.525 ' CE1' ' HB ' ' A' ' 20' ' ' VAL . 7.0 p90 -155.73 174.79 14.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.192 -0.942 . . . . 0.0 110.833 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.5 m -98.32 132.6 43.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 40.5 t80 -130.35 179.63 5.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.443 -0.786 . . . . 0.0 109.238 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.467 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.8 t -129.38 155.9 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.81 -1.181 . . . . 0.0 110.352 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.614 HG11 HG11 ' A' ' 18' ' ' VAL . 31.8 m -125.21 159.02 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.404 -0.81 . . . . 0.0 110.357 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -133.21 132.9 42.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.263 -0.898 . . . . 0.0 110.034 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -72.8 -10.83 60.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.137 -0.977 . . . . 0.0 110.362 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.2 p -150.29 139.37 21.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.131 -0.981 . . . . 0.0 110.536 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 9.6 p90 -168.09 138.76 2.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.299 -0.876 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.2 OUTLIER -68.68 137.34 54.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.258 -0.901 . . . . 0.0 110.091 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 45' ' ' CYS . . . -121.7 -166.48 12.88 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 p . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.305 -1.115 . . . . 0.0 110.138 -179.997 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.307 0.575 . . . . 0.0 110.283 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 44' ' ' ALA . 74.0 t -125.21 159.1 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.383 -0.823 . . . . 0.0 110.21 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -154.75 146.61 23.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.882 . . . . 0.0 110.056 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.81 17.73 22.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 110.105 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.62 -42.78 61.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 110.674 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -117.74 -16.42 10.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.148 -0.97 . . . . 0.0 110.361 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.43 147.09 34.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.953 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.17 154.51 27.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 0.0 110.178 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.45 ' HB3' ' OE1' ' A' ' 35' ' ' GLN . 82.7 m -120.93 162.74 19.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 0.0 110.329 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -146.09 121.3 10.18 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.31 -0.868 . . . . 0.0 110.237 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 34' ' ' ALA . 45.2 tp -86.95 112.1 21.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.046 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.584 ' HA3' ' CD2' ' A' ' 104' ' ' HIS . . . -121.14 163.37 14.61 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.501 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 102' ' ' LEU . . . -132.42 159.07 40.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.551 -0.97 . . . . 0.0 110.507 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 101' ' ' ASP . . . 169.31 159.2 14.45 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 31' ' ' TYR . 1.5 p30 -143.34 -41.14 0.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.991 -1.299 . . . . 0.0 111.246 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.43 78.01 1.2 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.951 -1.093 . . . . 0.0 111.294 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.45 9.24 29.97 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.72 HD22 ' HE1' ' A' ' 31' ' ' TYR . 1.6 tt -99.35 -51.33 3.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.285 . . . . 0.0 109.827 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.523 ' HA ' ' CA ' ' A' ' 96' ' ' GLY . 1.1 m-20 54.21 164.54 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.485 -0.759 . . . . 0.0 110.123 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 31.7 mt -126.36 -47.68 1.59 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.904 -179.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 167.35 174.35 36.36 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.584 ' CD2' ' HA3' ' A' ' 94' ' ' GLY . 1.9 m170 -129.56 126.77 39.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.851 -0.793 . . . . 0.0 109.652 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.646 HG11 HG12 ' A' ' 6' ' ' VAL . 20.0 t -108.23 120.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.048 -1.032 . . . . 0.0 110.439 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.06 107.55 10.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.932 . . . . 0.0 109.382 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 12.6 mt -88.61 171.86 9.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.308 -0.87 . . . . 0.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -147.77 158.68 44.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.449 -0.782 . . . . 0.0 109.838 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -122.16 119.85 32.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.058 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.59 179.997 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 N--CA 1.482 0.838 0 N-CA-C 110.49 -0.619 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -154.04 121.77 5.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.897 . . . . 0.0 110.334 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -141.47 110.79 6.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.211 -0.931 . . . . 0.0 109.562 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.8 t -150.69 161.13 43.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.078 -1.014 . . . . 0.0 110.999 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.91 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 6.2 p -114.93 160.42 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.494 -0.754 . . . . 0.0 109.674 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -62.96 -66.52 1.5 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.048 -1.032 . . . . 0.0 110.561 -179.993 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.758 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 43.1 Cg_endo -73.54 -73.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.424 1.223 . . . . 0.0 110.591 -179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.91 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 75.26 -1.04 3.15 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.443 -0.786 . . . . 0.0 110.203 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.446 ' OG ' ' C ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER -164.21 145.42 8.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 110.248 -179.951 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.96 41.22 61.83 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 108' ' ' THR . 1.3 mp -90.78 174.79 7.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -1.164 . . . . 0.0 110.091 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 1.5 t -128.56 150.34 50.24 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.361 -0.837 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 6.2 p-10 -56.94 108.04 0.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.189 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.92 -35.19 5.09 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.4 tt0 -45.95 152.94 0.33 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.303 -1.116 . . . . 0.0 110.357 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 3.6 p -103.53 154.4 19.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.403 -0.811 . . . . 0.0 110.378 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.1 m -129.13 150.23 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.302 -0.874 . . . . 0.0 110.026 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 m -94.91 115.15 27.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.136 -0.978 . . . . 0.0 109.842 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t -100.8 147.65 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 2.8 t -146.06 139.3 25.95 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.47 -0.769 . . . . 0.0 110.469 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 47.6 t -128.29 153.59 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.526 -0.734 . . . . 0.0 110.007 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.56 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 7.3 m -165.89 120.89 1.23 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.946 -1.096 . . . . 0.0 110.672 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 25' ' ' ALA . . . 139.29 -59.98 0.58 Allowed Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.354 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.75 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -39.53 -47.9 1.95 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.199 -1.177 . . . . 0.0 110.985 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 25' ' ' ALA . . . 73.99 141.79 0.07 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.398 -0.814 . . . . 0.0 110.595 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -39.13 136.33 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.527 0.68 . . . . 0.0 110.866 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.01 12.55 4.36 Favored Glycine 0 N--CA 1.481 1.643 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -156.3 126.73 6.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.056 -1.261 . . . . 0.0 110.62 179.975 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.809 HG23 ' OG1' ' A' ' 54' ' ' THR . 1.6 m -94.1 143.11 26.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.463 -0.773 . . . . 0.0 109.858 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.618 ' CE1' HD22 ' A' ' 100' ' ' LEU . 25.7 m-85 -134.34 146.14 49.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.08 -1.012 . . . . 0.0 111.154 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.609 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 97.5 m-85 -113.86 124.48 52.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.389 -0.82 . . . . 0.0 109.05 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.763 ' CG2' HG23 ' A' ' 51' ' ' THR . 12.4 tt -96.3 120.44 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.83 -1.169 . . . . 0.0 110.652 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.477 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -152.07 153.29 33.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 110.142 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . 14.3 pt20 -121.41 150.39 41.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.111 -0.993 . . . . 0.0 110.288 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 96.6 m -152.02 164.28 37.53 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.202 -0.936 . . . . 0.0 111.095 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -153.06 158.47 32.86 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.662 -0.649 . . . . 0.0 109.978 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.01 173.11 8.83 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.792 1.417 . . . . 0.0 110.668 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.78 ' O ' HG22 ' A' ' 39' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.242 -0.912 . . . . 0.0 111.043 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.4 0.619 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.48 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -140.17 151.17 45.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.455 -0.778 . . . . 0.0 109.741 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.505 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 0.8 OUTLIER -139.77 161.62 37.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 0.0 110.444 179.97 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -107.9 89.81 5.82 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.344 -0.848 . . . . 0.0 110.179 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 48.6 Cg_endo -76.27 -31.79 4.44 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.974 1.513 . . . . 0.0 110.681 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.3 -27.16 63.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.304 -0.873 . . . . 0.0 110.438 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 p -108.55 39.18 2.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 110.149 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.31 138.9 31.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 110.414 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.763 HG23 ' CG2' ' A' ' 33' ' ' ILE . 3.7 t -153.1 134.96 14.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.892 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.609 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 87.9 p -108.04 145.09 34.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.727 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 14.7 p90 -150.97 -175.75 5.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 109.586 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.809 ' OG1' HG23 ' A' ' 30' ' ' THR . 7.0 m -145.5 160.53 41.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.178 -0.951 . . . . 0.0 109.627 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.71 HG21 ' HB3' ' A' ' 25' ' ' ALA . 3.0 p -60.72 -162.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.94 -1.1 . . . . 0.0 109.966 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -143.19 -164.24 1.81 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.044 -1.035 . . . . 0.0 109.879 -179.981 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.11 67.02 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.036 -1.04 . . . . 0.0 109.414 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.2 p -89.73 18.28 5.71 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 59.13 29.38 65.44 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -105.99 123.82 48.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.293 -1.122 . . . . 0.0 110.499 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.761 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -126.5 85.12 2.34 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.6 p -106.15 124.94 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.235 -0.916 . . . . 0.0 109.699 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.639 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 4.8 p90 -153.89 177.03 11.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.076 -1.015 . . . . 0.0 110.645 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.39 141.31 28.87 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.5 -0.75 . . . . 0.0 110.625 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.432 ' C ' ' CG2' ' A' ' 66' ' ' VAL . 45.8 t80 -138.78 -174.75 3.92 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.432 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 3.2 t -147.22 161.54 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.824 -1.173 . . . . 0.0 110.242 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 26.7 m -133.64 -177.04 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.397 -0.814 . . . . 0.0 110.012 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 26.4 mtt180 -158.45 123.29 4.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.038 -1.039 . . . . 0.0 110.629 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.54 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 10.9 tttm -62.42 -43.59 98.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.867 . . . . 0.0 109.556 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m -127.97 118.88 24.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -131.24 143.63 50.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.953 . . . . 0.0 110.461 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.5 m -60.91 141.91 56.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.96 . . . . 0.0 109.885 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.48 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -127.76 154.76 19.84 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.394 -1.062 . . . . 0.0 110.274 179.986 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 69.8 m . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.277 0.561 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.442 HG21 ' CB ' ' A' ' 44' ' ' ALA . 70.9 t -122.41 149.58 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.213 -0.929 . . . . 0.0 109.999 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -127.58 162.35 26.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.168 -0.957 . . . . 0.0 110.553 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 89' ' ' ALA . 19.1 m -106.36 -9.76 16.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 0.0 110.095 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.16 -52.55 9.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.345 -0.847 . . . . 0.0 110.334 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.6 t -71.36 -19.6 62.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.15 -0.969 . . . . 0.0 109.866 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 86' ' ' CYS . . . -133.12 -160.17 1.03 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.391 -0.818 . . . . 0.0 109.873 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.88 135.11 45.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.173 -0.955 . . . . 0.0 109.857 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 1.9 p -121.27 146.7 46.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.133 -0.979 . . . . 0.0 109.774 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -127.6 147.84 50.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.09 -1.006 . . . . 0.0 111.146 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 34' ' ' ALA . 8.0 tp -119.05 114.75 22.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.455 -0.778 . . . . 0.0 109.053 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -129.13 178.77 17.11 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.578 -1.296 . . . . 0.0 110.26 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -140.73 172.33 12.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.394 -1.062 . . . . 0.0 110.163 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 144.74 169.4 13.28 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' CG ' ' N ' ' A' ' 98' ' ' SER . 5.2 p30 -89.47 -45.19 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -1.187 . . . . 0.0 110.276 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.473 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER 171.54 -41.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.429 -0.795 . . . . 0.0 109.955 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.84 -12.41 22.52 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.618 HD22 ' CE1' ' A' ' 31' ' ' TYR . 1.1 tt -87.21 -65.83 0.97 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.196 -1.179 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 100' ' ' LEU . 13.9 t0 68.17 75.13 0.28 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.348 -0.845 . . . . 0.0 110.012 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.99 -36.53 28.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.335 -0.853 . . . . 0.0 110.45 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.44 170.37 13.13 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.439 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -135.31 125.74 26.66 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.216 -1.167 . . . . 0.0 109.91 179.983 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.48 124.54 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.985 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.07 125.52 25.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.246 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 107' ' ' LEU . 76.6 mt -95.84 164.99 12.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.291 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.566 ' O ' HD12 ' A' ' 12' ' ' LEU . 6.2 m -158.5 175.99 12.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.311 -0.868 . . . . 0.0 110.054 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.54 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 69.0 m-85 -142.64 152.0 42.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.308 -0.87 . . . . 0.0 110.277 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.039 -1.423 . . . . 0.0 109.598 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.903 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.903 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 47.7 Cg_endo -74.74 -171.0 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.797 1.42 . . . . 0.0 110.226 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.77 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -140.62 123.18 16.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 110.796 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.452 ' HD1' HG22 ' A' ' 22' ' ' VAL . 81.9 t80 -141.52 100.22 3.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.502 -0.749 . . . . 0.0 109.119 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.11 172.12 13.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 110.978 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 6' ' ' VAL . 5.2 p -137.02 128.44 42.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.642 -0.661 . . . . 0.0 109.612 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.635 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.1 m -46.62 -72.89 0.12 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.117 . . . . 0.0 110.221 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.635 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 53.0 Cg_endo -75.9 97.77 1.14 Allowed 'Trans proline' 0 N--CA 1.483 0.87 0 O-C-N 123.04 1.021 . . . . 0.0 110.031 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.32 4.4 41.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.13 -0.981 . . . . 0.0 110.25 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.6 p -155.57 167.7 29.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 110.245 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.39 42.22 97.37 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.541 ' O ' ' CE2' ' A' ' 109' ' ' PHE . 85.3 mt -90.43 136.83 32.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.303 -1.116 . . . . 0.0 110.137 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.487 ' HB2' ' OE1' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -110.75 156.53 20.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 110.459 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 8.1 p-10 -57.22 119.28 6.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.04 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.42 -35.5 4.86 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.487 ' OE1' ' HB2' ' A' ' 13' ' ' SER . 33.4 tt0 -48.72 142.65 5.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -1.116 . . . . 0.0 110.044 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 58.9 p -95.3 161.6 14.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.351 -0.843 . . . . 0.0 110.597 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.542 HG23 ' HB3' ' A' ' 65' ' ' PHE . 16.5 m -132.29 151.07 34.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.412 -0.805 . . . . 0.0 109.636 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 1.5 m -99.35 122.02 41.9 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.063 -1.023 . . . . 0.0 109.804 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.483 ' CG1' ' CE1' ' A' ' 63' ' ' PHE . 7.4 t -110.95 146.47 15.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.38 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.0 p -140.68 128.64 21.97 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.389 -0.819 . . . . 0.0 110.397 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.792 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 39.9 t -121.66 100.78 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.77 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.4 OUTLIER -130.23 110.21 11.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.978 . . . . 0.0 110.251 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 169.32 -50.71 0.21 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.922 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -59.97 -138.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -1.131 . . . . 0.0 109.883 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -179.11 164.56 1.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.976 -1.078 . . . . 0.0 110.347 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.804 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . . . -54.26 128.89 33.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.398 -0.814 . . . . 0.0 110.479 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 119.69 18.92 4.24 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 9.5 mm-40 -154.9 127.31 7.87 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.235 -1.156 . . . . 0.0 110.457 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.471 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -93.56 170.1 9.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.344 -0.848 . . . . 0.0 109.952 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 79.5 m-85 -152.94 155.44 37.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.416 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 78.8 m-85 -122.81 111.25 16.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.663 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.752 HG23 HG23 ' A' ' 51' ' ' THR . 5.4 tt -95.98 120.91 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.102 -0.999 . . . . 0.0 110.433 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.66 160.37 43.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.112 -0.992 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.522 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 25.3 tt0 -114.15 133.56 55.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.64 -0.662 . . . . 0.0 109.219 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 66.0 m -139.49 156.24 47.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.985 -1.072 . . . . 0.0 111.146 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.63 144.0 16.92 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 41.6 Cg_endo -69.97 159.95 51.38 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.819 1.431 . . . . 0.0 110.68 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 42' ' ' GLN . 6.6 m -127.91 162.77 33.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.517 -0.739 . . . . 0.0 110.02 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -50.94 -22.62 6.31 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.26 -70.17 1.3 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.772 ' H ' HG23 ' A' ' 39' ' ' VAL . 2.9 tp-100 -147.79 -86.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -1.0 . . . . 0.0 110.407 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 7.1 m-20 -150.99 153.46 35.22 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.146 -0.971 . . . . 0.0 110.36 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.442 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -144.89 151.69 39.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.18 -0.95 . . . . 0.0 110.321 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 m -131.23 155.11 47.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.309 -0.869 . . . . 0.0 110.199 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.465 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 36.2 t-20 -87.9 124.08 67.78 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.07 -1.019 . . . . 0.0 110.195 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -81.83 -41.06 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.898 1.473 . . . . 0.0 111.046 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.63 93.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.321 -0.862 . . . . 0.0 111.021 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 47.7 p -80.64 7.14 10.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.142 -0.974 . . . . 0.0 110.365 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.78 104.98 6.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 110.223 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.752 HG23 HG23 ' A' ' 33' ' ' ILE . 9.8 t -136.9 163.16 31.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.884 . . . . 0.0 110.197 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -132.8 162.19 32.13 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 110.241 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 46.6 p90 -151.23 171.06 18.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.439 -0.788 . . . . 0.0 109.659 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.6 m -130.97 155.99 45.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.137 -0.977 . . . . 0.0 110.139 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.922 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -88.75 176.11 7.22 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.095 -1.003 . . . . 0.0 110.187 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.804 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 11.0 t70 -177.13 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.183 -0.948 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.43 86.92 0.07 Allowed 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.212 -0.93 . . . . 0.0 109.13 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.95 15.95 8.8 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 79.1 52.27 4.97 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.07 149.22 28.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -1.168 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.792 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -163.53 78.37 0.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 110.526 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.8 m -101.55 130.28 47.81 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.294 -0.879 . . . . 0.0 109.706 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.483 ' CE1' ' CG1' ' A' ' 20' ' ' VAL . 1.7 p90 -153.32 171.3 18.79 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.005 -1.059 . . . . 0.0 111.086 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.1 m -92.94 125.51 37.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.449 -0.782 . . . . 0.0 110.642 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.542 ' HB3' HG23 ' A' ' 18' ' ' VAL . 28.8 t80 -118.47 -173.07 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.597 -0.689 . . . . 0.0 109.375 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 3.9 t -147.76 167.78 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 120.756 -1.215 . . . . 0.0 110.371 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 13.1 m -139.37 161.78 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 0.0 110.243 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -143.35 122.79 13.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.262 -0.899 . . . . 0.0 110.097 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ARG . 2.7 ttpt -45.63 -48.19 14.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.044 -1.035 . . . . 0.0 109.365 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 6.6 m -127.3 123.81 37.27 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.58 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 28.3 p90 -125.13 140.18 53.11 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.079 -1.013 . . . . 0.0 111.28 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 85.7 m -58.35 99.91 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.396 -0.815 . . . . 0.0 109.957 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.67 177.15 26.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.0 t -158.04 143.63 16.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -1.173 . . . . 0.0 110.193 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.654 HG22 ' HD2' ' A' ' 76' ' ' PRO . 3.9 m -69.8 149.64 96.62 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.855 . . . . 0.0 110.231 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.654 ' HD2' HG22 ' A' ' 75' ' ' THR . 47.6 Cg_endo -82.88 14.68 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.009 1.531 . . . . 0.0 110.404 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -118.31 41.52 2.93 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.193 -0.942 . . . . 0.0 110.171 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.61 23.39 54.9 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 79' ' ' THR . 5.6 m -124.62 87.76 54.23 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.194 -1.18 . . . . 0.0 110.284 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.45 86.06 0.85 Allowed 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.89 1.468 . . . . 0.0 110.187 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.572 HG13 ' N ' ' A' ' 82' ' ' GLY . 5.6 p -51.48 -45.2 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.339 -0.851 . . . . 0.0 110.544 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.572 ' N ' HG13 ' A' ' 81' ' ' VAL . . . 142.58 -144.24 13.75 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 19.4 m -81.27 160.01 24.34 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.337 -1.096 . . . . 0.0 110.762 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 70' ' ' SER . 40.6 t -125.02 148.63 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 59.3 p30 -127.23 166.22 18.16 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.063 -1.023 . . . . 0.0 110.721 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -112.71 1.77 15.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.499 -0.751 . . . . 0.0 110.414 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.32 -58.26 4.66 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.69 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -81.64 -27.38 34.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.116 -0.99 . . . . 0.0 110.501 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.05 176.99 4.78 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.39 155.88 22.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.8 m -116.93 139.11 51.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 0.0 110.185 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -123.29 125.73 45.58 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 110.322 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -102.02 108.52 19.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.283 -0.886 . . . . 0.0 109.078 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.2 163.5 12.38 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.498 -1.334 . . . . 0.0 110.141 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.602 ' O ' HD12 ' A' ' 102' ' ' LEU . . . -155.16 118.27 4.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.449 -1.03 . . . . 0.0 109.872 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.61 -177.06 46.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -118.15 177.41 4.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -1.136 . . . . 0.0 110.265 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.0 t -70.64 -20.12 62.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.127 -0.983 . . . . 0.0 110.146 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.1 -44.05 5.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.755 HD13 ' C ' ' A' ' 100' ' ' LEU . 3.4 tm? -118.87 135.74 54.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.242 -1.152 . . . . 0.0 109.938 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.745 ' N ' HD13 ' A' ' 100' ' ' LEU . 41.0 m-20 -116.12 101.66 8.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.0 . . . . 0.0 110.322 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 95' ' ' ALA . 19.8 mt -66.03 -61.16 2.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 110.003 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.12 -173.98 30.46 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -148.26 150.38 33.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.466 -1.02 . . . . 0.0 110.117 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.504 HG11 HG12 ' A' ' 6' ' ' VAL . 12.0 t -107.77 126.02 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.329 -0.857 . . . . 0.0 110.335 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.9 114.06 10.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.914 . . . . 0.0 109.841 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.522 ' CD1' ' OE1' ' A' ' 35' ' ' GLN . 58.1 mt -81.4 147.03 30.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.94 . . . . 0.0 110.573 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -127.74 158.16 38.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.853 . . . . 0.0 110.096 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 13.1 m-85 -128.74 92.26 3.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.275 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.433 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -73.19 -162.73 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.86 1.453 . . . . 0.0 110.423 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -162.14 115.5 1.79 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.88 . . . . 0.0 110.405 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -126.96 114.85 18.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.2 m -143.76 170.35 16.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.06 -1.025 . . . . 0.0 110.593 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.917 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 4.0 p -134.5 138.4 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.386 -0.821 . . . . 0.0 110.239 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.543 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -54.84 -57.13 20.79 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.357 -0.839 . . . . 0.0 110.962 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.762 ' HD2' HG22 ' A' ' 6' ' ' VAL . 42.4 Cg_endo -69.09 -87.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.864 1.455 . . . . 0.0 110.797 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.917 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 71.53 14.19 6.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.283 -0.885 . . . . 0.0 109.836 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.2 t -178.13 149.13 0.53 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.88 45.92 62.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' A' ' 8' ' ' PRO . 17.2 mt -98.79 174.3 6.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.326 -1.102 . . . . 0.0 110.231 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.81 159.72 44.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 110.12 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.53 ' HB3' ' CB ' ' A' ' 69' ' ' LYS . 1.5 p30 -59.76 116.33 3.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.265 -0.897 . . . . 0.0 110.206 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.41 -33.6 6.07 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -45.68 154.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -1.108 . . . . 0.0 110.106 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.521 ' O ' ' NE2' ' A' ' 16' ' ' GLN . 5.5 t -98.53 172.03 7.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.54 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.4 m -149.09 154.68 9.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.385 -0.822 . . . . 0.0 109.9 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.488 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 0.4 OUTLIER -111.6 114.83 28.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.257 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.7 t -103.72 152.01 6.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.323 -0.861 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 18.8 t -149.36 132.56 16.39 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.492 -0.755 . . . . 0.0 109.998 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.829 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 6.6 t -124.09 153.24 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 110.338 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.661 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 1.0 OUTLIER -161.29 120.01 2.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 131.26 4.85 3.93 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 1.001 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -103.61 -30.04 10.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.998 -1.295 . . . . 0.0 110.374 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.539 ' HA ' ' HA3' ' A' ' 59' ' ' GLY . . . 58.57 133.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.816 0.817 . . . . 0.0 111.43 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -39.08 141.63 0.29 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.538 0.685 . . . . 0.0 110.505 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.19 -10.11 13.44 Favored Glycine 0 C--N 1.288 -2.137 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.485 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 5.1 mm-40 -125.39 123.49 39.44 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.376 -1.073 . . . . 0.0 109.829 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.544 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 71.5 m -97.52 159.62 14.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.386 -0.821 . . . . 0.0 109.767 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 50.4 m-85 -147.38 153.16 39.3 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.192 -0.942 . . . . 0.0 110.344 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 52' ' ' SER . 88.1 m-85 -115.54 108.82 16.95 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 109.372 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.706 HD11 HD21 ' A' ' 93' ' ' LEU . 4.5 tt -98.39 128.35 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.124 -0.985 . . . . 0.0 110.73 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.57 152.0 32.31 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.306 -0.871 . . . . 0.0 110.458 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.4 135.06 33.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.845 . . . . 0.0 109.615 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.6 m -147.21 159.46 43.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 0.0 110.684 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.76 157.0 34.67 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.602 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 44.3 Cg_endo -72.39 163.38 38.78 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.751 1.395 . . . . 0.0 110.764 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 39' ' ' VAL . 16.7 m -133.2 54.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.699 0.762 . . . . 0.0 109.756 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.34 47.8 55.47 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.49 -67.59 0.25 Allowed Glycine 0 N--CA 1.491 2.359 0 O-C-N 121.0 -1.294 . . . . 0.0 110.05 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.446 ' OE1' HG21 ' A' ' 75' ' ' THR . 1.7 mt-30 -116.41 -161.45 0.8 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.351 -1.088 . . . . 0.0 110.365 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 10.0 t70 -127.35 119.97 27.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.317 -0.864 . . . . 0.0 109.831 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.5 158.68 15.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.913 . . . . 0.0 110.427 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.2 168.04 15.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.291 -0.881 . . . . 0.0 110.186 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.525 ' OD1' ' CG ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -104.25 102.74 34.66 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 109.923 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.15 -29.28 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.986 1.519 . . . . 0.0 110.437 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.82 -27.44 68.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.365 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 40.0 p -111.29 30.31 7.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.394 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.3 128.32 34.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 109.929 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.655 ' CG2' HG23 ' A' ' 33' ' ' ILE . 9.0 t -138.22 131.94 31.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.96 . . . . 0.0 110.543 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.491 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 28.8 t -111.91 142.55 44.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.408 -0.808 . . . . 0.0 109.952 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 45.9 p90 -144.24 -174.98 4.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.316 -0.865 . . . . 0.0 110.342 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 55' ' ' THR . 28.2 m -150.01 151.34 33.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.95 . . . . 0.0 109.796 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 1.001 ' CG2' ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -56.19 -160.67 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.024 -1.048 . . . . 0.0 110.529 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.653 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 2.3 m-20 -153.92 -158.29 0.85 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.091 -1.006 . . . . 0.0 110.36 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.27 74.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.873 -1.142 . . . . 0.0 109.671 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.2 m -84.15 10.63 9.74 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.343 -0.848 . . . . 0.0 109.341 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 26' ' ' ALA . . . 52.5 53.76 30.56 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.81 113.3 13.33 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.242 -1.152 . . . . 0.0 110.086 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.829 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -101.54 80.93 2.11 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.396 -0.815 . . . . 0.0 109.806 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 62.1 p -114.67 125.97 54.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 110.118 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.4 p90 -154.59 176.07 12.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.314 -0.866 . . . . 0.0 110.575 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 89.6 p -97.63 119.26 35.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.488 -0.757 . . . . 0.0 110.485 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 51.6 t80 -115.93 174.78 5.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.336 -0.852 . . . . 0.0 109.621 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.562 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 12.6 t -125.48 163.97 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.909 -1.119 . . . . 0.0 110.419 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.91 173.79 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.269 -0.894 . . . . 0.0 110.216 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -148.72 151.29 34.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.292 -0.88 . . . . 0.0 110.125 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.53 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 6.7 tttt -83.93 -39.86 19.25 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.235 -0.916 . . . . 0.0 109.884 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.422 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 28.8 p -132.85 147.29 52.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 109.753 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 12.6 p90 -165.92 148.33 7.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.961 -1.087 . . . . 0.0 111.028 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 13.0 m -64.08 123.3 18.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.311 -0.868 . . . . 0.0 109.638 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.04 175.29 15.88 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 t -165.16 123.7 1.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -1.075 . . . . 0.0 109.854 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.446 HG21 ' OE1' ' A' ' 42' ' ' GLN . 32.1 p -59.94 144.21 86.6 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.922 . . . . 0.0 110.577 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.82 0.95 9.42 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 124.255 1.661 . . . . 0.0 110.467 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -90.41 -44.35 9.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.938 . . . . 0.0 110.431 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.37 60.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.428 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 15.0 m -166.11 99.7 0.72 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.184 -1.186 . . . . 0.0 110.275 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 79' ' ' THR . 43.5 Cg_endo -70.77 119.35 6.26 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.988 1.52 . . . . 0.0 110.113 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.459 ' H ' HG12 ' A' ' 81' ' ' VAL . 2.7 p -94.6 -26.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.262 -0.899 . . . . 0.0 110.358 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.82 -147.15 16.39 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.8 p -65.79 153.82 40.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.45 -1.03 . . . . 0.0 110.669 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.0 t -131.69 102.32 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.47 -0.769 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.422 ' OD1' ' HB2' ' A' ' 70' ' ' SER . 1.1 m-20 -88.94 141.02 28.84 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.844 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.97 15.07 28.37 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.365 -0.835 . . . . 0.0 110.407 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.55 -59.74 2.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 t -77.37 -20.08 55.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -103.64 -163.2 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.887 . . . . 0.0 110.126 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.84 144.45 45.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.317 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.57 133.69 53.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.198 -0.939 . . . . 0.0 109.895 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -142.53 132.98 25.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 110.594 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.706 HD21 HD11 ' A' ' 33' ' ' ILE . 16.5 tp -93.45 118.03 30.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.883 . . . . 0.0 109.247 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.592 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -112.43 152.04 17.95 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.447 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -148.59 134.53 19.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.585 -0.95 . . . . 0.0 109.872 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.53 165.65 32.47 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.781 -1.2 . . . . 0.0 110.145 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -83.58 -157.14 0.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -1.102 . . . . 0.0 110.088 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.7 t -82.11 -31.11 30.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 110.26 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.08 -15.32 4.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.526 HD13 ' N ' ' A' ' 101' ' ' ASP . 0.8 OUTLIER -100.32 125.35 46.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -1.159 . . . . 0.0 110.143 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.526 ' N ' HD13 ' A' ' 100' ' ' LEU . 3.9 p30 -109.33 115.9 30.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.159 -0.963 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 81.7 mt -80.48 -62.08 1.78 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.151 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.55 -179.03 42.29 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.445 -1.36 . . . . 0.0 110.512 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.592 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 1.5 m-70 -137.41 121.35 17.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.744 -0.856 . . . . 0.0 109.673 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -94.07 123.7 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 0.0 110.145 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.82 105.05 5.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 110.305 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.698 HD11 ' HB2' ' A' ' 93' ' ' LEU . 39.0 mt -78.5 132.25 37.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 110.164 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.06 149.71 39.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -110.27 169.4 8.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 110.198 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.563 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.91 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.91 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 45.8 Cg_endo -72.64 -162.2 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.959 1.505 . . . . 0.0 109.906 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -111.2 129.77 55.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.32 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 5.5 t80 -148.73 112.16 5.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.233 -0.917 . . . . 0.0 109.589 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.19 148.96 28.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 111.0 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 7' ' ' SER . 5.4 p -107.01 174.55 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.45 -0.781 . . . . 0.0 109.525 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.687 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -81.97 -70.54 0.15 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.987 -1.071 . . . . 0.0 109.969 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.687 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 56.1 Cg_endo -83.15 91.12 0.94 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 O-C-N 122.972 0.985 . . . . 0.0 109.906 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.34 -1.52 55.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.891 -1.131 . . . . 0.0 110.687 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.0 m -138.28 118.88 13.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.196 -0.94 . . . . 0.0 109.979 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.46 72.88 1.13 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.796 ' CD1' HD22 ' A' ' 107' ' ' LEU . 12.9 mt -95.3 167.41 11.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.327 -1.102 . . . . 0.0 110.41 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.568 ' HB2' ' CB ' ' A' ' 16' ' ' GLN . 51.7 m -115.42 140.75 48.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 110.358 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 24.1 p30 -65.09 128.28 35.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.33 -0.856 . . . . 0.0 110.811 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.1 -26.77 6.53 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.568 ' CB ' ' HB2' ' A' ' 13' ' ' SER . 29.9 tt0 -62.2 149.08 42.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.126 . . . . 0.0 110.72 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -96.35 146.76 24.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.455 -0.778 . . . . 0.0 110.15 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.421 HG12 ' HG2' ' A' ' 8' ' ' PRO . 27.4 m -118.33 156.49 20.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.26 -0.9 . . . . 0.0 109.892 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.35 124.57 38.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.185 -0.947 . . . . 0.0 109.919 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.3 t -111.08 145.67 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.231 -0.918 . . . . 0.0 109.824 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.6 127.29 18.07 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.387 -0.821 . . . . 0.0 110.351 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 98.1 t -124.97 137.39 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.293 -0.88 . . . . 0.0 110.15 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 73.8 m -150.21 116.54 5.72 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.984 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 157.58 -64.78 0.3 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -52.82 -175.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -1.124 . . . . 0.0 110.018 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.542 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -150.88 150.01 30.37 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.014 -1.054 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -30.19 136.37 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.402 0.62 . . . . 0.0 111.237 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.401 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 108.12 11.22 24.55 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.492 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 69.4 mm-40 -142.25 118.59 10.84 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.266 -1.137 . . . . 0.0 110.695 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 m -103.98 137.77 41.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.087 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.612 ' CG ' HD11 ' A' ' 102' ' ' LEU . 34.5 m-85 -123.36 166.11 15.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.969 -1.082 . . . . 0.0 111.171 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -121.65 110.13 15.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.537 -0.727 . . . . 0.0 109.597 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.718 HG23 ' O ' ' A' ' 33' ' ' ILE . 4.9 tt -87.88 113.09 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 110.327 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.81 166.17 28.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.716 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.602 ' HG3' HD12 ' A' ' 107' ' ' LEU . 0.5 OUTLIER -127.92 140.84 51.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.472 -0.768 . . . . 0.0 110.021 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.6 m -138.21 165.85 25.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.937 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.437 ' HB2' ' SG ' ' A' ' 91' ' ' CYS . . . -150.97 153.93 33.69 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.641 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.71 167.45 25.65 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.796 1.419 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 42' ' ' GLN . 17.2 m -131.51 62.16 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.882 . . . . 0.0 110.118 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.67 5.09 49.57 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 163.75 -58.06 0.27 Allowed Glycine 0 N--CA 1.493 2.493 0 O-C-N 121.058 -1.26 . . . . 0.0 110.274 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.536 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . 49.6 mt-30 -78.77 -163.25 0.45 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.19 -1.182 . . . . 0.0 110.456 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -133.16 139.34 47.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.853 . . . . 0.0 110.308 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.405 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -142.78 127.19 17.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.362 -0.836 . . . . 0.0 109.881 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 11.9 t -110.67 168.11 9.71 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.092 -1.005 . . . . 0.0 110.709 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 41.7 p-10 -108.54 102.26 46.6 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.346 -0.847 . . . . 0.0 110.636 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.67 -21.32 12.95 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.001 1.527 . . . . 0.0 110.742 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.19 -41.91 85.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.234 -0.916 . . . . 0.0 110.589 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.37 10.09 42.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.259 -0.901 . . . . 0.0 110.002 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.0 131.45 35.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 110.256 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.663 HG23 ' CG2' ' A' ' 33' ' ' ILE . 4.5 t -138.38 165.21 27.34 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.307 -0.871 . . . . 0.0 109.887 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m -127.79 146.6 50.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 110.744 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 35.1 p90 -140.16 -177.6 5.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 109.858 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.5 m -141.29 156.64 45.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.963 . . . . 0.0 110.058 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.416 HG23 ' HE2' ' A' ' 31' ' ' TYR . 17.2 p -67.28 -156.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.0 110.38 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 11.8 t0 -154.78 -162.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.954 . . . . 0.0 110.235 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.65 -55.49 34.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.268 -0.895 . . . . 0.0 109.416 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 p -78.32 4.15 13.65 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.432 -0.793 . . . . 0.0 109.353 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 66.11 46.55 79.56 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.99 162.78 20.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.107 -1.231 . . . . 0.0 110.242 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -159.11 83.87 0.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.179 -0.951 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 m -111.04 121.9 46.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.283 -0.885 . . . . 0.0 109.362 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 20.6 p90 -155.54 179.98 8.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 110.782 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.1 m -92.25 151.81 20.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.473 -0.767 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.455 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 56.3 t80 -142.48 179.36 7.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.538 -0.726 . . . . 0.0 109.112 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.455 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.4 t -133.08 154.96 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.741 -1.224 . . . . 0.0 110.415 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.468 HG21 HD22 ' A' ' 12' ' ' LEU . 29.7 m -138.01 164.82 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.436 -0.79 . . . . 0.0 109.808 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 8.0 mtt85 -141.22 126.02 18.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.918 . . . . 0.0 110.334 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 14.3 tttt -55.08 -40.68 70.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.832 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.3 p -130.25 134.48 47.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.385 -0.822 . . . . 0.0 109.735 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 17.2 p90 -144.94 153.28 41.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.116 -0.99 . . . . 0.0 110.636 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 21.3 m -73.94 124.78 26.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.265 -0.897 . . . . 0.0 110.247 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.405 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -77.24 159.41 48.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 t -168.78 127.81 1.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -1.133 . . . . 0.0 110.004 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 74.9 p -63.09 160.47 38.97 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.979 . . . . 0.0 110.471 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.11 13.89 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.084 1.571 . . . . 0.0 110.806 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -111.28 -21.4 11.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.938 . . . . 0.0 110.304 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.31 18.43 5.83 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 53.4 m -112.48 121.1 39.77 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.214 -1.168 . . . . 0.0 110.244 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.25 -170.6 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.896 1.472 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 82' ' ' GLY . 7.7 p -173.83 -37.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.163 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.454 ' N ' HG13 ' A' ' 81' ' ' VAL . . . 158.85 -179.82 34.22 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER -86.87 172.76 9.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -1.136 . . . . 0.0 110.014 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.427 HG11 ' OH ' ' A' ' 71' ' ' TYR . 82.6 t -134.45 146.05 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.234 -0.916 . . . . 0.0 110.163 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -134.66 125.49 27.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.006 . . . . 0.0 110.173 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 72.1 m -86.72 12.63 10.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.47 -58.28 8.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.816 . . . . 0.0 110.068 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -110.29 9.51 23.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.33 178.21 4.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.318 -0.864 . . . . 0.0 110.194 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.15 95.39 5.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 37' ' ' ALA . 80.9 m -92.5 138.15 31.76 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.182 -0.949 . . . . 0.0 109.94 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -130.47 149.96 51.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.17 -0.956 . . . . 0.0 110.434 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 35' ' ' GLN . 0.3 OUTLIER -125.0 122.48 37.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 109.719 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.3 175.78 20.72 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.33 171.59 13.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -1.08 . . . . 0.0 110.12 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.81 165.06 10.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.468 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -129.69 -104.24 0.3 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -1.194 . . . . 0.0 110.622 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.423 ' N ' HD22 ' A' ' 97' ' ' ASN . 0.6 OUTLIER -65.42 -84.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.937 -1.102 . . . . 0.0 110.575 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.1 52.64 0.82 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.604 HD13 ' HE1' ' A' ' 31' ' ' TYR . 4.4 tt -115.21 -58.94 2.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.207 -1.172 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.5 t0 50.83 101.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.403 -0.811 . . . . 0.0 110.251 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.889 HD23 ' CG ' ' A' ' 2' ' ' PRO . 0.5 OUTLIER -73.86 -67.72 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -161.68 179.28 37.17 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -148.04 117.17 6.84 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.357 -1.084 . . . . 0.0 110.03 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.1 136.09 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.69 118.62 23.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.233 -0.917 . . . . 0.0 110.183 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.796 HD22 ' CD1' ' A' ' 12' ' ' LEU . 48.6 mt -90.05 134.1 34.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -112.43 166.51 11.24 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.507 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 2.5 m-85 -152.72 71.44 0.93 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.528 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.5 Cg_endo -70.46 -160.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.83 1.437 . . . . 0.0 110.493 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.406 ' HB3' ' H ' ' A' ' 23' ' ' SER . . . -149.32 148.9 30.07 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.086 -1.009 . . . . 0.0 111.196 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.443 ' CB ' ' HB3' ' A' ' 102' ' ' LEU . 24.2 t80 -151.5 102.67 2.91 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 109.633 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.07 158.45 43.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.927 -1.108 . . . . 0.0 111.002 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.484 HG12 HG11 ' A' ' 105' ' ' VAL . 5.1 p -126.77 138.81 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 109.76 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.606 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -62.49 -66.17 1.71 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.127 -0.983 . . . . 0.0 110.499 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.606 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 53.1 Cg_endo -76.96 74.18 5.09 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 O-C-N 123.493 1.259 . . . . 0.0 110.48 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.41 -0.64 57.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.986 -1.071 . . . . 0.0 110.236 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.7 t -150.88 150.7 31.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 109.974 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.65 60.96 6.35 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.6 HD21 ' O ' ' A' ' 8' ' ' PRO . 5.1 mt -102.61 154.39 19.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.251 -1.147 . . . . 0.0 110.132 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 73.3 m -109.35 155.78 20.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.149 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 32.7 t0 -64.49 127.84 33.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.057 -1.027 . . . . 0.0 110.612 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.49 -30.4 5.3 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 13' ' ' SER . 5.1 tp60 -46.78 145.66 1.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -1.116 . . . . 0.0 110.162 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.38 133.42 42.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.383 -0.823 . . . . 0.0 109.523 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.745 HG23 ' HB3' ' A' ' 65' ' ' PHE . 18.0 m -98.0 172.94 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.093 -1.004 . . . . 0.0 110.027 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.4 m -124.09 114.14 19.3 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 t -102.19 151.5 5.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 O-C-N 121.482 -0.761 . . . . 0.0 109.732 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.0 135.29 27.3 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.334 -0.854 . . . . 0.0 110.435 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.948 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 58.6 t -126.14 137.81 56.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.513 -0.742 . . . . 0.0 109.472 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' ' 3' ' ' ALA . 42.3 m -140.6 127.7 20.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.075 -1.016 . . . . 0.0 110.637 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 129.92 -48.69 0.96 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.522 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -57.45 -158.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -1.158 . . . . 0.0 109.345 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.599 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -170.95 149.99 3.05 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.596 -1.315 . . . . 0.0 111.818 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -40.12 141.98 0.42 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.438 0.637 . . . . 0.0 110.166 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.05 10.71 36.18 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 2.5 mm-40 -137.76 133.65 34.34 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.355 -1.085 . . . . 0.0 109.757 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 52.6 m -112.0 152.77 27.74 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.211 -0.93 . . . . 0.0 109.908 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.641 ' HE2' HD12 ' A' ' 100' ' ' LEU . 17.2 m-85 -135.26 159.46 41.47 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 109.809 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -119.39 105.91 11.75 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.24 -0.913 . . . . 0.0 110.044 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.599 ' CG1' HD11 ' A' ' 93' ' ' LEU . 9.4 tt -95.12 125.42 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 109.86 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.609 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -137.85 148.02 45.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.888 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -116.76 126.63 53.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.441 -0.787 . . . . 0.0 109.571 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 72.7 m -145.21 173.08 12.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -0.99 . . . . 0.0 110.923 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.45 160.27 32.08 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.529 -0.732 . . . . 0.0 109.506 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.29 163.58 38.19 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.744 1.392 . . . . 0.0 111.208 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.953 HG13 ' HB2' ' A' ' 42' ' ' GLN . 2.4 p -141.63 68.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.524 -0.735 . . . . 0.0 110.288 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.62 48.58 12.74 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.6 -33.37 4.62 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.953 ' HB2' HG13 ' A' ' 39' ' ' VAL . 4.3 mt-30 -80.55 -160.29 0.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.452 -1.028 . . . . 0.0 109.522 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.422 ' HB2' ' HG3' ' A' ' 76' ' ' PRO . 3.2 m-20 -141.55 140.77 33.49 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.045 -1.034 . . . . 0.0 110.694 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -130.29 159.2 37.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.238 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.59 154.55 48.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.953 -1.092 . . . . 0.0 111.186 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.568 ' OD1' ' CZ ' ' A' ' 71' ' ' TYR . 3.7 m120 -94.55 107.91 33.27 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.603 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.53 -33.3 8.77 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.902 1.475 . . . . 0.0 110.074 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.65 -6.63 27.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.362 -0.836 . . . . 0.0 110.175 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.407 ' OG1' ' CB ' ' A' ' 46' ' ' ASN . 53.0 p -120.29 -6.95 9.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.106 -0.996 . . . . 0.0 110.383 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.81 125.62 25.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.208 -0.933 . . . . 0.0 110.078 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.7 t -170.46 168.94 7.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.141 -0.975 . . . . 0.0 110.596 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.8 p -129.2 154.95 46.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 29.1 p90 -137.4 148.17 45.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.292 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.2 m -103.0 154.81 18.86 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.343 -0.848 . . . . 0.0 110.298 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.522 HG21 ' HB1' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -62.66 -156.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.27 -0.894 . . . . 0.0 110.544 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -142.84 -164.92 1.94 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.03 -1.044 . . . . 0.0 109.99 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.66 -52.51 64.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.087 -1.008 . . . . 0.0 108.975 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 p -84.17 12.77 5.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.515 -0.741 . . . . 0.0 109.073 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.599 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 67.93 12.79 63.05 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -89.38 108.95 19.93 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.272 -1.134 . . . . 0.0 109.542 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.948 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -97.22 87.85 4.29 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.353 -0.842 . . . . 0.0 110.244 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.18 115.48 28.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.42 -0.8 . . . . 0.0 109.474 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.629 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 7.9 p90 -144.64 177.23 8.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.047 -1.033 . . . . 0.0 111.191 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -102.4 122.22 43.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.634 -0.666 . . . . 0.0 110.837 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.745 ' HB3' HG23 ' A' ' 18' ' ' VAL . 68.4 t80 -106.83 -177.18 3.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 109.043 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.425 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.2 t -135.2 155.31 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.745 -1.222 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.1 m -141.3 174.56 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.493 -0.755 . . . . 0.0 109.486 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 5.0 mtt180 -155.9 126.51 6.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.993 -1.067 . . . . 0.0 110.805 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 8.5 ttpt -49.76 -46.13 50.28 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.205 -0.935 . . . . 0.0 109.449 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.0 m -128.62 156.45 43.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.587 -0.695 . . . . 0.0 109.165 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.568 ' CZ ' ' OD1' ' A' ' 46' ' ' ASN . 37.0 p90 -167.89 143.76 3.92 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.775 -1.203 . . . . 0.0 110.984 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 23.8 m -65.52 141.21 58.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.138 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.82 174.58 22.3 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.62 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.406 ' HA ' HG22 ' A' ' 81' ' ' VAL . 34.6 p -134.73 -149.8 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.713 -0.875 . . . . 0.0 109.005 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 79' ' ' THR . 46.1 p -112.03 161.4 26.02 Favored Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 121.069 -1.019 . . . . 0.0 110.255 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.469 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 51.7 Cg_endo -86.57 25.84 0.66 Allowed 'Trans proline' 0 C--N 1.3 -2.022 0 O-C-N 124.165 1.613 . . . . 0.0 110.661 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -155.14 16.69 0.42 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.996 -1.065 . . . . 0.0 111.504 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.435 ' O ' ' OG1' ' A' ' 79' ' ' THR . . . 88.48 74.22 1.28 Allowed Glycine 0 N--CA 1.498 2.825 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.286 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.675 ' O ' HG23 ' A' ' 75' ' ' THR . 4.0 m -172.53 127.6 0.55 Allowed Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.41 -1.053 . . . . 0.0 109.481 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -80.38 146.72 17.61 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.739 1.389 . . . . 0.0 110.592 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 74' ' ' SER . 1.3 m -132.64 -33.91 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.358 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.14 -152.61 20.63 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER -94.11 157.89 15.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -1.165 . . . . 0.0 110.524 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.402 HG21 ' CB ' ' A' ' 44' ' ' ALA . 97.8 t -116.93 152.5 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.403 -0.81 . . . . 0.0 109.997 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.25 127.49 39.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.084 -1.01 . . . . 0.0 110.029 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 4.2 t -84.07 -11.16 57.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.215 -0.928 . . . . 0.0 110.451 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.13 90.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 110.27 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.4 t -86.82 2.27 49.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.218 -0.926 . . . . 0.0 110.169 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.56 -140.13 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.21 159.02 44.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.303 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 55.7 m -119.94 141.06 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.95 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -133.36 135.4 44.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.466 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 34' ' ' ALA . 18.9 tp -109.76 120.13 41.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.848 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.503 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . -111.18 166.35 12.26 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -160.56 173.72 15.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -1.144 . . . . 0.0 110.024 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.13 -176.81 16.28 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -139.33 -150.69 0.34 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -1.072 . . . . 0.0 110.041 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.81 40.32 1.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 110.153 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -147.11 -43.48 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.641 HD12 ' HE2' ' A' ' 31' ' ' TYR . 69.7 mt -103.27 -153.74 0.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -1.166 . . . . 0.0 110.077 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -170.58 117.26 0.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 110.31 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.443 ' HB3' ' CB ' ' A' ' 4' ' ' PHE . 18.9 mt -118.56 -49.36 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.0 110.09 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.03 -150.71 17.82 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.574 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 3.6 p80 -146.89 136.93 23.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -1.11 . . . . 0.0 110.417 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.484 HG11 HG12 ' A' ' 6' ' ' VAL . 18.3 t -85.06 113.16 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.416 -0.803 . . . . 0.0 110.112 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.05 94.3 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -0.86 . . . . 0.0 110.112 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.88 162.02 14.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.315 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.54 152.41 46.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.414 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 3.3 m-85 -127.45 75.68 1.61 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.858 . . . . 0.0 110.005 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 CA-C-O 117.961 -1.466 . . . . 0.0 109.596 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.512 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.0 Cg_endo -71.24 -159.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.117 1.588 . . . . 0.0 110.481 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -148.63 127.43 12.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.974 . . . . 0.0 110.432 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -142.08 106.3 4.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.369 -0.832 . . . . 0.0 109.471 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.2 t -150.25 154.14 37.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.961 -1.087 . . . . 0.0 111.247 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.6 HG12 HG11 ' A' ' 105' ' ' VAL . 13.4 p -119.05 156.9 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.647 -0.658 . . . . 0.0 109.448 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.592 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -77.04 -65.89 0.36 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.926 -1.109 . . . . 0.0 110.217 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.683 ' O ' HD21 ' A' ' 12' ' ' LEU . 52.7 Cg_endo -76.2 74.97 4.4 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.607 1.32 . . . . 0.0 110.221 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.53 -16.79 60.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.028 -1.045 . . . . 0.0 110.243 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.2 p -138.8 166.26 24.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.072 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.95 48.91 61.93 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.683 HD21 ' O ' ' A' ' 8' ' ' PRO . 20.7 mt -95.04 166.9 11.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -1.105 . . . . 0.0 110.242 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -126.05 152.43 45.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.286 -0.884 . . . . 0.0 110.346 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -63.67 117.23 6.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.83 -30.41 9.39 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 13' ' ' SER . 8.1 tt0 -52.52 155.09 2.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.342 -1.093 . . . . 0.0 110.27 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.23 138.03 43.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 0.0 110.115 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.567 ' CG1' HD22 ' A' ' 12' ' ' LEU . 17.1 m -103.81 153.56 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 109.859 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 0.7 OUTLIER -95.61 111.34 23.29 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.491 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 t -104.87 151.61 7.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.46 -0.775 . . . . 0.0 110.049 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 34.2 t -149.82 133.11 16.45 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.445 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.814 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 53.2 t -123.75 146.59 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.527 -0.733 . . . . 0.0 109.992 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 2.3 p -162.56 120.22 2.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.118 -0.989 . . . . 0.0 110.282 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 149.39 -55.87 0.48 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.652 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -63.92 -139.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.157 -1.202 . . . . 0.0 110.097 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.489 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.66 175.57 5.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.223 -0.923 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -65.2 131.74 47.31 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.493 -0.755 . . . . 0.0 110.666 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.6 6.85 7.76 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 2.6 mt-10 -132.0 106.09 7.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -1.199 . . . . 0.0 110.551 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 57.5 m -90.44 123.28 34.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.278 -0.889 . . . . 0.0 109.812 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.658 ' OH ' HD22 ' A' ' 100' ' ' LEU . 59.6 m-85 -107.42 161.59 14.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 111.059 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -113.48 112.51 23.72 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.392 -0.817 . . . . 0.0 109.602 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 33' ' ' ILE . 4.5 tt -93.94 106.31 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.124 -0.985 . . . . 0.0 110.635 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 1.022 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -142.23 168.53 19.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.381 -0.825 . . . . 0.0 109.772 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 9.8 pt20 -132.71 151.52 51.95 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 110.385 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.72 157.33 44.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 110.558 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 90' ' ' ALA . . . -151.56 157.35 34.76 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.274 -0.891 . . . . 0.0 110.499 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 43.3 Cg_endo -69.5 174.99 8.48 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.942 1.496 . . . . 0.0 110.22 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -141.15 58.37 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.072 -1.018 . . . . 0.0 110.845 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.16 -23.86 5.82 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.77 -49.36 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -88.18 -150.98 0.19 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -1.104 . . . . 0.0 110.043 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 11.7 p-10 -149.07 149.14 30.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.944 . . . . 0.0 110.39 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.568 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -136.12 155.35 50.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.426 -0.796 . . . . 0.0 109.7 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.1 m -126.28 151.47 47.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.211 -0.93 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.482 ' ND2' ' HB2' ' A' ' 71' ' ' TYR . 47.6 t-20 -97.16 108.5 44.5 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.15 -0.969 . . . . 0.0 110.243 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 49.9 Cg_endo -81.79 -33.96 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.919 1.484 . . . . 0.0 110.484 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.97 50.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 110.313 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 p -79.67 -3.05 45.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.262 -0.899 . . . . 0.0 110.064 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 47' ' ' PRO . . . -72.72 81.66 1.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.868 . . . . 0.0 110.5 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.535 HG23 ' CG2' ' A' ' 33' ' ' ILE . 4.2 t -100.26 174.49 6.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.291 -0.881 . . . . 0.0 109.883 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.65 122.34 15.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 110.304 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.494 ' C ' ' CD1' ' A' ' 53' ' ' PHE . 5.0 p90 -116.5 -175.01 2.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.912 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 55' ' ' THR . 7.2 m -134.69 143.35 47.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.961 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -57.33 -155.94 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.136 -0.977 . . . . 0.0 110.299 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -145.49 -156.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.077 -1.015 . . . . 0.0 110.176 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.57 -61.89 2.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.028 -1.045 . . . . 0.0 109.909 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 52.7 p -87.94 28.5 1.03 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.242 -0.911 . . . . 0.0 109.325 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.489 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 55.88 28.3 52.54 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -93.45 117.29 29.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.375 -1.074 . . . . 0.0 110.136 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.814 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -124.81 83.41 2.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 0.0 110.113 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -109.23 123.15 48.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.875 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 9.4 p90 -155.68 174.72 14.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.601 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.69 114.03 26.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.394 -0.816 . . . . 0.0 110.38 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.505 ' HB3' HG23 ' A' ' 18' ' ' VAL . 41.3 t80 -99.12 176.83 5.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.409 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.1 t -130.42 153.87 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.967 -1.083 . . . . 0.0 109.924 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.2 143.82 27.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.359 -0.838 . . . . 0.0 110.093 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -120.02 129.74 54.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 110.088 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -52.6 -35.91 55.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.905 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.3 p -131.35 143.37 50.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.936 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.482 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 22.7 p90 -145.16 153.0 40.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.17 -0.956 . . . . 0.0 110.511 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 9.2 m -72.18 124.43 25.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.305 -0.872 . . . . 0.0 109.847 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.568 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -99.19 171.87 24.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 5.6 p 175.26 130.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -1.09 . . . . 0.0 109.869 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.408 ' OG1' ' HB ' ' A' ' 79' ' ' THR . 32.5 p -84.04 149.22 55.55 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.164 -0.96 . . . . 0.0 110.604 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.6 -21.28 5.2 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.284 1.676 . . . . 0.0 110.333 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.17 -66.23 0.62 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.345 -0.847 . . . . 0.0 110.365 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.452 ' O ' ' OG1' ' A' ' 79' ' ' THR . . . 172.0 67.3 0.04 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 78' ' ' GLY . 57.1 m -166.3 92.07 0.8 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.396 -1.061 . . . . 0.0 109.853 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.58 79.46 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.06 1.558 . . . . 0.0 110.475 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.566 HG23 ' N ' ' A' ' 82' ' ' GLY . 27.8 m -49.22 -44.11 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.365 -0.835 . . . . 0.0 110.056 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.566 ' N ' HG23 ' A' ' 81' ' ' VAL . . . 113.85 -159.07 13.89 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 5.0 p -58.25 169.77 0.8 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -1.13 . . . . 0.0 110.139 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.52 HG21 ' CB ' ' A' ' 44' ' ' ALA . 45.7 t -150.87 133.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -109.21 141.59 41.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.937 . . . . 0.0 110.1 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.0 m -115.0 -3.8 12.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.199 -0.938 . . . . 0.0 110.143 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.19 -56.97 14.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 110.066 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 88' ' ' THR . 5.4 t -89.14 -16.41 31.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 110.05 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.46 -175.2 3.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 110.18 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.634 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -96.43 140.98 30.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -0.907 . . . . 0.0 110.325 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.43 ' C ' ' OD1' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -139.5 126.86 21.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.355 -0.841 . . . . 0.0 110.033 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.43 ' OD1' ' C ' ' A' ' 91' ' ' CYS . 31.9 m-20 -129.3 147.2 51.11 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 110.291 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.022 HD12 ' O ' ' A' ' 34' ' ' ALA . 14.3 tp -112.72 109.67 19.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.618 ' CA ' ' CD2' ' A' ' 104' ' ' HIS . . . -105.14 153.26 17.31 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.312 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.89 167.44 22.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.478 -1.013 . . . . 0.0 109.713 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.516 ' HA2' ' CD1' ' A' ' 31' ' ' TYR . . . 118.85 -175.7 15.81 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 100' ' ' LEU . 20.7 p-10 -137.8 -142.25 0.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -1.195 . . . . 0.0 110.433 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -102.78 -34.84 8.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.303 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.42 -30.69 64.23 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.658 HD22 ' OH ' ' A' ' 31' ' ' TYR . 6.0 tt -146.88 131.2 17.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -1.146 . . . . 0.0 110.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -96.88 138.48 34.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -0.993 . . . . 0.0 110.087 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 102' ' ' LEU . 16.4 mt -97.56 -81.15 0.43 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.273 -0.892 . . . . 0.0 110.295 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 174.99 163.13 27.61 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.618 ' CD2' ' CA ' ' A' ' 94' ' ' GLY . 41.5 m170 -119.13 123.95 45.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.993 . . . . 0.0 110.069 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.6 HG11 HG12 ' A' ' 6' ' ' VAL . 31.5 t -102.68 115.51 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.111 -0.993 . . . . 0.0 110.183 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.51 127.26 32.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.297 -0.877 . . . . 0.0 110.162 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.1 mt -98.42 169.52 9.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.335 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.3 m -155.26 160.36 40.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -132.66 105.33 7.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 0.0 110.135 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.431 179.949 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 120.748 0.309 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 45.8 Cg_endo -73.8 176.51 9.31 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.043 1.549 . . . . 0.0 110.407 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.451 ' HB3' ' OG ' ' A' ' 23' ' ' SER . . . -147.0 151.2 36.58 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.172 -0.955 . . . . 0.0 110.747 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.547 ' CE1' ' HB3' ' A' ' 95' ' ' ALA . 76.9 t80 -149.98 116.72 5.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 110.022 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.64 149.72 31.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.073 -1.017 . . . . 0.0 110.611 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.005 HG12 HG11 ' A' ' 105' ' ' VAL . 4.3 p -130.87 139.0 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.923 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -69.76 -62.5 2.39 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.048 -1.032 . . . . 0.0 110.182 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 49.4 Cg_endo -74.32 77.51 2.85 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.837 1.441 . . . . 0.0 110.468 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.69 -5.63 57.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.114 -0.991 . . . . 0.0 110.13 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.0 p -151.62 166.45 31.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 110.241 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.8 52.46 48.24 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.492 HD13 ' HB3' ' A' ' 107' ' ' LEU . 1.4 mt -102.51 172.87 6.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.146 -1.208 . . . . 0.0 110.055 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.488 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -143.71 149.85 37.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 110.387 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 3.7 p30 -58.0 123.95 17.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.325 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.97 -34.81 4.56 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 0.9 OUTLIER -50.96 156.41 1.01 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -1.134 . . . . 0.0 109.815 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.95 137.83 47.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.634 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 67' ' ' VAL . 16.5 m -107.66 175.41 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.424 -0.797 . . . . 0.0 110.131 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.468 ' OG ' ' HD3' ' A' ' 8' ' ' PRO . 3.6 p -120.78 118.92 31.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 109.996 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.493 HG21 HD11 ' A' ' 33' ' ' ILE . 20.8 t -110.31 151.79 12.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.244 -0.91 . . . . 0.0 110.067 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -143.12 128.16 18.51 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 110.31 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.771 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 30.7 t -121.26 145.65 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 109.824 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -151.43 139.4 20.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 110.382 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 120.17 -75.34 0.32 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.561 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -49.54 126.7 14.0 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.179 -1.189 . . . . 0.0 109.563 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.571 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -97.08 165.65 11.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.111 -0.993 . . . . 0.0 111.092 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -44.23 139.85 2.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.545 0.688 . . . . 0.0 110.568 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.92 9.22 8.34 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 50.4 mm-40 -147.65 121.84 9.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.119 -1.224 . . . . 0.0 110.406 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 53' ' ' PHE . 80.6 m -104.43 125.63 50.81 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.436 -0.79 . . . . 0.0 109.49 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.737 ' CE1' HD13 ' A' ' 100' ' ' LEU . 17.0 m-85 -110.01 176.94 4.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.09 -1.006 . . . . 0.0 110.434 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 12.5 m-85 -126.51 112.85 16.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.301 -0.874 . . . . 0.0 110.488 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 33' ' ' ILE . 13.0 tt -98.5 103.65 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 0.0 109.933 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.61 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -138.56 169.33 17.98 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.294 -0.879 . . . . 0.0 110.651 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.788 ' OE1' HD12 ' A' ' 107' ' ' LEU . 34.1 mt-30 -106.07 155.47 19.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.423 -0.798 . . . . 0.0 110.334 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 98.1 m -150.69 148.52 28.68 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.219 -0.926 . . . . 0.0 110.471 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 1.052 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -151.76 165.83 16.57 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 49.9 Cg_endo -75.02 175.51 11.15 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.99 1.521 . . . . 0.0 110.391 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.444 ' CG1' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.68 58.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.264 -0.898 . . . . 0.0 110.157 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.14 -6.64 34.35 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 179.66 -56.28 0.08 OUTLIER Glycine 0 N--CA 1.493 2.451 0 O-C-N 120.823 -1.398 . . . . 0.0 109.921 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -85.21 -167.24 1.76 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -1.168 . . . . 0.0 110.44 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 1.6 p30 -118.72 166.72 12.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.373 -0.829 . . . . 0.0 110.036 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.09 157.87 39.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 110.399 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 m -140.48 163.05 33.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.184 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.788 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -81.54 123.91 80.5 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 110.358 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.583 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 48.8 Cg_endo -84.74 -72.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.931 1.49 . . . . 0.0 110.621 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.15 -62.89 1.52 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.206 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.509 ' OG1' ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -46.47 -22.54 0.28 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.444 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.788 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -62.83 105.38 0.66 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.031 . . . . 0.0 109.816 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -110.47 141.42 43.6 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.234 -0.916 . . . . 0.0 110.442 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.49 ' HB3' ' CD2' ' A' ' 32' ' ' TYR . 48.9 p -106.88 119.11 38.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 109.888 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.629 ' O ' HG23 ' A' ' 30' ' ' THR . 53.1 p90 -106.46 -178.06 3.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.034 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 55' ' ' THR . 6.4 m -139.05 145.44 39.59 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.939 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.561 HG21 ' CB ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -57.17 -158.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.147 -0.97 . . . . 0.0 109.851 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -145.43 -161.78 1.37 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.881 -1.137 . . . . 0.0 110.448 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.81 -48.98 79.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.087 -1.008 . . . . 0.0 109.164 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p -87.03 13.82 8.56 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.515 -0.74 . . . . 0.0 109.099 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 57.27 30.31 61.08 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.02 118.91 37.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -1.094 . . . . 0.0 109.863 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.771 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -118.81 81.2 1.66 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.511 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.9 m -110.61 122.65 48.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.304 -0.873 . . . . 0.0 109.293 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.586 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 12.3 p90 -157.31 179.1 9.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.024 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.09 138.04 31.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 110.726 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 73.9 t80 -123.14 178.62 5.01 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.427 -0.795 . . . . 0.0 109.182 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.557 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 5.2 t -123.05 159.44 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.806 -1.184 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 18' ' ' VAL . 30.9 m -137.96 124.69 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.393 -0.817 . . . . 0.0 110.099 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 9.5 mmm-85 -115.85 123.85 49.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.53 -59.93 3.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -0.978 . . . . 0.0 109.204 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 p -108.41 126.44 52.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.306 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.542 ' CD1' ' ND2' ' A' ' 46' ' ' ASN . 50.0 p90 -140.31 163.91 31.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 110.485 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.09 123.87 21.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 0.0 109.637 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.439 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -98.21 166.42 22.13 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 89.5 p -178.56 130.02 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.39 -1.064 . . . . 0.0 109.599 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 79' ' ' THR . 55.0 p -43.0 153.41 0.34 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.214 -0.929 . . . . 0.0 110.388 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.97 0.07 9.34 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 124.112 1.585 . . . . 0.0 110.309 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -93.58 -52.66 4.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.326 -0.859 . . . . 0.0 110.186 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.13 -24.27 0.19 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.441 ' O ' ' OG1' ' A' ' 75' ' ' THR . 4.1 m -70.44 132.71 87.46 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.098 -1.236 . . . . 0.0 110.292 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.7 141.06 27.11 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.892 1.469 . . . . 0.0 109.755 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.6 p -117.73 -4.96 11.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 120.987 -1.071 . . . . 0.0 110.168 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.1 -155.13 16.22 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.06 174.85 6.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -1.128 . . . . 0.0 110.389 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.444 HG22 ' CG1' ' A' ' 39' ' ' VAL . 49.1 t -144.15 154.63 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 110.13 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -134.58 131.57 38.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 110.064 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 32.7 m -92.97 33.23 1.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.878 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.15 -61.09 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 110.39 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.475 ' H ' HG22 ' A' ' 88' ' ' THR . 5.0 t -87.67 -23.05 24.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.331 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.58 -178.32 3.59 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 110.096 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -123.82 148.81 46.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.181 -0.949 . . . . 0.0 110.12 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 1.052 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -126.85 133.78 50.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.026 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 5.7 m-20 -99.9 147.22 25.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 110.107 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.864 ' HB2' HD11 ' A' ' 107' ' ' LEU . 15.8 tp -106.7 110.96 23.28 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.1 -1.0 . . . . 0.0 109.52 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.502 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -112.65 153.43 17.48 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.547 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . . . -133.29 104.87 6.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.428 -1.042 . . . . 0.0 110.122 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.58 174.17 46.41 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 5.5 p-10 -114.0 -156.84 0.61 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -1.156 . . . . 0.0 110.357 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -91.99 52.6 2.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 110.184 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 174.4 -32.03 0.1 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.737 HD13 ' CE1' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -117.38 86.03 2.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -1.169 . . . . 0.0 110.297 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.53 116.31 22.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.941 . . . . 0.0 109.984 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 95' ' ' ALA . 87.8 mt -81.94 -74.6 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.322 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.13 173.58 41.66 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.502 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 9.8 m-70 -136.69 122.62 20.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.584 -0.951 . . . . 0.0 110.111 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.005 HG11 HG12 ' A' ' 6' ' ' VAL . 17.2 t -112.23 107.45 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.072 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . . . -57.71 147.09 28.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 110.505 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.864 HD11 ' HB2' ' A' ' 93' ' ' LEU . 29.7 mt -116.18 141.56 47.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 109.984 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -110.82 165.55 11.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 110.34 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -139.95 97.51 3.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.24 -0.913 . . . . 0.0 110.321 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.958 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.958 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 43.9 Cg_endo -72.43 -159.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 124.002 1.527 . . . . 0.0 110.361 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -123.89 128.72 49.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.182 -0.949 . . . . 0.0 110.445 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.493 ' HB2' HD22 ' A' ' 102' ' ' LEU . 85.4 t80 -149.63 104.46 3.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.677 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.613 ' HA ' HG21 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -149.8 157.37 43.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.899 -1.126 . . . . 0.0 111.496 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.634 HG12 HG11 ' A' ' 105' ' ' VAL . 9.3 p -106.18 139.85 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.399 -0.813 . . . . 0.0 109.312 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.651 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 m -53.82 -72.4 0.19 Allowed Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 120.828 -1.17 . . . . 0.0 110.002 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.668 ' O ' HD21 ' A' ' 12' ' ' LEU . 56.7 Cg_endo -80.13 79.37 3.36 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 O-C-N 122.956 0.977 . . . . 0.0 109.952 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.43 -20.97 61.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.846 -1.159 . . . . 0.0 109.999 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t -134.51 141.11 46.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.325 -0.86 . . . . 0.0 110.043 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.91 61.21 1.29 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.668 HD21 ' O ' ' A' ' 8' ' ' PRO . 3.5 mt -117.21 169.53 9.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.162 -1.199 . . . . 0.0 110.232 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 4.2 t -124.65 158.95 31.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 110.286 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.16 124.97 22.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.216 -0.927 . . . . 0.0 110.188 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 89.45 -29.45 6.17 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.492 ' HB3' ' O ' ' A' ' 13' ' ' SER . 28.9 tp60 -43.81 156.25 0.07 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.324 -1.104 . . . . 0.0 110.447 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.424 ' N ' ' HG3' ' A' ' 16' ' ' GLN . 1.8 m -107.16 134.92 49.56 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.448 -0.783 . . . . 0.0 109.315 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.448 ' CG1' HD22 ' A' ' 12' ' ' LEU . 32.7 m -110.97 153.93 12.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.801 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -105.97 121.37 43.97 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.973 -1.08 . . . . 0.0 110.237 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.6 t -97.1 151.82 4.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.581 -0.7 . . . . 0.0 109.223 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 t -142.46 121.25 12.69 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 121.281 -0.887 . . . . 0.0 109.857 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 33.9 t -116.11 142.74 28.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 110.065 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.685 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.1 OUTLIER -160.38 105.17 1.47 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 110.254 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 157.3 -47.79 0.46 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.792 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -59.41 -147.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.419 -1.047 . . . . 0.0 109.485 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.529 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -172.42 165.89 5.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.76 -1.213 . . . . 0.0 111.037 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -48.36 138.58 9.83 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.592 0.711 . . . . 0.0 110.782 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.07 25.49 12.74 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 2.3 mt-10 -141.07 105.95 4.94 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.203 -1.175 . . . . 0.0 110.375 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.7 m -103.73 151.31 23.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.822 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 46.6 m-85 -140.24 165.97 25.96 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.296 -0.877 . . . . 0.0 110.188 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 23.5 m-85 -112.66 109.77 19.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -0.901 . . . . 0.0 109.851 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 33' ' ' ILE . 3.2 tt -89.5 111.72 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.059 -1.026 . . . . 0.0 110.162 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 1.032 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -144.05 159.45 42.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.468 -0.77 . . . . 0.0 110.247 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.745 HE21 HD13 ' A' ' 107' ' ' LEU . 14.6 tt0 -112.94 148.12 35.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.342 -0.849 . . . . 0.0 110.515 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 62.9 m -153.54 162.23 41.47 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.376 -0.827 . . . . 0.0 110.225 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.515 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.64 160.27 32.9 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.235 -0.915 . . . . 0.0 110.288 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.472 ' C ' HG13 ' A' ' 39' ' ' VAL . 49.4 Cg_endo -74.54 172.34 16.37 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.781 1.411 . . . . 0.0 110.343 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.665 HG23 ' CB ' ' A' ' 42' ' ' GLN . 33.4 m -149.94 65.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.233 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.59 41.26 90.12 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.04 -38.13 3.46 Favored Glycine 0 N--CA 1.487 2.061 0 O-C-N 121.025 -1.279 . . . . 0.0 110.001 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.665 ' CB ' HG23 ' A' ' 39' ' ' VAL . 1.1 mt-30 -80.41 -172.42 3.53 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.26 -1.141 . . . . 0.0 109.62 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -136.15 135.54 39.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.046 -1.034 . . . . 0.0 110.348 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.596 ' HB2' HG11 ' A' ' 39' ' ' VAL . . . -125.43 159.35 32.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.691 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.466 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.3 m -144.76 157.07 44.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.145 -0.972 . . . . 0.0 110.385 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.418 ' ND2' ' OG1' ' A' ' 49' ' ' THR . 3.2 t-20 -96.27 109.92 49.83 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.204 -0.935 . . . . 0.0 110.288 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 50.8 Cg_endo -86.92 -42.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.894 1.47 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.41 66.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.401 -0.812 . . . . 0.0 110.855 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.418 ' OG1' ' ND2' ' A' ' 46' ' ' ASN . 18.0 p -113.47 31.5 6.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.059 -1.025 . . . . 0.0 110.374 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.48 131.72 36.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.557 HG23 ' CG2' ' A' ' 33' ' ' ILE . 7.0 t -148.65 170.24 18.58 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.252 -0.905 . . . . 0.0 110.235 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.7 t -135.6 166.99 21.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.068 -1.02 . . . . 0.0 110.983 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 16.3 p90 -148.91 -177.08 5.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.467 -0.771 . . . . 0.0 109.832 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.6 m -144.21 166.85 23.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.058 -1.026 . . . . 0.0 110.268 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.792 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -86.98 -156.94 0.35 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.239 -0.913 . . . . 0.0 110.416 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -144.36 -163.75 1.75 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.781 -1.199 . . . . 0.0 109.931 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.5 77.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.134 -0.979 . . . . 0.0 109.441 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.6 p -88.03 15.48 7.29 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.405 -0.81 . . . . 0.0 108.848 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 65.23 16.91 63.11 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.15 122.24 32.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.091 -1.241 . . . . 0.0 109.901 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 55' ' ' THR . . . -132.96 85.22 2.2 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.179 -0.951 . . . . 0.0 110.386 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.62 129.02 49.07 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.525 -0.735 . . . . 0.0 109.196 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 6.0 p90 -161.02 179.9 8.07 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.14 -0.975 . . . . 0.0 110.571 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 m -108.29 144.62 35.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.297 -0.877 . . . . 0.0 111.548 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 36.5 t80 -135.71 166.09 24.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.58 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 3.6 t -106.85 154.95 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.607 -1.308 . . . . 0.0 110.963 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.4 m -140.73 158.66 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.531 -0.731 . . . . 0.0 109.958 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.18 148.48 41.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 110.578 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -52.84 13.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -124.51 150.17 46.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.152 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 71' ' ' TYR . 45.6 p90 -161.1 132.1 5.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.03 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 99.6 m -57.37 119.63 6.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.484 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.417 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -99.41 -178.05 31.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.33 140.41 12.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.111 -1.229 . . . . 0.0 110.411 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.505 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 25.6 p -48.08 167.19 0.19 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.432 -0.792 . . . . 0.0 110.279 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 41.5 Cg_endo -67.1 -12.78 37.35 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.785 1.413 . . . . 0.0 110.644 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -86.36 -15.71 39.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 109.946 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.62 26.86 8.33 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.2 m -113.16 132.25 22.49 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.336 -1.097 . . . . 0.0 110.389 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.61 127.96 11.4 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.936 1.493 . . . . 0.0 110.395 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 82' ' ' GLY . 14.5 p -122.59 -35.94 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 109.98 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.485 ' N ' HG13 ' A' ' 81' ' ' VAL . . . -175.08 157.77 24.94 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 58.6 p -78.13 157.63 29.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -1.167 . . . . 0.0 110.231 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 37' ' ' ALA . 20.9 t -106.68 164.2 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.291 -0.881 . . . . 0.0 110.425 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.917 ' OD2' HG22 ' A' ' 88' ' ' THR . 26.0 p-10 -153.52 149.36 27.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.343 -0.848 . . . . 0.0 110.184 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 34.8 m -104.11 -2.98 25.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.14 -65.8 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.968 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.917 HG22 ' OD2' ' A' ' 85' ' ' ASP . 7.1 t -82.39 -19.82 38.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.079 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 85' ' ' ASP . . . -106.37 158.13 17.11 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.22 -0.925 . . . . 0.0 109.938 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.71 109.68 21.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.939 . . . . 0.0 110.234 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 24.2 p -108.7 164.36 12.44 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.205 -0.934 . . . . 0.0 109.824 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -149.03 159.64 44.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.1 -1.0 . . . . 0.0 110.626 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.032 HD12 ' O ' ' A' ' 34' ' ' ALA . 20.2 tp -107.27 113.53 26.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.365 -0.834 . . . . 0.0 109.174 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.46 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . -103.51 154.34 17.96 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.038 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -143.01 124.98 15.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.326 -1.102 . . . . 0.0 110.175 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.57 -171.0 36.64 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' SER . 11.9 p-10 -130.88 -50.57 1.04 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -1.222 . . . . 0.0 110.638 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 97' ' ' ASN . 0.5 OUTLIER 166.57 -39.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.219 -0.926 . . . . 0.0 110.474 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.61 -21.21 62.33 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.576 HD13 ' OH ' ' A' ' 31' ' ' TYR . 6.6 tt -120.75 -66.77 1.03 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -1.183 . . . . 0.0 110.137 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.58 87.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 110.476 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.519 HD23 ' HG2' ' A' ' 2' ' ' PRO . 0.3 OUTLIER -62.38 -39.04 91.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.048 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.25 -162.59 25.7 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.46 ' HB3' ' CA ' ' A' ' 94' ' ' GLY . 0.6 OUTLIER -146.51 129.4 16.32 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.284 -1.127 . . . . 0.0 110.014 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.634 HG11 HG12 ' A' ' 6' ' ' VAL . 6.3 t -92.01 119.94 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.253 -0.904 . . . . 0.0 110.341 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.62 158.85 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 109.983 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.745 HD13 HE21 ' A' ' 35' ' ' GLN . 12.9 mt -134.83 150.25 50.47 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.086 -1.009 . . . . 0.0 110.697 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.7 m -140.96 159.61 41.84 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.35 -0.844 . . . . 0.0 110.046 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -127.16 145.31 50.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.126 -0.984 . . . . 0.0 110.197 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.529 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.5 ' O ' ' HA3' ' A' ' 24' ' ' GLY . . . . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 120.794 0.33 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 1' ' ' ALA . 45.5 Cg_endo -71.09 167.49 25.98 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.085 1.571 . . . . 0.0 110.648 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -155.3 138.45 15.61 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.264 -0.898 . . . . 0.0 110.898 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 1.6 t80 -152.36 102.96 2.8 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.345 -0.847 . . . . 0.0 109.793 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.9 t -146.2 151.9 38.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.097 -1.002 . . . . 0.0 110.734 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.878 ' CG1' HG11 ' A' ' 105' ' ' VAL . 8.0 p -115.63 122.62 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.799 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 m -47.1 -68.02 0.35 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.109 -0.994 . . . . 0.0 110.567 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 55.3 Cg_endo -76.06 79.14 2.98 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 O-C-N 123.311 1.164 . . . . 0.0 109.83 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.33 -6.73 57.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.974 -1.079 . . . . 0.0 110.689 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 p -146.96 146.43 30.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.212 -0.93 . . . . 0.0 109.71 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.425 ' C ' ' HG ' ' A' ' 12' ' ' LEU . . . 79.61 71.78 1.24 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' A' ' 8' ' ' PRO . 4.0 mt -129.87 169.95 14.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -1.108 . . . . 0.0 109.751 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -136.23 169.49 17.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.49 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 30.5 p-10 -65.19 131.04 45.49 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.113 -0.992 . . . . 0.0 110.184 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.46 -29.86 5.53 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.5 ' HB3' ' O ' ' A' ' 13' ' ' SER . 9.4 tp60 -49.48 143.01 7.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -1.114 . . . . 0.0 110.308 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.32 133.62 42.48 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.742 HG23 ' HB3' ' A' ' 65' ' ' PHE . 16.6 m -101.85 163.26 3.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 109.785 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.431 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -113.1 121.57 44.94 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.983 -1.073 . . . . 0.0 110.28 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.91 151.41 14.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.68 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.5 m -146.34 121.68 10.27 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.323 -0.861 . . . . 0.0 109.992 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 86.2 t -120.54 139.38 48.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 109.831 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.9 p -157.66 136.44 11.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.054 -1.029 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 1' ' ' ALA . . . 124.28 -46.47 1.09 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 1.042 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -45.69 -52.11 11.38 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.155 -1.203 . . . . 0.0 110.237 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 25' ' ' ALA . . . 72.07 137.92 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.435 -0.791 . . . . 0.0 110.888 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -33.37 130.66 0.23 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.391 0.615 . . . . 0.0 110.762 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 29' ' ' GLU . . . 122.37 9.59 6.49 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 60.1 mt-10 -147.99 130.15 15.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.0 110.185 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.497 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 3.4 m -111.57 146.63 37.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.402 -0.811 . . . . 0.0 109.898 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.729 ' OH ' ' HB1' ' A' ' 25' ' ' ALA . 30.6 m-85 -132.08 174.51 10.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.084 -1.01 . . . . 0.0 110.662 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' ' 52' ' ' SER . 73.7 m-85 -130.46 102.05 5.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.486 -0.759 . . . . 0.0 109.626 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 33' ' ' ILE . 1.3 tt -87.85 104.15 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.087 -1.008 . . . . 0.0 110.185 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -138.97 157.21 46.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.845 . . . . 0.0 110.618 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.407 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 1.1 tt0 -122.92 147.06 47.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.53 -0.731 . . . . 0.0 110.08 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 67.3 m -150.24 171.21 17.31 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.194 -0.941 . . . . 0.0 110.668 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.43 152.15 28.53 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.532 -0.73 . . . . 0.0 109.71 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.03 166.5 29.41 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.835 1.439 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.843 HG21 ' HB2' ' A' ' 44' ' ' ALA . 30.6 t -134.35 146.78 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.415 -0.803 . . . . 0.0 109.921 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -48.49 -35.89 16.54 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -76.64 -42.07 22.64 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -170.18 -79.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.176 -1.191 . . . . 0.0 110.211 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.44 166.79 18.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.116 -0.99 . . . . 0.0 110.162 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.843 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -154.14 149.49 27.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.121 -0.987 . . . . 0.0 110.036 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.483 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -124.47 156.66 36.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.139 -0.975 . . . . 0.0 110.001 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.458 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 0.2 OUTLIER -100.12 101.91 16.08 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.044 -1.035 . . . . 0.0 110.516 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.8 Cg_endo -73.8 -30.78 9.03 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.976 1.514 . . . . 0.0 110.532 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.85 85.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.268 -0.895 . . . . 0.0 110.556 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 5.1 p -95.35 1.83 54.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.219 -0.925 . . . . 0.0 110.52 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.79 119.44 21.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.129 -0.982 . . . . 0.0 110.037 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.412 HG23 ' CG2' ' A' ' 33' ' ' ILE . 11.3 t -146.33 145.24 30.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.985 . . . . 0.0 110.631 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.567 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 1.1 m -110.58 147.54 34.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 13.8 p90 -144.18 -176.4 5.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -0.876 . . . . 0.0 110.08 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.8 m -149.12 156.18 41.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.597 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 1.042 HG21 ' HB3' ' A' ' 25' ' ' ALA . 6.9 p -68.53 -161.64 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.045 -1.034 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -160.2 -155.5 0.44 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.963 -1.085 . . . . 0.0 110.943 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.69 64.56 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 109.346 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.5 t -71.03 -5.38 30.89 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.437 -0.79 . . . . 0.0 109.16 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 26' ' ' ALA . . . 53.72 53.98 33.11 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.78 126.63 8.95 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.161 -1.199 . . . . 0.0 110.7 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.514 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -113.38 85.77 2.26 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.321 -0.862 . . . . 0.0 110.002 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.17 136.45 49.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.658 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -171.03 173.26 5.13 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.203 -0.936 . . . . 0.0 110.782 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 m -94.37 117.26 29.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.376 -0.827 . . . . 0.0 110.342 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.742 ' HB3' HG23 ' A' ' 18' ' ' VAL . 36.1 t80 -98.63 -179.44 4.31 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.355 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 t -134.5 156.39 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.874 -1.141 . . . . 0.0 110.286 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.3 m -143.3 153.96 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.367 -0.833 . . . . 0.0 110.048 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -132.37 120.67 22.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 110.213 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HE2' ' CD2' ' A' ' 109' ' ' PHE . 4.3 tttt -49.41 -45.74 46.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.283 -0.886 . . . . 0.0 109.762 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.1 m -120.5 135.29 55.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.479 -0.763 . . . . 0.0 109.608 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -151.32 144.27 24.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.151 -0.968 . . . . 0.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 29.3 m -65.59 149.8 49.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 0.0 110.28 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.0 -167.17 13.64 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.97 -165.63 2.09 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.298 -1.119 . . . . 0.0 110.0 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 7.6 p -111.18 165.3 13.0 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.16 -0.962 . . . . 0.0 110.338 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 48.0 Cg_endo -77.75 -8.43 16.89 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.105 1.582 . . . . 0.0 109.963 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.87 8.24 40.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.43 -0.794 . . . . 0.0 110.065 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.8 55.14 5.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.7 m -149.72 133.4 8.7 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.225 -1.162 . . . . 0.0 110.547 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.04 110.07 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.917 1.483 . . . . 0.0 110.211 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.4 p -90.5 -18.44 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.404 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.29 -152.59 19.54 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 3.9 m -97.83 161.73 13.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -1.183 . . . . 0.0 110.284 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.65 HG21 ' CB ' ' A' ' 44' ' ' ALA . 62.7 t -116.95 123.84 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.02 111.1 23.75 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.163 -0.961 . . . . 0.0 110.094 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -90.15 9.02 29.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 110.084 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.36 -41.29 88.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.551 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 t -114.35 0.99 14.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.13 -0.981 . . . . 0.0 110.326 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -100.64 -139.16 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.24 142.16 31.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.4 m -128.9 133.82 48.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.1 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -129.27 148.26 51.18 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.189 -0.945 . . . . 0.0 110.091 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.537 HD12 ' C ' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -125.61 118.97 26.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.072 -1.018 . . . . 0.0 109.153 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -122.74 159.59 17.34 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.275 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -146.92 143.31 28.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.549 -0.971 . . . . 0.0 109.765 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 166.37 174.86 36.15 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.094 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 30' ' ' THR . 12.0 p-10 -119.35 -137.61 0.34 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.31 -1.112 . . . . 0.0 110.157 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.4 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -121.14 60.79 0.91 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.146 -0.971 . . . . 0.0 110.214 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.29 -24.26 0.12 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.833 HD13 ' N ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER -118.37 -60.84 1.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.235 . . . . 0.0 110.278 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.833 ' N ' HD13 ' A' ' 100' ' ' LEU . 38.9 t0 58.27 119.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 110.139 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.1 mt -84.81 -70.84 0.55 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.427 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 177.61 -175.6 47.64 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.577 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 1.6 m-70 -131.59 124.24 29.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.522 -0.987 . . . . 0.0 109.78 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.878 HG11 ' CG1' ' A' ' 6' ' ' VAL . 66.6 t -95.35 107.31 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.047 . . . . 0.0 110.515 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.01 112.37 2.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.7 mt -86.52 133.02 33.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.131 -0.981 . . . . 0.0 110.722 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.3 m -114.17 169.01 9.34 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.442 -0.786 . . . . 0.0 109.77 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.43 ' CD2' ' HE2' ' A' ' 69' ' ' LYS . 11.4 m-85 -134.14 163.4 29.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 110.075 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.269 0 CA-C-O 117.948 -1.474 . . . . 0.0 109.601 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.515 ' HB2' HD23 ' A' ' 102' ' ' LEU . 47.1 Cg_endo -72.51 -161.67 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.935 1.492 . . . . 0.0 110.517 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -142.43 133.9 26.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 110.498 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -146.31 111.01 5.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.233 -0.917 . . . . 0.0 109.955 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.07 149.98 34.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.129 -0.982 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.68 HG12 HG11 ' A' ' 105' ' ' VAL . 9.2 p -117.04 154.51 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 109.532 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.622 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -72.83 -68.18 0.41 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.04 . . . . 0.0 110.014 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.622 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 54.6 Cg_endo -77.58 75.94 4.5 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.308 1.162 . . . . 0.0 109.978 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.52 -8.12 57.82 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.934 -1.104 . . . . 0.0 110.527 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.5 p -142.72 123.39 14.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.28 75.56 1.3 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.57 ' O ' ' CE1' ' A' ' 109' ' ' PHE . 2.3 mt -120.07 165.93 14.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -1.14 . . . . 0.0 110.085 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.444 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 9.4 m -124.16 161.2 26.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 109.876 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 8.7 p-10 -62.43 121.6 13.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 110.075 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.87 -27.56 8.83 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.508 ' O ' HG22 ' A' ' 67' ' ' VAL . 2.7 tt0 -43.32 143.85 0.8 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.306 -1.114 . . . . 0.0 110.728 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.0 p -96.75 150.72 20.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.659 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.76 154.33 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 110.084 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.4 m -101.92 132.91 47.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.007 . . . . 0.0 110.02 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 t -120.8 146.66 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.075 -1.016 . . . . 0.0 109.896 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.71 126.2 21.84 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.424 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 84.8 t -117.67 141.61 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 109.919 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.585 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -152.96 145.53 24.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.135 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 121.35 -58.95 0.57 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.824 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -52.54 -175.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.578 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.499 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -154.36 155.14 34.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.017 -1.052 . . . . 0.0 110.783 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -37.03 133.9 0.58 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.436 0.636 . . . . 0.0 110.864 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.36 16.25 16.83 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -143.61 120.29 11.15 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.168 -1.195 . . . . 0.0 110.382 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.438 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 8.8 m -103.44 148.22 26.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.983 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.717 ' CE1' HD22 ' A' ' 100' ' ' LEU . 33.2 m-85 -136.21 170.77 15.48 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 110.4 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 22.5 m-85 -117.68 167.23 11.54 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.427 -0.796 . . . . 0.0 109.967 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.809 ' CG2' HG23 ' A' ' 51' ' ' THR . 4.4 tt -151.9 97.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.555 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.504 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -140.8 161.79 36.96 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.254 -0.903 . . . . 0.0 110.914 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.668 HE21 HD12 ' A' ' 107' ' ' LEU . 17.6 tt0 -116.78 139.98 49.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.52 -0.737 . . . . 0.0 109.81 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 96.0 m -136.76 162.58 32.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.519 ' HB2' ' SG ' ' A' ' 91' ' ' CYS . . . -151.52 159.12 33.85 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.428 -0.795 . . . . 0.0 110.01 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 46.2 Cg_endo -75.45 164.61 32.22 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.879 1.463 . . . . 0.0 110.678 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.651 ' CG1' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -142.3 170.25 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.357 -0.839 . . . . 0.0 109.941 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.28 -40.78 61.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 42' ' ' GLN . . . -67.5 -60.56 5.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.563 ' H ' HG23 ' A' ' 39' ' ' VAL . 2.6 mt-30 -166.81 -68.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.441 -1.035 . . . . 0.0 110.132 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 1.4 t70 -161.1 166.65 27.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 110.297 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.494 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -159.05 173.62 16.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 110.225 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 m -138.99 157.48 45.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.293 -0.879 . . . . 0.0 110.313 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 52.2 t-20 -95.69 114.77 64.69 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 110.007 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.96 -30.72 8.8 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.967 1.509 . . . . 0.0 110.519 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.6 95.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.951 . . . . 0.0 110.143 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.2 p -87.29 7.23 29.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.375 -0.828 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.96 119.26 21.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.312 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.809 HG23 ' CG2' ' A' ' 33' ' ' ILE . 9.7 t -156.17 170.71 21.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.859 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.458 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 14.6 p -141.91 148.11 38.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.072 -1.017 . . . . 0.0 110.565 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 48.8 p90 -135.46 -176.13 4.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.415 -0.803 . . . . 0.0 109.97 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.5 m -146.48 154.39 41.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.073 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.824 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -72.6 -158.79 0.05 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 14.5 t0 -155.83 -157.09 0.7 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.783 -1.198 . . . . 0.0 110.498 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.62 -46.53 89.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.14 -0.975 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.8 t -83.6 9.91 10.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.278 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.499 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 51.14 49.98 41.4 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -133.0 138.63 46.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -1.091 . . . . 0.0 109.927 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -135.3 85.04 2.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 110.829 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 p -108.06 125.72 51.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.298 -0.876 . . . . 0.0 108.953 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -154.07 -179.19 7.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.026 -1.046 . . . . 0.0 111.405 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.49 135.3 39.54 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.465 0.65 . . . . 0.0 110.563 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 38.4 t80 -125.49 178.74 5.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 0.0 109.502 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 3.4 t -134.05 161.08 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.859 -1.151 . . . . 0.0 110.536 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 16' ' ' GLN . 30.3 m -137.17 179.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.487 -0.758 . . . . 0.0 109.902 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 8.8 mtt85 -152.21 152.72 32.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.095 -1.003 . . . . 0.0 110.365 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 5.7 tttm -82.41 -25.46 33.68 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.263 -0.898 . . . . 0.0 109.314 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 85' ' ' ASP . 1.1 m -150.26 107.53 3.61 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.454 -0.778 . . . . 0.0 109.653 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.636 ' CZ ' HG11 ' A' ' 84' ' ' VAL . 25.1 p90 -105.07 143.59 33.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 110.394 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.3 m -74.25 115.22 13.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 110.467 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.494 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -90.72 -174.5 44.33 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.86 152.89 0.79 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -1.202 . . . . 0.0 110.482 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.412 HG23 HG23 ' A' ' 81' ' ' VAL . 46.0 p -90.02 160.56 40.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.344 -0.848 . . . . 0.0 110.348 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -83.07 -20.47 5.15 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.01 1.532 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.54 -74.33 0.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.104 -0.998 . . . . 0.0 110.472 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.19 58.36 0.06 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 m -154.91 106.89 2.31 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.278 -1.131 . . . . 0.0 109.975 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.11 105.51 1.98 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.968 1.509 . . . . 0.0 110.29 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.455 HG11 ' HB ' ' A' ' 39' ' ' VAL . 45.5 t -63.78 -34.42 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 110.245 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.95 -150.74 18.04 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -85.31 167.06 15.95 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.287 -1.125 . . . . 0.0 110.315 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.651 HG22 ' CG1' ' A' ' 39' ' ' VAL . 96.1 t -138.29 110.19 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.322 -0.861 . . . . 0.0 110.023 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 1.6 m-20 -92.71 161.24 14.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.246 -0.909 . . . . 0.0 110.551 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 94.7 m -109.88 -0.11 18.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.181 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.97 -60.88 2.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.173 -0.954 . . . . 0.0 110.333 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -74.94 -30.48 61.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.174 -0.954 . . . . 0.0 110.279 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.09 155.72 20.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.892 . . . . 0.0 110.296 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.86 135.14 34.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.344 -0.847 . . . . 0.0 110.166 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 37' ' ' ALA . 2.0 m -114.14 137.9 51.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 109.845 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -125.28 151.9 45.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.109 -0.995 . . . . 0.0 110.801 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 34' ' ' ALA . 5.6 tp -122.46 109.16 14.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 0.0 109.073 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -107.39 164.45 13.06 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.532 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.643 ' O ' HD12 ' A' ' 102' ' ' LEU . . . -145.51 136.29 24.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.631 -0.923 . . . . 0.0 110.04 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.57 178.06 17.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -105.84 -160.07 0.73 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -1.197 . . . . 0.0 110.15 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.76 45.81 1.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 110.038 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.48 -51.77 0.05 OUTLIER Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.717 HD22 ' CE1' ' A' ' 31' ' ' TYR . 7.9 tt -103.05 91.33 4.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -1.193 . . . . 0.0 110.143 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -100.86 122.74 43.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 95' ' ' ALA . 2.1 mp -74.11 -29.36 61.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 110.174 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 140.53 -169.84 24.67 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.448 ' O ' ' ND1' ' A' ' 104' ' ' HIS . 31.0 p80 -144.23 126.71 15.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -1.11 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.68 HG11 HG12 ' A' ' 6' ' ' VAL . 85.8 t -92.58 128.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.189 -0.944 . . . . 0.0 110.228 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.57 136.04 42.09 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.668 HD12 HE21 ' A' ' 35' ' ' GLN . 88.7 mt -110.21 119.45 39.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.249 -0.907 . . . . 0.0 110.152 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -90.88 160.89 15.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.306 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.57 ' CE1' ' O ' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -146.79 78.67 1.5 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.822 . . . . 0.0 110.148 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 CA-C-O 117.948 -1.474 . . . . 0.0 109.591 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 120.744 0.307 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.492 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 46.3 Cg_endo -72.85 -159.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.025 1.539 . . . . 0.0 110.294 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -141.55 136.21 30.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.087 -1.008 . . . . 0.0 110.772 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.458 ' HD1' HG22 ' A' ' 22' ' ' VAL . 87.9 t80 -149.37 114.64 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.486 -0.759 . . . . 0.0 109.168 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.47 153.7 35.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.868 -1.145 . . . . 0.0 111.317 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.757 HG22 ' HD2' ' A' ' 8' ' ' PRO . 9.5 p -113.67 165.69 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.67 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -74.66 -61.87 1.04 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.663 -1.273 . . . . 0.0 110.432 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.757 ' HD2' HG22 ' A' ' 6' ' ' VAL . 55.9 Cg_endo -91.6 76.3 0.57 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 O-C-N 123.104 1.055 . . . . 0.0 110.143 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.89 -23.76 65.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.031 -1.043 . . . . 0.0 109.94 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.9 m -139.39 135.68 33.92 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.44 -0.787 . . . . 0.0 109.964 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.87 54.28 1.93 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.701 HD21 ' O ' ' A' ' 8' ' ' PRO . 2.2 mt -102.43 171.02 7.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.257 -1.143 . . . . 0.0 109.972 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -125.17 149.36 48.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 69' ' ' LYS . 4.4 p-10 -59.85 120.89 10.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.85 . . . . 0.0 109.978 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.8 -31.04 7.22 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.498 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 10.1 tt0 -55.52 147.93 16.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -1.127 . . . . 0.0 110.326 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 26.0 p -97.82 150.86 20.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 0.0 110.325 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.722 HG12 ' HG2' ' A' ' 8' ' ' PRO . 22.6 m -119.46 150.94 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.797 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 m -93.88 116.38 28.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.131 -0.981 . . . . 0.0 110.247 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 t -102.9 149.94 6.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.315 -0.865 . . . . 0.0 109.991 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 32.2 t -150.85 129.81 12.53 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 110.251 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.707 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 75.8 t -116.25 151.99 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.809 . . . . 0.0 109.901 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.755 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -164.7 113.07 1.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.208 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.65 -55.81 0.42 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.75 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -62.52 -142.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -1.148 . . . . 0.0 110.326 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.557 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -175.61 166.57 3.21 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.169 -0.957 . . . . 0.0 110.458 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -54.88 133.04 47.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.424 -0.798 . . . . 0.0 110.653 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.423 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 119.67 9.72 8.21 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 19.6 mm-40 -140.68 120.93 13.89 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.161 -1.2 . . . . 0.0 110.468 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 53' ' ' PHE . 63.6 m -106.36 130.44 54.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.261 -0.899 . . . . 0.0 109.88 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 50.0 m-85 -115.65 -168.31 1.39 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.233 -0.917 . . . . 0.0 110.786 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 40.8 m-85 -138.68 112.11 8.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.432 -0.793 . . . . 0.0 109.987 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 33' ' ' ILE . 5.6 tt -94.42 112.69 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.187 -0.946 . . . . 0.0 109.735 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.46 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -146.71 155.3 42.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 111.307 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 22.6 tt0 -109.7 127.41 54.56 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 1.8 m -143.25 165.92 26.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.067 -1.021 . . . . 0.0 110.705 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.493 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.77 164.17 21.28 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.613 -0.679 . . . . 0.0 109.441 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 43.3 Cg_endo -71.79 162.83 40.82 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.748 1.394 . . . . 0.0 110.674 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 39' ' ' VAL . 33.4 m -140.81 66.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.378 -0.827 . . . . 0.0 110.283 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.53 -28.99 7.03 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.19 -35.46 0.13 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -84.37 -170.35 3.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -1.163 . . . . 0.0 110.096 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -122.37 134.12 54.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.55 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.521 ' CB ' HG11 ' A' ' 39' ' ' VAL . . . -132.1 156.7 45.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.85 . . . . 0.0 109.671 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 12.2 t -147.55 160.7 42.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.106 -0.996 . . . . 0.0 110.511 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.464 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 41.2 t-20 -84.37 117.64 69.22 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.318 -0.864 . . . . 0.0 110.12 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.63 -37.16 2.44 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.908 1.478 . . . . 0.0 110.554 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.07 -20.95 58.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.327 -0.858 . . . . 0.0 110.322 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 82.4 p -113.86 -10.96 12.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.925 . . . . 0.0 110.352 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.4 106.43 2.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.4 t -139.9 152.96 46.83 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.255 -0.903 . . . . 0.0 110.318 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 6.0 p -105.83 157.33 17.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.106 -0.996 . . . . 0.0 110.51 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 6.4 p90 -146.0 -177.4 5.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.047 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.3 m -138.6 161.29 37.48 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.216 -0.927 . . . . 0.0 110.013 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.75 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -76.22 -158.09 0.09 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.205 -0.934 . . . . 0.0 109.934 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 1.6 t0 -141.75 -151.31 0.35 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.967 -1.083 . . . . 0.0 110.406 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.6 -54.62 29.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.926 . . . . 0.0 109.533 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.6 p -90.37 21.28 3.95 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.557 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 61.51 17.49 53.61 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -89.68 137.83 31.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -1.164 . . . . 0.0 110.056 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.707 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -140.74 84.62 1.95 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 110.269 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.8 p -104.86 115.59 30.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.84 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -146.12 179.0 7.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.258 -0.901 . . . . 0.0 110.675 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.36 138.64 31.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.511 -0.743 . . . . 0.0 110.863 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.484 ' HB3' HG23 ' A' ' 18' ' ' VAL . 51.4 t80 -132.84 -175.55 3.81 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 21.7 t -144.66 163.03 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.726 -1.234 . . . . 0.0 110.798 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.427 ' C ' ' HG2' ' A' ' 68' ' ' ARG . 33.7 m -138.28 160.83 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 109.657 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.427 ' HG2' ' C ' ' A' ' 67' ' ' VAL . 0.9 OUTLIER -141.05 139.27 34.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.939 -1.1 . . . . 0.0 110.527 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 3.2 ttmt -61.14 -44.92 96.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.903 . . . . 0.0 109.746 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 95.5 p -138.75 149.46 45.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.767 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -155.03 153.65 31.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 110.337 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 7.0 m -70.42 128.4 36.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.892 . . . . 0.0 110.138 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 74' ' ' SER . . . -87.71 173.2 43.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 5.5 t -177.18 145.53 0.46 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.282 -1.128 . . . . 0.0 110.111 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.479 ' OG1' ' HB ' ' A' ' 79' ' ' THR . 48.2 p -74.95 153.41 86.77 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.236 -0.915 . . . . 0.0 110.639 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 75' ' ' THR . 53.0 Cg_endo -82.19 9.47 3.96 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.272 1.67 . . . . 0.0 110.396 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -114.61 -22.04 9.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.112 -0.993 . . . . 0.0 110.719 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.519 ' N ' ' HG3' ' A' ' 77' ' ' GLU . . . 123.84 62.9 0.19 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.479 ' HB ' ' OG1' ' A' ' 75' ' ' THR . 7.7 m -156.1 97.83 2.23 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.264 -1.139 . . . . 0.0 109.933 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 79' ' ' THR . 44.0 Cg_endo -71.03 105.13 1.63 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.003 1.528 . . . . 0.0 110.433 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 82' ' ' GLY . 24.1 t -79.79 -71.66 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.331 -0.856 . . . . 0.0 110.318 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.435 ' N ' HG12 ' A' ' 81' ' ' VAL . . . -169.88 -151.67 7.52 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.2 OUTLIER -103.43 160.5 14.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.377 -1.072 . . . . 0.0 110.526 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -127.62 155.87 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.411 -0.806 . . . . 0.0 109.676 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -143.97 140.71 29.79 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.033 -1.042 . . . . 0.0 110.499 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 89' ' ' ALA . 69.3 m -85.16 -9.78 57.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.817 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.77 -44.9 72.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 109.929 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 t -94.91 -8.78 36.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.958 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 86' ' ' CYS . . . -140.37 163.9 31.54 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.332 -0.855 . . . . 0.0 109.981 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.24 139.64 35.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.511 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 1.4 p -123.22 142.48 50.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.302 -0.874 . . . . 0.0 109.714 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -125.47 161.43 27.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.995 . . . . 0.0 110.604 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.46 HD12 ' C ' ' A' ' 34' ' ' ALA . 13.7 tp -117.12 112.11 20.43 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.388 -0.82 . . . . 0.0 109.172 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -110.47 150.29 17.63 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.466 -1.35 . . . . 0.0 109.914 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -142.41 132.14 24.09 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.485 -1.009 . . . . 0.0 109.669 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.528 ' CA ' ' HB3' ' A' ' 31' ' ' TYR . . . 149.35 -159.37 28.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 100' ' ' LEU . 8.9 t-20 -121.18 159.08 26.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -1.083 . . . . 0.0 110.04 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -54.37 -30.57 52.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.1 -1.0 . . . . 0.0 110.107 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.74 -45.76 4.47 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.594 HD22 ' CE1' ' A' ' 31' ' ' TYR . 8.8 tt -87.89 143.52 27.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.183 . . . . 0.0 110.204 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -117.25 92.68 3.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.129 -0.982 . . . . 0.0 110.354 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.4 OUTLIER -71.13 -54.87 9.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.897 . . . . 0.0 110.125 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 158.72 155.15 7.49 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.499 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.525 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 8.7 m-70 -125.82 119.52 28.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.675 -0.897 . . . . 0.0 109.264 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.9 t -103.46 107.35 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 110.632 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.91 48.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.264 -0.897 . . . . 0.0 109.717 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 41.1 mt -95.98 158.37 15.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 0.0 110.65 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.554 HG22 ' N ' ' A' ' 109' ' ' PHE . 75.1 m -149.36 172.88 14.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.363 -0.835 . . . . 0.0 109.989 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 36.5 m-85 -135.09 118.24 16.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.199 -0.938 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.875 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 120.556 0.217 . . . . 0.0 110.444 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.875 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 44.5 Cg_endo -74.65 -172.29 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.933 1.491 . . . . 0.0 110.622 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.536 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -151.22 151.2 31.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -150.19 113.8 4.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.213 -0.929 . . . . 0.0 109.984 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.5 t -150.56 150.31 31.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.099 -1.001 . . . . 0.0 110.571 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.584 HG12 HG11 ' A' ' 105' ' ' VAL . 9.9 p -123.11 155.28 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.405 -0.809 . . . . 0.0 109.65 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -75.08 -66.4 0.43 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.036 -1.04 . . . . 0.0 110.382 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 46.3 Cg_endo -74.05 81.98 1.86 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.458 1.241 . . . . 0.0 110.259 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.06 -4.85 53.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.311 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.5 p -143.92 159.44 42.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.433 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.06 51.05 58.24 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.509 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 5.3 mt -88.5 154.79 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -1.154 . . . . 0.0 109.922 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 4.3 t -132.92 157.06 46.07 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.134 -0.979 . . . . 0.0 110.346 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -63.58 115.92 5.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.79 -32.63 7.36 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 26.5 tt0 -50.82 143.97 9.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -1.073 . . . . 0.0 110.116 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.4 t -98.85 152.61 19.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.54 ' HA ' ' HG3' ' A' ' 8' ' ' PRO . 28.7 m -128.11 150.47 33.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.288 -0.883 . . . . 0.0 109.927 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -98.29 131.36 44.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 110.133 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.39 149.02 18.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -144.9 134.55 23.4 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.391 -0.818 . . . . 0.0 110.524 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.934 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 52.5 t -127.7 149.0 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.439 -0.788 . . . . 0.0 110.006 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 2' ' ' PRO . 0.7 OUTLIER -153.12 -177.25 6.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.811 . . . . 0.0 109.596 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 1' ' ' ALA . . . 71.52 17.3 76.24 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.498 -1.334 . . . . 0.0 109.819 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.803 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -119.12 -159.47 0.77 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.155 -1.203 . . . . 0.0 110.269 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.573 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -170.98 161.06 6.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.443 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -53.6 131.17 38.3 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.572 -0.705 . . . . 0.0 110.272 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.59 21.58 5.72 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -144.36 116.44 8.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.235 -1.156 . . . . 0.0 110.621 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.405 HG23 ' OG1' ' A' ' 54' ' ' THR . 61.3 m -109.66 128.96 55.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 109.563 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 8.7 m-85 -114.31 175.5 5.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.004 -1.06 . . . . 0.0 110.715 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -124.93 124.5 42.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.473 -0.767 . . . . 0.0 109.46 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 33' ' ' ILE . 1.2 tt -105.06 124.38 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.089 -1.007 . . . . 0.0 110.482 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.99 155.87 38.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 111.201 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.517 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 36.6 tt0 -124.33 135.11 53.09 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.437 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 3.7 m -144.96 179.67 7.19 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.79 -1.194 . . . . 0.0 111.111 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.608 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -152.07 175.71 2.77 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.608 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 46.3 Cg_endo -83.23 163.28 15.2 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.751 1.395 . . . . 0.0 110.782 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.808 HG13 ' H ' ' A' ' 42' ' ' GLN . 14.9 p -150.28 158.66 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 109.982 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -50.72 -43.51 47.05 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 42' ' ' GLN . . . -62.49 -43.5 98.94 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.808 ' H ' HG13 ' A' ' 39' ' ' VAL . 0.6 OUTLIER 171.01 -75.28 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.513 -0.993 . . . . 0.0 109.602 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.436 ' CA ' HG12 ' A' ' 39' ' ' VAL . 19.5 t0 -149.76 137.5 20.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 110.417 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -131.79 173.3 11.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.789 . . . . 0.0 109.588 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.8 t -154.09 165.84 34.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.139 -0.976 . . . . 0.0 110.723 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 29.4 t-20 -80.03 124.58 82.91 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 46' ' ' ASN . 50.5 Cg_endo -86.01 -35.56 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.873 1.46 . . . . 0.0 111.389 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.24 3.61 4.45 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.139 -0.976 . . . . 0.0 111.506 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 71.7 p -124.07 7.29 8.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.863 -1.148 . . . . 0.0 110.677 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.32 120.3 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.026 -1.046 . . . . 0.0 110.193 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.462 HG23 ' CG2' ' A' ' 33' ' ' ILE . 10.0 t -160.57 165.63 30.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.226 -0.922 . . . . 0.0 110.315 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.8 t -136.01 163.59 29.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.216 -0.928 . . . . 0.0 110.43 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 7.3 p90 -146.55 179.68 7.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.297 -0.877 . . . . 0.0 109.764 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.405 ' OG1' HG23 ' A' ' 30' ' ' THR . 32.8 m -145.21 154.2 42.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.594 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.803 HG21 ' HB1' ' A' ' 25' ' ' ALA . 7.4 p -73.94 -156.15 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.355 -0.84 . . . . 0.0 110.068 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 27' ' ' ALA . 1.3 t0 -160.9 -151.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.924 -1.11 . . . . 0.0 110.799 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.21 -48.0 83.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 109.959 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.25 9.14 9.37 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.233 -0.917 . . . . 0.0 109.414 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.573 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 50.01 48.17 39.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.61 125.78 43.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.141 -1.211 . . . . 0.0 110.283 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.934 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -115.06 83.08 1.85 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 0.0 110.3 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.5 p -112.12 126.86 55.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.232 -0.918 . . . . 0.0 109.745 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 7.0 p90 -157.06 175.38 14.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 0.0 110.802 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 p -94.4 152.56 18.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.422 -0.799 . . . . 0.0 110.355 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.552 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 73.3 t80 -142.45 179.35 7.0 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 109.634 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.552 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.7 t -135.38 159.11 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.929 -1.107 . . . . 0.0 109.825 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 16' ' ' GLN . 33.7 m -132.79 161.28 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.19 -0.944 . . . . 0.0 110.672 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -135.84 138.43 42.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.89 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.818 ' HD3' ' HB2' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -76.9 -44.31 32.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.092 -1.005 . . . . 0.0 110.471 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.48 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 4.3 p -129.25 147.3 51.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.947 . . . . 0.0 110.413 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.508 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 11.0 p90 -161.82 156.03 22.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.223 -0.923 . . . . 0.0 110.347 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 73' ' ' GLY . 1.4 m -68.97 105.69 2.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.33 -0.856 . . . . 0.0 110.171 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 72' ' ' THR . . . -42.48 147.87 0.59 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 97.1 p -170.16 117.42 0.55 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.29 -1.123 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.48 ' OG1' ' HB ' ' A' ' 79' ' ' THR . 79.5 p -58.36 161.18 8.05 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.893 . . . . 0.0 110.502 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.62 1.41 8.85 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 124.183 1.622 . . . . 0.0 110.303 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -100.74 -26.56 13.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.546 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.64 65.89 0.2 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.48 ' HB ' ' OG1' ' A' ' 75' ' ' THR . 88.3 m -155.78 96.77 2.35 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.197 -1.178 . . . . 0.0 110.036 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.5 110.95 3.17 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.963 1.507 . . . . 0.0 110.366 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.5 t -83.25 -67.85 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.239 -0.913 . . . . 0.0 110.283 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.02 -150.54 6.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 m -88.16 157.27 18.87 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.377 -1.072 . . . . 0.0 110.252 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.4 t -144.88 111.24 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.153 -0.967 . . . . 0.0 110.701 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.48 ' OD1' ' HB2' ' A' ' 70' ' ' SER . 1.7 m-20 -104.99 104.47 14.22 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 109.009 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.673 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -92.07 24.27 3.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.006 -1.059 . . . . 0.0 110.921 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.818 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . . . -68.8 -37.83 79.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.178 -0.951 . . . . 0.0 109.204 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 t -116.0 -3.36 12.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.58 -0.7 . . . . 0.0 109.679 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.673 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -89.53 -139.98 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.354 -0.841 . . . . 0.0 110.294 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.78 102.88 8.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 110.415 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.92 126.15 44.52 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 15.6 p30 -130.5 139.23 50.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.093 -1.005 . . . . 0.0 110.798 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.745 ' HB2' HD11 ' A' ' 107' ' ' LEU . 6.1 tp -119.19 110.39 16.97 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.604 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -113.16 162.51 12.34 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.805 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.46 157.53 44.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.644 -0.915 . . . . 0.0 109.997 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 31' ' ' TYR . . . 107.75 -177.67 21.29 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.518 ' OD1' HD23 ' A' ' 100' ' ' LEU . 4.5 p-10 -126.68 -155.75 0.7 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.194 -1.18 . . . . 0.0 109.996 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 94.3 p -92.62 69.33 4.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.307 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.57 -55.12 0.08 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.753 HD22 ' N ' ' A' ' 100' ' ' LEU . 3.9 mm? -75.79 -32.66 59.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -1.135 . . . . 0.0 109.547 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 49.27 80.19 0.07 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.633 -0.667 . . . . 0.0 110.232 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.463 ' HG ' ' HA3' ' A' ' 96' ' ' GLY . 21.8 mt -76.16 -69.82 0.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 110.238 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.35 179.61 36.17 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.806 -1.187 . . . . 0.0 110.14 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.604 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 3.5 m-70 -134.59 123.37 23.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.585 -0.95 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.584 HG11 HG12 ' A' ' 6' ' ' VAL . 60.2 t -90.11 111.04 22.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.248 -0.908 . . . . 0.0 110.313 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.54 118.81 10.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.97 . . . . 0.0 109.29 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 93' ' ' LEU . 49.7 mt -89.85 158.68 17.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 110.852 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -123.26 164.09 19.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.503 -0.748 . . . . 0.0 109.72 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.442 ' CD1' ' HG3' ' A' ' 69' ' ' LYS . 4.5 m-85 -149.28 174.57 12.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.199 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.916 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.916 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 49.3 Cg_endo -74.31 175.11 11.41 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.976 1.514 . . . . 0.0 110.103 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -155.37 135.04 12.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.962 . . . . 0.0 110.306 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 1.2 t80 -147.78 99.3 3.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.399 -0.813 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.08 158.74 43.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 111.069 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.694 HG12 HG11 ' A' ' 105' ' ' VAL . 6.4 p -121.95 157.99 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.517 -0.739 . . . . 0.0 109.355 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.614 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.7 m -72.46 -70.19 0.29 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.883 -1.136 . . . . 0.0 110.137 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.614 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 53.9 Cg_endo -76.42 97.38 1.13 Allowed 'Trans proline' 0 N--CA 1.481 0.751 0 O-C-N 123.144 1.076 . . . . 0.0 110.031 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.5 -4.33 25.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.047 -1.033 . . . . 0.0 110.144 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.47 127.37 19.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 110.144 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' O ' HD23 ' A' ' 12' ' ' LEU . . . 88.06 80.62 1.26 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.498 HD12 ' HB3' ' A' ' 107' ' ' LEU . 45.3 mt -126.44 162.09 26.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.311 -1.111 . . . . 0.0 110.248 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.78 158.03 44.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.117 -0.99 . . . . 0.0 110.813 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -61.51 121.53 12.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 110.195 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.19 -39.03 2.93 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.551 ' O ' HG22 ' A' ' 67' ' ' VAL . 37.6 tt0 -49.47 134.05 19.62 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.28 -1.129 . . . . 0.0 109.885 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.2 p -95.51 138.74 32.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.38 -0.825 . . . . 0.0 110.066 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 65' ' ' PHE . 15.9 m -108.58 170.18 2.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.375 -0.828 . . . . 0.0 109.665 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.511 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 27.0 p -116.65 121.59 42.11 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.18 -0.95 . . . . 0.0 109.262 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t -112.16 150.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.118 -0.989 . . . . 0.0 110.41 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.65 132.55 22.74 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.492 -0.755 . . . . 0.0 110.114 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.81 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 18.3 t -120.71 139.43 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 3' ' ' ALA . 2.4 p -151.35 143.56 24.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.252 -0.905 . . . . 0.0 110.108 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 120.39 -67.77 0.41 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 24' ' ' GLY . . . -54.18 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.086 -1.243 . . . . 0.0 109.363 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.52 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -165.55 162.65 19.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.943 -1.098 . . . . 0.0 110.976 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.5 130.91 1.3 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.459 0.647 . . . . 0.0 110.409 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.417 ' C ' ' HG3' ' A' ' 29' ' ' GLU . . . 120.04 4.61 11.23 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 33.6 mt-10 -138.72 122.75 17.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.199 -1.177 . . . . 0.0 109.85 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.56 HG23 ' OG1' ' A' ' 54' ' ' THR . 62.4 m -105.02 133.69 49.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 109.99 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.924 ' CE2' HD21 ' A' ' 100' ' ' LEU . 11.1 m-85 -120.05 171.8 8.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.533 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 14.0 m-85 -131.68 102.1 5.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 109.113 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.659 ' CG2' HG23 ' A' ' 51' ' ' THR . 3.0 tt -90.47 117.8 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.084 -1.01 . . . . 0.0 110.905 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.45 158.5 44.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.219 -0.926 . . . . 0.0 110.299 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.462 ' HG2' ' N ' ' A' ' 36' ' ' CYS . 2.2 tt0 -116.85 144.47 44.47 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.226 -0.921 . . . . 0.0 110.19 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 77.2 m -150.23 161.43 42.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.283 -0.885 . . . . 0.0 110.776 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . . . -138.17 156.04 74.0 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 121.371 -0.831 . . . . 0.0 109.816 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 44.4 Cg_endo -70.82 163.62 38.48 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.825 1.434 . . . . 0.0 111.836 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.775 HG23 ' H ' ' A' ' 42' ' ' GLN . 5.8 m -137.66 167.03 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.689 . . . . 0.0 109.748 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -50.24 -30.36 17.63 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.14 -69.63 1.38 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.775 ' H ' HG23 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -149.98 -75.76 0.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -1.111 . . . . 0.0 109.966 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.568 ' CA ' HG22 ' A' ' 39' ' ' VAL . 12.5 t70 -155.79 167.58 29.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.253 -0.905 . . . . 0.0 110.911 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -149.72 162.88 39.37 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.68 162.15 27.22 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.916 -1.115 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . 57.4 t30 -103.91 113.35 65.47 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.553 -0.717 . . . . 0.0 110.171 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.26 -27.93 7.63 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.993 1.523 . . . . 0.0 110.242 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.26 -3.78 11.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.849 . . . . 0.0 110.285 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.435 ' OG1' ' ND2' ' A' ' 46' ' ' ASN . 3.5 p -131.24 -1.85 3.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.258 -0.901 . . . . 0.0 110.172 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.7 127.38 31.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.26 -0.9 . . . . 0.0 110.183 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.659 HG23 ' CG2' ' A' ' 33' ' ' ILE . 4.4 t -159.47 150.51 19.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.979 . . . . 0.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 t -122.42 143.25 49.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.309 -0.869 . . . . 0.0 110.149 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -140.24 138.07 34.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.146 -0.971 . . . . 0.0 110.432 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.56 ' OG1' HG23 ' A' ' 30' ' ' THR . 15.6 m -105.48 151.56 24.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.194 -0.941 . . . . 0.0 109.525 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -61.71 -170.76 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.811 -1.18 . . . . 0.0 109.481 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 6.5 t0 -145.45 -158.72 0.92 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.914 -1.116 . . . . 0.0 110.818 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.39 -53.23 60.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 109.47 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 p -76.78 1.99 15.68 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 109.083 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 53.75 44.49 70.0 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.14 132.99 47.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.289 -1.124 . . . . 0.0 110.051 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.81 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -123.13 83.55 2.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.181 -0.95 . . . . 0.0 110.876 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.22 120.22 41.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.263 -0.898 . . . . 0.0 109.648 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -154.91 168.03 28.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.175 -0.953 . . . . 0.0 110.833 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 t -90.96 131.63 36.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.448 -0.783 . . . . 0.0 110.278 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 76.7 t80 -116.35 -179.73 3.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.557 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.1 t -133.37 158.1 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 120.858 -1.151 . . . . 0.0 110.01 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 16' ' ' GLN . 29.1 m -129.42 126.72 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.153 -0.967 . . . . 0.0 110.818 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 134.99 47.83 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.206 -0.934 . . . . 0.0 109.888 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -73.91 -45.86 47.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.218 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.4 m -135.12 152.11 51.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.939 . . . . 0.0 110.066 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.578 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 8.8 p90 -169.68 148.19 3.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.928 . . . . 0.0 110.317 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.3 OUTLIER -54.61 124.77 17.32 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.146 -0.971 . . . . 0.0 109.395 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.669 ' HA3' HG21 ' A' ' 84' ' ' VAL . . . -110.14 167.6 12.77 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.505 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 12.6 t -173.52 154.35 2.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.658 -0.907 . . . . 0.0 108.909 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 79' ' ' THR . 1.0 OUTLIER -126.44 158.03 68.58 Favored Pre-proline 0 N--CA 1.486 1.369 0 O-C-N 120.554 -1.341 . . . . 0.0 112.42 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 75' ' ' THR . 49.3 Cg_endo -81.99 -48.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.513 1.796 . . . . 0.0 108.659 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -87.59 -27.16 22.7 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.448 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . -99.8 -9.86 48.2 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 75' ' ' THR . 0.5 OUTLIER 67.28 162.55 0.13 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.361 -1.081 . . . . 0.0 110.919 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.629 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 37.5 Cg_endo -63.21 114.17 2.36 Favored 'Trans proline' 0 C--N 1.301 -1.951 0 O-C-N 124.364 1.718 . . . . 0.0 111.088 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.5 t -87.59 -62.24 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.489 -0.757 . . . . 0.0 110.019 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.23 -153.37 11.22 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 5.3 m -74.31 159.77 31.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -1.166 . . . . 0.0 110.033 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.669 HG21 ' HA3' ' A' ' 73' ' ' GLY . 88.0 t -125.82 156.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.183 -0.948 . . . . 0.0 110.297 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -156.19 130.92 9.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.19 -0.944 . . . . 0.0 110.381 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -90.52 7.89 36.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 109.978 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.53 -47.44 69.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.343 -0.848 . . . . 0.0 110.247 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.0 t -113.32 -0.04 14.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 110.174 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -103.46 -163.71 1.01 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.224 -0.923 . . . . 0.0 110.278 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.7 133.23 56.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 110.136 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.56 111.25 23.72 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.184 -0.948 . . . . 0.0 110.016 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -121.49 140.43 52.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.131 -0.981 . . . . 0.0 110.64 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.1 tp -112.84 141.42 46.67 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.435 -0.791 . . . . 0.0 109.244 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.24 167.73 32.41 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.08 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 33' ' ' ILE . . . -155.01 168.52 26.72 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.602 -0.94 . . . . 0.0 109.173 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.3 175.95 26.07 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.166 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 30' ' ' THR . 28.7 t30 -148.37 172.19 14.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -1.081 . . . . 0.0 109.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.99 -10.51 14.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 0.0 110.318 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.96 -43.58 7.1 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.924 HD21 ' CE2' ' A' ' 31' ' ' TYR . 2.3 pt? -154.12 -160.86 1.14 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -1.193 . . . . 0.0 110.436 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.518 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 3.4 m-20 -149.91 113.46 4.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.286 -0.884 . . . . 0.0 110.294 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.588 HD11 ' CD2' ' A' ' 31' ' ' TYR . 96.9 mt -71.58 -54.47 10.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 110.202 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.77 -160.34 27.71 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 7.5 p80 -158.35 140.62 14.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.267 -1.137 . . . . 0.0 109.999 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.694 HG11 HG12 ' A' ' 6' ' ' VAL . 15.9 t -103.04 124.1 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.112 -0.992 . . . . 0.0 110.587 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.61 103.21 3.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.256 -0.902 . . . . 0.0 109.956 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.498 ' HB3' HD12 ' A' ' 12' ' ' LEU . 12.8 mt -83.01 127.61 33.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.21 -0.931 . . . . 0.0 110.314 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 109' ' ' PHE . 37.4 m -94.61 171.18 8.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.205 -0.935 . . . . 0.0 110.297 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.505 ' N ' HG22 ' A' ' 108' ' ' THR . 1.2 m-85 -145.25 154.49 42.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.391 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 120.723 0.297 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.867 ' HB2' HD21 ' A' ' 102' ' ' LEU . 44.3 Cg_endo -69.36 -178.92 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.99 1.521 . . . . 0.0 109.873 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -156.6 149.12 23.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.863 -1.148 . . . . 0.0 111.552 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.446 ' CE2' HG23 ' A' ' 105' ' ' VAL . 44.5 t80 -151.14 107.07 3.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.597 -0.689 . . . . 0.0 109.322 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.48 151.35 43.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.968 -1.083 . . . . 0.0 111.51 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.75 ' CG1' HG11 ' A' ' 105' ' ' VAL . 7.8 p -133.12 132.77 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.642 -0.661 . . . . 0.0 109.425 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.612 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -63.22 -66.74 1.36 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.038 -1.039 . . . . 0.0 110.839 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 50.9 Cg_endo -73.44 83.29 1.52 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.6 1.316 . . . . 0.0 110.667 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.7 4.62 53.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.112 -0.992 . . . . 0.0 110.005 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.8 p -151.75 170.38 19.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.95 55.92 28.19 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.519 ' CD1' HD22 ' A' ' 107' ' ' LEU . 58.0 mt -107.86 145.38 33.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -1.081 . . . . 0.0 109.953 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 16' ' ' GLN . 0.4 OUTLIER -119.55 158.11 26.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 110.541 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 14' ' ' ASP . 41.0 t0 -59.34 124.04 18.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.894 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.01 -32.01 6.78 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.453 ' HB3' ' O ' ' A' ' 13' ' ' SER . 37.9 tt0 -56.9 146.38 26.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.305 -1.115 . . . . 0.0 109.985 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 11.3 m -102.37 153.22 20.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.57 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.655 HG23 ' HB3' ' A' ' 65' ' ' PHE . 6.3 m -116.8 153.32 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.337 -0.852 . . . . 0.0 109.818 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -97.79 109.18 21.98 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.16 -0.962 . . . . 0.0 110.055 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.45 ' CG2' HG23 ' A' ' 6' ' ' VAL . 46.2 t -111.17 157.6 11.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 121.435 -0.791 . . . . 0.0 109.846 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 m -150.59 117.3 5.81 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.257 -0.902 . . . . 0.0 110.383 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 4.2 t -105.25 123.7 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 0.0 109.892 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.555 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.1 OUTLIER -132.86 155.76 48.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.995 -1.066 . . . . 0.0 110.499 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 106.63 -35.74 4.85 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.693 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -68.34 -150.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.306 -1.114 . . . . 0.0 109.747 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 25' ' ' ALA . . . 176.19 147.68 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.859 -1.151 . . . . 0.0 111.339 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -39.41 143.28 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.611 0.72 . . . . 0.0 110.415 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.45 18.47 14.49 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.623 ' O ' HG23 ' A' ' 54' ' ' THR . 4.5 tp10 -151.02 135.64 17.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.227 -1.161 . . . . 0.0 110.745 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.54 HG23 ' OG1' ' A' ' 54' ' ' THR . 3.7 m -114.3 145.15 42.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.751 ' CE1' HG23 ' A' ' 55' ' ' THR . 24.5 m-85 -128.34 179.58 5.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -0.95 . . . . 0.0 110.504 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -132.33 100.69 5.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.208 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.76 HG23 ' O ' ' A' ' 33' ' ' ILE . 7.6 tt -89.0 103.25 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -0.922 . . . . 0.0 110.134 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.497 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -138.7 163.24 32.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.139 -0.975 . . . . 0.0 110.555 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.434 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 18.0 pt20 -128.77 148.75 50.88 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.16 -0.962 . . . . 0.0 110.269 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 1.8 m -145.5 172.93 12.51 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.213 -0.929 . . . . 0.0 110.389 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.25 161.57 35.87 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.533 -0.729 . . . . 0.0 109.409 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.665 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 43.7 Cg_endo -71.4 171.78 15.48 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.713 1.375 . . . . 0.0 110.329 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 40' ' ' GLY . 2.8 t -144.08 60.58 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.1 -1.0 . . . . 0.0 110.402 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' VAL . . . 43.37 40.19 4.6 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.07 -68.36 0.23 Allowed Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.006 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.59 -151.45 0.48 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.443 -1.034 . . . . 0.0 109.588 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 1.8 p30 -138.89 124.81 19.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.833 -1.167 . . . . 0.0 110.363 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.687 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -108.49 147.12 32.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.37 -0.832 . . . . 0.0 109.163 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 12.2 t -124.14 170.41 10.73 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.793 -1.192 . . . . 0.0 111.007 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.438 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 8.4 t-20 -105.76 119.61 51.91 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 109.995 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.79 -35.04 3.62 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.871 1.459 . . . . 0.0 110.41 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.14 73.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.276 -0.89 . . . . 0.0 110.213 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.6 p -75.65 -16.71 60.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.317 -0.865 . . . . 0.0 109.983 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -76.26 87.93 3.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.837 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 33' ' ' ILE . 12.0 t -112.46 148.4 34.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.264 -0.898 . . . . 0.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 p -93.58 132.46 37.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.35 -0.844 . . . . 0.0 109.86 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 35.3 p90 -133.34 124.51 27.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.12 -0.988 . . . . 0.0 110.698 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 29' ' ' GLU . 47.3 m -89.22 153.87 20.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 110.345 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.751 HG23 ' CE1' ' A' ' 31' ' ' TYR . 1.8 p -61.67 -158.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.297 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 9.2 m-20 -149.18 -160.24 1.15 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.853 -1.154 . . . . 0.0 110.675 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.51 76.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.163 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.8 m -85.9 13.3 7.65 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.564 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 54.25 23.58 26.18 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -110.94 114.94 28.64 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.456 -1.026 . . . . 0.0 110.434 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.28 80.01 1.27 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.505 -0.747 . . . . 0.0 110.096 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -103.67 143.92 32.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.431 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -172.79 169.78 4.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.135 -0.978 . . . . 0.0 111.055 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.62 92.45 8.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.31 -0.869 . . . . 0.0 110.112 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.655 ' HB3' HG23 ' A' ' 18' ' ' VAL . 77.7 t80 -73.39 -174.97 1.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.438 -0.789 . . . . 0.0 109.505 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.521 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.1 t -138.66 155.42 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.883 -1.136 . . . . 0.0 109.561 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 12' ' ' LEU . 33.0 m -136.28 144.9 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.032 -1.043 . . . . 0.0 110.535 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.01 138.43 50.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -0.843 . . . . 0.0 110.228 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -64.16 -58.76 5.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.865 . . . . 0.0 110.234 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 p -130.04 155.23 46.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.269 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 11.0 p90 -168.35 158.3 9.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 109.796 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.7 OUTLIER -62.58 127.59 32.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.157 -0.965 . . . . 0.0 110.191 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.505 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -96.05 168.1 25.7 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 13.2 t 177.74 146.4 0.13 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.182 -1.187 . . . . 0.0 110.308 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.8 p -66.59 154.79 90.53 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.245 -0.909 . . . . 0.0 110.173 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -80.44 12.07 2.68 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.012 1.532 . . . . 0.0 110.74 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.421 ' OE1' ' C ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -114.54 -72.14 0.71 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.132 -0.98 . . . . 0.0 110.296 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.91 56.08 0.08 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 53.3 m -156.04 92.9 2.56 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.291 -1.123 . . . . 0.0 110.168 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.56 138.49 29.64 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.992 1.522 . . . . 0.0 110.027 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.0 t -108.37 -33.64 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.936 . . . . 0.0 110.58 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.95 -171.65 29.93 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 15.9 p -68.98 166.51 17.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.401 -1.058 . . . . 0.0 110.454 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.687 HG21 ' HB3' ' A' ' 44' ' ' ALA . 53.0 t -138.53 142.34 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.34 -0.85 . . . . 0.0 109.635 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.3 137.92 41.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.017 -1.052 . . . . 0.0 110.672 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 91' ' ' CYS . 65.1 m -93.19 27.48 2.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.44 -51.55 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.44 -0.787 . . . . 0.0 109.976 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.446 ' H ' HG22 ' A' ' 88' ' ' THR . 4.4 t -97.64 -20.25 17.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.35 -0.843 . . . . 0.0 109.654 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.665 ' HB1' ' HG2' ' A' ' 38' ' ' PRO . . . -96.79 -161.85 0.91 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.361 -0.837 . . . . 0.0 109.77 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.49 130.88 56.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 110.59 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 86' ' ' CYS . 0.5 OUTLIER -107.3 116.39 31.85 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.342 -0.849 . . . . 0.0 109.551 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 91' ' ' CYS . 42.9 m-20 -130.77 136.35 48.63 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.966 -1.084 . . . . 0.0 111.268 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 34' ' ' ALA . 2.6 tp -107.12 118.27 36.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.491 -0.756 . . . . 0.0 109.671 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -111.21 161.3 12.84 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.28 170.82 17.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.337 -1.096 . . . . 0.0 110.195 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.32 167.96 12.65 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.494 ' HB3' ' O ' ' A' ' 30' ' ' THR . 4.2 p-10 -118.4 -151.12 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 110.405 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.18 89.59 4.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.229 -0.919 . . . . 0.0 110.377 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.56 -21.53 3.59 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.845 HD21 ' HG3' ' A' ' 2' ' ' PRO . 2.9 tm? -103.81 -76.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.379 -1.071 . . . . 0.0 109.913 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.713 ' N ' HD13 ' A' ' 100' ' ' LEU . 4.3 t70 70.09 138.29 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.207 -0.933 . . . . 0.0 110.726 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.867 HD21 ' HB2' ' A' ' 2' ' ' PRO . 4.2 mt -133.0 -42.13 0.9 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.423 -0.798 . . . . 0.0 110.372 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.81 -149.01 20.39 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.43 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 14.2 p80 -158.74 134.39 8.78 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.253 -1.146 . . . . 0.0 110.312 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.75 HG11 ' CG1' ' A' ' 6' ' ' VAL . 2.5 t -86.16 161.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.387 -0.821 . . . . 0.0 109.593 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.98 124.93 48.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 0.0 110.242 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.519 HD22 ' CD1' ' A' ' 12' ' ' LEU . 79.3 mt -100.78 85.82 2.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.619 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.5 m -68.42 162.94 24.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.756 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.458 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 5.2 m-85 -136.52 75.76 1.56 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.144 -0.972 . . . . 0.0 110.382 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.358 0 CA-C-O 118.025 -1.43 . . . . 0.0 109.623 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' A' ' 24' ' ' GLY . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.763 0.316 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.476 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 49.3 Cg_endo -75.24 -176.85 3.12 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.914 1.481 . . . . 0.0 110.425 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -162.21 79.49 0.52 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.126 -0.984 . . . . 0.0 110.527 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.529 ' HD1' HG22 ' A' ' 22' ' ' VAL . 25.0 t80 -91.37 114.9 27.55 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.056 -1.028 . . . . 0.0 109.718 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.6 p -150.81 152.44 33.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.044 -1.035 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.745 HG12 HG11 ' A' ' 105' ' ' VAL . 8.0 p -120.37 123.31 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.569 -0.707 . . . . 0.0 109.574 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.614 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 m -45.94 -67.95 0.34 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.999 . . . . 0.0 110.122 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.614 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 48.6 Cg_endo -76.15 78.98 3.04 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.342 1.18 . . . . 0.0 110.014 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.481 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -99.59 6.57 45.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 110.282 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -158.24 148.51 20.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.928 . . . . 0.0 110.338 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.63 67.61 1.92 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.55 ' CD1' HD22 ' A' ' 107' ' ' LEU . 11.8 mt -122.22 173.62 7.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.387 -1.067 . . . . 0.0 110.162 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -137.83 157.3 46.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.158 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -60.82 109.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.135 -0.978 . . . . 0.0 110.26 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.85 -39.34 2.82 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.43 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.2 tm0? -46.38 141.07 3.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.145 -1.209 . . . . 0.0 109.941 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.78 152.99 21.02 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.952 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.637 HG11 HG11 ' A' ' 67' ' ' VAL . 5.6 m -126.98 166.44 23.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.4 t -119.36 130.34 55.29 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.141 -0.974 . . . . 0.0 110.174 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.9 t -117.25 144.6 24.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 O-C-N 121.602 -0.686 . . . . 0.0 109.792 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 40.2 t -150.99 134.52 16.31 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.296 -0.878 . . . . 0.0 110.494 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.529 HG22 ' HD1' ' A' ' 4' ' ' PHE . 22.5 t -122.66 111.9 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.764 . . . . 0.0 110.092 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.64 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 58.8 m -125.47 113.34 17.36 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.083 -1.011 . . . . 0.0 111.068 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 154.16 -38.11 0.69 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 26' ' ' ALA . . . -69.49 -141.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -1.146 . . . . 0.0 109.807 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 25' ' ' ALA . . . 176.0 160.31 0.3 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.152 -0.968 . . . . 0.0 110.445 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.76 133.35 31.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.735 . . . . 0.0 110.417 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.424 ' O ' ' CD ' ' A' ' 29' ' ' GLU . . . 127.35 12.17 3.19 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.524 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 73.5 mm-40 -152.18 144.61 24.09 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.949 -1.324 . . . . 0.0 110.545 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.403 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 23.7 m -122.36 148.37 45.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.416 -0.803 . . . . 0.0 109.791 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.721 ' HE2' HD22 ' A' ' 100' ' ' LEU . 9.6 m-85 -140.02 -177.14 4.86 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.07 -1.018 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.589 ' CD1' ' HB3' ' A' ' 52' ' ' SER . 19.0 m-85 -132.81 124.83 28.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -108.53 117.0 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.877 -1.14 . . . . 0.0 110.916 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.612 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -152.53 151.16 30.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 110.471 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.534 ' HB2' HD13 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -103.1 135.22 45.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.382 -0.824 . . . . 0.0 109.529 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 1.5 m -146.58 173.06 12.67 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.082 -1.011 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.02 152.35 31.3 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.524 -0.735 . . . . 0.0 109.466 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.41 156.41 61.71 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.689 1.363 . . . . 0.0 110.96 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.846 HG11 HG11 ' A' ' 81' ' ' VAL . 4.8 m -124.36 -167.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.489 -0.757 . . . . 0.0 110.109 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.99 18.97 10.81 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 42' ' ' GLN . . . -146.36 -57.36 0.02 OUTLIER Glycine 0 N--CA 1.489 2.226 0 O-C-N 120.929 -1.336 . . . . 0.0 110.171 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.629 ' H ' HG23 ' A' ' 39' ' ' VAL . 8.3 mp0 -143.58 -108.36 0.12 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.149 -1.206 . . . . 0.0 110.215 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -149.47 134.33 17.88 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.997 -1.064 . . . . 0.0 110.229 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.744 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -126.85 152.22 47.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.863 . . . . 0.0 109.801 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 10.4 t -129.56 165.16 22.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 110.283 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -86.86 112.06 44.59 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.194 -0.941 . . . . 0.0 110.109 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.7 Cg_endo -74.49 -27.65 10.85 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.94 1.495 . . . . 0.0 110.661 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.46 -23.62 67.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.171 -0.956 . . . . 0.0 110.285 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.526 HG21 ' HE ' ' A' ' 68' ' ' ARG . 4.9 p -113.1 26.62 10.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.208 -0.932 . . . . 0.0 110.375 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.7 143.36 33.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.22 -0.925 . . . . 0.0 110.068 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.482 HG23 HG23 ' A' ' 33' ' ' ILE . 7.5 t -170.35 137.33 1.45 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.015 . . . . 0.0 110.627 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.589 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 5.4 p -107.6 155.79 19.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.305 -0.872 . . . . 0.0 110.548 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 31' ' ' TYR . 12.3 p90 -151.93 -178.31 6.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.167 -0.958 . . . . 0.0 110.556 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 29' ' ' GLU . 31.2 m -141.16 168.67 19.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.458 -0.776 . . . . 0.0 109.64 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.425 ' N ' HG22 ' A' ' 54' ' ' THR . 1.0 OUTLIER -74.2 -164.7 0.26 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.956 -1.09 . . . . 0.0 110.462 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.35 -162.18 1.31 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.858 . . . . 0.0 109.779 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.04 -58.0 10.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -0.962 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 p -90.7 23.71 2.98 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.325 -0.859 . . . . 0.0 108.962 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 57.61 39.35 90.88 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -106.86 124.44 49.62 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.34 -1.094 . . . . 0.0 110.564 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -132.29 84.43 2.15 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.342 -0.849 . . . . 0.0 109.504 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 57.1 m -110.94 120.76 43.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 110.526 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.634 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 2.2 p90 -143.82 170.98 14.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 110.649 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 p -93.32 122.15 35.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.376 -0.828 . . . . 0.0 110.671 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.426 ' HB3' HG23 ' A' ' 18' ' ' VAL . 9.1 t80 -116.87 -169.62 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.489 -0.757 . . . . 0.0 109.206 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.412 HG23 ' C ' ' A' ' 65' ' ' PHE . 11.2 t -145.51 165.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.8 -1.188 . . . . 0.0 109.623 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.637 HG11 HG11 ' A' ' 18' ' ' VAL . 34.2 m -130.43 152.95 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.069 -1.019 . . . . 0.0 110.789 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.526 ' HE ' HG21 ' A' ' 49' ' ' THR . 0.0 OUTLIER -133.42 150.46 51.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.339 -0.851 . . . . 0.0 109.96 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.573 ' HE2' ' CG ' ' A' ' 109' ' ' PHE . 3.2 ttmt -83.42 -36.99 23.81 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.097 -1.002 . . . . 0.0 110.553 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 p -136.04 150.01 49.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.197 -0.94 . . . . 0.0 110.092 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.561 ' CZ ' HG11 ' A' ' 84' ' ' VAL . 16.4 p90 -161.34 166.11 27.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.254 -0.904 . . . . 0.0 110.328 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -88.53 117.53 27.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.218 -0.926 . . . . 0.0 110.061 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.744 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -101.37 154.78 19.02 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 2.5 p 171.22 130.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.312 -1.111 . . . . 0.0 110.017 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.469 ' OG1' ' HB ' ' A' ' 79' ' ' THR . 22.9 p -84.45 143.68 41.96 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 110.48 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 75' ' ' THR . 49.9 Cg_endo -88.93 21.29 0.99 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.067 1.562 . . . . 0.0 110.713 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -108.03 -11.42 15.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.064 -1.023 . . . . 0.0 110.547 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.02 23.46 1.61 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.469 ' HB ' ' OG1' ' A' ' 75' ' ' THR . 19.9 m -140.49 63.65 22.12 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.123 -1.222 . . . . 0.0 110.258 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.04 145.82 50.73 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.946 1.498 . . . . 0.0 110.199 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.846 HG11 HG11 ' A' ' 39' ' ' VAL . 56.2 t -112.02 -44.69 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.95 . . . . 0.0 110.619 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.21 -150.75 18.54 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m -57.53 148.92 22.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.443 -1.033 . . . . 0.0 110.593 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.561 HG11 ' CZ ' ' A' ' 71' ' ' TYR . 49.4 t -139.18 102.8 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.383 -0.823 . . . . 0.0 109.806 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -93.88 126.06 38.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.369 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 3.5 m -85.92 4.13 38.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.821 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.17 -63.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 109.991 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.429 HG23 ' N ' ' A' ' 89' ' ' ALA . 13.3 t -72.85 -33.86 66.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.268 -0.895 . . . . 0.0 110.009 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.429 ' N ' HG23 ' A' ' 88' ' ' THR . . . -93.35 -177.77 4.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.326 -0.859 . . . . 0.0 109.919 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.48 139.17 38.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.373 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.34 130.47 54.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.64 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.422 ' ND2' ' N ' ' A' ' 92' ' ' ASN . 3.1 m-80 -133.93 163.69 28.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 110.796 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.612 HD12 ' O ' ' A' ' 34' ' ' ALA . 41.2 tp -127.58 111.12 13.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 0.0 109.214 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.27 165.49 18.36 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.056 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -157.38 101.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -1.072 . . . . 0.0 110.105 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.83 174.88 46.96 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.489 ' CG ' ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -123.46 -155.01 0.63 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.068 -1.254 . . . . 0.0 109.88 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.489 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 11.3 p -99.97 78.14 2.08 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.31 -36.19 0.24 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.155 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.721 HD22 ' HE2' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -109.17 -47.52 3.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.908 -1.348 . . . . 0.0 110.744 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 100' ' ' LEU . 33.7 m-20 54.27 105.79 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.293 -0.88 . . . . 0.0 110.12 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 2' ' ' PRO . 5.4 mt -94.43 -60.96 1.6 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 0.0 110.467 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 159.94 -162.5 33.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 15.7 p80 -151.29 132.39 14.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.295 -1.121 . . . . 0.0 110.261 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.745 HG11 HG12 ' A' ' 6' ' ' VAL . 16.1 t -87.2 130.1 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.188 -0.945 . . . . 0.0 110.011 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.56 123.2 28.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.0 110.16 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.55 HD22 ' CD1' ' A' ' 12' ' ' LEU . 39.4 mt -92.89 170.06 9.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 0.0 110.586 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.552 HG22 ' N ' ' A' ' 109' ' ' PHE . 85.3 m -141.74 171.82 13.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.408 -0.807 . . . . 0.0 109.794 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.573 ' CG ' ' HE2' ' A' ' 69' ' ' LYS . 3.0 m-85 -146.08 115.76 7.24 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.861 . . . . 0.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.406 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 120.735 0.303 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.406 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 45.1 Cg_endo -73.02 -157.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.051 1.553 . . . . 0.0 110.133 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -140.49 129.57 23.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 110.52 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -148.96 99.23 2.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 0.0 109.538 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.5 p -148.01 148.27 30.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.757 HG12 HG11 ' A' ' 105' ' ' VAL . 10.1 p -106.15 159.52 6.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.622 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -74.15 -71.01 0.23 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.889 -1.132 . . . . 0.0 109.832 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.622 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 55.4 Cg_endo -77.8 84.68 1.94 Allowed 'Trans proline' 0 C--N 1.322 -0.853 0 O-C-N 123.209 1.11 . . . . 0.0 110.366 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 107' ' ' LEU . . . -73.92 -14.2 61.02 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.89 -1.131 . . . . 0.0 109.667 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.8 t -139.58 162.29 35.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.627 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.24 47.49 10.83 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.63 ' CD1' HD22 ' A' ' 107' ' ' LEU . 14.0 mt -101.28 170.67 8.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.383 -1.069 . . . . 0.0 109.962 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 m -145.61 162.16 38.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.041 -1.037 . . . . 0.0 111.012 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.41 125.64 24.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.24 -26.8 7.43 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.467 ' OE1' ' N ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -51.22 138.62 20.28 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.345 -1.091 . . . . 0.0 110.29 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.467 ' N ' ' OE1' ' A' ' 16' ' ' GLN . 1.3 t -99.76 122.13 42.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.464 -0.773 . . . . 0.0 109.88 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 65' ' ' PHE . 34.9 m -98.9 168.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.981 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.7 m -116.44 120.48 38.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.975 . . . . 0.0 110.24 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.78 152.52 8.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.347 -0.845 . . . . 0.0 109.945 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.7 t -142.45 125.0 15.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.758 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 48.2 t -116.01 147.51 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.455 -0.778 . . . . 0.0 109.819 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 3' ' ' ALA . 11.8 t -160.24 153.55 22.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.082 -1.012 . . . . 0.0 110.189 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.34 -47.18 1.07 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -60.22 -154.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.322 -1.105 . . . . 0.0 110.204 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.536 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -176.11 143.57 0.55 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 110.481 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -30.77 130.72 0.1 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.43 0.633 . . . . 0.0 111.236 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.455 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 112.61 6.37 23.38 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.475 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 1.6 mt-10 -131.81 121.37 24.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.12 -1.223 . . . . 0.0 110.278 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.576 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 57.6 m -104.22 147.15 27.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.986 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.672 ' CE1' HD22 ' A' ' 100' ' ' LEU . 16.2 m-85 -134.7 168.66 18.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.909 . . . . 0.0 110.4 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 17.7 m-85 -126.53 118.59 25.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.347 -0.846 . . . . 0.0 109.698 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.66 ' CG2' HG23 ' A' ' 51' ' ' THR . 7.8 tt -98.63 124.37 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 110.555 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.67 155.67 37.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.852 . . . . 0.0 110.235 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.415 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 26.6 tt0 -110.03 142.62 41.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 70.9 m -148.78 163.46 37.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.974 -1.079 . . . . 0.0 110.772 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -146.13 166.16 18.01 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.519 -0.738 . . . . 0.0 109.42 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 43.5 Cg_endo -71.54 163.49 38.83 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.736 1.387 . . . . 0.0 110.464 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 39' ' ' VAL . 7.2 p -148.36 69.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.175 -0.953 . . . . 0.0 110.477 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.38 9.15 87.24 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.2 -57.81 0.52 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.34 -150.89 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.335 -1.097 . . . . 0.0 109.898 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -150.41 116.69 5.69 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.147 -0.971 . . . . 0.0 110.418 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -86.04 173.4 9.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.54 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.0 m -140.76 154.98 46.51 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.027 -1.046 . . . . 0.0 111.061 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.573 ' OD1' ' CG ' ' A' ' 71' ' ' TYR . 0.2 OUTLIER -89.51 116.41 66.27 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.35 -0.844 . . . . 0.0 110.082 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -85.2 -31.17 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.876 1.461 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.11 -10.53 54.71 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.311 -0.868 . . . . 0.0 110.663 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 63.6 p -124.95 25.5 7.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.094 -1.004 . . . . 0.0 110.399 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.79 108.54 18.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.068 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.66 HG23 ' CG2' ' A' ' 33' ' ' ILE . 10.1 t -130.95 157.15 43.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.892 . . . . 0.0 110.421 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.508 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 74.2 p -126.51 152.88 45.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.848 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 12.1 p90 -148.3 -179.6 7.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.422 -0.799 . . . . 0.0 109.549 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.6 m -143.33 161.23 38.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.937 -1.102 . . . . 0.0 110.306 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.621 HG21 ' HB1' ' A' ' 25' ' ' ALA . 21.8 p -65.11 -154.66 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.342 -0.849 . . . . 0.0 109.966 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -160.27 -158.8 0.65 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.142 -0.974 . . . . 0.0 110.422 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.7 -48.71 80.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.889 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.32 9.35 11.08 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.338 -0.852 . . . . 0.0 109.438 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 54.98 51.47 53.45 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.74 152.36 47.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.309 -1.112 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.758 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -141.22 81.79 1.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.577 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.3 m -104.0 118.79 37.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 20.1 p90 -155.16 177.54 11.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.135 -0.978 . . . . 0.0 111.073 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.31 131.3 41.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.644 -0.66 . . . . 0.0 110.445 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.743 ' O ' HG22 ' A' ' 18' ' ' VAL . 59.3 t80 -121.88 137.07 54.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.452 -0.78 . . . . 0.0 108.989 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.5 154.02 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.17 151.66 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.498 -0.751 . . . . 0.0 110.273 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.88 179.29 4.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.177 -0.952 . . . . 0.0 110.73 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.46 ' HG3' ' CE2' ' A' ' 109' ' ' PHE . 24.0 tttm -100.96 -30.43 11.65 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.777 0.799 . . . . 0.0 108.899 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.55 163.92 37.26 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.573 ' CG ' ' OD1' ' A' ' 46' ' ' ASN . 16.6 p90 -170.9 156.57 5.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.913 -1.117 . . . . 0.0 110.031 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 m -71.84 136.98 47.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.185 -0.947 . . . . 0.0 110.715 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.46 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -106.87 162.74 13.46 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.0 t -149.61 168.12 24.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.241 -1.152 . . . . 0.0 110.172 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.437 HG23 ' CG2' ' A' ' 81' ' ' VAL . 17.5 p -97.02 161.28 26.83 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.965 . . . . 0.0 110.41 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.93 -17.5 17.52 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.104 1.581 . . . . 0.0 110.746 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -78.89 -37.03 41.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.183 -0.948 . . . . 0.0 110.564 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 126.26 50.29 0.18 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 m -148.55 135.97 10.81 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.357 -1.084 . . . . 0.0 109.856 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.97 158.07 46.44 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.037 1.546 . . . . 0.0 110.269 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.437 ' CG2' HG23 ' A' ' 75' ' ' THR . 21.2 t -130.37 -46.79 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 110.249 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.3 -156.17 27.93 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 p -105.59 136.71 44.68 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.185 -1.185 . . . . 0.0 110.35 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' A' ' 44' ' ' ALA . 95.5 t -98.78 160.52 3.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.359 -0.838 . . . . 0.0 109.643 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -153.14 134.82 14.5 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.018 -1.051 . . . . 0.0 110.546 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 67.7 m -95.07 14.16 22.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.982 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.06 -45.16 9.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.258 -0.901 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.2 t -98.84 -16.75 18.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.313 -0.867 . . . . 0.0 110.142 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.59 -143.59 0.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.861 . . . . 0.0 110.195 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.39 155.64 35.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 110.01 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.77 125.27 29.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.289 -0.882 . . . . 0.0 109.904 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 20.6 p30 -134.25 137.06 44.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 110.418 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 104' ' ' HIS . 1.4 tp -108.41 137.19 46.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.687 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.545 ' HA3' ' ND1' ' A' ' 104' ' ' HIS . . . -134.72 159.86 24.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -134.34 156.39 48.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.374 -1.074 . . . . 0.0 110.052 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 32' ' ' TYR . . . 142.42 162.99 9.48 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.449 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 14.1 p-10 -133.49 -151.01 0.43 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.203 -1.175 . . . . 0.0 110.455 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 p -91.7 95.1 9.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.307 -0.871 . . . . 0.0 110.274 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 132.91 -18.45 4.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.872 HD23 ' N ' ' A' ' 101' ' ' ASP . 8.0 tt -154.93 151.42 28.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.172 -1.193 . . . . 0.0 110.442 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.872 ' N ' HD23 ' A' ' 100' ' ' LEU . 1.8 p30 -135.6 162.58 32.31 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.375 -0.828 . . . . 0.0 109.796 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.6 mt -119.57 -85.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.102 -0.999 . . . . 0.0 110.397 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.539 ' C ' ' CD2' ' A' ' 104' ' ' HIS . . . -168.84 -169.24 32.0 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.545 ' ND1' ' HA3' ' A' ' 94' ' ' GLY . 38.1 m-70 -142.74 120.49 11.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -1.134 . . . . 0.0 110.234 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.757 HG11 HG12 ' A' ' 6' ' ' VAL . 85.4 t -89.39 129.12 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -0.877 . . . . 0.0 109.853 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.3 112.12 11.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.044 -1.035 . . . . 0.0 110.434 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.63 HD22 ' CD1' ' A' ' 12' ' ' LEU . 72.0 mt -87.58 172.64 9.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 110.037 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.428 ' OG1' ' C ' ' A' ' 107' ' ' LEU . 1.4 m -162.8 159.64 24.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.286 -0.884 . . . . 0.0 110.117 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.46 ' CE2' ' HG3' ' A' ' 69' ' ' LYS . 15.1 m-85 -129.61 164.16 24.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 110.447 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 CA-C-O 117.948 -1.473 . . . . 0.0 109.5 179.991 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 120.879 0.371 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.532 ' HG2' ' HA ' ' A' ' 102' ' ' LEU . 45.2 Cg_endo -73.02 -157.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.978 1.515 . . . . 0.0 110.283 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -119.52 134.71 55.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.247 -0.908 . . . . 0.0 110.559 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.481 ' HD1' HG22 ' A' ' 22' ' ' VAL . 72.7 t80 -151.51 113.62 4.52 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.424 -0.797 . . . . 0.0 109.858 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.61 156.84 42.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.011 -1.056 . . . . 0.0 111.046 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.007 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 4.4 p -118.91 165.26 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.805 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -74.36 -65.25 0.59 Allowed Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.001 -1.062 . . . . 0.0 110.814 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.726 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 41.9 Cg_endo -71.08 -79.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.559 1.294 . . . . 0.0 110.827 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 1.007 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 70.85 19.33 5.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.205 -0.934 . . . . 0.0 110.0 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 t 178.3 148.78 0.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 110.167 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.49 59.71 9.79 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.505 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 1.2 mt -104.39 178.16 4.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.292 -1.123 . . . . 0.0 110.715 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 16' ' ' GLN . 3.2 m -134.35 142.3 47.17 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.416 -0.803 . . . . 0.0 110.015 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 10.0 p-10 -56.93 106.03 0.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.946 . . . . 0.0 110.272 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.45 -45.1 1.32 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.505 ' OE1' ' HA ' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -47.1 157.62 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -1.107 . . . . 0.0 109.703 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -101.09 178.72 4.58 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.361 -0.837 . . . . 0.0 110.443 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.575 HG11 HG11 ' A' ' 67' ' ' VAL . 5.8 m -146.33 152.83 13.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.547 -0.721 . . . . 0.0 109.428 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.506 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -97.41 140.05 32.43 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 109.986 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.413 HG11 ' CZ ' ' A' ' 63' ' ' PHE . 14.7 t -129.1 149.07 33.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.142 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.89 129.07 17.68 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.492 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.794 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 52.1 t -119.92 143.58 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.601 -0.687 . . . . 0.0 109.755 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -155.65 177.55 11.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.048 -1.033 . . . . 0.0 110.307 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.74 -38.69 3.15 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.575 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -67.32 -151.43 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.16 -1.2 . . . . 0.0 110.673 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.599 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -172.84 159.15 4.08 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.224 -0.922 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.885 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -50.45 125.38 12.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.541 -0.725 . . . . 0.0 110.463 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' O ' ' OE1' ' A' ' 29' ' ' GLU . . . 124.79 13.18 3.79 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 6.5 mm-40 -144.14 120.79 11.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.037 -1.272 . . . . 0.0 110.874 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.421 HG23 ' OG1' ' A' ' 54' ' ' THR . 60.4 m -105.06 132.75 50.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.529 -0.732 . . . . 0.0 109.255 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.852 ' CE1' HD22 ' A' ' 100' ' ' LEU . 31.4 m-85 -120.77 173.86 6.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.956 -1.09 . . . . 0.0 111.246 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -130.27 123.35 29.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.658 -0.651 . . . . 0.0 109.697 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.839 ' CG2' HG23 ' A' ' 51' ' ' THR . 14.3 tt -100.44 125.2 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.131 -0.98 . . . . 0.0 110.651 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.62 146.53 25.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -0.906 . . . . 0.0 110.604 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -98.78 147.69 24.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.854 . . . . 0.0 109.239 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.6 m -144.35 155.9 44.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.028 -1.045 . . . . 0.0 111.512 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.425 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -154.0 141.33 13.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.38 166.19 24.43 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.63 1.332 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.852 HG11 HG22 ' A' ' 84' ' ' VAL . 4.2 m -147.5 172.98 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.312 -0.867 . . . . 0.0 110.591 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -52.77 -46.89 59.56 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.62 -59.23 10.94 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.612 ' H ' HG23 ' A' ' 39' ' ' VAL . 1.4 tt0 -174.48 -75.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.405 -1.056 . . . . 0.0 110.118 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -143.49 150.16 38.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.182 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.451 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -147.82 145.01 28.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.502 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 18.4 m -128.23 178.21 6.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.015 . . . . 0.0 110.236 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.456 ' O ' ' CG ' ' A' ' 46' ' ' ASN . 15.3 p-10 -101.44 106.02 43.5 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 50.2 Cg_endo -88.12 -39.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.773 1.407 . . . . 0.0 110.65 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.98 -4.6 17.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 110.631 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.404 ' OG1' ' HB2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -130.6 25.34 5.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.092 -1.005 . . . . 0.0 110.144 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.06 143.24 29.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.303 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.839 HG23 ' CG2' ' A' ' 33' ' ' ILE . 2.9 t -148.83 162.63 39.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 0.0 109.897 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 96.0 p -134.56 154.53 51.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.166 -0.959 . . . . 0.0 110.452 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 11.2 p90 -145.41 -177.6 5.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.758 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.421 ' OG1' HG23 ' A' ' 30' ' ' THR . 24.1 m -149.69 160.35 43.6 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 110.399 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.575 HG21 ' CB ' ' A' ' 25' ' ' ALA . 2.2 p -77.01 -160.94 0.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.35 -0.844 . . . . 0.0 110.487 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.885 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 16.3 p-10 -158.22 -147.38 0.17 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.953 -1.092 . . . . 0.0 111.115 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.569 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -84.72 71.36 10.83 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.056 0.932 . . . . 0.0 108.985 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER 154.67 -13.56 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.599 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.97 66.12 2.12 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.33 129.37 18.55 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.259 -1.142 . . . . 0.0 110.789 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.794 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -130.17 83.9 2.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 110.007 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.4 m -100.35 123.76 44.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.544 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 6.9 p90 -158.77 176.04 12.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.24 -0.912 . . . . 0.0 110.556 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.2 t -101.66 158.7 15.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.721 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 85.7 t80 -147.02 -176.88 5.38 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.562 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.8 t -133.58 158.46 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.386 -1.446 . . . . 0.0 110.5 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.575 HG11 HG11 ' A' ' 18' ' ' VAL . 20.4 m -130.32 159.75 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.782 . . . . 0.0 109.471 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 13.4 mtm180 -143.63 112.01 6.36 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.373 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 68' ' ' ARG . 4.5 ttpm? -44.72 -50.33 10.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 108.875 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.08 111.02 17.77 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 36.1 p90 -121.26 131.84 54.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.213 -0.929 . . . . 0.0 110.816 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 26.1 m -61.64 124.38 20.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.451 -0.781 . . . . 0.0 110.303 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.4 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -95.69 -166.14 34.7 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -173.66 146.84 1.34 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 110.517 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 77.2 p -96.83 164.17 18.6 Favored Pre-proline 0 C--N 1.304 -1.389 0 O-C-N 121.37 -0.831 . . . . 0.0 110.233 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -81.68 -0.46 10.41 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 124.033 1.544 . . . . 0.0 110.237 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -101.27 29.26 4.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 110.612 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.74 55.59 28.11 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.0 m -153.37 113.55 2.64 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.247 -1.149 . . . . 0.0 110.248 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.67 105.39 1.77 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.959 1.505 . . . . 0.0 110.37 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.53 -11.24 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.179 -0.951 . . . . 0.0 110.028 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.21 -157.67 15.08 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.7 m -96.95 148.35 23.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -1.164 . . . . 0.0 110.069 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.852 HG22 HG11 ' A' ' 39' ' ' VAL . 98.8 t -108.62 102.08 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.231 -0.918 . . . . 0.0 109.904 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.8 OUTLIER -98.82 120.32 39.06 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.417 -0.802 . . . . 0.0 109.575 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.82 37.26 0.58 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 110.717 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.59 -36.83 43.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.166 -0.958 . . . . 0.0 109.3 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.9 t -109.91 -11.5 14.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.433 -0.792 . . . . 0.0 109.48 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.06 -171.15 1.79 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.396 -0.815 . . . . 0.0 110.158 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.19 128.33 49.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.928 . . . . 0.0 110.14 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.1 m -93.78 151.79 19.37 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.102 -0.999 . . . . 0.0 109.861 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -142.88 123.89 14.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 110.694 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.552 HD11 HG12 ' A' ' 33' ' ' ILE . 16.4 tp -92.49 112.65 24.68 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.542 ' HA3' ' NE2' ' A' ' 104' ' ' HIS . . . -115.44 166.67 12.24 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.253 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.709 ' HB1' HD12 ' A' ' 102' ' ' LEU . . . -144.56 162.96 35.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.515 -0.991 . . . . 0.0 110.062 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 130.14 176.06 14.28 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.484 ' OD1' ' HB3' ' A' ' 100' ' ' LEU . 8.3 p-10 -128.89 -156.16 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.249 . . . . 0.0 110.57 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.71 82.25 7.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.536 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 139.8 -35.87 1.88 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.852 HD22 ' CE1' ' A' ' 31' ' ' TYR . 4.7 tt -115.2 145.45 42.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -1.18 . . . . 0.0 110.336 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.8 121.61 32.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 110.061 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.709 HD12 ' HB1' ' A' ' 95' ' ' ALA . 20.2 mt -77.18 -71.49 0.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.929 . . . . 0.0 110.12 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.36 -173.02 42.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.542 ' NE2' ' HA3' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -147.81 112.28 5.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -1.052 . . . . 0.0 109.895 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.427 HG11 ' CG1' ' A' ' 6' ' ' VAL . 17.5 t -96.12 121.74 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.174 -0.954 . . . . 0.0 110.339 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.46 132.76 43.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.102 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.9 mt -104.81 141.57 36.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.258 -0.901 . . . . 0.0 110.478 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 109' ' ' PHE . 8.7 m -119.07 171.39 8.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.858 . . . . 0.0 109.859 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.401 ' N ' HG22 ' A' ' 108' ' ' THR . 8.8 m-85 -147.73 85.98 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.231 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 CA-C-O 118.007 -1.44 . . . . 0.0 109.504 179.91 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.517 ' O ' ' HA3' ' A' ' 24' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.511 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 43.6 Cg_endo -69.22 165.37 30.59 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.105 1.581 . . . . 0.0 110.609 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -155.85 141.9 18.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.202 -0.936 . . . . 0.0 110.718 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.602 ' CE2' ' CB ' ' A' ' 95' ' ' ALA . 25.2 t80 -150.24 116.92 5.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 t -150.41 164.92 34.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.9 -1.125 . . . . 0.0 111.355 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.961 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 4.8 p -122.2 176.16 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.602 -0.686 . . . . 0.0 109.662 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.6 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.3 m -78.19 -67.54 0.26 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.005 -1.059 . . . . 0.0 110.534 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.738 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 42.8 Cg_endo -72.81 -79.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.929 0 O-C-N 123.358 1.188 . . . . 0.0 110.629 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.961 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 72.66 28.37 2.15 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.355 -0.841 . . . . 0.0 110.513 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER 171.05 119.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.19 -0.944 . . . . 0.0 110.231 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.56 66.63 2.02 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 109' ' ' PHE . 1.5 mp -104.02 159.25 15.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -1.168 . . . . 0.0 110.537 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.502 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 29.0 t -107.76 151.3 25.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 110.028 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.4 127.87 33.27 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.225 -0.922 . . . . 0.0 111.164 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.66 -27.64 6.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 2.4 tt0 -52.35 141.89 18.48 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.291 -1.123 . . . . 0.0 110.596 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.54 148.98 22.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.358 -0.839 . . . . 0.0 109.869 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.528 HG12 ' HG3' ' A' ' 8' ' ' PRO . 24.4 m -129.76 179.76 3.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.794 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.19 134.72 55.22 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.382 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.486 HG11 ' CD1' ' A' ' 33' ' ' ILE . 4.8 t -114.94 150.71 16.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -146.91 124.72 11.9 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.096 -1.003 . . . . 0.0 110.865 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 87.0 t -113.04 141.3 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.575 -0.703 . . . . 0.0 109.579 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.712 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -158.64 144.96 17.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.073 . . . . 0.0 110.666 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 1' ' ' ALA . . . 118.85 -54.1 0.64 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.513 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -59.07 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -1.134 . . . . 0.0 109.833 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.544 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.48 169.99 8.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.066 -1.021 . . . . 0.0 110.323 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . -59.97 131.69 51.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.532 -0.73 . . . . 0.0 110.888 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.15 16.25 4.0 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.516 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 65.5 mm-40 -149.24 132.72 16.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.166 -1.196 . . . . 0.0 110.385 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.434 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 3.6 m -104.28 162.96 12.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.354 -0.841 . . . . 0.0 110.13 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.771 ' CE1' HD13 ' A' ' 100' ' ' LEU . 74.8 m-85 -150.84 173.23 14.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.207 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 52.8 m-85 -133.97 102.88 5.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 109.324 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.839 ' CG2' HG23 ' A' ' 51' ' ' THR . 8.5 tt -89.56 107.95 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.941 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.424 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -147.95 157.22 43.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.158 -0.964 . . . . 0.0 110.803 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.509 ' OE1' ' CD1' ' A' ' 107' ' ' LEU . 2.0 tt0 -95.69 123.56 39.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.645 -0.659 . . . . 0.0 109.88 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.429 ' HA ' ' OH ' ' A' ' 71' ' ' TYR . 1.2 m -137.42 154.1 50.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.235 -0.916 . . . . 0.0 110.101 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.522 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -146.59 166.79 15.52 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 0.0 109.247 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 41.4 Cg_endo -69.38 159.03 55.27 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.556 1.293 . . . . 0.0 110.633 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.673 HG12 HG22 ' A' ' 84' ' ' VAL . 16.1 m -144.12 63.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.468 -0.77 . . . . 0.0 110.026 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.88 -29.84 9.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -175.41 -46.77 0.06 OUTLIER Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 5.1 mt-30 -89.24 -166.76 1.68 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.388 -1.066 . . . . 0.0 110.219 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 4.8 p30 -130.7 110.97 11.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 110.34 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.74 157.81 15.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.902 . . . . 0.0 109.755 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.488 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 5.8 t -135.55 165.99 24.24 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.041 -1.037 . . . . 0.0 110.295 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.546 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -83.65 111.65 33.74 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.204 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 48.9 Cg_endo -77.87 -37.53 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.893 1.47 . . . . 0.0 110.32 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.63 98.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.886 . . . . 0.0 110.493 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.48 HG21 ' NE ' ' A' ' 68' ' ' ARG . 1.2 p -96.32 3.38 53.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.261 -0.899 . . . . 0.0 110.425 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -65.85 129.25 39.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.139 -0.975 . . . . 0.0 109.85 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.839 HG23 ' CG2' ' A' ' 33' ' ' ILE . 1.3 t -128.24 131.58 48.78 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.13 -0.982 . . . . 0.0 110.762 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.37 138.14 40.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.445 -0.784 . . . . 0.0 109.393 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 15.8 p90 -141.76 172.21 13.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.051 -1.03 . . . . 0.0 110.547 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.5 m -133.87 162.41 32.11 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 109.375 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.513 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -75.77 -164.74 0.38 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.914 -1.116 . . . . 0.0 110.384 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 27' ' ' ALA . 5.7 m-20 -145.34 -158.31 0.88 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.18 -0.95 . . . . 0.0 109.575 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.27 -50.04 75.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.902 -1.124 . . . . 0.0 109.53 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.4 t -90.36 21.06 4.05 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.349 -0.844 . . . . 0.0 108.813 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.544 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 49.81 32.0 17.39 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.33 140.73 41.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.371 -1.076 . . . . 0.0 110.483 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -145.59 84.96 1.69 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.411 -0.806 . . . . 0.0 109.704 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -99.99 120.95 40.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 109.983 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.2 p90 -150.63 178.39 9.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.223 -0.923 . . . . 0.0 110.831 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.8 p -96.62 139.12 33.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.46 -0.775 . . . . 0.0 111.016 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 50.2 t80 -131.15 176.17 8.49 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.561 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.8 t -124.61 157.09 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 120.727 -1.233 . . . . 0.0 110.299 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 67' ' ' VAL . 13.8 m -134.9 128.35 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.397 -0.814 . . . . 0.0 109.904 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.48 ' NE ' HG21 ' A' ' 49' ' ' THR . 0.0 OUTLIER -115.82 144.38 44.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 110.343 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -56.94 -39.68 75.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.394 -0.816 . . . . 0.0 109.796 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.74 165.54 33.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.418 -0.801 . . . . 0.0 109.828 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.522 ' CB ' ' OD1' ' A' ' 46' ' ' ASN . 19.2 p90 -166.9 147.41 5.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 110.361 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.6 OUTLIER -66.18 118.58 10.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.038 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.48 179.81 25.7 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -160.44 150.14 17.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.287 -1.125 . . . . 0.0 110.055 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 70.6 p -45.34 164.37 0.19 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 44.9 Cg_endo -72.54 -12.39 26.98 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.094 1.576 . . . . 0.0 110.481 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -86.96 -69.75 0.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 110.199 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.62 51.18 0.03 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 m -141.22 126.66 11.01 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.26 -1.141 . . . . 0.0 110.193 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.31 121.63 6.96 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.814 1.428 . . . . 0.0 110.403 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.39 -17.45 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.295 -0.878 . . . . 0.0 110.068 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.34 -159.65 28.5 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 11.5 p -104.44 169.57 8.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.199 -1.177 . . . . 0.0 110.367 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.673 HG22 HG12 ' A' ' 39' ' ' VAL . 72.9 t -133.6 162.04 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.9 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 16.7 p-10 -160.43 161.97 33.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.963 . . . . 0.0 110.302 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 96.7 m -97.95 11.14 38.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.313 -0.867 . . . . 0.0 110.331 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.96 -42.03 14.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.19 -0.944 . . . . 0.0 110.34 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.418 HG22 ' OD2' ' A' ' 85' ' ' ASP . 13.4 t -113.49 -1.08 14.23 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.157 -0.965 . . . . 0.0 110.384 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.51 135.67 44.56 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.241 -0.912 . . . . 0.0 110.61 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.77 105.41 5.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.973 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.487 ' CB ' ' HB2' ' A' ' 37' ' ' ALA . 26.7 p -99.39 140.16 33.98 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.086 -1.009 . . . . 0.0 109.66 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.484 ' OD1' ' HA ' ' A' ' 106' ' ' ALA . 19.1 m-20 -131.05 143.29 50.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.114 -0.991 . . . . 0.0 110.837 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.495 ' HB2' HD11 ' A' ' 107' ' ' LEU . 22.6 tp -88.41 99.41 12.25 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.07 165.45 27.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.731 ' O ' HD12 ' A' ' 102' ' ' LEU . . . -152.28 80.04 1.24 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.412 -1.051 . . . . 0.0 110.386 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -137.25 -167.59 11.12 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.477 ' O ' ' OG ' ' A' ' 98' ' ' SER . 2.2 p-10 -129.4 -63.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.246 . . . . 0.0 110.627 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 97' ' ' ASN . 19.6 m -170.83 -32.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.125 -0.984 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.77 -13.23 5.15 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.712 -1.233 . . . . 0.0 110.411 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.771 HD13 ' CE1' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -94.87 -52.39 4.27 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.972 -1.31 . . . . 0.0 110.532 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.0 p-10 40.61 98.29 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.701 0.762 . . . . 0.0 110.73 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 95' ' ' ALA . 6.7 mt -84.45 -45.44 12.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.016 -1.052 . . . . 0.0 110.104 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.56 -161.82 30.0 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -155.06 142.35 19.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -1.153 . . . . 0.0 110.181 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.47 103.8 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.189 -0.944 . . . . 0.0 110.146 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.484 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . . . -50.62 103.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.893 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.509 ' CD1' ' OE1' ' A' ' 35' ' ' GLN . 54.0 mt -82.83 137.01 34.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 110.144 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.9 167.5 10.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.811 . . . . 0.0 110.092 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 12' ' ' LEU . 3.2 m-85 -142.04 166.83 23.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.927 . . . . 0.0 110.324 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 109' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.35 0 CA-C-O 118.008 -1.44 . . . . 0.0 109.586 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.907 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.497 1.921 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.907 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 48.2 Cg_endo -74.81 -170.78 0.81 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.867 1.456 . . . . 0.0 110.206 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.498 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -145.71 145.75 31.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.078 -1.014 . . . . 0.0 110.302 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 39.0 t80 -151.29 113.04 4.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.226 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.47 151.53 36.56 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.683 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 19' ' ' SER . 9.2 p -128.48 149.19 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.776 . . . . 0.0 109.743 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.596 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -67.27 -66.59 1.14 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.052 -1.03 . . . . 0.0 110.191 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.711 ' HB2' HD21 ' A' ' 12' ' ' LEU . 50.4 Cg_endo -75.65 95.29 1.0 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.46 1.242 . . . . 0.0 110.233 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.83 10.56 32.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.097 -1.002 . . . . 0.0 110.311 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.1 t -168.64 154.54 6.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.899 . . . . 0.0 110.084 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.99 56.49 10.65 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.711 HD21 ' HB2' ' A' ' 8' ' ' PRO . 2.7 mt -109.59 166.05 11.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -1.126 . . . . 0.0 110.15 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -128.53 164.34 23.01 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.237 -0.915 . . . . 0.0 110.28 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -62.26 125.45 23.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.316 -0.865 . . . . 0.0 109.94 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 89.61 -31.05 5.38 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.69 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.5 tm0? -42.4 143.9 0.58 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.417 -1.049 . . . . 0.0 110.014 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.463 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 2.1 p -95.55 167.61 11.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 110.287 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 65' ' ' PHE . 30.6 m -147.82 168.21 4.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.323 -0.861 . . . . 0.0 109.762 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.825 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -117.04 137.68 52.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.161 -0.962 . . . . 0.0 110.242 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 t -126.32 152.57 33.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.444 -0.785 . . . . 0.0 109.81 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.11 127.55 14.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.381 -0.824 . . . . 0.0 110.169 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.795 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 10.9 t -119.28 147.63 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.322 -0.861 . . . . 0.0 110.077 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 3' ' ' ALA . 6.2 p -155.52 131.99 10.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.132 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 131.21 -54.28 0.79 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.803 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -58.73 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -1.123 . . . . 0.0 109.074 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -169.95 156.92 6.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.732 -1.23 . . . . 0.0 110.712 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 26' ' ' ALA . . . -43.85 133.08 5.0 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.7 -0.625 . . . . 0.0 110.133 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 29' ' ' GLU . . . 115.28 11.95 10.26 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 1.8 mt-10 -141.94 116.59 9.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.335 -1.097 . . . . 0.0 110.191 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.2 m -104.21 134.01 48.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.757 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 29' ' ' GLU . 27.4 m-85 -117.88 -174.94 2.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.966 . . . . 0.0 110.81 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 34.5 m-85 -136.07 111.31 9.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.522 -0.736 . . . . 0.0 109.399 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.705 ' CG2' HG23 ' A' ' 51' ' ' THR . 3.8 tt -86.86 112.96 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.888 . . . . 0.0 110.773 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.411 ' C ' HD12 ' A' ' 93' ' ' LEU . . . -148.34 162.95 38.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.533 -0.729 . . . . 0.0 109.887 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . 14.8 pt20 -116.29 146.07 42.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.925 . . . . 0.0 110.718 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.6 m -137.81 150.79 47.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.264 -0.897 . . . . 0.0 110.169 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.992 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.32 173.28 4.44 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.304 -0.873 . . . . 0.0 109.264 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.763 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 41.5 Cg_endo -67.71 165.02 29.03 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.736 1.387 . . . . 0.0 110.123 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 42' ' ' GLN . 15.0 p -134.66 56.13 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.26 21.31 56.53 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.21 -63.18 0.22 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.09 -1.528 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.631 ' O ' HG12 ' A' ' 39' ' ' VAL . 5.4 mm100 -102.69 -160.23 0.77 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.293 -1.122 . . . . 0.0 110.94 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -115.24 122.66 46.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.184 -0.948 . . . . 0.0 110.727 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.473 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -105.79 160.05 15.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.643 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -134.92 162.92 31.05 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.024 -1.047 . . . . 0.0 110.633 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.484 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 3.9 m120 -89.34 115.79 64.65 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.855 . . . . 0.0 110.134 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -90.08 -50.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.896 1.472 . . . . 0.0 111.254 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.98 79.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.389 -0.819 . . . . 0.0 111.52 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 22.4 p -82.7 19.25 1.35 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.09 -1.006 . . . . 0.0 111.108 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -87.1 67.63 9.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.973 -1.08 . . . . 0.0 109.94 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.705 HG23 ' CG2' ' A' ' 33' ' ' ILE . 2.6 t -79.82 164.34 23.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.359 -0.838 . . . . 0.0 110.432 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 94.2 p -118.44 143.39 46.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.289 -0.882 . . . . 0.0 110.769 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.472 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 31.0 p90 -140.55 128.88 22.49 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.274 -0.891 . . . . 0.0 109.962 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 9.3 m -92.15 168.57 11.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 110.829 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.803 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -78.1 -158.89 0.14 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.465 -0.772 . . . . 0.0 110.339 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.37 -161.71 1.23 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.058 -1.026 . . . . 0.0 109.916 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.27 -53.81 54.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.023 -1.048 . . . . 0.0 109.158 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.4 p -84.41 11.36 8.67 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.472 -0.767 . . . . 0.0 109.075 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.533 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 69.91 13.42 69.34 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.21 121.28 28.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -1.123 . . . . 0.0 110.02 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.795 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -118.25 80.79 1.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.977 . . . . 0.0 110.499 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.82 129.63 48.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -0.972 . . . . 0.0 109.924 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 14.8 p90 -168.19 161.49 12.38 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.458 -0.776 . . . . 0.0 110.358 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 m -92.33 133.57 35.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.198 -0.939 . . . . 0.0 110.624 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.81 ' O ' HG22 ' A' ' 18' ' ' VAL . 29.2 t80 -121.73 155.35 35.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 109.323 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.573 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 3.5 t -96.96 160.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.805 -1.184 . . . . 0.0 110.521 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 16' ' ' GLN . 29.7 m -131.77 177.24 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 0.0 109.989 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 2.3 mtt180 -150.35 135.69 17.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 0.0 110.501 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 87' ' ' ALA . 0.9 OUTLIER -67.67 -16.88 64.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -0.961 . . . . 0.0 109.234 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.8 p -150.34 156.39 41.43 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.56 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 16.7 p90 -163.72 144.1 8.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.981 -1.074 . . . . 0.0 110.54 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 28.5 m -65.89 132.93 49.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.892 . . . . 0.0 110.026 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.403 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -112.69 -177.59 19.74 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.9 p -172.72 160.15 4.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -1.181 . . . . 0.0 110.188 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 79' ' ' THR . 82.6 p -87.69 158.92 50.39 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.277 -0.889 . . . . 0.0 110.361 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -79.14 4.62 6.4 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 124.186 1.624 . . . . 0.0 110.143 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -99.49 27.98 4.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.297 -0.877 . . . . 0.0 110.343 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.63 49.67 76.08 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.402 ' O ' ' OG1' ' A' ' 75' ' ' THR . 22.7 m -155.18 110.73 2.27 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.221 -1.164 . . . . 0.0 110.311 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.46 124.69 10.57 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.987 1.52 . . . . 0.0 110.131 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 p -95.48 -13.43 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.424 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.39 -155.43 24.65 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.8 m -113.54 176.06 5.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.301 -1.117 . . . . 0.0 110.46 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.473 HG21 ' CB ' ' A' ' 44' ' ' ALA . 54.6 t -128.97 162.27 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.455 -0.778 . . . . 0.0 110.044 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.431 ' N ' HG12 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -138.73 102.06 4.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.218 -0.926 . . . . 0.0 110.46 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 2.7 m -74.52 -2.63 26.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.298 -0.876 . . . . 0.0 110.232 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 69' ' ' LYS . . . -46.72 -45.25 19.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.192 -0.942 . . . . 0.0 109.906 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.1 t -116.69 -10.81 11.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.908 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 86' ' ' CYS . . . -94.09 -177.27 4.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.116 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.61 131.84 53.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.903 . . . . 0.0 110.068 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.992 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -127.29 139.49 52.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' A' ' 106' ' ' ALA . 16.0 m-80 -103.85 125.81 50.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.973 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.849 ' HB2' HD11 ' A' ' 107' ' ' LEU . 11.7 tp -88.7 101.96 14.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 109.817 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -108.12 171.57 16.17 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -156.67 120.98 4.43 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.437 -1.037 . . . . 0.0 110.297 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.37 176.36 47.95 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -115.8 -76.89 0.57 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -1.135 . . . . 0.0 109.849 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -168.19 -37.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.408 -0.808 . . . . 0.0 110.097 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.38 -12.14 57.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.637 HD13 ' C ' ' A' ' 100' ' ' LEU . 2.2 tm? -148.5 90.17 1.77 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -1.161 . . . . 0.0 110.053 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.18 134.86 34.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.478 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 4' ' ' PHE . 71.0 mt -82.69 -70.76 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 0.0 110.034 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.415 ' C ' ' CG ' ' A' ' 104' ' ' HIS . . . 168.38 -162.3 36.07 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.459 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -147.96 129.22 14.7 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.482 -1.011 . . . . 0.0 109.612 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.76 HG11 HG12 ' A' ' 6' ' ' VAL . 93.5 t -98.3 108.48 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.092 -1.005 . . . . 0.0 110.6 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.4 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . . . -57.53 105.51 0.25 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.234 -0.916 . . . . 0.0 110.024 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.849 HD11 ' HB2' ' A' ' 93' ' ' LEU . 59.4 mt -82.64 164.51 20.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.24 -0.912 . . . . 0.0 110.374 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.5 m -133.15 168.13 19.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.391 -0.818 . . . . 0.0 110.267 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -153.33 167.35 29.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 CA-C-O 117.949 -1.473 . . . . 0.0 109.522 179.988 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.816 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.765 0.316 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 45.3 Cg_endo -73.42 -175.9 2.24 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.892 1.469 . . . . 0.0 110.144 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.893 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -134.4 134.98 42.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.047 -1.033 . . . . 0.0 110.581 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 8.1 t80 -141.24 115.45 9.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.468 -0.77 . . . . 0.0 109.531 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.589 ' HA ' HG21 ' A' ' 105' ' ' VAL . 4.0 t -153.1 172.54 16.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.077 -1.014 . . . . 0.0 110.811 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.999 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 12.0 p -120.8 144.97 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.662 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.583 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -54.66 -62.22 4.46 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.276 -0.89 . . . . 0.0 111.082 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.864 ' HD2' HG22 ' A' ' 6' ' ' VAL . 42.5 Cg_endo -71.85 -78.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.781 1.411 . . . . 0.0 110.629 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.999 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 69.13 14.68 8.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.015 . . . . 0.0 109.879 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.4 t -170.77 148.24 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.336 -0.852 . . . . 0.0 110.297 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.02 56.87 22.28 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.573 ' HB2' ' CE1' ' A' ' 109' ' ' PHE . 58.6 mt -98.28 166.47 11.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -1.129 . . . . 0.0 110.091 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.468 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -129.49 155.65 45.39 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.223 -0.923 . . . . 0.0 110.108 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.526 ' OD2' ' CD ' ' A' ' 68' ' ' ARG . 6.9 t70 -61.68 115.97 4.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 110.387 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 94.24 -28.45 10.79 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 0.2 OUTLIER -41.75 144.02 0.45 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.31 -1.112 . . . . 0.0 110.483 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 p -95.35 125.49 40.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.826 . . . . 0.0 110.193 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.667 HG11 HG11 ' A' ' 67' ' ' VAL . 35.7 m -104.38 -179.07 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.387 -0.82 . . . . 0.0 110.184 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -136.14 114.61 11.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.786 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.4 t -91.4 152.79 3.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.405 -0.81 . . . . 0.0 110.483 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 t -147.41 130.89 16.71 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.474 -0.766 . . . . 0.0 109.331 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.986 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 87.9 t -128.54 136.56 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.111 -0.993 . . . . 0.0 110.671 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.548 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 3.3 m -131.51 110.54 11.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.421 -0.799 . . . . 0.0 109.873 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 155.5 -58.14 0.39 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.868 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -57.9 -159.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -1.175 . . . . 0.0 109.664 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.562 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -166.21 159.45 15.14 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.899 -1.126 . . . . 0.0 111.014 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -42.06 136.98 1.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.717 -0.614 . . . . 0.0 110.576 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.41 -6.95 42.6 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.489 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 3.3 mm-40 -114.09 103.52 11.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -1.142 . . . . 0.0 110.26 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 53' ' ' PHE . 97.1 m -103.82 121.24 42.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.314 -0.866 . . . . 0.0 109.627 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.683 ' OH ' ' HB1' ' A' ' 25' ' ' ALA . 9.9 m-85 -107.0 -170.19 1.67 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 0.0 110.662 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 50.0 m-85 -131.58 111.54 11.83 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.491 -0.755 . . . . 0.0 109.505 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.479 HG22 HG23 ' A' ' 51' ' ' THR . 1.1 tt -89.63 137.06 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.074 -1.016 . . . . 0.0 111.215 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.402 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -153.83 155.06 35.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.497 -0.752 . . . . 0.0 110.267 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -98.59 146.7 25.56 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.224 -0.923 . . . . 0.0 110.463 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 t -156.69 145.5 20.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.094 -1.004 . . . . 0.0 111.186 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -147.23 142.08 16.54 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.09 165.33 32.25 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 O-C-N 123.73 1.384 . . . . 0.0 110.79 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 39' ' ' VAL . 18.7 m -122.68 54.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.435 -0.79 . . . . 0.0 109.719 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 45.06 41.35 7.66 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 167.72 -69.29 0.17 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.646 -1.264 . . . . 0.0 109.984 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.5 ' NE2' HG11 ' A' ' 81' ' ' VAL . 37.3 mt-30 -104.89 -164.54 1.05 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.323 -1.104 . . . . 0.0 110.59 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -116.32 143.02 46.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.402 -0.811 . . . . 0.0 110.073 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -130.26 120.59 24.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.138 -0.976 . . . . 0.0 110.022 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.34 155.58 30.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.98 -1.075 . . . . 0.0 110.707 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -106.61 119.88 50.2 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.434 -0.791 . . . . 0.0 109.8 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -80.35 -22.81 6.65 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.882 1.464 . . . . 0.0 110.692 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.61 -37.82 85.68 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.192 -0.943 . . . . 0.0 110.593 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.9 p -91.99 23.08 3.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.24 -0.912 . . . . 0.0 110.489 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 82.37 4.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 110.567 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.479 HG23 HG22 ' A' ' 33' ' ' ILE . 4.0 t -106.7 170.37 7.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.893 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.545 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 52.8 p -118.46 147.68 43.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.027 -1.046 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.546 ' CE1' ' HB2' ' A' ' 31' ' ' TYR . 5.5 p90 -148.24 -179.19 6.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 109.006 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.405 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 3.1 t -157.33 170.93 21.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.875 -1.14 . . . . 0.0 110.928 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.868 HG21 ' HB3' ' A' ' 25' ' ' ALA . 1.5 p -81.03 -155.66 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.461 -0.774 . . . . 0.0 109.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.638 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 4.1 p-10 -157.22 -153.62 0.42 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.728 -1.232 . . . . 0.0 110.803 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 -60.61 3.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.079 -1.013 . . . . 0.0 109.947 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -66.37 -6.76 15.43 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.89 7.23 69.69 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -91.55 119.28 31.34 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.137 -1.213 . . . . 0.0 110.176 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.986 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -92.61 82.27 4.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.893 . . . . 0.0 109.862 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.68 124.47 51.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.28 -0.888 . . . . 0.0 109.897 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -162.78 172.55 15.05 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.675 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.0 t -95.26 130.04 42.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.343 -0.848 . . . . 0.0 110.44 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 91.1 t80 -122.01 172.82 7.95 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.584 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -116.13 152.99 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.622 -1.298 . . . . 0.0 109.945 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.667 HG11 HG11 ' A' ' 18' ' ' VAL . 36.0 m -134.33 169.26 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.2 -0.938 . . . . 0.0 110.597 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.526 ' CD ' ' OD2' ' A' ' 14' ' ' ASP . 2.0 mmm-85 -139.59 164.64 29.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.823 . . . . 0.0 109.824 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -93.42 -54.04 3.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.177 -0.952 . . . . 0.0 110.04 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.01 129.27 47.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.288 -0.883 . . . . 0.0 109.88 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 10.0 p90 -138.23 139.88 39.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 0.0 110.492 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -65.72 114.84 5.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 110.032 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.527 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -85.07 170.65 45.49 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 95.7 p -162.47 177.1 9.79 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -1.166 . . . . 0.0 110.574 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.538 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 2.0 p -86.09 172.93 7.57 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.443 -0.786 . . . . 0.0 109.913 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.538 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 46.6 Cg_endo -75.36 11.69 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.727 1.383 . . . . 0.0 111.204 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.12 -27.37 3.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.85 63.9 0.11 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.14 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.501 ' HB ' ' OG1' ' A' ' 75' ' ' THR . 29.9 m -159.6 107.95 1.48 Allowed Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.165 -1.197 . . . . 0.0 110.087 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 44.6 Cg_endo -71.46 110.43 2.86 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.053 1.554 . . . . 0.0 110.855 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.5 HG11 ' NE2' ' A' ' 42' ' ' GLN . 23.3 t -74.58 -30.0 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.909 . . . . 0.0 109.53 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.1 153.11 9.53 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -63.25 142.63 58.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.17 -1.194 . . . . 0.0 110.185 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.532 HG11 ' CZ ' ' A' ' 71' ' ' TYR . 36.7 t -105.45 137.75 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.818 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.895 ' OD2' ' HB3' ' A' ' 87' ' ' ALA . 6.7 t70 -134.21 135.6 43.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.096 -1.002 . . . . 0.0 110.001 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -86.07 -4.75 59.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.895 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . . . -65.27 -62.28 1.63 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.304 -0.872 . . . . 0.0 110.652 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.0 t -92.23 3.56 55.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.937 . . . . 0.0 110.46 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 85' ' ' ASP . . . -132.36 -176.4 4.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.16 -0.962 . . . . 0.0 110.094 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.87 141.38 51.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 110.172 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 61.8 m -106.85 171.78 7.18 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.907 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -151.22 119.35 6.29 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.305 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.534 ' HB2' HD11 ' A' ' 107' ' ' LEU . 21.7 tp -94.12 101.65 13.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -108.27 167.24 13.18 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.375 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -147.61 160.26 42.86 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.653 -0.91 . . . . 0.0 109.715 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.57 173.99 44.41 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.957 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 31' ' ' TYR . 24.7 t30 -141.0 169.21 18.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.447 -1.031 . . . . 0.0 110.031 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.91 84.42 0.32 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.243 -0.911 . . . . 0.0 110.426 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.37 -19.43 5.67 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.448 ' HA ' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -146.85 99.6 3.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.002 -1.293 . . . . 0.0 110.881 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.468 ' O ' HD23 ' A' ' 102' ' ' LEU . 6.6 m-20 -92.66 -173.21 3.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.273 -0.892 . . . . 0.0 109.814 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 101' ' ' ASP . 84.4 mt -142.54 -86.36 0.15 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.027 -1.045 . . . . 0.0 110.711 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.552 ' C ' ' CD2' ' A' ' 104' ' ' HIS . . . -178.74 -169.73 39.8 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.552 ' CD2' ' C ' ' A' ' 103' ' ' GLY . 9.0 m-70 -133.76 140.4 46.93 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.227 -1.161 . . . . 0.0 110.852 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' A' ' 5' ' ' SER . 0.9 OUTLIER -97.75 121.3 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.66 103.79 2.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.812 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 93' ' ' LEU . 68.4 mt -75.16 170.54 15.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.367 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.76 149.12 44.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 110.374 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 12' ' ' LEU . 1.3 m-85 -139.17 91.05 2.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.116 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 120.745 0.307 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.51 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 44.8 Cg_endo -74.29 -157.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.954 1.502 . . . . 0.0 110.131 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -137.3 93.6 2.84 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.935 -1.103 . . . . 0.0 111.281 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -112.62 106.04 14.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.071 -1.018 . . . . 0.0 109.614 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.9 m -151.08 155.82 39.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.944 -1.098 . . . . 0.0 111.112 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.847 HG22 ' HD2' ' A' ' 8' ' ' PRO . 7.5 p -109.41 160.55 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.467 -0.771 . . . . 0.0 109.708 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.582 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -80.16 -59.55 0.53 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.052 . . . . 0.0 110.206 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.847 ' HD2' HG22 ' A' ' 6' ' ' VAL . 54.0 Cg_endo -80.22 74.43 5.55 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.629 1.331 . . . . 0.0 110.38 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.98 -14.42 60.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.019 -1.05 . . . . 0.0 110.065 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.0 m -138.98 178.86 6.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 110.057 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.58 45.64 76.74 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.507 HD21 ' O ' ' A' ' 8' ' ' PRO . 21.5 mt -89.34 159.81 17.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -1.085 . . . . 0.0 110.192 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -129.63 145.91 51.46 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.318 -0.864 . . . . 0.0 110.212 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 69' ' ' LYS . 13.1 p-10 -57.21 111.18 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.44 -32.92 6.99 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 55.5 tt0 -49.0 155.49 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -1.163 . . . . 0.0 110.383 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.54 ' O ' HG13 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -97.04 -178.16 4.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.371 -0.831 . . . . 0.0 110.568 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.843 HG22 ' O ' ' A' ' 65' ' ' PHE . 25.1 m -156.57 170.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.511 -0.743 . . . . 0.0 109.508 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 m -120.06 123.85 44.42 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.945 -1.097 . . . . 0.0 110.688 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.6 143.01 22.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.441 -0.787 . . . . 0.0 109.657 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.47 133.8 33.19 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.795 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 56.7 t -123.35 111.9 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.464 -0.773 . . . . 0.0 109.913 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.3 OUTLIER -130.22 116.09 17.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.105 -0.997 . . . . 0.0 110.487 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 150.04 -29.57 1.11 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.425 ' HB1' HG21 ' A' ' 55' ' ' THR . . . -79.95 -147.27 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -1.136 . . . . 0.0 110.195 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.565 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -175.19 142.17 0.6 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.027 -1.046 . . . . 0.0 111.145 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.05 132.1 1.03 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.414 0.626 . . . . 0.0 110.699 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.443 ' O ' ' OE2' ' A' ' 29' ' ' GLU . . . 118.35 6.1 12.28 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' OE2' ' O ' ' A' ' 28' ' ' GLY . 53.1 mm-40 -140.11 119.28 12.8 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.217 -1.166 . . . . 0.0 110.521 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.51 HG23 ' OG1' ' A' ' 54' ' ' THR . 5.2 m -101.32 133.84 45.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.43 -0.794 . . . . 0.0 109.491 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.614 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . 39.0 m-85 -121.15 -172.52 2.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.085 -1.009 . . . . 0.0 111.032 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.506 ' CD1' ' HB2' ' A' ' 52' ' ' SER . 68.0 m-85 -130.25 160.63 33.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.607 -0.683 . . . . 0.0 109.633 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 33' ' ' ILE . 4.5 tt -145.66 116.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.067 -1.021 . . . . 0.0 110.391 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.825 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -151.35 169.95 20.72 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.151 -0.968 . . . . 0.0 111.052 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -104.15 160.08 15.15 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.515 -0.741 . . . . 0.0 109.386 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -160.98 141.53 11.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.021 -1.05 . . . . 0.0 111.385 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -140.51 154.53 69.45 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.98 164.59 34.2 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.622 1.327 . . . . 0.0 111.121 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 42' ' ' GLN . 11.6 m -136.62 55.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.661 0.743 . . . . 0.0 109.919 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.89 -22.64 8.96 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -179.76 -39.47 0.07 OUTLIER Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.674 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.868 ' O ' HG22 ' A' ' 39' ' ' VAL . 2.4 mm-40 -91.68 168.1 11.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.957 -1.319 . . . . 0.0 110.419 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.39 139.14 32.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.094 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.877 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -129.99 130.2 44.71 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -117.8 159.57 22.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 110.276 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.47 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 6.0 t-20 -90.77 117.51 67.99 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 0.0 110.363 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -81.19 -34.11 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.855 1.45 . . . . 0.0 110.636 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.71 95.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.255 -0.903 . . . . 0.0 110.342 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.47 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 6.4 p -88.31 20.71 3.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.364 -0.835 . . . . 0.0 110.063 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.23 132.25 37.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.0 110.086 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.58 HG23 ' CG2' ' A' ' 33' ' ' ILE . 9.8 t -161.96 159.05 26.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.297 -0.877 . . . . 0.0 109.983 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.506 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 33.5 t -127.99 161.23 29.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.188 -0.945 . . . . 0.0 110.431 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.614 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 33.8 p90 -146.99 -176.41 5.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.294 -0.879 . . . . 0.0 110.381 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.51 ' OG1' HG23 ' A' ' 30' ' ' THR . 29.3 m -141.48 154.08 45.32 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.502 ' HB ' ' HA2' ' A' ' 59' ' ' GLY . 43.1 p -63.24 -150.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.067 -1.02 . . . . 0.0 110.429 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.783 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -152.5 -161.03 1.22 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.187 -0.946 . . . . 0.0 110.292 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.63 -53.38 58.15 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 109.176 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 p -87.95 15.9 6.65 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 62.41 39.05 97.28 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -117.09 106.17 13.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -1.087 . . . . 0.0 110.231 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.506 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -107.06 89.73 3.09 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.505 -0.747 . . . . 0.0 110.094 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.6 p -112.01 128.42 56.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.819 . . . . 0.0 109.554 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -153.08 176.38 11.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.126 -0.984 . . . . 0.0 110.824 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 p -94.59 141.43 28.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.33 -0.856 . . . . 0.0 110.521 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.843 ' O ' HG22 ' A' ' 18' ' ' VAL . 75.0 t80 -133.36 162.35 32.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.458 -0.777 . . . . 0.0 109.575 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.476 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 21.6 t -112.13 168.19 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 120.731 -1.231 . . . . 0.0 110.801 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.633 HG11 HG11 ' A' ' 18' ' ' VAL . 25.1 m -138.08 174.99 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.401 -0.812 . . . . 0.0 110.382 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -148.88 145.81 27.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.31 -0.868 . . . . 0.0 110.121 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 3.2 ttpt -65.8 -51.49 58.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.995 . . . . 0.0 109.464 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.433 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 96.0 p -135.45 165.86 24.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 109.617 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.732 ' CZ ' HG11 ' A' ' 84' ' ' VAL . 37.7 p90 -170.26 150.96 3.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.086 -1.009 . . . . 0.0 110.223 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -68.52 113.39 6.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.225 -0.922 . . . . 0.0 110.094 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.877 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -59.24 -175.79 0.82 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 12.1 m -140.69 -173.67 3.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -1.11 . . . . 0.0 110.62 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.519 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 3.0 p -106.68 170.17 6.01 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.565 -0.709 . . . . 0.0 110.028 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 39.2 Cg_endo -64.83 -11.19 28.18 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.775 1.408 . . . . 0.0 109.843 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -88.31 -33.61 17.96 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.484 -0.76 . . . . 0.0 109.543 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 120.7 41.44 0.53 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.0 m -136.25 126.53 16.37 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.262 -1.14 . . . . 0.0 110.685 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 44.2 Cg_endo -72.89 120.52 6.69 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.971 1.511 . . . . 0.0 110.245 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.554 HG13 ' N ' ' A' ' 82' ' ' GLY . 7.3 p -141.84 -43.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.216 -0.928 . . . . 0.0 110.42 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.554 ' N ' HG13 ' A' ' 81' ' ' VAL . . . -90.78 155.44 23.87 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.3 p -93.13 153.23 18.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.379 -1.071 . . . . 0.0 110.209 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.732 HG11 ' CZ ' ' A' ' 71' ' ' TYR . 5.9 t -141.39 156.99 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.333 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.794 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 23.8 m-20 -146.68 149.43 33.46 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.433 -0.792 . . . . 0.0 109.789 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 68.8 m -114.35 -13.8 12.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.85 -56.59 16.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.233 -0.917 . . . . 0.0 110.816 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.471 ' H ' HG22 ' A' ' 88' ' ' THR . 3.3 t -100.74 -13.02 18.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.065 -1.022 . . . . 0.0 110.784 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' A' ' 85' ' ' ASP . . . -91.32 -141.98 0.18 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.254 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.38 82.98 0.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.906 . . . . 0.0 109.781 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.683 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 28.1 p -97.34 164.82 12.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.109 -0.994 . . . . 0.0 110.436 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 92' ' ' ASN . 2.2 m120 -141.47 166.52 24.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 110.031 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.825 HD12 ' O ' ' A' ' 34' ' ' ALA . 5.7 tp -116.01 127.25 54.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 109.603 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.602 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -118.31 157.71 15.08 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -141.73 140.79 33.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -1.107 . . . . 0.0 110.086 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 139.42 163.69 9.6 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -124.29 -156.99 0.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.23 -1.159 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.8 t -90.14 36.81 0.88 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.905 . . . . 0.0 110.404 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -141.4 -50.19 0.05 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.6 HD13 ' OH ' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -135.13 89.38 2.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.196 -1.179 . . . . 0.0 110.409 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.02 158.34 11.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.158 -0.963 . . . . 0.0 109.814 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.495 HD23 ' HG3' ' A' ' 2' ' ' PRO . 91.8 mt -121.52 -84.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 110.432 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.98 -177.37 38.67 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.005 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.602 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 27.5 m-70 -139.92 113.56 8.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.571 -0.958 . . . . 0.0 109.887 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.59 HG11 HG12 ' A' ' 6' ' ' VAL . 18.0 t -88.25 161.55 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 109.836 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.81 134.21 49.3 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.157 -0.964 . . . . 0.0 110.122 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.609 HD11 ' HB2' ' A' ' 93' ' ' LEU . 58.1 mt -105.48 147.45 28.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.236 -0.915 . . . . 0.0 110.432 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.97 159.68 42.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.408 -0.808 . . . . 0.0 109.824 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.491 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 42.3 m-85 -128.17 156.18 43.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.562 179.986 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 120.729 0.299 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.51 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 47.4 Cg_endo -73.68 -165.9 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.011 1.532 . . . . 0.0 110.353 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -151.53 109.45 3.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.085 -1.01 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -108.36 115.83 30.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.6 m -146.13 151.84 38.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.894 -1.129 . . . . 0.0 111.159 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.831 HG22 ' HD2' ' A' ' 8' ' ' PRO . 9.8 p -115.97 151.8 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.467 -0.771 . . . . 0.0 109.473 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.614 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -77.22 -57.87 1.05 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.923 -1.111 . . . . 0.0 110.411 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.831 ' HD2' HG22 ' A' ' 6' ' ' VAL . 54.9 Cg_endo -86.55 68.81 4.48 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.538 1.283 . . . . 0.0 110.334 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.38 -20.35 65.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 109.811 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.5 p -142.76 130.04 21.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.434 -0.791 . . . . 0.0 110.239 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.19 47.56 0.99 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -108.15 172.03 7.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -1.097 . . . . 0.0 110.221 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 t -148.08 164.28 34.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.94 . . . . 0.0 110.343 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.462 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 23.9 t70 -64.85 123.39 19.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 110.137 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.78 -30.42 7.96 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 12' ' ' LEU . 47.1 tt0 -58.75 146.83 35.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -1.119 . . . . 0.0 110.207 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.3 p -90.35 179.51 5.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 110.539 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.66 HG23 ' HB3' ' A' ' 65' ' ' PHE . 5.3 m -149.41 160.66 5.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.504 -0.747 . . . . 0.0 109.83 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 7' ' ' SER . 14.0 m -112.04 118.49 35.57 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.949 -1.094 . . . . 0.0 110.107 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 t -109.06 147.95 13.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 110.073 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.7 t -142.28 129.06 20.51 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.482 -0.761 . . . . 0.0 110.159 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 12.2 t -118.55 107.67 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.368 -0.832 . . . . 0.0 110.024 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.4 OUTLIER -111.92 141.42 45.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.271 -0.893 . . . . 0.0 110.567 179.989 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 122.0 -74.11 0.36 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.503 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -54.79 145.14 20.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -1.178 . . . . 0.0 109.707 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.574 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -118.47 157.8 26.54 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.102 -0.999 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -34.07 136.24 0.13 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.506 0.669 . . . . 0.0 110.819 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.39 1.93 12.2 Favored Glycine 0 C--N 1.295 -1.74 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 1.0 OUTLIER -137.52 129.01 28.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.324 -1.104 . . . . 0.0 110.189 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.518 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 89.0 m -107.22 146.68 31.1 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.525 -0.734 . . . . 0.0 109.815 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 29' ' ' GLU . 13.2 m-85 -133.09 169.09 17.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.129 -0.982 . . . . 0.0 110.728 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CD2' ' HB3' ' A' ' 52' ' ' SER . 19.4 m-85 -128.64 106.87 9.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 109.539 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.612 ' CG2' HG23 ' A' ' 51' ' ' THR . 18.1 tt -89.54 136.61 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.255 -0.903 . . . . 0.0 110.845 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.65 177.84 9.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.334 -0.854 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.553 ' HB2' HD12 ' A' ' 93' ' ' LEU . 55.5 tt0 -134.73 150.72 50.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.307 -0.871 . . . . 0.0 109.964 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 69.5 m -150.95 163.44 38.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.102 -0.999 . . . . 0.0 111.224 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.564 ' HB3' ' OH ' ' A' ' 71' ' ' TYR . . . -153.1 152.49 28.07 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.791 -0.568 . . . . 0.0 109.709 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.57 172.15 16.31 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.802 1.422 . . . . 0.0 110.339 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 44' ' ' ALA . 16.0 m -138.15 55.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.929 -1.107 . . . . 0.0 110.589 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.94 24.9 74.42 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.91 -57.45 0.47 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.045 -1.55 . . . . 0.0 111.142 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -88.56 -164.47 1.13 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.118 -1.225 . . . . 0.0 110.667 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -122.32 155.63 35.57 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.473 -0.767 . . . . 0.0 110.496 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.717 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -150.21 118.75 6.5 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 109.094 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.1 m -108.9 162.03 14.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.971 -1.08 . . . . 0.0 111.089 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -111.52 92.98 17.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.432 -0.792 . . . . 0.0 109.746 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.98 -12.52 32.63 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.047 1.551 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.31 -31.83 71.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.133 -0.98 . . . . 0.0 110.178 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 p -97.15 8.63 44.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 110.149 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.14 110.53 5.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.409 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.612 HG23 ' CG2' ' A' ' 33' ' ' ILE . 1.1 t -129.03 140.38 51.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 110.054 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.496 ' HB3' ' CD2' ' A' ' 32' ' ' TYR . 6.9 p -109.21 148.51 30.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.173 -0.955 . . . . 0.0 110.227 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 22.7 p90 -148.06 -177.13 5.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.0 110.177 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 55' ' ' THR . 25.4 m -137.62 153.05 49.94 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 110.091 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 3.3 p -56.85 -159.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.179 -0.951 . . . . 0.0 110.142 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 45.3 m-20 -146.89 -161.81 1.41 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.936 -1.103 . . . . 0.0 110.599 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.31 -51.02 70.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.28 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.93 12.35 7.66 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.574 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 60.25 20.09 53.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.75 110.16 22.26 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -1.114 . . . . 0.0 110.22 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.678 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -101.36 90.95 4.27 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.541 -0.724 . . . . 0.0 109.417 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 p -103.48 115.08 29.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 109.548 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.546 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 15.1 p90 -147.74 171.06 16.26 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.395 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.9 155.3 17.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 0.0 110.84 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.66 ' HB3' HG23 ' A' ' 18' ' ' VAL . 90.0 t80 -140.32 176.78 8.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.483 -0.76 . . . . 0.0 108.971 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.578 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -128.35 154.56 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.576 -1.328 . . . . 0.0 110.442 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 67' ' ' VAL . 29.4 m -129.87 125.8 61.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.526 -0.734 . . . . 0.0 109.85 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -111.73 116.55 30.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 110.407 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 14' ' ' ASP . 29.6 ttpt -56.76 -55.95 27.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.615 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.4 m -99.57 130.03 45.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.828 . . . . 0.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.564 ' OH ' ' HB3' ' A' ' 37' ' ' ALA . 33.9 p90 -155.3 131.08 9.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -0.878 . . . . 0.0 109.982 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.4 m -54.58 134.41 46.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.118 -0.989 . . . . 0.0 110.394 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.717 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -115.47 167.32 12.35 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.52 ' CB ' ' HA ' ' A' ' 80' ' ' PRO . 59.6 p -173.83 83.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.028 -1.278 . . . . 0.0 110.564 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.633 ' HB ' ' CD ' ' A' ' 76' ' ' PRO . 25.0 p 37.63 -147.8 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.414 0 O-C-N 121.613 -0.679 . . . . 0.0 109.454 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.633 ' CD ' ' HB ' ' A' ' 75' ' ' THR . 43.9 Cg_endo -72.2 -51.8 0.2 Allowed 'Trans proline' 0 C--O 1.214 -0.712 0 CA-C-N 119.224 0.758 . . . . 0.0 110.571 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 6.7 tt0 179.66 77.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.213 -0.93 . . . . 0.0 110.182 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.8 -15.01 0.07 OUTLIER Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.342 -1.409 . . . . 0.0 111.197 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.402 ' HB ' HG21 ' A' ' 75' ' ' THR . 97.9 m -135.87 107.63 9.79 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.552 -1.558 . . . . 0.0 111.213 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.52 ' HA ' ' CB ' ' A' ' 74' ' ' SER . 48.9 Cg_endo -76.94 119.85 5.24 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.066 1.561 . . . . 0.0 109.976 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 m -103.52 -12.52 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.083 -1.01 . . . . 0.0 110.565 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.92 -174.04 27.77 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.5 p -90.98 160.97 15.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -1.165 . . . . 0.0 110.156 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.437 HG21 ' HB1' ' A' ' 44' ' ' ALA . 34.4 t -121.44 157.83 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.129 -0.982 . . . . 0.0 110.424 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 85' ' ' ASP . 39.6 p-10 -152.06 118.28 5.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.854 . . . . 0.0 110.052 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.3 m -90.58 32.31 0.98 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.165 -0.959 . . . . 0.0 110.306 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.1 87.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.213 -0.93 . . . . 0.0 109.983 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -130.67 6.16 4.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.51 -159.17 0.59 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.846 . . . . 0.0 109.811 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -115.49 120.38 39.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.51 141.0 44.24 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.77 144.1 29.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.062 -1.023 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.553 HD12 ' HB2' ' A' ' 35' ' ' GLN . 0.4 OUTLIER -123.58 135.39 53.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.646 -0.659 . . . . 0.0 109.254 179.956 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.95 177.02 21.7 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.223 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -151.68 170.82 18.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.452 -1.028 . . . . 0.0 109.986 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.413 ' HA2' ' HG ' ' A' ' 102' ' ' LEU . . . 150.76 159.3 8.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 99' ' ' GLY . 21.0 t30 -119.2 158.18 26.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -1.177 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.78 92.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.067 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 97' ' ' ASN . . . 124.02 -45.33 1.19 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -91.47 132.11 36.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -1.129 . . . . 0.0 110.202 179.914 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.679 ' N ' HD13 ' A' ' 100' ' ' LEU . 5.8 m-20 -105.8 144.65 32.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 110.191 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 101' ' ' ASP . 21.1 mt -122.36 -75.14 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.162 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 159.38 -179.72 34.78 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.591 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 0.0 OUTLIER -145.72 128.74 16.52 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.491 -1.005 . . . . 0.0 109.56 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.642 HG11 HG12 ' A' ' 6' ' ' VAL . 58.2 t -105.11 155.12 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.409 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -92.18 147.07 23.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.818 . . . . 0.0 109.833 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.48 105.66 9.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 110.353 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 109' ' ' PHE . 3.6 m -79.58 173.96 12.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.882 . . . . 0.0 110.167 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.445 ' H ' HG22 ' A' ' 108' ' ' THR . 2.1 m-85 -136.77 88.68 2.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 CA-C-O 118.005 -1.442 . . . . 0.0 109.569 179.96 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.922 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 120.663 0.268 . . . . 0.0 110.409 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.922 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 48.6 Cg_endo -73.52 179.72 5.29 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.931 1.49 . . . . 0.0 110.537 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . -129.18 144.82 51.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.873 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.492 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 23.5 t80 -150.36 104.75 3.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.926 . . . . 0.0 109.888 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p -150.58 152.55 34.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 110.68 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.03 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 14.8 p -106.52 158.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -0.838 . . . . 0.0 109.55 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.594 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -60.46 -63.76 3.9 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.113 -0.992 . . . . 0.0 110.787 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.99 ' HD2' HG22 ' A' ' 6' ' ' VAL . 44.7 Cg_endo -72.33 -86.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.772 1.406 . . . . 0.0 111.189 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 1.03 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 71.81 18.35 5.15 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.407 -0.808 . . . . 0.0 109.918 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.484 ' HA ' ' HB ' ' A' ' 108' ' ' THR . 3.9 m -171.4 108.48 0.27 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.362 -0.836 . . . . 0.0 110.076 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.09 76.09 1.32 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.522 HD21 ' HB2' ' A' ' 8' ' ' PRO . 9.7 mt -128.05 172.74 10.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -1.101 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -138.29 162.82 33.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 110.082 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -57.93 123.99 17.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.067 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' GLN . . . 94.99 -32.32 6.23 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 17' ' ' SER . 9.0 tm0? -42.01 138.26 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.39 -1.065 . . . . 0.0 110.149 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.46 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -94.07 150.39 20.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.983 -179.99 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 65' ' ' PHE . 33.3 m -128.79 176.95 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.926 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 0.3 OUTLIER -133.48 121.78 22.7 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.939 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 21' ' ' SER . 68.0 t -98.31 158.86 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.254 -0.903 . . . . 0.0 110.053 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.41 ' N ' HG12 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -151.08 122.26 7.75 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.388 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.844 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 53.1 t -121.24 144.27 30.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.339 -0.85 . . . . 0.0 109.758 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.456 ' H ' ' HB3' ' A' ' 3' ' ' ALA . 1.1 m -156.61 127.55 6.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 142.61 -63.58 0.5 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.562 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -56.67 -159.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 109.816 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.57 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -165.8 162.7 18.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.928 -1.107 . . . . 0.0 111.054 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -41.24 134.5 2.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.551 -0.718 . . . . 0.0 110.241 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 114.6 7.41 18.13 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 54' ' ' THR . 5.6 mt-10 -139.86 128.64 23.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.243 -1.151 . . . . 0.0 109.906 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.502 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 20.6 m -108.87 157.8 18.28 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.866 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.963 ' CD2' HD11 ' A' ' 102' ' ' LEU . 15.8 m-85 -137.34 173.2 11.94 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 110.019 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 14.7 m-85 -131.08 103.52 6.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 110.021 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.684 ' CG2' HG23 ' A' ' 51' ' ' THR . 1.2 tt -87.23 124.29 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.179 -0.951 . . . . 0.0 110.272 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 1.026 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -150.56 160.46 43.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 110.207 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.486 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -126.59 138.2 53.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 110.544 179.978 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.2 m -146.94 169.22 19.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.25 -0.906 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.61 152.35 28.61 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.17 -0.956 . . . . 0.0 110.119 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.22 174.73 10.98 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.006 1.529 . . . . 0.0 110.178 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.526 HG12 ' H ' ' A' ' 40' ' ' GLY . 4.7 t -134.58 177.38 6.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.218 -0.926 . . . . 0.0 109.582 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.526 ' H ' HG12 ' A' ' 39' ' ' VAL . . . -70.53 -0.47 31.44 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.431 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.472 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -154.35 -29.52 0.03 OUTLIER Glycine 0 N--CA 1.494 2.519 0 O-C-N 120.806 -1.408 . . . . 0.0 110.963 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.472 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 2.0 mm-40 -143.13 -159.42 0.98 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.023 -1.281 . . . . 0.0 109.745 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.465 ' HA ' HG23 ' A' ' 39' ' ' VAL . 37.1 m-20 -119.6 142.04 48.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.935 -1.103 . . . . 0.0 110.79 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.726 ' CB ' HG21 ' A' ' 84' ' ' VAL . . . -118.33 165.39 13.91 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.423 -0.798 . . . . 0.0 108.902 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -147.05 158.18 43.85 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.721 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.577 ' OD1' ' CD2' ' A' ' 71' ' ' TYR . 3.4 m120 -100.11 116.11 64.87 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.489 -0.757 . . . . 0.0 109.694 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.62 -28.59 4.19 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.818 1.431 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.11 -35.42 74.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.245 -0.91 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.6 p -86.94 14.08 7.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.214 -0.929 . . . . 0.0 110.684 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.38 95.62 10.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.952 . . . . 0.0 110.271 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.684 HG23 ' CG2' ' A' ' 33' ' ' ILE . 5.0 t -137.03 167.62 21.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 95.7 p -126.2 149.54 48.96 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.196 -0.94 . . . . 0.0 110.34 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 20.7 p90 -143.41 141.93 31.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.142 -0.974 . . . . 0.0 110.135 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 29' ' ' GLU . 18.6 m -104.21 155.55 18.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -0.933 . . . . 0.0 110.494 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.562 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -63.04 -156.08 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.319 -0.863 . . . . 0.0 109.806 179.946 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -140.83 -166.88 2.24 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.927 -1.108 . . . . 0.0 110.436 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.93 -57.24 13.93 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -1.85 23.63 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.254 -0.904 . . . . 0.0 108.999 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 72.83 69.06 1.46 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.58 125.69 13.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -1.084 . . . . 0.0 109.618 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.844 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -118.6 80.6 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 110.781 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.29 140.21 46.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -0.831 . . . . 0.0 109.078 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.4 ' HZ ' HD13 ' A' ' 33' ' ' ILE . 32.7 p90 -171.1 -179.65 2.78 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.114 -0.991 . . . . 0.0 111.38 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t -96.43 140.78 30.58 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.608 0.718 . . . . 0.0 110.551 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.587 ' HB3' HG23 ' A' ' 18' ' ' VAL . 20.3 t80 -134.32 -172.19 2.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -0.79 . . . . 0.0 108.888 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.3 t -143.69 165.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.645 -1.285 . . . . 0.0 110.325 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.572 HG11 HG11 ' A' ' 18' ' ' VAL . 33.2 m -137.88 142.51 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.312 -0.868 . . . . 0.0 110.305 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -121.22 134.52 55.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.072 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 23.3 ttmt -73.26 -59.81 2.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.137 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t -109.58 141.84 41.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 110.196 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.577 ' CD2' ' OD1' ' A' ' 46' ' ' ASN . 33.4 p90 -153.56 122.5 6.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.825 . . . . 0.0 109.986 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 92.2 m -43.89 124.74 3.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.307 -0.871 . . . . 0.0 110.738 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.66 148.88 19.08 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.2 t -151.29 148.19 27.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.787 -1.419 . . . . 0.0 111.168 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.53 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 75.5 p -84.61 175.63 4.46 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.484 -0.76 . . . . 0.0 109.902 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.53 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 50.0 Cg_endo -87.95 21.96 0.95 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.748 1.394 . . . . 0.0 110.631 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -128.97 12.27 6.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.127 -0.983 . . . . 0.0 110.565 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 80' ' ' PRO . . . 78.86 11.89 84.75 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.2 m -96.68 105.44 23.25 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.066 -1.256 . . . . 0.0 110.099 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 78' ' ' GLY . 45.4 Cg_endo -72.75 137.2 26.82 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.043 1.549 . . . . 0.0 110.143 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 81' ' ' VAL . 9.2 p -119.76 16.02 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.215 -0.928 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.87 -169.66 18.17 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 20.0 p -104.5 153.42 21.17 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.088 -1.243 . . . . 0.0 109.918 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.726 HG21 ' CB ' ' A' ' 44' ' ' ALA . 74.6 t -102.34 153.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 109.993 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -132.8 148.7 52.32 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 110.203 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 1.8 t -104.94 15.01 28.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 110.17 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.23 -56.16 4.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 110.334 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -87.7 -28.12 21.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.23 -0.919 . . . . 0.0 110.238 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.7 -158.26 0.64 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.218 -0.926 . . . . 0.0 110.01 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.45 147.95 42.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.9 . . . . 0.0 110.225 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.469 ' HB3' ' OE1' ' A' ' 35' ' ' GLN . 94.4 m -106.61 130.35 54.38 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 109.911 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -112.77 125.23 54.1 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 110.557 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.026 HD12 ' O ' ' A' ' 34' ' ' ALA . 50.1 tp -107.62 112.34 25.02 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.599 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -120.89 160.2 15.3 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.487 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -144.07 124.48 13.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.506 -0.996 . . . . 0.0 109.802 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.35 167.37 39.39 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.414 ' CG ' ' N ' ' A' ' 98' ' ' SER . 4.0 t30 -104.43 -86.08 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -1.094 . . . . 0.0 110.416 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.414 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 46.8 t -159.89 71.07 0.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.255 -0.903 . . . . 0.0 110.007 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.01 -17.3 6.74 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 31' ' ' TYR . 38.3 tp -94.86 -66.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.462 -1.022 . . . . 0.0 109.655 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 100' ' ' LEU . 4.9 t0 61.89 128.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.76 . . . . 0.0 110.632 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.963 HD11 ' CD2' ' A' ' 31' ' ' TYR . 35.3 mt -96.85 -39.51 9.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.468 -0.77 . . . . 0.0 109.571 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.18 177.58 26.01 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.599 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 2.0 m-70 -133.7 120.05 20.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.656 -0.908 . . . . 0.0 109.601 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.6 t -92.25 132.59 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.207 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.18 106.71 18.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 110.325 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.2 mt -74.83 126.81 31.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.24 -0.913 . . . . 0.0 110.13 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.484 ' HB ' ' HA ' ' A' ' 10' ' ' SER . 2.2 m -90.37 162.49 15.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.926 . . . . 0.0 110.092 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 108' ' ' THR . 3.9 m-85 -148.4 171.81 15.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.548 179.979 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.541 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 54.9 Cg_endo -74.6 -102.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.9 1.474 . . . . 0.0 109.447 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 22' ' ' VAL . . . 179.73 133.58 0.1 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.887 -1.133 . . . . 0.0 110.461 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -150.85 97.98 2.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.401 -0.812 . . . . 0.0 109.543 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.1 p -139.26 168.83 18.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.059 -1.026 . . . . 0.0 111.148 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG12 HG11 ' A' ' 105' ' ' VAL . 8.0 p -124.98 148.64 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.555 -0.716 . . . . 0.0 109.09 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.648 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 2.0 m -62.21 -76.87 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.868 -1.145 . . . . 0.0 110.463 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 55.6 Cg_endo -77.81 75.3 4.84 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 O-C-N 122.788 0.888 . . . . 0.0 109.847 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.09 -22.89 63.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.148 -0.97 . . . . 0.0 110.301 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.5 t -131.69 135.18 46.66 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.174 -0.954 . . . . 0.0 110.12 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.98 65.71 1.28 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.626 HD21 ' O ' ' A' ' 8' ' ' PRO . 7.4 mt -110.21 165.05 12.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -1.139 . . . . 0.0 109.887 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.5 157.22 28.74 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.21 -0.931 . . . . 0.0 110.169 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -68.5 127.2 32.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.84 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.8 -25.54 11.4 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -54.47 149.55 10.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.337 -1.096 . . . . 0.0 110.437 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 m -101.99 129.19 48.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.229 -0.92 . . . . 0.0 109.957 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 18' ' ' VAL . 16.4 m -95.91 175.29 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 7' ' ' SER . 23.3 p -129.37 113.57 15.12 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.376 -0.828 . . . . 0.0 109.734 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t -97.57 151.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.275 -0.891 . . . . 0.0 110.05 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 t -141.82 118.49 11.03 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.323 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 35.3 t -113.83 138.14 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.558 -0.714 . . . . 0.0 109.778 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.459 ' H ' ' HB3' ' A' ' 3' ' ' ALA . 19.3 p -150.9 116.25 5.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.983 -1.073 . . . . 0.0 110.754 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.541 ' HA3' ' CB ' ' A' ' 2' ' ' PRO . . . 156.31 -52.44 0.42 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.528 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -58.15 -157.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.358 -1.083 . . . . 0.0 109.711 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.506 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -161.26 160.59 30.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.966 -1.084 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -45.91 130.6 9.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.604 -0.685 . . . . 0.0 110.25 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.432 ' C ' ' HG3' ' A' ' 29' ' ' GLU . . . 117.92 12.33 7.84 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.541 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 70.6 mt-10 -139.18 113.26 8.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.283 . . . . 0.0 110.444 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.408 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 31.1 m -90.83 166.46 13.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.471 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.681 ' HE1' HD23 ' A' ' 100' ' ' LEU . 93.9 m-85 -150.61 167.11 28.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.992 -1.068 . . . . 0.0 110.827 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' A' ' 31' ' ' TYR . 12.3 m-85 -131.68 106.92 8.46 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.413 ' CG2' HG23 ' A' ' 51' ' ' THR . 4.7 tt -98.25 137.8 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.994 . . . . 0.0 111.452 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.04 161.02 43.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.669 -0.645 . . . . 0.0 109.458 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 35' ' ' GLN . 5.3 pt20 -119.23 134.04 55.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 110.523 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.419 ' SG ' ' C ' ' A' ' 35' ' ' GLN . 3.5 m -144.23 -178.5 5.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.43 -0.794 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.61 156.95 33.57 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.301 -0.875 . . . . 0.0 109.467 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 41.3 Cg_endo -71.96 151.4 56.29 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 O-C-N 123.748 1.394 . . . . 0.0 110.686 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.6 HG13 ' H ' ' A' ' 41' ' ' GLY . 10.8 p -132.79 175.28 11.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 121.502 -0.749 . . . . 0.0 109.476 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.571 ' N ' HG22 ' A' ' 39' ' ' VAL . . . -54.28 -22.39 22.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.6 ' H ' HG13 ' A' ' 39' ' ' VAL . . . -97.27 -74.14 1.17 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.447 ' O ' ' OD2' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -138.4 -74.03 0.4 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -1.118 . . . . 0.0 110.094 -179.965 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.503 ' N ' HG12 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -164.93 118.12 1.25 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.186 -0.946 . . . . 0.0 111.007 -179.943 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.8 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -95.24 133.08 39.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.283 -0.886 . . . . 0.0 108.942 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 15.7 t -113.91 168.0 10.17 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.779 -1.201 . . . . 0.0 111.604 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -108.88 112.09 60.41 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.71 . . . . 0.0 110.037 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.62 -24.78 15.57 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.0 1.526 . . . . 0.0 110.646 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -8.86 10.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.206 -0.934 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.02 35.69 4.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.977 -1.077 . . . . 0.0 110.541 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.79 133.66 34.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.163 -0.961 . . . . 0.0 110.541 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.413 HG23 ' CG2' ' A' ' 33' ' ' ILE . 9.9 t -159.95 156.84 27.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.35 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t -130.03 161.6 30.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.162 -0.961 . . . . 0.0 110.755 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 7.9 p90 -149.28 179.73 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.401 -0.812 . . . . 0.0 109.763 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.4 m -146.88 158.11 43.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.051 -1.031 . . . . 0.0 110.332 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.528 HG21 ' HB3' ' A' ' 25' ' ' ALA . 2.8 p -73.3 -161.23 0.09 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -161.07 -152.16 0.26 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.1 -1.0 . . . . 0.0 110.885 -179.947 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.35 -46.51 89.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.889 . . . . 0.0 109.488 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.4 t -85.16 12.96 6.88 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.569 -0.707 . . . . 0.0 109.209 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.506 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 45.3 40.66 7.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.81 126.16 41.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 110.374 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 53' ' ' PHE . . . -112.1 90.08 3.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 110.539 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.78 117.01 32.99 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.329 -0.857 . . . . 0.0 109.562 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.634 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 5.4 p90 -149.91 171.15 17.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.249 -0.907 . . . . 0.0 110.877 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.04 128.11 47.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 110.647 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.51 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 50.0 t80 -113.64 -179.96 3.79 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.51 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.7 t -128.27 156.89 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.704 -1.248 . . . . 0.0 109.907 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG13 ' C ' ' A' ' 66' ' ' VAL . 30.7 m -146.82 157.09 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 110.308 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.23 150.51 50.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.428 -0.795 . . . . 0.0 110.187 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' CYS . 29.7 tttt -76.5 -59.4 2.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 110.566 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.0 m -117.57 137.62 52.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.143 -0.973 . . . . 0.0 110.169 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -162.2 151.53 15.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.12 -0.987 . . . . 0.0 110.304 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 38.1 m -68.47 134.29 49.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.0 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.636 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -118.82 -176.48 16.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER 179.45 138.82 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -1.154 . . . . 0.0 109.915 -179.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.7 p -73.55 144.46 83.61 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 110.396 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.58 -16.51 10.46 Favored 'Trans proline' 0 C--N 1.297 -2.135 0 O-C-N 124.2 1.632 . . . . 0.0 110.069 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -73.16 -13.38 61.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.368 -0.833 . . . . 0.0 110.275 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.455 ' O ' ' OG1' ' A' ' 79' ' ' THR . . . 106.3 62.86 0.6 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 78' ' ' GLY . 70.7 m -165.54 95.65 0.82 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.255 -1.144 . . . . 0.0 110.348 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.05 142.19 46.0 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 O-C-N 123.823 1.433 . . . . 0.0 109.944 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.506 HG11 HG21 ' A' ' 39' ' ' VAL . 3.5 p -120.79 -34.18 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.148 -0.97 . . . . 0.0 110.676 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.89 -147.81 19.4 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 82.5 p -90.3 168.83 11.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.354 -1.086 . . . . 0.0 110.45 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.8 HG21 ' HB3' ' A' ' 44' ' ' ALA . 78.3 t -133.05 116.43 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.393 -0.817 . . . . 0.0 109.882 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.767 ' OD2' HG22 ' A' ' 88' ' ' THR . 4.9 p-10 -101.26 142.0 33.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 0.0 110.392 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 4.4 t -98.2 17.28 18.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.25 -0.907 . . . . 0.0 110.031 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.1 -59.92 2.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 110.214 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.767 HG22 ' OD2' ' A' ' 85' ' ' ASP . 5.9 t -79.78 -24.85 41.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.289 -0.882 . . . . 0.0 110.081 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -101.01 -154.96 0.49 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.382 -0.824 . . . . 0.0 109.909 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.21 146.47 33.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.401 -0.812 . . . . 0.0 110.086 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.28 126.85 43.94 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.261 -0.9 . . . . 0.0 109.67 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -110.8 121.2 44.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 111.005 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 65' ' ' PHE . 1.1 tp -107.05 118.41 36.63 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.418 -0.801 . . . . 0.0 108.912 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -137.47 176.73 20.38 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.279 -1.439 . . . . 0.0 110.529 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.89 175.75 11.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.615 -0.932 . . . . 0.0 110.054 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 136.63 167.06 11.05 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -131.46 -153.15 0.54 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.187 -1.184 . . . . 0.0 109.933 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 t -104.04 80.15 1.7 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.176 -0.953 . . . . 0.0 110.089 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.55 -18.31 0.36 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.681 HD23 ' HE1' ' A' ' 31' ' ' TYR . 7.9 tp -140.79 -67.95 0.41 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.282 . . . . 0.0 110.561 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.5 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.7 OUTLIER 69.42 153.06 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.306 -0.871 . . . . 0.0 110.091 179.983 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.7 mt -121.79 -86.31 0.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 110.38 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -167.91 -160.66 15.94 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -159.09 138.45 11.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -1.09 . . . . 0.0 110.335 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.497 HG11 HG12 ' A' ' 6' ' ' VAL . 81.5 t -104.9 127.96 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.255 -0.903 . . . . 0.0 110.207 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.87 93.74 5.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.511 HD22 HD11 ' A' ' 12' ' ' LEU . 65.9 mt -60.19 170.13 1.38 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 109' ' ' PHE . 17.4 m -141.19 169.84 16.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 0.0 110.096 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.412 ' N ' HG22 ' A' ' 108' ' ' THR . 5.9 m-85 -142.65 96.57 2.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.913 . . . . 0.0 110.138 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.61 179.978 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.631 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.631 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 42.8 Cg_endo -69.82 -159.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.897 1.472 . . . . 0.0 110.428 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -140.38 135.8 32.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.025 -1.047 . . . . 0.0 111.004 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.404 ' CE2' HG23 ' A' ' 105' ' ' VAL . 65.9 t80 -150.84 108.53 3.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.557 -0.715 . . . . 0.0 109.096 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.0 p -146.56 161.59 40.18 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.82 -1.175 . . . . 0.0 111.484 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.889 HG12 HG11 ' A' ' 105' ' ' VAL . 7.7 p -129.94 143.32 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.594 -0.691 . . . . 0.0 109.719 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.612 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.2 m -56.86 -68.84 0.53 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.976 -1.077 . . . . 0.0 110.224 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 50.7 Cg_endo -75.88 95.1 1.01 Allowed 'Trans proline' 0 C--N 1.321 -0.89 0 O-C-N 123.354 1.186 . . . . 0.0 110.228 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.96 -1.94 28.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.0 -1.063 . . . . 0.0 110.364 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 t -157.21 109.51 2.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.955 . . . . 0.0 110.057 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.45 60.99 0.54 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.506 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 1.1 mp -108.25 165.84 11.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -1.166 . . . . 0.0 110.068 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 11.4 t -117.27 147.97 42.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.319 -0.863 . . . . 0.0 110.072 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.23 119.21 7.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 110.326 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.11 -35.15 4.97 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 34.2 tt0 -49.21 153.81 0.92 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.326 -1.102 . . . . 0.0 110.381 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 m -105.46 132.75 51.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.959 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.506 ' CG1' ' CD2' ' A' ' 12' ' ' LEU . 24.4 m -100.6 178.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.255 -0.903 . . . . 0.0 110.282 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.9 m -121.1 117.28 26.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 109.807 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.484 HG21 HD13 ' A' ' 33' ' ' ILE . 20.8 t -102.54 150.2 6.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.393 -0.817 . . . . 0.0 110.154 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.91 127.94 18.49 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.309 -0.869 . . . . 0.0 110.4 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 58.7 t -117.37 147.59 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.632 -0.667 . . . . 0.0 109.917 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.732 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 3.6 p -168.05 119.76 0.84 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.127 -0.983 . . . . 0.0 110.393 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.78 3.4 5.48 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.884 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -105.64 -39.67 6.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.056 -1.261 . . . . 0.0 110.266 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 25' ' ' ALA . . . 72.62 147.84 0.09 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.327 -0.858 . . . . 0.0 110.837 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.79 134.22 10.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.713 -0.617 . . . . 0.0 110.768 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . 131.82 1.51 4.56 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 39.6 mm-40 -146.45 130.61 17.44 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.87 -1.371 . . . . 0.0 110.896 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.687 HG23 ' OG1' ' A' ' 54' ' ' THR . 0.2 OUTLIER -96.72 171.67 8.38 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.879 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.547 ' CD1' ' O ' ' A' ' 30' ' ' THR . 61.3 m-85 -151.61 172.54 15.9 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.871 -1.143 . . . . 0.0 111.028 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 52' ' ' SER . 61.4 m-85 -144.31 109.46 5.07 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.443 -0.785 . . . . 0.0 109.752 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.699 HD11 HD21 ' A' ' 93' ' ' LEU . 5.6 tt -88.41 132.68 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.213 -0.929 . . . . 0.0 110.451 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.58 167.63 25.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.203 -0.936 . . . . 0.0 110.426 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.455 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 10.5 pt20 -126.56 141.81 51.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.315 -0.865 . . . . 0.0 109.991 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -143.38 157.71 44.24 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.979 -1.076 . . . . 0.0 110.479 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.748 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -144.19 157.05 57.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.37 159.13 54.91 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 123.741 1.39 . . . . 0.0 110.792 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.01 HG22 ' O ' ' A' ' 42' ' ' GLN . 32.5 m -130.38 -158.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.478 -0.763 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.52 32.23 4.27 Favored Glycine 0 C--N 1.279 -2.617 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -173.94 -52.38 0.05 OUTLIER Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.365 -1.398 . . . . 0.0 111.058 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 1.01 ' O ' HG22 ' A' ' 39' ' ' VAL . 5.3 mm100 -141.24 -157.45 0.77 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.121 -1.223 . . . . 0.0 110.76 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -106.04 122.24 45.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.177 -0.952 . . . . 0.0 110.059 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.869 ' HB2' HG11 ' A' ' 81' ' ' VAL . . . -111.29 139.29 46.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 8.7 t -123.49 144.51 49.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.176 -0.953 . . . . 0.0 110.506 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.453 ' HB3' ' OG1' ' A' ' 49' ' ' THR . 32.0 t-20 -71.67 122.97 88.67 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.26 -0.9 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.539 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 52.4 Cg_endo -83.47 -39.11 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.932 1.491 . . . . 0.0 110.953 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.88 -56.92 15.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.426 -0.796 . . . . 0.0 110.766 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 46' ' ' ASN . 1.8 p -56.87 -14.53 3.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.642 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 47' ' ' PRO . . . -56.98 137.28 55.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 110.768 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.628 HG23 HG22 ' A' ' 33' ' ' ILE . 13.0 t -147.03 165.9 28.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.589 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -130.95 152.91 49.75 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.874 -1.142 . . . . 0.0 111.82 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 31' ' ' TYR . 32.3 p90 -149.12 146.25 27.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.502 -0.749 . . . . 0.0 109.779 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.687 ' OG1' HG23 ' A' ' 30' ' ' THR . 76.2 m -108.75 155.27 20.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.975 -1.078 . . . . 0.0 110.771 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.884 HG21 ' HB3' ' A' ' 25' ' ' ALA . 1.2 p -65.42 -157.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.305 -0.872 . . . . 0.0 109.606 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.94 -159.78 1.08 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.818 -1.176 . . . . 0.0 110.478 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.06 62.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.156 -0.965 . . . . 0.0 109.743 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 t -85.46 13.69 6.45 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.424 -0.797 . . . . 0.0 108.854 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 60.58 27.35 65.98 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -110.83 114.16 27.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.345 -1.091 . . . . 0.0 110.35 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.502 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -117.56 88.63 2.95 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.2 p -102.29 125.99 49.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.487 -0.758 . . . . 0.0 109.395 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -154.01 176.19 12.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.957 . . . . 0.0 111.079 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 t -100.22 129.89 46.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.468 -0.77 . . . . 0.0 110.362 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 55.1 t80 -118.45 177.91 4.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 109.307 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.555 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.6 t -125.77 154.99 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.811 -1.181 . . . . 0.0 110.389 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.416 HG11 HG11 ' A' ' 18' ' ' VAL . 5.6 m -132.7 171.69 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.822 . . . . 0.0 109.704 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.89 139.21 23.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.984 . . . . 0.0 110.282 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.529 ' HA ' ' CE2' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -77.39 -47.71 19.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.339 -0.851 . . . . 0.0 110.204 179.991 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -122.95 136.1 54.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.847 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -163.36 157.05 19.56 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 3.2 m -69.48 111.14 5.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.425 -0.797 . . . . 0.0 109.992 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.29 162.75 54.3 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.433 ' N ' ' HB1' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -176.54 158.25 1.74 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.111 -1.229 . . . . 0.0 110.75 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.566 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 43.8 p -70.85 171.26 8.68 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.451 -0.78 . . . . 0.0 109.514 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 46.4 Cg_endo -74.73 -7.89 19.82 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.473 1.249 . . . . 0.0 110.931 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -96.78 -59.36 1.82 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.061 -1.025 . . . . 0.0 110.14 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.86 55.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -129.72 108.6 17.12 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.226 -1.161 . . . . 0.0 110.154 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.74 78.94 2.0 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.931 1.49 . . . . 0.0 110.574 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.869 HG11 ' HB2' ' A' ' 44' ' ' ALA . 10.7 p -57.89 -22.37 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 110.104 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.52 152.02 5.55 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.4 p -58.76 172.87 0.47 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.256 -1.144 . . . . 0.0 110.034 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 37' ' ' ALA . 55.2 t -141.4 155.84 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -0.903 . . . . 0.0 110.318 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -144.36 139.83 28.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.863 . . . . 0.0 110.126 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -100.73 2.44 41.35 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 110.178 -179.97 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.34 -60.5 2.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.881 . . . . 0.0 110.622 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.8 t -91.94 -20.89 20.92 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.207 -0.933 . . . . 0.0 110.731 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.63 -176.16 3.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.578 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.26 147.13 45.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.345 -0.847 . . . . 0.0 110.1 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 29.7 m -120.61 156.3 31.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.175 -0.953 . . . . 0.0 110.436 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 18.5 p30 -136.69 143.44 43.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 109.947 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.699 HD21 HD11 ' A' ' 33' ' ' ILE . 1.5 tp -105.62 135.79 46.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.249 -0.907 . . . . 0.0 109.998 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.501 ' HA3' ' ND1' ' A' ' 104' ' ' HIS . . . -131.69 149.46 19.32 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -137.15 155.77 49.18 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.502 -0.999 . . . . 0.0 109.899 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.27 164.61 13.25 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.458 ' CG ' ' N ' ' A' ' 98' ' ' SER . 1.4 t30 -113.42 173.45 6.4 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.248 -1.148 . . . . 0.0 109.857 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.458 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 88.9 p -66.09 89.32 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.152 -0.968 . . . . 0.0 109.943 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 131.69 -20.4 4.61 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 101' ' ' ASP . 1.2 tt -111.37 161.21 16.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.395 -1.062 . . . . 0.0 110.055 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.591 ' N ' HD23 ' A' ' 100' ' ' LEU . 4.6 p-10 -148.57 98.25 2.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.214 -0.929 . . . . 0.0 110.368 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.2 mt -78.73 -70.14 0.52 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.294 -0.879 . . . . 0.0 110.131 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.535 ' C ' ' CD2' ' A' ' 104' ' ' HIS . . . 164.1 -177.12 39.97 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.588 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 4.9 m-70 -131.8 129.5 40.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -1.091 . . . . 0.0 110.03 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.889 HG11 HG12 ' A' ' 6' ' ' VAL . 46.0 t -93.39 116.8 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 110.473 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.56 128.95 39.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.39 -0.819 . . . . 0.0 110.086 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.509 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 74.8 mt -114.44 119.09 35.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 110.508 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.424 HG22 ' N ' ' A' ' 109' ' ' PHE . 23.6 m -98.57 169.37 9.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 109.932 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.529 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 10.7 m-85 -132.3 136.11 46.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.995 . . . . 0.0 110.326 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.995 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.829 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 120.771 0.32 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.829 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 47.5 Cg_endo -73.81 -172.62 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.013 1.533 . . . . 0.0 110.479 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.47 135.03 47.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.895 . . . . 0.0 110.162 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -150.56 107.44 3.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.789 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -146.13 153.07 40.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.096 -1.003 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.918 HG12 HG11 ' A' ' 105' ' ' VAL . 9.0 p -115.24 135.82 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.344 -0.847 . . . . 0.0 109.776 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -57.01 -67.63 0.8 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.056 -1.028 . . . . 0.0 110.262 -179.987 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 52.7 Cg_endo -75.69 87.94 1.34 Allowed 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.338 1.178 . . . . 0.0 109.956 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.61 -3.1 56.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.143 -0.973 . . . . 0.0 110.67 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.0 m -149.75 166.58 29.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.202 -0.936 . . . . 0.0 110.336 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.95 37.56 94.43 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 8' ' ' PRO . 40.5 mt -92.9 173.71 7.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.254 -1.144 . . . . 0.0 110.138 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.3 152.07 35.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 110.393 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 1.6 t70 -60.01 126.76 28.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 109.99 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.83 -33.27 5.65 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -56.61 149.47 17.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.345 -1.091 . . . . 0.0 109.893 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.01 134.07 47.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 110.663 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 65' ' ' PHE . 31.5 m -113.28 173.13 3.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.483 -0.76 . . . . 0.0 109.704 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -117.76 133.5 55.87 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.097 -1.002 . . . . 0.0 110.314 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.9 t -119.7 151.21 22.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.746 -0.596 . . . . 0.0 109.513 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.6 p -143.6 133.33 23.8 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 85.2 t -122.44 138.51 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.507 -0.746 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.8 m -150.02 80.1 1.37 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.861 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . -161.85 -71.55 0.02 OUTLIER Glycine 0 C--N 1.283 -2.386 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.477 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -56.09 -164.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -1.198 . . . . 0.0 109.902 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.577 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -160.39 157.77 28.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.143 -0.973 . . . . 0.0 110.387 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -36.14 118.55 0.53 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.602 -0.686 . . . . 0.0 110.633 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.56 -0.34 2.46 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -146.85 130.63 17.04 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.086 -1.244 . . . . 0.0 110.661 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.4 HG23 ' OG1' ' A' ' 54' ' ' THR . 37.9 m -107.27 121.8 45.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.561 -0.712 . . . . 0.0 109.701 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.651 ' HE1' HD13 ' A' ' 100' ' ' LEU . 52.2 m-85 -103.62 177.77 4.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.052 -1.03 . . . . 0.0 110.603 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.638 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 10.0 m-85 -132.81 116.69 16.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -0.892 . . . . 0.0 110.096 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.598 ' CG2' HG23 ' A' ' 51' ' ' THR . 0.5 OUTLIER -94.33 123.72 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.893 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.88 156.31 39.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.117 -0.99 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.694 ' OE1' HD12 ' A' ' 107' ' ' LEU . 0.3 OUTLIER -100.17 152.91 19.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.316 -0.865 . . . . 0.0 109.532 179.944 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 99.1 m -151.6 152.25 32.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.062 -1.024 . . . . 0.0 110.934 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.793 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.41 145.79 19.01 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.476 -0.765 . . . . 0.0 109.292 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.74 161.03 42.66 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.79 1.416 . . . . 0.0 110.989 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.685 HG12 HG22 ' A' ' 84' ' ' VAL . 33.8 m -127.09 -166.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.471 -0.768 . . . . 0.0 110.17 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.13 28.26 5.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.595 ' H ' HG23 ' A' ' 39' ' ' VAL . . . -149.88 -58.95 0.01 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.448 ' HG2' ' C ' ' A' ' 41' ' ' GLY . 20.7 mm100 -145.62 -121.8 0.07 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.207 -1.172 . . . . 0.0 110.02 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -129.0 147.51 50.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.994 -1.066 . . . . 0.0 110.067 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.94 164.94 24.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.133 -0.979 . . . . 0.0 110.028 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.3 m -143.74 -178.74 6.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.27 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 5.6 m120 -105.59 76.14 0.34 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 0.0 110.319 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 43.2 Cg_endo -69.32 -41.3 4.97 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.987 1.519 . . . . 0.0 110.324 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.98 -34.95 74.0 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.38 -0.825 . . . . 0.0 110.005 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.9 34.2 5.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.856 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -86.33 103.67 15.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.014 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.598 HG23 ' CG2' ' A' ' 33' ' ' ILE . 10.0 t -102.37 167.65 9.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 0.0 110.502 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 2.4 m -143.99 162.94 34.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.955 . . . . 0.0 110.673 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 51.5 p90 -143.27 -177.13 5.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.4 ' OG1' HG23 ' A' ' 30' ' ' THR . 50.0 m -146.19 149.9 34.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.348 -0.845 . . . . 0.0 109.746 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.494 HG21 ' N ' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -64.22 -174.77 0.13 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.04 -1.038 . . . . 0.0 109.707 -179.978 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.736 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -146.8 -147.77 0.23 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.96 -1.088 . . . . 0.0 110.806 -179.903 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.585 ' O ' ' CB ' ' A' ' 58' ' ' SER . . . -83.02 71.24 10.12 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.15 0.976 . . . . 0.0 109.255 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER 152.7 -14.58 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.577 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 75.57 28.68 60.95 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.42 129.66 56.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.226 -1.161 . . . . 0.0 110.015 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -131.99 86.24 2.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.317 -0.864 . . . . 0.0 110.641 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.39 111.85 24.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.848 . . . . 0.0 109.412 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 19.2 p90 -143.58 178.56 7.7 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.084 -1.01 . . . . 0.0 110.967 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.1 p -98.98 125.54 44.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.469 -0.769 . . . . 0.0 110.247 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.671 ' O ' HG22 ' A' ' 18' ' ' VAL . 8.3 t80 -120.65 139.92 52.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.37 156.43 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.891 -1.131 . . . . 0.0 110.473 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.416 HG13 HG22 ' A' ' 18' ' ' VAL . 26.8 m -124.97 151.82 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.539 -0.726 . . . . 0.0 110.077 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.01 107.04 10.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 110.408 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.566 ' HB2' ' CE1' ' A' ' 109' ' ' PHE . 4.4 ttpt -55.39 -49.61 71.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.643 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.0 m -114.15 132.43 56.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -0.8 . . . . 0.0 109.905 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 71' ' ' TYR . 23.4 p90 -150.36 146.7 26.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.2 m -68.62 129.75 40.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 110.036 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.25 148.52 18.43 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.7 p -171.75 178.65 3.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.293 -1.122 . . . . 0.0 110.345 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.2 p -101.61 163.11 18.49 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.208 -0.932 . . . . 0.0 110.263 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.04 -4.78 15.26 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.076 1.566 . . . . 0.0 110.668 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.43 -58.17 2.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.216 -0.927 . . . . 0.0 110.334 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.08 56.92 0.02 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.6 m -139.57 95.71 8.87 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.345 -1.091 . . . . 0.0 110.128 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.12 100.81 1.33 Allowed 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.059 1.558 . . . . 0.0 110.495 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.0 m -71.6 -26.69 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.195 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.33 -172.05 22.89 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.3 p -88.62 149.35 23.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -1.204 . . . . 0.0 110.095 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.685 HG22 HG12 ' A' ' 39' ' ' VAL . 84.0 t -119.06 147.08 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 110.167 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -137.04 137.23 39.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.176 -0.952 . . . . 0.0 110.697 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 62.6 m -92.1 7.8 40.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.725 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.01 -62.0 1.74 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 110.5 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.9 t -104.65 14.31 30.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.192 -0.943 . . . . 0.0 110.432 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.17 -167.94 1.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.234 -0.916 . . . . 0.0 110.055 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.06 98.97 4.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 110.325 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.793 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 12.0 p -108.03 151.44 25.83 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.928 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -127.47 158.7 36.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.732 ' HB2' HD11 ' A' ' 107' ' ' LEU . 10.0 tp -109.03 121.61 45.5 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.565 ' HA3' ' ND1' ' A' ' 104' ' ' HIS . . . -126.87 157.91 20.7 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.592 -1.29 . . . . 0.0 110.341 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -132.37 161.44 33.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -1.062 . . . . 0.0 110.082 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.848 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 138.73 -171.35 23.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 98' ' ' SER . 6.1 p-10 -109.25 -46.09 3.63 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.021 -1.282 . . . . 0.0 110.362 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER 174.19 -27.66 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.207 -0.933 . . . . 0.0 110.446 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.86 3.95 4.23 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.305 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.651 HD13 ' HE1' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -84.87 -42.08 15.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.945 -1.326 . . . . 0.0 110.174 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 100' ' ' LEU . 17.4 t0 65.44 81.07 0.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.326 -0.859 . . . . 0.0 110.261 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.848 HD12 ' HA2' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -79.77 -63.88 1.31 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 110.146 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.11 162.48 29.4 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.565 ' ND1' ' HA3' ' A' ' 94' ' ' GLY . 93.3 m-70 -138.57 113.24 9.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.518 -0.989 . . . . 0.0 109.686 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.918 HG11 HG12 ' A' ' 6' ' ' VAL . 94.1 t -101.59 113.97 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.226 -0.921 . . . . 0.0 110.795 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.17 139.1 55.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.107 -0.996 . . . . 0.0 109.321 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.732 HD11 ' HB2' ' A' ' 93' ' ' LEU . 80.7 mt -115.34 167.91 10.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.957 -1.089 . . . . 0.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 109' ' ' PHE . 19.2 m -149.1 175.35 11.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 109.975 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 69' ' ' LYS . 43.3 m-85 -147.45 102.37 3.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.375 -0.828 . . . . 0.0 110.2 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.966 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.806 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.806 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 46.2 Cg_endo -73.07 -176.25 2.32 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.947 1.498 . . . . 0.0 110.315 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -135.98 138.15 41.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.073 -1.017 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -152.0 108.82 3.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.307 -0.871 . . . . 0.0 109.675 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 t -148.69 161.22 42.19 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.972 -1.08 . . . . 0.0 111.161 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.669 HG22 ' HD2' ' A' ' 8' ' ' PRO . 8.1 p -121.67 147.54 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.534 -0.729 . . . . 0.0 109.859 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.611 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -55.91 -67.56 0.73 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 120.84 -1.163 . . . . 0.0 109.064 179.975 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.669 ' HD2' HG22 ' A' ' 6' ' ' VAL . 52.9 Cg_endo -76.94 129.71 10.83 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 O-C-N 123.473 1.249 . . . . 0.0 109.552 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.1 26.74 2.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.936 -1.102 . . . . 0.0 110.263 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.07 145.79 0.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.032 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.01 58.88 10.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 8' ' ' PRO . 20.5 mt -105.81 175.11 5.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.255 -1.144 . . . . 0.0 110.41 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.6 t -133.09 148.15 52.17 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.251 -0.906 . . . . 0.0 110.403 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.541 ' HB3' ' CB ' ' A' ' 69' ' ' LYS . 29.9 p30 -57.33 119.89 7.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 110.459 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.14 -35.34 5.11 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -47.62 148.65 1.41 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.028 -1.278 . . . . 0.0 110.428 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.586 ' C ' HG13 ' A' ' 18' ' ' VAL . 2.6 p -97.36 177.24 5.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 110.155 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.606 HG12 ' CG ' ' A' ' 8' ' ' PRO . 29.3 m -156.47 169.66 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.277 -0.889 . . . . 0.0 110.077 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 m -114.8 121.23 42.66 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.2 -0.938 . . . . 0.0 109.76 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 t -105.86 142.04 19.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.419 -0.8 . . . . 0.0 109.969 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.1 m -138.56 126.3 22.23 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.492 -0.755 . . . . 0.0 110.004 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 55.7 t -117.97 127.46 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.649 -0.657 . . . . 0.0 110.39 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.8 108.84 8.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.173 -0.955 . . . . 0.0 109.957 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 150.47 -82.38 0.18 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.501 ' O ' ' CA ' ' A' ' 59' ' ' GLY . . . -42.41 131.08 3.8 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.265 -1.138 . . . . 0.0 109.836 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.562 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -103.74 158.93 16.04 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.093 -1.005 . . . . 0.0 111.972 -179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.34 141.95 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.554 0.692 . . . . 0.0 111.07 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.11 7.28 4.11 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.577 ' CG ' ' CZ ' ' A' ' 31' ' ' TYR . 14.8 tp10 -161.92 136.58 7.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.923 -1.339 . . . . 0.0 111.223 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 53' ' ' PHE . 68.8 m -104.47 124.43 49.25 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.764 ' CD1' HD11 ' A' ' 102' ' ' LEU . 76.2 m-85 -103.13 172.96 6.52 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.106 -0.996 . . . . 0.0 111.55 -179.826 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.531 ' CE1' ' OG ' ' A' ' 52' ' ' SER . 96.3 m-85 -124.13 100.25 6.63 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.768 HG23 ' O ' ' A' ' 33' ' ' ILE . 5.7 tt -86.59 104.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.12 -0.988 . . . . 0.0 109.863 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.624 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -148.83 166.24 29.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.446 -0.784 . . . . 0.0 110.478 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.604 ' CD ' HD12 ' A' ' 107' ' ' LEU . 8.1 mt-30 -97.82 144.33 27.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 109.782 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.8 m -145.27 151.22 38.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.01 . . . . 0.0 110.952 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -148.78 164.6 20.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.585 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 41.6 Cg_endo -69.15 162.35 42.11 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.788 1.415 . . . . 0.0 110.605 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 40' ' ' GLY . 8.2 p -141.73 174.72 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.468 -0.77 . . . . 0.0 110.17 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.526 ' N ' HG22 ' A' ' 39' ' ' VAL . . . -49.21 -46.03 34.57 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.35 -67.58 1.96 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -163.49 -72.58 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.307 -1.114 . . . . 0.0 110.029 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 5.8 p30 -132.33 158.57 41.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 110.208 179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.67 165.4 33.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.975 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.498 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.8 m -141.77 168.12 20.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.179 -0.951 . . . . 0.0 110.236 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.51 ' OD1' ' CB ' ' A' ' 71' ' ' TYR . 0.3 OUTLIER -100.86 100.35 12.54 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.172 -179.976 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 46.0 Cg_endo -72.78 -34.61 6.65 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.013 1.533 . . . . 0.0 110.416 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.09 92.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 110.3 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.3 p -98.57 25.41 6.44 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.333 -0.854 . . . . 0.0 109.994 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 46' ' ' ASN . . . -86.49 110.75 19.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.915 . . . . 0.0 110.302 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.582 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 7.5 t -116.32 133.45 56.01 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.319 -0.863 . . . . 0.0 110.018 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.531 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 12.2 t -108.77 137.79 46.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.279 -0.888 . . . . 0.0 110.58 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 30.3 p90 -135.38 -177.98 4.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 110.016 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 40.3 m -138.29 152.88 48.94 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.317 -0.865 . . . . 0.0 109.761 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.632 HG23 ' HE2' ' A' ' 31' ' ' TYR . 2.5 p -61.58 -162.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.942 -1.099 . . . . 0.0 109.963 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.612 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 3.0 t70 -143.43 -164.26 1.83 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.06 -1.025 . . . . 0.0 110.675 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.81 82.82 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.097 -1.002 . . . . 0.0 108.831 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -90.25 16.27 8.92 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 55.45 30.48 55.68 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.81 133.88 52.98 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.459 -1.024 . . . . 0.0 110.341 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.52 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -137.57 84.97 2.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.268 -0.895 . . . . 0.0 110.683 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.66 112.71 25.6 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.268 -0.895 . . . . 0.0 109.149 179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -145.91 179.53 7.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.106 -0.996 . . . . 0.0 111.024 -179.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -93.9 145.44 24.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.572 -0.705 . . . . 0.0 110.565 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.542 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 52.6 t80 -139.64 177.18 8.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.435 -0.791 . . . . 0.0 109.593 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.542 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 21.6 t -132.08 165.23 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.825 -1.172 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 66' ' ' VAL . 13.5 m -141.33 129.22 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.452 -0.78 . . . . 0.0 110.098 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -108.58 144.79 35.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 110.259 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.541 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 20.6 ttpt -68.95 -39.7 79.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.077 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 p -132.8 155.12 49.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.548 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 13.4 p90 -162.17 147.58 12.9 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.149 -0.97 . . . . 0.0 110.661 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 m -60.17 113.6 2.44 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.354 -0.841 . . . . 0.0 110.367 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.513 ' HA3' ' CG2' ' A' ' 84' ' ' VAL . . . -99.14 150.31 19.22 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.9 m -138.26 152.25 48.39 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.151 -1.206 . . . . 0.0 110.215 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.484 HG23 ' CG2' ' A' ' 81' ' ' VAL . 68.8 p -69.48 165.58 38.87 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.335 -0.853 . . . . 0.0 110.209 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 47.0 Cg_endo -74.14 -22.64 16.64 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.916 1.482 . . . . 0.0 110.583 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -15.88 63.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.21 -0.931 . . . . 0.0 110.226 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.65 37.71 3.64 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.0 m -135.59 122.29 14.47 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.227 -1.161 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.01 127.1 9.77 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.912 1.48 . . . . 0.0 110.188 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.484 ' CG2' HG23 ' A' ' 75' ' ' THR . 5.9 t -102.18 -35.97 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 110.176 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 173.11 -150.95 12.83 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 m -108.69 138.83 44.38 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.303 -1.116 . . . . 0.0 110.31 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.513 ' CG2' ' HA3' ' A' ' 73' ' ' GLY . 58.9 t -92.49 133.6 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.81 . . . . 0.0 109.665 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -113.38 135.72 53.55 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.99 -1.069 . . . . 0.0 110.117 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 69' ' ' LYS . 1.3 t -85.26 1.07 49.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.69 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.54 -61.66 1.72 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.085 -1.009 . . . . 0.0 110.547 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.3 t -84.56 -16.74 41.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.215 -0.928 . . . . 0.0 110.384 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.04 158.7 22.74 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.142 -0.974 . . . . 0.0 110.265 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.84 144.7 27.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.083 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 3.7 m -125.01 129.52 50.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.24 -0.913 . . . . 0.0 110.098 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 92' ' ' ASN . 1.8 m120 -111.62 127.68 55.82 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 110.014 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.624 HD12 ' O ' ' A' ' 34' ' ' ALA . 15.1 tp -93.23 108.9 20.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.92 . . . . 0.0 109.216 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -128.88 170.87 19.93 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.25 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -140.13 123.42 16.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -1.022 . . . . 0.0 109.866 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.93 166.59 36.29 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.492 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 5.1 p-10 -100.54 -43.39 6.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -1.113 . . . . 0.0 110.288 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 43.0 t -179.41 -43.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.18 -0.95 . . . . 0.0 110.627 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.67 27.45 3.21 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.512 HD22 ' HE1' ' A' ' 31' ' ' TYR . 3.4 tt -111.84 -44.57 3.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -1.187 . . . . 0.0 110.061 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.8 96.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.342 -0.848 . . . . 0.0 110.249 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.764 HD11 ' CD1' ' A' ' 31' ' ' TYR . 43.6 mt -83.68 -41.1 18.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -0.906 . . . . 0.0 110.258 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.99 162.24 12.97 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 104' ' ' HIS . 5.3 p80 -145.5 122.06 11.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.519 -0.989 . . . . 0.0 109.751 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.502 HG11 HG12 ' A' ' 6' ' ' VAL . 91.5 t -96.86 113.92 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.541 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.4 117.84 6.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 109.812 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.604 HD12 ' CD ' ' A' ' 35' ' ' GLN . 83.5 mt -93.52 144.43 25.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.249 -0.907 . . . . 0.0 110.516 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 m -127.18 162.14 26.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 110.288 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.472 ' CD2' ' HG3' ' A' ' 69' ' ' LYS . 6.6 m-85 -135.72 126.62 27.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.202 -0.937 . . . . 0.0 110.058 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 118.036 -1.424 . . . . 0.0 109.611 179.897 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.4 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.755 0.312 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.506 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 47.3 Cg_endo -72.74 -163.66 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.909 1.478 . . . . 0.0 110.495 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -148.31 148.7 30.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.899 . . . . 0.0 110.411 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 17.1 t80 -148.24 115.45 6.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.305 -0.872 . . . . 0.0 109.76 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 t -143.55 153.45 42.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.991 -1.068 . . . . 0.0 111.092 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.532 HG22 ' HD2' ' A' ' 8' ' ' PRO . 4.8 p -131.27 168.81 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.516 -0.74 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.645 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -93.22 -63.1 0.16 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.864 -1.147 . . . . 0.0 110.329 179.965 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.645 ' HD3' ' CB ' ' A' ' 7' ' ' SER . 55.2 Cg_endo -84.66 99.9 0.74 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 O-C-N 123.159 1.084 . . . . 0.0 110.08 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.03 -0.8 50.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.997 -1.065 . . . . 0.0 110.352 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.1 p -151.49 165.64 33.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.903 . . . . 0.0 109.95 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.09 64.27 3.91 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.44 ' O ' ' CE2' ' A' ' 109' ' ' PHE . 4.7 mt -117.03 139.63 50.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.412 -1.052 . . . . 0.0 110.337 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 15.0 t -100.96 158.72 15.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 110.241 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 4.4 p-10 -68.84 112.4 5.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 0.0 110.14 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.1 -24.92 21.9 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 37.6 tt0 -59.36 155.29 14.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.29 -1.123 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 18' ' ' VAL . 20.7 t -99.32 -179.17 4.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.478 -0.763 . . . . 0.0 110.245 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.794 HG23 ' HB3' ' A' ' 65' ' ' PHE . 14.0 m -154.55 176.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 0.0 110.045 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.5 m -118.25 123.73 46.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 110.094 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.27 151.3 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.155 -0.966 . . . . 0.0 110.299 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.9 m -140.62 123.35 16.25 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.406 -0.809 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 84.7 t -113.88 132.69 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 75.5 m -145.12 128.28 16.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.041 . . . . 0.0 110.59 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 140.02 -57.39 0.6 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.76 ' CB ' HG21 ' A' ' 55' ' ' THR . . . -54.63 -167.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -1.163 . . . . 0.0 109.741 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.551 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -159.35 156.14 28.03 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.032 -1.043 . . . . 0.0 110.669 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -38.7 121.87 1.09 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.644 -0.66 . . . . 0.0 110.968 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.76 10.56 3.91 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 4.4 mm-40 -146.36 119.07 8.59 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.071 -1.252 . . . . 0.0 110.843 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.417 HG23 ' OG1' ' A' ' 54' ' ' THR . 88.0 m -105.92 114.11 28.06 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.973 ' CE1' HD22 ' A' ' 100' ' ' LEU . 32.2 m-85 -96.85 -178.16 4.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.1 -1.0 . . . . 0.0 111.769 -179.804 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 31' ' ' TYR . 22.4 m-85 -134.54 124.43 25.48 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 33' ' ' ILE . 3.3 tt -105.41 119.66 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.904 -1.123 . . . . 0.0 110.991 -179.823 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . . . -152.96 171.85 17.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.331 -0.856 . . . . 0.0 110.01 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 6.1 pt20 -127.52 156.27 42.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.24 -0.913 . . . . 0.0 110.006 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 9.6 m -140.73 169.51 17.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.12 -0.988 . . . . 0.0 110.383 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -150.07 163.13 25.69 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.331 -0.856 . . . . 0.0 110.028 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -79.05 170.29 18.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.951 1.501 . . . . 0.0 110.635 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.874 HG23 ' H ' ' A' ' 42' ' ' GLN . 1.5 m -133.22 -169.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.335 -0.853 . . . . 0.0 110.305 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.79 34.03 4.21 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.46 -39.99 0.02 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.874 ' H ' HG23 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -157.19 -116.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -1.166 . . . . 0.0 110.301 -179.978 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -133.0 167.0 21.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.765 -1.209 . . . . 0.0 110.425 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -159.3 175.24 13.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.358 -0.839 . . . . 0.0 110.072 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 38.9 t -158.95 165.92 33.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.346 -0.846 . . . . 0.0 110.242 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.504 ' ND2' HG23 ' A' ' 49' ' ' THR . 57.1 t-20 -97.29 121.29 59.12 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.295 -0.878 . . . . 0.0 110.629 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -81.75 -33.41 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.936 1.493 . . . . 0.0 110.822 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.81 96.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.192 -0.943 . . . . 0.0 110.595 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.504 HG23 ' ND2' ' A' ' 46' ' ' ASN . 54.1 p -78.05 5.72 9.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 0.0 110.443 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.568 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -84.12 88.76 7.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 110.565 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.549 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 12.8 t -99.53 174.49 6.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.556 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 2.8 t -131.78 148.42 52.56 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.988 -1.07 . . . . 0.0 111.063 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 24.9 p90 -150.3 151.62 33.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.508 -0.745 . . . . 0.0 109.343 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.417 ' OG1' HG23 ' A' ' 30' ' ' THR . 10.4 m -119.84 155.54 32.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.028 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.76 HG21 ' CB ' ' A' ' 25' ' ' ALA . 3.8 p -67.13 -158.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.298 -0.876 . . . . 0.0 110.297 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 8.8 m-20 -143.75 -162.93 1.55 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.06 -1.025 . . . . 0.0 109.985 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.77 -40.21 96.13 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.096 -1.002 . . . . 0.0 109.188 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 t -90.27 10.77 23.43 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.516 -0.74 . . . . 0.0 109.507 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.551 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 59.35 61.06 7.71 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.59 135.18 23.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.282 -1.128 . . . . 0.0 110.088 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -137.13 84.92 2.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 110.92 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.11 118.31 36.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.115 -0.991 . . . . 0.0 108.619 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -151.98 179.55 8.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.952 -1.092 . . . . 0.0 110.908 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.6 p -89.6 157.16 18.15 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.544 -0.722 . . . . 0.0 110.156 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.794 ' HB3' HG23 ' A' ' 18' ' ' VAL . 34.4 t80 -138.41 177.43 7.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.423 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.435 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.5 t -135.87 155.18 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.817 -1.177 . . . . 0.0 110.108 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 12' ' ' LEU . 25.7 m -133.25 169.76 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.432 -0.792 . . . . 0.0 109.814 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 14' ' ' ASP . 1.3 ttt85 -149.1 141.9 24.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.202 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -74.16 -48.07 31.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 110.22 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 95.4 p -119.9 144.75 47.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.933 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.543 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 21.5 p90 -162.01 142.79 10.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.112 -0.992 . . . . 0.0 110.693 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 54.1 m -55.66 122.29 11.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.304 -0.872 . . . . 0.0 109.877 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.1 168.78 13.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.9 t -157.95 153.01 25.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -1.065 . . . . 0.0 109.979 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.475 ' OG1' ' HB ' ' A' ' 79' ' ' THR . 57.0 p -56.55 162.21 3.58 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.095 -1.003 . . . . 0.0 110.199 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.22 -31.39 5.98 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.147 1.604 . . . . 0.0 110.383 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -68.8 -34.42 75.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.334 -0.854 . . . . 0.0 110.187 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.8 67.49 0.14 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.475 ' HB ' ' OG1' ' A' ' 75' ' ' THR . 11.4 m -150.77 106.33 3.05 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.183 -1.187 . . . . 0.0 110.019 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.35 136.87 27.24 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.075 1.566 . . . . 0.0 110.539 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.6 t -123.18 -76.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.333 -0.855 . . . . 0.0 110.271 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.12 -155.91 6.74 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 90.7 p -97.4 150.69 20.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.31 -1.112 . . . . 0.0 110.427 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.466 HG22 HG12 ' A' ' 39' ' ' VAL . 78.0 t -112.19 153.79 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.279 -0.888 . . . . 0.0 110.134 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -140.11 126.05 19.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 110.147 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 43.3 t -85.03 43.51 1.01 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.196 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.35 -52.13 5.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 110.193 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.6 t -101.28 1.08 38.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.124 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.36 -162.84 0.91 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.17 -0.956 . . . . 0.0 110.288 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.26 136.03 51.42 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.868 . . . . 0.0 110.151 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 2.3 p -125.05 127.79 47.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 110.071 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -107.89 165.75 11.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.377 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 107' ' ' LEU . 7.8 tp -128.54 110.71 12.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 109.544 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.579 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -116.28 162.58 12.59 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.298 -179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.39 167.87 13.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.978 . . . . 0.0 109.869 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 115.8 -166.05 12.24 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.403 ' CG ' ' N ' ' A' ' 98' ' ' SER . 7.9 t30 -147.59 168.71 21.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -1.177 . . . . 0.0 110.222 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.403 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 1.6 m -49.71 107.12 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 121.9 -46.69 1.09 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.973 HD22 ' CE1' ' A' ' 31' ' ' TYR . 0.4 OUTLIER -103.05 163.14 12.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -1.142 . . . . 0.0 110.135 179.987 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -146.68 131.25 17.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.333 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 4' ' ' PHE . 97.8 mt -106.96 -45.55 4.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.087 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 161.17 173.11 29.38 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.579 ' CE1' ' HA3' ' A' ' 94' ' ' GLY . 3.1 m-70 -140.85 108.32 5.57 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.343 -1.092 . . . . 0.0 109.94 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.525 HG11 HG12 ' A' ' 6' ' ' VAL . 1.9 t -90.21 113.67 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.32 -0.863 . . . . 0.0 110.445 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.69 130.87 47.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.169 -0.957 . . . . 0.0 109.88 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.876 HD11 ' HB2' ' A' ' 93' ' ' LEU . 31.5 mt -100.29 166.61 10.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.1 -1.0 . . . . 0.0 110.175 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -137.03 161.52 35.85 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.282 -0.886 . . . . 0.0 110.013 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' A' ' 12' ' ' LEU . 7.2 m-85 -139.65 148.16 42.03 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.349 -0.844 . . . . 0.0 110.05 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.04 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.964 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.402 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.749 0.309 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.502 ' HA ' ' HA3' ' A' ' 24' ' ' GLY . 46.1 Cg_endo -71.28 -158.34 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.999 1.526 . . . . 0.0 110.145 179.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -147.06 124.81 11.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.103 -0.998 . . . . 0.0 110.427 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.514 ' HE2' HD12 ' A' ' 33' ' ' ILE . 14.1 t80 -138.76 114.6 10.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.408 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.455 ' HA ' HG21 ' A' ' 105' ' ' VAL . 34.2 t -150.43 172.24 15.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.987 -1.071 . . . . 0.0 110.943 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.546 HG23 HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -130.02 145.55 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.854 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.622 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -66.17 -66.99 1.07 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.974 -1.079 . . . . 0.0 109.906 179.993 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.799 ' O ' HD21 ' A' ' 12' ' ' LEU . 56.0 Cg_endo -79.27 69.47 7.91 Favored 'Trans proline' 0 N--CA 1.483 0.873 0 O-C-N 123.465 1.245 . . . . 0.0 110.081 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.41 -11.92 59.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.951 -1.093 . . . . 0.0 110.481 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.8 126.23 31.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 110.164 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.9 71.69 1.25 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.799 HD21 ' O ' ' A' ' 8' ' ' PRO . 91.5 mt -112.57 165.67 12.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -1.144 . . . . 0.0 110.077 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -133.22 148.56 52.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.152 -0.967 . . . . 0.0 110.487 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -60.43 129.5 41.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.887 . . . . 0.0 110.141 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.01 -30.56 5.79 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -57.26 151.96 14.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.362 -1.081 . . . . 0.0 110.411 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -101.97 135.03 44.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.389 -0.819 . . . . 0.0 110.088 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.525 HG11 HG11 ' A' ' 67' ' ' VAL . 18.2 m -100.95 171.25 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.981 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.96 114.09 24.16 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.028 -1.045 . . . . 0.0 109.968 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.546 HG22 HG23 ' A' ' 6' ' ' VAL . 17.6 t -101.6 149.27 6.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.264 -0.897 . . . . 0.0 110.297 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.0 t -150.02 128.18 12.0 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.483 -0.76 . . . . 0.0 110.183 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 52.4 t -120.71 137.69 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 109.887 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.719 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 2.3 p -150.52 111.0 4.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.957 -1.089 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 2' ' ' PRO . . . 160.95 -52.14 0.34 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.583 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -60.27 -151.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -1.131 . . . . 0.0 110.096 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.531 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -167.83 163.51 14.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.137 -0.977 . . . . 0.0 110.545 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -50.24 128.75 20.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.557 -0.714 . . . . 0.0 111.059 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.432 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . 122.36 7.94 7.34 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.526 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 5.7 mm-40 -141.3 129.72 22.49 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.093 -1.239 . . . . 0.0 110.687 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.568 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.7 m -115.02 151.94 33.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 109.324 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 30' ' ' THR . 7.9 m-85 -139.7 -178.16 5.29 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.902 -1.124 . . . . 0.0 111.298 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 52' ' ' SER . 55.4 m-85 -132.99 108.35 8.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.744 HG22 HG23 ' A' ' 51' ' ' THR . 4.1 tt -87.56 125.44 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.154 -0.966 . . . . 0.0 110.851 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.729 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -152.1 165.21 35.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.24 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.457 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 1.0 OUTLIER -118.05 150.85 38.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.204 -0.935 . . . . 0.0 110.029 179.986 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 72.2 m -150.8 164.65 35.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.897 . . . . 0.0 111.001 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.42 149.41 22.73 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.571 -0.706 . . . . 0.0 109.495 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.52 164.42 32.93 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.839 1.442 . . . . 0.0 110.536 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 42' ' ' GLN . 17.4 m -134.32 57.22 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.333 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.57 -14.81 15.83 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -178.2 -48.22 0.07 OUTLIER Glycine 0 N--CA 1.492 2.433 0 O-C-N 120.688 -1.478 . . . . 0.0 110.671 179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.822 ' O ' HG22 ' A' ' 39' ' ' VAL . 1.8 tp60 -88.92 165.4 14.63 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.07 -1.253 . . . . 0.0 110.693 -179.875 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -98.95 127.44 44.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 110.039 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 36' ' ' CYS . . . -110.52 150.71 28.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.155 -0.966 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.422 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.3 m -136.65 160.38 39.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.261 -0.899 . . . . 0.0 110.267 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.84 95.37 16.84 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.242 -0.911 . . . . 0.0 110.369 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 48.8 Cg_endo -76.55 -30.45 5.05 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.966 1.508 . . . . 0.0 110.452 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.84 -38.95 70.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.309 -0.869 . . . . 0.0 110.295 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.49 36.82 1.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.817 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.3 144.11 28.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.489 -0.757 . . . . 0.0 110.788 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.744 HG23 HG22 ' A' ' 33' ' ' ILE . 11.0 t -151.22 143.51 24.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.833 . . . . 0.0 109.736 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.496 ' HB3' ' CE1' ' A' ' 32' ' ' TYR . 12.2 p -109.76 151.61 26.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.083 -1.011 . . . . 0.0 110.532 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -151.14 136.22 17.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.52 ' OG1' HG23 ' A' ' 30' ' ' THR . 26.3 m -102.15 171.95 7.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.256 -0.902 . . . . 0.0 110.571 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.583 HG21 ' HB3' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -84.89 -160.89 0.52 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.301 -0.874 . . . . 0.0 110.222 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 1.6 m-20 -149.1 -157.88 0.86 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.205 -0.935 . . . . 0.0 109.827 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.7 -53.66 55.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.91 -1.119 . . . . 0.0 109.997 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 t -87.12 16.17 5.38 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.265 -0.897 . . . . 0.0 109.215 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 56.84 48.79 75.63 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.0 129.98 56.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.282 -1.128 . . . . 0.0 110.426 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.572 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -132.18 85.1 2.21 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.331 -0.856 . . . . 0.0 110.077 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.7 p -110.63 134.3 52.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 109.901 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 25.8 p90 -163.85 173.64 12.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.233 -0.917 . . . . 0.0 110.504 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 t -94.08 137.9 32.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.797 . . . . 0.0 110.446 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.485 ' CE2' ' O ' ' A' ' 66' ' ' VAL . 55.8 t80 -127.39 -179.46 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.532 -0.73 . . . . 0.0 109.374 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.485 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 2.2 t -128.02 154.92 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.853 -1.154 . . . . 0.0 110.209 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 22.2 m -129.0 178.67 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.373 -0.83 . . . . 0.0 110.111 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 3.0 mtp180 -150.31 118.66 6.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.849 . . . . 0.0 110.313 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 11.2 ttmt -49.81 -36.71 27.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.197 -0.939 . . . . 0.0 109.773 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.64 141.81 31.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.902 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.469 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 24.2 p90 -151.67 141.76 22.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.5 OUTLIER -66.51 136.93 56.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.173 -179.933 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.74 170.38 49.06 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 79' ' ' THR . 8.4 t -152.97 132.89 13.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -1.172 . . . . 0.0 110.231 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.523 ' OG1' ' CB ' ' A' ' 79' ' ' THR . 8.5 p -89.72 167.91 16.2 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.181 -0.949 . . . . 0.0 110.065 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 49.4 Cg_endo -77.74 8.12 3.56 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.019 1.536 . . . . 0.0 110.74 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.486 ' OE2' ' OG1' ' A' ' 79' ' ' THR . 0.4 OUTLIER -127.76 -28.35 2.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.092 -1.005 . . . . 0.0 110.403 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.413 ' C ' ' OG1' ' A' ' 79' ' ' THR . . . 137.47 81.65 0.1 Allowed Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.536 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.523 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 2.8 m -163.76 118.35 1.09 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.216 -1.167 . . . . 0.0 109.793 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.51 -14.27 36.62 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.863 1.454 . . . . 0.0 110.573 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.693 ' O ' HG12 ' A' ' 81' ' ' VAL . 93.6 t 49.33 21.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.231 -0.918 . . . . 0.0 110.344 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.64 -153.88 43.01 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.7 OUTLIER -102.16 139.1 38.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.498 -1.001 . . . . 0.0 110.841 -179.859 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.538 HG22 HG12 ' A' ' 39' ' ' VAL . 56.0 t -112.01 108.71 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 109.546 179.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -88.24 135.78 33.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 0.0 110.246 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 91' ' ' CYS . 7.5 m -110.79 41.82 1.72 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.88 -52.01 3.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 109.964 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -99.17 -9.24 24.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.861 . . . . 0.0 110.063 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.87 -133.41 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 109.935 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -151.05 97.26 2.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.082 -1.011 . . . . 0.0 110.807 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -88.51 113.41 24.07 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.184 -0.948 . . . . 0.0 109.048 179.914 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 16.6 p30 -113.48 129.73 56.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.972 -1.08 . . . . 0.0 111.293 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 34' ' ' ALA . 13.1 tp -99.43 111.13 23.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.366 -0.834 . . . . 0.0 109.373 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -125.43 171.92 17.39 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 102' ' ' LEU . . . -134.84 178.98 6.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -1.078 . . . . 0.0 110.021 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 101' ' ' ASP . . . 138.48 157.56 7.45 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.42 ' OD1' ' HB2' ' A' ' 98' ' ' SER . 8.2 p30 -107.55 -29.19 9.33 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.28 -1.129 . . . . 0.0 110.328 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.42 ' HB2' ' OD1' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -172.18 -72.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.7 -10.7 32.37 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.54 ' CD2' ' CE1' ' A' ' 31' ' ' TYR . 21.5 tp -73.78 -64.59 0.97 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.02 -1.282 . . . . 0.0 110.196 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 92.3 m-20 55.29 103.33 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -79.01 -6.11 55.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 110.374 179.966 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 94' ' ' GLY . . . 106.97 -175.39 20.62 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.476 ' O ' ' ND1' ' A' ' 104' ' ' HIS . 34.2 p80 -148.7 132.22 16.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.251 -1.146 . . . . 0.0 110.132 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.455 HG21 ' HA ' ' A' ' 5' ' ' SER . 54.4 t -93.83 130.46 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.147 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.47 114.29 8.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 110.408 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HB3' HD12 ' A' ' 12' ' ' LEU . 34.7 mt -93.2 136.5 33.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.848 . . . . 0.0 110.354 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.594 HG22 ' N ' ' A' ' 109' ' ' PHE . 98.3 m -107.25 173.2 6.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.291 -0.88 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.594 ' N ' HG22 ' A' ' 108' ' ' THR . 7.6 m-85 -142.8 122.69 13.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.889 . . . . 0.0 110.292 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.973 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 120.747 0.308 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 47.1 Cg_endo -72.77 -162.58 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.115 1.587 . . . . 0.0 110.551 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -132.13 146.7 52.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.222 -0.924 . . . . 0.0 110.596 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 12.4 t80 -149.5 113.17 5.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.462 -0.774 . . . . 0.0 109.592 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.62 ' HA ' HG21 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -151.15 167.02 29.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.032 -1.042 . . . . 0.0 110.959 -179.9 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.646 HG12 HG11 ' A' ' 105' ' ' VAL . 7.5 p -128.25 141.05 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.725 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -55.88 -67.38 0.77 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.08 -1.012 . . . . 0.0 110.289 -179.965 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 7' ' ' SER . 49.5 Cg_endo -74.4 82.81 1.8 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.386 1.203 . . . . 0.0 109.807 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.65 1.99 52.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.975 . . . . 0.0 110.501 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.8 p -150.27 148.89 29.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.252 -0.905 . . . . 0.0 110.165 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.3 58.71 3.55 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mt -105.44 170.63 7.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.303 -1.116 . . . . 0.0 110.45 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.47 149.4 43.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 110.183 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.8 96.94 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.83 -34.06 3.23 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -54.22 142.89 24.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 110.143 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 66.3 m -91.68 134.09 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 110.069 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.614 HG11 HG11 ' A' ' 67' ' ' VAL . 23.2 m -100.88 148.86 6.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 110.168 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.21 106.1 18.11 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.34 -0.85 . . . . 0.0 109.309 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.525 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 36.9 t -93.37 149.74 4.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.499 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.75 119.27 5.63 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.857 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.85 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 23.8 t -107.08 132.51 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.771 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.673 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 30.3 m -127.77 120.36 27.72 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 25' ' ' ALA . . . 148.75 -77.69 0.23 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.609 ' HB3' HG21 ' A' ' 55' ' ' THR . . . -47.12 172.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.216 -1.167 . . . . 0.0 110.029 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.542 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . . . -139.6 161.63 37.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 110.464 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -39.04 122.79 1.25 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.674 -0.641 . . . . 0.0 110.653 -179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.57 0.76 7.84 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.497 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . 30.9 mm-40 -132.93 130.51 39.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -1.184 . . . . 0.0 110.597 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.427 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 57.5 m -106.34 161.25 14.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.503 -0.748 . . . . 0.0 109.659 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.72 ' HE1' HD22 ' A' ' 100' ' ' LEU . 80.1 m-85 -149.96 176.47 10.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.041 -1.037 . . . . 0.0 110.552 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 17.7 m-85 -122.78 147.62 46.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.456 -0.778 . . . . 0.0 109.093 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.585 ' CG2' ' CG2' ' A' ' 51' ' ' THR . 5.2 tt -128.35 116.53 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.955 -1.091 . . . . 0.0 110.15 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.615 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -148.46 158.58 44.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.917 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.45 ' OE1' ' HB3' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -93.62 136.12 34.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.608 -0.682 . . . . 0.0 109.958 179.912 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.2 m -142.98 143.39 31.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.783 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -144.89 174.72 3.24 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.454 -0.778 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.783 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 43.1 Cg_endo -71.86 165.67 31.86 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.733 1.386 . . . . 0.0 110.351 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.4 p -146.41 84.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.297 -0.877 . . . . 0.0 110.366 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.28 3.8 54.23 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 143.11 -51.7 0.66 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.58 -141.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.367 -1.078 . . . . 0.0 110.006 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.36 127.76 7.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.106 -0.996 . . . . 0.0 110.405 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.473 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -117.37 151.9 36.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.35 -0.844 . . . . 0.0 109.895 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.49 ' O ' ' HA2' ' A' ' 73' ' ' GLY . 2.4 m -116.05 164.34 14.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.153 -0.967 . . . . 0.0 110.368 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.47 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 59.3 t-20 -96.0 123.2 56.17 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.275 -0.891 . . . . 0.0 110.174 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.76 -33.74 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.861 1.453 . . . . 0.0 110.681 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.45 -19.77 65.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.346 -0.846 . . . . 0.0 110.815 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.16 32.93 5.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.045 -1.035 . . . . 0.0 110.476 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.52 106.29 18.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.224 -0.922 . . . . 0.0 110.511 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.585 ' CG2' ' CG2' ' A' ' 33' ' ' ILE . 14.9 t -131.42 -178.57 4.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.0 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.4 ' CB ' ' CD1' ' A' ' 32' ' ' TYR . 55.6 p -144.12 147.19 33.4 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.115 -0.991 . . . . 0.0 110.839 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 20.6 p90 -136.09 -176.99 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.763 . . . . 0.0 109.539 179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.5 m -145.47 154.32 42.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.796 -1.19 . . . . 0.0 110.256 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.609 HG21 ' HB3' ' A' ' 25' ' ' ALA . 2.0 p -69.99 -158.02 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.209 -0.932 . . . . 0.0 109.915 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 3.3 m-20 -160.03 -155.67 0.45 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.902 -1.124 . . . . 0.0 110.148 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.14 78.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.918 -1.114 . . . . 0.0 109.527 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 t -79.29 4.99 13.51 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.379 -0.825 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 56.05 38.03 74.05 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -124.91 127.19 46.71 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.268 -1.136 . . . . 0.0 110.104 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.85 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -101.14 80.35 2.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 110.365 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.9 m -101.08 120.18 39.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.676 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.525 ' CE1' ' HB ' ' A' ' 20' ' ' VAL . 7.0 p90 -155.73 174.79 14.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.192 -0.942 . . . . 0.0 110.833 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.5 m -98.32 132.6 43.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 40.5 t80 -130.35 179.63 5.8 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.443 -0.786 . . . . 0.0 109.238 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.467 ' N ' ' CG ' ' A' ' 65' ' ' PHE . 2.8 t -129.38 155.9 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.81 -1.181 . . . . 0.0 110.352 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.614 HG11 HG11 ' A' ' 18' ' ' VAL . 31.8 m -125.21 159.02 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.404 -0.81 . . . . 0.0 110.357 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -133.21 132.9 42.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.263 -0.898 . . . . 0.0 110.034 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -72.8 -10.83 60.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.137 -0.977 . . . . 0.0 110.362 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.2 p -150.29 139.37 21.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.131 -0.981 . . . . 0.0 110.536 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 9.6 p90 -168.09 138.76 2.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.299 -0.876 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 0.2 OUTLIER -68.68 137.34 54.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.258 -0.901 . . . . 0.0 110.091 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 45' ' ' CYS . . . -121.7 -166.48 12.88 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 p -158.88 -176.01 5.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -1.115 . . . . 0.0 110.138 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.4 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 1.2 p -75.69 168.49 27.28 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.36 -0.838 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 49.5 Cg_endo -80.2 14.57 1.91 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.058 1.557 . . . . 0.0 111.106 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' A' ' 78' ' ' GLY . 12.8 pt-20 -123.2 -41.09 2.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.947 -1.096 . . . . 0.0 110.358 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.522 ' N ' ' HG3' ' A' ' 77' ' ' GLU . . . 142.09 52.14 0.04 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.1 m -151.35 113.51 3.04 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.289 -1.124 . . . . 0.0 110.119 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.31 145.19 42.81 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.913 1.48 . . . . 0.0 110.693 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.452 HG13 ' N ' ' A' ' 82' ' ' GLY . 6.2 p -138.86 -36.94 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 110.319 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.452 ' N ' HG13 ' A' ' 81' ' ' VAL . . . -162.98 -171.79 29.65 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.7 OUTLIER -105.79 176.1 5.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -1.147 . . . . 0.0 110.283 179.947 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 44' ' ' ALA . 74.0 t -125.21 159.1 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.383 -0.823 . . . . 0.0 110.21 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -154.75 146.61 23.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.882 . . . . 0.0 110.056 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.81 17.73 22.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 110.105 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.62 -42.78 61.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 110.674 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -117.74 -16.42 10.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.148 -0.97 . . . . 0.0 110.361 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.43 147.09 34.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.953 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.17 154.51 27.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 0.0 110.178 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.45 ' HB3' ' OE1' ' A' ' 35' ' ' GLN . 82.7 m -120.93 162.74 19.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 0.0 110.329 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -146.09 121.3 10.18 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.31 -0.868 . . . . 0.0 110.237 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 34' ' ' ALA . 45.2 tp -86.95 112.1 21.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.046 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.584 ' HA3' ' CD2' ' A' ' 104' ' ' HIS . . . -121.14 163.37 14.61 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.501 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 102' ' ' LEU . . . -132.42 159.07 40.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.551 -0.97 . . . . 0.0 110.507 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 101' ' ' ASP . . . 169.31 159.2 14.45 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 31' ' ' TYR . 1.5 p30 -143.34 -41.14 0.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.991 -1.299 . . . . 0.0 111.246 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.43 78.01 1.2 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.951 -1.093 . . . . 0.0 111.294 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.45 9.24 29.97 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.72 HD22 ' HE1' ' A' ' 31' ' ' TYR . 1.6 tt -99.35 -51.33 3.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.285 . . . . 0.0 109.827 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.523 ' HA ' ' CA ' ' A' ' 96' ' ' GLY . 1.1 m-20 54.21 164.54 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.485 -0.759 . . . . 0.0 110.123 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 31.7 mt -126.36 -47.68 1.59 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.904 -179.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 167.35 174.35 36.36 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.584 ' CD2' ' HA3' ' A' ' 94' ' ' GLY . 1.9 m170 -129.56 126.77 39.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.851 -0.793 . . . . 0.0 109.652 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.646 HG11 HG12 ' A' ' 6' ' ' VAL . 20.0 t -108.23 120.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.048 -1.032 . . . . 0.0 110.439 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.06 107.55 10.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.932 . . . . 0.0 109.382 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 12.6 mt -88.61 171.86 9.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.308 -0.87 . . . . 0.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -147.77 158.68 44.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.449 -0.782 . . . . 0.0 109.838 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -122.16 119.85 32.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.058 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.59 179.997 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.437 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.809 0.338 . . . . 0.0 110.138 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 1' ' ' ALA . 43.8 Cg_endo -69.3 -174.01 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.999 1.526 . . . . 0.0 110.49 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 23' ' ' SER . . . -154.04 121.77 5.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.897 . . . . 0.0 110.334 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -141.47 110.79 6.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.211 -0.931 . . . . 0.0 109.562 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.8 t -150.69 161.13 43.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.078 -1.014 . . . . 0.0 110.999 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.91 ' CG1' ' HB2' ' A' ' 9' ' ' ALA . 6.2 p -114.93 160.42 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.494 -0.754 . . . . 0.0 109.674 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -62.96 -66.52 1.5 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.048 -1.032 . . . . 0.0 110.561 -179.993 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.758 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 43.1 Cg_endo -73.54 -73.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.424 1.223 . . . . 0.0 110.591 -179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.91 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . . . 75.26 -1.04 3.15 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.443 -0.786 . . . . 0.0 110.203 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.446 ' OG ' ' C ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER -164.21 145.42 8.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 110.248 -179.951 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.96 41.22 61.83 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 108' ' ' THR . 1.3 mp -90.78 174.79 7.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -1.164 . . . . 0.0 110.091 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 16' ' ' GLN . 1.5 t -128.56 150.34 50.24 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.361 -0.837 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 6.2 p-10 -56.94 108.04 0.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.189 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.92 -35.19 5.09 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.4 tt0 -45.95 152.94 0.33 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.303 -1.116 . . . . 0.0 110.357 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 3.6 p -103.53 154.4 19.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.403 -0.811 . . . . 0.0 110.378 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.1 m -129.13 150.23 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.302 -0.874 . . . . 0.0 110.026 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 m -94.91 115.15 27.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.136 -0.978 . . . . 0.0 109.842 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t -100.8 147.65 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 2.8 t -146.06 139.3 25.95 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.47 -0.769 . . . . 0.0 110.469 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 61' ' ' ALA . 47.6 t -128.29 153.59 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.526 -0.734 . . . . 0.0 110.007 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.56 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 7.3 m -165.89 120.89 1.23 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.946 -1.096 . . . . 0.0 110.672 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 25' ' ' ALA . . . 139.29 -59.98 0.58 Allowed Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.354 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.75 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -39.53 -47.9 1.95 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.199 -1.177 . . . . 0.0 110.985 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 25' ' ' ALA . . . 73.99 141.79 0.07 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.398 -0.814 . . . . 0.0 110.595 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 56' ' ' ASP . . . -39.13 136.33 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.527 0.68 . . . . 0.0 110.866 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.01 12.55 4.36 Favored Glycine 0 N--CA 1.481 1.643 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -156.3 126.73 6.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.056 -1.261 . . . . 0.0 110.62 179.975 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.809 HG23 ' OG1' ' A' ' 54' ' ' THR . 1.6 m -94.1 143.11 26.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.463 -0.773 . . . . 0.0 109.858 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.618 ' CE1' HD22 ' A' ' 100' ' ' LEU . 25.7 m-85 -134.34 146.14 49.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.08 -1.012 . . . . 0.0 111.154 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.609 ' CE1' ' HB2' ' A' ' 52' ' ' SER . 97.5 m-85 -113.86 124.48 52.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.389 -0.82 . . . . 0.0 109.05 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.763 ' CG2' HG23 ' A' ' 51' ' ' THR . 12.4 tt -96.3 120.44 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.83 -1.169 . . . . 0.0 110.652 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.477 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -152.07 153.29 33.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 110.142 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . 14.3 pt20 -121.41 150.39 41.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.111 -0.993 . . . . 0.0 110.288 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 35' ' ' GLN . 96.6 m -152.02 164.28 37.53 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.202 -0.936 . . . . 0.0 111.095 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 91' ' ' CYS . . . -153.06 158.47 32.86 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.662 -0.649 . . . . 0.0 109.978 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.01 173.11 8.83 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.792 1.417 . . . . 0.0 110.668 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.915 HG13 ' HB2' ' A' ' 42' ' ' GLN . 2.1 p -146.91 70.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.242 -0.912 . . . . 0.0 111.043 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.56 33.24 67.41 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.63 -44.24 1.55 Allowed Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.915 ' HB2' HG13 ' A' ' 39' ' ' VAL . 4.6 mm-40 -76.01 -154.94 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.421 -1.047 . . . . 0.0 109.845 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -136.44 153.03 51.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.027 -1.046 . . . . 0.0 110.637 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.48 ' HB1' ' HA3' ' A' ' 73' ' ' GLY . . . -140.17 151.17 45.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.455 -0.778 . . . . 0.0 109.741 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.505 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 0.8 OUTLIER -139.77 161.62 37.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 0.0 110.444 179.97 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -107.9 89.81 5.82 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.344 -0.848 . . . . 0.0 110.179 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 48.6 Cg_endo -76.27 -31.79 4.44 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.974 1.513 . . . . 0.0 110.681 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.3 -27.16 63.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.304 -0.873 . . . . 0.0 110.438 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 p -108.55 39.18 2.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 110.149 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.31 138.9 31.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 110.414 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.763 HG23 ' CG2' ' A' ' 33' ' ' ILE . 3.7 t -153.1 134.96 14.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.892 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.609 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 87.9 p -108.04 145.09 34.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.727 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 14.7 p90 -150.97 -175.75 5.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 109.586 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.809 ' OG1' HG23 ' A' ' 30' ' ' THR . 7.0 m -145.5 160.53 41.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.178 -0.951 . . . . 0.0 109.627 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.71 HG21 ' HB3' ' A' ' 25' ' ' ALA . 3.0 p -60.72 -162.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.94 -1.1 . . . . 0.0 109.966 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -143.19 -164.24 1.81 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.044 -1.035 . . . . 0.0 109.879 -179.981 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.11 67.02 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.036 -1.04 . . . . 0.0 109.414 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.2 p -89.73 18.28 5.71 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 26' ' ' ALA . . . 59.13 29.38 65.44 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -105.99 123.82 48.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.293 -1.122 . . . . 0.0 110.499 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.761 ' HB3' ' HB ' ' A' ' 22' ' ' VAL . . . -126.5 85.12 2.34 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.6 p -106.15 124.94 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.235 -0.916 . . . . 0.0 109.699 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.639 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 4.8 p90 -153.89 177.03 11.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.076 -1.015 . . . . 0.0 110.645 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.39 141.31 28.87 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.5 -0.75 . . . . 0.0 110.625 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.432 ' C ' ' CG2' ' A' ' 66' ' ' VAL . 45.8 t80 -138.78 -174.75 3.92 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.432 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 3.2 t -147.22 161.54 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.824 -1.173 . . . . 0.0 110.242 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 26.7 m -133.64 -177.04 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.397 -0.814 . . . . 0.0 110.012 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 26.4 mtt180 -158.45 123.29 4.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.038 -1.039 . . . . 0.0 110.629 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.54 ' HA ' ' CZ ' ' A' ' 109' ' ' PHE . 10.9 tttm -62.42 -43.59 98.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.867 . . . . 0.0 109.556 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m -127.97 118.88 24.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -131.24 143.63 50.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.953 . . . . 0.0 110.461 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 1.5 m -60.91 141.91 56.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.96 . . . . 0.0 109.885 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.48 ' HA3' ' HB1' ' A' ' 44' ' ' ALA . . . -127.76 154.76 19.84 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 p -141.21 162.17 36.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -1.062 . . . . 0.0 110.274 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.623 ' HB ' ' HD2' ' A' ' 76' ' ' PRO . 3.8 p -80.25 176.62 3.61 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.847 . . . . 0.0 109.561 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.623 ' HD2' ' HB ' ' A' ' 75' ' ' THR . 46.3 Cg_endo -74.51 -25.21 13.16 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.751 1.395 . . . . 0.0 110.545 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -13.22 60.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 109.939 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.32 57.09 1.22 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 83.4 m -135.75 117.61 12.04 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.226 -1.161 . . . . 0.0 110.195 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.43 80.89 1.87 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.894 1.471 . . . . 0.0 110.372 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.2 t -57.65 -37.78 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.915 . . . . 0.0 110.233 179.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.36 -154.55 25.35 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 69.8 m -100.43 161.03 13.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.235 -1.156 . . . . 0.0 110.458 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.442 HG21 ' CB ' ' A' ' 44' ' ' ALA . 70.9 t -122.41 149.58 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.213 -0.929 . . . . 0.0 109.999 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -127.58 162.35 26.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.168 -0.957 . . . . 0.0 110.553 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 89' ' ' ALA . 19.1 m -106.36 -9.76 16.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 0.0 110.095 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.16 -52.55 9.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.345 -0.847 . . . . 0.0 110.334 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.6 t -71.36 -19.6 62.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.15 -0.969 . . . . 0.0 109.866 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 86' ' ' CYS . . . -133.12 -160.17 1.03 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.391 -0.818 . . . . 0.0 109.873 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.88 135.11 45.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.173 -0.955 . . . . 0.0 109.857 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 37' ' ' ALA . 1.9 p -121.27 146.7 46.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.133 -0.979 . . . . 0.0 109.774 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -127.6 147.84 50.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.09 -1.006 . . . . 0.0 111.146 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 34' ' ' ALA . 8.0 tp -119.05 114.75 22.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.455 -0.778 . . . . 0.0 109.053 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 104' ' ' HIS . . . -129.13 178.77 17.11 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.578 -1.296 . . . . 0.0 110.26 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' TYR . . . -140.73 172.33 12.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.394 -1.062 . . . . 0.0 110.163 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 144.74 169.4 13.28 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' CG ' ' N ' ' A' ' 98' ' ' SER . 5.2 p30 -89.47 -45.19 9.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -1.187 . . . . 0.0 110.276 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.473 ' N ' ' CG ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER 171.54 -41.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.429 -0.795 . . . . 0.0 109.955 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.84 -12.41 22.52 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.618 HD22 ' CE1' ' A' ' 31' ' ' TYR . 1.1 tt -87.21 -65.83 0.97 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.196 -1.179 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 100' ' ' LEU . 13.9 t0 68.17 75.13 0.28 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.348 -0.845 . . . . 0.0 110.012 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.99 -36.53 28.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.335 -0.853 . . . . 0.0 110.45 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.44 170.37 13.13 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.439 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -135.31 125.74 26.66 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.216 -1.167 . . . . 0.0 109.91 179.983 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.48 124.54 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.985 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.07 125.52 25.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.246 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 107' ' ' LEU . 76.6 mt -95.84 164.99 12.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.291 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.566 ' O ' HD12 ' A' ' 12' ' ' LEU . 6.2 m -158.5 175.99 12.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.311 -0.868 . . . . 0.0 110.054 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.54 ' CZ ' ' HA ' ' A' ' 69' ' ' LYS . 69.0 m-85 -142.64 152.0 42.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.308 -0.87 . . . . 0.0 110.277 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.039 -1.423 . . . . 0.0 109.598 179.993 . . . . . . . . 0 0 . 1 stop_ save_